Citrus Sinensis ID: 041438
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 752 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VZG8 | 1045 | Probable LRR receptor-lik | yes | no | 0.836 | 0.601 | 0.393 | 1e-144 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.819 | 0.55 | 0.415 | 1e-137 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.836 | 0.571 | 0.329 | 2e-99 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.811 | 0.553 | 0.317 | 1e-90 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.831 | 0.547 | 0.331 | 1e-89 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.820 | 0.543 | 0.327 | 1e-88 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.835 | 0.558 | 0.329 | 2e-88 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.829 | 0.498 | 0.311 | 2e-87 | |
| O65440 | 992 | Leucine-rich repeat recep | no | no | 0.828 | 0.628 | 0.326 | 6e-87 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.817 | 0.492 | 0.315 | 1e-86 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 511 bits (1316), Expect = e-144, Method: Compositional matrix adjust.
Identities = 308/782 (39%), Positives = 426/782 (54%), Gaps = 153/782 (19%)
Query: 104 SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILH 163
SF + ++ L+++ N+L IPP+I N++ L+ L TNKL+G IPS + + L +LH
Sbjct: 257 SFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLH 316
Query: 164 ISRNQLNGSIPHEV------------------------GQLNFLNHLILDSNFLGGSIPR 199
+ NQLNGSIP E+ G+L L L L N L G IP
Sbjct: 317 LYLNQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPP 376
Query: 200 SLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSID--------- 250
++N T L L L N+F+G +P I L ++ L N G +P S+
Sbjct: 377 GIANSTELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVR 436
Query: 251 -------------WGRCPQLSLLDVSINN------------------------ITGNIPF 273
+G P L+ +D+S NN ITG IP
Sbjct: 437 FKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPP 496
Query: 274 EIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLD 333
EI QL LDLSSN I GE+P + NI ++++ L+GN+LSG+IP + L NLEYLD
Sbjct: 497 EIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLD 556
Query: 334 LSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISS 393
LS+N S+ + +L +L +LYY+NLS N L Q IP L L L LDLS+N L +ISS
Sbjct: 557 LSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISS 616
Query: 394 RICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEAL 453
+ +++LE+L+LS+NNLSG IP F+++ L H+D+S+N L+G IP++ FR+AP +A
Sbjct: 617 QFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAF 676
Query: 454 QGNKGLCGDI---RGFLSC------------------------------------MSYRK 474
+GNK LCG + +G C + +RK
Sbjct: 677 EGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRK 736
Query: 475 ASRKI----------WIVIVFPLLGKIVYEEIIRATNDFDAKHCIGKGGHGSVYIARVPS 524
+++I + +F GK+ Y+EII+AT +FD K+ IG GGHG VY A++P+
Sbjct: 737 RTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPN 796
Query: 525 GEIFAVKKFHSPLPDN------------------------------FCSHPRQSFIVYEY 554
I AVKK + + FCSH R +F+VYEY
Sbjct: 797 A-IMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEY 855
Query: 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL 614
+E GSL K+L ND AK+L W +R+NV+KGVA AL Y+H++ P IVH DISS N+LL
Sbjct: 856 MERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGE 915
Query: 615 GYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK 674
YEA +SDF AK L DSSNWS +AGT+G VAPELAY MKVTEKCDVYSFGVL LEVIK
Sbjct: 916 DYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIK 975
Query: 675 GKHPRDFLFEMSSSSSNMNI---EILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRP 731
G+HP D + +SSS + + I D RLP P+ +++ + + I++VA CL +P +RP
Sbjct: 976 GEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARP 1035
Query: 732 TM 733
TM
Sbjct: 1036 TM 1037
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 488 bits (1256), Expect = e-137, Method: Compositional matrix adjust.
Identities = 290/698 (41%), Positives = 397/698 (56%), Gaps = 82/698 (11%)
Query: 114 LDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSI 173
LDL N+L +P N +KLE L N LSG IP ++ +HLT L + N G
Sbjct: 419 LDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFF 478
Query: 174 PHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFD 233
P V + L ++ LD N L G IP+SL + +L+ N F+G I + G L
Sbjct: 479 PETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNF 538
Query: 234 MKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVG 293
+ N+ +G I S +W + P+L L +S NNITG IP EI QL LDLS+N + G
Sbjct: 539 IDFSHNKFHGEI--SSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFG 596
Query: 294 EIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKL 353
E+P +GN+ L+R+ L+GN+LSGR+P L L NLE LDLS+N+ S+ + ++ S +KL
Sbjct: 597 ELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKL 656
Query: 354 YYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSG 413
+ +NLS NK IP L L L++LDLSHN L +I S++ ++SL+KL+LS+NNLSG
Sbjct: 657 HDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSG 715
Query: 414 LIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEALQGNKGLCGDI--RGFLSCMS 471
LIP FE + L ++DIS NKLEG +P++ TFR A +AL+ N GLC +I + C
Sbjct: 716 LIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRE 775
Query: 472 YRKASRK----IWIVI----------------------------------------VFPL 487
+K + +WI++ +F +
Sbjct: 776 LKKPKKNGNLVVWILVPILGVLVILSICANTFTYCIRKRKLQNGRNTDPETGENMSIFSV 835
Query: 488 LGKIVYEEIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-------- 539
GK Y++II +TN+FD H IG GG+ VY A + I AVK+ H + +
Sbjct: 836 DGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANL-QDTIIAVKRLHDTIDEEISKPVVK 894
Query: 540 ----------------------NFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQ 577
FCSH R +F++YEY+E GSL+K+L ND AK L WT+
Sbjct: 895 QEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTK 954
Query: 578 RLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637
R+NV+KGVA AL Y+H++ PIVH DISS N+LLD Y A +SDF AK L DSSNWS
Sbjct: 955 RINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWS 1014
Query: 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN-MNIE- 695
+AGT+G VAPE AYTMKVTEKCDVYSFGVL LE+I GKHP D + +SSS +++
Sbjct: 1015 AVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEALSLRS 1074
Query: 696 ILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTM 733
I D R+ P + K + ++++A CL NP SRPTM
Sbjct: 1075 ISDERVLEPRGQNREKLLKMVEMALLCLQANPESRPTM 1112
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 364 bits (934), Expect = 2e-99, Method: Compositional matrix adjust.
Identities = 245/743 (32%), Positives = 361/743 (48%), Gaps = 114/743 (15%)
Query: 105 FSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHI 164
F +L L L+ N L IP ++ L+ LE LD N+L+G IP E+ L +L L +
Sbjct: 327 FGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQL 386
Query: 165 SRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQ 224
NQL G IP +G + + L + +N L G IP F L+ L L +N SG+IP+
Sbjct: 387 FDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRD 446
Query: 225 IGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYL 284
+ KSL + L NQL G++P I+ L+ L++ N ++GNI ++G+ L+ L
Sbjct: 447 LKTCKSLTKLMLGDNQLTGSLP--IELFNLQNLTALELHQNWLSGNISADLGKLKNLERL 504
Query: 285 DLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVL 344
L++N GEIP ++GN+ + ++S N+L+G IP ELGS + ++ LDLS N S ++
Sbjct: 505 RLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIA 564
Query: 345 ESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLE-K 403
+ LG LV L L LS N+L+ +IP +L L EL L N L E I + ++ SL+
Sbjct: 565 QELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQIS 624
Query: 404 LNLSYNNLSGLIPRCFEELH------------------------GLLHIDISYNKLEGHI 439
LN+S+NNLSG IP L LL +IS N L G +
Sbjct: 625 LNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTV 684
Query: 440 PNSTTFRDAPLEALQGNKGLCGDIRGFLSCMSYRKASRKIWIV----------IVFPLLG 489
P++ F+ GN GLC R + S+ W++ I ++G
Sbjct: 685 PDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIG 744
Query: 490 KI-----------------------------------------VYEEIIRATNDFDAKHC 508
+ Y+ ++ AT +F
Sbjct: 745 SVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVV 804
Query: 509 IGKGGHGSVYIARVPSGEIFAVKKFHS----PLPDN----------------------FC 542
+G+G G+VY A + GE+ AVKK +S DN FC
Sbjct: 805 LGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFC 864
Query: 543 SHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVH 602
H + ++YEY+ GSL + L L W R + G A+ L YLH++C P IVH
Sbjct: 865 YHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVH 924
Query: 603 WDISSKNVLLDLGYEAHVSDFRIAKFLNLD-SSNWSKLAGTHGNVAPELAYTMKVTEKCD 661
DI S N+LLD ++AHV DF +AK ++L S + S +AG++G +APE AYTMKVTEKCD
Sbjct: 925 RDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCD 984
Query: 662 VYSFGVLALEVIKGKHP-------RDFLFEMSSSSSNM--NIEILDSRLPYPSLDVQNKF 712
+YSFGV+ LE+I GK P D + + S NM IE+ D+RL ++
Sbjct: 985 IYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPTIEMFDARLDTNDKRTVHEM 1044
Query: 713 MSIMQVAFSCLDQNPVSRPTMKR 735
++++A C +P SRPTM+
Sbjct: 1045 SLVLKIALFCTSNSPASRPTMRE 1067
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 335 bits (858), Expect = 1e-90, Method: Compositional matrix adjust.
Identities = 238/750 (31%), Positives = 363/750 (48%), Gaps = 140/750 (18%)
Query: 111 LAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLN 170
L L L+ N+L IP ++S L L LD N L+G IP L L +L + +N L+
Sbjct: 339 LELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLS 398
Query: 171 GSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKS 230
G+IP ++G + L L + N L G IP L +N++ L L N+ SG+IP I K+
Sbjct: 399 GTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKT 458
Query: 231 LFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSI--NNITGNIPFEIGESPQLQYLDLSS 288
L ++L N L G P ++ C Q+++ + + N G+IP E+G LQ L L+
Sbjct: 459 LVQLRLARNNLVGRFPSNL----CKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLAD 514
Query: 289 NYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLG 348
N GE+P ++G + L +++S NKL+G +P E+ + L+ LD+ N+ S + +G
Sbjct: 515 NGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVG 574
Query: 349 SLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLE-KLNLS 407
SL +L L LS+N LS IP+ L NL L+EL + N I + + L+ LNLS
Sbjct: 575 SLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLS 634
Query: 408 YNNL------------------------SGLIPRCFEELHGLLHIDISYNKLEGHIPNST 443
YN L SG IP F L LL + SYN L G IP
Sbjct: 635 YNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP--- 691
Query: 444 TFRDAPLEALQGNKGLCG-------DIRGFLSCMSYRKA----SRKIWIVIVFPLLGKI- 491
R+ + + GN+GLCG + F S K S KI I I ++G +
Sbjct: 692 LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKI-IAITAAVIGGVS 750
Query: 492 ------------------------------------------VYEEIIRATNDFDAKHCI 509
+++++ AT++FD +
Sbjct: 751 LMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVV 810
Query: 510 GKGGHGSVYIARVPSGEIFAVKKFHSPLP-------DN---------------------- 540
G+G G+VY A +P+G AVKK S DN
Sbjct: 811 GRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHG 870
Query: 541 FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 600
FC+H + ++YEY+ GSL +IL++ + L W++R + G A L YLH++C P I
Sbjct: 871 FCNHQGSNLLLYEYMPKGSLGEILHDPSC--NLDWSKRFKIALGAAQGLAYLHHDCKPRI 928
Query: 601 VHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD-SSNWSKLAGTHGNVAPELAYTMKVTEK 659
H DI S N+LLD +EAHV DF +AK +++ S + S +AG++G +APE AYTMKVTEK
Sbjct: 929 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEK 988
Query: 660 CDVYSFGVLALEVIKGKHP--------------RDFLFEMSSSSSNMNIEILDSRLPYPS 705
D+YS+GV+ LE++ GK P R ++ + SS +LD+RL
Sbjct: 989 SDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSSG-----VLDARLTLED 1043
Query: 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKR 735
+ + ++++++A C +PV+RP+M++
Sbjct: 1044 ERIVSHMLTVLKIALLCTSVSPVARPSMRQ 1073
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 331 bits (849), Expect = 1e-89, Method: Compositional matrix adjust.
Identities = 250/755 (33%), Positives = 360/755 (47%), Gaps = 130/755 (17%)
Query: 110 HLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQL 169
+L +DL N L IP I LS LE NK SG IP+ IS + L L + +NQ+
Sbjct: 323 NLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQI 382
Query: 170 NGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLK 229
+G IP E+G L L SN L GSIP L++ T+L L L NS +G+IP + L+
Sbjct: 383 SGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLR 442
Query: 230 SLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSN 289
+L + L N L+G IP I G C L L + N ITG IP IG ++ +LD SSN
Sbjct: 443 NLTKLLLISNSLSGFIPQEI--GNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSN 500
Query: 290 YIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGS 349
+ G++P ++G+ L I LS N L G +P + SL L+ LD+SAN S + SLG
Sbjct: 501 RLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGR 560
Query: 350 LVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLE-KLNLSY 408
LV L L LS N S IP L L LDL N L +I S + +E+LE LNLS
Sbjct: 561 LVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSS 620
Query: 409 NNLSGLIPRCFEELH-----------------------GLLHIDISYNKLEGHIPNSTTF 445
N L+G IP L+ L+ ++ISYN G++P++ F
Sbjct: 621 NRLTGKIPSKIASLNKLSILDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLF 680
Query: 446 RDAPLEALQGNKGLCGDIRGFLSC-MSYRK---------ASRK----------IWIVIVF 485
R + L+GNK LC + SC ++YRK ASR I + +V
Sbjct: 681 RQLSPQDLEGNKKLCSSTQD--SCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVL 738
Query: 486 PLLGKIVYEEIIRATNDFDAK---------------------------------HCIGKG 512
+LG + +IRA + D + + IGKG
Sbjct: 739 MILGAVA---VIRARRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKG 795
Query: 513 GHGSVYIARVPSGEIFAVKKFHSPL------------PDNF------------------- 541
G VY A V +GE+ AVKK + D+F
Sbjct: 796 CSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFL 855
Query: 542 --CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 599
C + ++Y+Y+ +GSL +L ++ L W R ++ G A L YLH++C PP
Sbjct: 856 GCCWNRNTRLLMYDYMPNGSLGSLL-HERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPP 914
Query: 600 IVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK----LAGTHGNVAPELAYTMK 655
IVH DI + N+L+ L +E +++DF +AK +D + + +AG++G +APE Y+MK
Sbjct: 915 IVHRDIKANNILIGLDFEPYIADFGLAKL--VDEGDIGRCSNTVAGSYGYIAPEYGYSMK 972
Query: 656 VTEKCDVYSFGVLALEVIKGKHPRDFLFEMS------SSSSNMNIEILDSRLPYPSLDVQ 709
+TEK DVYS+GV+ LEV+ GK P D + ++E+LDS L +
Sbjct: 973 ITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQNRGSLEVLDSTLRSRTEAEA 1032
Query: 710 NKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744
++ M ++ A C++ +P RPTMK K+
Sbjct: 1033 DEMMQVLGTALLCVNSSPDERPTMKDVAAMLKEIK 1067
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 328 bits (841), Expect = 1e-88, Method: Compositional matrix adjust.
Identities = 242/740 (32%), Positives = 357/740 (48%), Gaps = 123/740 (16%)
Query: 111 LAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLN 170
L +DL N IP NLS L+ L +N ++G IPS +S T L I NQ++
Sbjct: 325 LNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQIS 384
Query: 171 GSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKS 230
G IP E+G L LN + N L G+IP L+ NL L L N +GS+P + L++
Sbjct: 385 GLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRN 444
Query: 231 LFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNY 290
L + L N ++G IPL I G C L L + N ITG IP IG L +LDLS N
Sbjct: 445 LTKLLLISNAISGVIPLEI--GNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENN 502
Query: 291 IVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSL 350
+ G +P ++ N L ++LS N L G +P L SL L+ LD+S+N L+ + +SLG L
Sbjct: 503 LSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHL 562
Query: 351 VKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLE-KLNLSYN 409
+ L L LS N + +IP L + +L LDLS N + I + ++ L+ LNLS+N
Sbjct: 563 ISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWN 622
Query: 410 NLSGLIPR-----------------------CFEELHGLLHIDISYNKLEGHIPNSTTFR 446
+L G IP L L+ ++IS+N+ G++P+S FR
Sbjct: 623 SLDGFIPERISALNRLSVLDISHNMLSGDLSALSGLENLVSLNISHNRFSGYLPDSKVFR 682
Query: 447 DAPLEALQGNKGLCGDIRGFLSCMSYRKA---------SRKIWIVI-----------VFP 486
++GN GLC +GF SC + S ++ I I V
Sbjct: 683 QLIGAEMEGNNGLCS--KGFRSCFVSNSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLG 740
Query: 487 LLGKIVYEEIIRATND-------------------FDAKH---------CIGKGGHGSVY 518
+L I +++IR ND F +H IGKG G VY
Sbjct: 741 VLAVIRAKQMIRDDNDSETGENLWTWQFTPFQKLNFTVEHVLKCLVEGNVIGKGCSGIVY 800
Query: 519 IARVPSGEIFAVKKF-------------HSPLPDNF---------------------CSH 544
A +P+ E+ AVKK S + D+F C +
Sbjct: 801 KAEMPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWN 860
Query: 545 PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWD 604
++Y+Y+ +GSL +L+ + LGW R +I G A L YLH++C PPIVH D
Sbjct: 861 KNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRD 920
Query: 605 ISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK----LAGTHGNVAPELAYTMKVTEKC 660
I + N+L+ +E ++ DF +AK +D ++++ +AG++G +APE Y+MK+TEK
Sbjct: 921 IKANNILIGPDFEPYIGDFGLAKL--VDDGDFARSSNTIAGSYGYIAPEYGYSMKITEKS 978
Query: 661 DVYSFGVLALEVIKGKHP-----RDFLFEMSSSSSNMNIEILDSRL-PYPSLDVQNKFMS 714
DVYS+GV+ LEV+ GK P D L + +I+++D L P +V+ + M
Sbjct: 979 DVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWVKKIRDIQVIDQGLQARPESEVE-EMMQ 1037
Query: 715 IMQVAFSCLDQNPVSRPTMK 734
+ VA C++ P RPTMK
Sbjct: 1038 TLGVALLCINPIPEDRPTMK 1057
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 327 bits (837), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 240/729 (32%), Positives = 356/729 (48%), Gaps = 101/729 (13%)
Query: 105 FSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHI 164
S +LA LDL N L IPP NL+ + L N LSG IP + L + L ++
Sbjct: 369 LSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDF 428
Query: 165 SRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQ 224
S NQL+G IP + Q + L L L SN + G+IP + +L+ L + N +G P +
Sbjct: 429 SENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTE 488
Query: 225 IGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYL 284
+ L +L ++L N+ +G +P I G C +L L ++ N + N+P EI + L
Sbjct: 489 LCKLVNLSAIELDQNRFSGPLPPEI--GTCQKLQRLHLAANQFSSNLPNEISKLSNLVTF 546
Query: 285 DLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVL 344
++SSN + G IP+++ N L R+ LS N G +P ELGSL LE L LS N S +
Sbjct: 547 NVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIP 606
Query: 345 ESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLS-ELDLSHNFLGEKISSRICRMESLEK 403
++G+L L L + N S IP +L L L ++LS+N +I I + L
Sbjct: 607 FTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMY 666
Query: 404 LNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEALQGNKGLC-GD 462
L+L+ N+LSG IP FE L LL + SYN L G +P++ F++ L + GNKGLC G
Sbjct: 667 LSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGH 726
Query: 463 IRG---------FLSCMSYRKASRK-----------------IWIVIVF----------- 485
+R +S + A R I IV+ F
Sbjct: 727 LRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPY 786
Query: 486 -----PLLG----------KIVYEEIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAV 530
P + ++I+ AT F + +G+G G+VY A +PSG+ AV
Sbjct: 787 VHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAV 846
Query: 531 KKFHSPLPD-------------------------------NFCSH--PRQSFIVYEYLES 557
KK S +FC H + ++YEY+
Sbjct: 847 KKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSR 906
Query: 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE 617
GSL ++L+ S + W R + G A+ L YLH++C P I+H DI S N+L+D +E
Sbjct: 907 GSLGELLHGGKS-HSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFE 965
Query: 618 AHVSDFRIAKFLNLD-SSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 676
AHV DF +AK +++ S + S +AG++G +APE AYTMKVTEKCD+YSFGV+ LE++ GK
Sbjct: 966 AHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGK 1025
Query: 677 HPRDFLFEMSSSSS---------NMNIEILDSRLPYPSLDV-QNKFMSIMQVAFSCLDQN 726
P L + ++ ++ EILD L DV N +++ ++A C +
Sbjct: 1026 APVQPLEQGGDLATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSS 1085
Query: 727 PVSRPTMKR 735
P RPTM+
Sbjct: 1086 PSDRPTMRE 1094
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 323 bits (829), Expect = 2e-87, Method: Compositional matrix adjust.
Identities = 248/796 (31%), Positives = 368/796 (46%), Gaps = 172/796 (21%)
Query: 110 HLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQL 169
L + LY N +P +I N ++L+ +D+ N+LSG IPS I L LT LH+ N+L
Sbjct: 434 KLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENEL 493
Query: 170 NGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLK 229
G+IP +G + + + L N L GSIP S T L +YNNS G++P + NLK
Sbjct: 494 VGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLK 553
Query: 230 SLFDMKLCINQLNGAIP--------LSID------------------------------- 250
+L + N+ NG+I LS D
Sbjct: 554 NLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFT 613
Query: 251 ------WGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIY 304
+G+ +LSLLD+S N+++G IP E+G +L ++DL++NY+ G IPT LG +
Sbjct: 614 GRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPL 673
Query: 305 LNRISLS------------------------GNKLSGRIPGELGSLINLEYLDLSANHLS 340
L + LS GN L+G IP E+G+L L L+L N LS
Sbjct: 674 LGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLS 733
Query: 341 NFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHL-SELDLSHNFLGEKISSRICRME 399
+ ++G L KL+ L LS N L+ +IP+E+ L L S LDLS+N +I S I +
Sbjct: 734 GPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLP 793
Query: 400 SLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEALQGNKGL 459
LE L+LS+N L G +P ++ L ++++SYN LEG + F +A GN GL
Sbjct: 794 KLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKL--KKQFSRWQADAFVGNAGL 851
Query: 460 CG------------DIRGF-------LSCMSYRKASRKIWIVIVF--------------- 485
CG + R +S +S A + +VI+
Sbjct: 852 CGSPLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGG 911
Query: 486 -------------PLLGKIVYEEIIRATNDFDAKH------CIGKGGHGSVYIARVPSGE 526
PL + I+ + +A H IG GG G VY A + +GE
Sbjct: 912 NSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGE 971
Query: 527 IFAVKK--FHSPLPDN-----------------------FCSHPRQ--SFIVYEYLESGS 559
AVKK + L N +CS + ++YEY+ +GS
Sbjct: 972 TIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGS 1031
Query: 560 LDKIL--NNDASAKE-LGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY 616
+ L N + KE LGW RL + G+A + YLH +C PPIVH DI S NVLLD
Sbjct: 1032 VWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNI 1091
Query: 617 EAHVSDFRIAKFL--NLDSSNWSK--LAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEV 672
EAH+ DF +AK L N D++ S AG++G +APE AY++K TEK DVYS G++ +E+
Sbjct: 1092 EAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEI 1151
Query: 673 IKGKHPRDFLFEMSSS-------------SSNMNIEILDSRLPYPSLDVQNKFMSIMQVA 719
+ GK P + +F+ + S +++DS L + ++++A
Sbjct: 1152 VTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIA 1211
Query: 720 FSCLDQNPVSRPTMKR 735
C P RP+ ++
Sbjct: 1212 LQCTKSYPQERPSSRQ 1227
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65440|BAME3_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 OS=Arabidopsis thaliana GN=BAM3 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 322 bits (826), Expect = 6e-87, Method: Compositional matrix adjust.
Identities = 243/744 (32%), Positives = 358/744 (48%), Gaps = 121/744 (16%)
Query: 105 FSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHI 164
F +L +LDL N L IP ++ NL LE L TN+L+G +P E+ +T L L +
Sbjct: 243 FGRLINLVHLDLANCSLKGSIPAELGNLKNLEVLFLQTNELTGSVPRELGNMTSLKTLDL 302
Query: 165 SRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQ 224
S N L G IP E+ L L L N L G IP +S +L L L++N+F+G IP +
Sbjct: 303 SNNFLEGEIPLELSGLQKLQLFNLFFNRLHGEIPEFVSELPDLQILKLWHNNFTGKIPSK 362
Query: 225 IGNLKSLFDMKLCINQLNGAIPLSI----------------------DWGRCPQLSLLDV 262
+G+ +L ++ L N+L G IP S+ D G+C L +
Sbjct: 363 LGSNGNLIEIDLSTNKLTGLIPESLCFGRRLKILILFNNFLFGPLPEDLGQCEPLWRFRL 422
Query: 263 SINNITGNIPFEIGESPQLQYLDLSSNYIVGEIP-TQLGNIIY--LNRISLSGNKLSGRI 319
N +T +P + P L L+L +N++ GEIP + GN + L +I+LS N+LSG I
Sbjct: 423 GQNFLTSKLPKGLIYLPNLSLLELQNNFLTGEIPEEEAGNAQFSSLTQINLSNNRLSGPI 482
Query: 320 PGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSE 379
PG + +L +L+ L L AN LS + +GSL L +++S N S + P E + + L+
Sbjct: 483 PGSIRNLRSLQILLLGANRLSGQIPGEIGSLKSLLKIDMSRNNFSGKFPPEFGDCMSLTY 542
Query: 380 LDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHI 439
LDLSHN + +I +I ++ L LN+S+N+ + +P + L D S+N G +
Sbjct: 543 LDLSHNQISGQIPVQISQIRILNYLNVSWNSFNQSLPNELGYMKSLTSADFSHNNFSGSV 602
Query: 440 PNSTTFRDAPLEALQGNKGLCG-----------------------DIRGFLSCM------ 470
P S F + GN LCG RG +S
Sbjct: 603 PTSGQFSYFNNTSFLGNPFLCGFSSNPCNGSQNQSQSQLLNQNNARSRGEISAKFKLFFG 662
Query: 471 -------------------SYRKASRKIWIVIVFPLLGKIVYEEIIRATNDFDAKHCIGK 511
RK + +W +I F LG E I+ + H IGK
Sbjct: 663 LGLLGFFLVFVVLAVVKNRRMRKNNPNLWKLIGFQKLG-FRSEHILECVKE---NHVIGK 718
Query: 512 GGHGSVYIARVPSGEIFAVKKFHSPLP----DN----------------------FCSHP 545
GG G VY +P+GE AVKK + DN FCS+
Sbjct: 719 GGRGIVYKGVMPNGEEVAVKKLLTITKGSSHDNGLAAEIQTLGRIRHRNIVRLLAFCSNK 778
Query: 546 RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDI 605
+ +VYEY+ +GSL ++L+ A L W RL + A L YLH++C P I+H D+
Sbjct: 779 DVNLLVYEYMPNGSLGEVLHGKAGVF-LKWETRLQIALEAAKGLCYLHHDCSPLIIHRDV 837
Query: 606 SSKNVLLDLGYEAHVSDFRIAKFLNLD---SSNWSKLAGTHGNVAPELAYTMKVTEKCDV 662
S N+LL +EAHV+DF +AKF+ D S S +AG++G +APE AYT+++ EK DV
Sbjct: 838 KSNNILLGPEFEAHVADFGLAKFMMQDNGASECMSSIAGSYGYIAPEYAYTLRIDEKSDV 897
Query: 663 YSFGVLALEVIKGKHPRD-------FLFEMSSSSSNMN----IEILDSRLPYPSLDVQNK 711
YSFGV+ LE+I G+ P D + + S +N N ++I+D RL L +
Sbjct: 898 YSFGVVLLELITGRKPVDNFGEEGIDIVQWSKIQTNCNRQGVVKIIDQRLSNIPLA---E 954
Query: 712 FMSIMQVAFSCLDQNPVSRPTMKR 735
M + VA C+ ++ V RPTM+
Sbjct: 955 AMELFFVAMLCVQEHSVERPTMRE 978
|
Necessary for male gametophyte development, as well as ovule specification and function. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 321 bits (823), Expect = 1e-86, Method: Compositional matrix adjust.
Identities = 247/783 (31%), Positives = 366/783 (46%), Gaps = 168/783 (21%)
Query: 111 LAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLN 170
L +D++ N IPP I L +L L N+L G +P+ + L IL ++ NQL+
Sbjct: 458 LKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLS 517
Query: 171 GSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYL------------------ 212
GSIP G L L L+L +N L G++P SL + NL + L
Sbjct: 518 GSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSY 577
Query: 213 -----YNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267
NN F IP ++GN ++L ++L NQL G IP ++ G+ +LSLLD+S N +
Sbjct: 578 LSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTL--GKIRELSLLDMSSNAL 635
Query: 268 TGNIPFE------------------------IGESPQLQYLDLSSNYIVGEIPTQLGNII 303
TG IP + +G+ QL L LSSN V +PT+L N
Sbjct: 636 TGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCT 695
Query: 304 YLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKL 363
L +SL GN L+G IP E+G+L L L+L N S + +++G L KLY L LS N L
Sbjct: 696 KLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSL 755
Query: 364 SQQIPIELDNLIHL-SELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEL 422
+ +IP+E+ L L S LDLS+N I S I + LE L+LS+N L+G +P ++
Sbjct: 756 TGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDM 815
Query: 423 HGLLHIDISYNKLEGHIPNSTTFRDAPLEALQGNKGLCGD-------IRG---------- 465
L ++++S+N L G + F P ++ GN GLCG +R
Sbjct: 816 KSLGYLNVSFNNLGGKL--KKQFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSAR 873
Query: 466 ---FLSCMSYRKASRKIWIVIVF-------------------------------PLLGKI 491
+S +S A + +VI PL
Sbjct: 874 SVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNG 933
Query: 492 VYEEIIRATNDFDAKH------CIGKGGHGSVYIARVPSGEIFAVKK--FHSPLPDN--- 540
+ IR + +A H IG GG G VY A + +GE AVKK + L N
Sbjct: 934 ASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSF 993
Query: 541 --------------------FCSHPRQ--SFIVYEYLESGSLDKILNNDASAKE-----L 573
+CS + + ++YEY+++GS+ L+ D E L
Sbjct: 994 SREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLL 1053
Query: 574 GWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL---- 629
W RL + G+A + YLH++C PPIVH DI S NVLLD EAH+ DF +AK L
Sbjct: 1054 DWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENC 1113
Query: 630 --NLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLF---- 683
N DS+ W A ++G +APE AY++K TEK DVYS G++ +E++ GK P D +F
Sbjct: 1114 DTNTDSNTW--FACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEM 1171
Query: 684 ----------EMSSSSSNMNIE-ILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT 732
E++ S+ + I+ L LP+ ++ ++++A C +P RP+
Sbjct: 1172 DMVRWVETHLEVAGSARDKLIDPKLKPLLPFE----EDAACQVLEIALQCTKTSPQERPS 1227
Query: 733 MKR 735
++
Sbjct: 1228 SRQ 1230
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 752 | ||||||
| 359491512 | 1078 | PREDICTED: probable LRR receptor-like se | 0.857 | 0.598 | 0.462 | 1e-166 | |
| 147767326 | 1032 | hypothetical protein VITISV_008862 [Viti | 0.857 | 0.625 | 0.465 | 1e-166 | |
| 225456159 | 1038 | PREDICTED: probable LRR receptor-like se | 0.868 | 0.629 | 0.454 | 1e-164 | |
| 359491509 | 1032 | PREDICTED: probable LRR receptor-like se | 0.857 | 0.625 | 0.461 | 1e-163 | |
| 147772402 | 996 | hypothetical protein VITISV_022117 [Viti | 0.837 | 0.632 | 0.446 | 1e-163 | |
| 225456161 | 1037 | PREDICTED: probable LRR receptor-like se | 0.837 | 0.607 | 0.442 | 1e-162 | |
| 224127218 | 841 | predicted protein [Populus trichocarpa] | 0.933 | 0.834 | 0.421 | 1e-160 | |
| 297743684 | 789 | unnamed protein product [Vitis vinifera] | 0.909 | 0.866 | 0.444 | 1e-156 | |
| 224136648 | 843 | predicted protein [Populus trichocarpa] | 0.929 | 0.829 | 0.417 | 1e-156 | |
| 255545702 | 1008 | receptor protein kinase, putative [Ricin | 0.839 | 0.625 | 0.434 | 1e-154 |
| >gi|359491512|ref|XP_002278614.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 592 bits (1525), Expect = e-166, Method: Compositional matrix adjust.
Identities = 345/746 (46%), Positives = 450/746 (60%), Gaps = 101/746 (13%)
Query: 88 GINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSG 147
GI+L + +L+G + S L L LY N+L IPP+I NL L L+ N+L+G
Sbjct: 292 GISLYANNLSGPI-PASLGDLSGLTLLHLYANQLSGPIPPEIGNLKSLVDLELSENQLNG 350
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207
IP+ + LT+L IL + N L+G P E+G+L+ L L +D+N L GS+P + +L
Sbjct: 351 SIPTSLGNLTNLEILFLRDNHLSGYFPKEIGKLHKLVVLEIDTNRLSGSLPEGICQGGSL 410
Query: 208 VFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAI---------------------- 245
V + +N SG IP+ + N ++L NQL G I
Sbjct: 411 VRFTVSDNLLSGPIPKSMKNCRNLTRALFGGNQLTGNISEVVGDCPNLEYIDLSYNRFHG 470
Query: 246 PLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYL 305
LS +WGRCPQL L+++ N+ITG+IP + G S L LDLSSN++VGEIP ++G++ L
Sbjct: 471 ELSHNWGRCPQLQRLEMAGNDITGSIPEDFGISTNLTLLDLSSNHLVGEIPKKMGSLTSL 530
Query: 306 NRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQ 365
+ L+ N+LSG IP ELGSL +L +LDLSAN L+ + E+LG+ + L+YLNLS+NKLS
Sbjct: 531 LELKLNDNQLSGSIPPELGSLFSLAHLDLSANRLNGSITENLGACLNLHYLNLSNNKLSN 590
Query: 366 QIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGL 425
+IP ++ L HLS+LDLSHN L +I +I +ESLE LNLS+NNLSG IP+ FEE+ GL
Sbjct: 591 RIPAQMGKLSHLSQLDLSHNLLSGEIPPQIEGLESLENLNLSHNNLSGFIPKAFEEMRGL 650
Query: 426 LHIDISYNKLEGHIPNSTTFRDAPLEALQGNKGLCGDIRGFLSCMSYRKASR-------K 478
IDISYN+L+G IPNS FRDA +E L+GNK LCG+++G C + A + K
Sbjct: 651 SDIDISYNQLQGPIPNSKAFRDATIELLKGNKDLCGNVKGLQPCKNDSGAGQQPVKKGHK 710
Query: 479 IWIVIVFPLLGKIV-----------------------------------------YEEII 497
I +IVFPLLG +V YEEII
Sbjct: 711 IVFIIVFPLLGALVLLFAFIGIFLIAERTKRTPEIEEGDVQNDLFSISTFDGRAMYEEII 770
Query: 498 RATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD------------------ 539
+AT DFD +CIGKGGHGSVY A + SG I AVKK ++ D
Sbjct: 771 KATKDFDPMYCIGKGGHGSVYKAELSSGNIVAVKKLYASDIDMANQRDFFNEVRALTEIK 830
Query: 540 --------NFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFY 591
FCSHPR SF+VYEYLE GSL +L+ + AK+LGW R+N+IKGVA AL Y
Sbjct: 831 HRNIVKLLGFCSHPRHSFLVYEYLERGSLAAMLSRE-EAKKLGWATRINIIKGVAHALSY 889
Query: 592 LHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELA 651
+H++C PPIVH DISS N+LLD YE H+SDF AK L LDSSN S LAGT G VAPE A
Sbjct: 890 MHHDCSPPIVHRDISSNNILLDSQYEPHISDFGTAKLLKLDSSNQSALAGTFGYVAPEHA 949
Query: 652 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI---EILDSRLPYPSLDV 708
YTMKVTEK DVYSFGV+ LEVIKG+HP D + +S S NI ++LD RLP +
Sbjct: 950 YTMKVTEKTDVYSFGVITLEVIKGRHPGDQILSLSVSPEKENIVLEDMLDPRLPPLTAQD 1009
Query: 709 QNKFMSIMQVAFSCLDQNPVSRPTMK 734
+ + +SI+ +A +CL NP SRPTMK
Sbjct: 1010 EGEVISIINLATACLSVNPESRPTMK 1035
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147767326|emb|CAN68996.1| hypothetical protein VITISV_008862 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1521), Expect = e-166, Method: Compositional matrix adjust.
Identities = 345/741 (46%), Positives = 455/741 (61%), Gaps = 96/741 (12%)
Query: 89 INLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGH 148
++L+S L+G + S L L L++N+L IP ++ NL L L+ N+L+G
Sbjct: 283 LSLSSNYLSGPI-PMSLGDLSGLKSLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQLNGS 341
Query: 149 IPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLV 208
IP+ + L +L IL++ N+L+ SIP E+G+L+ L L +D+N L G +P + +L
Sbjct: 342 IPTSLGNLINLEILYLRDNKLSSSIPPEIGKLHKLVELEIDTNQLSGFLPEGICQGGSLE 401
Query: 209 FLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAI----------------------P 246
+++N G IP+ + N SL +L NQL G I
Sbjct: 402 NFTVFDNFLIGPIPESLKNCPSLARARLQRNQLTGNISEAFGVCPNLYHINLSNNKFYGE 461
Query: 247 LSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLN 306
LS +WGRC +L LD++ NNITG+IP + G S QL L+LSSN++VGEIP +LG++ L
Sbjct: 462 LSQNWGRCHKLQWLDIAGNNITGSIPADFGISTQLTVLNLSSNHLVGEIPKKLGSVSSLW 521
Query: 307 RISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQ 366
++ L+ N+LSG IP ELGSL +L YLDLS N L+ + E LG+ + L YLNLS+NKLS
Sbjct: 522 KLILNDNRLSGNIPPELGSLADLGYLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHG 581
Query: 367 IPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLL 426
IP+++ L HLS LDLSHN L +I S+I ++SLEKLNLS+NNLSG+IP+ FE++HGL
Sbjct: 582 IPVQMGKLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLNLSHNNLSGIIPKAFEDMHGLW 641
Query: 427 HIDISYNKLEGHIPNSTTFRDAPLEALQGNKGLCGDIRGFLSC--MSYRKASRKIWIVIV 484
+DISYN L+G IPNS F++ +E LQGNKGLCG ++G C S K + K +I+
Sbjct: 642 QVDISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKGLQPCENRSATKGTHKAVFIII 701
Query: 485 FPLL------------------------------------------GKIVYEEIIRATND 502
F LL G+ YE II AT D
Sbjct: 702 FSLLGALLILSAFIGISLISQGRRNAKMEKAGDVQTENLFSISTFDGRTTYEAIIEATKD 761
Query: 503 FDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD----------------------- 539
FD +CIG+GGHGSVY A +PSG I AVKK H D
Sbjct: 762 FDPMYCIGEGGHGSVYKAELPSGNIVAVKKLHRFDIDMAHQKDFMNEIRALTEIKHRNIV 821
Query: 540 ---NFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNC 596
FCSH R SF+VYEYLE GSL IL+ + AKE+GW R+N+IKGVA AL YLH++C
Sbjct: 822 KLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWGTRVNIIKGVAHALSYLHHDC 881
Query: 597 FPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKV 656
PPIVH DISS NVLLD YEAHVSDF AKFL LDSSNWS LAGT+G VAPELAYTMKV
Sbjct: 882 VPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNWSTLAGTYGYVAPELAYTMKV 941
Query: 657 TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI---EILDSRLPYPSLDVQNKFM 713
TEKCDVYSFGVLALEV++G+HP D + +S+S N+ ++LD RLP P+L + + M
Sbjct: 942 TEKCDVYSFGVLALEVMRGRHPGDLISSLSASPGKDNVVLKDVLDPRLPPPTLRDEAEVM 1001
Query: 714 SIMQVAFSCLDQNPVSRPTMK 734
S++Q+A +CL+ +P SRPTM+
Sbjct: 1002 SVIQLATACLNGSPQSRPTMQ 1022
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456159|ref|XP_002278561.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 584 bits (1505), Expect = e-164, Method: Compositional matrix adjust.
Identities = 337/742 (45%), Positives = 444/742 (59%), Gaps = 89/742 (11%)
Query: 70 ISLCTWSGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQI 129
+SLC SG+ H L + L+G + + + L L+L N+L IP +
Sbjct: 299 VSLCDLSGLTLLH--------LYANQLSGPIPQ-EIGNLKSLVDLELSENQLNGSIPTSL 349
Query: 130 SNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILD 189
NL+ LE L N+LSG+IP EI L L +L I NQL GS+P + Q L +
Sbjct: 350 GNLTNLEILFLRDNQLSGYIPQEIGKLHKLVVLEIDTNQLFGSLPEGICQAGSLVRFAVS 409
Query: 190 SNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSI 249
N L G IP+SL N NL N +G+I + +G+ +L + L N+ +G LS
Sbjct: 410 DNHLSGPIPKSLKNCRNLTRALFQGNRLTGNISEVVGDCPNLEFIDLSYNRFHGE--LSH 467
Query: 250 DWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRIS 309
+WGRCPQL L+++ NNITG+IP + G S L LDLSSN++VGEIP ++G++ L +
Sbjct: 468 NWGRCPQLQRLEIAGNNITGSIPEDFGISTNLTLLDLSSNHLVGEIPKKMGSLTSLLGLI 527
Query: 310 LSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPI 369
L+ N+LSG IP ELGSL +LEYLDLSAN L+ + E LG + L+YLNLS+NKLS IP+
Sbjct: 528 LNDNQLSGSIPPELGSLSHLEYLDLSANRLNGSIPEHLGDCLDLHYLNLSNNKLSHGIPV 587
Query: 370 ELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHID 429
++ L HLS+LDLSHN L I +I ++SLE L+LS+NNL G IP+ FE++ L ++D
Sbjct: 588 QMGKLSHLSQLDLSHNLLAGGIPPQIQGLQSLEMLDLSHNNLCGFIPKAFEDMPALSYVD 647
Query: 430 ISYNKLEGHIPNSTTFRDAPLEALQGNKGLCGDIRGFLSC-------MSYRKASRKIWIV 482
ISYN+L+G IP+S FR+A +E L+GNK LCG+++G C K S K+ +
Sbjct: 648 ISYNQLQGPIPHSNAFRNATIEVLKGNKDLCGNVKGLQPCKYGFGVDQQPVKKSHKVVFI 707
Query: 483 IVFPLLGKIV-----------------------------------------YEEIIRATN 501
I+FPLLG +V YEEII+AT
Sbjct: 708 IIFPLLGALVLLFAFIGIFLIAERRERTPEIEEGDVQNDLFSISNFDGRTMYEEIIKATK 767
Query: 502 DFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD---------------------- 539
DFD +CIGKGGHGSVY A +PS I AVKK H +
Sbjct: 768 DFDPMYCIGKGGHGSVYKAELPSSNIVAVKKLHPSDTEMANQKDFLNEIRALTEIKHRNI 827
Query: 540 ----NFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNN 595
FCSHPR F+VYEYLE GSL IL+ + AK+LGW R+N+IKGVA AL Y+H++
Sbjct: 828 VKLLGFCSHPRHKFLVYEYLERGSLATILSRE-EAKKLGWATRVNIIKGVAHALAYMHHD 886
Query: 596 CFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMK 655
C PPIVH D+SS N+LLD YEAH+SDF AK L LDSSN S LAGT G +APELAYTMK
Sbjct: 887 CSPPIVHRDVSSNNILLDSQYEAHISDFGTAKLLKLDSSNQSILAGTFGYLAPELAYTMK 946
Query: 656 VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI---EILDSRLPYPSLDVQNKF 712
VTEK DV+SFGV+ALEVIKG+HP D + +S S NI ++LD RLP + + +
Sbjct: 947 VTEKTDVFSFGVIALEVIKGRHPGDQILSLSVSPEKDNIALEDMLDPRLPPLTPQDEGEV 1006
Query: 713 MSIMQVAFSCLDQNPVSRPTMK 734
++I++ A CL NP SRPTM+
Sbjct: 1007 IAILKQAIECLKANPQSRPTMQ 1028
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491509|ref|XP_002278522.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 583 bits (1503), Expect = e-163, Method: Compositional matrix adjust.
Identities = 342/741 (46%), Positives = 452/741 (60%), Gaps = 96/741 (12%)
Query: 89 INLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGH 148
++L+S L+G + S L L L++N+L IP ++ NL L L+ N+L+G
Sbjct: 283 LSLSSNYLSGPI-PMSLGDLSGLKSLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQLNGS 341
Query: 149 IPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLV 208
IP+ + L +L IL++ N+L+ SIP E+G+L+ L L +D+N L G +P + +L
Sbjct: 342 IPTLLGNLINLEILYLRDNKLSSSIPPEIGKLHKLVELEIDTNQLSGFLPEGICQGGSLE 401
Query: 209 FLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAI----------------------P 246
+++N G IP+ + N SL +L NQL G I
Sbjct: 402 NFTVFDNFLIGPIPESLKNCPSLARARLQGNQLTGNISEAFGVCPNLYHINLSNNKFYGE 461
Query: 247 LSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLN 306
LS +WGRC +L LD++ NNITG+IP + G S QL L+LSSN++VGEIP +LG++ L
Sbjct: 462 LSQNWGRCHKLQWLDIAGNNITGSIPADFGISTQLTVLNLSSNHLVGEIPKKLGSVSSLW 521
Query: 307 RISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQ 366
++ L+ N+LSG IP ELGSL +L YLDLS N L+ + E LG+ + L YLNLS+NKLS
Sbjct: 522 KLILNDNRLSGNIPPELGSLADLGYLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHG 581
Query: 367 IPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLL 426
IP+++ L HLS LDLSHN L +I S+I ++SLEKLNLS+NNLSG+IP+ FE++HGL
Sbjct: 582 IPVQMGKLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLNLSHNNLSGIIPKAFEDMHGLW 641
Query: 427 HIDISYNKLEGHIPNSTTFRDAPLEALQGNKGLCGDIRGFLSC--MSYRKASRKIWIVIV 484
+DISYN L+G IPNS F++ +E LQGNKGLCG ++G C S K + K +I+
Sbjct: 642 QVDISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKGLQPCENRSATKGTHKAVFIII 701
Query: 485 FPLL------------------------------------------GKIVYEEIIRATND 502
F LL G+ YE II AT D
Sbjct: 702 FSLLGALLILSAFIGISLISQGRRNAKMEKAGDVQTENLFSISTFDGRTTYEAIIEATKD 761
Query: 503 FDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD----------------------- 539
FD +CIG+GGHGSVY A +PSG I AVKK H D
Sbjct: 762 FDPMYCIGEGGHGSVYKAELPSGNIVAVKKLHRFDIDMAHQKDFVNEIRALTEIKHRNIV 821
Query: 540 ---NFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNC 596
FCSH R SF+VYEYLE GSL IL+ + AKE+GW R+N+IKGV+ AL YLH++C
Sbjct: 822 KLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWGTRVNIIKGVSHALSYLHHDC 881
Query: 597 FPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKV 656
PPIVH DISS NVLLD YEAHVSDF AKFL LDSSNWS LAGT+G VAPELAYTMKV
Sbjct: 882 VPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNWSTLAGTYGYVAPELAYTMKV 941
Query: 657 TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI---EILDSRLPYPSLDVQNKFM 713
TEKCDVYSFGVLALEV++G+HP D + +S S N+ ++LD RLP P+ + +
Sbjct: 942 TEKCDVYSFGVLALEVMRGRHPGDLISSLSDSPGKDNVVLKDVLDPRLPPPTFRDEAEVT 1001
Query: 714 SIMQVAFSCLDQNPVSRPTMK 734
S++Q+A +CL+ +P SRPTM+
Sbjct: 1002 SVIQLATACLNGSPQSRPTMQ 1022
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147772402|emb|CAN73988.1| hypothetical protein VITISV_022117 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 581 bits (1497), Expect = e-163, Method: Compositional matrix adjust.
Identities = 347/778 (44%), Positives = 440/778 (56%), Gaps = 148/778 (19%)
Query: 104 SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILH 163
+F + L L L+NN L IPP+I NL L+ L N LSG IP+ + L+ LT+LH
Sbjct: 210 TFGNLKRLTVLYLFNNRLSGHIPPEIGNLKSLQGLSLYENNLSGPIPASLGDLSGLTLLH 269
Query: 164 ISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSG---- 219
+ NQL+G IP E+G L L L L N L GSIP SL N TNL L+L +N SG
Sbjct: 270 LYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLETLFLRDNQLSGYIPQ 329
Query: 220 --------------------SIPQQIGNLKSLFDMKLCINQLNGAIP------------- 246
S+P+ I SL + N L+G IP
Sbjct: 330 EIGKLHKLVVLEIDTNQLFGSLPEGICQGGSLERFTVSDNHLSGPIPKSLKNCKNLTRAL 389
Query: 247 ---------------------------------LSIDWGRCPQLSLLDVSINNITGNIPF 273
LS +WGR P+L L+++ NNITG+IP
Sbjct: 390 FGGNQLTGNISEVVGDCPNLEYINVSYNSFHGELSHNWGRYPRLQRLEMAWNNITGSIPE 449
Query: 274 EIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLD 333
+ G S L LDLSSN++ GEIP ++G++ L ++ L+ N+LSG IP ELGSL +L YLD
Sbjct: 450 DFGISTDLTLLDLSSNHLFGEIPKKMGSVTSLWKLILNDNQLSGNIPPELGSLADLGYLD 509
Query: 334 LSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISS 393
LSAN L+ + E LG + L YLNLS+NKLS IP+++ L HLS+LDLSHN L I
Sbjct: 510 LSANRLNGSIPEHLGDCLGLNYLNLSNNKLSHGIPVQMGKLGHLSQLDLSHNLLTGDIPP 569
Query: 394 RICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEAL 453
+I ++SLE LNLS+NNLSG IP+ FEE+ GL +DISYN+L+G IPNS FRDA +EAL
Sbjct: 570 QIEGLQSLENLNLSHNNLSGFIPKAFEEMLGLSDVDISYNQLQGPIPNSKAFRDATIEAL 629
Query: 454 QGNKGLCGDIRGFLSC-------MSYRKASRKIWIVIVFPLLGKIV-------------- 492
+GNKGLCG+++ C K S K+ +I+FPLLG +V
Sbjct: 630 KGNKGLCGNVKRLRPCKYGSGVDQQPVKKSHKVVFIIIFPLLGALVLLFAFIGIFLIAAR 689
Query: 493 ---------------------------YEEIIRATNDFDAKHCIGKGGHGSVYIARVPSG 525
YEEII+AT DFD +CIGKGGHGSVY A +PS
Sbjct: 690 RERTPEIKEGEVQNDLFSISTFDGRTMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSS 749
Query: 526 EIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEYLESGS 559
I AVKK H + FCSHPR F+VYEYLE GS
Sbjct: 750 NIVAVKKLHPSDTEMANQKDFLNEIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLERGS 809
Query: 560 LDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAH 619
L IL+ + AK+LGW R+N+IKGVA AL Y+H++C PPIVH DISS N+LLD YEAH
Sbjct: 810 LATILSRE-EAKKLGWATRVNIIKGVAHALAYMHHDCSPPIVHRDISSNNILLDSQYEAH 868
Query: 620 VSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPR 679
+SDF AK L LDSSN S LAGT G +APELAYTMKVTEK DV+SFGV+ALEVIKG+HP
Sbjct: 869 ISDFGTAKLLKLDSSNQSILAGTFGYLAPELAYTMKVTEKTDVFSFGVIALEVIKGRHPG 928
Query: 680 DFLFEMSSSSSNMNI---EILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
D + +S S NI ++LD RLP + + + ++I++ A CL NP SRPTM+
Sbjct: 929 DQILSLSVSPEKDNIALEDMLDPRLPPLTPQDEGEVIAIIKQATECLKANPQSRPTMQ 986
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456161|ref|XP_002278590.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 578 bits (1490), Expect = e-162, Method: Compositional matrix adjust.
Identities = 344/777 (44%), Positives = 444/777 (57%), Gaps = 147/777 (18%)
Query: 104 SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILH 163
+F + HL L L+NN L IPP+I NL L+ L N LSG IP + L+ LT+LH
Sbjct: 252 TFGNLKHLTVLYLFNNSLSGPIPPEIGNLKSLQGLSLYGNNLSGPIPVSLCDLSGLTLLH 311
Query: 164 ISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSG---- 219
+ NQL+G IP E+G L L L L N L GSIP SL N TNL L+L +N SG
Sbjct: 312 LYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNRLSGYFPQ 371
Query: 220 --------------------SIPQQIGNLKSLFDMKLCINQLNGAIP------------- 246
S+P+ I SL + N L+G IP
Sbjct: 372 EIGKLHKLVVLEIDTNQLFGSLPEGICQGGSLERFTVSDNHLSGPIPKSLKNCRNLTRAL 431
Query: 247 ---------------------------------LSIDWGRCPQLSLLDVSINNITGNIPF 273
LS +WGRCPQL L+++ NNITG+IP
Sbjct: 432 FQGNRLTGNVSEVVGDCPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPE 491
Query: 274 EIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLD 333
+ G S L LDLSSN++VGEIP ++G++ L + L+ N+LSG IP ELGSL +LEYLD
Sbjct: 492 DFGISTNLILLDLSSNHLVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELGSLSHLEYLD 551
Query: 334 LSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISS 393
LSAN L+ + E LG + L+YLNLS+NKLS IP+++ L HLS+LDLSHN L I +
Sbjct: 552 LSANRLNGSIPEHLGDCLDLHYLNLSNNKLSHGIPVQMGKLSHLSQLDLSHNLLTGGIPA 611
Query: 394 RICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEAL 453
+I +ESLE L+LS+NNL G IP+ FE++ L ++DISYN+L+G IP+S FR+A +E L
Sbjct: 612 QIQGLESLEMLDLSHNNLCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNAFRNATIEVL 671
Query: 454 QGNKGLCGDIRGFLSC-------MSYRKASRKIWIVIVFPLLGKIV-------------- 492
+GNK LCG+++G C K S K+ +I+FPLLG +V
Sbjct: 672 KGNKDLCGNVKGLQPCKYGFGVDQQPVKKSHKVVFIIIFPLLGALVLLSAFIGIFLIAER 731
Query: 493 ---------------------------YEEIIRATNDFDAKHCIGKGGHGSVYIARVPSG 525
YEEII+AT DFD +CIGKGGHGSVY A +PSG
Sbjct: 732 RERTPEIEEGDVQNNLLSISTFDGRAMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSG 791
Query: 526 EIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEYLESGS 559
I AVKK H D FCS+PR SF+VYEYLE GS
Sbjct: 792 NIVAVKKLHPSDMDMANQKDFLNKVRAMTEIKHRNIVRLLGFCSYPRHSFLVYEYLERGS 851
Query: 560 LDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAH 619
L IL+ + AK+LGW R+ +IKGVA AL Y+H++C PPIVH DISS N+LLD YEAH
Sbjct: 852 LATILSRE-EAKKLGWATRVKIIKGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEAH 910
Query: 620 VSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPR 679
+S+ AK L +DSSN SKLAGT G VAPE AYTMKVTEK DVYSFGV+ALEVIKG+HP
Sbjct: 911 ISNLGTAKLLKVDSSNQSKLAGTVGYVAPEHAYTMKVTEKTDVYSFGVIALEVIKGRHPG 970
Query: 680 DFLFEMSSSSSNMNI--EILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
D + +S S + ++LD RLP + + + ++I+++A +CL+ NP SRPTM+
Sbjct: 971 DQILSISVSPEKNIVLKDMLDPRLPPLTPQDEGEVVAIIKLATACLNANPQSRPTME 1027
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127218|ref|XP_002329429.1| predicted protein [Populus trichocarpa] gi|222870479|gb|EEF07610.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 572 bits (1474), Expect = e-160, Method: Compositional matrix adjust.
Identities = 340/807 (42%), Positives = 470/807 (58%), Gaps = 105/807 (13%)
Query: 38 EAHALVKWKASLEVHSRSLLHSWSLSFVNATKISLCTWSGIHCNHAGRVFGINLTSISLN 97
E AL+KW+ SL ++SLL SW V + IS CTWSGIHCN G V INLT+ L
Sbjct: 23 EVEALLKWRKSLSGQAQSLLSSWKP--VPGSNISPCTWSGIHCNDGGSVSTINLTNFQLK 80
Query: 98 GTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKL-------EYLDFLTNKLSGHIP 150
GTL +FSFSSF +L+ LDL +N L IPP ISNLSKL + L N LSG +P
Sbjct: 81 GTLDDFSFSSFHNLSCLDLQHNSLKGNIPPHISNLSKLTILNLGLKVLSLYGNHLSGPLP 140
Query: 151 SEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFL 210
EI+ LT+LT+ +S N ++G +P ++ L +N G+IP+ L N TNL L
Sbjct: 141 PEINKLTNLTLFFLSNNSISGLLPEKICHGGILEDFCASNNRFTGTIPKGLKNCTNLSRL 200
Query: 211 YLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGN 270
L N+ G+I + G +L + L N +G + S +WG+C +L+ L +S ++TG
Sbjct: 201 RLDRNNLVGNISEDFGVYPNLDYIDLSYNNFHGQV--SPNWGKCQRLTSLKISNCHVTGV 258
Query: 271 IPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLE 330
IP E+ ES L YLDLSSN + G IP +LG + L ++LS N LSG+IP E+GSL +L
Sbjct: 259 IPPELEESTALHYLDLSSNKLEGRIPNELGKLKSLFNLTLSFNSLSGKIPPEIGSLPDLS 318
Query: 331 YLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSE-LDLSHNFLGE 389
YLDL+AN+LS + + LG K+ YLNLS+N IP E+ NL+ L LDLS N L
Sbjct: 319 YLDLAANNLSGTIPKQLGKCSKMLYLNLSNNSFHDGIPAEIGNLVSLQVLLDLSRNLLSG 378
Query: 390 KISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAP 449
+I ++ + LE L LS+NN +G IP +++ L +D+SYN+LEG IP S F++AP
Sbjct: 379 EIPWQLGNLIKLEVLVLSHNNFTGFIPSTMDQMQSLRIVDLSYNELEGPIPKSKAFQEAP 438
Query: 450 LEALQGNKGLCGDIRGFLSC---MSYRKASRKIWIVIVFPLL------------------ 488
EA NKGLCG+ ++C ++ K + + ++IV P+
Sbjct: 439 PEAFTHNKGLCGNRTSLMNCPPPLNTTKDRKHLLLLIVLPVSGASFFLTILIGFVCILRK 498
Query: 489 -------------------------GKIVYEEIIRATNDFDAKHCIGKGGHGSVYIARVP 523
GK+VYE+I T F+AK+CIG GGHGSVY A++
Sbjct: 499 EWRKSMRNKLIDSQQGNLFTIWSYDGKLVYEDINEVTEGFNAKYCIGVGGHGSVYKAKLS 558
Query: 524 SGEIFAVKKFHSPLP----------------------------DNFCSHPRQSFIVYEYL 555
+G+I AVKK H PL FC H +QSF+VYEYL
Sbjct: 559 TGQIVAVKKLH-PLQYTRSDDLKTFESEIQALNKIRHRNIVKLHGFCLHAKQSFLVYEYL 617
Query: 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG 615
E GSL +IL+N A EL W++R+N++KGV +AL Y+H++C PPI+H DISS N+LLD
Sbjct: 618 ERGSLARILDNVEQATELDWSKRINIVKGVVNALCYMHHDCKPPIIHRDISSSNILLDRK 677
Query: 616 YEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKG 675
YEA VSDF A+ + LDSSNW+ LAGT+G +APELAYTMKVTEKCDVYSFGV+ALE+I G
Sbjct: 678 YEARVSDFGTARLIKLDSSNWTGLAGTYGYIAPELAYTMKVTEKCDVYSFGVVALEIIMG 737
Query: 676 KHPRDFL---------FEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQN 726
HP + + E + S+ + ++LD RL P+ ++ + I+++ F+C++ +
Sbjct: 738 HHPGELIGSLSTLSTSSEWNPGSTTLLKDLLDKRLETPARELAVQVAIIIKLGFTCINAD 797
Query: 727 PVSRPTM---------KRFEVQSKQFH 744
P SRPTM R ++ S +H
Sbjct: 798 PKSRPTMPQVSQELSISRLDISSAPWH 824
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297743684|emb|CBI36567.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 560 bits (1443), Expect = e-156, Method: Compositional matrix adjust.
Identities = 321/722 (44%), Positives = 440/722 (60%), Gaps = 38/722 (5%)
Query: 37 EEAHALVKWKASLEVHSRSLLHSWSLSFVNATKISLCT-WSGIHCNHAGRVFGINLTSIS 95
+EA AL+ WK+SL + S+S L SWS +S C W G+ C+ + V +NL S
Sbjct: 56 KEALALLTWKSSLHIRSQSFLSSWS-------GVSPCNNWFGVTCHKSKSVSSLNLESCG 108
Query: 96 LNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSK-LEYLDFLTNKLSGHIPSEIS 154
L GTL +F S P+L LDLYNN + IIP ISNLSK + LD TNKLSG IP EI
Sbjct: 109 LRGTLYNLNFLSLPNLVTLDLYNNSFYGIIPTHISNLSKFITILDLATNKLSGPIPQEID 168
Query: 155 LLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYN 214
L HL LH+ N G +P ++ L + N G IP SL N T+L + L
Sbjct: 169 NLIHLKSLHLEENNFTGHLPQQMCLGGALENFTAMGNHFTGPIPMSLRNCTSLFRVRLER 228
Query: 215 NSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFE 274
N G+I + G +L M L N L G LS WG+C L+ L++S NN++G IP +
Sbjct: 229 NQLEGNITEVFGVYPNLNFMDLSSNNLYGE--LSHKWGQCGSLTSLNISHNNLSGIIPPQ 286
Query: 275 IGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDL 334
+GE+ QL LDLSSN+++G+IP +LG + + + LS N+LSG IP E+G+L NLE+L L
Sbjct: 287 LGEAIQLHRLDLSSNHLLGKIPRELGKLTSMFHLVLSNNQLSGNIPLEVGNLFNLEHLSL 346
Query: 335 SANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSR 394
++N+LS + + LG L KL++LNLS NK + IP E+ N+ L LDLS N L KI +
Sbjct: 347 TSNNLSGSIPKQLGMLSKLFFLNLSKNKFGESIPDEIGNMHSLQNLDLSQNMLNGKIPQQ 406
Query: 395 ICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEALQ 454
+ ++ LE LNLS+N LSG IP FE++ L +DIS N+LEG +P+ F++AP EA
Sbjct: 407 LGELQRLETLNLSHNELSGSIPSTFEDMLSLTSVDISSNQLEGPLPDIKAFQEAPFEAFM 466
Query: 455 GNKGLCGDIRGFLSCMSYRKASRKIWIVIVFPLLGKIVYEEIIRATNDFDAKHCIGKGGH 514
N GLCG+ G S + ++ G I+Y++II T +F++K+CIG GG
Sbjct: 467 SNGGLCGNATGKSSETPCED------LFAIWDHDGGILYQDIIEVTEEFNSKYCIGSGGQ 520
Query: 515 GSVYIARVPSGEIFAVKKFHSPLPD----------NFCSHPRQSFIVYEYLESGSLDKIL 564
G+VY A +P+G + AVKK H P + +CSH R SF+VY+ +E GSL IL
Sbjct: 521 GTVYKAELPTGRVVAVKKLHPPQDEIRHRNIVKFYGYCSHARHSFLVYKLMEKGSLRNIL 580
Query: 565 NNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFR 624
+N+ A L W +RLN++KGVA+AL Y+H++C PPI+H DISS NVLLD YEAHVSDF
Sbjct: 581 SNEEEAIGLDWIRRLNIVKGVAEALSYMHHDCSPPIIHRDISSNNVLLDSEYEAHVSDFG 640
Query: 625 IAKFLNLD-SSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLF 683
A+ L D SSNW+ AGT G APELAYT +V K DVYS+GV+ LEVI GKHP D +
Sbjct: 641 TARLLKPDSSSNWTSFAGTFGYSAPELAYTTQVNNKTDVYSYGVVTLEVIMGKHPGDLIS 700
Query: 684 EMSSSSSNMNI----------EILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTM 733
+SS+SS+ ++ + +D RL P + + +++AF+C NP RPTM
Sbjct: 701 SLSSASSSSSVTAVADSLLLKDAIDQRLSPPIHQISEEVAFAVKLAFACQHVNPHCRPTM 760
Query: 734 KR 735
++
Sbjct: 761 RQ 762
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224136648|ref|XP_002322381.1| predicted protein [Populus trichocarpa] gi|222869377|gb|EEF06508.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 558 bits (1438), Expect = e-156, Method: Compositional matrix adjust.
Identities = 330/791 (41%), Positives = 453/791 (57%), Gaps = 92/791 (11%)
Query: 30 AVSSNSTEEAHALVKWKASLEVHSRSLLHSWSLSFVNATKISLCTWSGIHCNHAGRVFGI 89
A ++N +EA AL++WK SL+ S+SLL SW S C W GI C+ +G V I
Sbjct: 36 AEAANGRKEAEALLEWKVSLDNQSQSLLSSWDGD-------SPCNWFGISCDQSGSVTNI 88
Query: 90 NLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHI 149
+L++ SL GTL FSSFP+L L L N L+ +P I NL +L N LSG I
Sbjct: 89 SLSNSSLRGTLNSLRFSSFPNLIELTLSYNSLYGYVPSHIGNLKRLSAFIVGNNNLSGPI 148
Query: 150 PSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVF 209
P E++ LTHL L I N+L+G++P +V L + N+ G IP+SL N ++L+
Sbjct: 149 PPEMNNLTHLFALQIFSNRLSGNLPRDVCLGGSLLYFSASENYFTGPIPKSLRNCSSLLR 208
Query: 210 LYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITG 269
L L N SG+I + G L M L N+L+G LS+ W + L+ +S N I+G
Sbjct: 209 LRLERNQLSGNISEAFGTHPHLKYMDLSDNELHGE--LSLKWEQFNNLTAFRISGNKISG 266
Query: 270 NIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINL 329
IP +G++ LQ LDLSSN +VG IP +LGN+ L ++L+ N+LSG IP ++ SL +L
Sbjct: 267 EIPAALGKATHLQALDLSSNQLVGRIPEELGNL-KLIELALNDNRLSGDIPFDVASLSDL 325
Query: 330 EYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGE 389
+ L L+AN+ S +L+ LG KL LN+S N+ + IP E+ L L LDLS N L
Sbjct: 326 QRLGLAANNFSATILKQLGKCSKLILLNMSKNRFAGSIPAEMGYLQSLQSLDLSWNSLMG 385
Query: 390 KISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAP 449
I+ + +M+ LE LNLS+N LSGLIP F L GL +D+SYNKLEG IP+ FR+AP
Sbjct: 386 GIAPELGQMQQLEVLNLSHNMLSGLIPTSFSRLQGLTKVDVSYNKLEGPIPDIKAFREAP 445
Query: 450 LEALQGNKGLCGDIRGFLSC------MSYRKASRKIWIVIVFPLL--------------- 488
EA+ N LCG+ G +C + K K+ + VF LL
Sbjct: 446 FEAICNNTNLCGNATGLEACSDLVKNKTVHKKGPKVVFLTVFSLLGSLLGLIVGFLIFFQ 505
Query: 489 ----------------------GKIVYEEIIRATNDFDAKHCIGKGGHGSVYIARVPSGE 526
G + YE+II AT +FD+K+CIG GG+G VY A +PS +
Sbjct: 506 SRRKKRLVETPQRDVTARWCPGGDLRYEDIIEATEEFDSKYCIGTGGYGVVYKAVLPSEQ 565
Query: 527 IFAVKKFHSPLPD----------------------------NFCSHPRQSFIVYEYLESG 558
+ AVKKFH P+ FCSH + SF+VYE++E G
Sbjct: 566 VLAVKKFHQ-TPEVEMSSLKAFRSEIDVLMGIRHRNIVKLYGFCSHAKHSFLVYEFVERG 624
Query: 559 SLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEA 618
SL K+LN++ A ++ W +R+N+IKGVA+AL Y+H++C PPI+H DISS NVLLD YEA
Sbjct: 625 SLRKVLNDEEQAGKMDWDKRMNLIKGVANALSYMHHDCSPPIIHRDISSNNVLLDSEYEA 684
Query: 619 HVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 678
VSDF A+ L DSSNW+ AGT G APELAYTMKV EKCDVYSFGVL LEV+ GKHP
Sbjct: 685 RVSDFGTARLLMPDSSNWTSFAGTFGYTAPELAYTMKVDEKCDVYSFGVLTLEVMMGKHP 744
Query: 679 RDFLFEMSSSSSNMNI----------EILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPV 728
DF+ + S+S + ++LD RLP P ++ + + ++AF+CL +P
Sbjct: 745 GDFISSLMVSASTSSSSPIGHNTVLKDVLDQRLPPPENELADGVAHVAKLAFACLQTDPH 804
Query: 729 SRPTMKRFEVQ 739
+PTM++ +
Sbjct: 805 YQPTMRQVSTE 815
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545702|ref|XP_002513911.1| receptor protein kinase, putative [Ricinus communis] gi|223546997|gb|EEF48494.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 550 bits (1418), Expect = e-154, Method: Compositional matrix adjust.
Identities = 339/780 (43%), Positives = 443/780 (56%), Gaps = 149/780 (19%)
Query: 104 SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILH 163
+F S L L LYNN+L IP ++ +L L L N LSG IP+ + LT LTILH
Sbjct: 223 TFGSLTKLVQLFLYNNQLSGHIPQELGDLKSLTSLSLFGNNLSGPIPASLGGLTSLTILH 282
Query: 164 ISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIP- 222
+ +NQL+G+IP E+G LN L++L L N L GSIP SL N + L L+L NN SG IP
Sbjct: 283 LYQNQLSGTIPKELGNLNSLSNLELSENKLTGSIPASLGNLSRLELLFLKNNQLSGPIPE 342
Query: 223 -----------------------QQIGNLKSLFDMKLCINQLNGAIPLSI---------- 249
Q I K L + + N+L G IP S+
Sbjct: 343 QIANLSKLSLLQLQSNQLTGYLPQNICQSKVLQNFSVNDNRLEGPIPKSMRDCKSLVRLH 402
Query: 250 ------------------------------------DWGRCPQLSLLDVSINNITGNIPF 273
WG CP L L +S NNI+G IP
Sbjct: 403 LEGNQFIGNISEDFGVYPYLQFVDIRYNKFHGEISSKWGMCPHLGTLLISGNNISGIIPP 462
Query: 274 EIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLD 333
EIG + +LQ LD SSN +VG IP +LG + L R++L N+LS +P E GSL +LE LD
Sbjct: 463 EIGNAARLQGLDFSSNQLVGRIPKELGKLTSLVRVNLEDNQLSDGVPSEFGSLTDLESLD 522
Query: 334 LSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISS 393
LSAN + + ++G+LVKL YLNLS+N+ SQ+IPI+L L+HLS+LDLS NFL +I S
Sbjct: 523 LSANRFNQSIPGNIGNLVKLNYLNLSNNQFSQEIPIQLGKLVHLSKLDLSQNFLIGEIPS 582
Query: 394 RICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEAL 453
+ M+SLE LNLS NNLSG IP +E+HGL IDISYNKLEG +P++ F+++ +EA
Sbjct: 583 ELSGMQSLEVLNLSRNNLSGFIPGDLKEMHGLSSIDISYNKLEGPVPDNKAFQNSSIEAF 642
Query: 454 QGNKGLCGDIRGFLSCM-------SYRKASRKIWIVIVFPLL------------------ 488
QGNKGLCG ++G C S K +++++VI PL
Sbjct: 643 QGNKGLCGHVQGLQPCKPSSTEQGSSIKFHKRLFLVISLPLFGAFLILSFLGVLFFQSKR 702
Query: 489 ------------------------GKIVYEEIIRATNDFDAKHCIGKGGHGSVYIARVPS 524
GK +++EII AT+ F+ +CIGKGG GSVY A++ S
Sbjct: 703 SKEALEAEKSSQESEEILLITSFDGKSMHDEIIEATDSFNDIYCIGKGGCGSVYKAKLSS 762
Query: 525 GEIFAVKKFHS------PLPD---------------------NFCSHPRQSFIVYEYLES 557
G AVKK H P FCS+ SF+VYE +E
Sbjct: 763 GSTVAVKKLHQSHDAWKPYQKEFWSEIRALTEIKHRNIVKFYGFCSYSAYSFLVYECIEK 822
Query: 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE 617
GSL IL ++ +AKEL W +R N+IKGVA+AL Y+H++C PPIVH DISSKN+LLD E
Sbjct: 823 GSLATILRDNEAAKELEWFKRANIIKGVANALSYMHHDCSPPIVHRDISSKNILLDSENE 882
Query: 618 AHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 677
A VSDF IA+ LNLDSS+ + LAGT G +APELAY++ VTEKCDVYSFGVLALEVI GKH
Sbjct: 883 ARVSDFGIARILNLDSSHRTALAGTFGYMAPELAYSIVVTEKCDVYSFGVLALEVINGKH 942
Query: 678 PRDFLFEMSSSSSNMNI---EILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
P + + +SSSSS + I+D RLP+PS +VQ + ++I+ +AF+CL+ NP RPTM+
Sbjct: 943 PGEIISSISSSSSTRKMLLENIVDLRLPFPSPEVQVELVNILNLAFTCLNSNPQVRPTME 1002
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 752 | ||||||
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.523 | 0.377 | 0.383 | 5.8e-135 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.561 | 0.376 | 0.377 | 3.5e-132 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.523 | 0.357 | 0.356 | 6.5e-94 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.506 | 0.333 | 0.383 | 1.4e-92 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.505 | 0.334 | 0.371 | 2.9e-91 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.523 | 0.315 | 0.355 | 1.4e-90 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.466 | 0.318 | 0.360 | 8.1e-87 | |
| TAIR|locus:2161825 | 1090 | AT5G56040 [Arabidopsis thalian | 0.554 | 0.382 | 0.347 | 3.4e-86 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.481 | 0.322 | 0.361 | 8.3e-85 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.498 | 0.299 | 0.349 | 2.3e-84 |
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 672 (241.6 bits), Expect = 5.8e-135, Sum P(3) = 5.8e-135
Identities = 155/404 (38%), Positives = 231/404 (57%)
Query: 96 LNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEXXX 155
LNG++ + L++ N+L +P L+ LE+L N+LSG IP
Sbjct: 322 LNGSIPP-ELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIAN 380
Query: 156 XXXXXXXXXXRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNN 215
N G +P + + L +L LD N G +P+SL + +L+ + N
Sbjct: 381 STELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGN 440
Query: 216 SFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEI 275
SFSG I + G +L + L N +G LS +W + +L +S N+ITG IP EI
Sbjct: 441 SFSGDISEAFGVYPTLNFIDLSNNNFHGQ--LSANWEQSQKLVAFILSNNSITGAIPPEI 498
Query: 276 GESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLS 335
QL LDLSSN I GE+P + NI ++++ L+GN+LSG+IP + L NLEYLDLS
Sbjct: 499 WNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLS 558
Query: 336 ANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRI 395
+N S+ + +L +L +LYY+NLS N L Q IP L L L LDLS+N L +ISS+
Sbjct: 559 SNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQF 618
Query: 396 CRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEALQG 455
+++LE+L+LS+NNLSG IP F+++ L H+D+S+N L+G IP++ FR+AP +A +G
Sbjct: 619 RSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEG 678
Query: 456 NKGLCGDI---RGFLSCM--SYRKA--SRKIWIVIVFPLLGKIV 492
NK LCG + +G C S +K+ R + I I+ P++G I+
Sbjct: 679 NKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAII 722
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 685 (246.2 bits), Expect = 3.5e-132, Sum P(3) = 3.5e-132
Identities = 161/427 (37%), Positives = 237/427 (55%)
Query: 17 FPLILFLVLDFSLAVSSNST-EEAHALVKWKASLEVXXXXXXXXXXXXFVNATKISLCTW 75
F +LF+ + S ++S+++T EA+AL+KWK++ N T S +W
Sbjct: 11 FRFLLFISIILSCSISASATIAEANALLKWKSTF-TNSSKLSSWVHDANTN-TSFSCTSW 68
Query: 76 SGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKL 135
G+ CN G + +NLT+ + GT +F F S +LAY+DL N L IPPQ NLSKL
Sbjct: 69 YGVSCNSRGSIEELNLTNTGIEGTFQDFPFISLSNLAYVDLSMNLLSGTIPPQFGNLSKL 128
Query: 136 EYLDFLTNKLSGHIPSEXXXXXXXXXXXXXRNQLNGSIPHEVGQLNFLNHLILDSNFLGG 195
Y D TN L+G I +N L IP E+G + + L L N L G
Sbjct: 129 IYFDLSTNHLTGEISPSLGNLKNLTVLYLHQNYLTSVIPSELGNMESMTDLALSQNKLTG 188
Query: 196 SIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCP 255
SIP SL N NL+ LYLY N +G IP ++GN++S+ D+ L N+L G+IP ++ G
Sbjct: 189 SIPSSLGNLKNLMVLYLYENYLTGVIPPELGNMESMTDLALSQNKLTGSIPSTL--GNLK 246
Query: 256 QLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKL 315
L +L + N +TG IP EIG + L LS N + G IP+ LGN+ L +SL N L
Sbjct: 247 NLMVLYLYENYLTGVIPPEIGNMESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYL 306
Query: 316 SGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLI 375
+G IP +LG++ ++ L+LS N L+ + SLG+L L L L N L+ IP EL N+
Sbjct: 307 TGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNME 366
Query: 376 HLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKL 435
+ +L L++N L I S +++L L L N L+G+IP+ + ++++D+S NKL
Sbjct: 367 SMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKL 426
Query: 436 EGHIPNS 442
G +P+S
Sbjct: 427 TGSVPDS 433
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 525 (189.9 bits), Expect = 6.5e-94, Sum P(3) = 6.5e-94
Identities = 143/401 (35%), Positives = 200/401 (49%)
Query: 73 CTWSGIHC-NHAG--RVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQI 129
C W+G+ C N++ V +NL+S+ L+G L S HL LDL N L IP +I
Sbjct: 59 CGWTGVMCSNYSSDPEVLSLNLSSMVLSGKLSP-SIGGLVHLKQLDLSYNGLSGKIPKEI 117
Query: 130 SNLSKLEYLDFLTNKLSGHIPSEXXXXXXXXXXXXXRNQLNGSIPHEVGQLNFLNHLILD 189
N S LE L N+ G IP E N+++GS+P E+G L L+ L+
Sbjct: 118 GNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTY 177
Query: 190 SNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSI 249
SN + G +PRS+ N L N SGS+P +IG +SL + L NQL+G +P I
Sbjct: 178 SNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEI 237
Query: 250 DWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRIS 309
G +LS + + N +G IP EI L+ L L N +VG IP +LG++ L +
Sbjct: 238 --GMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLY 295
Query: 310 LSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPI 369
L N L+G IP E+G+L +D S N L+ + LG++ L L L N+L+ IP+
Sbjct: 296 LYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPV 355
Query: 370 ELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHID 429
EL L +LS+LDLS N L I + L L L N+LSG IP L +D
Sbjct: 356 ELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLD 415
Query: 430 ISYNKLEGHIPNSTTFRDAPLEALQGNKGLCGDI-RGFLSC 469
+S N L G IP+ + G L G+I G +C
Sbjct: 416 MSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTC 456
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 583 (210.3 bits), Expect = 1.4e-92, Sum P(3) = 1.4e-92
Identities = 151/394 (38%), Positives = 213/394 (54%)
Query: 90 NLTSISLNGTLLEFSF-SSFPHLAYLDLY---NNELFDIIPPQISNLSKLEYLDFLTNKL 145
NL I L+ LL S SS L++L+ + +N+ IP ISN S L L N++
Sbjct: 323 NLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQI 382
Query: 146 SGHIPSEXXXXXXXXXXXXXRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFT 205
SG IPSE NQL GSIP + L L L N L G+IP L
Sbjct: 383 SGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLR 442
Query: 206 NLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSIN 265
NL L L +NS SG IPQ+IGN SL ++L N++ G IP I G +++ LD S N
Sbjct: 443 NLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGI--GSLKKINFLDFSSN 500
Query: 266 NITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGS 325
+ G +P EIG +LQ +DLS+N + G +P + ++ L + +S N+ SG+IP LG
Sbjct: 501 RLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGR 560
Query: 326 LINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLS-ELDLSH 384
L++L L LS N S + SLG L L+L N+LS +IP EL ++ +L L+LS
Sbjct: 561 LVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSS 620
Query: 385 NFLGEKISSRICRMESLEKLNLSYNNLSG-LIPRCFEELHGLLHIDISYNKLEGHIPNST 443
N L KI S+I + L L+LS+N L G L P + L+ ++ISYN G++P++
Sbjct: 621 NRLTGKIPSKIASLNKLSILDLSHNMLEGDLAP--LANIENLVSLNISYNSFSGYLPDNK 678
Query: 444 TFRDAPLEALQGNKGLCGDIRGFLSC-MSYRKAS 476
FR + L+GNK LC + SC ++YRK +
Sbjct: 679 LFRQLSPQDLEGNKKLCSSTQD--SCFLTYRKGN 710
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 567 (204.7 bits), Expect = 2.9e-91, Sum P(3) = 2.9e-91
Identities = 145/390 (37%), Positives = 210/390 (53%)
Query: 84 GRVFGINLTSISLN---GTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDF 140
G + +N +S+N GT+ + SF + +L L L +N + IP +SN +KL
Sbjct: 320 GFMKSLNAIDLSMNYFSGTIPK-SFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQI 378
Query: 141 LTNKLSGHIPSEXXXXXXXXXXXXXRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRS 200
N++SG IP E +N+L G+IP E+ L L L N+L GS+P
Sbjct: 379 DANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAG 438
Query: 201 LSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLL 260
L NL L L +N+ SG IP +IGN SL ++L N++ G IP I G LS L
Sbjct: 439 LFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGI--GFLQNLSFL 496
Query: 261 DVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIP 320
D+S NN++G +P EI QLQ L+LS+N + G +P L ++ L + +S N L+G+IP
Sbjct: 497 DLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIP 556
Query: 321 GELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLS-E 379
LG LI+L L LS N + + SLG L L+LS N +S IP EL ++ L
Sbjct: 557 DSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIA 616
Query: 380 LDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHI 439
L+LS N L I RI + L L++S+N LSG + L L+ ++IS+N+ G++
Sbjct: 617 LNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDLS-ALSGLENLVSLNISHNRFSGYL 675
Query: 440 PNSTTFRDAPLEALQGNKGLCGDIRGFLSC 469
P+S FR ++GN GLC +GF SC
Sbjct: 676 PDSKVFRQLIGAEMEGNNGLCS--KGFRSC 703
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 564 (203.6 bits), Expect = 1.4e-90, Sum P(3) = 1.4e-90
Identities = 143/402 (35%), Positives = 207/402 (51%)
Query: 66 NATKISLCTWSGIHCNHAG--RVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFD 123
N+ I+ C+W+G+ C++ G RV +NLT + L G++ + F F +L +LDL +N L
Sbjct: 51 NSDNINYCSWTGVTCDNTGLFRVIALNLTGLGLTGSISPW-FGRFDNLIHLDLSSNNLVG 109
Query: 124 IIPPQISNLSKLEYLDFLTNKLSGHIPSEXXXXXXXXXXXXXRNQLNGSIPHEVGQLNFL 183
IP +SNL+ LE L +N+L+G IPS+ N+L G IP +G L L
Sbjct: 110 PIPTALSNLTSLESLFLFSNQLTGEIPSQLGSLVNIRSLRIGDNELVGDIPETLGNLVNL 169
Query: 184 NHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNG 243
L L S L G IP L + L L +N G IP ++GN L N LNG
Sbjct: 170 QMLALASCRLTGPIPSQLGRLVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNG 229
Query: 244 AIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNII 303
IP + GR L +L+++ N++TG IP ++GE QLQYL L +N + G IP L ++
Sbjct: 230 TIPAEL--GRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLG 287
Query: 304 YLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSL-VKLYYLNLSHNK 362
L + LS N L+G IP E ++ L L L+ NHLS + +S+ S L L LS +
Sbjct: 288 NLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQ 347
Query: 363 LSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEL 422
LS +IP+EL L +LDLS+N L I + + L L L N L G + L
Sbjct: 348 LSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNL 407
Query: 423 HGLLHIDISYNKLEGHIPNS-TTFRDAPLEALQGNKGLCGDI 463
L + + +N LEG +P + R + L N+ G+I
Sbjct: 408 TNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENR-FSGEI 448
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 531 (192.0 bits), Expect = 8.1e-87, Sum P(2) = 8.1e-87
Identities = 128/355 (36%), Positives = 192/355 (54%)
Query: 89 INLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGH 148
I+ + L G + + F +L L L+ N L IP ++ L+ LE LD N+L+G
Sbjct: 312 IDFSENQLTGFIPK-EFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGT 370
Query: 149 IPSEXXXXXXXXXXXXXRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLV 208
IP E NQL G IP +G + + L + +N L G IP F L+
Sbjct: 371 IPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLI 430
Query: 209 FLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNIT 268
L L +N SG+IP+ + KSL + L NQL G++P+ + L+ L++ N ++
Sbjct: 431 LLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELF--NLQNLTALELHQNWLS 488
Query: 269 GNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLIN 328
GNI ++G+ L+ L L++N GEIP ++GN+ + ++S N+L+G IP ELGS +
Sbjct: 489 GNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVT 548
Query: 329 LEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLG 388
++ LDLS N S ++ + LG LV L L LS N+L+ +IP +L L EL L N L
Sbjct: 549 IQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLS 608
Query: 389 EKISSRICRMESLE-KLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNS 442
E I + ++ SL+ LN+S+NNLSG IP L L + ++ NKL G IP S
Sbjct: 609 ENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPAS 663
|
|
| TAIR|locus:2161825 AT5G56040 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 551 (199.0 bits), Expect = 3.4e-86, Sum P(3) = 3.4e-86
Identities = 149/429 (34%), Positives = 208/429 (48%)
Query: 17 FPLILFLVLDFSLAVSS---NSTEEAHALVKWKASLEVXXXXXXXXXXXXFVNATKISLC 73
F LFL+ SL S + E+ AL+ WK+ L + A++ + C
Sbjct: 7 FCFFLFLLFHSSLFFSIPCFSIDEQGLALLSWKSQLNISGDALSSW------KASESNPC 60
Query: 74 TWSGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLS 133
W GI CN G+V I L + G L + L L L + L IP ++ +LS
Sbjct: 61 QWVGIKCNERGQVSEIQLQVMDFQGPLPATNLRQIKSLTLLSLTSVNLTGSIPKELGDLS 120
Query: 134 KLEYLDFLTNKLSGHIPSEXXXXXXXXXXXXXRNQLNGSIPHEVGQLNFLNHLILDSNFL 193
+LE LD N LSG IP + N L G IP E+G L L L L N L
Sbjct: 121 ELEVLDLADNSLSGEIPVDIFKLKKLKILSLNTNNLEGVIPSELGNLVNLIELTLFDNKL 180
Query: 194 GGSIPRSLSNFTNL-VFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWG 252
G IPR++ NL +F N + G +P +IGN +SL + L L+G +P SI G
Sbjct: 181 AGEIPRTIGELKNLEIFRAGGNKNLRGELPWEIGNCESLVTLGLAETSLSGRLPASI--G 238
Query: 253 RCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSG 312
++ + + + ++G IP EIG +LQ L L N I G IP +G + L + L
Sbjct: 239 NLKKVQTIALYTSLLSGPIPDEIGNCTELQNLYLYQNSISGSIPVSMGRLKKLQSLLLWQ 298
Query: 313 NKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELD 372
N L G+IP ELG+ L +DLS N L+ + S G+L L L LS N+LS IP EL
Sbjct: 299 NNLVGKIPTELGTCPELFLVDLSENLLTGNIPRSFGNLPNLQELQLSVNQLSGTIPEELA 358
Query: 373 NLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISY 432
N L+ L++ +N + +I I ++ SL N L+G+IP + L ID+SY
Sbjct: 359 NCTKLTHLEIDNNQISGEIPPLIGKLTSLTMFFAWQNQLTGIIPESLSQCQELQAIDLSY 418
Query: 433 NKLEGHIPN 441
N L G IPN
Sbjct: 419 NNLSGSIPN 427
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 499 (180.7 bits), Expect = 8.3e-85, Sum P(3) = 8.3e-85
Identities = 133/368 (36%), Positives = 190/368 (51%)
Query: 96 LNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEXXX 155
L G ++ S +LA LDL N L IPP NL+ + L N LSG IP
Sbjct: 361 LTG-IIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGL 419
Query: 156 XXXXXXXXXXRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNN 215
NQL+G IP + Q + L L L SN + G+IP + +L+ L + N
Sbjct: 420 YSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGN 479
Query: 216 SFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEI 275
+G P ++ L +L ++L N+ +G +P I G C +L L ++ N + N+P EI
Sbjct: 480 RLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEI--GTCQKLQRLHLAANQFSSNLPNEI 537
Query: 276 GESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLS 335
+ L ++SSN + G IP+++ N L R+ LS N G +P ELGSL LE L LS
Sbjct: 538 SKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLS 597
Query: 336 ANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLS-ELDLSHN-FLGEKISS 393
N S + ++G+L L L + N S IP +L L L ++LS+N F GE I
Sbjct: 598 ENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGE-IPP 656
Query: 394 RICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEAL 453
I + L L+L+ N+LSG IP FE L LL + SYN L G +P++ F++ L +
Sbjct: 657 EIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSF 716
Query: 454 QGNKGLCG 461
GNKGLCG
Sbjct: 717 LGNKGLCG 724
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 520 (188.1 bits), Expect = 2.3e-84, Sum P(3) = 2.3e-84
Identities = 134/383 (34%), Positives = 194/383 (50%)
Query: 66 NATKISLCTWSGIHCNHAGR-VFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDI 124
N+ S C W+G+ C GR + G+NL+ + L G++ S F +L ++DL +N L
Sbjct: 54 NSGSPSYCNWTGVTCG--GREIIGLNLSGLGLTGSISP-SIGRFNNLIHIDLSSNRLVGP 110
Query: 125 IPPQISNLSK-LEYLDFLTNKLSGHIPSEXXXXXXXXXXXXXRNQLNGSIPHEVGQLNFL 183
IP +SNLS LE L +N LSG IPS+ N+LNG+IP G L L
Sbjct: 111 IPTTLSNLSSSLESLHLFSNLLSGDIPSQLGSLVNLKSLKLGDNELNGTIPETFGNLVNL 170
Query: 184 NHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNG 243
L L S L G IP L L L +N G IP +IGN SL N+LNG
Sbjct: 171 QMLALASCRLTGLIPSRFGRLVQLQTLILQDNELEGPIPAEIGNCTSLALFAAAFNRLNG 230
Query: 244 AIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNII 303
++P ++ R L L++ N+ +G IP ++G+ +QYL+L N + G IP +L +
Sbjct: 231 SLPAELN--RLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELA 288
Query: 304 YLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSL-VKLYYLNLSHNK 362
L + LS N L+G I E + LE+L L+ N LS + +++ S L L LS +
Sbjct: 289 NLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQ 348
Query: 363 LSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEL 422
LS +IP E+ N L LDLS+N L +I + ++ L L L+ N+L G + L
Sbjct: 349 LSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNL 408
Query: 423 HGLLHIDISYNKLEGHIPNSTTF 445
L + +N LEG +P F
Sbjct: 409 TNLQEFTLYHNNLEGKVPKEIGF 431
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 752 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-83 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-59 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-58 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-26 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-24 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-24 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-20 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-20 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-19 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-19 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-17 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-14 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-13 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-12 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 8e-12 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-11 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-10 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-10 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-10 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-10 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-09 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-08 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-08 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-08 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-07 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-07 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-06 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-06 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-06 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-06 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-05 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-05 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-05 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-05 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-05 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-05 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-05 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-04 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-04 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-04 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-04 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-04 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-04 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-04 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-04 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 4e-04 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-04 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-04 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.001 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 0.001 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 0.001 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.001 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 0.001 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 0.002 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.002 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.002 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 0.002 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 0.002 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 0.002 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.002 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 0.002 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.003 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.003 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.003 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 0.003 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.003 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.004 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.004 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.004 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.004 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 0.004 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.004 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.004 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 284 bits (727), Expect = 4e-83
Identities = 217/701 (30%), Positives = 331/701 (47%), Gaps = 89/701 (12%)
Query: 104 SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILH 163
S + +L YL LY N+L IPP I +L KL LD N LSG IP + L +L ILH
Sbjct: 255 SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILH 314
Query: 164 ISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQ 223
+ N G IP + L L L L SN G IP++L NL L L N+ +G IP+
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374
Query: 224 QIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQY 283
+ + +LF + L N L G IP S+ G C L + + N+ +G +P E + P + +
Sbjct: 375 GLCSSGNLFKLILFSNSLEGEIPKSL--GACRSLRRVRLQDNSFSGELPSEFTKLPLVYF 432
Query: 284 LDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFV 343
LD+S+N + G I ++ ++ L +SL+ NK G +P GS LE LDLS N S V
Sbjct: 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAV 491
Query: 344 LESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEK 403
LGSL +L L LS NKLS +IP EL + L LDLSHN L +I + M L +
Sbjct: 492 PRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQ 551
Query: 404 LNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEALQGNKGLCGD- 462
L+LS N LSG IP+ + L+ ++IS+N L G +P++ F A+ GN LCG
Sbjct: 552 LDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGD 611
Query: 463 -IRGFLSCMSYRKASRKIWIVIVFPLLGKIVY----------------EEIIRATND--- 502
G C RK W + LG + E+ R N+
Sbjct: 612 TTSGLPPCKRVRKT--PSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGT 669
Query: 503 -----FDAK-----------------HCIGKGGHGSVYIARVPSGEI-FAVKKFH--SPL 537
FD+K + I +G G+ Y + + F VK+ + + +
Sbjct: 670 WELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI 729
Query: 538 PDNF------------------CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRL 579
P + C + +++++EY+E +L ++L N L W +R
Sbjct: 730 PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRR 783
Query: 580 NVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKL 639
+ G+A AL +LH C P +V ++S + +++D E H+ + L D+ +
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS 842
Query: 640 AGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS--------SSN 691
A VAPE T +TEK D+Y FG++ +E++ GK P D F + S S+
Sbjct: 843 A----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD 898
Query: 692 MNIEI-LDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRP 731
++++ +D + QN+ + +M +A C +P +RP
Sbjct: 899 CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 217 bits (555), Expect = 1e-59
Identities = 155/446 (34%), Positives = 228/446 (51%), Gaps = 19/446 (4%)
Query: 18 PLILFLVLDFSLAVSSNSTEEAHALVKWKASLEVHSRSLLHSWSLSFVNATKISLCTWSG 77
P ++F++ L S EE L+ +K+S+ + L +W+ + +C W G
Sbjct: 10 PYLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLK-YLSNWN------SSADVCLWQG 62
Query: 78 IHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLS-KLE 136
I CN++ RV I+L+ +++G + F P++ ++L NN+L IP I S L
Sbjct: 63 ITCNNSSRVVSIDLSGKNISGKISSAIF-RLPYIQTINLSNNQLSGPIPDDIFTTSSSLR 121
Query: 137 YLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGS 196
YL+ N +G IP + +L L +S N L+G IP+++G + L L L N L G
Sbjct: 122 YLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK 179
Query: 197 IPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQ 256
IP SL+N T+L FL L +N G IP+++G +KSL + L N L+G IP I G
Sbjct: 180 IPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI--GGLTS 237
Query: 257 LSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLS 316
L+ LD+ NN+TG IP +G LQYL L N + G IP + ++ L + LS N LS
Sbjct: 238 LNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS 297
Query: 317 GRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIH 376
G IP + L NLE L L +N+ + + +L SL +L L L NK S +IP L +
Sbjct: 298 GEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNN 357
Query: 377 LSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLE 436
L+ LDLS N L +I +C +L KL L N+L G IP+ L + + N
Sbjct: 358 LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS 417
Query: 437 GHIPNSTT------FRDAPLEALQGN 456
G +P+ T F D LQG
Sbjct: 418 GELPSEFTKLPLVYFLDISNNNLQGR 443
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 2e-58
Identities = 140/363 (38%), Positives = 192/363 (52%), Gaps = 5/363 (1%)
Query: 107 SFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISR 166
SF L LDL N L IP ++NL+ LE+L +N+L G IP E+ + L +++
Sbjct: 162 SFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGY 221
Query: 167 NQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIG 226
N L+G IP+E+G L LNHL L N L G IP SL N NL +L+LY N SG IP I
Sbjct: 222 NNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF 281
Query: 227 NLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDL 286
+L+ L + L N L+G IP + + L +L + NN TG IP + P+LQ L L
Sbjct: 282 SLQKLISLDLSDNSLSGEIPELV--IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQL 339
Query: 287 SSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLES 346
SN GEIP LG L + LS N L+G IP L S NL L L +N L + +S
Sbjct: 340 WSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKS 399
Query: 347 LGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNL 406
LG+ L + L N S ++P E L + LD+S+N L +I+SR M SL+ L+L
Sbjct: 400 LGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSL 459
Query: 407 SYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNS-TTFRDAPLEALQGNKGLCGDIRG 465
+ N G +P F L ++D+S N+ G +P + + L NK L G+I
Sbjct: 460 ARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENK-LSGEIPD 517
Query: 466 FLS 468
LS
Sbjct: 518 ELS 520
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 68/255 (26%), Positives = 103/255 (40%), Gaps = 36/255 (14%)
Query: 508 CIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF--------------CSHP------- 545
+G G G+VY A+ +G+I AVK + SHP
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 546 -----RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 600
++V EY E G L L+ L + + + L YLH+N I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLHSN---GI 119
Query: 601 VHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPE-LAYTMKVTEK 659
+H D+ +N+LLD ++DF +AK L SS+ + GT +APE L K
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 660 CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVA 719
DV+S GV+ E++ GK P F E + IL L + + +
Sbjct: 180 VDVWSLGVILYELLTGKPP--FSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 720 FSCLDQNPVSRPTMK 734
CL+++P RPT +
Sbjct: 238 KKCLNKDPSKRPTAE 252
|
Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 72/264 (27%), Positives = 105/264 (39%), Gaps = 53/264 (20%)
Query: 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKF-HSPLPD-----------NFCSHP--- 545
F+ IGKGG G VY AR +G+ A+K C HP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 546 ---------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLN------VIKGVADALF 590
+ +IV E+ GSL +L + Q L V K + L
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKS--------TNQTLTESQIAYVCKELLKGLE 112
Query: 591 YLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPEL 650
YLH+N I+H DI + N+LL E + DF ++ L+ D+ + + GT +APE+
Sbjct: 113 YLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMVGTPYWMAPEV 168
Query: 651 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710
K D++S G+ A+E+ +GK P E+ M + P L
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGKPP---YSELPP----MKALFKIATNGPPGLR-NP 220
Query: 711 KFMSIMQVAF--SCLDQNPVSRPT 732
+ S F CL +NP RPT
Sbjct: 221 EKWSDEFKDFLKKCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 59/260 (22%), Positives = 103/260 (39%), Gaps = 42/260 (16%)
Query: 503 FDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF-------------CSHP--- 545
++ +G+G G VY+AR +G++ A+K HP
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 546 ---------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNC 596
+ ++V EY E G L +L E + ++ + AL YLH+
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE---DEARFYLRQILSALEYLHSKG 117
Query: 597 FPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKV 656
IVH D+ +N+LLD ++DF +A+ L+ + GT +APE+
Sbjct: 118 ---IVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFVGTPEYMAPEVLLGKGY 173
Query: 657 TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM--NIEILDSRLPYPSLDVQNKFMS 714
+ D++S GV+ E++ GK P F + I P P D+ +
Sbjct: 174 GKAVDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKD 229
Query: 715 IMQVAFSCLDQNPVSRPTMK 734
+++ L ++P R T +
Sbjct: 230 LIR---KLLVKDPEKRLTAE 246
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 54/191 (28%), Positives = 89/191 (46%), Gaps = 33/191 (17%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF-------------CSHP--------- 545
+G+GG G+VY+AR +G+ A+K + +HP
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 546 ---RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVH 602
++V EY E GSL +L + +L + L ++ + + L YLH+N I+H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLHSN---GIIH 115
Query: 603 WDISSKNVLLDLG-YEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPE-LAYTMKVTEKC 660
D+ +N+LLD + ++DF ++K L D S + GT +APE L +EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 661 DVYSFGVLALE 671
D++S GV+ E
Sbjct: 176 DIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 3e-20
Identities = 67/268 (25%), Positives = 102/268 (38%), Gaps = 65/268 (24%)
Query: 507 HCIGKGGHGSVYIAR-VPSGEIFAVKK--FHSPLPDNFCS------------HPRQSFIV 551
+G+G GSVY+A +GE+ AVK + + HP IV
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHP---NIV 62
Query: 552 -Y----------------EYLESGSLDKILNNDASAKELGWTQRLNVIKGVA----DALF 590
Y EY+ GSL +L E VI+ + L
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE-------PVIRKYTRQILEGLA 115
Query: 591 YLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS--KLAGTHGNVAP 648
YLH+N IVH DI N+L+D ++DF AK L + + GT +AP
Sbjct: 116 YLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 649 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN-IEILDSRLPYP--- 704
E+ + D++S G +E+ GK P E+ + + + I P
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKPP---WSELGNPMAALYKIGSSGEPPEIPEHL 229
Query: 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPT 732
S + ++ F+ CL ++P RPT
Sbjct: 230 SEEAKD-FLR------KCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (226), Expect = 3e-20
Identities = 55/209 (26%), Positives = 83/209 (39%), Gaps = 40/209 (19%)
Query: 541 FCSHPRQSFIVYEYLESGSLDKIL-NNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 599
C+ +IV EY+ G L L + L L + +A + YL + F
Sbjct: 69 VCTQGEPLYIVTEYMPGGDLLDFLRKHGEK---LTLKDLLQMALQIAKGMEYLESKNF-- 123
Query: 600 IVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTM 654
VH D++++N L+ +SDF +++ + D G + APE
Sbjct: 124 -VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY---RKRGGGKLPIKWMAPESLKDG 179
Query: 655 KVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYP---S 705
K T K DV+SFGVL E+ G+ P MS N E+L+ RLP P
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQP---YPGMS------NEEVLELLEDGYRLPRPENCP 230
Query: 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
++ +M C +P RPT
Sbjct: 231 DELYE----LML---QCWAYDPEDRPTFS 252
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 65/267 (24%), Positives = 95/267 (35%), Gaps = 62/267 (23%)
Query: 509 IGKGGHGSVYIAR-----VPSGEIFAVKKFHSPLPDN----------------------- 540
+G+G G VY AVK +
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 541 --FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 598
C+ IV EY+ G L L KEL + L+ +A + YL +
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSFALQIARGMEYLESK--- 122
Query: 599 PIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYT 653
+H D++++N L+ +SDF +++ L D K G + APE
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK----GGKLPIRWMAPESLKE 178
Query: 654 MKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILD-----SRLPYPSLD 707
K T K DV+SFGVL E+ G+ P MS N E+L+ RLP P
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYP---GMS------NAEVLEYLKKGYRLPKPPNC 229
Query: 708 VQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+ +M C ++P RPT
Sbjct: 230 PP-ELYKLML---QCWAEDPEDRPTFS 252
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 63/265 (23%), Positives = 99/265 (37%), Gaps = 59/265 (22%)
Query: 509 IGKGGHGSVYIAR----VPSGEIF-AVKKFHSPLPDN----------------------- 540
+G+G G VY + ++ AVK +
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 541 --FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 598
C+ +IV EY+E G L L + +L + L+ +A + YL +
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLESK--- 121
Query: 599 PIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APELAYTMK 655
+H D++++N L+ +SDF +++ L D + G + APE K
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY--RKRGGKLPIRWMAPESLKEGK 179
Query: 656 VTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEIL-----DSRLPYPSLDVQ 709
T K DV+SFGVL E+ G+ P MS N E+L RLP P
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYP---GMS------NEEVLEYLKNGYRLPQPPNCPP 230
Query: 710 NKFMSIMQVAFSCLDQNPVSRPTMK 734
+ +M C ++P RPT
Sbjct: 231 -ELYDLML---QCWAEDPEDRPTFS 251
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 4e-19
Identities = 55/210 (26%), Positives = 83/210 (39%), Gaps = 36/210 (17%)
Query: 542 CSHPRQSFIVYEYLESGSLDKIL------NNDASAKELGWTQRLNVIKGVADALFYLHNN 595
C+ ++V EY+E G L L L L+ +A + YL +
Sbjct: 65 CTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK 124
Query: 596 CFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APEL 650
VH D++++N L+ +SDF +++ + D K T G + APE
Sbjct: 125 ---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK---TGGKLPIRWMAPES 178
Query: 651 AYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILD-----SRLPYP 704
T K DV+SFGVL E+ G P +S N E+L+ RLP P
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATP---YPGLS------NEEVLEYLRKGYRLPKP 229
Query: 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
++ +M SC +P RPT
Sbjct: 230 E-YCPDELYELML---SCWQLDPEDRPTFS 255
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 72/271 (26%), Positives = 109/271 (40%), Gaps = 55/271 (20%)
Query: 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF------------CSHPR-- 546
D++ IG G +G VY AR + +GE+ A+K D+F C HP
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV 63
Query: 547 ----------QSFIVYEYLESGSLDKILN-NDASAKELGWTQRLNVIKGVADALFYLHNN 595
+ +IV EY GSL I EL Q V + L YLH
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL---QIAYVCRETLKGLAYLHET 120
Query: 596 CFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELA---Y 652
+H DI N+LL + ++DF ++ L + GT +APE+A
Sbjct: 121 ---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 653 TMKVTEKCDVYSFGVLALEVIKGK------HPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706
KCD+++ G+ A+E+ + + HP LF +S S+ P P L
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN-----------FPPPKL 226
Query: 707 DVQNKFMSIMQVAF--SCLDQNPVSRPTMKR 735
+ K+ + F CL ++P RPT +
Sbjct: 227 KDKEKWSPVFH-DFIKKCLTKDPKKRPTATK 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 69/262 (26%), Positives = 106/262 (40%), Gaps = 43/262 (16%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF-------------CSHP- 545
+D + +G+G G VY R P+G+I+A+KK H + F C P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 546 -----------RQSFIVYEYLESGSLDKILNNDASAKELGWTQR-LNVI-KGVADALFYL 592
+ IV EY++ GSL +L K + L I + + L YL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGLDYL 115
Query: 593 HNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAY 652
H I+H DI N+L++ E ++DF I+K L + GT ++PE
Sbjct: 116 HTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ 173
Query: 653 TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712
+ D++S G+ LE GK P FL S + I D P + +
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFP--FLPPGQPSFFELMQAICDG----PPPSLPAEE 227
Query: 713 MSIMQVAF--SCLDQNPVSRPT 732
S F +CL ++P RP+
Sbjct: 228 FSPEFRDFISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 38/199 (19%)
Query: 550 IVYEYLESGSLDKIL-NNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
I+ EY+E+GSLDK L ND + Q + +++G+A + YL + VH D++++
Sbjct: 82 IITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEMNY---VHRDLAAR 135
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGN------VAPE-LAYTMKVTEKCD 661
N+L++ VSDF +++ L + ++ T G APE +AY K T D
Sbjct: 136 NILVNSNLVCKVSDFGLSRRLEDSEATYT----TKGGKIPIRWTAPEAIAYR-KFTSASD 190
Query: 662 VYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQNKFMSI 715
V+SFG++ EV+ G+ P ++MS N +++ + RLP P +D + +
Sbjct: 191 VWSFGIVMWEVMSYGERP---YWDMS------NQDVIKAVEDGYRLP-PPMDCPSALYQL 240
Query: 716 MQVAFSCLDQNPVSRPTMK 734
M C ++ RPT
Sbjct: 241 ML---DCWQKDRNERPTFS 256
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 8e-15
Identities = 55/196 (28%), Positives = 85/196 (43%), Gaps = 31/196 (15%)
Query: 509 IGKGGHGSVYIA-RVPSGEIFAVKKFH--SPLPDNF---------CSHP----------- 545
IG+G G VY A +G+ A+KK + C HP
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 546 -RQSFIVYEYLESGSL-DKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHW 603
+ ++V EY++ GSL D I N E Q V + V L YLH+ ++H
Sbjct: 87 GDELWVVMEYMDGGSLTDIITQNFVRMNE---PQIAYVCREVLQGLEYLHSQ---NVIHR 140
Query: 604 DISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVY 663
DI S N+LL ++DF A L + S + + GT +APE+ K D++
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIW 200
Query: 664 SFGVLALEVIKGKHPR 679
S G++ +E+ +G+ P
Sbjct: 201 SLGIMCIEMAEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 67/262 (25%), Positives = 115/262 (43%), Gaps = 49/262 (18%)
Query: 502 DFDAKHCIGKGGHGSVYIA-RVPSGEIFAVKKFH-------------------SPLPDNF 541
DF+ + IGKG G V+ R ++A+K+ + L ++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 542 CSHPRQSF-------IVYEYLESGSLDKILNNDAS---AKELGWTQRLNVIKGVADALFY 591
+SF IV EY E+G L K+L ++ W + ++ G+A +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116
Query: 592 LHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK-LAGTHGNVAPEL 650
LH+ I+H DI S N+ LD + D +AK L+ D++N++ + GT ++PEL
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPEL 172
Query: 651 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710
EK DV++ GV+ E GKHP D +++ + ++I+ P V
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFD-----ANNQGALILKIIRGVFP----PVSQ 223
Query: 711 KF-MSIMQVAFSCLDQNPVSRP 731
+ + Q+ CL ++ RP
Sbjct: 224 MYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 3e-14
Identities = 65/269 (24%), Positives = 107/269 (39%), Gaps = 55/269 (20%)
Query: 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFH-SPLPDNF-------------CSHP- 545
++ IGKG G VY+ R G+++ +K+ S + + +HP
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 546 ----RQSF-------IVYEYLESGSLDKILNNDASAKE-------LGW-TQRLNVIKGVA 586
+SF IV EY + G L + + + L W Q +
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ-------LC 113
Query: 587 DALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV 646
AL YLH+ I+H DI +N+ L + DF I+K L+ + GT +
Sbjct: 114 LALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYL 170
Query: 647 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706
+PEL K D++S G + E+ KHP FE + +IL + YP +
Sbjct: 171 SPELCQNKPYNYKSDIWSLGCVLYELCTLKHP----FEGENLLELAL-KIL--KGQYPPI 223
Query: 707 DVQ-NKFMSIMQVAFSCLDQNPVSRPTMK 734
Q + + + S L ++P RP++
Sbjct: 224 PSQYSSELR--NLVSSLLQKDPEERPSIA 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 29/203 (14%)
Query: 542 CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIV 601
C+ R FIV EY+ +G L L +LG L++ V +A+ YL +N F +
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLR--ERKGKLGTEWLLDMCSDVCEAMEYLESNGF---I 122
Query: 602 HWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APELAYTMKVTE 658
H D++++N L+ VSDF +A+++ LD S GT V PE+ + +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYV-LDDQYTSS-QGTKFPVKWAPPEVFDYSRFSS 180
Query: 659 KCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQNKF 712
K DV+SFGVL EV +GK P +E S N E+++S RL P L
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMP----YERFS-----NSEVVESVSAGYRLYRPKLAP---- 227
Query: 713 MSIMQVAFSCLDQNPVSRPTMKR 735
+ + +SC + P RP K+
Sbjct: 228 TEVYTIMYSCWHEKPEDRPAFKK 250
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 61/210 (29%), Positives = 89/210 (42%), Gaps = 46/210 (21%)
Query: 509 IGKGGHGSVYIA-RVPSGEIFAVKKFHSPLPDNFCSHPRQSF------------------ 549
IG G GSVY+ SGE+ AVK+ P ++S
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 550 ---------------IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN 594
I EY+ GS+ +LNN + +E T N ++ + L YLHN
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE---TLVRNFVRQILKGLNYLHN 124
Query: 595 NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK------LAGTHGNVAP 648
I+H DI N+L+D +SDF I+K L +S + L G+ +AP
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 649 ELAYTMKVTEKCDVYSFGVLALEVIKGKHP 678
E+ T K D++S G L +E++ GKHP
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 8e-14
Identities = 38/89 (42%), Positives = 50/89 (56%), Gaps = 3/89 (3%)
Query: 239 NQ-LNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPT 297
NQ L G IP D + L +++S N+I GNIP +G L+ LDLS N G IP
Sbjct: 427 NQGLRGFIP--NDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 298 QLGNIIYLNRISLSGNKLSGRIPGELGSL 326
LG + L ++L+GN LSGR+P LG
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 58/198 (29%), Positives = 102/198 (51%), Gaps = 33/198 (16%)
Query: 546 RQSFIVYEYLESGSLDKIL-NNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWD 604
+ + I+ EY+E+G+LDK L ++D E Q + +++G+A + YL + + VH D
Sbjct: 79 KPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSDMNY---VHRD 132
Query: 605 ISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTMKVTEK 659
++++N+L++ E VSDF +++ L D +G G + APE K T
Sbjct: 133 LAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSG--GKIPIRWTAPEAIAYRKFTSA 190
Query: 660 CDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQNKFM 713
DV+SFG++ EV+ G+ P ++MS N E++ + RLP P +D +
Sbjct: 191 SDVWSFGIVMWEVMSFGERP---YWDMS------NHEVMKAINDGFRLPAP-MDCPS--- 237
Query: 714 SIMQVAFSCLDQNPVSRP 731
++ Q+ C Q+ RP
Sbjct: 238 AVYQLMLQCWQQDRARRP 255
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 56/193 (29%), Positives = 100/193 (51%), Gaps = 21/193 (10%)
Query: 546 RQSFIVYEYLESGSLDKILN-NDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWD 604
R I+ E++E+G+LD L ND + Q + +++G+A + YL + VH D
Sbjct: 78 RPVMIITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEMNY---VHRD 131
Query: 605 ISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTMKVTEK 659
++++N+L++ VSDF +++FL D+S+ + + G + APE K T
Sbjct: 132 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSA 191
Query: 660 CDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQV 718
DV+S+G++ EV+ G+ P ++MS+ IE D RLP P +D ++ Q+
Sbjct: 192 SDVWSYGIVMWEVMSYGERP---YWDMSNQDVINAIE-QDYRLP-PPMDCPT---ALHQL 243
Query: 719 AFSCLDQNPVSRP 731
C ++ +RP
Sbjct: 244 MLDCWQKDRNARP 256
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 78/255 (30%), Positives = 119/255 (46%), Gaps = 12/255 (4%)
Query: 201 LSNFTNLVFLYLYNNSF--SGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLS 258
S+ + L+ L L + S S + + NL L + L +N+L I ++ L
Sbjct: 63 PSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLD 122
Query: 259 LLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGR 318
L + +I +I I L+ LDLS N I +P+ L N+ L + LS N LS
Sbjct: 123 LDNNNITDIPPLIGLL---KSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-D 177
Query: 319 IPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLS 378
+P L +L NL LDLS N +S+ + + L L L+LS+N + ++ L NL +LS
Sbjct: 178 LPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSI-IELLSSLSNLKNLS 235
Query: 379 ELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGH 438
L+LS+N L E + I + +LE L+LS N +S L L +D+S N L
Sbjct: 236 GLELSNNKL-EDLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNA 292
Query: 439 IPNSTTFRDAPLEAL 453
+P L
Sbjct: 293 LPLIALLLLLLELLL 307
|
Length = 394 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-13
Identities = 38/102 (37%), Positives = 52/102 (50%), Gaps = 9/102 (8%)
Query: 114 LDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSI 173
L L N L IP IS L L+ ++ N + G+IP + +T L +L +S N NGSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 174 PHEVGQLNFLNHLILDSNFLGGSIPRSLS---------NFTN 206
P +GQL L L L+ N L G +P +L NFT+
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTD 524
|
Length = 623 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 65/258 (25%), Positives = 110/258 (42%), Gaps = 40/258 (15%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF-----------CSHP--- 545
FD +G+G +GSVY A +G++ A+K D C P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-EDLQEIIKEISILKQCDSPYIV 61
Query: 546 ---------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNC 596
+IV EY +GS+ I+ + K L + ++ L YLH+N
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGSVSDIMK--ITNKTLTEEEIAAILYQTLKGLEYLHSN- 118
Query: 597 FPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKV 656
+H DI + N+LL+ +A ++DF ++ L + + + GT +APE+ +
Sbjct: 119 --KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 657 TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIM 716
K D++S G+ A+E+ +GK P ++ M + P P+L K+ S
Sbjct: 177 NNKADIWSLGITAIEMAEGKPP---YSDIHP----MRAIFMIPNKPPPTLSDPEKW-SPE 228
Query: 717 QVAF--SCLDQNPVSRPT 732
F CL ++P RP+
Sbjct: 229 FNDFVKKCLVKDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 58/195 (29%), Positives = 94/195 (48%), Gaps = 19/195 (9%)
Query: 542 CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIV 601
C+ + +IV E++E+G L L +L L++ + V + + YL N F +
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNSF---I 122
Query: 602 HWDISSKNVLLDLGYEAHVSDFRIAKFLNLD---SSNWSKLAGTHGNVAPELAYTMKVTE 658
H D++++N L+ VSDF + +++ D SS+ +K PE+ K +
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWS--PPEVFNFSKYSS 180
Query: 659 KCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717
K DV+SFGVL EV +GK P FE S+ + + RL P L M++ +
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMP----FEKKSNYEVVEMISRGFRLYRPKLAS----MTVYE 232
Query: 718 VAFSCLDQNPVSRPT 732
V +SC + P RPT
Sbjct: 233 VMYSCWHEKPEGRPT 247
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 27/206 (13%)
Query: 542 CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIV 601
CS +I+ E +E GSL L + + L +++ VA+ + YL +
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQ---NSI 126
Query: 602 HWDISSKNVLLDLGYEAHVSDFRIAKFLNLD--SSNWSKLAGTHGNVAPELAYTMKVTEK 659
H D++++N+L+ V+DF +A+ + D S+ K+ + APE A + K
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAASHGTFSTK 184
Query: 660 CDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQNKFM 713
DV+SFG+L E+ G+ P + + N E+ D R+P P+ Q
Sbjct: 185 SDVWSFGILLYEMFTYGQVP----YPGMN-----NHEVYDQITAGYRMPCPAKCPQE--- 232
Query: 714 SIMQVAFSCLDQNPVSRPTMKRFEVQ 739
I ++ C P RP+ K +
Sbjct: 233 -IYKIMLECWAAEPEDRPSFKALREE 257
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 8e-13
Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 19/197 (9%)
Query: 542 CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIV 601
C+ R +IV EY+ +G L L K +Q L + K V + + YL + F +
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLRE--HGKRFQPSQLLEMCKDVCEGMAYLESKQF---I 122
Query: 602 HWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APELAYTMKVTE 658
H D++++N L+D VSDF +++++ LD S + G+ V PE+ K +
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSSV-GSKFPVRWSPPEVLLYSKFSS 180
Query: 659 KCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717
K DV++FGVL EV GK P +E ++S + RL P L + +
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMP----YERFNNSETVEKVSQGLRLYRPHLASE----KVYA 232
Query: 718 VAFSCLDQNPVSRPTMK 734
+ +SC + RPT +
Sbjct: 233 IMYSCWHEKAEERPTFQ 249
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 73/284 (25%), Positives = 102/284 (35%), Gaps = 82/284 (28%)
Query: 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVK--KFHSPLPDNFC---------SHP---- 545
+ IGKG G V + G+ AVK K S F HP
Sbjct: 6 KELKLGATIGKGEFGDVMLG-DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQ 64
Query: 546 --------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCF 597
+IV EY+ GSL L + A + Q+L V + + YL F
Sbjct: 65 LLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEKNF 123
Query: 598 PPIVHWDISSKNVLLDLGYEAHVSDFRIAK--FLNLDSS----NWSKLAGTHGNVAPELA 651
VH D++++NVL+ A VSDF +AK DS W+ APE
Sbjct: 124 ---VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT---------APEAL 171
Query: 652 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL---DV 708
K + K DV+SFG+L E+ + F R+PYP + DV
Sbjct: 172 REKKFSTKSDVWSFGILLWEI--------YSF---------------GRVPYPRIPLKDV 208
Query: 709 QNKFMS-------------IMQVAFSCLDQNPVSRPTMKRFEVQ 739
+ +V C + +P RPT K+ Q
Sbjct: 209 VPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQ 252
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-12
Identities = 42/130 (32%), Positives = 62/130 (47%), Gaps = 7/130 (5%)
Query: 356 LNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLI 415
L L + L IP ++ L HL ++LS N + I + + SLE L+LSYN+ +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 416 PRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEA----LQGNKGLCGDIRGFLSCMS 471
P +L L ++++ N L G +P + R L N GLCG I G +C
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR--LLHRASFNFTDNAGLCG-IPGLRACGP 539
Query: 472 YRKASRKIWI 481
+ KI I
Sbjct: 540 HLSVGAKIGI 549
|
Length = 623 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 47/166 (28%), Positives = 75/166 (45%), Gaps = 21/166 (12%)
Query: 585 VADALFYLHNNCFPPIVHWDISSKNVLLD-LGYEAHVSDFRIAKFLNLDSSNWSKLAGTH 643
+ AL YLH+ I+H DI N+LLD G+ H++DF IA + D+ S +GT
Sbjct: 109 IVLALEYLHSK---GIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTST-SGTP 163
Query: 644 GNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE--ILDSRL 701
G +APE+ + D +S GV A E ++GK P + S + I + +
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP----YRGHSRTIRDQIRAKQETADV 219
Query: 702 PYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNP 747
YP+ +I ++ L+++P KR K +P
Sbjct: 220 LYPATWSTEAIDAINKL----LERDP-----QKRLGDNLKDLKNHP 256
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 68/261 (26%), Positives = 106/261 (40%), Gaps = 49/261 (18%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVK-----KFHSPLPD--------NFCSHP--------- 545
IG G VY A +P+ E A+K K + + + + C+HP
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 546 ---RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVH 602
+ ++V YL GSL I+ + L V+K V L YLH+N +H
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIH 125
Query: 603 WDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK----LAGTHGNVAPELAYTMK-VT 657
DI + N+LL ++DF ++ L K GT +APE+ +
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185
Query: 658 EKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRL--PYPSLDV---QNKF 712
K D++SFG+ A+E+ G P M ++L L PSL+ K+
Sbjct: 186 FKADIWSFGITAIELATGAAPYSKYPPM---------KVLMLTLQNDPPSLETGADYKKY 236
Query: 713 -MSIMQVAFSCLDQNPVSRPT 732
S ++ CL ++P RPT
Sbjct: 237 SKSFRKMISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 69/270 (25%), Positives = 114/270 (42%), Gaps = 52/270 (19%)
Query: 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF------------CSHPR-- 546
DF+ IG G +G VY AR V +GE+ A+K ++F C H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 547 ----------QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNC 596
+ +I E+ GSL I + E Q V + L+YLH+
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSES---QIAYVSRETLQGLYYLHSK- 125
Query: 597 FPPIVHWDISSKNVLL-DLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMK 655
+H DI N+LL D G+ ++DF ++ + + GT +APE+A +
Sbjct: 126 --GKMHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182
Query: 656 ---VTEKCDVYSFGVLALEVIKGK------HPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706
+ CD+++ G+ A+E+ + + HP LF M + SN L ++ +
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--TKSNFQPPKLKDKMKW--- 237
Query: 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRF 736
N F +++A L +NP RPT ++
Sbjct: 238 --SNSFHHFVKMA---LTKNPKKRPTAEKL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 6e-12
Identities = 41/103 (39%), Positives = 59/103 (57%), Gaps = 1/103 (0%)
Query: 284 LDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFV 343
L L + + G IP + + +L I+LSGN + G IP LGS+ +LE LDLS N + +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 344 LESLGSLVKLYYLNLSHNKLSQQIPIELDN-LIHLSELDLSHN 385
ESLG L L LNL+ N LS ++P L L+H + + + N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 6e-12
Identities = 46/156 (29%), Positives = 75/156 (48%), Gaps = 10/156 (6%)
Query: 526 EIFAVKKFHSPLPDNFCSH---PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVI 582
EI +K+ +P NF + F+V EYL GSL ++ + Q V
Sbjct: 66 EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC----MDEAQIAAVC 121
Query: 583 KGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGT 642
+ AL +LH N ++H DI S NVLL + ++DF + + S S + GT
Sbjct: 122 RECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 178
Query: 643 HGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 678
+APE+ K D++S G++A+E+++G+ P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 7e-12
Identities = 53/181 (29%), Positives = 79/181 (43%), Gaps = 22/181 (12%)
Query: 5 ALKNNRVIISL--VFPLILFLVLDFSLAVSSNSTEEAHALVKWKASLEVHSRSLLHSWSL 62
K II+ VF +I A S EE AL K+SL + R W+
Sbjct: 346 PKKGTHAIINAIEVFEIIT--------AESKTLLEEVSALQTLKSSLGLPLR---FGWN- 393
Query: 63 SFVNATKISLCTWSGIHC---NHAGRVF--GINLTSISLNGTLLEFSFSSFPHLAYLDLY 117
+ WSG C + G+ F G+ L + L G + S HL ++L
Sbjct: 394 --GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPN-DISKLRHLQSINLS 450
Query: 118 NNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEV 177
N + IPP + +++ LE LD N +G IP + LT L IL+++ N L+G +P +
Sbjct: 451 GNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
Query: 178 G 178
G
Sbjct: 511 G 511
|
Length = 623 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 68/266 (25%), Positives = 105/266 (39%), Gaps = 52/266 (19%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKK------------------FHSPLPDNF 541
F CIGKG G VY A + ++ A+K F S +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 542 CSHPRQSF-------IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN 594
+ SF I+ EY GS +L +L T +++ V L YLH
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK----PGKLDETYIAFILREVLLGLEYLHE 116
Query: 595 NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTM 654
+H DI + N+LL + ++DF ++ L S + GT +APE+
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQS 173
Query: 655 KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN---- 710
EK D++S G+ A+E+ KG+ P S M + L + PSL+
Sbjct: 174 GYDEKADIWSLGITAIELAKGEPPL-------SDLHPMRVLFLIPKNNPPSLEGNKFSKP 226
Query: 711 --KFMSIMQVAFSCLDQNPVSRPTMK 734
F+S CL+++P RP+ K
Sbjct: 227 FKDFVS------LCLNKDPKERPSAK 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 8e-12
Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 13/281 (4%)
Query: 90 NLTSISLNGTLLEFSFSS---FPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLS 146
L S+ LN L + S +L LDL NN + DI P S L+ LD NK+
Sbjct: 94 PLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE 153
Query: 147 GHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTN 206
+PS + L +L L +S N L+ +P + L+ LN+L L N + +P + +
Sbjct: 154 -SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI-SDLPPEIELLSA 210
Query: 207 LVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINN 266
L L L NNS + + NLK+L ++L N+L +P SI G L LD+S NN
Sbjct: 211 LEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESI--GNLSNLETLDLS-NN 265
Query: 267 ITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSL 326
+I +G L+ LDLS N + + ++ L + L+ + +L S+
Sbjct: 266 QISSIS-SLGSLTNLRELDLSGN-SLSNALPLIALLLLLLELLLNLLLTLKALELKLNSI 323
Query: 327 INLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQI 367
+ + + S L L SL L+ L+ + ++ +
Sbjct: 324 LLNNNILSNGETSSPEALSILESLNNLWTLDNALDESNLNR 364
|
Length = 394 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 9e-12
Identities = 48/198 (24%), Positives = 80/198 (40%), Gaps = 33/198 (16%)
Query: 508 CIGKGGHGSVYIA-RVPSGEIFAVKKF--HSPLPDNFCS------------HP------- 545
IG+G G VY + +G+ A+K+ + S HP
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 546 -----RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 600
+I+ EY E+GSL +I+ E + + V L YLH +
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPE---SLVAVYVYQVLQGLAYLHEQ---GV 120
Query: 601 VHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKC 660
+H DI + N+L ++DF +A LN S + + + GT +APE+ +
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTAS 180
Query: 661 DVYSFGVLALEVIKGKHP 678
D++S G +E++ G P
Sbjct: 181 DIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 68/258 (26%), Positives = 111/258 (43%), Gaps = 56/258 (21%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN----------FCSHPRQS--------- 548
IG+G +G+VY + VP+G + A+K + PD+ S RQS
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 549 ---------FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 599
+I+ EY E GS+ ++ A + +I+ V AL Y+H
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMK--AGPIAEKYISV--IIREVLVALKYIHKV---G 121
Query: 600 IVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPEL-----AYTM 654
++H DI + N+L+ + DF +A LN +SS S GT +APE+ Y
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDT 181
Query: 655 KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714
K D++S G+ E+ G P S + + ++ P P L+ N +
Sbjct: 182 KA----DIWSLGITIYEMATGNPP------YSDVDAFRAMMLIPKSKP-PRLE-DNGYSK 229
Query: 715 IMQ--VAFSCLDQNPVSR 730
+++ VA +CLD+ P R
Sbjct: 230 LLREFVA-ACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-11
Identities = 35/82 (42%), Positives = 47/82 (57%)
Query: 145 LSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNF 204
L G IP++IS L HL +++S N + G+IP +G + L L L N GSIP SL
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 205 TNLVFLYLYNNSFSGSIPQQIG 226
T+L L L NS SG +P +G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 44/201 (21%)
Query: 509 IGKGGHGSVYIA-RVPSGEIFAVKKFHSPLPDNFCSHPRQSFI----------------- 550
IG+G G+VY A V +G+ A+K+ N P++ I
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM------NLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 551 -------------VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCF 597
V EYL GSL ++ + + Q V + AL +LH+N
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN-- 134
Query: 598 PPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVT 657
++H DI S N+LL + ++DF + + S S + GT +APE+
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193
Query: 658 EKCDVYSFGVLALEVIKGKHP 678
K D++S G++A+E+++G+ P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 73/278 (26%), Positives = 117/278 (42%), Gaps = 52/278 (18%)
Query: 495 EIIRAT--NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF---------- 541
+I+R +D++ +G G +G VY AR + +GE+ AVK D+F
Sbjct: 1 DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMV 60
Query: 542 --CSHP------------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVAD 587
C H + +I EY GSL I + EL Q V +
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL---QIAYVCRETLQ 117
Query: 588 ALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVA 647
L YLH+ +H DI N+LL + ++DF +A + + GT +A
Sbjct: 118 GLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMA 174
Query: 648 PELAYTMK---VTEKCDVYSFGVLALEVIKGK------HPRDFLFEMSSSSSNMNIEILD 698
PE+A K + CD+++ G+ A+E+ + + HP LF M S SN L
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--SKSNFQPPKLK 232
Query: 699 SRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRF 736
+ + S F + ++++ L +NP RPT +R
Sbjct: 233 DKTKWSS-----TFHNFVKIS---LTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 62/265 (23%), Positives = 105/265 (39%), Gaps = 51/265 (19%)
Query: 502 DFDAKHCIGKGGHGSVY-IARVPSGEIFAVKKFH-SPLPDN-------------FCSHP- 545
DF +GKG +GSVY + R+ + +A+K+ + +HP
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 546 ----RQSF-------IVYEYLESGSLDKILNNDASAK-----ELGWTQRLNVIKGVADAL 589
+++F IV EY G L K ++ + + W + +++G L
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG----L 116
Query: 590 FYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLA-GTHGNVAP 648
LH I+H D+ S N+LL + D I+K L N +K GT +AP
Sbjct: 117 QALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAP 170
Query: 649 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708
E+ + K D++S G L E+ P FE + S ++ ++ + P P +
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPP----FE-ARSMQDLRYKVQRGKYP-PIPPI 224
Query: 709 QNKFMSIMQVAFSCLDQNPVSRPTM 733
++ + S L P RP
Sbjct: 225 YSQDLQ--NFIRSMLQVKPKLRPNC 247
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 52/201 (25%), Positives = 86/201 (42%), Gaps = 44/201 (21%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNFCSHPRQSFI----------------- 550
IG+G G+VY A V +G+ A+++ N P++ I
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM------NLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 551 -------------VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCF 597
V EYL GSL ++ + Q V + AL +LH+N
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN-- 135
Query: 598 PPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVT 657
++H DI S N+LL + ++DF + + S S + GT +APE+
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 658 EKCDVYSFGVLALEVIKGKHP 678
K D++S G++A+E+I+G+ P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 19/190 (10%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+I+ EYL GS +L A Q ++K + L YLH+ +H DI +
Sbjct: 78 WIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAA 130
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVL 668
NVLL + ++DF +A L + GT +APE+ K D++S G+
Sbjct: 131 NVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGIT 190
Query: 669 ALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL--DVQNKFMSIMQVAFSCLDQN 726
A+E+ KG+ P +S M + L + P+L + F + +CL+++
Sbjct: 191 AIELAKGEPP-------NSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFID---ACLNKD 240
Query: 727 PVSRPTMKRF 736
P RPT K
Sbjct: 241 PSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-11
Identities = 36/91 (39%), Positives = 51/91 (56%), Gaps = 2/91 (2%)
Query: 262 VSINN--ITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRI 319
+ ++N + G IP +I + LQ ++LS N I G IP LG+I L + LS N +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 320 PGELGSLINLEYLDLSANHLSNFVLESLGSL 350
P LG L +L L+L+ N LS V +LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 73/275 (26%), Positives = 103/275 (37%), Gaps = 69/275 (25%)
Query: 509 IGKGGHGSVYIARVP-SGEIFAVKKFH-SPLPD------------NFCSHP--------- 545
+G+G GSV R+ +G IFA+K P PD C P
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 546 -----RQSFIVYEYLESGSLDKIL------NNDASAKELGWTQRLNVIKGVADALFYLHN 594
I EY E GSLD I K LG + + V L YLH+
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVLKGLSYLHS 123
Query: 595 NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPE----L 650
I+H DI N+LL + + DF ++ L +S GT +APE
Sbjct: 124 R---KIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGTFTGTSFYMAPERIQGK 178
Query: 651 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD--SRLPYPSL-- 706
Y++ DV+S G+ LEV + + P F IE+L +P P L
Sbjct: 179 PYSI----TSDVWSLGLTLLEVAQNRFP----FPPEGEPPLGPIELLSYIVNMPNPELKD 230
Query: 707 DVQNK------FMSIMQVAFSCLDQNPVSRPTMKR 735
+ N F ++ CL+++P RPT
Sbjct: 231 EPGNGIKWSEEFKDFIKQ---CLEKDPTRRPTPWD 262
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 6e-11
Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 44/201 (21%)
Query: 509 IGKGGHGSVYIA-RVPSGEIFAVKKFHSPLPDNFCSHPRQSFI----------------- 550
IG+G G+VY A + +G+ A+K+ N P++ I
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM------NLQQQPKKELIINEILVMRENKNPNIVN 80
Query: 551 -------------VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCF 597
V EYL GSL ++ + Q V + AL +LH+N
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALDFLHSN-- 134
Query: 598 PPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVT 657
++H DI S N+LL + ++DF + + S S + GT +APE+
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193
Query: 658 EKCDVYSFGVLALEVIKGKHP 678
K D++S G++A+E+++G+ P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 63/263 (23%), Positives = 101/263 (38%), Gaps = 40/263 (15%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF-------------CSHP- 545
+D + +G G G V P+G+I AVK + + C+ P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 546 -----------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN 594
I EY++ GSLDKIL + + V L YLH
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHE 118
Query: 595 NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTM 654
I+H D+ N+L++ + + DF ++ L +S GT +APE
Sbjct: 119 KH--KIIHRDVKPSNILVNSRGQIKLCDFGVSG--QLVNSLAKTFVGTSSYMAPERIQGN 174
Query: 655 KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRL--PYPSLDVQNKF 712
+ K D++S G+ +E+ G+ P + + E+L + P P L KF
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPP----ENDPPDGIFELLQYIVNEPPPRLP-SGKF 229
Query: 713 MSIMQVAFS-CLDQNPVSRPTMK 734
Q + CL ++P RP+ K
Sbjct: 230 SPDFQDFVNLCLIKDPRERPSYK 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 30/201 (14%)
Query: 542 CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIV 601
CS +IV EY+ GSL L + K+L Q +++ +A+ + YL + + +
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRNY---I 125
Query: 602 HWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APELAYTMKVTE 658
H D++++N+L+ ++DF +A+ + D ++ G + APE A + T
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDE--YTAREGAKFPIKWTAPEAANYGRFTI 183
Query: 659 KCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNM-NIEILDS-----RLPYPSLDVQNK 711
K DV+SFG+L E++ G+ P M N E+L+ R+P P N
Sbjct: 184 KSDVWSFGILLTEIVTYGRVP----------YPGMTNREVLEQVERGYRMPRP----PNC 229
Query: 712 FMSIMQVAFSCLDQNPVSRPT 732
+ + C D++P RPT
Sbjct: 230 PEELYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 42/105 (40%), Positives = 60/105 (57%), Gaps = 7/105 (6%)
Query: 167 NQ-LNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQI 225
NQ L G IP+++ +L L + L N + G+IP SL + T+L L L NSF+GSIP+ +
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 226 GNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGN 270
G L SL + L N L+G +P ++ GR LL + N T N
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG-GR-----LLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 60/193 (31%), Positives = 84/193 (43%), Gaps = 30/193 (15%)
Query: 550 IVYEYLESGSLDKIL--NNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISS 607
+V E G L K L + +L + VA + YL + F VH D+++
Sbjct: 72 LVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLESKHF---VHRDLAA 123
Query: 608 KNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGN-----VAPELAYTMKVTEKCDV 662
+NVLL ++A +SDF +++ L S + A T G APE K + K DV
Sbjct: 124 RNVLLVNRHQAKISDFGMSRALGAGSDYYR--ATTAGRWPLKWYAPECINYGKFSSKSDV 181
Query: 663 YSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS--RLPYPSLDVQNKFMSIMQVA 719
+S+GV E G P EM + I +L+S RLP P Q + SIM
Sbjct: 182 WSYGVTLWEAFSYGAKPYG---EMKGAEV---IAMLESGERLPRPEECPQEIY-SIML-- 232
Query: 720 FSCLDQNPVSRPT 732
SC P RPT
Sbjct: 233 -SCWKYRPEDRPT 244
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 55/189 (29%), Positives = 93/189 (49%), Gaps = 23/189 (12%)
Query: 550 IVYEYLESGSLDKIL-NNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
IV EY+E+GSLD L +D + Q + +++G+A + YL + + VH D++++
Sbjct: 82 IVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDMGY---VHRDLAAR 135
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTMKVTEKCDVY 663
N+L++ VSDF +++ L D + G + APE K T DV+
Sbjct: 136 NILVNSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVW 193
Query: 664 SFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSC 722
S+G++ EV+ G+ P +EMS+ IE RLP P +D ++ Q+ C
Sbjct: 194 SYGIVMWEVMSYGERP---YWEMSNQDVIKAIE-EGYRLPAP-MDCP---AALHQLMLDC 245
Query: 723 LDQNPVSRP 731
++ RP
Sbjct: 246 WQKDRNERP 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 64/266 (24%), Positives = 103/266 (38%), Gaps = 46/266 (17%)
Query: 502 DFDAKHCIGKGGHGSVYIA-RVPSGEIFAVKKFH---------SPLPDNF-----CSHP- 545
D++ IGKG G+V R G+I K+ L HP
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60
Query: 546 ----------RQS---FIVYEYLESGSLDKILNNDASAKE-LGWTQRLNVIKGVADALFY 591
R + +IV EY E G L +++ ++ + ++ + AL+
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 592 LHNNCFPP--IVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPE 649
HN P ++H D+ N+ LD + DF +AK L DSS GT ++PE
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPE 180
Query: 650 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD---SRLPYPSL 706
M EK D++S G L E+ P F + + + +I + R+PY
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALSPP----FT-ARNQLQLASKIKEGKFRRIPYRYS 235
Query: 707 DVQNKFMSIMQVAFSCLDQNPVSRPT 732
N+ + S L+ +P RP+
Sbjct: 236 SELNEVIK------SMLNVDPDKRPS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 53/188 (28%), Positives = 84/188 (44%), Gaps = 15/188 (7%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+I+ EYL GS +L L TQ +++ + L YLH+ +H DI +
Sbjct: 78 WIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAA 130
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVL 668
NVLL E ++DF +A L + GT +APE+ K D++S G+
Sbjct: 131 NVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 190
Query: 669 ALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPV 728
A+E+ KG+ P S M + L + P+L+ N + + +CL++ P
Sbjct: 191 AIELAKGEPPH-------SELHPMKVLFLIPKNNPPTLE-GNYSKPLKEFVEACLNKEPS 242
Query: 729 SRPTMKRF 736
RPT K
Sbjct: 243 FRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 63.2 bits (152), Expect = 2e-10
Identities = 62/270 (22%), Positives = 110/270 (40%), Gaps = 51/270 (18%)
Query: 509 IGKGGHGSVYIARVPSGEIFAVKKFHSPLPD----------------------------N 540
+G+G G VY+AR ++ A+K L +
Sbjct: 8 LGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 541 FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 600
F ++V EY++ GSL+ +L L ++ L ++ + AL YLH+ I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---I 122
Query: 601 VHWDISSKNVLLD-LGYEAHVSDFRIAKFLNLDSSN------WSKLAGTHGNVAPELAYT 653
+H DI +N+LLD G + DF +AK L S S GT G +APE+
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 654 M---KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEIL------DSRLPYP 704
+ + D++S G+ E++ G P F E +SS+++ ++I+ P
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPP--FEGEKNSSATSQTLKIILELPTPSLASPLS 240
Query: 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+ + + + L ++P +R +
Sbjct: 241 PSNPELISKAASDLLKKLLAKDPKNRLSSS 270
|
Length = 384 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 59/202 (29%), Positives = 90/202 (44%), Gaps = 22/202 (10%)
Query: 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKN 609
+V E E G L+K L + E T+ ++ V+ + YL F VH D++++N
Sbjct: 72 LVMELAELGPLNKFLQKNKHVTEKNITE---LVHQVSMGMKYLEETNF---VHRDLAARN 125
Query: 610 VLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGN-----VAPELAYTMKVTEKCDVYS 664
VLL + A +SDF ++K L D N+ K A THG APE K + K DV+S
Sbjct: 126 VLLVTQHYAKISDFGLSKALGAD-ENYYK-AKTHGKWPVKWYAPECMNYYKFSSKSDVWS 183
Query: 665 FGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCL 723
FGVL E G+ P M + IE R+ P + +M++ C
Sbjct: 184 FGVLMWEAFSYGQKP---YKGMKGNEVTQMIE-SGERMECPQ-RCPPEMYDLMKL---CW 235
Query: 724 DQNPVSRPTMKRFEVQSKQFHY 745
RP E++ + ++Y
Sbjct: 236 TYGVDERPGFAVVELRLRNYYY 257
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 57/208 (27%), Positives = 82/208 (39%), Gaps = 48/208 (23%)
Query: 509 IGKGGHGSVYIA-RVPSGEIFAVK--KFHSPLPDNF------------CSHP-------- 545
IG G G VY A + +GE+ AVK + P HP
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 546 ----RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVA----DALFYLHNNCF 597
+ +I EY G+L+++L E G +VI+ + L YLH++
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELL-------EHGRILDEHVIRVYTLQLLEGLAYLHSH-- 118
Query: 598 PPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS----SNWSKLAGTHGNVAPELAYT 653
IVH DI N+ LD + DF A L ++ LAGT +APE+
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 654 MKVTEK---CDVYSFGVLALEVIKGKHP 678
K D++S G + LE+ GK P
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 28/198 (14%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+IV EY+ GSL L D + L +++ VA + Y+ + +H D+ S
Sbjct: 76 YIVTEYMSKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGMAYIERMNY---IHRDLRSA 131
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APELAYTMKVTEKCDVYSF 665
N+L+ G ++DF +A+ + + + ++ G + APE A + T K DV+SF
Sbjct: 132 NILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189
Query: 666 GVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQNKFMSIMQVA 719
G+L E++ KG+ P + N E+L+ R+P P Q+ +S+ ++
Sbjct: 190 GILLTELVTKGRVPYPGM---------NNREVLEQVERGYRMPCP----QDCPISLHELM 236
Query: 720 FSCLDQNPVSRPTMKRFE 737
C ++P RPT + +
Sbjct: 237 LQCWKKDPEERPTFEYLQ 254
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 38/130 (29%), Positives = 65/130 (50%), Gaps = 7/130 (5%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+++ E+L+ G+L I+ S L Q V + V AL YLH+ ++H DI S
Sbjct: 94 WVLMEFLQGGALTDIV----SQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSD 146
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVL 668
++LL L +SDF ++ D L GT +APE+ + D++S G++
Sbjct: 147 SILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIM 206
Query: 669 ALEVIKGKHP 678
+E++ G+ P
Sbjct: 207 VIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 33/199 (16%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+IV E ++ GSL + L A + L Q +++ VA + YL + +H D++++
Sbjct: 77 YIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQNY---IHRDLAAR 132
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APELAYTMKVTEKCDVYSF 665
NVL+ V+DF +A+ + + G + APE A + + K DV+SF
Sbjct: 133 NVLVGENNICKVADFGLARVI--KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSF 190
Query: 666 GVLALEVIK-GKHPRDFLFEMSSSSSNM-NIEILDS-----RLPYPSLDVQNKFMSIMQV 718
G+L E++ G+ P M N E+L R+P P + IM
Sbjct: 191 GILLTEIVTYGRMP----------YPGMTNAEVLQQVDQGYRMPCPP-GCPKELYDIML- 238
Query: 719 AFSCLDQNPVSRPTMKRFE 737
C ++P RPT FE
Sbjct: 239 --DCWKEDPDDRPT---FE 252
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 68/288 (23%), Positives = 112/288 (38%), Gaps = 74/288 (25%)
Query: 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN-------------FCSH 544
T F+ IG+G +G VY AR +G++ A+K + D + +H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILRKYSNH 62
Query: 545 PR------------------QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVI---- 582
P Q ++V E GS+ ++ ++ G + I
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKG---LRKKGKRLKEEWIAYIL 119
Query: 583 KGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK--LA 640
+ L YLH N ++H DI +N+LL E + DF ++ LDS+ +
Sbjct: 120 RETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFI 174
Query: 641 GTHGNVAPELAYTMKVTE-----KCDVYSFGVLALEVIKGK------HPRDFLFEMSSSS 689
GT +APE+ + + + DV+S G+ A+E+ GK HP LF++ +
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP 234
Query: 690 SNMNIEILDSRLPYPSLDVQ--NKFMSIMQVAFSCLDQNPVSRPTMKR 735
L P + N F+S CL +N RP M+
Sbjct: 235 P--------PTLKSPENWSKKFNDFIS------ECLIKNYEQRPFMEE 268
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 67/270 (24%), Positives = 114/270 (42%), Gaps = 56/270 (20%)
Query: 509 IGKGGHGSVYIA-RVPSGEIFAVKKFHSPLPDNFCSHPRQSFIV---------------- 551
IGKG +G VY+A V +GE+ AVK+ P RQ +V
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 552 ------------------YEYLESGSLDKILNNDASAKE---LGWTQRLNVIKGVADALF 590
EY+ GS+ L +E +T++ V++G+A
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--VLEGLA---- 122
Query: 591 YLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN--LDSSNWSKLAGTHGNVAP 648
YLH+ I+H D+ + N+L+D +SDF I+K + D+ + G+ +AP
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 649 EL--AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706
E+ +Y+ + K D++S G + LE+ G+ P + + ++ + S P P
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS---DEEAIAAMFKLGNKRSAPPIPP- 235
Query: 707 DVQNKFMSI-MQVAFSCLDQNPVSRPTMKR 735
DV + + +C NP +RPT +
Sbjct: 236 DVSMNLSPVALDFLNACFTINPDNRPTARE 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 50/195 (25%), Positives = 93/195 (47%), Gaps = 28/195 (14%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+IV E++ GSL L + K L Q +++ +AD + Y+ + +H D+ +
Sbjct: 76 YIVTEFMGKGSLLDFLK-EGDGKYLKLPQLVDMAAQIADGMAYIERMNY---IHRDLRAA 131
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APELAYTMKVTEKCDVYSF 665
N+L+ ++DF +A+ + + + ++ G + APE A + T K DV+SF
Sbjct: 132 NILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189
Query: 666 GVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQNKFMSIMQVA 719
G+L E++ KG+ P + +N E+L+ R+P P Q S+ ++
Sbjct: 190 GILLTELVTKGRVPYPGM---------VNREVLEQVERGYRMPCP----QGCPESLHELM 236
Query: 720 FSCLDQNPVSRPTMK 734
C ++P RPT +
Sbjct: 237 KLCWKKDPDERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 32/195 (16%)
Query: 509 IGKGGHGSVYIARVPS-GEIFAVKK---------------------FHSP-LPDNFCSH- 544
IG+G G V IA S G AVKK + P + + + S+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 545 -PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHW 603
+ ++V E+LE G+L I+ + + Q V V AL +LH ++H
Sbjct: 87 VGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLAVLKALSFLHAQ---GVIHR 139
Query: 604 DISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVY 663
DI S ++LL +SDF ++ + L GT +APE+ + + D++
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIW 199
Query: 664 SFGVLALEVIKGKHP 678
S G++ +E++ G+ P
Sbjct: 200 SLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 28/198 (14%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+IV EY+ GSL L + K L Q +++ +A + Y+ + VH D+ +
Sbjct: 76 YIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAA 131
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APELAYTMKVTEKCDVYSF 665
N+L+ V+DF +A+ + + + ++ G + APE A + T K DV+SF
Sbjct: 132 NILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189
Query: 666 GVLALEV-IKGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQNKFMSIMQVA 719
G+L E+ KG+ P + +N E+LD R+P P + S+ +
Sbjct: 190 GILLTELTTKGRVPYPGM---------VNREVLDQVERGYRMPCPPECPE----SLHDLM 236
Query: 720 FSCLDQNPVSRPTMKRFE 737
C + P RPT + +
Sbjct: 237 CQCWRKEPEERPTFEYLQ 254
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 27/196 (13%)
Query: 549 FIVYEYLESGSLDKILNNDAS--AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDIS 606
+V+E++E G L L ++E L+V +G+A YL ++ +H D++
Sbjct: 75 CLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMA----YLESSNV---IHRDLA 127
Query: 607 SKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APELAYTMKVTEKCDVY 663
++N L+ VSDF + +F+ LD ++ GT V +PE+ K + K DV+
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFV-LDD-QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 664 SFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS--RLPYPSLDVQNKFMSIMQVAF 720
SFGVL EV +GK P + + S++ +E +++ RL P L Q S+ ++
Sbjct: 186 SFGVLMWEVFSEGKTPYE------NRSNSEVVETINAGFRLYKPRLASQ----SVYELMQ 235
Query: 721 SCLDQNPVSRPTMKRF 736
C + P RP+
Sbjct: 236 HCWKERPEDRPSFSLL 251
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 54/195 (27%), Positives = 90/195 (46%), Gaps = 32/195 (16%)
Query: 509 IGKGGHGSVYIA-RVPSGEIFAVKKF----------------------HSPLPDNFCSH- 544
IG+G G V IA +G+ AVKK H + D + S+
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 545 -PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHW 603
+ ++V E+LE G+L I+ + +E T L+V++ AL YLHN ++H
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLR----ALSYLHNQ---GVIHR 142
Query: 604 DISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVY 663
DI S ++LL +SDF ++ + L GT +APE+ + + D++
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 664 SFGVLALEVIKGKHP 678
S G++ +E+I G+ P
Sbjct: 203 SLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 53/195 (27%), Positives = 88/195 (45%), Gaps = 32/195 (16%)
Query: 509 IGKGGHGSVYIARV-PSGEIFAVKKF----------------------HSPLPDNFCSH- 544
IG+G G V IA V SG++ AVKK H + + + S+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 545 -PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHW 603
+ ++V E+LE G+L I+ + +E L V+K AL LH ++H
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLK----ALSVLHAQ---GVIHR 140
Query: 604 DISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVY 663
DI S ++LL +SDF ++ + L GT +APEL + + D++
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 664 SFGVLALEVIKGKHP 678
S G++ +E++ G+ P
Sbjct: 201 SLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 69/255 (27%), Positives = 106/255 (41%), Gaps = 48/255 (18%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKF-------HSPLPD--------NFCSHPR------ 546
IG G G+VY AR V + E+ A+KK + D HP
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 547 ------QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 600
+++V EY GS IL + K L + + G L YLH++
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDIL--EVHKKPLQEVEIAAICHGALQGLAYLHSHE---R 136
Query: 601 VHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTM---KVT 657
+H DI + N+LL ++DF A ++ +S GT +APE+ M +
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGTPYWMAPEVILAMDEGQYD 192
Query: 658 EKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717
K DV+S G+ +E+ + K P LF M++ S+ +I DS P+L +
Sbjct: 193 GKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNDS----PTLSSNDWSDYFRN 245
Query: 718 VAFSCLDQNPVSRPT 732
SCL + P RP+
Sbjct: 246 FVDSCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 73/276 (26%), Positives = 104/276 (37%), Gaps = 80/276 (28%)
Query: 509 IGKGGHGSVYIARVPSGEIFAVK-----------------KFHSP--------------- 536
+GKG +G+VY G++ AVK K
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 537 ----LPDNFCSHPRQSFIVYEYLESGSLDKILNNDASAKEL---GWTQRLNVIKGVADAL 589
L DN S I E++ GS+ ILN E +T++ ++ GVA
Sbjct: 68 LGTCLDDNTIS------IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ--ILDGVA--- 116
Query: 590 FYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV--- 646
YLHNNC +VH DI NV+L + DF A+ L W L GTH N+
Sbjct: 117 -YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA-----WVGLHGTHSNMLKS 167
Query: 647 --------APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD 698
APE+ K D++S G E+ GK P + +++ I
Sbjct: 168 MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM-----FYIGA 222
Query: 699 SRLPYPSLDVQNKFMSIMQVAF--SCLDQNPVSRPT 732
R P L + F S + F SCL ++ RP+
Sbjct: 223 HRGLMPRLP--DSF-SAAAIDFVTSCLTRDQHERPS 255
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 64/277 (23%), Positives = 106/277 (38%), Gaps = 73/277 (26%)
Query: 509 IGKGGHGSVYIARVPS-GEIFAVK------------------------KFHSP-LPDNFC 542
I KG +G V++A+ S G+I+A+K + SP + +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 543 S--HPRQSFIVYEYLESGSLDKILNN-----DASAKELGWTQRLNVIKGVADALFYLHNN 595
S + ++V EYL G L +L N + A+ I + AL YLH+N
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR--------IYIAEIVLALEYLHSN 112
Query: 596 CFPPIVHWDISSKNVLLDLGYEAHV--SDF--------RIAKFLNLDSSNWSKLAGTHGN 645
I+H D+ N+L+D H+ +DF R LN D ++ GT
Sbjct: 113 ---GIIHRDLKPDNILID--SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 646 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE-ILDSRLPYP 704
+APE+ ++ D +S G + E + G P F + + IL+ ++ +P
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP----FHG--ETPEEIFQNILNGKIEWP 221
Query: 705 SLDVQNKFMSIMQVAFS----CLDQNPVSRPTMKRFE 737
+ + A L +P R K E
Sbjct: 222 E------DVEVSDEAIDLISKLLVPDPEKRLGAKSIE 252
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 52/190 (27%), Positives = 86/190 (45%), Gaps = 19/190 (10%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+I+ EYL GS +L L T +++ + L YLH+ +H DI +
Sbjct: 78 WIIMEYLGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAA 130
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVL 668
NVLL + ++DF +A L + GT +APE+ K D++S G+
Sbjct: 131 NVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGIT 190
Query: 669 ALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK--FMSIMQVAFSCLDQN 726
A+E+ KG+ P +S M + L + P+L+ Q F ++ +CL+++
Sbjct: 191 AIELAKGEPP-------NSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVE---ACLNKD 240
Query: 727 PVSRPTMKRF 736
P RPT K
Sbjct: 241 PRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-08
Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 2/98 (2%)
Query: 182 FLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQL 241
F++ L LD+ L G IP +S +L + L NS G+IP +G++ SL + L N
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 242 NGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESP 279
NG+IP S+ G+ L +L+++ N+++G +P +G
Sbjct: 479 NGSIPESL--GQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 44/158 (27%), Positives = 81/158 (51%), Gaps = 28/158 (17%)
Query: 550 IVYEYLESGSLDKILNN---DA----------SAKELGWTQRLNVIKGVADALFYLHNNC 596
+V+EY++ G L+K L DA + ELG +Q L++ +A + YL +
Sbjct: 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH 143
Query: 597 FPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVA-----PELA 651
F VH D++++N L+ + DF +++ ++ S+++ ++ G H + PE
Sbjct: 144 F---VHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRVGG-HTMLPIRWMPPESI 197
Query: 652 YTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSS 688
K T + DV+SFGV+ E+ GK P F++S++
Sbjct: 198 MYRKFTTESDVWSFGVILWEIFTYGKQP---WFQLSNT 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 59/179 (32%)
Query: 581 VIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLA 640
V KG++ F NC +H D++++N+LL G + DF +A+ + DS+ K
Sbjct: 223 VAKGMS---FLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK-- 273
Query: 641 GTHGN-------VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN 693
GN +APE + T + DV+S+G+L E +F + SS
Sbjct: 274 ---GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWE----------IFSLGSS----- 315
Query: 694 IEILDSRLPYPSLDVQNKFMSIMQVAF-----------------SCLDQNPVSRPTMKR 735
PYP + V +KF +++ + SC D +P+ RPT K+
Sbjct: 316 --------PYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQ 366
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 62/255 (24%), Positives = 98/255 (38%), Gaps = 49/255 (19%)
Query: 509 IGKGGHGSVYIARVPSGEIFAVKKFHSPLPDNF-------------CSHPR--------- 546
IGKG G VY + AVK S LP + HP
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 547 QS---FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVH 602
Q +IV E + GSL L + + + L + A + YL + NC +H
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLTVK--KLLQMSLDAAAGMEYLESKNC----IH 116
Query: 603 WDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTMKVT 657
D++++N L+ +SDF +++ + ++ G + APE + T
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGL-KQIPIKWTAPEALNYGRYT 173
Query: 658 EKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIM 716
+ DV+S+G+L E G P MS+ + IE R+P P L + +M
Sbjct: 174 SESDVWSYGILLWETFSLGDTPYP---GMSNQQTRERIES-GYRMPAPQL-CPEEIYRLM 228
Query: 717 QVAFSCLDQNPVSRP 731
C +P +RP
Sbjct: 229 L---QCWAYDPENRP 240
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (133), Expect = 3e-08
Identities = 63/263 (23%), Positives = 103/263 (39%), Gaps = 69/263 (26%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKFH-SPLPDN--------------FCSHPRQSFIV- 551
+GKG G V + R +G+++A+K + +HP FIV
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHP---FIVK 57
Query: 552 -----------Y---EYLESGSLDKILNNDASAKELGWTQRLNVIKGVAD---ALFYLHN 594
Y EY G L L+ + E + A+ AL YLH+
Sbjct: 58 LHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE-ERARFY-----AAEIVLALEYLHS 111
Query: 595 NCFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAK-FLNLDSSNWSKLAGTHGNVAPEL- 650
I++ D+ +N+LLD + H+ +DF +AK + S + GT +APE+
Sbjct: 112 L---GIIYRDLKPENILLD--ADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVL 165
Query: 651 ---AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLD 707
Y V D +S GVL E++ GK P F + + +IL L +P
Sbjct: 166 LGKGYGKAV----DWWSLGVLLYEMLTGKPP----FY-AEDRKEIYEKILKDPLRFPE-F 215
Query: 708 VQNKFMSIMQVAFSCLDQNPVSR 730
+ + ++ L ++P R
Sbjct: 216 LSPEARDLIS---GLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 62/276 (22%), Positives = 104/276 (37%), Gaps = 67/276 (24%)
Query: 509 IGKGGHGSVYIARVP-----SGEIFAVKKFHSPLPDNFCS-------------------- 543
+G+G G V + R +GE AVK + + S
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 544 -------HPRQSFIVYEYLESGSLDKIL----NNDASAKELGWTQRLNVIKGVADALFYL 592
R ++ EYL SGSL L + + L ++ + + + YL
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ------ICKGMDYL 125
Query: 593 HNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----A 647
+ +H D++++N+L++ +SDF +AK L D + G A
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYY--VKEPGESPIFWYA 180
Query: 648 PELAYTMKVTEKCDVYSFGVLALEVI----KGKHP-RDFLFEMSSSSSNMN----IEILD 698
PE T K + DV+SFGV E+ + P +FL + + M +E+L
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240
Query: 699 S--RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT 732
RLP P ++ +M+ C + P RP+
Sbjct: 241 EGERLPRPP-SCPDEVYDLMK---LCWEAEPQDRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 28/194 (14%)
Query: 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKN 609
I+ E+ + G+LD I+ + L Q V + + +AL +LH++ ++H D+ + N
Sbjct: 79 ILIEFCDGGALDSIM--LELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGN 133
Query: 610 VLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAY--TMKVTE---KCDVYS 664
+LL L + ++DF ++ GT +APE+ T K K D++S
Sbjct: 134 ILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWS 193
Query: 665 FGVLALEVIKGKHPRDFLFEMSSSSSNMN-----IEILDSRLPYPSLDVQNKFMSIMQ-V 718
G+ +E+ + + P +N ++IL S P+LD +K+ S
Sbjct: 194 LGITLIELAQMEPPH----------HELNPMRVLLKILKS--EPPTLDQPSKWSSSFNDF 241
Query: 719 AFSCLDQNPVSRPT 732
SCL ++P RPT
Sbjct: 242 LKSCLVKDPDDRPT 255
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 68/261 (26%), Positives = 104/261 (39%), Gaps = 48/261 (18%)
Query: 503 FDAKHCIGKGGHGSVYIA-RVPSGEIFAVKKF-------HSPLPDNF--------CSHP- 545
F H IG G G+VY A + E+ AVKK + D HP
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 546 -----------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN 594
+++V EY + D + + K L + + G L YLH+
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 595 NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTM 654
+ ++H DI + N+LL + ++DF A SS + GT +APE+ M
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANSFVGTPYWMAPEVILAM 192
Query: 655 KVTE---KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711
+ K DV+S G+ +E+ + K P LF M++ S+ +I DS P+L
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNDS----PTLQSNEW 245
Query: 712 FMSIMQVAFSCLDQNPVSRPT 732
S CL + P RP
Sbjct: 246 TDSFRGFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 43/124 (34%), Positives = 62/124 (50%), Gaps = 7/124 (5%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+IV EY+ GSL L + + LG L V +A+ YL N F VH D++++
Sbjct: 76 YIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANNF---VHRDLAAR 131
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVL 668
NVL+ A VSDF + K + + + KL APE K + K DV+SFG+L
Sbjct: 132 NVLVSEDNVAKVSDFGLTKEAS-STQDTGKLPVKW--TAPEALREKKFSTKSDVWSFGIL 188
Query: 669 ALEV 672
E+
Sbjct: 189 LWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 48/213 (22%), Positives = 91/213 (42%), Gaps = 50/213 (23%)
Query: 542 CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIV 601
C+ +I+ E++ G+L L + + +E+ L + ++ A+ YL F +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEKKNF---I 126
Query: 602 HWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APE-LAYTMKVT 657
H D++++N L+ + V+DF +++ + D+ ++ AG + APE LAY K +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KFS 183
Query: 658 EKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF----- 712
K DV++FGVL E+ + MS PYP +D+ +
Sbjct: 184 IKSDVWAFGVLLWEIAT--------YGMS---------------PYPGIDLSQVYELLEK 220
Query: 713 -----------MSIMQVAFSCLDQNPVSRPTMK 734
+ ++ +C NP RP+
Sbjct: 221 GYRMERPEGCPPKVYELMRACWQWNPSDRPSFA 253
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 66/222 (29%)
Query: 542 CSHPRQSFIVYEYLESGSLDKILNNDASA-----KELGWTQRLNVIKGVADALFYLHNNC 596
C+ ++ EY G L L + L ++ + V KG+A F NC
Sbjct: 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ--VAKGMA---FLASKNC 162
Query: 597 FPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGN-------VAPE 649
+H D++++NVLL G + DF +A+ + DS+ K GN +APE
Sbjct: 163 ----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVK-----GNARLPVKWMAPE 213
Query: 650 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709
+ T + DV+S+G+L L+E+ S SN PYP + V
Sbjct: 214 SIFNCVYTFESDVWSYGIL-------------LWEIFSLGSN----------PYPGMPVD 250
Query: 710 NKFMSIMQVAF-----------------SCLDQNPVSRPTMK 734
+KF +++ + +C D +P+ RPT K
Sbjct: 251 SKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFK 292
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 4/167 (2%)
Query: 294 EIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKL 353
+ L N++ L + L+ N+L I EL L NL LDL N++++ L
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRLRSNIS-ELLELTNLTSLDLDNNNITDIPPLIGLLKSNL 142
Query: 354 YYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSG 413
L+LS NK+ +P L NL +L LDLS N L + + + +L L+LS N +S
Sbjct: 143 KELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDL-SDLPKLLSNLSNLNNLDLSGNKIS- 199
Query: 414 LIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEALQGNKGLC 460
+P E L L +D+S N + + + + ++ L NK
Sbjct: 200 DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED 246
|
Length = 394 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 66/255 (25%), Positives = 104/255 (40%), Gaps = 48/255 (18%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKF-HSPLPDN--------------FCSHP------- 545
IG G G+VY AR V + E+ A+KK +S N HP
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 546 -----RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 600
+++V EY + D + + K L + V G L YLH++ +
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSH---NM 136
Query: 601 VHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTE-- 658
+H D+ + N+LL + DF A + + GT +APE+ M +
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEGQYD 192
Query: 659 -KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717
K DV+S G+ +E+ + K P LF M++ S+ +I +S P+L +
Sbjct: 193 GKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNES----PALQSGHWSEYFRN 245
Query: 718 VAFSCLDQNPVSRPT 732
SCL + P RPT
Sbjct: 246 FVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 32/211 (15%)
Query: 542 CSHPRQSFIVYEYLESGSLDKIL------------NNDASAKELGWTQRLNVIKGVADAL 589
C+ R +V+EY+ G L++ L D + +L Q L + +A +
Sbjct: 76 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGM 135
Query: 590 FYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTH----GN 645
YL + F VH D++++N L+ G + DF +++ ++ S+++ ++ G
Sbjct: 136 VYLASLHF---VHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGGRTMLPIRW 190
Query: 646 VAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIE-ILDSRLPY 703
+ PE K T + D++SFGV+ E+ GK P +++S++ + IE I R
Sbjct: 191 MPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP---WYQLSNTEA---IECITQGRELE 244
Query: 704 PSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+ +IMQ C + P R +K
Sbjct: 245 RPRTCPPEVYAIMQ---GCWQREPQQRMVIK 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 24/199 (12%)
Query: 547 QSFIVYEYLESGSL-DKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDI 605
Q ++V E+ +GS+ D I N + + W + + + L +LH + ++H DI
Sbjct: 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH---KVIHRDI 137
Query: 606 SSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTE-----KC 660
+NVLL E + DF ++ L+ + GT +APE+ + + K
Sbjct: 138 KGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKS 197
Query: 661 DVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ---NKFMSIMQ 717
D++S G+ A+E+ +G P L +M M L R P P L + KF S ++
Sbjct: 198 DLWSLGITAIEMAEGAPP---LCDMHP----MRALFLIPRNPAPRLKSKKWSKKFQSFIE 250
Query: 718 VAFSCLDQNPVSRPTMKRF 736
SCL +N RPT ++
Sbjct: 251 ---SCLVKNHSQRPTTEQL 266
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 4e-07
Identities = 22/60 (36%), Positives = 32/60 (53%)
Query: 376 HLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKL 435
+L LDLS+N L + +L+ L+LS NNL+ + P F L L +D+S N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 47/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)
Query: 549 FIVYEYLESGSL-DKILNNDA---SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWD 604
I EY G+L DKI+ + + W + + A+ Y+H I+H D
Sbjct: 75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYIHKA---GILHRD 126
Query: 605 ISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYS 664
I + N+ L + DF I+K L + S + GT ++PEL +K K D+++
Sbjct: 127 IKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWA 186
Query: 665 FGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLD 724
G + E++ K D +++ N+ ++I+ P + V + + + + S L
Sbjct: 187 LGCVLYELLTLKRTFD-----ATNPLNLVVKIVQGNYT-PVVSVYSSEL--ISLVHSLLQ 238
Query: 725 QNPVSRPT 732
Q+P RPT
Sbjct: 239 QDPEKRPT 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 53/189 (28%), Positives = 85/189 (44%), Gaps = 21/189 (11%)
Query: 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADA----LFYLHNNCFPPIVHWDISSK 608
E+++ GSLD+I K+ G + ++ +A A L YL+N I+H DI
Sbjct: 83 EFMDCGSLDRIY------KKGG-PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPS 133
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVL 668
N+L++ + + DF ++ L +S GT ++PE K T K DV+S G+
Sbjct: 134 NILVNSRGQIKLCDFGVSG--ELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGIS 191
Query: 669 ALEVIKGKHPRDFLFEMS-SSSSNMNIEILDSRL---PYPSLDVQNKFMSIMQVAFS-CL 723
+E+ GK P F M I L ++ P P L + F ++ CL
Sbjct: 192 IIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP-SSDFPEDLRDFVDACL 250
Query: 724 DQNPVSRPT 732
++P RPT
Sbjct: 251 LKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 61/274 (22%), Positives = 110/274 (40%), Gaps = 62/274 (22%)
Query: 509 IGKGGHGSVYIARVPSG------EIFAVKKFHSPLPD--------------NF------- 541
+G+G G V++ E+ AVK + NF
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 542 ----CSHPRQSFIVYEYLESGSLDKIL-----------NNDASAKELGWTQRLNVIKGVA 586
C+ +V+EY+E G L+K L + D+ EL +Q L + +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 587 DALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTH--- 643
+ YL + F VH D++++N L+ + DF +++ ++ ++++ ++ G
Sbjct: 133 SGMVYLASQHF---VHRDLATRNCLVGYDLVVKIGDFGMSR--DVYTTDYYRVGGHTMLP 187
Query: 644 -GNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-R 700
+ PE K T + DV+SFGV+ E+ GK P + +S+ IE + R
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP---WYGLSNEEV---IECITQGR 241
Query: 701 LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
L ++ IM C ++P R +K
Sbjct: 242 LLQRPRTCPSEVYDIML---GCWKRDPQQRINIK 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 52/198 (26%), Positives = 83/198 (41%), Gaps = 36/198 (18%)
Query: 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKN 609
++ + + G L + N +G LN +A + YL +VH D++++N
Sbjct: 85 LITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARN 139
Query: 610 VLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTMKVTEKCDVYS 664
VL+ ++DF +AK L++D + G G V A E T K DV+S
Sbjct: 140 VLVKTPQHVKITDFGLAKLLDVDEKEY-HAEG--GKVPIKWMALESILHRIYTHKSDVWS 196
Query: 665 FGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILD-----SRLPYPSLDVQNKFMSIMQV 718
+GV E++ G P + + +EI D RLP P + + +M V
Sbjct: 197 YGVTVWELMTFGAKPYEGI---------PAVEIPDLLEKGERLPQPPICTIDVYM----V 243
Query: 719 AFSC--LDQNPVSRPTMK 734
C +D SRPT K
Sbjct: 244 LVKCWMIDAE--SRPTFK 259
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 49/199 (24%), Positives = 79/199 (39%), Gaps = 35/199 (17%)
Query: 509 IGKGGHGSVYIARVP-SGEIFAVKKF--------------------------HSPLPDNF 541
+GKG G V++A + + + FA+K H L +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 542 CSHPRQS--FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 599
C+ + F V EYL G L + + S + + + L +LH+
Sbjct: 63 CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---G 116
Query: 600 IVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEK 659
IV+ D+ N+LLD ++DF + K L + GT +APE+ K
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS 176
Query: 660 CDVYSFGVLALEVIKGKHP 678
D +SFGVL E++ G+ P
Sbjct: 177 VDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 67/255 (26%), Positives = 106/255 (41%), Gaps = 48/255 (18%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKF-HSPLPDN--------------FCSHPRQ----- 547
IG G G+VY AR V + E+ A+KK +S N HP
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 548 -------SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 600
+++V EY + D + + K L + + G L YLH++ +
Sbjct: 93 CYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSH---NM 146
Query: 601 VHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTE-- 658
+H DI + N+LL + ++DF A + +S GT +APE+ M +
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAMDEGQYD 202
Query: 659 -KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717
K DV+S G+ +E+ + K P LF M++ S+ +I +S P+L
Sbjct: 203 GKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNES----PTLQSNEWSDYFRN 255
Query: 718 VAFSCLDQNPVSRPT 732
SCL + P RPT
Sbjct: 256 FVDSCLQKIPQDRPT 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 64/270 (23%), Positives = 113/270 (41%), Gaps = 45/270 (16%)
Query: 484 VFPLLGKIVYEEIIRATNDFDAKHCIGKGGHGSVYIARVPSGE--------IFAVKKFHS 535
+ +G+ + +I A D++HC+ K + + ++P E I K H
Sbjct: 4 IIKKIGEGSFGKIYLAKAKSDSEHCVIK----EIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 536 PLPDNFCSHPRQS--FIVYEYLESGSLDKILNND-----ASAKELGWTQRLNVIKGVADA 588
+ F S FIV EY + G L K +N + + L W ++++
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------G 113
Query: 589 LFYLHNNCFPPIVHWDISSKNVLLDL-GYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVA 647
L ++H+ I+H DI S+N+ L G A + DF IA+ LN GT ++
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLS 170
Query: 648 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRL----PY 703
PE+ K D++S G + E+ KHP FE ++ + ++I P
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHP----FE-GNNLHQLVLKICQGYFAPISPN 225
Query: 704 PSLDVQNKFMSIMQVAFSCLDQNPVSRPTM 733
S D+++ + +V+ P RP++
Sbjct: 226 FSRDLRSLISQLFKVS-------PRDRPSI 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 47/188 (25%), Positives = 87/188 (46%), Gaps = 18/188 (9%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+I+ EY+ GSL L +D K L + ++ +A+ + Y+ + +H D+ +
Sbjct: 77 YIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY---IHRDLRAA 132
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APELAYTMKVTEKCDVYSF 665
NVL+ ++DF +A+ + + + ++ G + APE T K DV+SF
Sbjct: 133 NVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 190
Query: 666 GVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLD 724
G+L E++ GK P + S+S M+ R+P + ++ IM+ +C
Sbjct: 191 GILLYEIVTYGKIP----YPGMSNSDVMSALQRGYRMPRME-NCPDELYDIMK---TCWK 242
Query: 725 QNPVSRPT 732
+ RPT
Sbjct: 243 EKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 45/188 (23%), Positives = 87/188 (46%), Gaps = 18/188 (9%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+I+ EY+E+GSL L K L + +++ +A+ + ++ + +H D+ +
Sbjct: 76 YIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIERKNY---IHRDLRAA 131
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APELAYTMKVTEKCDVYSF 665
N+L+ ++DF +A+ + + + ++ G + APE T K DV+SF
Sbjct: 132 NILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 189
Query: 666 GVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLD 724
G+L E++ G+ P M++ N+E R+P P N + ++ C
Sbjct: 190 GILLTEIVTYGRIPYP---GMTNPEVIQNLERG-YRMPRP----DNCPEELYELMRLCWK 241
Query: 725 QNPVSRPT 732
+ P RPT
Sbjct: 242 EKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 47/156 (30%), Positives = 71/156 (45%), Gaps = 22/156 (14%)
Query: 585 VADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHG 644
VA + YL + F VH D++++N +LD + V+DF +A+ + D +S T
Sbjct: 107 VAKGMEYLASKKF---VHRDLAARNCMLDESFTVKVADFGLARDI-YDKEYYSVHNHTGA 162
Query: 645 NV-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHP-RDFLFEMSSSSSNMNIEIL 697
+ A E T K T K DV+SFGVL E++ +G P D S ++ + +L
Sbjct: 163 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------DSFDITVYLL 216
Query: 698 DS-RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT 732
RL P + +M SC P RPT
Sbjct: 217 QGRRLLQPEY-CPDPLYEVML---SCWHPKPEMRPT 248
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 63/266 (23%), Positives = 106/266 (39%), Gaps = 61/266 (22%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD-------------NFCSHPR-------- 546
+GKG +GSVY P+G A+K+ L + + P
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 547 ----QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYL---HNNCFPP 599
++ EY+++GSLDK+ + + + + V L +L HN
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN----- 123
Query: 600 IVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPE---------- 649
I+H D+ NVL++ + + DF ++ NL +S G +APE
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNIGCQSYMAPERIKSGGPNQN 181
Query: 650 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS---RLPYPSL 706
YT+ + DV+S G+ LE+ G++P + E ++ I+D LP
Sbjct: 182 PTYTV----QSDVWSLGLSILEMALGRYP--YPPETYANIFAQLSAIVDGDPPTLPSGYS 235
Query: 707 DVQNKFMSIMQVAFSCLDQNPVSRPT 732
D F++ CL++ P RPT
Sbjct: 236 DDAQDFVA------KCLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 67/267 (25%), Positives = 104/267 (38%), Gaps = 69/267 (25%)
Query: 509 IGKGGHGSVYIA-RVPSGEIFAVKKFHSPLPDNFC-------------------SHP--- 545
+G G GSVY + G+ FAVK+ L D+ HP
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKE--VSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 546 ------RQS---FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNC 596
R+ +I E + GSL K+L S E + + L YLH+
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE---PVIRLYTRQILLGLEYLHDR- 121
Query: 597 FPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPEL-----A 651
VH DI N+L+D ++DF +AK + ++ S G+ +APE+
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKSFKGSPYWMAPEVIAQQGG 178
Query: 652 YTMKVTEKCDVYSFGVLALEVIKGKHPRD------FLFEMSSSSSNMNIEILDSRLPYPS 705
Y + D++S G LE+ GK P +F++ S I D S
Sbjct: 179 YGLAA----DIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP--PIPDHL----S 228
Query: 706 LDVQNKFMSIMQVAFSCLDQNPVSRPT 732
+ ++ F I++ CL ++P RPT
Sbjct: 229 DEAKD-F--ILK----CLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 2e-06
Identities = 23/58 (39%), Positives = 28/58 (48%)
Query: 328 NLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHN 385
NL+ LDLS N L+ + L L L+LS N L+ P L L LDLS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 65/276 (23%), Positives = 119/276 (43%), Gaps = 59/276 (21%)
Query: 503 FDAKHCIGKGGHGSVYIAR-VPSGEIFAVK----------------------KFHSPLPD 539
F+ +G G +G VY R V +G++ A+K H +
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 540 NFCS--------HPRQSFIVYEYLESGSL-DKILNNDASAKELGWTQRL--NVIKGVADA 588
+ + H Q ++V E+ +GS+ D + N +A + W + +++G+A
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA-- 135
Query: 589 LFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAP 648
+LH + ++H DI +NVLL E + DF ++ L+ + GT +AP
Sbjct: 136 --HLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 190
Query: 649 ELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPY 703
E+ + + + D++S G+ A+E+ +G P L +M M L R P
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP---LCDMHP----MRALFLIPRNPP 243
Query: 704 PSLDVQ---NKFMSIMQVAFSCLDQNPVSRPTMKRF 736
P L + KF+ ++ CL +N +SRP+ ++
Sbjct: 244 PKLKSKKWSKKFIDFIE---GCLVKNYLSRPSTEQL 276
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 47/167 (28%), Positives = 74/167 (44%), Gaps = 24/167 (14%)
Query: 526 EIFAVKKFHSP----LPDNFCSHPRQSFIVYEYLESGSLDKILNNDA--SAKELGWTQRL 579
E + + P L D+ + P F V+EY+ +L ++L D A E G RL
Sbjct: 28 ETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETG---RL 84
Query: 580 NVIKGVADALFYLHNNCFPPIVHWDISSKNVLL---DLGYEAHVSDFRIAKFLN------ 630
+ V DAL HN IVH D+ +N+++ + A V DF I L
Sbjct: 85 --MLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDAD 139
Query: 631 -LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 676
+ +++ GT APE VT D+Y++G++ LE + G+
Sbjct: 140 VATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 73/278 (26%), Positives = 112/278 (40%), Gaps = 49/278 (17%)
Query: 494 EEIIRATNDFDAKHCIGKGGHGSVY-IARVPSGEIFAVKKFHSPLPD------------- 539
E + T+ ++ IGKG +G VY + G + AVK P+ D
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL-DPISDVDEEIEAEYNILQ 73
Query: 540 NFCSHPR-----QSFIVYEYLESGSLDKILN--NDASAKEL-----GWTQRLN------V 581
+ +HP F + L G L +L N S EL QRL+ +
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 582 IKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAG 641
+ G L +LHNN I+H D+ N+LL + DF ++ L + G
Sbjct: 134 LYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 190
Query: 642 THGNVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEI 696
T +APE+ Y +CDV+S G+ A+E+ G P LF+M + I
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP---LFDMHPVKTLFKI-- 245
Query: 697 LDSRLPYPSLDVQNKFM-SIMQVAFSCLDQNPVSRPTM 733
R P P+L K+ S CL ++ +RP++
Sbjct: 246 --PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSV 281
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 60/269 (22%), Positives = 100/269 (37%), Gaps = 61/269 (22%)
Query: 509 IGKGGHGSVYIARVPSGE------IFAVKKFHSPLPDNFCSHPRQS-------------- 548
+G+G G V++A+ E + VK +N S R+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 549 -----------FIVYEYLESGSLDKILNNDASAKE------LGWTQRLNVIKGVADALFY 591
+++ EY + G L + L S E L Q++ + +A + +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 592 LHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGN------ 645
L N F VH D++++N L+ E VS L+L ++ N
Sbjct: 133 LSNARF---VHRDLAARNCLVSSQREVKVS------LLSLSKDVYNSEYYKLRNALIPLR 183
Query: 646 -VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDSRLPY 703
+APE + K DV+SFGVL EV +G+ P + +S ++ LP
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP---FYGLSDEEVLNRLQAGKLELPV 240
Query: 704 PSLDVQNKFMSIMQVAFSCLDQNPVSRPT 732
P ++ +M C NP RP+
Sbjct: 241 PE-GCPSRLYKLMT---RCWAVNPKDRPS 265
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 52/195 (26%), Positives = 81/195 (41%), Gaps = 18/195 (9%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+IV + E G L L + K L Q + +A AL YLH I+H D+ ++
Sbjct: 76 YIVMGFCEGGDLYHKLK-EQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQ 131
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVL 668
NV L V D IA+ L S L GT ++PEL K DV++ G
Sbjct: 132 NVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCC 191
Query: 669 ALEVIKGKHPRDFLFEMSSSSSNMN---IEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQ 725
E+ KH + ++ +MN I++ +LP D + ++ + L +
Sbjct: 192 VYEMATLKH--------AFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIA---TMLSK 240
Query: 726 NPVSRPTMKRFEVQS 740
P RP++K Q
Sbjct: 241 RPEKRPSVKSILRQP 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 69/288 (23%), Positives = 110/288 (38%), Gaps = 70/288 (24%)
Query: 503 FDAKHCI-----GKGGHGSVYIARVP-----SGEIFAVKKFHSPLPDNFCSHPRQ----- 547
F+ +H GKG GSV + R +GE+ AVKK ++ R+
Sbjct: 1 FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILK 60
Query: 548 ----SFIV-----------------YEYLESGSLDKILNNDASAKELGWTQRL-----NV 581
IV EYL GSL L +E ++L +
Sbjct: 61 SLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQI 117
Query: 582 IKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAG 641
KG+ YL + + VH D++++N+L++ + DF + K L D +
Sbjct: 118 CKGME----YLGSKRY---VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREP 170
Query: 642 THGNV---APELAYTMKVTEKCDVYSFGVLALEVI----KGKHP-RDFLFEMSSSSSNMN 693
+ APE K + DV+SFGV+ E+ K P +F+ M +
Sbjct: 171 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQM 230
Query: 694 I-----EILDS--RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
I E+L + RLP P + +IM+ C + +P RP+
Sbjct: 231 IVYHLIELLKNNGRLPAP-PGCPAEIYAIMK---ECWNNDPSQRPSFS 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 38/145 (26%), Positives = 71/145 (48%), Gaps = 21/145 (14%)
Query: 542 CSHPRQSFIVYEYLESGSLDKIL------NNDAS--AKELGWTQRLNVIKGVADALFYLH 593
C+ ++ EY+E+G L++ L + + +K L ++ L + +A + YL
Sbjct: 88 CTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE 147
Query: 594 NNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAP----- 648
+ F VH D++++N L+ Y ++DF +++ NL SS++ ++ G P
Sbjct: 148 SLNF---VHRDLATRNCLVGKNYTIKIADFGMSR--NLYSSDYYRVQGR--APLPIRWMA 200
Query: 649 -ELAYTMKVTEKCDVYSFGVLALEV 672
E K T K DV++FGV E+
Sbjct: 201 WESVLLGKFTTKSDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 42/137 (30%), Positives = 66/137 (48%), Gaps = 20/137 (14%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+IV E + G+L L A + Q L VA+ + YL + +VH D++++
Sbjct: 74 YIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAAR 129
Query: 609 NVLLDLGYEAHVSDFRIAKF--LNLDSS----NWSKLAGTHGNVAPELAYTMKVTEKCDV 662
N+L+ A VSDF +A+ + +D+S W+ APE K + K DV
Sbjct: 130 NILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT---------APEALKHKKFSSKSDV 180
Query: 663 YSFGVLALEVIK-GKHP 678
+S+GVL EV G+ P
Sbjct: 181 WSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 63/259 (24%), Positives = 95/259 (36%), Gaps = 60/259 (23%)
Query: 509 IGKGGHGSVYIARVP-SGEIFAVKKF--------------------------HSPLPDNF 541
+GKG G V +A + + E++AVK H L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 542 CSHPRQS--FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 599
+ F V EY+ G L + E + + L +LH
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDE---PRARFYAAEIVLGLQFLHER---G 116
Query: 600 IVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVT 657
I++ D+ NVLLD E H+ +DF + K L S GT +APE+
Sbjct: 117 IIYRDLKLDNVLLD--SEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYG 174
Query: 658 EKCDVYSFGVLALEVIKGKHP-----RDFLFEMSSSSSNMNIEILDSRLPYP-SLDVQNK 711
D ++ GVL E++ G+ P D LF+ IL+ + YP L +
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ----------SILEDEVRYPRWLSK--E 222
Query: 712 FMSIMQVAFSCLDQNPVSR 730
SI++ S L +NP R
Sbjct: 223 AKSILK---SFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 47/185 (25%), Positives = 81/185 (43%), Gaps = 12/185 (6%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+IV +Y E G L K +N Q L+ + AL ++H+ I+H DI S+
Sbjct: 75 YIVMDYCEGGDLYKKINAQRGVL-FPEDQILDWFVQICLALKHVHDR---KILHRDIKSQ 130
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVL 668
N+ L + DF IA+ LN GT ++PE+ K D+++ G +
Sbjct: 131 NIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCV 190
Query: 669 ALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPV 728
E+ KH FE + + N+ ++I+ R YP + + + + +NP
Sbjct: 191 LYEMCTLKHA----FE-AGNMKNLVLKII--RGSYPPVSSHYSY-DLRNLVSQLFKRNPR 242
Query: 729 SRPTM 733
RP++
Sbjct: 243 DRPSV 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 38/216 (17%)
Query: 489 GKIVYEEIIRATNDFDAKHCIGK------GGHGSVYIARVPSGEIFAVKKFHSPLPDNFC 542
GK++ E+ + TN+F A + K + R + A+ H L FC
Sbjct: 9 GKVMLAEL-KGTNEFFAIKALKKDVVLEDDDVECTMVER----RVLALAWEHPFLTHLFC 63
Query: 543 SHPRQS--FIVYEYLESGSL-----DKILNNDASAKELGWTQRLNVIKGVADALFYLHNN 595
+ + F V EYL G L ++A A+ +I G L +LH
Sbjct: 64 TFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYA----AEIICG----LQFLHKK 115
Query: 596 CFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYT 653
I++ D+ NVLLD + H+ +DF + K S GT +APE+
Sbjct: 116 ---GIIYRDLKLDNVLLD--KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170
Query: 654 MKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFE 684
K E D +SFGVL E++ G+ P D LF+
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 70/278 (25%), Positives = 119/278 (42%), Gaps = 54/278 (19%)
Query: 493 YEEIIRATNDFDAKHCIGK---GGHGSVYIAR-VPSGEIFAVK----KFHSPLPDNF--- 541
YE + R + + IG+ G G VY A+ +G + A K K L D
Sbjct: 1 YEHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEI 60
Query: 542 -----CSHPR------------QSFIVYEYLESGSLDKI-LNNDASAKELGWTQRLNVIK 583
C+HP + +I+ E+ G++D I L D E Q + +
Sbjct: 61 EILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVICR 117
Query: 584 GVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTH 643
+ +AL YLH+ I+H D+ + NVLL L + ++DF ++ GT
Sbjct: 118 QMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTP 174
Query: 644 GNVAPELAY--TMKVTE---KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD 698
+APE+ TMK T K D++S G+ +E+ + + P L + M + +
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-------NPMRVLLKI 227
Query: 699 SRLPYPSLDVQNK----FMSIMQVAFSCLDQNPVSRPT 732
++ P+L +K F ++ A LD++P +RP+
Sbjct: 228 AKSEPPTLSQPSKWSMEFRDFLKTA---LDKHPETRPS 262
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 41/172 (23%), Positives = 67/172 (38%), Gaps = 22/172 (12%)
Query: 585 VADALFYL---HNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAG 641
+ AL YL H ++H D+ N+LLD + DF I+ L +DS ++ AG
Sbjct: 123 IVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRL-VDSKAKTRSAG 176
Query: 642 THGNVAPELAYTMKVTEK----CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEIL 697
+APE K DV+S G+ +E+ G+ P ++ + + +IL
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP----YKNCKTEFEVLTKIL 232
Query: 698 DSRLPYPSLDVQNKFMSIMQVAF--SCLDQNPVSRPTMKRFEVQSKQFHYNP 747
P N+ S +F CL ++ RP + Y
Sbjct: 233 QEEPPSLPP---NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 5e-06
Identities = 23/59 (38%), Positives = 32/59 (54%)
Query: 305 LNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKL 363
L + LS N+L+ G L NL+ LDLS N+L++ E+ L L L+LS N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 59/257 (22%), Positives = 100/257 (38%), Gaps = 50/257 (19%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD----NFC---------SHPR-------- 546
IG G G+VY P+G ++A+K + D C +HP
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141
Query: 547 ----QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVH 602
+ ++ E+++ GSL+ A E +V + + + YLH IVH
Sbjct: 142 DHNGEIQVLLEFMDGGSLE----GTHIADEQ---FLADVARQILSGIAYLHRR---HIVH 191
Query: 603 WDISSKNVLLDLGYEAHVSDFRIAKFLN--LDSSNWSKLAGTHGNVAPE-----LAYTMK 655
DI N+L++ ++DF +++ L +D N S GT ++PE L +
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPERINTDLNHGAY 249
Query: 656 VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSI 715
D++S GV LE G+ P F +++ I S+ P +F
Sbjct: 250 DGYAGDIWSLGVSILEFYLGRFP--FGVGRQGDWASLMCAICMSQPPEAPATASREFRHF 307
Query: 716 MQVAFSCLDQNPVSRPT 732
+ CL + P R +
Sbjct: 308 ISC---CLQREPAKRWS 321
|
Length = 353 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 58/238 (24%), Positives = 92/238 (38%), Gaps = 52/238 (21%)
Query: 502 DFDAKHCIGKGGHGSVYIA-RVPSGEIFAVK----------------------------- 531
DF+ +GKG G V +A R + E++A+K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 532 KFHSPLPDNFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFY 591
F + L F + R F V EY+ G L + KE + +A LF+
Sbjct: 61 PFLTQLHSCFQTMDRLYF-VMEYVNGGDLMYQIQQVGRFKE---PHAVFYAAEIAIGLFF 116
Query: 592 LHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELA 651
LH+ I++ D+ NV+LD ++DF + K D GT +APE+
Sbjct: 117 LHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII 173
Query: 652 YTMKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEMSSSSSNMNIEILDSRLPYP 704
+ D ++FGVL E++ G+ P D LF+ I++ + YP
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ----------SIMEHNVAYP 221
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 5e-06
Identities = 39/150 (26%), Positives = 63/150 (42%), Gaps = 26/150 (17%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+ V EY +G L + + S E T+ + AL YLH+ I+H D+ +
Sbjct: 78 YFVLEYAPNGELLQYIRKYGSLDEK-CTR--FYAAEILLALEYLHSK---GIIHRDLKPE 131
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLA--------------------GTHGNVAP 648
N+LLD ++DF AK L+ +SS S GT V+P
Sbjct: 132 NILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSP 191
Query: 649 ELAYTMKVTEKCDVYSFGVLALEVIKGKHP 678
EL + D+++ G + +++ GK P
Sbjct: 192 ELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 39/135 (28%), Positives = 65/135 (48%), Gaps = 13/135 (9%)
Query: 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKN 609
+V E G L+K L+ E+ + + ++ V+ + YL F VH D++++N
Sbjct: 71 LVMEMASGGPLNKFLS--GKKDEITVSNVVELMHQVSMGMKYLEGKNF---VHRDLAARN 125
Query: 610 VLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGN-----VAPELAYTMKVTEKCDVYS 664
VLL + A +SDF ++K L D S + A + G APE K + + DV+S
Sbjct: 126 VLLVNQHYAKISDFGLSKALGADDSYYK--ARSAGKWPLKWYAPECINFRKFSSRSDVWS 183
Query: 665 FGVLALEVIK-GKHP 678
+G+ E G+ P
Sbjct: 184 YGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 52/206 (25%), Positives = 84/206 (40%), Gaps = 42/206 (20%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKF-----HSPLPDNFC-------------SHP---- 545
+G G S Y AR V +G + AVK+ S + +HP
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 546 -------RQSFIVY-EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCF 597
F ++ E++ GS+ +L+ + KE +N + + L YLH N
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE---AVIINYTEQLLRGLSYLHEN-- 122
Query: 598 PPIVHWDISSKNVLLD-LGYEAHVSDFRIAKFLNLDSSN----WSKLAGTHGNVAPELAY 652
I+H D+ N+L+D G ++DF A L + +L GT +APE+
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 653 TMKVTEKCDVYSFGVLALEVIKGKHP 678
+ CDV+S G + +E+ K P
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 37/209 (17%)
Query: 502 DFDAKHCIGKGGHGSVYIA-RVPSGEIFAVK----------------------------- 531
DF+ +GKG G V +A R + E++A+K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 532 KFHSPLPDNFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFY 591
F + L F + R F V EY+ G L + KE Q + ++ LF+
Sbjct: 61 PFLTQLHSCFQTVDRLYF-VMEYVNGGDLMYHIQQVGKFKE---PQAVFYAAEISVGLFF 116
Query: 592 LHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELA 651
LH I++ D+ NV+LD ++DF + K +D GT +APE+
Sbjct: 117 LHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII 173
Query: 652 YTMKVTEKCDVYSFGVLALEVIKGKHPRD 680
+ D +++GVL E++ G+ P D
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 47/176 (26%), Positives = 72/176 (40%), Gaps = 63/176 (35%)
Query: 585 VADALFYL-HNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTH 643
VA + +L NC +H D++++NVLL G A + DF +A+ + DS+ K
Sbjct: 221 VAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK----- 271
Query: 644 GN-------VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEI 696
GN +APE + T + DV+S+G+L L+E+ S +
Sbjct: 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGIL-------------LWEIFSLGKS----- 313
Query: 697 LDSRLPYPSLDVQNKF--------------------MSIMQVAFSCLDQNPVSRPT 732
PYP + V +KF SIM+ C + P RPT
Sbjct: 314 -----PYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMK---MCWNLEPTERPT 361
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 25/209 (11%)
Query: 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKN 609
++ EY+ GSL L +L Q L + + + + YLH+ + +H D++++N
Sbjct: 85 LIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQHY---IHRDLAARN 137
Query: 610 VLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APELAYTMKVTEKCDVYSFG 666
VLLD + DF +AK + + V A E K + DV+SFG
Sbjct: 138 VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFG 197
Query: 667 VLALEVI-----KGKHPRDFLFEMSSSSSNMN----IEILDS--RLPYPSLDVQNKFMSI 715
V E++ K P+ F + M IE+L+ RLP P + + +
Sbjct: 198 VTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPK-NCPQEVYIL 256
Query: 716 MQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744
M+ +C + RPT + K+ H
Sbjct: 257 MK---NCWETEAKFRPTFRSLIPILKEMH 282
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 67/253 (26%), Positives = 104/253 (41%), Gaps = 44/253 (17%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFH-----SPLPDNFCSHPRQS------ 548
DFD K +G+G G V + R +G+I+A+K + +F R
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 549 ----------------FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYL 592
++V EY G L +LN + Q + + A+ +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY--LAELVLAIHSV 118
Query: 593 HNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKL-AGTHGNVAPELA 651
H + VH DI +NVL+D ++DF A L + SKL GT +APE+
Sbjct: 119 HQMGY---VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVL 175
Query: 652 YTMKVTEK------CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPS 705
TM K CD +S GV+A E+I G+ P E +S+ + NI L +P
Sbjct: 176 TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP---FHEGTSAKTYNNIMNFQRFLKFPE 232
Query: 706 -LDVQNKFMSIMQ 717
V + F+ ++Q
Sbjct: 233 DPKVSSDFLDLIQ 245
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 40/145 (27%), Positives = 73/145 (50%), Gaps = 22/145 (15%)
Query: 550 IVYEYLESGSLDKILNN---DA-------SAKELGWTQRLNVIKGVADALFYLHNNCFPP 599
+V+EY++ G L+K L DA EL +Q L++ + +A + YL + F
Sbjct: 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHF-- 141
Query: 600 IVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVA-----PELAYTM 654
VH D++++N L+ + DF +++ ++ S+++ ++ G H + PE
Sbjct: 142 -VHRDLATRNCLVGENLLVKIGDFGMSR--DVYSTDYYRVGG-HTMLPIRWMPPESIMYR 197
Query: 655 KVTEKCDVYSFGVLALEVIK-GKHP 678
K T + DV+S GV+ E+ GK P
Sbjct: 198 KFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 8/101 (7%)
Query: 589 LFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAP 648
L +LH+ I++ D+ NV+LD ++DF + K + S GT +AP
Sbjct: 109 LQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAP 165
Query: 649 ELAYTMKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFE 684
E+ +K T D +SFGVL E++ G+ P D LFE
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 30/113 (26%), Positives = 55/113 (48%), Gaps = 7/113 (6%)
Query: 577 QRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW 636
Q L + K + + L YLH I+H D+ ++N+ ++ + + D A+F + + +
Sbjct: 158 QALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAF 213
Query: 637 SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS 689
LAGT APE+ K K D++S G++ E++ +FE S+
Sbjct: 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST---IFEDPPST 263
|
Length = 357 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 63/258 (24%), Positives = 104/258 (40%), Gaps = 58/258 (22%)
Query: 509 IGKGGHGSVYIARVP-SGEIFAVKKF--------------------------HSPLPDNF 541
+GKG G V +AR+ SG ++AVK H L +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 542 C--SHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 599
C P + F V E++ G L + + ++ + + AL +LH+
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDK---G 116
Query: 600 IVHWDISSKNVLLDLGYEAH--VSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVT 657
I++ D+ NVLLD +E H ++DF + K + S GT +APE+ M
Sbjct: 117 IIYRDLKLDNVLLD--HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 658 EKCDVYSFGVLALEVIKGKHP-----RDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712
D ++ GVL E++ G P D LFE IL+ + YP+ +
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----------ILNDEVVYPTW-LSQDA 223
Query: 713 MSIMQVAFSCLDQNPVSR 730
+ I++ + + +NP R
Sbjct: 224 VDILK---AFMTKNPTMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 69/309 (22%), Positives = 108/309 (34%), Gaps = 54/309 (17%)
Query: 138 LDFLTNKLS-GHIPSEISLLTHLTILHISRNQLNGS----IPHEVGQLNFLNHLILDSNF 192
L L + L L +L + N L + + L L L N
Sbjct: 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNE 62
Query: 193 LG------GSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNL---KSLFDMKLCINQLNG 243
G S+ + L+ L L L +N+ + +L SL ++KL N L
Sbjct: 63 TGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGD 122
Query: 244 AI-PLSIDWGRCPQLSL--LDVSINNITGNIPFEIGE----SPQLQYLDLSSNYIVGEIP 296
L + +L L + N + G + + + L+ L+L++N I
Sbjct: 123 RGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDA-- 180
Query: 297 TQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHL----SNFVLESLGSLVK 352
I L L + NLE LDL+ N L ++ + E+L SL
Sbjct: 181 ----GIRALAEG--------------LKANCNLEVLDLNNNGLTDEGASALAETLASLKS 222
Query: 353 LYYLNLSHNKLSQQIPIELDN-----LIHLSELDLSHNFLGEKISSRICR----MESLEK 403
L LNL N L+ L + I L L LS N + + + + ESL +
Sbjct: 223 LEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLE 282
Query: 404 LNLSYNNLS 412
L+L N
Sbjct: 283 LDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 47/202 (23%)
Query: 509 IGKGGHGSVYIARV-PSGEIFAVKKFHSP-----LPDNF---------CSHPR------- 546
IG+G HG V+ A+ +GE A+KK +P+ C HP
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 547 ----QSF-IVYEYLESGSLDKILNN------DASAKELGWTQRLNVIKGVADALFYLHNN 595
F +V EY+ S L ++L + +A K + + L +KGVA Y+H N
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVK--SYMRML--LKGVA----YMHAN 118
Query: 596 CFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN-WSKLAGTHGNVAPELAY-T 653
I+H D+ N+L+ ++DF +A+ + + +S T APEL Y
Sbjct: 119 ---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 654 MKVTEKCDVYSFGVLALEVIKG 675
K D+++ G + E++ G
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 50/204 (24%), Positives = 81/204 (39%), Gaps = 49/204 (24%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVK--KFHSPLPDNFCSHPR------------------- 546
I KG GSVY+A+ +G+ FA+K K + N ++ +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 547 ---QS----FIVYEYLESGSLDKILNNDASAKELG-----WTQRLNVIKGVADALFYLHN 594
QS ++V EYL G ++ K LG W + I V + LH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLI------KTLGGLPEDWAK--QYIAEVVLGVEDLHQ 115
Query: 595 NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTM 654
I+H DI +N+L+D ++DF +++ + K GT +APE +
Sbjct: 116 R---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK----KFVGTPDYLAPETILGV 168
Query: 655 KVTEKCDVYSFGVLALEVIKGKHP 678
+ D +S G + E + G P
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 35/205 (17%)
Query: 550 IVYEYLESGSLDKIL-----NNDASAKELGWTQR--------LNVIKGVADALFYLHNNC 596
+++EYL G L + L ++D A+ T + L++ +A + YL ++
Sbjct: 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH 144
Query: 597 FPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTH----GNVAPELAY 652
F VH D++++N L+ G +SDF +++ ++ S+++ ++ + PE
Sbjct: 145 F---VHRDLAARNCLVGEGLTVKISDFGLSR--DIYSADYYRVQSKSLLPVRWMPPEAIL 199
Query: 653 TMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSR--LPYPSLDVQ 709
K T + D++SFGV+ E+ G P + F S+ IE++ SR LP P D
Sbjct: 200 YGKFTTESDIWSFGVVLWEIFSYGLQPY-YGF-----SNQEVIEMIRSRQLLPCPE-DCP 252
Query: 710 NKFMSIMQVAFSCLDQNPVSRPTMK 734
+ ++M C ++ P RP K
Sbjct: 253 ARVYALMI---ECWNEIPARRPRFK 274
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 43/182 (23%), Positives = 76/182 (41%), Gaps = 23/182 (12%)
Query: 508 CIGKGGHGSVYIARVP------------SGEIFAVKKFHSPLP----DNFCSHPRQSFIV 551
C K V I ++P E +K P +NF + IV
Sbjct: 19 CRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED-KALMIV 77
Query: 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVL 611
EY G+L + + ++ L L+ + AL ++H I+H D+ ++N+L
Sbjct: 78 MEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNIL 133
Query: 612 LDLGYE-AHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLAL 670
LD + DF I+K L+ S ++ + GT ++PEL +K D+++ G +
Sbjct: 134 LDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPELCEGKPYNQKSDIWALGCVLY 192
Query: 671 EV 672
E+
Sbjct: 193 EL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 48/199 (24%), Positives = 82/199 (41%), Gaps = 38/199 (19%)
Query: 550 IVYEYLESGSL-DKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+V + GSL D + + S L + LN +A ++YL + +VH +++++
Sbjct: 85 LVTQLSPLGSLLDHVRQHRDS---LDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAAR 138
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFG 666
N+LL ++DF +A L D +S+ +A E + T + DV+S+G
Sbjct: 139 NILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYG 198
Query: 667 VLALEVIK-------GKHPRDF--LFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717
V E++ G P + L E RL P + + +M
Sbjct: 199 VTVWEMMSYGAEPYAGMRPHEVPDLLEKG------------ERLAQPQICTIDVYM---- 242
Query: 718 VAFSC--LDQNPVSRPTMK 734
V C +D+N RPT K
Sbjct: 243 VMVKCWMIDEN--VRPTFK 259
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 34/97 (35%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 369 IELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPR-CFEELHGLLH 427
I +N + +DLS + KISS I R+ ++ +NLS N LSG IP F L +
Sbjct: 63 ITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRY 122
Query: 428 IDISYNKLEGHIPNSTTFRDAPLEALQ-GNKGLCGDI 463
+++S N G IP + LE L N L G+I
Sbjct: 123 LNLSNNNFTGSIPRGSIPN---LETLDLSNNMLSGEI 156
|
Length = 968 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 31/107 (28%), Positives = 54/107 (50%), Gaps = 7/107 (6%)
Query: 579 LNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF-LNLDSSNWS 637
L + + V A+ YLH N I+H DI ++N+ ++ + + DF A F ++++++ +
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFE 684
AGT APEL D++S G++ E+ D LFE
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH---DSLFE 285
|
Length = 391 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 52/209 (24%), Positives = 82/209 (39%), Gaps = 37/209 (17%)
Query: 502 DFDAKHCIGKGGHGSVYIA-RVPSGEIFAVK----------------------------- 531
DF+ +GKG G V +A R + E++A+K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 532 KFHSPLPDNFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFY 591
F + L F + R F V EY+ G L + KE + +A LF+
Sbjct: 61 PFLTQLHSCFQTMDRLYF-VMEYVNGGDLMYHIQQVGKFKE---PHAVFYAAEIAIGLFF 116
Query: 592 LHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELA 651
LH+ I++ D+ NV+LD ++DF + K GT +APE+
Sbjct: 117 LHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII 173
Query: 652 YTMKVTEKCDVYSFGVLALEVIKGKHPRD 680
+ D ++FGVL E++ G+ P D
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 40/193 (20%), Positives = 85/193 (44%), Gaps = 18/193 (9%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+I+ E++ GSL L +D +K+ + ++ +A+ + ++ + +H D+ +
Sbjct: 76 YIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRNY---IHRDLRAA 131
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APELAYTMKVTEKCDVYSF 665
N+L+ ++DF +A+ + + + ++ G + APE T K DV+SF
Sbjct: 132 NILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 189
Query: 666 GVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLD 724
G+L +E++ G+ P S+ I L+ P + + + + C
Sbjct: 190 GILLMEIVTYGRIP------YPGMSNPEVIRALERGYRMPRPENCPE--ELYNIMMRCWK 241
Query: 725 QNPVSRPTMKRFE 737
P RPT + +
Sbjct: 242 NRPEERPTFEYIQ 254
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 60/277 (21%), Positives = 104/277 (37%), Gaps = 43/277 (15%)
Query: 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFH-----SPLPDNFC----------S 543
+F + IGKG VY A + G + A+KK C
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 544 HPR-----QSF-------IVYEYLESGSLDKILNNDASAKELGWTQRL-NVIKGVADALF 590
HP SF IV E ++G L +++ + K L + + + AL
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 591 YLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPEL 650
++H+ I+H DI NV + + D + +F + ++ L GT ++PE
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 651 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLP---YPSLD 707
+ K D++S G L E+ + P F MN+ L ++ YP L
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDK----MNLYSLCKKIEKCDYPPLP 229
Query: 708 VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744
+ + + C++ +P RP + +K+ H
Sbjct: 230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 50/188 (26%), Positives = 83/188 (44%), Gaps = 23/188 (12%)
Query: 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKN 609
IV EY+ +G+LD L +L Q + ++ G+A + YL + VH +++
Sbjct: 83 IVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEMGY---VHKGLAAHK 137
Query: 610 VLLDLGYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNV--APELAYTMKVTEKCDVYSF 665
VL++ +S FR L D S ++ ++G + APE + DV+SF
Sbjct: 138 VLVNSDLVCKISGFRR---LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSF 194
Query: 666 GVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RLPYPSLDVQNKFMSIMQVAFSCL 723
G++ EV+ G+ P ++MS +E D RLP P + N +M C
Sbjct: 195 GIVMWEVMSYGERP---YWDMSGQDVIKAVE--DGFRLPAPR-NCPNLLHQLM---LDCW 245
Query: 724 DQNPVSRP 731
+ RP
Sbjct: 246 QKERGERP 253
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 51/216 (23%), Positives = 81/216 (37%), Gaps = 63/216 (29%)
Query: 508 CIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNFCS----------------------- 543
+G+G G VY+ V +G AVK+ F
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQV------PFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 544 HPR--QSF----------IVYEYLESGSL-DKI-----LNNDASAKELGWTQRLNVIKGV 585
H R Q + I EY+ GS+ D++ L + K +T++ +
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRK---YTRQ------I 113
Query: 586 ADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN---LDSSNWSKLAGT 642
+ + YLH+N IVH DI N+L D + DF +K L + + GT
Sbjct: 114 LEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170
Query: 643 HGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 678
++PE+ K DV+S G +E++ K P
Sbjct: 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 9e-05
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 56/210 (26%)
Query: 506 KHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD------------------------- 539
+G+G +G VY AR +GEI A+KK +
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 540 -NFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRL--NVIKGVADALFYLHNNC 596
+ R+ ++V+EY + L K L+ + + +++G+A Y H++
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLA----YCHSHR 118
Query: 597 FPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APEL- 650
I+H D+ +N+L++ ++DF +A+ + + TH V APE+
Sbjct: 119 ---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-----THEVVTLWYRAPEIL 170
Query: 651 ----AYTMKVTEKCDVYSFGVLALEVIKGK 676
Y+ V D++S G + E+I GK
Sbjct: 171 LGSKHYSTAV----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 42/172 (24%), Positives = 75/172 (43%), Gaps = 14/172 (8%)
Query: 579 LNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK 638
LN +A + YL +VH D++++NVL+ ++DF +AK L D +
Sbjct: 112 LNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA 168
Query: 639 LAGTH--GNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIE 695
G +A E T + DV+S+GV E++ G P D + +S +I
Sbjct: 169 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEISSIL 224
Query: 696 ILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNP 747
RLP P + + +M +++ C + SRP + ++ + +P
Sbjct: 225 EKGERLPQPPICTIDVYMIMVK----CWMIDADSRPKFRELIIEFSKMARDP 272
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 36/152 (23%), Positives = 67/152 (44%), Gaps = 21/152 (13%)
Query: 305 LNRISLSGNKLSGR----IPGELGSLINLEYLDLSANHLSNF----VLESLGSLVKLYYL 356
L ++ L N+L G + L + +L+ L+L+ N + + + E L + L L
Sbjct: 139 LEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVL 198
Query: 357 NLSHNKL----SQQIPIELDNLIHLSELDLSHNFLGEKISSRIC---RME--SLEKLNLS 407
+L++N L + + L +L L L+L N L + ++ + SL L+LS
Sbjct: 199 DLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLS 258
Query: 408 YNNLSGL----IPRCFEELHGLLHIDISYNKL 435
N+++ + E LL +D+ NK
Sbjct: 259 CNDITDDGAKDLAEVLAEKESLLELDLRGNKF 290
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 45/177 (25%), Positives = 74/177 (41%), Gaps = 24/177 (13%)
Query: 579 LNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK 638
LN +A + YL +VH D++++NVL+ ++DF +A+ L D ++
Sbjct: 112 LNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 168
Query: 639 LAGTH--GNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIE 695
G +A E + K T + DV+S+GV E++ G P D + E
Sbjct: 169 DGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI---------PTRE 219
Query: 696 ILD-----SRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNP 747
I D RLP P + + +M V C + SRP K + + +P
Sbjct: 220 IPDLLEKGERLPQPPICTIDVYM----VMVKCWMIDADSRPKFKELAAEFSRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 59/277 (21%), Positives = 109/277 (39%), Gaps = 63/277 (22%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKK----FHSP-----------------------LPDN 540
IG+G +G VY AR +GEI A+KK F S L D
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 541 FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 600
F H ++V+E++++ L K++ + L + + + + L + H++ I
Sbjct: 67 F-RHKGDLYLVFEFMDT-DLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 601 VHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKV-TEK 659
+H D+ +N+L++ ++DF +A+ ++ T APEL K +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 660 CDVYSFGVLALEVIK------GKHPRDFLF---------------EMSSSSSNMNIEILD 698
D++S G + E++ GK D LF + +S + N
Sbjct: 180 VDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239
Query: 699 -SRLPYPSL--DVQNKFMSIMQVAFSCLDQNPVSRPT 732
+ +P P L + + + ++ L +P R T
Sbjct: 240 KAGMPLPKLFPNASPQALDLLS---QMLHYDPHKRIT 273
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 31/103 (30%), Positives = 43/103 (41%), Gaps = 14/103 (13%)
Query: 586 ADALFY----------LHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635
A A+FY LH IV+ D+ +NVLLD +SD +A L
Sbjct: 95 ARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKK 150
Query: 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 678
AGT G +APE+ D ++ G E+I G+ P
Sbjct: 151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 1e-04
Identities = 60/244 (24%), Positives = 95/244 (38%), Gaps = 64/244 (26%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVK------------------------KFHS 535
+DF+ +G G G V + R SG+ +A+K
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 536 PLPDNFCS---HPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIK----GVADA 588
P N ++V EY+ G L L E V + V A
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPE-------PVARFYAAQVVLA 113
Query: 589 LFYLHNNCFPPIVHWDISSKNVLLD-LGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVA 647
L YLH+ IV+ D+ +N+LLD GY ++DF AK + ++ L GT +A
Sbjct: 114 LEYLHSL---DIVYRDLKPENLLLDSDGY-IKITDFGFAKR--VKGRTYT-LCGTPEYLA 166
Query: 648 PEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI--EILDSRL 701
PE+ Y V D ++ G+L E++ G P F + + I +IL+ ++
Sbjct: 167 PEIILSKGYGKAV----DWWALGILIYEMLAGYPP--F-----FDDNPIQIYEKILEGKV 215
Query: 702 PYPS 705
+PS
Sbjct: 216 RFPS 219
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 52/207 (25%), Positives = 76/207 (36%), Gaps = 33/207 (15%)
Query: 541 FCSHPRQSFIVYEYLESGSLDKIL----NNDASAKELGWTQRLNVIKGVADALFYLHNNC 596
F PR FI+ E + G L L L L + VA YL N
Sbjct: 79 FERLPR--FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH 136
Query: 597 FPPIVHWDISSKNVLLDL---GYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVA---PEL 650
F +H DI+++N LL G A ++DF +A+ + +S + K + PE
Sbjct: 137 F---IHRDIAARNCLLTCKGPGRVAKIADFGMARDI-YRASYYRKGGRAMLPIKWMPPEA 192
Query: 651 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD-----SRLPYPS 705
T K DV+SFGVL E+ F N E+++ RL P
Sbjct: 193 FLDGIFTSKTDVWSFGVLLWEI--------FSLGYMPYPGRTNQEVMEFVTGGGRLDPP- 243
Query: 706 LDVQNKFMSIMQVAFSCLDQNPVSRPT 732
+ + ++ C P RP
Sbjct: 244 ---KGCPGPVYRIMTDCWQHTPEDRPN 267
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 49/175 (28%), Positives = 79/175 (45%), Gaps = 21/175 (12%)
Query: 585 VADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHG 644
++ AL YLH I++ D+ NVLLD ++D+ + K S GT
Sbjct: 105 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN 161
Query: 645 NVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE------ILD 698
+APE+ D ++ GVL E++ G+ P D + SS + + N E IL+
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV--GSSDNPDQNTEDYLFQVILE 219
Query: 699 SRLPYP-SLDVQNKFMSIMQVAFSCLDQNPVSR----PTMKRFEVQSKQFHYNPD 748
++ P SL V K S+++ S L+++P R P ++Q F N D
Sbjct: 220 KQIRIPRSLSV--KAASVLK---SFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 269
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 35/132 (26%), Positives = 57/132 (43%), Gaps = 9/132 (6%)
Query: 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKN 609
I EY+ GS+ L + E + + + + + YLH+N IVH DI N
Sbjct: 83 IFMEYMPGGSVKDQLKAYGALTE---SVTRKYTRQILEGMSYLHSNM---IVHRDIKGAN 136
Query: 610 VLLDLGYEAHVSDFRIAKFLN---LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFG 666
+L D + DF +K L + + + GT ++PE+ K DV+S G
Sbjct: 137 ILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLG 196
Query: 667 VLALEVIKGKHP 678
+E++ K P
Sbjct: 197 CTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 50/186 (26%), Positives = 81/186 (43%), Gaps = 16/186 (8%)
Query: 549 FIVYEYLESGSL-DKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISS 607
+IV EY + G L KI K L + + ++H ++H DI S
Sbjct: 74 YIVMEYCDGGDLMQKI--KLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKS 128
Query: 608 KNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGV 667
KN+ L + + DF A+ L + GT V PE+ M K D++S G
Sbjct: 129 KNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGC 188
Query: 668 LALEVIKGKHPRDFLFEMSSSSSNMNIEILD-SRLPYPSLDVQNKFMSIMQVAFSCLDQN 726
+ E+ KHP F+ ++S N+ +++ S P PS + S+++ F +N
Sbjct: 189 ILYELCTLKHP----FQ-ANSWKNLILKVCQGSYKPLPS-HYSYELRSLIKQMFK---RN 239
Query: 727 PVSRPT 732
P SRP+
Sbjct: 240 PRSRPS 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 51/214 (23%)
Query: 542 CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIV 601
C +S +V EY++ GSLD L + + + W +L V K +A AL +L + +
Sbjct: 68 CVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK---GLT 122
Query: 602 HWDISSKNVLL-----------------DLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHG 644
H ++ +KNVLL D G +S + K + L+ W
Sbjct: 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPG----ISITVLPKEILLERIPW-------- 170
Query: 645 NVAPE-LAYTMKVTEKCDVYSFGVLALEVIKG-KHPRDFLFEMSSSSSNMNIEILDSR-- 700
V PE + ++ D +SFG E+ G P +S+ S ++ + R
Sbjct: 171 -VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP------LSALDSQKKLQFYEDRHQ 223
Query: 701 LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
LP P K+ + + C+D P RP+ +
Sbjct: 224 LPAP------KWTELANLINQCMDYEPDFRPSFR 251
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 59/203 (29%), Positives = 83/203 (40%), Gaps = 45/203 (22%)
Query: 509 IGKGGHGSVYIARV-PSGEIFAVKKF--HSPLPDNF-------------CSHP-----RQ 547
+G GG G V + +V FA+K + C+HP +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 548 SFI----VY---EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 600
+F +Y EY G L IL + E +T R I V A YLHN I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE--YTARF-YIACVVLAFEYLHNR---GI 114
Query: 601 VHWDISSKNVLLDL-GYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPEL----AYTMK 655
++ D+ +N+LLD GY + DF AK L W+ GT VAPE+ Y
Sbjct: 115 IYRDLKPENLLLDSNGY-VKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEIILNKGYDFS 172
Query: 656 VTEKCDVYSFGVLALEVIKGKHP 678
V D +S G+L E++ G+ P
Sbjct: 173 V----DYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 29/84 (34%), Positives = 43/84 (51%), Gaps = 6/84 (7%)
Query: 601 VHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLA-GTHGNVAPELAYTM----- 654
VH DI NVLLD+ ++DF +N D + S +A GT ++PE+ M
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183
Query: 655 KVTEKCDVYSFGVLALEVIKGKHP 678
K +CD +S GV E++ G+ P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 37/206 (17%)
Query: 501 NDFDAKHCIGKGGHGSVY-IARVPSGEIFAVKKFH---SPLPDNF----------CSHPR 546
+DF+ +G G G V+ ++ PSG I A K H P N C+ P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 547 ------------QSFIVYEYLESGSLDKILNNDASAKE--LGWTQRLNVIKGVADALFYL 592
+ I E+++ GSLD++L E LG + VIKG L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS-IAVIKG----LTYL 119
Query: 593 HNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAY 652
I+H D+ N+L++ E + DF ++ L S + GT ++PE
Sbjct: 120 REK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQ 175
Query: 653 TMKVTEKCDVYSFGVLALEVIKGKHP 678
+ + D++S G+ +E+ G++P
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 62/251 (24%), Positives = 117/251 (46%), Gaps = 43/251 (17%)
Query: 509 IGKGGHGSVYIAR----VPSGEIFAVK-----------KFHSPLPDNFCSHPRQSFIV-- 551
+G+G G V++ R +G+++A+K + + + + + FIV
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 552 -YEYLESGSLDKILN----NDAS---AKELGWTQRLNV---IKGVADALFYLHNNCFPPI 600
Y + G L IL+ D +KE+ +T+ +V + +A AL +LH+ I
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-DVKFYLAELALALDHLHS---LGI 119
Query: 601 VHWDISSKNVLLDLGYEAHVSDFRIAK-FLNLDSSNWSKLAGTHGNVAPELAYTMKVTEK 659
++ D+ +N+LLD ++DF ++K ++ + +S GT +APE+ T+
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNRRGHTQS 178
Query: 660 CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVA 719
D +SFGVL E++ G P F+ M + IL ++L P + + S+++
Sbjct: 179 ADWWSFGVLMFEMLTGSLP----FQGKDRKETMTM-ILKAKLGMPQF-LSPEAQSLLRAL 232
Query: 720 FSCLDQNPVSR 730
F +NP +R
Sbjct: 233 FK---RNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 60/236 (25%), Positives = 99/236 (41%), Gaps = 37/236 (15%)
Query: 502 DFDAKHCIGKGGHGSVYIARVPSG----EIFAVKKF-------------HSPLPDNFCSH 544
+F+ +G G +G V++ R SG +++A+K H+ H
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 545 PRQS-FIV---YEYLESGSLDKILN--------NDASAKELGWTQRLNVIKG-VADALFY 591
RQS F+V Y + L IL+ S +E Q + + G + AL +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 592 LHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK-FLNLDSSNWSKLAGTHGNVAPEL 650
LH I++ DI +N+LLD ++DF ++K F + GT +AP++
Sbjct: 121 LHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177
Query: 651 AYTMKV--TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYP 704
+ D +S GVL E++ G P E +S + ++ IL S PYP
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSEPPYP 232
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 48/210 (22%), Positives = 82/210 (39%), Gaps = 40/210 (19%)
Query: 509 IGKGGHGSVYIA-RVPSGEIFAVKKF--------------------------HSPLPDNF 541
+GKG G V +A + E++A+K H L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 542 CSH--PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 599
C + F V EY+ G L + +++ + V AL +LH +
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---G 116
Query: 600 IVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEK 659
+++ D+ N+LLD ++DF + K L+ + GT +APE+ ++
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPS 176
Query: 660 CDVYSFGVLALEVIKGKHP-----RDFLFE 684
D ++ GVL E++ G+ P D LFE
Sbjct: 177 VDWWALGVLMYEMMAGQPPFEADNEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 67/241 (27%), Positives = 105/241 (43%), Gaps = 44/241 (18%)
Query: 502 DFDAKHCIGKGGHGSVYIARVPSG----EIFAVKKF-------------HSPLPDNFCSH 544
+F+ +G G +G V++ R +G +++A+K H+ N H
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 545 PRQS-FIV---YEYLESGSLDKILNNDASAKEL--GWTQRLNVIKG--------VADALF 590
RQS F+V Y + L IL+ S E+ QR N + + AL
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDY-VSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE 119
Query: 591 YLHNNCFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAK-FLNLDSSNWSKLAGTHGNVA 647
+LH IV+ DI +N+LLD E HV +DF ++K FL+ + GT +A
Sbjct: 120 HLHK---LGIVYRDIKLENILLD--SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 648 PELAYTMKVTEKC-DVYSFGVLALEVIKGKHPRDFLFE-MSSSSSNMNIEILDSRLPYPS 705
PE+ K D +S G+L E++ G P F E ++ S ++ IL P+PS
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASP--FTLEGERNTQSEVSRRILKCDPPFPS 232
Query: 706 L 706
Sbjct: 233 F 233
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 35/131 (26%), Positives = 64/131 (48%), Gaps = 11/131 (8%)
Query: 550 IVYEYLESGSLDKILNNDASAKE--LGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISS 607
I E+++ GSLD++L E LG + V++G+A YL I+H D+
Sbjct: 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVS-IAVLRGLA----YLREK--HQIMHRDVKP 132
Query: 608 KNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGV 667
N+L++ E + DF ++ L S + GT ++PE + + D++S G+
Sbjct: 133 SNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 190
Query: 668 LALEVIKGKHP 678
+E+ G++P
Sbjct: 191 SLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 52/207 (25%), Positives = 83/207 (40%), Gaps = 41/207 (19%)
Query: 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKF-------------------------HS 535
D + +G G G V++ R S +A+K H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 536 PLPDNFCSHPRQSFI--VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLH 593
+ F + Q F+ + EY+ G L L N + + L + AL YLH
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLH 118
Query: 594 NNCFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNWSKLAGTHGNVAPELA 651
+ IV+ D+ +N+LLD E H+ +DF AK L W+ L GT +APE+
Sbjct: 119 SK---EIVYRDLKPENILLD--KEGHIKLTDFGFAK--KLRDRTWT-LCGTPEYLAPEVI 170
Query: 652 YTMKVTEKCDVYSFGVLALEVIKGKHP 678
+ + D ++ G+L E++ G P
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 49/207 (23%), Positives = 79/207 (38%), Gaps = 35/207 (16%)
Query: 509 IGKGGHGSVYIARVPSGEIFAVKKF-----HSPLPDNF--------CSHPR--------- 546
+G G G VY A+ + A K L D C HP
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 547 ---QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHW 603
+I+ E+ G++D ++ + L Q V K +AL YLH N I+H
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHR 127
Query: 604 DISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTE----- 658
D+ + N+L L + ++DF ++ GT +APE+ +
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 187
Query: 659 KCDVYSFGVLALEVIKGKHPRDFLFEM 685
K DV+S G+ +E+ + + P L M
Sbjct: 188 KADVWSLGITLIEMAQIEPPHHELNPM 214
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 4e-04
Identities = 13/45 (28%), Positives = 24/45 (53%), Gaps = 5/45 (11%)
Query: 37 EEAHALVKWKASLEVHSRSLLHSWSLSFVNATKISLCTWSGIHCN 81
++ AL+ +K+SL L SW+ S + C+W+G+ C+
Sbjct: 3 DDRDALLAFKSSLNGDPSGALSSWNPSSSDP-----CSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 41/154 (26%), Positives = 65/154 (42%), Gaps = 18/154 (11%)
Query: 585 VADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHG 644
+A+ + YL + F +H D++++N+LL + + DF + + L + ++ H
Sbjct: 106 IANGMRYLESKRF---IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE--HL 160
Query: 645 NV-----APELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILD 698
V APE T + DV+ FGV E+ G+ P +S S I+
Sbjct: 161 KVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP---WAGLSGSQILKKIDKEG 217
Query: 699 SRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT 732
RL P Q+ I V C NP RPT
Sbjct: 218 ERLERPEACPQD----IYNVMLQCWAHNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 53/212 (25%), Positives = 86/212 (40%), Gaps = 52/212 (24%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNFCSHPRQ-------------SFIVYEY 554
+G+G +G V R VP+G I AVK+ + + N R + V Y
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATV--NSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 555 --------------LESGSLDKILNNDASAKELGWTQRLNVIK----GVADALFYLHNNC 596
+ SLDK + G T +++ + AL YLH+
Sbjct: 67 GALFREGDVWICMEVMDTSLDKFYKK---VYDKGLTIPEDILGKIAVSIVKALEYLHSKL 123
Query: 597 FPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPEL------ 650
++H D+ NVL++ + + DF I+ +L +DS + AG +APE
Sbjct: 124 --SVIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDAGCKPYMAPERINPELN 180
Query: 651 --AYTMKVTEKCDVYSFGVLALEVIKGKHPRD 680
Y +K DV+S G+ +E+ G+ P D
Sbjct: 181 QKGYDVK----SDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 44/196 (22%), Positives = 84/196 (42%), Gaps = 9/196 (4%)
Query: 550 IVYEYLESGSLDKILNNDASAKELGWTQRL-NVIKGVADALFYLHNNCFPPIVHWDISSK 608
IV E ++G L +++ + K L + + + AL ++H+ ++H DI
Sbjct: 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPA 135
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVL 668
NV + + D + +F + ++ L GT ++PE + K D++S G L
Sbjct: 136 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCL 195
Query: 669 ALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPV 728
E+ + P + +M+ S IE D YP L + + Q+ C++ +P
Sbjct: 196 LYEMAALQSPF-YGDKMNLYSLCKKIEQCD----YPPLPSDHYSEELRQLVNMCINPDPE 250
Query: 729 SRPTMKRFEVQSKQFH 744
RP + +K+ H
Sbjct: 251 KRPDITYVYDVAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 29/90 (32%), Positives = 42/90 (46%), Gaps = 3/90 (3%)
Query: 589 LFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAP 648
L +LH I++ D+ +NVLLD +SD +A L S AGT G +AP
Sbjct: 110 LEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAP 166
Query: 649 ELAYTMKVTEKCDVYSFGVLALEVIKGKHP 678
EL + D ++ GV E+I + P
Sbjct: 167 ELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 19/188 (10%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWT---QRL-NVIKGVADALFYLHNNCFPPIVHWD 604
+IV + +E L + N S KE +R+ N+ + AL YLH IVH D
Sbjct: 85 YIVMDLIEGAPLGEHFN---SLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRD 139
Query: 605 ISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYS 664
++ N++L + ++DF +AK +S S GT PE+ EK DV++
Sbjct: 140 LTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSV-VGTILYSCPEIVKNEPYGEKADVWA 198
Query: 665 FGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRL-PYPSLDVQNKFMSIMQVAFSCL 723
FG + ++ + P F S++ ++ +I+++ P P ++ SCL
Sbjct: 199 FGCILYQMCTLQPP--F---YSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVIT---SCL 250
Query: 724 DQNPVSRP 731
+ +RP
Sbjct: 251 TPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 23/199 (11%)
Query: 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKN 609
++ E+L SGSL + L + + L Q+L + + YL + + VH D++++N
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNKINL--KQQLKYAVQICKGMDYLGSRQY---VHRDLAARN 139
Query: 610 VLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APELAYTMKVTEKCDVYSFG 666
VL++ ++ + DF + K + D ++ V APE K DV+SFG
Sbjct: 140 VLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFG 199
Query: 667 VLALEVI-----KGKHPRDFLFEMSSSSSNMNIEIL------DSRLPYPSLDVQNKFMSI 715
V E++ + FL + + M + L RLP P N +
Sbjct: 200 VTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPP----NCPEEV 255
Query: 716 MQVAFSCLDQNPVSRPTMK 734
Q+ C + P R T +
Sbjct: 256 YQLMRKCWEFQPSKRTTFQ 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 35/133 (26%), Positives = 59/133 (44%), Gaps = 11/133 (8%)
Query: 550 IVYEYLESGSL-DKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
I EY+ GS+ D++ A + + +++GV YLH+N IVH DI
Sbjct: 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGV----SYLHSNM---IVHRDIKGA 135
Query: 609 NVLLDLGYEAHVSDFRIAKFLN---LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSF 665
N+L D + DF +K + + + + GT ++PE+ K DV+S
Sbjct: 136 NILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSV 195
Query: 666 GVLALEVIKGKHP 678
+E++ K P
Sbjct: 196 ACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 48/215 (22%)
Query: 498 RATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFH----------SPLPD----NFC 542
R+ +F+ + IG+G +G VY AR SGEI A+KK S L +
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL 63
Query: 543 SHPR--------------QSFIVYEYLESGSLDKILNN------DASAKELGWTQRLNVI 582
HP F+V EY E L +L+N ++ K L L ++
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCL----MLQLL 118
Query: 583 KGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGT 642
+G+ YLH N I+H D+ N+LL ++DF +A+ L + + T
Sbjct: 119 RGLQ----YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVT 171
Query: 643 HGNVAPELAYTMKV-TEKCDVYSFGVLALEVIKGK 676
APEL T D+++ G + E++ K
Sbjct: 172 LWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 38/125 (30%), Positives = 62/125 (49%), Gaps = 10/125 (8%)
Query: 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHWDISSKNV 610
Y+ + +L++D S + L L+ VA + +L + NC VH D++++NV
Sbjct: 214 YKGSNDSEVKNLLSDDGS-EGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNV 268
Query: 611 LLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APELAYTMKVTEKCDVYSFGV 667
LL G + DF +A+ + DS+ SK T V APE + T DV+S+G+
Sbjct: 269 LLAQGKIVKICDFGLARDIMHDSNYVSK-GSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 668 LALEV 672
L E+
Sbjct: 328 LLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 7e-04
Identities = 36/133 (27%), Positives = 62/133 (46%), Gaps = 11/133 (8%)
Query: 550 IVYEYLESGSL-DKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
I E++ GS+ D++ + A + + +++GV+ YLH+N IVH DI
Sbjct: 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS----YLHSNM---IVHRDIKGA 135
Query: 609 NVLLDLGYEAHVSDFRIAKFLN---LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSF 665
N+L D + DF +K L L + + GT ++PE+ K D++S
Sbjct: 136 NILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSV 195
Query: 666 GVLALEVIKGKHP 678
G +E++ K P
Sbjct: 196 GCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 8e-04
Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 11/131 (8%)
Query: 550 IVYEYLESGSLDKILNNDASAKE--LGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISS 607
I E+++ GSLD++L E LG + V L YL I+H D+
Sbjct: 76 ICMEHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLREK--HKIMHRDVKP 128
Query: 608 KNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGV 667
N+L++ E + DF ++ L +DS S GT ++PE T + D++S G+
Sbjct: 129 SNILVNSRGEIKLCDFGVSGQL-IDSMANS-FVGTRSYMSPERLQGTHYTVQSDIWSLGL 186
Query: 668 LALEVIKGKHP 678
+E+ G++P
Sbjct: 187 SLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 9e-04
Identities = 39/167 (23%), Positives = 75/167 (44%), Gaps = 18/167 (10%)
Query: 573 LGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632
+G LN +A + YL +VH D++++NVL+ ++DF +A+ L++D
Sbjct: 106 IGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162
Query: 633 SSNWSKLAGTH--GNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSS 689
+ + G +A E + T + DV+S+GV E++ G P D
Sbjct: 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD------GIP 216
Query: 690 SNMNIEILDS--RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+ ++L+ RLP P + + +M +++ C + RP +
Sbjct: 217 AREIPDLLEKGERLPQPPICTIDVYMIMVK----CWMIDSECRPRFR 259
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 0.001
Identities = 64/282 (22%), Positives = 103/282 (36%), Gaps = 75/282 (26%)
Query: 509 IGKGGHGSVYIARVPS-GEIFAVKKFHSPLPDNFCSHPR--------------------- 546
IGKGG G VY+A P A+KK L +N R
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 547 ---QSFIVY---EYLESGSLDKILNN----DASAKELGWTQR----LNVIKGVADALFYL 592
VY Y+E +L +L + ++ +KEL L++ + + Y+
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV 129
Query: 593 HNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD---------------SSNWS 637
H+ ++H D+ N+LL L E + D+ A F L+ S+ +
Sbjct: 130 HSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186
Query: 638 ---KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP------RDFLFEMSSS 688
K+ GT +APE + +E D+Y+ GV+ +++ P R +
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVIL 246
Query: 689 SSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSR 730
S IE+ R P L Q+A L +P R
Sbjct: 247 SP---IEVAPYREIPPFLS---------QIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 57/258 (22%), Positives = 100/258 (38%), Gaps = 52/258 (20%)
Query: 509 IGKGGHGSVYIARVPS-GEIFAVKKFHSPLP----DNF---------------------C 542
IG+G G V+ R+ + AVK LP F C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 543 SHPRQSFIVYEYLESGSLDKILNNDAS---AKELGWTQRLNVIKGVADALFYLHNNCFPP 599
+ + +IV E ++ G L + KEL + +++ A + YL +
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKEL-----IQMVENAAAGMEYLESKH--- 114
Query: 600 IVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGN----VAPELAYTMK 655
+H D++++N L+ +SDF +++ + ++ G APE +
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 656 VTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714
+ + DV+SFG+L E G P +S+ + IE RLP P L +
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYA---NLSNQQTREAIE-QGVRLPCPELCPDAVY-R 227
Query: 715 IMQVAFSCLDQNPVSRPT 732
+M+ C + +P RP+
Sbjct: 228 LME---RCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 52/207 (25%), Positives = 85/207 (41%), Gaps = 38/207 (18%)
Query: 542 CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIV 601
C ++ +V E++E G LD L + + W ++ V + +A AL YL + +V
Sbjct: 85 CVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLASALSYLEDK---NLV 139
Query: 602 HWDISSKNVLL-DLGYEAHVSDF-----------RIAKFLNLDSSNWSKLAGTHGNVAPE 649
H ++ +KN+LL LG S F +++ ++ W +APE
Sbjct: 140 HGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPW---------IAPE 190
Query: 650 -LAYTMKVTEKCDVYSFGVLALEV-IKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLD 707
+ ++ D +SFG LE+ G+ P L E + S E RLP PS
Sbjct: 191 CVPGGNSLSTAADKWSFGTTLLEICFDGEVP---LKERTPSEKERFYE-KKHRLPEPSCK 246
Query: 708 VQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+S CL P RP+ +
Sbjct: 247 ELATLIS------QCLTYEPTQRPSFR 267
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.001
Identities = 49/208 (23%), Positives = 81/208 (38%), Gaps = 43/208 (20%)
Query: 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------- 539
N ++ +G+G +G V R +GEI A+KKF D
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 540 ------NFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLH 593
+ ++V+EY+E L+ + +AS L + I + A+ Y H
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCH 117
Query: 594 NNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS-SNWSKLAGTHGNVAPEL-- 650
++ I+H DI +N+L+ + DF A+ L S + T APEL
Sbjct: 118 SH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174
Query: 651 ---AYTMKVTEKCDVYSFGVLALEVIKG 675
Y V DV++ G + E++ G
Sbjct: 175 GDTNYGKPV----DVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 30/108 (27%), Positives = 51/108 (47%), Gaps = 7/108 (6%)
Query: 588 ALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVA 647
AL +LH I++ D+ NVLLD ++D+ + K S GT +A
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIA 164
Query: 648 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE 695
PE+ + D ++ GVL E++ G+ P F++ + + +MN E
Sbjct: 165 PEILRGEEYGFSVDWWALGVLMFEMMAGRSP----FDIITDNPDMNTE 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 28/84 (33%), Positives = 41/84 (48%), Gaps = 6/84 (7%)
Query: 601 VHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLA-GTHGNVAPELAYTM----- 654
VH DI NVLLD ++DF L D + S +A GT ++PE+ M
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 655 KVTEKCDVYSFGVLALEVIKGKHP 678
+ +CD +S GV E++ G+ P
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 57/250 (22%), Positives = 93/250 (37%), Gaps = 58/250 (23%)
Query: 485 FPLLGK-IVYEEIIRATNDFDAKHCIGKGGHGSVY-IARVPSGEIFAVKKFHSPLPD--- 539
FPL GK I+++ ++ ++ IGKG +G V+ + +G AVK P+ D
Sbjct: 1 FPLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDE 59
Query: 540 ----------NFCSHPR-----------------QSFIVYEYLESGSLDKILNNDASAKE 572
HP Q ++V E GS+ D
Sbjct: 60 EIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-----TDLVKGF 114
Query: 573 LGWTQRLN------VIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626
L +R+ ++ L +LH N +H D+ N+LL + DF ++
Sbjct: 115 LKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVS 171
Query: 627 KFLNLDSSNWSKLAGTHGNVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGK----- 676
L + GT +APE+ +CDV+S G+ A+E+ G
Sbjct: 172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231
Query: 677 -HPRDFLFEM 685
HP LF++
Sbjct: 232 LHPMRALFKI 241
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 35/141 (24%), Positives = 65/141 (46%), Gaps = 17/141 (12%)
Query: 600 IVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTM 654
+VH D++++NVL+ G + +SDF +++ + + S + + G + A E +
Sbjct: 148 LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS---YVKRSKGRIPVKWMAIESLFDH 204
Query: 655 KVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713
T + DV+SFGVL E++ G +P + + N+ R+ P +N
Sbjct: 205 IYTTQSDVWSFGVLLWEIVTLGGNP----YPGIAPERLFNLLKTGYRMERP----ENCSE 256
Query: 714 SIMQVAFSCLDQNPVSRPTMK 734
+ + +C Q P RPT
Sbjct: 257 EMYNLMLTCWKQEPDKRPTFA 277
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.002
Identities = 22/60 (36%), Positives = 26/60 (43%)
Query: 110 HLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQL 169
+L LDL NN L I L L+ LD N L+ P S L L L +S N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 34/145 (23%), Positives = 62/145 (42%), Gaps = 5/145 (3%)
Query: 600 IVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEK 659
++H DI NV + + D + +F + ++ L GT ++PE + K
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 186
Query: 660 CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVA 719
D++S G L E+ + P + +M+ S IE D YP L ++ + ++
Sbjct: 187 SDIWSLGCLLYEMAALQSPF-YGDKMNLFSLCQKIEQCD----YPPLPTEHYSEKLRELV 241
Query: 720 FSCLDQNPVSRPTMKRFEVQSKQFH 744
C+ +P RP + +KQ H
Sbjct: 242 SMCIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 25/81 (30%), Positives = 42/81 (51%), Gaps = 4/81 (4%)
Query: 600 IVHWDISSKNVLLDLGYEAHVS--DFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVT 657
+++ D+ +N+LLD Y+ H++ DF + K D + GT +APEL T
Sbjct: 114 VIYRDLKPENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT 171
Query: 658 EKCDVYSFGVLALEVIKGKHP 678
+ D ++ GVL E++ G P
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 32/121 (26%), Positives = 55/121 (45%), Gaps = 11/121 (9%)
Query: 588 ALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVA 647
L ++HN +V+ D+ N+LLD +SD +A + + S GTHG +A
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMA 163
Query: 648 PE-LAYTMKVTEKCDVYSFGVLALEVIKG-----KHPRDFLFEMSSSSSNMNIEILDSRL 701
PE L D +S G + ++++G +H E+ + +N+E+ DS
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFS 223
Query: 702 P 702
P
Sbjct: 224 P 224
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 56/219 (25%), Positives = 85/219 (38%), Gaps = 48/219 (21%)
Query: 509 IGKGGHGSVYIARVPSGEI-FAVK-------KFHSPLPDNFCSHPRQSF----------- 549
+GKG +G VY AR S ++ A+K ++ PL + H
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 550 ------IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHW 603
I E + GSL +L + + + K + + L YLH+N IVH
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHR 132
Query: 604 DISSKNVLLDLGYEA--HVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEK-- 659
DI NVL++ Y +SDF +K L + GT +APE V +K
Sbjct: 133 DIKGDNVLVNT-YSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPE------VIDKGP 185
Query: 660 ------CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM 692
D++S G +E+ GK P E+ + M
Sbjct: 186 RGYGAPADIWSLGCTIVEMATGKPP---FIELGEPQAAM 221
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 26/209 (12%)
Query: 529 AVKKFHSPL--PDNFCSHPRQSFIVYEYLESGSLD-KILNNDASAKELGWTQRLNVIKGV 585
A+ KFH+ D FC I+ EY E LD K+ + K L Q +
Sbjct: 63 AIVKFHASFLERDAFC-------IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 586 ADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGN 645
+ Y+H I+H D+ +KN+ L + DF +++ L + GT
Sbjct: 116 LLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYY 171
Query: 646 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPS 705
++PE K D++S G + E+ H FE + S + + I++ P PS
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEMCCLAHA----FEGQNFLS-VVLRIVEG--PTPS 224
Query: 706 LD--VQNKFMSIMQVAFSCLDQNPVSRPT 732
L + SIMQ S L+++P RP+
Sbjct: 225 LPETYSRQLNSIMQ---SMLNKDPSLRPS 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 32/101 (31%), Positives = 45/101 (44%), Gaps = 14/101 (13%)
Query: 585 VADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHG 644
AL YL I+H D+ N+LLD + DF I+ L +DS ++ AG
Sbjct: 116 TVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSIAKTRDAGCRP 172
Query: 645 NVAPEL-------AYTMKVTEKCDVYSFGVLALEVIKGKHP 678
+APE Y + + DV+S G+ EV GK P
Sbjct: 173 YMAPERIDPSARDGYDV----RSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 23/164 (14%)
Query: 533 FHSPLPDNFCSHPRQSFIVYEYLESGSL------DKILNNDASAKELGWTQRLNVIKGVA 586
F + L +F +H R F++ EY G L +++ + D A+ G +
Sbjct: 56 FLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSED-RARFYG--------AEIV 105
Query: 587 DALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV 646
AL YLH+ +V+ D+ +N++LD ++DF + K D + GT +
Sbjct: 106 SALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYL 163
Query: 647 APELAYTMKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEM 685
APE+ D + GV+ E++ G+ P + LFE+
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 47/213 (22%), Positives = 84/213 (39%), Gaps = 36/213 (16%)
Query: 542 CSHPRQSFIVYEYLESGSL------DKILNND-------ASAKELGWTQRLNVIKGVADA 588
C H ++ EY G+L ++L D ++A L Q L+ VA
Sbjct: 77 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 136
Query: 589 LFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAP 648
+ YL F +H D++++N+L+ Y A ++DF +++ +
Sbjct: 137 MDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIE 193
Query: 649 ELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPY---- 703
L Y++ T DV+S+GVL E++ G P M L +LP
Sbjct: 194 SLNYSVYTTNS-DVWSYGVLLWEIVSLGGTP----------YCGMTCAELYEKLPQGYRL 242
Query: 704 -PSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKR 735
L+ ++ +M+ C + P RP+ +
Sbjct: 243 EKPLNCDDEVYDLMR---QCWREKPYERPSFAQ 272
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 35.9 bits (84), Expect = 0.002
Identities = 17/37 (45%), Positives = 24/37 (64%), Gaps = 2/37 (5%)
Query: 328 NLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLS 364
NLE LDLS N +++ L L +L L L+LS NK++
Sbjct: 2 NLETLDLSNNQITD--LPPLSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.003
Identities = 13/37 (35%), Positives = 21/37 (56%)
Query: 400 SLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLE 436
+L+ L+LS N L+ + F+ L L +D+S N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT 37
|
Length = 60 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 25/174 (14%)
Query: 588 ALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNWSKLAGTHGN 645
AL +LH I++ D+ NVLLD E H+ +D+ + K S GT
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLD--AEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNY 162
Query: 646 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE------ILDS 699
+APE+ D ++ GVL E++ G+ P D + S + + N E IL+
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV--GMSDNPDQNTEDYLFQVILEK 220
Query: 700 RLPYP-SLDVQNKFMSIMQVAFSCLDQNPVSR----PTMKRFEVQSKQFHYNPD 748
++ P SL V K S+++ L+++P R P +++S F N D
Sbjct: 221 QIRIPRSLSV--KASSVLK---GFLNKDPKERLGCHPQTGFRDIKSHPFFRNID 269
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 16/160 (10%)
Query: 533 FHSPLPDNFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKG--VADALF 590
F + L +F + R F++ EY+ G L L ++E +++ G + AL
Sbjct: 56 FLTSLKYSFQTKDRLCFVM-EYVNGGELFFHL-----SRERVFSEDRTRFYGAEIVSALD 109
Query: 591 YLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPEL 650
YLH+ IV+ D+ +N++LD ++DF + K D++ GT +APE+
Sbjct: 110 YLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEV 166
Query: 651 AYTMKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEM 685
D + GV+ E++ G+ P + LFE+
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 2/83 (2%)
Query: 600 IVHWDISSKNVLLDLGYEAHVSDFRIAK-FLNLDSSNWSK-LAGTHGNVAPELAYTMKVT 657
++H DI S N+LL + DF +K + S + + GT VAPE+ +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 658 EKCDVYSFGVLALEVIKGKHPRD 680
+K D++S GVL E++ K P D
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 0.003
Identities = 51/221 (23%), Positives = 91/221 (41%), Gaps = 69/221 (31%)
Query: 503 FDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKF------------------------H--- 534
++ IG+G +G VY AR +GE+ A+KK H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 535 SPLPDNFCSHPRQS-FIVYEYLE---SGSLDKILNNDASAKEL-GWTQRLNVIKGVADAL 589
L + S + S ++V+EY++ +G LD + ++ + ++L ++G+
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSP-EVKFTESQIKCYMKQL--LEGLQ--- 114
Query: 590 FYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN---------WSKLA 640
YLH+N I+H DI N+L++ ++DF +A+ +S W +
Sbjct: 115 -YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR-- 168
Query: 641 GTHGNVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGK 676
PEL Y +V D++S G + E+ GK
Sbjct: 169 ------PPELLLGATRYGPEV----DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 34/138 (24%), Positives = 67/138 (48%), Gaps = 21/138 (15%)
Query: 550 IVYEYLESGSLDKILNN--------DASAKELGWTQRLNVIKGVADALFYLHNNCFPPIV 601
++ EY+E+G L++ L+ A + ++ + + +A + YL + F V
Sbjct: 96 MITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF---V 152
Query: 602 HWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAP------ELAYTMK 655
H D++++N L+ Y ++DF +++ NL S ++ ++ G V P E K
Sbjct: 153 HRDLATRNCLVGKNYTIKIADFGMSR--NLYSGDYYRIQGR--AVLPIRWMSWESILLGK 208
Query: 656 VTEKCDVYSFGVLALEVI 673
T DV++FGV E++
Sbjct: 209 FTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.004
Identities = 38/135 (28%), Positives = 54/135 (40%), Gaps = 21/135 (15%)
Query: 310 LSGNKLSGR----IPGELGSLINLEYLDLSANHLSNF------VLESLGSLVKLYYLNLS 359
L GN L + L +L+ L LS N +L+ L L L+LS
Sbjct: 30 LEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLS 89
Query: 360 HNKLSQQIPIELDNLIH---LSELDLSHNFLGEKISSRICR-----MESLEKLNLSYNNL 411
N L L++L+ L EL L++N LG++ + + +LEKL L N L
Sbjct: 90 DNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRL 149
Query: 412 SGLIPRCFEELHGLL 426
G E L L
Sbjct: 150 EG---ASCEALAKAL 161
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 36/156 (23%), Positives = 58/156 (37%), Gaps = 52/156 (33%)
Query: 601 VHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGN-------VAPELAYT 653
+H D++++N+LL + DF +A+ + D K G+ +APE +
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK-----GDARLPLKWMAPESIFD 249
Query: 654 MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713
T + DV+SFGVL E+ F + +S PYP + + +F
Sbjct: 250 KVYTTQSDVWSFGVLLWEI----------FSLGAS-------------PYPGVQIDEEFC 286
Query: 714 -----------------SIMQVAFSCLDQNPVSRPT 732
I + C NP RPT
Sbjct: 287 RRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT 322
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 41/174 (23%), Positives = 68/174 (39%), Gaps = 45/174 (25%)
Query: 585 VADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA------KFLNLDSSNWSK 638
VA L +LH F +H D++ +N L + D+ +A + +
Sbjct: 109 VASGLLWLHQADF---IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP 165
Query: 639 LAGTHGNVAPELA-------YTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS--S 689
L APEL T+K +++S GV E LF +
Sbjct: 166 LRWL----APELVEIRGQDLLPKDQTKKSNIWSLGVTMWE----------LFTAADQPYP 211
Query: 690 SNMNIEIL-------DSRLPYPSLDVQ--NKFMSIMQVAFSCLDQNPVSRPTMK 734
+ ++L D +LP P LD++ +++ +MQ F LD P +RPT +
Sbjct: 212 DLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQ--FCWLD--PETRPTAE 261
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 40/158 (25%), Positives = 69/158 (43%), Gaps = 27/158 (17%)
Query: 588 ALFYLHNNCFPPIVHWDISSKNVLL---------DLGYEAHVSDFRIAKFLNLDSSNWSK 638
AL +H+ ++H D+ S N+ L D G+ SD ++LD + S
Sbjct: 181 ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS-----VSLDVA--SS 230
Query: 639 LAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD 698
GT +APEL + ++K D++S GV+ E++ P F+ S M +
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP----FKGPSQREIMQQVLYG 286
Query: 699 SRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRF 736
P+P V + +++ L +NP RPT ++
Sbjct: 287 KYDPFPC-PVSSGMKALLD---PLLSKNPALRPTTQQL 320
|
Length = 478 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 53/214 (24%), Positives = 83/214 (38%), Gaps = 30/214 (14%)
Query: 542 CSHPRQSFIVYEYLESGSL------DKILNND-ASAKELGWT------QRLNVIKGVADA 588
C + +I EY G+L ++L D A AKE G Q L VA
Sbjct: 72 CENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATG 131
Query: 589 LFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAP 648
+ YL F +H D++++NVL+ + ++DF +++ +
Sbjct: 132 MQYLSEKQF---IHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIE 188
Query: 649 ELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLP--YPS 705
L Y++ T K DV+SFGVL E++ G P M L +LP Y
Sbjct: 189 SLNYSVYTT-KSDVWSFGVLLWEIVSLGGTP----------YCGMTCAELYEKLPQGYRM 237
Query: 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739
+N + ++ C P RP + VQ
Sbjct: 238 EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 51/210 (24%), Positives = 79/210 (37%), Gaps = 54/210 (25%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKFHS-------------------------------- 535
IGKG +G V A +GE A+KK +
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 536 ---PLPDNFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYL 592
P F + ++V+E +ES I ND E +++ L Y+
Sbjct: 68 MLPPSRREF----KDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRA----LKYI 119
Query: 593 H-NNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN---WSKLAGTHGNVAP 648
H N F H D+ KN+L + + + DF +A+ D+ W+ T AP
Sbjct: 120 HTANVF----HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 649 EL--AYTMKVTEKCDVYSFGVLALEVIKGK 676
EL ++ K T D++S G + EV+ GK
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.004
Identities = 27/84 (32%), Positives = 42/84 (50%), Gaps = 6/84 (7%)
Query: 601 VHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLA-GTHGNVAPELAYTM----- 654
VH DI N+L+D+ ++DF L D + S +A GT ++PE+ M
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183
Query: 655 KVTEKCDVYSFGVLALEVIKGKHP 678
K +CD +S GV E++ G+ P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 24/79 (30%), Positives = 41/79 (51%), Gaps = 1/79 (1%)
Query: 600 IVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEK 659
IV+ D+ +N+LLD +SD +A + + ++ GT G +APE+ + T
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFS 181
Query: 660 CDVYSFGVLALEVIKGKHP 678
D ++ G L E+I G+ P
Sbjct: 182 PDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 752 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.98 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.98 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.98 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.98 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.98 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.98 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.98 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.9 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.89 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.8 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.8 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.76 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.73 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.73 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.73 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.72 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.68 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.66 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.65 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.63 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.5 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.47 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.45 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.44 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.41 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.4 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.39 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.33 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.31 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.24 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.23 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.16 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.15 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.15 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.13 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.11 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.09 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.09 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.07 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.06 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.06 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.05 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.04 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.04 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.03 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.0 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.96 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.92 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.86 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.82 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.79 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.69 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.66 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.66 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.63 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.6 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.53 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.52 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.5 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.48 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.46 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.41 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.4 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.29 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.28 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-88 Score=829.40 Aligned_cols=690 Identities=34% Similarity=0.550 Sum_probs=441.2
Q ss_pred CCCHHHHHHHHHHHHccccCCccccCCCCccccCCCCCCCCcccceeeCCCCCEEEEEcCCCCCcccccccccCCCCCCC
Q 041438 33 SNSTEEAHALVKWKASLEVHSRSLLHSWSLSFVNATKISLCTWSGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLA 112 (752)
Q Consensus 33 ~~~~~~~~aLl~fk~~~~~~~~~~l~sW~~~~~~~~~~~~c~w~gv~C~~~~~v~~l~l~~~~l~g~l~~~~f~~l~~L~ 112 (752)
...++|+.||++||+++. +|.+.+.+|. ...+||.|.||+|+..++|+.++|+++++.|.++ .+|..+++|+
T Consensus 25 ~~~~~~~~~l~~~~~~~~-~~~~~~~~w~------~~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~-~~~~~l~~L~ 96 (968)
T PLN00113 25 MLHAEELELLLSFKSSIN-DPLKYLSNWN------SSADVCLWQGITCNNSSRVVSIDLSGKNISGKIS-SAIFRLPYIQ 96 (968)
T ss_pred CCCHHHHHHHHHHHHhCC-CCcccCCCCC------CCCCCCcCcceecCCCCcEEEEEecCCCccccCC-hHHhCCCCCC
Confidence 336789999999999995 5667789996 1248999999999888899999999887776552 2444444444
Q ss_pred EEECCCCcccccC-----------------------------------------------CccCcCCCCCCeeecCCCcc
Q 041438 113 YLDLYNNELFDII-----------------------------------------------PPQISNLSKLEYLDFLTNKL 145 (752)
Q Consensus 113 ~L~L~~n~l~~~~-----------------------------------------------p~~~~~l~~L~~L~L~~N~l 145 (752)
+|+|++|++++.+ |..|+++++|++|+|++|.+
T Consensus 97 ~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l 176 (968)
T PLN00113 97 TINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVL 176 (968)
T ss_pred EEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcc
Confidence 4444444444333 33344444444444444444
Q ss_pred cccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccc
Q 041438 146 SGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQI 225 (752)
Q Consensus 146 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 225 (752)
.+.+|..|+++++|++|+|++|.+++.+|..++++++|++|+|++|++++.+|..|+++++|++|+|++|++++.+|..|
T Consensus 177 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l 256 (968)
T PLN00113 177 VGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL 256 (968)
T ss_pred cccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhH
Confidence 44444444444444444444444444444444444444444444444444444444444455555555555444444445
Q ss_pred cCccccccccccccccCCCcCCCCCCCCCCCCcEEEcccc------------------------ccCCCCCcccCCCCCC
Q 041438 226 GNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSIN------------------------NITGNIPFEIGESPQL 281 (752)
Q Consensus 226 ~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N------------------------~l~~~~p~~~~~l~~L 281 (752)
+++++|+.|++++|++++.+|.. +..+++|+.|++++| .+++..|..+..+++|
T Consensus 257 ~~l~~L~~L~L~~n~l~~~~p~~--l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L 334 (968)
T PLN00113 257 GNLKNLQYLFLYQNKLSGPIPPS--IFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRL 334 (968)
T ss_pred hCCCCCCEEECcCCeeeccCchh--HhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCC
Confidence 55555555555555544444332 123334444444444 4444444444444555
Q ss_pred CEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCccc------------------------CCCccc--------
Q 041438 282 QYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGEL------------------------GSLINL-------- 329 (752)
Q Consensus 282 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~------------------------~~l~~L-------- 329 (752)
+.|+|++|.+.+.+|..++.+++|+.|++++|++++.+|..+ +.+++|
T Consensus 335 ~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n 414 (968)
T PLN00113 335 QVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414 (968)
T ss_pred CEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCC
Confidence 555555555555555555555555555555555443332221 111122
Q ss_pred ---------------------------------------------------------------ceeeccccccccccchh
Q 041438 330 ---------------------------------------------------------------EYLDLSANHLSNFVLES 346 (752)
Q Consensus 330 ---------------------------------------------------------------~~L~Ls~N~l~~~~~~~ 346 (752)
+.|+|++|++++..|..
T Consensus 415 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~ 494 (968)
T PLN00113 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRK 494 (968)
T ss_pred EeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChh
Confidence 22222233333333334
Q ss_pred hcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCc
Q 041438 347 LGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLL 426 (752)
Q Consensus 347 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 426 (752)
|.++++|+.|+|++|++++.+|..+.++++|++|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+..+++|+
T Consensus 495 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 574 (968)
T PLN00113 495 LGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLV 574 (968)
T ss_pred hhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccC
Confidence 44555566666666666666777777777888888888888888888888888888888888888888888888888888
Q ss_pred EEEccCCcccCcCCCCcccCCCCcccccCCCCCCCCc--cccccccccccccceEEEEEE-e-------------cc---
Q 041438 427 HIDISYNKLEGHIPNSTTFRDAPLEALQGNKGLCGDI--RGFLSCMSYRKASRKIWIVIV-F-------------PL--- 487 (752)
Q Consensus 427 ~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~--~~~~~c~~~~~~~~~~~~~~~-~-------------~~--- 487 (752)
.|++++|+++|.+|....+.......+.||+++||.. .+...|...++......++.. + ..
T Consensus 575 ~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (968)
T PLN00113 575 QVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRG 654 (968)
T ss_pred EEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHh
Confidence 8888888888888888777777778899999999853 123346432221111111100 0 00
Q ss_pred -------------------------cccchHHHHHHhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--
Q 041438 488 -------------------------LGKIVYEEIIRATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-- 539 (752)
Q Consensus 488 -------------------------~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-- 539 (752)
...++++++ ...|...+.||+|+||.||+|+. .+++.||||+++.....
T Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~ 731 (968)
T PLN00113 655 RNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS 731 (968)
T ss_pred hhcccccccccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccH
Confidence 001222232 34567778999999999999995 68999999988643211
Q ss_pred ------------------CccccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 041438 540 ------------------NFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIV 601 (752)
Q Consensus 540 ------------------~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iv 601 (752)
+++.+.+..|+||||+++|+|.++++. ++|.++.+|+.|+++|++|+|..+.++|+
T Consensus 732 ~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~ii 805 (968)
T PLN00113 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVV 805 (968)
T ss_pred HHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCee
Confidence 456677889999999999999999952 78999999999999999999976666999
Q ss_pred ecCCCCCCEEeCCCCceEEeecccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcch
Q 041438 602 HWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDF 681 (752)
Q Consensus 602 H~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~ 681 (752)
||||||+||+++.++.+++. ||.+...... ....+|+.|+|||++.+..++.|+|||||||++|||+||+.||+.
T Consensus 806 H~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 806 VGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred cCCCCHHhEEECCCCceEEE-eccccccccC----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 99999999999998888876 6655433211 223688999999999999999999999999999999999999853
Q ss_pred hhcccccc---------ccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 682 LFEMSSSS---------SNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 682 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
........ ......+.+...............++.+++.+||+.||++||||+|+++.|+++...
T Consensus 881 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 881 EFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred ccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 22111000 001111222222111111234556788999999999999999999999999998653
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=369.46 Aligned_cols=257 Identities=37% Similarity=0.609 Sum_probs=211.7
Q ss_pred cccchHHHHHHhhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCC--C----------------------Cccc
Q 041438 488 LGKIVYEEIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLP--D----------------------NFCS 543 (752)
Q Consensus 488 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~----------------------~~~~ 543 (752)
...|+++|+..||++|.....||+|+||.||+|...+|+.||||++..... . +||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 345899999999999999999999999999999999999999998875432 1 7888
Q ss_pred cCC-ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEee
Q 041438 544 HPR-QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSD 622 (752)
Q Consensus 544 ~~~-~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~D 622 (752)
+.+ +.++|+|||++|+|.+++...... .++|.++.+||.++|+||+|||..+.|.||||||||+|||+|+++++||+|
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 888 599999999999999999876543 799999999999999999999999988999999999999999999999999
Q ss_pred cccceeccCCCCCcccc-cCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccc----------cccc
Q 041438 623 FRIAKFLNLDSSNWSKL-AGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------SSSN 691 (752)
Q Consensus 623 fG~a~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~----------~~~~ 691 (752)
||+|+............ .||.+|+|||++..+..+.|+|||||||++.|++||+.|.+....... ....
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 99997654312222222 899999999999999999999999999999999999988763220000 0111
Q ss_pred chHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 692 MNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
...+++|.++.............+..+..+|++.+|++||+|.||++.|+.+..
T Consensus 301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 455666766542111112566679999999999999999999999999977653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=353.82 Aligned_cols=229 Identities=25% Similarity=0.361 Sum_probs=188.3
Q ss_pred ccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC-------------------------CccccCC-ceEEEEEe
Q 041438 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD-------------------------NFCSHPR-QSFIVYEY 554 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------------------------~~~~~~~-~~~lV~E~ 554 (752)
+.+..+.||+|..|+||+++ .++++.+|+|.++..... +.+.++. +++++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 44556899999999999999 468999999998443222 3344556 59999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|.+|+|++++...+ .+++....+|+.+|++||.|||+ + +||||||||+|||++..|++||||||.++.+...
T Consensus 160 MDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999998653 48889999999999999999996 6 9999999999999999999999999999987643
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHH
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
.....+||..|||||.+.+..|+.++||||||++++|+++|+.||...........+....+++...+... ...+++
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP--~~~fS~ 309 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLP--EGEFSP 309 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCC--cccCCH
Confidence 45667999999999999999999999999999999999999999853211111223355566665444322 125788
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
++.+++..||++||.+||+++|+++|=
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 999999999999999999999999774
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=355.95 Aligned_cols=230 Identities=25% Similarity=0.361 Sum_probs=198.3
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC-------------------------------CccccCC
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD-------------------------------NFCSHPR 546 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------------------------------~~~~~~~ 546 (752)
..+.|.+.+.+|+|+||.|-+|. ..+|+.||||++++.... ++++.++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 35678899999999999999998 678999999998764322 5567778
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC---CceEEeec
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG---YEAHVSDF 623 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~---~~~kl~Df 623 (752)
..|+||||++||+|.+.+-.++. +.+...+.+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 89999999999999999876653 67788899999999999999999 99999999999999765 67999999
Q ss_pred ccceeccCCCCCcccccCCCCccCccccccCCC---CCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccC
Q 041438 624 RIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKV---TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR 700 (752)
Q Consensus 624 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 700 (752)
|+|+..+ ....+...|||+.|.|||++.+..+ ..|+|+||+||++|-+++|.+||.. .........++..++
T Consensus 324 GlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~----~~~~~sl~eQI~~G~ 398 (475)
T KOG0615|consen 324 GLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSE----EYTDPSLKEQILKGR 398 (475)
T ss_pred chhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccc----ccCCccHHHHHhcCc
Confidence 9999876 4566777899999999999986653 3488999999999999999999952 112223667888899
Q ss_pred CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 701 LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 701 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+.+....+...+.+..++|.+||..||++|||++|+++|
T Consensus 399 y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 399 YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 988878889999999999999999999999999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=368.64 Aligned_cols=225 Identities=25% Similarity=0.404 Sum_probs=201.8
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~ 552 (752)
.+|+..+.||+|||+.||+++. .+|+.||+|++.+.... +++++.+.+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999996 89999999998663221 6788899999999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
|+|..++|..+++++ +++++.+++.+++||+.||.|||++ +|+|||||..|+++++++++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999999854 4599999999999999999999999 9999999999999999999999999999999877
Q ss_pred CCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHH
Q 041438 633 SSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (752)
.....+.||||.|.|||++....++..+||||+||++|.|++|++||+ .....+....+....+..|. ..+
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe-----tk~vkety~~Ik~~~Y~~P~----~ls 242 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE-----TKTVKETYNKIKLNEYSMPS----HLS 242 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc-----cchHHHHHHHHHhcCccccc----ccC
Confidence 777778899999999999999999999999999999999999999996 33345667777777777774 566
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
.++.+||.++|++||.+|||+++|+.|=
T Consensus 243 ~~A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 243 AEAKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 7789999999999999999999999764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=348.72 Aligned_cols=220 Identities=25% Similarity=0.371 Sum_probs=188.8
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------------CccccCCceEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFI 550 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~l 550 (752)
..++|++.++||+|+||+||.++ ..+++.||+|++++.... ..+++.+..|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 46789999999999999999999 567999999998765332 23567789999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
|+||+.||.|...+++.+ .+++..++.++.+|+.||.|||+. |||||||||+|||+|.+|+++|+|||+++..-
T Consensus 103 Vld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999998655 388899999999999999999999 99999999999999999999999999999766
Q ss_pred CCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
.........+||+.|||||++.+..|+.++|+||+||++|||++|.+||. ..........+...+.+.+. .-
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~-----~~~~~~~~~~I~~~k~~~~p---~~ 248 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY-----AEDVKKMYDKILKGKLPLPP---GY 248 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc-----CccHHHHHHHHhcCcCCCCC---cc
Confidence 56566667899999999999999999999999999999999999999996 33445566666666644332 22
Q ss_pred HHHHHHHHHHhccCcCCCCCCC
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPT 732 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps 732 (752)
.+.+..++++++++.||++|..
T Consensus 249 ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 249 LSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred CCHHHHHHHHHHhccCHHHhcC
Confidence 4557889999999999999963
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=360.09 Aligned_cols=229 Identities=23% Similarity=0.348 Sum_probs=197.1
Q ss_pred HHhhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC----------------------------CccccCCc
Q 041438 497 IRATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD----------------------------NFCSHPRQ 547 (752)
Q Consensus 497 ~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----------------------------~~~~~~~~ 547 (752)
.+..++|.+.+.||+|+|++|++|+ ..+++.||||++.+...- ..+++...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 5678899999999999999999999 678999999998664321 23467788
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
.|+|+||+++|+|.+++++.+ .+++...+.++.||+.||+|||++ |||||||||+|||+|++|++||+|||.|+
T Consensus 149 LYFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999998775 488999999999999999999999 99999999999999999999999999999
Q ss_pred eccCCCCC-------------cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchH
Q 041438 628 FLNLDSSN-------------WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI 694 (752)
Q Consensus 628 ~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~ 694 (752)
.+...... ...++||..|.+||++.+...++.+||||||||+|+|+.|++||. .....-...
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFr-----a~NeyliFq 297 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFR-----AANEYLIFQ 297 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCc-----cccHHHHHH
Confidence 87542211 134799999999999999999999999999999999999999996 223334567
Q ss_pred hhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 695 EILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
.+++-.+.+|. +.++.+.+|+.+.|..||.+|+|++||-+|-
T Consensus 298 kI~~l~y~fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 298 KIQALDYEFPE----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHhcccCCC----CCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 77777777773 4557889999999999999999998888764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=334.32 Aligned_cols=233 Identities=21% Similarity=0.334 Sum_probs=193.0
Q ss_pred hcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC----------------------------CccccCCceEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFI 550 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~l 550 (752)
..+|++.++||+|+||+||+++ ..+|..||.|.++-...+ .+.++.+..+|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 3468899999999999999999 689999999998743332 12233445899
Q ss_pred EEEeccCCChHHHhccCcc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCEEeCCCCceEEeecccce
Q 041438 551 VYEYLESGSLDKILNNDAS-AKELGWTQRLNVIKGVADALFYLHNNCFPP--IVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~--ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
|||||..|||.+.++.... .+.+++..+++++.|+++||..+|.. .|+ |+||||||.||+++..|.+|++|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999986443 45689999999999999999999994 225 9999999999999999999999999999
Q ss_pred eccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChh
Q 041438 628 FLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLD 707 (752)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (752)
.+..........+|||.||+||.+.+.+|++||||||+||++|||..-++||.. +...+....+....++ +.+
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-----~n~~~L~~KI~qgd~~--~~p 249 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-----DNLLSLCKKIEQGDYP--PLP 249 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-----ccHHHHHHHHHcCCCC--CCc
Confidence 998777667778999999999999999999999999999999999999999962 2233344455555443 233
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
...++.++..+|..|+..||+.||+...++..+
T Consensus 250 ~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 250 DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred HHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 467888999999999999999999855554444
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=413.61 Aligned_cols=347 Identities=35% Similarity=0.498 Sum_probs=223.6
Q ss_pred Cccc-ceeeCCCCCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCc
Q 041438 73 CTWS-GIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPS 151 (752)
Q Consensus 73 c~w~-gv~C~~~~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 151 (752)
-.|. +..|+.+..|++- ...+++.|+|++|++++.+|..|..+++|++|+|++|++++.+|.
T Consensus 49 ~~w~~~~~~c~w~gv~c~-----------------~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~ 111 (968)
T PLN00113 49 SNWNSSADVCLWQGITCN-----------------NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPD 111 (968)
T ss_pred CCCCCCCCCCcCcceecC-----------------CCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCCh
Confidence 3685 4566666666541 124688999999999999999999999999999999999988887
Q ss_pred ccc-cccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccc
Q 041438 152 EIS-LLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKS 230 (752)
Q Consensus 152 ~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 230 (752)
.+. .+++|++|+|++|.+++.+|. +.+++|++|+|++|.+++.+|..++++++|++|+|++|.+.+.+|..++++++
T Consensus 112 ~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 189 (968)
T PLN00113 112 DIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTS 189 (968)
T ss_pred HHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcC
Confidence 654 888888888888888776664 34666777777777776666666666777777777777666666666666666
Q ss_pred cccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEc
Q 041438 231 LFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISL 310 (752)
Q Consensus 231 L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 310 (752)
|++|++++|++++.+|.. ++.+++|++|+|++|++++.+|..+..+++|++|+|++|.+++.+|..++++++|+.|++
T Consensus 190 L~~L~L~~n~l~~~~p~~--l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 267 (968)
T PLN00113 190 LEFLTLASNQLVGQIPRE--LGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFL 267 (968)
T ss_pred CCeeeccCCCCcCcCChH--HcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEEC
Confidence 666666666666665543 345566666666666666666666666666666666666666666666666666666666
Q ss_pred cCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCC
Q 041438 311 SGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEK 390 (752)
Q Consensus 311 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 390 (752)
++|++.+.+|..+.++++|++|+|++|.+.+..|..+.++++|+.|++++|.+++..|..+..+++|+.|+|++|.+.+.
T Consensus 268 ~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 347 (968)
T PLN00113 268 YQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGE 347 (968)
T ss_pred cCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCc
Confidence 66666555555555555566666665555555555555555555555555555555555555555555555555555555
Q ss_pred CCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCCcccCcCC
Q 041438 391 ISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIP 440 (752)
Q Consensus 391 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 440 (752)
+|..+..+++|+.|+|++|++++.+|..+..+++|+.|++++|++.+.+|
T Consensus 348 ~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p 397 (968)
T PLN00113 348 IPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP 397 (968)
T ss_pred CChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCC
Confidence 55555555555555555555554444444444444444444444444333
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=345.15 Aligned_cols=227 Identities=26% Similarity=0.404 Sum_probs=178.9
Q ss_pred HhhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------CccccCCceEE
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFI 550 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~l 550 (752)
+..++|+..+.||+|+||+||+|+ ..++..||||.+.+.... +++..++.+|+
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 456889999999999999999999 467899999998765321 55677889999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC------CceEEeecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG------YEAHVSDFR 624 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~------~~~kl~DfG 624 (752)
|||||.||||.++++.++ .+++.+++.++.|+|.||++||++ +||||||||+|||++.. -.+||+|||
T Consensus 87 VMEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 999999999999998765 388899999999999999999999 99999999999999754 458999999
Q ss_pred cceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCC
Q 041438 625 IAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYP 704 (752)
Q Consensus 625 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (752)
+|+.+.. .......+|++.|||||++...+|+.|+|+||+|+|+|+|++|+.||+ .....+....+.......+
T Consensus 161 fAR~L~~-~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~-----a~t~~eL~~~~~k~~~~~~ 234 (429)
T KOG0595|consen 161 FARFLQP-GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD-----AETPKELLLYIKKGNEIVP 234 (429)
T ss_pred hhhhCCc-hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc-----ccCHHHHHHHHhccccccC
Confidence 9999873 344456799999999999999999999999999999999999999996 2222222222222222222
Q ss_pred ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHH
Q 041438 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFE 737 (752)
Q Consensus 705 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 737 (752)
.. .......+.+++...++.+|.+|.+..+-.
T Consensus 235 ~~-~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 235 VL-PAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred ch-hhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 11 122333445666666777777776665544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=329.78 Aligned_cols=233 Identities=21% Similarity=0.322 Sum_probs=186.5
Q ss_pred cccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E 553 (752)
+.|+...++|+|+||.||+++ ..+|+.||||++.....+ .++...+..++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 468889999999999999999 568999999998654432 45677789999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
||+. ++.+-+.+.. ..++...+++|++|++.|+.|+|++ ++|||||||+||||+.++.+||||||+|+.+..+.
T Consensus 82 ~~dh-TvL~eLe~~p--~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDH-TVLHELERYP--NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecch-HHHHHHHhcc--CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 9998 5555555443 3378899999999999999999999 99999999999999999999999999999998777
Q ss_pred CCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhcccccc---------ccchHhhhccC---
Q 041438 634 SNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS---------SNMNIEILDSR--- 700 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~---------~~~~~~~~~~~--- 700 (752)
...+.++.|.+|+|||.+.+ .+|+..+||||+||++.||++|++.|....++++-. ......++...
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 78888999999999999887 679999999999999999999999986443322210 01112222221
Q ss_pred ----CCCCC------hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 701 ----LPYPS------LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 701 ----~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+|.+. ...+....-+.+++++|++.||++|++.+|++.|
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11111 0122344568899999999999999999999865
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=354.61 Aligned_cols=370 Identities=25% Similarity=0.265 Sum_probs=331.2
Q ss_pred EEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeecc
Q 041438 86 VFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHIS 165 (752)
Q Consensus 86 v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 165 (752)
+..+|++++.++..-. ..|.++++|+.++|.+|.++. +|...+...+|+.|+|.+|.|+.+..+++..++.|+.||||
T Consensus 80 t~~LdlsnNkl~~id~-~~f~nl~nLq~v~l~~N~Lt~-IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDF-EFFYNLPNLQEVNLNKNELTR-IPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred eeeeeccccccccCcH-HHHhcCCcceeeeeccchhhh-cccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 4568888888775432 357899999999999999976 57666677779999999999999999999999999999999
Q ss_pred CcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCc
Q 041438 166 RNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAI 245 (752)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~ 245 (752)
.|.|+.+.-..|..-.++++|+|++|+|+..-...|.++.+|..|.|++|+++...+..|.+|++|+.|+|..|+|.-.
T Consensus 158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iriv- 236 (873)
T KOG4194|consen 158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIV- 236 (873)
T ss_pred hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeee-
Confidence 9999987778899989999999999999999999999999999999999999988889999999999999999998733
Q ss_pred CCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCC
Q 041438 246 PLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGS 325 (752)
Q Consensus 246 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 325 (752)
....|..+++|+.|.|..|.|...-...|..+.++++|+|+.|+++..-..++.++++|+.|+||+|.|..+.++.+.-
T Consensus 237 -e~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsf 315 (873)
T KOG4194|consen 237 -EGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSF 315 (873)
T ss_pred -hhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhh
Confidence 3446889999999999999999998999999999999999999999888899999999999999999999999999999
Q ss_pred CcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCC---cccccccccc
Q 041438 326 LINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKIS---SRICRMESLE 402 (752)
Q Consensus 326 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~ 402 (752)
.++|++||||+|+|+...+++|..+..|++|+|++|.++.+....|..+++|+.|||++|.|+..+. ..|.++++|+
T Consensus 316 tqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lr 395 (873)
T KOG4194|consen 316 TQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLR 395 (873)
T ss_pred cccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhh
Confidence 9999999999999999999999999999999999999998889999999999999999999987654 4578899999
Q ss_pred eEEccCCcCCcCCchhhhccCCCcEEEccCCcccCcCCCCcccCCCCccc--ccCCCCCCC
Q 041438 403 KLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEA--LQGNKGLCG 461 (752)
Q Consensus 403 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~--~~~n~~~c~ 461 (752)
.|+|.+|+|..+.-.+|.++.+|++|||.+|.+...-|+. |....+.. +..-.-+|.
T Consensus 396 kL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nA--Fe~m~Lk~Lv~nSssflCD 454 (873)
T KOG4194|consen 396 KLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNA--FEPMELKELVMNSSSFLCD 454 (873)
T ss_pred heeecCceeeecchhhhccCcccceecCCCCcceeecccc--cccchhhhhhhcccceEEe
Confidence 9999999999998999999999999999999998777763 43333333 333334564
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=345.16 Aligned_cols=229 Identities=28% Similarity=0.465 Sum_probs=186.1
Q ss_pred cccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC--------------------------CccccCC-ceEEEEEec
Q 041438 503 FDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD--------------------------NFCSHPR-QSFIVYEYL 555 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~-~~~lV~E~~ 555 (752)
..+.+.||+|+||+||+|.+.....||||++...... ++|..+. ..++||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 3445669999999999999865555999998764311 5555655 789999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCC-eeecCCCCCCEEeCCCC-ceEEeecccceeccCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP-IVHWDISSKNVLLDLGY-EAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~-ivH~DlKp~NIll~~~~-~~kl~DfG~a~~~~~~~ 633 (752)
++|+|.+++... ....+++..+..++.|||+|+.|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999874 235699999999999999999999999 8 99999999999999997 99999999998866433
Q ss_pred CCcccccCCCCccCccccc--cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhh-c-cCCCCCChhhH
Q 041438 634 SNWSKLAGTHGNVAPELAY--TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEIL-D-SRLPYPSLDVQ 709 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~--~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~ 709 (752)
...+...||+.|||||++. ...|+.|+|||||||++|||+||+.||.... .......+. . .+...+ .
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~-----~~~~~~~v~~~~~Rp~~p----~ 269 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA-----PVQVASAVVVGGLRPPIP----K 269 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhcCCCCCCC----c
Confidence 3444468999999999999 5689999999999999999999999996322 122222222 2 222233 2
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
.+++.+..++.+||+.||++||++.|++..|+.+.
T Consensus 270 ~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 270 ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 36778899999999999999999999999999775
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.04 Aligned_cols=235 Identities=17% Similarity=0.277 Sum_probs=188.2
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------CccccCC-ceEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSHPR-QSFI 550 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~~~-~~~l 550 (752)
..++|.+.++||.|+||.||+|+ ..+|+.||||++++.... +++.+.+ ..|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 35689999999999999999999 678999999998765443 2333334 8999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
|||||+. +|+++++.+. +.+++.+++.|++||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+.+.
T Consensus 88 VfE~Md~-NLYqLmK~R~--r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRN--RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhhh-hHHHHHhhcC--CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 9999988 9999999873 6699999999999999999999999 99999999999999988899999999999886
Q ss_pred CCCCCcccccCCCCccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccc---------------cc-cch
Q 041438 631 LDSSNWSKLAGTHGNVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS---------------SS-NMN 693 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~---------------~~-~~~ 693 (752)
+ ....+.++.|.+|+|||++. ...|+.+.|+||+|||++|+.+-++.|....+.++. .+ ...
T Consensus 162 S-kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 162 S-KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred c-CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 4 34567789999999999866 556899999999999999999999988543332211 00 111
Q ss_pred HhhhccCCCCC-Ch----hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 694 IEILDSRLPYP-SL----DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 694 ~~~~~~~~~~~-~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
...+.-+++.- .. -....+.++.++|.+|+.+||++||||+|+++|-
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 22222222211 10 1233667899999999999999999999999874
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=341.59 Aligned_cols=220 Identities=25% Similarity=0.336 Sum_probs=182.4
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------------CccccCCceEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFI 550 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~l 550 (752)
..++|++.+.||+|+||.||+|+ ..+|+.||+|++++.... ..+++.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 67899999999999999999999 568999999999764321 23567889999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||++|||+..++...+ .|++..++.++.+++.|++.+|+. |+|||||||+|+|||..|++||+|||++.-+.
T Consensus 219 iMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999998654 489999999999999999999999 99999999999999999999999999986431
Q ss_pred C-----------------------CCC-----C-------------------cccccCCCCccCccccccCCCCCccchh
Q 041438 631 L-----------------------DSS-----N-------------------WSKLAGTHGNVAPELAYTMKVTEKCDVY 663 (752)
Q Consensus 631 ~-----------------------~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~ksDIw 663 (752)
. +.. . ....+|||.|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 000 0 0124799999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCcchhhccccccccchHhhhccC--CCCCChhhHHHHHHHHHHHHhccCcCCCCCCC
Q 041438 664 SFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR--LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT 732 (752)
Q Consensus 664 SlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 732 (752)
|+|||+|||+.|.+||. .....+....++.-+ +.+|. .....+++.++|.+|+. ||++|..
T Consensus 373 SLG~ImyEmLvGyPPF~-----s~tp~~T~rkI~nwr~~l~fP~--~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFC-----SETPQETYRKIVNWRETLKFPE--EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHhCCCCCC-----CCCHHHHHHHHHHHhhhccCCC--cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999996 333444445554444 44443 24455889999999999 9999976
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=316.25 Aligned_cols=214 Identities=24% Similarity=0.338 Sum_probs=188.4
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------------CccccCCceEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFI 550 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~l 550 (752)
..++|++.+.||.|+||.|.+++ ..+|..||+|++.+...- +.+.+....|+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 35689999999999999999999 567899999998764321 34567789999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||++||-|..++++.+ +++++.++.+|.||+.||+|||+. +|++||+||+|||+|++|.+||+|||+|+...
T Consensus 122 vmeyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EEeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999998755 488999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
.. ....||||.|+|||++....++.++|+|||||++|||+.|.+||. ..........++..+..+|. -
T Consensus 196 ~r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~-----~~~~~~iY~KI~~~~v~fP~----~ 263 (355)
T KOG0616|consen 196 GR---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY-----DDNPIQIYEKILEGKVKFPS----Y 263 (355)
T ss_pred Cc---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc-----CCChHHHHHHHHhCcccCCc----c
Confidence 32 455799999999999999999999999999999999999999995 33445677888999998885 3
Q ss_pred HHHHHHHHHHhccCcCCCCC
Q 041438 711 KFMSIMQVAFSCLDQNPVSR 730 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~R 730 (752)
...++.+|+.+.++.|-.+|
T Consensus 264 fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 264 FSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cCHHHHHHHHHHHhhhhHhh
Confidence 45678899999999999999
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=344.78 Aligned_cols=219 Identities=23% Similarity=0.317 Sum_probs=191.5
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC----------------------------CccccCCceE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSF 549 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~ 549 (752)
..++|.+.++||+|+||+|++|. ..+++.||||.+++...- ..++..++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 46789999999999999999999 567899999999876432 3456779999
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+||||+.||++..+.+. ..+++..++.|+.+|+.||+|||++ ||||||||.+|||+|.+|++||+|||+++..
T Consensus 446 fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999995444432 3499999999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 630 NLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
-......++.+||+.|||||++.+..|+.++|+|||||++|||+.|+.||. .+..++....++.....+|.
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~-----gddEee~FdsI~~d~~~yP~---- 589 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP-----GDDEEEVFDSIVNDEVRYPR---- 589 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC-----CCCHHHHHHHHhcCCCCCCC----
Confidence 545556777899999999999999999999999999999999999999996 34556677888888888874
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCH
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTM 733 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~ 733 (752)
..+.+..+++++++.++|++|..+
T Consensus 590 ~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 590 FLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred cccHHHHHHHHHHhccCcccccCC
Confidence 456788899999999999999865
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=336.74 Aligned_cols=226 Identities=23% Similarity=0.361 Sum_probs=188.8
Q ss_pred hcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEe
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~ 554 (752)
...|...++||+|+.|.||.|+ ..+++.||||++...... ..+-..++.|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 4567778999999999999998 668899999998654332 112234789999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
|+||+|.+++.... +++.++..|++++++||+|||.+ ||+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 352 m~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999999997654 89999999999999999999999 999999999999999999999999999999887666
Q ss_pred CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhcc-CCCCCChhhHHHHH
Q 041438 635 NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS-RLPYPSLDVQNKFM 713 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 713 (752)
.....+||+.|||||++....|++|+||||||++++||+.|++||- ....-.....+.+. ..... .....++
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYl-----nE~PlrAlyLIa~ng~P~lk--~~~klS~ 497 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYL-----NENPLRALYLIATNGTPKLK--NPEKLSP 497 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCcc-----CCChHHHHHHHhhcCCCCcC--CccccCH
Confidence 6667799999999999999999999999999999999999999983 12222222222222 22222 2356778
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+.+++.+||+.||++|++|.|+++|
T Consensus 498 ~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 498 ELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 89999999999999999999999986
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=343.54 Aligned_cols=345 Identities=28% Similarity=0.292 Sum_probs=313.4
Q ss_pred CCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEcc
Q 041438 110 HLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILD 189 (752)
Q Consensus 110 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 189 (752)
..+.||+++|.|+.+.+..|.++++|+.++|.+|.++ .+|.......+|+.|+|.+|.|+.+-.+++..++.|+.||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 4678999999999999999999999999999999999 678766667779999999999999888999999999999999
Q ss_pred CCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCC
Q 041438 190 SNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITG 269 (752)
Q Consensus 190 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 269 (752)
.|.|+.+.-.+|..-.++++|+|++|+|+....+.|.++.+|..|.|+.|+++...+.. |.++++|+.|+|..|+|.-
T Consensus 158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~--Fk~L~~L~~LdLnrN~iri 235 (873)
T KOG4194|consen 158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRS--FKRLPKLESLDLNRNRIRI 235 (873)
T ss_pred hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHH--hhhcchhhhhhccccceee
Confidence 99999887788988889999999999999999999999999999999999999776654 6889999999999999986
Q ss_pred CCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcc
Q 041438 270 NIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGS 349 (752)
Q Consensus 270 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 349 (752)
..-..|.++++|+.|.|..|.|...-...|..+.++++|+|+.|+++..-.+++-+|+.|+.|+||+|.|..+.++++.-
T Consensus 236 ve~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsf 315 (873)
T KOG4194|consen 236 VEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSF 315 (873)
T ss_pred ehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhh
Confidence 65678999999999999999999888899999999999999999999999999999999999999999999999999999
Q ss_pred cccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCch---hhhccCCCc
Q 041438 350 LVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPR---CFEELHGLL 426 (752)
Q Consensus 350 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~---~~~~l~~L~ 426 (752)
.++|++|+|++|+|+...+..|..+..|++|+|++|.++......|..+++|++|||++|.|+..+.+ .|..+++|+
T Consensus 316 tqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lr 395 (873)
T KOG4194|consen 316 TQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLR 395 (873)
T ss_pred cccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999987654 588999999
Q ss_pred EEEccCCcccCcCCC--CcccCCCCcccccCCCC
Q 041438 427 HIDISYNKLEGHIPN--STTFRDAPLEALQGNKG 458 (752)
Q Consensus 427 ~L~ls~N~l~~~~p~--~~~~~~~~~~~~~~n~~ 458 (752)
.|++.+|+|.. ||. ...+..+....+.+|+-
T Consensus 396 kL~l~gNqlk~-I~krAfsgl~~LE~LdL~~Nai 428 (873)
T KOG4194|consen 396 KLRLTGNQLKS-IPKRAFSGLEALEHLDLGDNAI 428 (873)
T ss_pred heeecCceeee-cchhhhccCcccceecCCCCcc
Confidence 99999999974 332 12233334445555553
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=300.44 Aligned_cols=233 Identities=19% Similarity=0.265 Sum_probs=186.4
Q ss_pred cccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E 553 (752)
.+|...+++|+|.||.||+|+ ..+|+.||||+++..... +.+.+.+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 468889999999999999999 678999999999765332 45567788899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
||+. +|+..++... ..++..+++.++.++++|++|||++ .|+||||||.|+|++.+|.+||+|||+|+.+..+.
T Consensus 82 fm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9998 9999998654 4588899999999999999999999 99999999999999999999999999999998777
Q ss_pred CCcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccccc----------ccc------chHhh
Q 041438 634 SNWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------SSN------MNIEI 696 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~----------~~~------~~~~~ 696 (752)
......+-|.+|+|||.+.|. .|+..+|+||.|||+.||+-|.+-|....+.++- .++ .....
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 666666889999999988765 5999999999999999999988877532221110 000 00001
Q ss_pred hcc-CCCCCCh--hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 697 LDS-RLPYPSL--DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 697 ~~~-~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+- ..+.+.. -......++.+++.+|+..||.+|+++.|+++|
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 110 1121111 123455678999999999999999999999976
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=335.81 Aligned_cols=227 Identities=24% Similarity=0.351 Sum_probs=191.3
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCC----CC---C-----------------------CccccCCc
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSP----LP---D-----------------------NFCSHPRQ 547 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~----~~---~-----------------------~~~~~~~~ 547 (752)
..++|++.+.||+|+||.|+.|+ ..+++.||+|++.+. .. . .+......
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 46789999999999999999998 567899999976653 11 1 23344567
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC-CceEEeecccc
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG-YEAHVSDFRIA 626 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~-~~~kl~DfG~a 626 (752)
+|+|||||.||+|.+++...+ ++.+..++.+++|+++|++|||++ ||+||||||+||+++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 999999999999999998743 478899999999999999999999 99999999999999999 99999999999
Q ss_pred eeccCCCCCcccccCCCCccCccccccCC-CC-CccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCC
Q 041438 627 KFLNLDSSNWSKLAGTHGNVAPELAYTMK-VT-EKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYP 704 (752)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (752)
.............+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+. .........+....+..|
T Consensus 169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-----~~~~~l~~ki~~~~~~~p 243 (370)
T KOG0583|consen 169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-----SNVPNLYRKIRKGEFKIP 243 (370)
T ss_pred cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-----ccHHHHHHHHhcCCccCC
Confidence 98743445566789999999999999877 74 789999999999999999999972 333344555777777777
Q ss_pred ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 705 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.... ++++.+++.+|+..||.+|+|+.++++|
T Consensus 244 ~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 244 SYLL---SPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred CCcC---CHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 4321 7789999999999999999999999944
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=328.99 Aligned_cols=235 Identities=24% Similarity=0.334 Sum_probs=183.9
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------Ccc-cc-CCceE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFC-SH-PRQSF 549 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~-~~-~~~~~ 549 (752)
..+.|+.+++||+|+||.||+|+ ..+|+.||+|+++..... +.. +. ...+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 35678888999999999999999 678999999998765432 111 12 46899
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+|+|||+. ||..++...+ -.|++.+++.+++|++.||+|||++ ||.|||||.+|||||.+|.+||+|||+|+++
T Consensus 195 lVFeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 99999998 9999987543 3589999999999999999999999 9999999999999999999999999999988
Q ss_pred cCCCCC-cccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCcchhhcccc---------cccc-chH---
Q 041438 630 NLDSSN-WSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS---------SSSN-MNI--- 694 (752)
Q Consensus 630 ~~~~~~-~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~~pf~~~~~~~~---------~~~~-~~~--- 694 (752)
...... .+..+-|.+|+|||++.|.. |+.++|+||.|||+.||++|++.|+...++.+ ...+ .+.
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 755433 66778899999999988764 99999999999999999999999864332211 1111 111
Q ss_pred ----hhhccCCCCCCh---hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 695 ----EILDSRLPYPSL---DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 695 ----~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.......++... .....+....+|+..+|..||++|.||.+++++
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 111111111111 122234568899999999999999999998854
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=312.14 Aligned_cols=235 Identities=21% Similarity=0.220 Sum_probs=186.4
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC----------------------------CccccCCceE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSF 549 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~ 549 (752)
..++|+....|++|+||.||+|+ .++++.||+|+++..... -+..+-+.+|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 45678889999999999999999 578999999999765432 1223446799
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+|||||+. ||..+++.-. +++...+++.++.|+++|++|||++ .|+||||||+|+|+...|.+||+|||+|+.+
T Consensus 154 ~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence 99999998 9999998654 5688899999999999999999999 9999999999999999999999999999999
Q ss_pred cCCCCCcccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCcchhhccccc----------cccc------
Q 041438 630 NLDSSNWSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------SSNM------ 692 (752)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~----------~~~~------ 692 (752)
+.+....+..+-|.+|+|||++.+.+ |+.+.|+||+|||+.|++++++.|....++++. .+..
T Consensus 228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 98877788889999999999988765 899999999999999999999998543332111 0000
Q ss_pred hHhhhccCC-CCCChh----hHH--HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 693 NIEILDSRL-PYPSLD----VQN--KFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 693 ~~~~~~~~~-~~~~~~----~~~--~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...+....+ ..|... +.. ....-.+++..++..||.+|.||+|.++|
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 000000010 011101 111 23567889999999999999999999876
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=323.52 Aligned_cols=232 Identities=25% Similarity=0.362 Sum_probs=180.7
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCC--ceEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPR--QSFIVY 552 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~--~~~lV~ 552 (752)
..+|...+.||+|+||.||++.. ++|+..|||.+...... +.....+ .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 45678889999999999999995 45999999988765210 1111222 589999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC-CCceEEeecccceeccC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL-GYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~-~~~~kl~DfG~a~~~~~ 631 (752)
||+++|+|.+++.+.+. +++++.++.+++||++||+|||++ |||||||||+|||++. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999988764 589999999999999999999999 9999999999999999 69999999999987763
Q ss_pred CC---CCcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChh
Q 041438 632 DS---SNWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLD 707 (752)
Q Consensus 632 ~~---~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (752)
.. .......||+.|||||++.++ ...+++||||+||++.||+||++||... .........+.... ..|. .
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~ig~~~-~~P~-i 244 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLLIGRED-SLPE-I 244 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHHHhccC-CCCC-C
Confidence 11 123346899999999999853 3446999999999999999999998632 11111111121111 1111 1
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
....+.+..+++.+|++.||++||||+++++|..-
T Consensus 245 p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 245 PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 13466788999999999999999999999998754
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=329.47 Aligned_cols=223 Identities=25% Similarity=0.370 Sum_probs=192.9
Q ss_pred cccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E 553 (752)
++|.+.+.||+|+||.||||+ ..+.+.||+|.+.+.... +.++...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 578899999999999999998 567899999988654332 45677889999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
||.| +|..++...+. ++++.++.++++++.||.|||+. +|.|||+||.|||++..|.+|+||||+|+.+....
T Consensus 82 ~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9988 99999987653 88999999999999999999999 99999999999999999999999999999988776
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHH
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
...+...|||.|||||++.+.+|+..+|.||+|||+||+++|++||. ..........+......+| ...+.
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~-----a~si~~Lv~~I~~d~v~~p----~~~S~ 225 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY-----ARSITQLVKSILKDPVKPP----STASS 225 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch-----HHHHHHHHHHHhcCCCCCc----ccccH
Confidence 66777899999999999999999999999999999999999999984 2222334445555555554 35667
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+..++...+.+||.+|.+..+++.|
T Consensus 226 ~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 226 SFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHHHHHHHHhhcChhhcccHHHHhcC
Confidence 78899999999999999999998865
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.06 Aligned_cols=233 Identities=24% Similarity=0.364 Sum_probs=186.3
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC-------------------------CccccCCceEEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~ 552 (752)
..++|++.+.||.|..+.||+|+ .+.++.||||++.-+... ..+..+...|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 35789999999999999999999 678999999998654332 1123457889999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
+||.+|++.++++..-. ..+++..+..|.+++++||.|||++ |.||||||+.||||+.+|.+||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999986543 3389999999999999999999999 9999999999999999999999999998776554
Q ss_pred CCCc----ccccCCCCccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCC---
Q 041438 633 SSNW----SKLAGTHGNVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPY--- 703 (752)
Q Consensus 633 ~~~~----~~~~gt~~y~aPE~~~~--~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 703 (752)
.... ...+||++|||||++.. ..|+.|+||||||++..|+.+|..||.... ........+....+.
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p-----PmkvLl~tLqn~pp~~~t 254 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP-----PMKVLLLTLQNDPPTLLT 254 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC-----hHHHHHHHhcCCCCCccc
Confidence 4332 34589999999999553 358999999999999999999999996322 112222333333331
Q ss_pred ---CChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 704 ---PSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 704 ---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
+..........+.+++..||++||++|||++++++|-
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 2222344556899999999999999999999999763
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=325.79 Aligned_cols=226 Identities=26% Similarity=0.366 Sum_probs=185.1
Q ss_pred hcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E 553 (752)
...|+..+.||+|+||.||+|. ..+++.||+|++.-+... +.+-.....+++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 4567778999999999999999 578999999998754432 11224566789999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
||.||++.+.++... .+++..+..|++++..|+.|+|.+ +.+|||||+.||++..+|.+|++|||.+..+....
T Consensus 92 y~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999997654 247788899999999999999999 99999999999999999999999999999887666
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHH
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
.....++||+.|||||++.+..|+.|+||||||++.+||++|.+|+.... .......+-.. ..|... ..+++
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h-----PmrvlflIpk~--~PP~L~-~~~S~ 237 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH-----PMRVLFLIPKS--APPRLD-GDFSP 237 (467)
T ss_pred hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC-----cceEEEeccCC--CCCccc-cccCH
Confidence 55577899999999999998899999999999999999999999984211 11111122222 222222 36677
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+.+++..||++||+.||+|.++++|
T Consensus 238 ~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 238 PFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 89999999999999999999999976
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=328.89 Aligned_cols=232 Identities=25% Similarity=0.397 Sum_probs=189.4
Q ss_pred cccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEeccCCC
Q 041438 503 FDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYLESGS 559 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~~~g~ 559 (752)
+...+.||+|-||+||.|.+.....||+|.++..... ++|..++.+|||||||+.|+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 4457899999999999999977779999988764222 56777778999999999999
Q ss_pred hHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc-c
Q 041438 560 LDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS-K 638 (752)
Q Consensus 560 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~-~ 638 (752)
|.++++... ...+...+...++.|||+|++||+++ ++|||||-+.||||+++..+||+|||+|+...++..... .
T Consensus 288 Ll~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 288 LLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred HHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 999998732 34588899999999999999999999 999999999999999999999999999996543322111 1
Q ss_pred ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHH
Q 041438 639 LAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717 (752)
Q Consensus 639 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 717 (752)
..-...|.|||.+...+++.|||||||||++|||+| |+.||. ........+.++.....|.. ..+++.+.+
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~------~msn~ev~~~le~GyRlp~P--~~CP~~vY~ 435 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP------GMSNEEVLELLERGYRLPRP--EGCPDEVYE 435 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC------CCCHHHHHHHHhccCcCCCC--CCCCHHHHH
Confidence 123457999999999999999999999999999998 888874 22222333344444444322 568889999
Q ss_pred HHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 718 VAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 718 li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
+|..||+.+|++|||++.+...++++...
T Consensus 436 lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 436 LMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 99999999999999999999999987643
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=331.94 Aligned_cols=226 Identities=22% Similarity=0.338 Sum_probs=197.5
Q ss_pred hcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV 551 (752)
.+-|+..+.||.|+.|.|-.|+ ..+|+.+|||++.+.... ++++...+.|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 4668899999999999999999 578999999998765111 556778899999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
.||+++|-|.+++-.++ ++++.++.++++||+.|+.|||.. +|+|||+||+|+|+|..+++||+|||+|..-.
T Consensus 91 lEyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~- 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV- 163 (786)
T ss_pred EEecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc-
Confidence 99999999999998665 488899999999999999999999 99999999999999999999999999998644
Q ss_pred CCCCcccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
++.-....||++.|.|||++.|.+| +.++||||.|||+|.++||+.||+ ++........+..+.+..| ..
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-----DdNir~LLlKV~~G~f~MP----s~ 234 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-----DDNIRVLLLKVQRGVFEMP----SN 234 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-----CccHHHHHHHHHcCcccCC----Cc
Confidence 4445566799999999999999998 689999999999999999999997 4445556677777888777 45
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHHHh
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 741 (752)
++.++.+|+.+|+..||++|.|++||++|--
T Consensus 235 Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 235 ISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred CCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 6778899999999999999999999998853
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=289.82 Aligned_cols=240 Identities=20% Similarity=0.348 Sum_probs=192.0
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC-----------------------------CccccCCce
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD-----------------------------NFCSHPRQS 548 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-----------------------------~~~~~~~~~ 548 (752)
..++|.+.+.+|+|||+.||.++ ..++..||+|++...... +..+...+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 46789999999999999999999 778999999998655422 111234568
Q ss_pred EEEEEeccCCChHHHhccCcc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 549 FIVYEYLESGSLDKILNNDAS-AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
|++++|...|+|.+.+....- ...+++.++..|+.+|++||++||+. .|+++||||||.||++.+++.+++.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999986543 34689999999999999999999998 3359999999999999999999999999998
Q ss_pred eccCCCCC---------cccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHh
Q 041438 628 FLNLDSSN---------WSKLAGTHGNVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE 695 (752)
Q Consensus 628 ~~~~~~~~---------~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~ 695 (752)
...-.-.. +.....|..|+|||.+. +...++++|||||||++|+|+.|..||+..+. .-......
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---~GgSlaLA 254 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---QGGSLALA 254 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---cCCeEEEe
Confidence 65321111 12235689999999876 34578999999999999999999999985544 12223344
Q ss_pred hhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 696 ILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
+..+.+.+|.. ..++..+.++|+.|++.||.+||++.+++.+++.+.
T Consensus 255 v~n~q~s~P~~--~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 255 VQNAQISIPNS--SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eeccccccCCC--CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 55555555543 337788999999999999999999999999998753
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=322.09 Aligned_cols=220 Identities=26% Similarity=0.424 Sum_probs=182.9
Q ss_pred ceeeccCCceEEEEEEeCCCcEEEEEccCCCCC-----------------CCccccCCceEEEEEeccCCChHHHhccCc
Q 041438 506 KHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLP-----------------DNFCSHPRQSFIVYEYLESGSLDKILNNDA 568 (752)
Q Consensus 506 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------------~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~ 568 (752)
.+-||+|+.|.||+|++ .++.||||+++.-.. .++|.....++||||||..|-|..+++...
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~ 207 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGR 207 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccC
Confidence 56799999999999998 578999998753221 178888899999999999999999998654
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcccccCCCCccCc
Q 041438 569 SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAP 648 (752)
Q Consensus 569 ~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aP 648 (752)
+++......|.++||.|+.|||.+ .|||||||.-||||..+..+||+|||-++..... .....++||..||||
T Consensus 208 ---~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTVaWMAP 280 (904)
T KOG4721|consen 208 ---PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAGTVAWMAP 280 (904)
T ss_pred ---ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhhhhHhhhCH
Confidence 467788999999999999999999 9999999999999999999999999999987644 444567999999999
Q ss_pred cccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhcc--CCCCCChhhHHHHHHHHHHHHhccCcC
Q 041438 649 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS--RLPYPSLDVQNKFMSIMQVAFSCLDQN 726 (752)
Q Consensus 649 E~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~d 726 (752)
|++...++++|+||||||||+|||+||..||..... . ..+--+-.. .++.| ..+++-+.-|+++||+..
T Consensus 281 EvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds---s--AIIwGVGsNsL~LpvP----stcP~GfklL~Kqcw~sK 351 (904)
T KOG4721|consen 281 EVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS---S--AIIWGVGSNSLHLPVP----STCPDGFKLLLKQCWNSK 351 (904)
T ss_pred HHhhcCCcccccceehhHHHHHHHHhcCCCccccch---h--eeEEeccCCcccccCc----ccCchHHHHHHHHHHhcC
Confidence 999999999999999999999999999999852211 1 111111111 23333 445667888999999999
Q ss_pred CCCCCCHHHHHHHHhh
Q 041438 727 PVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 727 P~~Rps~~evl~~L~~ 742 (752)
|..||++++++.||+-
T Consensus 352 pRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 352 PRNRPSFRQILLHLDI 367 (904)
T ss_pred CCCCccHHHHHHHHhh
Confidence 9999999999999964
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=326.13 Aligned_cols=236 Identities=21% Similarity=0.304 Sum_probs=180.6
Q ss_pred hcccccceeeccCCceEEEEEEe------CCCcEEEEEccCCCCCC--------------------------Ccccc-CC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV------PSGEIFAVKKFHSPLPD--------------------------NFCSH-PR 546 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--------------------------~~~~~-~~ 546 (752)
.++|++.++||+|+||.||+|+. .+++.||||+++..... +++.. ..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46899999999999999999973 23578999998643211 12222 34
Q ss_pred ceEEEEEeccCCChHHHhccCcc---------------------------------------------------------
Q 041438 547 QSFIVYEYLESGSLDKILNNDAS--------------------------------------------------------- 569 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~--------------------------------------------------------- 569 (752)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999999875321
Q ss_pred --ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC--cccccCCCCc
Q 041438 570 --AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGN 645 (752)
Q Consensus 570 --~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y 645 (752)
..++++.++..++.||++||+|||+. +|+||||||+||++++++.+||+|||+++........ .....++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 12477889999999999999999999 9999999999999999999999999999865432211 1223456789
Q ss_pred cCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccC
Q 041438 646 VAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLD 724 (752)
Q Consensus 646 ~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 724 (752)
+|||++.+..++.++|||||||++|||++ |..||.... ..+.....+.+...... ....++++.+++.+||+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~----~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~ 315 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ----INEEFCQRLKDGTRMRA---PENATPEIYRIMLACWQ 315 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC----ccHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcc
Confidence 99999999899999999999999999997 999985211 11111222222221111 12345678999999999
Q ss_pred cCCCCCCCHHHHHHHHhhhhc
Q 041438 725 QNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 725 ~dP~~Rps~~evl~~L~~~~~ 745 (752)
.||++|||+.|+++.|+++..
T Consensus 316 ~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 316 GDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=315.55 Aligned_cols=231 Identities=23% Similarity=0.321 Sum_probs=187.3
Q ss_pred HhhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC-------------------------------------
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD------------------------------------- 539 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------------------------------------- 539 (752)
+..+.|++.+.||+|.||.|-+|+ ..+++.||||++.+....
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 467899999999999999999999 568999999998653221
Q ss_pred -Cccc--cCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC
Q 041438 540 -NFCS--HPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY 616 (752)
Q Consensus 540 -~~~~--~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~ 616 (752)
.+.+ ..+.+|+|+|||..|.+...-. ....+++.++++|++++..||+|||.+ |||||||||+|+|++++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 1111 2367899999999887654322 122389999999999999999999999 999999999999999999
Q ss_pred ceEEeecccceeccCC-----CCCcccccCCCCccCccccccCC----CCCccchhhHHHHHHHHHhCCCCcchhhcccc
Q 041438 617 EAHVSDFRIAKFLNLD-----SSNWSKLAGTHGNVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS 687 (752)
Q Consensus 617 ~~kl~DfG~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDIwSlGvil~elltg~~pf~~~~~~~~ 687 (752)
++||+|||.+...... .......+|||.|+|||.+.++. .+.+.||||+||++|+++.|+.||- ..
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~-----~~ 322 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF-----DD 322 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc-----cc
Confidence 9999999999876322 11223468999999999988733 3678999999999999999999984 33
Q ss_pred ccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHh
Q 041438 688 SSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 741 (752)
...+....++...+.+|.. .+...++.++|++||++||++|.+..+|..|.-
T Consensus 323 ~~~~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 323 FELELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred hHHHHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 3445667777777777754 356778999999999999999999999987764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.56 Aligned_cols=228 Identities=21% Similarity=0.256 Sum_probs=177.8
Q ss_pred ccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------------CccccCCceEEEEE
Q 041438 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E 553 (752)
.|+..+.||+|+||.||+|. ..+|+.||+|.+...... ..+...+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 37788999999999999998 468999999987542110 23455678899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG- 155 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-
Confidence 999999998876432 23488899999999999999999999 9999999999999999999999999999875432
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHH
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
.......||..|+|||++.+..++.++||||+||++|||++|+.||...... .........+.......+ ...+.
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~----~~~s~ 230 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-VKREEVDRRVKEDQEEYS----EKFSE 230 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc-hhHHHHHHHhhcccccCC----ccCCH
Confidence 2223457899999999999999999999999999999999999998632110 000111111111112222 23456
Q ss_pred HHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 041438 714 SIMQVAFSCLDQNPVSRPT-----MKRFEVQ 739 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps-----~~evl~~ 739 (752)
++.+++.+||+.||++||+ ++++++|
T Consensus 231 ~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 231 DAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 7889999999999999997 7888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=307.11 Aligned_cols=235 Identities=22% Similarity=0.310 Sum_probs=184.4
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC-------------------------------CccccCC
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD-------------------------------NFCSHPR 546 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------------------------------~~~~~~~ 546 (752)
....|...+.||+|+||.|+.|. ..+|+.||||++...+.. .....-+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34566668999999999999998 568999999998754433 1123346
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
.+|+|+|+|+. +|.+.++... .++...+..+++|+++||+|+|+. +|+|||+||+|++++.+..+||||||+|
T Consensus 100 DvYiV~elMet-DL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELMET-DLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHHhh-HHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence 78999999976 9999997654 388899999999999999999999 9999999999999999999999999999
Q ss_pred eeccC--CCCCcccccCCCCccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCcchhhccc---------cc-c----
Q 041438 627 KFLNL--DSSNWSKLAGTHGNVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS---------SS-S---- 689 (752)
Q Consensus 627 ~~~~~--~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~---------~~-~---- 689 (752)
+.... ....++..+.|.+|+|||++. ...|+.+.||||.|||+.||++|++.|....... .. .
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 98754 233456778999999999866 4569999999999999999999999985322211 00 1
Q ss_pred ----ccchHhhhccCCCCCChh----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 690 ----SNMNIEILDSRLPYPSLD----VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 690 ----~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
.+.....+......+... .++..+.+.+++.+||..||.+|+|++|+++|-
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 111222333333333322 234556899999999999999999999999773
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=297.10 Aligned_cols=229 Identities=23% Similarity=0.338 Sum_probs=196.3
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------CccccCCceEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV 551 (752)
.++.|++.+.||+|.|+.||++. .++|+.+|+|++...... ....+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 46789999999999999999997 578999999987533211 233456778999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC---CCCceEEeeccccee
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD---LGYEAHVSDFRIAKF 628 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~---~~~~~kl~DfG~a~~ 628 (752)
+|+|.|++|..-+-.+ .-+++..+-.+++||++||.|+|.+ +|||||+||+|+++- ...-+|++|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999997555433 2378899999999999999999999 999999999999994 334589999999999
Q ss_pred ccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhh
Q 041438 629 LNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708 (752)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (752)
+. +...+...+|||+|||||++...+|+..+|||+.|||+|-++.|.+||. ..........+..+.+.++...+
T Consensus 163 l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~-----~~~~~rlye~I~~g~yd~~~~~w 236 (355)
T KOG0033|consen 163 VN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW-----DEDQHRLYEQIKAGAYDYPSPEW 236 (355)
T ss_pred eC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCC-----CccHHHHHHHHhccccCCCCccc
Confidence 88 5666777899999999999999999999999999999999999999984 33455677788888888888788
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+...++..+++++||..||.+|.|+.|.++|
T Consensus 237 ~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 237 DTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 8899999999999999999999999998865
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.49 Aligned_cols=223 Identities=22% Similarity=0.368 Sum_probs=178.7
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------CccccCCceEEEE
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~lV~ 552 (752)
+|++.+.||+|+||.||+|+. .+++.||||++++.... .++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 588999999999999999984 46789999987642110 2334567889999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999986543 378899999999999999999999 9999999999999999999999999998754333
Q ss_pred CCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHH
Q 041438 633 SSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (752)
........||+.|+|||++.+..++.++||||+||++|||+||+.||.. .........+.......+. ..+
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-----~~~~~~~~~i~~~~~~~~~----~~~ 225 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-----EDEDELFQSIMEHNVSYPK----SLS 225 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-----CCHHHHHHHHHcCCCCCCC----CCC
Confidence 3333445799999999999999999999999999999999999999852 1222333344444444432 345
Q ss_pred HHHHHHHHhccCcCCCCCCCH-----HHHHHH
Q 041438 713 MSIMQVAFSCLDQNPVSRPTM-----KRFEVQ 739 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~-----~evl~~ 739 (752)
.++.+++.+||++||++|+++ +++.+|
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 226 KEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 578899999999999999986 555544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=323.03 Aligned_cols=239 Identities=22% Similarity=0.327 Sum_probs=187.1
Q ss_pred HHHHHhhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC--------------------------CccccCCc
Q 041438 494 EEIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQ 547 (752)
Q Consensus 494 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~ 547 (752)
+++....+...+.+.||+|+||+||+|++. -.||||++...... ++|..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 444445556677899999999999999974 37999998765433 66766666
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
.||+.+|+|.+|+.+++... .+|+..+.+.|++|||+|+.|||.+ +|||||||..||++.++++|||+|||++.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccccee
Confidence 89999999999999998654 4588899999999999999999999 99999999999999999999999999987
Q ss_pred eccC--CCCCcccccCCCCccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCC-
Q 041438 628 FLNL--DSSNWSKLAGTHGNVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRL- 701 (752)
Q Consensus 628 ~~~~--~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~- 701 (752)
.-.. .........|...|||||+++. .+|++.+|||||||++|||+||..||. . ...+...-.+-.+..
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i----~~~dqIifmVGrG~l~ 611 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-I----QNRDQIIFMVGRGYLM 611 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-C----CChhheEEEecccccC
Confidence 5321 2222334578889999999874 358999999999999999999999985 1 111111111111111
Q ss_pred CCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 702 PYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 702 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
+........+++++.+|+..||+.++++||.+.+++..|+.+..
T Consensus 612 pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 612 PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 12222335677789999999999999999999999998887755
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=326.40 Aligned_cols=218 Identities=22% Similarity=0.274 Sum_probs=176.4
Q ss_pred eeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEEEeccCC
Q 041438 507 HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYEYLESG 558 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E~~~~g 558 (752)
+.||+|+||.||+|+. .+|+.||+|+++..... ..+...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999984 57899999987643110 2345667889999999999
Q ss_pred ChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCccc
Q 041438 559 SLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK 638 (752)
Q Consensus 559 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 638 (752)
+|.+++.... .+++.++..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence 9999987543 478899999999999999999999 9999999999999999999999999999864333333344
Q ss_pred ccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHH
Q 041438 639 LAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQV 718 (752)
Q Consensus 639 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 718 (752)
.+||+.|+|||++.+..++.++||||+||++|||++|+.||.. .........+.......+ ...++++.++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-----~~~~~~~~~~~~~~~~~p----~~~~~~~~~l 225 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-----QDHEKLFELILMEEIRFP----RTLSPEAKSL 225 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC-----CCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Confidence 6799999999999999999999999999999999999999852 112222333333333333 2345678899
Q ss_pred HHhccCcCCCCCC-----CHHHHHHH
Q 041438 719 AFSCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 719 i~~cl~~dP~~Rp-----s~~evl~~ 739 (752)
+.+||+.||++|| +++++++|
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 226 LAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 9999999999999 79988865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=306.89 Aligned_cols=224 Identities=21% Similarity=0.315 Sum_probs=192.7
Q ss_pred hcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV 551 (752)
..+|++.+.||+|+||.|-+|+ ...|+.||||.+++.... .+++..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 4578999999999999999998 578999999999876543 456677889999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||..+|.|++|+.+.+ .+++.+++.+++||.+|+.|+|.+ +++|||||.+|||+|+++++||+|||++..+..
T Consensus 132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999998765 389999999999999999999999 999999999999999999999999999988764
Q ss_pred CCCCcccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
......+||++-|.+||++.+.+| ++.+|.||+||++|.++.|.+||+. .......+++-.+.+..|..
T Consensus 206 -~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-----~Dhk~lvrQIs~GaYrEP~~---- 275 (668)
T KOG0611|consen 206 -KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-----RDHKRLVRQISRGAYREPET---- 275 (668)
T ss_pred -ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-----chHHHHHHHhhcccccCCCC----
Confidence 344566899999999999999988 6899999999999999999999972 23344556666666655432
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
+.+..-+|++||..+|++|.|+++|..|-
T Consensus 276 -PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 276 -PSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -CchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 33466799999999999999999998763
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=325.08 Aligned_cols=223 Identities=22% Similarity=0.361 Sum_probs=179.9
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------CccccCCceEEEE
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~lV~ 552 (752)
+|++.+.||+|+||.||+|+. .+++.||||++.+.... .++...+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588999999999999999984 46789999987643210 2344567789999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999886543 378899999999999999999999 9999999999999999999999999999865433
Q ss_pred CCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHH
Q 041438 633 SSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (752)
........||+.|+|||++.+..++.++|||||||++|||+||+.||.. .........+.......+. ..+
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-----~~~~~~~~~i~~~~~~~p~----~~s 225 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-----EDEDELFQSIMEHNVAYPK----SMS 225 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC-----CCHHHHHHHHHhCCCCCCC----cCC
Confidence 3333456799999999999999999999999999999999999999852 1222333444444444442 345
Q ss_pred HHHHHHHHhccCcCCCCCCCH-----HHHHHH
Q 041438 713 MSIMQVAFSCLDQNPVSRPTM-----KRFEVQ 739 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~-----~evl~~ 739 (752)
.++.+++.+|++.||++|+++ +++.+|
T Consensus 226 ~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 226 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 678899999999999999985 555543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=285.91 Aligned_cols=227 Identities=27% Similarity=0.382 Sum_probs=194.8
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------------CccccCCceEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFI 550 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~l 550 (752)
+.++|++.+.||+|.||.||.|+ .+++-.||+|++.+.... +++.+...+|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 46789999999999999999999 567889999987554221 56677889999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
++||...|.+...+..... ..+++.....+++|+|.|+.|+|.. +|+||||||+|+|++..+..|++|||.+....
T Consensus 100 ilEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999999985442 4488899999999999999999999 99999999999999999999999999997643
Q ss_pred CCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
...-...+||..|.|||+..+..++.++|+|++|++.||++.|.+||+ .....+....+...+...| ..
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFe-----s~~~~etYkrI~k~~~~~p----~~ 244 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFE-----SQSHSETYKRIRKVDLKFP----ST 244 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchh-----hhhhHHHHHHHHHccccCC----cc
Confidence 333455699999999999999999999999999999999999999996 2234556667777777666 45
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
.+..+.++|.+|+.++|.+|.+..|+++|-
T Consensus 245 is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 245 ISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred cChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 566788999999999999999999999763
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=318.37 Aligned_cols=221 Identities=24% Similarity=0.298 Sum_probs=180.9
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~ 552 (752)
++|++.+.||+|+||.||+|+. .+++.||+|++...... +++.+....|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4789999999999999999995 47899999987532110 3345567889999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++ ||+||||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999997543 478899999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHH
Q 041438 633 SSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (752)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.. .........+.......+. ...
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-----~~~~~~~~~i~~~~~~~~~----~~~ 222 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-----DNPFGIYEKILAGKLEFPR----HLD 222 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-----CCHHHHHHHHHhCCcCCCc----cCC
Confidence 2235789999999999988899999999999999999999999852 1222233444444444442 235
Q ss_pred HHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 041438 713 MSIMQVAFSCLDQNPVSRPT-----MKRFEVQ 739 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps-----~~evl~~ 739 (752)
..+.+++.+||+.||.+||+ ++|+++|
T Consensus 223 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 223 LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 57889999999999999995 8888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=334.62 Aligned_cols=236 Identities=22% Similarity=0.351 Sum_probs=194.2
Q ss_pred hcccccceeeccCCceEEEEEEeCCC-cEEEEEccCCCCCC----------------------Cccc---------c-CC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSG-EIFAVKKFHSPLPD----------------------NFCS---------H-PR 546 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~----------------------~~~~---------~-~~ 546 (752)
..++++.+.|.+|||+.||.|+...+ ..||+|++-..... .|++ . ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 45677899999999999999996555 99999987544221 2222 1 24
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
+++|.||||+||.|-+++..+.... |++.++++|++|+++|+++||.. .|+|||||||-+||||..+++.||||||.|
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 6789999999999999998766544 99999999999999999999986 678999999999999999999999999999
Q ss_pred eeccCCCCCcc---------cccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchH
Q 041438 627 KFLNLDSSNWS---------KLAGTHGNVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI 694 (752)
Q Consensus 627 ~~~~~~~~~~~---------~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~ 694 (752)
........... ...-|+.|+|||++. +..+++|+|||||||++|.++....||+. .-..
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~---------sg~l 264 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE---------SGKL 264 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc---------Ccce
Confidence 76432221111 125689999999754 67799999999999999999999999962 1234
Q ss_pred hhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCCC
Q 041438 695 EILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPD 748 (752)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 748 (752)
.|++.++.+|.. +.++..+.+||+.||+.||++||++.||++++.++...+.
T Consensus 265 aIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 265 AILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred eEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 677888888753 6788999999999999999999999999999998876554
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=301.65 Aligned_cols=240 Identities=19% Similarity=0.304 Sum_probs=183.4
Q ss_pred hcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------------CccccCC-----
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------------NFCSHPR----- 546 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------------~~~~~~~----- 546 (752)
...|+..++||+|+||+||+|+ ..+|+.||+|+++-.... +++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3457778899999999999999 678999999998755331 1222223
Q ss_pred -ceEEEEEeccCCChHHHhccCccc-cccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecc
Q 041438 547 -QSFIVYEYLESGSLDKILNNDASA-KELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFR 624 (752)
Q Consensus 547 -~~~lV~E~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG 624 (752)
..++||||++. +|.+++...... ..++...++.+++||++||+|||++ +|+||||||+||+|+++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 78899999987 999999876532 3466688999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCCCcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhcccc----------cccc--
Q 041438 625 IAKFLNLDSSNWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------SSSN-- 691 (752)
Q Consensus 625 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~----------~~~~-- 691 (752)
+|+...-+....+..++|..|+|||++.+. .|+...||||+|||++||+++++.|....+.++ ..++
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 999877565556677899999999999887 589999999999999999999998864332111 0011
Q ss_pred -chHhhhccCCCCCCh----h----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--Hhhh
Q 041438 692 -MNIEILDSRLPYPSL----D----VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ--SKQF 743 (752)
Q Consensus 692 -~~~~~~~~~~~~~~~----~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~~ 743 (752)
......+.+..++.. . .....++..+++.+|++.+|.+|.|++.+++| +...
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 011111111111111 0 11112478899999999999999999999987 5444
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=294.15 Aligned_cols=231 Identities=22% Similarity=0.324 Sum_probs=199.1
Q ss_pred HhhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------------------Cccc
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------------------NFCS 543 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------------------~~~~ 543 (752)
..-+.|+..+.+|+|..+.|-++. .++|..+|+|++...... ++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 345678888999999999999887 578999999988532211 4566
Q ss_pred cCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeec
Q 041438 544 HPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDF 623 (752)
Q Consensus 544 ~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~Df 623 (752)
.+..+++|+|.|+.|.|.+++... -.+++...++|++|+..|++|||.+ +||||||||+|||+|++.++||+||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 778889999999999999999754 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCCCcccccCCCCccCcccccc------CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhh
Q 041438 624 RIAKFLNLDSSNWSKLAGTHGNVAPELAYT------MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEIL 697 (752)
Q Consensus 624 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 697 (752)
|+|+.+. ++......||||+|.|||.+.- ..|+..+|+||.|||+|.++.|.+||- -...-.+.+.++
T Consensus 168 GFa~~l~-~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw-----HRkQmlMLR~Im 241 (411)
T KOG0599|consen 168 GFACQLE-PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW-----HRKQMLMLRMIM 241 (411)
T ss_pred ceeeccC-CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh-----HHHHHHHHHHHH
Confidence 9999887 4456677899999999997652 347889999999999999999999973 122334667788
Q ss_pred ccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 698 DSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 698 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
.+++.+....+.+++.+..++|.+||+.||.+|.|++|+++|-
T Consensus 242 eGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 242 EGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred hcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 8999998889999999999999999999999999999999764
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=320.71 Aligned_cols=221 Identities=24% Similarity=0.302 Sum_probs=177.9
Q ss_pred cccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------------CccccCCceEEE
Q 041438 503 FDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------------~~~~~~~~~~lV 551 (752)
|++.+.||+|+||.||+|+. .+++.||||++++.... +++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67889999999999999984 57899999988532100 334556789999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+++|+|..++... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999999888643 388999999999999999999999 999999999999999999999999999876443
Q ss_pred CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
.........|++.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ ...
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~-----~~~~~~~~i~~~~~~~p----~~~ 224 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD-----DEEEVFDSIVNDEVRYP----RFL 224 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCCCC----CCC
Confidence 333334567999999999999989999999999999999999999998521 12222333434333333 234
Q ss_pred HHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 041438 712 FMSIMQVAFSCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 739 (752)
+..+.+++.+||+.||++|| +++++++|
T Consensus 225 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 225 SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 56788999999999999999 56676654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=320.28 Aligned_cols=218 Identities=25% Similarity=0.395 Sum_probs=174.8
Q ss_pred eeeccCCceEEEEEEe-CCCcEEEEEccCCCCC---C-------------------------CccccCCceEEEEEeccC
Q 041438 507 HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP---D-------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~-------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
+.||+|+||.||+|+. .+++.||||++++... . +++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 5689999998764210 0 334556788999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence 99999887543 488899999999999999999999 999999999999999999999999999886543333344
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHH
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 717 (752)
...||+.|+|||++.+..++.++||||+||++|||++|+.||.. .........+.......+. ..+.++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-----~~~~~~~~~i~~~~~~~~~----~~~~~~~~ 225 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-----ENEDDLFEAILNDEVVYPT----WLSQDAVD 225 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC-----CCHHHHHHHHhcCCCCCCC----CCCHHHHH
Confidence 46799999999999988999999999999999999999999852 1122233334443333332 24567889
Q ss_pred HHHhccCcCCCCCCCH------HHHHHH
Q 041438 718 VAFSCLDQNPVSRPTM------KRFEVQ 739 (752)
Q Consensus 718 li~~cl~~dP~~Rps~------~evl~~ 739 (752)
++.+||+.||++||++ +++++|
T Consensus 226 li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 226 ILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 9999999999999998 555544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=321.90 Aligned_cols=222 Identities=23% Similarity=0.276 Sum_probs=181.2
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV 551 (752)
.++|++.+.||+|+||.||+|+. .+++.||||+++..... +.+...+..|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 46899999999999999999995 57899999987542110 344567889999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999987543 478889999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.. .........+.......+. ..
T Consensus 171 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-----~~~~~~~~~i~~~~~~~p~----~~ 238 (329)
T PTZ00263 171 R---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-----DTPFRIYEKILAGRLKFPN----WF 238 (329)
T ss_pred C---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC-----CCHHHHHHHHhcCCcCCCC----CC
Confidence 2 2235799999999999999999999999999999999999999852 1122233444444444442 23
Q ss_pred HHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 041438 712 FMSIMQVAFSCLDQNPVSRPT-----MKRFEVQ 739 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 739 (752)
+..+.+++.+||+.||++||+ ++++++|
T Consensus 239 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 239 DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 456889999999999999997 6777765
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.61 Aligned_cols=227 Identities=24% Similarity=0.364 Sum_probs=192.4
Q ss_pred hcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------CccccCCc-eEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQ-SFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~-~~lV 551 (752)
-++|+..+++|+|+||.++.++ ..++..||+|.+.-.... +.+..++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 3679999999999999999998 457889999988644321 22334445 8999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|+||+||++.+.+.+.. ...++++.+..|+.|++.|+.|||+. +|+|||||+.||+++.+..+||.|||+|+.+..
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999998765 35589999999999999999999999 999999999999999999999999999999987
Q ss_pred CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccC-CCCCChhhHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR-LPYPSLDVQN 710 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 710 (752)
+.......+||+.||.||++.+.+|+.|+||||+||++|||++-+++|+ ..........+.... .+.| ..
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~-----a~~m~~Li~ki~~~~~~Plp----~~ 229 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFK-----ASNMSELILKINRGLYSPLP----SM 229 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccC-----ccchHHHHHHHhhccCCCCC----cc
Confidence 7666777899999999999999999999999999999999999999996 223333444444444 2233 56
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
++.++..+|..|+..+|+.||++.+++.+
T Consensus 230 ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 230 YSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 77789999999999999999999999976
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=318.24 Aligned_cols=217 Identities=24% Similarity=0.341 Sum_probs=172.7
Q ss_pred eeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------CccccCCceEEEEEeccC
Q 041438 507 HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
+.||+|+||.||+|+. .+++.||||.++..... +++......|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999994 56889999987642110 233456788999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence 99999987543 478899999999999999999999 999999999999999999999999999986543333344
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHH
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 717 (752)
..+||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ ...+.++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~-----~~~~~~~~i~~~~~~~~----~~~~~~~~~ 225 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE-----DEDELFDSILNDRPHFP----RWISKEAKD 225 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCCCCCC----CCCCHHHHH
Confidence 567999999999999989999999999999999999999998521 11222233333333333 224556789
Q ss_pred HHHhccCcCCCCCCCHH-HHHH
Q 041438 718 VAFSCLDQNPVSRPTMK-RFEV 738 (752)
Q Consensus 718 li~~cl~~dP~~Rps~~-evl~ 738 (752)
++.+||+.||++||++. ++++
T Consensus 226 ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 226 CLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHccCCHHHcCCChHHHHc
Confidence 99999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=319.54 Aligned_cols=218 Identities=22% Similarity=0.276 Sum_probs=175.6
Q ss_pred eeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEEEeccCC
Q 041438 507 HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYEYLESG 558 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E~~~~g 558 (752)
+.||+|+||.||+|+. .+|+.||+|+++..... +.+...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4689999999999984 57899999987542110 3345667899999999999
Q ss_pred ChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCccc
Q 041438 559 SLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK 638 (752)
Q Consensus 559 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 638 (752)
+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence 9998886543 478899999999999999999999 9999999999999999999999999998764333333344
Q ss_pred ccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHH
Q 041438 639 LAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQV 718 (752)
Q Consensus 639 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 718 (752)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.. .........+.......+ ...++++.++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-----~~~~~~~~~~~~~~~~~p----~~~~~~~~~l 225 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-----QDHERLFELILMEEIRFP----RTLSPEAKSL 225 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC-----CCHHHHHHHHhcCCCCCC----CCCCHHHHHH
Confidence 5799999999999999999999999999999999999999852 112222333333333333 2345678899
Q ss_pred HHhccCcCCCCCC-----CHHHHHHH
Q 041438 719 AFSCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 719 i~~cl~~dP~~Rp-----s~~evl~~ 739 (752)
+.+||+.||++|| ++.++++|
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 226 LAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 9999999999998 88888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=319.97 Aligned_cols=218 Identities=22% Similarity=0.281 Sum_probs=175.3
Q ss_pred eeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEEEeccCC
Q 041438 507 HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYEYLESG 558 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E~~~~g 558 (752)
+.||+|+||.||+|+. .+++.||+|++.+.... ..+...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999999984 57899999988643210 2345667889999999999
Q ss_pred ChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCccc
Q 041438 559 SLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK 638 (752)
Q Consensus 559 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 638 (752)
+|..++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence 9998886543 488899999999999999999999 9999999999999999999999999999864333333344
Q ss_pred ccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHH
Q 041438 639 LAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQV 718 (752)
Q Consensus 639 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 718 (752)
.+||+.|+|||++.+..++.++||||+||++|||++|+.||... ........+.......+ ...+.++.++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~-----~~~~~~~~~~~~~~~~p----~~~~~~~~~l 225 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHEKLFELILMEDIKFP----RTLSADAKSL 225 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC-----CHHHHHHHhccCCccCC----CCCCHHHHHH
Confidence 57999999999999889999999999999999999999998521 11222223333333333 2345678899
Q ss_pred HHhccCcCCCCCC-----CHHHHHHH
Q 041438 719 AFSCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 719 i~~cl~~dP~~Rp-----s~~evl~~ 739 (752)
+.+||++||++|| +++|+++|
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 226 LSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 9999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=321.91 Aligned_cols=225 Identities=20% Similarity=0.263 Sum_probs=179.5
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~ 552 (752)
++|++.+.||+|+||.||+|+. .+++.||||+++..... .++......|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 4799999999999999999995 46899999987643110 3345667899999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999997543 478899999999999999999999 999999999999999999999999999986543
Q ss_pred CCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc--cCCCCCCh--hh
Q 041438 633 SSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD--SRLPYPSL--DV 708 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~--~~ 708 (752)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+....+.. .....+.. ..
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~ 226 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST-----PNETWENLKYWKETLQRPVYDDPR 226 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC-----HHHHHHHHHhccccccCCCCCccc
Confidence 2334579999999999999999999999999999999999999985211 1111111111 11111110 01
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...+.++.+++.+||..+|++||+++|+++|
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 2346678899999999999999999999977
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=318.62 Aligned_cols=217 Identities=23% Similarity=0.383 Sum_probs=175.5
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC---C-------------------------CccccCCceEEEE
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP---D-------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~-------------------------~~~~~~~~~~lV~ 552 (752)
+|++.+.||+|+||.||+|+. .+|+.||+|++.+... . .++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999984 5789999998754210 0 2344567789999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999986543 488899999999999999999999 9999999999999999999999999999865433
Q ss_pred CCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHH
Q 041438 633 SSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (752)
........||+.|+|||++.+..++.++||||+||++|||++|+.||... ........+.......+. ..+
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~-----~~~~~~~~i~~~~~~~p~----~~~ 225 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE-----DEDELFQSIMEHNVSYPK----SLS 225 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCCCCc----cCC
Confidence 33333457999999999999888999999999999999999999998521 222233344444444432 345
Q ss_pred HHHHHHHHhccCcCCCCCCCH
Q 041438 713 MSIMQVAFSCLDQNPVSRPTM 733 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~ 733 (752)
.++.+++.+||++||++|++.
T Consensus 226 ~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 226 KEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHHHHHHHcccCHhhCCCC
Confidence 578899999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=317.54 Aligned_cols=216 Identities=23% Similarity=0.335 Sum_probs=173.4
Q ss_pred eccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEEEeccCCCh
Q 041438 509 IGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYEYLESGSL 560 (752)
Q Consensus 509 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E~~~~g~L 560 (752)
||+|+||.||+|+. .+++.||+|+++..... ..+...+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999995 46889999987542110 345567889999999999999
Q ss_pred HHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCccccc
Q 041438 561 DKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLA 640 (752)
Q Consensus 561 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 640 (752)
.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.............
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence 99997543 488899999999999999999999 999999999999999999999999999986443333334457
Q ss_pred CCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHHH
Q 041438 641 GTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAF 720 (752)
Q Consensus 641 gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 720 (752)
||+.|+|||++.+..++.++||||+||++|||++|+.||.. .........+.......+ ...++++.+++.
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~-----~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~ 225 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-----ENVNEMYRKILQEPLRFP----DGFDRDAKDLLI 225 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC-----CCHHHHHHHHHcCCCCCC----CcCCHHHHHHHH
Confidence 99999999999999999999999999999999999999852 112223333444433333 234567889999
Q ss_pred hccCcCCCCCCC---HHHHHHH
Q 041438 721 SCLDQNPVSRPT---MKRFEVQ 739 (752)
Q Consensus 721 ~cl~~dP~~Rps---~~evl~~ 739 (752)
+||+.||++||+ +.|++.|
T Consensus 226 ~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 226 GLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHcCCCHHHcCCCCCHHHHHcC
Confidence 999999999985 5666554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=319.19 Aligned_cols=218 Identities=22% Similarity=0.346 Sum_probs=175.6
Q ss_pred eeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------CccccCCceEEEEEeccC
Q 041438 507 HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
+.||+|+||.||+|+. .+++.||||+++..... +++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999985 46889999987642110 334566788999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
|+|...+.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence 99998886543 478899999999999999999999 999999999999999999999999999986543333344
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHH
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 717 (752)
...||+.|+|||++.+..++.++||||+||++|||++|+.||... ........+.......+. ..+.++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~-----~~~~~~~~i~~~~~~~p~----~~~~~~~~ 225 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD-----NEDDLFESILHDDVLYPV----WLSKEAVS 225 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC-----CHHHHHHHHHcCCCCCCC----CCCHHHHH
Confidence 457999999999999889999999999999999999999998521 222233344444433332 23457889
Q ss_pred HHHhccCcCCCCCC-------CHHHHHHH
Q 041438 718 VAFSCLDQNPVSRP-------TMKRFEVQ 739 (752)
Q Consensus 718 li~~cl~~dP~~Rp-------s~~evl~~ 739 (752)
++.+||+.||++|| +++++++|
T Consensus 226 ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 226 ILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 99999999999999 77888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=318.09 Aligned_cols=217 Identities=24% Similarity=0.340 Sum_probs=172.4
Q ss_pred eeeccCCceEEEEEEe-CCCcEEEEEccCCCCC----C------------------------CccccCCceEEEEEeccC
Q 041438 507 HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP----D------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
+.||+|+||.||+|+. .+|+.||+|.++.... . +.+...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999995 5789999998864210 0 234556788999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
|+|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence 99999887543 478899999999999999999999 999999999999999999999999999875433333344
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHH
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 717 (752)
...||+.|+|||++.+..++.++||||+||++|||++|+.||... ........+.......+. ..+.++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~-----~~~~~~~~~~~~~~~~~~----~~~~~~~~ 225 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD-----DEDELFESIRVDTPHYPR----WITKESKD 225 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCCCCC----CCCHHHHH
Confidence 567999999999999999999999999999999999999998521 112222222222222332 24557889
Q ss_pred HHHhccCcCCCCCCCHH-HHHH
Q 041438 718 VAFSCLDQNPVSRPTMK-RFEV 738 (752)
Q Consensus 718 li~~cl~~dP~~Rps~~-evl~ 738 (752)
++.+||+.||++||++. ++.+
T Consensus 226 li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 226 ILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred HHHHHccCCHHHcCCChHHHHc
Confidence 99999999999999984 5653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=299.43 Aligned_cols=230 Identities=21% Similarity=0.291 Sum_probs=191.7
Q ss_pred hhcccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC---------------------------CccccCCceEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFI 550 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~l 550 (752)
..++|+..+.||+|.-|+||+|+.. ++..+|+|++.+.... ..++.++..|+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 3457888999999999999999954 5689999998764322 44567788999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
|||||+||+|..+.++.. .+.++++.++.++.+|+.||+|||-. |||+|||||+||||.++|++-|+||.++....
T Consensus 155 ~meyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 999999999999988755 35699999999999999999999999 99999999999999999999999999865321
Q ss_pred C---------------------------------C-C----------------------CCcccccCCCCccCccccccC
Q 041438 631 L---------------------------------D-S----------------------SNWSKLAGTHGNVAPELAYTM 654 (752)
Q Consensus 631 ~---------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~ 654 (752)
. . . .....++||-.|.|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 0 001134799999999999999
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCC--
Q 041438 655 KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT-- 732 (752)
Q Consensus 655 ~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-- 732 (752)
..+.++|+|+|||++|||+.|..||. ....++....++.....+|.. ...+..+.+||++.|.+||.+|..
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFK-----G~~~~~Tl~NIv~~~l~Fp~~--~~vs~~akDLIr~LLvKdP~kRlg~~ 383 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFK-----GSNNKETLRNIVGQPLKFPEE--PEVSSAAKDLIRKLLVKDPSKRLGSK 383 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcC-----CCCchhhHHHHhcCCCcCCCC--CcchhHHHHHHHHHhccChhhhhccc
Confidence 99999999999999999999999996 445667788888888887754 366778999999999999999998
Q ss_pred --HHHHHHH
Q 041438 733 --MKRFEVQ 739 (752)
Q Consensus 733 --~~evl~~ 739 (752)
|.||-+|
T Consensus 384 rGA~eIK~H 392 (459)
T KOG0610|consen 384 RGAAEIKRH 392 (459)
T ss_pred cchHHhhcC
Confidence 5555443
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.34 Aligned_cols=234 Identities=17% Similarity=0.198 Sum_probs=175.3
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E 553 (752)
.++|++.++||+|+||.||+|+. .+++.||+|+++..... +++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 35799999999999999999984 57899999988643211 23445667899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++ +|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 84 YLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 9986 9998886543 3467899999999999999999999 99999999999999999999999999998754433
Q ss_pred CCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccc----------cccccchH--------
Q 041438 634 SNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS----------SSSSNMNI-------- 694 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~----------~~~~~~~~-------- 694 (752)
.......+++.|+|||++.+ ..++.++||||+||++|||+||+.||....... ....+...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 33344578999999998865 558999999999999999999999985211000 00000000
Q ss_pred -hhhccCCCC-CC-hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 695 -EILDSRLPY-PS-LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 695 -~~~~~~~~~-~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
......... +. ........++.+++.+|++.||.+|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 00 0011234568899999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=308.94 Aligned_cols=233 Identities=22% Similarity=0.294 Sum_probs=175.2
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E 553 (752)
++|++.+.||+|+||.||+|+. .+++.||+|+++..... +++...+..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4799999999999999999995 46889999988643211 34556678899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|++++.+..+.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99987766554322 3478899999999999999999999 99999999999999999999999999998764322
Q ss_pred C-CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccc----------cccchHhh-hcc--
Q 041438 634 S-NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------SSNMNIEI-LDS-- 699 (752)
Q Consensus 634 ~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~----------~~~~~~~~-~~~-- 699 (752)
. ......|++.|+|||++.+..++.++||||+||++|||++|+.||......... ........ .+.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 1 223357899999999999888999999999999999999999998532110000 00000000 000
Q ss_pred -CCCCCCh---------hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 700 -RLPYPSL---------DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 700 -~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
....+.. .....+.++.+++.+||++||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 011245679999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=293.25 Aligned_cols=225 Identities=23% Similarity=0.289 Sum_probs=191.3
Q ss_pred hcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV 551 (752)
-++|+..+.||+|.||+|-.++ ..+++.||+|++++...- ..++..++.++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 3678889999999999999999 678999999999876432 224556889999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||..||.|.-++.+.. .+++...+.+-.+|+.||.|||++ +||.||+|.+|.|+|.+|++||+|||+++.--.
T Consensus 247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999998887643 488899999999999999999999 999999999999999999999999999987655
Q ss_pred CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
.......+||||.|.|||++.+..|+.++|+|.+||++|||++|+.||. ....+....-++...+.+|. ..
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy-----n~dh~kLFeLIl~ed~kFPr----~l 391 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY-----NKDHEKLFELILMEDLKFPR----TL 391 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc-----ccchhHHHHHHHhhhccCCc----cC
Confidence 5566677899999999999999999999999999999999999999995 33444555566666666763 45
Q ss_pred HHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 041438 712 FMSIMQVAFSCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 739 (752)
.++...++...|.+||.+|. .++||.+|
T Consensus 392 s~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 392 SPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred CHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 56788899999999999995 45666554
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=320.34 Aligned_cols=218 Identities=21% Similarity=0.276 Sum_probs=175.3
Q ss_pred eeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------------CccccCCceEEEEEeccCC
Q 041438 507 HCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYEYLESG 558 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E~~~~g 558 (752)
+.||+|+||.||+|+ ..+|+.||+|+++..... ..+......|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 468999999999998 457899999988643210 2345567899999999999
Q ss_pred ChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc
Q 041438 559 SLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 559 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 9998886543 48889999999999999999997 7 999999999999999999999999999976443333334
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHH
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 717 (752)
...||+.|+|||++.+..++.++|||||||++|||+||+.||.. .........+.......+ ...++++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~-----~~~~~~~~~i~~~~~~~p----~~~~~~~~~ 225 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-----QDHEKLFELILMEEIRFP----RTLSPEAKS 225 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC-----CCHHHHHHHHhcCCCCCC----CCCCHHHHH
Confidence 45799999999999998999999999999999999999999852 112222233333333333 234567889
Q ss_pred HHHhccCcCCCCCC-----CHHHHHHH
Q 041438 718 VAFSCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 718 li~~cl~~dP~~Rp-----s~~evl~~ 739 (752)
++.+||+.||++|+ +++++++|
T Consensus 226 li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 226 LLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 99999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=323.75 Aligned_cols=225 Identities=22% Similarity=0.334 Sum_probs=181.5
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~ 552 (752)
++|++.+.||+|+||.||+|+. .+++.||||+++..... ..+.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 4799999999999999999995 47999999988643110 3445677899999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++++|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999765 3488899999999999999999999 9999999999999999999999999999876543
Q ss_pred C-----------------------------CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhh
Q 041438 633 S-----------------------------SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLF 683 (752)
Q Consensus 633 ~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~ 683 (752)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~- 233 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD- 233 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC-
Confidence 3 1123357999999999999999999999999999999999999998521
Q ss_pred ccccccccchHhhhc--cCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCC-HHHHHHH
Q 041438 684 EMSSSSSNMNIEILD--SRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT-MKRFEVQ 739 (752)
Q Consensus 684 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~ 739 (752)
........+.. .....+.. ...++++.++|.+|+. ||++||+ ++|+++|
T Consensus 234 ----~~~~~~~~i~~~~~~~~~p~~--~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 ----TLQETYNKIINWKESLRFPPD--PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ----CHHHHHHHHhccCCcccCCCC--CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11222222332 22222221 2256778999999997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=322.52 Aligned_cols=226 Identities=20% Similarity=0.299 Sum_probs=173.7
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~ 552 (752)
++|++.+.||+|+||.||+|+. .+++.||+|++++.... ..+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4799999999999999999984 57899999988642110 2345567889999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++|+|.+++...+ .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999997543 488899999999999999999999 9999999999999999999999999998754321
Q ss_pred CC-----------------------------------CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCC
Q 041438 633 SS-----------------------------------NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 677 (752)
Q Consensus 633 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~ 677 (752)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 0123479999999999999999999999999999999999999
Q ss_pred CcchhhccccccccchHhhhcc--CCCCCChhhHHHHHHHHHHHHhccC--cCCCCCCCHHHHHHH
Q 041438 678 PRDFLFEMSSSSSNMNIEILDS--RLPYPSLDVQNKFMSIMQVAFSCLD--QNPVSRPTMKRFEVQ 739 (752)
Q Consensus 678 pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~Rps~~evl~~ 739 (752)
||.. ....+....+... ....+. ....++++.+++.+|+. .++..||+++|+++|
T Consensus 235 Pf~~-----~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCS-----ETPQETYKKVMNWKETLIFPP--EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCC-----CCHHHHHHHHHcCcCcccCCC--cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9852 1122222333321 222221 11234567788887554 233346899999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=324.13 Aligned_cols=228 Identities=22% Similarity=0.336 Sum_probs=181.2
Q ss_pred HhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC----C-----------------------CccccCCceE
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP----D-----------------------NFCSHPRQSF 549 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~-----------------------~~~~~~~~~~ 549 (752)
...++|++.+.||+|+||.||+|+. .+++.||+|++.+... . +++.+....|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 4567899999999999999999984 5789999998753210 0 3345667899
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||.+...
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999998653 377888999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCC-CcccccCCCCccCccccccC----CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccC--CC
Q 041438 630 NLDSS-NWSKLAGTHGNVAPELAYTM----KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR--LP 702 (752)
Q Consensus 630 ~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~ 702 (752)
..... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.. .........+.... ..
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-----~~~~~~~~~i~~~~~~~~ 267 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-----DSLVGTYSKIMDHKNSLT 267 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-----CCHHHHHHHHHcCCCcCC
Confidence 43322 22345799999999988653 378999999999999999999999852 11222333343322 22
Q ss_pred CCChhhHHHHHHHHHHHHhccCcCCCC--CCCHHHHHHH
Q 041438 703 YPSLDVQNKFMSIMQVAFSCLDQNPVS--RPTMKRFEVQ 739 (752)
Q Consensus 703 ~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 739 (752)
.+. ....+.++.+++.+|++.+|++ ||+++|+++|
T Consensus 268 ~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 FPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 221 1235678899999999999988 9999999877
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=310.83 Aligned_cols=234 Identities=17% Similarity=0.238 Sum_probs=174.8
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E 553 (752)
.++|++.+.||+|+||.||+|+. .+++.||||+++..... +++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 47899999999999999999995 47899999988643211 34455678899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+.+ ++.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVHT-DLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCCc-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 9964 8888776543 3478899999999999999999999 99999999999999999999999999998654333
Q ss_pred CCcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchH-----------h------
Q 041438 634 SNWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI-----------E------ 695 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~-----------~------ 695 (752)
.......+|+.|+|||++.+. .++.++||||+||++|||++|+.||............... .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 333445789999999988654 5789999999999999999999999632111000000000 0
Q ss_pred hhccCCC--CCChh-----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 696 ILDSRLP--YPSLD-----VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 696 ~~~~~~~--~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
....... .+... .......+.+++.+||+.||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0000000 00000 00123467899999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=314.81 Aligned_cols=217 Identities=24% Similarity=0.346 Sum_probs=171.9
Q ss_pred eeeccCCceEEEEEEe-CCCcEEEEEccCCCCC---C-------------------------CccccCCceEEEEEeccC
Q 041438 507 HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP---D-------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~-------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
+.||+|+||.||+|+. .+++.||||+++.... . +++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999995 4688999998764311 0 234456788999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence 99999987542 478899999999999999999999 999999999999999999999999999976433333334
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHH
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 717 (752)
...||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+....+.......+ .....++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~-----~~~~~~~~i~~~~~~~~----~~~~~~~~~ 225 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH-----DEEELFQSIRMDNPCYP----RWLTREAKD 225 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCCCC----ccCCHHHHH
Confidence 457999999999999989999999999999999999999998521 11222222222222222 124456889
Q ss_pred HHHhccCcCCCCCCCHH-HHHH
Q 041438 718 VAFSCLDQNPVSRPTMK-RFEV 738 (752)
Q Consensus 718 li~~cl~~dP~~Rps~~-evl~ 738 (752)
++.+||+.||++||++. ++.+
T Consensus 226 li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 226 ILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHhccCHhhcCCChHHHHc
Confidence 99999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=330.55 Aligned_cols=231 Identities=23% Similarity=0.302 Sum_probs=181.9
Q ss_pred HHhhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------Ccccc-----
Q 041438 497 IRATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSH----- 544 (752)
Q Consensus 497 ~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~----- 544 (752)
....++|++.+.||+|+||.||+|+ ..+|+.||||++...... ..+..
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 3456799999999999999999998 567999999988643221 00000
Q ss_pred ---CCceEEEEEeccCCChHHHhccCc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEE
Q 041438 545 ---PRQSFIVYEYLESGSLDKILNNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV 620 (752)
Q Consensus 545 ---~~~~~lV~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl 620 (752)
....++||||+++|+|.+++.... ....+++..+..++.|++.||+|+|+. +|+||||||+||+++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 013689999999999999987533 234588999999999999999999999 9999999999999999999999
Q ss_pred eecccceeccCCC--CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc
Q 041438 621 SDFRIAKFLNLDS--SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD 698 (752)
Q Consensus 621 ~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 698 (752)
+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.. .........+..
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~-----~~~~~~~~~~~~ 259 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-----ENMEEVMHKTLA 259 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-----CCHHHHHHHHhc
Confidence 9999998764321 122345799999999999999999999999999999999999999852 111222222332
Q ss_pred cCCC-CCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 699 SRLP-YPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 699 ~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.... .+ ...++++.+++.+||+.||++||++.+++++
T Consensus 260 ~~~~~~~----~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 GRYDPLP----PSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCC----CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 2221 22 3355678999999999999999999999876
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=317.03 Aligned_cols=223 Identities=23% Similarity=0.325 Sum_probs=174.2
Q ss_pred eeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------CccccCCceEEEEEeccC
Q 041438 507 HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
+.||+|+||.||+|+. .+++.||+|++++.... +++......|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999994 57889999988643211 334556788999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
|+|..++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence 99998886543 488899999999999999999999 999999999999999999999999999976433333334
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccccc---c-cchHhhhccCCCCCChhhHHHHH
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS---S-NMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.......... . .....+.......| ...+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~~ 230 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSV 230 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCCH
Confidence 4679999999999999999999999999999999999999985321111110 1 11222333333343 23455
Q ss_pred HHHHHHHhccCcCCCCCCCH------HHHHHH
Q 041438 714 SIMQVAFSCLDQNPVSRPTM------KRFEVQ 739 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~------~evl~~ 739 (752)
++.+++.+||+.||++||++ +++++|
T Consensus 231 ~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 231 KAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 78899999999999999984 676655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=318.62 Aligned_cols=227 Identities=21% Similarity=0.297 Sum_probs=176.1
Q ss_pred ccccceeeccCCceEEEEEEe----CCCcEEEEEccCCCCCC-----------------------------CccccCCce
Q 041438 502 DFDAKHCIGKGGHGSVYIARV----PSGEIFAVKKFHSPLPD-----------------------------NFCSHPRQS 548 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-----------------------------~~~~~~~~~ 548 (752)
+|++.+.||+|+||.||+|+. .+++.||+|++.+.... ..+...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999999984 36889999987532100 233456778
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999986543 378899999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCC-CcccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCCh
Q 041438 629 LNLDSS-NWSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706 (752)
Q Consensus 629 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (752)
...... ......||+.|+|||++.+.. ++.++|||||||++|||+||+.||...... .........+.....+.+
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~-- 231 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER-NTQSEVSRRILKCDPPFP-- 231 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC-CCHHHHHHHHhcCCCCCC--
Confidence 543222 223457999999999988654 789999999999999999999998522110 111112222333333332
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 739 (752)
...++.+.+++.+||+.||++|| +++++++|
T Consensus 232 --~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 232 --SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 23456788999999999999999 67788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=317.43 Aligned_cols=223 Identities=22% Similarity=0.313 Sum_probs=174.8
Q ss_pred eeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------CccccCCceEEEEEeccC
Q 041438 507 HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
+.||+|+||.||+|+. .+++.||||++++.... +++......|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999999984 57899999988642110 234456788999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence 99998886543 488999999999999999999999 999999999999999999999999999975433333334
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccc----cccchHhhhccCCCCCChhhHHHHH
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----SSNMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
...||+.|+|||++.+..++.++||||+||++|||++|+.||+........ .......+.......|. ..+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~----~~~~ 230 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSV 230 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC----CCCH
Confidence 468999999999999999999999999999999999999999632111100 11122233333334332 3455
Q ss_pred HHHHHHHhccCcCCCCCCC------HHHHHHH
Q 041438 714 SIMQVAFSCLDQNPVSRPT------MKRFEVQ 739 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps------~~evl~~ 739 (752)
++.+++.+||+.||++||+ ++++++|
T Consensus 231 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 7889999999999999997 5677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.34 Aligned_cols=223 Identities=19% Similarity=0.247 Sum_probs=180.3
Q ss_pred hhcccccceeeccCCceEEEEEEeC-C-CcEEEEEccCCCCCC---------------------------CccccCCceE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP-S-GEIFAVKKFHSPLPD---------------------------NFCSHPRQSF 549 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~---------------------------~~~~~~~~~~ 549 (752)
..++|++.+.||+|+||.||+|+.. + +..||+|++...... +++......|
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 3567999999999999999999843 3 368999987432100 3455667899
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 108 lv~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999997543 378899999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 630 NLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.. .........+.......+.
T Consensus 182 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-----~~~~~~~~~i~~~~~~~p~---- 249 (340)
T PTZ00426 182 DTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA-----NEPLLIYQKILEGIIYFPK---- 249 (340)
T ss_pred CCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC-----CCHHHHHHHHhcCCCCCCC----
Confidence 422 2345799999999999988899999999999999999999999852 1222233344444444432
Q ss_pred HHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 739 (752)
..+..+.+++.+|++.||++|+ +++|+++|
T Consensus 250 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 250 FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 2345678999999999999995 89988876
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=323.06 Aligned_cols=225 Identities=21% Similarity=0.294 Sum_probs=177.2
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~ 552 (752)
++|++.+.||+|+||.||+|+. .+++.||||++...... +.+.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4799999999999999999995 57899999988642100 3445678899999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999987543 488899999999999999999999 9999999999999999999999999998764321
Q ss_pred CC--------------------------------------CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh
Q 041438 633 SS--------------------------------------NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK 674 (752)
Q Consensus 633 ~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt 674 (752)
.. .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 10 0012369999999999999899999999999999999999
Q ss_pred CCCCcchhhccccccccchHhhhccC--CCCCChhhHHHHHHHHHHHHhccCcCCCCCCC---HHHHHHH
Q 041438 675 GKHPRDFLFEMSSSSSNMNIEILDSR--LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT---MKRFEVQ 739 (752)
Q Consensus 675 g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~ 739 (752)
|..||... ........+.... ...+. ....++++.+++.+|+. +|.+|++ ++|+++|
T Consensus 235 G~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSD-----NPQETYRKIINWKETLQFPD--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCC-----CHHHHHHHHHcCCCccCCCC--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99998521 1112222222222 22221 12345678899999996 9999997 8888775
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=300.78 Aligned_cols=234 Identities=21% Similarity=0.251 Sum_probs=174.2
Q ss_pred cccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------Cccc---c-CCceEEEEEe
Q 041438 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------NFCS---H-PRQSFIVYEY 554 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------~~~~---~-~~~~~lV~E~ 554 (752)
-.|+..+.+|+|+||.||+|. ..+++.||||++-.+... .+.. . .-...+||||
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 356678999999999999999 456799999987543321 1111 1 1244589999
Q ss_pred ccCCChHHHhccCc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC-CceEEeecccceeccCC
Q 041438 555 LESGSLDKILNNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG-YEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 555 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~-~~~kl~DfG~a~~~~~~ 632 (752)
|+. +|.++++... ....++...++-+++||.+||.|||+. +|+||||||+|+|+|.+ |.+||||||.|+.+...
T Consensus 104 mP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 104 MPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred chH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 998 9999998531 124477788999999999999999998 99999999999999966 89999999999998755
Q ss_pred CCCcccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCcchhhcccc---------cc-ccchHhh----h
Q 041438 633 SSNWSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS---------SS-SNMNIEI----L 697 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~~pf~~~~~~~~---------~~-~~~~~~~----~ 697 (752)
... ..+..|..|+|||.+.+.. |+.+.||||.|||+.||+.|++-|......++ .. .+....+ .
T Consensus 180 epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 180 EPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred CCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 443 4567799999999988764 89999999999999999999999853221110 00 0000000 0
Q ss_pred ccCCC------CCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 698 DSRLP------YPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 698 ~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..+.+ +........+++..+++.++++.+|.+|.++.|++.|
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 00110 0011223456789999999999999999999999865
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=314.38 Aligned_cols=218 Identities=24% Similarity=0.324 Sum_probs=175.6
Q ss_pred eeeccCCceEEEEEEe----CCCcEEEEEccCCCCC-----C-----------------------CccccCCceEEEEEe
Q 041438 507 HCIGKGGHGSVYIARV----PSGEIFAVKKFHSPLP-----D-----------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-----~-----------------------~~~~~~~~~~lV~E~ 554 (752)
+.||+|+||.||+|+. .+++.||||+++.... . +.+...+..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999984 3688999998754210 0 345566789999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++|+|.+++...+ .+.+..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999987543 367888999999999999999999 999999999999999999999999999986543333
Q ss_pred CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 635 NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
......||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+. ..+++
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~-----~~~~~~~~~~~~~~~~~~----~~~~~ 226 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE-----NRKKTIDKILKGKLNLPP----YLTPE 226 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC-----CHHHHHHHHHcCCCCCCC----CCCHH
Confidence 334457999999999999888999999999999999999999998521 122233344444444432 24557
Q ss_pred HHHHHHhccCcCCCCCC-----CHHHHHHH
Q 041438 715 IMQVAFSCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rp-----s~~evl~~ 739 (752)
+.+++.+||++||++|| +++++++|
T Consensus 227 ~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 227 ARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 88999999999999999 78888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=306.81 Aligned_cols=228 Identities=20% Similarity=0.291 Sum_probs=173.6
Q ss_pred cccccceeeccCCceEEEEEEe--CCCcEEEEEccCCCCCC-----------------------------Ccc-----cc
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV--PSGEIFAVKKFHSPLPD-----------------------------NFC-----SH 544 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~-----------------------------~~~-----~~ 544 (752)
++|++.+.||+|+||.||+|+. .+++.||+|+++..... +++ ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4799999999999999999985 34688999987532211 111 12
Q ss_pred CCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecc
Q 041438 545 PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFR 624 (752)
Q Consensus 545 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG 624 (752)
....++||||+.+ +|.+++..... ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 3457899999974 99998875432 3478899999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc------
Q 041438 625 IAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD------ 698 (752)
Q Consensus 625 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~------ 698 (752)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|++||...... +....+.+
T Consensus 156 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-----~~~~~i~~~~~~~~ 229 (290)
T cd07862 156 LARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKILDVIGLPG 229 (290)
T ss_pred ceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-----HHHHHHHHHhCCCC
Confidence 99876533 2233457899999999998888999999999999999999999998632110 11111110
Q ss_pred ----------------cCCCCCC-hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 699 ----------------SRLPYPS-LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 699 ----------------~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.....+. ......+..+.+++.+||+.||++|||+.|+++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000000 0012244567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=318.14 Aligned_cols=236 Identities=22% Similarity=0.317 Sum_probs=180.5
Q ss_pred hhcccccceeeccCCceEEEEEEe------CCCcEEEEEccCCCCCC--------------------------CccccCC
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV------PSGEIFAVKKFHSPLPD--------------------------NFCSHPR 546 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--------------------------~~~~~~~ 546 (752)
..++|++.+.||+|+||.||+|+. .+++.||||+++..... +.+....
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 345899999999999999999873 23458999988653211 3445567
Q ss_pred ceEEEEEeccCCChHHHhccCcc---------------------------------------------------------
Q 041438 547 QSFIVYEYLESGSLDKILNNDAS--------------------------------------------------------- 569 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~--------------------------------------------------------- 569 (752)
..++||||+++|+|.+++.....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 88999999999999998854210
Q ss_pred ----------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC--cc
Q 041438 570 ----------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN--WS 637 (752)
Q Consensus 570 ----------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~ 637 (752)
...+++.+++.++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++........ ..
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 12478889999999999999999999 9999999999999999999999999999875433211 11
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHH
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIM 716 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 716 (752)
...++..|+|||++.+..++.++|||||||++|||++ |+.||.... ................. ....++++.
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~-----~~~~~~~~~~~~~~~~~--~~~~~~~l~ 345 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL-----VNSKFYKMVKRGYQMSR--PDFAPPEIY 345 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc-----ccHHHHHHHHcccCccC--CCCCCHHHH
Confidence 2235567999999988889999999999999999997 999985221 11112222222211111 112356789
Q ss_pred HHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 717 QVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 717 ~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
+++.+||+.||++|||++++++.|+++.
T Consensus 346 ~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 346 SIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=317.70 Aligned_cols=225 Identities=22% Similarity=0.342 Sum_probs=171.4
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E 553 (752)
.++|+..++||+|+||.||+|+. .+++.||||++...... +++.+.+..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 34567789999999999999984 57899999988543211 34566778999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++|+|.+.. ..++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 153 ~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 153 FMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred cCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 99999986532 245677889999999999999999 99999999999999999999999999998765433
Q ss_pred CCcccccCCCCccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhh
Q 041438 634 SNWSKLAGTHGNVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (752)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||.... ..........+....... ..
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~---~~ 297 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR--QGDWASLMCAICMSQPPE---AP 297 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CccHHHHHHHHhccCCCC---CC
Confidence 33344579999999998743 234578999999999999999999985111 000001111111111111 11
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...+.++.++|.+||+.||++||+++|+++|
T Consensus 298 ~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 298 ATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3455678999999999999999999999987
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=321.54 Aligned_cols=225 Identities=20% Similarity=0.302 Sum_probs=174.5
Q ss_pred ccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------------CccccCCceEEEEE
Q 041438 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E 553 (752)
.|++.+.||+|+||.||+|+ ..+++.||||++...... ..+.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68899999999999999998 467899999988643210 34456778999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++++||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999987543 378899999999999999999999 99999999999999999999999999976431100
Q ss_pred C-----------------------------------------------CcccccCCCCccCccccccCCCCCccchhhHH
Q 041438 634 S-----------------------------------------------NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFG 666 (752)
Q Consensus 634 ~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlG 666 (752)
. .....+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 01124799999999999988899999999999
Q ss_pred HHHHHHHhCCCCcchhhccccccccchHhhhc--cCCCCCChhhHHHHHHHHHHHHh--ccCcCCCCCCCHHHHHHH
Q 041438 667 VLALEVIKGKHPRDFLFEMSSSSSNMNIEILD--SRLPYPSLDVQNKFMSIMQVAFS--CLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 667 vil~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~Rps~~evl~~ 739 (752)
|++|||+||+.||... ........+.. .....+. ....++++.+++.+ |+..+|.+||+++|+++|
T Consensus 236 ~il~elltG~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~--~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 236 VILFEMLVGQPPFLAP-----TPTETQLKVINWENTLHIPP--QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred hHHHHHHhCCCCCcCC-----CHHHHHHHHHccccccCCCC--CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999999998521 11122222222 1222221 12345678889988 556666679999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=315.81 Aligned_cols=213 Identities=24% Similarity=0.300 Sum_probs=171.3
Q ss_pred eeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------CccccCCceEEEEEeccC
Q 041438 507 HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
+.||+|+||.||+|+. .+|+.||||++...... ..+...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999995 57999999987542110 233456788999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
|+|.+++.... .+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence 99999887543 478899999999999999999999 999999999999999999999999999876433333334
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHH
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 717 (752)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.. ....+....+.......+ ...+..+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-----~~~~~~~~~i~~~~~~~~----~~~~~~~~~ 225 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-----RDTAEMYDNILNKPLRLK----PNISVSARH 225 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC-----CCHHHHHHHHHcCCCCCC----CCCCHHHHH
Confidence 45799999999999999999999999999999999999999852 112223333333333332 234567889
Q ss_pred HHHhccCcCCCCCCCHH
Q 041438 718 VAFSCLDQNPVSRPTMK 734 (752)
Q Consensus 718 li~~cl~~dP~~Rps~~ 734 (752)
++.+|++.||++||++.
T Consensus 226 li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 226 LLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHhhcCHHhCCCCC
Confidence 99999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=316.36 Aligned_cols=171 Identities=24% Similarity=0.348 Sum_probs=151.0
Q ss_pred ccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC-----------------------------CccccCCceEEE
Q 041438 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD-----------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-----------------------------~~~~~~~~~~lV 551 (752)
+|++.+.||+|+||.|.+|. ..+++.||||+++..... +++.+.++.|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 89999999999999999999 567999999998754221 566778999999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC--CceEEeecccceec
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG--YEAHVSDFRIAKFL 629 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~--~~~kl~DfG~a~~~ 629 (752)
+|.+.. +|+++++.+.. ..++...++.++.||+.||.+||+. +|||+||||+|||+.+. ..+||+|||.|+..
T Consensus 267 fELL~~-NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred ehhhhh-hHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999977 99999998764 4489999999999999999999999 99999999999999643 36999999999975
Q ss_pred cCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcc
Q 041438 630 NLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD 680 (752)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~ 680 (752)
.. .....+.+..|+|||++.|.+|+.+.||||||||++||++|.+.|.
T Consensus 342 ~q---~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 342 SQ---RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred CC---cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 42 2336688999999999999999999999999999999999988874
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=306.18 Aligned_cols=223 Identities=23% Similarity=0.294 Sum_probs=173.1
Q ss_pred eccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEEEeccCCCh
Q 041438 509 IGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYEYLESGSL 560 (752)
Q Consensus 509 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E~~~~g~L 560 (752)
||+|+||+||+|+. .+++.||+|.+...... .++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999984 57899999987542110 234456778999999999999
Q ss_pred HHHhccCc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcccc
Q 041438 561 DKILNNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKL 639 (752)
Q Consensus 561 ~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 639 (752)
..++.... ....+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||.+.............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 98875422 234588999999999999999999999 99999999999999999999999999998765443333445
Q ss_pred cCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHH
Q 041438 640 AGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVA 719 (752)
Q Consensus 640 ~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 719 (752)
.||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........+.......+ ...+..+.+++
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~----~~~~~~~~~li 232 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILNDSVTYP----DKFSPASKSFC 232 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhcccCCCCc----ccCCHHHHHHH
Confidence 78999999999999999999999999999999999999985211100 00111112222222222 33556788999
Q ss_pred HhccCcCCCCCC-----CHHHHHHH
Q 041438 720 FSCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 720 ~~cl~~dP~~Rp-----s~~evl~~ 739 (752)
.+||+.||++|| +++++++|
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 999999999999 77888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.87 Aligned_cols=223 Identities=17% Similarity=0.262 Sum_probs=177.0
Q ss_pred ceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC---------------------------Ccccc----CCceEEEEEe
Q 041438 506 KHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD---------------------------NFCSH----PRQSFIVYEY 554 (752)
Q Consensus 506 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~----~~~~~lV~E~ 554 (752)
...||+|++|.||+|+. +|+.||||+++..... +++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999988 7899999998754221 22222 3467899999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++|+|.+++.... .+++.....++.|++.|+.|+|+.. +++||||||+||++++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 104 CTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999997643 4788999999999999999999832 78899999999999999999999999998654322
Q ss_pred CcccccCCCCccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHH
Q 041438 635 NWSKLAGTHGNVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~--~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (752)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||... ...+....+.......+. ....+
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~-----~~~~~~~~i~~~~~~~~~--~~~~~ 248 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL-----TTKEIYDLIINKNNSLKL--PLDCP 248 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHhcCCCCCC--CCcCc
Confidence 23468899999999876 67899999999999999999999998621 112222333222222111 12356
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
+.+.+++.+||+.||++|||++|+++.|+++.
T Consensus 249 ~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 249 LEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 67999999999999999999999999999875
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=320.69 Aligned_cols=231 Identities=21% Similarity=0.309 Sum_probs=180.1
Q ss_pred HHHHhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCC
Q 041438 495 EIIRATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPR 546 (752)
Q Consensus 495 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~ 546 (752)
++....++|++.+.||+|+||.||+|+. .+++.||+|.+.+.... +.+..+.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 3444568899999999999999999995 56889999987531100 3345667
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
..|+||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccc
Confidence 899999999999999999653 378889999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCC-CcccccCCCCccCccccccCC----CCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccC-
Q 041438 627 KFLNLDSS-NWSKLAGTHGNVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR- 700 (752)
Q Consensus 627 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~- 700 (752)
........ .....+||+.|+|||++.+.. ++.++||||+||++|||++|+.||... ........+.+..
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~-----~~~~~~~~i~~~~~ 264 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD-----SLVGTYSKIMDHKN 264 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCc
Confidence 87643222 223457999999999987543 788999999999999999999998521 1222233343322
Q ss_pred -CCCCChhhHHHHHHHHHHHHhccCcCCCC--CCCHHHHHHH
Q 041438 701 -LPYPSLDVQNKFMSIMQVAFSCLDQNPVS--RPTMKRFEVQ 739 (752)
Q Consensus 701 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 739 (752)
...+. ....+..+.+++.+|+..+|.+ |++++|+++|
T Consensus 265 ~~~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 SLNFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ccCCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 22222 2334667888999999855543 8899999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=313.89 Aligned_cols=218 Identities=24% Similarity=0.344 Sum_probs=175.1
Q ss_pred eeeccCCceEEEEEEe-CCCcEEEEEccCCCCC---C-------------------------CccccCCceEEEEEeccC
Q 041438 507 HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP---D-------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~-------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
+.||+|+||.||+|+. .+++.||||++++... . +++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999985 4688999998764210 0 334556789999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence 99998887543 488999999999999999999999 999999999999999999999999999876433333334
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHH
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 717 (752)
..+|++.|+|||++.+..++.++||||+||++|||++|+.||... ........+.......+ ...+..+.+
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~-----~~~~~~~~i~~~~~~~~----~~~~~~~~~ 225 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD-----DEDELFQSILEDEVRYP----RWLSKEAKS 225 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC-----CHHHHHHHHHcCCCCCC----CcCCHHHHH
Confidence 457999999999999999999999999999999999999998521 12222333333333333 234567889
Q ss_pred HHHhccCcCCCCCCCH-----HHHHHH
Q 041438 718 VAFSCLDQNPVSRPTM-----KRFEVQ 739 (752)
Q Consensus 718 li~~cl~~dP~~Rps~-----~evl~~ 739 (752)
++.+||+.||++||++ .+++++
T Consensus 226 li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 226 ILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999999 877765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.16 Aligned_cols=226 Identities=25% Similarity=0.337 Sum_probs=178.5
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~ 552 (752)
++|++.+.||+|+||.||+|+. .+++.||+|+++..... ..+......|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4799999999999999999984 57899999988643210 3344567889999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999997652 3488899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCC-cccccCCCCccCccccc------cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccC--CCC
Q 041438 633 SSN-WSKLAGTHGNVAPELAY------TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR--LPY 703 (752)
Q Consensus 633 ~~~-~~~~~gt~~y~aPE~~~------~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~ 703 (752)
... .....||+.|+|||++. +..++.++|||||||++|||++|+.||... ........+.... ...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-----~~~~~~~~i~~~~~~~~~ 230 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-----TSAKTYNNIMNFQRFLKF 230 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC-----CHHHHHHHHHcCCCccCC
Confidence 322 22347899999999886 456789999999999999999999998521 1112222222221 122
Q ss_pred CChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 704 PSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 704 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+. ....+.++.+++.+|++ +|++||+++++++|
T Consensus 231 ~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 231 PE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 21 12345678899999998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=304.89 Aligned_cols=226 Identities=22% Similarity=0.259 Sum_probs=184.3
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------------CccccCCceEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFI 550 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~l 550 (752)
..+.|..-++||+|+||.||-++ ..+|+.||+|++.+.... ..++..+..++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 35668899999999999999998 568999999987543221 23567889999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||..|.||||.-++...+. +.++++.++.++.+|+.||++||++ +||.||+||+|||+|+.|+++|+|.|+|..+.
T Consensus 263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999987765 4599999999999999999999999 99999999999999999999999999999887
Q ss_pred CCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
... .....+||.+|||||++.++.|+...|+||+||++|||+.|+.||..-.+- ...++..+.+......++ ..
T Consensus 339 ~g~-~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK-vk~eEvdrr~~~~~~ey~----~k 412 (591)
T KOG0986|consen 339 EGK-PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK-VKREEVDRRTLEDPEEYS----DK 412 (591)
T ss_pred CCC-ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh-hhHHHHHHHHhcchhhcc----cc
Confidence 443 344559999999999999999999999999999999999999999622111 111122222333233333 55
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMK 734 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~ 734 (752)
.++++.++.+..|.+||++|....
T Consensus 413 FS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 413 FSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cCHHHHHHHHHHHccCHHHhccCC
Confidence 677889999999999999997443
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=300.38 Aligned_cols=236 Identities=20% Similarity=0.257 Sum_probs=185.1
Q ss_pred cccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------------CccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~ 552 (752)
++|++.+.||+|+||.||+|+ ..+++.||||.++..... +++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 579999999999999999999 457899999976532110 3344567889999
Q ss_pred EeccCCChHHHhccCcc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 553 EYLESGSLDKILNNDAS-AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
||+++|+|.+++..... ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998864321 23478899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
.........|++.|+|||.+.+..++.++||||+|+++|||++|+.||.... .........+.... .+.......
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~---~~~~~~~~~~~~~~--~~~~~~~~~ 233 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLFSLCQKIEQCD--YPPLPTEHY 233 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc---ccHHHHHHHHhcCC--CCCCChhhc
Confidence 3332334578889999999988889999999999999999999999984210 01111111111111 121122345
Q ss_pred HHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 712 FMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
+..+.+++.+||+.+|++||+++++++.+++++
T Consensus 234 ~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 234 SEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 567899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=310.40 Aligned_cols=228 Identities=23% Similarity=0.333 Sum_probs=199.5
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------CccccCCceE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSF 549 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~ 549 (752)
....|++.+.||+|.||.||+++. .+|+.+|+|.+.+.... +.++....++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 356788899999999999999995 45999999998765431 4456678899
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC----CceEEeeccc
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG----YEAHVSDFRI 625 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~----~~~kl~DfG~ 625 (752)
+|||+|.||.|.+.+... .+++..+..++.|++.|++|||+. ||+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999998766 289999999999999999999999 99999999999999633 5799999999
Q ss_pred ceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCC
Q 041438 626 AKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPS 705 (752)
Q Consensus 626 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (752)
|..... .......+||+.|+|||++.+..|+.++||||+||++|.|++|.+||. ..........+...++.+..
T Consensus 186 a~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~-----~~~~~~~~~~i~~~~~~f~~ 259 (382)
T KOG0032|consen 186 AKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFW-----GETEFEIFLAILRGDFDFTS 259 (382)
T ss_pred ceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCc-----CCChhHHHHHHHcCCCCCCC
Confidence 999875 555667899999999999999999999999999999999999999985 33334455578888888887
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..+...+..+.+++.+|+..||.+|+|+.++++|
T Consensus 260 ~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 260 EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 7888899999999999999999999999999997
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.94 Aligned_cols=234 Identities=23% Similarity=0.314 Sum_probs=179.0
Q ss_pred hcccccceeeccCCceEEEEEEe------CCCcEEEEEccCCCCCC--------------------------CccccCCc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV------PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQ 547 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--------------------------~~~~~~~~ 547 (752)
.++|++.+.||+|+||.||+|+. .++..||||+++..... +++.....
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788999999999999999963 34668999998643211 34556677
Q ss_pred eEEEEEeccCCChHHHhccCcc----------------------------------------------------------
Q 041438 548 SFIVYEYLESGSLDKILNNDAS---------------------------------------------------------- 569 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~---------------------------------------------------------- 569 (752)
.++|||||++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 8999999999999999864321
Q ss_pred --------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC
Q 041438 570 --------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635 (752)
Q Consensus 570 --------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 635 (752)
...+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 12478889999999999999999999 9999999999999999999999999999876433221
Q ss_pred --cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHH
Q 041438 636 --WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712 (752)
Q Consensus 636 --~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (752)
.....++..|+|||++.+..++.++|||||||++|||++ |..||.... ................. ....+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~-----~~~~~~~~~~~~~~~~~--~~~~~ 343 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP-----VDSKFYKMIKEGYRMLS--PECAP 343 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC-----chHHHHHHHHhCccCCC--CCCCC
Confidence 112234567999999999999999999999999999998 888985211 11111122222111110 01234
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
.++.+++.+||+.||++||+++|+++.|++.
T Consensus 344 ~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 344 SEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 5788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=315.04 Aligned_cols=219 Identities=24% Similarity=0.260 Sum_probs=172.9
Q ss_pred eeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------CccccCCceEEEEEeccC
Q 041438 507 HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
+.||+|+||.||+|+. .+++.||+|++...... ..+...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999995 46788999987532100 234556788999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
|+|.+++.... .+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence 99999987543 367788999999999999999999 999999999999999999999999999976443333344
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHH
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 717 (752)
..+||+.|+|||++.+..++.++||||+||++|||++|+.||.. ....+....+.......+ ...+..+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-----~~~~~~~~~i~~~~~~~~----~~~~~~~~~ 225 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-----RNTAEMYDNILNKPLQLK----PNITNSARH 225 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC-----CCHHHHHHHHHhCCcCCC----CCCCHHHHH
Confidence 56799999999999999999999999999999999999999852 111222233333333322 234567889
Q ss_pred HHHhccCcCCCCCCCHHHHHHHH
Q 041438 718 VAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 718 li~~cl~~dP~~Rps~~evl~~L 740 (752)
++.+|++.||.+||++.+.+..+
T Consensus 226 li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 226 LLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred HHHHHcccCHHHCCCCCCCHHHH
Confidence 99999999999999987544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=327.61 Aligned_cols=235 Identities=17% Similarity=0.168 Sum_probs=172.4
Q ss_pred HHHHhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------------Ccc-c
Q 041438 495 EIIRATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------------NFC-S 543 (752)
Q Consensus 495 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------------~~~-~ 543 (752)
++....++|++.++||+|+||.||+|+. .+++.||||+++..... .++ .
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3344578999999999999999999984 56889999988532110 111 2
Q ss_pred cCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCEEeCCCC------
Q 041438 544 HPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHWDISSKNVLLDLGY------ 616 (752)
Q Consensus 544 ~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~ivH~DlKp~NIll~~~~------ 616 (752)
.....++|||++ +++|.+++.+.+ .+++..+..|+.||+.||+|||+ . |||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccc
Confidence 235688999988 568888886543 48889999999999999999997 6 999999999999998665
Q ss_pred ----------ceEEeecccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccc
Q 041438 617 ----------EAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS 686 (752)
Q Consensus 617 ----------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~ 686 (752)
.+||+|||.+.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||+......
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred cccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 49999999886432 22334689999999999999999999999999999999999999995321100
Q ss_pred c----------cccc--------chHhhhccCC----CCCC-----------hhhHHHHHHHHHHHHhccCcCCCCCCCH
Q 041438 687 S----------SSSN--------MNIEILDSRL----PYPS-----------LDVQNKFMSIMQVAFSCLDQNPVSRPTM 733 (752)
Q Consensus 687 ~----------~~~~--------~~~~~~~~~~----~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~Rps~ 733 (752)
. .... ....+.+... .... .......+.+.+||.+||++||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 0 0000 0000000000 0000 0000123457899999999999999999
Q ss_pred HHHHHH
Q 041438 734 KRFEVQ 739 (752)
Q Consensus 734 ~evl~~ 739 (752)
+|+++|
T Consensus 433 ~e~L~H 438 (467)
T PTZ00284 433 RQMTTH 438 (467)
T ss_pred HHHhcC
Confidence 999975
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=294.16 Aligned_cols=228 Identities=27% Similarity=0.344 Sum_probs=186.4
Q ss_pred ccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC----------------------CccccCCceEEEEEeccCC
Q 041438 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD----------------------NFCSHPRQSFIVYEYLESG 558 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----------------------~~~~~~~~~~lV~E~~~~g 558 (752)
-|.+.++||+|+||.||+|. ..+|+.+|||.+.....- +.+......|+|||||..|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 36778999999999999998 568999999987543211 3334567789999999999
Q ss_pred ChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCccc
Q 041438 559 SLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK 638 (752)
Q Consensus 559 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 638 (752)
+..++++.+. +++++.++..+.+..++||+|||.. .-+|||||..|||+..+|.+|++|||.|..+.+.-.....
T Consensus 114 SiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT 188 (502)
T KOG0574|consen 114 SISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT 188 (502)
T ss_pred cHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence 9999998654 5699999999999999999999999 8899999999999999999999999999887654444566
Q ss_pred ccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHH
Q 041438 639 LAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQV 718 (752)
Q Consensus 639 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 718 (752)
..||+.|||||++..-.|+.++||||+|++..||..|++||.....+ ...-++-.+.+......+.++.++.++
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM------RAIFMIPT~PPPTF~KPE~WS~~F~DF 262 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM------RAIFMIPTKPPPTFKKPEEWSSEFNDF 262 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc------ceeEeccCCCCCCCCChHhhhhHHHHH
Confidence 79999999999999999999999999999999999999998522211 111111122221112336677889999
Q ss_pred HHhccCcCCCCCCCHHHHHHHH
Q 041438 719 AFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 719 i~~cl~~dP~~Rps~~evl~~L 740 (752)
+++||-+.|++|-|+-++++|-
T Consensus 263 i~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 263 IRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred HHHHhcCCHHHHHHHHHHhhhh
Confidence 9999999999999999998874
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.05 Aligned_cols=232 Identities=23% Similarity=0.292 Sum_probs=179.2
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E 553 (752)
.++|++.+.||+|+||.||+|+. .++..||+|.++..... +++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 47899999999999999999995 47889999987643211 34456678999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 999999999997543 3788999999999999999999862 6999999999999999999999999999865432
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcc------cc----cccc------------
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM------SS----SSSN------------ 691 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~------~~----~~~~------------ 691 (752)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...... .. ....
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 223457899999999999889999999999999999999999998521100 00 0000
Q ss_pred -------------------chHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 692 -------------------MNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 692 -------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
....+..... +.......+.++.+++.+||+.||++|||++|+++|-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPP--PKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCC--cCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000000 0001123456789999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.97 Aligned_cols=231 Identities=20% Similarity=0.297 Sum_probs=180.2
Q ss_pred hcccccceeeccCCceEEEEEEe----CCCcEEEEEccCCCCCC-------------------------CccccCCceEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV----PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFI 550 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~l 550 (752)
.++|++.+.||+|+||.||+|.. ..+..||+|.++..... +++......++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 35789999999999999999974 34678999988754321 34456678999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999999987543 3488999999999999999999999 99999999999999999999999999876543
Q ss_pred CCCCC-cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhh
Q 041438 631 LDSSN-WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708 (752)
Q Consensus 631 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (752)
..... .....++..|+|||.+.+..++.++|||||||++||+++ |+.||... ........+.+. ...+. .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~-----~~~~~~~~~~~~-~~~~~--~ 230 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM-----SGQDVIKAVEDG-FRLPA--P 230 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC-----CHHHHHHHHHCC-CCCCC--C
Confidence 22111 111245678999999999999999999999999999775 99998521 111122222222 11111 1
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
..++..+.+++.+||+.+|++||+++|+.+.|+++
T Consensus 231 ~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 231 RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 34566789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.01 Aligned_cols=238 Identities=19% Similarity=0.279 Sum_probs=175.3
Q ss_pred hcccccceeeccCCceEEEEEEeC-----------------CCcEEEEEccCCCCCC-----------------------
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP-----------------SGEIFAVKKFHSPLPD----------------------- 539 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~----------------------- 539 (752)
.++|++.++||+|+||.||+|+.. ++..||+|.++.....
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 357899999999999999999743 2347999988653211
Q ss_pred --CccccCCceEEEEEeccCCChHHHhccCc----------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 041438 540 --NFCSHPRQSFIVYEYLESGSLDKILNNDA----------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIV 601 (752)
Q Consensus 540 --~~~~~~~~~~lV~E~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iv 601 (752)
+++...+..++||||+++|+|.+++.... ....+++..+..++.||+.||+|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 33445677899999999999999986432 112467889999999999999999999 999
Q ss_pred ecCCCCCCEEeCCCCceEEeecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh--CCC
Q 041438 602 HWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK--GKH 677 (752)
Q Consensus 602 H~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt--g~~ 677 (752)
||||||+||++++++.+||+|||+++........ .....++..|+|||++.+..++.++|||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865432211 122345788999999988889999999999999999987 566
Q ss_pred CcchhhccccccccchHhhhccC-CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 678 PRDFLFEMSSSSSNMNIEILDSR-LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 678 pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
||...... ............. ..........++..+.+++.+||+.||++|||++|+.+.|++
T Consensus 241 p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDE--QVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHH--HHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 76421100 0000000111100 000000112345678999999999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=298.77 Aligned_cols=232 Identities=21% Similarity=0.344 Sum_probs=183.3
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEecc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~~ 556 (752)
.++|++.++||+|+||.||+|...+++.||+|.+...... +.+...+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 4689999999999999999999888889999987643221 33455677899999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC-
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN- 635 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~- 635 (752)
+++|.+++.... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||.+.........
T Consensus 85 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 85 KGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 999999997543 23478899999999999999999999 9999999999999999999999999999876432211
Q ss_pred cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
.....++..|+|||++.+..++.++|||||||++|+|+| |+.||... ........+. .....+. ....+.+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-----~~~~~~~~~~-~~~~~~~--~~~~~~~ 232 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM-----SNSDVMSALQ-RGYRMPR--MENCPDE 232 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC-----CHHHHHHHHH-cCCCCCC--CCCCCHH
Confidence 122345678999999988889999999999999999998 99998521 1111112221 1122221 1234567
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
+.+++.+|++.+|++||+++++.+.|+++
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 233 LYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 88999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=302.23 Aligned_cols=233 Identities=21% Similarity=0.364 Sum_probs=182.1
Q ss_pred hcccccceeeccCCceEEEEEEeCC------CcEEEEEccCCCCCC-------------------------CccccCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPS------GEIFAVKKFHSPLPD-------------------------NFCSHPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-------------------------~~~~~~~~~ 548 (752)
.++|++.+.||+|+||.||+|.... .+.||+|.++..... +++...+..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 3578899999999999999998432 267999988643221 234455678
Q ss_pred EEEEEeccCCChHHHhccCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC
Q 041438 549 FIVYEYLESGSLDKILNNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG 615 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~ 615 (752)
+++|||+++|+|.+++..... ...+++.++..++.|++.||+|||+. +++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence 999999999999999975421 13478899999999999999999999 99999999999999999
Q ss_pred CceEEeecccceeccCCCC--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccc
Q 041438 616 YEAHVSDFRIAKFLNLDSS--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNM 692 (752)
Q Consensus 616 ~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~ 692 (752)
+.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||... ...+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~-----~~~~~ 235 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF-----SNQEV 235 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC-----CHHHH
Confidence 9999999999986543221 1223356788999999988889999999999999999998 99998521 11222
Q ss_pred hHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 693 NIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
...+....... .....+.++.+++.+||+.||++||+++|+.++|+.+
T Consensus 236 ~~~i~~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 236 IEMIRSRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHcCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 22222222211 1134567899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=309.24 Aligned_cols=236 Identities=21% Similarity=0.294 Sum_probs=179.8
Q ss_pred hcccccceeeccCCceEEEEEEe------CCCcEEEEEccCCCCCC--------------------------Ccc-ccCC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV------PSGEIFAVKKFHSPLPD--------------------------NFC-SHPR 546 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--------------------------~~~-~~~~ 546 (752)
.++|++.+.||+|+||.||+|+. .+++.||+|+++..... +++ ....
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 35799999999999999999963 23578999988643211 112 2335
Q ss_pred ceEEEEEeccCCChHHHhccCcc---------------------------------------------------------
Q 041438 547 QSFIVYEYLESGSLDKILNNDAS--------------------------------------------------------- 569 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~--------------------------------------------------------- 569 (752)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999999864221
Q ss_pred -ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC--cccccCCCCcc
Q 041438 570 -AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNV 646 (752)
Q Consensus 570 -~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~ 646 (752)
...+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++..+...... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 12578999999999999999999999 9999999999999999999999999999876432211 12235567899
Q ss_pred CccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCc
Q 041438 647 APELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQ 725 (752)
Q Consensus 647 aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 725 (752)
|||++.+..++.++|||||||++|||++ |+.||.... ..+............. ......+++.+++.+||+.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~-----~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~cl~~ 315 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ-----IDEEFCRRLKEGTRMR--APEYATPEIYSIMLDCWHN 315 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC-----ccHHHHHHHhccCCCC--CCccCCHHHHHHHHHHccC
Confidence 9999999999999999999999999998 999985211 1111111111111111 0123456789999999999
Q ss_pred CCCCCCCHHHHHHHHhhhhc
Q 041438 726 NPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 726 dP~~Rps~~evl~~L~~~~~ 745 (752)
+|++||+++|++++|+++..
T Consensus 316 ~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 316 NPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=320.31 Aligned_cols=224 Identities=19% Similarity=0.279 Sum_probs=173.4
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEEE
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E 553 (752)
+|++.++||+|+||.||+|+. .+++.||+|++.+.... ..+......|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 688999999999999999984 57899999988643210 34456678999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
||++|+|.+++.+.+ .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999987543 378899999999999999999999 99999999999999999999999999975321000
Q ss_pred -----------------------------------------------CCcccccCCCCccCccccccCCCCCccchhhHH
Q 041438 634 -----------------------------------------------SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFG 666 (752)
Q Consensus 634 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlG 666 (752)
......+||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 001124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCcchhhccccccccchHhhhc--cCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCC---HHHHHHH
Q 041438 667 VLALEVIKGKHPRDFLFEMSSSSSNMNIEILD--SRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT---MKRFEVQ 739 (752)
Q Consensus 667 vil~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~ 739 (752)
|++|||++|+.||... ...+....+.. .....+. ....++++.+++.+|+ .+|++|++ ++|+++|
T Consensus 236 vil~elltG~~Pf~~~-----~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 236 VILYEMLVGQPPFLAQ-----TPLETQMKVINWQTSLHIPP--QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHHHHhCCCCCCCC-----CHHHHHHHHHccCCCcCCCC--cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 9999999999998521 11122222222 1222221 1334567788888876 59999987 8888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=298.24 Aligned_cols=237 Identities=21% Similarity=0.264 Sum_probs=186.6
Q ss_pred cccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------------CccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~ 552 (752)
++|++.+.||+|+||.||+|+ ..+++.||||.+...... +++...+..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 578899999999999999999 468999999976532110 3344567889999
Q ss_pred EeccCCChHHHhccCc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 553 EYLESGSLDKILNNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
||+++++|.+++.... ....+++.+++.++.|++.|+.|||++ +++|+||||+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999886422 234588999999999999999999999 999999999999999999999999999887654
Q ss_pred CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
.........|+..|+|||++.+..++.++||||||+++|+|++|..||.... .........+.... .+.......
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~--~~~~~~~~~ 233 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIEQCD--YPPLPSDHY 233 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc---chHHHHhhhhhcCC--CCCCCcccc
Confidence 3333334578899999999988889999999999999999999999984211 01111111221111 111122345
Q ss_pred HHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 712 FMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
+..+.+++.+||+.||++|||+.+|++.++++++
T Consensus 234 ~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 267 (267)
T cd08229 234 SEELRQLVNMCINPDPEKRPDITYVYDVAKRMHA 267 (267)
T ss_pred cHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhcC
Confidence 6689999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=312.39 Aligned_cols=223 Identities=22% Similarity=0.324 Sum_probs=173.7
Q ss_pred eeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------CccccCCceEEEEEeccC
Q 041438 507 HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
+.||+|+||.||+|+. .+++.||+|++++.... +.+......|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999994 56889999998643210 234456778999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
|+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence 99998886543 488999999999999999999999 999999999999999999999999999986433333334
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccc--ccccchHhhhccCCCCCChhhHHHHHHH
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS--SSSNMNIEILDSRLPYPSLDVQNKFMSI 715 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l 715 (752)
..+||+.|+|||++.+..++.++|||||||++|||++|+.||+....... ........+.......|. ..+..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~----~~~~~~ 230 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKA 230 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCC----CCCHHH
Confidence 56799999999999999999999999999999999999999953211111 111122233333333332 244568
Q ss_pred HHHHHhccCcCCCCCCCH------HHHHHH
Q 041438 716 MQVAFSCLDQNPVSRPTM------KRFEVQ 739 (752)
Q Consensus 716 ~~li~~cl~~dP~~Rps~------~evl~~ 739 (752)
.+++.+||+.||++|+++ +++.+|
T Consensus 231 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 231 SHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 899999999999999985 466554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=284.44 Aligned_cols=235 Identities=22% Similarity=0.270 Sum_probs=198.7
Q ss_pred hhcccccc-eeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC------------------------CccccCCceEEEE
Q 041438 499 ATNDFDAK-HCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 499 ~~~~y~~~-~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~ 552 (752)
.+++|.+. ++||-|-.|.|..+. ..+|+.+|+|++...... ..+.......+||
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 46677664 689999999999998 568999999988543221 1233456678999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC---CCceEEeecccceec
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL---GYEAHVSDFRIAKFL 629 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~---~~~~kl~DfG~a~~~ 629 (752)
|.|+||.|...++.++. +.+++.++..|++||+.|+.|||+. +|.||||||+|+|... +..+||+|||+|+.-
T Consensus 139 E~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 139 ECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred ecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccccccc
Confidence 99999999999987764 5599999999999999999999999 9999999999999963 456999999999975
Q ss_pred cCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 630 NLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
... ......+-|+.|.|||++..++|+..+|+||+||++|-|++|.+||..... ...+..+...+..+.+.+|...+.
T Consensus 215 ~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-~aispgMk~rI~~gqy~FP~pEWs 292 (400)
T KOG0604|consen 215 QEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMKRRIRTGQYEFPEPEWS 292 (400)
T ss_pred CCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-ccCChhHHhHhhccCccCCChhHh
Confidence 532 334556889999999999999999999999999999999999999963322 333556778888899999999999
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..+++..++|+.+|+.+|.+|.|++|+++|
T Consensus 293 ~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 293 CVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 999999999999999999999999999976
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=321.57 Aligned_cols=227 Identities=18% Similarity=0.239 Sum_probs=174.1
Q ss_pred cccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------------CccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~ 552 (752)
++|++.+.||+|+||.||+|+ ..+++.||||++.+.... ..+.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 479999999999999999999 457899999988542100 3345678899999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++|+|.+++...+ .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999997643 378889999999999999999999 9999999999999999999999999997532100
Q ss_pred C-------------------------------------------CCcccccCCCCccCccccccCCCCCccchhhHHHHH
Q 041438 633 S-------------------------------------------SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLA 669 (752)
Q Consensus 633 ~-------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil 669 (752)
. ......+||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 001124799999999999999999999999999999
Q ss_pred HHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCC---CHHHHHHH
Q 041438 670 LEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRP---TMKRFEVQ 739 (752)
Q Consensus 670 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~evl~~ 739 (752)
|||++|+.||.... ..+....+...............++++.+++.+|+ .+|++|+ ++.|+++|
T Consensus 235 yell~G~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 235 YEMLVGQPPFLADT-----PAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred eehhhCCCCCCCCC-----HHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999985211 11111222221111111111234566788888876 5999999 89999877
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=311.98 Aligned_cols=213 Identities=24% Similarity=0.297 Sum_probs=170.2
Q ss_pred eeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------CccccCCceEEEEEeccC
Q 041438 507 HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
+.||+|+||.||+|+. .+++.||+|++.+.... ..+.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 57899999987532110 334566788999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
|+|...+.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence 99998886533 377889999999999999999999 999999999999999999999999999876433333334
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHH
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 717 (752)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.. .........+.......+ .....++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-----~~~~~~~~~i~~~~~~~~----~~~~~~~~~ 225 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-----RDVSQMYDNILHKPLQLP----GGKTVAACD 225 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC-----CCHHHHHHHHhcCCCCCC----CCCCHHHHH
Confidence 45799999999999988899999999999999999999999852 112223333444433333 233456889
Q ss_pred HHHhccCcCCCCCCCHH
Q 041438 718 VAFSCLDQNPVSRPTMK 734 (752)
Q Consensus 718 li~~cl~~dP~~Rps~~ 734 (752)
++.+|++.||++||++.
T Consensus 226 li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 226 LLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHccCCHhhcCCCC
Confidence 99999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=299.43 Aligned_cols=234 Identities=24% Similarity=0.347 Sum_probs=187.6
Q ss_pred HhhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC------------------------CccccCCceEEEEE
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E 553 (752)
+...+|++.++||+|+||.||+|+..+++.+|+|.+...... +++......++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 456789999999999999999999877999999998754331 34556678899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++++|.+++.... ...+++.++..++.|++.|++|||+. +|+||||||+||++++++.+||+|||.+.......
T Consensus 83 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999997643 24588999999999999999999999 99999999999999999999999999998765433
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHH
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (752)
.......++..|+|||...+..++.++||||||+++|+|++ |+.||... ...+....+.. ....+. ....+
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~-----~~~~~~~~~~~-~~~~~~--~~~~~ 230 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM-----NNHEVYDQITA-GYRMPC--PAKCP 230 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC-----CHHHHHHHHHh-CCcCCC--CCCCC
Confidence 22233356678999999988889999999999999999998 89998521 11122222222 111111 13445
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
+.+.+++.+||+.||++|||++++++.|+.+
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 231 QEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 6788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=317.02 Aligned_cols=234 Identities=21% Similarity=0.318 Sum_probs=181.0
Q ss_pred HHHHHHhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------Ccccc
Q 041438 493 YEEIIRATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSH 544 (752)
Q Consensus 493 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~ 544 (752)
+.++....++|++.+.||+|+||.||+|+. .+++.||+|++.+.... +.+..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 344555678999999999999999999994 57889999987531100 23455
Q ss_pred CCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecc
Q 041438 545 PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFR 624 (752)
Q Consensus 545 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG 624 (752)
....|+||||+++|+|.+++.... +++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 678999999999999999986532 77888999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCC-CcccccCCCCccCccccccCC----CCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhcc
Q 041438 625 IAKFLNLDSS-NWSKLAGTHGNVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS 699 (752)
Q Consensus 625 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 699 (752)
+++....... .....+||+.|+|||++.+.. ++.++||||+||++|||++|+.||.. .........+...
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-----~~~~~~~~~i~~~ 262 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-----DSLVGTYSKIMNH 262 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-----CCHHHHHHHHHcC
Confidence 9987653322 223457999999999987543 78999999999999999999999852 1112223333332
Q ss_pred C--CCCCChhhHHHHHHHHHHHHhccCcCCCC--CCCHHHHHHHH
Q 041438 700 R--LPYPSLDVQNKFMSIMQVAFSCLDQNPVS--RPTMKRFEVQS 740 (752)
Q Consensus 700 ~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~L 740 (752)
. ...+ .....+..+.++|.+|+..++.+ |++++|+++|.
T Consensus 263 ~~~~~~~--~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 263 KNSLTFP--DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCcccCC--CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 2 2222 12345667889999999844433 78999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=294.91 Aligned_cols=236 Identities=21% Similarity=0.269 Sum_probs=185.6
Q ss_pred cccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC---------------------------CccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~ 552 (752)
++|++.+.||+|+||.||+|... +|+.||+|.++..... +.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999954 8999999987532110 3344567789999
Q ss_pred EeccCCChHHHhccCc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 553 EYLESGSLDKILNNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
||+++++|.+++.... ....+++.++..++.|++.|+.|||+. ||+||||||+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999986532 234578899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
.........++..|+|||.+.+..++.++|||||||++|+|++|+.||.... ............... +.......
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~--~~~~~~~~ 233 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIEKCDY--PPLPADHY 233 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhhhcCCC--CCCChhhc
Confidence 3333334578899999999988889999999999999999999999984211 000011111111111 11112245
Q ss_pred HHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 712 FMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
+..+.+++.+||+.+|++|||+.++++.+++++
T Consensus 234 ~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 234 SEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 567889999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=313.86 Aligned_cols=219 Identities=22% Similarity=0.278 Sum_probs=173.2
Q ss_pred eeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------CccccCCceEEEEEeccC
Q 041438 507 HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
+.||+|+||.||+|+. .+|+.||+|++...... ..+...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999984 57899999987542110 234556788999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
|+|..++.... .+++..+..++.||+.||+|||+. ||+||||||+||++++++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence 99998886543 478899999999999999999999 999999999999999999999999999876433333334
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHH
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 717 (752)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.. .........+.......+ ...+..+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-----~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 225 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC-----RDVAEMYDNILHKPLVLR----PGASLTAWS 225 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC-----CCHHHHHHHHHcCCccCC----CCCCHHHHH
Confidence 45799999999999999999999999999999999999999852 122223333333333322 124456789
Q ss_pred HHHhccCcCCCCCCCHHHHHHHH
Q 041438 718 VAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 718 li~~cl~~dP~~Rps~~evl~~L 740 (752)
++.+|++.||++||++++.++.+
T Consensus 226 ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 226 ILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred HHHHHhccCHHhcCCCCCCHHHH
Confidence 99999999999999886444333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=292.67 Aligned_cols=218 Identities=23% Similarity=0.378 Sum_probs=189.3
Q ss_pred hcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC----------------------------CccccCCceEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFI 550 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~l 550 (752)
..+|....+||+|+||.|.+|. ..+.+.||||++++...- ..++..+..|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3578889999999999999998 456789999999875431 23456688999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+.||+|-..+++.+. +.++.+..+|.+||-||-|||++ ||+.||||.+|||+|.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999999987654 66789999999999999999999 99999999999999999999999999998755
Q ss_pred CCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
.+.......+|||.|+|||++...+|+.++|+||+||++|||+.|++||+ ....++....+.+....+| ..
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd-----GeDE~elF~aI~ehnvsyP----Ks 572 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD-----GEDEDELFQAIMEHNVSYP----KS 572 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC-----CCCHHHHHHHHHHccCcCc----cc
Confidence 55555667899999999999999999999999999999999999999997 3445667788888888887 35
Q ss_pred HHHHHHHHHHhccCcCCCCCCC
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPT 732 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps 732 (752)
.+.++.++++..+.+.|.+|..
T Consensus 573 lSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 573 LSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ccHHHHHHHHHHhhcCCccccC
Confidence 6677889999999999999953
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=303.30 Aligned_cols=228 Identities=21% Similarity=0.269 Sum_probs=177.5
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEEE
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E 553 (752)
+|++.+.||+|+||.||++.. .+++.||||++...... +.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488899999999999999994 57899999987542110 23445678999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999998886532 23588999999999999999999999 99999999999999999999999999998764322
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHH
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
......|+..|+|||++.+..++.++||||+||++|||++|+.||...... ...+.....+.......+ ...+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~----~~~~~ 230 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEVERRVKEDQEEYS----EKFSE 230 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHHHHHhhhcccccC----cccCH
Confidence 223347899999999999888999999999999999999999998621100 000111111111111121 33556
Q ss_pred HHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 041438 714 SIMQVAFSCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rp-----s~~evl~~ 739 (752)
.+.+++.+||+.||++|| +++++++|
T Consensus 231 ~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 231 AARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 788999999999999999 88888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=295.61 Aligned_cols=226 Identities=25% Similarity=0.364 Sum_probs=179.2
Q ss_pred cccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEeccC
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~~~ 557 (752)
++|++.+.||+|+||.||+|+..++..+|+|.+...... +++......++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 568899999999999999999888889999987643221 345667788999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC-c
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN-W 636 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~ 636 (752)
|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||.++........ .
T Consensus 84 ~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 84 GCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 99999987543 2478899999999999999999999 9999999999999999999999999998865422211 1
Q ss_pred ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCC-CCCChhhHHHHHH
Q 041438 637 SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRL-PYPSLDVQNKFMS 714 (752)
Q Consensus 637 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 714 (752)
....++..|+|||++.+..++.++||||||+++|||++ |+.||... ........+..... ..+ ...+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~-----~~~~~~~~i~~~~~~~~~----~~~~~~ 229 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK-----SNYEVVEMISRGFRLYRP----KLASMT 229 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHHCCCCCCCC----CCCCHH
Confidence 12245568999999988889999999999999999999 89998521 11122222222211 112 123456
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
+.+++.+||+.||++||+++|+++.|
T Consensus 230 ~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 230 VYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHhh
Confidence 88999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=319.14 Aligned_cols=225 Identities=21% Similarity=0.298 Sum_probs=174.3
Q ss_pred cccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------------CccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~ 552 (752)
++|++.+.||+|+||.||+|+ ..+++.||||++.+.... +++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 479999999999999999998 467899999987532100 3445677899999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999987543 478899999999999999999999 9999999999999999999999999998643210
Q ss_pred CC-----------------------------------------------CcccccCCCCccCccccccCCCCCccchhhH
Q 041438 633 SS-----------------------------------------------NWSKLAGTHGNVAPELAYTMKVTEKCDVYSF 665 (752)
Q Consensus 633 ~~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSl 665 (752)
.. .....+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0012469999999999999899999999999
Q ss_pred HHHHHHHHhCCCCcchhhccccccccchHhhhc--cCCCCCChhhHHHHHHHHHHHHhccCcCCCCC---CCHHHHHHH
Q 041438 666 GVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD--SRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSR---PTMKRFEVQ 739 (752)
Q Consensus 666 Gvil~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---ps~~evl~~ 739 (752)
||++|||++|+.||... ........+.. .....+. ....+.++.+++.+|+. +|.+| +++.|+++|
T Consensus 235 Gvil~elltG~~Pf~~~-----~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 235 GAIMFECLIGWPPFCSE-----NSHETYRKIINWRETLYFPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred chhhhhhhcCCCCCCCC-----CHHHHHHHHHccCCccCCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999999998521 11122222222 1222221 12345678899999997 77775 599998876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=315.28 Aligned_cols=217 Identities=25% Similarity=0.295 Sum_probs=169.6
Q ss_pred eccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------------CccccCCceEEEEEeccC
Q 041438 509 IGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 509 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
||+|+||.||+|+. .+++.||||++.+.... ..+......|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999984 57899999987532110 123456778999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
|+|.+++.... .+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence 99999887543 478899999999999999999999 999999999999999999999999999976443333334
Q ss_pred cccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHH
Q 041438 638 KLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIM 716 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 716 (752)
..+||+.|+|||++.+. .++.++||||+||++|||++|+.||.. ....+....+.......+. ...+.++.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-----~~~~~~~~~i~~~~~~~~~---~~~~~~~~ 226 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-----EDTQQMYRNIAFGKVRFPK---NVLSDEGR 226 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-----CCHHHHHHHHHcCCCCCCC---ccCCHHHH
Confidence 56799999999998765 479999999999999999999999852 1122223333333333332 12455778
Q ss_pred HHHHhccCcCCCCCCC----HHHHHHH
Q 041438 717 QVAFSCLDQNPVSRPT----MKRFEVQ 739 (752)
Q Consensus 717 ~li~~cl~~dP~~Rps----~~evl~~ 739 (752)
+++.+||++||++||+ ++|+++|
T Consensus 227 ~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 227 QFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred HHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 9999999999999984 5555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=298.03 Aligned_cols=224 Identities=20% Similarity=0.300 Sum_probs=194.0
Q ss_pred cccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E 553 (752)
+=|...+.||+|.|+.|-+|+ .-+|+.||||++.+...+ .+.+.....|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 457788899999999999999 569999999999876554 33455678899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC-CCCceEEeecccceeccCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD-LGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~-~~~~~kl~DfG~a~~~~~~ 632 (752)
.-.+|+|.+|+-++.. .+.+...++++.||+.|+.|+|+. .+|||||||+||++- .-|-+|+.|||++..+. +
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-P 171 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC-C
Confidence 9999999999987653 388999999999999999999999 999999999999874 56889999999998876 4
Q ss_pred CCCcccccCCCCccCccccccCCCC-CccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 633 SSNWSKLAGTHGNVAPELAYTMKVT-EKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
.......+|+..|.|||++.+..|+ +++||||+|||+|-+++|++||+ .....+....+++-++..| ...
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFq-----eANDSETLTmImDCKYtvP----shv 242 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQ-----EANDSETLTMIMDCKYTVP----SHV 242 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccc-----cccchhhhhhhhcccccCc----hhh
Confidence 4556678999999999999999886 68999999999999999999997 2334556778888888887 467
Q ss_pred HHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 712 FMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+.++.++|..||..||.+|.+.+||..+
T Consensus 243 S~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 243 SKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 7889999999999999999999999753
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=310.95 Aligned_cols=231 Identities=23% Similarity=0.340 Sum_probs=171.0
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Cccc-----cCCceE
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCS-----HPRQSF 549 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~-----~~~~~~ 549 (752)
+|++.+.||+|+||.||+|+. .+++.||||+++..... +++. .....|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588999999999999999994 57899999987642111 1111 113479
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+||||+. ++|.+++.... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 58998886543 488999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCC---CcccccCCCCccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCcchhhccc----------cccccchH
Q 041438 630 NLDSS---NWSKLAGTHGNVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS----------SSSSNMNI 694 (752)
Q Consensus 630 ~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~----------~~~~~~~~ 694 (752)
..... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... ........
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32221 1234579999999998875 578999999999999999999999985321100 00000000
Q ss_pred h-----------hhccCCCCCC-hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 695 E-----------ILDSRLPYPS-LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 695 ~-----------~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
. ......+.+. ......++++.+++.+||+.||++|||++|+++|
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 0011111110 0111234567899999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=299.45 Aligned_cols=232 Identities=23% Similarity=0.395 Sum_probs=182.3
Q ss_pred hcccccceeeccCCceEEEEEEeC------CCcEEEEEccCCCCCC-------------------------CccccCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP------SGEIFAVKKFHSPLPD-------------------------NFCSHPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-------------------------~~~~~~~~~ 548 (752)
.++|.+.+.||+|+||.||+|+.. +++.||||.++..... +++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 457889999999999999999853 3578999998654221 334456788
Q ss_pred EEEEEeccCCChHHHhccCcc-----------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCc
Q 041438 549 FIVYEYLESGSLDKILNNDAS-----------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE 617 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~ 617 (752)
++||||+++++|.+++...+. ...+++.++..++.|++.|++|+|+. +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 999999999999999975421 23478899999999999999999999 9999999999999999999
Q ss_pred eEEeecccceeccCCCC--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchH
Q 041438 618 AHVSDFRIAKFLNLDSS--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNI 694 (752)
Q Consensus 618 ~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~ 694 (752)
+||+|||.++....... ......+++.|+|||++.+..+++++|||||||++|||++ |+.||.. ........
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~-----~~~~~~~~ 235 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG-----LSNEEVIE 235 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCC-----CCHHHHHH
Confidence 99999999986533221 1122345778999999999999999999999999999998 9999842 11222223
Q ss_pred hhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 695 EILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
.+.......+. ...+..+.+++.+||+.||++||+++|+++.|++
T Consensus 236 ~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 CITQGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 33333222211 2355678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=298.34 Aligned_cols=230 Identities=27% Similarity=0.354 Sum_probs=177.8
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEe
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~ 554 (752)
.++|++.+.||+|+||.||+|+. .+++.||+|+++..... +.+...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45799999999999999999994 67899999988643211 234456788999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++++|.+++.... .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999999886543 478899999999999999999999 999999999999999999999999999987653332
Q ss_pred CcccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCCh-hhHH
Q 041438 635 NWSKLAGTHGNVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL-DVQN 710 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 710 (752)
......|+..|+|||.+. ...++.++||||+||++|||++|+.||...... .....+.......+.. ....
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-----RALFLMSKSNFQPPKLKDKTK 236 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-----hhheeeecCCCCCCCCccccc
Confidence 233457889999999874 344788999999999999999999998422111 0000111111111110 1123
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
.+..+.+++.+||+.||++||+++++++++
T Consensus 237 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 237 WSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 456789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=303.94 Aligned_cols=226 Identities=24% Similarity=0.362 Sum_probs=177.1
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC---------------------------CccccCCceEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~ 552 (752)
...|++.++||+||.+.||++...+.+.||+|++.....+ +|.-.++..|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 4568999999999999999999888899999987543332 3334568899999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||-+. ||..++++..... .+| .++.|.+||+.|+.++|.+ ||||.||||.|+|+- +|.+||+|||+|..+..+
T Consensus 440 E~Gd~-DL~kiL~k~~~~~-~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECGDI-DLNKILKKKKSID-PDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred ecccc-cHHHHHHhccCCC-chH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 98766 9999998765322 223 7889999999999999999 999999999999997 478999999999988766
Q ss_pred CCCc--ccccCCCCccCccccccC-----------CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhcc
Q 041438 633 SSNW--SKLAGTHGNVAPELAYTM-----------KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS 699 (752)
Q Consensus 633 ~~~~--~~~~gt~~y~aPE~~~~~-----------~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 699 (752)
.... ...+||+.||+||.+... ++++++||||+|||+|+|+.|+.||+.... .......+.+.
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n----~~aKl~aI~~P 588 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN----QIAKLHAITDP 588 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH----HHHHHHhhcCC
Confidence 5433 345999999999987632 257899999999999999999999963221 12233444444
Q ss_pred CC--CCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 700 RL--PYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 700 ~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.. ++|... . ..++.++++.||++||++||++.|+++|
T Consensus 589 ~~~Iefp~~~--~-~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 589 NHEIEFPDIP--E-NDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred CccccccCCC--C-chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 32 344321 1 1238899999999999999999999976
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=294.49 Aligned_cols=230 Identities=26% Similarity=0.419 Sum_probs=181.5
Q ss_pred hcccccceeeccCCceEEEEEEeC----CCcEEEEEccCCCCCC-------------------------CccccCCceEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP----SGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFI 550 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~l 550 (752)
.++|++.+.||+|+||.||+|+.. +...||||.++..... +++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 357999999999999999999853 2468999988654321 23445677899
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+++++|.+++.... ..+++.++..++.|++.|++|||++ +|+||||||+||++++++.++|+|||.++...
T Consensus 83 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999999997643 2588999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCCc--ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc-CCCCCCh
Q 041438 631 LDSSNW--SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RLPYPSL 706 (752)
Q Consensus 631 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 706 (752)
...... ....++..|+|||.+.+..++.++||||||+++|||++ |..||... ........+... ..+.+
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~-- 230 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM-----SNQDVIKAVEDGYRLPPP-- 230 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHcCCCCCCC--
Confidence 222211 12244578999999998889999999999999999998 99998421 111122222221 11111
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
...+..+.+++.+||+.+|++||+++|++++|+++
T Consensus 231 --~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 231 --MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 23456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=311.64 Aligned_cols=214 Identities=23% Similarity=0.314 Sum_probs=172.7
Q ss_pred eeeccCCceEEEEEEe----CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEecc
Q 041438 507 HCIGKGGHGSVYIARV----PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~~~ 556 (752)
+.||+|+||.||+++. .+|+.||+|+++..... +++......|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999974 46899999988642110 34456778999999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW 636 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 636 (752)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.........
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence 999999986543 488999999999999999999999 99999999999999999999999999998765443334
Q ss_pred ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHH
Q 041438 637 SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIM 716 (752)
Q Consensus 637 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 716 (752)
....||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ ...++++.
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-----~~~~~~~~i~~~~~~~p----~~~~~~~~ 226 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK-----DRKETMTMILKAKLGMP----QFLSPEAQ 226 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC-----CHHHHHHHHHcCCCCCC----CCCCHHHH
Confidence 4567999999999999888999999999999999999999998521 12222333434444333 23456788
Q ss_pred HHHHhccCcCCCCCCCHHH
Q 041438 717 QVAFSCLDQNPVSRPTMKR 735 (752)
Q Consensus 717 ~li~~cl~~dP~~Rps~~e 735 (752)
+++.+||+.||++||++.+
T Consensus 227 ~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 227 SLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHhhcCHhHcCCCCC
Confidence 9999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=296.80 Aligned_cols=236 Identities=21% Similarity=0.372 Sum_probs=182.7
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCc----EEEEEccCCCCCC-------------------------CccccCCceE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGE----IFAVKKFHSPLPD-------------------------NFCSHPRQSF 549 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~-------------------------~~~~~~~~~~ 549 (752)
.++|++.++||+|+||.||+|++ .+++ .||+|.++..... +++. ....+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICL-TSTVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEc-CCCcE
Confidence 56899999999999999999983 4554 4899987643221 1222 34567
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
++|||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 9999999999999987543 3478899999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCc--ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCCh
Q 041438 630 NLDSSNW--SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706 (752)
Q Consensus 630 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (752)
....... ....++..|+|||...+..++.++|||||||++|||++ |..||+... ... ...........+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~-~~~~~~~~~~~~~- 232 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-----ARE-IPDLLEKGERLPQ- 232 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHH-HHHHHHCCCcCCC-
Confidence 5332211 11234678999999988889999999999999999998 899985211 111 1111222111111
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCCCC
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPDH 749 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 749 (752)
....+.++.+++.+||+.||++||++.++++.++++...|.+
T Consensus 233 -~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~ 274 (279)
T cd05109 233 -PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSR 274 (279)
T ss_pred -CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcC
Confidence 123456788999999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=316.06 Aligned_cols=225 Identities=21% Similarity=0.306 Sum_probs=173.7
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~ 552 (752)
++|++.+.||+|+||.||+|+. .+++.||+|+++..... ..+...+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4789999999999999999984 57899999988532100 2345567889999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999987543 378899999999999999999999 9999999999999999999999999998754321
Q ss_pred CC-----------------------------------CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCC
Q 041438 633 SS-----------------------------------NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 677 (752)
Q Consensus 633 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~ 677 (752)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 0113479999999999999999999999999999999999999
Q ss_pred CcchhhccccccccchHhhhcc--CCCCCChhhHHHHHHHHHHHHhccCcCCCCCCC---HHHHHHH
Q 041438 678 PRDFLFEMSSSSSNMNIEILDS--RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT---MKRFEVQ 739 (752)
Q Consensus 678 pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~ 739 (752)
||.. .........+... ....+.. ...+.++.+++.+|+ .||++|++ ++|+++|
T Consensus 235 Pf~~-----~~~~~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCS-----ETPQETYRKVMNWKETLVFPPE--VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCC-----CCHHHHHHHHHcCCCceecCCC--CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 9852 1122222223221 2222211 124456788888876 49999985 5666655
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=293.87 Aligned_cols=231 Identities=22% Similarity=0.315 Sum_probs=181.4
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEecc
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~~ 556 (752)
.+|++.+.||+|+||.||+|.. .+++.||+|.+...... +++......++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 4688899999999999999984 56889999988654321 34455677899999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW 636 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 636 (752)
+++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.+..........
T Consensus 86 ~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 86 YGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999987543 23478899999999999999999999 99999999999999999999999999998765332111
Q ss_pred -ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 637 -SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 637 -~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
....++..|+|||.+.+..++.++|||||||++|||++ |..||... ...+....+ ....... .....+.+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-----~~~~~~~~~-~~~~~~~--~~~~~~~~ 233 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYELL-EKGYRME--RPEGCPPK 233 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH-HCCCCCC--CCCCCCHH
Confidence 11234567999999988899999999999999999998 99997521 111111111 1111111 11334567
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
+.+++.+||+.||++||++.++++.|+.+
T Consensus 234 ~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 234 VYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 89999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.68 Aligned_cols=232 Identities=24% Similarity=0.381 Sum_probs=183.0
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEecc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~~ 556 (752)
.++|++.+.||+|+||.||+|...+++.||+|.++..... +++...+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 4678999999999999999999777889999998753221 34556677899999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW 636 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 636 (752)
+++|.+++.... ...+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||+++.........
T Consensus 85 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 85 YGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred CCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 999999997643 23588999999999999999999999 99999999999999999999999999998765322111
Q ss_pred -ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 637 -SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 637 -~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
.....+..|+|||+..+..++.++|||||||++|||+| |+.||... ........+ ......+. ....+..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-----~~~~~~~~~-~~~~~~~~--~~~~~~~ 232 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM-----TNAEVLQQV-DQGYRMPC--PPGCPKE 232 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHH-HcCCCCCC--CCcCCHH
Confidence 11123457999999998889999999999999999999 99998521 111112222 22222111 1234567
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
+.+++.+|++.+|++||+++++.+.|+.+
T Consensus 233 ~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 233 LYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 89999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=298.07 Aligned_cols=233 Identities=19% Similarity=0.289 Sum_probs=179.5
Q ss_pred hhcccccceeeccCCceEEEEEEeC------CCcEEEEEccCCCCCC-------------------------CccccCCc
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP------SGEIFAVKKFHSPLPD-------------------------NFCSHPRQ 547 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-------------------------~~~~~~~~ 547 (752)
..++|++.+.||+|+||.||+|+.. +++.||||++...... +++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999998742 3568999987543210 34456678
Q ss_pred eEEEEEeccCCChHHHhccCcc-------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEE
Q 041438 548 SFIVYEYLESGSLDKILNNDAS-------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV 620 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl 620 (752)
.++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 8999999999999999865321 12357788999999999999999999 9999999999999999999999
Q ss_pred eecccceeccCCCCCc--ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhh
Q 041438 621 SDFRIAKFLNLDSSNW--SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEIL 697 (752)
Q Consensus 621 ~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 697 (752)
+|||+++......... ....++..|+|||++.+..++.++|||||||++|||++ |..||... ........+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~-----~~~~~~~~~~ 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM-----SNEQVLRFVM 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHH
Confidence 9999987654322111 12245778999999998889999999999999999999 78887521 1122222222
Q ss_pred ccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 698 DSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 698 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
........ ...+..+.+++.+||+.||++|||+.|++++|++
T Consensus 236 ~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 EGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCcCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 22221111 2345678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=299.26 Aligned_cols=236 Identities=22% Similarity=0.358 Sum_probs=183.7
Q ss_pred hcccccceeeccCCceEEEEEEe------CCCcEEEEEccCCCCCC------------------------CccccCCceE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV------PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSF 549 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~ 549 (752)
.++|.+.+.||+|+||.||++.. .++..||+|.+...... +++......+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 35788999999999999999973 23567999988643211 3455667889
Q ss_pred EEEEeccCCChHHHhccCc----------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceE
Q 041438 550 IVYEYLESGSLDKILNNDA----------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAH 619 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~k 619 (752)
+||||+++++|.+++.... ....+++.++..++.|++.||+|||+. |++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999999987432 123489999999999999999999999 999999999999999999999
Q ss_pred EeecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhh
Q 041438 620 VSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEI 696 (752)
Q Consensus 620 l~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~ 696 (752)
|+|||.++........ .....++..|+|||++.+..++.++|||||||++|||++ |..||.... .......+
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~-----~~~~~~~i 235 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-----NNEVIECI 235 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHH
Confidence 9999999865432211 122345778999999998889999999999999999998 899985211 11222223
Q ss_pred hccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 697 LDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
......... ...+.++.+++.+||+.||.+|||++|+.+.|+++...
T Consensus 236 ~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 236 TQGRVLQRP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HcCCcCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 222221111 23445789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=299.05 Aligned_cols=226 Identities=22% Similarity=0.305 Sum_probs=173.8
Q ss_pred eccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEEEeccCCCh
Q 041438 509 IGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYEYLESGSL 560 (752)
Q Consensus 509 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E~~~~g~L 560 (752)
||+|+||.||+++. .+|+.||+|.+...... ..+......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999984 57999999987532110 334566788999999999999
Q ss_pred HHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCccccc
Q 041438 561 DKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLA 640 (752)
Q Consensus 561 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 640 (752)
.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRA 155 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccC
Confidence 988865432 3478899999999999999999999 99999999999999999999999999998765322 223357
Q ss_pred CCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHHH
Q 041438 641 GTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAF 720 (752)
Q Consensus 641 gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 720 (752)
|+..|+|||++.+..++.++||||+||++|||++|+.||..... ..................+ ....+.++.+++.
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~ 231 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE-KVAKEELKRRTLEDEVKFE---HQNFTEESKDICR 231 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc-hhhHHHHHHHhhccccccc---cccCCHHHHHHHH
Confidence 89999999999988899999999999999999999999852111 0011111122222222221 1235667899999
Q ss_pred hccCcCCCCCCCHHHHHHHHhhh
Q 041438 721 SCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 721 ~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
+||++||++||+++|+++++..-
T Consensus 232 ~~L~~~P~~R~~~~~~~~~~~~h 254 (277)
T cd05607 232 LFLAKKPEDRLGSREKNDDPRKH 254 (277)
T ss_pred HHhccCHhhCCCCccchhhhhcC
Confidence 99999999999997776555443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=317.36 Aligned_cols=236 Identities=20% Similarity=0.247 Sum_probs=170.5
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------Ccc--------ccCCceE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------NFC--------SHPRQSF 549 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------~~~--------~~~~~~~ 549 (752)
...+|++.+.||+|+||.||+|+. .+++.||||++...... +++ ......+
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 356799999999999999999985 57899999987532211 111 1112467
Q ss_pred EEEEeccCCChHHHhccCc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC-ceEEeecccce
Q 041438 550 IVYEYLESGSLDKILNNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY-EAHVSDFRIAK 627 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~-~~kl~DfG~a~ 627 (752)
+||||+++ ++.+++.... ....+++..++.++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||+|+
T Consensus 144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 89999986 7777765321 234588999999999999999999999 999999999999998654 69999999998
Q ss_pred eccCCCCCcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhcccc---------ccccchHhhh
Q 041438 628 FLNLDSSNWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS---------SSSNMNIEIL 697 (752)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~---------~~~~~~~~~~ 697 (752)
...... ......||+.|+|||++.+. .++.++||||+||++|||++|.+||........ ..........
T Consensus 220 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 298 (440)
T PTZ00036 220 NLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM 298 (440)
T ss_pred hccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 765332 22345789999999988764 689999999999999999999999853211000 0000000000
Q ss_pred cc---CCCCCC---hhh-----HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 698 DS---RLPYPS---LDV-----QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 698 ~~---~~~~~~---~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.. ...++. ... ...+.++.+++.+||++||++|||+.|+++|
T Consensus 299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00 000110 000 1234578999999999999999999999966
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=293.42 Aligned_cols=228 Identities=24% Similarity=0.354 Sum_probs=179.6
Q ss_pred cccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEeccC
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~~~ 557 (752)
++|++.+.||+|+||.||+|+..++..||+|.++..... +++......++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 578899999999999999998777778999988754321 344556678999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC-c
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN-W 636 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~ 636 (752)
|+|.+++.... ..+++.+++.++.||+.||+|||+. +++|+||||+||++++++.+||+|||.++....+... .
T Consensus 84 ~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 84 GCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 99999987543 2488999999999999999999999 9999999999999999999999999999865433211 1
Q ss_pred ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHH
Q 041438 637 SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSI 715 (752)
Q Consensus 637 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 715 (752)
....++..|+|||+..+..++.++|||||||++|||++ |+.||.... .......+......... ...+..+
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~---~~~~~~~ 230 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-----NSETVEKVSQGLRLYRP---HLASEKV 230 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC-----HHHHHHHHhcCCCCCCC---CCCCHHH
Confidence 12245678999999988889999999999999999998 999985211 11122222222221111 2235678
Q ss_pred HHHHHhccCcCCCCCCCHHHHHHHHh
Q 041438 716 MQVAFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 716 ~~li~~cl~~dP~~Rps~~evl~~L~ 741 (752)
.+++.+||+.||++||++.++++.++
T Consensus 231 ~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 231 YAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 99999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=310.54 Aligned_cols=233 Identities=18% Similarity=0.187 Sum_probs=175.3
Q ss_pred hcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC------------------CccccCCceEEEEEeccCCCh
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD------------------NFCSHPRQSFIVYEYLESGSL 560 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------------------~~~~~~~~~~lV~E~~~~g~L 560 (752)
.++|++.+.||+|+||.||+|+ ..+++.||+|........ +++......++|||++. ++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L 169 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDL 169 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCH
Confidence 4679999999999999999999 467899999976532111 34556778899999996 588
Q ss_pred HHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC-CCcccc
Q 041438 561 DKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS-SNWSKL 639 (752)
Q Consensus 561 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 639 (752)
..++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|+...... ......
T Consensus 170 ~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 243 (391)
T PHA03212 170 YCYLAAKR---NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243 (391)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccc
Confidence 88886543 378899999999999999999999 99999999999999999999999999997543221 222345
Q ss_pred cCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccc--cccchHhh---------------------
Q 041438 640 AGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS--SSNMNIEI--------------------- 696 (752)
Q Consensus 640 ~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~--~~~~~~~~--------------------- 696 (752)
.||+.|+|||++.+..+++++||||+||++|||++|+.||-........ .......+
T Consensus 244 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~ 323 (391)
T PHA03212 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDE 323 (391)
T ss_pred cCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHH
Confidence 7999999999999989999999999999999999999886311100000 00000000
Q ss_pred -----hccCC--C--CCC-hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 697 -----LDSRL--P--YPS-LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 697 -----~~~~~--~--~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..... + .+. ......+.++.+++.+||+.||++|||++|+++|
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 324 IYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 0 000 0112345678999999999999999999999965
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=302.02 Aligned_cols=234 Identities=14% Similarity=0.224 Sum_probs=175.3
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEe
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~ 554 (752)
++|++.+.||+|+||.||+|+. .+++.||+|.++..... +++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 6799999999999999999984 47889999988643211 334556788999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++ ++.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||.++.......
T Consensus 86 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 986 8888876543 3478899999999999999999999 999999999999999999999999999986544333
Q ss_pred CcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhcccc----------ccccchHh------hh
Q 041438 635 NWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------SSSNMNIE------IL 697 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~----------~~~~~~~~------~~ 697 (752)
......+++.|+|||++.+ ..++.++||||+||++|||+||+.||........ ........ ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 3334578899999998765 4588999999999999999999999852211000 00000000 00
Q ss_pred ccCCC-CCC----hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 698 DSRLP-YPS----LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 698 ~~~~~-~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
+...+ ... ......+.++.+++.+|++.||++|||++|+++|-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 00000 000 01122455788999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.09 Aligned_cols=226 Identities=27% Similarity=0.367 Sum_probs=181.9
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEe
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~ 554 (752)
+|++.+.||+|++|.||+|+. .+++.||+|.+...... +++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 578899999999999999984 57899999987543211 344556788999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++++|.+++.... ...+++.++..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||.++.......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999997642 24588899999999999999999999 999999999999999999999999999987654433
Q ss_pred CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 635 NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
......|++.|+|||+..+..++.++|||||||++|||++|+.||.... .......+.....+... ...+.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~---~~~~~~ 228 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-----QGALILKIIRGVFPPVS---QMYSQQ 228 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHcCCCCCCc---cccCHH
Confidence 3344578899999999998889999999999999999999999985221 12222223222222111 245567
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+.+++.+||+.+|++||++.+++++
T Consensus 229 ~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 229 LAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHhhC
Confidence 8999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=320.21 Aligned_cols=227 Identities=19% Similarity=0.224 Sum_probs=179.4
Q ss_pred cccccceeeccCCceEEEEEEe-CC-CcEEEEEccCCCCCC------------------------CccccCCceEEEEEe
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PS-GEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~ 554 (752)
..|.+.+.||+|+||.||+|.. .+ ++.||+|.+...... +++...+..|+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 3488999999999999999984 33 678899876432211 345567889999999
Q ss_pred ccCCChHHHhccCc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 555 LESGSLDKILNNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 555 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
+++|+|.+++.... ...++++..+..++.|++.||+|+|++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 99999999886432 234588899999999999999999999 99999999999999999999999999998765332
Q ss_pred C--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCC-CCChhhHH
Q 041438 634 S--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLP-YPSLDVQN 710 (752)
Q Consensus 634 ~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 710 (752)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.. .........+...... .+ ..
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~-----~~~~~~~~~~~~~~~~~~~----~~ 294 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG-----PSQREIMQQVLYGKYDPFP----CP 294 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-----CCHHHHHHHHHhCCCCCCC----cc
Confidence 1 12345799999999999999999999999999999999999999852 1112222333333222 22 23
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+.++.+++.+||+.||++||++++++.+
T Consensus 295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 295 VSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 45678999999999999999999998754
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=298.39 Aligned_cols=227 Identities=24% Similarity=0.296 Sum_probs=172.4
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------------Cccc-----cCC
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------------NFCS-----HPR 546 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------------~~~~-----~~~ 546 (752)
+|++.+.||+|+||.||+|+. .+++.||+|.++..... +++. ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 588999999999999999984 57899999987642111 1111 124
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
..++||||+.+ +|.+++..... ..+++..++.++.|++.||+|+|+. +|+||||||+||++++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 47899999985 89888875432 3488999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhh---------
Q 041438 627 KFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEIL--------- 697 (752)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~--------- 697 (752)
+..... .......||..|+|||++.+..++.++||||+||++|||++|++||...... .....+.
T Consensus 156 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-----~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 156 RIYSCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-----DQLGKIFDLIGLPPED 229 (288)
T ss_pred ccccCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-----HHHHHHHHHhCCCChh
Confidence 876432 2223457899999999999888999999999999999999999998521110 0000000
Q ss_pred -------------ccCCCCC-ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 698 -------------DSRLPYP-SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 698 -------------~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
......+ .........++.+++.+|+++||++|||++|++.|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 00112345568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=326.25 Aligned_cols=234 Identities=23% Similarity=0.296 Sum_probs=191.9
Q ss_pred HHHHHHhhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCC----CC-----------------------Ccccc
Q 041438 493 YEEIIRATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPL----PD-----------------------NFCSH 544 (752)
Q Consensus 493 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~----~~-----------------------~~~~~ 544 (752)
..++.-..++|++.+.||+|+||.|..++ ..+++.||+|++.+.. .+ ..+++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 34566678899999999999999999999 4679999999987621 11 23567
Q ss_pred CCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecc
Q 041438 545 PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFR 624 (752)
Q Consensus 545 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG 624 (752)
+++.|+|||||+||||-.++.+.. .+++.-++.|+.+|+.||.-+|+. |+|||||||+|||+|..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccch
Confidence 889999999999999999998765 488899999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCCCc-ccccCCCCccCccccc----c-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc
Q 041438 625 IAKFLNLDSSNW-SKLAGTHGNVAPELAY----T-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD 698 (752)
Q Consensus 625 ~a~~~~~~~~~~-~~~~gt~~y~aPE~~~----~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 698 (752)
.+-.+..++... ...+|||-|.+||++. + +.|++.+|+||+||++|||+.|..||.... -.+.+..|++
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-----lveTY~KIm~ 295 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-----LVETYGKIMN 295 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-----HHHHHHHHhc
Confidence 998887655443 3459999999999876 2 568999999999999999999999996322 2233344444
Q ss_pred c--CCCCCChhhHHHHHHHHHHHHhccCcCCCCCCC---HHHHHHHH
Q 041438 699 S--RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT---MKRFEVQS 740 (752)
Q Consensus 699 ~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~L 740 (752)
- .+.+| .....+.++.+||.+.+. +|+.|.. ++++-.|-
T Consensus 296 hk~~l~FP--~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 296 HKESLSFP--DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred hhhhcCCC--cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 4 44555 234577889999998875 6889987 88887764
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.62 Aligned_cols=236 Identities=21% Similarity=0.296 Sum_probs=181.6
Q ss_pred hhcccccceeeccCCceEEEEEEeC------CCcEEEEEccCCCCCC--------------------------CccccCC
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP------SGEIFAVKKFHSPLPD--------------------------NFCSHPR 546 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--------------------------~~~~~~~ 546 (752)
..++|++.+.||+|+||.||+|+.. .+..||||+++..... +++....
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3568899999999999999999742 2347999998643221 3455667
Q ss_pred ceEEEEEeccCCChHHHhccCcc---------------------------------------------------------
Q 041438 547 QSFIVYEYLESGSLDKILNNDAS--------------------------------------------------------- 569 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~--------------------------------------------------------- 569 (752)
..|+|||||++|+|.+++.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 89999999999999998864310
Q ss_pred ------------------------------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC
Q 041438 570 ------------------------------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD 613 (752)
Q Consensus 570 ------------------------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~ 613 (752)
...+++.++..++.||++||+|||+. +|+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 12377888899999999999999999 999999999999999
Q ss_pred CCCceEEeecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccc
Q 041438 614 LGYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSS 690 (752)
Q Consensus 614 ~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~ 690 (752)
+++.+||+|||+++........ .....++..|+|||++.+..+++++|||||||++|||++ |..||.... ..
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~-----~~ 346 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI-----VD 346 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc-----hh
Confidence 9999999999999876432221 122356788999999998889999999999999999997 999985211 11
Q ss_pred cchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 691 NMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
.............+ .....+.++.+++.+||+.||++||++.++.+.|+++.
T Consensus 347 ~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 347 STFYNKIKSGYRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHHHhcCCCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 11111111111111 11345667899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=304.47 Aligned_cols=231 Identities=23% Similarity=0.311 Sum_probs=176.6
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E 553 (752)
.++|++.++||+|+||.||+|+. .+++.+|+|.++..... +++...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 47899999999999999999995 47889999987643211 34556788999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.. +|+||||||+||++++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 999999999997543 3788899999999999999999742 7999999999999999999999999999765322
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccc----------c-ccc-----------
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------S-SSN----------- 691 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~----------~-~~~----------- 691 (752)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........ . ...
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 12334789999999999988899999999999999999999999852110000 0 000
Q ss_pred -----------------chHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 692 -----------------MNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 692 -----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
....+..... +.........++.+++.+||+.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCC--ccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000000000 000001234568899999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=296.94 Aligned_cols=231 Identities=24% Similarity=0.340 Sum_probs=177.2
Q ss_pred HhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------Ccccc------CC
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSH------PR 546 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~------~~ 546 (752)
.+.+.|++.+.||+|+||.||+|+. .+++.||+|++...... +++.. ..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4677899999999999999999984 57889999987543211 11111 24
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
..|+||||+++++|.+++.... ...+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 5789999999999999987643 23588999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCCCcccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCC
Q 041438 627 KFLNLDSSNWSKLAGTHGNVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRL 701 (752)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 701 (752)
..............|+..|+|||++. +..++.++||||+||++|||++|+.||..... ..........
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-----~~~~~~~~~~-- 231 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----MRALFLIPRN-- 231 (272)
T ss_pred eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-----HHHHHHHhcC--
Confidence 87643333334457899999999876 34578899999999999999999999852111 1111111111
Q ss_pred CCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 702 PYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 702 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..+.......+.++.+++.+||..||++|||++|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 11111112345678899999999999999999999865
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.43 Aligned_cols=235 Identities=22% Similarity=0.375 Sum_probs=181.1
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCc----EEEEEccCCCCCC-------------------------CccccCCceE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGE----IFAVKKFHSPLPD-------------------------NFCSHPRQSF 549 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~-------------------------~~~~~~~~~~ 549 (752)
..+|++.+.||+|+||.||+|++ .+++ .||+|.++..... +++. ....+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~-~~~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEc-CCCce
Confidence 45799999999999999999984 3444 4899998643221 2222 24568
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+|+||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 9999999999999997643 3478889999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCc--ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCCh
Q 041438 630 NLDSSNW--SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706 (752)
Q Consensus 630 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (752)
....... ....++..|+|||++.+..++.++|||||||++|||++ |+.||+.. .......+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~------~~~~~~~~~~~~~~~~~~ 233 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI------PASEISSILEKGERLPQP 233 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------CHHHHHHHHhCCCCCCCC
Confidence 5433221 11234668999999999999999999999999999998 99998521 111112222222221111
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCCC
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPD 748 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 748 (752)
..+..++.+++.+||+.||++||++.+++.++.++...+.
T Consensus 234 --~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 234 --PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred --CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 2234568899999999999999999999999998876553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=290.90 Aligned_cols=231 Identities=22% Similarity=0.327 Sum_probs=181.3
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEecc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~~ 556 (752)
.++|++.++||+|+||.||+|+..++..||+|+++..... +. ......++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~-~~~~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEE-ECCCCcEEEEEcCC
Confidence 3579999999999999999999777778999988753221 11 23455789999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW 636 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 636 (752)
+|+|.+++.... ...+++..+..++.|++.||+|+|+. +|+||||||+||++++++.+||+|||.+..........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 84 KGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999997543 23478899999999999999999999 99999999999999999999999999998764332211
Q ss_pred -ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 637 -SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 637 -~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
....++..|+|||+..+..++.++|||||||++|||+| |+.||... ........+.. ....+. ....+..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~-----~~~~~~~~~~~-~~~~~~--~~~~~~~ 231 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-----VNREVLDQVER-GYRMPC--PPECPES 231 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-----ChHHHHHHHhc-CCCCCC--ccccCHH
Confidence 12346678999999988889999999999999999999 88888521 11112222211 111111 1345667
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
+.+++.+|+++||++||+++++++.|++.
T Consensus 232 l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 232 LHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 89999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=291.17 Aligned_cols=230 Identities=19% Similarity=0.330 Sum_probs=181.4
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEecc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~~ 556 (752)
.++|++.++||+|+||.||+|...+++.||+|.+...... ++ ...+..++||||++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~-~~~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAV-VTQEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEE-EccCCcEEEEEcCC
Confidence 4679999999999999999999888999999988754332 11 13456899999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC-C
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS-N 635 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~ 635 (752)
+++|.+++..... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+........ .
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 84 NGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 9999999865432 3578899999999999999999999 999999999999999999999999999987652221 1
Q ss_pred cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
.....++..|+|||++.+..++.++||||||+++||+++ |+.||... ........+ ......+. ....+.+
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-----~~~~~~~~~-~~~~~~~~--~~~~~~~ 231 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM-----TNPEVIQNL-ERGYRMPR--PDNCPEE 231 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC-----ChHHHHHHH-HcCCCCCC--CCCCCHH
Confidence 122345678999999988889999999999999999999 99998521 111111111 11111111 1234457
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
+.+++.+|++.+|++||+++++.+.|+.
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 232 LYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 8999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=298.22 Aligned_cols=227 Identities=20% Similarity=0.255 Sum_probs=176.0
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEEE
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E 553 (752)
.|++.+.||+|+||.||+|.. .+++.||||.+...... +.+...+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 477889999999999999984 57899999987543110 23445678899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++++|.+++..... ..+++.++..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999998864332 3488899999999999999999999 99999999999999999999999999997654322
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhcc-CCCCCChhhHHHH
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS-RLPYPSLDVQNKF 712 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 712 (752)
......|+..|+|||++.+..++.++||||+||++|||++|+.||..... ............. ....+ ....
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~----~~~~ 229 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK--KIKREEVERLVKEVQEEYS----EKFS 229 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCc--cchHHHHHhhhhhhhhhcC----ccCC
Confidence 22334789999999999988899999999999999999999999862111 0000111111111 01111 2345
Q ss_pred HHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 041438 713 MSIMQVAFSCLDQNPVSRPT-----MKRFEVQ 739 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps-----~~evl~~ 739 (752)
+++.+++.+||+.||++||| ++|+++|
T Consensus 230 ~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 230 PDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 57889999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=297.29 Aligned_cols=234 Identities=24% Similarity=0.385 Sum_probs=183.0
Q ss_pred cccccceeeccCCceEEEEEEe------CCCcEEEEEccCCCCCC------------------------CccccCCceEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV------PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFI 550 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~l 550 (752)
.+|.+.+.||+|+||.||+|+. .++..+|+|.+...... +++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 4688899999999999999973 24567999987643211 34556678899
Q ss_pred EEEeccCCChHHHhccCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCc
Q 041438 551 VYEYLESGSLDKILNNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE 617 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~ 617 (752)
||||+++++|.+++..... ...+++..++.++.||+.|++|||++ +|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999999975421 23478999999999999999999999 9999999999999999999
Q ss_pred eEEeecccceeccCCCC--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchH
Q 041438 618 AHVSDFRIAKFLNLDSS--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNI 694 (752)
Q Consensus 618 ~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~ 694 (752)
++|+|||.++....... ......++..|+|||++.+..++.++|||||||++|||+| |+.||... .......
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-----~~~~~~~ 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL-----SNTEVIE 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHH
Confidence 99999999976543221 1123456788999999999899999999999999999999 99997421 1111222
Q ss_pred hhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 695 EILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
.+........ ....+..+.+++.+||+.||++||+++++++.|+++..
T Consensus 237 ~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 CITQGRVLER---PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHhCCCCCCC---CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 2222222211 12345678899999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=298.38 Aligned_cols=227 Identities=23% Similarity=0.349 Sum_probs=179.6
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEe
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~ 554 (752)
..+|++.+.||+|+||.||+|+. .+++.||+|.+...... +.+......|+||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 46799999999999999999984 57899999988643321 234456789999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++++|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+........
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 9999999998643 378899999999999999999999 999999999999999999999999999886543333
Q ss_pred CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 635 NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||..... ...............+ .....+..
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~--~~~~~~~~ 245 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALYLIATNGTPELQ--NPEKLSAI 245 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH----HHhHHHHhcCCCCCCC--CccccCHH
Confidence 33345788999999999888899999999999999999999999852111 1111111111111111 11345567
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+.+++.+||.+||++||+++|++++
T Consensus 246 l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 246 FRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHHHHHHCcCCcccCcCHHHHhhC
Confidence 8899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=305.50 Aligned_cols=232 Identities=20% Similarity=0.264 Sum_probs=172.8
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Cccc------cC
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCS------HP 545 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~------~~ 545 (752)
..++|++.+.||+|+||.||+|+. .+|+.||||++...... +++. ..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999984 57899999998653211 1111 12
Q ss_pred CceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccc
Q 041438 546 RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRI 625 (752)
Q Consensus 546 ~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~ 625 (752)
...|+||||+++ ++.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 357999999976 66666532 277889999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccc----------cccc----
Q 041438 626 AKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------SSSN---- 691 (752)
Q Consensus 626 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~----------~~~~---- 691 (752)
++..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||........ ....
T Consensus 170 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 170 ARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred ccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 9765322 223345789999999999999999999999999999999999999953211000 0000
Q ss_pred ---chHhhhccCCCCCChh----------------hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 692 ---MNIEILDSRLPYPSLD----------------VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 692 ---~~~~~~~~~~~~~~~~----------------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
............+... .......+.+++.+||+.||++|||++|+++|-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0001111111111000 011235688999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=293.23 Aligned_cols=236 Identities=21% Similarity=0.314 Sum_probs=180.5
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCc----EEEEEccCCCCCC-------------------------CccccCCceE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGE----IFAVKKFHSPLPD-------------------------NFCSHPRQSF 549 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~-------------------------~~~~~~~~~~ 549 (752)
.++|++.+.||+|+||.||+|+. .+++ .||+|.+...... +++ .....+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~-~~~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGIC-PGASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEE-CCCccE
Confidence 35788899999999999999985 3454 4788877532211 122 234568
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+++||+++|+|.+++.... ..+++..+..++.||+.||+|+|+. +++||||||+||++++++.+||+|||.++..
T Consensus 85 ~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999997543 3488999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCCh
Q 041438 630 NLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706 (752)
Q Consensus 630 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (752)
...... .....++..|+|||++.+..++.++|||||||++||+++ |+.||.... ......+.......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~------~~~~~~~~~~~~~~~~- 232 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR------PHEVPDLLEKGERLAQ- 232 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHHCCCcCCC-
Confidence 433221 223456778999999988889999999999999999998 999985211 1111122221111111
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCCCC
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPDH 749 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 749 (752)
...+..++.+++.+||..||++|||+.|+++.|+.+...|..
T Consensus 233 -~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~ 274 (279)
T cd05111 233 -PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPR 274 (279)
T ss_pred -CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcc
Confidence 012344678899999999999999999999999998766643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=291.12 Aligned_cols=226 Identities=27% Similarity=0.400 Sum_probs=177.9
Q ss_pred cccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEeccC
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~~~ 557 (752)
.+|++.+.||+|+||.||+|+..++..+|+|.+...... +++......++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 468889999999999999999877789999988653221 334556778999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc-
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW- 636 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~- 636 (752)
++|.+++.... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||.++.........
T Consensus 84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 99999997543 2478999999999999999999999 99999999999999999999999999998654322111
Q ss_pred ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc-CCCCCChhhHHHHHH
Q 041438 637 SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RLPYPSLDVQNKFMS 714 (752)
Q Consensus 637 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 714 (752)
....++..|+|||.+.+..++.++|||||||++||+++ |+.||+... ..+....+... ....+ ...+.+
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~----~~~~~~ 229 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS-----NSEVVESVSAGYRLYRP----KLAPTE 229 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHHHcCCcCCCC----CCCCHH
Confidence 11123457999999998889999999999999999999 899985211 11111122111 11112 234667
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
+.+++.+||+.+|++|||++|+++.|
T Consensus 230 ~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 230 VYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 89999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=325.10 Aligned_cols=235 Identities=23% Similarity=0.350 Sum_probs=179.2
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~ 552 (752)
++|++.++||+|+||.||+|+. .+|+.||+|+++..... +++.+.+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 6899999999999999999995 46899999988643211 3445667889999
Q ss_pred EeccCCChHHHhccCcc--------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecc
Q 041438 553 EYLESGSLDKILNNDAS--------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFR 624 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG 624 (752)
||+++|+|.+++..... ...+++..+..++.||++||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 12356678899999999999999999 99999999999999999999999999
Q ss_pred cceeccCCC------------------CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccc
Q 041438 625 IAKFLNLDS------------------SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS 686 (752)
Q Consensus 625 ~a~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~ 686 (752)
+++...... ......+||+.|+|||++.+..++.++||||+||++|||+||+.||....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~--- 235 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK--- 235 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc---
Confidence 998762111 01112469999999999999999999999999999999999999985211
Q ss_pred cccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCC-CHHHHHHHHhhhh
Q 041438 687 SSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRP-TMKRFEVQSKQFH 744 (752)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~~~ 744 (752)
................ ......++.+.+++.+|++.||++|| +++++.+.|+.+.
T Consensus 236 -~~ki~~~~~i~~P~~~--~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 236 -GRKISYRDVILSPIEV--APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred -hhhhhhhhhccChhhc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111111111100000 01134556788999999999999995 6777777777663
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=302.99 Aligned_cols=222 Identities=26% Similarity=0.343 Sum_probs=178.5
Q ss_pred eeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEeccCCChH
Q 041438 507 HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEYLESGSLD 561 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~~~~g~L~ 561 (752)
-+||+|+||+||.|+. .+...+|||.+...... +.+.+.+.+-|.||.++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 4799999999999994 56678999988654322 5567788889999999999999
Q ss_pred HHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC-CCCceEEeecccceeccCCCCCccccc
Q 041438 562 KILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD-LGYEAHVSDFRIAKFLNLDSSNWSKLA 640 (752)
Q Consensus 562 ~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~ 640 (752)
++++..-++-+=.+.++-.+.+||++||.|||+. .|||||||-+||||. -.|.+||+|||-++.+..-......+.
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 9998643222227889999999999999999999 999999999999996 578999999999998765555556678
Q ss_pred CCCCccCccccccCC--CCCccchhhHHHHHHHHHhCCCCcchhhccccccccc-hHhhhccCCCCCChhhHHHHHHHHH
Q 041438 641 GTHGNVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM-NIEILDSRLPYPSLDVQNKFMSIMQ 717 (752)
Q Consensus 641 gt~~y~aPE~~~~~~--~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~ 717 (752)
||..|||||++..++ |++++|||||||++.||.||++||... ......+ ...+.+...+.| .+.+.++..
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El---gspqAAMFkVGmyKvHP~iP----eelsaeak~ 810 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL---GSPQAAMFKVGMYKVHPPIP----EELSAEAKN 810 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec---CChhHhhhhhcceecCCCCc----HHHHHHHHH
Confidence 999999999998664 899999999999999999999999521 1111111 111222223333 677888999
Q ss_pred HHHhccCcCCCCCCCHHHHHH
Q 041438 718 VAFSCLDQNPVSRPTMKRFEV 738 (752)
Q Consensus 718 li~~cl~~dP~~Rps~~evl~ 738 (752)
+|.+|+.+||.+||+|+++++
T Consensus 811 FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 811 FILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHcCCCcccCccHHHhcc
Confidence 999999999999999999885
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=289.91 Aligned_cols=230 Identities=22% Similarity=0.367 Sum_probs=180.9
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEecc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~~ 556 (752)
.++|++.++||+|+||.||+|...++..||+|.++..... ++. .....++||||++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~-~~~~~~lv~e~~~ 83 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV-SEEPIYIVTEYMS 83 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEE-CCCCcEEEEEecC
Confidence 4578999999999999999999888889999988753321 122 3456799999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC-
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN- 635 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~- 635 (752)
+++|.+++.... ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.++|+|||.+.........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 84 KGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999997543 23478999999999999999999999 9999999999999999999999999999876432211
Q ss_pred cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
.....++..|+|||+..+..++.++||||||+++|||++ |..||... ...+....+.. ....+. ....+..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-----~~~~~~~~~~~-~~~~~~--~~~~~~~ 231 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-----NNREVLEQVER-GYRMPC--PQDCPIS 231 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHHHc-CCCCCC--CCcCCHH
Confidence 112245568999999988889999999999999999999 89998521 11112222222 111111 1234567
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
+.+++.+|+++||++|||++++.+.|++
T Consensus 232 ~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 232 LHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 8999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=291.61 Aligned_cols=226 Identities=21% Similarity=0.312 Sum_probs=179.4
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEec
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~~ 555 (752)
+|++.+.||+|+||.||+++. .+++.||+|.++..... +.+......|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 588999999999999999984 57899999987543211 2345667899999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 635 (752)
++++|.+++.... ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++++|||.+.........
T Consensus 81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 9999999886532 23478899999999999999999999 9999999999999999999999999999876544333
Q ss_pred cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHH
Q 041438 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSI 715 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 715 (752)
.....|++.|+|||++.+..++.++||||||+++|+|++|+.||... ........+........ ....+..+
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~---~~~~~~~~ 228 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN-----SWKNLILKVCQGSYKPL---PSHYSYEL 228 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC-----CHHHHHHHHhcCCCCCC---CcccCHHH
Confidence 34457899999999998888999999999999999999999998521 11111222222222111 12345568
Q ss_pred HHHHHhccCcCCCCCCCHHHHHHH
Q 041438 716 MQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 716 ~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+++.+||+.||++||++.|++..
T Consensus 229 ~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 229 RSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHhCCcccCCCHHHHhhc
Confidence 899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=289.47 Aligned_cols=226 Identities=26% Similarity=0.339 Sum_probs=179.3
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Cccc-cCCceEEEEE
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCS-HPRQSFIVYE 553 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~-~~~~~~lV~E 553 (752)
+|++.+.||+|++|.||+++. .+++.||+|++...... +.+. .....|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 588999999999999999994 46789999987543211 1122 2345789999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++++|.+++.... ...+++.++..++.|++.|++|+|+. +|+||||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999987543 23488999999999999999999999 99999999999999999999999999998775443
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHH
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
.......+++.|+|||+..+..++.++||||+||++|++++|+.||... ........+.....+.. ....++
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-----~~~~~~~~~~~~~~~~~---~~~~~~ 228 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-----DMNSLVYRIIEGKLPPM---PKDYSP 228 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhcCCCCC---ccccCH
Confidence 3334457889999999999988999999999999999999999998521 11112222223222211 134556
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+.+++.+|++.||++||++.++++|
T Consensus 229 ~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 229 ELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHHHHHHhccCcccCCCHHHHhcC
Confidence 78999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=294.77 Aligned_cols=231 Identities=19% Similarity=0.331 Sum_probs=178.7
Q ss_pred cccccceeeccCCceEEEEEEe-----CCCcEEEEEccCCCCCC-------------------------CccccCCceEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-----PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFI 550 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~l 550 (752)
++|++.+.||+|+||.||+|+. .+++.||+|.+...... +++......|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5788999999999999999973 35678999998743211 23445677899
Q ss_pred EEEeccCCChHHHhccCcc--------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC
Q 041438 551 VYEYLESGSLDKILNNDAS--------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY 616 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~ 616 (752)
||||+++++|.+++..... ...+++.++..++.|++.||+|||+. +|+||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999853221 23478889999999999999999999 999999999999999999
Q ss_pred ceEEeecccceeccCCCC--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccch
Q 041438 617 EAHVSDFRIAKFLNLDSS--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMN 693 (752)
Q Consensus 617 ~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~ 693 (752)
.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||... .....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~------~~~~~ 235 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF------SNQEV 235 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------CHHHH
Confidence 999999999987543221 1122345678999999988889999999999999999998 99997421 11111
Q ss_pred HhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 694 IEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
.+........+. ....+..+.+++.+||+.||++||++.++.++|+.
T Consensus 236 ~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 IEMVRKRQLLPC--SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHcCCcCCC--CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 222222211111 12345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=305.73 Aligned_cols=231 Identities=19% Similarity=0.222 Sum_probs=172.5
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Ccc------ccC
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFC------SHP 545 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~------~~~ 545 (752)
..++|++.+.||+|+||.||+|+. ..++.||||++...... +++ ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999984 56889999998653211 111 112
Q ss_pred CceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccc
Q 041438 546 RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRI 625 (752)
Q Consensus 546 ~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~ 625 (752)
...|+||||+++ ++.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999976 77777642 377889999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccc----------ccc----
Q 041438 626 AKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------SSN---- 691 (752)
Q Consensus 626 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~----------~~~---- 691 (752)
++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||......... ..+
T Consensus 173 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 173 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred ccccCCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 9865432 2223457899999999999999999999999999999999999998532110000 000
Q ss_pred ---chHhhhccCCCCC----------------ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 692 ---MNIEILDSRLPYP----------------SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 692 ---~~~~~~~~~~~~~----------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
........+.... .........++.+++.+|++.||++|||++|+++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000001110000 00001123468899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.54 Aligned_cols=241 Identities=21% Similarity=0.273 Sum_probs=182.2
Q ss_pred chHHHHHHhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------Ccc---
Q 041438 491 IVYEEIIRATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFC--- 542 (752)
Q Consensus 491 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~--- 542 (752)
+.++.+..+.++|++.+.||+|+||.||+|+. .+++.||+|.+...... +++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34456667899999999999999999999984 56889999987542210 111
Q ss_pred --ccCCceEEEEEeccCCChHHHhccCc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceE
Q 041438 543 --SHPRQSFIVYEYLESGSLDKILNNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAH 619 (752)
Q Consensus 543 --~~~~~~~lV~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~k 619 (752)
......++||||+++++|.+++.... ....+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence 23356899999999999999876422 224578899999999999999999999 999999999999999999999
Q ss_pred EeecccceeccCCCCCcccccCCCCccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchH
Q 041438 620 VSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI 694 (752)
Q Consensus 620 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~ 694 (752)
|+|||.++.............|++.|+|||++.. ..++.++||||+||++|||++|+.||..... .....
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-----~~~~~ 239 (286)
T cd06638 165 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-----MRALF 239 (286)
T ss_pred EccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-----hHHHh
Confidence 9999999876543333334578999999998753 4478899999999999999999999852211 01111
Q ss_pred hhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 695 EILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
.......+ ..........++.+++.+||+.||++|||+.|++++.
T Consensus 240 ~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 240 KIPRNPPP-TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hccccCCC-cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 11111100 0000112345688999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=298.88 Aligned_cols=229 Identities=29% Similarity=0.438 Sum_probs=178.1
Q ss_pred cccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEec
Q 041438 503 FDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~~ 555 (752)
|++.+.||+|+||.||+|+. .+++.||+|++...... ++..+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 77899999999999999995 45678999998765322 3344578889999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 635 (752)
++++|.+++... ..+++..+..++.|+++||++||+. +|+|+||||+||++++++.++|+|||.+.........
T Consensus 81 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp TTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred cccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 999999999732 3488999999999999999999999 9999999999999999999999999999865333344
Q ss_pred cccccCCCCccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 636 WSKLAGTHGNVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~-~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
.....++..|+|||++. +..++.++||||+|+++|+|++|..||..... ............................
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKILKRPLPSSSQQSREKSEE 232 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHHHTHHHHHTTSHTTSHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhhcccccccccccccchhHHH
Confidence 45568899999999988 78899999999999999999999999863200 0011111111111111000001111368
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+.+++.+||+.||++||++++++++
T Consensus 233 l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 233 LRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=296.17 Aligned_cols=228 Identities=21% Similarity=0.263 Sum_probs=175.9
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEEE
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E 553 (752)
.|+..+.||+|+||.||+|+. .+++.||+|.+...... ..+...+..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 367789999999999999984 57899999987543110 23445677899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999998886543 23589999999999999999999999 99999999999999999999999999997654322
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHH
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
......|+..|+|||++.+..++.++||||+||++|||++|+.||....... ........+.......+ ...+.
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~~~~~~~~~~~~~----~~~~~ 230 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEVDRRVLETEEVYS----AKFSE 230 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhhccccccC----ccCCH
Confidence 2234578999999999988889999999999999999999999985211100 00111111111111111 23455
Q ss_pred HHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 041438 714 SIMQVAFSCLDQNPVSRPT-----MKRFEVQ 739 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps-----~~evl~~ 739 (752)
++.+++.+|++.||++||+ ++++++|
T Consensus 231 ~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 231 EAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 6889999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=296.82 Aligned_cols=234 Identities=21% Similarity=0.331 Sum_probs=181.5
Q ss_pred hhcccccceeeccCCceEEEEEEeC------CCcEEEEEccCCCCCC--------------------------CccccCC
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP------SGEIFAVKKFHSPLPD--------------------------NFCSHPR 546 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--------------------------~~~~~~~ 546 (752)
..++|++.+.||+|+||.||++... ....||+|.++..... +++....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 4567999999999999999999843 3468999988653211 3345567
Q ss_pred ceEEEEEeccCCChHHHhccC-------------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC
Q 041438 547 QSFIVYEYLESGSLDKILNND-------------ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD 613 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~ 613 (752)
..++||||+++|+|.+++... .....+++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 789999999999999998643 1234588999999999999999999999 999999999999999
Q ss_pred CCCceEEeecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccc
Q 041438 614 LGYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSS 690 (752)
Q Consensus 614 ~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~ 690 (752)
+++.+||+|||.++........ .....++..|+|||++.+..++.++|||||||++||+++ |..||... ...
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~~ 241 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-----PVE 241 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC-----CHH
Confidence 9999999999999876432211 112234568999999988889999999999999999997 99997421 111
Q ss_pred cchHhhhccC-CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 691 NMNIEILDSR-LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 691 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
+......... ...+ ...+..+.+++.+||+.||++|||++|++++|+.+.
T Consensus 242 ~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 ELFKLLKEGYRMEKP----QNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHHcCCcCCCC----CCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111111111 1111 234557889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=305.48 Aligned_cols=228 Identities=21% Similarity=0.295 Sum_probs=175.1
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~ 552 (752)
++|++.++||+|+||.||+++. .+++.||+|++.+.... ..+......|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4799999999999999999995 46788999987531100 2345667889999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++|+|.+++.+.. ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 9999999999997532 2478899999999999999999999 9999999999999999999999999999765433
Q ss_pred CCC-cccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccC--CCCC
Q 041438 633 SSN-WSKLAGTHGNVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR--LPYP 704 (752)
Q Consensus 633 ~~~-~~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~ 704 (752)
... .....||+.|+|||++. ...++.++|||||||++|||++|+.||... ........+.... .+.+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~-----~~~~~~~~i~~~~~~~~~p 230 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVETYGKIMNHKERFQFP 230 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC-----CHHHHHHHHhCCCccccCC
Confidence 222 22357999999999886 345789999999999999999999998521 1122222232222 2222
Q ss_pred ChhhHHHHHHHHHHHHhccCcCCCC--CCCHHHHHHH
Q 041438 705 SLDVQNKFMSIMQVAFSCLDQNPVS--RPTMKRFEVQ 739 (752)
Q Consensus 705 ~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 739 (752)
. .....++++.+++.+|+..++++ |++++|+++|
T Consensus 231 ~-~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 231 A-QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred C-ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 2 11345667889999988655444 6899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=295.65 Aligned_cols=227 Identities=25% Similarity=0.351 Sum_probs=179.9
Q ss_pred hcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEe
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~ 554 (752)
..+|++.+.||.|+||.||+|. ..+++.||+|.+...... +++...+..|+||||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 3469999999999999999998 467999999987543221 344556789999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++++|.+++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 98 LAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred cCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 9999999988643 378999999999999999999999 999999999999999999999999999887654333
Q ss_pred CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 635 NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
......++..|+|||.+.+..++.++|||||||++|++++|+.||.... .......+.....+.. ......++.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~-----~~~~~~~~~~~~~~~~-~~~~~~~~~ 244 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN-----PLRALYLIATNGTPEL-QNPEKLSPI 244 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcCCccc-CCcccCCHH
Confidence 3334578899999999988889999999999999999999999985211 1111111111111110 011334567
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+.++|.+||..||++||++.+++++
T Consensus 245 ~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 245 FRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHHHHHHhhcChhhCCCHHHHhhC
Confidence 8899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=293.35 Aligned_cols=226 Identities=22% Similarity=0.292 Sum_probs=175.5
Q ss_pred cccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEe
Q 041438 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~ 554 (752)
++|++.+.||+|+||.||+|+ ..+++.||+|.+...... +.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 468889999999999999998 467899999987543211 344556778999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
++++++..+. .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999987542 267788999999999999999999 9999999999999999999999999999865432
Q ss_pred CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccccc--ccchHhhhccCCCCCChhhHHHH
Q 041438 635 NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS--SNMNIEILDSRLPYPSLDVQNKF 712 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 712 (752)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||.......... ......+.+...+.. .....+
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 226 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL--PVGQFS 226 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC--CCCcCC
Confidence 2234578999999999998889999999999999999999999986322111111 011111111111111 112345
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
+++.+++.+|++.||++||+++|++++-
T Consensus 227 ~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 227 EKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred HHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 5788999999999999999999999774
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=293.60 Aligned_cols=229 Identities=25% Similarity=0.345 Sum_probs=176.6
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEe
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~ 554 (752)
.++|++.+.||+|+||.||+|+. .+++.||+|.++..... +.+...+..|+||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 45788999999999999999984 57899999987643211 233456788999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++++|.+++...+ .+++.++..++.|++.|++|||+. +++|+||||+||+++.++.+||+|||.+........
T Consensus 88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 88 CGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 99999999986543 478899999999999999999999 999999999999999999999999999987653333
Q ss_pred CcccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCC-hhhHH
Q 041438 635 NWSKLAGTHGNVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPS-LDVQN 710 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 710 (752)
......|+..|+|||++. ...++.++||||+||++|+|++|+.||.... ...............+. .....
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH-----PMRALFLMTKSNFQPPKLKDKMK 236 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc-----chhhHHhhhccCCCCCcccccCC
Confidence 333457899999999874 4558899999999999999999999974211 11111111111111110 01112
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+..+.+++.+|++.||++||+++++++|
T Consensus 237 ~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 237 WSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 34568899999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.81 Aligned_cols=232 Identities=18% Similarity=0.204 Sum_probs=173.3
Q ss_pred HhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Ccc------cc
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFC------SH 544 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~------~~ 544 (752)
...++|++.+.||+|+||.||+|+. .+++.||||++...... +++ ..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3467899999999999999999984 57899999988654221 111 12
Q ss_pred CCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecc
Q 041438 545 PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFR 624 (752)
Q Consensus 545 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG 624 (752)
....|+||||+++ ++.+.+.. .+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 2357999999976 67766642 377889999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccc----------cc----
Q 041438 625 IAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------SS---- 690 (752)
Q Consensus 625 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~----------~~---- 690 (752)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..
T Consensus 165 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 165 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred ccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99865432 2233457899999999999989999999999999999999999998532110000 00
Q ss_pred ---cchHhhhccCCC----------------CCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 691 ---NMNIEILDSRLP----------------YPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 691 ---~~~~~~~~~~~~----------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
............ ...........++.+++.+|++.||++|||++|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000001110000 0000011123567899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=295.37 Aligned_cols=231 Identities=16% Similarity=0.246 Sum_probs=178.9
Q ss_pred cccccceeeccCCceEEEEEEeC------CCcEEEEEccCCCCCC-------------------------CccccCCceE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVP------SGEIFAVKKFHSPLPD-------------------------NFCSHPRQSF 549 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~ 549 (752)
.+|++.+.||+|+||.||+|+.. +++.||+|+++..... +++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45788899999999999999842 3578999998754321 2344556789
Q ss_pred EEEEeccCCChHHHhccCc-------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC
Q 041438 550 IVYEYLESGSLDKILNNDA-------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY 616 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~ 616 (752)
+++||+.+++|.+++.... ....+++..+..++.|++.||+|+|++ +|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985321 123478888999999999999999999 999999999999999999
Q ss_pred ceEEeecccceeccCCCC--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccch
Q 041438 617 EAHVSDFRIAKFLNLDSS--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMN 693 (752)
Q Consensus 617 ~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~ 693 (752)
.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||... ...+..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-----~~~~~~ 236 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY-----SNQDVI 236 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-----CHHHHH
Confidence 999999999886543221 1122356779999999988889999999999999999998 88887521 112223
Q ss_pred HhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 694 IEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
..+........ ....+..+.+++.+||+.+|++||+++|+++.|+.
T Consensus 237 ~~i~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRNRQVLPC---PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHcCCcCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 33333322111 13456678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=295.69 Aligned_cols=234 Identities=19% Similarity=0.267 Sum_probs=175.3
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEe
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~ 554 (752)
+|++.+.||+|++|.||+|+. .+++.||+|+++..... +++..+...|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 588899999999999999995 57899999987643211 344566788999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
++ ++|.+++........+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 98 58988887654445689999999999999999999999 999999999999999999999999999986654333
Q ss_pred CcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhcccc----------ccccc---hH--hhhc
Q 041438 635 NWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------SSSNM---NI--EILD 698 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~----------~~~~~---~~--~~~~ 698 (752)
......+++.|+|||++.+. .++.++|||||||++|||+||+.||........ ..... .. ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 33334678899999987654 478999999999999999999999853211000 00000 00 0000
Q ss_pred cCCC---CC--ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 699 SRLP---YP--SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 699 ~~~~---~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...+ .. .......++++.+++.+||+.||++|||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000 00 00011245678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=289.04 Aligned_cols=227 Identities=25% Similarity=0.346 Sum_probs=178.2
Q ss_pred cccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC----------------------Cc-cccCCceEEEEEeccC
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD----------------------NF-CSHPRQSFIVYEYLES 557 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~-~~~~~~~~lV~E~~~~ 557 (752)
++|++.+.||+|+||.||+|.. .|+.||+|.++..... ++ .......++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 5789999999999999999976 4788999988654221 12 2344678999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|||.+....... .
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~ 157 (256)
T cd05082 85 GSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---D 157 (256)
T ss_pred CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---C
Confidence 999999876442 3478899999999999999999999 99999999999999999999999999988654322 2
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHH
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIM 716 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 716 (752)
...++..|+|||++.+..++.++|||||||++|||++ |+.||... ........+ ....... .....++.+.
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~-~~~~~~~--~~~~~~~~~~ 229 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRV-EKGYKMD--APDGCPPVVY 229 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHH-hcCCCCC--CCCCCCHHHH
Confidence 2345668999999988889999999999999999997 99997521 111111111 1111111 1134566789
Q ss_pred HHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 717 QVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 717 ~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
+++.+|++.+|++|||+++++++|+++
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=289.65 Aligned_cols=229 Identities=20% Similarity=0.323 Sum_probs=176.3
Q ss_pred cccceeeccCCceEEEEEEeC----CCcEEEEEccCCCCCC--------------------------CccccC------C
Q 041438 503 FDAKHCIGKGGHGSVYIARVP----SGEIFAVKKFHSPLPD--------------------------NFCSHP------R 546 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--------------------------~~~~~~------~ 546 (752)
|++.+.||+|+||.||+|... .+..||+|+++..... +++... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567899999999999999843 2478999988754221 112121 2
Q ss_pred ceEEEEEeccCCChHHHhccCc---cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeec
Q 041438 547 QSFIVYEYLESGSLDKILNNDA---SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDF 623 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~Df 623 (752)
..++||||+++|+|..++.... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 3789999999999999885432 223588999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCCCc--ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccC
Q 041438 624 RIAKFLNLDSSNW--SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSR 700 (752)
Q Consensus 624 G~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 700 (752)
|.++......... ....++..|+|||.+.+..++.++|||||||++|||++ |..||... ...+....+....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~-----~~~~~~~~~~~~~ 232 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV-----ENHEIYDYLRHGN 232 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHcCC
Confidence 9998765332211 11235678999999988889999999999999999999 88998521 1112222222222
Q ss_pred C-CCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 701 L-PYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 701 ~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
. ..+ ...+.++.+++.+||+.||++||++.|++++|+++
T Consensus 233 ~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 RLKQP----EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCC----cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 122 34556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.51 Aligned_cols=228 Identities=22% Similarity=0.314 Sum_probs=173.8
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC---------------------------CCccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP---------------------------DNFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------------------------~~~~~~~~~~~lV~ 552 (752)
++|++.+.||+|+||.||+++. .+++.||+|++.+... ...+......|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4799999999999999999994 5689999998753110 03345667899999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++|+|.+++.+.. ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999997532 3478899999999999999999999 9999999999999999999999999999776433
Q ss_pred CCC-cccccCCCCccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccC--CCCC
Q 041438 633 SSN-WSKLAGTHGNVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR--LPYP 704 (752)
Q Consensus 633 ~~~-~~~~~gt~~y~aPE~~~~-----~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~ 704 (752)
... .....||+.|+|||++.. ..++.++||||+||++|||++|+.||... ...+....+.... ...+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~-----~~~~~~~~i~~~~~~~~~~ 230 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVETYGKIMNHKEHFQFP 230 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC-----CHHHHHHHHHcCCCcccCC
Confidence 322 223469999999999863 45788999999999999999999998521 1111222222211 2222
Q ss_pred ChhhHHHHHHHHHHHHhccCcCCC--CCCCHHHHHHH
Q 041438 705 SLDVQNKFMSIMQVAFSCLDQNPV--SRPTMKRFEVQ 739 (752)
Q Consensus 705 ~~~~~~~~~~l~~li~~cl~~dP~--~Rps~~evl~~ 739 (752)
. .....+..+.+++.+|+..+++ .||+++++++|
T Consensus 231 ~-~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 231 P-DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred C-ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1 1123456788899998865443 37899999887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=287.46 Aligned_cols=230 Identities=21% Similarity=0.309 Sum_probs=179.8
Q ss_pred cccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC----------------------CccccCCceEEEEEeccCC
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD----------------------NFCSHPRQSFIVYEYLESG 558 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~~~~lV~E~~~~g 558 (752)
++|++.+.||+|+||.||+|....+..+|+|.+...... ..+......++||||++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~ 85 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKG 85 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCCC
Confidence 568999999999999999999777778999987653221 0112345678999999999
Q ss_pred ChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC-cc
Q 041438 559 SLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN-WS 637 (752)
Q Consensus 559 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~ 637 (752)
+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+......... ..
T Consensus 86 ~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05069 86 SLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred CHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccC
Confidence 9999997543 23478899999999999999999999 9999999999999999999999999999876432211 11
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHH
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIM 716 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 716 (752)
...++..|+|||...+..++.++|||||||++|||+| |+.||... ........+.. ....+ .....+..+.
T Consensus 162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-----~~~~~~~~~~~-~~~~~--~~~~~~~~~~ 233 (260)
T cd05069 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-----VNREVLEQVER-GYRMP--CPQGCPESLH 233 (260)
T ss_pred CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHc-CCCCC--CCcccCHHHH
Confidence 2345678999999988889999999999999999999 89998521 11112222221 21111 1134566789
Q ss_pred HHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 717 QVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 717 ~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
+++.+||++||++||+++++.+.|++
T Consensus 234 ~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 234 ELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHccCCcccCcCHHHHHHHHhc
Confidence 99999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=304.85 Aligned_cols=228 Identities=23% Similarity=0.314 Sum_probs=175.5
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~ 552 (752)
++|++.+.||+|+||.||+++. .+++.||+|.+.+.... .++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5799999999999999999994 57889999987542100 2345677899999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++|+|.+++.... ..+++..+..++.|++.||+|+|++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999997532 3478899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCc-ccccCCCCccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhcc--CCCCC
Q 041438 633 SSNW-SKLAGTHGNVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS--RLPYP 704 (752)
Q Consensus 633 ~~~~-~~~~gt~~y~aPE~~~~-----~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~ 704 (752)
.... ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||... ...+....+... +.+.+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~-----~~~~~~~~i~~~~~~~~~p 230 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVETYGKIMNHEERFQFP 230 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC-----CHHHHHHHHHcCCCcccCC
Confidence 3221 23479999999998875 45788999999999999999999998521 111222222222 22222
Q ss_pred ChhhHHHHHHHHHHHHhccCcCCCC--CCCHHHHHHH
Q 041438 705 SLDVQNKFMSIMQVAFSCLDQNPVS--RPTMKRFEVQ 739 (752)
Q Consensus 705 ~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 739 (752)
. .....+.++.+++.+|+..++++ |++++++++|
T Consensus 231 ~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 231 S-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred C-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 2 11234567889999999876544 4688888766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=300.61 Aligned_cols=234 Identities=21% Similarity=0.317 Sum_probs=177.6
Q ss_pred hcccccceeeccCCceEEEEEEe------CCCcEEEEEccCCCCCC--------------------------Ccc-ccCC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV------PSGEIFAVKKFHSPLPD--------------------------NFC-SHPR 546 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--------------------------~~~-~~~~ 546 (752)
.++|++.+.||+|+||.||+|+. .+++.||||+++..... +++ ....
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46899999999999999999973 35789999998653211 112 2234
Q ss_pred ceEEEEEeccCCChHHHhccCcc---------------------------------------------------------
Q 041438 547 QSFIVYEYLESGSLDKILNNDAS--------------------------------------------------------- 569 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~--------------------------------------------------------- 569 (752)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999864311
Q ss_pred -------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC--ccccc
Q 041438 570 -------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN--WSKLA 640 (752)
Q Consensus 570 -------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~ 640 (752)
...+++.++..++.|+++||+|||++ +|+||||||+||++++++.+||+|||++......... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 12367888899999999999999999 9999999999999999999999999999865332211 11234
Q ss_pred CCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc-CCCCCChhhHHHHHHHHHH
Q 041438 641 GTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RLPYPSLDVQNKFMSIMQV 718 (752)
Q Consensus 641 gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l 718 (752)
++..|+|||.+.+..++.++|||||||++|||++ |..||.... ........+... ....+ ...++++.++
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 314 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK----IDEEFCRRLKEGTRMRAP----DYTTPEMYQT 314 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc----ccHHHHHHHhccCCCCCC----CCCCHHHHHH
Confidence 5678999999988889999999999999999997 999985211 111111111111 11112 1234568899
Q ss_pred HHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 719 AFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 719 i~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
+.+||+.||++|||+.|++++|+.+.
T Consensus 315 ~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 315 MLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=294.40 Aligned_cols=238 Identities=23% Similarity=0.341 Sum_probs=182.7
Q ss_pred chHHHHHHhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------Ccc---
Q 041438 491 IVYEEIIRATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFC--- 542 (752)
Q Consensus 491 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~--- 542 (752)
.+..++..+.+.|++.+.||+|+||.||+|+. .+++.||+|.+...... +++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45566667789999999999999999999994 57899999987543211 111
Q ss_pred ---ccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceE
Q 041438 543 ---SHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAH 619 (752)
Q Consensus 543 ---~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~k 619 (752)
......|+||||+++|+|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 124567999999999999999875432 3477888999999999999999999 999999999999999999999
Q ss_pred EeecccceeccCCCCCcccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchH
Q 041438 620 VSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI 694 (752)
Q Consensus 620 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~ 694 (752)
|+|||.+..............|++.|+|||.+. +..++.++|||||||++|||++|+.||.... ......
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~-----~~~~~~ 236 (282)
T cd06636 162 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH-----PMRALF 236 (282)
T ss_pred EeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC-----HHhhhh
Confidence 999999886543333334457899999999876 3457889999999999999999999985211 111111
Q ss_pred hhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 695 EILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+.... .+.......+.++.++|.+||..||.+||++.|++++
T Consensus 237 ~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 237 LIPRNP--PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hHhhCC--CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 111111 1111123456689999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=297.11 Aligned_cols=236 Identities=21% Similarity=0.297 Sum_probs=181.1
Q ss_pred hcccccceeeccCCceEEEEEEeC--------CCcEEEEEccCCCCCC--------------------------CccccC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP--------SGEIFAVKKFHSPLPD--------------------------NFCSHP 545 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--------------------------~~~~~~ 545 (752)
.++|.+.+.||+|+||.||+|+.. ++..||+|.++..... +++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467999999999999999999742 2357999998754211 234456
Q ss_pred CceEEEEEeccCCChHHHhccCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe
Q 041438 546 RQSFIVYEYLESGSLDKILNNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL 612 (752)
Q Consensus 546 ~~~~lV~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll 612 (752)
...|+||||+++|+|.+++..... ...+++.++..++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 778999999999999999976432 12478899999999999999999999 99999999999999
Q ss_pred CCCCceEEeecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhcccccc
Q 041438 613 DLGYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSS 689 (752)
Q Consensus 613 ~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~ 689 (752)
++++.+||+|||.++........ .....++..|+|||++.+..++.++|||||||++|||++ |..||... ..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-----~~ 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-----PV 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-----CH
Confidence 99999999999999765422111 111234568999999988889999999999999999998 88887421 11
Q ss_pred ccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 690 SNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
.+.... ........ .....+.++.+++.+||..+|++||++.++++.|+++...
T Consensus 249 ~~~~~~-~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 249 EELFKL-LKEGHRMD--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHH-HHcCCCCC--CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 111112 12221111 1123456788999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=293.87 Aligned_cols=233 Identities=21% Similarity=0.287 Sum_probs=180.0
Q ss_pred hhcccccceeeccCCceEEEEEEeC------CCcEEEEEccCCCCCC-------------------------CccccCCc
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP------SGEIFAVKKFHSPLPD-------------------------NFCSHPRQ 547 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-------------------------~~~~~~~~ 547 (752)
..++|++.+.||+|+||.||+|... .+..||+|.+...... +++.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999742 2458999987543211 33455677
Q ss_pred eEEEEEeccCCChHHHhccCcc-------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEE
Q 041438 548 SFIVYEYLESGSLDKILNNDAS-------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV 620 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl 620 (752)
.++||||+++|+|.+++..... ...+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 8999999999999999975321 23456778899999999999999999 9999999999999999999999
Q ss_pred eecccceeccCCCCCc--ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhh
Q 041438 621 SDFRIAKFLNLDSSNW--SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEIL 697 (752)
Q Consensus 621 ~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 697 (752)
+|||+++......... ....++..|+|||.+.+..++.++|||||||++|||++ |+.||... ..++....+.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~-----~~~~~~~~~~ 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL-----SNEQVLKFVM 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHH
Confidence 9999998654322111 12245678999999988889999999999999999998 78887521 1122222222
Q ss_pred ccCC-CCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 698 DSRL-PYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 698 ~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
+... ..+ ...++.+.+++.+|++.||++|||+.++++.+++.
T Consensus 236 ~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 236 DGGYLDQP----DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred cCCCCCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 2222 111 23356799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=294.26 Aligned_cols=232 Identities=23% Similarity=0.330 Sum_probs=176.2
Q ss_pred cccccceeeccCCceEEEEEEeC-CCc--EEEEEccCCCCCC--------------------------CccccCCceEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVP-SGE--IFAVKKFHSPLPD--------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~--------------------------~~~~~~~~~~lV 551 (752)
++|++.+.||+|+||.||+|+.. ++. .+|+|.++..... +++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 67999999999999999999853 343 4688877632111 233445668999
Q ss_pred EEeccCCChHHHhccCc-------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCce
Q 041438 552 YEYLESGSLDKILNNDA-------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEA 618 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~ 618 (752)
|||+++++|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999996532 113478899999999999999999999 99999999999999999999
Q ss_pred EEeecccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhh
Q 041438 619 HVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEIL 697 (752)
Q Consensus 619 kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 697 (752)
||+|||++....... .......+..|+|||+..+..++.++|||||||++|||++ |..||... ........+.
T Consensus 159 kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~-----~~~~~~~~~~ 232 (297)
T cd05089 159 KIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM-----TCAELYEKLP 232 (297)
T ss_pred EECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHh
Confidence 999999986432111 1111233557999999988889999999999999999997 99998521 1111122222
Q ss_pred ccC-CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 698 DSR-LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 698 ~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
... ...+ ...+..+.+++.+||+.+|.+||+++++++.|+.+..
T Consensus 233 ~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 233 QGYRMEKP----RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred cCCCCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111 1111 2345678899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=292.15 Aligned_cols=232 Identities=23% Similarity=0.306 Sum_probs=177.7
Q ss_pred hhcccccceeeccCCceEEEEEEeC------CCcEEEEEccCCCCCC-------------------------CccccCCc
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP------SGEIFAVKKFHSPLPD-------------------------NFCSHPRQ 547 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-------------------------~~~~~~~~ 547 (752)
..++|++.+.||+|+||.||+|... .+..||+|.+...... +++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3567999999999999999999853 4678999987643211 33445667
Q ss_pred eEEEEEeccCCChHHHhccCcc----ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC---ceEE
Q 041438 548 SFIVYEYLESGSLDKILNNDAS----AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY---EAHV 620 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~---~~kl 620 (752)
.++||||+++++|.+++..... ...+++..+..++.||+.|++|||+. +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 8999999999999999976432 12488999999999999999999999 999999999999998654 5999
Q ss_pred eecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhh
Q 041438 621 SDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEIL 697 (752)
Q Consensus 621 ~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 697 (752)
+|||+++........ ......+..|+|||++.+..++.++|||||||++|||++ |+.||+.. ........+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~-----~~~~~~~~~~ 235 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR-----TNQEVMEFVT 235 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHH
Confidence 999999876322111 111233567999999998889999999999999999997 99998521 1111111121
Q ss_pred cc-CCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 698 DS-RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 698 ~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
.. +...+ ...+..+.+++.+|++.+|++||++.+++++|++
T Consensus 236 ~~~~~~~~----~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 236 GGGRLDPP----KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred cCCcCCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 11 11122 2345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=288.34 Aligned_cols=226 Identities=22% Similarity=0.262 Sum_probs=178.4
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------------CccccCCceEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------------NFCSHPRQSFI 550 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------------~~~~~~~~~~l 550 (752)
++|++.+.||+|++|.||+|.. .+++.||+|.++..... +++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999984 57899999987533210 34456678999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||.++...
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999987543 378899999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCc---ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChh
Q 041438 631 LDSSNW---SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLD 707 (752)
Q Consensus 631 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (752)
...... ....++..|+|||++.+..++.++||||+||++|||++|+.||... ................. .
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-----~~~~~~~~~~~~~~~~~--~ 228 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF-----EAMAAIFKIATQPTNPQ--L 228 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc-----chHHHHHHHhccCCCCC--C
Confidence 322111 2346788999999999988999999999999999999999998521 11111111111111111 1
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.......+.+++.+||..+|++|||+.|++++
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 229 PSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 13355678899999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=304.42 Aligned_cols=231 Identities=22% Similarity=0.287 Sum_probs=171.5
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCC-----ceE
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPR-----QSF 549 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~-----~~~ 549 (752)
+|++.+.||+|+||.||+|+. .+++.||||++...... +++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 578899999999999999994 57999999988643211 2222333 689
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+||||+.+ +|.+.+... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 81 lv~e~~~~-~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQS-DLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeecccc-CHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 99999975 888877543 3488899999999999999999999 9999999999999999999999999999875
Q ss_pred cCCCC-CcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhcccc----------cccc------
Q 041438 630 NLDSS-NWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------SSSN------ 691 (752)
Q Consensus 630 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~----------~~~~------ 691 (752)
..... ......+++.|+|||++.+. .++.++||||+||++|||++|+.||........ ....
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 43322 22334688999999998774 478999999999999999999999853211000 0000
Q ss_pred --chHhhhccCCCCCCh-----hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 692 --MNIEILDSRLPYPSL-----DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 692 --~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
....+.......+.. .....++++.+++.+||+.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000111111100 001234578899999999999999999999976
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=275.01 Aligned_cols=231 Identities=22% Similarity=0.329 Sum_probs=181.3
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~ 552 (752)
.++.+....||.|+.|.|++++. .+|...|||.+.+.... +++..+..+++.|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 45566678899999999999994 56899999998764322 3444455566667
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
|.|.. .++.+++.-. +++++.-+-++...+++||.||.+++ +|+|||+||+|||+|+.|++|+||||++..+.+.
T Consensus 171 elMs~-C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHH-HHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 77754 5666665433 45788888899999999999999887 9999999999999999999999999999887644
Q ss_pred CCCcccccCCCCccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 633 SSNWSKLAGTHGNVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
. ..+...|-+.|||||.+.- .+|+.++||||||++++|++||+.||. ......+....+++...+... ...
T Consensus 246 k-AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~----~c~tdFe~ltkvln~ePP~L~-~~~ 319 (391)
T KOG0983|consen 246 K-AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYK----GCKTDFEVLTKVLNEEPPLLP-GHM 319 (391)
T ss_pred c-ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCC----CCCccHHHHHHHHhcCCCCCC-ccc
Confidence 3 3345689999999998763 458899999999999999999999985 233344556666665544222 223
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHHHh
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 741 (752)
..++++.+++..||.+|+.+||...++++|=-
T Consensus 320 gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F 351 (391)
T KOG0983|consen 320 GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPF 351 (391)
T ss_pred CcCHHHHHHHHHHhhcCcccCcchHHHhcCcc
Confidence 47788999999999999999999999998743
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=286.65 Aligned_cols=223 Identities=21% Similarity=0.354 Sum_probs=172.2
Q ss_pred eeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEeccCCCh
Q 041438 507 HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEYLESGSL 560 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~~~~g~L 560 (752)
+.||+|+||.||+|+. .+++.||+|.+...... +++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999985 57999999987643221 345566788999999999999
Q ss_pred HHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc--cc
Q 041438 561 DKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW--SK 638 (752)
Q Consensus 561 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~--~~ 638 (752)
.+++.... ..+++.+++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.+.......... ..
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 99987543 3478899999999999999999999 99999999999999999999999999987644221111 11
Q ss_pred ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHH
Q 041438 639 LAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717 (752)
Q Consensus 639 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 717 (752)
..++..|+|||.+.+..++.++|||||||++|||++ |..||.... ... ...........+. ....+..+.+
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~-----~~~-~~~~~~~~~~~~~--~~~~~~~~~~ 227 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS-----NQQ-TREAIEQGVRLPC--PELCPDAVYR 227 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC-----HHH-HHHHHHcCCCCCC--cccCCHHHHH
Confidence 123456999999988889999999999999999998 888875211 111 1111111111111 1234567899
Q ss_pred HHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 718 VAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 718 li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
++.+|++.||++|||++|+.+.|++
T Consensus 228 li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 228 LMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHhC
Confidence 9999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=287.38 Aligned_cols=221 Identities=25% Similarity=0.355 Sum_probs=172.9
Q ss_pred eeccCCceEEEEEEe---CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEeccCC
Q 041438 508 CIGKGGHGSVYIARV---PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEYLESG 558 (752)
Q Consensus 508 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~~~~g 558 (752)
.||+|+||.||+|.+ .+++.||+|+++..... +++ ..+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEE-cCCCcEEEEecCCCC
Confidence 589999999999963 46789999988644321 122 245678999999999
Q ss_pred ChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc--
Q 041438 559 SLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW-- 636 (752)
Q Consensus 559 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~-- 636 (752)
+|.+++.... .+++..+..++.|++.|++|+|+. +|+||||||+||++++++.+||+|||.+..........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999996543 478899999999999999999999 99999999999999999999999999998765332211
Q ss_pred -ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccC-CCCCChhhHHHHH
Q 041438 637 -SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSR-LPYPSLDVQNKFM 713 (752)
Q Consensus 637 -~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 713 (752)
....++..|+|||.+....++.++|||||||++|||++ |+.||.... .......+.... .+.+ ...+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~i~~~~~~~~~----~~~~~ 225 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK-----GNEVTQMIESGERMECP----QRCPP 225 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHCCCCCCCC----CCCCH
Confidence 12234578999999988889999999999999999998 999985211 111122222211 1222 23556
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
++.++|.+||+.||++||++++|.+.|+++-
T Consensus 226 ~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05116 226 EMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256 (257)
T ss_pred HHHHHHHHHhccCchhCcCHHHHHHHHhccc
Confidence 7899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=295.04 Aligned_cols=236 Identities=20% Similarity=0.312 Sum_probs=181.9
Q ss_pred hhcccccceeeccCCceEEEEEEe--------CCCcEEEEEccCCCCCC--------------------------Ccccc
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV--------PSGEIFAVKKFHSPLPD--------------------------NFCSH 544 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~--------------------------~~~~~ 544 (752)
..++|++.+.||+|+||.||+|+. .++..||+|.++..... +++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 456889999999999999999973 13457999988643211 33445
Q ss_pred CCceEEEEEeccCCChHHHhccCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEE
Q 041438 545 PRQSFIVYEYLESGSLDKILNNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVL 611 (752)
Q Consensus 545 ~~~~~lV~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIl 611 (752)
....|+||||+++|+|.+++..... ...+++.++..++.||+.||+|||+. ||+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 6778999999999999999976421 13478889999999999999999999 9999999999999
Q ss_pred eCCCCceEEeecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccc
Q 041438 612 LDLGYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSS 688 (752)
Q Consensus 612 l~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~ 688 (752)
+++++.+||+|||.++........ .....++..|+|||++.+..++.++|||||||++||+++ |..||... .
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-----~ 244 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-----P 244 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-----C
Confidence 999999999999999876432221 122345678999999988889999999999999999998 78887421 1
Q ss_pred cccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 689 SSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
..+....+... .... ....++..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 245 ~~~~~~~~~~~-~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 245 VEELFKLLKEG-HRMD--KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHHHHHHHcC-CcCC--CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 11112222111 1111 112445678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=294.53 Aligned_cols=240 Identities=23% Similarity=0.300 Sum_probs=182.5
Q ss_pred chHHHHHHhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------Ccccc-
Q 041438 491 IVYEEIIRATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSH- 544 (752)
Q Consensus 491 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~- 544 (752)
+.++++..++++|++.+.||+|+||.||+|.. .+++.||+|.+...... +++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 45567777899999999999999999999995 57899999988542111 11211
Q ss_pred ----CCceEEEEEeccCCChHHHhccCc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceE
Q 041438 545 ----PRQSFIVYEYLESGSLDKILNNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAH 619 (752)
Q Consensus 545 ----~~~~~lV~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~k 619 (752)
....++||||+++++|.++++... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 245899999999999999886422 224588999999999999999999999 999999999999999999999
Q ss_pred EeecccceeccCCCCCcccccCCCCccCccccccC-----CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchH
Q 041438 620 VSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI 694 (752)
Q Consensus 620 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~ 694 (752)
|+|||.+..............|+..|+|||++... .++.++|||||||++|||++|+.||.... ......
T Consensus 169 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~-----~~~~~~ 243 (291)
T cd06639 169 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH-----PVKTLF 243 (291)
T ss_pred EeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc-----HHHHHH
Confidence 99999988765333233345788999999987643 26889999999999999999999985211 111111
Q ss_pred hhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 695 EILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+.....+. ..........+.++|.+||+.||++||++.|+++|
T Consensus 244 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 KIPRNPPPT-LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHhcCCCCC-CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111111110 00112344578899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=295.82 Aligned_cols=227 Identities=24% Similarity=0.339 Sum_probs=179.8
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEe
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~ 554 (752)
..+|++.+.||+|+||.||+|+. .+++.||+|.+...... +++...+..|+||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46799999999999999999994 67999999988643221 344566789999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++++|.+++.+. .+++.++..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||.+........
T Consensus 98 ~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 9999999998643 378889999999999999999999 999999999999999999999999999987654433
Q ss_pred CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 635 NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
......+++.|+|||...+..++.++|||||||++|++++|+.||..... ......+.....+. .......+..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~-----~~~~~~~~~~~~~~-~~~~~~~~~~ 244 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-----LRALYLIATNGTPE-LQNPERLSAV 244 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc-----chheeeeccCCCCC-CCCccccCHH
Confidence 33345788999999999988899999999999999999999999852111 11111111111111 0011334566
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+.+++.+||+.||++||++++++++
T Consensus 245 ~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 245 FRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 8899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=291.37 Aligned_cols=231 Identities=21% Similarity=0.294 Sum_probs=180.5
Q ss_pred hcccccceeeccCCceEEEEEEeC------CCcEEEEEccCCCCCC-------------------------CccccCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP------SGEIFAVKKFHSPLPD-------------------------NFCSHPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-------------------------~~~~~~~~~ 548 (752)
.++|++.+.||+|+||.||+|... ++..||+|.+...... +++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 467899999999999999999843 3478999998644321 344556788
Q ss_pred EEEEEeccCCChHHHhccCcc-------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEe
Q 041438 549 FIVYEYLESGSLDKILNNDAS-------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVS 621 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~ 621 (752)
++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 999999999999999875332 12367889999999999999999999 99999999999999999999999
Q ss_pred ecccceeccCCCC--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhc
Q 041438 622 DFRIAKFLNLDSS--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILD 698 (752)
Q Consensus 622 DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 698 (752)
|||.++....... ......++..|+|||.+.+..++.++|||||||++||++| |+.||.. .........+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-----~~~~~~~~~~~~ 236 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-----LSNEEVLKFVID 236 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-----CCHHHHHHHHhc
Confidence 9999976543221 1122356788999999988889999999999999999998 9999842 111222222222
Q ss_pred cC-CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 699 SR-LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 699 ~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
.. ...+ ...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 237 ~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 237 GGHLDLP----ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCCCCC----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 21 1222 2235678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=299.66 Aligned_cols=233 Identities=20% Similarity=0.261 Sum_probs=173.4
Q ss_pred HHHhhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------Ccc------
Q 041438 496 IIRATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFC------ 542 (752)
Q Consensus 496 ~~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~------ 542 (752)
.....++|++.+.||+|+||.||+|+ ..+++.||||++...... +++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 33456889999999999999999998 457889999988653211 111
Q ss_pred ccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEee
Q 041438 543 SHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSD 622 (752)
Q Consensus 543 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~D 622 (752)
......|++||++ +++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcC
Confidence 1124578999988 66998887643 388999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccc----------ccccc
Q 041438 623 FRIAKFLNLDSSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS----------SSSSN 691 (752)
Q Consensus 623 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~----------~~~~~ 691 (752)
||+++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....... .....
T Consensus 162 fg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 162 FGLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238 (343)
T ss_pred CccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999875432 234578999999999876 468999999999999999999999985211100 00000
Q ss_pred --------chHhhhccCCCCCChh----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 692 --------MNIEILDSRLPYPSLD----VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 692 --------~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
............+... .....+.+.+++.+|++.||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000011000 01123457899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=297.19 Aligned_cols=171 Identities=20% Similarity=0.329 Sum_probs=137.1
Q ss_pred ceeeccCCceEEEEEEeC---CCcEEEEEccCCCCCC----------------------Ccc--ccCCceEEEEEeccCC
Q 041438 506 KHCIGKGGHGSVYIARVP---SGEIFAVKKFHSPLPD----------------------NFC--SHPRQSFIVYEYLESG 558 (752)
Q Consensus 506 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~----------------------~~~--~~~~~~~lV~E~~~~g 558 (752)
.++||+|+||.||+|+.. +++.||+|.+...... +.+ ......++||||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-
Confidence 468999999999999853 5689999988653221 111 224567899999975
Q ss_pred ChHHHhccCc------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe----CCCCceEEeeccccee
Q 041438 559 SLDKILNNDA------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL----DLGYEAHVSDFRIAKF 628 (752)
Q Consensus 559 ~L~~~l~~~~------~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll----~~~~~~kl~DfG~a~~ 628 (752)
+|.+++.... ....+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+|+.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 8888875321 123488899999999999999999999 99999999999999 4567899999999987
Q ss_pred ccCCCC---CcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcc
Q 041438 629 LNLDSS---NWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRD 680 (752)
Q Consensus 629 ~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~ 680 (752)
...... ......||+.|+|||++.+. .++.++||||+||++|||++|++||.
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 653321 22345789999999998764 58999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=287.99 Aligned_cols=229 Identities=20% Similarity=0.295 Sum_probs=173.0
Q ss_pred cccceeeccCCceEEEEEEeCC-Cc--EEEEEccCCCCCC--------------------------Cccc------cCCc
Q 041438 503 FDAKHCIGKGGHGSVYIARVPS-GE--IFAVKKFHSPLPD--------------------------NFCS------HPRQ 547 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~--------------------------~~~~------~~~~ 547 (752)
|.+.+.||+|+||.||+|+... ++ .||+|.++..... +++. ....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999998543 33 6899987543211 1111 1124
Q ss_pred eEEEEEeccCCChHHHhccCc---cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecc
Q 041438 548 SFIVYEYLESGSLDKILNNDA---SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFR 624 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG 624 (752)
.++||||+++|+|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874321 223478999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCC
Q 041438 625 IAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRL 701 (752)
Q Consensus 625 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 701 (752)
.++........ .....+++.|+|||+..+..++.++|||||||++|||++ |+.||... ........+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~~~~~~~~~~~~~ 232 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV-----ENSEIYDYLRQGNR 232 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHHcCCC
Confidence 99876433211 112245678999999998889999999999999999999 88998521 11112222222221
Q ss_pred -CCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 702 -PYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 702 -~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
+.+ ...+..+.+++.+||+.||++|||+.+++++|+++
T Consensus 233 ~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 LKQP----PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 23455688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=314.64 Aligned_cols=234 Identities=24% Similarity=0.386 Sum_probs=191.8
Q ss_pred cccccceeeccCCceEEEEEEe------CCCcEEEEEccCCCCCC-------------------------CccccCCceE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV------PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSF 549 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~ 549 (752)
.+-+..+.||+|.||+||+|+. ++.+.||||.++..... +.|...+..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 3455678999999999999983 34578999999875433 6788899999
Q ss_pred EEEEeccCCChHHHhccCcc-----------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCce
Q 041438 550 IVYEYLESGSLDKILNNDAS-----------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEA 618 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~ 618 (752)
+|+|||..|||.+++..... +.+++..+...||.|||.|++||-++ .+|||||-..|+||.+...|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence 99999999999999975321 23388899999999999999999999 99999999999999999999
Q ss_pred EEeecccceeccCCCCCc--ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHh
Q 041438 619 HVSDFRIAKFLNLDSSNW--SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIE 695 (752)
Q Consensus 619 kl~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~ 695 (752)
||+|||+++..-..+... ....-..+|||||.+..++++.+||||||||++||+++ |+.||.. -..++....
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g-----lSn~EVIe~ 717 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG-----LSNQEVIEC 717 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccc-----cchHHHHHH
Confidence 999999998765433211 11233568999999999999999999999999999997 9999752 223344444
Q ss_pred hhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 696 ILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
+.+++. .+ ..++++.++.+||..||+.+|.+||+++||-..|+.+..
T Consensus 718 i~~g~l-L~--~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 718 IRAGQL-LS--CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHcCCc-cc--CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 545444 33 236788999999999999999999999999999998763
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=295.47 Aligned_cols=232 Identities=24% Similarity=0.356 Sum_probs=176.7
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCc--EEEEEccCCCCCC--------------------------CccccCCceEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGE--IFAVKKFHSPLPD--------------------------NFCSHPRQSFI 550 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~--~vavK~~~~~~~~--------------------------~~~~~~~~~~l 550 (752)
.++|++.+.||+|+||.||+|+. .++. .+|+|.++..... +++.+.+..|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 46889999999999999999985 3454 4578776532110 34455677899
Q ss_pred EEEeccCCChHHHhccCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCc
Q 041438 551 VYEYLESGSLDKILNNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE 617 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~ 617 (752)
||||+++++|.+++..... ...+++.+++.++.|++.|++|||++ ||+||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999975421 13478899999999999999999999 9999999999999999999
Q ss_pred eEEeecccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhh
Q 041438 618 AHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEI 696 (752)
Q Consensus 618 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~ 696 (752)
+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||... ...+....+
T Consensus 163 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-----~~~~~~~~~ 236 (303)
T cd05088 163 AKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-----TCAELYEKL 236 (303)
T ss_pred EEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC-----ChHHHHHHH
Confidence 9999999986432111 1111234567999999988889999999999999999998 99998521 111111112
Q ss_pred hcc-CCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 697 LDS-RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 697 ~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
... ....+ ...+.++.+++.+||+.+|++||+++++++.++++.
T Consensus 237 ~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 237 PQGYRLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred hcCCcCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 11111 223457889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=286.32 Aligned_cols=231 Identities=23% Similarity=0.397 Sum_probs=182.6
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEecc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~~ 556 (752)
.++|++.++||+|+||.||+|...+++.||||.+...... +++......++||||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 4689999999999999999999878889999988754221 33455577899999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC-
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN- 635 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~- 635 (752)
+++|.+++.... ...+++.++..++.|++.|++|||+. +++|+||||+||++++++.+|++|||.++........
T Consensus 85 ~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 85 KGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 999999997643 23588999999999999999999999 9999999999999999999999999999876432111
Q ss_pred cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
.....++..|+|||.+.+..+++++||||+||++||+++ |+.||... ........+.. ....+. ....+.+
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-----~~~~~~~~~~~-~~~~~~--~~~~~~~ 232 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM-----TNREVLEQVER-GYRMPR--PPNCPEE 232 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHc-CCCCCC--CCCCCHH
Confidence 112234568999999998889999999999999999998 99998421 11112222221 111111 1223567
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
+.+++.+|++.+|++||+++++.+.|+.
T Consensus 233 ~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 233 LYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 8999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=292.77 Aligned_cols=230 Identities=23% Similarity=0.319 Sum_probs=177.8
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E 553 (752)
..+.|++.++||+|+||.||+|+. .+++.||+|.+...... +.+......++|||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 346799999999999999999995 46899999998644321 23445678999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|++++++..++.... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+.......
T Consensus 90 ~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 90 FCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred cCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 999999988876433 3488899999999999999999999 99999999999999999999999999987654333
Q ss_pred CCcccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhh
Q 041438 634 SNWSKLAGTHGNVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (752)
.......++..|+|||++. ...++.++|||||||++|||++|+.||.... .......+.....+.. ...
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~~~~-~~~ 238 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-----PMRVLLKIAKSEPPTL-SQP 238 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-----HHHHHHHHhcCCCccC-CCC
Confidence 3334457889999999875 3446889999999999999999999985211 1111122222211111 011
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...+.++.+++.+||+.||++||+++|++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 239 SKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 2345578899999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=291.01 Aligned_cols=234 Identities=23% Similarity=0.339 Sum_probs=180.2
Q ss_pred ccccceeeccCCceEEEEEEeC------CCcEEEEEccCCCCCC-------------------------CccccCCceEE
Q 041438 502 DFDAKHCIGKGGHGSVYIARVP------SGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFI 550 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~l 550 (752)
+|++.+.||+|+||.||+|+.. ....+|+|.+...... +.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4788999999999999999842 2357899987643221 33455677899
Q ss_pred EEEeccCCChHHHhccCc---------------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCC
Q 041438 551 VYEYLESGSLDKILNNDA---------------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKN 609 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~N 609 (752)
||||+.+|+|.+++.... ....+++.++..++.|++.||+|||+. +|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999986421 113478899999999999999999999 99999999999
Q ss_pred EEeCCCCceEEeecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccc
Q 041438 610 VLLDLGYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMS 686 (752)
Q Consensus 610 Ill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~ 686 (752)
|++++++.+||+|||+++........ .....++..|+|||++.+..++.++||||||+++|||+| |..||...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---- 233 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI---- 233 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC----
Confidence 99999999999999999865432221 122345678999999988889999999999999999998 99998521
Q ss_pred cccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 687 SSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
...............+. ....+.++.+++.+||+.||++||+++|+++.|+++...
T Consensus 234 --~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 234 --APERLFNLLKTGYRMER--PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred --CHHHHHHHHhCCCCCCC--CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 11111222222222111 133456788999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=290.08 Aligned_cols=235 Identities=23% Similarity=0.318 Sum_probs=177.2
Q ss_pred ccc-ccceeeccCCceEEEEEE-----eCCCcEEEEEccCCCCCC-------------------------Ccccc--CCc
Q 041438 501 NDF-DAKHCIGKGGHGSVYIAR-----VPSGEIFAVKKFHSPLPD-------------------------NFCSH--PRQ 547 (752)
Q Consensus 501 ~~y-~~~~~lg~G~~g~Vy~~~-----~~~~~~vavK~~~~~~~~-------------------------~~~~~--~~~ 547 (752)
++| ++.+.||+|+||.||++. ..+++.||+|.++..... +++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 344 889999999999998865 246789999988754321 12222 345
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
.++||||+++++|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccc
Confidence 78999999999999999653 389999999999999999999999 99999999999999999999999999998
Q ss_pred eccCCCCC---cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcc----ccc-c----ccchHh
Q 041438 628 FLNLDSSN---WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM----SSS-S----SNMNIE 695 (752)
Q Consensus 628 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~----~~~-~----~~~~~~ 695 (752)
........ .....++..|+|||++.+..++.++|||||||++|||+||..||...... ... . ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 76532211 11224566799999998888999999999999999999999997532110 000 0 000111
Q ss_pred hhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 696 ILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
..+.....+ .....+.++.+++.+||+.||++|||++++++.|++++
T Consensus 236 ~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111111111 01234568999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=291.09 Aligned_cols=228 Identities=23% Similarity=0.301 Sum_probs=175.9
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEecc
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~~~ 556 (752)
-|++.+.||+|+||.||+|+. .++..+|+|.+...... +++......++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 377889999999999999995 46788999987543211 33455678899999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW 636 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 636 (752)
+++|..++.... .++++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 86 ~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 86 GGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence 999998876432 3488999999999999999999999 99999999999999999999999999987654333333
Q ss_pred ccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 637 SKLAGTHGNVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 637 ~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
....++..|+|||++. +..++.++||||+||++|||++|++||.... .......+.....+... .....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~-~~~~~ 234 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-----PMRVLLKIAKSEPPTLA-QPSRW 234 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-----HHHHHHHHhhcCCCCCC-Ccccc
Confidence 3457899999999874 3457889999999999999999999985211 11111222221111110 11234
Q ss_pred HHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 712 FMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
+.++.+++.+||+.||++||++++++++-
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 235 SSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 56789999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=286.61 Aligned_cols=231 Identities=25% Similarity=0.407 Sum_probs=179.8
Q ss_pred hcccccceeeccCCceEEEEEEeC-CC---cEEEEEccCCCCCC-------------------------CccccCCceEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP-SG---EIFAVKKFHSPLPD-------------------------NFCSHPRQSFI 550 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~-------------------------~~~~~~~~~~l 550 (752)
.++|+..+.||+|+||.||+|+.. ++ ..+|+|.++..... +++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888999999999999999853 33 37999988654211 34455677899
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999997543 3488899999999999999999999 99999999999999999999999999998664
Q ss_pred CCCCCcc---cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCCh
Q 041438 631 LDSSNWS---KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706 (752)
Q Consensus 631 ~~~~~~~---~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (752)
....... ....+..|+|||++.+..++.++|||||||++||+++ |+.||... ........+.. ....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~-----~~~~~~~~i~~-~~~~~~- 231 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM-----SNHEVMKAIND-GFRLPA- 231 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC-----CHHHHHHHHhc-CCCCCC-
Confidence 3221111 1123457999999988889999999999999999997 99998421 11122222222 112221
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
....+.++.+++.+||+.+|++||++.++++.|+++
T Consensus 232 -~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 232 -PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 123456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=286.96 Aligned_cols=231 Identities=26% Similarity=0.364 Sum_probs=181.0
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEe
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~ 554 (752)
++|++.+.||.|+||.||+|.. .+++.+|+|++...... +.+...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4799999999999999999984 57889999988643221 234456788999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++++|.+++........+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999997643334588999999999999999999999 999999999999999999999999999887654332
Q ss_pred Cc----ccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCC-CCCh-h
Q 041438 635 NW----SKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLP-YPSL-D 707 (752)
Q Consensus 635 ~~----~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~ 707 (752)
.. ....|+..|+|||++... .++.++|+|||||++|||++|+.||..... ............+ .+.. .
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-----MKVLMLTLQNDPPSLETGAD 232 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh-----hhhHHHHhcCCCCCcCCccc
Confidence 21 234688999999998776 689999999999999999999999852211 1112222222111 1110 1
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
....+..+.+++.+||+.||++||+++|+++|
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 12456778999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=286.69 Aligned_cols=232 Identities=21% Similarity=0.305 Sum_probs=181.3
Q ss_pred HHHHHHhhcccccceee--ccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------CccccCCceE
Q 041438 493 YEEIIRATNDFDAKHCI--GKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------NFCSHPRQSF 549 (752)
Q Consensus 493 ~~~~~~~~~~y~~~~~l--g~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------~~~~~~~~~~ 549 (752)
..++....++|++.+.+ |+|+||.||+++ ..+++.+|+|.+...... +.+...+..+
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 45566667888888887 999999999998 467889999987653211 2334567889
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC-ceEEeeccccee
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY-EAHVSDFRIAKF 628 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~-~~kl~DfG~a~~ 628 (752)
+||||+++++|.+++.... .+++.++..++.|+++|+.|||+. +++||||||+||+++.++ .++|+|||.+..
T Consensus 86 iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 9999999999999997653 589999999999999999999999 999999999999999988 999999999987
Q ss_pred ccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhh
Q 041438 629 LNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708 (752)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (752)
..... ...++..|+|||++.+..++.++||||+||++|||++|+.||....... ..............+. .
T Consensus 160 ~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~----~ 230 (267)
T PHA03390 160 IGTPS----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQQKKLPF----I 230 (267)
T ss_pred cCCCc----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhhcccCCc----c
Confidence 64322 2368899999999998889999999999999999999999986221100 0001111111111111 2
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCC-HHHHHHH
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPT-MKRFEVQ 739 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~ 739 (752)
...++.+.+++.+||+.||.+||+ ++|+++|
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 231 KNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred cccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 346678999999999999999996 5888854
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=284.08 Aligned_cols=227 Identities=22% Similarity=0.306 Sum_probs=183.3
Q ss_pred ccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEe
Q 041438 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~ 554 (752)
+|++.+.||+|+||.||.++ ..+++.+|+|.+...... +++...+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58899999999999999998 567899999987543211 345566788999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++++|.+++.... ...+++.++..++.|++.|+.|||+. +++||||||+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999997653 24578899999999999999999999 999999999999999999999999999987654443
Q ss_pred CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 635 NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
......+++.|+|||+..+..++.++||||||+++|||++|+.||.. ....+....+........ ....+.+
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-----~~~~~~~~~~~~~~~~~~---~~~~~~~ 228 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA-----TNPLNLVVKIVQGNYTPV---VSVYSSE 228 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC-----CCHHHHHHHHHcCCCCCC---ccccCHH
Confidence 33445789999999999888899999999999999999999999852 112222223333332221 1345567
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
+.+++.+||..+|++||+++|++++.
T Consensus 229 ~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 229 LISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHHHHHHcccCcccCCCHHHHhhCc
Confidence 88999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=293.69 Aligned_cols=234 Identities=16% Similarity=0.223 Sum_probs=175.4
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E 553 (752)
.++|++.+.||+|+||.||+|+. .+++.||+|.++..... +++......++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 46799999999999999999985 46889999988643211 34455678899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++ +|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 85 ~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 85 YLDK-DLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cccc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 9985 8988886543 3478899999999999999999999 99999999999999999999999999998654333
Q ss_pred CCcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccc----------cccccchHhhhcc---
Q 041438 634 SNWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS----------SSSSNMNIEILDS--- 699 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~----------~~~~~~~~~~~~~--- 699 (752)
.......+++.|+|||++.+. .++.++|||||||++|||+||++||....... .........+...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 333344678999999987654 47889999999999999999999985321100 0000000000000
Q ss_pred -CCCCCC-------hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 700 -RLPYPS-------LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 700 -~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
....+. ......++.+.++|.+|++.||.+|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000110 0012245578899999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=292.17 Aligned_cols=233 Identities=22% Similarity=0.313 Sum_probs=179.9
Q ss_pred hcccccceeeccCCceEEEEEEe------CCCcEEEEEccCCCCCC--------------------------CccccCCc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV------PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQ 547 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--------------------------~~~~~~~~ 547 (752)
.++|++.+.||+|+||.||+|.. .++..||||.++..... +++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 45799999999999999999973 23568999987643211 23445677
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
.++||||+++|+|.+++..... ..+++.++..++.|++.||+|||+. +|+|+||||+||+++.++.+|++|||.++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence 8999999999999999975332 2378999999999999999999999 99999999999999999999999999998
Q ss_pred eccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCC
Q 041438 628 FLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYP 704 (752)
Q Consensus 628 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (752)
........ .....++..|+|||++.+..++.++||||+||++|||++ |..||.... ................
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~-----~~~~~~~~~~~~~~~~ 264 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP-----VDSKFYKLIKEGYRMA 264 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC-----chHHHHHHHHcCCcCC
Confidence 65433211 112345678999999998889999999999999999998 999985211 1111122222221111
Q ss_pred ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 705 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
. ....++++.+++.+|++++|++|||+.|+++.|+++
T Consensus 265 ~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 265 Q--PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred C--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1 122345788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=285.65 Aligned_cols=229 Identities=25% Similarity=0.344 Sum_probs=181.1
Q ss_pred hcccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC----------------------CccccCCceEEEEEecc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD----------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----------------------~~~~~~~~~~lV~E~~~ 556 (752)
.++|++.+.||+|+||.||+|+.. +++.||+|.+...... +.+......|+++||++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 468999999999999999999964 4889999987643210 34556678999999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW 636 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 636 (752)
+++|.+++.... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|||.+..........
T Consensus 82 ~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 82 AGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 999999986533 4588999999999999999999999 99999999999999999999999999998765443233
Q ss_pred ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHH
Q 041438 637 SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIM 716 (752)
Q Consensus 637 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 716 (752)
....++..|+|||++.+..++.++|||||||++|+|++|+.||..... ......+...... ...........+.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~-~~~~~~~~~~~~~ 230 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP-----MRAIFMIPNKPPP-TLSDPEKWSPEFN 230 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch-----hhhhhhhccCCCC-CCCchhhcCHHHH
Confidence 345688999999999888899999999999999999999999852211 1111111111111 1111123456789
Q ss_pred HHHHhccCcCCCCCCCHHHHHHH
Q 041438 717 QVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 717 ~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+++.+||+.||++|||++|++++
T Consensus 231 ~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 231 DFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HHHHHHHhcChhhCcCHHHHhcC
Confidence 99999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=301.71 Aligned_cols=234 Identities=20% Similarity=0.257 Sum_probs=172.1
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------CccccCCceEEEEEeccCCC
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------NFCSHPRQSFIVYEYLESGS 559 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------~~~~~~~~~~lV~E~~~~g~ 559 (752)
...+|++.+.||+|+||.||+|+. .+++.||+|........ +++......++||||+.+ +
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 142 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-D 142 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCC-c
Confidence 456899999999999999999995 46789999975432211 445567788999999965 8
Q ss_pred hHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcccc
Q 041438 560 LDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKL 639 (752)
Q Consensus 560 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 639 (752)
|.+++.... ..+++..+..|+.||+.||.|||++ +|+||||||+||+++.++.+||+|||.++..... ......
T Consensus 143 l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~ 216 (357)
T PHA03209 143 LYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGL 216 (357)
T ss_pred HHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC-cccccc
Confidence 888886543 3588999999999999999999999 9999999999999999999999999999754322 222345
Q ss_pred cCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCc-chhhcccc----ccccchHhhhcc---------------
Q 041438 640 AGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPR-DFLFEMSS----SSSNMNIEILDS--------------- 699 (752)
Q Consensus 640 ~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf-~~~~~~~~----~~~~~~~~~~~~--------------- 699 (752)
.||+.|+|||++.+..++.++|||||||++|||+++..|+ +....... ........+...
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 296 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR 296 (357)
T ss_pred cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence 7999999999999999999999999999999999865543 21100000 000000000000
Q ss_pred ------------CCCCCC---hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 700 ------------RLPYPS---LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 700 ------------~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+.+... ......+.++.++|.+||+.||++|||++|+++|
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 000000 0011223456779999999999999999999976
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=284.16 Aligned_cols=223 Identities=25% Similarity=0.387 Sum_probs=177.8
Q ss_pred eeeccCCceEEEEEEeCC----CcEEEEEccCCCCCC-------------------------CccccCCceEEEEEeccC
Q 041438 507 HCIGKGGHGSVYIARVPS----GEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
+.||+|+||.||+|.... +..||+|.++..... +++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999543 889999998764331 344556788999999999
Q ss_pred CChHHHhccCcc------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 558 GSLDKILNNDAS------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 558 g~L~~~l~~~~~------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
++|.+++..... ...+++.+++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999987521 24589999999999999999999999 999999999999999999999999999987754
Q ss_pred CC--CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccC-CCCCChh
Q 041438 632 DS--SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSR-LPYPSLD 707 (752)
Q Consensus 632 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 707 (752)
.. .......++..|+|||.+.+..++.++||||+||++|||++ |..||... ........+.... ...+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~--- 229 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-----SNEEVLEYLRKGYRLPKP--- 229 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHHHcCCCCCCC---
Confidence 32 11233467889999999988889999999999999999999 69998532 1112222222211 1122
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHh
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 741 (752)
...+.++.+++.+||+.||++|||++|++++|+
T Consensus 230 -~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 230 -EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 334678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=289.57 Aligned_cols=230 Identities=23% Similarity=0.311 Sum_probs=177.3
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEe
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~ 554 (752)
++|++.+.||+|+||.||+|+. .+++.||+|.++..... +.+......|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 4788999999999999999995 47899999987643211 334556789999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++++|..++........+++..+..++.|++.|+.|||+.+ +|+||||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999999876432335899999999999999999999632 89999999999999999999999999997654222
Q ss_pred CcccccCCCCccCccccccCC------CCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhh
Q 041438 635 NWSKLAGTHGNVAPELAYTMK------VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~------~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (752)
.....++..|+|||++.+.. ++.++||||+||++|+|++|+.||..... .........+.....+. ..
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~---~~ 231 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--ANIFAQLSAIVDGDPPT---LP 231 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--hhHHHHHHHHhhcCCCC---CC
Confidence 22346888999999885443 48899999999999999999999852110 00001111222222111 11
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...+.++.+++.+||+.+|++||++++++++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 3366778999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=288.97 Aligned_cols=225 Identities=26% Similarity=0.346 Sum_probs=177.7
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEe
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~ 554 (752)
+.|+..+.||+|+||.||+|.. .+++.||+|.+...... +.+......|+||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 3467788999999999999984 56889999987643221 344556789999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++++|.+++... .+++..+..++.|+++|+.|||+. +++|+||||+||++++++.++++|||++........
T Consensus 84 ~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 9999999988643 478899999999999999999999 999999999999999999999999999987654332
Q ss_pred CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 635 NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.... .......+.....+. .....+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-----~~~~~~~~~~~~~~~---~~~~~~~~ 228 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH-----PMRVLFLIPKNSPPT---LEGQYSKP 228 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc-----hhhHHhhhhcCCCCC---CCcccCHH
Confidence 2333468889999999998889999999999999999999999985211 111111111111111 11234567
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
+.+++.+||+.+|++||++.+++++-
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 229 FKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHhH
Confidence 88999999999999999999999863
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=288.94 Aligned_cols=235 Identities=20% Similarity=0.299 Sum_probs=182.9
Q ss_pred hcccccceeeccCCceEEEEEEeCC-----CcEEEEEccCCCCCC-------------------------Cccc-cCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPS-----GEIFAVKKFHSPLPD-------------------------NFCS-HPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-------------------------~~~~-~~~~~ 548 (752)
.++|++.+.||+|+||.||+|.... ++.||+|++...... +++. .....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 5689999999999999999999654 788999987643221 2222 24678
Q ss_pred EEEEEeccCCChHHHhccCccc-----cccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeec
Q 041438 549 FIVYEYLESGSLDKILNNDASA-----KELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDF 623 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~Df 623 (752)
++++||+++++|.+++...... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998754322 4588999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccC
Q 041438 624 RIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSR 700 (752)
Q Consensus 624 G~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 700 (752)
|+++.+...... .....++..|+|||++.+..++.++|||||||++||+++ |+.||... .... ........
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-----~~~~-~~~~~~~~ 235 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI-----DPFE-MAAYLKDG 235 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC-----CHHH-HHHHHHcC
Confidence 999865432211 112345678999999988889999999999999999999 99998521 1111 11222222
Q ss_pred CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 701 LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 701 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
...+. ....++++.+++.+||..||++|||+.|+++.|++++.
T Consensus 236 ~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 236 YRLAQ--PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCCC--CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 22111 12345678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.38 Aligned_cols=234 Identities=21% Similarity=0.322 Sum_probs=180.1
Q ss_pred hcccccceeeccCCceEEEEEEeC--------CCcEEEEEccCCCCCC--------------------------CccccC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP--------SGEIFAVKKFHSPLPD--------------------------NFCSHP 545 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--------------------------~~~~~~ 545 (752)
.++|++.+.||+|+||.||+|+.. ....||+|.++..... +++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 468889999999999999999731 3457999987643211 234456
Q ss_pred CceEEEEEeccCCChHHHhccCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe
Q 041438 546 RQSFIVYEYLESGSLDKILNNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL 612 (752)
Q Consensus 546 ~~~~lV~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll 612 (752)
...++||||+++|+|.+++..... ...+++.++..++.|++.||+|+|++ ||+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 778999999999999999975321 13488899999999999999999999 99999999999999
Q ss_pred CCCCceEEeecccceeccCCCCCc--ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhcccccc
Q 041438 613 DLGYEAHVSDFRIAKFLNLDSSNW--SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSS 689 (752)
Q Consensus 613 ~~~~~~kl~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~ 689 (752)
++++.+||+|||.++......... ....++..|+|||++.+..++.++|||||||++|||++ |..||... ..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~-----~~ 242 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-----PV 242 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC-----CH
Confidence 999999999999998654322111 11234467999999988889999999999999999999 88887521 11
Q ss_pred ccchHhhhccC-CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 690 SNMNIEILDSR-LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 690 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
......+.... ...+ ...+.++.+++.+||+.||++||++.|+++.|+++..
T Consensus 243 ~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 243 EELFKLLREGHRMDKP----SNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHHHHHHcCCCCCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11122222211 1111 2345578899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=289.90 Aligned_cols=231 Identities=23% Similarity=0.379 Sum_probs=177.6
Q ss_pred cccccceeeccCCceEEEEEEe------CCCcEEEEEccCCCCCC------------------------CccccCCceEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV------PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFI 550 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~l 550 (752)
.+|+..++||+|+||.||+|+. .++..+|+|.+...... +++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4678899999999999999963 24668999987542211 34455677899
Q ss_pred EEEeccCCChHHHhccCcc------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCce
Q 041438 551 VYEYLESGSLDKILNNDAS------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEA 618 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~ 618 (752)
||||+++++|.+++..... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999999875431 12478899999999999999999999 99999999999999999999
Q ss_pred EEeecccceeccCCCC--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHh
Q 041438 619 HVSDFRIAKFLNLDSS--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIE 695 (752)
Q Consensus 619 kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~ 695 (752)
||+|||++........ ......+++.|+|||++.+..++.++|||||||++|||++ |++||... ........
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~~~~~~~ 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL-----SNTEAIEC 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC-----CHHHHHHH
Confidence 9999999976542221 1112345678999999998899999999999999999998 99998421 11112222
Q ss_pred hhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 696 ILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
+....... ....+++.+.+++.+||+.||++||+++|+.+.|++
T Consensus 237 ~~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 237 ITQGRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHcCccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 22221111 112345678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=301.73 Aligned_cols=236 Identities=22% Similarity=0.294 Sum_probs=181.0
Q ss_pred hhcccccceeeccCCceEEEEEEeC------CCcEEEEEccCCCCCC--------------------------CccccCC
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP------SGEIFAVKKFHSPLPD--------------------------NFCSHPR 546 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--------------------------~~~~~~~ 546 (752)
..++|.+.++||+|+||.||+|++. .++.||+|+++..... +.+....
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456888999999999999999843 3468999998754221 2344557
Q ss_pred ceEEEEEeccCCChHHHhccCcc---------------------------------------------------------
Q 041438 547 QSFIVYEYLESGSLDKILNNDAS--------------------------------------------------------- 569 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~--------------------------------------------------------- 569 (752)
..++||||+++|+|.+++++...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 78999999999999999865321
Q ss_pred --------------------------------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEE
Q 041438 570 --------------------------------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVL 611 (752)
Q Consensus 570 --------------------------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIl 611 (752)
...+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEE
Confidence 12367778899999999999999999 9999999999999
Q ss_pred eCCCCceEEeecccceeccCCCC--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccc
Q 041438 612 LDLGYEAHVSDFRIAKFLNLDSS--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSS 688 (752)
Q Consensus 612 l~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~ 688 (752)
+++++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~----- 346 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP----- 346 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC-----
Confidence 99999999999999986532221 1122356788999999988889999999999999999998 899975211
Q ss_pred cccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 689 SSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
..+............+. ....+.++.+++.+||..+|++||+++|+++.|+++.
T Consensus 347 ~~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 347 MNEQFYNAIKRGYRMAK--PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred chHHHHHHHHcCCCCCC--CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111122222211111 1234567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=286.41 Aligned_cols=230 Identities=23% Similarity=0.380 Sum_probs=179.6
Q ss_pred cccccceeeccCCceEEEEEEeC----CCcEEEEEccCCCCCC-------------------------CccccCCceEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVP----SGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV 551 (752)
.+|++.+.||+|+||.||+|+.. .+..||+|.++..... +++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57889999999999999999842 2347999988653211 344566788999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+.....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999997643 3478899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCcc---cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChh
Q 041438 632 DSSNWS---KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLD 707 (752)
Q Consensus 632 ~~~~~~---~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (752)
...... ...++..|+|||++.+..++.++|||||||++||+++ |+.||... ...+....+.+. ...+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-----~~~~~~~~~~~~-~~~~~-- 230 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM-----SNQDVIKAIEEG-YRLPA-- 230 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC-----CHHHHHHHHhCC-CcCCC--
Confidence 322111 1223567999999998889999999999999999886 99998521 111122222222 11121
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
....+..+.+++.+|++++|++||++.++++.|+++
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 231 PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=288.29 Aligned_cols=225 Identities=26% Similarity=0.367 Sum_probs=180.3
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEe
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~ 554 (752)
++|++.+.||.|+||.||+|+. .+++.||+|.+...... +++......++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 4788999999999999999994 47899999987644211 234455778999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++++|.+++... .+++..+..++.|++.|+.|+|+. +++||||+|+||++++++.++|+|||.++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999998754 488999999999999999999999 999999999999999999999999999988764433
Q ss_pred CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 635 NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
......++..|+|||++.+..++.++|||||||++|+|+||+.||.... .......+.....+.. .....+.+
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~-----~~~~~~~~~~~~~~~~--~~~~~~~~ 226 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH-----PMRVLFLIPKNNPPSL--EGNKFSKP 226 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc-----hHHHHHHhhhcCCCCC--cccccCHH
Confidence 3444578889999999998889999999999999999999999985211 1111111111111111 11115567
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+.+++.+||..||++|||+++++++
T Consensus 227 ~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 227 FKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhhC
Confidence 8899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=283.75 Aligned_cols=228 Identities=25% Similarity=0.370 Sum_probs=181.1
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEecc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~~ 556 (752)
.++|++.+.||+|+||.||+|.. .|+.||+|.++..... +++......++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46789999999999999999986 4789999998765431 33445678899999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW 636 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 636 (752)
+++|.+++..... ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.++.......
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999976442 3488999999999999999999999 999999999999999999999999999987632221
Q ss_pred ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHH
Q 041438 637 SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSI 715 (752)
Q Consensus 637 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 715 (752)
...++..|+|||++.+..++.++||||||+++||+++ |+.||... ........+ ....... .....++.+
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~~~~~~~-~~~~~~~--~~~~~~~~~ 228 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPHV-EKGYRME--APEGCPPEV 228 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHH-hcCCCCC--CccCCCHHH
Confidence 2344568999999988889999999999999999997 99998521 111111111 1111111 112345678
Q ss_pred HHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 716 MQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 716 ~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
.+++.+||+.+|++||+++|+++.|+++
T Consensus 229 ~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 229 YKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 9999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=289.05 Aligned_cols=236 Identities=22% Similarity=0.328 Sum_probs=177.8
Q ss_pred cccccceeeccCCceEEEEEEe-----CCCcEEEEEccCCCCCC-------------------------Ccccc--CCce
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-----PSGEIFAVKKFHSPLPD-------------------------NFCSH--PRQS 548 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~-------------------------~~~~~--~~~~ 548 (752)
..|++.+.||+|+||.||+|+. .++..||+|.++..... +++.. ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3478899999999999999973 35789999998644211 22222 3568
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
++||||+++++|.+++.... ..+++.++..++.|++.||+|+|++ ||+||||||+||+++.++.+||+|||.++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 89999999999999986543 3478999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCC---cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhc----cc-ccc-c---cchHhh
Q 041438 629 LNLDSSN---WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFE----MS-SSS-S---NMNIEI 696 (752)
Q Consensus 629 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~----~~-~~~-~---~~~~~~ 696 (752)
....... .....++..|+|||++.+..++.++|||||||++||++|++.|+..... .. ... + ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6533221 1234567789999999888899999999999999999998776421110 00 000 0 001111
Q ss_pred hccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 697 LDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
.......+ .....+.++.+++.+||+.||++||+++++++.++++
T Consensus 239 ~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKRLP--RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCccCC--CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111111 1123566899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=291.75 Aligned_cols=235 Identities=21% Similarity=0.329 Sum_probs=177.6
Q ss_pred hcccccceeeccCCceEEEEEEeCC-----------------CcEEEEEccCCCCCC-----------------------
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPS-----------------GEIFAVKKFHSPLPD----------------------- 539 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~----------------------- 539 (752)
.++|++.+.||+|+||.||+|+... +..||+|.+......
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4689999999999999999987432 356899988654211
Q ss_pred --CccccCCceEEEEEeccCCChHHHhccCcc--------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCC
Q 041438 540 --NFCSHPRQSFIVYEYLESGSLDKILNNDAS--------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKN 609 (752)
Q Consensus 540 --~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~N 609 (752)
+++...+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 334455788999999999999999876431 12588999999999999999999999 99999999999
Q ss_pred EEeCCCCceEEeecccceeccCCCC--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh--CCCCcchhhcc
Q 041438 610 VLLDLGYEAHVSDFRIAKFLNLDSS--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPRDFLFEM 685 (752)
Q Consensus 610 Ill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt--g~~pf~~~~~~ 685 (752)
|+++.++.++|+|||.++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999986543221 1122356778999999988889999999999999999998 677774211
Q ss_pred ccccccchHhhhcc----CCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 686 SSSSSNMNIEILDS----RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 686 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
........... ............+.++.+++.+||+.||++|||+.|+++.|++
T Consensus 239 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 ---DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ---hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11111111100 0000000112344679999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=283.66 Aligned_cols=222 Identities=23% Similarity=0.320 Sum_probs=171.6
Q ss_pred eeccCCceEEEEEEeC---CCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEeccCCC
Q 041438 508 CIGKGGHGSVYIARVP---SGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEYLESGS 559 (752)
Q Consensus 508 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~~~~g~ 559 (752)
.||+|+||.||+|... ++..||+|++...... +++ .....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~-~~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE-cCCCeEEEEEeCCCCC
Confidence 4899999999999743 4567999988654321 222 2456789999999999
Q ss_pred hHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc--
Q 041438 560 LDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS-- 637 (752)
Q Consensus 560 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~-- 637 (752)
|.+++.... ..+++.++..++.|++.||+|||++ +++||||||+||+++.++.+||+|||.+...........
T Consensus 81 L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999986533 3488999999999999999999999 999999999999999999999999999986543322111
Q ss_pred -cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccC-CCCCChhhHHHHHH
Q 041438 638 -KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSR-LPYPSLDVQNKFMS 714 (752)
Q Consensus 638 -~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 714 (752)
...++..|+|||++.+..++.++|||||||++||+++ |+.||.... .......+.... ...+ ...+++
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~----~~~~~~ 226 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK-----GPEVMSFIEQGKRLDCP----AECPPE 226 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC-----HHHHHHHHHCCCCCCCC----CCCCHH
Confidence 1233568999999988889999999999999999996 999985211 111112222211 1122 234567
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
+.+++.+||..||++||++.+|.+.|+.+.
T Consensus 227 l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 227 MYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.28 Aligned_cols=345 Identities=32% Similarity=0.422 Sum_probs=220.7
Q ss_pred EEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCccccc-----------------
Q 041438 86 VFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGH----------------- 148 (752)
Q Consensus 86 v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~----------------- 148 (752)
|.++|+++++++|.-.+.+...+++++.|.|...++.. +|..++.|.+|+.|.+++|++..+
T Consensus 9 VrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~~-vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~ 87 (1255)
T KOG0444|consen 9 VRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLEQ-VPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRD 87 (1255)
T ss_pred eecccccCCcCCCCcCchhHHHhhheeEEEechhhhhh-ChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhc
Confidence 45566666666654444444444445555444444432 344444444444444444444421
Q ss_pred -------CCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccc
Q 041438 149 -------IPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSI 221 (752)
Q Consensus 149 -------~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 221 (752)
+|..+-.|..|+.||||+|+++ ..|..+..-.++-.|+||+|+|..++...|.+++.|-.||||+|++. .+
T Consensus 88 N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~L 165 (1255)
T KOG0444|consen 88 NNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-ML 165 (1255)
T ss_pred cccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hc
Confidence 2333444555555555555554 34444444445555555555555333334445555555555555554 33
Q ss_pred cccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccC-CCCCcccCCCCCCCEEecCCCcCcCCCCcccc
Q 041438 222 PQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNIT-GNIPFEIGESPQLQYLDLSSNYIVGEIPTQLG 300 (752)
Q Consensus 222 p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 300 (752)
|..+..|..|+.|+|++|.+...-... +..+++|++|.+|+.+=+ ..+|.++..+.+|..+|||.|.+. ..|+.+.
T Consensus 166 PPQ~RRL~~LqtL~Ls~NPL~hfQLrQ--LPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly 242 (1255)
T KOG0444|consen 166 PPQIRRLSMLQTLKLSNNPLNHFQLRQ--LPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLY 242 (1255)
T ss_pred CHHHHHHhhhhhhhcCCChhhHHHHhc--CccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHh
Confidence 344444555555555555443211100 112334455555554422 356778888888888889988887 7888888
Q ss_pred CCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCc-cccchhccccccCCe
Q 041438 301 NIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLS-QQIPIELDNLIHLSE 379 (752)
Q Consensus 301 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~ 379 (752)
++.+|+.|+||+|+|+ .+....+.+.+|++|+||.|+++. .|.+++.+++|+.|++.+|+++ .-+|..++.+.+|++
T Consensus 243 ~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt~-LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Lev 320 (1255)
T KOG0444|consen 243 KLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLTV-LPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEV 320 (1255)
T ss_pred hhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhcc-chHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHH
Confidence 8888999999999887 455556677888889999999876 5678888999999999999875 346888889999999
Q ss_pred eecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCCcccCcCC
Q 041438 380 LDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIP 440 (752)
Q Consensus 380 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 440 (752)
+..++|.+ ...|..++.+..|+.|.|+.|++-.+ |+.+.-|+.|..||+..|+=---.|
T Consensus 321 f~aanN~L-ElVPEglcRC~kL~kL~L~~NrLiTL-PeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 321 FHAANNKL-ELVPEGLCRCVKLQKLKLDHNRLITL-PEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred HHhhcccc-ccCchhhhhhHHHHHhcccccceeec-hhhhhhcCCcceeeccCCcCccCCC
Confidence 99988888 67888899999999999999998765 8888889999999999887443333
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=284.57 Aligned_cols=230 Identities=27% Similarity=0.378 Sum_probs=180.4
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEe
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~ 554 (752)
.++|++.+.||+|+||.||+|+. .+++.+|+|.+...... ++.......|++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 36899999999999999999985 56789999987654221 234456788999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++++|.+++.... ..+++.++..++.|++.|++|||+. +|+|+||||+||++++++.+||+|||.+........
T Consensus 82 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 82 CGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 99999999987642 3488899999999999999999999 999999999999999999999999999987654332
Q ss_pred CcccccCCCCccCccccccC---CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCC-hhhHH
Q 041438 635 NWSKLAGTHGNVAPELAYTM---KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPS-LDVQN 710 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~---~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 710 (752)
......++..|+|||.+.+. .++.++|||||||++|||+||+.||.... ...............+. .....
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 231 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH-----PMRALFLISKSNFPPPKLKDKEK 231 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhccCCCccccchhh
Confidence 33345788899999998776 78999999999999999999999985211 11111111111111111 11234
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+.++.+++.+||..||++|||+++++.+
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 232 WSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred hhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 56678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=323.16 Aligned_cols=233 Identities=20% Similarity=0.286 Sum_probs=175.7
Q ss_pred HhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Ccc--ccCCce
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFC--SHPRQS 548 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~--~~~~~~ 548 (752)
...++|++.+.||+|+||.||+|+. .+++.||+|.+...... +++ .....+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3567899999999999999999994 56788999987643211 111 234568
Q ss_pred EEEEEeccCCChHHHhccCc-cccccCHHHHHHHHHHHHHHHHHHHhCCC----CCeeecCCCCCCEEeCC---------
Q 041438 549 FIVYEYLESGSLDKILNNDA-SAKELGWTQRLNVIKGVADALFYLHNNCF----PPIVHWDISSKNVLLDL--------- 614 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~~----~~ivH~DlKp~NIll~~--------- 614 (752)
|+||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999987532 12458999999999999999999998521 15999999999999964
Q ss_pred --------CCceEEeecccceeccCCCCCcccccCCCCccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCcchhhc
Q 041438 615 --------GYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFLFE 684 (752)
Q Consensus 615 --------~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDIwSlGvil~elltg~~pf~~~~~ 684 (752)
...+||+|||++....... ......||+.|+|||++.+ ..+++++|||||||++|||+||+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~- 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN- 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC-
Confidence 2348999999998764322 2234579999999998864 448899999999999999999999985211
Q ss_pred cccccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 685 MSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
........+......+ ....+.++.++|.+||+.+|++||++.|++.+
T Consensus 248 ----~~~qli~~lk~~p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 248 ----NFSQLISELKRGPDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred ----cHHHHHHHHhcCCCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 1111111122222221 12345678999999999999999999999954
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=292.28 Aligned_cols=225 Identities=27% Similarity=0.336 Sum_probs=174.8
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEecc
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~~~ 556 (752)
.|.....||+|+||.||++.. .+++.||||.+...... +.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 344456799999999999984 57899999987542211 33455678899999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW 636 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 636 (752)
+++|.+++... .+++.++..++.||+.|++|||+. +|+||||||+||++++++.++|+|||++..........
T Consensus 103 ~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 103 GGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 99999988543 378899999999999999999999 99999999999999999999999999987654333333
Q ss_pred ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHH
Q 041438 637 SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIM 716 (752)
Q Consensus 637 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 716 (752)
....|+..|+|||+..+..++.++|||||||++|||++|+.||.... .......+.. ..+.........+..+.
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 249 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP-----PLQAMRRIRD-NLPPRVKDSHKVSSVLR 249 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHh-cCCCccccccccCHHHH
Confidence 34578999999999988889999999999999999999999985211 1111111111 11111111123455688
Q ss_pred HHHHhccCcCCCCCCCHHHHHHH
Q 041438 717 QVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 717 ~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+++.+|+..||++|||++|++++
T Consensus 250 ~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 250 GFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHccCChhHCcCHHHHhhC
Confidence 99999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=286.01 Aligned_cols=226 Identities=26% Similarity=0.343 Sum_probs=177.4
Q ss_pred ccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC------------------------------CccccCCceEEE
Q 041438 502 DFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD------------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------------------~~~~~~~~~~lV 551 (752)
+|++.+.||+|+||.||+|...+++.+|+|.++..... +++......++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 58889999999999999999888999999987543210 345566788999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+++++|.+++.... .+++..+..++.|++.||+|+|+. +|+|+||||+||++++++.++|+|||.+.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999997543 378899999999999999999999 999999999999999999999999999876532
Q ss_pred CC------CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCC
Q 041438 632 DS------SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPS 705 (752)
Q Consensus 632 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (752)
.. .......|+..|+|||++.+..++.++||||+||++|+|++|+.||.... .......+.......+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~ 229 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD-----RLAAMFYIGAHRGLMPR 229 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC-----hHHHHHHhhhccCCCCC
Confidence 11 11123468899999999998889999999999999999999999985211 11111111111111111
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
. ......++.+++.+||+++|++||++.|++++
T Consensus 230 ~-~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 230 L-PDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred C-CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1 12345678899999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=297.64 Aligned_cols=230 Identities=23% Similarity=0.314 Sum_probs=183.6
Q ss_pred hhcccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC------------------------CccccCCceEEEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E 553 (752)
..+.|+|+..||.|+||.||+|..+ ++-..|.|++...... +.+...+..++..|
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 4566899999999999999999844 4555667776533211 23345678899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
||.||..+.++-.-+ ..+++.++..+++|++.||.|||+. +|||||||..|||++-+|.++++|||.+.......
T Consensus 110 FC~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~ 184 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR 184 (1187)
T ss_pred ecCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH
Confidence 999999999887654 4589999999999999999999999 99999999999999999999999999987654444
Q ss_pred CCcccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhh
Q 041438 634 SNWSKLAGTHGNVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (752)
.....++|||+|||||++. +.+|+.++||||||+++.||..+.+|.+.. ........+.....+... ..
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-----npMRVllKiaKSePPTLl-qP 258 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-----NPMRVLLKIAKSEPPTLL-QP 258 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-----chHHHHHHHhhcCCCccc-Cc
Confidence 4445679999999999865 567999999999999999999999996522 122233344444444322 23
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..+...+.+++.+||.+||+.||++.++++|
T Consensus 259 S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 259 SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 5677789999999999999999999999976
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=284.60 Aligned_cols=226 Identities=22% Similarity=0.324 Sum_probs=180.5
Q ss_pred ccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEe
Q 041438 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~ 554 (752)
+|++.+.||+|+||.||+++ ..+|+.||+|.+...... +++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 58899999999999999998 457899999987532111 344566789999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+.+++|.+++..... ..+++.++..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||.+........
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999999875432 3478899999999999999999999 999999999999999999999999999987654333
Q ss_pred CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 635 NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
......|+..|+|||+..+..++.++|||||||++|+|++|+.||.. .........+.....+.. ....+.+
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-----~~~~~~~~~~~~~~~~~~---~~~~~~~ 228 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA-----GNMKNLVLKIIRGSYPPV---SSHYSYD 228 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC-----CCHHHHHHHHhcCCCCCC---cccCCHH
Confidence 33334688899999999888899999999999999999999999852 112222233333332211 1234567
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+.++|.+||+.+|++||+++|+++|
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 229 LRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhhC
Confidence 8999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=286.89 Aligned_cols=224 Identities=25% Similarity=0.345 Sum_probs=178.7
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEe
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~ 554 (752)
..|+..+.||+|+||.||+|+. .+++.||+|.+...... +.+......++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 4577889999999999999985 46899999987643211 334556789999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++++|.+++... ++++.++..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||.+........
T Consensus 84 ~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 9999999998643 378899999999999999999999 999999999999999999999999999987654333
Q ss_pred CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 635 NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
......++..|+|||++.+..++.++|||||||++|||+||+.||.... .......+..... + ......+..
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-----~~~~~~~~~~~~~--~-~~~~~~~~~ 228 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH-----PMRVLFLIPKNNP--P-TLTGEFSKP 228 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC-----hHhHhhhhhcCCC--C-CCchhhhHH
Confidence 3333468889999999988889999999999999999999999985211 1111111111111 1 112346678
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+.+++.+||+.+|++||++++++++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 229 FKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHcccCcccCcCHHHHHhC
Confidence 8999999999999999999999877
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=291.05 Aligned_cols=224 Identities=29% Similarity=0.425 Sum_probs=169.8
Q ss_pred cceeeccCCceEEEEEEeC-----CCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEe
Q 041438 505 AKHCIGKGGHGSVYIARVP-----SGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 505 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~ 554 (752)
+.+.||.|.||.||+|.+. .+..|+||.++..... +++.+.+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 5688999999999999965 3678999999653221 455666779999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++|+|.+++.... ...+++.++..|+.||++||+|||++ +++|+||+++||+++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 99999999998762 23488999999999999999999999 999999999999999999999999999987632211
Q ss_pred C--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 635 N--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 635 ~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
. .........|+|||.+.+..++.++||||||+++||+++ |+.||... ........+.+...... ...+
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-----~~~~~~~~~~~~~~~~~---~~~~ 230 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-----DNEEIIEKLKQGQRLPI---PDNC 230 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-----CHHHHHHHHHTTEETTS---BTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccccccccccccccee---ccch
Confidence 1 122356778999999998889999999999999999999 78887421 11222222222221111 1334
Q ss_pred HHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 712 FMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
+..+.+++.+||+.||++||+++++++.|
T Consensus 231 ~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 231 PKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp BHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 56788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=289.02 Aligned_cols=218 Identities=19% Similarity=0.270 Sum_probs=168.4
Q ss_pred eeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------------CccccCCceEEEEEecc
Q 041438 508 CIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 508 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------------~~~~~~~~~~lV~E~~~ 556 (752)
.||+|+||.||+|+. .+++.||+|.+...... ..+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 56899999987543211 12334567899999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW 636 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 636 (752)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.++++|||++....... .
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 152 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P 152 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--c
Confidence 999999887543 489999999999999999999999 99999999999999999999999999997654322 2
Q ss_pred ccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHH
Q 041438 637 SKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSI 715 (752)
Q Consensus 637 ~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 715 (752)
....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||..... ................. ....+.++
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~----~~~~~~~~ 226 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT--KDKHEIDRMTLTVNVEL----PDSFSPEL 226 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC--cCHHHHHHHhhcCCcCC----ccccCHHH
Confidence 23478999999998864 5589999999999999999999999852211 01111111111111111 13456678
Q ss_pred HHHHHhccCcCCCCCC-----CHHHHHHH
Q 041438 716 MQVAFSCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 716 ~~li~~cl~~dP~~Rp-----s~~evl~~ 739 (752)
.+++.+||+.||++|| +++|+++|
T Consensus 227 ~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 227 KSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 8999999999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=289.26 Aligned_cols=232 Identities=22% Similarity=0.370 Sum_probs=180.1
Q ss_pred hcccccceeeccCCceEEEEEEeC------CCcEEEEEccCCCCCC-------------------------CccccCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP------SGEIFAVKKFHSPLPD-------------------------NFCSHPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-------------------------~~~~~~~~~ 548 (752)
.++|++.+.||+|+||.||+|+.. ++..||+|.+...... +++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 568999999999999999999853 5789999988654321 344556778
Q ss_pred EEEEEeccCCChHHHhccCc-------------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCC
Q 041438 549 FIVYEYLESGSLDKILNNDA-------------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKN 609 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~N 609 (752)
++||||+++|+|.+++.... ....+++.+++.++.|++.||+|+|+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999997431 113477889999999999999999999 99999999999
Q ss_pred EEeCCCCceEEeecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccc
Q 041438 610 VLLDLGYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMS 686 (752)
Q Consensus 610 Ill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~ 686 (752)
|++++++.++|+|||.+......... ......+..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~---- 236 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM---- 236 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----
Confidence 99999999999999998765432211 112244667999999988889999999999999999997 88887411
Q ss_pred cccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 687 SSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
...+....+.+...... ....+.++.+++.+||+.||++|||++|+++.|++
T Consensus 237 -~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 -AHEEVIYYVRDGNVLSC---PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -CHHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11222233333322111 12345678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=288.92 Aligned_cols=228 Identities=23% Similarity=0.336 Sum_probs=175.4
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E 553 (752)
++|++.+.||+|+||.||+|+. .+|+.||+|+++..... +++......|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4789999999999999999995 57999999988654321 23445677899999
Q ss_pred eccCCChHHHhccCc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 554 YLESGSLDKILNNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
|++ |+|.+++.... ....+++..++.++.||+.||+|||+++ +++||||||+||+++.++.+||+|||.+......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 48888876532 2345899999999999999999999853 8999999999999999999999999999865432
Q ss_pred CCCcccccCCCCccCcccccc----CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccC-CCCCChh
Q 041438 633 SSNWSKLAGTHGNVAPELAYT----MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR-LPYPSLD 707 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 707 (752)
. ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.... ...+....+.... ...+
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~--- 229 (283)
T cd06617 158 V-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK----TPFQQLKQVVEEPSPQLP--- 229 (283)
T ss_pred c-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc----cCHHHHHHHHhcCCCCCC---
Confidence 2 2223468889999998764 446889999999999999999999985211 1111112222211 1111
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
....+.++.+++.+||..+|++||++++++++
T Consensus 230 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12355678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=288.46 Aligned_cols=237 Identities=24% Similarity=0.367 Sum_probs=177.4
Q ss_pred hcccccceeeccCCceEEEEEEe-----CCCcEEEEEccCCCCCC------------------------Ccc--ccCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-----PSGEIFAVKKFHSPLPD------------------------NFC--SHPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~------------------------~~~--~~~~~~ 548 (752)
..+|++.+.||+|+||.||+|+. .+++.||+|+++..... +++ ......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 35789999999999999999974 35889999998643211 111 223467
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. ||+||||||+||++++++.+||+|||++..
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 89999999999999996543 3478999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCc---ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcc-----ccccc--c---chHh
Q 041438 629 LNLDSSNW---SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM-----SSSSS--N---MNIE 695 (752)
Q Consensus 629 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~-----~~~~~--~---~~~~ 695 (752)
........ ....++..|+|||+..+..++.++|||||||++|||++|..|+...... ..... . ...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 64332211 1112345699999998888999999999999999999987775321100 00000 0 0111
Q ss_pred hhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 696 ILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
........+. ....+.++.+++.+||+.+|++|||++|+++.|+.+
T Consensus 238 ~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLKNNGRLPA--PPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHhcCCcCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111111111 123456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=282.59 Aligned_cols=230 Identities=20% Similarity=0.355 Sum_probs=179.9
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEecc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~~ 556 (752)
.++|++.++||+|+||.||+|...++..+|+|.++..... +.+.+ ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 4679999999999999999999777888999987653221 12222 66799999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC-
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN- 635 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~- 635 (752)
+++|.+++.... ...+++.++..++.|++.||.|||+. +++||||||+||+++.++.+||+|||.+.........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 84 KGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 999999997643 23478899999999999999999999 9999999999999999999999999999866432211
Q ss_pred cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
.....++..|+|||++....++.++|||||||++|+++| |+.||... ...... .........+. ....+.+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-----~~~~~~-~~~~~~~~~~~--~~~~~~~ 231 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-----SNPEVI-RALERGYRMPR--PENCPEE 231 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC-----CHHHHH-HHHhCCCCCCC--cccCCHH
Confidence 112245677999999988889999999999999999999 99998521 111111 11122222221 1344567
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
+.+++.+|++.+|++||++.++.+.|+.
T Consensus 232 ~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 232 LYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 8899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=290.44 Aligned_cols=229 Identities=24% Similarity=0.329 Sum_probs=179.5
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEe
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~ 554 (752)
.++|++.+.||+|+||.||+|+. .+++.||+|.+...... +.+..+...|+||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 46799999999999999999995 47899999987543211 344566788999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++++|.+++.... ..+++..++.++.|++.|+.|||+. +|+||||||+||+++.++.++|+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 99999999987543 3488999999999999999999999 999999999999999999999999999876544333
Q ss_pred CcccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 635 NWSKLAGTHGNVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
......+++.|+|||++. +..++.++|||||||++|||++|+.||... ........+.....+.. ....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~-~~~~ 232 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-----NPMRVLLKILKSEPPTL-DQPS 232 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-----CHHHHHHHHhcCCCCCc-CCcc
Confidence 334457899999999875 344678999999999999999999998521 11111222222211111 0112
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..+.++.+++.+||+.||++||++++++++
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 233 KWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 345678899999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=281.72 Aligned_cols=222 Identities=21% Similarity=0.315 Sum_probs=173.0
Q ss_pred eeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEeccCCChH
Q 041438 507 HCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEYLESGSLD 561 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~~~~g~L~ 561 (752)
+.||+|+||.||+|...+++.||+|.++..... +++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 468999999999999888999999987654321 3445567789999999999999
Q ss_pred HHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc-cccc
Q 041438 562 KILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW-SKLA 640 (752)
Q Consensus 562 ~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~-~~~~ 640 (752)
+++.... ..+++..+..++.|++.||.|+|+. +++||||||+||++++++.+|++|||++.......... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 9986543 3478899999999999999999999 99999999999999999999999999997643222111 1123
Q ss_pred CCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHH
Q 041438 641 GTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVA 719 (752)
Q Consensus 641 gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 719 (752)
++..|+|||++.+..++.++||||||+++|++++ |..||.... .......+.. ..... .....+.++.+++
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~-----~~~~~~~~~~-~~~~~--~~~~~~~~~~~li 227 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT-----NQQAREQVEK-GYRMS--CPQKCPDDVYKVM 227 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHHHc-CCCCC--CCCCCCHHHHHHH
Confidence 4567999999988889999999999999999998 999985211 1111111111 11111 1123456789999
Q ss_pred HhccCcCCCCCCCHHHHHHHHh
Q 041438 720 FSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 720 ~~cl~~dP~~Rps~~evl~~L~ 741 (752)
.+|++.+|++||++.|+++.|.
T Consensus 228 ~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 228 QRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHcccCcccCCCHHHHHHHhc
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=282.51 Aligned_cols=227 Identities=25% Similarity=0.371 Sum_probs=177.7
Q ss_pred cccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEeccC
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~~~ 557 (752)
.+|++.+.||+|+||.||+|...+++.+|+|.+...... +++......++||||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 578889999999999999999777889999988754321 334456778999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC-c
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN-W 636 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~ 636 (752)
++|.+++.... ..++++.++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+......... .
T Consensus 84 ~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 84 GCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 99999987543 2478899999999999999999999 9999999999999999999999999998865432211 1
Q ss_pred ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc-CCCCCChhhHHHHHH
Q 041438 637 SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RLPYPSLDVQNKFMS 714 (752)
Q Consensus 637 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 714 (752)
....++..|+|||++.+..++.++||||+||++|||++ |..||... ............ ....+ ...+..
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~----~~~~~~ 229 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR-----SNSEVVETINAGFRLYKP----RLASQS 229 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC-----CHHHHHHHHhCCCCCCCC----CCCCHH
Confidence 12235578999999988889999999999999999998 99998521 111111121111 11111 123457
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHHh
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~L~ 741 (752)
+.+++.+||+.+|++||+++|++++|.
T Consensus 230 ~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 230 VYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=291.40 Aligned_cols=237 Identities=20% Similarity=0.317 Sum_probs=175.3
Q ss_pred hcccccceeeccCCceEEEEEEeCC---------------CcEEEEEccCCCCCC-------------------------
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPS---------------GEIFAVKKFHSPLPD------------------------- 539 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~------------------------- 539 (752)
.++|++.+.||+|+||.||+|+... ...||+|.++.....
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3589999999999999999987432 235899988754211
Q ss_pred CccccCCceEEEEEeccCCChHHHhccCcc---------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCE
Q 041438 540 NFCSHPRQSFIVYEYLESGSLDKILNNDAS---------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNV 610 (752)
Q Consensus 540 ~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~---------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NI 610 (752)
+++......++||||+++++|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 344556788999999999999999864321 12367889999999999999999999 999999999999
Q ss_pred EeCCCCceEEeecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh--CCCCcchhhccc
Q 041438 611 LLDLGYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPRDFLFEMS 686 (752)
Q Consensus 611 ll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt--g~~pf~~~~~~~ 686 (752)
++++++.+||+|||++......... .....++..|+|||+..+..++.++|||||||++|||++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999999765432211 112245678999999988889999999999999999998 667774211100
Q ss_pred cccccchHhhhcc--CCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 687 SSSSNMNIEILDS--RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 687 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
........... ...... .....+..+.+++.+||+.||++||++++|++.|++
T Consensus 241 --~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 --VIENTGEFFRNQGRQIYLS-QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred --HHHHHHHhhhhccccccCC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 00000000010 000000 112245679999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=284.20 Aligned_cols=227 Identities=25% Similarity=0.340 Sum_probs=180.0
Q ss_pred ccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------Ccc--ccCCceEEEE
Q 041438 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFC--SHPRQSFIVY 552 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~--~~~~~~~lV~ 552 (752)
+|++.+.||.|+||.||+|. ..+++.||+|.+...... +++ ......+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58889999999999999998 457899999987543211 111 2335679999
Q ss_pred EeccCCChHHHhccCc-cccccCHHHHHHHHHHHHHHHHHHH-----hCCCCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 553 EYLESGSLDKILNNDA-SAKELGWTQRLNVIKGVADALFYLH-----NNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH-----~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
||+++++|.+++.... ....+++..++.++.|++.||+|+| +. +++|+||||+||++++++.+||+|||.+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999987532 2345889999999999999999999 77 9999999999999999999999999999
Q ss_pred eeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCCh
Q 041438 627 KFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706 (752)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (752)
..............+++.|+|||++.+..++.++||||||+++|+|++|+.||... ........+.....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~-- 230 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-----NQLQLASKIKEGKFRRI-- 230 (265)
T ss_pred ccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc-----CHHHHHHHHhcCCCCCC--
Confidence 88764443234457899999999999888999999999999999999999998621 11222222222222211
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
....+..+.+++.+|++.+|++||++++++++
T Consensus 231 -~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 231 -PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 13455678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=288.15 Aligned_cols=232 Identities=19% Similarity=0.275 Sum_probs=172.0
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEe
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~ 554 (752)
+|++.+.||+|+||.||+|+. .+|+.||+|+++..... +++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 488899999999999999995 57999999988642111 234456778999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++ +|.+++.... ..+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||.++.......
T Consensus 81 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CDQ-DLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 975 8888776433 3488999999999999999999999 999999999999999999999999999987654333
Q ss_pred CcccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCcchhhccccc-----------cccch---Hhhhcc
Q 041438 635 NWSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS-----------SSNMN---IEILDS 699 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~-----------~~~~~---~~~~~~ 699 (752)
......++..|+|||++.+.. ++.++|||||||++|||+||..|+......... ..... ....+.
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 333456789999999887654 689999999999999999999886311110000 00000 000000
Q ss_pred -CCC-CCC-----hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 700 -RLP-YPS-----LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 700 -~~~-~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..+ .+. ......+.++.+++.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000 000 0011235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=284.95 Aligned_cols=233 Identities=23% Similarity=0.267 Sum_probs=176.5
Q ss_pred HHhhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC------------------------CccccCCceEEE
Q 041438 497 IRATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 497 ~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV 551 (752)
+.+++.+.....||+|+||.||+|+ ..+++.||+|.+...... +++...+..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 3456677777899999999999998 456788999987643221 345566789999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC-CCceEEeecccceecc
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL-GYEAHVSDFRIAKFLN 630 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~-~~~~kl~DfG~a~~~~ 630 (752)
|||+++++|.+++.........++..+..++.|++.|++|||+. +|+||||||+||+++. ++.++|+|||.+....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 99999999999997543211127788899999999999999999 9999999999999986 6789999999998664
Q ss_pred CCCCCcccccCCCCccCccccccCC--CCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHh-hhccCCCCCChh
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE-ILDSRLPYPSLD 707 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 707 (752)
..........|++.|+|||++.+.. ++.++||||+|+++|+|++|+.||.... ......... ........+
T Consensus 161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~--- 234 (268)
T cd06624 161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG---EPQAAMFKVGMFKIHPEIP--- 234 (268)
T ss_pred cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc---ChhhhHhhhhhhccCCCCC---
Confidence 3333233346889999999986543 7889999999999999999999985211 100111111 111111122
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
....+++.+++.+||+.+|++|||+.|+++|
T Consensus 235 -~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 235 -ESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -cccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 2345678899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=292.00 Aligned_cols=228 Identities=23% Similarity=0.300 Sum_probs=180.7
Q ss_pred cccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC---------------------------CccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~ 552 (752)
++|++.+.||+|+||.||+|+.. +++.||+|.+...... +.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47899999999999999999954 5899999988654221 2344567789999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+.+++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999987543 24588999999999999999999999 9999999999999999999999999998765322
Q ss_pred CC-----------------------------CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhh
Q 041438 633 SS-----------------------------NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLF 683 (752)
Q Consensus 633 ~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~ 683 (752)
.. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~- 235 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS- 235 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC-
Confidence 11 011236788999999999888999999999999999999999998521
Q ss_pred ccccccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCC----HHHHHHH
Q 041438 684 EMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT----MKRFEVQ 739 (752)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~evl~~ 739 (752)
........+.......+.. ...+..+.+++.+||+.||++||+ ++|++++
T Consensus 236 ----~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 236 ----NRDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred ----chHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 1122233333333333321 225678999999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=289.65 Aligned_cols=236 Identities=19% Similarity=0.318 Sum_probs=175.5
Q ss_pred hcccccceeeccCCceEEEEEEeC-----------------CCcEEEEEccCCCCCC-----------------------
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP-----------------SGEIFAVKKFHSPLPD----------------------- 539 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~----------------------- 539 (752)
.++|++.++||+|+||.||+|+.. ++..||+|.++.....
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357999999999999999998532 2457999988753211
Q ss_pred --CccccCCceEEEEEeccCCChHHHhccCcc--------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCC
Q 041438 540 --NFCSHPRQSFIVYEYLESGSLDKILNNDAS--------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKN 609 (752)
Q Consensus 540 --~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~N 609 (752)
+++...+..++||||+++|+|.+++..... ...+++.++..++.|++.|++|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 344556778999999999999999875421 12467889999999999999999999 99999999999
Q ss_pred EEeCCCCceEEeecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh--CCCCcchhhcc
Q 041438 610 VLLDLGYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPRDFLFEM 685 (752)
Q Consensus 610 Ill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt--g~~pf~~~~~~ 685 (752)
|++++++.++|+|||.++........ .....++..|+|||...+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999999865432211 112244678999999888889999999999999999998 77887421110
Q ss_pred ccccccchHhhhcc---CCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 686 SSSSSNMNIEILDS---RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 686 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
.. . ......... ....+. ...++..+.+++.+||+.||++||+++|+.+.|++
T Consensus 241 ~~-~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QV-I-ENTGEFFRDQGRQVYLPK--PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH-H-HHHHHHHhhccccccCCC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 0 000000000 001111 12344678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=287.78 Aligned_cols=233 Identities=21% Similarity=0.339 Sum_probs=175.3
Q ss_pred cccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC--------------------------CccccCCceEEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E 553 (752)
++|++.+.||+|+||.||+|+.. +++.||+|++...... +++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47899999999999999999954 6899999987532110 33455678899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|++++.+..+..... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999988888765432 488999999999999999999999 99999999999999999999999999998775443
Q ss_pred CCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhcccccc------cc---chHhhhcc----
Q 041438 634 SNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS------SN---MNIEILDS---- 699 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~------~~---~~~~~~~~---- 699 (752)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||.......... .. ....+.+.
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 33334567889999998876 457899999999999999999999985221100000 00 00000000
Q ss_pred ---CCCCCC------hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 700 ---RLPYPS------LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 700 ---~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..+.+. ......+..+.+++.+||++||++||++.|++.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000 0112335678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=290.34 Aligned_cols=224 Identities=26% Similarity=0.350 Sum_probs=175.3
Q ss_pred cccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEeccC
Q 041438 503 FDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
|+....||+|+||.||+|+. .+++.||+|.+...... +++...+..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 44556899999999999984 57899999987542211 344556789999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
++|.+++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...........
T Consensus 103 ~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 103 GALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred CCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 9999987542 378899999999999999999999 999999999999999999999999999876544333334
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHH
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 717 (752)
...|+..|+|||++.+..++.++|||||||++|||++|+.||... ........+....... .......+..+.+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-----~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 249 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD-----SPVQAMKRLRDSPPPK-LKNAHKISPVLRD 249 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhccCCCC-ccccCCCCHHHHH
Confidence 457899999999999888999999999999999999999998521 1111111111111111 1111234557889
Q ss_pred HHHhccCcCCCCCCCHHHHHHH
Q 041438 718 VAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 718 li~~cl~~dP~~Rps~~evl~~ 739 (752)
++.+||+.+|++||++++++++
T Consensus 250 ~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 250 FLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHhcCCcccCcCHHHHhhC
Confidence 9999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=283.64 Aligned_cols=230 Identities=25% Similarity=0.431 Sum_probs=177.5
Q ss_pred cccccceeeccCCceEEEEEEeC-CC---cEEEEEccCCCCCC-------------------------CccccCCceEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVP-SG---EIFAVKKFHSPLPD-------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV 551 (752)
++|++.+.||+|+||.||+|+.. ++ ..||||.++..... +++......++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 46889999999999999999853 33 36999998754221 334556778999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+.....
T Consensus 84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999987543 3478899999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCc--c-ccc--CCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCC
Q 041438 632 DSSNW--S-KLA--GTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPS 705 (752)
Q Consensus 632 ~~~~~--~-~~~--gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (752)
..... . ... .+..|+|||++.+..++.++|||||||++||+++ |..||... ........+ ......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~-----~~~~~~~~i-~~~~~~~~ 232 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-----SNQDVINAI-EQDYRLPP 232 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC-----CHHHHHHHH-HcCCcCCC
Confidence 22111 1 111 2357999999998899999999999999999886 99998421 111111122 11122221
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
..+.+..+.+++.+||+++|++||++++++..|+++
T Consensus 233 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 233 --PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 133456788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=316.22 Aligned_cols=232 Identities=25% Similarity=0.382 Sum_probs=186.1
Q ss_pred cccccceeeccCCceEEEEEEeC--CCc----EEEEEccCCCCCC-------------------------CccccCCceE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVP--SGE----IFAVKKFHSPLPD-------------------------NFCSHPRQSF 549 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~~-------------------------~~~~~~~~~~ 549 (752)
..-+..+.||+|.||.||+|... .|. .||||.+++.... ++|-+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 34566789999999999999843 343 4999988765332 5666678899
Q ss_pred EEEEeccCCChHHHhccCcc----ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccc
Q 041438 550 IVYEYLESGSLDKILNNDAS----AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRI 625 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~ 625 (752)
|++|||++|||..++++... ...++..+...++.|||+|+.||+++ ++|||||-..|+|++....|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999987521 24588899999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCCCc-ccc-cCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchH-hhhccCC
Q 041438 626 AKFLNLDSSNW-SKL-AGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNI-EILDSRL 701 (752)
Q Consensus 626 a~~~~~~~~~~-~~~-~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~-~~~~~~~ 701 (752)
|+.+....... ... .-...|||||.+.++.++.|+|||||||++||++| |..||. .....+... ....+++
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~-----~~~n~~v~~~~~~ggRL 923 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYP-----SRSNFEVLLDVLEGGRL 923 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCC-----CcchHHHHHHHHhCCcc
Confidence 99543222111 111 22358999999999999999999999999999998 899985 222233333 3344455
Q ss_pred CCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 702 PYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 702 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
+.| ..++..+.++|.+||+.+|++||++..+++++.++.
T Consensus 924 ~~P----~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 924 DPP----SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred CCC----CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 555 456778899999999999999999999999988875
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=280.47 Aligned_cols=222 Identities=25% Similarity=0.311 Sum_probs=172.4
Q ss_pred eeeccCCceEEEEEEeC-C---CcEEEEEccCCCCCC-------------------------CccccCCceEEEEEeccC
Q 041438 507 HCIGKGGHGSVYIARVP-S---GEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
++||+|+||.||+|+.. . +..||+|.++..... +++ .....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC-KGEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-cCCceEEEEEeCCC
Confidence 46999999999999732 2 378999998755431 122 34567999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
|+|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++..........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999997654 478899999999999999999999 999999999999999999999999999987654332221
Q ss_pred c---ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHH
Q 041438 638 K---LAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 638 ~---~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
. ..++..|+|||.+.+..++.++|||||||++|||++ |+.||.... .......+... ...+ .....+.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~-----~~~~~~~~~~~-~~~~--~~~~~~~ 225 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-----GAEVIAMLESG-ERLP--RPEECPQ 225 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC-----HHHHHHHHHcC-CcCC--CCCCCCH
Confidence 1 123467999999988889999999999999999998 999985211 11111112111 1111 1133456
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
.+.+++.+||+.+|++||++.++++.|+++
T Consensus 226 ~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 226 EIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=284.56 Aligned_cols=236 Identities=23% Similarity=0.373 Sum_probs=183.0
Q ss_pred hcccccceeeccCCceEEEEEEeC-CCc----EEEEEccCCCCCC-------------------------CccccCCceE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP-SGE----IFAVKKFHSPLPD-------------------------NFCSHPRQSF 549 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~-------------------------~~~~~~~~~~ 549 (752)
..+|++.+.||+|+||.||+|... +|+ .||+|........ +++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 367889999999999999999843 333 6899987654321 22333 6788
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+||||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||.++..
T Consensus 85 ~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 9999999999999997643 2388999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCcc--cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccC-CCCCC
Q 041438 630 NLDSSNWS--KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSR-LPYPS 705 (752)
Q Consensus 630 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~ 705 (752)
........ ...++..|+|||.+....++.++|||||||++||+++ |+.||+.. ...+....+.... .+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~- 233 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-----PAVEIPDLLEKGERLPQP- 233 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHhCCCCCCCC-
Confidence 53322111 1223568999999988889999999999999999998 99998521 1122222222221 1222
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCCCCC
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPDHN 750 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~ 750 (752)
.....++.+++.+||..||++||++.++++.|+++...|..-
T Consensus 234 ---~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~ 275 (279)
T cd05057 234 ---PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQRY 275 (279)
T ss_pred ---CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcce
Confidence 223456889999999999999999999999999987766543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=321.97 Aligned_cols=231 Identities=27% Similarity=0.366 Sum_probs=185.7
Q ss_pred HHHhhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------CccccCCce
Q 041438 496 IIRATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQS 548 (752)
Q Consensus 496 ~~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~ 548 (752)
+...+-+|+...+||.|.||.||-|. ..+|+..|+|.++..... ++--|.+.+
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 34467789999999999999999998 678999999977543221 344567888
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
+|.||||++|+|.+.+...+- .++.....+..|++.|+.|||++ |||||||||+||+++.+|.+|++|||.|..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeE
Confidence 999999999999999976542 45566778899999999999999 999999999999999999999999999998
Q ss_pred ccCCCCC----cccccCCCCccCccccccCC---CCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccC-
Q 041438 629 LNLDSSN----WSKLAGTHGNVAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR- 700 (752)
Q Consensus 629 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~---~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~- 700 (752)
+...... .....||+.|||||++.+.. ...++||||+|||+.||+||+.||... +.....+..+..+.
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~----dne~aIMy~V~~gh~ 1459 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL----DNEWAIMYHVAAGHK 1459 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc----cchhHHHhHHhccCC
Confidence 8755322 22358999999999988654 567899999999999999999998521 12233344444443
Q ss_pred CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 701 LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 701 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
++.| ...+.+-.+++..|++.||++|+++.|++++-
T Consensus 1460 Pq~P----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1460 PQIP----ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred CCCc----hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 3344 34777888999999999999999999998763
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=289.10 Aligned_cols=230 Identities=18% Similarity=0.168 Sum_probs=166.1
Q ss_pred hcccccceeeccCCceEEEEEEeCC----CcEEEEEccCCCCCC-----------------------------------C
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPS----GEIFAVKKFHSPLPD-----------------------------------N 540 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-----------------------------------~ 540 (752)
.++|++.+.||+|+||.||+|+..+ +..+|+|........ +
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999999543 456677753221110 0
Q ss_pred cccc----CCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC
Q 041438 541 FCSH----PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY 616 (752)
Q Consensus 541 ~~~~----~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~ 616 (752)
.+.. ....+++||++.. ++.+.+.... ..++..+..++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 0000 0133677887754 6666665432 246788899999999999999999 999999999999999999
Q ss_pred ceEEeecccceeccCCCC-------CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccccc
Q 041438 617 EAHVSDFRIAKFLNLDSS-------NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS 689 (752)
Q Consensus 617 ~~kl~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~ 689 (752)
.++|+|||+|+....... ......||+.|+|||+..+..++.++|||||||++|||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999987643221 1122469999999999999999999999999999999999999996321100000
Q ss_pred ----ccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHh
Q 041438 690 ----SNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 690 ----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 741 (752)
......+...... ....++.+.+++..|++.+|++||+++++.+.++
T Consensus 244 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFIKRLHEGKIK-----IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHHHHhhhhhhc-----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0011111111111 1234567899999999999999999999998763
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=292.20 Aligned_cols=234 Identities=21% Similarity=0.316 Sum_probs=179.8
Q ss_pred hcccccceeeccCCceEEEEEEeC--------CCcEEEEEccCCCCCC--------------------------CccccC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP--------SGEIFAVKKFHSPLPD--------------------------NFCSHP 545 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--------------------------~~~~~~ 545 (752)
..+|++.+.||+|+||.||+|+.. .+..||+|.++..... +++.+.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 357899999999999999999732 1237899987643211 334556
Q ss_pred CceEEEEEeccCCChHHHhccCc-------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe
Q 041438 546 RQSFIVYEYLESGSLDKILNNDA-------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL 612 (752)
Q Consensus 546 ~~~~lV~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll 612 (752)
...++||||+++|+|.+++.... ....+++.++..++.|++.||+|||+. +|+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence 77899999999999999987532 123478899999999999999999999 99999999999999
Q ss_pred CCCCceEEeecccceeccCCCCCc--ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhcccccc
Q 041438 613 DLGYEAHVSDFRIAKFLNLDSSNW--SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSS 689 (752)
Q Consensus 613 ~~~~~~kl~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~ 689 (752)
++++.+||+|||.++......... ....++..|+|||++.+..++.++|||||||++|||++ |..||... ..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~ 242 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-----PV 242 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC-----CH
Confidence 999999999999998764322111 11234567999999999889999999999999999998 88887421 11
Q ss_pred ccchHhhhccCC-CCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 690 SNMNIEILDSRL-PYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 690 ~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
......+..... ..+ ...+.++.+++.+||+.+|++||++.|++++|+++..
T Consensus 243 ~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 243 EELFKLLKEGHRMDKP----ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHHHcCCCCCCC----CCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 222222222111 111 2345578899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=284.52 Aligned_cols=230 Identities=23% Similarity=0.330 Sum_probs=179.8
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEe
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~ 554 (752)
++|++.+.||+|+||.||+|.. .+++.||+|.+...... +.+......++||||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 4688899999999999999995 47899999987654321 234456788999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
+++++|.+++.... ..+++..+..++.|++.|++|+|+ . +++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999997643 457889999999999999999999 8 99999999999999999999999999987654322
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHH
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
.. ...++..|+|||++.+..++.++||||+|+++|+|++|+.||................+.....+.. .....+.
T Consensus 156 ~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 231 (265)
T cd06605 156 AK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRL--PSGKFSP 231 (265)
T ss_pred hh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCC--ChhhcCH
Confidence 11 2578889999999988899999999999999999999999985221100111111222222221111 1122566
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
++.++|.+||..||++|||+.|++.+
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 232 DFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 78999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=289.18 Aligned_cols=231 Identities=23% Similarity=0.295 Sum_probs=176.6
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEe
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~ 554 (752)
++|++.+.||+|+||.||+|+. .+++.||+|.++..... +.+..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 4799999999999999999984 57889999987643211 344567889999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ +++||||||+||++++++.+||+|||.+......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 9999999999754 34788999999999999999999732 8999999999999999999999999998765322
Q ss_pred CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccc------ccccc-----------------
Q 041438 635 NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS------SSSSN----------------- 691 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~------~~~~~----------------- 691 (752)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....... .....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 1233578999999999888889999999999999999999999985211000 00000
Q ss_pred --------chHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 692 --------MNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 692 --------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
......... .+.........++.+++.+||..||++||+++|++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 234 PRPMAIFELLDYIVNEP--PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cchhhHHHHHHHHhcCC--CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000000 00001112455789999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=285.86 Aligned_cols=233 Identities=25% Similarity=0.335 Sum_probs=178.7
Q ss_pred HhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------Cccc------cCC
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCS------HPR 546 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~------~~~ 546 (752)
.++++|++.+.||+|++|.||+|+. .+++.||+|++...... +++. ...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999995 46789999987643211 1121 134
Q ss_pred ceEEEEEeccCCChHHHhccCc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRI 625 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~ 625 (752)
..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4799999999999999886532 124588999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCCCcccccCCCCccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccC
Q 041438 626 AKFLNLDSSNWSKLAGTHGNVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR 700 (752)
Q Consensus 626 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 700 (752)
+..............|+..|+|||++.. ..++.++|||||||++|+|++|+.||... ........+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~ 234 (275)
T cd06608 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM-----HPMRALFKIPRNP 234 (275)
T ss_pred ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc-----chHHHHHHhhccC
Confidence 9876543333344578999999998753 34678999999999999999999998521 1111112222211
Q ss_pred CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 701 LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 701 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+. .......+..+.+++.+||..||++|||++|++++
T Consensus 235 ~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 235 PPT-LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CCC-CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111 11112356678999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=283.48 Aligned_cols=230 Identities=21% Similarity=0.328 Sum_probs=180.0
Q ss_pred ccccceeeccCCceEEEEEEeC--CCcEEEEEccCCCCC---------------------------C--------Ccccc
Q 041438 502 DFDAKHCIGKGGHGSVYIARVP--SGEIFAVKKFHSPLP---------------------------D--------NFCSH 544 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~---------------------------~--------~~~~~ 544 (752)
+|++.+.||+|+||.||+|+.. .++.+|+|.+..... . +++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 5888999999999999999954 478899997642110 0 34455
Q ss_pred CCceEEEEEeccCCChHHHhccC-ccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCEEeCCCCceEEee
Q 041438 545 PRQSFIVYEYLESGSLDKILNND-ASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHWDISSKNVLLDLGYEAHVSD 622 (752)
Q Consensus 545 ~~~~~lV~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~ivH~DlKp~NIll~~~~~~kl~D 622 (752)
.+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+ . +++|+||||+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 67899999999999999887542 123458889999999999999999996 5 899999999999999999999999
Q ss_pred cccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCC
Q 041438 623 FRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLP 702 (752)
Q Consensus 623 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 702 (752)
||.+....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||... ........+......
T Consensus 158 fg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~ 231 (269)
T cd08528 158 FGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-----NMLSLATKIVEAVYE 231 (269)
T ss_pred ccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc-----CHHHHHHHHhhccCC
Confidence 99998765433 334457889999999999888999999999999999999999998521 111122222222221
Q ss_pred CCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 703 YPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 703 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
.. .....++.+.+++.+||+.||++||++.|+.+++++
T Consensus 232 ~~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 232 PL--PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred cC--CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 11 112345678999999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=301.03 Aligned_cols=232 Identities=19% Similarity=0.214 Sum_probs=175.1
Q ss_pred hcccccceeeccCCceEEEEEEe---CCCcEEEEEccCCCCCC-------------------CccccCCceEEEEEeccC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV---PSGEIFAVKKFHSPLPD-------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~-------------------~~~~~~~~~~lV~E~~~~ 557 (752)
..+|++.+.||+|+||.||+|.. ..++.||+|.+...... +++......++||||+.+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC 170 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcCC
Confidence 45799999999999999999974 34678999987543221 334456788999999974
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC--
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN-- 635 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-- 635 (752)
+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 171 -~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 171 -DLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred -CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 888888433 3488999999999999999999999 9999999999999999999999999999876533221
Q ss_pred cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhh------------------
Q 041438 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEIL------------------ 697 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~------------------ 697 (752)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+.
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~l~~i~~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS--SSSQLRSIIRCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC--cHHHHHHHHHHhccCccccCCccchhH
Confidence 223579999999999999999999999999999999999999984221100 000000000
Q ss_pred -----------ccCCCCCCh-hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 698 -----------DSRLPYPSL-DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 698 -----------~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
......+.. .......++.++|.+||..||++|||+.|++.|=
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 000001100 0012345678899999999999999999999874
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=290.72 Aligned_cols=171 Identities=20% Similarity=0.337 Sum_probs=136.6
Q ss_pred ceeeccCCceEEEEEEeC---CCcEEEEEccCCCCCC----------------------Ccc--ccCCceEEEEEeccCC
Q 041438 506 KHCIGKGGHGSVYIARVP---SGEIFAVKKFHSPLPD----------------------NFC--SHPRQSFIVYEYLESG 558 (752)
Q Consensus 506 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~----------------------~~~--~~~~~~~lV~E~~~~g 558 (752)
..+||+|+||.||+|+.. ++..||+|.+...... +++ ......++||||+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 468999999999999854 4578999988654221 111 234677999999976
Q ss_pred ChHHHhccCc------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe----CCCCceEEeeccccee
Q 041438 559 SLDKILNNDA------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL----DLGYEAHVSDFRIAKF 628 (752)
Q Consensus 559 ~L~~~l~~~~------~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll----~~~~~~kl~DfG~a~~ 628 (752)
++.+++.... ....+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 7877775321 123478899999999999999999999 99999999999999 5667899999999987
Q ss_pred ccCCCC---CcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcc
Q 041438 629 LNLDSS---NWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRD 680 (752)
Q Consensus 629 ~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~ 680 (752)
...... ......||+.|+|||++.+. .++.++||||+||++|||+||++||.
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 653322 12334789999999988764 57999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=282.47 Aligned_cols=223 Identities=29% Similarity=0.388 Sum_probs=175.9
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------------CccccCCc
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------------NFCSHPRQ 547 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------------~~~~~~~~ 547 (752)
+|.+.+.||+|+||.||+|.. .+++.||+|.+...... +++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 478889999999999999984 56889999977543211 33445678
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 899999999999999997543 478899999999999999999999 99999999999999999999999999998
Q ss_pred eccCCCC------CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCC
Q 041438 628 FLNLDSS------NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRL 701 (752)
Q Consensus 628 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 701 (752)
....... ......|+..|+|||.+.+..++.++||||+||++|+|++|+.||.... .......+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~ 229 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT-----QLQAIFKIGENAS 229 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc-----HHHHHHHHhccCC
Confidence 7653211 1112357889999999988889999999999999999999999985211 1111111111111
Q ss_pred -CCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 702 -PYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 702 -~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..+ ...+..+.+++.+||++||++||++.|++++
T Consensus 230 ~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 230 PEIP----SNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CcCC----cccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 111 2345678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=282.53 Aligned_cols=220 Identities=23% Similarity=0.281 Sum_probs=172.4
Q ss_pred eeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------CccccCCceEEEEEeccC
Q 041438 507 HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
+.||+|+||.||+|.. .+++.||+|.+++.... +.+...+..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5789999999999984 56899999988643210 334456778999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
++|.+++.... .+++..+..++.|++.||.|+|+. +++||||||+||++++++.+||+|||.+..... ..
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 151 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK 151 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence 99999997543 478899999999999999999999 999999999999999999999999999876432 22
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHH
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 717 (752)
...++..|+|||.+.+..++.++||||+|+++|||++|+.||... ........+.......+.......++.+.+
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE-----TPDAVFDNILSRRINWPEEVKEFCSPEAVD 226 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHhcccCCCCcccccCCHHHHH
Confidence 346888999999998888899999999999999999999998521 112222222222222222222345678899
Q ss_pred HHHhccCcCCCCCCCHHHHHHHHh
Q 041438 718 VAFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 718 li~~cl~~dP~~Rps~~evl~~L~ 741 (752)
++.+||+.||++||++.++.+.+.
T Consensus 227 ~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 227 LINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HHHHHccCCHHHccCCCcHHHHHc
Confidence 999999999999997765555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=280.80 Aligned_cols=224 Identities=25% Similarity=0.369 Sum_probs=169.0
Q ss_pred eeeccCCceEEEEEEeC----CCcEEEEEccCCCCCC-------------------------Ccc-ccCCceEEEEEecc
Q 041438 507 HCIGKGGHGSVYIARVP----SGEIFAVKKFHSPLPD-------------------------NFC-SHPRQSFIVYEYLE 556 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-------------------------~~~-~~~~~~~lV~E~~~ 556 (752)
+.||+|+||.||+|... .+..||+|++...... +++ ..+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999842 2457999987532110 222 23456789999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC--
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS-- 634 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~-- 634 (752)
+|+|.+++.... ...++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999997543 2356778899999999999999999 999999999999999999999999999976543211
Q ss_pred --CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhC-CCCcchhhccccccccchHhhhccCC-CCCChhhHH
Q 041438 635 --NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKG-KHPRDFLFEMSSSSSNMNIEILDSRL-PYPSLDVQN 710 (752)
Q Consensus 635 --~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 710 (752)
......++..|+|||++.+..++.++|||||||++|||++| .+||... ........+..... ..+ ..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~----~~ 226 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----DSFDITVYLLQGRRLLQP----EY 226 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHhcCCCCCCC----Cc
Confidence 11123456789999999888899999999999999999995 5565311 11112222222211 111 22
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
.+..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 227 ~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 227 CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 3457889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=280.54 Aligned_cols=226 Identities=23% Similarity=0.352 Sum_probs=176.6
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC----------------------CccccCCceEEEEEeccC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD----------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~~~~lV~E~~~~ 557 (752)
.++|++.+.||+|+||.||++.. +++.||+|.++..... +++ ..+..++||||+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~~v~e~~~~ 82 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVI-LHNGLYIVMELMSK 82 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEE-cCCCcEEEEECCCC
Confidence 36789999999999999999975 6788999988653211 222 23457999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
++|.+++..... ..+++..+..++.|++.|+.|+|+. |++||||||+||+++.++.+||+|||.+...... ..
T Consensus 83 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---~~ 155 (254)
T cd05083 83 GNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---VD 155 (254)
T ss_pred CCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc---CC
Confidence 999999976432 3478899999999999999999999 9999999999999999999999999999764322 12
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHH
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIM 716 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 716 (752)
....+..|+|||++.+..++.++|||||||++|||++ |+.||... ...+....+ ....... .....+..+.
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-----~~~~~~~~~-~~~~~~~--~~~~~~~~~~ 227 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM-----SLKEVKECV-EKGYRME--PPEGCPADVY 227 (254)
T ss_pred CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC-----CHHHHHHHH-hCCCCCC--CCCcCCHHHH
Confidence 2244568999999988889999999999999999997 99998521 111111222 2222111 1134556788
Q ss_pred HHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 717 QVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 717 ~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
+++.+||+.+|++||+++++++.|++
T Consensus 228 ~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 228 VLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 99999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=283.47 Aligned_cols=224 Identities=26% Similarity=0.385 Sum_probs=176.3
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------CccccCCceEEEE
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~lV~ 552 (752)
.|++.+.||+|+||.||+|.. .+++.||+|.+...... +++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 578889999999999999994 67899999987543211 2334556789999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++++|.+++... .+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||.+......
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999998653 488999999999999999999999 9999999999999999999999999999877654
Q ss_pred CCCcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 633 SSNWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
........|+..|+|||++.+. .++.++|||||||++|+|++|+.||..... ......+... ..+.......
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~~~~~~~~~~--~~~~~~~~~~ 227 (277)
T cd06917 155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----FRAMMLIPKS--KPPRLEDNGY 227 (277)
T ss_pred ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----hhhhhccccC--CCCCCCcccC
Confidence 4334445789999999987654 468999999999999999999999852211 1111111111 1111111225
Q ss_pred HHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 712 FMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+.++.+++.+||+.||++||++.|++++
T Consensus 228 ~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 228 SKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 5678999999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=286.61 Aligned_cols=221 Identities=24% Similarity=0.295 Sum_probs=178.8
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~ 552 (752)
++|++.+.||+|+||.||+|+. .+++.||+|.++..... +++.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4789999999999999999984 46899999987532110 3445567889999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999987653 478899999999999999999999 9999999999999999999999999999876533
Q ss_pred CCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHH
Q 041438 633 SSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (752)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||... ........+.......+. ..+
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~----~~~ 222 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD-----NPIQIYEKILEGKVRFPS----FFS 222 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcCCccCCc----cCC
Confidence 23347899999999998888899999999999999999999998521 122223333344444332 235
Q ss_pred HHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 041438 713 MSIMQVAFSCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 739 (752)
..+.+++.+||+.||++|+ +++|+++|
T Consensus 223 ~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 223 PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 6788999999999999999 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=285.47 Aligned_cols=227 Identities=23% Similarity=0.345 Sum_probs=179.1
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEe
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~ 554 (752)
.++|++.+.||+|+||.||++.. .+++.||+|.+...... +++...+..|+|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 46899999999999999999984 57889999987532211 344556788999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++++|.+++.+. .+++..+..++.|++.|+.|||++ +++||||||+||+++.++.+||+|||.+........
T Consensus 98 ~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 9999999998653 377889999999999999999999 999999999999999999999999999876654333
Q ss_pred CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 635 NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
......+++.|+|||.+.+..++.++|||||||++|++++|+.||..... ...............+ .....+..
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~----~~~~~~~~~~~~~~~~--~~~~~~~~ 244 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP----LRALYLIATNGTPELQ--NPEKLSAI 244 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----hhheeehhcCCCCCCC--CccccCHH
Confidence 33345788899999999888899999999999999999999999852211 0110000111111111 12334567
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+.+++.+||+.+|++||++++++.|
T Consensus 245 l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 245 FRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 8899999999999999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-33 Score=292.53 Aligned_cols=221 Identities=26% Similarity=0.359 Sum_probs=176.5
Q ss_pred cccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------------CccccCCceEEEEEe
Q 041438 503 FDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E~ 554 (752)
|+-.+.||.|+||.||-|+ ..+.+.||||++.-.... +++-.....|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 5556789999999999999 578899999987543221 334455677999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
|-| +-.+++.-.. +++.+..+..|..+.+.||+|||+. +.||||||..|||+++.|.||++|||.|....+
T Consensus 108 ClG-SAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 108 CLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred Hhc-cHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 976 7778776544 4588899999999999999999999 999999999999999999999999999987643
Q ss_pred CcccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 635 NWSKLAGTHGNVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
...++|||.|||||++. .+.|+-|+||||+||+..|+...++|.- .+. .-.....+.....|.. ...++
T Consensus 179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF---nMN--AMSALYHIAQNesPtL--qs~eW 250 (948)
T KOG0577|consen 179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMN--AMSALYHIAQNESPTL--QSNEW 250 (948)
T ss_pred -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc---Cch--HHHHHHHHHhcCCCCC--CCchh
Confidence 34579999999999865 5679999999999999999999999952 221 1112223333333322 23566
Q ss_pred HHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 712 FMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
+..+..++..||++-|.+|||.+++++|-
T Consensus 251 S~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 251 SDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred HHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 77788999999999999999999998874
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=288.18 Aligned_cols=230 Identities=23% Similarity=0.294 Sum_probs=178.0
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~ 552 (752)
++|++.+.||+|+||.||+++. .+++.||+|.+...... +.+......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4789999999999999999994 56889999987643210 2344567789999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++++|.+++.... .+++..+..++.|++.|++|+|+. +++||||||+||+++.++.+|++|||.++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999997543 478899999999999999999999 9999999999999999999999999998742111
Q ss_pred CC---------------CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhh
Q 041438 633 SS---------------NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEIL 697 (752)
Q Consensus 633 ~~---------------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 697 (752)
.. ......++..|+|||.+.+..++.++|||||||++||+++|+.||.. ....+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~-----~~~~~~~~~~~ 229 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-----DTPEELFGQVI 229 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-----CCHHHHHHHHH
Confidence 00 00123578899999999888899999999999999999999999841 11222233333
Q ss_pred ccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 698 DSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 698 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
......+... ...+.++.+++.+||+.||++||++.++.+.++.
T Consensus 230 ~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 SDDIEWPEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred hcccCCCCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 3333333211 2355678999999999999999997666666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=280.93 Aligned_cols=225 Identities=24% Similarity=0.353 Sum_probs=169.4
Q ss_pred eeeccCCceEEEEEEeC-CCc--EEEEEccCCCCCC--------------------------CccccCCceEEEEEeccC
Q 041438 507 HCIGKGGHGSVYIARVP-SGE--IFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
+.||+|+||.||+|+.. ++. .+|+|.++..... +++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999853 443 4688877642211 233445678999999999
Q ss_pred CChHHHhccCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecc
Q 041438 558 GSLDKILNNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFR 624 (752)
Q Consensus 558 g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG 624 (752)
|+|.+++..... ...++++++..++.|++.|++|||+. +++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999875321 12478899999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc-CCC
Q 041438 625 IAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RLP 702 (752)
Q Consensus 625 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~ 702 (752)
++....... .......+..|+|||++.+..++.++|||||||++|||++ |+.||.... .......+... ...
T Consensus 158 l~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~~~~~~~~~~~~~~~ 231 (270)
T cd05047 158 LSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYEKLPQGYRLE 231 (270)
T ss_pred Cccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-----HHHHHHHHhCCCCCC
Confidence 986322111 1111233567999999988889999999999999999997 999985211 11111112111 111
Q ss_pred CCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 703 YPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 703 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
.+ ...+.++.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 232 ~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 232 KP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CC----CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11 223456889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=291.12 Aligned_cols=231 Identities=19% Similarity=0.255 Sum_probs=169.2
Q ss_pred cceeeccC--CceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEec
Q 041438 505 AKHCIGKG--GHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 505 ~~~~lg~G--~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~~ 555 (752)
+.++||+| +|++||+++ ..+|+.||+|+++..... +++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 688999998 468999999998754221 3455677899999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC-
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS- 634 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 634 (752)
++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999999965432 3488999999999999999999999 999999999999999999999999987544321111
Q ss_pred ------CcccccCCCCccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCcchhhcccc-------cccc-------c
Q 041438 635 ------NWSKLAGTHGNVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS-------SSSN-------M 692 (752)
Q Consensus 635 ------~~~~~~gt~~y~aPE~~~~--~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~-------~~~~-------~ 692 (752)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ .... .
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 0112356778999999876 4589999999999999999999999853211000 0000 0
Q ss_pred hHhh--------hcc-----CC---CCC-------ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 693 NIEI--------LDS-----RL---PYP-------SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 693 ~~~~--------~~~-----~~---~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.... .+. .. ..+ ........+.+.+++.+||+.||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0000 000 00 000 00112345678899999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-33 Score=271.81 Aligned_cols=237 Identities=22% Similarity=0.288 Sum_probs=175.8
Q ss_pred hcccccceeeccCCceEEEEEEeC---C--CcEEEEEccCCCCCC---------------------------CccccCCc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP---S--GEIFAVKKFHSPLPD---------------------------NFCSHPRQ 547 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~---------------------------~~~~~~~~ 547 (752)
...|+....||+|+||.||+|... + ...+|+|+++..... .+..++..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 457899999999999999999622 2 347999999865322 23345788
Q ss_pred eEEEEEeccCCChHHHhccCc--cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC----CceEEe
Q 041438 548 SFIVYEYLESGSLDKILNNDA--SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG----YEAHVS 621 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~----~~~kl~ 621 (752)
+++++||.+. +|..+++-+. ..+.++...++.|+.||+.|+.|||++ -|+||||||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 9999999998 9999987543 234578889999999999999999999 99999999999999866 899999
Q ss_pred ecccceeccCCCCCc---ccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCcchhhcccccccc----ch
Q 041438 622 DFRIAKFLNLDSSNW---SKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN----MN 693 (752)
Q Consensus 622 DfG~a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~----~~ 693 (752)
|+|+|+.+..+-... ...+-|.+|+|||.+.+.. |+++.||||.|||+.||+|-++.|....+....... ..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999999887554332 3457899999999988765 899999999999999999988877532211110000 00
Q ss_pred -------------------------HhhhccCCC-CCCh-------hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 694 -------------------------IEILDSRLP-YPSL-------DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 694 -------------------------~~~~~~~~~-~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
..+-+.+.. +... .....++...+++.++|..||.+|.|+++.+++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 000000000 0000 0001122477899999999999999999999875
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=267.77 Aligned_cols=228 Identities=20% Similarity=0.320 Sum_probs=188.3
Q ss_pred ceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEeccCCC
Q 041438 506 KHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEYLESGS 559 (752)
Q Consensus 506 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~~~~g~ 559 (752)
.+.||+|+|+.|--+. ..+|..||||++.+.... .+++++..+|+|||-|.||.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 4689999999999998 789999999999876322 56788899999999999999
Q ss_pred hHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCc---eEEeecccceeccCCC--C
Q 041438 560 LDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE---AHVSDFRIAKFLNLDS--S 634 (752)
Q Consensus 560 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~---~kl~DfG~a~~~~~~~--~ 634 (752)
|...+.++. .+++.++.+++++|+.||+|||.+ ||.|||+||+|||...... +|||||.++.-..... +
T Consensus 163 lLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 163 LLSHIQKRK---HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 999998654 488899999999999999999999 9999999999999975543 8999998875432211 1
Q ss_pred -----CcccccCCCCccCccccc---c--CCCCCccchhhHHHHHHHHHhCCCCcchhhc----cccc------cccchH
Q 041438 635 -----NWSKLAGTHGNVAPELAY---T--MKVTEKCDVYSFGVLALEVIKGKHPRDFLFE----MSSS------SSNMNI 694 (752)
Q Consensus 635 -----~~~~~~gt~~y~aPE~~~---~--~~~~~ksDIwSlGvil~elltg~~pf~~~~~----~~~~------~~~~~~ 694 (752)
.....+|+..|||||++. + ..|+.++|.||+|||+|-|+.|.+||...-. ++.. ......
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 123458999999999754 2 2489999999999999999999999953211 1111 233567
Q ss_pred hhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 695 EILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+.++.+.+|...+..++.+..+++...+..||.+|.++.+++.|
T Consensus 317 sIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 317 SIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 788999999999999999999999999999999999999998863
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=300.56 Aligned_cols=235 Identities=19% Similarity=0.187 Sum_probs=173.6
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCC---------------CC---CccccCCceEEEEEeccCCC
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPL---------------PD---NFCSHPRQSFIVYEYLESGS 559 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------------~~---~~~~~~~~~~lV~E~~~~g~ 559 (752)
...+|.+.+.||+|+||.||+|+. .+++.||||...... .. +++...+..++|||++. ++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~ 245 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SD 245 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CC
Confidence 355799999999999999999995 468899999643211 00 34456678899999996 58
Q ss_pred hHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC--cc
Q 041438 560 LDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN--WS 637 (752)
Q Consensus 560 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~ 637 (752)
|.+++.... ..+++.+++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 246 L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 246 LYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 988886533 3589999999999999999999999 9999999999999999999999999999876432221 12
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcc-c-cccccchHhhh-ccC--------------
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM-S-SSSSNMNIEIL-DSR-------------- 700 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~-~-~~~~~~~~~~~-~~~-------------- 700 (752)
...||..|+|||++.+..++.++|||||||++|||++|..|+-..... . .........++ ...
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 347999999999999999999999999999999999987664211000 0 00000000000 000
Q ss_pred -------------CCCCChhhH---HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 701 -------------LPYPSLDVQ---NKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 701 -------------~~~~~~~~~---~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.......+. ....++.++|.+||+.||++|||+.|+++|
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000011 223468899999999999999999999976
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=286.78 Aligned_cols=234 Identities=23% Similarity=0.352 Sum_probs=178.7
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCc----EEEEEccCCCCCC-------------------------CccccCCceE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGE----IFAVKKFHSPLPD-------------------------NFCSHPRQSF 549 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~-------------------------~~~~~~~~~~ 549 (752)
.++|+..+.||+|+||.||+|+. .+|+ .||+|.+...... +++. ....+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-~~~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCL-SPTIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc-CCCce
Confidence 46788899999999999999984 4454 5789987654321 2222 23467
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+++||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||.++..
T Consensus 85 ~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 8999999999999987543 3478899999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCCh
Q 041438 630 NLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706 (752)
Q Consensus 630 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (752)
...... .....++..|+|||++.+..++.++|||||||++||+++ |+.||.... ..............+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~------~~~~~~~~~~~~~~~~- 232 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP------TREIPDLLEKGERLPQ- 232 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHCCCCCCC-
Confidence 433221 122345678999999988889999999999999999997 899985211 1111122222111111
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCC
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNP 747 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 747 (752)
....+.++.+++.+||..+|++||+++++++.++++...+
T Consensus 233 -~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 233 -PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred -CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 1223457889999999999999999999999999876444
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=285.00 Aligned_cols=233 Identities=20% Similarity=0.337 Sum_probs=175.5
Q ss_pred cccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC--------------------------CccccCCceEEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E 553 (752)
++|++.+.||+|+||.||+|+.. +++.||+|++...... +++...+..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47899999999999999999964 6899999987542211 34556678999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|++++++.++..... .+++.++..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999988888765432 378999999999999999999999 99999999999999999999999999998765444
Q ss_pred CCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhcccc---------ccccchHhhhccC---
Q 041438 634 SNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS---------SSSNMNIEILDSR--- 700 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~---------~~~~~~~~~~~~~--- 700 (752)
.......++..|+|||++.+ ..++.++|||||||++|||++|++||........ .............
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 33344568899999998875 3478899999999999999999999852111000 0000000000000
Q ss_pred --CCCCC--------hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 701 --LPYPS--------LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 701 --~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...+. ......+..+.+++.+||+.+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000 0012345678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-33 Score=296.55 Aligned_cols=235 Identities=23% Similarity=0.317 Sum_probs=184.6
Q ss_pred HhhcccccceeeccCCceEEEEEEeCC--C---cEEEEEccCCCC-CC--------------------------CccccC
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARVPS--G---EIFAVKKFHSPL-PD--------------------------NFCSHP 545 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~~~-~~--------------------------~~~~~~ 545 (752)
-..++-...++||+|+||.||+|++.. + ..||||..+... .. +++...
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 345555667999999999999998432 2 238999887522 11 566778
Q ss_pred CceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccc
Q 041438 546 RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRI 625 (752)
Q Consensus 546 ~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~ 625 (752)
...++|||+|.||+|.+++++.+. .++..++..++.+.|+||+|||++ +++||||-.+|+|++.++.+||+|||+
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccc
Confidence 889999999999999999987653 588899999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCC
Q 041438 626 AKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYP 704 (752)
Q Consensus 626 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (752)
++....-........-...|+|||.+....+++++|||||||++||+++ |..||... ...+....+....++.+
T Consensus 309 s~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~-----~~~~v~~kI~~~~~r~~ 383 (474)
T KOG0194|consen 309 SRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM-----KNYEVKAKIVKNGYRMP 383 (474)
T ss_pred ccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC-----CHHHHHHHHHhcCccCC
Confidence 8764311111111234568999999999999999999999999999998 88898522 12233334433333332
Q ss_pred ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 705 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
.. ...+.++..++.+||..||++||+|.++.+.++.+.
T Consensus 384 ~~--~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 384 IP--SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred CC--CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 21 355667888999999999999999999999998875
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=276.85 Aligned_cols=222 Identities=24% Similarity=0.340 Sum_probs=172.6
Q ss_pred eeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEeccCCChH
Q 041438 507 HCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEYLESGSLD 561 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~~~~g~L~ 561 (752)
++||+|+||.||+|...+++.||+|.+...... +++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999999766999999987654321 3445667789999999999999
Q ss_pred HHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc--ccc
Q 041438 562 KILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW--SKL 639 (752)
Q Consensus 562 ~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~--~~~ 639 (752)
+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++......... ...
T Consensus 81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 9986543 2478899999999999999999999 99999999999999999999999999998654221111 112
Q ss_pred cCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHH
Q 041438 640 AGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQV 718 (752)
Q Consensus 640 ~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 718 (752)
.++..|+|||.+.+..++.++|||||||++|||+| |..||.... ..............+. ....+.++.++
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~------~~~~~~~~~~~~~~~~--~~~~~~~~~~l 227 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS------NQQTRERIESGYRMPA--PQLCPEEIYRL 227 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC------HHHHHHHHhcCCCCCC--CccCCHHHHHH
Confidence 33567999999988889999999999999999999 888874211 1111111221111111 12345678999
Q ss_pred HHhccCcCCCCCCCHHHHHHHHh
Q 041438 719 AFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 719 i~~cl~~dP~~Rps~~evl~~L~ 741 (752)
+.+|+..+|++||+++|+++.|+
T Consensus 228 i~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 228 MLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHhccChhhCcCHHHHHHHhh
Confidence 99999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=279.36 Aligned_cols=231 Identities=26% Similarity=0.336 Sum_probs=178.8
Q ss_pred hcccccceeeccCCceEEEEEEeCC----CcEEEEEccCCCCCC-------------------------CccccCCceEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPS----GEIFAVKKFHSPLPD-------------------------NFCSHPRQSFI 550 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-------------------------~~~~~~~~~~l 550 (752)
.++|++.+.||+|+||.||+|...+ ...||||........ +++ .....++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVI-TENPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEE-cCCCcEE
Confidence 3568889999999999999998533 347899987654321 222 2456789
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+++|+|.+++.... ..+++.++..++.|++.||+|+|+. +++||||||+||+++.++.+|++|||.++...
T Consensus 84 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 999999999999997543 2478999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCC-cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc-CCCCCChh
Q 041438 631 LDSSN-WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RLPYPSLD 707 (752)
Q Consensus 631 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 707 (752)
..... .....++..|+|||.+....++.++|||||||++||+++ |+.||.... ..+....+... ..+.+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~--- 230 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK-----NNDVIGRIENGERLPMP--- 230 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHcCCcCCCC---
Confidence 33211 112234568999999888889999999999999999986 999985221 11111122111 12222
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
...+..+.+++.+|+..+|++|||+.++++.|+++..
T Consensus 231 -~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 231 -PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 2345678999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=279.23 Aligned_cols=215 Identities=20% Similarity=0.288 Sum_probs=163.3
Q ss_pred eeeccCCceEEEEEEeCC-------------CcEEEEEccCCCCCC------------------------CccccCCceE
Q 041438 507 HCIGKGGHGSVYIARVPS-------------GEIFAVKKFHSPLPD------------------------NFCSHPRQSF 549 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~------------------------~~~~~~~~~~ 549 (752)
+.||+|+||.||+|+... ...||+|.+...... +++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998422 235899976543211 3455667789
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCc-------eEEee
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE-------AHVSD 622 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~-------~kl~D 622 (752)
+||||+++|+|..++.... ..+++..+..++.||++|++|||+. +|+||||||+||+++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999998886543 3488899999999999999999999 9999999999999986654 89999
Q ss_pred cccceeccCCCCCcccccCCCCccCccccc-cCCCCCccchhhHHHHHHHHH-hCCCCcchhhccccccccchHhhhccC
Q 041438 623 FRIAKFLNLDSSNWSKLAGTHGNVAPELAY-TMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDSR 700 (752)
Q Consensus 623 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDIwSlGvil~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~ 700 (752)
||.+...... ....++..|+|||++. +..++.++|||||||++|||+ +|..||.... ...........
T Consensus 156 ~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~------~~~~~~~~~~~ 225 (262)
T cd05077 156 PGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT------LAEKERFYEGQ 225 (262)
T ss_pred CCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc------hhHHHHHHhcC
Confidence 9998765322 2346788999999886 456899999999999999998 5888874211 01111111111
Q ss_pred CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 701 LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 701 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
.... .....++.+++.+||+.||++||++.++++++
T Consensus 226 ~~~~----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 226 CMLV----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ccCC----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1111 11235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=285.36 Aligned_cols=233 Identities=24% Similarity=0.327 Sum_probs=179.6
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E 553 (752)
.++|++.+.||+|+||.||+|+. .+++.||+|++...... +++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 46789999999999999999984 56899999976543211 34455678899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++++|.+++...+ .+++..+..++.|++.|+.|||+.. +++||||||+||++++++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 84 FMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred cCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999999987543 4788999999999999999999732 89999999999999999999999999987553221
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccc--c----ccchHhhhccCCCCCChh
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS--S----SNMNIEILDSRLPYPSLD 707 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~--~----~~~~~~~~~~~~~~~~~~ 707 (752)
.....|+..|+|||++.+..++.++|||||||++|+++||+.||......... . ......+.....+.. .
T Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 234 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL--P 234 (284)
T ss_pred --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC--C
Confidence 22347899999999998888999999999999999999999998632211000 0 011112221111111 1
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHh
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 741 (752)
....+.++.+++.+|++.||++|||++|++++..
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 1235567899999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=277.05 Aligned_cols=225 Identities=21% Similarity=0.341 Sum_probs=176.9
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEe
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~ 554 (752)
+|++.+.||+|+||.||+|.. .+++.+|+|.+...... +.....+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588899999999999999984 57899999987643211 233446778999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC-CceEEeecccceeccCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG-YEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~-~~~kl~DfG~a~~~~~~~ 633 (752)
+++++|.+++.... ...+++..+..++.|++.|++|+|++ +|+|+||||+||+++++ +.+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999997643 23478899999999999999999999 99999999999999855 458999999998765332
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHH
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||... ........+........ ....+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~~~---~~~~~~ 227 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA-----NLPALVLKIMSGTFAPI---SDRYSP 227 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC-----chHHHHHHHHhcCCCCC---CCCcCH
Confidence 223356889999999998888999999999999999999999998521 11122222222221111 123456
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
++.+++.+||+.||++|||++|++++
T Consensus 228 ~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 228 DLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhC
Confidence 78899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=284.93 Aligned_cols=232 Identities=20% Similarity=0.242 Sum_probs=174.7
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------------CccccCCceEEE
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------------~~~~~~~~~~lV 551 (752)
+|++.+.||+|+||.||+|.. .+++.||||+++..... +++......++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999985 47899999998643211 334456788999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+ +|+|.+++.... ..+++..+..++.||++||+|||+. +|+||||||+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 889999997543 3588999999999999999999999 999999999999999999999999999988765
Q ss_pred CCCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccc----------cccchH------
Q 041438 632 DSSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------SSNMNI------ 694 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~----------~~~~~~------ 694 (752)
.........+++.|+|||.+.+ ..++.++|||||||++|||++|.+||......... ......
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 4433344467889999998765 45789999999999999999998877421110000 000000
Q ss_pred hhhccC--CCCC-ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 695 EILDSR--LPYP-SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 695 ~~~~~~--~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...... ...+ .......+..+.+++.+||++||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000 0000 00112335678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=282.22 Aligned_cols=218 Identities=20% Similarity=0.273 Sum_probs=169.4
Q ss_pred eeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------------CccccCCceEEEEEecc
Q 041438 508 CIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 508 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------------~~~~~~~~~~lV~E~~~ 556 (752)
.||+|+||.||+|+. .+++.||+|.+...... .++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999984 56899999987543211 22345577899999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW 636 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 636 (752)
+|+|.+++.... .+++..++.++.|+++|++|||+. +|+||||||+||+++.++.+||+|||.+....... .
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~ 152 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P 152 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--C
Confidence 999999886543 488999999999999999999999 99999999999999999999999999987654322 2
Q ss_pred ccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHH
Q 041438 637 SKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSI 715 (752)
Q Consensus 637 ~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 715 (752)
....|+..|+|||++.+. .++.++||||+||++|||++|+.||..... .................+ ...+.++
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~----~~~s~~~ 226 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT--KDKHEIDRMTLTMAVELP----DSFSPEL 226 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCc--cchHHHHHHhhccCCCCC----CcCCHHH
Confidence 234789999999998754 589999999999999999999999852211 011111111111122222 2235678
Q ss_pred HHHHHhccCcCCCCCC-----CHHHHHHH
Q 041438 716 MQVAFSCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 716 ~~li~~cl~~dP~~Rp-----s~~evl~~ 739 (752)
.+++.+|+..+|++|| ++.+++++
T Consensus 227 ~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 227 RSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 9999999999999999 99999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=278.27 Aligned_cols=223 Identities=24% Similarity=0.301 Sum_probs=173.2
Q ss_pred eeeccCCceEEEEEEeCC--C--cEEEEEccCCCCC-C------------------------CccccCCceEEEEEeccC
Q 041438 507 HCIGKGGHGSVYIARVPS--G--EIFAVKKFHSPLP-D------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
+.||+|++|.||+|+..+ + ..||||.+..... . +.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998532 3 3699999876544 1 22233 678999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC--
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN-- 635 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-- 635 (752)
++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.++........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999976543 4588999999999999999999999 9999999999999999999999999999876543221
Q ss_pred -cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHH
Q 041438 636 -WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 636 -~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||... ...+....+.......+. ....+.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-----~~~~~~~~~~~~~~~~~~--~~~~~~ 228 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-----SGSQILKKIDKEGERLER--PEACPQ 228 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHhcCCcCCC--CccCCH
Confidence 112356789999999988889999999999999999998 99998521 111111111111111111 123456
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHHHh
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~L~ 741 (752)
.+.+++.+|++.+|++||++.|+++.|.
T Consensus 229 ~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 229 DIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 7889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=285.05 Aligned_cols=235 Identities=18% Similarity=0.245 Sum_probs=171.4
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCc-----
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQ----- 547 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~----- 547 (752)
++|++.+.||+|+||.||+|+. .+++.||+|.++..... +++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4789999999999999999995 57899999987543211 11222222
Q ss_pred eEEEEEeccCCChHHHhccCcc--ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC-CCceEEeecc
Q 041438 548 SFIVYEYLESGSLDKILNNDAS--AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL-GYEAHVSDFR 624 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~-~~~~kl~DfG 624 (752)
.|+||||+++ ++.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 89888765332 24589999999999999999999999 9999999999999998 8899999999
Q ss_pred cceeccCCCCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccc----------cccch
Q 041438 625 IAKFLNLDSSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------SSNMN 693 (752)
Q Consensus 625 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~----------~~~~~ 693 (752)
.+..............+++.|+|||++.+ ..++.++|||||||++|+|++|..||......... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 99876443333333467889999998765 45789999999999999999999998522111000 00000
Q ss_pred Hhhh-------ccCCC--CCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 694 IEIL-------DSRLP--YPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 694 ~~~~-------~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.... ..... .........+.++.++|.+||++||++||+++|++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 00000 0000112345678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=284.80 Aligned_cols=235 Identities=17% Similarity=0.206 Sum_probs=172.3
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~ 552 (752)
++++|++.+.||+|+||.||+|+. .+++.||+|++...... +++......|+||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 467899999999999999999984 57899999988643211 3344567789999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+. +++.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 57777765432 2367788999999999999999999 9999999999999999999999999999865433
Q ss_pred CCCcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccccc-----------cccch-------
Q 041438 633 SSNWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS-----------SSNMN------- 693 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~-----------~~~~~------- 693 (752)
........++..|+|||++.+. .++.++|||||||++|||++|+.||+........ .....
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 3333344678999999988754 4788999999999999999999998532110000 00000
Q ss_pred ---HhhhccCCCCCCh---hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 694 ---IEILDSRLPYPSL---DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 694 ---~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
........+.... ........+.+++.+|++.||++|||++|++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000000000 000123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=279.11 Aligned_cols=228 Identities=25% Similarity=0.369 Sum_probs=183.6
Q ss_pred cccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEe
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~ 554 (752)
++|++.+.||+|++|.||+|+.. +++.||||++...... +++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 47889999999999999999954 6999999988765321 344566789999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
+++++|.+++... ..+++..+..++.|+++|++|+|+ . +++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999764 348889999999999999999999 9 99999999999999999999999999998776444
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH-HH
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN-KF 712 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 712 (752)
.......++..|+|||.+.+..++.++||||||+++|+|+||+.||..... .........+.....+.. . .. .+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~--~-~~~~~ 229 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAICDGPPPSL--P-AEEFS 229 (264)
T ss_pred CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHhcCCCCCC--C-cccCC
Confidence 433345788999999999988899999999999999999999999853221 011112222222221111 1 22 56
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..+.+++.+||+.+|++||++.|++++
T Consensus 230 ~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 230 PEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 689999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=282.25 Aligned_cols=216 Identities=23% Similarity=0.345 Sum_probs=164.5
Q ss_pred eeeccCCceEEEEEEeC-C-------CcEEEEEccCCCCCC------------------------CccccCCceEEEEEe
Q 041438 507 HCIGKGGHGSVYIARVP-S-------GEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~~-~-------~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~ 554 (752)
+.||+|+||.||+|... . ...||+|.+...... +++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46999999999999842 2 234888877532211 344455778999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCc--------eEEeecccc
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE--------AHVSDFRIA 626 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~--------~kl~DfG~a 626 (752)
+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++. ++++|||.+
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999997654 2478899999999999999999999 9999999999999987765 699999998
Q ss_pred eeccCCCCCcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCC-CCcchhhccccccccchHhhhccCCCCC
Q 041438 627 KFLNLDSSNWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGK-HPRDFLFEMSSSSSNMNIEILDSRLPYP 704 (752)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (752)
..... .....++..|+|||++.+. .++.++|||||||++|||++|. .||... ...............+
T Consensus 156 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~------~~~~~~~~~~~~~~~~ 225 (258)
T cd05078 156 ITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL------DSQKKLQFYEDRHQLP 225 (258)
T ss_pred cccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc------cHHHHHHHHHccccCC
Confidence 75432 1234678899999998864 4789999999999999999985 565311 1111122222233333
Q ss_pred ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHh
Q 041438 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 705 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 741 (752)
. ..+.++.+++.+||+.||++|||++++++.|+
T Consensus 226 ~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 226 A----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred C----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 2 23356889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=277.41 Aligned_cols=226 Identities=27% Similarity=0.387 Sum_probs=177.0
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEe
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~ 554 (752)
+|++.+.||+|+||.||+|+. .+++.||+|.++..... +.+......++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588899999999999999984 57899999998654331 234456788999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++++|.+++.... .+++..+..++.|++.|++|||+. +|+|+||||+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999997543 377889999999999999999999 999999999999999999999999999987654332
Q ss_pred Ccc----cccCCCCccCccccccCC---CCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhh-ccCCCCCCh
Q 041438 635 NWS----KLAGTHGNVAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEIL-DSRLPYPSL 706 (752)
Q Consensus 635 ~~~----~~~gt~~y~aPE~~~~~~---~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 706 (752)
... ...++..|+|||++.+.. ++.++||||||+++||+++|+.||.... ........+. ......+.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~- 229 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD----NEFQIMFHVGAGHKPPIPD- 229 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc----chHHHHHHHhcCCCCCCCc-
Confidence 221 246788999999988766 8899999999999999999999985211 1111111111 11112221
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.......+.+++.+||+.+|++||+++|++.+
T Consensus 230 -~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 230 -SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred -ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 12335678899999999999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=280.25 Aligned_cols=232 Identities=22% Similarity=0.354 Sum_probs=179.4
Q ss_pred cccccceeeccCCceEEEEEEeC------CCcEEEEEccCCCCCC-------------------------CccccCCceE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVP------SGEIFAVKKFHSPLPD-------------------------NFCSHPRQSF 549 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~ 549 (752)
++|++.+.||+|+||.||+|+.. +.+.||+|.+...... +++......+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999843 3567999987543221 3445567789
Q ss_pred EEEEeccCCChHHHhccCccc------cccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeec
Q 041438 550 IVYEYLESGSLDKILNNDASA------KELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDF 623 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~Df 623 (752)
+||||+++|+|.+++...... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999764421 2588999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCC-CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCC
Q 041438 624 RIAKFLNLDS-SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRL 701 (752)
Q Consensus 624 G~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 701 (752)
|++....... .......++..|+|||.+.+..+++++|||||||++|++++ |..||... ..............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~-----~~~~~~~~~~~~~~ 236 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL-----SDEEVLNRLQAGKL 236 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-----chHHHHHHHHcCCc
Confidence 9987543221 11223356778999999888888999999999999999998 88887421 11122222222222
Q ss_pred CCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 702 PYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 702 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
..+. ....+..+.+++.+||+.||++||++.|+++.|.+
T Consensus 237 ~~~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 237 ELPV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCCC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 2221 12345678999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=280.50 Aligned_cols=223 Identities=27% Similarity=0.366 Sum_probs=176.8
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEec
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~~ 555 (752)
-|++.+.||+|+||.||+|.. .+++.||+|.+...... +++......++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 477889999999999999984 57899999987543211 2344567789999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 635 (752)
++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||.+.........
T Consensus 85 ~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 85 GGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence 999999998643 378899999999999999999999 9999999999999999999999999999876543322
Q ss_pred cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHH
Q 041438 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSI 715 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 715 (752)
.....++..|+|||.+.+..++.++|||||||++|+|++|..||.... .......+.....+. .....+.++
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~---~~~~~~~~~ 229 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH-----PMKVLFLIPKNNPPT---LEGNYSKPL 229 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc-----hHHHHHHHhcCCCCC---CCcccCHHH
Confidence 333468889999999988888999999999999999999999985211 111111111111111 112345678
Q ss_pred HHHHHhccCcCCCCCCCHHHHHHH
Q 041438 716 MQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 716 ~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+++.+||+.+|++||+++++++|
T Consensus 230 ~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 230 KEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHccCChhhCcCHHHHHhC
Confidence 899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=285.02 Aligned_cols=234 Identities=17% Similarity=0.275 Sum_probs=173.1
Q ss_pred hcccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC-------------------------CccccCCceEEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E 553 (752)
.++|++.+.||+|++|.||+|+.. +++.||||.+...... +++...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 468999999999999999999954 7899999987543211 34556678999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+.+ +|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.++......
T Consensus 84 ~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 84 YLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 9985 9999887543 2478899999999999999999999 99999999999999999999999999987654322
Q ss_pred CCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhcccc-----------ccccchHhhh----
Q 041438 634 SNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS-----------SSSNMNIEIL---- 697 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~-----------~~~~~~~~~~---- 697 (752)
.......++..|+|||++.+ ..++.++||||+||++|||++|+.||........ ........+.
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 22233357889999998875 4578999999999999999999999852210000 0000000000
Q ss_pred --ccCCCC--CCh---hhHHH--HHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 698 --DSRLPY--PSL---DVQNK--FMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 698 --~~~~~~--~~~---~~~~~--~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...... +.. ..... ..++.+++.+|++.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000 000 00011 1567899999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=268.51 Aligned_cols=224 Identities=24% Similarity=0.333 Sum_probs=185.8
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC----------------------------CccccCCceE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSF 549 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~ 549 (752)
..++|...++||+|+|++|..++ .++.+.||+|++++.... ..++.+...+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 35789999999999999999999 568899999999875332 2345567889
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+|.||++||+|--.+++.. +++++.++.+..+|.-||.|||++ ||+.||||.+|||+|..|++|+.|||+++.-
T Consensus 328 fvieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999988776543 489999999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccc--cccc-chHhhhccCCCCCCh
Q 041438 630 NLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS--SSSN-MNIEILDSRLPYPSL 706 (752)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~--~~~~-~~~~~~~~~~~~~~~ 706 (752)
-.+....+.++|||.|.|||++++..|+..+|+|++||+++||+.|+.||+....... ..+. ....++...+..|.
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr- 480 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR- 480 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc-
Confidence 6666677788999999999999999999999999999999999999999975431111 1111 34445566666653
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCC
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPT 732 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps 732 (752)
..+.....+++.-+++||.+|..
T Consensus 481 ---slsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 481 ---SLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ---eeehhhHHHHHHhhcCCcHHhcC
Confidence 34445677888999999999953
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=278.24 Aligned_cols=225 Identities=21% Similarity=0.292 Sum_probs=171.1
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------------Cccc--cCCce
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------------NFCS--HPRQS 548 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------------~~~~--~~~~~ 548 (752)
.+|++.+.||+|+||.||+|.. .++..||+|++...... +++. .....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4789999999999999999985 56899999987543110 1122 23567
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
+++|||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999999987543 378899999999999999999999 999999999999999999999999999876
Q ss_pred ccCCC---CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCC
Q 041438 629 LNLDS---SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPS 705 (752)
Q Consensus 629 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (752)
..... .......++..|+|||++.+..++.++||||+||++||+++|+.||... ............. ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~-----~~~~~~~~~~~~~-~~~~ 229 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY-----EAMAAIFKIATQP-TNPQ 229 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc-----chHHHHHHHhcCC-CCCC
Confidence 53211 1112346888999999999888999999999999999999999998521 1111111111111 1111
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
......+.+.+++ +||..+|++||+++|+++|
T Consensus 230 -~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 230 -LPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 1123445566777 7888999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=279.22 Aligned_cols=227 Identities=21% Similarity=0.279 Sum_probs=165.4
Q ss_pred eeeccCCceEEEEEEeC---CCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEeccCC
Q 041438 507 HCIGKGGHGSVYIARVP---SGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEYLESG 558 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~~~~g 558 (752)
+.||+|+||.||+|+.. ++..+|+|.++..... +.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999853 3467999988654321 3445567789999999999
Q ss_pred ChHHHhccCcc--ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC-
Q 041438 559 SLDKILNNDAS--AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN- 635 (752)
Q Consensus 559 ~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~- 635 (752)
+|.+++..... ....++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975332 22356778889999999999999999 9999999999999999999999999999754322211
Q ss_pred -cccccCCCCccCccccccC-------CCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCCh
Q 041438 636 -WSKLAGTHGNVAPELAYTM-------KVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706 (752)
Q Consensus 636 -~~~~~gt~~y~aPE~~~~~-------~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (752)
.....++..|+|||++.+. .++.++|||||||++|||++ |+.||..... .+.....+.......+..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD----EQVLTYTVREQQLKLPKP 233 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh----HHHHHHHhhcccCCCCCC
Confidence 1223567889999987642 35789999999999999996 9999852211 111111111111111111
Q ss_pred h-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHh
Q 041438 707 D-VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 707 ~-~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 741 (752)
. ....++.+.+++.+|+ .+|++|||++||...|+
T Consensus 234 ~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1 1123456778999999 68999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-33 Score=301.01 Aligned_cols=234 Identities=24% Similarity=0.423 Sum_probs=191.0
Q ss_pred ccccceeeccCCceEEEEEEeC----CCcEEEEEccCCCCCC-------------Cccc------------cCCceEEEE
Q 041438 502 DFDAKHCIGKGGHGSVYIARVP----SGEIFAVKKFHSPLPD-------------NFCS------------HPRQSFIVY 552 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-------------~~~~------------~~~~~~lV~ 552 (752)
...+.++||.|.||+||+|+++ ....||||.++....+ +.++ ..+.+.||+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 3467899999999999999943 3468999999865443 2233 346678999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
|||++|+|+.+++.+. ..+++.+...+.++||.|++||-++ ++|||||-+.|||++.+...|++|||+++.+.++
T Consensus 710 EyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 9999999999998876 3489999999999999999999999 9999999999999999999999999999988655
Q ss_pred CCCc-ccccC--CCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhh
Q 041438 633 SSNW-SKLAG--THGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708 (752)
Q Consensus 633 ~~~~-~~~~g--t~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (752)
.... +...| ...|.|||.+...+++.+||||||||+|||.++ |..||= +...+.....+...+..|. .
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW------dmSNQdVIkaIe~gyRLPp--P 856 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW------DMSNQDVIKAIEQGYRLPP--P 856 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc------ccchHHHHHHHHhccCCCC--C
Confidence 5322 22222 358999999999999999999999999999886 999961 1222223333344444442 2
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCCC
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPD 748 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 748 (752)
.+++..+.+|+..||++|-.+||.+.|++..|.++..+|.
T Consensus 857 mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 857 MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 6788899999999999999999999999999999998884
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=281.09 Aligned_cols=233 Identities=20% Similarity=0.297 Sum_probs=173.4
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEe
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~ 554 (752)
+|++.+.||+|++|.||+|+. .+++.||||+++..... +++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 488899999999999999985 57899999988643211 345567789999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+. ++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.+........
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 58988886543 24588999999999999999999999 999999999999999999999999999986654333
Q ss_pred CcccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCcchhhccccc---------cccc----hHhhhc--
Q 041438 635 NWSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS---------SSNM----NIEILD-- 698 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~---------~~~~----~~~~~~-- 698 (752)
......++..|+|||++.+.. ++.++|||||||++|||+||+.||....+.... .... ......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 333446788999999887654 588999999999999999999998522110000 0000 000000
Q ss_pred cCCC-CCChh----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 699 SRLP-YPSLD----VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 699 ~~~~-~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...+ ..... ......++.++|.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000 00000 01234567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=281.58 Aligned_cols=236 Identities=23% Similarity=0.326 Sum_probs=180.2
Q ss_pred cccccceeeccCCceEEEEEEeC-----CCcEEEEEccCCCCCC-------------------------Ccccc--CCce
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVP-----SGEIFAVKKFHSPLPD-------------------------NFCSH--PRQS 548 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-------------------------~~~~~--~~~~ 548 (752)
.+|++.+.||+|+||.||+|+.. +++.||||.+...... +++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999843 4789999988754331 22223 4568
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999997644 2488999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCc---ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccc---------ccccchHhh
Q 041438 629 LNLDSSNW---SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS---------SSSNMNIEI 696 (752)
Q Consensus 629 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~---------~~~~~~~~~ 696 (752)
........ ....++..|+|||...+..++.++|||||||++|||+||+.|+........ .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 65322211 112445679999999888899999999999999999999999753211000 000111112
Q ss_pred hccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 697 LDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
.......+. ...++.++.+++.+||+.+|++|||+.|+++.|+++
T Consensus 239 ~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 222222211 123446789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=277.94 Aligned_cols=228 Identities=24% Similarity=0.367 Sum_probs=177.0
Q ss_pred ccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC------------------------------CccccCCceEE
Q 041438 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD------------------------------NFCSHPRQSFI 550 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------------------------------~~~~~~~~~~l 550 (752)
+|+..+.||+|+||.||+|+ ..+++.||+|.+...... +++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47888999999999999998 467899999988643210 44556788999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC-ceEEeecccceec
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY-EAHVSDFRIAKFL 629 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~-~~kl~DfG~a~~~ 629 (752)
||||+++++|.+++.... ++++..+..++.|++.||.|||+. +++|+||||+||+++.++ .+||+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999997543 478899999999999999999999 999999999999998775 5999999999876
Q ss_pred cCCCCC----cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCC
Q 041438 630 NLDSSN----WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPS 705 (752)
Q Consensus 630 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (752)
...... .....++..|+|||++.+..++.++||||+||++|++++|+.||..... ................ +
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~-~- 230 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH--SNHLALIFKIASATTA-P- 230 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--cchHHHHHHHhccCCC-C-
Confidence 533211 1224678899999999888899999999999999999999999852111 0001111111111111 1
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.......+++.+++.+|+..+|++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 1113456788999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=281.57 Aligned_cols=233 Identities=23% Similarity=0.324 Sum_probs=174.7
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E 553 (752)
++|++.+.||+|+||.||+|.. .+++.||+|+++..... +++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 4789999999999999999985 46889999987643211 34455677899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|++++.+..+.... ..+++.++..++.||+.|++|||+. +++||||||+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99987776665432 2378899999999999999999999 99999999999999999999999999998765443
Q ss_pred C-CcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccccc---------cccchHhhhcc---
Q 041438 634 S-NWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS---------SSNMNIEILDS--- 699 (752)
Q Consensus 634 ~-~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~---------~~~~~~~~~~~--- 699 (752)
. ......++..|+|||++.+. .++.++||||||+++|+|++|+.||......... ...........
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 2 23345788999999999888 7899999999999999999999998522110000 00000000000
Q ss_pred ----CCCCCC--hh-----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 700 ----RLPYPS--LD-----VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 700 ----~~~~~~--~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..+... .. ....+.++.++|.+||..+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000 00 01125678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=276.34 Aligned_cols=225 Identities=21% Similarity=0.258 Sum_probs=172.1
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------------Ccccc--CCce
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------------NFCSH--PRQS 548 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------------~~~~~--~~~~ 548 (752)
.+|++.+.||+|+||.||+|+. .+++.||||.+...... +++.+ ....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4789999999999999999984 56899999987532110 11222 2457
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||.+..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999999987543 377888999999999999999999 999999999999999999999999999886
Q ss_pred ccCCC---CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCC
Q 041438 629 LNLDS---SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPS 705 (752)
Q Consensus 629 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (752)
..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||... ............. ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-----~~~~~~~~~~~~~-~~~~ 229 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF-----EAMAAIFKIATQP-TNPV 229 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc-----chHHHHHHHhcCC-CCCC
Confidence 54211 1122346889999999998888999999999999999999999998521 1111111111111 1111
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
........+.+++.+|+. +|++||+++|++++
T Consensus 230 -~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 230 -LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 113445678889999995 99999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=277.30 Aligned_cols=226 Identities=23% Similarity=0.305 Sum_probs=178.2
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEe
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~ 554 (752)
+|++.+.||+|+||.||+|.. .+|..||+|.+...... +.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 588899999999999999994 56889999987543110 345566788999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC-ceEEeecccceeccCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY-EAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~-~~kl~DfG~a~~~~~~~ 633 (752)
+++++|.+++..... ..+++..+..++.|++.|+.|||+. +++|+||||+||++++++ .+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999875432 3478999999999999999999999 999999999999999875 46999999998765443
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHH
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
.......|++.|+|||+..+..++.++|||||||++|||++|+.||... ................. ....+.
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~---~~~~~~ 228 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-----NLHQLVLKICQGYFAPI---SPNFSR 228 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHhcccCCCC---CCCCCH
Confidence 3333456889999999998888999999999999999999999998521 11112222222222111 123445
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
++.+++.+|++.+|++|||++|++++
T Consensus 229 ~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 229 DLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhhC
Confidence 78899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=276.44 Aligned_cols=224 Identities=25% Similarity=0.300 Sum_probs=175.9
Q ss_pred ccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC-----------------------------CccccCCceEEE
Q 041438 502 DFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD-----------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----------------------------~~~~~~~~~~lV 551 (752)
+|+..+.||+|+||.||+|... +++.||+|.+...... +++......++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999964 7899999987543210 344556788999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+++++|.+++.... .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999997543 478899999999999999999999 999999999999999999999999999887643
Q ss_pred CCCCcccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
.. ......|+..|+|||.+.... ++.++|+|||||++|++++|+.||.... .......+... ...+. ....
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~-~~~~~-~~~~ 226 (258)
T cd06632 155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-----GVAAVFKIGRS-KELPP-IPDH 226 (258)
T ss_pred cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-----HHHHHHHHHhc-ccCCC-cCCC
Confidence 32 223456889999999987766 8999999999999999999999985221 11111111110 01111 1123
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..+++.+++.+||+.+|++||++++++++
T Consensus 227 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 227 LSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 45678899999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=281.09 Aligned_cols=215 Identities=21% Similarity=0.319 Sum_probs=162.4
Q ss_pred eeccCCceEEEEEEeCC-------------------------CcEEEEEccCCCCCC-----------------------
Q 041438 508 CIGKGGHGSVYIARVPS-------------------------GEIFAVKKFHSPLPD----------------------- 539 (752)
Q Consensus 508 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~----------------------- 539 (752)
+||+|+||.||+|.... ...||+|.+......
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997311 235889987542211
Q ss_pred -CccccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC--
Q 041438 540 -NFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY-- 616 (752)
Q Consensus 540 -~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~-- 616 (752)
+++......++||||+++|+|..++.... ..+++..+..++.||++||+|||++ +|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcc
Confidence 44556678899999999999999986533 3478899999999999999999999 999999999999997543
Q ss_pred -----ceEEeecccceeccCCCCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHH-hCCCCcchhhcccccc
Q 041438 617 -----EAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSS 689 (752)
Q Consensus 617 -----~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~ell-tg~~pf~~~~~~~~~~ 689 (752)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||... ..
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-----~~ 227 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER-----TP 227 (274)
T ss_pred cCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc-----Ch
Confidence 3799999988654321 22357888999998865 55899999999999999995 799998521 11
Q ss_pred ccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHh
Q 041438 690 SNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 741 (752)
.............+. ...+++.+++.+||+.+|++|||+++++++|.
T Consensus 228 -~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 228 -SEKERFYEKKHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -HHHHHHHHhccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111122222222221 12346889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=281.27 Aligned_cols=225 Identities=24% Similarity=0.324 Sum_probs=175.6
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEecc
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~~~ 556 (752)
.|...+.||+|++|.||+|.. .+++.||+|+++..... +++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 455668999999999999984 57899999987532211 23445678899999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW 636 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 636 (752)
+++|.+++... .+++..+..++.|++.|++|+|+. +|+||||||+||+++.++.++|+|||.+..........
T Consensus 100 ~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~ 172 (285)
T cd06648 100 GGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR 172 (285)
T ss_pred CCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCccc
Confidence 99999998762 378899999999999999999999 99999999999999999999999999887654333222
Q ss_pred ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHH
Q 041438 637 SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIM 716 (752)
Q Consensus 637 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 716 (752)
....|++.|+|||...+..++.++|||||||++|||++|+.||... ........+.....+... .....+..+.
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~-----~~~~~~~~~~~~~~~~~~-~~~~~~~~l~ 246 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE-----PPLQAMKRIRDNLPPKLK-NLHKVSPRLR 246 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC-----CHHHHHHHHHhcCCCCCc-ccccCCHHHH
Confidence 3356899999999998888999999999999999999999998521 111111222221111111 1122456789
Q ss_pred HHHHhccCcCCCCCCCHHHHHHH
Q 041438 717 QVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 717 ~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+++.+||+.+|++||++.+++++
T Consensus 247 ~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 247 SFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHHHHHcccChhhCcCHHHHccC
Confidence 99999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=285.63 Aligned_cols=230 Identities=26% Similarity=0.292 Sum_probs=174.2
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Cccc--cCCceE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCS--HPRQSF 549 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~--~~~~~~ 549 (752)
..++|++.+.||+|+||.||+|+. .+|+.||+|+++..... +++. ..+..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 457899999999999999999995 57999999988532211 1111 224679
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+||||+.+ +|.+++.... ..+++.++..++.||+.||+|||+. +++||||||+||++++++.+||+|||.+...
T Consensus 85 lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 99999975 8888887543 4588999999999999999999999 9999999999999999999999999999877
Q ss_pred cCCCCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc----------
Q 041438 630 NLDSSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD---------- 698 (752)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~---------- 698 (752)
...........++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... .....+.+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-----EQLDLIIQLLGTPNESIW 233 (309)
T ss_pred CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhcCCCChhhc
Confidence 644333334456888999998865 45789999999999999999999998522110 00000000
Q ss_pred ---------cCC-----CCCC--hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 699 ---------SRL-----PYPS--LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 699 ---------~~~-----~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
... +... ......++++.++|.+|++.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 0000 0011235678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=280.87 Aligned_cols=232 Identities=20% Similarity=0.291 Sum_probs=174.7
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEe
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~ 554 (752)
+|++.+.||+|+||.||+|+. .+|+.||+|++...... +++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 588999999999999999995 57899999988654321 334456788999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+ +++|.+++.... ..+++.+++.++.||++||+|||+. +++|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999987543 4588999999999999999999999 999999999999999999999999999987654332
Q ss_pred -CcccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCcchhhccccc----------cccchH------hh
Q 041438 635 -NWSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------SSNMNI------EI 696 (752)
Q Consensus 635 -~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~----------~~~~~~------~~ 696 (752)
......|+..|+|||++.+.. ++.++||||+||++|||++|++||......... ...... ..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 123347899999999886544 689999999999999999998887421110000 000000 00
Q ss_pred hccCCCCC-C----hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 697 LDSRLPYP-S----LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 697 ~~~~~~~~-~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.....+.. . ....+....+.+++.+|++.||++||+++++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 0 0011334678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=309.03 Aligned_cols=180 Identities=23% Similarity=0.373 Sum_probs=138.1
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
..||-||||+...+.++++.+.... .....+++++||++||.|+|++ |||||||||.||+++++..|||+|||+|
T Consensus 670 ~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLA 744 (1351)
T KOG1035|consen 670 ILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLA 744 (1351)
T ss_pred EEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccc
Confidence 4689999999977788887654211 2467899999999999999999 9999999999999999999999999999
Q ss_pred eecc------------------CCCCCcccccCCCCccCccccccCC---CCCccchhhHHHHHHHHHhCCCCcchhhcc
Q 041438 627 KFLN------------------LDSSNWSKLAGTHGNVAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFLFEM 685 (752)
Q Consensus 627 ~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDIwSlGvil~elltg~~pf~~~~~~ 685 (752)
+... .+....+..+||.-|+|||++.+.. |+.|+|+||+|||++||+. ||.- .+
T Consensus 745 t~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T--sM 819 (1351)
T KOG1035|consen 745 TDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGT--SM 819 (1351)
T ss_pred hhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCc--hH
Confidence 8721 0111345568999999999988654 9999999999999999984 4531 11
Q ss_pred ccccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 041438 686 SSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEV 738 (752)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 738 (752)
..........+..++.+..-.....+.-.++|.+|+++||++||||.|++.
T Consensus 820 --ERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 820 --ERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred --HHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 111223333445555542223445556678999999999999999999985
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=274.91 Aligned_cols=226 Identities=25% Similarity=0.346 Sum_probs=175.7
Q ss_pred cccceeeccCCceEEEEEEeCC-----CcEEEEEccCCCCCC-------------------------CccccCCceEEEE
Q 041438 503 FDAKHCIGKGGHGSVYIARVPS-----GEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~ 552 (752)
+++.+.||+|+||.||+|+... +..||+|+++..... +++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4577899999999999998543 488999998755421 2344557889999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++++|.+++..... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+......
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999975432 1278999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCcc-cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 633 SSNWS-KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 633 ~~~~~-~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
..... ...+++.|+|||...+..++.++||||+||++|+|++ |+.||.. .........+........ ...
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-----~~~~~~~~~~~~~~~~~~---~~~ 228 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-----MSNEEVLEYLKKGYRLPK---PEN 228 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-----CCHHHHHHHHhcCCCCCC---CCc
Confidence 22111 1236789999999988889999999999999999998 7888752 111112222222221111 123
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
.+.++.+++.+|++.||++|||+.|+++.|
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 229 CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 566789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=279.55 Aligned_cols=227 Identities=26% Similarity=0.344 Sum_probs=175.4
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------------CccccCC
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------------NFCSHPR 546 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------------~~~~~~~ 546 (752)
+|.+.+.||+|+||.||+|.. .+|+.||+|.++..... +++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 577889999999999999984 57899999987532100 3445567
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.++++|||.+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 8899999999999999997653 488899999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCC--CcccccCCCCccCccccccCC--CCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhcc--C
Q 041438 627 KFLNLDSS--NWSKLAGTHGNVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS--R 700 (752)
Q Consensus 627 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~ 700 (752)
+....... ......|+..|+|||.+.... ++.++||||+|+++||+++|..||.... ........... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~ 230 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE-----AIAAMFKLGNKRSA 230 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc-----hHHHHHHhhccccC
Confidence 76542211 122346888999999887654 7899999999999999999999984211 11111111111 1
Q ss_pred CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 701 LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 701 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...+.......+.++.+++.+||.+||++||+++|+++|
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 231 PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 112211123456789999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=282.78 Aligned_cols=234 Identities=20% Similarity=0.231 Sum_probs=174.6
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccC--CceEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHP--RQSFI 550 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~--~~~~l 550 (752)
.++|++.+.||+|+||.||+|+. .+++.||+|.++..... +++... ...|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 46899999999999999999995 46889999988633211 222333 78999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+++ +|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||.+....
T Consensus 84 v~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 84 VMEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred EehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 9999985 9999887543 2588999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCCcccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCcchhhccccc----------cccchH---h-
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------SSNMNI---E- 695 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~----------~~~~~~---~- 695 (752)
..........+++.|+|||.+.+.. ++.++||||+||++|||++|..||......... ...... .
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 5433334456788999999887654 689999999999999999999998522110000 000000 0
Q ss_pred --hhccCCCCC-----ChhhHH--HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 696 --ILDSRLPYP-----SLDVQN--KFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 696 --~~~~~~~~~-----~~~~~~--~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
......... ...... ..+.+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000 000111 25668899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=280.05 Aligned_cols=234 Identities=19% Similarity=0.282 Sum_probs=175.4
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEec
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~~ 555 (752)
+|++.++||+|++|.||+|+. .+|+.||||+++..... +++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 588999999999999999995 47899999987643211 3445567789999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 635 (752)
++ +|.+++........+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||.+.........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 86 8988887654444589999999999999999999999 9999999999999999999999999999865433322
Q ss_pred cccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhcccc----------ccccchHhhh-----cc
Q 041438 636 WSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------SSSNMNIEIL-----DS 699 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~----------~~~~~~~~~~-----~~ 699 (752)
.....++..|+|||++.+. .++.++||||+||++|++++|+.||........ ........+. ..
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 3334678899999987654 468899999999999999999999853211000 0000000000 00
Q ss_pred CCCCCC-hh----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 700 RLPYPS-LD----VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 700 ~~~~~~-~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..+... .. ....+..+.+++.+|++.||++||+++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111000 00 11235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=277.75 Aligned_cols=226 Identities=20% Similarity=0.253 Sum_probs=164.1
Q ss_pred eeeccCCceEEEEEEeC---CCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEeccCC
Q 041438 507 HCIGKGGHGSVYIARVP---SGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEYLESG 558 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~~~~g 558 (752)
+.||+|+||.||+|+.. ....+|+|.+...... +.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 36899999999999743 3457899977543211 3345567789999999999
Q ss_pred ChHHHhccCcc--ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC-
Q 041438 559 SLDKILNNDAS--AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN- 635 (752)
Q Consensus 559 ~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~- 635 (752)
+|.+++..... ....++.....++.||+.|++|||+. +|+||||||+||++++++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 22356788899999999999999999 9999999999999999999999999998754322111
Q ss_pred -cccccCCCCccCcccccc-------CCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhh-hccCCCCCC
Q 041438 636 -WSKLAGTHGNVAPELAYT-------MKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEI-LDSRLPYPS 705 (752)
Q Consensus 636 -~~~~~gt~~y~aPE~~~~-------~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~ 705 (752)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||.... ..+..... .......+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-----~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS-----DEQVLKQVVREQDIKLPK 232 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC-----HHHHHHHHhhccCccCCC
Confidence 122345678999998642 356889999999999999999 788875211 11111111 111111111
Q ss_pred h-hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHh
Q 041438 706 L-DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 706 ~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 741 (752)
. .....+..+.+++..|| .||++|||++||++.|.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 233 PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1 11234556778888898 59999999999998863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=287.71 Aligned_cols=227 Identities=22% Similarity=0.340 Sum_probs=192.5
Q ss_pred HhhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------CccccCCceEE
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFI 550 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~l 550 (752)
.....|.+...||+|.|+.|..|+ ..++..||||.+++.... .+.......|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 456789999999999999999999 467999999999876543 34455778999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+.+|.+++++.+++. ..+..++.++.|+.+|++|||++ .|||||||++||+++.++++||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999988764 45588999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCcccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
. .......+|++.|.|||++.+.+| ++++|+||+|+++|-++.|..||+ .....+....++..++..+..
T Consensus 207 ~-~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD-----G~~lk~Lr~rvl~gk~rIp~~--- 277 (596)
T KOG0586|consen 207 Y-GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD-----GQNLKELRPRVLRGKYRIPFY--- 277 (596)
T ss_pred c-cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC-----Ccccccccchheeeeecccce---
Confidence 3 344556799999999999999886 689999999999999999999997 233444455566666665532
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
.+.++.++|++++..+|.+|++++++.++-
T Consensus 278 -ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 278 -MSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred -eechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 344678899999999999999999998763
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=278.73 Aligned_cols=229 Identities=18% Similarity=0.209 Sum_probs=170.7
Q ss_pred cccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------CccccC--CceEEEEE
Q 041438 503 FDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSHP--RQSFIVYE 553 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~~--~~~~lV~E 553 (752)
|++.++||+|+||.||+|+ ..+++.||+|+++..... +++... +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 6788999999999999998 457899999987653211 233344 77899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++ ++.+.+.... ..+++.++..++.|++.||+|||+. +++||||||+||+++. +.+||+|||.++......
T Consensus 81 ~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9975 8888776533 3488999999999999999999999 9999999999999999 999999999998764332
Q ss_pred CCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccc---------cccccchHhhhc----c
Q 041438 634 SNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS---------SSSSNMNIEILD----S 699 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~---------~~~~~~~~~~~~----~ 699 (752)
......++..|+|||++.. ..++.++||||+||++|||++|+.||....... ............ .
T Consensus 154 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 154 -PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred -CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 2233467899999997654 457899999999999999999999985321100 000000000000 0
Q ss_pred CCCCCCh-------hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 700 RLPYPSL-------DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 700 ~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
....+.. .....+.++.+++.+||++||++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0011100 012346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=279.01 Aligned_cols=234 Identities=25% Similarity=0.281 Sum_probs=177.2
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------Ccc--ccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFC--SHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~--~~~~~~~lV~ 552 (752)
++|+..+.||.|++|.||+|.. .+++.||+|.+...... +++ ......++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4788999999999999999995 56899999988643221 122 2234689999
Q ss_pred EeccCCChHHHhccCc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 553 EYLESGSLDKILNNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
||+++++|.+++.... ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999998876422 234478899999999999999999999 999999999999999999999999999876542
Q ss_pred CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCC-C--Chhh
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPY-P--SLDV 708 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~ 708 (752)
.. .....++..|+|||.+.+..++.++||||+||++|+|++|+.||+..........+....+.....+. + ....
T Consensus 158 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd06621 158 SL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG 235 (287)
T ss_pred cc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCC
Confidence 22 12346788999999998888999999999999999999999998633210011111112222211111 1 0011
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...++.+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 2345678999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=274.06 Aligned_cols=215 Identities=23% Similarity=0.327 Sum_probs=164.6
Q ss_pred eeeccCCceEEEEEEeCC-C----------cEEEEEccCCCCCC-----------------------CccccCCceEEEE
Q 041438 507 HCIGKGGHGSVYIARVPS-G----------EIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~ 552 (752)
+.||+|+||.||+|.... + ..||+|.+...... +++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 468999999999999643 3 25788876543321 33334 6679999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC-------ceEEeeccc
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY-------EAHVSDFRI 625 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~-------~~kl~DfG~ 625 (752)
||+++|+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||+
T Consensus 80 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 80 EYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999976442 478899999999999999999999 999999999999999887 799999999
Q ss_pred ceeccCCCCCcccccCCCCccCccccccC--CCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCC
Q 041438 626 AKFLNLDSSNWSKLAGTHGNVAPELAYTM--KVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLP 702 (752)
Q Consensus 626 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 702 (752)
+..... .....++..|+|||++.+. .++.++|||||||++||+++ |..||.... ......... ....
T Consensus 155 a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-----~~~~~~~~~-~~~~ 224 (259)
T cd05037 155 PITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-----SSEKERFYQ-DQHR 224 (259)
T ss_pred cccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-----chhHHHHHh-cCCC
Confidence 987543 1223567789999998876 78999999999999999999 577764211 111111111 1111
Q ss_pred CCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHh
Q 041438 703 YPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 703 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 741 (752)
.+.. ....+.+++.+||+.+|++|||+.|+++.|+
T Consensus 225 ~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 225 LPMP----DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCC----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1111 1157889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=279.66 Aligned_cols=232 Identities=20% Similarity=0.256 Sum_probs=172.9
Q ss_pred cccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEec
Q 041438 503 FDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~~ 555 (752)
|++.+.||+|++|.||+|+. .+|+.||+|++...... +++......|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67889999999999999984 57999999987643210 3455668899999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 635 (752)
+ ++|.+++..... ..+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||.+.........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 6 589998875432 3488999999999999999999999 9999999999999999999999999999765433322
Q ss_pred cccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccccc---------cc-cc----------hH
Q 041438 636 WSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS---------SS-NM----------NI 694 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~---------~~-~~----------~~ 694 (752)
.....++..|+|||++.+. .++.++|||||||++|+|++|+.||......... .. .. ..
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 3334678899999987664 4688999999999999999999998522110000 00 00 00
Q ss_pred hhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 695 EILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.................+..+.+++.+|++.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000001112334578899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=276.81 Aligned_cols=224 Identities=26% Similarity=0.380 Sum_probs=171.5
Q ss_pred eeeccCCceEEEEEEeCC-------CcEEEEEccCCCCCC-------------------------CccccCCceEEEEEe
Q 041438 507 HCIGKGGHGSVYIARVPS-------GEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~ 554 (752)
+.||+|+||.||+|+..+ ++.||+|.+...... +++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998532 257999987643211 345566788999999
Q ss_pred ccCCChHHHhccCc----cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC-----ceEEeeccc
Q 041438 555 LESGSLDKILNNDA----SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY-----EAHVSDFRI 625 (752)
Q Consensus 555 ~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~-----~~kl~DfG~ 625 (752)
+++++|.+++.... ....+++.++..++.|++.|++|+|+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 123478899999999999999999999 999999999999999877 899999999
Q ss_pred ceeccCCCC--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc-CC
Q 041438 626 AKFLNLDSS--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RL 701 (752)
Q Consensus 626 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~ 701 (752)
++....... ......++..|+|||++.+..++.++|||||||++|||+| |+.||.... .......+... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~-----~~~~~~~~~~~~~~ 232 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN-----NQEVLQHVTAGGRL 232 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC-----HHHHHHHHhcCCcc
Confidence 976543221 1112245678999999998899999999999999999998 999985211 11111111111 11
Q ss_pred CCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 702 PYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 702 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
..+ ...+..+.+++.+||+.+|++||+++++.+.|++
T Consensus 233 ~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 233 QKP----ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CCc----ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111 3356678999999999999999999999998864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=279.74 Aligned_cols=232 Identities=25% Similarity=0.364 Sum_probs=183.0
Q ss_pred HhhcccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC-----------------------CccccCCceEEEEE
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E 553 (752)
...+.|++.+.||+|+||.||+|... +++.||+|++...... +.+......|+|+|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 35677999999999999999999964 7899999988654321 23445678899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++++|.+++.... ..+++..+..++.|++.||+|||+. ||+|+||||+||+++.++.++|+|||.+.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999998654 3589999999999999999999999 99999999999999999999999999987654333
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHH
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
.......++..|+|||++.+..++.++|||||||++|+|++|+.||.... .......+.....+ +.......+.
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~-~~~~~~~~~~ 244 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP-----PLRALFLITTKGIP-PLKNPEKWSP 244 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcCCC-CCcchhhCCH
Confidence 22233467889999999988889999999999999999999999985211 11111112111111 1111223566
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
.+.+++.+||+.+|++||++.+++++-
T Consensus 245 ~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 245 EFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 789999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=281.33 Aligned_cols=221 Identities=26% Similarity=0.345 Sum_probs=172.5
Q ss_pred ceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEeccCCCh
Q 041438 506 KHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEYLESGSL 560 (752)
Q Consensus 506 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~~~~g~L 560 (752)
..+||+|+||.||++.. .+++.||||++...... +.+...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 46799999999999985 57899999987532211 334556789999999999999
Q ss_pred HHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCccccc
Q 041438 561 DKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLA 640 (752)
Q Consensus 561 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 640 (752)
.+++... .+++..+..++.|++.|++|||+. |++||||||+||+++.++.++|+|||.+..............
T Consensus 105 ~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 177 (292)
T cd06657 105 TDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 177 (292)
T ss_pred HHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence 9987543 378899999999999999999999 999999999999999999999999999876643332233357
Q ss_pred CCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHHH
Q 041438 641 GTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAF 720 (752)
Q Consensus 641 gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 720 (752)
|+..|+|||.+.+..++.++||||+||++|+|++|+.||.... ..... .......+.........+..+.+++.
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~-----~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-----PLKAM-KMIRDNLPPKLKNLHKVSPSLKGFLD 251 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHH-HHHHhhCCcccCCcccCCHHHHHHHH
Confidence 8899999999988888999999999999999999999985211 11111 11111111111111234567889999
Q ss_pred hccCcCCCCCCCHHHHHHH
Q 041438 721 SCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 721 ~cl~~dP~~Rps~~evl~~ 739 (752)
+||+.||.+||++.+++++
T Consensus 252 ~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 252 RLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHhCCcccCcCHHHHhcC
Confidence 9999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=273.85 Aligned_cols=232 Identities=21% Similarity=0.279 Sum_probs=178.1
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------------CccccCCceE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------------NFCSHPRQSF 549 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------------~~~~~~~~~~ 549 (752)
+++|++...+|+|+||.|-++.. ..+..||||+++..... ++++..++.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 78999999999999999999983 45799999988642211 4567788999
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC----------------
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD---------------- 613 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~---------------- 613 (752)
+|+|.+ |-++.+++..+.. .+++..+++.+++|++++++|||+. +++|-||||+||++.
T Consensus 168 ivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccce
Confidence 999988 4499999987653 5588999999999999999999999 999999999999982
Q ss_pred ----CCCceEEeecccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhc-----
Q 041438 614 ----LGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFE----- 684 (752)
Q Consensus 614 ----~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~----- 684 (752)
....+||+|||.|+.... ..+..+.|..|+|||++.+..++.++||||+|||++|+.||...|+.-..
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e---~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLa 319 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHE---HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLA 319 (415)
T ss_pred eccCCCcceEEEecCCcceecc---CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHH
Confidence 123589999999987543 33567899999999999999999999999999999999999998852110
Q ss_pred -cc----cccccchHhh------hccCCCCCC---------------------hhhHHHHHHHHHHHHhccCcCCCCCCC
Q 041438 685 -MS----SSSSNMNIEI------LDSRLPYPS---------------------LDVQNKFMSIMQVAFSCLDQNPVSRPT 732 (752)
Q Consensus 685 -~~----~~~~~~~~~~------~~~~~~~~~---------------------~~~~~~~~~l~~li~~cl~~dP~~Rps 732 (752)
+. .....+.... ..+++.++. ........++.+|+++||..||.+|+|
T Consensus 320 MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT 399 (415)
T KOG0671|consen 320 MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT 399 (415)
T ss_pred HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc
Confidence 00 0000000000 000111100 011233447999999999999999999
Q ss_pred HHHHHHH
Q 041438 733 MKRFEVQ 739 (752)
Q Consensus 733 ~~evl~~ 739 (752)
+.|++.|
T Consensus 400 l~EAL~H 406 (415)
T KOG0671|consen 400 LREALSH 406 (415)
T ss_pred HHHHhcC
Confidence 9999876
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=278.89 Aligned_cols=221 Identities=22% Similarity=0.282 Sum_probs=169.1
Q ss_pred eccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------------CccccCCceEEEEEeccCCCh
Q 041438 509 IGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYEYLESGSL 560 (752)
Q Consensus 509 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E~~~~g~L 560 (752)
||+|+||+||+|. ..+|+.||+|.+...... +.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999998 457899999987532110 334456788999999999999
Q ss_pred HHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCccccc
Q 041438 561 DKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLA 640 (752)
Q Consensus 561 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 640 (752)
.+++..... ..+++..+..++.|++.|+.|||+. +++||||||+||++++++.+||+|||.+..... ........
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRA 155 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCcccccc
Confidence 999876442 3588999999999999999999999 999999999999999999999999999876543 22223346
Q ss_pred CCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHHH
Q 041438 641 GTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAF 720 (752)
Q Consensus 641 gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 720 (752)
++..|+|||++.+..++.++||||+||++|+|++|+.||...... .................+ ...++.+.+++.
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~ 230 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKRRTLEMAVEYP----DKFSPEAKDLCE 230 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHHHhccccccccCC----ccCCHHHHHHHH
Confidence 788999999998888999999999999999999999998522110 000111111111111122 234667899999
Q ss_pred hccCcCCCCCC-----CHHHHHHH
Q 041438 721 SCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 721 ~cl~~dP~~Rp-----s~~evl~~ 739 (752)
+||+.||++|| ++.++++|
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 231 ALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred HHccCChhHccCCCcccHHHHHhC
Confidence 99999999999 66666543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=286.37 Aligned_cols=231 Identities=19% Similarity=0.264 Sum_probs=173.0
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Ccc------ccC
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFC------SHP 545 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~------~~~ 545 (752)
..++|++.+.||+|+||.||+|+. .+++.||+|.+...... +++ .+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999994 57999999988643211 111 122
Q ss_pred CceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccc
Q 041438 546 RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRI 625 (752)
Q Consensus 546 ~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~ 625 (752)
...|+||||+.+ +|.+.+... +++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||.
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 357999999975 888877532 77889999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccc----------ccccc----
Q 041438 626 AKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS----------SSSSN---- 691 (752)
Q Consensus 626 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~----------~~~~~---- 691 (752)
++...... ......++..|+|||++.+..++.++||||+||++|+|++|+.||....... ....+
T Consensus 165 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 165 ARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred ceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 98764322 2233468899999999999999999999999999999999999985221100 00000
Q ss_pred ---chHhhhccCCC--------------CCCh---hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 692 ---MNIEILDSRLP--------------YPSL---DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 692 ---~~~~~~~~~~~--------------~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
........+.. .+.. .....+..+.+++.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000010000 0000 011235568899999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=287.36 Aligned_cols=222 Identities=21% Similarity=0.269 Sum_probs=179.6
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------CccccCCceEEEEEecc
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------~~~~~~~~~~lV~E~~~ 556 (752)
.++.|++...+|.|+|+.|-.+. ..+++..|+|++.+...+ +.+.+..+.|+|||++.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 47789999999999999999998 678999999999776221 45666788999999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe-CCCCceEEeecccceeccCCCCC
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL-DLGYEAHVSDFRIAKFLNLDSSN 635 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll-~~~~~~kl~DfG~a~~~~~~~~~ 635 (752)
|+-+.+.+.... .....+..|+.+|+.|+.|||++ ||||||+||+|||+ ++.++++|+|||.++.....
T Consensus 400 g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 400 GGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred ccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 988777665433 22267788999999999999999 99999999999999 58999999999999987644
Q ss_pred cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHH
Q 041438 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSI 715 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 715 (752)
....+-|..|.|||+.....|++++||||||+++|+|++|+.||..-. ...+....+..++.. ...+..+
T Consensus 470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P----~~~ei~~~i~~~~~s------~~vS~~A 539 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP----AGIEIHTRIQMPKFS------ECVSDEA 539 (612)
T ss_pred hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC----chHHHHHhhcCCccc------cccCHHH
Confidence 333467889999999999999999999999999999999999985211 111222222222111 5567789
Q ss_pred HHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 716 MQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 716 ~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
++|+.+||+.||.+||++.++..|=
T Consensus 540 KdLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 540 KDLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred HHHHHHhccCChhhCcChhhhccCc
Confidence 9999999999999999999998763
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=282.04 Aligned_cols=231 Identities=24% Similarity=0.290 Sum_probs=171.4
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E 553 (752)
++|+..+.||+|+||.||+++. .+++.||+|.+...... +++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 4667788999999999999984 56899999988643211 33445677889999
Q ss_pred eccCCChHHHhccC--ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 554 YLESGSLDKILNND--ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 554 ~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|+.. ++.++.... .....+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9875 655543211 11245888999999999999999999742 899999999999999999999999999976543
Q ss_pred CCCCcccccCCCCccCccccccC---CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCC-CCCChh
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTM---KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRL-PYPSLD 707 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 707 (752)
.. ......|+..|+|||++.+. .++.++||||+||++|||++|+.||.... ........+..... ..+...
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd06616 161 SI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKGDPPILSNSE 235 (288)
T ss_pred CC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCCCCCcCCCcC
Confidence 22 22334688999999998766 68999999999999999999999985221 01111111111111 111111
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
....+.++.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 236 EREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 13456689999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=286.06 Aligned_cols=237 Identities=22% Similarity=0.319 Sum_probs=174.2
Q ss_pred hcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC-------------------------Ccc-----ccCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD-------------------------NFC-----SHPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------------------------~~~-----~~~~~~ 548 (752)
.++|++.+.||+|+||.||+|+ ..+|+.||+|.+...... +++ ......
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 5789999999999999999998 467899999987532111 111 112357
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
|+||||+.+ ++.+++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 888887543 388999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCC---cccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhcc----------ccccccchH
Q 041438 629 LNLDSSN---WSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM----------SSSSSNMNI 694 (752)
Q Consensus 629 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~----------~~~~~~~~~ 694 (752)
....... .....|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||...... .....+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 5432221 123468899999998654 46899999999999999999999998521100 000000001
Q ss_pred hhhccC-------CCC-CCh----hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--Hhhhh
Q 041438 695 EILDSR-------LPY-PSL----DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ--SKQFH 744 (752)
Q Consensus 695 ~~~~~~-------~~~-~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~~~ 744 (752)
.+.... .+. +.. .....+.++.+++.+||+.||++|||+.|+++| +++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 000000 000 000 012235678899999999999999999999988 65554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=275.23 Aligned_cols=242 Identities=22% Similarity=0.334 Sum_probs=179.3
Q ss_pred cccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------Cccc----cCCceEEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCS----HPRQSFIVYE 553 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~----~~~~~~lV~E 553 (752)
...+..+.||+|+||.||+|++ +++.||||++...... +... ...++++|+|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 4455678899999999999998 4599999998643322 1111 1347899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCC------CCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNC------FPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~------~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
|.+.|+|.++++.+. ++|....+|+.-|++||+|||+.. .|+|+|||||+.||||..|++..|+|||+|.
T Consensus 289 fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 289 FHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999998765 999999999999999999999753 4689999999999999999999999999999
Q ss_pred eccCCCC--CcccccCCCCccCccccccCC-C-----CCccchhhHHHHHHHHHhCCCC--------cchhhc--cc--c
Q 041438 628 FLNLDSS--NWSKLAGTHGNVAPELAYTMK-V-----TEKCDVYSFGVLALEVIKGKHP--------RDFLFE--MS--S 687 (752)
Q Consensus 628 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~-----~~ksDIwSlGvil~elltg~~p--------f~~~~~--~~--~ 687 (752)
.+..... .....+||.+|||||++.+.. + -.+.||||+|.|+|||++.-.. |+..++ +. .
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 8864322 223369999999999987643 1 1368999999999999974332 221111 11 1
Q ss_pred ccccchHhhhccCC--CCCChh-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCC
Q 041438 688 SSSNMNIEILDSRL--PYPSLD-VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNP 747 (752)
Q Consensus 688 ~~~~~~~~~~~~~~--~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 747 (752)
..+++...++..+. .++..- .-.....+.+.+..||+.||+.|.|+.-+.+.+.++...+
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 12223333333322 222110 0123456889999999999999999999999998876443
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=279.90 Aligned_cols=230 Identities=23% Similarity=0.336 Sum_probs=176.4
Q ss_pred hhcccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC--------------------------CccccCCceEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV 551 (752)
..++|++.+.||+|+||.||+|+.. +++.||||.++..... +++......|+|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 4577899999999999999999965 4899999998643211 345566788999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
|||+.+ ++.++..... ..+++..+..++.|++.|++|||+ . +|+||||||+||++++++.+||+|||.+....
T Consensus 93 ~e~~~~-~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMST-CLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccCc-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 999865 7877775533 258889999999999999999997 5 89999999999999999999999999997654
Q ss_pred CCCCCcccccCCCCccCccccccCC----CCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCCh
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (752)
... ......++..|+|||++.+.. ++.++||||||+++|+|++|+.||... ....+....+.....+...
T Consensus 167 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~- 240 (296)
T cd06618 167 DSK-AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC----KTEFEVLTKILQEEPPSLP- 240 (296)
T ss_pred CCC-cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc----hhHHHHHHHHhcCCCCCCC-
Confidence 322 222346788999999987554 788999999999999999999998521 1111122222222221111
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
.....+.++.+++.+||+.||++||++++++++-
T Consensus 241 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 241 PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 1123456789999999999999999999998774
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=271.50 Aligned_cols=226 Identities=29% Similarity=0.387 Sum_probs=178.8
Q ss_pred ccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC------------------------CccccCCceEEEEEecc
Q 041438 502 DFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~~~ 556 (752)
+|++.+.||+|++|.||++... +++.||+|++...... +.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 5788999999999999999964 7899999998765421 33445678899999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW 636 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 636 (752)
+++|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 154 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-R 154 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-c
Confidence 999999987643 3588999999999999999999998 999999999999999999999999999987654332 2
Q ss_pred ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHH
Q 041438 637 SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIM 716 (752)
Q Consensus 637 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 716 (752)
....++..|+|||++.+..++.++||||||+++|+|++|+.||.... .............+.. ......+..+.
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 228 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP-----PMKALFKIATNGPPGL-RNPEKWSDEFK 228 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc-----hHHHHHHHHhcCCCCc-CcccccCHHHH
Confidence 34578899999999988889999999999999999999999985211 1111111111111110 01112256789
Q ss_pred HHHHhccCcCCCCCCCHHHHHHH
Q 041438 717 QVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 717 ~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+++.+||+.||++|||++|+++|
T Consensus 229 ~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 229 DFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHHccCChhhCCCHHHHhcC
Confidence 99999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=275.24 Aligned_cols=223 Identities=26% Similarity=0.339 Sum_probs=176.8
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEEE
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E 553 (752)
+|++.+.||+|+||.||+|+. .+++.||+|.+...... ..+......++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 588999999999999999995 46899999988643211 23455678999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++++|.+++... ..+++..+..++.|+++||.|||+. +++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999999764 2488899999999999999999999 99999999999999999999999999998765332
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc-cCCCCCChhhHHHH
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD-SRLPYPSLDVQNKF 712 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 712 (752)
......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||..... ........... .....+ ...+
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~----~~~~ 226 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR---TIRDQIRAKQETADVLYP----ATWS 226 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc---cHHHHHHHHhccccccCc----ccCc
Confidence 22345688899999999888899999999999999999999999862211 00111111111 222222 2345
Q ss_pred HHHHHHHHhccCcCCCCCCCH--HHHHH
Q 041438 713 MSIMQVAFSCLDQNPVSRPTM--KRFEV 738 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~--~evl~ 738 (752)
.++.+++.+||+.||++||++ +|+++
T Consensus 227 ~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 227 TEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 788999999999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=300.52 Aligned_cols=238 Identities=17% Similarity=0.158 Sum_probs=165.5
Q ss_pred hhcccccceeeccCCceEEEEEEe-CC----CcEEEEEccCCCCCC---------------------Cc-----cccCCc
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PS----GEIFAVKKFHSPLPD---------------------NF-----CSHPRQ 547 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~----~~~vavK~~~~~~~~---------------------~~-----~~~~~~ 547 (752)
..++|++.+.||+|+||.||+|+. .+ +..||||++...... .+ ..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence 567899999999999999999995 44 789999987542211 00 145678
Q ss_pred eEEEEEeccCCChHHHhccCccc-----------------cccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCE
Q 041438 548 SFIVYEYLESGSLDKILNNDASA-----------------KELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNV 610 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NI 610 (752)
.++||||+.+++|.+++...... .......+..++.||+.||+|||++ +|+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHE
Confidence 89999999999999998754211 0112345678999999999999999 999999999999
Q ss_pred EeCC-CCceEEeecccceeccCCC-CCcccccCCCCccCccccccC----------------------CCCCccchhhHH
Q 041438 611 LLDL-GYEAHVSDFRIAKFLNLDS-SNWSKLAGTHGNVAPELAYTM----------------------KVTEKCDVYSFG 666 (752)
Q Consensus 611 ll~~-~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~ksDIwSlG 666 (752)
|+++ ++.+||+|||+|+...... .......+++.|+|||.+... .++.++||||+|
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 9985 5789999999998654322 222345789999999965422 234567999999
Q ss_pred HHHHHHHhCCCCcchhhc-----cc--cccccchHhhhccCCCCCC----hhhHHHHHHHHHHHHhccCcCCCCCCCHHH
Q 041438 667 VLALEVIKGKHPRDFLFE-----MS--SSSSNMNIEILDSRLPYPS----LDVQNKFMSIMQVAFSCLDQNPVSRPTMKR 735 (752)
Q Consensus 667 vil~elltg~~pf~~~~~-----~~--~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 735 (752)
|++|||+++..|++.... .. ................... ...........+++.+||+.||++|||++|
T Consensus 367 viL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e 446 (566)
T PLN03225 367 LIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKA 446 (566)
T ss_pred HHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHH
Confidence 999999998877542100 00 0000011111111100000 000011223558999999999999999999
Q ss_pred HHHH
Q 041438 736 FEVQ 739 (752)
Q Consensus 736 vl~~ 739 (752)
+++|
T Consensus 447 ~L~H 450 (566)
T PLN03225 447 ALAH 450 (566)
T ss_pred HhCC
Confidence 9987
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=272.18 Aligned_cols=225 Identities=23% Similarity=0.292 Sum_probs=180.0
Q ss_pred ccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEe
Q 041438 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~ 554 (752)
+|++.++||+|+||.||+++ ..+++.+|+|.+...... +++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 58899999999999999998 457889999987643211 234455788999999
Q ss_pred ccCCChHHHhccCcc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 555 LESGSLDKILNNDAS-AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
+++++|.+++..... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+|++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999876322 24588899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHH
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
......++..|+|||.+.+..++.++|+||+|+++||+++|+.||... ........+.....+.. ......
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~---~~~~~~ 227 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR-----SMQDLRYKVQRGKYPPI---PPIYSQ 227 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcCCCCCC---chhhCH
Confidence 222346888999999999888999999999999999999999998521 11112222222222211 135567
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
++.+++.+|+..+|++||++.|++++
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 228 DLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 79999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=270.85 Aligned_cols=243 Identities=25% Similarity=0.329 Sum_probs=185.9
Q ss_pred cccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC--------------------Cccc-------cCCceEEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD--------------------NFCS-------HPRQSFIVYE 553 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------~~~~-------~~~~~~lV~E 553 (752)
.+..+.+.||+|+||+||+|++ .|+.||||++...... +|.. .-.+.|+|.+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred heeEEEEEecCccccceeeccc-cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 3456789999999999999998 6899999999765433 1111 1146899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhC-----CCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNN-----CFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-----~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
|-+.|+|.+++.... ++.+...+++..+|+||++||.. ..|.|+|||||+.|||+..++...|+|+|+|..
T Consensus 290 YHe~GSL~DyL~r~t----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 290 YHEHGSLYDYLNRNT----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred cccCCcHHHHHhhcc----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 999999999998644 88899999999999999999975 357899999999999999999999999999988
Q ss_pred ccCCCC----CcccccCCCCccCccccccCC----C--CCccchhhHHHHHHHHHh----------CCCCcchhhccccc
Q 041438 629 LNLDSS----NWSKLAGTHGNVAPELAYTMK----V--TEKCDVYSFGVLALEVIK----------GKHPRDFLFEMSSS 688 (752)
Q Consensus 629 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~----~--~~ksDIwSlGvil~ellt----------g~~pf~~~~~~~~~ 688 (752)
...... .....+||..|||||++...- + -..+||||||.|+||++. -+.||......+..
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs 445 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS 445 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC
Confidence 765432 234569999999999876532 1 236899999999999974 25677543333333
Q ss_pred cccchHhhhccCCCC--C-ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCCC
Q 041438 689 SSNMNIEILDSRLPY--P-SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPD 748 (752)
Q Consensus 689 ~~~~~~~~~~~~~~~--~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 748 (752)
.+++..-+...+... | ..........+.++|+.||..+|..|-|+-.+-+.|.++..+++
T Consensus 446 ~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~e 508 (513)
T KOG2052|consen 446 FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDE 508 (513)
T ss_pred HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChh
Confidence 344444333333321 1 11234456678899999999999999999999999988875543
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=270.89 Aligned_cols=227 Identities=25% Similarity=0.376 Sum_probs=180.9
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEe
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~ 554 (752)
+|++.+.||+|+||.||++.. .+++.||+|++...... +........++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 588899999999999999995 46899999998754321 223345788999999
Q ss_pred ccCCChHHHhccCc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 555 LESGSLDKILNNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 555 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
+++++|.+++.... ....+++.++..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997642 124588999999999999999999999 99999999999999999999999999998765443
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHH
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
.......|++.|+|||...+..++.++||||+|+++++|++|+.||... .................. ...+.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~---~~~~~ 229 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE-----NLLELALKILKGQYPPIP---SQYSS 229 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC-----cHHHHHHHHhcCCCCCCC---CCCCH
Confidence 2333457889999999998888999999999999999999999998521 111222222222221111 23456
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+.+++.+||..+|++||++.|++++
T Consensus 230 ~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 230 ELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 78899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=273.21 Aligned_cols=229 Identities=20% Similarity=0.306 Sum_probs=172.8
Q ss_pred cccceeeccCCceEEEEEEeC----CCcEEEEEccCCCCCC--------------------------CccccC------C
Q 041438 503 FDAKHCIGKGGHGSVYIARVP----SGEIFAVKKFHSPLPD--------------------------NFCSHP------R 546 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--------------------------~~~~~~------~ 546 (752)
|++.+.||+|+||.||+|... +++.||||++...... +++... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 667889999999999999842 4789999987653211 111111 1
Q ss_pred ceEEEEEeccCCChHHHhccCc---cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeec
Q 041438 547 QSFIVYEYLESGSLDKILNNDA---SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDF 623 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~Df 623 (752)
..++++||+.+|+|.+++.... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988875321 123478899999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccC
Q 041438 624 RIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSR 700 (752)
Q Consensus 624 G~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 700 (752)
|.++........ .....+++.|++||...+..++.++|||||||++|||++ |++||.... .......+....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~-----~~~~~~~~~~~~ 232 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-----NSEIYNYLIKGN 232 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC-----HHHHHHHHHcCC
Confidence 999876432211 122345678999999988889999999999999999999 888875211 111122222221
Q ss_pred -CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 701 -LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 701 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
...+ ...+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 233 ~~~~~----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 RLKQP----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 23456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=276.75 Aligned_cols=224 Identities=23% Similarity=0.331 Sum_probs=179.0
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------CccccCCceEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~lV 551 (752)
++|++.+.||+|+||.||+|+. .+++.||+|++...... +.+...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4789999999999999999995 47999999988642110 234456788999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++|||.+.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999997653 489999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC--------------------CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccccccc
Q 041438 632 DSS--------------------NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN 691 (752)
Q Consensus 632 ~~~--------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~ 691 (752)
... ......++..|+|||...+..++.++||||+|++++++++|+.||.... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~ 229 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-----EYL 229 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-----HHH
Confidence 321 1122357889999999888889999999999999999999999986221 111
Q ss_pred chHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCH----HHHHHH
Q 041438 692 MNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTM----KRFEVQ 739 (752)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~----~evl~~ 739 (752)
....+.......+ ...++.+.+++.+||+.||++||++ +|+++|
T Consensus 230 ~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 230 TFQKILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHHhcCCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 2222333333333 2335678899999999999999999 777654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-34 Score=299.12 Aligned_cols=329 Identities=26% Similarity=0.344 Sum_probs=276.7
Q ss_pred ccCCCCCCCEEECCCCcccc-cCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCC
Q 041438 104 SFSSFPHLAYLDLYNNELFD-IIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNF 182 (752)
Q Consensus 104 ~f~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 182 (752)
.++.||.|+.++++.|++.. -+|..+-.|..|+.||||+|++. ..|..+..-+++-.|+||+|+|..+....|-+|+.
T Consensus 73 ELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtD 151 (1255)
T KOG0444|consen 73 ELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTD 151 (1255)
T ss_pred hhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHh
Confidence 46788999999999999963 37888889999999999999999 77888999999999999999999665566889999
Q ss_pred CcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccC-CCcCCCCCCCCCCCCcEEE
Q 041438 183 LNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLN-GAIPLSIDWGRCPQLSLLD 261 (752)
Q Consensus 183 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~-~~~~~~~~~~~l~~L~~L~ 261 (752)
|-.||||+|++. .+|.....+.+|++|.|++|.+...--..+..+++|..|.+++.+=+ ..+|.++ ..+.+|..+|
T Consensus 152 LLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsl--d~l~NL~dvD 228 (1255)
T KOG0444|consen 152 LLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSL--DDLHNLRDVD 228 (1255)
T ss_pred Hhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCch--hhhhhhhhcc
Confidence 999999999999 56777899999999999999987665667778889999999887644 3455554 5788999999
Q ss_pred ccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeecccccccc
Q 041438 262 VSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSN 341 (752)
Q Consensus 262 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 341 (752)
+|.|++. ..|..+..+++|+.|+||+|+|+ .+....+...+|++|+||.|+++ .+|++++.|+.|+.|++.+|+++-
T Consensus 229 lS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~F 305 (1255)
T KOG0444|consen 229 LSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTF 305 (1255)
T ss_pred ccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccc
Confidence 9999998 78999999999999999999998 45556677789999999999999 789999999999999999999863
Q ss_pred -ccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhh
Q 041438 342 -FVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFE 420 (752)
Q Consensus 342 -~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 420 (752)
-+|..++.+.+|+.+..++|++. .+|..++.+..|+.|.|++|++.. .|+.+.-++.|+.|||..|.=--.+|..-.
T Consensus 306 eGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiT-LPeaIHlL~~l~vLDlreNpnLVMPPKP~d 383 (1255)
T KOG0444|consen 306 EGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLIT-LPEAIHLLPDLKVLDLRENPNLVMPPKPND 383 (1255)
T ss_pred cCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceee-chhhhhhcCCcceeeccCCcCccCCCCcch
Confidence 26788999999999999999995 899999999999999999999954 688899999999999999974444443322
Q ss_pred ccCCCcEEEccC---C--cccCcCCC
Q 041438 421 ELHGLLHIDISY---N--KLEGHIPN 441 (752)
Q Consensus 421 ~l~~L~~L~ls~---N--~l~~~~p~ 441 (752)
.-+.|..-++.. + +|.|..|.
T Consensus 384 a~~~lefYNIDFSLq~QlrlAG~~pa 409 (1255)
T KOG0444|consen 384 ARKKLEFYNIDFSLQHQLRLAGQMPA 409 (1255)
T ss_pred hhhcceeeecceehhhHHhhccCCcc
Confidence 224444433322 2 35565554
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=277.88 Aligned_cols=224 Identities=25% Similarity=0.351 Sum_probs=173.6
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV 551 (752)
...|++.+.||+|+||.||+|+. .+++.||+|.+...... +++.+.+..|+|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 45688999999999999999985 47899999987532211 345566788999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+.+ ++.+++.... ..+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||++.....
T Consensus 94 ~e~~~g-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCLG-SASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhCC-CHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 999975 7777765433 3488999999999999999999999 999999999999999999999999999876542
Q ss_pred CCCCcccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhh
Q 041438 632 DSSNWSKLAGTHGNVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (752)
. ....+++.|+|||++. ...++.++||||||+++|||+||+.||.... .......+.....+ ....
T Consensus 168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-----~~~~~~~~~~~~~~--~~~~ 236 (307)
T cd06607 168 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQNDSP--TLSS 236 (307)
T ss_pred C----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-----HHHHHHHHhcCCCC--CCCc
Confidence 2 2346788999999874 3568899999999999999999999984211 11111111111111 1112
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
...+..+.+++.+||..||++||++.+++.+.
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 237 NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred hhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 34566789999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=283.97 Aligned_cols=237 Identities=21% Similarity=0.250 Sum_probs=176.4
Q ss_pred hcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------Ccccc-----CCc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSH-----PRQ 547 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~-----~~~ 547 (752)
.++|++.+.||+|+||.||+|+ ..+++.||||.++..... +++.. ...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4679999999999999999998 457899999987643211 11111 134
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
.|+||||+. ++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 58988886543 488899999999999999999999 99999999999999999999999999998
Q ss_pred eccCCCCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhcc----------cccc-------
Q 041438 628 FLNLDSSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM----------SSSS------- 689 (752)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~----------~~~~------- 689 (752)
.............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 76543333344568889999998765 46889999999999999999999998532100 0000
Q ss_pred -ccchHhhhccCC--CCCC--hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--Hhhh
Q 041438 690 -SNMNIEILDSRL--PYPS--LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ--SKQF 743 (752)
Q Consensus 690 -~~~~~~~~~~~~--~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~~ 743 (752)
............ +.+. ......++++.+++.+||+.||++|||++|+++| ++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000110000 0000 0112345678999999999999999999999988 5554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=277.94 Aligned_cols=234 Identities=19% Similarity=0.261 Sum_probs=171.5
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E 553 (752)
++|++.+.||+|++|.||+|+. .+++.||+|++...... +++......|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 5799999999999999999985 47899999988643211 34456678999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC-CCceEEeecccceeccCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL-GYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~-~~~~kl~DfG~a~~~~~~ 632 (752)
|+++ ++.+++..... ..+++..+..++.||+.||+|||++ +++||||||+||++++ ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLDL-DLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cccc-cHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9965 88888765432 2357788899999999999999999 9999999999999985 557999999999865433
Q ss_pred CCCcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccccc----------cccchH------h
Q 041438 633 SSNWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------SSNMNI------E 695 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~----------~~~~~~------~ 695 (752)
........+++.|+|||++.+. .++.++||||+||++|+|+||+.||......... ...... .
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 3333344678899999988664 5789999999999999999999998522110000 000000 0
Q ss_pred hhc--cCCCCCC--hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 696 ILD--SRLPYPS--LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 696 ~~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
... ....... ......++++.+++.+|++.||++||++++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0000000 0012234568899999999999999999999864
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=273.95 Aligned_cols=231 Identities=19% Similarity=0.262 Sum_probs=175.5
Q ss_pred cccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEec
Q 041438 503 FDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~~ 555 (752)
|++.+.||+|++|.||+|+. .+++.+|+|++...... +++......++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67789999999999999985 57899999987654221 3345567889999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 635 (752)
++ ++.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||.+.........
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 86 8888886543 3588999999999999999999999 9999999999999999999999999999877644322
Q ss_pred cccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhcccc----------ccccchHhhh-------
Q 041438 636 WSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------SSSNMNIEIL------- 697 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~----------~~~~~~~~~~------- 697 (752)
.....++..|+|||.+.+. .++.++||||+|+++|+|+||+.||........ ..........
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 3335688899999998776 689999999999999999999999852211000 0000000000
Q ss_pred ----ccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 698 ----DSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 698 ----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..............+.++.++|.+||++||.+||++++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000011123456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=280.60 Aligned_cols=237 Identities=22% Similarity=0.280 Sum_probs=177.6
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccC-----CceE
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHP-----RQSF 549 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~-----~~~~ 549 (752)
+|++.+.||+|+||.||+|+. .+++.||||++...... +++... ...|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 588999999999999999995 45899999988754311 222222 3689
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+||||+++ +|.+++.... .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.++|+|||.+...
T Consensus 81 lv~e~~~~-~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999985 8988886543 588999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCC---CCcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccc----------ccc------
Q 041438 630 NLDS---SNWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS----------SSS------ 689 (752)
Q Consensus 630 ~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~----------~~~------ 689 (752)
.... .......++..|+|||++.+. .++.++||||+||++|+|++|+.||....... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 5443 123345688899999999887 78999999999999999999999985221100 000
Q ss_pred --ccchHhhhccCCCCCChh----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--Hhhhhc
Q 041438 690 --SNMNIEILDSRLPYPSLD----VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ--SKQFHY 745 (752)
Q Consensus 690 --~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~~~~ 745 (752)
.................. ....+.++.+++.+||++||++||++++++++ ++++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000000000000000000 11235678899999999999999999999986 555543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=272.88 Aligned_cols=226 Identities=23% Similarity=0.314 Sum_probs=172.7
Q ss_pred cccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC-----------------------------CccccCCc-----
Q 041438 503 FDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD-----------------------------NFCSHPRQ----- 547 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----------------------------~~~~~~~~----- 547 (752)
|++.+.||+|+||.||+|+.. +++.||+|+++..... +++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999965 5899999988632111 12222333
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
.+++|||+.+ +|.+++..... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||.+.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999985 89888865432 3488999999999999999999999 99999999999999999999999999998
Q ss_pred eccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc---------
Q 041438 628 FLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD--------- 698 (752)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~--------- 698 (752)
...... ......++..|+|||++.+..++.++|||||||++|||++|++||..... .+....+.+
T Consensus 156 ~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 156 IYSFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-----ADQLDKIFDVIGLPSEEE 229 (287)
T ss_pred eccCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-----HHHHHHHHHHcCCCChHh
Confidence 765332 22334578899999999988899999999999999999999999852111 000000100
Q ss_pred -------------cCCC-CCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 699 -------------SRLP-YPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 699 -------------~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.... ............+.+++.+||+.||++||+++|++.|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000 0011123445678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=277.07 Aligned_cols=225 Identities=25% Similarity=0.344 Sum_probs=174.9
Q ss_pred cccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEEEe
Q 041438 503 FDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E~ 554 (752)
|+..+.||+|+||.||+|+. .+++.||+|++...... +++......++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 77789999999999999994 57899999988643211 334456778999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+.+ ++.+.+.... .++++.++..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 107 ~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 975 8877775433 3488999999999999999999999 9999999999999999999999999998754322
Q ss_pred CcccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 635 NWSKLAGTHGNVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
....|++.|+|||++. +..++.++|||||||++|||++|+.||... ........+.....+.. .....
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-----~~~~~~~~~~~~~~~~~--~~~~~ 249 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NAMSALYHIAQNESPTL--QSNEW 249 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHHhccCCCC--CCccc
Confidence 2346888999999874 456889999999999999999999997421 11111222222222111 12345
Q ss_pred HHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 712 FMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
+..+.+++.+||+.+|++||++.+++++.....
T Consensus 250 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 250 SDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred cHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 567899999999999999999999999876544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=272.12 Aligned_cols=226 Identities=18% Similarity=0.238 Sum_probs=160.8
Q ss_pred eeeccCCceEEEEEEeCCC---cEEEEEccCCCCCC-------------------------CccccCCceEEEEEeccCC
Q 041438 507 HCIGKGGHGSVYIARVPSG---EIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEYLESG 558 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~~~~g 558 (752)
+.||+|+||.||+|+..++ ..+++|.+...... +.+......|+||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999974333 35667765533211 3345567789999999999
Q ss_pred ChHHHhccCcc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC--CC
Q 041438 559 SLDKILNNDAS-AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS--SN 635 (752)
Q Consensus 559 ~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~--~~ 635 (752)
+|.+++.+... ....++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+....... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999976432 23456677889999999999999999 99999999999999999999999999986432211 11
Q ss_pred cccccCCCCccCcccccc-------CCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc-CCCCCC-
Q 041438 636 WSKLAGTHGNVAPELAYT-------MKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RLPYPS- 705 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~-------~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~- 705 (752)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||.... ..+....+... ....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-----~~~~~~~~~~~~~~~~~~~ 232 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS-----DREVLNHVIKDQQVKLFKP 232 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHhhcccccCCC
Confidence 223467889999998753 235789999999999999997 567774211 11111111111 111110
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHh
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 741 (752)
.......+.+.+++.+|| .+|++||+++|+++.|.
T Consensus 233 ~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 233 QLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 011224456788999999 67999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=271.13 Aligned_cols=216 Identities=26% Similarity=0.325 Sum_probs=171.6
Q ss_pred eccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEEEeccCCCh
Q 041438 509 IGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYEYLESGSL 560 (752)
Q Consensus 509 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E~~~~g~L 560 (752)
||.|+||.||+|+. .+++.||+|.+...... +.+.+....++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999995 45899999988643211 344566788999999999999
Q ss_pred HHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCccccc
Q 041438 561 DKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLA 640 (752)
Q Consensus 561 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 640 (752)
.+++.+.. .+++..+..++.|++.||+|+|+. +++|+||||+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~ 153 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC 153 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence 99997643 378899999999999999999999 99999999999999999999999999998765432 223347
Q ss_pred CCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc--cCCCCCChhhHHHHHHHHHH
Q 041438 641 GTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD--SRLPYPSLDVQNKFMSIMQV 718 (752)
Q Consensus 641 gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~l 718 (752)
++..|+|||.+.+..++.++|+||+|+++|+|++|+.||..... ........+.. .....+ ...+.++.++
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 226 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE---DPMEIYNDILKGNGKLEFP----NYIDKAAKDL 226 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC---CHHHHHHHHhccCCCCCCC----cccCHHHHHH
Confidence 88999999998888899999999999999999999999852211 11222333332 222232 1225678999
Q ss_pred HHhccCcCCCCCCC-----HHHHHH
Q 041438 719 AFSCLDQNPVSRPT-----MKRFEV 738 (752)
Q Consensus 719 i~~cl~~dP~~Rps-----~~evl~ 738 (752)
+.+||+.||++||+ ++|+++
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 227 IKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHccCChhhCcCCcccCHHHHhc
Confidence 99999999999999 677665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=270.51 Aligned_cols=231 Identities=20% Similarity=0.314 Sum_probs=172.1
Q ss_pred cccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEec
Q 041438 503 FDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~~ 555 (752)
|++.+.||+|++|.||+|+.. +++.||||++...... +++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 678899999999999999964 5889999987543221 2344567889999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 635 (752)
+|++.+++.... ...+++.++..++.|++.||.|||+. +++|+||||+||++++++.++|+|||.+....... .
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-P 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC-C
Confidence 779998887643 23588999999999999999999999 99999999999999999999999999998765322 2
Q ss_pred cccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccc----------cccc------hHhhhc
Q 041438 636 WSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------SSNM------NIEILD 698 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~----------~~~~------~~~~~~ 698 (752)
.....++..|+|||++.+ ..++.++||||||++++||++|++||......... .... .....+
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 234568889999998754 45789999999999999999999998522110000 0000 000000
Q ss_pred cCCCCCC-----hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 699 SRLPYPS-----LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 699 ~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...+... ........++.+++.+||+.||++|||++|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 0001124578899999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=268.38 Aligned_cols=223 Identities=25% Similarity=0.377 Sum_probs=178.8
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEe
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~ 554 (752)
+|++.+.||+|++|.||+|+. .+++.||+|.+...... +++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 588899999999999999985 46889999998665431 234456778999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++++|.+++... ..+++..+..++.|++.|+.|||+. ||+||||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998765 3488999999999999999999999 999999999999999999999999999988765443
Q ss_pred CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhh-ccCCCCCChhhHHHHH
Q 041438 635 NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEIL-DSRLPYPSLDVQNKFM 713 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 713 (752)
......++..|+|||...+..++.++||||+|+++|+|++|+.||.... ......... ......+ ...+.
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~----~~~~~ 225 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-----PMAALFRIVQDDHPPLP----EGISP 225 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhccCCCCCC----CCCCH
Confidence 3344578899999999888888999999999999999999999985211 111111111 1111111 23456
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+.+++.+||..+|++||++.|++.+
T Consensus 226 ~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 226 ELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 78899999999999999999999854
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=278.22 Aligned_cols=233 Identities=20% Similarity=0.295 Sum_probs=169.3
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Ccccc-------
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSH------- 544 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~------- 544 (752)
..++|++.++||+|+||.||+|+. .+++.||||.+...... +++..
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 456899999999999999999995 57899999987532211 11111
Q ss_pred -CCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeec
Q 041438 545 -PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDF 623 (752)
Q Consensus 545 -~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~Df 623 (752)
....++||||+.+ ++.+++.... ..+++.+++.++.|++.||+|||++ +++|+||||+||+++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 2345999999975 8888876543 3488999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCCC----cccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc
Q 041438 624 RIAKFLNLDSSN----WSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD 698 (752)
Q Consensus 624 G~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 698 (752)
|.+......... .....++..|+|||++.+.. ++.++||||||+++|||++|+.||....... .......+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~--~~~~~~~~~~ 241 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH--QLTLISQLCG 241 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhC
Confidence 999866433221 12346788999999876654 6889999999999999999999985221100 0000000000
Q ss_pred ----------------cCCCCCChh---h------HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 699 ----------------SRLPYPSLD---V------QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 699 ----------------~~~~~~~~~---~------~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.....+... . ......+.++|.+||..||++|||++|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000000 0 0113457789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=275.55 Aligned_cols=227 Identities=23% Similarity=0.324 Sum_probs=173.2
Q ss_pred ccccceeeccCCceEEEEEEe----CCCcEEEEEccCCCCCC-----------------------------CccccCCce
Q 041438 502 DFDAKHCIGKGGHGSVYIARV----PSGEIFAVKKFHSPLPD-----------------------------NFCSHPRQS 548 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-----------------------------~~~~~~~~~ 548 (752)
+|++.+.||+|+||.||+|+. .+|+.||+|++...... ..+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999984 47899999988642110 223445678
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
|+||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999987543 477899999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCC-CcccccCCCCccCccccccC--CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCC
Q 041438 629 LNLDSS-NWSKLAGTHGNVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPS 705 (752)
Q Consensus 629 ~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (752)
...... ......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||..... ..........+.....+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~- 232 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSEPPYP- 232 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccCCCCC-
Confidence 643321 12234688999999988753 467899999999999999999999852111 0011112222222222222
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 739 (752)
....+.+.+++.+||+.||++|| ++++++++
T Consensus 233 ---~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 233 ---QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ---ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 23456788999999999999997 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=280.22 Aligned_cols=237 Identities=19% Similarity=0.277 Sum_probs=185.6
Q ss_pred cccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEec
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~~ 555 (752)
+...+.++||+|.||+|..+....+..||||+++..... ++|-.++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 456678999999999999999878899999999865433 6677788999999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 635 (752)
++|+|.+++.++.... +..+....|+.||+.|++||.+. ++||||+.+.|+|+|.++++||+|||+++.+-.....
T Consensus 618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999998764322 45566778999999999999999 9999999999999999999999999999966543322
Q ss_pred --cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh--CCCCcchhhccccccccchHhhhccCCC-CCChhhHH
Q 041438 636 --WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPRDFLFEMSSSSSNMNIEILDSRLP-YPSLDVQN 710 (752)
Q Consensus 636 --~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 710 (752)
....+-...|||||.+.-++++.++|||+||+++||+++ .+.||....+ +...+....+.+.... .-.....-
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~--e~vven~~~~~~~~~~~~~l~~P~~ 771 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD--EQVVENAGEFFRDQGRQVVLSRPPA 771 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH--HHHHHhhhhhcCCCCcceeccCCCc
Confidence 122345679999999999999999999999999999975 7888853221 1111111122222111 00111244
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
++..+.+++.+||..|-++||+++++..+|++.
T Consensus 772 cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 772 CPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 667889999999999999999999999999875
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=280.33 Aligned_cols=234 Identities=21% Similarity=0.281 Sum_probs=173.9
Q ss_pred hcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------Ccc----ccCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFC----SHPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~----~~~~~~ 548 (752)
.++|++.+.||+|+||.||+|+ ..+|+.||+|++...... +++ ......
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 4789999999999999999998 457999999988653211 111 123467
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
++||||+. ++|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||.+..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 58999886543 388999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCC----cccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccc----------ccc----
Q 041438 629 LNLDSSN----WSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS----------SSS---- 689 (752)
Q Consensus 629 ~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~----------~~~---- 689 (752)
....... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 6432211 123478899999998765 458899999999999999999999985211100 000
Q ss_pred ----ccchHhhhc---cCCCCCC-hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 690 ----SNMNIEILD---SRLPYPS-LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 690 ----~~~~~~~~~---~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
........+ .....+. ......+.++.+++.+||+.||++||++++++.+-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 000000000 0001110 00123456799999999999999999999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=276.73 Aligned_cols=234 Identities=20% Similarity=0.273 Sum_probs=171.2
Q ss_pred ccccceeeccCCceEEEEEEeC---CCcEEEEEccCCCC---CC------------------------CccccC--CceE
Q 041438 502 DFDAKHCIGKGGHGSVYIARVP---SGEIFAVKKFHSPL---PD------------------------NFCSHP--RQSF 549 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~------------------------~~~~~~--~~~~ 549 (752)
+|++.++||+|+||.||+|+.. +++.||+|.+.... .. +++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788999999999999999953 58999999987632 10 233334 7799
Q ss_pred EEEEeccCCChHHHhccCcc--ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC----CCceEEeec
Q 041438 550 IVYEYLESGSLDKILNNDAS--AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL----GYEAHVSDF 623 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~----~~~~kl~Df 623 (752)
+||||+++ ++.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 77777653321 23588899999999999999999999 9999999999999999 899999999
Q ss_pred ccceeccCCCC---CcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhcccccc----ccchHh
Q 041438 624 RIAKFLNLDSS---NWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS----SNMNIE 695 (752)
Q Consensus 624 G~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~----~~~~~~ 695 (752)
|++........ ......++..|+|||++.+. .++.++|||||||++|+|++|++||.......... ......
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 12234678899999987764 57899999999999999999999986322111000 000000
Q ss_pred h--------------------------hccCCCCCChhhH-------HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 696 I--------------------------LDSRLPYPSLDVQ-------NKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 696 ~--------------------------~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+ .......+..... ....++.+++.+|++.||++|||+.|+++|
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 0000111100000 233468899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=275.13 Aligned_cols=232 Identities=22% Similarity=0.312 Sum_probs=177.0
Q ss_pred ccccceeeccCCceEEEEEEe----CCCcEEEEEccCCCCCC-----------------------------CccccCCce
Q 041438 502 DFDAKHCIGKGGHGSVYIARV----PSGEIFAVKKFHSPLPD-----------------------------NFCSHPRQS 548 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-----------------------------~~~~~~~~~ 548 (752)
+|++.+.||+|+||.||+|+. .+++.||||.+++.... +.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478899999999999999973 35788999987632110 233445678
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
++||||+++|+|.+++.... .+++..+..++.|+++||.|||+. +++||||||+||+++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999999986532 478899999999999999999999 999999999999999999999999999887
Q ss_pred ccCCCCC-cccccCCCCccCccccccCC--CCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCC
Q 041438 629 LNLDSSN-WSKLAGTHGNVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPS 705 (752)
Q Consensus 629 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (752)
....... .....|+..|+|||.+.+.. .+.++||||||+++|||++|..||....... ........+.....+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~- 232 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRILKSKPPFP- 232 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHHccCCCCC-
Confidence 5433221 12246889999999987655 7889999999999999999999985211110 11112222223322322
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
......+.+++.+||+.||++|||+.++.+.++...
T Consensus 233 ---~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 233 ---KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred ---cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 224457889999999999999999988877776543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=282.92 Aligned_cols=239 Identities=28% Similarity=0.354 Sum_probs=179.7
Q ss_pred cccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC----------------------Ccc---------ccCCce
Q 041438 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD----------------------NFC---------SHPRQS 548 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----------------------~~~---------~~~~~~ 548 (752)
..|...+.||+|+||.||+++ ..+|+.||||.++..... .++ .-.+..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 346667899999999999999 778999999988763211 111 113456
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC--CCC--ceEEeecc
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD--LGY--EAHVSDFR 624 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~--~~~--~~kl~DfG 624 (752)
.+|||||.||+|+..+.+......|++.+...+..+++.||.|||++ |||||||||.||++- .+| ..||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 89999999999999998766666799999999999999999999999 999999999999983 334 37999999
Q ss_pred cceeccCCCCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHh--------
Q 041438 625 IAKFLNLDSSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE-------- 695 (752)
Q Consensus 625 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~-------- 695 (752)
.|+.++++ +.....+||..|.+||++.. ..|+..+|.|||||++|+++||..||..........+.....
T Consensus 170 ~Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 170 AARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred ccccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 99998754 46677899999999999884 778999999999999999999999984211110000000000
Q ss_pred ------------hhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCC--CHHHHHHHHhhh
Q 041438 696 ------------ILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRP--TMKRFEVQSKQF 743 (752)
Q Consensus 696 ------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp--s~~evl~~L~~~ 743 (752)
.....+|+|..........+-..+..+|..+|++|. ...+....+..+
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 011122333323344555677788889999999998 666665555444
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=268.03 Aligned_cols=226 Identities=20% Similarity=0.255 Sum_probs=172.7
Q ss_pred ccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCC---C--------------------------CccccCCceEEE
Q 041438 502 DFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLP---D--------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~--------------------------~~~~~~~~~~lV 551 (752)
+|.+.+.||+|+||.||+++.. .+..+++|.++.... . +++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888999999999999999843 344455555432110 0 234455678999
Q ss_pred EEeccCCChHHHhccCc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 552 YEYLESGSLDKILNNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
|||+++++|.+++.... ....+++..++.++.|++.|+.|||+. +++|+||||+||++++ +.+||+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999886422 234589999999999999999999999 9999999999999975 569999999998765
Q ss_pred CCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
..........|++.|+|||...+..++.++|+||||+++|+|++|..||... ..............+.. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~~~---~~~ 228 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-----NFLSVVLRIVEGPTPSL---PET 228 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHHcCCCCCC---cch
Confidence 4433333456888999999988888899999999999999999999998521 11112222222222211 134
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+.++.+++.+||+.||++||++.|++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 229 YSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred hcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 56688999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=278.27 Aligned_cols=227 Identities=23% Similarity=0.327 Sum_probs=191.0
Q ss_pred hccccc--ceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------CccccCCceEE
Q 041438 500 TNDFDA--KHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFI 550 (752)
Q Consensus 500 ~~~y~~--~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~l 550 (752)
..-|++ .+.||+|.||+||-|+ .++|+.||||++.+.... ..++.++.+++
T Consensus 561 stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFV 640 (888)
T KOG4236|consen 561 STVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFV 640 (888)
T ss_pred HHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEE
Confidence 334444 5799999999999999 578999999998764332 24567899999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC---CceEEeecccce
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG---YEAHVSDFRIAK 627 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~---~~~kl~DfG~a~ 627 (752)
|||-+.|.-|+-++... ...+++...+.++.||+.||.|||.+ +|||.||||+|||+... -.+||||||+|+
T Consensus 641 VMEKl~GDMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 641 VMEKLHGDMLEMILSSE--KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred EehhhcchHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccccee
Confidence 99999875555555543 24588899999999999999999999 99999999999999633 469999999999
Q ss_pred eccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChh
Q 041438 628 FLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLD 707 (752)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (752)
.+... ......+||+.|.|||++....|...-|+||.|||+|--+.|..||. ..++...++.+..+.+|..+
T Consensus 716 iIgEk-sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN-------EdEdIndQIQNAaFMyPp~P 787 (888)
T KOG4236|consen 716 IIGEK-SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN-------EDEDINDQIQNAAFMYPPNP 787 (888)
T ss_pred ecchh-hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC-------CccchhHHhhccccccCCCc
Confidence 98743 33455799999999999999999999999999999999999999985 23455667778888899889
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+.+++....++|...|+..-.+|-|.++.+.|
T Consensus 788 W~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred hhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 99999999999999999999999999887765
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-33 Score=263.81 Aligned_cols=229 Identities=24% Similarity=0.277 Sum_probs=177.9
Q ss_pred cccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEec
Q 041438 503 FDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~~ 555 (752)
.+-...||.|+||+|+|-. .+.|+..|||+++..... +.+..++..|+.||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 3345789999999999998 578999999999865542 4456678899999999
Q ss_pred cCCChHHHhccCc--cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 556 ESGSLDKILNNDA--SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 556 ~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
.- +++.+.+..- ....+++.-.-+|+...+.||.||.... .|+|||+||+|||++..|.+|+||||.+..+..+
T Consensus 146 d~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S- 221 (361)
T KOG1006|consen 146 DI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS- 221 (361)
T ss_pred hh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH-
Confidence 76 7766554311 1234788888899999999999999875 8999999999999999999999999999876532
Q ss_pred CCcccccCCCCccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCC--hhhH
Q 041438 634 SNWSKLAGTHGNVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPS--LDVQ 709 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~--~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 709 (752)
...+...|-..|||||.+.. ..|+.+|||||+|+++||+.||+.|++. |. ...+....+..+..+.-. ....
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~--w~--svfeql~~Vv~gdpp~l~~~~~~~ 297 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK--WD--SVFEQLCQVVIGDPPILLFDKECV 297 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch--HH--HHHHHHHHHHcCCCCeecCccccc
Confidence 22344578899999998773 3489999999999999999999999852 11 123344455555554321 1223
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+.+..+.++|.-|+.+|-.+||...++.++
T Consensus 298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 298 HYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 467789999999999999999999987753
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=269.12 Aligned_cols=221 Identities=24% Similarity=0.358 Sum_probs=173.6
Q ss_pred eccCCceEEEEEEeC-CCcEEEEEccCCCCCC---------------------------CccccCCceEEEEEeccCCCh
Q 041438 509 IGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYEYLESGSL 560 (752)
Q Consensus 509 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E~~~~g~L 560 (752)
||+|+||.||+|+.. +|+.||+|.+...... +.+......|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999965 5999999988654321 233456778999999999999
Q ss_pred HHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC------
Q 041438 561 DKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS------ 634 (752)
Q Consensus 561 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~------ 634 (752)
.+++.... .+++..+..++.||+.||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99997643 488899999999999999999999 999999999999999999999999999876543311
Q ss_pred --CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHH
Q 041438 635 --NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712 (752)
Q Consensus 635 --~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (752)
......++..|+|||...+..++.++||||||+++|++++|+.||... ........+.......+.. ...+
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~~--~~~~ 227 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE-----TPEEIFQNILNGKIEWPED--VEVS 227 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcCCcCCCcc--ccCC
Confidence 223346788999999998888999999999999999999999998521 1222222333333333321 1236
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
..+.+++.+||+.+|++|||+.++.+.++.
T Consensus 228 ~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 228 DEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred HHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 678999999999999999999666665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=255.23 Aligned_cols=235 Identities=20% Similarity=0.281 Sum_probs=173.6
Q ss_pred hcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC----------------------------------Ccccc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD----------------------------------NFCSH 544 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----------------------------------~~~~~ 544 (752)
.+.|+-..+||+|.||+||+|+ ..+|+.||+|++-.+... .....
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 4556777899999999999999 557888999876332111 11223
Q ss_pred CCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecc
Q 041438 545 PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFR 624 (752)
Q Consensus 545 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG 624 (752)
...+|+||++|+. +|..++.... ..++..++.+++.+++.||.|+|+. .|+|||+||+|+||+.++.+||+|||
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 4568999999998 9999997653 4588899999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCC----CcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccc-------------
Q 041438 625 IAKFLNLDSS----NWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS------------- 686 (752)
Q Consensus 625 ~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~------------- 686 (752)
+|+.+..... ..+..+-|.+|++||.+.+. .|+++.|||+.|||+.||.||.+-++...+..
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 9977654322 23445779999999988765 58999999999999999999999875322100
Q ss_pred --ccccc---chHhhhccCCCCCCh---hhHHH------HHHHHHHHHhccCcCCCCCCCHHHHHHHHh
Q 041438 687 --SSSSN---MNIEILDSRLPYPSL---DVQNK------FMSIMQVAFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 687 --~~~~~---~~~~~~~~~~~~~~~---~~~~~------~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 741 (752)
..... ...+.+... +.+.. ...+. .++..+++.+++..||.+|+++++++.|--
T Consensus 250 kevWP~~d~lpL~~sie~e-Pl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELE-PLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred cccCCCcccchHHHhccCC-CCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 00000 000111000 01100 01111 236789999999999999999999998753
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=275.47 Aligned_cols=241 Identities=20% Similarity=0.293 Sum_probs=194.1
Q ss_pred HHHHHhhcccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC-----------------------CccccCCceE
Q 041438 494 EEIIRATNDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD-----------------------NFCSHPRQSF 549 (752)
Q Consensus 494 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~ 549 (752)
+++.-...+.....+||-|.||.||.|.++ -.-.||||.++.+... ++|.++..+|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 444444456677899999999999999964 4678999988765332 7899999999
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
||+|||.+|+|.+|+++... ..++.-....++.||++|++||..+ ++|||||-..|.|+.++..+||+|||+++.+
T Consensus 340 IiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999987543 4466677889999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCcc-cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChh
Q 041438 630 NLDSSNWS-KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLD 707 (752)
Q Consensus 630 ~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (752)
..+..... ...-...|.|||-+....++.|+|||+|||++||+.| |-.||... ........+...+....
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi------dlSqVY~LLEkgyRM~~-- 487 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYGLLEKGYRMDG-- 487 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc------cHHHHHHHHhccccccC--
Confidence 75432211 1123467999999999999999999999999999998 77786421 12233344444444332
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
.+++++.+.+||+.||++.|.+||+++|+-+.++.+..+
T Consensus 488 PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 488 PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 267888999999999999999999999999999987543
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=278.45 Aligned_cols=238 Identities=18% Similarity=0.268 Sum_probs=175.5
Q ss_pred hHHHHHHhhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------Ccc--
Q 041438 492 VYEEIIRATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFC-- 542 (752)
Q Consensus 492 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~-- 542 (752)
..+++....++|++.+.||+|+||.||+|. ..+++.||+|++...... +++
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 445677788999999999999999999998 467999999988653211 111
Q ss_pred ----ccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCce
Q 041438 543 ----SHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEA 618 (752)
Q Consensus 543 ----~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~ 618 (752)
......|++++++ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 1123467888877 67998887643 388899999999999999999999 99999999999999999999
Q ss_pred EEeecccceeccCCCCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccc---------
Q 041438 619 HVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS--------- 688 (752)
Q Consensus 619 kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~--------- 688 (752)
||+|||++..... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.........
T Consensus 160 kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 160 KILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred EEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999986532 2233478899999998766 46789999999999999999999998421110000
Q ss_pred -cccc--------hHhhhccCCCCCChh----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 689 -SSNM--------NIEILDSRLPYPSLD----VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 689 -~~~~--------~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
.... ...........+... ....++++.+++.+|++.||++||++.++++|=
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 0000 000000000000000 012345688999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=265.06 Aligned_cols=224 Identities=26% Similarity=0.344 Sum_probs=179.6
Q ss_pred ccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC--------------------------CccccC--CceEEEE
Q 041438 502 DFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD--------------------------NFCSHP--RQSFIVY 552 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~--~~~~lV~ 552 (752)
+|+..+.||+|++|.||+|... +++.|++|++...... +.+... ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999954 7899999988765421 233344 6789999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++++|.+++.... .+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999997653 588999999999999999999999 9999999999999999999999999999887644
Q ss_pred CC--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc--cCCCCCChhh
Q 041438 633 SS--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD--SRLPYPSLDV 708 (752)
Q Consensus 633 ~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 708 (752)
.. ......++..|+|||...+..++.++||||||+++|+|++|+.||.... ........+.. .....+
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~---- 226 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----NPMAALYKIGSSGEPPEIP---- 226 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHhccccCCCcCCC----
Confidence 32 1234578899999999988889999999999999999999999986321 11111111111 111111
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...+..+.+++.+|++.||++||++.|++++
T Consensus 227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 2346689999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=280.11 Aligned_cols=237 Identities=22% Similarity=0.305 Sum_probs=174.5
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------Cccc--cCCce
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCS--HPRQS 548 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~--~~~~~ 548 (752)
..++|++.+.||+|+||.||+|.. .+++.||+|++...... +++. +....
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 467899999999999999999995 46889999987532110 1222 23457
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
|+||||+++ +|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+..
T Consensus 85 ~lv~e~~~~-~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYMET-DLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEeccccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 999999985 999888654 478899999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCC-----CcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhcccc----------ccc--
Q 041438 629 LNLDSS-----NWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------SSS-- 690 (752)
Q Consensus 629 ~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~----------~~~-- 690 (752)
...... ......|+..|+|||++.+ ..++.++|||||||++|+|+||+.||........ ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 643321 1223468999999998765 4578999999999999999999999852111000 000
Q ss_pred ------cchHhhhc----cCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--Hhhh
Q 041438 691 ------NMNIEILD----SRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ--SKQF 743 (752)
Q Consensus 691 ------~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~~ 743 (752)
.......+ .............+.++.+++.+||+.||++|||+.+++++ ++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 00000000 00000001112245678999999999999999999999976 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=266.64 Aligned_cols=225 Identities=21% Similarity=0.257 Sum_probs=172.6
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC----C-------------------------Ccccc--CCce
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP----D-------------------------NFCSH--PRQS 548 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~-------------------------~~~~~--~~~~ 548 (752)
.+|++.+.||+|+||.||+|+. .+++.||+|.+..... . +++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4789999999999999999984 5799999998743210 0 11222 3457
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999987543 377889999999999999999999 999999999999999999999999999986
Q ss_pred ccCCC---CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCC
Q 041438 629 LNLDS---SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPS 705 (752)
Q Consensus 629 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (752)
..... .......++..|+|||++.+..++.++|||||||++|++++|+.||... ............... +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~-~- 228 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY-----EAMAAIFKIATQPTK-P- 228 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc-----CHHHHHHHHHcCCCC-C-
Confidence 53211 1122346889999999999888999999999999999999999998521 111111222211111 1
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.......+.+.+++.+|++ +|.+||++.+++.|
T Consensus 229 ~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 229 MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1113455678999999999 57999999988865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=271.03 Aligned_cols=231 Identities=23% Similarity=0.320 Sum_probs=171.6
Q ss_pred cccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC--------------------------CccccC--CceEEEEE
Q 041438 503 FDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD--------------------------NFCSHP--RQSFIVYE 553 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~--~~~~lV~E 553 (752)
|++.+.||+|+||.||+|+.. +++.||+|++...... +++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999954 5899999998754200 233444 78999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++ +|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9985 8988886543 3588999999999999999999999 99999999999999999999999999998765433
Q ss_pred C-CcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccc----------cccc--------h
Q 041438 634 S-NWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------SSNM--------N 693 (752)
Q Consensus 634 ~-~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~----------~~~~--------~ 693 (752)
. ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||+........ .... .
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 1 1233467889999997765 45789999999999999999999998522110000 0000 0
Q ss_pred HhhhccCCCCCC---hhhHH-HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 694 IEILDSRLPYPS---LDVQN-KFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 694 ~~~~~~~~~~~~---~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..........+. ..... ++.++.+++.+||..+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000000000 00011 25678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=277.90 Aligned_cols=232 Identities=21% Similarity=0.296 Sum_probs=170.6
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Ccccc------CC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSH------PR 546 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~------~~ 546 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||+++..... +++.. ..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999994 57999999988653211 11111 13
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
..++||||+.. ++.++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999975 7777653 2378899999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccc---------c-c-----
Q 041438 627 KFLNLDSSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS---------S-S----- 690 (752)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~---------~-~----- 690 (752)
+.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... . .
T Consensus 165 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 165 RHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred cCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 76532 2233467889999998876 45889999999999999999999998632110000 0 0
Q ss_pred ---cchHhhhccCCCCCChh----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--Hhhh
Q 041438 691 ---NMNIEILDSRLPYPSLD----VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ--SKQF 743 (752)
Q Consensus 691 ---~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~~ 743 (752)
.............+... ....+.++.+++.+||+.||++||+++|++.| ++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000000000011100 11234568899999999999999999999976 5554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=275.37 Aligned_cols=225 Identities=20% Similarity=0.274 Sum_probs=166.1
Q ss_pred eeeccC--CceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEeccC
Q 041438 507 HCIGKG--GHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 507 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
..||+| +||+||+|+. .+|+.||+|++...... +++...+..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999995 58999999997643211 344556778999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc-
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW- 636 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~- 636 (752)
+++.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999999876532 3478899999999999999999999 99999999999999999999999998654332111110
Q ss_pred ------ccccCCCCccCccccccC--CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccC--------
Q 041438 637 ------SKLAGTHGNVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR-------- 700 (752)
Q Consensus 637 ------~~~~gt~~y~aPE~~~~~--~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------- 700 (752)
....++..|+|||++.+. .++.++||||+||++|||++|+.||...... ..........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT-----QMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH-----HHHHHHhcCCCCCCcccc
Confidence 112345679999998764 4789999999999999999999998532110 0000000000
Q ss_pred -----------------------------------CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 701 -----------------------------------LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 701 -----------------------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
..............+.+++.+||+.||++|||++|+++|-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 0000111234567889999999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=272.95 Aligned_cols=234 Identities=22% Similarity=0.281 Sum_probs=172.2
Q ss_pred HhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Cccc-------
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCS------- 543 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~------- 543 (752)
...++|++.+.||+|+||.||+|.. .+++.||+|+++..... +++.
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4568899999999999999999995 46899999988643211 1111
Q ss_pred ---cCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEE
Q 041438 544 ---HPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV 620 (752)
Q Consensus 544 ---~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl 620 (752)
+....++||||+++ ++...+.... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence 12378999999987 7777776432 3588999999999999999999999 9999999999999999999999
Q ss_pred eecccceeccCCCCC-cccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc
Q 041438 621 SDFRIAKFLNLDSSN-WSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD 698 (752)
Q Consensus 621 ~DfG~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 698 (752)
+|||.+......... .....++..|+|||.+.+. .++.++||||+||++|||++|++||........ .........
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~--~~~~~~~~~ 235 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ--LELISRLCG 235 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhC
Confidence 999999876533321 1223567889999987653 478999999999999999999999852211000 000000000
Q ss_pred cC--------------------CC---CCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 699 SR--------------------LP---YPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 699 ~~--------------------~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.. .. .........+..+.+++.+||+.||++||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 00 0000111235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=284.62 Aligned_cols=237 Identities=24% Similarity=0.356 Sum_probs=192.4
Q ss_pred hHHHHHHhhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC------------------------Ccc----
Q 041438 492 VYEEIIRATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD------------------------NFC---- 542 (752)
Q Consensus 492 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------------------------~~~---- 542 (752)
.++.+-..++.|++.+.||.|.+|.||+++ .++++.+|+|+....... +++
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 344445568889999999999999999999 678999999988654332 111
Q ss_pred -ccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEe
Q 041438 543 -SHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVS 621 (752)
Q Consensus 543 -~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~ 621 (752)
..+++.|+|||||.+|+..++++... ...+.|+.+..|++++++|+.+||.. .++|||||-.|||++.++.+|++
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 23578999999999999999998766 56699999999999999999999999 99999999999999999999999
Q ss_pred ecccceeccCCCCCcccccCCCCccCccccccC-----CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhh
Q 041438 622 DFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEI 696 (752)
Q Consensus 622 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 696 (752)
|||.+..++.........+||+.|||||++... .|+..+|+||+|++..||..|.+|+- + ...+..-+
T Consensus 166 DFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~------D-mHPmraLF 238 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC------D-MHPMRALF 238 (953)
T ss_pred eeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc------C-cchhhhhc
Confidence 999999887666666778999999999987743 36789999999999999999999962 1 11111112
Q ss_pred hccCCCCCCh-hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 697 LDSRLPYPSL-DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 697 ~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...+-|.|.. .....++++.++|..|+.+|-++||++.++++|
T Consensus 239 ~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 239 LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 2222222222 256788899999999999999999999988865
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=278.92 Aligned_cols=231 Identities=19% Similarity=0.281 Sum_probs=171.7
Q ss_pred HhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCC----
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPR---- 546 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~---- 546 (752)
...++|++.+.||+|++|.||+|+. .+++.||||++...... +++...+
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3467899999999999999999995 46889999988653211 1112222
Q ss_pred --ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecc
Q 041438 547 --QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFR 624 (752)
Q Consensus 547 --~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG 624 (752)
..++|+||+ +++|.+++... .+++..+..++.|++.||+|||+. ||+||||||+||++++++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 389999999 55999988652 488999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhcccc---------c-ccc--
Q 041438 625 IAKFLNLDSSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS---------S-SSN-- 691 (752)
Q Consensus 625 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~---------~-~~~-- 691 (752)
.+...... .....++..|+|||.+.+ ..++.++||||+||++||+++|+.||........ . ...
T Consensus 164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 164 LARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred cccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 99875432 233467889999998765 3578999999999999999999999852111000 0 000
Q ss_pred ------chHhhhccCCCCCChh----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 692 ------MNIEILDSRLPYPSLD----VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 692 ------~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
................ ....+.++.+++.+|++.||++|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000000000000000 01235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=273.19 Aligned_cols=227 Identities=25% Similarity=0.337 Sum_probs=174.2
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV 551 (752)
...|+..+.||+|+||.||+|+. .+++.||+|.+...... +++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 34577889999999999999994 56889999987532110 234456778999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+. |++.+++.... ..+++.++..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 94 ~e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 94 MEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 99997 58887775433 3478899999999999999999999 999999999999999999999999999886543
Q ss_pred CCCCcccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhh
Q 041438 632 DSSNWSKLAGTHGNVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (752)
. ....++..|+|||++. ...++.++|||||||++|+|++|+.||... ........+.....+.. ..
T Consensus 168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-----~~~~~~~~~~~~~~~~~--~~ 236 (308)
T cd06634 168 A----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NAMSALYHIAQNESPAL--QS 236 (308)
T ss_pred c----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc-----cHHHHHHHHhhcCCCCc--Cc
Confidence 2 2346888999999874 345788999999999999999999997421 11111122222222211 12
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
...+..+.++|.+||+.+|++||++++++++-...
T Consensus 237 ~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred ccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 34556788999999999999999999999875543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=268.63 Aligned_cols=231 Identities=22% Similarity=0.309 Sum_probs=174.6
Q ss_pred cccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEec
Q 041438 503 FDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~~ 555 (752)
|+..+.||+|+||.||+|+. .+++.||+|.+...... +++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 56778999999999999995 46999999988764211 3344567899999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 635 (752)
++ +|.+++.... ..+++..+..++.|++.||+|||+. +|+||||+|+||++++++.+||+|||.+.........
T Consensus 81 ~~-~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 DM-DLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred Cc-CHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 85 9999997653 3488999999999999999999999 9999999999999999999999999999876544333
Q ss_pred cccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhcccc----------ccccchHhh-----hcc
Q 041438 636 WSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------SSSNMNIEI-----LDS 699 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~----------~~~~~~~~~-----~~~ 699 (752)
.....++..|+|||.+.+. .++.++|||||||++||+++|+.||........ ......... .+.
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 3344567889999998766 789999999999999999999999853211000 000000000 000
Q ss_pred CCCC-C----ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 700 RLPY-P----SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 700 ~~~~-~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..+. . .......+..+.+++.+||+.||++||++++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000 0 00112235679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=263.10 Aligned_cols=212 Identities=25% Similarity=0.338 Sum_probs=170.7
Q ss_pred eccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEEEeccCCCh
Q 041438 509 IGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYEYLESGSL 560 (752)
Q Consensus 509 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E~~~~g~L 560 (752)
||+|+||.||++.. .+++.||+|.+...... +.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999995 46899999987653221 234566788999999999999
Q ss_pred HHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCccccc
Q 041438 561 DKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLA 640 (752)
Q Consensus 561 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 640 (752)
.+++.... .+++..+..++.|++.|+.|+|+. +++|+||||+||+++.++.++|+|||.+..............
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence 99997543 478899999999999999999999 999999999999999999999999999987654332334457
Q ss_pred CCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHHH
Q 041438 641 GTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAF 720 (752)
Q Consensus 641 gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 720 (752)
++..|+|||...+...+.++|+||||+++|++++|+.||.... .......+.....+.+. ..+..+.+++.
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~----~~~~~l~~~i~ 225 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED-----RKEIYEKILKDPLRFPE----FLSPEARDLIS 225 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHhcCCCCCCC----CCCHHHHHHHH
Confidence 8889999999988888999999999999999999999985211 12223333333333332 23567889999
Q ss_pred hccCcCCCCCCCHHH
Q 041438 721 SCLDQNPVSRPTMKR 735 (752)
Q Consensus 721 ~cl~~dP~~Rps~~e 735 (752)
+||..||++||++++
T Consensus 226 ~~l~~~p~~R~~~~~ 240 (250)
T cd05123 226 GLLQKDPTKRLGSGG 240 (250)
T ss_pred HHhcCCHhhCCCccc
Confidence 999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=271.98 Aligned_cols=234 Identities=21% Similarity=0.262 Sum_probs=168.6
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Ccc--------cc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFC--------SH 544 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~--------~~ 544 (752)
.++|++.++||+|+||.||+|+. .+++.||||++...... +++ ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999994 57899999987432110 111 12
Q ss_pred CCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecc
Q 041438 545 PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFR 624 (752)
Q Consensus 545 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG 624 (752)
....++||||+.+ ++...+.... ..+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence 2357999999976 7777765432 3488999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCCC-----------cccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccccc----
Q 041438 625 IAKFLNLDSSN-----------WSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS---- 688 (752)
Q Consensus 625 ~a~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~---- 688 (752)
++......... .....+++.|+|||++.+. .++.++|||||||++|||++|++||.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99865432211 1223568889999987654 5789999999999999999999998521110000
Q ss_pred ------cccc---hH---h----hhccCCCCC-ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 689 ------SSNM---NI---E----ILDSRLPYP-SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 689 ------~~~~---~~---~----~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.... .. . ......+.. ........+.+.+++.+|++.||++|||+.|++.|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0000 00 0 000000000 00011223568899999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=262.81 Aligned_cols=201 Identities=20% Similarity=0.185 Sum_probs=159.5
Q ss_pred CCceEEEEEE-eCCCcEEEEEccCCCCCC-------------------CccccCCceEEEEEeccCCChHHHhccCcccc
Q 041438 512 GGHGSVYIAR-VPSGEIFAVKKFHSPLPD-------------------NFCSHPRQSFIVYEYLESGSLDKILNNDASAK 571 (752)
Q Consensus 512 G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------------------~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~ 571 (752)
|.+|.||+|+ ..+++.||+|+++..... +++.+.+..++||||+++|+|.+++....
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--- 80 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL--- 80 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc---
Confidence 8999999999 467899999998753211 33455678999999999999999986543
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcccccCCCCccCcccc
Q 041438 572 ELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELA 651 (752)
Q Consensus 572 ~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~ 651 (752)
.+++..+..++.|++.||+|+|+. +|+||||||+||+++.++.++++|||.+...... .....++..|+|||..
T Consensus 81 ~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE~~ 154 (237)
T cd05576 81 NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPEVG 154 (237)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCCccc
Confidence 388999999999999999999999 9999999999999999999999999988665422 2233567789999999
Q ss_pred ccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCC
Q 041438 652 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRP 731 (752)
Q Consensus 652 ~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 731 (752)
.+..+++++||||+||++|||++|+.|+..... . . .. ......+ ...++.+.+++.+|++.||++||
T Consensus 155 ~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~----~--~-~~--~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 155 GISEETEACDWWSLGAILFELLTGKTLVECHPS----G--I-NT--HTTLNIP----EWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred CCCCCCchhhHHHHHHHHHHHHHCcchhhcCch----h--c-cc--ccccCCc----ccCCHHHHHHHHHHccCCHHHhc
Confidence 888899999999999999999999988642110 0 0 00 0011112 22445788999999999999999
Q ss_pred CHH
Q 041438 732 TMK 734 (752)
Q Consensus 732 s~~ 734 (752)
++.
T Consensus 222 ~~~ 224 (237)
T cd05576 222 GAG 224 (237)
T ss_pred CCC
Confidence 973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=292.37 Aligned_cols=234 Identities=15% Similarity=0.181 Sum_probs=162.4
Q ss_pred hhcccccceeeccCCceEEEEEEeC--CCcEEEEE------------------ccCCC--------------------CC
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP--SGEIFAVK------------------KFHSP--------------------LP 538 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK------------------~~~~~--------------------~~ 538 (752)
..++|++.+.||+|+||.||+|..+ .++.+++| .+... ..
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999998642 22222222 11110 00
Q ss_pred ---CCccccCCceEEEEEeccCCChHHHhccCcc--ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC
Q 041438 539 ---DNFCSHPRQSFIVYEYLESGSLDKILNNDAS--AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD 613 (752)
Q Consensus 539 ---~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~ 613 (752)
.+++.+.+..|+|+|++.+ ++.+++..... .......+++.++.||+.||+|||++ +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 0445566788999999965 77777654321 11234567788999999999999999 999999999999999
Q ss_pred CCCceEEeecccceeccCCCCC-cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCC-cchhhcccccccc
Q 041438 614 LGYEAHVSDFRIAKFLNLDSSN-WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-RDFLFEMSSSSSN 691 (752)
Q Consensus 614 ~~~~~kl~DfG~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~p-f~~~~~~~~~~~~ 691 (752)
.++.+||+|||+++.+...... .....||..|+|||++.+..++.++|||||||++|||++|..+ |.... .....
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~---~~~~~ 378 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGG---GKPGK 378 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCC---CCHHH
Confidence 9999999999999877543222 2235799999999999999999999999999999999998764 32100 00000
Q ss_pred chHhhhc----------------------cCCCCCC------hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 692 MNIEILD----------------------SRLPYPS------LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 692 ~~~~~~~----------------------~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
....++. ..+.... ........++.+++.+||+.||++|||+.|+++|
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000 0000000 0001123457788999999999999999999875
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=273.84 Aligned_cols=232 Identities=18% Similarity=0.177 Sum_probs=165.5
Q ss_pred ccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEeccC
Q 041438 504 DAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 504 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
.+.+.+|.|+++.||+++. +++.||||++...... +++...+..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445555556655555544 7999999998654211 334456788999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC--
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN-- 635 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-- 635 (752)
|++.+++..... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+|++|||.+.........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 999999976432 3478899999999999999999999 9999999999999999999999999998765422211
Q ss_pred -----cccccCCCCccCccccccC--CCCCccchhhHHHHHHHHHhCCCCcchhhcccccccc-----------chHh--
Q 041438 636 -----WSKLAGTHGNVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN-----------MNIE-- 695 (752)
Q Consensus 636 -----~~~~~gt~~y~aPE~~~~~--~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~-----------~~~~-- 695 (752)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||..........+. ....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 1223577889999998763 5789999999999999999999998532110000000 0000
Q ss_pred ---h-------hccC--CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 696 ---I-------LDSR--LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 696 ---~-------~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
. .... ...+.........++.+++.+||+.||++|||++|+++|-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 0 0000 0000011123446788999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=275.92 Aligned_cols=233 Identities=22% Similarity=0.303 Sum_probs=173.5
Q ss_pred HHHhhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------Ccc-ccCCc
Q 041438 496 IIRATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFC-SHPRQ 547 (752)
Q Consensus 496 ~~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~-~~~~~ 547 (752)
+...+++|++.+.||+|+||.||+|+ ..+++.||||++...... +++ .....
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 34578899999999999999999998 458999999987542211 222 23457
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
.++||||+. ++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||.+.
T Consensus 85 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELLG-TDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehhc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 899999995 5898888643 367788899999999999999999 99999999999999999999999999997
Q ss_pred eccCCCCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhcc----------ccccccchHh-
Q 041438 628 FLNLDSSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM----------SSSSSNMNIE- 695 (752)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~----------~~~~~~~~~~- 695 (752)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ....++....
T Consensus 157 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 157 IQDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred ccCCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 64322 223467889999998765 56899999999999999999999998521110 0000000000
Q ss_pred -------h---hccCCCCCCh-hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 696 -------I---LDSRLPYPSL-DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 696 -------~---~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
. .....+.+.. .....+.++.++|.+|++.+|++||++++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000011100 011234678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=281.40 Aligned_cols=221 Identities=21% Similarity=0.303 Sum_probs=172.4
Q ss_pred cceeeccCCceEEEEEEe-CCCcEEEEEccC-------------------------CCCCC---Ccc--ccCCceEEEEE
Q 041438 505 AKHCIGKGGHGSVYIARV-PSGEIFAVKKFH-------------------------SPLPD---NFC--SHPRQSFIVYE 553 (752)
Q Consensus 505 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~-------------------------~~~~~---~~~--~~~~~~~lV~E 553 (752)
...+||+|+|-+||+|.. .+|..||.-.++ .+..- .++ .+.....+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 457899999999999984 457667643221 11111 111 23456789999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC-CCCceEEeecccceeccCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD-LGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~-~~~~~kl~DfG~a~~~~~~ 632 (752)
.+..|+|..|.++.+. ++...++.|++||++||.|||++ .|+|+|||||.+||+|+ ..|.|||+|.|+|......
T Consensus 124 L~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999987654 67789999999999999999998 77999999999999997 5689999999999987543
Q ss_pred CCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHH
Q 041438 633 SSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (752)
.....+|||.|||||++. ..|++.+||||||+.++||+|+.+||. ........+..+..+..|..-. .-..
T Consensus 200 --~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs----EC~n~AQIYKKV~SGiKP~sl~--kV~d 270 (632)
T KOG0584|consen 200 --HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS----ECTNPAQIYKKVTSGIKPAALS--KVKD 270 (632)
T ss_pred --ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh----hhCCHHHHHHHHHcCCCHHHhh--ccCC
Confidence 334479999999999776 789999999999999999999999974 2333444555565555442211 1224
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+++.++|.+|+.. ..+|||+.|++++
T Consensus 271 Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 271 PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 5789999999999 8999999999865
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=298.83 Aligned_cols=122 Identities=26% Similarity=0.398 Sum_probs=105.9
Q ss_pred hcccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC---------------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV 551 (752)
.++|++.++||+|+||.||+|+.. +++.||||+++..... ..+......|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 468999999999999999999954 7899999998653211 233456788999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
|||+.+++|.+++.... .+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999997543 378899999999999999999999 99999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=271.00 Aligned_cols=220 Identities=26% Similarity=0.346 Sum_probs=169.0
Q ss_pred cccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEEEe
Q 041438 503 FDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E~ 554 (752)
|...++||+|+||.||+|+. .+++.||+|++...... +++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999984 57899999987642211 344556778999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+.+ ++.+++.... .++++.++..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||.+....
T Consensus 103 ~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 103 CLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 965 7877775433 3488999999999999999999999 99999999999999999999999999986432
Q ss_pred CcccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 635 NWSKLAGTHGNVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
......|+..|+|||++. ...++.++|||||||++|||++|+.||... ..............+. ......
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~-----~~~~~~~~~~~~~~~~--~~~~~~ 245 (313)
T cd06633 173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NAMSALYHIAQNDSPT--LQSNEW 245 (313)
T ss_pred CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhcCCCC--CCcccc
Confidence 123357889999999874 456888999999999999999999997421 1111111111111111 111234
Q ss_pred HHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 712 FMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+..+.+++.+||+.+|++||++.+++.+
T Consensus 246 ~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 246 TDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 4568899999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=275.46 Aligned_cols=232 Identities=19% Similarity=0.261 Sum_probs=170.9
Q ss_pred HHhhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------CccccC----
Q 041438 497 IRATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSHP---- 545 (752)
Q Consensus 497 ~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~~---- 545 (752)
....++|++.+.||+|+||.||+|. ..+++.||||++...... +++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 3457789999999999999999998 557999999988543211 111111
Q ss_pred --CceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeec
Q 041438 546 --RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDF 623 (752)
Q Consensus 546 --~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~Df 623 (752)
...++||||+ +++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|++||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 2458999999 66998888642 388999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccc----------cccc
Q 041438 624 RIAKFLNLDSSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------SSNM 692 (752)
Q Consensus 624 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~----------~~~~ 692 (752)
|.+...... .....+++.|+|||.+.+ ..++.++||||+||++|++++|+.||......... ....
T Consensus 163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 163 GLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred ccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 999865422 223467889999998876 45789999999999999999999998522110000 0000
Q ss_pred --------hHhhhccCCCCCC----hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 693 --------NIEILDSRLPYPS----LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 693 --------~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.......-..... .......+++.+++.+|++.||++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000 0012234568899999999999999999999954
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=273.25 Aligned_cols=232 Identities=20% Similarity=0.247 Sum_probs=167.0
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------Cccc-----------
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCS----------- 543 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~----------- 543 (752)
..+|++.+.||.|+||.||+|+. .+|+.||+|++...... +.+.
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46899999999999999999984 57899999987543211 0111
Q ss_pred ---cCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC-CCceE
Q 041438 544 ---HPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL-GYEAH 619 (752)
Q Consensus 544 ---~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~-~~~~k 619 (752)
+....|+||||+++ +|.+++... .+++..++.++.||+.||.|||+. ||+||||||+||+++. ++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYMET-DLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeecccc-cHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence 11357899999975 898888643 378899999999999999999999 9999999999999974 55789
Q ss_pred EeecccceeccCCCCC---cccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccc-------
Q 041438 620 VSDFRIAKFLNLDSSN---WSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS------- 688 (752)
Q Consensus 620 l~DfG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~------- 688 (752)
++|||.+......... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.........
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999865432111 122367889999997654 55788999999999999999999998522110000
Q ss_pred ---cc----c---chHhhhc--cCC-CCCCh-hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 689 ---SS----N---MNIEILD--SRL-PYPSL-DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 689 ---~~----~---~~~~~~~--~~~-~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.. . ....... ... ..+.. .......++.+++.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00 0 0000000 000 00000 011234578899999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-31 Score=271.60 Aligned_cols=226 Identities=22% Similarity=0.283 Sum_probs=183.7
Q ss_pred hhcccccceeeccCCceEEEEEEeCCCc-EEEEEccCCCCCC---------------------------CccccCCceEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPSGE-IFAVKKFHSPLPD---------------------------NFCSHPRQSFI 550 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~---------------------------~~~~~~~~~~l 550 (752)
...+++++..||-|+||.|-+++..... .+|+|++++.... ..+.+...+|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 4556777889999999999999864433 4899988765332 22456688999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
.||-|-||.+...++.++. ++..+.+.++..+++|++|||++ +||.|||||+|.++|.+|-+||.|||+|+.+.
T Consensus 498 LmEaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hHHhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 9999999999999987764 78899999999999999999999 99999999999999999999999999999988
Q ss_pred CCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccC--CCCCChhh
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR--LPYPSLDV 708 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 708 (752)
.... .-.++||+.|.|||++.+...+.++|.||+|+++||+++|++||..... ......++.+- +.+|
T Consensus 572 ~g~K-TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp-----mktYn~ILkGid~i~~P---- 641 (732)
T KOG0614|consen 572 SGRK-TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP-----MKTYNLILKGIDKIEFP---- 641 (732)
T ss_pred cCCc-eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch-----HHHHHHHHhhhhhhhcc----
Confidence 6544 3457999999999999999999999999999999999999999963322 22233333332 2233
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHHH
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPT-----MKRFEVQS 740 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~L 740 (752)
..+.+...++|++....+|.+|.. +.+|-+|-
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 345667888999999999999975 66666654
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=271.63 Aligned_cols=231 Identities=19% Similarity=0.255 Sum_probs=167.5
Q ss_pred ccccceeeccCCceEEEEEEeC-C--CcEEEEEccCCCCCC---------------------------Cc----cccCCc
Q 041438 502 DFDAKHCIGKGGHGSVYIARVP-S--GEIFAVKKFHSPLPD---------------------------NF----CSHPRQ 547 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~---------------------------~~----~~~~~~ 547 (752)
+|++.+.||+|+||.||+|+.. + ++.||+|++...... +. ......
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5888999999999999999943 4 789999987542111 00 011245
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
.|++|||+. ++|.+++.... .+++..++.++.||+.||+|||+. ||+||||||+||++++++.+||+|||.++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 688999987 48998886433 488899999999999999999999 99999999999999999999999999998
Q ss_pred eccCCCC----CcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhcc----------ccccccc
Q 041438 628 FLNLDSS----NWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM----------SSSSSNM 692 (752)
Q Consensus 628 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~----------~~~~~~~ 692 (752)
....... ......|+..|+|||++.+ ..++.++||||+||++|++++|++||...... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 7543221 1223478999999998765 46899999999999999999999998521100 0000000
Q ss_pred hHhhhc--------c--CCCCCCh--hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 693 NIEILD--------S--RLPYPSL--DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 693 ~~~~~~--------~--~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...+.. . ..+.... ........+.+++.+|++.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 0 0000000 011234578899999999999999999999854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=273.01 Aligned_cols=229 Identities=21% Similarity=0.208 Sum_probs=169.8
Q ss_pred hccccc-ceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------------------
Q 041438 500 TNDFDA-KHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------------------- 539 (752)
Q Consensus 500 ~~~y~~-~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------------------- 539 (752)
.++|.. .+.||+|+||.||+|+. .+++.||||++......
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 456654 57799999999999984 57999999987532110
Q ss_pred CccccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceE
Q 041438 540 NFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAH 619 (752)
Q Consensus 540 ~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~k 619 (752)
+++...+..++||||+. |+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 23445577899999997 49999886533 378899999999999999999999 999999999999999999999
Q ss_pred EeecccceeccCC--------------CCCcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhc
Q 041438 620 VSDFRIAKFLNLD--------------SSNWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFE 684 (752)
Q Consensus 620 l~DfG~a~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~ 684 (752)
|+|||.+...... ........++..|+|||++.+. .++.++||||+||++|||++|+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999876411 1112223568899999988764 468999999999999999999999852211
Q ss_pred cccccccchHhhhc--------------------c-CCCCCC---hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 685 MSSSSSNMNIEILD--------------------S-RLPYPS---LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 685 ~~~~~~~~~~~~~~--------------------~-~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
. .....+.. . ....+. ......+.++.+++.+||+.||++||+++|++.+-
T Consensus 240 ~-----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 240 I-----DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred H-----HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 0 00000000 0 000000 00112345788999999999999999999999753
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=233.22 Aligned_cols=232 Identities=19% Similarity=0.270 Sum_probs=174.5
Q ss_pred ccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEe
Q 041438 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~ 554 (752)
+|.-.++||+|+||+||+|+ ..+++.||+|+++-...+ +....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 56677899999999999999 678999999998765433 223345678899999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
|.. +|..+..... ..++.+.++.++.|+++||.|+|++ ++.|||+||+|.+|..+|++|++|||+|+.++-+-.
T Consensus 83 cdq-dlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 987 9998887644 3478899999999999999999999 999999999999999999999999999998876554
Q ss_pred CcccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHh-CCCCcchhh---------cccc-ccccc---hHhhhcc
Q 041438 635 NWSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIK-GKHPRDFLF---------EMSS-SSSNM---NIEILDS 699 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~ellt-g~~pf~~~~---------~~~~-~~~~~---~~~~~~~ 699 (752)
..+..+-|..|++|.++.+.+ |+...|+||.|||+.|+.. |++.|.... +.-. ..++. ....-+
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd- 235 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD- 235 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC-
Confidence 445557899999999988876 7999999999999999996 555553211 0000 00110 000001
Q ss_pred CCCCCC----hhhHHHHH----HHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 700 RLPYPS----LDVQNKFM----SIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 700 ~~~~~~----~~~~~~~~----~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
-.++|. ..+....+ .=.+++.+.+.-+|.+|.++++.++|-
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp 284 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP 284 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence 011111 11222222 346788899999999999999988763
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-32 Score=276.10 Aligned_cols=340 Identities=29% Similarity=0.431 Sum_probs=185.0
Q ss_pred CCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcE
Q 041438 106 SSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNH 185 (752)
Q Consensus 106 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 185 (752)
.++.+|..|+.++|.+.. .|+.++.+..|..|+..+|+++ ..|+.+..+.+|..|++.+|++....|+.+. ++.|++
T Consensus 111 ~s~~~l~~l~~s~n~~~e-l~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ 187 (565)
T KOG0472|consen 111 GSLISLVKLDCSSNELKE-LPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKH 187 (565)
T ss_pred hhhhhhhhhhccccceee-cCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHh
Confidence 333344444444444433 2333444444444444444444 2333444444444444444444432222222 444445
Q ss_pred EEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEcccc
Q 041438 186 LILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSIN 265 (752)
Q Consensus 186 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N 265 (752)
||..+|-++ .+|..+++|.+|+.|||..|+|. ..| .|.++..|.+++++.|++.-. |... ..++++|.+|||..|
T Consensus 188 ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~l-pae~-~~~L~~l~vLDLRdN 262 (565)
T KOG0472|consen 188 LDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEML-PAEH-LKHLNSLLVLDLRDN 262 (565)
T ss_pred cccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhh-HHHH-hcccccceeeecccc
Confidence 554444444 34444555555555555555554 233 445555555555555554421 1111 235566666666666
Q ss_pred ccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCccc---------------------------
Q 041438 266 NITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGR--------------------------- 318 (752)
Q Consensus 266 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--------------------------- 318 (752)
+++ ..|.++.-+.+|++||+|+|.|++ .|..++++ .|+.|.+.+|.+..+
T Consensus 263 klk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~ 339 (565)
T KOG0472|consen 263 KLK-EVPDEICLLRSLERLDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQ 339 (565)
T ss_pred ccc-cCchHHHHhhhhhhhcccCCcccc-CCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCC
Confidence 665 456666666666677777776663 44555555 555555555544210
Q ss_pred -----------CCcccC---CCcc--------------------------cceeeccccccc------------------
Q 041438 319 -----------IPGELG---SLIN--------------------------LEYLDLSANHLS------------------ 340 (752)
Q Consensus 319 -----------~p~~~~---~l~~--------------------------L~~L~Ls~N~l~------------------ 340 (752)
++..|. ...+ .+..+++.|++.
T Consensus 340 se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~l 419 (565)
T KOG0472|consen 340 SEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVL 419 (565)
T ss_pred CcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHh
Confidence 000000 0000 223333333332
Q ss_pred -----cccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCC
Q 041438 341 -----NFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLI 415 (752)
Q Consensus 341 -----~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 415 (752)
+++|..++.+++|+.|+|++|-+. .+|.+++.+..|+.||+|+|++. .+|..+..+..++.+-.++|++....
T Consensus 420 snn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd 497 (565)
T KOG0472|consen 420 SNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVD 497 (565)
T ss_pred hcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccC
Confidence 334556678889999999999886 68889999999999999999884 35666556666666666667776666
Q ss_pred chhhhccCCCcEEEccCCcccCcCCCCcccCCCCcccccCCCC
Q 041438 416 PRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEALQGNKG 458 (752)
Q Consensus 416 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~ 458 (752)
|+.+.++.+|..|||.+|.+....|............+.|||.
T Consensus 498 ~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpf 540 (565)
T KOG0472|consen 498 PSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPF 540 (565)
T ss_pred hHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCcc
Confidence 6667777777777777777766656555555555556666654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=270.38 Aligned_cols=217 Identities=21% Similarity=0.287 Sum_probs=164.1
Q ss_pred cccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------------CccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~ 552 (752)
.-|..++.||-|+||+|.+++ .++...||+|.+++...- ..+.+.+..|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 347788999999999999998 566788999988654221 2346778899999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC-
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL- 631 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~- 631 (752)
||++||++-.++-+.+ -+.+..++.++.++.+|+++.|.. |+|||||||+|||||.+|++||.|||++.-+..
T Consensus 709 dYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999887654 377899999999999999999999 999999999999999999999999999864310
Q ss_pred --------CC----------------CC-----------------cccccCCCCccCccccccCCCCCccchhhHHHHHH
Q 041438 632 --------DS----------------SN-----------------WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLAL 670 (752)
Q Consensus 632 --------~~----------------~~-----------------~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ 670 (752)
.. .. ....+||+.|+|||++....|+.-+|+||.|||+|
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 00 00 01237999999999999999999999999999999
Q ss_pred HHHhCCCCcchhhccccccccchHhhhc--cCCCCCChhhHHHHHHHHHHHHhccCcCCCCCC
Q 041438 671 EVIKGKHPRDFLFEMSSSSSNMNIEILD--SRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRP 731 (752)
Q Consensus 671 elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 731 (752)
||+.|++||.. +...+....++. ..+.++. ..+.++++.++|.+.. .++++|.
T Consensus 863 em~~g~~pf~~-----~tp~~tq~kv~nw~~~l~~~~--~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 863 EMLVGQPPFLA-----DTPGETQYKVINWRNFLHIPY--QGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred HHhhCCCCccC-----CCCCcceeeeeehhhcccccc--ccccCHHHHHHHHHHh-cChhhhh
Confidence 99999999962 222221111111 1111221 1344556777777644 3567775
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=266.57 Aligned_cols=229 Identities=24% Similarity=0.322 Sum_probs=181.3
Q ss_pred ccccceeeccCCceEEEEEEeC---CC--cEEEEEccCCCCCC-------------------------CccccCCceEEE
Q 041438 502 DFDAKHCIGKGGHGSVYIARVP---SG--EIFAVKKFHSPLPD-------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~~---~~--~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV 551 (752)
..+..++||.|-||.||+|.+. .| -.||||..+.+... ++| .....|+|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~-~e~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVC-VEQPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeee-eccceeEE
Confidence 3445688999999999999842 23 36899988874432 222 23568999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
||.++.|.|..+++.+. ..++......+++||+.||+|||+. +.|||||-..|||+....-+|++|||+++.+..
T Consensus 469 mEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 99999999999998765 4588889999999999999999999 999999999999999999999999999999875
Q ss_pred CCCCccc-ccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 632 DSSNWSK-LAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 632 ~~~~~~~-~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
+...... ..-...|||||-+.-..++.++|||-|||.+||++. |..||..... ......--...+++.| +
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----sDVI~~iEnGeRlP~P----~ 615 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----SDVIGHIENGERLPCP----P 615 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----cceEEEecCCCCCCCC----C
Confidence 5433222 233568999999999999999999999999999986 9999863221 1111111122345554 5
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
.+++.+..++.+||++||.+||.+.|+...|.++.
T Consensus 616 nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 616 NCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred CCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 67888999999999999999999999998887653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=273.15 Aligned_cols=236 Identities=15% Similarity=0.169 Sum_probs=167.2
Q ss_pred hhcccccceeeccCCceEEEEEEe-----------------CCCcEEEEEccCCCCCC----------------------
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-----------------PSGEIFAVKKFHSPLPD---------------------- 539 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~---------------------- 539 (752)
..++|++.++||+|+||.||+|.. ..++.||||++......
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999963 24568999997532100
Q ss_pred ---------------------Cccc--------cCCceEEEEEeccCCChHHHhccCcc---------------------
Q 041438 540 ---------------------NFCS--------HPRQSFIVYEYLESGSLDKILNNDAS--------------------- 569 (752)
Q Consensus 540 ---------------------~~~~--------~~~~~~lV~E~~~~g~L~~~l~~~~~--------------------- 569 (752)
+++. ..+..++||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 1111 23567999999999999999874211
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC-cccccCCCCccCc
Q 041438 570 AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN-WSKLAGTHGNVAP 648 (752)
Q Consensus 570 ~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~gt~~y~aP 648 (752)
...+++..++.++.|++.||.|+|+. +|+||||||+||+++.++.+||+|||++......... .....+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 11346778899999999999999999 9999999999999999999999999999765432211 1122457899999
Q ss_pred cccccCC--------------------C--CCccchhhHHHHHHHHHhCCC-Ccchhhccccc------cccchHhhhcc
Q 041438 649 ELAYTMK--------------------V--TEKCDVYSFGVLALEVIKGKH-PRDFLFEMSSS------SSNMNIEILDS 699 (752)
Q Consensus 649 E~~~~~~--------------------~--~~ksDIwSlGvil~elltg~~-pf~~~~~~~~~------~~~~~~~~~~~ 699 (752)
|.+.... + ..+.||||+||++|+|++|.. ||......... .......+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9875432 1 134799999999999999876 66421111110 00111112222
Q ss_pred CCCCCChhhHHHHHHHHHHHHhccCcCC---CCCCCHHHHHHH
Q 041438 700 RLPYPSLDVQNKFMSIMQVAFSCLDQNP---VSRPTMKRFEVQ 739 (752)
Q Consensus 700 ~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~Rps~~evl~~ 739 (752)
...++ ..........+++.+|+..+| .+|+|++|+++|
T Consensus 460 ~~~~~--~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 KYDFS--LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CCCcc--cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 22222 223456678899999999766 689999999976
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=269.48 Aligned_cols=224 Identities=25% Similarity=0.353 Sum_probs=175.3
Q ss_pred cceeeccCCceEEEEEEeC--CCc--EEEEEccCCCCCC----Cc---------ccc-----------CCceEEEEEecc
Q 041438 505 AKHCIGKGGHGSVYIARVP--SGE--IFAVKKFHSPLPD----NF---------CSH-----------PRQSFIVYEYLE 556 (752)
Q Consensus 505 ~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~----~~---------~~~-----------~~~~~lV~E~~~ 556 (752)
..++||+|.||.|++|.|. .|+ .||||.++..... ++ .+| +....+|||+++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELap 193 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELAP 193 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhcc
Confidence 4578999999999999853 344 6899999865443 11 011 144568999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW 636 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 636 (752)
.|+|.+.+++ .....|-......++.|||.|+.||.++ +.|||||-..|+++-..-.+||+|||+.+.+......+
T Consensus 194 lGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 194 LGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred cchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 9999999987 3345677888899999999999999999 99999999999999988899999999999887655433
Q ss_pred c---cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc--CCCCCChhhHH
Q 041438 637 S---KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS--RLPYPSLDVQN 710 (752)
Q Consensus 637 ~---~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 710 (752)
. ...-.+.|.|||.+...+++.++|||+|||++|||+| |+.||-. .....+-+.+|. +++.| ..
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G------~~g~qIL~~iD~~erLpRP----k~ 339 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG------CRGIQILKNIDAGERLPRP----KY 339 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC------CCHHHHHHhccccccCCCC----CC
Confidence 1 1233568999999999999999999999999999998 8889842 112222222222 33444 45
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
+++++++++++||..+|++|||+..+.+.+-.
T Consensus 340 csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 77889999999999999999999999755433
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-32 Score=271.39 Aligned_cols=320 Identities=29% Similarity=0.395 Sum_probs=217.7
Q ss_pred cccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCC
Q 041438 103 FSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNF 182 (752)
Q Consensus 103 ~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 182 (752)
..+.++.+|..|++.+|++....|..+. ++.|++||..+|-++ .+|..++++.+|.-|+|.+|+|. ..| +|.+...
T Consensus 154 ~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~ 229 (565)
T KOG0472|consen 154 EDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSL 229 (565)
T ss_pred hHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHH
Confidence 3455666666677777777665554444 667777777777665 55666777777777777777776 444 6777777
Q ss_pred CcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEc
Q 041438 183 LNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDV 262 (752)
Q Consensus 183 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~L 262 (752)
|++|+++.|+|.-...+...++++|.+|||.+|+++ ..|+.+.-+.+|.+||+++|.+++..+. .+++ +|+.|-+
T Consensus 230 L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~s---Lgnl-hL~~L~l 304 (565)
T KOG0472|consen 230 LKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYS---LGNL-HLKFLAL 304 (565)
T ss_pred HHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcc---cccc-eeeehhh
Confidence 777777777776333333346777777777777776 5666677777777777777777654332 3455 5666666
Q ss_pred cccccCCC--------------------------------------CCccc---CCCCCCC-------------------
Q 041438 263 SINNITGN--------------------------------------IPFEI---GESPQLQ------------------- 282 (752)
Q Consensus 263 s~N~l~~~--------------------------------------~p~~~---~~l~~L~------------------- 282 (752)
.+|.+..+ .+..+ ..+.+.+
T Consensus 305 eGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea 384 (565)
T KOG0472|consen 305 EGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEA 384 (565)
T ss_pred cCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHH
Confidence 66644210 00000 0011122
Q ss_pred -------EEecCCCcCcCCCCccccCCcccCE-EEccCCcCcccCCcccCCCcccceeeccccccccccchhhccccccc
Q 041438 283 -------YLDLSSNYIVGEIPTQLGNIIYLNR-ISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLY 354 (752)
Q Consensus 283 -------~L~Ls~N~l~~~~p~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 354 (752)
..+++.|++. .+|..+..+..+.+ +.+++|.++ -+|..++.+++|+.|+|++|.+... |..++.+..|+
T Consensus 385 ~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln~L-P~e~~~lv~Lq 461 (565)
T KOG0472|consen 385 AKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLNDL-PEEMGSLVRLQ 461 (565)
T ss_pred hhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhhhc-chhhhhhhhhh
Confidence 3334444443 33333333333322 334444443 5677788899999999999999885 56678888899
Q ss_pred EEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCCc
Q 041438 355 YLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNK 434 (752)
Q Consensus 355 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 434 (752)
.||+|+|++. ..|.....+..|+.+-.++|++....++.+.+|.+|..|||.+|.+..+ |..++++++|++|++.+|+
T Consensus 462 ~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~I-Pp~LgnmtnL~hLeL~gNp 539 (565)
T KOG0472|consen 462 TLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQI-PPILGNMTNLRHLELDGNP 539 (565)
T ss_pred eecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhC-ChhhccccceeEEEecCCc
Confidence 9999999996 7888877777888888888999999999899999999999999999865 6689999999999999999
Q ss_pred cc
Q 041438 435 LE 436 (752)
Q Consensus 435 l~ 436 (752)
+.
T Consensus 540 fr 541 (565)
T KOG0472|consen 540 FR 541 (565)
T ss_pred cC
Confidence 97
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=231.02 Aligned_cols=177 Identities=24% Similarity=0.366 Sum_probs=144.3
Q ss_pred hcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------CccccCCceEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~ 552 (752)
.++......||+|+||.|-+.+ ..+|+..|+|+++..... +.......+++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 3445557889999999999988 568999999998654322 3334567899999
Q ss_pred EeccCCChHHHhccC-ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 553 EYLESGSLDKILNND-ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 553 E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|.|.. +|+.+-.+. .....+++.-+-+|+..+.+||.|||++. .++|||+||+|||++.+|++|+||||.+..+.+
T Consensus 125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 99976 887765542 12345788889999999999999999986 899999999999999999999999999988763
Q ss_pred CCCCcccccCCCCccCcccccc----CCCCCccchhhHHHHHHHHHhCCCCcc
Q 041438 632 DSSNWSKLAGTHGNVAPELAYT----MKVTEKCDVYSFGVLALEVIKGKHPRD 680 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDIwSlGvil~elltg~~pf~ 680 (752)
+- ..+...|-..|||||.+.. ..|+.|+||||+|+++.||.+++.||+
T Consensus 202 Si-Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 202 SI-AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred hh-HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 32 2233478889999998763 368999999999999999999999986
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=252.24 Aligned_cols=229 Identities=20% Similarity=0.271 Sum_probs=172.5
Q ss_pred hcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC-------------------------------Cc----cc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD-------------------------------NF----CS 543 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------------------------------~~----~~ 543 (752)
.++|.+.++||-|.|++||+|. ....+.||+|+.+..... +. ..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 4789999999999999999998 467789999998754221 11 22
Q ss_pred cCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC----------
Q 041438 544 HPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD---------- 613 (752)
Q Consensus 544 ~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~---------- 613 (752)
...++++|+|++. .+|..+|..... +.++...++.|++||+.||.|||+.| ||||-||||+|||+.
T Consensus 157 NG~HVCMVfEvLG-dnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 157 NGQHVCMVFEVLG-DNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred CCcEEEEEehhhh-hHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhh
Confidence 4578999999994 499999987543 44889999999999999999999999 999999999999980
Q ss_pred --------------------------------------------------------------------------------
Q 041438 614 -------------------------------------------------------------------------------- 613 (752)
Q Consensus 614 -------------------------------------------------------------------------------- 613 (752)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred ------------------------C----------------------------------------------------CCc
Q 041438 614 ------------------------L----------------------------------------------------GYE 617 (752)
Q Consensus 614 ------------------------~----------------------------------------------------~~~ 617 (752)
. +.+
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 0 012
Q ss_pred eEEeecccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccc-c-------
Q 041438 618 AHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS-S------- 689 (752)
Q Consensus 618 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~-~------- 689 (752)
+||+|||-|++.. .+.+..+.|..|+|||++.+..|++.+||||++|+++|++||...|+--....-. .
T Consensus 393 vKIaDlGNACW~~---khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i 469 (590)
T KOG1290|consen 393 VKIADLGNACWVH---KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI 469 (590)
T ss_pred EEEeeccchhhhh---hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence 5666666666543 2233446789999999999999999999999999999999999998521100000 0
Q ss_pred -----------------------------------ccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHH
Q 041438 690 -----------------------------------SNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734 (752)
Q Consensus 690 -----------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 734 (752)
.-....++..++.++ .+...++.+++.-||+.+|++||||.
T Consensus 470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s----~e~A~~fsdFL~PmLef~PeKR~tA~ 545 (590)
T KOG1290|consen 470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWS----EEDAQQFSDFLSPMLEFDPEKRPTAA 545 (590)
T ss_pred HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCC----HHHHHHHHHHHHHHHhcCccccccHH
Confidence 001112222222222 34566789999999999999999999
Q ss_pred HHHHH
Q 041438 735 RFEVQ 739 (752)
Q Consensus 735 evl~~ 739 (752)
+.++|
T Consensus 546 ~cl~h 550 (590)
T KOG1290|consen 546 QCLKH 550 (590)
T ss_pred HHhcC
Confidence 98865
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-29 Score=256.60 Aligned_cols=229 Identities=27% Similarity=0.378 Sum_probs=175.4
Q ss_pred hcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCC--C-----------------------------C-ccccCC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLP--D-----------------------------N-FCSHPR 546 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~-----------------------------~-~~~~~~ 546 (752)
.++|-....||+|||+.||+|. ....+.||||+-+.... + + +.-+.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 4568888999999999999998 55678899997543211 1 1 122456
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC---CCCceEEeec
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD---LGYEAHVSDF 623 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~---~~~~~kl~Df 623 (752)
.++-|+|||+|-+|+-|++.+. .+++.+++.|+.||+.||.||... .|+|||-||||.|||+. .-|.+||.||
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 7889999999999999998765 378899999999999999999987 67999999999999995 4578999999
Q ss_pred ccceeccCCCCC-------cccccCCCCccCccccccC----CCCCccchhhHHHHHHHHHhCCCCcchhhcccccccc-
Q 041438 624 RIAKFLNLDSSN-------WSKLAGTHGNVAPELAYTM----KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN- 691 (752)
Q Consensus 624 G~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~----~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~- 691 (752)
|+++.++.+... .+...||.+|.+||.+.-+ +++.|+||||.|||+|.++.|+.||.... ....
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq----sQQdI 693 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ----SQQDI 693 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch----hHHHH
Confidence 999998765433 2345899999999987643 36889999999999999999999996211 1111
Q ss_pred -chHhhhc-cCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 041438 692 -MNIEILD-SRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEV 738 (752)
Q Consensus 692 -~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 738 (752)
....++. ....+|.. +....+...+|++||++--++|....++..
T Consensus 694 LqeNTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 LQENTILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HhhhchhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1111222 22334432 345567889999999999999988877664
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-29 Score=237.24 Aligned_cols=230 Identities=17% Similarity=0.235 Sum_probs=174.6
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E 553 (752)
.+.|.+.+.+|+|.||.+-+|++ .+.+.+|+|-++.+... ..++..+.+++++|
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 45789999999999999999994 57889999999877543 22445678889999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC--CCCceEEeecccceeccC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD--LGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~--~~~~~kl~DfG~a~~~~~ 631 (752)
|++.|+|.+-+...+ +.+...++++.|+++|+.|||+. ++||||||.+||||- +..++|+||||..+..+.
T Consensus 103 ~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999999887654 77889999999999999999999 999999999999993 345799999999886542
Q ss_pred CCCCcccccCCCCccCccccccC-----CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCCh
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (752)
- ....-.+..|.|||..... +..+.+|||.||+++|.++||++||+... ..+.+.....+......+..+.
T Consensus 176 t---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 176 T---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred e---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHHHhcccCccCch
Confidence 1 2223345679999976532 35788999999999999999999998333 2232222333333333332222
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
.....++.+.++.++-+.++|++|--+.++.+.-
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 3455667788999999999999995555544443
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=266.10 Aligned_cols=231 Identities=26% Similarity=0.401 Sum_probs=183.9
Q ss_pred cccceeeccCCceEEEEEE-eCCCc----EEEEEccCCCCCC-------------------------CccccCCceEEEE
Q 041438 503 FDAKHCIGKGGHGSVYIAR-VPSGE----IFAVKKFHSPLPD-------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~-~~~~~----~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~ 552 (752)
.+..++||+|+||.||+|. .+.|+ +||+|++...... ++|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 3446899999999999998 45554 6899987654322 3343333 67899
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
+|++.|+|.++++.++ ..+.......|.+|||+|+.|||.+ ++|||||-..|||+..-..+||.|||+|+....+
T Consensus 777 q~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999998765 3477789999999999999999999 9999999999999999999999999999988766
Q ss_pred CCCcccc--cCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhc--cCCCCCChh
Q 041438 633 SSNWSKL--AGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILD--SRLPYPSLD 707 (752)
Q Consensus 633 ~~~~~~~--~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 707 (752)
....... .-.+.|||=|.+....|+.++|||||||++||++| |..|++.. +.+.+...+. .+++.|
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi------~~~eI~dlle~geRLsqP--- 922 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI------PAEEIPDLLEKGERLSQP--- 922 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC------CHHHhhHHHhccccCCCC---
Confidence 5544333 33567999999999999999999999999999998 99997522 1222222222 234444
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCCCC
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPDH 749 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 749 (752)
+.+..++..++.+||..|++.||+++++.+.+.++-..|.+
T Consensus 923 -piCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqr 963 (1177)
T KOG1025|consen 923 -PICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQR 963 (1177)
T ss_pred -CCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcce
Confidence 44566788999999999999999999999999998777654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-29 Score=272.95 Aligned_cols=221 Identities=25% Similarity=0.377 Sum_probs=168.0
Q ss_pred ceeeccCCce-EEEEEEeCCCcEEEEEccCCCCCC--------------------Ccc--ccCCceEEEEEeccCCChHH
Q 041438 506 KHCIGKGGHG-SVYIARVPSGEIFAVKKFHSPLPD--------------------NFC--SHPRQSFIVYEYLESGSLDK 562 (752)
Q Consensus 506 ~~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~--------------------~~~--~~~~~~~lV~E~~~~g~L~~ 562 (752)
.+.+|.|+.| .||+|.. +|+.||||++-....+ .|| .++...||..|.|.. +|.+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~d 591 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQD 591 (903)
T ss_pred HHHcccCCCCcEEEEEee-CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHH
Confidence 4568888887 5899987 6789999998544332 233 356778999999988 9999
Q ss_pred HhccCc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC---C--CceEEeecccceeccCCCCC-
Q 041438 563 ILNNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL---G--YEAHVSDFRIAKFLNLDSSN- 635 (752)
Q Consensus 563 ~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~---~--~~~kl~DfG~a~~~~~~~~~- 635 (752)
+++... ..........+.+..|+++||++||+. +||||||||.||||+. + ..++|+|||+++.+..+...
T Consensus 592 lie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~ 668 (903)
T KOG1027|consen 592 LIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF 668 (903)
T ss_pred HHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence 998741 111111245678899999999999998 9999999999999975 3 46999999999998765433
Q ss_pred --cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhC-CCCcchhhccccccccchHhhhccCCCCCChh-hHHH
Q 041438 636 --WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKG-KHPRDFLFEMSSSSSNMNIEILDSRLPYPSLD-VQNK 711 (752)
Q Consensus 636 --~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 711 (752)
.....||-+|+|||++....-+.++||||+||++|+.++| .+||... .+....++.......... ..++
T Consensus 669 ~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~-------~~R~~NIl~~~~~L~~L~~~~d~ 741 (903)
T KOG1027|consen 669 SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS-------LERQANILTGNYTLVHLEPLPDC 741 (903)
T ss_pred hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch-------HHhhhhhhcCccceeeeccCchH
Confidence 2345899999999999998888899999999999999985 9999622 222233444433322111 1112
Q ss_pred HHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 712 FMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
++.+||.+|+++||..||+|.+|+.|=
T Consensus 742 --eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 742 --EAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred --HHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 788999999999999999999999763
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=273.35 Aligned_cols=231 Identities=24% Similarity=0.356 Sum_probs=180.2
Q ss_pred ccccceeeccCCceEEEEEEeC----C----CcEEEEEccCCCCCC--------------------------CccccCCc
Q 041438 502 DFDAKHCIGKGGHGSVYIARVP----S----GEIFAVKKFHSPLPD--------------------------NFCSHPRQ 547 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~--------------------------~~~~~~~~ 547 (752)
+.++.+.+|+|.||.|++|... . ...||||.++..... +.|...+.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 3455669999999999999721 1 467999998754432 55666788
Q ss_pred eEEEEEeccCCChHHHhccCc---------c--c--cccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC
Q 041438 548 SFIVYEYLESGSLDKILNNDA---------S--A--KELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL 614 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~---------~--~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~ 614 (752)
.++|+||+..|+|.++++..+ . . ..++..+...++.|||.|++||++. ++|||||-..|||+.+
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecC
Confidence 999999999999999998765 0 0 1388889999999999999999999 9999999999999999
Q ss_pred CCceEEeecccceeccCCCCCc-ccccC--CCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccc
Q 041438 615 GYEAHVSDFRIAKFLNLDSSNW-SKLAG--THGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSS 690 (752)
Q Consensus 615 ~~~~kl~DfG~a~~~~~~~~~~-~~~~g--t~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~ 690 (752)
+..+||+|||+|+......... ....| ...|||||.+....|+.|+|||||||++||++| |..||... ....
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~----~~~~ 529 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI----PPTE 529 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC----CcHH
Confidence 9999999999999654332221 11222 235999999999999999999999999999998 88897521 1112
Q ss_pred cchHhhhcc-CCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 691 NMNIEILDS-RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 691 ~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
+....+.++ +...| ..+.+++.++++.||+.+|++||++.|+.+.++..
T Consensus 530 ~l~~~l~~G~r~~~P----~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 530 ELLEFLKEGNRMEQP----EHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHHHHhcCCCCCCC----CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 222222222 22333 34567888999999999999999999999999873
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=253.13 Aligned_cols=234 Identities=18% Similarity=0.164 Sum_probs=182.1
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC-----------------------------CccccCCce
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD-----------------------------NFCSHPRQS 548 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-----------------------------~~~~~~~~~ 548 (752)
-.++|.+....|+|-|+.|.+|+ ...|+.||||+++..... ..+.+..+.
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL 509 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL 509 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence 45789999999999999999998 456889999999765332 234577899
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC-CceEEeecccce
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG-YEAHVSDFRIAK 627 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~-~~~kl~DfG~a~ 627 (752)
|+|+|-+.- +|.+++++.+....|....++.|+.|+..||..|-.. ||+|.||||+|||+.+. ..+||||||.|.
T Consensus 510 ClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 510 CLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred EEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCcccc
Confidence 999998866 9999999887766688899999999999999999998 99999999999999865 458999999998
Q ss_pred eccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhc-----------------------
Q 041438 628 FLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFE----------------------- 684 (752)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~----------------------- 684 (752)
...... .+.+.-+..|.|||++.|.+|+...|+||.||++||+.||+..|.....
T Consensus 586 ~~~ene--itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgq 663 (752)
T KOG0670|consen 586 FASENE--ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQ 663 (752)
T ss_pred cccccc--ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcc
Confidence 765433 3344557789999999999999999999999999999999988742110
Q ss_pred ----------------ccccccc-------------chHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHH
Q 041438 685 ----------------MSSSSSN-------------MNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKR 735 (752)
Q Consensus 685 ----------------~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 735 (752)
.+...+. .....+......+. ........+.+|+.+|+..||++|.|..|
T Consensus 664 F~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~d-eq~~~~~~~rdLLdkml~LdP~KRit~nq 742 (752)
T KOG0670|consen 664 FKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPD-EQPKIVQQLRDLLDKMLILDPEKRITVNQ 742 (752)
T ss_pred hhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCc-hhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence 0000000 00001111111121 22445668999999999999999999999
Q ss_pred HHHH
Q 041438 736 FEVQ 739 (752)
Q Consensus 736 vl~~ 739 (752)
+++|
T Consensus 743 AL~H 746 (752)
T KOG0670|consen 743 ALKH 746 (752)
T ss_pred HhcC
Confidence 9876
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=229.77 Aligned_cols=231 Identities=17% Similarity=0.224 Sum_probs=171.7
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC----------------------Ccc--ccCCceEEEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD----------------------NFC--SHPRQSFIVYE 553 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----------------------~~~--~~~~~~~lV~E 553 (752)
..++|++.+++|+|.|++||.|. ..+.+.++||++++.... +.. .......+|+|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 46789999999999999999998 567899999998764332 111 22355679999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC-CceEEeecccceeccCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG-YEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~-~~~kl~DfG~a~~~~~~ 632 (752)
|+++.+...+. +.++...++.++.|++.||.|+|++ ||+|||+||.|++||.. -+++|+|+|+|.+....
T Consensus 116 ~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 116 YVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 99998877665 3478889999999999999999999 99999999999999954 46999999999987643
Q ss_pred CCCcccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCcchhhccc--------------------cc---
Q 041438 633 SSNWSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMS--------------------SS--- 688 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~~pf~~~~~~~--------------------~~--- 688 (752)
....-.+.+..|.-||.+.+.+ |+..-|+|||||++..|+..+.||-...... ..
T Consensus 187 -~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 187 -KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred -ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 3444457788999999988755 7889999999999999999999972111000 00
Q ss_pred cccchHhhhccCCCCC------ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 689 SSNMNIEILDSRLPYP------SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 689 ~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
-......++..-...+ .....-..+++.+++.+.|..|..+|+|++|.+.|
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0001111111110000 00111124678999999999999999999999876
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-29 Score=239.64 Aligned_cols=232 Identities=22% Similarity=0.285 Sum_probs=171.9
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------Ccccc-----------------CCceE
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------NFCSH-----------------PRQSF 549 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------~~~~~-----------------~~~~~ 549 (752)
+.+-.+.||-|+||.||.+.. ++|+.||.|++...... .++.+ -++.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 455678999999999999984 58999999987543322 11111 14678
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+++|.|.. +|..++-. .+.++...++-+.+||++||+|||+. +|.||||||.|.|++.+..+||||||+|+..
T Consensus 134 V~TELmQS-DLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHHh-hhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccccc
Confidence 89999977 88888753 45688899999999999999999999 9999999999999999999999999999976
Q ss_pred cCCC-CCcccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCcchhhccc----------c--------cc
Q 041438 630 NLDS-SNWSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMS----------S--------SS 689 (752)
Q Consensus 630 ~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~~pf~~~~~~~----------~--------~~ 689 (752)
+.+. .+++..+-|..|+|||++.+.. |+.+.||||.|||+.|++..+..|+...... . .-
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 5443 2344557788999999988765 8999999999999999998888875221110 0 01
Q ss_pred ccchHhhhccCCCCCChh-------hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 690 SNMNIEILDSRLPYPSLD-------VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
+.....++......|... ......+...+..+++..||++|.+.++.+.+.
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 112222333322222110 112233567788899999999999999888665
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-27 Score=238.29 Aligned_cols=214 Identities=25% Similarity=0.356 Sum_probs=167.9
Q ss_pred CceEEEEEEeC-CCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEeccCCChHHHhcc
Q 041438 513 GHGSVYIARVP-SGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEYLESGSLDKILNN 566 (752)
Q Consensus 513 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~~~~g~L~~~l~~ 566 (752)
+||.||+|+.. +++.+|+|++...... +.+......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999964 5899999998754321 334455788999999999999999875
Q ss_pred CccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcccccCCCCcc
Q 041438 567 DASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV 646 (752)
Q Consensus 567 ~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~ 646 (752)
... +++..+..++.+++.++.|||+. +++|+||+|+||++++++.++++|||.+....... ......++..|+
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYM 153 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCC
Confidence 432 78899999999999999999999 99999999999999999999999999998875432 233457888999
Q ss_pred CccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcC
Q 041438 647 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQN 726 (752)
Q Consensus 647 aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 726 (752)
|||...+..+++++||||+|++++++++|..||... ................... .....+.++.+++.+|+..+
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~----~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~ 228 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD----DQLLELFKKIGKPKPPFPP-PEWKISPEAKDLIRKLLVKD 228 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHhccCCCCcc-ccccCCHHHHHHHHHHccCC
Confidence 999998888899999999999999999999998521 1111122222222222111 11114567889999999999
Q ss_pred CCCCCCHHHHHH
Q 041438 727 PVSRPTMKRFEV 738 (752)
Q Consensus 727 P~~Rps~~evl~ 738 (752)
|++||++.++++
T Consensus 229 p~~Rp~~~~~~~ 240 (244)
T smart00220 229 PEKRLTAEEALQ 240 (244)
T ss_pred chhccCHHHHhh
Confidence 999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=239.96 Aligned_cols=241 Identities=20% Similarity=0.266 Sum_probs=189.3
Q ss_pred HHHHHHhhcccccceeeccCCceEEEEEEeC------CCcEEEEEccCCCCCC-------------------------Cc
Q 041438 493 YEEIIRATNDFDAKHCIGKGGHGSVYIARVP------SGEIFAVKKFHSPLPD-------------------------NF 541 (752)
Q Consensus 493 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-------------------------~~ 541 (752)
..|+.....+++....+-+|.||.||+|.+. +.+.|-+|.++..... ++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4566666677888889999999999999653 2455667766543222 11
Q ss_pred -cccCCceEEEEEeccCCChHHHhc-----cCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC
Q 041438 542 -CSHPRQSFIVYEYLESGSLDKILN-----NDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG 615 (752)
Q Consensus 542 -~~~~~~~~lV~E~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~ 615 (752)
.++....++++.++.-|+|..++. +....+.++..+...++.|++.|++|||++ +|||.||-..|.+||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 234466788999999999999998 333345678889999999999999999999 99999999999999999
Q ss_pred CceEEeecccceeccCCCCCcc--cccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccc
Q 041438 616 YEAHVSDFRIAKFLNLDSSNWS--KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNM 692 (752)
Q Consensus 616 ~~~kl~DfG~a~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~ 692 (752)
-.+||+|-.+++.+-+.+.+.- .......||+||.+....|+.++|||||||++|||+| |+.|+. +-+..++
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya-----eIDPfEm 507 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA-----EIDPFEM 507 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc-----ccCHHHH
Confidence 9999999999987654433221 1234568999999999999999999999999999998 999974 2233344
Q ss_pred hHhhhccC-CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 693 NIEILDSR-LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 693 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
...+.++. +..| .++++++..++.-||..+|++||+++|+...|.+++.
T Consensus 508 ~~ylkdGyRlaQP----~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 508 EHYLKDGYRLAQP----FNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred HHHHhccceecCC----CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 44444432 3333 5678899999999999999999999999999998874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-28 Score=236.05 Aligned_cols=229 Identities=19% Similarity=0.202 Sum_probs=169.8
Q ss_pred hcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------------CccccCC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------------NFCSHPR 546 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------------~~~~~~~ 546 (752)
..+|.-.+.+|.|.- .|..|. .-.++.||+|++..+... .......
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 345666788888887 566665 346889999988665332 1112235
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
.+|+|||||.. +|...+.. +++-.++..+.+|+++|++|+|+. ||+||||||+||++..+..+||.|||+|
T Consensus 95 e~y~v~e~m~~-nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILM-----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 67999999976 99888862 367789999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccc---------ccc------
Q 041438 627 KFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS---------SSN------ 691 (752)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~---------~~~------ 691 (752)
+..... -..+..+.|..|.|||++.+..+.+.+||||.||++.||++|+..|......++. ...
T Consensus 166 r~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 166 RTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred cccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 876543 3566779999999999999999999999999999999999999987521111000 000
Q ss_pred --chHhhh----------------ccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 692 --MNIEIL----------------DSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 692 --~~~~~~----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..+.+. |..++............+.+++.+||..||++|.+++++++|
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000000 001110000111233457889999999999999999999987
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-28 Score=246.40 Aligned_cols=274 Identities=22% Similarity=0.205 Sum_probs=117.8
Q ss_pred EEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCC-CcccccCCcccccccccceeecc
Q 041438 87 FGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLT-NKLSGHIPSEISLLTHLTILHIS 165 (752)
Q Consensus 87 ~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls 165 (752)
+.++|..+.+. .+++.+|..+++|+.||||+|+|+.|-|.+|.+|.+|.+|-+.+ |+|+.+..+.|++|..|+.|.+.
T Consensus 70 veirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllN 148 (498)
T KOG4237|consen 70 VEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLN 148 (498)
T ss_pred eEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcC
Confidence 34444444443 23444555555555555555555555555555555544444433 55554444455555555555555
Q ss_pred CcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccc------------cccccccccCcccccc
Q 041438 166 RNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSF------------SGSIPQQIGNLKSLFD 233 (752)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l------------~~~~p~~~~~l~~L~~ 233 (752)
-|++..+..++|..|++|..|.|-+|.+..+.-.+|.++.+++.+++..|.+ ....|..++.......
T Consensus 149 an~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p 228 (498)
T KOG4237|consen 149 ANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSP 228 (498)
T ss_pred hhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecch
Confidence 5555544445555555555555555555433333455555555555555541 1112222222222222
Q ss_pred ccccccccCCCcCCCCCCCC-CCCCcEEEccccccCCCCC-cccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEcc
Q 041438 234 MKLCINQLNGAIPLSIDWGR-CPQLSLLDVSINNITGNIP-FEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLS 311 (752)
Q Consensus 234 l~l~~N~l~~~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 311 (752)
..+.++++....+..+ .. +..+..--.+.....+..| ..|..+++|+.|+|++|+|+++-+.+|.+...++.|.|.
T Consensus 229 ~rl~~~Ri~q~~a~kf--~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~ 306 (498)
T KOG4237|consen 229 YRLYYKRINQEDARKF--LCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLT 306 (498)
T ss_pred HHHHHHHhcccchhhh--hhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcC
Confidence 2222222221111100 00 0000000011111111222 234444455555555555544444445555555555555
Q ss_pred CCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcC
Q 041438 312 GNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKL 363 (752)
Q Consensus 312 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 363 (752)
.|+|..+-...|.++..|+.|+|.+|+|+.+.|.+|..+..|..|+|-.|.+
T Consensus 307 ~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 307 RNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred cchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence 5554444444444455555555555555544444454444444444444443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-26 Score=219.51 Aligned_cols=165 Identities=21% Similarity=0.193 Sum_probs=127.8
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
|+|.+++...+ ..+++.+++.|+.|++.||+|||++ + ||+||+++.++.+|+ ||.++......
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 68999997543 3489999999999999999999999 6 999999999999999 99998764322
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCC---CCChhhHHHHH-
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLP---YPSLDVQNKFM- 713 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~- 713 (752)
..||+.|+|||++.+..+++++|||||||++|||+||+.||...... ......+...... ...........
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL----SAILEILLNGMPADDPRDRSNLESVSAA 138 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh----cHHHHHHHHHhccCCccccccHHHHHhh
Confidence 26889999999999999999999999999999999999998532111 1111111111111 11111123333
Q ss_pred -HHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 714 -SIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 714 -~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
++.+++.+||+.||++||++.|+++++..+.
T Consensus 139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 139 RSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred hhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 6899999999999999999999999997764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-28 Score=265.70 Aligned_cols=363 Identities=28% Similarity=0.365 Sum_probs=218.0
Q ss_pred EEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeecc
Q 041438 86 VFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHIS 165 (752)
Q Consensus 86 v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 165 (752)
...+|++.+.+... +..+..+++|+.|.++.|.|.. .|.+..++.+|++|.|.+|.+. ..|..+..+++|++|++|
T Consensus 47 L~~l~lsnn~~~~f--p~~it~l~~L~~ln~s~n~i~~-vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS 122 (1081)
T KOG0618|consen 47 LKSLDLSNNQISSF--PIQITLLSHLRQLNLSRNYIRS-VPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS 122 (1081)
T ss_pred eEEeeccccccccC--CchhhhHHHHhhcccchhhHhh-Cchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence 34555554433321 2234555666666666666654 3455666666666666666665 455666666666666666
Q ss_pred CcccCCCCCcccCCCCC-------------------CcEEEccCCCCCCcCCcCccCCCcceEEeecccccccccccccc
Q 041438 166 RNQLNGSIPHEVGQLNF-------------------LNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIG 226 (752)
Q Consensus 166 ~N~l~~~~p~~~~~l~~-------------------L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 226 (752)
.|.+. .+|..+..++. .+.++|..|.+.+.++....+++. .|+|..|++.. -.+.
T Consensus 123 ~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~---~dls 196 (1081)
T KOG0618|consen 123 FNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEV---LDLS 196 (1081)
T ss_pred hhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhhh---hhhh
Confidence 66665 44443333333 333344444444444444444443 46666665541 1222
Q ss_pred CccccccccccccccCCCcCC-----CC-----------CCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCc
Q 041438 227 NLKSLFDMKLCINQLNGAIPL-----SI-----------DWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNY 290 (752)
Q Consensus 227 ~l~~L~~l~l~~N~l~~~~~~-----~~-----------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 290 (752)
++..|+.+....|+++...-. .+ .-..-.+|+++|++.|++++ +|.++..+.+|+.++..+|+
T Consensus 197 ~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~ 275 (1081)
T KOG0618|consen 197 NLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNR 275 (1081)
T ss_pred hccchhhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchhhhhc-chHHHHhcccceEecccchh
Confidence 333333333333333211100 00 00122467788888888874 45777788888888888887
Q ss_pred CcC----------------------CCCccccCCcccCEEEccCCcCcccCCcccC------------------------
Q 041438 291 IVG----------------------EIPTQLGNIIYLNRISLSGNKLSGRIPGELG------------------------ 324 (752)
Q Consensus 291 l~~----------------------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~------------------------ 324 (752)
|+. -+|....++++|++|+|..|+|...++..|.
T Consensus 276 l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e 355 (1081)
T KOG0618|consen 276 LVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEE 355 (1081)
T ss_pred HHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccc
Confidence 752 2333444556666666666666532221111
Q ss_pred -CCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccce
Q 041438 325 -SLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEK 403 (752)
Q Consensus 325 -~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 403 (752)
..+.|+.|+|.+|.+++.....+.++..|+.|+|++|+|.......+.++..|++|+||+|+|+. +|..+..++.|++
T Consensus 356 ~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~-Lp~tva~~~~L~t 434 (1081)
T KOG0618|consen 356 NNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTT-LPDTVANLGRLHT 434 (1081)
T ss_pred hhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhh-hhHHHHhhhhhHH
Confidence 12235666666677666666666777788888888888876666677888888888888888865 4577788888888
Q ss_pred EEccCCcCCcCCchhhhccCCCcEEEccCCcccC-cCCCCcccCCCCcccccCCCCCCCC
Q 041438 404 LNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEG-HIPNSTTFRDAPLEALQGNKGLCGD 462 (752)
Q Consensus 404 L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~~~~~~~~~~~n~~~c~~ 462 (752)
|...+|++... | .+..++.|+.+|+|.|+|+- .+|.....+.+.-..+.||.++-.+
T Consensus 435 L~ahsN~l~~f-P-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d 492 (1081)
T KOG0618|consen 435 LRAHSNQLLSF-P-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFD 492 (1081)
T ss_pred HhhcCCceeec-h-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccc
Confidence 88888888755 5 78899999999999999975 4455444456666788999876543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=246.88 Aligned_cols=229 Identities=26% Similarity=0.339 Sum_probs=178.3
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC------------------------CccccCCceEEEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E 553 (752)
..++|+....+|+|+||.||||+ ..+++..|+|+++-...+ +.+-..+..+++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 45789999999999999999999 578999999998754333 11223467899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
||.+|+|.+.-+.. .++++.++..+.++.++|++|+|+. |-+|||||-.||++++.|.+|++|||.+..+...-
T Consensus 93 ycgggslQdiy~~T---gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred ecCCCcccceeeec---ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh
Confidence 99999999987654 3588899999999999999999999 99999999999999999999999999998776544
Q ss_pred CCcccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCCh-hhH
Q 041438 634 SNWSKLAGTHGNVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL-DVQ 709 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 709 (752)
.+...+.||+.|||||+.. .+.|..++|||+.|+...|+-.-++|-- + ........-.-...+..|.. +..
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf---d--lhpmr~l~LmTkS~~qpp~lkDk~ 241 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF---D--LHPMRALFLMTKSGFQPPTLKDKT 241 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc---c--cchHHHHHHhhccCCCCCcccCCc
Confidence 4445679999999999754 4568999999999999999988888721 0 00111111111111221211 224
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTMKRFEV 738 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~~evl~ 738 (752)
...+.+.++++.|+.++|++||+++.++.
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 45667889999999999999999988765
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=7e-24 Score=260.39 Aligned_cols=338 Identities=25% Similarity=0.257 Sum_probs=244.7
Q ss_pred CCEEEEEcCCCCCc-ccccccccCCCCCCCEEECCCCc------ccccCCccCcCCC-CCCeeecCCCcccccCCccccc
Q 041438 84 GRVFGINLTSISLN-GTLLEFSFSSFPHLAYLDLYNNE------LFDIIPPQISNLS-KLEYLDFLTNKLSGHIPSEISL 155 (752)
Q Consensus 84 ~~v~~l~l~~~~l~-g~l~~~~f~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~ 155 (752)
..|.++.+.-.... -.+.+.+|.++++|+.|.+.++. +...+|+.|..++ +|+.|++.+|.++ .+|..| .
T Consensus 532 ~~v~~i~l~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~ 609 (1153)
T PLN03210 532 KKVLGITLDIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-R 609 (1153)
T ss_pred ceeeEEEeccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-C
Confidence 34555544322222 12445679999999999997664 3345677887775 5999999999987 567777 5
Q ss_pred ccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCcccccccc
Q 041438 156 LTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMK 235 (752)
Q Consensus 156 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ 235 (752)
+.+|+.|+|++|++. .++..+..+++|+.|+|++|.....+|. ++.+++|+.|+|++|..-..+|..++++++|+.|+
T Consensus 610 ~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~ 687 (1153)
T PLN03210 610 PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLD 687 (1153)
T ss_pred ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEe
Confidence 789999999999998 5788889999999999998765556664 88899999999999887778899999999999999
Q ss_pred ccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcC
Q 041438 236 LCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKL 315 (752)
Q Consensus 236 l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 315 (752)
+++|..-..+|..+ .+++|+.|++++|...+.+|.. .++|++|+|++|.+. .+|..+ .+++|+.|++.++..
T Consensus 688 L~~c~~L~~Lp~~i---~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~ 759 (1153)
T PLN03210 688 MSRCENLEILPTGI---NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKS 759 (1153)
T ss_pred CCCCCCcCccCCcC---CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccch
Confidence 99876555666543 6789999999998766666643 467899999999987 456544 467777777766432
Q ss_pred -------cccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCC
Q 041438 316 -------SGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLG 388 (752)
Q Consensus 316 -------~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 388 (752)
....+..+...++|+.|+|++|......|.+++++++|+.|++++|..-+.+|... ++++|+.|+|++|...
T Consensus 760 ~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L 838 (1153)
T PLN03210 760 EKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRL 838 (1153)
T ss_pred hhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcc
Confidence 11122223334677888888877666677778888888888888765444566554 6777888888876554
Q ss_pred CCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccC-CcccCc
Q 041438 389 EKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISY-NKLEGH 438 (752)
Q Consensus 389 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~-N~l~~~ 438 (752)
..+|.. ..+|+.|+|++|.++. +|..+..+++|+.|++++ |++.+.
T Consensus 839 ~~~p~~---~~nL~~L~Ls~n~i~~-iP~si~~l~~L~~L~L~~C~~L~~l 885 (1153)
T PLN03210 839 RTFPDI---STNISDLNLSRTGIEE-VPWWIEKFSNLSFLDMNGCNNLQRV 885 (1153)
T ss_pred cccccc---ccccCEeECCCCCCcc-ChHHHhcCCCCCEEECCCCCCcCcc
Confidence 444432 3567777888887764 466777777888888877 455543
|
syringae 6; Provisional |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=228.12 Aligned_cols=236 Identities=24% Similarity=0.268 Sum_probs=171.4
Q ss_pred HHHhhcccccceeeccCCceEEEEEEeC----CCcEEEEEccCCCCCC-----------------------CccccCCce
Q 041438 496 IIRATNDFDAKHCIGKGGHGSVYIARVP----SGEIFAVKKFHSPLPD-----------------------NFCSHPRQS 548 (752)
Q Consensus 496 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------------------~~~~~~~~~ 548 (752)
+....+.|..+++||+|+|++||+|... .++.||+|.+...... +.....+.+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 4445677999999999999999999832 5789999988654332 345567899
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC-CCceEEeecccce
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL-GYEAHVSDFRIAK 627 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~-~~~~kl~DfG~a~ 627 (752)
.+||||++.....++... ++...+..+++.+..||+++|.. |||||||||+|++.+. .+.-.|+|||+|.
T Consensus 111 ~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHH
Confidence 999999999888888753 66789999999999999999999 9999999999999974 4668999999997
Q ss_pred eccC----------------C--C---------------CC-----------cccccCCCCccCccccccCC-CCCccch
Q 041438 628 FLNL----------------D--S---------------SN-----------WSKLAGTHGNVAPELAYTMK-VTEKCDV 662 (752)
Q Consensus 628 ~~~~----------------~--~---------------~~-----------~~~~~gt~~y~aPE~~~~~~-~~~ksDI 662 (752)
..+. . . .. .....||++|+|||++...+ .++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 2110 0 0 00 01236999999999877554 6899999
Q ss_pred hhHHHHHHHHHhCCCCcchhhcc-----------------------cc------cc----cc------ch--HhhhccCC
Q 041438 663 YSFGVLALEVIKGKHPRDFLFEM-----------------------SS------SS----SN------MN--IEILDSRL 701 (752)
Q Consensus 663 wSlGvil~elltg~~pf~~~~~~-----------------------~~------~~----~~------~~--~~~~~~~~ 701 (752)
||.|||+..+++++.||-..... .. .. .+ .. ..+...+.
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 99999999999999998311110 00 00 00 00 00000000
Q ss_pred C-CCChhhHH-HHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 702 P-YPSLDVQN-KFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 702 ~-~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
+ .......+ .+..+.+++.+|++.||.+|.|++|.++|-
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 0 00111112 233789999999999999999999998763
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=213.28 Aligned_cols=187 Identities=30% Similarity=0.527 Sum_probs=158.8
Q ss_pred eccCCceEEEEEEeC-CCcEEEEEccCCCCC----C---------------------CccccCCceEEEEEeccCCChHH
Q 041438 509 IGKGGHGSVYIARVP-SGEIFAVKKFHSPLP----D---------------------NFCSHPRQSFIVYEYLESGSLDK 562 (752)
Q Consensus 509 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~---------------------~~~~~~~~~~lV~E~~~~g~L~~ 562 (752)
||+|++|.||+++.. +++.+++|++..... . +++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999964 489999999887643 1 23344467899999999999999
Q ss_pred HhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC-CCceEEeecccceeccCCCCCcccccC
Q 041438 563 ILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL-GYEAHVSDFRIAKFLNLDSSNWSKLAG 641 (752)
Q Consensus 563 ~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~g 641 (752)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+..............+
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccC
Confidence 987642 2478899999999999999999999 9999999999999998 899999999999876543322333567
Q ss_pred CCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHHH
Q 041438 642 THGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAF 720 (752)
Q Consensus 642 t~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 720 (752)
...|++||..... .++.++|+|++|++++++ ..+.+++.
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------~~~~~~l~ 195 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------PELKDLIR 195 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------HHHHHHHH
Confidence 8899999998877 788999999999999999 46788999
Q ss_pred hccCcCCCCCCCHHHHHHHH
Q 041438 721 SCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 721 ~cl~~dP~~Rps~~evl~~L 740 (752)
+|++.||++||+++++++++
T Consensus 196 ~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 196 KMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHhhCCcccCcCHHHHhhCC
Confidence 99999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=246.23 Aligned_cols=264 Identities=26% Similarity=0.312 Sum_probs=134.5
Q ss_pred CCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEcc
Q 041438 110 HLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILD 189 (752)
Q Consensus 110 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 189 (752)
.-..|+|++|+|+. +|..+. ++|+.|+|++|+|+. +|. .+++|++|+|++|+|+. +|.. .++|+.|+|+
T Consensus 202 ~~~~LdLs~~~Lts-LP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls 270 (788)
T PRK15387 202 GNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIF 270 (788)
T ss_pred CCcEEEcCCCCCCc-CCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCc-ccCc---ccccceeecc
Confidence 35567777777774 455554 367777777777774 443 24677777777777773 4432 3467777777
Q ss_pred CCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCC
Q 041438 190 SNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITG 269 (752)
Q Consensus 190 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 269 (752)
+|.|+. +|..+ ++|+.|+|++|+|+. +|.. +++|+.|++++|++++. |.. ..+|+.|++++|+|++
T Consensus 271 ~N~L~~-Lp~lp---~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~L-p~l-----p~~L~~L~Ls~N~L~~ 336 (788)
T PRK15387 271 SNPLTH-LPALP---SGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL-PAL-----PSELCKLWAYNNQLTS 336 (788)
T ss_pred CCchhh-hhhch---hhcCEEECcCCcccc-cccc---ccccceeECCCCccccC-CCC-----cccccccccccCcccc
Confidence 777763 33322 456667777777763 3332 24455556666655542 210 1234555555555553
Q ss_pred CCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcc
Q 041438 270 NIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGS 349 (752)
Q Consensus 270 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 349 (752)
+|. ...+|++|+|++|+|++ +|.. ..+|+.|++++|+|+. +|.. ..+|+.|+|++|+|++++. .
T Consensus 337 -LP~---lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~LP~-l--- 400 (788)
T PRK15387 337 -LPT---LPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTSLPV-L--- 400 (788)
T ss_pred -ccc---cccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccCCCC-c---
Confidence 221 11345555555555553 2322 1244455555555553 3322 1244555555555554321 1
Q ss_pred cccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhh
Q 041438 350 LVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCF 419 (752)
Q Consensus 350 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 419 (752)
.++|+.|++++|+|++ +|..+ .+|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|++..|..+
T Consensus 401 ~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 401 PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 2344455555555543 23211 23444444444443 234444444444444444444444444433
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-25 Score=232.21 Aligned_cols=175 Identities=21% Similarity=0.278 Sum_probs=151.0
Q ss_pred HhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------------------Cc
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------------------NF 541 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------------------~~ 541 (752)
....+|...+.+|+|+||.|+.|.+ ++...|+||.+.+...- .+
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 3456799999999999999999994 45678999988664321 67
Q ss_pred cccCCceEEEEEec-cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEE
Q 041438 542 CSHPRQSFIVYEYL-ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV 620 (752)
Q Consensus 542 ~~~~~~~~lV~E~~-~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl 620 (752)
+++++.+|++||-- ++-+|.+++..+. .+++.++..|++||+.|+++||+. ||||||||-+||.++.+|-+||
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEE
Confidence 88889999999965 4558999997654 488999999999999999999999 9999999999999999999999
Q ss_pred eecccceeccCCCCCcccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCcc
Q 041438 621 SDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRD 680 (752)
Q Consensus 621 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~elltg~~pf~ 680 (752)
+|||.|..... .....++||..|.|||++.|.+| +..-||||+|+++|.++....||.
T Consensus 712 idfgsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 712 IDFGSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eeccchhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999987643 33455799999999999999987 667899999999999999999974
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-25 Score=262.26 Aligned_cols=179 Identities=15% Similarity=0.156 Sum_probs=130.2
Q ss_pred CceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC-----------
Q 041438 546 RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL----------- 614 (752)
Q Consensus 546 ~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~----------- 614 (752)
+.++.+|||+. ++|.+++.... ..+++.+++.+++||++||+|||++ ||+||||||+|||++.
T Consensus 53 ~~~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~ 126 (793)
T PLN00181 53 DSIVRALECED-VSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQ---GIVVHNVRPSCFVMSSFNHVSFIESAS 126 (793)
T ss_pred chhhhhhccCC-ccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhC---CeeeccCCchhEEEcccCcEEEeeccc
Confidence 45778899885 49999997532 3488999999999999999999999 9999999999999954
Q ss_pred --------CCceEEeecccceeccCCC----------------CCcccccCCCCccCccccccCCCCCccchhhHHHHHH
Q 041438 615 --------GYEAHVSDFRIAKFLNLDS----------------SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLAL 670 (752)
Q Consensus 615 --------~~~~kl~DfG~a~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ 670 (752)
++.+|++|||+++...... .......||+.|||||++.+..++.++|||||||++|
T Consensus 127 ~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ 206 (793)
T PLN00181 127 CSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLF 206 (793)
T ss_pred cCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHH
Confidence 4456666777665421100 0001135888999999999999999999999999999
Q ss_pred HHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 671 EVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 671 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
||++|.+|+.... ........... +. ..........+++.+||++||.+||++.|+++|-
T Consensus 207 ELl~~~~~~~~~~-------~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 207 ELFCPVSSREEKS-------RTMSSLRHRVL--PP-QILLNWPKEASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred HHhhCCCchhhHH-------HHHHHHHHhhc--Ch-hhhhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence 9999998864211 01111111111 11 1111234456888999999999999999998753
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-26 Score=255.65 Aligned_cols=244 Identities=28% Similarity=0.282 Sum_probs=160.2
Q ss_pred CcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEc
Q 041438 183 LNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDV 262 (752)
Q Consensus 183 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~L 262 (752)
|+++++++|++++ +|++++.+.+|+.|...+|+|+ .+|..+...++|+.+.+..|.+.-..|. ...++.|++|||
T Consensus 243 l~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yip~~---le~~~sL~tLdL 317 (1081)
T KOG0618|consen 243 LQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYIPPF---LEGLKSLRTLDL 317 (1081)
T ss_pred ceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhCCCc---ccccceeeeeee
Confidence 3444444444442 2244444444444444444442 3334444444444444444444433221 123445555555
Q ss_pred cccccCCCCCcccCCCCC-CCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeecccccccc
Q 041438 263 SINNITGNIPFEIGESPQ-LQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSN 341 (752)
Q Consensus 263 s~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 341 (752)
..|+|....+..+.-+.. |..|+.+.|++.......=..++.|+.|++.+|.++...-..+.+..+|+.|+|++|+|..
T Consensus 318 ~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~ 397 (1081)
T KOG0618|consen 318 QSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNS 397 (1081)
T ss_pred hhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccccc
Confidence 555554333322222222 4445555555543222222344568889999999998777788899999999999999999
Q ss_pred ccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhc
Q 041438 342 FVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEE 421 (752)
Q Consensus 342 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 421 (752)
++...+.++..|+.|+||+|+|+ .+|..+.++..|+.|...+|++... | .+..++.|+.+|+|.|+|+...-..-..
T Consensus 398 fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~f-P-e~~~l~qL~~lDlS~N~L~~~~l~~~~p 474 (1081)
T KOG0618|consen 398 FPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSF-P-ELAQLPQLKVLDLSCNNLSEVTLPEALP 474 (1081)
T ss_pred CCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeec-h-hhhhcCcceEEecccchhhhhhhhhhCC
Confidence 99999999999999999999997 6789999999999999999999654 4 7889999999999999998764333334
Q ss_pred cCCCcEEEccCCc
Q 041438 422 LHGLLHIDISYNK 434 (752)
Q Consensus 422 l~~L~~L~ls~N~ 434 (752)
.++|++|||++|.
T Consensus 475 ~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 475 SPNLKYLDLSGNT 487 (1081)
T ss_pred CcccceeeccCCc
Confidence 4899999999997
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-24 Score=241.60 Aligned_cols=263 Identities=25% Similarity=0.281 Sum_probs=210.8
Q ss_pred CCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEee
Q 041438 133 SKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYL 212 (752)
Q Consensus 133 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 212 (752)
..-..|+|++|.|+ .+|..+. ++|+.|++++|+|+. +|.. +++|++|+|++|+|+. +|.. .++|+.|+|
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~L 269 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSI 269 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccCc-ccCc---ccccceeec
Confidence 45778999999999 5777775 489999999999995 5643 5789999999999995 4543 468999999
Q ss_pred ccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCc
Q 041438 213 YNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIV 292 (752)
Q Consensus 213 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 292 (752)
++|.|+. +|..+ ++|+.|++++|+++.. |. ..++|+.|+|++|+|++. |.. ..+|+.|++++|.|+
T Consensus 270 s~N~L~~-Lp~lp---~~L~~L~Ls~N~Lt~L-P~-----~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~ 335 (788)
T PRK15387 270 FSNPLTH-LPALP---SGLCKLWIFGNQLTSL-PV-----LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLT 335 (788)
T ss_pred cCCchhh-hhhch---hhcCEEECcCCccccc-cc-----cccccceeECCCCccccC-CCC---cccccccccccCccc
Confidence 9999984 45433 5677899999999864 32 247899999999999964 432 346889999999998
Q ss_pred CCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhcc
Q 041438 293 GEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELD 372 (752)
Q Consensus 293 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 372 (752)
+ +|.. ..+|+.|+|++|+|++ +|.. ..+|+.|++++|+|+.++ .. ..+|+.|+|++|+|++ +|..
T Consensus 336 ~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~LP-~l---~~~L~~LdLs~N~Lt~-LP~l-- 400 (788)
T PRK15387 336 S-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLP-AL---PSGLKELIVSGNRLTS-LPVL-- 400 (788)
T ss_pred c-cccc---ccccceEecCCCccCC-CCCC---CcccceehhhccccccCc-cc---ccccceEEecCCcccC-CCCc--
Confidence 5 5542 2579999999999996 4443 357889999999999754 32 3579999999999985 4543
Q ss_pred ccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCCcccCcCCC
Q 041438 373 NLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPN 441 (752)
Q Consensus 373 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 441 (752)
.++|+.|++++|+|++ +|.. ..+|+.|+|++|+|+. +|..+..+++|+.|+|++|+|++.+|.
T Consensus 401 -~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt~-LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 401 -PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred -ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCcccc-cChHHhhccCCCeEECCCCCCCchHHH
Confidence 3689999999999987 4543 3578899999999985 588899999999999999999998775
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.2e-23 Score=250.97 Aligned_cols=313 Identities=22% Similarity=0.216 Sum_probs=250.8
Q ss_pred ccCCCC-CCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCC
Q 041438 104 SFSSFP-HLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNF 182 (752)
Q Consensus 104 ~f~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 182 (752)
.|..++ +|+.|++.++.+.. +|..| ...+|+.|+|++|++. .++..+..+++|+.|+|++|.....+| .++.+++
T Consensus 583 ~~~~lp~~Lr~L~~~~~~l~~-lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~ 658 (1153)
T PLN03210 583 GFDYLPPKLRLLRWDKYPLRC-MPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATN 658 (1153)
T ss_pred chhhcCcccEEEEecCCCCCC-CCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCc
Confidence 455554 69999999999866 57777 5789999999999998 567788999999999999887555676 4889999
Q ss_pred CcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEc
Q 041438 183 LNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDV 262 (752)
Q Consensus 183 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~L 262 (752)
|+.|+|++|..-..+|.++.++++|+.|++++|..-+.+|..+ ++++|+.|++++|.....+|. ..++|+.|++
T Consensus 659 Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~-----~~~nL~~L~L 732 (1153)
T PLN03210 659 LETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPD-----ISTNISWLDL 732 (1153)
T ss_pred ccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCcccccc-----ccCCcCeeec
Confidence 9999999987777899999999999999999976555777665 789999999999876555553 2468999999
Q ss_pred cccccCCCCCcccCCCCCCCEEecCCCcC-------cCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeecc
Q 041438 263 SINNITGNIPFEIGESPQLQYLDLSSNYI-------VGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLS 335 (752)
Q Consensus 263 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-------~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 335 (752)
++|.++ .+|..+ .+++|++|++.++.. ....+..+...++|+.|+|++|...+.+|..++++++|+.|+|+
T Consensus 733 ~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls 810 (1153)
T PLN03210 733 DETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIE 810 (1153)
T ss_pred CCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECC
Confidence 999987 456554 578899998887442 22222233445789999999998888899999999999999999
Q ss_pred ccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccC-CcCCcC
Q 041438 336 ANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSY-NNLSGL 414 (752)
Q Consensus 336 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~ 414 (752)
+|..-+..|..+ ++++|+.|+|++|..-..+|.. .++|++|+|++|.++. +|..+..+++|+.|+|++ |++..
T Consensus 811 ~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~~-iP~si~~l~~L~~L~L~~C~~L~~- 884 (1153)
T PLN03210 811 NCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIEE-VPWWIEKFSNLSFLDMNGCNNLQR- 884 (1153)
T ss_pred CCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCcc-ChHHHhcCCCCCEEECCCCCCcCc-
Confidence 975444455544 7899999999998655555543 3689999999999965 677889999999999998 55665
Q ss_pred CchhhhccCCCcEEEccCCc
Q 041438 415 IPRCFEELHGLLHIDISYNK 434 (752)
Q Consensus 415 ~p~~~~~l~~L~~L~ls~N~ 434 (752)
+|..+..++.|+.++++++.
T Consensus 885 l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 885 VSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred cCcccccccCCCeeecCCCc
Confidence 56678889999999999875
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-26 Score=227.33 Aligned_cols=278 Identities=21% Similarity=0.214 Sum_probs=210.7
Q ss_pred CCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccC-cccCCCCCcccCCCCCCcEEEc
Q 041438 110 HLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISR-NQLNGSIPHEVGQLNFLNHLIL 188 (752)
Q Consensus 110 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L 188 (752)
....++|..|+|+.+.|++|+.+++|+.||||+|+|+.+-|++|.+|.+|..|-+-+ |+|+....+.|++|.+|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 567899999999999999999999999999999999999999999999998887776 9999888889999999999999
Q ss_pred cCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcC----------CCCCCCCCCCCc
Q 041438 189 DSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIP----------LSIDWGRCPQLS 258 (752)
Q Consensus 189 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~----------~~~~~~~l~~L~ 258 (752)
.-|++.-+..+.|..|++|..|.|.+|.+..+.-.+|..+.+++.+.+..|.+...-- ..+.++...-..
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 9999999999999999999999999999996666699999999999999888432110 011122222233
Q ss_pred EEEccccccCCCCCcccCCC-CCCC-EEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccc
Q 041438 259 LLDVSINNITGNIPFEIGES-PQLQ-YLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSA 336 (752)
Q Consensus 259 ~L~Ls~N~l~~~~p~~~~~l-~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 336 (752)
...+.++++....+..|... ..+. .+....+...-.....|..+++|++|+|++|+|+++-+.+|.++..+++|+|..
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~ 307 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR 307 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence 33344444443333333221 1111 112222222222224577778888888888888877778888888888888888
Q ss_pred cccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccC
Q 041438 337 NHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFL 387 (752)
Q Consensus 337 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 387 (752)
|+|..+....|.++..|+.|+|.+|+|+...|..|..+.+|.+|+|-.|.+
T Consensus 308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred chHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence 888777777788888888888888888777778888888888887777766
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=234.05 Aligned_cols=246 Identities=26% Similarity=0.364 Sum_probs=124.7
Q ss_pred CCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEcc
Q 041438 110 HLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILD 189 (752)
Q Consensus 110 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 189 (752)
+.+.|++++++++. +|..+. ++|+.|+|++|+|+. +|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLTT-IPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 34556666666654 343332 356666666666663 333332 35666666666665 3344332 245666666
Q ss_pred CCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCC
Q 041438 190 SNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITG 269 (752)
Q Consensus 190 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 269 (752)
+|++. .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++|+|++
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~----------------------------~sL~~L~Ls~N~Lt~ 297 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP----------------------------EELRYLSVYDNSIRT 297 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC----------------------------CCCcEEECCCCcccc
Confidence 66655 3344332 35555666666555 2343332 245555555555553
Q ss_pred CCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcc
Q 041438 270 NIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGS 349 (752)
Q Consensus 270 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 349 (752)
+|..+. ++|+.|++++|.++. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+.+ |..+
T Consensus 298 -LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~L-P~~l-- 365 (754)
T PRK15370 298 -LPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITVL-PETL-- 365 (754)
T ss_pred -Ccccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCcC-Chhh--
Confidence 232221 345555666665553 333221 355566666666553 333332 4566666666666543 2222
Q ss_pred cccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCc----ccccccccceEEccCCcCC
Q 041438 350 LVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISS----RICRMESLEKLNLSYNNLS 412 (752)
Q Consensus 350 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~ 412 (752)
.++|+.|+|++|+|+. +|..+. ..|+.|++++|+|.+. |. .+..++.+..|+|.+|.++
T Consensus 366 p~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~~L-P~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 366 PPTITTLDVSRNALTN-LPENLP--AALQIMQASRNNLVRL-PESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred cCCcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCcccC-chhHHHHhhcCCCccEEEeeCCCcc
Confidence 2456666666666653 333332 2466666666666532 22 2233456666777777665
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=202.63 Aligned_cols=173 Identities=29% Similarity=0.492 Sum_probs=145.4
Q ss_pred cccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEecc
Q 041438 503 FDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~~~ 556 (752)
|++.+.||+|++|.||+|+.. +++.+|+|.+...... +++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 567889999999999999965 4899999998754211 23444577899999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC-CC
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS-SN 635 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 635 (752)
+++|.+++..... .+++..+..++.+++.++.++|+. +++|+|++|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999999976432 178899999999999999999999 99999999999999999999999999998875432 12
Q ss_pred cccccCCCCccCcccc-ccCCCCCccchhhHHHHHHHHHhCCCCcc
Q 041438 636 WSKLAGTHGNVAPELA-YTMKVTEKCDVYSFGVLALEVIKGKHPRD 680 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~-~~~~~~~ksDIwSlGvil~elltg~~pf~ 680 (752)
.....++..|++||.. ....++.++|||+||++++||++|+.||.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 2334678899999998 66677889999999999999999999985
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=191.23 Aligned_cols=235 Identities=15% Similarity=0.194 Sum_probs=176.5
Q ss_pred cccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEecc
Q 041438 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~~ 556 (752)
-+|.+.++||+|+||.++.|+ .-+++.||||.-...... .+..+..+-.+|||.+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 478899999999999999998 678999999964322111 2234455667999988
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC-----CceEEeecccceeccC
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG-----YEAHVSDFRIAKFLNL 631 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~-----~~~kl~DfG~a~~~~~ 631 (752)
|.+|++++.-.+ ..++..++..+|+|++.-++|+|++ .+|.|||||+|+||... ..+.++|||+|+.+.+
T Consensus 107 GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 569999987655 4589999999999999999999999 99999999999999643 3589999999999876
Q ss_pred CCCCc-------ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCC
Q 041438 632 DSSNW-------SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYP 704 (752)
Q Consensus 632 ~~~~~-------~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (752)
+.+.. ....||..||+--...+...+.+.|.-|+|-++.+.+-|..||+... .....+....+-+.+...+
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK--A~tnK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK--ADTNKEKYEKIGETKRSTP 259 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc--CcchHHHHHHhccccccCC
Confidence 65443 23479999999998899999999999999999999999999997543 2223334444545444444
Q ss_pred Chhh-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 705 SLDV-QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 705 ~~~~-~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
.... .+.+.++..-+.-.=..+-++-|..+-+...+..+
T Consensus 260 i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dv 299 (449)
T KOG1165|consen 260 IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDV 299 (449)
T ss_pred HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 3222 23344555544444456777888877766655443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=185.32 Aligned_cols=241 Identities=19% Similarity=0.244 Sum_probs=177.4
Q ss_pred hHHHHHHhhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC-----------------------CccccCCc
Q 041438 492 VYEEIIRATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQ 547 (752)
Q Consensus 492 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~ 547 (752)
+.+++.. .+.|.++++||+|+||.+|.|. ..+|+.||||.-...... .+..+...
T Consensus 7 s~~~~iv-~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 7 SLEELIV-GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred chhhhee-ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 3444433 4789999999999999999998 678999999976443221 44566778
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC---CCceEEeecc
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL---GYEAHVSDFR 624 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~---~~~~kl~DfG 624 (752)
-.+|||.. |.+|++++.-.. ..++..++.-.+-|++.-++|+|.+ +++||||||+|+|..- ...+.++|||
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFG 159 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFG 159 (341)
T ss_pred ceeeeecc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEecc
Confidence 89999988 669999886543 3488899999999999999999999 9999999999999863 3468999999
Q ss_pred cceeccCCCCCc-------ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhh
Q 041438 625 IAKFLNLDSSNW-------SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEIL 697 (752)
Q Consensus 625 ~a~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 697 (752)
+|+.+.+..+.. ....||..|.+--...+...+.+.|+-|+|.++.+.--|..||+..... ...+....+.
T Consensus 160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~--tk~QKyEkI~ 237 (341)
T KOG1163|consen 160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA--TKKQKYEKIS 237 (341)
T ss_pred chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh--hHHHHHHHHH
Confidence 999876543321 2357999999988777778889999999999999999999999743321 1222333444
Q ss_pred ccCCCCCChhh-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHh
Q 041438 698 DSRLPYPSLDV-QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 698 ~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 741 (752)
..+...+.... .+.+.++.-.+.-|=..--++-|...-+-+.++
T Consensus 238 EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 238 EKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred HhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 44444442221 234445556666666666677777665554444
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.8e-21 Score=201.64 Aligned_cols=235 Identities=20% Similarity=0.186 Sum_probs=169.3
Q ss_pred ccccceeeccCCceEEEEEEeCC--CcEEEEEccCCCCCC----------------------------Ccc-ccCCceEE
Q 041438 502 DFDAKHCIGKGGHGSVYIARVPS--GEIFAVKKFHSPLPD----------------------------NFC-SHPRQSFI 550 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~----------------------------~~~-~~~~~~~l 550 (752)
+|++.++||+|+||.||.|.... .+.+|+|........ ... ......|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999999544 357888865432110 112 24557899
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC-----CceEEeeccc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG-----YEAHVSDFRI 625 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~-----~~~kl~DfG~ 625 (752)
||+.+ |.+|.++..... .+.++..++..|+.|++.+|+++|+. |++||||||+|+++... ..+.+.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 559999886655 45689999999999999999999999 99999999999999854 4599999999
Q ss_pred ce--eccCCC-C---C----cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHh
Q 041438 626 AK--FLNLDS-S---N----WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE 695 (752)
Q Consensus 626 a~--~~~~~~-~---~----~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~ 695 (752)
|+ ...... . . .....||..|.++....+...+++.|+||++.++.|+..|..||........ ......
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~~~~~ 251 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KSKFEK 251 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HHHHHH
Confidence 98 321111 1 0 1234699999999999999999999999999999999999999853221111 111111
Q ss_pred hhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 696 ILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
......... .....+.++.++...+-..+..++|....+.+.+++...
T Consensus 252 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 252 DPRKLLTDR--FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred Hhhhhcccc--ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 111111000 001122344555555556899999999999999877643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.2e-22 Score=222.77 Aligned_cols=227 Identities=20% Similarity=0.257 Sum_probs=163.1
Q ss_pred cceeeccCCceEEEEEE-eCCCcEEEEEccCC----CCCC---------Ccc-----------------ccCCceEEEEE
Q 041438 505 AKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHS----PLPD---------NFC-----------------SHPRQSFIVYE 553 (752)
Q Consensus 505 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~----~~~~---------~~~-----------------~~~~~~~lV~E 553 (752)
..+.+|.|++|.|+.+. ....+.++.|.++. .... +++ .+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 35778999999887776 33444455554431 1110 111 11223334499
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
||++ ||...+.... .++..++..+++|++.|++|+|+. ||.|||+|++|+++...|.+||+|||.+..+..+.
T Consensus 402 ~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 9999997652 377789999999999999999999 99999999999999999999999999998765443
Q ss_pred CC----cccccCCCCccCccccccCCCCC-ccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhh
Q 041438 634 SN----WSKLAGTHGNVAPELAYTMKVTE-KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708 (752)
Q Consensus 634 ~~----~~~~~gt~~y~aPE~~~~~~~~~-ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (752)
.. ....+|+..|+|||.+.+..|.+ ..||||.|+++..|.+|+.||......+.................+....
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 32 34568999999999999999875 68999999999999999999963322111100100000011111222233
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPTMKRFEV 738 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 738 (752)
...+.....+|.+|++.||.+|.|+++|++
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 455667788999999999999999999984
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.8e-21 Score=220.47 Aligned_cols=223 Identities=26% Similarity=0.428 Sum_probs=145.1
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeec
Q 041438 85 RVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHI 164 (752)
Q Consensus 85 ~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 164 (752)
..+.+++..+++.. ++. .+ .++|+.|+|++|+|+.+ |..+. ++|++|+|++|+|+. +|..+. .+|+.|+|
T Consensus 179 ~~~~L~L~~~~Lts-LP~-~I--p~~L~~L~Ls~N~LtsL-P~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~L 248 (754)
T PRK15370 179 NKTELRLKILGLTT-IPA-CI--PEQITTLILDNNELKSL-PENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMEL 248 (754)
T ss_pred CceEEEeCCCCcCc-CCc-cc--ccCCcEEEecCCCCCcC-Chhhc--cCCCEEECCCCcccc-CChhhh--ccccEEEC
Confidence 45678887777663 322 12 25799999999999974 55443 589999999999994 566553 58999999
Q ss_pred cCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCC
Q 041438 165 SRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGA 244 (752)
Q Consensus 165 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 244 (752)
++|+|. .+|..+. ++|+.|+|++|+|+. +|..+. ++|+.|+|++|+|++ +|..+. .+|+.|++++|+++..
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~L 319 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTAL 319 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccccC
Confidence 999999 6677664 589999999999994 676664 589999999999985 454433 3577777777777642
Q ss_pred cCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccC
Q 041438 245 IPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELG 324 (752)
Q Consensus 245 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 324 (752)
|..+ .++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++|+|+. +|..+.
T Consensus 320 -P~~l----~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~ 387 (754)
T PRK15370 320 -PETL----PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTN-LPENLP 387 (754)
T ss_pred -Cccc----cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCC-CCHhHH
Confidence 3211 2456666666666654 343332 45666666666555 2343332 345555555555553 222221
Q ss_pred CCcccceeeccccccc
Q 041438 325 SLINLEYLDLSANHLS 340 (752)
Q Consensus 325 ~l~~L~~L~Ls~N~l~ 340 (752)
.+|+.|++++|+|+
T Consensus 388 --~sL~~LdLs~N~L~ 401 (754)
T PRK15370 388 --AALQIMQASRNNLV 401 (754)
T ss_pred --HHHHHHhhccCCcc
Confidence 13444444444444
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.1e-21 Score=214.74 Aligned_cols=225 Identities=19% Similarity=0.209 Sum_probs=164.1
Q ss_pred ccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC---------------------------CccccCCceEEEEEe
Q 041438 502 DFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E~ 554 (752)
+|...+.+|+++|=+|.+|+.+.|. |+||++-+.... ......+..|+|=+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6777899999999999999998887 889988654422 112234556788888
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
... +|++.+..+. -+...+.+.|+.|++.||..+|.. ||+|||||.+||||+.-.-+.|+||..-+..--+..
T Consensus 103 vkh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 877 8988886543 367788999999999999999999 999999999999999999999999987665322222
Q ss_pred Ccc---c----ccCCCCccCccccccC----------C-CCCccchhhHHHHHHHHHh-CCCCcchhhccc--cccccch
Q 041438 635 NWS---K----LAGTHGNVAPELAYTM----------K-VTEKCDVYSFGVLALEVIK-GKHPRDFLFEMS--SSSSNMN 693 (752)
Q Consensus 635 ~~~---~----~~gt~~y~aPE~~~~~----------~-~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~--~~~~~~~ 693 (752)
... . ...-.+|.|||.+... . .+++.||||+||+++|+++ |++||....-.. .......
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDP 255 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCH
Confidence 211 1 1233589999986641 1 5788999999999999997 788886432211 1100111
Q ss_pred HhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 694 IEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
...+. .+ ....+..++..|++.||++|.+|++.++.-....
T Consensus 256 e~~Le-~I---------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 256 EQLLE-KI---------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred HHHHH-hC---------cCccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 11111 11 1124778999999999999999999998765543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-21 Score=207.30 Aligned_cols=280 Identities=25% Similarity=0.232 Sum_probs=128.7
Q ss_pred EEECCCCccc-ccCCccCcCCCCCCeeecCCCccccc----CCcccccccccceeeccCcccCC------CCCcccCCCC
Q 041438 113 YLDLYNNELF-DIIPPQISNLSKLEYLDFLTNKLSGH----IPSEISLLTHLTILHISRNQLNG------SIPHEVGQLN 181 (752)
Q Consensus 113 ~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~ 181 (752)
.|+|..+.++ +.....|..+++|++|+|+++.++.. ++..+...++|++|++++|.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4666777766 33444556666677777777766432 33344455566666666666552 1122344444
Q ss_pred CCcEEEccCCCCCCcCCcCccCCCc---ceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCC-CCC
Q 041438 182 FLNHLILDSNFLGGSIPRSLSNFTN---LVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRC-PQL 257 (752)
Q Consensus 182 ~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l-~~L 257 (752)
+|+.|+|++|.+.+..+..+..+.+ |++|++++|++++.....+.. .+..+ ++|
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~----------------------~l~~~~~~L 139 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK----------------------GLKDLPPAL 139 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHH----------------------HHHhCCCCc
Confidence 5555555555554433333333333 555555544443211100000 01122 455
Q ss_pred cEEEccccccCCC----CCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceee
Q 041438 258 SLLDVSINNITGN----IPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLD 333 (752)
Q Consensus 258 ~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 333 (752)
+.|++++|.+++. ++..+..+++|++|++++|.+++.... .++..+..+++|++|+
T Consensus 140 ~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~--------------------~l~~~l~~~~~L~~L~ 199 (319)
T cd00116 140 EKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIR--------------------ALAEGLKANCNLEVLD 199 (319)
T ss_pred eEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHH--------------------HHHHHHHhCCCCCEEe
Confidence 5555655555532 122333444455555555554421100 1112223334455555
Q ss_pred cccccccccc----chhhcccccccEEEcCCCcCccccchhccc-----cccCCeeecCCccCCC----CCCcccccccc
Q 041438 334 LSANHLSNFV----LESLGSLVKLYYLNLSHNKLSQQIPIELDN-----LIHLSELDLSHNFLGE----KISSRICRMES 400 (752)
Q Consensus 334 Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~~~~~~~l~~ 400 (752)
|++|.+++.. ...+..+++|++|++++|.+++.....+.. .+.|++|++++|.++. .+...+..+++
T Consensus 200 L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~ 279 (319)
T cd00116 200 LNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKES 279 (319)
T ss_pred ccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCC
Confidence 5555444322 122334455555555555554322222211 2455555555555541 11223334456
Q ss_pred cceEEccCCcCCcC----Cchhhhcc-CCCcEEEccCCc
Q 041438 401 LEKLNLSYNNLSGL----IPRCFEEL-HGLLHIDISYNK 434 (752)
Q Consensus 401 L~~L~L~~N~l~~~----~p~~~~~l-~~L~~L~ls~N~ 434 (752)
|+++++++|.++.. ....+... +.|+.+|+.+|+
T Consensus 280 L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 280 LLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS 318 (319)
T ss_pred ccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence 66666666666644 22233333 456666666654
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=7e-20 Score=185.92 Aligned_cols=209 Identities=22% Similarity=0.270 Sum_probs=137.7
Q ss_pred ccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------------------------
Q 041438 502 DFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------------------- 539 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------------------- 539 (752)
.+...+.||.|+++.||.++. .+++.+|||++......
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 345678999999999999995 56999999987433321
Q ss_pred -----CccccC---C-----ceEEEEEeccCCChHHHhcc---Ccc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 041438 540 -----NFCSHP---R-----QSFIVYEYLESGSLDKILNN---DAS-AKELGWTQRLNVIKGVADALFYLHNNCFPPIVH 602 (752)
Q Consensus 540 -----~~~~~~---~-----~~~lV~E~~~~g~L~~~l~~---~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH 602 (752)
.+.... . ..+++|+-+.+ ||.+++.. ... ...+....+..+..|+++.++++|+. |+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 000001 1 23678888865 89888653 111 12244455677789999999999999 9999
Q ss_pred cCCCCCCEEeCCCCceEEeecccceeccCCCCCcccccCCCCccCcccccc--------CCCCCccchhhHHHHHHHHHh
Q 041438 603 WDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYT--------MKVTEKCDVYSFGVLALEVIK 674 (752)
Q Consensus 603 ~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDIwSlGvil~ellt 674 (752)
+||||+|++++++|.++|+||+.....+.. ......+..|.+||.... -.++++.|.|++|+++|.|.+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEE---EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCce---eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 999999999999999999999988765422 111345578999997543 247889999999999999999
Q ss_pred CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCC
Q 041438 675 GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSR 730 (752)
Q Consensus 675 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 730 (752)
|..||+.......... .+.. +. +.++.+.++|.++|++||++|
T Consensus 246 ~~lPf~~~~~~~~~~~-----------~f~~-C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW-----------DFSR-CR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG-----------GGTT-SS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc-----------cchh-cC-CcCHHHHHHHHHHccCCcccC
Confidence 9999863221111110 1111 22 566778999999999999988
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.2e-21 Score=199.77 Aligned_cols=175 Identities=19% Similarity=0.317 Sum_probs=136.6
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
+.|+.|++|...+|.+++.+.......++.....++.|++.|++| + +.+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 478999999999999999876666667888999999999999999 6 8999999999999999999999999999
Q ss_pred eeccCCC------CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc
Q 041438 627 KFLNLDS------SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS 699 (752)
Q Consensus 627 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 699 (752)
....... ...+...||..||+||.+.+..|+.|+||||+|++++|++. -..+++ .......+.+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e--------r~~t~~d~r~g 475 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE--------RIATLTDIRDG 475 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH--------HHHhhhhhhcC
Confidence 8765443 12345689999999999999999999999999999999997 333332 11122333333
Q ss_pred CCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 041438 700 RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEV 738 (752)
Q Consensus 700 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 738 (752)
.++ .....+ .++-..++.+++.+.|.+||++.++.-
T Consensus 476 ~ip--~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~ 511 (516)
T KOG1033|consen 476 IIP--PEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVAL 511 (516)
T ss_pred CCC--hHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhh
Confidence 333 111122 233457888999999999996655543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=191.63 Aligned_cols=144 Identities=20% Similarity=0.195 Sum_probs=109.5
Q ss_pred HHhhcccccceeeccCCceEEEEEEeC--CCcEEEEEccCCCCC----C-------------------Cc---cccCCce
Q 041438 497 IRATNDFDAKHCIGKGGHGSVYIARVP--SGEIFAVKKFHSPLP----D-------------------NF---CSHPRQS 548 (752)
Q Consensus 497 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~----~-------------------~~---~~~~~~~ 548 (752)
....++|++.+.||+|+||+||+|+.. +++.||||++..... . .. ....+..
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~ 93 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKD 93 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCc
Confidence 345678999999999999999999853 578889998643211 0 00 1123467
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC-CCCCEEeCCCCceEEeecccce
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDI-SSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~Dl-Kp~NIll~~~~~~kl~DfG~a~ 627 (752)
|+||||++|++|... ... . ...++.|+++||+|||++ ||+|||| ||+||+++.++.+||+|||+|+
T Consensus 94 ~LVmE~~~G~~L~~~-~~~------~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 94 GLVRGWTEGVPLHLA-RPH------G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred EEEEEccCCCCHHHh-Ccc------c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 999999999999632 110 1 146789999999999999 9999999 9999999999999999999999
Q ss_pred eccCCCCC--------cccccCCCCccCcccccc
Q 041438 628 FLNLDSSN--------WSKLAGTHGNVAPELAYT 653 (752)
Q Consensus 628 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~ 653 (752)
........ .....+++.|+|||++.-
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 77543311 123468889999998764
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-21 Score=207.95 Aligned_cols=206 Identities=21% Similarity=0.206 Sum_probs=148.5
Q ss_pred EEcCCCCCcccccccccCCCCCCCEEECCCCccccc----CCccCcCCCCCCeeecCCCcccc------cCCcccccccc
Q 041438 89 INLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDI----IPPQISNLSKLEYLDFLTNKLSG------HIPSEISLLTH 158 (752)
Q Consensus 89 l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~------~~p~~~~~l~~ 158 (752)
++|..+.+.+.-....|..+++|++|+++++.++.. ++..+...++|++|++++|.+.+ .++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 556666676554455677888899999999999643 56667888999999999998873 33456778899
Q ss_pred cceeeccCcccCCCCCcccCCCCC---CcEEEccCCCCCC----cCCcCccCC-CcceEEeeccccccccccccccCccc
Q 041438 159 LTILHISRNQLNGSIPHEVGQLNF---LNHLILDSNFLGG----SIPRSLSNF-TNLVFLYLYNNSFSGSIPQQIGNLKS 230 (752)
Q Consensus 159 L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~ 230 (752)
|+.|+|++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++.....+..
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~--- 159 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK--- 159 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH---
Confidence 999999999998777777766666 9999999999983 333455666 89999999999998533222211
Q ss_pred cccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCC----CCcccCCCCCCCEEecCCCcCcCCCC----ccccCC
Q 041438 231 LFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGN----IPFEIGESPQLQYLDLSSNYIVGEIP----TQLGNI 302 (752)
Q Consensus 231 L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l 302 (752)
.+..+++|++|++++|.+++. ++..+...++|++|+|++|.+++... ..+..+
T Consensus 160 -------------------~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~ 220 (319)
T cd00116 160 -------------------ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASL 220 (319)
T ss_pred -------------------HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhccc
Confidence 123456788999999988842 33445566789999999988864322 233444
Q ss_pred cccCEEEccCCcCc
Q 041438 303 IYLNRISLSGNKLS 316 (752)
Q Consensus 303 ~~L~~L~Ls~N~l~ 316 (752)
++|+.|++++|.++
T Consensus 221 ~~L~~L~ls~n~l~ 234 (319)
T cd00116 221 KSLEVLNLGDNNLT 234 (319)
T ss_pred CCCCEEecCCCcCc
Confidence 55555555555554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-18 Score=186.00 Aligned_cols=231 Identities=26% Similarity=0.363 Sum_probs=170.0
Q ss_pred cccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC----------------------------CccccCCceEEEEEe
Q 041438 503 FDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~lV~E~ 554 (752)
|++.+.||.|+||.||++... ..+|+|.+...... .........++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 678899999999999999876 78888987643321 112233446999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC-ceEEeecccceeccCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY-EAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~-~~kl~DfG~a~~~~~~~ 633 (752)
+.++++.+++........++......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776543112477899999999999999999999 999999999999999888 79999999998665433
Q ss_pred C------CcccccCCCCccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCC-C
Q 041438 634 S------NWSKLAGTHGNVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLP-Y 703 (752)
Q Consensus 634 ~------~~~~~~gt~~y~aPE~~~~---~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~ 703 (752)
. ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||...... .........+.....+ .
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTLKIILELPTPSL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHhcCCccc
Confidence 2 2345689999999999887 57889999999999999999999997522110 0011111111111111 1
Q ss_pred CChhh----HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 704 PSLDV----QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 704 ~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..... ......+.+++.+|+..+|..|.++.+...+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 10000 1122467889999999999999998887765
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.2e-19 Score=172.56 Aligned_cols=226 Identities=20% Similarity=0.287 Sum_probs=164.3
Q ss_pred ccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEeccC
Q 041438 504 DAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 504 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
....+|.+...|+.|+|++. |..+++|++...... +.|..+....++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34567888999999999985 445555665422111 567778889999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcc
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
|+|+..+++... -..+..++.+++.+||+|++|||+. .|-|..-.+.+..|+||++.+++|+- +-+++.-.. .
T Consensus 272 gslynvlhe~t~-vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsfqe----~ 344 (448)
T KOG0195|consen 272 GSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQE----V 344 (448)
T ss_pred hHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeeeec----c
Confidence 999999987654 3367789999999999999999997 33344556889999999999888742 112211111 1
Q ss_pred cccCCCCccCccccccCCC---CCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 638 KLAGTHGNVAPELAYTMKV---TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~---~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
...-.+.||+||.+...+- -.++|+|||++++||+.|...||.....+. ..+......-+...| ++.+..
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme---cgmkialeglrv~ip----pgis~h 417 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME---CGMKIALEGLRVHIP----PGISRH 417 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh---hhhhhhhccccccCC----CCccHH
Confidence 1244689999999887654 357999999999999999999995322221 112222222233333 456677
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
+.+++.-|+..||.+||.++.++-.|+++.
T Consensus 418 m~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 418 MNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 889999999999999999999999999874
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.9e-19 Score=177.72 Aligned_cols=183 Identities=22% Similarity=0.252 Sum_probs=132.2
Q ss_pred cCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC--CCC--ceE
Q 041438 544 HPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD--LGY--EAH 619 (752)
Q Consensus 544 ~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~--~~~--~~k 619 (752)
++...|+||..++. +|.+++..+. .+.....-++.|+++|+.|||++ ||.|||+|++|||+. +|+ .+.
T Consensus 314 ~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LV 385 (598)
T KOG4158|consen 314 EPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLV 385 (598)
T ss_pred CCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEE
Confidence 45678999999988 9999997654 55577888999999999999999 999999999999984 444 368
Q ss_pred EeecccceeccCCC------CCcccccCCCCccCccccccCC------CCCccchhhHHHHHHHHHhCCCCcchhhcccc
Q 041438 620 VSDFRIAKFLNLDS------SNWSKLAGTHGNVAPELAYTMK------VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS 687 (752)
Q Consensus 620 l~DfG~a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~------~~~ksDIwSlGvil~elltg~~pf~~~~~~~~ 687 (752)
|+|||++-.-+... +......|.-.-||||+....+ --.|+|.|+.|.+.||+++...||..-.++--
T Consensus 386 vaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L 465 (598)
T KOG4158|consen 386 VADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL 465 (598)
T ss_pred EcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee
Confidence 89999875432211 1112346788899999876433 12589999999999999999999863111110
Q ss_pred ccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHh
Q 041438 688 SSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 741 (752)
....+....++.. .+.+++.+.+++...+++||.+|++..=....+.
T Consensus 466 ----~~r~Yqe~qLPal---p~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 466 ----DTRTYQESQLPAL---PSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred ----chhhhhhhhCCCC---cccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 1111222222221 1456678899999999999999998765555543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4e-20 Score=198.65 Aligned_cols=201 Identities=24% Similarity=0.321 Sum_probs=164.0
Q ss_pred eeccCCceEEEEEE----eCCCcEEEEEccCCCCCC---------------------------CccccCCceEEEEEecc
Q 041438 508 CIGKGGHGSVYIAR----VPSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 508 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~E~~~ 556 (752)
.+|+|.||.|+.++ ...|..||+|..++.... ..++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999999886 345778888887654322 12334567789999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW 636 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 636 (752)
+|++...+.+.. .+++.....+...++-|++++|+. +|+|||+|++||+++.+|++++.|||.++..-....
T Consensus 81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 999988776543 367788888999999999999999 999999999999999999999999999987653332
Q ss_pred ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHH
Q 041438 637 SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIM 716 (752)
Q Consensus 637 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 716 (752)
.+||..|||||++. ....++|.||||++++||+||..||.. +....+.......| ......+.
T Consensus 153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---------~~~~~Il~~~~~~p----~~l~~~a~ 215 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---------DTMKRILKAELEMP----RELSAEAR 215 (612)
T ss_pred --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---------HHHHHHhhhccCCc----hhhhHHHH
Confidence 28999999999988 567889999999999999999999862 55666777677776 45666788
Q ss_pred HHHHhccCcCCCCCCCH
Q 041438 717 QVAFSCLDQNPVSRPTM 733 (752)
Q Consensus 717 ~li~~cl~~dP~~Rps~ 733 (752)
+++.++...+|..|.-.
T Consensus 216 ~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 216 SLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHhhCHHHHhcc
Confidence 89999999999999755
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.2e-18 Score=198.18 Aligned_cols=230 Identities=21% Similarity=0.241 Sum_probs=173.6
Q ss_pred HHHHhhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCCCcc------------------------ccCCceEE
Q 041438 495 EIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPDNFC------------------------SHPRQSFI 550 (752)
Q Consensus 495 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~~l 550 (752)
+.......|.|.+.||+|+||+||+|...+|+.||+|+-+.+....++ .-.+..++
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 344456789999999999999999999878999999987766554221 22456789
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC-------CCCceEEeec
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD-------LGYEAHVSDF 623 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~-------~~~~~kl~Df 623 (752)
|+||.+.|+|.+++... +.++|..+..++.|+++-+++||.. +|||+||||+|.||. +...++|+||
T Consensus 772 v~ey~~~Gtlld~~N~~---~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTN---KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeccccccHHHhhccC---CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEec
Confidence 99999999999999833 3488999999999999999999999 999999999999994 2345899999
Q ss_pred ccceeccC--CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCC
Q 041438 624 RIAKFLNL--DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRL 701 (752)
Q Consensus 624 G~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 701 (752)
|.+-.+.. +.......++|-.+-.+|+..|..++..+|.|.++.++|.|+.|++.- ....... .+...
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q----~~~g~~~-----~~~~~- 915 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME----VKNGSSW-----MVKTN- 915 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH----hcCCcce-----ecccc-
Confidence 99976532 333455568899999999999999999999999999999999998751 0001110 11111
Q ss_pred CCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 702 PYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 702 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
+++....+.+..+.+ .+|+.|-..=|...++...++.+.
T Consensus 916 -~~Ry~~~~~W~~~F~---~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 916 -FPRYWKRDMWNKFFD---LLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred -chhhhhHHHHHHHHH---HHhCcCcccchhHHHHHHHHHHHH
Confidence 222233445555555 555555555588888888887653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.4e-19 Score=199.42 Aligned_cols=207 Identities=23% Similarity=0.334 Sum_probs=155.9
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-CccccCCceEEEEEeccCCChHHHhccCccccccCHH
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-NFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWT 576 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~ 576 (752)
...+|+.++.|..|+||.||.+++ .+.+.+|+|+=+..... +.....+..+.| ||-...++.-+ +++..
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~lilRnilt~a~npfvv------gDc~tllk~~g---~lPvd 151 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLILRNILTFAGNPFVV------GDCATLLKNIG---PLPVD 151 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccchhhhccccccCCccee------chhhhhcccCC---CCcch
Confidence 357899999999999999999985 46788999543333221 122222333333 45555554332 22222
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC---------------CcccccC
Q 041438 577 QRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS---------------NWSKLAG 641 (752)
Q Consensus 577 ~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~---------------~~~~~~g 641 (752)
++.+++|+|+. ||+|||+||+|.+|+.-|++|+.|||+++....... .....+|
T Consensus 152 --------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcg 220 (1205)
T KOG0606|consen 152 --------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCG 220 (1205)
T ss_pred --------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccC
Confidence 27899999999 999999999999999999999999999876422110 0123489
Q ss_pred CCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHHHh
Q 041438 642 THGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFS 721 (752)
Q Consensus 642 t~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 721 (752)
|+.|+|||++..+.|+..+|+|++|+|+||.+.|..||. .+..++....++.....++.. .....+++.+++.+
T Consensus 221 TPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpff-----Gdtpeelfg~visd~i~wpE~-dea~p~Ea~dli~~ 294 (1205)
T KOG0606|consen 221 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF-----GDTPEELFGQVISDDIEWPEE-DEALPPEAQDLIEQ 294 (1205)
T ss_pred CccccChhhhhhhccCCCccHHHHHHHHHHHheeeeecc-----CCCHHHHHhhhhhhhcccccc-CcCCCHHHHHHHHH
Confidence 999999999999999999999999999999999999985 445566666777666666654 45566789999999
Q ss_pred ccCcCCCCCC
Q 041438 722 CLDQNPVSRP 731 (752)
Q Consensus 722 cl~~dP~~Rp 731 (752)
.|+.+|.+|-
T Consensus 295 LL~qnp~~Rl 304 (1205)
T KOG0606|consen 295 LLRQNPLCRL 304 (1205)
T ss_pred HHHhChHhhc
Confidence 9999999995
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-18 Score=167.63 Aligned_cols=118 Identities=20% Similarity=0.267 Sum_probs=92.9
Q ss_pred ceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC---------------------------------C----------cc
Q 041438 506 KHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD---------------------------------N----------FC 542 (752)
Q Consensus 506 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------------~----------~~ 542 (752)
...||+|+||.||+|+..+|+.||||+++..... + ..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999779999999998643210 0 00
Q ss_pred ccC-----CceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHH-HhCCCCCeeecCCCCCCEEeCCCC
Q 041438 543 SHP-----RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYL-HNNCFPPIVHWDISSKNVLLDLGY 616 (752)
Q Consensus 543 ~~~-----~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~l-H~~~~~~ivH~DlKp~NIll~~~~ 616 (752)
..+ ...++||||++++++....... ..++..++..++.|++.+|+|+ |+. ||+||||||+||+++ ++
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CC
Confidence 001 2238999999998776543222 2478899999999999999999 688 999999999999998 47
Q ss_pred ceEEeecccceecc
Q 041438 617 EAHVSDFRIAKFLN 630 (752)
Q Consensus 617 ~~kl~DfG~a~~~~ 630 (752)
.++|+|||+|....
T Consensus 155 ~v~LiDFG~a~~~~ 168 (190)
T cd05147 155 KLYIIDVSQSVEHD 168 (190)
T ss_pred cEEEEEccccccCC
Confidence 89999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.2e-20 Score=164.97 Aligned_cols=119 Identities=34% Similarity=0.578 Sum_probs=68.8
Q ss_pred CCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEE
Q 041438 107 SFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHL 186 (752)
Q Consensus 107 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 186 (752)
.+.+++.|.||+|+++. +|+.++.|.+|+.|++++|+|+ ..|.+++.+++|++|+++-|++. ..|..|+.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~~-vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLTV-VPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCceee-cCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 34455566666666654 4555666666666666666665 44555666666666666666665 556666666666666
Q ss_pred EccCCCCC-CcCCcCccCCCcceEEeeccccccccccccccCcc
Q 041438 187 ILDSNFLG-GSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLK 229 (752)
Q Consensus 187 ~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 229 (752)
||..|++. ..+|..|..|+.|+.|+|++|.|. .+|..+++++
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt 150 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLT 150 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhc
Confidence 66666554 245555555555555555555554 3344443333
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.6e-17 Score=161.28 Aligned_cols=117 Identities=25% Similarity=0.365 Sum_probs=92.8
Q ss_pred ceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC---------------C------------------c----------c
Q 041438 506 KHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD---------------N------------------F----------C 542 (752)
Q Consensus 506 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------~------------------~----------~ 542 (752)
...||+|++|.||+|+..+|+.||||+++..... . + .
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5789999999999999778999999998754210 0 0 0
Q ss_pred ccC-----CceEEEEEeccCCChHHH-hccCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCEEeCCC
Q 041438 543 SHP-----RQSFIVYEYLESGSLDKI-LNNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHWDISSKNVLLDLG 615 (752)
Q Consensus 543 ~~~-----~~~~lV~E~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~ivH~DlKp~NIll~~~ 615 (752)
..+ ...++||||++++++... +.. ..++..+...++.|++.++.++|+ . ||+||||||+||+++ +
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence 000 123799999998755433 332 236778899999999999999999 8 999999999999999 7
Q ss_pred CceEEeecccceecc
Q 041438 616 YEAHVSDFRIAKFLN 630 (752)
Q Consensus 616 ~~~kl~DfG~a~~~~ 630 (752)
+.++|+|||+|....
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.2e-18 Score=165.88 Aligned_cols=157 Identities=13% Similarity=0.171 Sum_probs=114.9
Q ss_pred ccchHHHHHH--hhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC---------------------------
Q 041438 489 GKIVYEEIIR--ATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD--------------------------- 539 (752)
Q Consensus 489 ~~~~~~~~~~--~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------- 539 (752)
....|.++.. -.++|++.+.+|.|+||.||.+.. ++..+|||.++.....
T Consensus 17 ~~~~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~ 95 (232)
T PRK10359 17 NDNKYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSE 95 (232)
T ss_pred CcccHHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHC
Confidence 3333444443 257899999999999999999765 6778999998643221
Q ss_pred ------Cccc--------cCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC
Q 041438 540 ------NFCS--------HPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDI 605 (752)
Q Consensus 540 ------~~~~--------~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~Dl 605 (752)
.+.. .....++||||++|.+|.++.. ++. ....+++.++..+|+. |++|||+
T Consensus 96 GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Di 161 (232)
T PRK10359 96 GLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDP 161 (232)
T ss_pred CCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCC
Confidence 1111 1235789999999999988732 222 2456999999999999 9999999
Q ss_pred CCCCEEeCCCCceEEeecccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHH
Q 041438 606 SSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVI 673 (752)
Q Consensus 606 Kp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ell 673 (752)
||+||+++.++ ++++|||.......+... ..++....+..++||||||+++....
T Consensus 162 kp~Nili~~~g-i~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 162 HKGNFIVSKNG-LRIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ChHHEEEeCCC-EEEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999999888 999999988755322110 11344555778999999999876554
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.6e-19 Score=160.93 Aligned_cols=108 Identities=30% Similarity=0.444 Sum_probs=74.2
Q ss_pred CcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcce
Q 041438 129 ISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLV 208 (752)
Q Consensus 129 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 208 (752)
+-++++.+.|-||+|+++ .+|..+..|.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. +.|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 335667777888888887 45556788888888888888887 56777777777777777777777 6677777777777
Q ss_pred EEeeccccccc-cccccccCcccccccccccc
Q 041438 209 FLYLYNNSFSG-SIPQQIGNLKSLFDMKLCIN 239 (752)
Q Consensus 209 ~L~L~~N~l~~-~~p~~~~~l~~L~~l~l~~N 239 (752)
.|||+.|+++. .+|+.|..++.|..|+|+.|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dn 137 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDN 137 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCC
Confidence 77777777753 34444444444444443333
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.2e-16 Score=172.48 Aligned_cols=200 Identities=23% Similarity=0.392 Sum_probs=149.9
Q ss_pred CccccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCe-eecCCCCCCEEeCCCCce
Q 041438 540 NFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI-VHWDISSKNVLLDLGYEA 618 (752)
Q Consensus 540 ~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~i-vH~DlKp~NIll~~~~~~ 618 (752)
+.+-.....+.|.+||..|+|.+.+.... ..+++.-...++++|+.||+|+|.. +| +|+.+++.|.++|....+
T Consensus 14 g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s~nClvd~~w~l 88 (484)
T KOG1023|consen 14 GASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKSSNCLVDSRWVL 88 (484)
T ss_pred eeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeeccccceeeeeEEE
Confidence 34445588899999999999999998633 4588889999999999999999998 55 999999999999999999
Q ss_pred EEeecccceeccC--CCCCcccccCCCCccCccccccCC-------CCCccchhhHHHHHHHHHhCCCCcchhhcccccc
Q 041438 619 HVSDFRIAKFLNL--DSSNWSKLAGTHGNVAPELAYTMK-------VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS 689 (752)
Q Consensus 619 kl~DfG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~-------~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~ 689 (752)
|++|||+...... .........-..-|.|||.+.+.. .+.+.||||||++++|+++.+.||+........
T Consensus 89 klt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~- 167 (484)
T KOG1023|consen 89 KLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDP- 167 (484)
T ss_pred EechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCCh-
Confidence 9999999887642 111111123345799999887642 467899999999999999999999743322222
Q ss_pred ccchHhhhc-cCC-CCCChhhH-HHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 690 SNMNIEILD-SRL-PYPSLDVQ-NKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 690 ~~~~~~~~~-~~~-~~~~~~~~-~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
.+....+.+ ... ..|..... +..+++..++.+||..+|++||+++++-..++.+..
T Consensus 168 ~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 168 DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 223333333 221 22222212 444578999999999999999999999999887754
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.7e-16 Score=182.43 Aligned_cols=155 Identities=32% Similarity=0.486 Sum_probs=113.2
Q ss_pred CCCCHHHHHHHHHHHHccccCCccccCCCCccccCCCCCCCC-----cccceeeCCCCCEEEEEcCCCCCcccccccccC
Q 041438 32 SSNSTEEAHALVKWKASLEVHSRSLLHSWSLSFVNATKISLC-----TWSGIHCNHAGRVFGINLTSISLNGTLLEFSFS 106 (752)
Q Consensus 32 ~~~~~~~~~aLl~fk~~~~~~~~~~l~sW~~~~~~~~~~~~c-----~w~gv~C~~~~~v~~l~l~~~~l~g~l~~~~f~ 106 (752)
..+.+.|..||++||+++..+ . ..+|.. ++| .|.||.|......
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~-~--~~~W~g--------~~C~p~~~~w~Gv~C~~~~~~-------------------- 415 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLP-L--RFGWNG--------DPCVPQQHPWSGADCQFDSTK-------------------- 415 (623)
T ss_pred cccCchHHHHHHHHHHhcCCc-c--cCCCCC--------CCCCCcccccccceeeccCCC--------------------
Confidence 345678999999999998532 2 247851 334 7999999521100
Q ss_pred CCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEE
Q 041438 107 SFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHL 186 (752)
Q Consensus 107 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 186 (752)
....++.|+|++|.+.+.+|..|+++++|+.|+|++|+++|.+|..++.+++|+.|+|++|+|+|.+|..++++++|+.|
T Consensus 416 ~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L 495 (623)
T PLN03150 416 GKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRIL 495 (623)
T ss_pred CceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEE
Confidence 00124567777777777788888888888888888888888888888888888888888888888888888888888888
Q ss_pred EccCCCCCCcCCcCccCC-CcceEEeeccccc
Q 041438 187 ILDSNFLGGSIPRSLSNF-TNLVFLYLYNNSF 217 (752)
Q Consensus 187 ~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l 217 (752)
+|++|+++|.+|..+.++ .++..+++.+|..
T Consensus 496 ~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~ 527 (623)
T PLN03150 496 NLNGNSLSGRVPAALGGRLLHRASFNFTDNAG 527 (623)
T ss_pred ECcCCcccccCChHHhhccccCceEEecCCcc
Confidence 888888888888777653 3566777777753
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.1e-16 Score=148.76 Aligned_cols=161 Identities=13% Similarity=0.095 Sum_probs=116.8
Q ss_pred ccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEeccC
Q 041438 504 DAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 504 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
.+...|++|+||+||.+.. .+..++.+.+...... .... -...+++|||+.|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~-~~~~~lvmeyI~G 82 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLH-WDGRHLDRSYLAG 82 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEE-EcCEEEEEeeecC
Confidence 4578899999999998766 6677776655432110 1111 1346999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC-CCCCEEeCCCCceEEeecccceeccCCCCC-
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDI-SSKNVLLDLGYEAHVSDFRIAKFLNLDSSN- 635 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~Dl-Kp~NIll~~~~~~kl~DfG~a~~~~~~~~~- 635 (752)
.+|.+.... ....++.|++.+|+++|+. ||+|||| ||+||+++.++.++|+|||+|.........
T Consensus 83 ~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 83 AAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 888654321 1135788999999999999 9999999 799999999999999999999865433210
Q ss_pred ---c---------ccccCCCCccCccccccC-CCC-CccchhhHHHHHHHHHhCCCCc
Q 041438 636 ---W---------SKLAGTHGNVAPELAYTM-KVT-EKCDVYSFGVLALEVIKGKHPR 679 (752)
Q Consensus 636 ---~---------~~~~gt~~y~aPE~~~~~-~~~-~ksDIwSlGvil~elltg~~pf 679 (752)
. .....++.|++|+...-. ..+ .+.++++-|+-+|.++|+..|+
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 0 012357788888753322 223 5678999999999999999985
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-15 Score=154.27 Aligned_cols=127 Identities=20% Similarity=0.231 Sum_probs=99.3
Q ss_pred HHHhhcccccceeeccCCceEEEEEE--eCCCcEEEEEccCCCCCC----------------------------------
Q 041438 496 IIRATNDFDAKHCIGKGGHGSVYIAR--VPSGEIFAVKKFHSPLPD---------------------------------- 539 (752)
Q Consensus 496 ~~~~~~~y~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~---------------------------------- 539 (752)
+......|++.+.||+|+||.||+|. ..+|+.||||+++.....
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 33344458899999999999999998 578999999988643210
Q ss_pred -------------CccccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCC-eeecCC
Q 041438 540 -------------NFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP-IVHWDI 605 (752)
Q Consensus 540 -------------~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~-ivH~Dl 605 (752)
... .....++||||++++++........ .+...++..++.|++.+++++|+. | |+||||
T Consensus 103 ~L~~L~~~~i~~p~~~-~~~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Di 175 (237)
T smart00090 103 NLQRLYEAGVPVPKPI-AWRRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKE---GELVHGDL 175 (237)
T ss_pred HHHHHHhcCCCCCeee-EecCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCC
Confidence 000 1124589999999988876543222 245567789999999999999999 9 999999
Q ss_pred CCCCEEeCCCCceEEeecccceecc
Q 041438 606 SSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 606 Kp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||+||+++ ++.++|+|||.|....
T Consensus 176 kp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 176 SEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred ChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999999 7899999999987543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.1e-15 Score=147.01 Aligned_cols=125 Identities=18% Similarity=0.202 Sum_probs=98.5
Q ss_pred HHHHHhhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC----------------------------------
Q 041438 494 EEIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD---------------------------------- 539 (752)
Q Consensus 494 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------------- 539 (752)
+++.+....|.+.+.||+|+||.||+|..++|+.||||+++.....
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 4455555558889999999999999999888999999975432100
Q ss_pred ----Cc------cccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCC
Q 041438 540 ----NF------CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKN 609 (752)
Q Consensus 540 ----~~------~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~N 609 (752)
.. .......++||||+++++|.+.... .....++.+++.++.++|+. ||+||||||+|
T Consensus 88 ~~l~~~~i~v~~~~~~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~N 155 (198)
T cd05144 88 KALYEEGFPVPKPIDWNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFN 155 (198)
T ss_pred HHHHHcCCCCCceeecCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCccc
Confidence 00 0012356899999999998765421 33467889999999999999 99999999999
Q ss_pred EEeCCCCceEEeecccceecc
Q 041438 610 VLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 610 Ill~~~~~~kl~DfG~a~~~~ 630 (752)
|++++++.++|+|||.+....
T Consensus 156 ill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EEEcCCCcEEEEECCccccCC
Confidence 999999999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=3e-14 Score=139.45 Aligned_cols=116 Identities=22% Similarity=0.276 Sum_probs=87.9
Q ss_pred ceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----Ccc--------------------------------------
Q 041438 506 KHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----NFC-------------------------------------- 542 (752)
Q Consensus 506 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~-------------------------------------- 542 (752)
.+.||+|+||.||+|+..+++.||||+++..... .+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 5679999999999999878999999987643211 000
Q ss_pred ---ccCCceEEEEEeccCCChHH-HhccCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCEEeCCCCc
Q 041438 543 ---SHPRQSFIVYEYLESGSLDK-ILNNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHWDISSKNVLLDLGYE 617 (752)
Q Consensus 543 ---~~~~~~~lV~E~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~ivH~DlKp~NIll~~~~~ 617 (752)
......++||||++++++.. .+.... .. .....++.+++.++.++|. . +|+||||||+||+++ ++.
T Consensus 82 ~~~~~~~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 82 PKPIDLNRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CceEecCCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CCc
Confidence 00124579999999955431 111111 11 5678899999999999999 8 999999999999999 889
Q ss_pred eEEeecccceecc
Q 041438 618 AHVSDFRIAKFLN 630 (752)
Q Consensus 618 ~kl~DfG~a~~~~ 630 (752)
++++|||.+....
T Consensus 153 ~~liDfg~a~~~~ 165 (187)
T cd05119 153 VYIIDVPQAVEID 165 (187)
T ss_pred EEEEECccccccc
Confidence 9999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.1e-14 Score=140.73 Aligned_cols=110 Identities=24% Similarity=0.420 Sum_probs=90.7
Q ss_pred eeeccCCceEEEEEEeCCCcEEEEEccCCCCCC--------------------------------CccccCCceEEEEEe
Q 041438 507 HCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD--------------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------------~~~~~~~~~~lV~E~ 554 (752)
+.||+|++|.||+|+. .|..|++|+....... .++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6778999975432110 223345667899999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
++|++|.+++.... . .+..++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986432 1 7889999999999999999 999999999999999 78899999998864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=4.4e-15 Score=168.32 Aligned_cols=229 Identities=21% Similarity=0.295 Sum_probs=168.2
Q ss_pred hcccccceeeccCCceEEEEEEe--CCCcEEEEEccCCCCCC---------------------------CccccCCceEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV--PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFI 550 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~l 550 (752)
...|.+.+.||+|+|+.|-.+.. .....+|+|.+...... +...+++..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 34577788899999999988874 33455666665443211 23345677899
Q ss_pred EEEeccCCChHHHh-ccCccccccCHHHHHHHHHHHHHHHHHHH-hCCCCCeeecCCCCCCEEeCCCC-ceEEeecccce
Q 041438 551 VYEYLESGSLDKIL-NNDASAKELGWTQRLNVIKGVADALFYLH-NNCFPPIVHWDISSKNVLLDLGY-EAHVSDFRIAK 627 (752)
Q Consensus 551 V~E~~~~g~L~~~l-~~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~~~~ivH~DlKp~NIll~~~~-~~kl~DfG~a~ 627 (752)
++||..++++.+.+ .... ...+......++.|+..++.|+| .. ++.|||+||+|.+++..+ ..+++|||+|.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 99999999999888 4332 13566778899999999999999 77 999999999999999999 99999999998
Q ss_pred eccC-CCCC--cccccC-CCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCC
Q 041438 628 FLNL-DSSN--WSKLAG-THGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLP 702 (752)
Q Consensus 628 ~~~~-~~~~--~~~~~g-t~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 702 (752)
.+.. .+.. ....+| ++.|+|||...+.. ..+..|+||.|+++.-+++|..||+....... ....+...+..
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~----~~~~~~~~~~~ 249 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG----RYSSWKSNKGR 249 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc----cceeecccccc
Confidence 8765 2221 233578 99999999988854 57889999999999999999999864332221 11112222111
Q ss_pred CCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHH
Q 041438 703 YPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFE 737 (752)
Q Consensus 703 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 737 (752)
.....+........+++.+++..+|..|.+.+++-
T Consensus 250 ~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 250 FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccCccccCChhhhhcccccccCCchhcccccccc
Confidence 11122345556778899999999999999988765
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.50 E-value=7.1e-14 Score=138.30 Aligned_cols=106 Identities=22% Similarity=0.391 Sum_probs=85.6
Q ss_pred eeccCCceEEEEEEeCCCcEEEEEccCCCCCC--------------------------------CccccCCceEEEEEec
Q 041438 508 CIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD--------------------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 508 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------------~~~~~~~~~~lV~E~~ 555 (752)
.||+|+||.||+|.. ++..|++|........ .+.......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 6788999985432100 1122345568999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
+|++|.+++.... . .++.|++.+|.++|+. +++|||+||.||+++ ++.++++|||.+..
T Consensus 80 ~g~~l~~~~~~~~-------~---~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-------D---ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-------H---HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875321 1 7899999999999999 999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.4e-15 Score=157.80 Aligned_cols=193 Identities=30% Similarity=0.468 Sum_probs=120.9
Q ss_pred EECCCCcccccCCccC-cCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCC
Q 041438 114 LDLYNNELFDIIPPQI-SNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNF 192 (752)
Q Consensus 114 L~L~~n~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 192 (752)
|.|++-++....-+++ -.|+--...||+.|++. .+|..+..+..|+.|.|.+|.|. .+|..+.++..|++|||+.|+
T Consensus 55 l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~Nq 132 (722)
T KOG0532|consen 55 LLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQ 132 (722)
T ss_pred cccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccch
Confidence 3344444443322222 34555567777778777 66777777777888888888877 677778888888888888888
Q ss_pred CCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCC
Q 041438 193 LGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIP 272 (752)
Q Consensus 193 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 272 (752)
++ ..|..++.|+ |+.|-+++|+++ .+|+.++.+..|.. ||.+.|++. .+|
T Consensus 133 lS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~--------------------------ld~s~nei~-slp 182 (722)
T KOG0532|consen 133 LS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAH--------------------------LDVSKNEIQ-SLP 182 (722)
T ss_pred hh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHH--------------------------hhhhhhhhh-hch
Confidence 87 5666666666 778888888877 55666654444443 444444443 344
Q ss_pred cccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeecccccccc
Q 041438 273 FEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSN 341 (752)
Q Consensus 273 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 341 (752)
..++.+.+|+.|.+..|.+. .+|..+.. -.|.+||+|.|+++ .+|-.|..++.|++|-|.+|.|+.
T Consensus 183 sql~~l~slr~l~vrRn~l~-~lp~El~~-LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 183 SQLGYLTSLRDLNVRRNHLE-DLPEELCS-LPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred HHhhhHHHHHHHHHhhhhhh-hCCHHHhC-CceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC
Confidence 45555566666666666655 33444442 24566666666665 556666666666666666666665
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.7e-13 Score=156.19 Aligned_cols=116 Identities=21% Similarity=0.342 Sum_probs=88.5
Q ss_pred HhhcccccceeeccCCceEEEEEEeCCCcEEEEEc-cCCCCCC-------------------------------CccccC
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKK-FHSPLPD-------------------------------NFCSHP 545 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~-------------------------------~~~~~~ 545 (752)
.....|...+.||+|+||.||+|...... +++|+ +.+.... .++...
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 34455677899999999999999864443 33332 2111000 122234
Q ss_pred CceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccc
Q 041438 546 RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRI 625 (752)
Q Consensus 546 ~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~ 625 (752)
...++||||+++++|.+++. ....++.|++++|.|+|+. +++||||||+||++ +++.++|+|||+
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcc
Confidence 56789999999999998874 3467899999999999999 99999999999999 577999999999
Q ss_pred ceec
Q 041438 626 AKFL 629 (752)
Q Consensus 626 a~~~ 629 (752)
++..
T Consensus 474 a~~~ 477 (535)
T PRK09605 474 GKYS 477 (535)
T ss_pred cccC
Confidence 9753
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.9e-13 Score=132.48 Aligned_cols=112 Identities=16% Similarity=0.188 Sum_probs=79.5
Q ss_pred ccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------------CccccC---CceE-E
Q 041438 504 DAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------------NFCSHP---RQSF-I 550 (752)
Q Consensus 504 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------------~~~~~~---~~~~-l 550 (752)
.-.+.||+|+||.||. .+.....+||++...... ++.+++ +..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3467899999999996 433333479987643110 222222 2333 7
Q ss_pred EEEe--ccCCChHHHhccCccccccCHHHHHHHHHHHHHHH-HHHHhCCCCCeeecCCCCCCEEeCC----CCceEEeec
Q 041438 551 VYEY--LESGSLDKILNNDASAKELGWTQRLNVIKGVADAL-FYLHNNCFPPIVHWDISSKNVLLDL----GYEAHVSDF 623 (752)
Q Consensus 551 V~E~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL-~~lH~~~~~~ivH~DlKp~NIll~~----~~~~kl~Df 623 (752)
|||| +.+|+|.+++.+.. +++. ..++.|++.++ +|||++ +|+||||||+||+++. +..++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 55899999996532 4444 35688888888 999999 9999999999999974 347999995
Q ss_pred ccc
Q 041438 624 RIA 626 (752)
Q Consensus 624 G~a 626 (752)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.2e-14 Score=153.86 Aligned_cols=182 Identities=30% Similarity=0.432 Sum_probs=150.4
Q ss_pred CCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcE
Q 041438 106 SSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNH 185 (752)
Q Consensus 106 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 185 (752)
-.+......||+.|++.. +|..+..+..|+.|.|++|.|. .+|..+.+|..|++|||+.|+++ ..|..+..|+ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~e-lp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFSE-LPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhcccccccc-CchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 356667789999999977 6888999999999999999998 78999999999999999999999 7888888887 999
Q ss_pred EEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEcccc
Q 041438 186 LILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSIN 265 (752)
Q Consensus 186 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N 265 (752)
|.+++|+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|.+..|++....+.- . .-.|..||+|.|
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El---~-~LpLi~lDfScN 221 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEEL---C-SLPLIRLDFSCN 221 (722)
T ss_pred EEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHH---h-CCceeeeecccC
Confidence 999999999 67888999999999999999998 67889999999999999999887543321 1 224667777777
Q ss_pred ccCCCCCcccCCCCCCCEEecCCCcCcCCCCccc
Q 041438 266 NITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQL 299 (752)
Q Consensus 266 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 299 (752)
+++ .+|-.|..|..|++|-|.+|.++ ..|..+
T Consensus 222 kis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqI 253 (722)
T KOG0532|consen 222 KIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQI 253 (722)
T ss_pred cee-ecchhhhhhhhheeeeeccCCCC-CChHHH
Confidence 776 56777777777777777777776 344433
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.3e-13 Score=148.47 Aligned_cols=198 Identities=41% Similarity=0.569 Sum_probs=99.5
Q ss_pred eeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCC-CCcEEEccCCCCCCcCCcCccCCCcceEEeeccc
Q 041438 137 YLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLN-FLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNN 215 (752)
Q Consensus 137 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 215 (752)
.|+++.|.+... ...+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 455555555322 222344455666666666665 3444444443 5556666666555 33344555555555555555
Q ss_pred cccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCC
Q 041438 216 SFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEI 295 (752)
Q Consensus 216 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 295 (752)
+++. +|...+.+ ++|+.|++++|+++ .+|.....+..|++|++++|.+. ..
T Consensus 174 ~l~~-l~~~~~~~--------------------------~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~ 224 (394)
T COG4886 174 DLSD-LPKLLSNL--------------------------SNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-EL 224 (394)
T ss_pred hhhh-hhhhhhhh--------------------------hhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ec
Confidence 5552 22222222 33444444444444 23333233344555555555322 33
Q ss_pred CccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccch
Q 041438 296 PTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPI 369 (752)
Q Consensus 296 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 369 (752)
+..+.++.++..+.+++|++.. .+..++.++++++|++++|.++.+.. ++.+.+++.|++++|.+....|.
T Consensus 225 ~~~~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 225 LSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred chhhhhcccccccccCCceeee-ccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchh
Confidence 4445555555555555555542 24455555556666666666655443 55556666666666666544443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.3e-13 Score=148.54 Aligned_cols=200 Identities=36% Similarity=0.469 Sum_probs=140.5
Q ss_pred EEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCccccccc-ccceeeccCcccCCCCCcccCCCCCCcEEEccCC
Q 041438 113 YLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLT-HLTILHISRNQLNGSIPHEVGQLNFLNHLILDSN 191 (752)
Q Consensus 113 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 191 (752)
.|+++.|.+.. ....+..++.++.|++.+|.++ .+|.....++ +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 58888888743 2345566688999999999999 4555566674 9999999999998 56678899999999999999
Q ss_pred CCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCC
Q 041438 192 FLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNI 271 (752)
Q Consensus 192 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 271 (752)
+++ .+|...+.+++|+.|++++|+++ .+|...+.+..|.++.+++ |.+. ..
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~--------------------------N~~~-~~ 224 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSN--------------------------NSII-EL 224 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcC--------------------------Ccce-ec
Confidence 999 45655558899999999999998 4454443334454444444 4321 23
Q ss_pred CcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhh
Q 041438 272 PFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESL 347 (752)
Q Consensus 272 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 347 (752)
+..+..+.++..|.+.+|++. ..+..++++++++.|++++|+++...+ ++.+.+++.|++++|.+....+...
T Consensus 225 ~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 225 LSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred chhhhhcccccccccCCceee-eccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhh
Confidence 444555666666666666665 235566666677777777777764433 6777777777777777776655443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.33 E-value=3.1e-12 Score=140.85 Aligned_cols=117 Identities=19% Similarity=0.241 Sum_probs=90.0
Q ss_pred ceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC----------------------------------------------
Q 041438 506 KHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD---------------------------------------------- 539 (752)
Q Consensus 506 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------------------------- 539 (752)
.+.||+|++|.||+|+..+|+.||||+.++....
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 3689999999999999999999999987654211
Q ss_pred -----------------------CccccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHH-HHHHHHhC
Q 041438 540 -----------------------NFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVAD-ALFYLHNN 595 (752)
Q Consensus 540 -----------------------~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~-aL~~lH~~ 595 (752)
.+.......++||||++|+++.++...... .. ....++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 000112345799999999999887643211 11 23456666666 47889998
Q ss_pred CCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 596 CFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 596 ~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
|++|+|+||.||+++.++.++++|||++..+.
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999998775
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.31 E-value=7e-12 Score=117.60 Aligned_cols=113 Identities=21% Similarity=0.294 Sum_probs=90.0
Q ss_pred cceeeccCCceEEEEEEeCCCcEEEEEccCCCCC--C----------------------CccccCCceEEEEEeccCCCh
Q 041438 505 AKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLP--D----------------------NFCSHPRQSFIVYEYLESGSL 560 (752)
Q Consensus 505 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~----------------------~~~~~~~~~~lV~E~~~~g~L 560 (752)
+.+.||+|.++.||+++..+ ..+++|....... . .+....+..+++|||++++.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 45789999999999999744 7899998876542 1 111223468999999998766
Q ss_pred HHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 561 DKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 561 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
..+ +......++.+++++++++|.....+++|+|+||+||++++.+.++++|||.+..
T Consensus 81 ~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 543 3466678899999999999986434799999999999999988999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.3e-12 Score=126.30 Aligned_cols=189 Identities=22% Similarity=0.271 Sum_probs=127.4
Q ss_pred cccCCceEEEEEeccCCChHHHhccCcc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEE
Q 041438 542 CSHPRQSFIVYEYLESGSLDKILNNDAS-AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV 620 (752)
Q Consensus 542 ~~~~~~~~lV~E~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl 620 (752)
+.+..+..++.|||..|++..++++... ...+....-.+|+.||..||.|||+ |.|.|+|+++..+-|++..++-+|+
T Consensus 141 ~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~PpiihgnlTc~tifiq~ngLIki 219 (458)
T KOG1266|consen 141 YEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPIIHGNLTCDTIFIQHNGLIKI 219 (458)
T ss_pred cccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCccccCCcchhheeecCCceEEe
Confidence 3345667889999999999999986433 3446777788999999999999998 5889999999999999998888886
Q ss_pred eecccceeccC----CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhh
Q 041438 621 SDFRIAKFLNL----DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEI 696 (752)
Q Consensus 621 ~DfG~a~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 696 (752)
.--.-...... .........+-++|.|||.-.....+.++|||+||....||..+..--.. ..........+
T Consensus 220 g~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tn----seS~~~~ee~i 295 (458)
T KOG1266|consen 220 GSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTN----SESKVEVEENI 295 (458)
T ss_pred cccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCC----Ccceeehhhhh
Confidence 43111100000 00001112467899999987767778899999999999999887654210 00000000111
Q ss_pred hccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 697 LDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
....+... ...-.+.+.+|++..|..||+|++++.|.-.
T Consensus 296 a~~i~~le-------n~lqr~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 296 ANVIIGLE-------NGLQRGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred hhheeecc-------CccccCcCcccccCCCCCCcchhhhhcCcee
Confidence 11000000 0012357889999999999999999877543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.5e-11 Score=124.64 Aligned_cols=111 Identities=18% Similarity=0.303 Sum_probs=82.6
Q ss_pred eeec-cCCceEEEEEEeCCCcEEEEEccCCCCC----------C---------------------C--------ccc-cC
Q 041438 507 HCIG-KGGHGSVYIARVPSGEIFAVKKFHSPLP----------D---------------------N--------FCS-HP 545 (752)
Q Consensus 507 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------~---------------------~--------~~~-~~ 545 (752)
..|| .|+.|+||.+... +..+|||++..... . + +.. ..
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4677 7888999998774 77889987743110 0 0 001 11
Q ss_pred C---ceEEEEEeccC-CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEe
Q 041438 546 R---QSFIVYEYLES-GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVS 621 (752)
Q Consensus 546 ~---~~~lV~E~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~ 621 (752)
. ..++||||+++ .+|.+++... .++.. .+.|++.++.+||+. ||+||||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence 1 22599999997 6898888642 23333 367899999999999 99999999999999988899999
Q ss_pred ecccceec
Q 041438 622 DFRIAKFL 629 (752)
Q Consensus 622 DfG~a~~~ 629 (752)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99998753
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.9e-11 Score=132.16 Aligned_cols=120 Identities=18% Similarity=0.200 Sum_probs=85.3
Q ss_pred hcccccceeeccCCceEEEEEEeCC-CcEEEEEccCCCCCC---------------------------------------
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPS-GEIFAVKKFHSPLPD--------------------------------------- 539 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--------------------------------------- 539 (752)
-.+|+. +.||+|++|.||+|+.++ |+.||||+.++....
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345766 789999999999999876 999999998754210
Q ss_pred -----------------Ccccc-------------CCceEEEEEeccCCChHHHh--ccCc-cccccCHHHHHHHHHHHH
Q 041438 540 -----------------NFCSH-------------PRQSFIVYEYLESGSLDKIL--NNDA-SAKELGWTQRLNVIKGVA 586 (752)
Q Consensus 540 -----------------~~~~~-------------~~~~~lV~E~~~~g~L~~~l--~~~~-~~~~l~~~~~~~i~~qi~ 586 (752)
..+.+ ....++||||+.|+.+.++- ...+ ....+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 00111 23446999999999998742 2222 11123333444444444
Q ss_pred HHHHHHHhCCCCCeeecCCCCCCEEeCCCC----ceEEeecccceecc
Q 041438 587 DALFYLHNNCFPPIVHWDISSKNVLLDLGY----EAHVSDFRIAKFLN 630 (752)
Q Consensus 587 ~aL~~lH~~~~~~ivH~DlKp~NIll~~~~----~~kl~DfG~a~~~~ 630 (752)
+.. |++|+|+||.||+++.++ .++++|||++..++
T Consensus 277 ------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 ------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 346 999999999999999888 89999999998764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.4e-11 Score=133.53 Aligned_cols=223 Identities=25% Similarity=0.227 Sum_probs=159.2
Q ss_pred cccccceeecc--CCceEEEEEEe---CCCcEEEEEccCCCCCC---------------------------CccccCCce
Q 041438 501 NDFDAKHCIGK--GGHGSVYIARV---PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQS 548 (752)
Q Consensus 501 ~~y~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~ 548 (752)
..|.+.+.+|. |.+|.||.++. .++..+|+|+-+.+... ......+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34566788999 99999999985 56889999985443221 223455778
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHH----HHHHHHhCCCCCeeecCCCCCCEEeCCC-CceEEeec
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVAD----ALFYLHNNCFPPIVHWDISSKNVLLDLG-YEAHVSDF 623 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~----aL~~lH~~~~~~ivH~DlKp~NIll~~~-~~~kl~Df 623 (752)
|+-+|+|. .++..+..... ..++....+.+..+... |+.++|+. +++|-|+||+||+...+ ...++.||
T Consensus 194 fiqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 89999996 48877776543 23566788888888888 99999999 99999999999999988 88999999
Q ss_pred ccceeccCCCCCccc-----ccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc
Q 041438 624 RIAKFLNLDSSNWSK-----LAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD 698 (752)
Q Consensus 624 G~a~~~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 698 (752)
|....+......... ..|...|++||... .-++.++|||++|.++.+..++..+...... . .......
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-~--~W~~~r~--- 340 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN-S--SWSQLRQ--- 340 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC-C--Ccccccc---
Confidence 999888755422211 25778899999654 4578899999999999999998777531100 0 0000000
Q ss_pred cCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 041438 699 SRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEV 738 (752)
Q Consensus 699 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 738 (752)
.+ .+.........++...+.+|++.+|-.|++++.+..
T Consensus 341 -~~-ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 341 -GY-IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -cc-CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00 111111223344556888999999999999877653
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.9e-11 Score=140.98 Aligned_cols=119 Identities=30% Similarity=0.473 Sum_probs=100.7
Q ss_pred cccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEcc
Q 041438 352 KLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDIS 431 (752)
Q Consensus 352 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls 431 (752)
.++.|+|++|.++|.+|..+..+++|+.|+|++|.+.+.+|..++.+++|+.|+|++|+++|.+|..+..+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccCcCCCCccc--CCCCcccccCCCCCCCCccccccccc
Q 041438 432 YNKLEGHIPNSTTF--RDAPLEALQGNKGLCGDIRGFLSCMS 471 (752)
Q Consensus 432 ~N~l~~~~p~~~~~--~~~~~~~~~~n~~~c~~~~~~~~c~~ 471 (752)
+|+++|.+|....- .......+.+|+++|+.+ ++..|..
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p-~l~~C~~ 539 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP-GLRACGP 539 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCC-CCCCCcc
Confidence 99999999874321 223345688999999843 3556764
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.3e-12 Score=139.99 Aligned_cols=247 Identities=30% Similarity=0.314 Sum_probs=132.8
Q ss_pred CCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEE
Q 041438 107 SFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHL 186 (752)
Q Consensus 107 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 186 (752)
.+..++.++++.|.|.. +-..+..+++|+.|+|.+|+|..+.. .+..+++|++|+|++|.|+.+. .+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhccc-chhhhhcchheecccccccccc--chhhccchhhh
Confidence 45556666667776654 23346666777777777777764432 2556677777777777776442 34455557777
Q ss_pred EccCCCCCCcCCcCccCCCcceEEeecccccccccc-ccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEcccc
Q 041438 187 ILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIP-QQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSIN 265 (752)
Q Consensus 187 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N 265 (752)
++++|.|+.. ..+..+++|+.+++++|++....+ . ...+.+++.+++.+|.+.....
T Consensus 146 ~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~~------------------- 203 (414)
T KOG0531|consen 146 NLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIEG------------------- 203 (414)
T ss_pred eeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcccc-------------------
Confidence 7777776632 334556667777777777664433 1 3444555555555555442211
Q ss_pred ccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCc--ccCEEEccCCcCcccCCcccCCCcccceeecccccccccc
Q 041438 266 NITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNII--YLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFV 343 (752)
Q Consensus 266 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 343 (752)
+..+..+..+++..|.++..-+ +..+. .|+.+++++|.+.. .+..+..+.++..|++++|++....
T Consensus 204 ---------~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~~ 271 (414)
T KOG0531|consen 204 ---------LDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNLE 271 (414)
T ss_pred ---------hHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCcccc-ccccccccccccccchhhccccccc
Confidence 1222223333444444432211 11111 25555555555542 2244555566666666666665532
Q ss_pred chhhcccccccEEEcCCCcCccc---cchh-ccccccCCeeecCCccCCCCCCc
Q 041438 344 LESLGSLVKLYYLNLSHNKLSQQ---IPIE-LDNLIHLSELDLSHNFLGEKISS 393 (752)
Q Consensus 344 ~~~~~~l~~L~~L~Ls~N~l~~~---~p~~-~~~l~~L~~L~Ls~N~l~~~~~~ 393 (752)
.+.....+..+.++.|++... .... ......++.+.+..|.+....+.
T Consensus 272 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
T KOG0531|consen 272 --GLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISSL 323 (414)
T ss_pred --cccccchHHHhccCcchhcchhhhhccccccccccccccccccCcccccccc
Confidence 234445555666666665421 1111 45566777777777777665443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.7e-11 Score=131.35 Aligned_cols=227 Identities=21% Similarity=0.255 Sum_probs=161.9
Q ss_pred HhhcccccceeeccCCceEEEEEEe--CCCcEEEEEccCCCCCC---------------------------CccccCCce
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARV--PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQS 548 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~ 548 (752)
....+|..+..||.|.|+.|+++.. .++..|++|.+...... ..+...+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3467888899999999999999873 57889999987654322 112234566
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC-CceEEeecccce
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG-YEAHVSDFRIAK 627 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~-~~~kl~DfG~a~ 627 (752)
|+--|||++++...... ....+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.+.
T Consensus 342 ~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccc
Confidence 78999999988776552 234477788999999999999999999 99999999999999876 788999999987
Q ss_pred eccCCCCCcccccCCCCc-cCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCCh
Q 041438 628 FLNLDSSNWSKLAGTHGN-VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706 (752)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (752)
.+.-. ......++..| .+|+......+..+.|+||||..+.|.+++..--. .......+.....+...
T Consensus 416 ~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~--------~~~~~~~i~~~~~p~~~- 484 (524)
T KOG0601|consen 416 RLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE--------SGVQSLTIRSGDTPNLP- 484 (524)
T ss_pred cccee--cccccccccccccchhhccccccccccccccccccccccccCcccCc--------ccccceeeecccccCCC-
Confidence 43211 11111233444 35666667778899999999999999999876521 11112222233333221
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
....++..+.+.+..+++..||.+.+...+.+..+
T Consensus 485 ---~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 485 ---GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ---chHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 22245667777899999999999998887766544
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.8e-12 Score=139.59 Aligned_cols=215 Identities=30% Similarity=0.240 Sum_probs=96.8
Q ss_pred CCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEcc
Q 041438 110 HLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILD 189 (752)
Q Consensus 110 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 189 (752)
.++.++...+.+....-. ...+..++.+++..|.|.. +-..+..+++|+.|++.+|+|..+ ...+..+++|++|+|+
T Consensus 50 ~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls 126 (414)
T KOG0531|consen 50 DLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLS 126 (414)
T ss_pred hhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheecc
Confidence 444455555444322111 1344455555555555553 222344555555555555555522 2224444455555555
Q ss_pred CCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCC
Q 041438 190 SNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITG 269 (752)
Q Consensus 190 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 269 (752)
+|+|+.+. .+..++.|+.|++++|.|+. .. .+..++.|+.+++++|.++.
T Consensus 127 ~N~I~~i~--~l~~l~~L~~L~l~~N~i~~------------------------~~----~~~~l~~L~~l~l~~n~i~~ 176 (414)
T KOG0531|consen 127 FNKITKLE--GLSTLTLLKELNLSGNLISD------------------------IS----GLESLKSLKLLDLSYNRIVD 176 (414)
T ss_pred cccccccc--chhhccchhhheeccCcchh------------------------cc----CCccchhhhcccCCcchhhh
Confidence 55554332 23334444444444444442 11 11224455566666666654
Q ss_pred CCC-cccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcc--cceeeccccccccccchh
Q 041438 270 NIP-FEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLIN--LEYLDLSANHLSNFVLES 346 (752)
Q Consensus 270 ~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~Ls~N~l~~~~~~~ 346 (752)
..+ . ...+.+++.+++.+|.+... ..+..+..+..+++..|.++..-+ +..+.. |+.+++++|.+.... ..
T Consensus 177 ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~~~-~~ 250 (414)
T KOG0531|consen 177 IENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRISRSP-EG 250 (414)
T ss_pred hhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCcccccc-cc
Confidence 433 2 34556666666666666422 223333334444555555542211 111222 455555555554421 23
Q ss_pred hcccccccEEEcCCCcC
Q 041438 347 LGSLVKLYYLNLSHNKL 363 (752)
Q Consensus 347 ~~~l~~L~~L~Ls~N~l 363 (752)
+..+..+..|++++|++
T Consensus 251 ~~~~~~l~~l~~~~n~~ 267 (414)
T KOG0531|consen 251 LENLKNLPVLDLSSNRI 267 (414)
T ss_pred ccccccccccchhhccc
Confidence 33444444444444444
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.4e-11 Score=116.84 Aligned_cols=85 Identities=32% Similarity=0.366 Sum_probs=20.1
Q ss_pred CcCCCCCCeeecCCCcccccCCcccc-cccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCc-cCCCc
Q 041438 129 ISNLSKLEYLDFLTNKLSGHIPSEIS-LLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSL-SNFTN 206 (752)
Q Consensus 129 ~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~ 206 (752)
+.+..++++|+|++|.|+.+. .++ .+.+|+.|+|++|.|+.. +.+..++.|++|+|++|+|+.+. ..+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~-~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSIS-EGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-C-HHHHHH-TT
T ss_pred ccccccccccccccccccccc--chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccc-cchHHhCCc
Confidence 344455666666666666431 243 456666666666666633 23556666666666666666432 223 34666
Q ss_pred ceEEeecccccc
Q 041438 207 LVFLYLYNNSFS 218 (752)
Q Consensus 207 L~~L~L~~N~l~ 218 (752)
|++|+|++|+|.
T Consensus 90 L~~L~L~~N~I~ 101 (175)
T PF14580_consen 90 LQELYLSNNKIS 101 (175)
T ss_dssp --EEE-TTS---
T ss_pred CCEEECcCCcCC
Confidence 777777777665
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.2e-11 Score=112.89 Aligned_cols=103 Identities=30% Similarity=0.277 Sum_probs=33.7
Q ss_pred CcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCC-CcccccccccceE
Q 041438 326 LINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKI-SSRICRMESLEKL 404 (752)
Q Consensus 326 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L 404 (752)
+.+|+.|||++|.|+.+. .+..+++|+.|++++|+|+...+.....+++|++|+|++|+|.... -..+..+++|+.|
T Consensus 41 l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L 118 (175)
T PF14580_consen 41 LDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVL 118 (175)
T ss_dssp -TT--EEE-TTS--S--T--T----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EE
T ss_pred hcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCccee
Confidence 344444555555544432 3444555555555555554322211223455555555555554321 1334556667777
Q ss_pred EccCCcCCcCC---chhhhccCCCcEEEc
Q 041438 405 NLSYNNLSGLI---PRCFEELHGLLHIDI 430 (752)
Q Consensus 405 ~L~~N~l~~~~---p~~~~~l~~L~~L~l 430 (752)
+|.+|.++... .-.+..+++|+.||-
T Consensus 119 ~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 119 SLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp E-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred eccCCcccchhhHHHHHHHHcChhheeCC
Confidence 77777665431 123566777777763
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1e-11 Score=128.14 Aligned_cols=211 Identities=25% Similarity=0.221 Sum_probs=121.6
Q ss_pred cCCCCCCeeecCCCcccccCC-cccccccccceeeccCcccCCCCC--cccCCCCCCcEEEccCCCCCCcCCcC-ccCCC
Q 041438 130 SNLSKLEYLDFLTNKLSGHIP-SEISLLTHLTILHISRNQLNGSIP--HEVGQLNFLNHLILDSNFLGGSIPRS-LSNFT 205 (752)
Q Consensus 130 ~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~ 205 (752)
+++++|+...|.+..+..... .....+++++.||||+|-|..-.| .....|++|+.|+|+.|++....... -..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 455666666666665542211 234556667777777766653211 22355666777777777665322211 12356
Q ss_pred cceEEeeccccccccc-cccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCC-CcccCCCCCCCE
Q 041438 206 NLVFLYLYNNSFSGSI-PQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNI-PFEIGESPQLQY 283 (752)
Q Consensus 206 ~L~~L~L~~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~ 283 (752)
+|+.|.|+.|.|+.-- -......++|..|+|..|.. ..-.+.....+..|++|||++|++-... -...+.++.|..
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~--~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~ 275 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEI--ILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQ 275 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccc--cceecchhhhhhHHhhccccCCcccccccccccccccchhh
Confidence 6777777777776321 12234456677777777752 1222223344567777888877765322 134567777778
Q ss_pred EecCCCcCcCCC-Ccc-----ccCCcccCEEEccCCcCccc-CCcccCCCcccceeeccccccccc
Q 041438 284 LDLSSNYIVGEI-PTQ-----LGNIIYLNRISLSGNKLSGR-IPGELGSLINLEYLDLSANHLSNF 342 (752)
Q Consensus 284 L~Ls~N~l~~~~-p~~-----~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~ 342 (752)
|+++.+.+.... |+. ...+++|+.|+++.|++..- .-..+..+.+|+.|....|.++..
T Consensus 276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE 341 (505)
T ss_pred hhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence 888887776542 222 34567788888888887421 112345567777788778887653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.5e-09 Score=110.46 Aligned_cols=233 Identities=18% Similarity=0.238 Sum_probs=154.8
Q ss_pred cceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC----------------------------CccccC-CceEEEEEec
Q 041438 505 AKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD----------------------------NFCSHP-RQSFIVYEYL 555 (752)
Q Consensus 505 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------------~~~~~~-~~~~lV~E~~ 555 (752)
..+.||+|+.+.+|-.-. -...+.|+++.+... -+..+. ....+.|+.+
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v 92 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKV 92 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccC
Confidence 357899999999996532 122345777654332 111122 2367888888
Q ss_pred cCC-ChHHHhc---cCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 556 ESG-SLDKILN---NDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 556 ~~g-~L~~~l~---~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
.+. -...+.. ++...+..+|.-..++++.++.+.+-+|.. |.+-+|+.++|+|+++++.+.+.|-..-..- .
T Consensus 93 ~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~-~ 168 (637)
T COG4248 93 SGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN-A 168 (637)
T ss_pred CCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec-c
Confidence 764 2233332 233445688999999999999999999999 9999999999999999999999985443322 2
Q ss_pred CCCCcccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhC-CCCcchhhccccccccchHhhhc-------
Q 041438 632 DSSNWSKLAGTHGNVAPELAY-----TMKVTEKCDVYSFGVLALEVIKG-KHPRDFLFEMSSSSSNMNIEILD------- 698 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~~------- 698 (752)
........+|...|.+||... +..-++..|-|.+|+++++++.| ++||................+..
T Consensus 169 ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~ 248 (637)
T COG4248 169 NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYAS 248 (637)
T ss_pred CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeech
Confidence 333344458999999999644 34457789999999999999986 99996544322221111111111
Q ss_pred ----cCCCCC-ChhhHHHHHHHHHHHHhccCcC--CCCCCCHHHHHHHHhhh
Q 041438 699 ----SRLPYP-SLDVQNKFMSIMQVAFSCLDQN--PVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 699 ----~~~~~~-~~~~~~~~~~l~~li~~cl~~d--P~~Rps~~evl~~L~~~ 743 (752)
+..+.| ...+.-.++++..+..+|+..- |.-|||++..+..|..+
T Consensus 249 ~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 249 DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 111111 1233445567778888898643 56799999888777544
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.4e-11 Score=119.30 Aligned_cols=130 Identities=28% Similarity=0.283 Sum_probs=66.2
Q ss_pred cccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeec
Q 041438 303 IYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDL 382 (752)
Q Consensus 303 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 382 (752)
..|+++|||+|.|+ .+.....-++.++.|++|+|.|..+. .+..+++|+.||||+|.++ .+.++-..+-+++.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~--nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQ--NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceeeeh--hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 34444444444444 23333444445555555555554432 2444555555555555554 23334444555555555
Q ss_pred CCccCCCCCCcccccccccceEEccCCcCCcCC-chhhhccCCCcEEEccCCcccCc
Q 041438 383 SHNFLGEKISSRICRMESLEKLNLSYNNLSGLI-PRCFEELHGLLHIDISYNKLEGH 438 (752)
Q Consensus 383 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~ 438 (752)
+.|.|... +.+..+.+|..||+++|+|.... -+.+++++-|.++.|.+|++.+.
T Consensus 360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 55555322 22445556666666666665432 23456666666677777776653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=7.7e-11 Score=133.91 Aligned_cols=224 Identities=21% Similarity=0.236 Sum_probs=164.1
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCC------CCCC------------------Cc---cccCCceEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHS------PLPD------------------NF---CSHPRQSFI 550 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~------~~~~------------------~~---~~~~~~~~l 550 (752)
..+++.+.+-+-+|.++.++.++- ..|...++|.... +... .. .......++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 456778888888999999998862 3343334433211 1000 00 123455789
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
|++|..++++...++..+ ..+.+-.+.....+..+.+|||.. .+.|||+||.|+++..+++.++.|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccc
Confidence 999999999999987654 244456667778888999999998 89999999999999999999999998432211
Q ss_pred CC---------------------C----------CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCc
Q 041438 631 LD---------------------S----------SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPR 679 (752)
Q Consensus 631 ~~---------------------~----------~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf 679 (752)
.- . .......||+.|.|||...+......+|+|+.|++++|.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 0 0011246899999999999999999999999999999999999998
Q ss_pred chhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHH
Q 041438 680 DFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734 (752)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 734 (752)
. ....+.....+.....+++... ........+++.+.+..+|.+|-.+.
T Consensus 1036 n-----a~tpq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 N-----AETPQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred C-----CcchhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcc
Confidence 6 3334445566667677766432 44566788899999999999997765
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.5e-11 Score=125.32 Aligned_cols=111 Identities=24% Similarity=0.269 Sum_probs=60.4
Q ss_pred CCCCCcEEEccccccCCC-CCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccC-CcccCCCcccc
Q 041438 253 RCPQLSLLDVSINNITGN-IPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRI-PGELGSLINLE 330 (752)
Q Consensus 253 ~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~ 330 (752)
.+++|+.|.|+.+.|+-. +-......|+|+.|+|+.|...+.-......+..|+.|||++|++-... -...+.++.|+
T Consensus 195 ~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~ 274 (505)
T KOG3207|consen 195 LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLN 274 (505)
T ss_pred hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchh
Confidence 345677777777777622 1122345677777777777533333333444556666777766664211 12345566666
Q ss_pred eeeccccccccccchh------hcccccccEEEcCCCcC
Q 041438 331 YLDLSANHLSNFVLES------LGSLVKLYYLNLSHNKL 363 (752)
Q Consensus 331 ~L~Ls~N~l~~~~~~~------~~~l~~L~~L~Ls~N~l 363 (752)
.|.++.+.+..+-... ...+++|++|+++.|++
T Consensus 275 ~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I 313 (505)
T KOG3207|consen 275 QLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNI 313 (505)
T ss_pred hhhccccCcchhcCCCccchhhhcccccceeeecccCcc
Confidence 6666666665542211 13345555666665555
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.06 E-value=4.2e-11 Score=117.61 Aligned_cols=129 Identities=35% Similarity=0.376 Sum_probs=66.3
Q ss_pred CCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeecc
Q 041438 256 QLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLS 335 (752)
Q Consensus 256 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 335 (752)
.|+++|||+|.|+ .+..+..-.|.++.|++|+|.|... ..+..+.+|+.||||+|.++ .+.++-..+-|++.|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 3455555555554 2333444455555555555555421 12444445555555555544 222333334444444444
Q ss_pred ccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCC-CcccccccccceEEccCCcCCcC
Q 041438 336 ANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKI-SSRICRMESLEKLNLSYNNLSGL 414 (752)
Q Consensus 336 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~ 414 (752)
.|.|... ..+..+-+|..||+++|+|.... ...+++++-|+.|.|.+|.+.++
T Consensus 361 ~N~iE~L--------------------------SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 361 QNKIETL--------------------------SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhhHhhh--------------------------hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 4444331 22344445555555555554322 23467788888888888888776
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.1e-09 Score=105.93 Aligned_cols=117 Identities=21% Similarity=0.239 Sum_probs=84.3
Q ss_pred ceeeccCCceEEEEEEeCC-------CcEEEEEccCCCCCC-----C-----------ccc-------------------
Q 041438 506 KHCIGKGGHGSVYIARVPS-------GEIFAVKKFHSPLPD-----N-----------FCS------------------- 543 (752)
Q Consensus 506 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~-----~-----------~~~------------------- 543 (752)
...||.|.-+.||.|...+ +..+|||+++..... . +..
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998543 579999987532211 0 000
Q ss_pred -------------cCCceEEEEEeccCCChH-HHhccCccccccCHHHHHHHHHHHHHHHHHH-HhCCCCCeeecCCCCC
Q 041438 544 -------------HPRQSFIVYEYLESGSLD-KILNNDASAKELGWTQRLNVIKGVADALFYL-HNNCFPPIVHWDISSK 608 (752)
Q Consensus 544 -------------~~~~~~lV~E~~~~g~L~-~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~l-H~~~~~~ivH~DlKp~ 608 (752)
.-..-++||||+.++.+. ..++.. .++.++...+..+++.++..+ |+. ||||+|+++.
T Consensus 82 rl~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~ 154 (197)
T cd05146 82 RMQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEY 154 (197)
T ss_pred HHHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence 013457999999875432 122211 244456778889999999999 788 9999999999
Q ss_pred CEEeCCCCceEEeecccceecc
Q 041438 609 NVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 609 NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||+++ ++.++++|||.|....
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCC
Confidence 99997 4689999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.3e-11 Score=124.17 Aligned_cols=200 Identities=26% Similarity=0.286 Sum_probs=91.7
Q ss_pred CCCCCcEEEccCCCCCCcCCcC----ccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCC
Q 041438 179 QLNFLNHLILDSNFLGGSIPRS----LSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRC 254 (752)
Q Consensus 179 ~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l 254 (752)
..++|++|+||+|-|.-..+.. +..++.|++|+|.||.+.-.--..++. .|.+|. .|+.. +.-
T Consensus 90 ~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~kk~---------~~~ 156 (382)
T KOG1909|consen 90 GCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNKKA---------ASK 156 (382)
T ss_pred cCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHhcc---------CCC
Confidence 3445666666666665433332 344677777888777765221111211 122222 22211 122
Q ss_pred CCCcEEEccccccCCCC----CcccCCCCCCCEEecCCCcCcCC----CCccccCCcccCEEEccCCcCcccCCcccCCC
Q 041438 255 PQLSLLDVSINNITGNI----PFEIGESPQLQYLDLSSNYIVGE----IPTQLGNIIYLNRISLSGNKLSGRIPGELGSL 326 (752)
Q Consensus 255 ~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 326 (752)
+.|+++..++|++.... ...|...+.|+.+.++.|.|... +...|..+++|+.|||..|-++..-.
T Consensus 157 ~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs------ 230 (382)
T KOG1909|consen 157 PKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGS------ 230 (382)
T ss_pred cceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHH------
Confidence 45666666666654221 12334445555555555555311 11223444444444444444431100
Q ss_pred cccceeeccccccccccchhhcccccccEEEcCCCcCccccchhcc-----ccccCCeeecCCccCCCC----CCccccc
Q 041438 327 INLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELD-----NLIHLSELDLSHNFLGEK----ISSRICR 397 (752)
Q Consensus 327 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~----~~~~~~~ 397 (752)
......++.++.|+.|+++++.+.......|. ..++|++|.|.+|.++.. +...+..
T Consensus 231 --------------~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~e 296 (382)
T KOG1909|consen 231 --------------VALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAE 296 (382)
T ss_pred --------------HHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhc
Confidence 01122334444455555555554433222221 234555555555555432 2223344
Q ss_pred ccccceEEccCCcC
Q 041438 398 MESLEKLNLSYNNL 411 (752)
Q Consensus 398 l~~L~~L~L~~N~l 411 (752)
.+.|+.|+|++|.+
T Consensus 297 k~dL~kLnLngN~l 310 (382)
T KOG1909|consen 297 KPDLEKLNLNGNRL 310 (382)
T ss_pred chhhHHhcCCcccc
Confidence 66777777777777
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.04 E-value=8.1e-10 Score=106.11 Aligned_cols=110 Identities=18% Similarity=0.168 Sum_probs=81.2
Q ss_pred ceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC----------------------CccccCCceEEEEEeccCCChHHH
Q 041438 506 KHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD----------------------NFCSHPRQSFIVYEYLESGSLDKI 563 (752)
Q Consensus 506 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~~~~lV~E~~~~g~L~~~ 563 (752)
.+.++.|.++.||+++.. ++.|++|........ -+.......++||||++|.++...
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~ 81 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTE 81 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCccccc
Confidence 467899999999999874 778999987654311 011122346899999999877543
Q ss_pred hccCccccccCHHHHHHHHHHHHHHHHHHHhCC--CCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 564 LNNDASAKELGWTQRLNVIKGVADALFYLHNNC--FPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 564 l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
. .....++.+++++++.||+.. ..+++|+|+||.||+++ ++.++++|||.+..
T Consensus 82 ----~-------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 82 ----D-------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ----c-------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 0 112345789999999999982 11259999999999999 66899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.9e-10 Score=89.68 Aligned_cols=61 Identities=44% Similarity=0.608 Sum_probs=40.5
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCccc
Q 041438 109 PHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQL 169 (752)
Q Consensus 109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 169 (752)
|+|++|++++|+|+.+.+.+|.++++|++|+|++|+|+.+.|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4566666666666666666666666666666666666666666666666666666666654
|
... |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.8e-11 Score=123.18 Aligned_cols=114 Identities=26% Similarity=0.331 Sum_probs=84.0
Q ss_pred cCCCcccceeeccccccccc----cchhhcccccccEEEcCCCcCccc----cchhccccccCCeeecCCccCCCCCCcc
Q 041438 323 LGSLINLEYLDLSANHLSNF----VLESLGSLVKLYYLNLSHNKLSQQ----IPIELDNLIHLSELDLSHNFLGEKISSR 394 (752)
Q Consensus 323 ~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 394 (752)
|...+.|+.+.++.|.|... ....|..++.|+.|||..|-++.. ....+..+++|++|+++++.+...-...
T Consensus 181 ~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a 260 (382)
T KOG1909|consen 181 FQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIA 260 (382)
T ss_pred HHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHH
Confidence 44555666666666665432 335677788888888888888643 3456778899999999999997654433
Q ss_pred cc-----cccccceEEccCCcCCcC----CchhhhccCCCcEEEccCCccc
Q 041438 395 IC-----RMESLEKLNLSYNNLSGL----IPRCFEELHGLLHIDISYNKLE 436 (752)
Q Consensus 395 ~~-----~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~ 436 (752)
|. ..++|+.|.|.+|.++-. +..++...+.|..|+|++|.+.
T Consensus 261 ~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 261 FVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 32 368999999999999743 3345667889999999999993
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.8e-10 Score=87.44 Aligned_cols=59 Identities=36% Similarity=0.407 Sum_probs=30.8
Q ss_pred CCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCC
Q 041438 134 KLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNF 192 (752)
Q Consensus 134 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 192 (752)
+|++|+|++|+|+.+.+..|.++++|++|++++|.|+...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 45555555555555444555555555555555555554444455555555555555544
|
... |
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.2e-09 Score=78.06 Aligned_cols=42 Identities=31% Similarity=0.779 Sum_probs=30.4
Q ss_pred HHHHHHHHHHHHccccCCccccCCCCccccCCCCCCCCcccceeeC
Q 041438 36 TEEAHALVKWKASLEVHSRSLLHSWSLSFVNATKISLCTWSGIHCN 81 (752)
Q Consensus 36 ~~~~~aLl~fk~~~~~~~~~~l~sW~~~~~~~~~~~~c~w~gv~C~ 81 (752)
++|++||++||+++..+|.+.+.+|+. ....+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~----~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNP----SSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--T----T--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCC----cCCCCCeeeccEEeC
Confidence 679999999999999778889999983 213589999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.3e-09 Score=128.56 Aligned_cols=126 Identities=26% Similarity=0.295 Sum_probs=64.2
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCeeecCCCc--ccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEE
Q 041438 109 PHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNK--LSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHL 186 (752)
Q Consensus 109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 186 (752)
...+...+-+|.+..+ +.... .++|++|-+..|. +..+.++.|..++.|++|||++|.=-+.+|..++.|-+|++|
T Consensus 523 ~~~rr~s~~~~~~~~~-~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIEHI-AGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchhhc-cCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 3445555555555332 22211 1245555555554 333333335555666666666554444555555555556666
Q ss_pred EccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCcccccccccc
Q 041438 187 ILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLC 237 (752)
Q Consensus 187 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~ 237 (752)
+|++..++ .+|..+.+|.+|.+|++..+.-...+|.....|.+|++|.+.
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~ 650 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLP 650 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEee
Confidence 66665555 455555555566666555555443444444445555555443
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.5e-09 Score=127.93 Aligned_cols=108 Identities=31% Similarity=0.349 Sum_probs=94.8
Q ss_pred CCCCCEEECCCCc--ccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcE
Q 041438 108 FPHLAYLDLYNNE--LFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNH 185 (752)
Q Consensus 108 l~~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 185 (752)
.+.|++|-+..|. +..+.++.|..++.|++|||++|.=-+.+|..+++|-+|++|+|++..++ .+|..+++|..|.+
T Consensus 544 ~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~ 622 (889)
T KOG4658|consen 544 NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIY 622 (889)
T ss_pred CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhe
Confidence 3479999999996 66666667899999999999998877789999999999999999999999 78999999999999
Q ss_pred EEccCCCCCCcCCcCccCCCcceEEeecccc
Q 041438 186 LILDSNFLGGSIPRSLSNFTNLVFLYLYNNS 216 (752)
Q Consensus 186 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 216 (752)
|++..+.-...+|.....|++|++|.|..-.
T Consensus 623 Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 623 LNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred eccccccccccccchhhhcccccEEEeeccc
Confidence 9999988766778888889999999987665
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.5e-08 Score=91.38 Aligned_cols=107 Identities=26% Similarity=0.429 Sum_probs=80.5
Q ss_pred eeeccCCceEEEEEEeCCCcEEEEEc-cCCCCCC-------------------------------CccccCCceEEEEEe
Q 041438 507 HCIGKGGHGSVYIARVPSGEIFAVKK-FHSPLPD-------------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~-------------------------------~~~~~~~~~~lV~E~ 554 (752)
..+++|+-+.+|.+.+. |..+++|. +.+.... -+..++....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999763 44455653 3332221 234466777899999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
++|..|.+.+... ...++..+-.-+.-||.. ||+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888888654 134666777777889999 999999999999998664 99999999975
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=5.7e-09 Score=114.81 Aligned_cols=152 Identities=20% Similarity=0.209 Sum_probs=105.1
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc---------ccccCCCCccCcc
Q 041438 579 LNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW---------SKLAGTHGNVAPE 649 (752)
Q Consensus 579 ~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~---------~~~~gt~~y~aPE 649 (752)
..=+.+++.|+.|+|... ++||++|.|++|.++..+.+||+.|+.+.....+.... ....-...|.|||
T Consensus 102 f~nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE 179 (700)
T KOG2137|consen 102 FANLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPE 179 (700)
T ss_pred hhhhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccch
Confidence 333556679999999884 99999999999999999999999999987654322111 0113456899999
Q ss_pred ccccCCCCCccchhhHHHHHHHHH-hCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCC
Q 041438 650 LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPV 728 (752)
Q Consensus 650 ~~~~~~~~~ksDIwSlGvil~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 728 (752)
++.+...++++|+||+||.+|.+. .|+.-+....... .........+..... ...+.+.++.+-+.+++..++.
T Consensus 180 ~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~--~~~~~~~~~~~~~~~---~s~~~p~el~~~l~k~l~~~~~ 254 (700)
T KOG2137|consen 180 YLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL--SYSFSRNLLNAGAFG---YSNNLPSELRESLKKLLNGDSA 254 (700)
T ss_pred hhccccccccccceeeeeEEEEEecCCcchhhccCCcc--hhhhhhccccccccc---ccccCcHHHHHHHHHHhcCCcc
Confidence 999988899999999999999998 4555443110000 000001111111111 1145567888999999999999
Q ss_pred CCCCHHHHH
Q 041438 729 SRPTMKRFE 737 (752)
Q Consensus 729 ~Rps~~evl 737 (752)
.||++.++.
T Consensus 255 ~rp~~~~l~ 263 (700)
T KOG2137|consen 255 VRPTLDLLL 263 (700)
T ss_pred cCcchhhhh
Confidence 999776654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.6e-07 Score=94.44 Aligned_cols=118 Identities=24% Similarity=0.323 Sum_probs=88.5
Q ss_pred eeeccCCceEEEEEEeCCCcEEEEEccCCCCC----C-----------------------CccccC---CceEEEEEecc
Q 041438 507 HCIGKGGHGSVYIARVPSGEIFAVKKFHSPLP----D-----------------------NFCSHP---RQSFIVYEYLE 556 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~-----------------------~~~~~~---~~~~lV~E~~~ 556 (752)
+.|+.|.++.||+++..+|+.+++|....... . .+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 67899999999999986678999998765322 0 111111 25689999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNC---------------------------------------- 596 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---------------------------------------- 596 (752)
|.++.+.+.. ..++..+...++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888765532 12566777888888888888888531
Q ss_pred -------------CCCeeecCCCCCCEEeCC--CCceEEeeccccee
Q 041438 597 -------------FPPIVHWDISSKNVLLDL--GYEAHVSDFRIAKF 628 (752)
Q Consensus 597 -------------~~~ivH~DlKp~NIll~~--~~~~kl~DfG~a~~ 628 (752)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 136799999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.7e-07 Score=85.77 Aligned_cols=119 Identities=18% Similarity=0.273 Sum_probs=87.5
Q ss_pred cceeeccCCceEEEEEEeCCCcEEEEEc-cCCCC----CC---------------------------CccccCCceEEEE
Q 041438 505 AKHCIGKGGHGSVYIARVPSGEIFAVKK-FHSPL----PD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 505 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~----~~---------------------------~~~~~~~~~~lV~ 552 (752)
....+-+|+-+.|+++.+ .|+.+.||. +.+.. .+ -++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567889999999999987 677777773 22221 11 1233455567899
Q ss_pred EeccC-CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCc---eEEeeccccee
Q 041438 553 EYLES-GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE---AHVSDFRIAKF 628 (752)
Q Consensus 553 E~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~---~kl~DfG~a~~ 628 (752)
||++| .++.+++....... ...+.....+++|-+.+.-||.. +|+|+||..+||++..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 47788887654322 22233368889999999999999 9999999999999976553 58999999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=1e-07 Score=91.97 Aligned_cols=75 Identities=28% Similarity=0.412 Sum_probs=51.3
Q ss_pred ceEEEEEecc--CCChHHHhccCccccccCHHHHHHHHHHHHHHHHH-HHhCCCCCeeecCCCCCCEEeCCCCceEEeec
Q 041438 547 QSFIVYEYLE--SGSLDKILNNDASAKELGWTQRLNVIKGVADALFY-LHNNCFPPIVHWDISSKNVLLDLGYEAHVSDF 623 (752)
Q Consensus 547 ~~~lV~E~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~-lH~~~~~~ivH~DlKp~NIll~~~~~~kl~Df 623 (752)
.-++||||++ |..+..+.... ++.+....++.+++..+.. +|.. ||+|+|+.+.||+++++ .+.++||
T Consensus 80 ~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--G
T ss_pred CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEec
Confidence 3469999999 54454433221 2235567788888886666 4677 99999999999999987 9999999
Q ss_pred ccceecc
Q 041438 624 RIAKFLN 630 (752)
Q Consensus 624 G~a~~~~ 630 (752)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=3.9e-07 Score=100.29 Aligned_cols=156 Identities=20% Similarity=0.266 Sum_probs=107.0
Q ss_pred ccCCceEEEEEEeCCCcEE-----EEEcc---CCCCCC---CccccCCceEEEEEeccCCChHHHhccCccccccCHHHH
Q 041438 510 GKGGHGSVYIARVPSGEIF-----AVKKF---HSPLPD---NFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQR 578 (752)
Q Consensus 510 g~G~~g~Vy~~~~~~~~~v-----avK~~---~~~~~~---~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~ 578 (752)
..|++-.|+.....+++.+ |+|++ +.+..- ...+..+..|+|+|.+. .|..++++. +...+
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------GKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------HHHHH
Confidence 3566666776665555221 34433 333332 22345678999999985 677777643 34667
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcccccCCCCccCccccccCCCCC
Q 041438 579 LNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTE 658 (752)
Q Consensus 579 ~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 658 (752)
...+.||+.||.|||+.| +++|++|.-+-|+++..|+.||++|..+.....-........--..|..|+.+.... .
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~ 182 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--W 182 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--c
Confidence 778999999999999776 999999999999999999999999988865432221111112223456666543332 3
Q ss_pred ccchhhHHHHHHHHHhCCC
Q 041438 659 KCDVYSFGVLALEVIKGKH 677 (752)
Q Consensus 659 ksDIwSlGvil~elltg~~ 677 (752)
..|.|-|||+++|++.|..
T Consensus 183 s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 183 SIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred chhhhhHHHHHHHHhCccc
Confidence 4699999999999999943
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.6e-09 Score=114.79 Aligned_cols=182 Identities=30% Similarity=0.330 Sum_probs=121.6
Q ss_pred CcccCCCCCCCEEecCCCcCcCCCCccccCC-cccCEEEccCCcCcc---cCCc---ccC---CCcccceeecccccccc
Q 041438 272 PFEIGESPQLQYLDLSSNYIVGEIPTQLGNI-IYLNRISLSGNKLSG---RIPG---ELG---SLINLEYLDLSANHLSN 341 (752)
Q Consensus 272 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~---~~p~---~~~---~l~~L~~L~Ls~N~l~~ 341 (752)
|-.+....+|+.|.|.++.|... ..+..+ ..|++|. ..|.+.. ++.. .++ .+..|...+.+.|.+..
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~~--~GL~~lr~qLe~LI-C~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~~ 178 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLSTA--KGLQELRHQLEKLI-CHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLVL 178 (1096)
T ss_pred CceeccccceeeEEecCcchhhh--hhhHHHHHhhhhhh-hhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHHh
Confidence 55667778899999999888631 111111 1233332 2222210 0110 111 13467888889999876
Q ss_pred ccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhc
Q 041438 342 FVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEE 421 (752)
Q Consensus 342 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 421 (752)
. ..++.-++.|+.|||++|+++... .+..+++|++|||+.|.|....--...+.. |+.|+|++|.++.+ ..+.+
T Consensus 179 m-D~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~ 252 (1096)
T KOG1859|consen 179 M-DESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIEN 252 (1096)
T ss_pred H-HHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHHh
Confidence 4 467788899999999999997543 788899999999999999764433333333 99999999999876 45788
Q ss_pred cCCCcEEEccCCcccCcCCC--CcccCCCCcccccCCCCCCCC
Q 041438 422 LHGLLHIDISYNKLEGHIPN--STTFRDAPLEALQGNKGLCGD 462 (752)
Q Consensus 422 l~~L~~L~ls~N~l~~~~p~--~~~~~~~~~~~~~~n~~~c~~ 462 (752)
|.+|..||+++|-|++.-.- ...+..+....++|||-.|..
T Consensus 253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 99999999999999875321 122223334568999988864
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=3.7e-09 Score=115.47 Aligned_cols=102 Identities=28% Similarity=0.272 Sum_probs=46.4
Q ss_pred CcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccc
Q 041438 257 LSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSA 336 (752)
Q Consensus 257 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 336 (752)
|.+.+.+.|.+. ....++.-++.|+.|||++|+++..- .+..++.|++|||++|.+.-++--...++. |+.|.|++
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrn 241 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRN 241 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecc
Confidence 444555555554 22334444455555555555554321 444445555555555555432222222222 45555555
Q ss_pred cccccccchhhcccccccEEEcCCCcCc
Q 041438 337 NHLSNFVLESLGSLVKLYYLNLSHNKLS 364 (752)
Q Consensus 337 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 364 (752)
|.++... .+.++.+|+.|||++|-|.
T Consensus 242 N~l~tL~--gie~LksL~~LDlsyNll~ 267 (1096)
T KOG1859|consen 242 NALTTLR--GIENLKSLYGLDLSYNLLS 267 (1096)
T ss_pred cHHHhhh--hHHhhhhhhccchhHhhhh
Confidence 5544321 2344444455555555443
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.4e-08 Score=100.30 Aligned_cols=85 Identities=27% Similarity=0.302 Sum_probs=42.0
Q ss_pred CCCCeeecCCCcccc--cCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCc-CCcCccCCCcceE
Q 041438 133 SKLEYLDFLTNKLSG--HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGS-IPRSLSNFTNLVF 209 (752)
Q Consensus 133 ~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~ 209 (752)
+.++.|||.+|.|+. .+-..+.+|+.|++|+|+.|+++..|-..-..+.+|+.|.|.+..+... ....+..++.++.
T Consensus 71 ~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vte 150 (418)
T KOG2982|consen 71 TDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTE 150 (418)
T ss_pred hhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhh
Confidence 455556666665552 1222344566666666666666533322113444555555555555422 1223445555566
Q ss_pred Eeeccccc
Q 041438 210 LYLYNNSF 217 (752)
Q Consensus 210 L~L~~N~l 217 (752)
|++|.|++
T Consensus 151 lHmS~N~~ 158 (418)
T KOG2982|consen 151 LHMSDNSL 158 (418)
T ss_pred hhhccchh
Confidence 66665543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=3.9e-07 Score=101.08 Aligned_cols=117 Identities=20% Similarity=0.201 Sum_probs=84.9
Q ss_pred eeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------------------------------
Q 041438 507 HCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD----------------------------------------------- 539 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------------------------------- 539 (752)
+.|+.++-|.||+|+.++|+.||||+.++....
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 789999999999999999999999998765432
Q ss_pred ----------------------CccccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHH-HHHHHhCC
Q 041438 540 ----------------------NFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADA-LFYLHNNC 596 (752)
Q Consensus 540 ----------------------~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~a-L~~lH~~~ 596 (752)
-|.+......++|||++|-.+.+...... ...+ +..++..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d---~k~ia~~~~~~f~~q~~~d- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGID---RKELAELLVRAFLRQLLRD- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCC---HHHHHHHHHHHHHHHHHhc-
Confidence 11122356689999999988887742221 1122 23333333332 2333335
Q ss_pred CCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 597 FPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 597 ~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|++|.|.+|.||+++.++++.+.|||+...++.
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999987653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.2e-06 Score=89.77 Aligned_cols=79 Identities=29% Similarity=0.273 Sum_probs=65.0
Q ss_pred CceEEEEEeccCC-ChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC-------CCc
Q 041438 546 RQSFIVYEYLESG-SLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL-------GYE 617 (752)
Q Consensus 546 ~~~~lV~E~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~-------~~~ 617 (752)
...++|||++++. +|.+++..... .+.+...+..++.+++..+.-||+. ||+|+|+++.|||++. ++.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 3578999999986 79888854321 2245567789999999999999999 9999999999999975 467
Q ss_pred eEEeeccccee
Q 041438 618 AHVSDFRIAKF 628 (752)
Q Consensus 618 ~kl~DfG~a~~ 628 (752)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998854
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.1e-06 Score=87.11 Aligned_cols=116 Identities=23% Similarity=0.237 Sum_probs=82.4
Q ss_pred cccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------------------Cccc----
Q 041438 503 FDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------------------NFCS---- 543 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------------------~~~~---- 543 (752)
+.+..+||-|.-+.||.|..+.|.++|||.-+..... ....
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4467899999999999999999999999954322111 0000
Q ss_pred -----cCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCce
Q 041438 544 -----HPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEA 618 (752)
Q Consensus 544 -----~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~ 618 (752)
.-+.-.+||||++|--|...- ++.+....++..|++-+.-.-.. ||||+|+.+-||+++++|.+
T Consensus 173 VP~P~~~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 173 VPKPIAWNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred CCCccccccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCCE
Confidence 113457999999986555432 12234445555566655555566 99999999999999999999
Q ss_pred EEeecccceec
Q 041438 619 HVSDFRIAKFL 629 (752)
Q Consensus 619 kl~DfG~a~~~ 629 (752)
.++||--+...
T Consensus 242 ~vIDwPQ~v~~ 252 (304)
T COG0478 242 VVIDWPQAVPI 252 (304)
T ss_pred EEEeCcccccC
Confidence 99999766543
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.40 E-value=4.4e-08 Score=96.78 Aligned_cols=187 Identities=24% Similarity=0.231 Sum_probs=110.7
Q ss_pred CCCCCCEEECCCCcccc--cCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCC-CcccCCCCCC
Q 041438 107 SFPHLAYLDLYNNELFD--IIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSI-PHEVGQLNFL 183 (752)
Q Consensus 107 ~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L 183 (752)
..++++.|||.+|.|+. .+-..+.+|+.|++|+|+.|.+...|...=..+.+|++|-|.+..+.-.- ...+..++.+
T Consensus 69 ~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~v 148 (418)
T KOG2982|consen 69 SVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKV 148 (418)
T ss_pred HhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhh
Confidence 45789999999999985 23445789999999999999998655433246789999999988877443 3446788999
Q ss_pred cEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccc--cccCccccccccccccccCCCcCCCCCCCCCCCCcEEE
Q 041438 184 NHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQ--QIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLD 261 (752)
Q Consensus 184 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~ 261 (752)
++|++|.|.+. .+++..|.+....|. .+..+..+..++++.|++.... |++..+-
T Consensus 149 telHmS~N~~r--------------q~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~F---------pnv~sv~ 205 (418)
T KOG2982|consen 149 TELHMSDNSLR--------------QLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIF---------PNVNSVF 205 (418)
T ss_pred hhhhhccchhh--------------hhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhc---------ccchhee
Confidence 99999998543 233333333322211 1122223333344444443222 3444444
Q ss_pred ccccccCCCC-CcccCCCCCCCEEecCCCcCcCCCC-ccccCCcccCEEEccCCcCc
Q 041438 262 VSINNITGNI-PFEIGESPQLQYLDLSSNYIVGEIP-TQLGNIIYLNRISLSGNKLS 316 (752)
Q Consensus 262 Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 316 (752)
+-.|.|...- ...+...+.+..|+|+.|+|..... +.+.++++|..|.+++|.+.
T Consensus 206 v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 206 VCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred eecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 5555443211 1223344555566666666643221 34555556666666666554
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=4.3e-08 Score=86.08 Aligned_cols=86 Identities=26% Similarity=0.296 Sum_probs=44.1
Q ss_pred cccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEc
Q 041438 327 INLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNL 406 (752)
Q Consensus 327 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 406 (752)
..|+..+|++|.+..+++..-..++.++.|+|++|+|+ .+|.++..++.|+.|+++.|.+.. .|..+..+.++-.|+.
T Consensus 53 ~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~~-~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 53 YELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLNA-EPRVIAPLIKLDMLDS 130 (177)
T ss_pred ceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCcccc-chHHHHHHHhHHHhcC
Confidence 34445555555555554444444445555556666554 344455555555555555555532 3344444555555555
Q ss_pred cCCcCCcC
Q 041438 407 SYNNLSGL 414 (752)
Q Consensus 407 ~~N~l~~~ 414 (752)
.+|.+..+
T Consensus 131 ~~na~~ei 138 (177)
T KOG4579|consen 131 PENARAEI 138 (177)
T ss_pred CCCccccC
Confidence 55554433
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.28 E-value=5.3e-06 Score=80.86 Aligned_cols=121 Identities=17% Similarity=0.255 Sum_probs=85.8
Q ss_pred hHHHHHH--hhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC---------------------------Cc-
Q 041438 492 VYEEIIR--ATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD---------------------------NF- 541 (752)
Q Consensus 492 ~~~~~~~--~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~~- 541 (752)
.|.++.. ..++|.+.+.+-......|.+... +|+.+++|..+..... ++
T Consensus 20 ~y~~l~~~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~ 98 (229)
T PF06176_consen 20 KYLELGEKILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFT 98 (229)
T ss_pred HHHHHHHHHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcc
Confidence 3444443 346788888888887777777766 6789999987654321 10
Q ss_pred -------------cccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 041438 542 -------------CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608 (752)
Q Consensus 542 -------------~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~ 608 (752)
+.-....++||||++|..|.+... +++ .++.++++++.-+|+. |++|+|..|.
T Consensus 99 ~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpg 164 (229)
T PF06176_consen 99 EPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPG 164 (229)
T ss_pred ccccceeeeeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcC
Confidence 111244568999999977765432 222 2456677889999999 9999999999
Q ss_pred CEEeCCCCceEEeeccccee
Q 041438 609 NVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 609 NIll~~~~~~kl~DfG~a~~ 628 (752)
|++++++ .++++||+..+.
T Consensus 165 NFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 165 NFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred cEEEECC-cEEEEECccccc
Confidence 9999865 599999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 752 | ||||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-35 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-35 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-28 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-27 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-20 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-20 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-16 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-16 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-14 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-11 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 9e-11 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 1e-10 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 1e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-10 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 7e-10 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 7e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-10 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 1e-09 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 1e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-08 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-08 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 5e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-07 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 1e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-07 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-06 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 1e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-06 | ||
| 3zyo_A | 411 | Crystal Structure Of The N-Terminal Leucine Rich Re | 4e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-06 | ||
| 3zyn_A | 321 | Crystal Structure Of The N-Terminal Leucine Rich Re | 6e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-06 | ||
| 3b2d_A | 603 | Crystal Structure Of Human Rp105MD-1 Complex Length | 9e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-05 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 2e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-05 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-05 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-05 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-05 | ||
| 2z64_A | 599 | Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Comp | 3e-05 | ||
| 3vq1_A | 606 | Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLE | 3e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-05 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-05 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-05 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-05 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-05 | ||
| 2o6s_A | 208 | Structural Diversity Of The Hagfish Variable Lympho | 8e-05 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-05 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-05 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-05 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-04 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-04 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-04 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-04 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-04 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-04 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-04 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-04 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-04 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-04 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-04 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-04 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-04 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-04 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-04 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-04 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-04 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-04 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-04 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-04 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-04 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 2e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-04 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-04 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 2e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-04 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-04 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-04 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-04 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-04 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-04 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-04 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-04 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-04 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-04 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-04 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-04 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-04 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-04 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-04 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-04 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-04 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-04 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-04 | ||
| 3v47_A | 455 | Crystal Structure Of The N-Tetminal Fragment Of Zeb | 7e-04 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-04 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-04 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-04 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-04 | ||
| 3m19_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 8e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-04 | ||
| 3m18_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 8e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-04 |
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2Z64|A Chain A, Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Complex Length = 599 | Back alignment and structure |
|
| >pdb|3VQ1|A Chain A, Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLEX Length = 606 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 337 bits (867), Expect = e-105
Identities = 122/376 (32%), Positives = 180/376 (47%), Gaps = 9/376 (2%)
Query: 89 INLTSISLNGTL-LEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSG 147
++L+S + +G + + L L L NN IPP +SN S+L L N LSG
Sbjct: 373 LDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSG 432
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207
IPS + L+ L L + N L G IP E+ + L LILD N L G IP LSN TNL
Sbjct: 433 TIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNL 492
Query: 208 VFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267
++ L NN +G IP+ IG L++L +KL N +G IP + G C L LD++ N
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL--GDCRSLIWLDLNTNLF 550
Query: 268 TGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGN--KLSGRIPGELGS 325
G IP + + +++N+I G+ + N +GN + G +L
Sbjct: 551 NGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNR 606
Query: 326 LINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHN 385
L ++++ + + + +L++S+N LS IP E+ ++ +L L+L HN
Sbjct: 607 LSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666
Query: 386 FLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTF 445
+ I + + L L+LS N L G IP+ L L ID+S N L G IP F
Sbjct: 667 DISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQF 726
Query: 446 RDAPLEALQGNKGLCG 461
P N GLCG
Sbjct: 727 ETFPPAKFLNNPGLCG 742
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 327 bits (841), Expect = e-101
Identities = 132/476 (27%), Positives = 187/476 (39%), Gaps = 76/476 (15%)
Query: 27 FSLAVSSNSTEEAHALVKWKASLEVHSRSLLHSWSLSFVNATKISLCTWSGIHCNHAGRV 86
F + S + E H L+ +K L ++LL WS + + CT+ G+ C +V
Sbjct: 2 FQASPSQSLYREIHQLISFKDVL--PDKNLLPDWSSN------KNPCTFDGVTCRD-DKV 52
Query: 87 FGINLTSI---------------------------SLNGTLLEF---------------- 103
I+L+S +NG++ F
Sbjct: 53 TSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSL 112
Query: 104 --------SFSSFPHLAYLDLYNNELFDIIP-PQISNLSKLEYLDFLTNKLSGHIPSEIS 154
S S L +L++ +N L L+ LE LD N +SG
Sbjct: 113 SGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWV 172
Query: 155 L---LTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLY 211
L L L IS N+++G + V + L L + SN IP L + + L L
Sbjct: 173 LSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLD 229
Query: 212 LYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNI 271
+ N SG + I L + + NQ G IP L L ++ N TG I
Sbjct: 230 ISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP----LKSLQYLSLAENKFTGEI 285
Query: 272 PFEI-GESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGE-LGSLINL 329
P + G L LDLS N+ G +P G+ L ++LS N SG +P + L + L
Sbjct: 286 PDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGL 345
Query: 330 EYLDLSANHLSNFVLESLGSL-VKLYYLNLSHNKLSQQIPIELDN--LIHLSELDLSHNF 386
+ LDLS N S + ESL +L L L+LS N S I L L EL L +N
Sbjct: 346 KVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNG 405
Query: 387 LGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNS 442
KI + L L+LS+N LSG IP L L + + N LEG IP
Sbjct: 406 FTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQE 461
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 311 bits (798), Expect = 7e-95
Identities = 114/360 (31%), Positives = 173/360 (48%), Gaps = 10/360 (2%)
Query: 90 NLTSISLNGTLLEF---SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLS 146
NL + ++ L +LD+ N+L IS ++L+ L+ +N+
Sbjct: 201 NLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFV 260
Query: 147 GHIPSEISLLTHLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIPRSLSNFT 205
G IP L L L ++ N+ G IP + G + L L L N G++P + +
Sbjct: 261 GPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS 318
Query: 206 NLVFLYLYNNSFSGSIPQQ-IGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSI 264
L L L +N+FSG +P + ++ L + L N+ +G +P S+ L LD+S
Sbjct: 319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESL-TNLSASLLTLDLSS 377
Query: 265 NNITGNIPFEIGESP--QLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGE 322
NN +G I + ++P LQ L L +N G+IP L N L + LS N LSG IP
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSS 437
Query: 323 LGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDL 382
LGSL L L L N L + + L + L L L N L+ +IP L N +L+ + L
Sbjct: 438 LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISL 497
Query: 383 SHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNS 442
S+N L +I I R+E+L L LS N+ SG IP + L+ +D++ N G IP +
Sbjct: 498 SNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 305 bits (783), Expect = 1e-92
Identities = 112/380 (29%), Positives = 170/380 (44%), Gaps = 28/380 (7%)
Query: 89 INLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGH 148
++L G + +F + L LDL N + +PP + S LE L +N SG
Sbjct: 274 LSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGE 333
Query: 149 IPSE-ISLLTHLTILHISRNQLNGSIPHEVGQLNF-LNHLILDSNFLGGSIPRSLSNF-- 204
+P + + + L +L +S N+ +G +P + L+ L L L SN G I +L
Sbjct: 334 LPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPK 393
Query: 205 TNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSI 264
L LYL NN F+G IP + N L + L N L+G IP S+ G +L L + +
Sbjct: 394 NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL--GSLSKLRDLKLWL 451
Query: 265 NNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELG 324
N + G IP E+ L+ L L N + GEIP+ L N LN ISLS N+L+G IP +G
Sbjct: 452 NMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIG 511
Query: 325 SLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLS-------------------- 364
L NL L LS N S + LG L +L+L+ N +
Sbjct: 512 RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIA 571
Query: 365 QQIPIELDNLIHLSELDLSHNF--LGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEL 422
+ + + N E + N S ++ R+ + N++ G F+
Sbjct: 572 GKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNN 631
Query: 423 HGLLHIDISYNKLEGHIPNS 442
++ +D+SYN L G+IP
Sbjct: 632 GSMMFLDMSYNMLSGYIPKE 651
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 6e-12
Identities = 26/110 (23%), Positives = 43/110 (39%), Gaps = 3/110 (2%)
Query: 346 SLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLN 405
+ + + N + L +L L L LS++ + +S SL L+
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLD 106
Query: 406 LSYNNLSGLIPRCFE--ELHGLLHIDISYNKLEGHIPNSTTFRDAPLEAL 453
LS N+LSG + GL +++S N L+ S + LE L
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVL 156
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 4e-82
Identities = 93/356 (26%), Positives = 149/356 (41%), Gaps = 62/356 (17%)
Query: 34 NSTEEAHALVKWKASLEVHSRSLLHSWSLSFVNATKISLCTWSGIHCN---HAGRVFGIN 90
N ++ AL++ K L + + L SW + T TW G+ C+ RV ++
Sbjct: 4 NPQDKQ-ALLQIKKDL--GNPTTLSSWLPT----TDCCNRTWLGVLCDTDTQTYRVNNLD 56
Query: 91 LTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFL-TNKLSGHI 149
L+ ++L IP ++NL L +L N L G I
Sbjct: 57 LSGLNLPKPYP-----------------------IPSSLANLPYLNFLYIGGINNLVGPI 93
Query: 150 PSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVF 209
P I+ LT L L+I+ ++G+IP + Q+ L L N L G++P S+S+ NLV
Sbjct: 94 PPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153
Query: 210 LYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITG 269
+ N SG+IP G+ L + + +S N +TG
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKL-------------------------FTSMTISRNRLTG 188
Query: 270 NIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINL 329
IP + L ++DLS N + G+ G+ +I L+ N L+ + ++G NL
Sbjct: 189 KIPPTFA-NLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNL 246
Query: 330 EYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHN 385
LDL N + + + L L L+ LN+S N L +IP NL ++N
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG-NLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 8e-78
Identities = 85/345 (24%), Positives = 139/345 (40%), Gaps = 60/345 (17%)
Query: 125 IPPQISNLSKL----EYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGS--IPHEVG 178
I + N + L D G + + + L +S L IP +
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 179 QLNFLNHLIL-DSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLC 237
L +LN L + N L G IP +++ T L +LY+ + + SG+IP + +K+L
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT---- 129
Query: 238 INQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPT 297
LD S N ++G +P I P L + N I G IP
Sbjct: 130 ----------------------LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 298 QLGNIIYLNR-ISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYL 356
G+ L +++S N+L+G+IP +L NL ++DLS N L GS +
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 357 NLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIP 416
+L+ N L+ + ++ +L+ LDL +N + G +P
Sbjct: 227 HLAKNSLAFDLG-KVGLSKNLNGLDLRNN------------------------RIYGTLP 261
Query: 417 RCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEALQGNKGLCG 461
+ +L L +++S+N L G IP + + A NK LCG
Sbjct: 262 QGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 9e-23
Identities = 28/113 (24%), Positives = 46/113 (40%), Gaps = 2/113 (1%)
Query: 110 HLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQL 169
+LA++DL N L + + + N L+ + + L +L L + N++
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRI 256
Query: 170 NGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIP 222
G++P + QL FL+ L + N L G IP N NN P
Sbjct: 257 YGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 2e-69
Identities = 83/381 (21%), Positives = 147/381 (38%), Gaps = 15/381 (3%)
Query: 89 INLTSISLNG-TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSG 147
++ + L + ++ L+L +N+L + + S+L LD N +S
Sbjct: 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207
P L L +L++ N+L+ L L L SN + NL
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123
Query: 208 VFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267
+ L L +N S + L++L ++ L N++ +D L L++S N I
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183
Query: 268 TGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNII---YLNRISLSGNKLSGRIPGELG 324
P +L L L++ + + +L + + +SLS ++LS
Sbjct: 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243
Query: 325 SL--INLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDL 382
L NL LDLS N+L+ +S L +L Y L +N + L L ++ L+L
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303
Query: 383 SHNFLGEKISSR---------ICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYN 433
+F + IS ++ LE LN+ N++ G+ F L L ++ +S +
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363
Query: 434 KLEGHIPNSTTFRDAPLEALQ 454
+ TF L
Sbjct: 364 FTSLRTLTNETFVSLAHSPLH 384
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 3e-62
Identities = 84/403 (20%), Positives = 137/403 (33%), Gaps = 29/403 (7%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTN-- 143
NLT + L+ + SF+ P L Y L N + + + L + YL+ +
Sbjct: 249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFT 308
Query: 144 -------KLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGS 196
L L L L++ N + G + L L +L L ++F
Sbjct: 309 KQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLR 368
Query: 197 IPRSLS----NFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWG 252
+ + + L L L N S L L + L +N++ + W
Sbjct: 369 TLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQE-WR 427
Query: 253 RCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYI--VGEIPTQLGNIIYLNRISL 310
+ + +S N P LQ L L + V P+ + L + L
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487
Query: 311 SGNKLSGRIPGELGSLINLEYLDLSANHLSNF--------VLESLGSLVKLYYLNLSHNK 362
S N ++ L L LE LDL N+L+ + L L L+ LNL N
Sbjct: 488 SNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNG 547
Query: 363 LSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEE- 421
+ +L L +DL N L +S SL+ LNL N ++ + + F
Sbjct: 548 FDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPA 607
Query: 422 LHGLLHIDISYNKLEGHIPNSTTFRDAPLEALQGNKGLCGDIR 464
L +D+ +N + + F + E L
Sbjct: 608 FRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYL 650
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-30
Identities = 47/279 (16%), Positives = 88/279 (31%), Gaps = 48/279 (17%)
Query: 89 INLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSG- 147
++L + L + ++ + L N+ + + + L+ L L
Sbjct: 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNV 469
Query: 148 -HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTN 206
PS L +LTIL +S N + + L L L L N L
Sbjct: 470 DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA------------ 517
Query: 207 LVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINN 266
L+ ++ G + L L +L++ N
Sbjct: 518 ----RLWKHANPGGPIYFLKGL--------------------------SHLHILNLESNG 547
Query: 267 ITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELG-S 325
+ +L+ +DL N + + N + L ++L N ++ G +
Sbjct: 548 FDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPA 607
Query: 326 LINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLS 364
NL LD+ N ES+ V ++N +H +
Sbjct: 608 FRNLTELDMRFNPFDC-TCESIAWFVN--WINETHTNIP 643
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 1e-67
Identities = 65/458 (14%), Positives = 144/458 (31%), Gaps = 63/458 (13%)
Query: 25 LDFSLAVSSNSTEEAHALVKWKASLEVHSRSLLHSWSLSFVNATKISLCTWSGIHCNHAG 84
+ L+ ++ ++ AL + +L +WS W+
Sbjct: 18 VPIKLSRTAEYIKDYLALKEIWDALN------GKNWSQQGFGTQP--GANWN-------- 61
Query: 85 RVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNK 144
+ + G S +S + L L +P I L++LE L ++
Sbjct: 62 -----FNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHG 116
Query: 145 LSG----HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLN--HLILDSNFLGGSIP 198
P IS R + + +F + ++S+ SI
Sbjct: 117 EKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIK 176
Query: 199 RSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSI--------- 249
+S + +N+ + + + + L L + +
Sbjct: 177 KSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYA 235
Query: 250 --------DWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIV--------G 293
W L+ ++V +P + P++Q ++++ N +
Sbjct: 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDW 295
Query: 294 EIPTQLGNIIYLNRISLSGNKL-SGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVK 352
+ + I + N L + + L + L L+ N L L + GS +K
Sbjct: 296 QALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIK 354
Query: 353 LYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSR-ICRMESLEKLNLSYNNL 411
L LNL++N++++ + L +HN L + + + ++ SYN +
Sbjct: 355 LASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEI 414
Query: 412 SGLIPRCFEE-------LHGLLHIDISYNKLEGHIPNS 442
+ + F+ + I++S N++
Sbjct: 415 GSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKEL 452
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 1e-67
Identities = 62/387 (16%), Positives = 127/387 (32%), Gaps = 41/387 (10%)
Query: 90 NLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHI 149
L + + + + + + + + NL L ++ +
Sbjct: 207 KLRQFYMGNSPFV-AENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKL 265
Query: 150 PSEISLLTHLTILHISRNQL--------NGSIPHEVGQLNFLNHLILDSN-FLGGSIPRS 200
P+ + L + +++++ N+ + + + + + N + S
Sbjct: 266 PTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETS 325
Query: 201 LSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLL 260
L L L N G +P G+ L + L NQ+ IP + G Q+ L
Sbjct: 326 LQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE-IPANF-CGFTEQVENL 382
Query: 261 DVSINNITGNIP--FEIGESPQLQYLDLSSNYIVG-------EIPTQLGNIIYLNRISLS 311
+ N + IP F+ + +D S N I + I ++ I+LS
Sbjct: 383 SFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLS 441
Query: 312 GNKLSGRIPGELGSLINLEYLDLSANHLSNF-------VLESLGSLVKLYYLNLSHNKLS 364
N++S + L ++L N L+ E+ + L ++L NKL+
Sbjct: 442 NNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT 501
Query: 365 QQIP--IELDNLIHLSELDLSHNFLGEKISSRICRMESLEKL------NLSYNNLSGLIP 416
++ L +L +DLS+N K ++ +L+ + N P
Sbjct: 502 -KLSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWP 559
Query: 417 RCFEELHGLLHIDISYNKLEGHIPNST 443
L + I N + +
Sbjct: 560 EGITLCPSLTQLQIGSNDIRK-VNEKI 585
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 2e-60
Identities = 59/380 (15%), Positives = 122/380 (32%), Gaps = 38/380 (10%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLYNNELFDI--------IPPQISNLSKLEY 137
+LT + + T L + P + +++ N K++
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309
Query: 138 LDFLTNKL-SGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGS 196
+ N L + + + + + L +L NQL G +P G L L L N +
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEI 368
Query: 197 IPRSLSNFTNLVFLYLYNNSFSG-SIPQQIGNLKSLFDMKLCINQLNGAIP-----LSID 250
+ L +N ++ + + N++ L
Sbjct: 369 PANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPT 428
Query: 251 WGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVG-------EIPTQLGNII 303
+ +S +++S N I+ L ++L N + + N
Sbjct: 429 PFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTY 488
Query: 304 YLNRISLSGNKLSGRIPGEL--GSLINLEYLDLSANHLSNFV-----LESLGSLVKLYYL 356
L I L NKL+ + + +L L +DLS N S F +L
Sbjct: 489 LLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQR 547
Query: 357 NLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIP 416
+ N+ ++ P + L++L + N + K++ +I ++ L++ N +
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKI--TPNISVLDIKDNPNISIDL 604
Query: 417 RCFEELHGLLHIDISYNKLE 436
+ Y+K +
Sbjct: 605 SYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-36
Identities = 44/278 (15%), Positives = 80/278 (28%), Gaps = 32/278 (11%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLYNNELFDIIPP-QISNLSKLEYLDFLTNK 144
L S++L + + L +N+L I ++S + +DF N+
Sbjct: 354 KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNE 413
Query: 145 LSG-------HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGG-- 195
+ + +++ +++S NQ++ + L+ + L N L
Sbjct: 414 IGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIP 473
Query: 196 -----SIPRSLSNFTNLVFLYLYNNSFSGSIPQ-QIGNLKSLFDMKLCINQLNGAIPLSI 249
+ N L + L N + + L L + L N + P
Sbjct: 474 KNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQP 532
Query: 250 DWGRCPQLSLL------DVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNII 303
L D N P I P L L + SN I NI
Sbjct: 533 --LNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNIS 590
Query: 304 YLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSN 341
L+ + N + I L + +
Sbjct: 591 VLD---IKDNPNISIDLSYVCPYIEAGMYMLFYDKTQD 625
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 5e-61
Identities = 81/286 (28%), Positives = 132/286 (46%), Gaps = 53/286 (18%)
Query: 493 YEEIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPDN------------ 540
E+ A+++F K+ +G+GG G VY R+ G + AVK+ L +
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKR----LKEERTQGGELQFQTE 77
Query: 541 -----------------FCSHPRQSFIVYEYLESGSLDKILNNDASAKE-LGWTQRLNVI 582
FC P + +VY Y+ +GS+ L ++ L W +R +
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 583 KGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS-KLAG 641
G A L YLH++C P I+H D+ + N+LLD +EA V DF +AK ++ ++ + + G
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 197
Query: 642 THGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN-------- 693
T G++APE T K +EK DV+ +GV+ LE+I G+ D + +
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 694 ----IEILDSRLP--YPSLDVQNKFMSIMQVAFSCLDQNPVSRPTM 733
++D L Y +V ++QVA C +P+ RP M
Sbjct: 258 EKKLEALVDVDLQGNYKDEEV----EQLIQVALLCTQSSPMERPKM 299
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-58
Identities = 67/419 (15%), Positives = 128/419 (30%), Gaps = 52/419 (12%)
Query: 90 NLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHI 149
L I + + + + ++ SNL L ++ +
Sbjct: 449 KLQIIYFANSPFT-YDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507
Query: 150 PSEISLLTHLTILHISRNQLNG---------SIPHEVGQLNFLNHLILDSNFLGG-SIPR 199
P + L L L+I+ N+ + + + + N L
Sbjct: 508 PDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASA 567
Query: 200 SLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSL 259
SL L L +N + G L D+KL NQ+ IP Q+
Sbjct: 568 SLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEE-IPEDF-CAFTDQVEG 623
Query: 260 LDVSINNITGNIP--FEIGESPQLQYLDLSSNYIVGEIPTQLGNI-----IYLNRISLSG 312
L S N + IP F + +D S N I E ++ I + ++LS
Sbjct: 624 LGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSY 682
Query: 313 NKLSGRIPGELGSLINLEYLDLSANHLSNF-------VLESLGSLVKLYYLNLSHNKLSQ 365
N++ + + + LS N +++ + + L ++L NKL+
Sbjct: 683 NEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT- 741
Query: 366 QIP--IELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSY------NNLSGLIPR 417
+ L +LS +D+S+N ++ L+ + + N + P
Sbjct: 742 SLSDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPT 800
Query: 418 CFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEALQ-----GNKGLCGDIRGFLSCMS 471
L+ + I N + + L N + D+ +
Sbjct: 801 GITTCPSLIQLQIGSNDIR-KVDEKL------TPQLYILDIADNPNISIDVTSVCPYIE 852
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 202 bits (514), Expect = 9e-55
Identities = 68/440 (15%), Positives = 139/440 (31%), Gaps = 47/440 (10%)
Query: 30 AVSSNSTEEAHALVKWKASLEVHSRSLLHSWSLSFVNA-TKISLCTWS-GIHCNHAGRVF 87
V E A + +KA + +W I W+ + G
Sbjct: 256 NVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQP 315
Query: 88 GINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSG 147
G++L + + L L +P I L++L+ L F T+ +
Sbjct: 316 GVDLDNNG--------------RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETV 361
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQ-------LNFLNHLILDSNFLGGSIPRS 200
+ ++++ + L I + + S
Sbjct: 362 SGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421
Query: 201 LSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLL 260
+ + L N I + I L L + +
Sbjct: 422 RISLKDTQIGNLTNR--ITFISKAIQRLTKLQIIYFANSPFTYDNI-------AVDWEDA 472
Query: 261 DVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSG--- 317
+ N L ++L + + ++P L ++ L ++++ N+
Sbjct: 473 NSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQ 532
Query: 318 ------RIPGELGSLINLEYLDLSANHLSNFVLE-SLGSLVKLYYLNLSHNKLSQQIPIE 370
R+ + + ++ + N+L F SL +VKL L+ HNK+ +
Sbjct: 533 LKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-A 590
Query: 371 LDNLIHLSELDLSHNFLGEKISSRICR-MESLEKLNLSYNNLSGLIPRC-FEELHGLLHI 428
+ L++L L +N + E+I C + +E L S+N L + + ++ + +
Sbjct: 591 FGTNVKLTDLKLDYNQI-EEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSV 649
Query: 429 DISYNKLEGHIPNSTTFRDA 448
D SYNK+ N + D
Sbjct: 650 DFSYNKIGSEGRNISCSMDD 669
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-50
Identities = 69/383 (18%), Positives = 127/383 (33%), Gaps = 46/383 (12%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLYNNELFDI---------IPPQISNLSKLE 136
+LT + L T L P L L++ N + K++
Sbjct: 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQ 551
Query: 137 YLDFLTNKLSGHIPSEISL--LTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLG 194
N L P+ SL + L +L N++ G L L LD N +
Sbjct: 552 IFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE 608
Query: 195 GSIPRSL-SNFTNLVFLYLYNNSFSGSIPQ--QIGNLKSLFDMKLCINQLNG---AIPLS 248
IP + + L +N IP ++ + + N++ I S
Sbjct: 609 -EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCS 666
Query: 249 IDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYI-------VGEIPTQLGN 301
+D + S + +S N I + + LS+N + + N
Sbjct: 667 MDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKN 726
Query: 302 IIYLNRISLSGNKLSGRIPGEL--GSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLS 359
L I L NKL+ + + +L L +D+S N S+F + +L +
Sbjct: 727 TYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSSFP-TQPLNSSQLKAFGIR 784
Query: 360 H------NKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSG 413
H N++ +Q P + L +L + N + K+ ++ L L+++ N
Sbjct: 785 HQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQLYILDIADNPNIS 841
Query: 414 LIPRCFEELHGLLHIDISYNKLE 436
+ + Y+K +
Sbjct: 842 IDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-42
Identities = 55/330 (16%), Positives = 109/330 (33%), Gaps = 43/330 (13%)
Query: 90 NLTSISLNGTLLEF--SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSG 147
L + + +F + L L L N++ +I + ++E L F NKL
Sbjct: 574 KLGLLDCVHNKVRHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY 633
Query: 148 HIPSEISL--LTHLTILHISRNQLNG---SIPHEVGQLNFLN--HLILDSNFLGGSIPRS 200
IP+ + + + + S N++ +I + +N + L N +
Sbjct: 634 -IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTEL 692
Query: 201 LSNFTNLVFLYLYNNSFS-------GSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGR 253
+ + + + L NN + N L + L N+L +
Sbjct: 693 FATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATT 751
Query: 254 CPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGN 313
P LS +DVS N + P + S QL+ + GN
Sbjct: 752 LPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRD------------------AEGN 792
Query: 314 KLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDN 373
++ + P + + +L L + +N + +LY L+++ N +
Sbjct: 793 RILRQWPTGITTCPSLIQLQIGSNDIRKV---DEKLTPQLYILDIADNPNISIDVTSVCP 849
Query: 374 LIHLSELDLSHNFLGEKISSRICRMESLEK 403
I L ++ + I C +E+
Sbjct: 850 YIEAGMYVLLYDKT-QDIRG--CDALGIER 876
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 7e-10
Identities = 14/98 (14%), Positives = 34/98 (34%)
Query: 356 LNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLI 415
N + Q ++LDN ++ L L+ ++ I ++ L+ L+ ++ +
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 416 PRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEAL 453
+E + +++ H D L
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLS 401
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 4e-56
Identities = 77/388 (19%), Positives = 136/388 (35%), Gaps = 35/388 (9%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKL 145
+ + + T+ +FS +L +LDL +++ I + +L+ L N L
Sbjct: 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93
Query: 146 SGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFT 205
+ +S L L + ++ + L L L SN +
Sbjct: 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE 153
Query: 206 NLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCI-------------------------NQ 240
L L NN+ + + +L+ ++ L + Q
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQ 213
Query: 241 LNGAIPLSIDWGRCPQLSLLDVSINNITGNIP--FEIGESPQLQYLDLSSNYIVGEIPTQ 298
I + L L + P FE ++ ++L +Y
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273
Query: 299 LGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNL 358
L + L+ LS +P L L L+ L LSAN N S + L +L++
Sbjct: 274 FHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSI 332
Query: 359 SHNKLSQQIPIE-LDNLIHLSELDLSHNFLGEKISSR--ICRMESLEKLNLSYNNLSGLI 415
N ++ L+NL +L ELDLSH+ + + + L+ LNLSYN L
Sbjct: 333 KGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLK 392
Query: 416 PRCFEELHGLLHIDISYNKLEGHIPNST 443
F+E L +D+++ +L+ S
Sbjct: 393 TEAFKECPQLELLDLAFTRLKVKDAQSP 420
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 8e-55
Identities = 76/363 (20%), Positives = 143/363 (39%), Gaps = 15/363 (4%)
Query: 88 GINLTSISLNG------TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSK--LEYLD 139
S++ G S+ L + + DI P L + +E ++
Sbjct: 201 SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESIN 260
Query: 140 FLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPR 199
+ + + L L ++ L+ +P + L+ L L+L +N
Sbjct: 261 LQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQI 319
Query: 200 SLSNFTNLVFLYLYNNSFSGSI-PQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLS 258
S SNF +L L + N+ + + NL++L ++ L + + + ++ L
Sbjct: 320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQ 379
Query: 259 LLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVG-EIPTQLGNIIYLNRISLSGNKLSG 317
L++S N E PQL+ LDL+ + + + N+ L ++LS + L
Sbjct: 380 SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439
Query: 318 RIPGELGSLINLEYLDLSANHLSNFVLESLGS---LVKLYYLNLSHNKLSQQIPIELDNL 374
L L++L+L NH ++ S L +L L LS LS +L
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSL 499
Query: 375 IHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNK 434
++ +DLSHN L + ++ + LNL+ N++S ++P L I++ N
Sbjct: 500 KMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNP 558
Query: 435 LEG 437
L+
Sbjct: 559 LDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 5e-54
Identities = 67/368 (18%), Positives = 125/368 (33%), Gaps = 18/368 (4%)
Query: 90 NLTSISLNG-----TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISN--LSKLEYLDFLT 142
T++SLN +E L+ + +I + N + L F
Sbjct: 178 QATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFED 237
Query: 143 NKLSGHIPSEISLL--THLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRS 200
P+ L + +++ ++ + + L L L + L +P
Sbjct: 238 MDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSG 296
Query: 201 LSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLL 260
L + L L L N F N SL + + N + L L
Sbjct: 297 LVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLEN-LENLREL 355
Query: 261 DVSINNIT--GNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGR 318
D+S ++I ++ LQ L+LS N + L + L+ +L +
Sbjct: 356 DLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVK 415
Query: 319 IP-GELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIE---LDNL 374
+L L+ L+LS + L + L L +LNL N + + L L
Sbjct: 416 DAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475
Query: 375 IHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNK 434
L L LS L ++ + ++LS+N L+ L ++++++ N
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK-GIYLNLASNH 534
Query: 435 LEGHIPNS 442
+ +P+
Sbjct: 535 ISIILPSL 542
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-52
Identities = 71/376 (18%), Positives = 120/376 (31%), Gaps = 19/376 (5%)
Query: 79 HCNHAGRVF---GINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKL 135
+ + + L I L+ N L I S L L
Sbjct: 9 IEKEVNKTYNCENLGLNEIPGT---------LPNSTECLEFSFNVLPTIQNTTFSRLINL 59
Query: 136 EYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGG 195
+LD ++ L L ++ N L + L HL +
Sbjct: 60 TFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS 119
Query: 196 SIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCP 255
L N L LYL +N S + + L + N ++ + +
Sbjct: 120 IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQA 179
Query: 256 QLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGN--IIYLNRISLSGN 313
L+++ N+I G I +S Q L+ + I L N I L +
Sbjct: 180 TNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 314 KLSGRIPGELGSL--INLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIEL 371
P L +++E ++L ++ N + L L+L+ LS ++P L
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGL 297
Query: 372 DNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLI-PRCFEELHGLLHIDI 430
L L +L LS N SL L++ N + C E L L +D+
Sbjct: 298 VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDL 357
Query: 431 SYNKLEGHIPNSTTFR 446
S++ +E + R
Sbjct: 358 SHDDIETSDCCNLQLR 373
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-29
Identities = 40/209 (19%), Positives = 69/209 (33%), Gaps = 5/209 (2%)
Query: 260 LDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRI 319
+ + IP + + L+ S N + T +I L + L+ ++
Sbjct: 17 YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 320 PGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSE 379
S L+ L L+AN L +L L +L +S I L N L
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 380 LDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGL--LHIDISYNKLEG 437
L L N + + E L+ L+ N + L L L ++++ N + G
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
Query: 438 HIPNSTTFRDAPLEALQGNKGLCGDIRGF 466
P + G + L +G
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGL 222
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 3e-55
Identities = 66/366 (18%), Positives = 122/366 (33%), Gaps = 20/366 (5%)
Query: 89 INLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFD---IIPPQISNLSKLEYLDFLTNKL 145
+ L + + +++ L L E + + S L L L +L
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
Query: 146 S------GHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPR 199
+ I + LT+++ + + HL L + G
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF--SYNFGWQHLELVNCKFGQFPTL 322
Query: 200 SLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSL 259
L + L F G +L SL + L N L+ S L
Sbjct: 323 KLKSLKRLTFTSN-----KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 260 LDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQ-LGNIIYLNRISLSGNKLSGR 318
LD+S N + + QL++LD + + ++ L + +S
Sbjct: 378 LDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436
Query: 319 IPGELGSLINLEYLDLSANHLSNFVL-ESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHL 377
G L +LE L ++ N L + L L +L+LS +L Q P ++L L
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 496
Query: 378 SELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLL-HIDISYNKLE 436
L++SHN + + SL+ L+ S N++ + + L ++++ N
Sbjct: 497 QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556
Query: 437 GHIPNS 442
+
Sbjct: 557 CTCEHQ 562
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 5e-55
Identities = 79/391 (20%), Positives = 132/391 (33%), Gaps = 39/391 (9%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKL 145
+L+++ L G +L +FS L L L + I +L L+ L+ N +
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 146 -SGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQL----NFLNHLILDSNFLGGSIPRS 200
S +P S LT+L L +S N++ ++ L L L N + P +
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196
Query: 201 LSNFTNLVFLYLYNNSFSGSIPQQ-IGNLKSLFDMKLCINQLNGAIPLS-IDWGRCPQLS 258
L L L NN S ++ + I L L +L + + L D L
Sbjct: 197 FKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC 255
Query: 259 LLDVSINNIT------GNIPFEIGESPQLQYLDLSSNYIVGEIP---------------- 296
L + + +I + L S I
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCK 315
Query: 297 -TQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVL--ESLGSLVKL 353
Q + + L+ G L +LE+LDLS N LS +S L
Sbjct: 316 FGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 354 YYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRI-CRMESLEKLNLSYNNLS 412
YL+LS N + + L L LD H+ L + + + +L L++S+ +
Sbjct: 376 KYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 413 GLIPRCFEELHGLLHIDISYNKLEGHIPNST 443
F L L + ++ N + +
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-50
Identities = 68/388 (17%), Positives = 130/388 (33%), Gaps = 41/388 (10%)
Query: 90 NLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHI 149
N+T + + + LDL N L + + +L+ LD ++
Sbjct: 9 NITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE 68
Query: 150 PSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVF 209
L+HL+ L ++ N + L+ L L+ L + + L
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128
Query: 210 LYLYNNSF-SGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSL----LDVSI 264
L + +N S +P+ NL +L + L N++ + Q+ L LD+S+
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL--RVLHQMPLLNLSLDLSL 186
Query: 265 NNITGNIPFEIGESPQLQYLDLSSNYIVGEIP-TQLGNIIYLNRISLSGNKLSGR----- 318
N + I + +L L L +N+ + T + + L L +
Sbjct: 187 NPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245
Query: 319 -IPGELGSLINLEYLDLSANHLSNFVLE---SLGSLVKLYYLNLSHNKLSQQIPIELDNL 374
L L NL + +L ++ + L + +L + + +
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYN 303
Query: 375 IHLSELDLSHNFLGE-------------------KISSRICRMESLEKLNLSYNNLS--G 413
L+L + G+ + + SLE L+LS N LS G
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKG 363
Query: 414 LIPRCFEELHGLLHIDISYNKLEGHIPN 441
+ L ++D+S+N + N
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVITMSSN 391
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-32
Identities = 44/194 (22%), Positives = 77/194 (39%), Gaps = 9/194 (4%)
Query: 254 CPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGN 313
P ++ + N IP + + LDLS N + + L + LS
Sbjct: 7 VPNITYQCME-LNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC 62
Query: 314 KLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDN 373
++ G SL +L L L+ N + + L + L L L L+ + +
Sbjct: 63 EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122
Query: 374 LIHLSELDLSHNFL-GEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGL----LHI 428
L L EL+++HN + K+ + +LE L+LS N + + LH + L +
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 429 DISYNKLEGHIPNS 442
D+S N + P +
Sbjct: 183 DLSLNPMNFIQPGA 196
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-25
Identities = 40/194 (20%), Positives = 64/194 (32%), Gaps = 3/194 (1%)
Query: 96 LNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-S 154
L F S +L YLD+ + + LS LE L N + +I +
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 155 LLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYN 214
L +LT L +S+ QL P L+ L L + N +L L
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 527
Query: 215 NSFSGSIPQQIGNL-KSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPF 273
N S Q++ + SL + L N L V + + P
Sbjct: 528 NHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS 587
Query: 274 EIGESPQLQYLDLS 287
+ P + L+++
Sbjct: 588 DKQGMP-VLSLNIT 600
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-54
Identities = 80/349 (22%), Positives = 145/349 (41%), Gaps = 27/349 (7%)
Query: 90 NLTSISLNGTLLE--FSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSG 147
L + + + L + ++ I I L+ LEYL+ N+++
Sbjct: 23 EGIRAVLQKASVTDVVTQEELESITKLVVAGEKVASI--QGIEYLTNLEYLNLNGNQITD 80
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207
P +S L LT L+I N++ + + L L L L+ + + P L+N T +
Sbjct: 81 ISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LANLTKM 134
Query: 208 VFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267
L L N S + N+ L + + +++ P+ L L ++ N I
Sbjct: 135 YSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTPI----ANLTDLYSLSLNYNQI 189
Query: 268 TGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLI 327
P L Y N I P + N+ LN + + NK++ P L +L
Sbjct: 190 EDISPL--ASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLS 243
Query: 328 NLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFL 387
L +L++ N +S+ + ++ L KL LN+ N++S L+NL L+ L L++N L
Sbjct: 244 QLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQL 299
Query: 388 GEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLE 436
G + I + +L L LS N+++ + P L + D + ++
Sbjct: 300 GNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-53
Identities = 72/352 (20%), Positives = 138/352 (39%), Gaps = 27/352 (7%)
Query: 91 LTSISLNGTLLE--FSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGH 148
+++ + F + L + D++ L + L K++
Sbjct: 2 AATLATLPAPINQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS- 58
Query: 149 IPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLV 208
I LT+L L+++ NQ+ P + L L +L + +N + + +L N TNL
Sbjct: 59 -IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLR 113
Query: 209 FLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNIT 268
LYL ++ S P + NL ++ + L N + L+ L V+ + +
Sbjct: 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS---PLSNMTGLNYLTVTESKVK 168
Query: 269 GNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLIN 328
P L L L+ N I P L ++ L+ + N+++ P + ++
Sbjct: 169 DVTPI--ANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTR 222
Query: 329 LEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLG 388
L L + N +++ L L +L +L +L + N++S + +L L L++ N +
Sbjct: 223 LNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI- 277
Query: 389 EKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIP 440
IS + + L L L+ N L L L + +S N + P
Sbjct: 278 SDISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-45
Identities = 68/278 (24%), Positives = 131/278 (47%), Gaps = 21/278 (7%)
Query: 90 NLTSISLNGTLLEF--SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSG 147
LT++ + + + + +L L L + + DI P ++NL+K+ L+ N
Sbjct: 89 KLTNLYIGTNKITDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS 146
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207
+ S +S +T L L ++ +++ P + L L L L+ N + P L++ T+L
Sbjct: 147 DL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSL 201
Query: 208 VFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267
+ Y N + P + N+ L +K+ N++ PL QL+ L++ N I
Sbjct: 202 HYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPL----ANLSQLTWLEIGTNQI 255
Query: 268 TGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLI 327
+ +I + + +L+ L++ SN I + L N+ LN + L+ N+L +G L
Sbjct: 256 S-DIN-AVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLT 311
Query: 328 NLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQ 365
NL L LS NH+++ + L SL K+ + ++ + +
Sbjct: 312 NLTTLFLSQNHITD--IRPLASLSKMDSADFANQVIKK 347
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 8e-21
Identities = 30/161 (18%), Positives = 69/161 (42%), Gaps = 12/161 (7%)
Query: 281 LQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLS 340
L I +I ++ R L ++ + L ++ L ++ ++
Sbjct: 2 AATLATLPAPI-NQI-FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 341 NFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMES 400
+ ++ + L L YLNL+ N+++ P+ NL+ L+ L + N + IS+ + + +
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKI-TDISA-LQNLTN 111
Query: 401 LEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPN 441
L +L L+ +N+S + P L + +++ N +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP 150
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 5e-52
Identities = 78/287 (27%), Positives = 117/287 (40%), Gaps = 60/287 (20%)
Query: 493 YEEIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVK--------------------- 531
++ ATN+FD K IG G G VY + G A+K
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 532 KFHSPLPDN------FCSHPRQSFIVYEYLESGSLDKIL-NNDASAKELGWTQRLNVIKG 584
P + FC + ++Y+Y+E+G+L + L +D + W QRL + G
Sbjct: 91 FCRHP---HLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 585 VADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK-FLNLDSSNWS-KLAGT 642
A L YLH I+H D+ S N+LLD + ++DF I+K LD ++ S + GT
Sbjct: 148 AARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
Query: 643 HGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI-------- 694
G + PE ++TEK DVYSFGV+ EV+ + S +N+
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV----QSLPREMVNLAEWAVESH 260
Query: 695 ------EILDSRLP--YPSLDVQNKFMSIMQVAFSCLDQNPVSRPTM 733
+I+D L A CL + RP+M
Sbjct: 261 NNGQLEQIVDPNLADKIRP----ESLRKFGDTAVKCLALSSEDRPSM 303
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-50
Identities = 84/355 (23%), Positives = 145/355 (40%), Gaps = 31/355 (8%)
Query: 90 NLTSISLNGTLLE--FSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSG 147
NLT I+ + L + L + + NN++ DI P ++NL+ L L N+++
Sbjct: 69 NLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD 126
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207
P + LT+L L +S N ++ + L L L + + L+N T L
Sbjct: 127 IDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTL 179
Query: 208 VFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267
L + +N S + L +L + NQ++ PL G L L ++ N +
Sbjct: 180 ERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPL----GILTNLDELSLNGNQL 233
Query: 268 TGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLI 327
L LDL++N I P L + L + L N++S P L L
Sbjct: 234 KDIGTL--ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLT 287
Query: 328 NLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFL 387
L L+L+ N L + + + +L L YL L N +S P+ +L L L +N +
Sbjct: 288 ALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFYNNKV 343
Query: 388 GEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNS 442
+SS + + ++ L+ +N +S L P L + + ++ N
Sbjct: 344 -SDVSS-LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNY 394
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 1e-48
Identities = 88/353 (24%), Positives = 153/353 (43%), Gaps = 31/353 (8%)
Query: 90 NLTSISLNGTLLEF--SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSG 147
+T++ + ++ +L ++ NN+L DI P + NL+KL + N+++
Sbjct: 47 QVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 104
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207
+ ++ LT+LT L + NQ+ P + L LN L L SN + S +LS T+L
Sbjct: 105 --ITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTI--SDISALSGLTSL 158
Query: 208 VFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267
L N + P + NL +L + + N+++ L + L L + N I
Sbjct: 159 QQLSFGNQ-VTDLKP--LANLTTLERLDISSNKVSDISVL----AKLTNLESLIATNNQI 211
Query: 268 TGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLI 327
+ P +G L L L+ N + L ++ L + L+ N++S P L L
Sbjct: 212 SDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLT 265
Query: 328 NLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFL 387
L L L AN +SN + L L L L L+ N+L + NL +L+ L L N +
Sbjct: 266 KLTELKLGANQISN--ISPLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNI 321
Query: 388 GEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIP 440
IS + + L++L N +S + L + + +N++ P
Sbjct: 322 -SDISP-VSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQISDLTP 370
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-48
Identities = 86/338 (25%), Positives = 150/338 (44%), Gaps = 29/338 (8%)
Query: 103 FSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTIL 162
F+ ++ L + D + ++L ++ L + + L +LT +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQI 73
Query: 163 HISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIP 222
+ S NQL P + L L +++++N + P L+N TNL L L+NN + P
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129
Query: 223 QQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQ 282
+ NL +L ++L N ++ LS L L N +T P + L+
Sbjct: 130 --LKNLTNLNRLELSSNTISDISALS----GLTSLQQLSFG-NQVTDLKP--LANLTTLE 180
Query: 283 YLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNF 342
LD+SSN + + L + L + + N++S P LG L NL+ L L+ N L +
Sbjct: 181 RLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD- 235
Query: 343 VLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLE 402
+ +L SL L L+L++N++S P+ L L+EL L N + IS + + +L
Sbjct: 236 -IGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQI-SNISP-LAGLTALT 290
Query: 403 KLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIP 440
L L+ N L + P L L ++ + +N + P
Sbjct: 291 NLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 3e-46
Identities = 91/335 (27%), Positives = 147/335 (43%), Gaps = 29/335 (8%)
Query: 90 NLTSISLNGTLLE--FSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSG 147
L I +N + ++ +L L L+NN++ DI P + NL+ L L+ +N +S
Sbjct: 91 KLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD 148
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207
S +S LT L L NQ+ P + L L L + SN + S L+ TNL
Sbjct: 149 --ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKV--SDISVLAKLTNL 201
Query: 208 VFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267
L NN S P +G L +L ++ L NQL L+ L+ LD++ N I
Sbjct: 202 ESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLA----SLTNLTDLDLANNQI 255
Query: 268 TGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLI 327
+ P + +L L L +N I P L + L + L+ N+L P + +L
Sbjct: 256 SNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLK 309
Query: 328 NLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFL 387
NL YL L N++S+ + + SL KL L +NK+S L NL +++ L HN +
Sbjct: 310 NLTYLTLYFNNISD--ISPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQI 365
Query: 388 GEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEL 422
+ + + + +L L+ + +
Sbjct: 366 SDLTP--LANLTRITQLGLNDQAWTNAPVNYKANV 398
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-39
Identities = 75/329 (22%), Positives = 132/329 (40%), Gaps = 26/329 (7%)
Query: 90 NLTSISLNGTLLEFS-FSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGH 148
+L +S + + ++ L LD+ +N++ DI ++ L+ LE L N++S
Sbjct: 157 SLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDI 214
Query: 149 IPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLV 208
P + +LT+L L ++ NQL + L L L L +N + P LS T L
Sbjct: 215 TP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLT 268
Query: 209 FLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNIT 268
L L N S P + L +L +++L NQL P+ L+ L + NNI+
Sbjct: 269 ELKLGANQISNISP--LAGLTALTNLELNENQLEDISPI----SNLKNLTYLTLYFNNIS 322
Query: 269 GNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLIN 328
P + +LQ L +N + + L N+ +N +S N++S P L +L
Sbjct: 323 DISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTR 376
Query: 329 LEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQI-PIELDNLIHLSELDLSHNFL 387
+ L L+ +N + ++ N N I P + + +E D++ N
Sbjct: 377 ITQLGLNDQAWTNAPVNYKANVS---IPNTVKNVTGALIAPATISDGGSYTEPDITWNLP 433
Query: 388 GEKISSRICRMESLEKLNLSYNNLSGLIP 416
+ + SG +
Sbjct: 434 -SYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 8e-11
Identities = 18/138 (13%), Positives = 48/138 (34%), Gaps = 7/138 (5%)
Query: 90 NLTSISLNGTLLEF--SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSG 147
L + + S ++ ++ +L +N++ D+ P ++NL+++ L +
Sbjct: 332 KLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207
+ + ++ + L P + + N F+
Sbjct: 390 APVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQP 446
Query: 208 VFLYLYNNSFSGSIPQQI 225
V + +FSG++ Q +
Sbjct: 447 VTIGKGTTTFSGTVTQPL 464
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 3e-47
Identities = 68/357 (19%), Positives = 123/357 (34%), Gaps = 18/357 (5%)
Query: 89 INLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLT------ 142
+ L + +++ + L L E D +I S +E L +T
Sbjct: 209 LTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL 268
Query: 143 --NKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRS 200
+ L +++ + ++ + +V + L + L
Sbjct: 269 TYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQF---P 323
Query: 201 LSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLL 260
+ L L L N GSI + L SL + L N L+ + S L L
Sbjct: 324 TLDLPFLKSLTLTMNK--GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHL 381
Query: 261 DVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQ-LGNIIYLNRISLSGNKLSGRI 319
D+S N + +LQ+LD + + ++ L + +S
Sbjct: 382 DLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDF 440
Query: 320 PGELGSLINLEYLDLSANHLSNFVLES-LGSLVKLYYLNLSHNKLSQQIPIELDNLIHLS 378
G L +L L ++ N + L + + L +L+LS +L Q D L L
Sbjct: 441 DGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQ 500
Query: 379 ELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKL 435
L++SHN L SS ++ SL L+ S+N + L +++ N +
Sbjct: 501 LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-46
Identities = 72/367 (19%), Positives = 123/367 (33%), Gaps = 46/367 (12%)
Query: 108 FPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRN 167
+DL N L + SN S+L++LD ++ L HL+ L ++ N
Sbjct: 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90
Query: 168 QLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSG-SIPQQIG 226
+ P L L +L+ L + L L + +N +P
Sbjct: 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150
Query: 227 NLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSL--LDVSINNITGNIPFEIGESPQLQYL 284
NL +L + L N + + + R LD+S+N I I + + +L L
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHEL 209
Query: 285 DLSSNYIVGEIPTQLGNII---------------------------------YLNRISLS 311
L N+ I + ++ L+
Sbjct: 210 TLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269
Query: 312 GNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIEL 371
+ L N+ + L+ + LE + K L++ +L Q
Sbjct: 270 YTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ---FPT 324
Query: 372 DNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHG--LLHID 429
+L L L L+ N IS + + SL L+LS N LS + +L L H+D
Sbjct: 325 LDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382
Query: 430 ISYNKLE 436
+S+N
Sbjct: 383 LSFNGAI 389
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-28
Identities = 46/205 (22%), Positives = 84/205 (40%), Gaps = 11/205 (5%)
Query: 254 CPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGN 313
P ++ ++ +P +I S + +DLS N + N L + LS
Sbjct: 11 VPNITY-QCMDQKLS-KVPDDIPSS--TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRC 66
Query: 314 KLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDN 373
++ L +L L L+ N + +F S L L L KL+ +
Sbjct: 67 EIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQ 126
Query: 374 LIHLSELDLSHNFLGE-KISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGL----LHI 428
LI L +L+++HNF+ K+ + + +L ++LSYN + + + L L +
Sbjct: 127 LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSL 186
Query: 429 DISYNKLEGHIPNSTTFRDAPLEAL 453
D+S N ++ I + F+ L L
Sbjct: 187 DMSLNPID-FIQDQ-AFQGIKLHEL 209
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-46
Identities = 77/289 (26%), Positives = 120/289 (41%), Gaps = 55/289 (19%)
Query: 493 YEEIIRATNDFDAKHC------IGKGGHGSVYIARVPSGEIFAVKKFHSPLPDN------ 540
+ E+ TN+FD + +G+GG G VY V + + AVKK + +
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELKQ 75
Query: 541 ----------------------FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQR 578
F S +VY Y+ +GSL L+ L W R
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 579 LNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL--NLDSSNW 636
+ +G A+ + +LH N +H DI S N+LLD + A +SDF +A+ +
Sbjct: 136 CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192
Query: 637 SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS--------- 687
S++ GT +APE A ++T K D+YSFGV+ LE+I G D E
Sbjct: 193 SRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE 251
Query: 688 SSSNMNIEILDSRL-PYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKR 735
+ +D ++ S V ++ VA CL + RP +K+
Sbjct: 252 DEEKTIEDYIDKKMNDADSTSV----EAMYSVASQCLHEKKNKRPDIKK 296
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 9e-44
Identities = 75/375 (20%), Positives = 142/375 (37%), Gaps = 28/375 (7%)
Query: 89 INLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGH 148
+++ + + F + + + N+ + + + + ++E L+ ++
Sbjct: 26 VHIDMQTQD-VYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-E 83
Query: 149 IPSEI-SLLTHLTILHISRNQLNGSIPHEVGQ-LNFLNHLILDSNFLGGSIPRSLSNFTN 206
I + + + L++ N + +P V Q + L L+L+ N L N
Sbjct: 84 IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPK 142
Query: 207 LVFLYLYNNSFSGSIPQQI-GNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSIN 265
L L + NN+ I SL +++L N+L +D P L +VS N
Sbjct: 143 LTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-----HVDLSLIPSLFHANVSYN 196
Query: 266 NITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGS 325
++ + ++ LD S N I + L L N L+ L +
Sbjct: 197 LLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTILK---LQHNNLTD--TAWLLN 246
Query: 326 LINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHN 385
L +DLS N L + + +L L +S+N+L + + + L LDLSHN
Sbjct: 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 305
Query: 386 FLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTF 445
L + + + LE L L +N++ L H L ++ +S+N + F
Sbjct: 306 HL-LHVERNQPQFDRLENLYLDHNSIVTLKLSTH---HTLKNLTLSHNDWD-CNSLRALF 360
Query: 446 RDAPLEALQGNKGLC 460
R+ A+ C
Sbjct: 361 RNVARPAVDDADQHC 375
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 34/189 (17%), Positives = 65/189 (34%), Gaps = 25/189 (13%)
Query: 256 QLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKL 315
DV I+ T ++ F + + L++ ++ + +
Sbjct: 20 DCVFYDVHIDMQTQDVYF------GFEDITLNN----------------QKIVTFKNSTM 57
Query: 316 SGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLI 375
L S +E L+L+ + + + L + N + P N+
Sbjct: 58 RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP 117
Query: 376 HLSELDLSHNFLGEKISSRI-CRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNK 434
L+ L L N L + I L L++S NNL + F+ L ++ +S N+
Sbjct: 118 LLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 176
Query: 435 LEGHIPNST 443
L H+ S
Sbjct: 177 LT-HVDLSL 184
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 27/149 (18%), Positives = 50/149 (33%), Gaps = 1/149 (0%)
Query: 295 IPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLY 354
I + L + + E +L N + + + + L S ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 355 YLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGL 414
LNL+ ++ + + +L + N + + L L L N+LS L
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSL 132
Query: 415 IPRCFEELHGLLHIDISYNKLEGHIPNST 443
F L + +S N LE I + T
Sbjct: 133 PRGIFHNTPKLTTLSMSNNNLE-RIEDDT 160
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 8e-43
Identities = 58/331 (17%), Positives = 107/331 (32%), Gaps = 27/331 (8%)
Query: 90 NLTSISLNG-TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGH 148
++ G T L + + + +N + + L
Sbjct: 13 GRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS-AWRQANSNNPQIETRTGRALK-A 70
Query: 149 IPSEISLLTH--LTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTN 206
+ T L + L P + +L+ L H+ +D+ L +P ++ F
Sbjct: 71 TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAG 128
Query: 207 LVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINN 266
L L L N ++P I +L L + CP+L+ L + +
Sbjct: 129 LETLTLARNPLR-ALPASIASLNRL---------------RELSIRACPELTELPEPLAS 172
Query: 267 ITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSL 326
E LQ L L I +P + N+ L + + + LS + + L
Sbjct: 173 TD--ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHL 228
Query: 327 INLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNF 386
LE LDL G L L L +P+++ L L +LDL
Sbjct: 229 PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCV 288
Query: 387 LGEKISSRICRMESLEKLNLSYNNLSGLIPR 417
++ S I ++ + + + + + L
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-41
Identities = 58/324 (17%), Positives = 102/324 (31%), Gaps = 23/324 (7%)
Query: 129 ISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLIL 188
+ S E L F + +S +R + N
Sbjct: 8 HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNNPQIETR 63
Query: 189 DSNFLGGSIPRSLSNFT--NLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIP 246
L + L + T V L L + P Q L L M + L +P
Sbjct: 64 TGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELP 120
Query: 247 LSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIY-- 304
++ + L L ++ N + +P I +L+ L + + + E+P L +
Sbjct: 121 DTM--QQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 305 -------LNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLN 357
L + L + +P + +L NL+ L + + LS ++ L KL L+
Sbjct: 178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELD 235
Query: 358 LSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPR 417
L + P L L L + I R+ LEKL+L +P
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
Query: 418 CFEELHGLLHIDISYNKLEGHIPN 441
+L I + + +
Sbjct: 296 LIAQLPANCIILVPPHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-41
Identities = 45/310 (14%), Positives = 99/310 (31%), Gaps = 28/310 (9%)
Query: 90 NLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDI--IPPQISNLS--KLEYLDFLTNKL 145
S + + + + + + L+ + L
Sbjct: 34 QWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPL 93
Query: 146 SGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFT 205
P + L+HL + I L +P + Q L L L N L ++P S+++
Sbjct: 94 P-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLN 150
Query: 206 NLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSIN 265
L L + +P+ + + + + + +N L L +
Sbjct: 151 RLRELSIRACPELTELPEPLASTDASGEHQGLVN-----------------LQSLRLEWT 193
Query: 266 NITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGS 325
I ++P I L+ L + ++ + + + ++ L + L G P G
Sbjct: 194 GIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGG 251
Query: 326 LINLEYLDLS-ANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSH 384
L+ L L ++L + + L +L L+L ++P + L + +
Sbjct: 252 RAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPP 310
Query: 385 NFLGEKISSR 394
+ + R
Sbjct: 311 HLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 48/282 (17%), Positives = 91/282 (32%), Gaps = 21/282 (7%)
Query: 171 GSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKS 230
GS H + +L + LS + + N +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 231 LFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNY 290
L A ++ P L++ + P + LQ++ + +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 291 IVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSA-NHLSNF------- 342
++ E+P + L ++L+ N L +P + SL L L + A L+
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 343 -VLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESL 401
LV L L L + + +P + NL +L L + ++ L + I + L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGI-RSLPASIANLQNLKSLKIRNSPL-SALGPAIHHLPKL 231
Query: 402 EKLNLSYNNLSGLIPRCFEELHGLLHIDIS-YNKLEGHIPNS 442
E+L+L P F L + + + L +P
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLD 272
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 27/142 (19%), Positives = 51/142 (35%), Gaps = 4/142 (2%)
Query: 90 NLTSISLNGTLLEF---SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLS 146
NL S+ L T + S ++ +L L + N+ L + P I +L KLE LD
Sbjct: 184 NLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDLRGCTAL 242
Query: 147 GHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTN 206
+ P L L + ++P ++ +L L L L +P ++
Sbjct: 243 RNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302
Query: 207 LVFLYLYNNSFSGSIPQQIGNL 228
+ + + + +
Sbjct: 303 NCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 23/120 (19%), Positives = 39/120 (32%), Gaps = 5/120 (4%)
Query: 90 NLTSISLNGTLLEF---SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFL-TNKL 145
NL S+ + + L + P L LDL PP + L+ L + L
Sbjct: 207 NLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266
Query: 146 SGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFT 205
+P +I LT L L + +P + QL +++ +
Sbjct: 267 L-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 53/298 (17%), Positives = 99/298 (33%), Gaps = 60/298 (20%)
Query: 493 YEEIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPDNF----------- 541
E + + +G G V+ A++ E AVK F ++
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPG 74
Query: 542 ------------CSHPR----QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGV 585
+++ + E GSL L + + W + ++ + +
Sbjct: 75 MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAETM 130
Query: 586 ADALFYLHNNCF-------PPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS- 637
A L YLH + P I H DI SKNVLL A ++DF +A S
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190
Query: 638 -KLAGTHGNVAPELA-----YTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFE------M 685
GT +APE+ + + D+Y+ G++ E+ D +
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250
Query: 686 SSSSSNMNIEILDS-------RLPYPSLDVQNKFMSIM-QVAFSCLDQNPVSRPTMKR 735
+ ++E + R ++ M+++ + C D + +R +
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 7e-41
Identities = 79/399 (19%), Positives = 143/399 (35%), Gaps = 39/399 (9%)
Query: 73 CTWSGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNL 132
C++ G + NLT + L L N + + L
Sbjct: 2 CSFDGRIAFYRFC----NLTQV----------PQVLNTTERLLLSFNYIRTVTASSFPFL 47
Query: 133 SKLEYLDFLTNKLSGHIPSEI-SLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSN 191
+L+ L+ + I E L +L IL + +++ P L L L L
Sbjct: 48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFC 107
Query: 192 FLGGSI--PRSLSNFTNLVFLYLYNNSFSG-SIPQQIGNLKSLFDMKLCINQLNGAIPLS 248
L ++ N L L L N + G L SL + NQ+
Sbjct: 108 GLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHE 167
Query: 249 IDWGRCPQLSLLDVSINNITGNIPFEIGESPQ------LQYLDLSSNYIVGEIPTQLGNI 302
++ + LS ++ N++ + + G+ L+ LD+S N +I N
Sbjct: 168 LEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNA 227
Query: 303 I------------YLNRISLSGNKLSGRIPGELGSL--INLEYLDLSANHLSNFVLESLG 348
I ++ + + L ++ +LDLS + +
Sbjct: 228 ISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFE 287
Query: 349 SLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSY 408
+L L LNL++NK+++ L +L L+LS+N LGE SS + + ++L
Sbjct: 288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347
Query: 409 NNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRD 447
N+++ + + F+ L L +D+ N L I + D
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNALT-TIHFIPSIPD 385
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 1e-38
Identities = 83/386 (21%), Positives = 139/386 (36%), Gaps = 37/386 (9%)
Query: 89 INLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGH 148
+ L S T+ + +F + P+L LDL +++++ + P L L L LS
Sbjct: 53 LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDA 112
Query: 149 IPSEISL--LTHLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIPRSLSNFT 205
+ + L LT L +S+NQ+ H G+LN L + SN + L
Sbjct: 113 VLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172
Query: 206 --NLVFLYLYNNSFSGSIPQQI------------------GNLKSLFDMKLCINQLNGAI 245
L F L NS + GN ++ N ++ +
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQ 232
Query: 246 PLSIDWGRCPQLSLLDVSINNITGNIP--FEIGESPQLQYLDLSSNYIVGEIPTQLGNII 303
S+ + +NI F +++LDLS ++ +
Sbjct: 233 AFSLILA--HHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLK 290
Query: 304 YLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKL 363
L ++L+ NK++ L NL+ L+LS N L + L K+ Y++L N +
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
Query: 364 SQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELH 423
+ L L LDL N L + I + S+ + LS N L L
Sbjct: 351 AIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLVTLPKINLT--- 402
Query: 424 GLLHIDISYNKLEGHIPNSTTFRDAP 449
I +S N+LE ++ P
Sbjct: 403 -ANLIHLSENRLE-NLDILYFLLRVP 426
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-33
Identities = 83/403 (20%), Positives = 139/403 (34%), Gaps = 49/403 (12%)
Query: 92 TSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNL--SKLEYLDFLTNKLSGHI 149
+ FS H+ + + D + L S + +LD +
Sbjct: 223 NFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLN 282
Query: 150 PSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVF 209
L L +L+++ N++N L+ L L L N LG + + +
Sbjct: 283 SRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAY 342
Query: 210 LYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITG 269
+ L N + Q L+ L LD+ N +T
Sbjct: 343 IDLQKNHIAIIQDQTFKFLEKL--------------------------QTLDLRDNALT- 375
Query: 270 NIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSG-RIPGELGSLIN 328
I P + + LS N +V +P + N I LS N+L I L + +
Sbjct: 376 ----TIHFIPSIPDIFLSGNKLV-TLPK---INLTANLIHLSENRLENLDILYFLLRVPH 427
Query: 329 LEYLDLSANHLSNFVLESL-GSLVKLYYLNLSHNKLSQQIPIELD-----NLIHLSELDL 382
L+ L L+ N S+ + L L L N L EL L HL L L
Sbjct: 428 LQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYL 487
Query: 383 SHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNS 442
+HN+L + +L L+L+ N L+ L L +DIS N+L PN
Sbjct: 488 NHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQL--LAPNP 543
Query: 443 TTFRDAPLEALQGNKGLCG-DIRGFLSCMSYRKASRKIWIVIV 484
F + + NK +C ++ F++ +++ + +
Sbjct: 544 DVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADI 586
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-30
Identities = 70/395 (17%), Positives = 135/395 (34%), Gaps = 61/395 (15%)
Query: 90 NLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLS--KLEYLDFLTNKLSG 147
+ S+ L+ SF L +D +N++F + ++ L L + N L
Sbjct: 134 QIRSLYLHP-----SFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYS 188
Query: 148 HIPSEISLL------THLTILHI------------SRNQLNGSIPHEVGQLNFLNHLILD 189
+ + L IL + N ++ S + + +
Sbjct: 189 RVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFG 248
Query: 190 SNFLGGSIPRSLSNF--TNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPL 247
+ + + + +++ L L + + LK L + L N++N I
Sbjct: 249 FHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINK-IAD 307
Query: 248 SIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNR 307
+G L +L++S N + P++ Y+DL N+I + L
Sbjct: 308 EAFYG-LDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQT 366
Query: 308 ISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNF---------------------VLES 346
+ L N L+ + + ++ + LS N L +L
Sbjct: 367 LDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYF 421
Query: 347 LGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFLGEKISSRICR-----MES 400
L + L L L+ N+ S + L +L L N L + +C +
Sbjct: 422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH 481
Query: 401 LEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKL 435
L+ L L++N L+ L P F L L + ++ N+L
Sbjct: 482 LQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-29
Identities = 69/339 (20%), Positives = 132/339 (38%), Gaps = 35/339 (10%)
Query: 90 NLTSISLNGT-LLEFSFSSFPHLA-----YLDLYNNELFDIIPPQISNLSKLEYLDFLTN 143
++ + + ++F LA +LDL + +F + L L+ L+ N
Sbjct: 241 HIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYN 300
Query: 144 KLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSN 203
K++ L +L +L++S N L L + ++ L N + ++
Sbjct: 301 KINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360
Query: 204 FTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVS 263
L L L +N+ + I + S+ D+ L N+L +++ +L+ +S
Sbjct: 361 LEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINL------TANLIHLS 409
Query: 264 INNITGNIPFEIGES-PQLQYLDLSSNYIVG----EIPTQLGNIIYLNRISLSGNKLSGR 318
N + P LQ L L+ N + P++ ++ L L N L
Sbjct: 410 ENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLF---LGENMLQLA 466
Query: 319 IPGEL-----GSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDN 373
EL L +L+ L L+ N+L++ L L L+L+ N+L+ +
Sbjct: 467 WETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND-L 524
Query: 374 LIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLS 412
+L LD+S N L + + SL L++++N
Sbjct: 525 PANLEILDISRNQL-LAPNPDV--FVSLSVLDITHNKFI 560
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-12
Identities = 24/121 (19%), Positives = 42/121 (34%), Gaps = 5/121 (4%)
Query: 330 EYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGE 389
+L+ V + L + L LS N + L L L+L +
Sbjct: 7 RIAFYRFCNLTQ-VPQVLNTTE---RLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62
Query: 390 KISSRICR-MESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDA 448
I R + +L L+L + + L P F+ L L + + + L + FR+
Sbjct: 63 TIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNL 122
Query: 449 P 449
Sbjct: 123 K 123
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 57/256 (22%), Positives = 105/256 (41%), Gaps = 33/256 (12%)
Query: 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSP-LPDNF---------CSHP----- 545
+ + + +G+G G V A+ + A+K+ S F +HP
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKL 66
Query: 546 -----RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 600
+V EY E GSL +L+ ++ + + YLH+ +
Sbjct: 67 YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 601 VHWDISSKNVLLDLGYE-AHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEK 659
+H D+ N+LL G + DF A + ++ + G+ +APE+ +EK
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 660 CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEIL-DSRLPYPSLDVQNKFMSIMQV 718
CDV+S+G++ EVI + P D E+ + + + +R P ++ S+M
Sbjct: 184 CDVFSWGIILWEVITRRKPFD---EIGGPAFRIMWAVHNGTRPPLIK-NLPKPIESLMT- 238
Query: 719 AFSCLDQNPVSRPTMK 734
C ++P RP+M+
Sbjct: 239 --RCWSKDPSQRPSME 252
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 8e-40
Identities = 77/403 (19%), Positives = 145/403 (35%), Gaps = 39/403 (9%)
Query: 61 SLSFVNATKISLCTWSGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNE 120
+++ C + +H + F + + + N+
Sbjct: 15 EYKCIDSNLQYDCVFYDVHIDM------------QTQDVYFGFEDITLNNQKIVTFKNST 62
Query: 121 LFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTILHISRNQLNGSIPHEVGQ 179
+ + + + ++E L+ ++ I + + + L++ N + +P V Q
Sbjct: 63 MRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQ 120
Query: 180 -LNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQI-GNLKSLFDMKLC 237
+ L L+L+ N L N L L + NN+ I SL +++L
Sbjct: 121 NVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLS 179
Query: 238 INQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPT 297
N+L +D P L +VS N ++ + ++ LD S N I
Sbjct: 180 SNRLT-----HVDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGP 229
Query: 298 QLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLN 357
+ L L N L+ L + L +DLS N L + + +L L
Sbjct: 230 VNVELTILK---LQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLY 284
Query: 358 LSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPR 417
+S+N+L + + + L LDLSHN L + + + LE L L +N++ L
Sbjct: 285 ISNNRLV-ALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIVTL--- 339
Query: 418 CFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEALQGNKGLC 460
H L ++ +S+N + FR+ A+ C
Sbjct: 340 KLSTHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHC 381
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-27
Identities = 60/306 (19%), Positives = 122/306 (39%), Gaps = 19/306 (6%)
Query: 133 SKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNF 192
+ Y I S + +HI + E LN + ++
Sbjct: 3 GQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNST 62
Query: 193 LGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQI-GNLKSLFDMKLCINQLNGAIPLSIDW 251
+ L +F + L L + I ++ + + N + +P +
Sbjct: 63 MRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQ 120
Query: 252 GRCPQLSLLDVSINNITGNIPFEI-GESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISL 310
P L++L + N+++ ++P I +P+L L +S+N + L + L
Sbjct: 121 N-VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQL 178
Query: 311 SGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIE 370
S N+L+ + L + +L + ++S N LS +L + + L+ SHN ++ +
Sbjct: 179 SSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV---VR 227
Query: 371 LDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDI 430
+ L+ L L HN L + ++ + L +++LSYN L ++ F ++ L + I
Sbjct: 228 GPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYI 285
Query: 431 SYNKLE 436
S N+L
Sbjct: 286 SNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 61/283 (21%), Positives = 106/283 (37%), Gaps = 22/283 (7%)
Query: 164 ISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQ 223
R I + + +D N + N++ +P
Sbjct: 10 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPA 68
Query: 224 QI-GNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGES-PQL 281
+ + + + + L Q+ I + L + N I +P + ++ P L
Sbjct: 69 ALLDSFRQVELLNLNDLQIE-EIDTYAFAY-AHTIQKLYMGFNAIR-YLPPHVFQNVPLL 125
Query: 282 QYLDLSSNYIVGEIPTQL-GNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLS 340
L L N + +P + N L +S+S N L + +L+ L LS+N L+
Sbjct: 126 TVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 184
Query: 341 NFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMES 400
+ L + L++ N+S+N LS L I + ELD SHN + + +
Sbjct: 185 HV---DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI-NVVRGPVNV--E 233
Query: 401 LEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNST 443
L L L +NNL+ GL+ +D+SYN+LE I
Sbjct: 234 LTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELE-KIMYHP 273
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-39
Identities = 83/402 (20%), Positives = 145/402 (36%), Gaps = 61/402 (15%)
Query: 90 NLTSISLNGTLL----EFSFSSFPHLAYLDLYNNELFDI-IPPQISNLSKLEYLDFLTNK 144
+L + T L F L L++ +N + +P SNL+ LE+LD +NK
Sbjct: 101 SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160
Query: 145 LSGHIPSEISLLTHLTI----LHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPR- 199
+ +++ +L + + L +S N +N I + L+ L L +NF ++ +
Sbjct: 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKT 219
Query: 200 ---------------------------SLSNFTNLVFLYL------YNNSFSGSIPQQIG 226
S L L + Y + + I
Sbjct: 220 CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279
Query: 227 NLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDL 286
L ++ L + S ++G L L++ L+ L
Sbjct: 280 CLTNVSSFSLVSVTIERVKDFSYNFG-WQHLELVNCKFGQFPTLKL------KSLKRLTF 332
Query: 287 SSNYIVGEIP-TQLGNIIYLNRISLSGNKLS--GRIPGELGSLINLEYLDLSANHLSNFV 343
+SN L ++ +L+ LS N LS G +L+YLDLS N +
Sbjct: 333 TSNKGGNAFSEVDLPSLEFLD---LSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMS 389
Query: 344 LESLGSLVKLYYLNLSHNKLSQQIPIE-LDNLIHLSELDLSHNFLGEKISSRICRMESLE 402
+ L +L +L+ H+ L Q +L +L LD+SH + + SLE
Sbjct: 390 -SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448
Query: 403 KLNLSYNNLSGLIPR-CFEELHGLLHIDISYNKLEGHIPNST 443
L ++ N+ F EL L +D+S +LE + +
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTA 489
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-37
Identities = 76/341 (22%), Positives = 120/341 (35%), Gaps = 24/341 (7%)
Query: 109 PHLAYLDLYNNEL-FDIIPPQISNLSKLEYLDFLTNKLSGH---IPSEISLLTHLTILHI 164
L L L NN +++ I L+ LE + + + S L L L I
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 165 SRNQLNG------SIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFS 218
+L I L ++ L S + + S L L N F
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKFG 317
Query: 219 GSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNIT--GNIPFEIG 276
++ +LK L N+ A P L LD+S N ++ G
Sbjct: 318 QFPTLKLKSLKRL---TFTSNKGGNAFSEV----DLPSLEFLDLSRNGLSFKGCCSQSDF 370
Query: 277 ESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIP-GELGSLINLEYLDLS 335
+ L+YLDLS N ++ + + + L + + L SL NL YLD+S
Sbjct: 371 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 336 ANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIE-LDNLIHLSELDLSHNFLGEKISSR 394
H L L L ++ N + + L +L+ LDLS L + +
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489
Query: 395 ICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKL 435
+ SL+ LN++ N L + F+ L L I + N
Sbjct: 490 FNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 9e-35
Identities = 68/362 (18%), Positives = 122/362 (33%), Gaps = 37/362 (10%)
Query: 108 FPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRN 167
LDL N L + + +L+ LD ++ L+HL+ L ++ N
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 168 QLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSF-SGSIPQQIG 226
+ L+ L L+ L + + L L + +N S +P+
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 227 NLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSL--LDVSINNITGNIPFEIGESPQLQYL 284
NL +L + L N++ + L LD+S+N + I + +L L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKL 205
Query: 285 DLSSNYIVGEIP-TQLGNIIYLNRISL------SGNKLSGRIPGELGSLINLEYLDLSAN 337
L +N+ + T + + L L + L L L NL +
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
Query: 338 HLSNFVLESLGS---LVKLYYLNLSHNKLSQ-------------------QIPIELDNLI 375
+L ++ + + L + +L + + L
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLK 325
Query: 376 HLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLS--GLIPRCFEELHGLLHIDISYN 433
L L + N G S + SLE L+LS N LS G + L ++D+S+N
Sbjct: 326 SLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 434 KL 435
+
Sbjct: 384 GV 385
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-31
Identities = 69/344 (20%), Positives = 118/344 (34%), Gaps = 30/344 (8%)
Query: 88 GINLTSISLNG-----TLLEFSFSSFPHLAYLDLYNNELFD---IIPPQISNLSKLEYLD 139
I L ++L +++ L L E + + S L L L
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 140 FLTNKLSG------HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFL 193
+L+ I + LT+++ + + + HL L +
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFG-WQHLELVNCKF 316
Query: 194 GGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGR 253
G L + L +N + + +L SL + L N L+ S
Sbjct: 317 GQFPTLKLKSLKRL---TFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 254 CPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPT----QLGNIIYLNRIS 309
L LD+S N + + QL++LD + + L N+IYL+
Sbjct: 372 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD--- 427
Query: 310 LSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVL-ESLGSLVKLYYLNLSHNKLSQQIP 368
+S G L +LE L ++ N L + L L +L+LS +L Q P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
Query: 369 IELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLS 412
++L L L+++ N L R+ SL+K+ L N
Sbjct: 488 TAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 47/194 (24%), Positives = 86/194 (44%), Gaps = 6/194 (3%)
Query: 255 PQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNK 314
LD+S N + + P+LQ LDLS I ++ +L+ + L+GN
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 315 LSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKL-SQQIPIELDN 373
+ G L +L+ L +L++ +G L L LN++HN + S ++P N
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 374 LIHLSELDLSHNFLGEKISSRICRMESLE----KLNLSYNNLSGLIPRCFEELHGLLHID 429
L +L LDLS N + + + + + L+LS N ++ + P F+E+ L +
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLT 206
Query: 430 ISYNKLEGHIPNST 443
+ N ++ +
Sbjct: 207 LRNNFDSLNVMKTC 220
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 46/194 (23%), Positives = 77/194 (39%), Gaps = 10/194 (5%)
Query: 265 NNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELG 324
N IP + + LDLS N + + L + LS ++ G
Sbjct: 17 LNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ 73
Query: 325 SLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSH 384
SL +L L L+ N + + L + L L L L+ + +L L EL+++H
Sbjct: 74 SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133
Query: 385 NFLGE-KISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGL----LHIDISYNKLEGHI 439
N + K+ + +LE L+LS N + + LH + L +D+S N + I
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192
Query: 440 PNSTTFRDAPLEAL 453
F++ L L
Sbjct: 193 Q-PGAFKEIRLHKL 205
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 37/153 (24%), Positives = 60/153 (39%), Gaps = 4/153 (2%)
Query: 285 DLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVL 344
+IP L + LS N L S L+ LDLS +
Sbjct: 13 QCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 345 ESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKL 404
+ SL L L L+ N + L L +L L + I +++L++L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 405 NLSYNNLSGL-IPRCFEELHGLLHIDISYNKLE 436
N+++N + +P F L L H+D+S NK++
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-14
Identities = 34/140 (24%), Positives = 55/140 (39%), Gaps = 8/140 (5%)
Query: 90 NLTSISLNGTLLEF-----SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNK 144
L + + L+ F S +L YLD+ + + LS LE L N
Sbjct: 397 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 456
Query: 145 LSGHIPSEI-SLLTHLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIPRSLS 202
+ +I + L +LT L +S+ QL + L+ L L + SN L
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFD 515
Query: 203 NFTNLVFLYLYNNSFSGSIP 222
T+L ++L+ N + S P
Sbjct: 516 RLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 23/87 (26%), Positives = 39/87 (44%), Gaps = 2/87 (2%)
Query: 90 NLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHI 149
+ S L F+ +L +LDL +L + P ++LS L+ L+ +N+L +
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SV 509
Query: 150 PSEI-SLLTHLTILHISRNQLNGSIPH 175
P I LT L + + N + S P
Sbjct: 510 PDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 55/266 (20%), Positives = 93/266 (34%), Gaps = 17/266 (6%)
Query: 172 SIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSL 231
+I N + + L ++ + N+ L L N S + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 232 FDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYI 291
+ L N L + L L LD++ N + E+ P ++ L ++N I
Sbjct: 61 ELLNLSSNVLYETLDL----ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111
Query: 292 VGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESL-GSL 350
+ G I L+ NK++ + G ++YLDL N + L S
Sbjct: 112 -SRVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 351 VKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNN 410
L +LNL +N + + ++ L LDLS N L + + ++L N
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNK 225
Query: 411 LSGLIPRCFEELHGLLHIDISYNKLE 436
L I + L H D+ N
Sbjct: 226 LVL-IEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-37
Identities = 62/346 (17%), Positives = 123/346 (35%), Gaps = 52/346 (15%)
Query: 105 FSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHI 164
+ + ++ L + + ++ LD N LS ++++ T L +L++
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 165 SRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQ 224
S N L ++ L+ L L L++N++ + L ++ L+ NN+ S
Sbjct: 66 SSNVL--YETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS------ 112
Query: 225 IGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYL 284
+ R + ++ N IT + G ++QYL
Sbjct: 113 -----------------------RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYL 149
Query: 285 DLSSNYIVG-EIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFV 343
DL N I + L ++L N + + G++ L+ LDLS+N L+ +
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-M 206
Query: 344 LESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEK 403
S + +++L +NKL I L +L DL N +L
Sbjct: 207 GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF---------HCGTLRD 256
Query: 404 LNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAP 449
+ + + ++L G + + L + + D P
Sbjct: 257 FFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY--GAYCCEDLP 300
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 62/322 (19%), Positives = 108/322 (33%), Gaps = 42/322 (13%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKL 145
+ L S ++ LDL N L I ++ +KLE L+ +N L
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 146 SGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFT 205
++ L+ L L ++ N + E+ + L +N + + S
Sbjct: 71 YE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVS--CSRGQ 120
Query: 206 NLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSIN 265
+YL NN + G + + L +N+++ + + L L++ N
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLEHLNLQYN 179
Query: 266 NITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGS 325
I ++ ++ +L+ LDLSSN + + + + + ISL NKL I L
Sbjct: 180 FIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRF 235
Query: 326 LINLEYLDLSANHLSNFVLESL-GSLVKLYYLNLSHNKLSQQIPIE-------------- 370
NLE+ DL N L ++ + K E
Sbjct: 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYC 295
Query: 371 --------LDNLIHLSELDLSH 384
D LI L H
Sbjct: 296 CEDLPAPFADRLIALGHHHHHH 317
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 33/176 (18%), Positives = 74/176 (42%), Gaps = 13/176 (7%)
Query: 279 PQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANH 338
+ + ++ + + + + + + + LSGN LS +L LE L+LS+N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 339 LSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRM 398
L L SL L L+L++N + EL + L ++N + ++S
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSCSR--G 119
Query: 399 ESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEALQ 454
+ + + L+ N ++ L + ++D+ N+++ + + A + L+
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELA--ASSDTLE 172
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 25/125 (20%), Positives = 47/125 (37%), Gaps = 8/125 (6%)
Query: 319 IPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLS 378
I + + ++ + L + S + L+LS N LSQ +L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 379 ELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGH 438
L+LS N L E + + + +L L+L+ N + L + + + N +
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQEL-----LVGPSIETLHAANNNIS-R 113
Query: 439 IPNST 443
+ S
Sbjct: 114 VSCSR 118
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 3e-38
Identities = 60/400 (15%), Positives = 135/400 (33%), Gaps = 56/400 (14%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKL 145
+ S+ L+ + + +L L L ++ + I +L LE+LD N L
Sbjct: 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86
Query: 146 SGHIPSEISLLTHLTILHISRNQLNG-SIPHEVGQLNFLNHLILDSNFLGGSIPR-SLSN 203
S S L+ L L++ N + L L L + + I R +
Sbjct: 87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG 146
Query: 204 FTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVS 263
T+L L + S Q + +++ + + L +++ + + D + L++
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADI--LSSVRYLELR 204
Query: 264 INNITGN----------------------------------IPFEIGESPQLQYLDLSSN 289
N+ + I E ++++ D + N
Sbjct: 205 DTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLN 264
Query: 290 YIVGEIPTQLGNI--------IYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSN 341
+ P++ + + + R+ + L + L ++ + + + +
Sbjct: 265 GLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL 324
Query: 342 FVLESLGSLVKLYYLNLSHNKLSQQI---PIELDNLIHLSELDLSHNFLG--EKISSRIC 396
L L +L+LS N + ++ L L LS N L +K +
Sbjct: 325 VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILL 384
Query: 397 RMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLE 436
+++L L++S N +P + + +++S +
Sbjct: 385 TLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-35
Identities = 67/374 (17%), Positives = 137/374 (36%), Gaps = 38/374 (10%)
Query: 90 NLTSISLNG-----TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNK 144
NL ++ + + F+ L L++ L + + ++ + +L ++
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183
Query: 145 LSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLG-------GSI 197
+ + +L+ + L + L + + + + +
Sbjct: 184 SAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243
Query: 198 PRSLSNFTNLVFLYLYNNSFSG---------SIPQQIGNLKSLFDMKLCINQLNGAIPLS 248
+ L L + + + +G + ++G ++++ +L I Q LS
Sbjct: 244 LKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLS 303
Query: 249 IDWGRCPQLSLLDVSINNITGNIPFEIGES-PQLQYLDLSSNYIVGEIPTQ---LGNIIY 304
+ ++ + V + + +P + L++LDLS N +V E G
Sbjct: 304 TVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS 362
Query: 305 LNRISLSGNKLS--GRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNK 362
L + LS N L + L +L NL LD+S N +S K+ +LNLS
Sbjct: 363 LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPM-PDSCQWPEKMRFLNLSSTG 421
Query: 363 LSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEL 422
+ ++ L LD+S+N + S + L++L +S N L L
Sbjct: 422 IRV---VKTCIPQTLEVLDVSNN----NLDSFSLFLPRLQELYISRNKLKTLPDASL--F 472
Query: 423 HGLLHIDISYNKLE 436
LL + IS N+L+
Sbjct: 473 PVLLVMKISRNQLK 486
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-32
Identities = 52/345 (15%), Positives = 120/345 (34%), Gaps = 14/345 (4%)
Query: 108 FPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTILHISR 166
+ LDL N++ I + + L+ L +++++ I + L L L +S
Sbjct: 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSD 83
Query: 167 NQLNGSIPHEV-GQLNFLNHLILDSNFLGG-SIPRSLSNFTNLVFLYLYNNSFSGSIPQQ 224
N L+ S+ G L+ L +L L N + N TNL L + N I +
Sbjct: 84 NHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI 142
Query: 225 -IGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQY 283
L SL ++++ L S+ + L + ++ + ++Y
Sbjct: 143 DFAGLTSLNELEIKALSLRNYQSQSLKS--IRDIHHLTLHLSESAFLLEIFADILSSVRY 200
Query: 284 LDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFV 343
L+L + + L + + + S L+ L L + +
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE--- 257
Query: 344 LESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEK 403
+ + ++ + + + L + +L +S+ +E +++
Sbjct: 258 ---FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKR 314
Query: 404 LNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDA 448
+ + + + + + L L +D+S N + ++ + A
Sbjct: 315 ITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA 359
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-26
Identities = 52/315 (16%), Positives = 114/315 (36%), Gaps = 23/315 (7%)
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207
IPS ++ + L +S N++ ++ L LIL S+ + + + +L
Sbjct: 19 SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76
Query: 208 VFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267
L L +N S G L SL + L N + ++ + L L +
Sbjct: 77 EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVET 135
Query: 268 TGNIPFE-IGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSL 326
I L L++ + + L +I ++ ++L ++ + + L
Sbjct: 136 FSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADIL 195
Query: 327 INLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQ----------QIPIELDNLIH 376
++ YL+L +L+ F L + + S ++ + L
Sbjct: 196 SSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSE 255
Query: 377 LSELDLSHNFLGE------KISSRICRME--SLEKLNLSYNNLSGLIPRCFEELHGLLHI 428
+ D + N LG+ + S + ++E ++ +L++ L + + L + I
Sbjct: 256 VEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRI 315
Query: 429 DISYNKLEGHIPNST 443
+ +K+ +P S
Sbjct: 316 TVENSKVF-LVPCSF 329
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-26
Identities = 53/281 (18%), Positives = 90/281 (32%), Gaps = 41/281 (14%)
Query: 88 GINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSG 147
G+ + S + + E + L + LF + S L K++ + +K+
Sbjct: 265 GLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL 324
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHE---VGQLNFLNHLILDSNFLG--GSIPRSLS 202
S L L L +S N + G L L+L N L L
Sbjct: 325 VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILL 384
Query: 203 NFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDV 262
NL L + N+F +P + + L++
Sbjct: 385 TLKNLTSLDISRNTFH-PMPDSCQWPEK--------------------------MRFLNL 417
Query: 263 SINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGE 322
S I + I ++ L+ LD+S+N + L + L +S NKL +P +
Sbjct: 418 SSTGIR-VVKTCIPQT--LEVLDVSNNNL-DSFSLFLPRLQELY---ISRNKLK-TLP-D 468
Query: 323 LGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKL 363
L + +S N L + L L + L N
Sbjct: 469 ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 53/280 (18%), Positives = 95/280 (33%), Gaps = 31/280 (11%)
Query: 159 LTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFS 218
+ SIP + + L L N + L NL L L ++ +
Sbjct: 7 SGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN 63
Query: 219 GSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGES 278
+L L LD+S N+++ G
Sbjct: 64 TIEGDAFYSL--------------------------GSLEHLDLSDNHLSSLSSSWFGPL 97
Query: 279 PQLQYLDLSSNYIVG-EIPTQLGNIIYLNRISLSGNKLSGRIP-GELGSLINLEYLDLSA 336
L+YL+L N + + N+ L + + + I + L +L L++ A
Sbjct: 98 SSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKA 157
Query: 337 NHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRIC 396
L N+ +SL S+ +++L L ++ + + I D L + L+L L S +
Sbjct: 158 LSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLP 217
Query: 397 RMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLE 436
E + S L F EL LL + +++E
Sbjct: 218 VDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE 257
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 42/192 (21%), Positives = 72/192 (37%), Gaps = 30/192 (15%)
Query: 254 CPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGN 313
C + D + T +IP + + ++ LDLS N I I
Sbjct: 4 CDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKIT-YIG----------------- 42
Query: 314 KLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDN 373
G+L + NL+ L L ++ ++ ++ SL L +L+LS N LS
Sbjct: 43 ------HGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGP 96
Query: 374 LIHLSELDLSHNFLGE-KISSRICRMESLEKLNLSYNNLSGLIPR-CFEELHGLLHIDIS 431
L L L+L N ++S + +L+ L + I R F L L ++I
Sbjct: 97 LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156
Query: 432 YNKLEGHIPNST 443
L + + +
Sbjct: 157 ALSLR-NYQSQS 167
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-37
Identities = 68/371 (18%), Positives = 123/371 (33%), Gaps = 44/371 (11%)
Query: 90 NLTSISLNG-TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGH 148
+++ L H+ L + +N L +P L L+ N+L+
Sbjct: 41 GNAVLNVGESGLTTLPDCLPAHITTLVIPDNNL-TSLPALPPEL---RTLEVSGNQLT-S 95
Query: 149 IPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLV 208
+P L L+I L L L + N L S+P L
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLT-SLPVLP---PGLQ 144
Query: 209 FLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNIT 268
L + +N + S+P L L NQL ++P+ L L VS N +
Sbjct: 145 ELSVSDNQLA-SLPALPSELCKL---WAYNNQLT-SLPMLP-----SGLQELSVSDNQLA 194
Query: 269 GNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLIN 328
++P +L L +N + +P L + +SGN+L+ +P
Sbjct: 195 -SLPTLPS---ELYKLWAYNNRLT-SLPALPSG---LKELIVSGNRLT-SLPVLPS---E 242
Query: 329 LEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLG 388
L+ L +S N L++ + L+ L ++ N+L++ +P L +L + ++L N L
Sbjct: 243 LKELMVSGNRLTS-LPMLPSGLLSL---SVYRNQLTR-LPESLIHLSSETTVNLEGNPLS 297
Query: 389 EKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDA 448
E+ + + S + E L + + R
Sbjct: 298 ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWH 357
Query: 449 PLEALQGNKGL 459
Sbjct: 358 MFGQEDNADAF 368
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-33
Identities = 63/291 (21%), Positives = 109/291 (37%), Gaps = 46/291 (15%)
Query: 152 EISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLY 211
L +L++ + L ++P + + L++ N L S+P + L L
Sbjct: 35 RACLNNGNAVLNVGESGLT-TLPDCLPAH--ITTLVIPDNNL-TSLP---ALPPELRTLE 87
Query: 212 LYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNI 271
+ N + S+P L L + L L L + N +T ++
Sbjct: 88 VSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALP---------SGLCKLWIFGNQLT-SL 136
Query: 272 PFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEY 331
P LQ L +S N + +P + L N+L+ +P L+
Sbjct: 137 PVLPP---GLQELSVSDNQL-ASLPALPSELCKLW---AYNNQLT-SLPMLPS---GLQE 185
Query: 332 LDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKI 391
L +S N L++ L KL+ +N+L+ +P L EL +S N L +
Sbjct: 186 LSVSDNQLASLP-TLPSELYKLW---AYNNRLT-SLPALPSG---LKELIVSGNRLTS-L 236
Query: 392 SSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNS 442
L++L +S N L+ L P GLL + + N+L +P S
Sbjct: 237 PVLPS---ELKELMVSGNRLTSL-P---MLPSGLLSLSVYRNQLT-RLPES 279
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-33
Identities = 69/339 (20%), Positives = 122/339 (35%), Gaps = 54/339 (15%)
Query: 87 FGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLS 146
++T++ + L + P L L++ N+L + P L +L L
Sbjct: 59 LPAHITTLVIPDNNLTSLPALPPELRTLEVSGNQLTSL-PVLPPGLLELSIFSNPLTHLP 117
Query: 147 GHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSN--- 203
+L + L L I NQL S+P L L+ + N L S+P S
Sbjct: 118 -------ALPSGLCKLWIFGNQLT-SLPVLPPGLQELS---VSDNQLA-SLPALPSELCK 165
Query: 204 --------------FTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSI 249
+ L L + +N + S+P L L N+L ++P
Sbjct: 166 LWAYNNQLTSLPMLPSGLQELSVSDNQLA-SLPTLPSELYKL---WAYNNRLT-SLPALP 220
Query: 250 DWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRIS 309
L L VS N +T ++P +L+ L +S N + +P ++ L+
Sbjct: 221 -----SGLKELIVSGNRLT-SLPVLPS---ELKELMVSGNRLT-SLPMLPSGLLSLS--- 267
Query: 310 LSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLN---LSHNKLSQQ 366
+ N+L+ R+P L L + ++L N LS L++L + + + +
Sbjct: 268 VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGAS 326
Query: 367 IPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLN 405
P E L + L GE + R + +
Sbjct: 327 APRETRALHLAAADWLVPAREGE--PAPADRWHMFGQED 363
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-24
Identities = 42/201 (20%), Positives = 74/201 (36%), Gaps = 28/201 (13%)
Query: 242 NGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGN 301
A+ + ++L+V + +T +P + + L + N + +P
Sbjct: 27 RAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPE 82
Query: 302 IIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHN 361
+ L +SGN+L+ +P L+ L HL L L + N
Sbjct: 83 LRTLE---VSGNQLT-SLPVLPPGLLELSIFSNPLTHLPA-------LPSGLCKLWIFGN 131
Query: 362 KLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEE 421
+L+ +P+ L EL +S N L + + L KL N L+ L P
Sbjct: 132 QLT-SLPVLPPG---LQELSVSDNQL-ASLPALPS---ELCKLWAYNNQLTSL-P---ML 179
Query: 422 LHGLLHIDISYNKLEGHIPNS 442
GL + +S N+L +P
Sbjct: 180 PSGLQELSVSDNQLA-SLPTL 199
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-37
Identities = 67/335 (20%), Positives = 123/335 (36%), Gaps = 45/335 (13%)
Query: 107 SFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISR 166
S L +++ L +P + N+ ++ + P + + +
Sbjct: 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 167 NQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIG 226
+ L L++ L S+P +L L NS + +P+
Sbjct: 68 CLDRQ-----------AHELELNNLGL-SSLPELP---PHLESLVASCNSLT-ELPELPQ 111
Query: 227 NLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDL 286
+LKSL + L+ P L L VS N + +P E+ S L+ +D+
Sbjct: 112 SLKSLLVDNNNLKALSDLP---------PLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDV 160
Query: 287 SSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLES 346
+N + ++P ++ ++ N+L +P EL +L L + N L
Sbjct: 161 DNNSLK-KLPDLPPSLEFIA---AGNNQLE-ELP-ELQNLPFLTAIYADNNSLKKLP--- 211
Query: 347 LGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNL 406
+ L + +N L + EL NL L+ + +N L + + SLE LN+
Sbjct: 212 -DLPLSLESIVAGNNILEE--LPELQNLPFLTTIYADNNLL-KTLPDLPP---SLEALNV 264
Query: 407 SYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPN 441
N L+ L P + L L + ++ L PN
Sbjct: 265 RDNYLTDL-PELPQSLTFLDVSENIFSGLSELPPN 298
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-36
Identities = 81/383 (21%), Positives = 135/383 (35%), Gaps = 70/383 (18%)
Query: 90 NLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHI 149
+ LN L PHL L N L ++ P +L L + LS
Sbjct: 72 QAHELELNNLGLSSLPELPPHLESLVASCNSLTEL-PELPQSLKSLLVDNNNLKALSDLP 130
Query: 150 PS---------------EISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLG 194
P E+ + L I+ + N L +P L F+ +N L
Sbjct: 131 PLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIA---AGNNQLE 186
Query: 195 GSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRC 254
+P L N L +Y NNS +P +L+S+ N L +P +
Sbjct: 187 -ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESIV---AGNNILE-ELP---ELQNL 236
Query: 255 PQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNK 314
P L+ + N + +P L+ L++ NY+ ++P ++ +L+ +
Sbjct: 237 PFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSG 291
Query: 315 LSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNL 374
LS P NL YL+ S+N + + L LN+S+NKL + +P L
Sbjct: 292 LSELPP-------NLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLIE-LPALPPRL 339
Query: 375 IHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGL---------------IPRCF 419
L S N L ++ +L++L++ YN L +
Sbjct: 340 ---ERLIASFNHL-AEVPELPQ---NLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVP 392
Query: 420 EELHGLLHIDISYNKLEGHIPNS 442
E L + + N L P+
Sbjct: 393 ELPQNLKQLHVETNPLR-EFPDI 414
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-35
Identities = 74/364 (20%), Positives = 130/364 (35%), Gaps = 61/364 (16%)
Query: 90 NLTSISLNGTLLEF--SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSG 147
L + ++ LE + L +D+ NN L +P +L E++ N+L
Sbjct: 132 LLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSL-KKLPDLPPSL---EFIAAGNNQLE- 186
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207
+P E+ L LT ++ N L +P L ++ +N L L N L
Sbjct: 187 ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLE---SIVAGNNIL--EELPELQNLPFL 239
Query: 208 VFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267
+Y NN ++P +L++L + L L + + + +
Sbjct: 240 TTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDLPELP------QSLTFLDVSENIFSGL 292
Query: 268 TGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLI 327
+ P L YL+ SSN I + ++ LN +S NKL +P
Sbjct: 293 SELPP-------NLYYLNASSNEIR-SLCDLPPSLEELN---VSNNKLI-ELPALPP--- 337
Query: 328 NLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLS--------- 378
LE L S NHL+ V E +L +L ++ +N L + P +++ L
Sbjct: 338 RLERLIASFNHLAE-VPELPQNLKQL---HVEYNPLRE-FPDIPESVEDLRMNSHLAEVP 392
Query: 379 -------ELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDIS 431
+L + N L + ES+E L ++ + E L
Sbjct: 393 ELPQNLKQLHVETNPL-REFPDIP---ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFE 448
Query: 432 YNKL 435
++
Sbjct: 449 HHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-35
Identities = 73/366 (19%), Positives = 117/366 (31%), Gaps = 65/366 (17%)
Query: 90 NLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLS-------------KLE 136
NLT + + + +E PP +
Sbjct: 22 NLTEMPV-------EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAH 74
Query: 137 YLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGS 196
L+ LS +P HL L S N L +P L L + L
Sbjct: 75 ELELNNLGLS-SLPELP---PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDL 129
Query: 197 IPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQ 256
P L +L + NN +P ++ N L + + N L +P P
Sbjct: 130 PP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLP-----PS 174
Query: 257 LSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLS 316
L + N + +P E+ P L + +N + ++P + L I N L
Sbjct: 175 LEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNNILE 228
Query: 317 GRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIH 376
EL +L L + N L + + SL LN+ N L+ +P +L
Sbjct: 229 --ELPELQNLPFLTTIYADNNLLKT-LPDLPPSLEA---LNVRDNYLT-DLPELPQSLTF 281
Query: 377 LSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLE 436
L + + L E +L LN S N + L + L +++S NKL
Sbjct: 282 LDVSENIFSGLSELP-------PNLYYLNASSNEIRSLC----DLPPSLEELNVSNNKLI 330
Query: 437 GHIPNS 442
+P
Sbjct: 331 -ELPAL 335
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-34
Identities = 69/338 (20%), Positives = 129/338 (38%), Gaps = 53/338 (15%)
Query: 90 NLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHI 149
L I ++ L+ P L ++ NN+L ++ P++ NL L + N L +
Sbjct: 154 FLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEEL--PELQNLPFLTAIYADNNSLK-KL 210
Query: 150 PSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVF 209
P L + N L E+ L FL + D+N L ++P + L
Sbjct: 211 PDL---PLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPS---LEA 261
Query: 210 LYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITG 269
L + +N + +P+ +L L + + L+ P L L+ S N I
Sbjct: 262 LNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP---------NLYYLNASSNEIR- 310
Query: 270 NIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINL 329
++ P L+ L++S+N ++ E+P L R+ S N L+ +P NL
Sbjct: 311 SLCDLP---PSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQ---NL 359
Query: 330 EYLDLSANHLSNF--VLESLGSLV-------------KLYYLNLSHNKLSQQIPIELDNL 374
+ L + N L F + ES+ L L L++ N L + P +++
Sbjct: 360 KQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLRE-FPDIPESV 418
Query: 375 IHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLS 412
+L ++ + + + LE +++
Sbjct: 419 ---EDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-25
Identities = 56/294 (19%), Positives = 99/294 (33%), Gaps = 53/294 (18%)
Query: 90 NLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHI 149
LT+I + L+ L + NN L P++ NL L + N L +
Sbjct: 196 FLTAIYADNNSLKKLPDLPLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TL 252
Query: 150 PSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVF 209
P L L++ N L +P L FL+ + L P NL +
Sbjct: 253 PDLPP---SLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYY 301
Query: 210 LYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITG 269
L +N S+ +L+ L + N+L +P P+L L S N++
Sbjct: 302 LNASSNEIR-SLCDLPPSLEEL---NVSNNKLI-ELPALP-----PRLERLIASFNHLA- 350
Query: 270 NIPFEIGESPQLQYLDLSSNYI------------------VGEIPTQLGNIIYLNRISLS 311
+P L+ L + N + + E+P N+ L+ +
Sbjct: 351 EVPELPQ---NLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLH---VE 404
Query: 312 GNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQ 365
N L P ++E L +++ + + + + KL H+
Sbjct: 405 TNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHHH 454
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-37
Identities = 61/333 (18%), Positives = 119/333 (35%), Gaps = 42/333 (12%)
Query: 105 FSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHI 164
+ + ++ L + + ++ LD N LS ++++ T L +L++
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 165 SRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQ 224
S N L ++ L+ L L L++N++ + L ++ L+ NN+ S
Sbjct: 66 SSNVL--YETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS------ 112
Query: 225 IGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYL 284
+ R + ++ N IT + G ++QYL
Sbjct: 113 -----------------------RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYL 149
Query: 285 DLSSNYIVG-EIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFV 343
DL N I + L ++L N + + G++ L+ LDLS+N L+ +
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-M 206
Query: 344 LESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEK 403
S + +++L +NKL I L +L DL N + R ++
Sbjct: 207 GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF-HCGTLRDFFSKNQRV 264
Query: 404 LNLSYNNLSGLIPRCFEELHGLLHIDISYNKLE 436
++ + L + EE E
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-36
Identities = 55/286 (19%), Positives = 98/286 (34%), Gaps = 17/286 (5%)
Query: 172 SIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSL 231
+I N + + L ++ + N+ L L N S + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 232 FDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYI 291
+ L N L + L L LD++ N + E+ P ++ L ++N I
Sbjct: 61 ELLNLSSNVLYETLDL----ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111
Query: 292 VGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESL-GSL 350
+ G I L+ NK++ + G ++YLDL N + L S
Sbjct: 112 -SRVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 351 VKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNN 410
L +LNL +N + + ++ L LDLS N L + + ++L N
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNK 225
Query: 411 LSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEALQGN 456
L I + L H D+ N ++ ++ +
Sbjct: 226 LVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-32
Identities = 46/357 (12%), Positives = 102/357 (28%), Gaps = 17/357 (4%)
Query: 88 GINLTSISLNGTLL-EFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLS 146
G ++ ++ + S S + L NN++ + S+++YLD N++
Sbjct: 98 GPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
Query: 147 G-HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFT 205
+ + L L++ N + + +V L L L SN L + +
Sbjct: 158 TVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAA 214
Query: 206 NLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSIN 265
+ ++ L NN I + + ++L L N + + V+
Sbjct: 215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK---NQRVQTVAKQ 270
Query: 266 NITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSG----RIPG 321
+ E + +I L R + G R+
Sbjct: 271 TVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLEC 330
Query: 322 ELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELD 381
E + +D + + L L +Q+ L
Sbjct: 331 ERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTL 390
Query: 382 LSHNFLGE--KISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLE 436
E + ++ L + Y + + + + + + D+ +K
Sbjct: 391 QQAVGQIELQHATEEQSPLQLLRAIVKRYEEM--YVEQQSVQNNAIRDWDMYQHKET 445
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 70/260 (26%), Positives = 108/260 (41%), Gaps = 35/260 (13%)
Query: 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPDN-----F-------------- 541
D + K IG G G+V+ A G AVK F
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 542 -------CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN 594
+ P IV EYL GSL ++L+ + ++L +RL++ VA + YLHN
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 595 NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTM 654
PPIVH ++ S N+L+D Y V DF +++ + AGT +APE+
Sbjct: 156 RN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 655 KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714
EK DVYSFGV+ E+ + P ++ + + RL P ++ + +
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWG---NLNPAQVVAAVGFKCKRLEIPR-NLNPQVAA 270
Query: 715 IMQVAFSCLDQNPVSRPTMK 734
I++ C P RP+
Sbjct: 271 IIE---GCWTNEPWKRPSFA 287
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-36
Identities = 71/332 (21%), Positives = 116/332 (34%), Gaps = 34/332 (10%)
Query: 108 FPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTILHISR 166
LDL N + + + ++ LE L+ N +S + + L +L L +
Sbjct: 31 PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRS 89
Query: 167 NQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQI 225
N+L IP V L+ L L + N + + + NL L + +N I
Sbjct: 90 NRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISH-- 145
Query: 226 GNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEI-GESPQLQYL 284
L L L + N+T +IP E L L
Sbjct: 146 RAFSGL-----------------------NSLEQLTLEKCNLT-SIPTEALSHLHGLIVL 181
Query: 285 DLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVL 344
L I + L + +S + +NL L ++ +L+
Sbjct: 182 RLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPY 241
Query: 345 ESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICR-MESLEK 403
++ LV L +LNLS+N +S L L+ L E+ L L + R + L
Sbjct: 242 LAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQL-AVVEPYAFRGLNYLRV 300
Query: 404 LNLSYNNLSGLIPRCFEELHGLLHIDISYNKL 435
LN+S N L+ L F + L + + N L
Sbjct: 301 LNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-29
Identities = 57/279 (20%), Positives = 100/279 (35%), Gaps = 33/279 (11%)
Query: 183 LNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLN 242
L L N + ++F +L L L N S ++ G +L
Sbjct: 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEP--GAFNNL----------- 79
Query: 243 GAIPLSIDWGRCPQLSLLDVSINNITGNIPFEI-GESPQLQYLDLSSNYIVGEIPTQLGN 301
L L + N + IP + L LD+S N IV + +
Sbjct: 80 ------------FNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQD 126
Query: 302 IIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHN 361
+ L + + N L L +LE L L +L++ E+L L L L L H
Sbjct: 127 LYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHL 186
Query: 362 KLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEE 421
++ L L L++SH + ++ +L L++++ NL+ +
Sbjct: 187 NINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRH 246
Query: 422 LHGLLHIDISYNKLEGHIPNSTTFRDAP-LEAL--QGNK 457
L L +++SYN + I S + L+ + G +
Sbjct: 247 LVYLRFLNLSYNPIS-TIEGS-MLHELLRLQEIQLVGGQ 283
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-22
Identities = 56/266 (21%), Positives = 101/266 (37%), Gaps = 28/266 (10%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKL 145
NL ++ L + F+ +L LD+ N++ ++ +L L+ L+ N L
Sbjct: 81 NLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL 140
Query: 146 SGHIPSEI-SLLTHLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIPRSLSN 203
+I S L L L + + L SIP E L+ L L L + S
Sbjct: 141 V-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKR 198
Query: 204 FTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWG---RCPQLSLL 260
L L + + + ++ +L + + L ++ + L L
Sbjct: 199 LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-----AVPYLAVRHLVYLRFL 253
Query: 261 DVSINNITGNIPFEIGES-----PQLQYLDLSSNYIVGEIPTQ-LGNIIYLNRISLSGNK 314
++S N I+ I S +LQ + L + + + YL +++SGN+
Sbjct: 254 NLSYNPIS-----TIEGSMLHELLRLQEIQLVGGQL-AVVEPYAFRGLNYLRVLNVSGNQ 307
Query: 315 LSGRIPGELGSLINLEYLDLSANHLS 340
L+ S+ NLE L L +N L+
Sbjct: 308 LTTLEESVFHSVGNLETLILDSNPLA 333
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 67/273 (24%), Positives = 106/273 (38%), Gaps = 52/273 (19%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN----------FC------- 542
N+ + + IGKGG G V+ R V + A+K + F
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 543 --SHP----------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALF 590
+HP +V E++ G L L + A + W+ +L ++ +A +
Sbjct: 79 NLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIE 136
Query: 591 YLHNNCFPPIVHWDISSKNVLLDLGYE-----AHVSDFRIAKFLNLDSSNWSKLAGTHGN 645
Y+ N PPIVH D+ S N+ L E A V+DF +++ S L G
Sbjct: 137 YMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSG---LLGNFQW 192
Query: 646 VAPEL--AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS--RL 701
+APE A TEK D YSF ++ ++ G+ P D E S I + R
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD---EYSYGKIKFINMIREEGLRP 249
Query: 702 PYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
P D + ++++ C +P RP
Sbjct: 250 TIPE-DCPPRLRNVIE---LCWSGDPKKRPHFS 278
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 50/270 (18%)
Query: 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPDNF------------------- 541
+ + IG GG G VY A G+ AVK ++
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 542 ---------CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYL 592
C +V E+ G L+++L+ K + +N +A + YL
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYL 121
Query: 593 HNNCFPPIVHWDISSKNVLLDLGYEAH--------VSDFRIAKFLNLDSSNWSKLAGTHG 644
H+ PI+H D+ S N+L+ E ++DF +A+ + + AG +
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAAGAYA 179
Query: 645 NVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYP 704
+APE+ ++ DV+S+GVL E++ G+ P + + + + LP P
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR---GIDGLAVAYGVAMNKLALPIP 236
Query: 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
S F +M+ C + +P SRP+
Sbjct: 237 S-TCPEPFAKLME---DCWNPDPHSRPSFT 262
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-35
Identities = 79/365 (21%), Positives = 136/365 (37%), Gaps = 34/365 (9%)
Query: 109 PHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTILHISRN 167
H+ Y+DL N + ++ S L L++L I + L+ L IL + N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 168 QLNGSIPHEV-GQLNFLNHLILDSNFLGGSI--PRSLSNFTNLVFLYLYNNSFSGSIPQQ 224
Q + L L L L L G++ T+L L L +N+ P
Sbjct: 90 QF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 225 I-GNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESP---- 279
N++ + L N++ + + +LL +S + + +G
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208
Query: 280 ----QLQYLDLSSNYIVGEIPTQLGNIIYLNRI-------------SLSGNKLSGRIPGE 322
+ LDLS N + + + I +I S
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268
Query: 323 LGSLI--NLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIE-LDNLIHLSE 379
L ++ DLS + + + L L L+ N++ +I L HL +
Sbjct: 269 FKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEI-NKIDDNAFWGLTHLLK 327
Query: 380 LDLSHNFLGEKISSRICR-MESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGH 438
L+LS NFLG I SR+ ++ LE L+LSYN++ L + F L L + + N+L+
Sbjct: 328 LNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-S 385
Query: 439 IPNST 443
+P+
Sbjct: 386 VPDGI 390
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-30
Identities = 76/375 (20%), Positives = 138/375 (36%), Gaps = 60/375 (16%)
Query: 90 NLTSISLNGTLL----EFSFSSFPHLAYLDLYNNELFDIIPPQI-SNLSKLEYLDFLTNK 144
++ + L+ + E SFS L +L + +I LS L L N+
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 145 LSGHIPSEI-SLLTHLTILHISRNQLNGS-IPHEV-GQLNFLNHLILDSNFLGGSIPRSL 201
+ + + L +L +L +++ L+G+ + L L L+L N + P S
Sbjct: 91 FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 202 -SNFTNLVFLYLYNNSFSGSIPQQI---GNLKSLFDMKLCINQLNGAIPLSIDWGRC--- 254
N L L N SI ++ K ++L L + W +C
Sbjct: 150 FLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208
Query: 255 ---PQLSLLDVSINNITGNIP---FEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRI 308
++ LD+S N ++ F+ ++Q L LS++Y +G N +
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGS-SFGHTNFKDPDNF 267
Query: 309 SLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIP 368
+ G + S ++ DLS + + + L L L+ N++++
Sbjct: 268 TFKGLEAS-----------GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINK--- 313
Query: 369 IELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHI 428
I+ + L+ L KLNLS N L + R FE L L +
Sbjct: 314 IDDNAFWGLT---------------------HLLKLNLSQNFLGSIDSRMFENLDKLEVL 352
Query: 429 DISYNKLEGHIPNST 443
D+SYN + + + +
Sbjct: 353 DLSYNHIR-ALGDQS 366
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-29
Identities = 68/345 (19%), Positives = 133/345 (38%), Gaps = 40/345 (11%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLYNNELFD-IIPPQI-SNLSKLEYLDFLTN 143
+L + L+ L +F+ +L L L L ++ L+ LE L N
Sbjct: 80 SLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDN 139
Query: 144 KLSGHIPSEI-SLLTHLTILHISRNQLNGSIPHEVGQ-----------LNFLNHLILDSN 191
+ P+ + +L ++ N++ SI E L+ + ++
Sbjct: 140 NIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEY 198
Query: 192 FLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDW 251
+LG + T++ L L N F S+ ++ + + ++ I + + S
Sbjct: 199 WLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGH 258
Query: 252 GRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIV---GEIPTQLGNIIYLNRI 308
N F+ E+ ++ DLS + I + + + L ++
Sbjct: 259 TNFKDPD-----------NFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTD---LEQL 304
Query: 309 SLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIP 368
+L+ N+++ L +L L+LS N L + +L KL L+LS+N + + +
Sbjct: 305 TLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI-RALG 363
Query: 369 IEL-DNLIHLSELDLSHNFLGEKISSRI-CRMESLEKLNLSYNNL 411
+ L +L EL L N L + + I R+ SL+K+ L N
Sbjct: 364 DQSFLGLPNLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-22
Identities = 61/320 (19%), Positives = 111/320 (34%), Gaps = 34/320 (10%)
Query: 154 SLLTHLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIPR-SLSNFTNLVFLY 211
L H+ + +S N + + +L L L ++ G I + ++L+ L
Sbjct: 27 ELPAHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85
Query: 212 LYNNSFSGSIPQQI-GNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGN 270
L N F + L +L + L L+GA+ + L +L + NNI
Sbjct: 86 LDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKI 144
Query: 271 IPFEIGES-PQLQYLDLSSN----------YIVGEIPTQLGNIIYLNRISLSGNKLSGRI 319
P + + LDL+ N L + + ++ L
Sbjct: 145 QPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEK 204
Query: 320 PGELGSLINLEYLDLSANHLSNFVLE---SLGSLVKLYYLNLSHNK-----LSQQIPIEL 371
G ++ LDLS N + + + K+ L LS++ +
Sbjct: 205 CGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDP 264
Query: 372 DNLI-------HLSELDLSHNFLGEKISSRICR-MESLEKLNLSYNNLSGLIPRCFEELH 423
DN + DLS + + + + LE+L L+ N ++ + F L
Sbjct: 265 DNFTFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLT 323
Query: 424 GLLHIDISYNKLEGHIPNST 443
LL +++S N L G I +
Sbjct: 324 HLLKLNLSQNFL-GSIDSRM 342
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 41/165 (24%), Positives = 65/165 (39%), Gaps = 18/165 (10%)
Query: 60 WSLSFVNATKISLCTWSGIHCNHAGRVFGINLTSISLNG----TLLEFSFSSFPHLAYLD 115
S N T+ G+ + + + L+ LL+ FS F L L
Sbjct: 254 SSFGHTNFKDPDNFTFKGLEAS--------GVKTCDLSKSKIFALLKSVFSHFTDLEQLT 305
Query: 116 LYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTILHISRNQLNGSIP 174
L NE+ I L+ L L+ N L I S + L L +L +S N + ++
Sbjct: 306 LAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHI-RALG 363
Query: 175 HEV-GQLNFLNHLILDSNFLGGSIPRS-LSNFTNLVFLYLYNNSF 217
+ L L L LD+N L S+P T+L ++L+ N +
Sbjct: 364 DQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-34
Identities = 67/348 (19%), Positives = 125/348 (35%), Gaps = 41/348 (11%)
Query: 90 NLTSISLNGTLL-EFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGH 148
LT + + S +L YL +N+L ++ ++ L+KL YL+ TNKL+
Sbjct: 65 GLTKLICTSNNITTLDLSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT-- 119
Query: 149 IPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLV 208
++S LT L+ +RN L I V L L N + ++ T L
Sbjct: 120 -KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLT 173
Query: 209 FLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNIT 268
L N + + + K L + N + +D + QL+ LD S N +T
Sbjct: 174 TLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-----KLDLNQNIQLTFLDCSSNKLT 225
Query: 269 GNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLIN 328
++ QL Y D S N + + L + L+ L I L
Sbjct: 226 E---IDVTPLTQLTYFDCSVNPLTELDVSTLSKLTTLH---CIQTDLL-EID--LTHNTQ 276
Query: 329 LEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLG 388
L Y + + +LY L+ +++ ++L L L L++
Sbjct: 277 LIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGITE---LDLSQNPKLVYLYLNNT--- 328
Query: 389 EKISS-RICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKL 435
+++ + L+ L+ ++ ++ L + + +
Sbjct: 329 -ELTELDVSHNTKLKSLSCVNAHIQDFSS--VGKIPALNNNFEAEGQT 373
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-34
Identities = 72/339 (21%), Positives = 135/339 (39%), Gaps = 38/339 (11%)
Query: 97 NGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLL 156
S L LD +N+ + D+ I L+ L L +N ++ + +S
Sbjct: 30 MQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT-TLD--LSQN 84
Query: 157 THLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNS 216
T+LT L N+L ++ V L L +L D+N L + +S L +L N+
Sbjct: 85 TNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKL-TKLD--VSQNPLLTYLNCARNT 138
Query: 217 FSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIG 276
+ I + + L ++ +N+ + ++ QL+ LD S N IT ++
Sbjct: 139 LT-EID--VSHNTQLTELDCHLNKKITKLDVT----PQTQLTTLDCSFNKITE---LDVS 188
Query: 277 ESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSA 336
++ L L+ +N I ++ L I L + S NKL+ I + L L Y D S
Sbjct: 189 QNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSV 242
Query: 337 NHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRIC 396
N L+ + +L KL L+ L + I+L + L +++ +
Sbjct: 243 NPLTEL---DVSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRKIKELD--VT 294
Query: 397 RMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKL 435
L L+ ++ L + L+++ ++ +L
Sbjct: 295 HNTQLYLLDCQAAGITELD---LSQNPKLVYLYLNNTEL 330
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-33
Identities = 70/349 (20%), Positives = 130/349 (37%), Gaps = 41/349 (11%)
Query: 90 NLTSISLNGTLLEF--SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSG 147
LTS+ + + + L L +N + + +S + L YL +NKL+
Sbjct: 43 TLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNITTL---DLSQNTNLTYLACDSNKLT- 98
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207
++ ++ LT LT L+ N+L + V Q L +L N L I +S+ T L
Sbjct: 99 NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTL-TEID--VSHNTQL 150
Query: 208 VFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267
L + N + + L + N++ +D + L+ L+ NNI
Sbjct: 151 TELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-----ELDVSQNKLLNRLNCDTNNI 203
Query: 268 TGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLI 327
T ++ ++ QL +LD SSN + EI + + L S N L+ + + +L
Sbjct: 204 TK---LDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLS 254
Query: 328 NLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFL 387
L L L L +L Y + + +++ + L LD +
Sbjct: 255 KLTTLHCIQTDLLEI---DLTHNTQLIYFQAEGCRKIK--ELDVTHNTQLYLLDCQAAGI 309
Query: 388 GEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLE 436
++ + + L L L+ L+ L L + ++
Sbjct: 310 -TELD--LSQNPKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-31
Identities = 67/328 (20%), Positives = 115/328 (35%), Gaps = 35/328 (10%)
Query: 109 PHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQ 168
+ A E+ L+ L LD + ++ + I LT LT L + N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNN 75
Query: 169 LNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNL 228
+ ++ + Q L +L DSN L ++ ++ T L +L N + + +
Sbjct: 76 IT-TLD--LSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLT-KLD--VSQN 126
Query: 229 KSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSS 288
L + N L ID QL+ LD +N + QL LD S
Sbjct: 127 PLLTYLNCARNTLT-----EIDVSHNTQLTELDCHLNKKITKLDV--TPQTQLTTLDCSF 179
Query: 289 NYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLG 348
N I +Q + LN N ++ ++ L I L +LD S+N L+ +
Sbjct: 180 NKITELDVSQNKLLNRLN---CDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI---DVT 230
Query: 349 SLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSY 408
L +L Y + S N L++ +++ L L+ L L +I + L
Sbjct: 231 PLTQLTYFDCSVNPLTE---LDVSTLSKLTTLHCIQTDL-LEID--LTHNTQLIYFQAEG 284
Query: 409 NNLSGLIPRCFEELHGLLHIDISYNKLE 436
+ L +D +
Sbjct: 285 CRK--IKELDVTHNTQLYLLDCQAAGIT 310
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-23
Identities = 52/311 (16%), Positives = 105/311 (33%), Gaps = 36/311 (11%)
Query: 90 NLTSISLNGT--LLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSG 147
LT + + + + + L LD N++ ++ +S L L+ TN ++
Sbjct: 149 QLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT- 204
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207
+ ++ LT L S N+L I V L L + N L + +S + L
Sbjct: 205 KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKL 256
Query: 208 VFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267
L+ I + + L + + + ++ QL LLD I
Sbjct: 257 TTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELDVT----HNTQLYLLDCQAAGI 309
Query: 268 TGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLI 327
T ++ ++P+L YL L++ + E+ + + L +S + +G +
Sbjct: 310 T---ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQD-FS-SVGKIP 361
Query: 328 NLEYLDLSANHL-----SNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDL 382
L + SL V L+ N ++ I + + +
Sbjct: 362 ALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN--IEPGDGGVYDQATNTI 419
Query: 383 SHNFLGEKISS 393
+ L +
Sbjct: 420 TWENLSTDNPA 430
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 44/265 (16%), Positives = 87/265 (32%), Gaps = 46/265 (17%)
Query: 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPDN-----FC---------SHP- 545
+ + + G ++ R G VK F SHP
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 546 -------------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYL 592
++ ++ GSL +L+ + + +Q + +A + +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFL 127
Query: 593 HNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPEL-- 650
H P I ++S++V++D A +S + VAPE
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-----MYAPAWVAPEALQ 181
Query: 651 -AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709
D++SF VL E++ + P ++S+ M + + R P +
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFA---DLSNMEIGMKVALEGLRPTIPP-GIS 237
Query: 710 NKFMSIMQVAFSCLDQNPVSRPTMK 734
+M+ C++++P RP
Sbjct: 238 PHVSKLMK---ICMNEDPAKRPKFD 259
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 54/280 (19%), Positives = 100/280 (35%), Gaps = 51/280 (18%)
Query: 494 EEIIRATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF----------- 541
I R +D +GKG G +GE+ +K+ +
Sbjct: 4 HRIFRP-SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMR 62
Query: 542 -------------CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADA 588
++ + EY++ G+L I+ + + W+QR++ K +A
Sbjct: 63 CLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASG 120
Query: 589 LFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-- 646
+ YLH+ I+H D++S N L+ V+DF +A+ + + + L
Sbjct: 121 MAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 647 ------------APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI 694
APE+ EK DV+SFG++ E+I + + + + +
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP---DYLPRTMDFGL 234
Query: 695 EILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+ Y + F I C D +P RP+
Sbjct: 235 NVRGFLDRYCPPNCPPSFFPIT---VRCCDLDPEKRPSFV 271
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-30
Identities = 50/281 (17%), Positives = 99/281 (35%), Gaps = 36/281 (12%)
Query: 114 LDLYNNELFDI---IPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLN 170
+ + N + K N+ + L+ + L ++R L+
Sbjct: 15 QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQLNRLNLS 72
Query: 171 GSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKS 230
S+P + + L + N L S+P +L +L +N S ++P+ +LK
Sbjct: 73 -SLPDNLPPQ--ITVLEITQNALI-SLPELP---ASLEYLDACDNRLS-TLPELPASLKH 124
Query: 231 LFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNY 290
L + NQL +P L ++ N +T +P L+ L + +N
Sbjct: 125 L---DVDNNQLT-MLPELP-----ALLEYINADNNQLT-MLPELPT---SLEVLSVRNNQ 171
Query: 291 IVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLE----YLDLSANHLSNFVLES 346
+ +P + L + +S N L +P + E + N +++ + E+
Sbjct: 172 L-TFLPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPEN 225
Query: 347 LGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFL 387
+ SL + L N LS +I L + +
Sbjct: 226 ILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-26
Identities = 58/284 (20%), Positives = 102/284 (35%), Gaps = 35/284 (12%)
Query: 110 HLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQL 169
A NE ++ +++ L LS +P + +T+L I++N L
Sbjct: 38 KQALPGENRNEAVSLLK--ECLINQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNAL 92
Query: 170 NGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLK 229
S+P L +L+ N L ++P ++ L L + NN + +P+ L+
Sbjct: 93 -ISLPELPASLEYLD---ACDNRLS-TLPELPAS---LKHLDVDNNQLT-MLPELPALLE 143
Query: 230 SLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSN 289
+ NQL +P L +L V N +T +P L+ LD+S+N
Sbjct: 144 YI---NADNNQLT-MLPELP-----TSLEVLSVRNNQLTF-LPELPE---SLEALDVSTN 190
Query: 290 YIVGEIPTQLGNIIYLNR----ISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLE 345
+ +P + N+++ IP + SL + L N LS+ + E
Sbjct: 191 LLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE 248
Query: 346 SLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGE 389
SL + S N +H D + E
Sbjct: 249 SLSQQTAQPDYHGPRIYFSMSDGQ--QNTLHRPLADAVTAWFPE 290
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 33/230 (14%), Positives = 69/230 (30%), Gaps = 22/230 (9%)
Query: 90 NLTSISLNGTLLE---FSFSSFPHL----AYLDLYNNELFDIIPPQISNLSKLEYLDFLT 142
+L ++ ++ LLE H + N + I P I +L +
Sbjct: 181 SLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRITHI-PENILSLDPTCTIILED 239
Query: 143 NKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLS 202
N LS I +S T H R + S + + + + +S
Sbjct: 240 NPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQSDVS 297
Query: 203 NFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDV 262
+ + N+FS + ++ + S + Q+ + + + L
Sbjct: 298 QIWHAFEHEEHANTFS-AFLDRLSDTVSARNTSGFREQVAAWLE------KLSASAELRQ 350
Query: 263 SINNITGNIPFEIGESPQLQYLDLSSNYIV-----GEIPTQLGNIIYLNR 307
+ + + L + +L +V G G ++ L R
Sbjct: 351 QSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSLGR 400
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 18/89 (20%), Positives = 33/89 (37%), Gaps = 7/89 (7%)
Query: 356 LNLSHNKLSQQIPIELDNLI-HLSELDLSHNFLGEKISS-RICRMESLEKLNLSYNNLSG 413
N +N +S + + + L E +S + C + +L L+ NLS
Sbjct: 15 QNSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSS 73
Query: 414 LIPRCFEELHGLLHIDISYNKLEGHIPNS 442
L P + ++I+ N L +P
Sbjct: 74 L-PDNL--PPQITVLEITQNALI-SLPEL 98
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 3e-30
Identities = 61/307 (19%), Positives = 102/307 (33%), Gaps = 71/307 (23%)
Query: 493 YEEIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPDNFCS--------- 543
E ++ IG+G +G+VY + AVK F NF +
Sbjct: 5 ASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPL 63
Query: 544 --HP-----------------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKG 584
H + +V EY +GSL K L+ W +
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHS 119
Query: 585 VADALFYLHN------NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK 638
V L YLH + P I H D++S+NVL+ +SDF ++ L +
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 639 --------LAGTHGNVAPE-------LAYTMKVTEKCDVYSFGVLALEVI---KGKHPRD 680
GT +APE L ++ D+Y+ G++ E+ P +
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 681 FLFEM-----SSSSSNMNIEILDS-------RLPYPS--LDVQNKFMSIMQVAFSCLDQN 726
+ E + ++ E + R +P + S+ + C DQ+
Sbjct: 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299
Query: 727 PVSRPTM 733
+R T
Sbjct: 300 AEARLTA 306
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 60/289 (20%), Positives = 100/289 (34%), Gaps = 70/289 (24%)
Query: 507 HCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPDNFC-----------SHP---------- 545
C+GKG +G V+ GE AVK F S ++ H
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 546 ------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCF-- 597
Q +++ Y E GSL L L L ++ +A L +LH F
Sbjct: 73 TSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 598 ---PPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV------AP 648
P I H D+ SKN+L+ + ++D +A S G + V AP
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM--HSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 649 EL------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM-----SSSSSNMNIEIL 697
E+ ++ D+++FG++ EV + + + ++ + E +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 698 -------DSRLPYPSLDVQN----KFMSIMQVAFSCLDQNPVSRPTMKR 735
R P+ + +M+ C QNP +R T R
Sbjct: 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALR 292
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 72/342 (21%), Positives = 128/342 (37%), Gaps = 77/342 (22%)
Query: 108 FPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTILHISR 166
P A LDL NN++ +I NL L L + NK+S I + L L L++S+
Sbjct: 51 PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSK 109
Query: 167 NQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIG 226
NQL +P + L L ++ N + + +
Sbjct: 110 NQLK-------------------------ELPEKM--PKTLQELRVHENEIT-KVRK--S 139
Query: 227 NLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIG---ESPQLQY 283
L Q+ ++++ N + + E G +L Y
Sbjct: 140 VFNGL-----------------------NQMIVVELGTNPLK-SSGIENGAFQGMKKLSY 175
Query: 284 LDLSSNYIVGEIPTQL-GNIIYLNRISLSGNKLSGRIPGE-LGSLINLEYLDLSANHLSN 341
+ ++ I IP L ++ L+ L GNK++ ++ L L NL L LS N +S
Sbjct: 176 IRIADTNIT-TIPQGLPPSLTELH---LDGNKIT-KVDAASLKGLNNLAKLGLSFNSISA 230
Query: 342 FVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSR------- 394
SL + L L+L++NKL ++P L + ++ + L +N + I S
Sbjct: 231 VDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNI-SAIGSNDFCPPGY 288
Query: 395 ICRMESLEKLNLSYNNL--SGLIPRCFEELHGLLHIDISYNK 434
+ S ++L N + + P F ++ + + K
Sbjct: 289 NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 67/323 (20%), Positives = 115/323 (35%), Gaps = 50/323 (15%)
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIPRSLSNFTN 206
+P ++ +L + N++ I L L+ LIL +N + P + +
Sbjct: 45 KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 101
Query: 207 LVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINN 266
L LYL N +P+ + L L V N
Sbjct: 102 LERLYLSKNQLK-ELPE------KMP----------------------KTLQELRVHENE 132
Query: 267 ITGNIPFEI-GESPQLQYLDLSSNYI-VGEIPTQ-LGNIIYLNRISLSGNKLSGRIPGEL 323
IT + + Q+ ++L +N + I + L+ I ++ ++ IP
Sbjct: 133 IT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ-- 188
Query: 324 GSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLS 383
G +L L L N ++ SL L L L LS N +S L N HL EL L+
Sbjct: 189 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 248
Query: 384 HNFLGEKISSRICRMESLEKLNLSYNNLSGL------IPRCFEELHGLLHIDISYNKLEG 437
+N L K+ + + ++ + L NN+S + P + + + N ++
Sbjct: 249 NNKL-VKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307
Query: 438 HIPNSTTFRDAP-LEA--LQGNK 457
+TFR A L K
Sbjct: 308 WEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 58/289 (20%), Positives = 109/289 (37%), Gaps = 33/289 (11%)
Query: 182 FLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQL 241
L + L +P+ L + L L NN + NLK+L + L N++
Sbjct: 32 HLRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 242 NGAIPLSIDWG---RCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIP-- 296
+ I G +L L +S N + +P ++ LQ L + N I ++
Sbjct: 89 S-----KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKS 139
Query: 297 --TQLGNIIYLNRISLSGNKL-SGRIP-GELGSLINLEYLDLSANHLSNFVLESLGSLVK 352
L +I + L N L S I G + L Y+ ++ +++ G
Sbjct: 140 VFNGLNQMIVVE---LGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI---PQGLPPS 193
Query: 353 LYYLNLSHNKLSQQIPIE-LDNLIHLSELDLSHNFLGEKISSRICR-MESLEKLNLSYNN 410
L L+L NK+++ + L L +L++L LS N + + + L +L+L+ N
Sbjct: 194 LTELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSI-SAVDNGSLANTPHLRELHLNNNK 251
Query: 411 LSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEALQGNKGL 459
L +P + + + + N + I ++ G+
Sbjct: 252 LV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGV 298
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 67/298 (22%), Positives = 118/298 (39%), Gaps = 24/298 (8%)
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIPRSLSNFTN 206
+P EIS T+L + N ++ + + L L L+L +N + ++ S
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRK 103
Query: 207 LVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINN 266
L LY+ N IP + SL ++++ N++ +P + + ++ +++ N
Sbjct: 104 LQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGV-FSGLRNMNCIEMGGNP 158
Query: 267 IT-GNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGE-LG 324
+ + +L YL +S + IP L LN + L NK+ I E L
Sbjct: 159 LENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLL 214
Query: 325 SLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSH 384
L L L N + SL L L L+L +NKLS+ +P L +L L + L
Sbjct: 215 RYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHT 273
Query: 385 NFLGEKISSRICRME------SLEKLNLSYNNLS--GLIPRCFEELHGLLHIDISYNK 434
N + + + C + ++L N + + P F + L I K
Sbjct: 274 NNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 64/311 (20%), Positives = 101/311 (32%), Gaps = 50/311 (16%)
Query: 90 NLTSISLNGTLL----EFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKL 145
+ T + L + + F HL L L NN++ I S L KL+ L N L
Sbjct: 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114
Query: 146 SGHIPSEISLLTHLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSNFLG-GSIPRSLSN 203
IP L + L L I N++ +P V L +N + + N L +
Sbjct: 115 V-EIPPN--LPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
Query: 204 FTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVS 263
L +L + + IP K L L+ L +
Sbjct: 171 GLKLNYLRISEAKLT-GIP------KDLP----------------------ETLNELHLD 201
Query: 264 INNITGNIPFEI-GESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGE 322
N I I E +L L L N I L + L + L NKLS R+P
Sbjct: 202 HNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG 259
Query: 323 LGSLINLEYLDLSANHLSNF------VLESLGSLVKLYYLNLSHNKLSQQI--PIELDNL 374
L L L+ + L N+++ + ++L +N + P +
Sbjct: 260 LPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCV 319
Query: 375 IHLSELDLSHN 385
+ +
Sbjct: 320 TDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 59/268 (22%), Positives = 100/268 (37%), Gaps = 24/268 (8%)
Query: 182 FLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQL 241
L + L ++P+ +S + L L NN S L+ L+ + L N++
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 242 NGAIPLSIDWG---RCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQ 298
+ I +L L +S N++ IP + L L + N I
Sbjct: 91 S-----KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGV 142
Query: 299 LGNIIYLNRISLSGNKL-SGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLN 357
+ +N I + GN L + + L YL +S L+ L L+
Sbjct: 143 FSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGI---PKDLPETLNELH 199
Query: 358 LSHNKLSQQIPIE-LDNLIHLSELDLSHNFLGEKISSRICR-MESLEKLNLSYNNLSGLI 415
L HNK+ I +E L L L L HN + I + + +L +L+L N LS +
Sbjct: 200 LDHNKIQA-IELEDLLRYSKLYRLGLGHNQI-RMIENGSLSFLPTLRELHLDNNKLS-RV 256
Query: 416 PRCFEELHGLLHIDISYNKLEGHIPNST 443
P +L L + + N + + +
Sbjct: 257 PAGLPDLKLLQVVYLHTNNIT-KVGVND 283
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 58/287 (20%), Positives = 96/287 (33%), Gaps = 66/287 (22%)
Query: 507 HCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPDNF-----------CSHP---------- 545
IGKG G V+ + GE AVK F S ++ H
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106
Query: 546 ------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCF-- 597
Q ++V +Y E GSL LN + + + A L +LH
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 598 ---PPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL----NLDSSNWSKLAGTHGNVAPEL 650
P I H D+ SKN+L+ ++D +A + + GT +APE+
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 651 ------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM-----SSSSSNMNIEIL-- 697
+ ++ D+Y+ G++ E+ + + S+ ++E +
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282
Query: 698 -----DSRLPYP----SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKR 735
R P S + IM+ C N +R T R
Sbjct: 283 VVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALR 326
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 60/284 (21%), Positives = 102/284 (35%), Gaps = 60/284 (21%)
Query: 507 HCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPDNFC-----------SHP---------- 545
IGKG +G V++ + GE AVK F + ++ H
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADI 101
Query: 546 ------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCF-- 597
Q +++ +Y E+GSL L + L L + L +LH F
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 598 ---PPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW----SKLAGTHGNVAPEL 650
P I H D+ SKN+L+ ++D +A D++ + GT + PE+
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 651 ------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN-----IEIL-- 697
+ D+YSFG++ EV + + E ++ E +
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277
Query: 698 -----DSRLPYPSLDVQNKFMSIM-QVAFSCLDQNPVSRPTMKR 735
R +P+ ++ + M ++ C NP SR T R
Sbjct: 278 IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-29
Identities = 71/369 (19%), Positives = 137/369 (37%), Gaps = 26/369 (7%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKL 145
L + ++ L F L YLDL +N+L I L++LD N
Sbjct: 46 KLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL-VKISCH--PTVNLKHLDLSFNAF 102
Query: 146 -SGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLN-HLILDSNFLGGSIPRSLSN 203
+ I E ++ L L +S L S + LN L+L + P L +
Sbjct: 103 DALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQD 162
Query: 204 F--TNLVFLYLYNNSFSGSIPQQIGNLKSL----FDMKLCINQLNGAIPLSIDWGRCPQL 257
F +L ++ N F + + + +L L N+ + + + P+L
Sbjct: 163 FNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKL 222
Query: 258 SLLDVSINNITGNIPFEIGE---SPQLQYLDLSSNYIVGEIPTQLGNII-----YLNRIS 309
S L ++ T N I + + Y +S+ + G++ + + L+
Sbjct: 223 SNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQ 282
Query: 310 LSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPI 369
+ + N+ + + + + + +L+ S+N L+ +
Sbjct: 283 VVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFE 342
Query: 370 ELDNLIHLSELDLSHNFLG--EKISSRICRMESLEKLNLSYNNLSGLIPRC-FEELHGLL 426
+L L L L N L KI+ +M+SL++L++S N++S + LL
Sbjct: 343 NCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402
Query: 427 HIDISYNKL 435
+++S N L
Sbjct: 403 SLNMSSNIL 411
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 62/368 (16%), Positives = 118/368 (32%), Gaps = 31/368 (8%)
Query: 99 TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTH 158
L S L L + +N + + +LEYLD NKL I +
Sbjct: 35 ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVN 91
Query: 159 LTILHISRNQLNGSIPH--EVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNS 216
L L +S N + ++P E G ++ L L L + L S +++ L + +
Sbjct: 92 LKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150
Query: 217 FSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGN------ 270
+ L+ L I I ++ ++ ++NI
Sbjct: 151 YGEKED--PEGLQDFNTESLHIVFPTNKEFHFIL--DVSVKTVANLELSNIKCVLEDNKC 206
Query: 271 -----IPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIY--------LNRISLSGNKLSG 317
I ++ +P+L L L++ ++ +++ ++ + L G
Sbjct: 207 SYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFR 266
Query: 318 RIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHL 377
SL L + ++ + N + + + +
Sbjct: 267 DFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPF 326
Query: 378 SELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGL--IPRCFEELHGLLHIDISYNKL 435
LD S+N L + + + LE L L N L L I ++ L +DIS N +
Sbjct: 327 LHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSV 386
Query: 436 EGHIPNST 443
Sbjct: 387 SYDEKKGD 394
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 64/388 (16%), Positives = 131/388 (33%), Gaps = 54/388 (13%)
Query: 90 NLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHI 149
++ + F + L +L L L I++L+ + L L
Sbjct: 101 AFDALPICKE-----FGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKE 155
Query: 150 PSE---ISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNF-- 204
E L I+ + + + + V + L + LS
Sbjct: 156 DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAK 215
Query: 205 -------------------------------TNLVFLYLYNNSFSGSIPQQIG-----NL 228
T + + + N G + + +L
Sbjct: 216 LQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSL 275
Query: 229 KSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSS 288
K+L ++ + P S + +++ + +++ + +LD S+
Sbjct: 276 KALSIHQVVSDVFG--FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSN 333
Query: 289 NYIVGEIPTQLGNIIYLNRISLSGNKLS--GRIPGELGSLINLEYLDLSANHLSNFVLES 346
N + + G++ L + L N+L +I + +L+ LD+S N +S +
Sbjct: 334 NLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG 393
Query: 347 L-GSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLN 405
L LN+S N L+ I L + LDL N + + I ++ ++E+L++LN
Sbjct: 394 DCSWTKSLLSLNMSSNILTDTIFRCLPPR--IKVLDLHSNKI-KSIPKQVVKLEALQELN 450
Query: 406 LSYNNLSGLIPRCFEELHGLLHIDISYN 433
++ N L + F+ L L I + N
Sbjct: 451 VASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 59/329 (17%), Positives = 129/329 (39%), Gaps = 24/329 (7%)
Query: 89 INLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGH 148
I + +L+ S + +L ++ + +S L+KL+ L+N +
Sbjct: 170 IVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNN 229
Query: 149 IPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLV 208
I T + + I + + ++ + ++++ L S ++ L
Sbjct: 230 IE-----TTWNSFIRILQLVWHTTVWY-----FSISNVKLQGQLDFRDFDYSGTSLKALS 279
Query: 209 FLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNIT 268
+ ++ F ++ ++ + + + LD S N +T
Sbjct: 280 IHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR-MVHMLC-PSKISPFLHLDFSNNLLT 337
Query: 269 GNIPFEIGESPQLQYLDLSSNYI-----VGEIPTQLGNIIYLNRISLSGNKLSGRIP-GE 322
+ G +L+ L L N + + E+ TQ+ ++ L+ +S N +S G+
Sbjct: 338 DTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD---ISQNSVSYDEKKGD 394
Query: 323 LGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDL 382
+L L++S+N L++ + L ++ L+L NK+ + IP ++ L L EL++
Sbjct: 395 CSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKI-KSIPKQVVKLEALQELNV 451
Query: 383 SHNFLGEKISSRICRMESLEKLNLSYNNL 411
+ N L R+ SL+K+ L N
Sbjct: 452 ASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 4e-22
Identities = 59/322 (18%), Positives = 115/322 (35%), Gaps = 13/322 (4%)
Query: 48 SLEVHSRSLLHSWSLSFVNATKISLCTWSGIHCNHAGRVFGINLTSISLNG--TLLEFSF 105
S ++ + F +S+ T + + ++ V N S L+ L
Sbjct: 162 DFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPK 221
Query: 106 SSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-----SLLTHLT 160
S L ++ N I Q+ + + Y KL G + + L L+
Sbjct: 222 LSNLTLNNIETTWNSFIRI--LQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALS 279
Query: 161 ILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGS 220
I + + + + +N + S + + L NN + +
Sbjct: 280 IHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDT 339
Query: 221 IPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESP- 279
+ + G+L L + L +NQL ++ + L LD+S N+++ +
Sbjct: 340 VFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK 399
Query: 280 QLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHL 339
L L++SSN + I L + + L NK+ IP ++ L L+ L++++N L
Sbjct: 400 SLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL 456
Query: 340 SNFVLESLGSLVKLYYLNLSHN 361
+ L L + L N
Sbjct: 457 KSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 2e-16
Identities = 61/330 (18%), Positives = 110/330 (33%), Gaps = 49/330 (14%)
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207
H+P ++S TIL+IS+N ++ ++ L+ L LI+ N + L
Sbjct: 14 HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 208 VFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267
+L L +N I +L + L N + A+P+ ++G QL L +S ++
Sbjct: 72 EYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHL 127
Query: 268 TGNIPFEIGESPQLQY--LDLSSNYIVGEIPTQLGNIIYL-NRISLSGNKLSGRIPGE-L 323
+ L L Y E P L + I NK I +
Sbjct: 128 E-KSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSV 186
Query: 324 GSLINLEYLDLSANHLSN---------------------------------FVLESLGSL 350
++ NLE ++ N + L
Sbjct: 187 KTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWH 246
Query: 351 VKLYYLNLSHNKLSQQIPIELDNLIH-----LSELDLSHNFLGEKISSRICRMESLEKLN 405
++Y ++S+ KL Q+ + LS + + G S ++ N
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKN 306
Query: 406 LSYNNLSGLIPRCFEELHGLLHIDISYNKL 435
+ + + C ++ LH+D S N L
Sbjct: 307 FTVSGTRMVHMLCPSKISPFLHLDFSNNLL 336
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 1e-14
Identities = 52/197 (26%), Positives = 81/197 (41%), Gaps = 11/197 (5%)
Query: 259 LLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGR 318
L+D S N + ++P ++ S + L++S NYI + + ++ L + +S N++
Sbjct: 4 LVDRSKNGLI-HVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 319 IPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPI--ELDNLIH 376
LEYLDLS N L S V L +L+LS N +PI E N+
Sbjct: 61 DISVFKFNQELEYLDLSHNKLVKI---SCHPTVNLKHLDLSFNAF-DALPICKEFGNMSQ 116
Query: 377 LSELDLSHNFLGEKISSRICRMESLE-KLNLSYNNLSGLIPRCFEELHGL-LHIDISYNK 434
L L LS L + I + + L L P ++ + LHI NK
Sbjct: 117 LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNK 176
Query: 435 LEGHIPNSTTFRDAPLE 451
I + + A LE
Sbjct: 177 EFHFILDVSVKTVANLE 193
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 43/232 (18%), Positives = 82/232 (35%), Gaps = 15/232 (6%)
Query: 206 NLVFLYLYNNSFSGSIPQQI-GNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSI 264
+ + N +P+ + L + N ++ I +L +L +S
Sbjct: 1 SEFLVDRSKNGLI-HVPKDLSQKTTIL---NISQNYISELWTSDIL--SLSKLRILIISH 54
Query: 265 NNITGNIPFEIGES-PQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKL-SGRIPGE 322
N I + + + +L+YLDLS N +V N+ +L+ LS N + I E
Sbjct: 55 NRIQ-YLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHLD---LSFNAFDALPICKE 110
Query: 323 LGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDL 382
G++ L++L LS HL + + L L + + + + L + L
Sbjct: 111 FGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGE--KEDPEGLQDFNTESL 168
Query: 383 SHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNK 434
F K I + NL +N+ ++ + + N
Sbjct: 169 HIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNP 220
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 41/194 (21%), Positives = 75/194 (38%), Gaps = 15/194 (7%)
Query: 260 LDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIP----TQLGNIIYLNRISLSGNKL 315
L++S N I+ +I +L+ L +S N I + + YL+ LS NKL
Sbjct: 26 LNISQNYISELWTSDILSLSKLRILIISHNRI-QYLDISVFKFNQELEYLD---LSHNKL 81
Query: 316 SGRIPGELGSLINLEYLDLSANHLSNF-VLESLGSLVKLYYLNLSHNKLSQQIPIELDNL 374
I +NL++LDLS N + + G++ +L +L LS L + + + +L
Sbjct: 82 VK-IS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138
Query: 375 IHLSELDLSHNFLGEKISS---RICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDIS 431
L + GEK + ESL + + ++ + + L +I
Sbjct: 139 NISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIK 198
Query: 432 YNKLEGHIPNSTTF 445
+ +
Sbjct: 199 CVLEDNKCSYFLSI 212
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 60/313 (19%), Positives = 118/313 (37%), Gaps = 48/313 (15%)
Query: 103 FSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTIL 162
F + + + + + D + ++L + L ++ I + L +L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGL 68
Query: 163 HISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIP 222
+ NQ+ + + L + L L N L +++ ++ L L +
Sbjct: 69 ELKDNQIT-DLA-PLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTST------- 117
Query: 223 QQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQ 282
QI ++ L + L +L + +N IT NI + LQ
Sbjct: 118 -QITDVTPLAGL--------------------SNLQVLYLDLNQIT-NIS-PLAGLTNLQ 154
Query: 283 YLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNF 342
YL + + + P L N+ L + NK+S I L SL NL + L N +S+
Sbjct: 155 YLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISD- 209
Query: 343 VLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKIS-SRICRMESL 401
+ L + L+ + L++ ++ Q +NL+ ++ G I+ + I +
Sbjct: 210 -VSPLANTSNLFIVTLTNQTITNQPVFYNNNLVV---PNVVKGPSGAPIAPATISDNGTY 265
Query: 402 EKLNLSYNNLSGL 414
NL++N S +
Sbjct: 266 ASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 42/235 (17%), Positives = 96/235 (40%), Gaps = 20/235 (8%)
Query: 201 LSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLL 260
N + + ++ + ++ +L + + + + L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEGVQ----YLNNLIGL 68
Query: 261 DVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIP 320
++ N IT ++ + ++ L+LS N + + + + + + + L+ +++ P
Sbjct: 69 ELKDNQIT-DLA-PLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP 124
Query: 321 GELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSEL 380
L L NL+ L L N ++N + L L L YL++ + ++S P L NL L+ L
Sbjct: 125 --LAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTL 178
Query: 381 DLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKL 435
N + IS + + +L +++L N +S + P L + ++ +
Sbjct: 179 KADDNKI-SDISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTI 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 56/273 (20%), Positives = 107/273 (39%), Gaps = 44/273 (16%)
Query: 156 LTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNN 215
L + + ++ + ++ L+ + L + +I + NL+ L L +N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDN 73
Query: 216 SFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEI 275
QI +L L ++ +++ L++S N + N+ I
Sbjct: 74 --------QITDLAPLKNL--------------------TKITELELSGNPLK-NVS-AI 103
Query: 276 GESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLS 335
++ LDL+S I P L + L + L N+++ I L L NL+YL +
Sbjct: 104 AGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIG 159
Query: 336 ANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRI 395
+S+ L L +L KL L NK+S I L +L +L E+ L +N + +S +
Sbjct: 160 NAQVSD--LTPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQI-SDVSP-L 213
Query: 396 CRMESLEKLNLSYNNLSGLIPRCFEELHGLLHI 428
+L + L+ ++ L +
Sbjct: 214 ANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVV 246
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 35/182 (19%), Positives = 72/182 (39%), Gaps = 14/182 (7%)
Query: 255 PQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNK 314
+ +N+T + + + L + + + L + L N+
Sbjct: 19 ANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDNQ 74
Query: 315 LSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNL 374
++ + L +L + L+LS N L N + ++ L + L+L+ +++ P L L
Sbjct: 75 IT-DLAP-LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTP--LAGL 128
Query: 375 IHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNK 434
+L L L N + IS + + +L+ L++ +S L P L L + NK
Sbjct: 129 SNLQVLYLDLNQI-TNISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK 184
Query: 435 LE 436
+
Sbjct: 185 IS 186
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 67/324 (20%), Positives = 117/324 (36%), Gaps = 70/324 (21%)
Query: 91 LTSISLNGTLLE--FSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGH 148
+ T ++ F +F +L + D + + L+ ++ + + +
Sbjct: 1 MGETITVSTPIKQIFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-S 57
Query: 149 IPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLV 208
+ I L ++T L ++ N+L I L+N NL
Sbjct: 58 V-QGIQYLPNVTKLFLNGNKLT-------------------------DIK-PLTNLKNLG 90
Query: 209 FLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNIT 268
+L+L N +I +L SL D +L L + N I+
Sbjct: 91 WLFLDEN--------KIKDLSSLKD--------------------LKKLKSLSLEHNGIS 122
Query: 269 GNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLIN 328
+I + PQL+ L L +N I T L + L+ +SL N++S I L L
Sbjct: 123 -DING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTK 176
Query: 329 LEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLG 388
L+ L LS NH+S+ L +L L L L L + + NL+ + + + L
Sbjct: 177 LQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 234
Query: 389 EKISSRICRMESLEKLNLSYNNLS 412
I EK N+ ++
Sbjct: 235 TPEI--ISDDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 56/260 (21%), Positives = 100/260 (38%), Gaps = 20/260 (7%)
Query: 183 LNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLN 242
+ I S + P F + L S + ++ Q L S+ + + +
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 56
Query: 243 GAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNI 302
+ P ++ L ++ N +T +I + L +L L N I ++ + L ++
Sbjct: 57 SVQGIQ----YLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DLSS-LKDL 108
Query: 303 IYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNK 362
L +SL N +S I G L L LE L L N +++ + L L KL L+L N+
Sbjct: 109 KKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQ 164
Query: 363 LSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEEL 422
+S +P L L L L LS N + + + + +++L+ L L L
Sbjct: 165 ISDIVP--LAGLTKLQNLYLSKNHI-SDLRA-LAGLKNLDVLELFSQECLNKPINHQSNL 220
Query: 423 HGLLHIDISYNKLEGHIPNS 442
+ + L S
Sbjct: 221 VVPNTVKNTDGSLVTPEIIS 240
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 56/243 (23%), Positives = 88/243 (36%), Gaps = 29/243 (11%)
Query: 196 SIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCP 255
S+P + ++ L L +N L L + L N L+ S
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 256 QLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKL 315
L LD+S N + + QL++LD + L +
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS--------NLKQMSE----------- 118
Query: 316 SGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIE-LDNL 374
SL NL YLD+S H L L L ++ N + + L
Sbjct: 119 ----FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 174
Query: 375 IHLSELDLSHNFLGEKISSRI-CRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYN 433
+L+ LDLS L E++S + SL+ LN+S+NN L ++ L+ L +D S N
Sbjct: 175 RNLTFLDLSQCQL-EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233
Query: 434 KLE 436
+
Sbjct: 234 HIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 66/260 (25%), Positives = 96/260 (36%), Gaps = 15/260 (5%)
Query: 160 TILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNN--SF 217
T + + L S+P + + L L+SN L T L L L +N SF
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 218 SGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEI-G 276
G Q SL + L N + +S ++ QL LD +N+ F +
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVIT---MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 123
Query: 277 ESPQLQYLDLSSNYIVGEIPTQ-LGNIIYLNRISLSGNKLSGRI-PGELGSLINLEYLDL 334
L YLD+S + + L + ++GN P L NL +LDL
Sbjct: 124 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182
Query: 335 SANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSR 394
S L + SL L LN+SHN L L LD S N + +
Sbjct: 183 SQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI-MTSKKQ 241
Query: 395 ICR--MESLEKLNLSYNNLS 412
+ SL LNL+ N+ +
Sbjct: 242 ELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 53/263 (20%), Positives = 94/263 (35%), Gaps = 34/263 (12%)
Query: 108 FPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLS-GHIPSEISL-LTHLTILHIS 165
L+L +N+L + L++L L +N LS S+ T L L +S
Sbjct: 27 PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86
Query: 166 RNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSL-SNFTNLVFLYLYNNSFSGSIPQQ 224
N + ++ L L HL + L S+ + NL++L + +
Sbjct: 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNG 144
Query: 225 IGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGES-PQLQY 283
I F+ L +L ++ N+ N +I L +
Sbjct: 145 I------FN-------------------GLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 179
Query: 284 LDLSSNYIVGEIPTQ-LGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNF 342
LDLS + ++ ++ L +++S N L +L+ LD S NH+
Sbjct: 180 LDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 238
Query: 343 VLESLGSLVK-LYYLNLSHNKLS 364
+ L L +LNL+ N +
Sbjct: 239 KKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 37/153 (24%), Positives = 57/153 (37%), Gaps = 6/153 (3%)
Query: 305 LNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLES--LGSLVKLYYLNLSHNK 362
R+ L NKL G L L L LS+N LS S L YL+LS N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 363 LSQQIPIELDNLIHLSELDLSHNFLGEKISSRICR-MESLEKLNLSYNNLSGLIPRCFEE 421
+ + L L LD H+ L + + + +L L++S+ + F
Sbjct: 90 VIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 148
Query: 422 LHGLLHIDISYNKLEGHIPNSTTFRDAP-LEAL 453
L L + ++ N + + F + L L
Sbjct: 149 LSSLEVLKMAGNSFQENFL-PDIFTELRNLTFL 180
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 24/110 (21%), Positives = 43/110 (39%), Gaps = 10/110 (9%)
Query: 90 NLTSISLNG-----TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNK 144
+L + + G L F+ +L +LDL +L + P ++LS L+ L+ N
Sbjct: 151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 210
Query: 145 LSGHIPSEI-SLLTHLTILHISRNQLNGSIPHEV--GQLNFLNHLILDSN 191
+ + L L +L S N + + + + L L L N
Sbjct: 211 FF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 20/87 (22%), Positives = 38/87 (43%), Gaps = 7/87 (8%)
Query: 90 NLTSISLNGTLLEF----SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKL 145
NLT + L+ LE +F+S L L++ +N F + L+ L+ LD+ N +
Sbjct: 176 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 235
Query: 146 SGHIPSEI--SLLTHLTILHISRNQLN 170
+ + L L++++N
Sbjct: 236 M-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 48/280 (17%), Positives = 88/280 (31%), Gaps = 67/280 (23%)
Query: 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----NF-------------- 541
+ IGKG G VY R GE+ A++ + F
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 542 -------CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN 594
C P I+ + +L ++ + L + + + + + YLH
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHA 148
Query: 595 NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK-----FLNLDSSNWSKLAGTHGNVAPE 649
I+H D+ SKNV D G + ++DF + G ++APE
Sbjct: 149 ---KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 650 L---------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE-IL-- 697
+ + ++ DV++ G + E+ + P F+ E I+
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP----FK------TQPAEAIIWQ 254
Query: 698 ---DSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+ + + + I+ C RPT
Sbjct: 255 MGTGMKPNLSQIGMGKEISDILL---FCWAFEQEERPTFT 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-26
Identities = 69/242 (28%), Positives = 110/242 (45%), Gaps = 13/242 (5%)
Query: 196 SIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCP 255
+P + TN L L+ N +L+ L ++L N + I + G
Sbjct: 57 EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNG-LA 112
Query: 256 QLSLLDVSINNITGNIPFEI-GESPQLQYLDLSSNYIVGEIPTQL-GNIIYLNRISLSG- 312
L+ L++ N +T IP +L+ L L +N I IP+ I L R+ L
Sbjct: 113 NLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGEL 170
Query: 313 NKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELD 372
+LS G L NL YL+L+ +L + +L L+KL L+LS N LS P
Sbjct: 171 KRLSYISEGAFEGLSNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLSAIRPGSFQ 228
Query: 373 NLIHLSELDLSHNFLGEKISSR-ICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDIS 431
L+HL +L + + + + I ++SL ++NL++NNL+ L F LH L I +
Sbjct: 229 GLMHLQKLWMIQSQI-QVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLH 287
Query: 432 YN 433
+N
Sbjct: 288 HN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 66/240 (27%), Positives = 105/240 (43%), Gaps = 9/240 (3%)
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207
+P IS T+ +L++ NQ+ + L L L L N + + + NL
Sbjct: 57 EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 208 VFLYLYNNSFSGSIPQQI-GNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINN 266
L L++N + +IP L L ++ L N + +IP + R P L LD+
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYA-FNRIPSLRRLDLGELK 171
Query: 267 ITGNIPFEIGES-PQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGS 325
I E L+YL+L+ + EIP L +I L+ + LSGN LS PG
Sbjct: 172 RLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQG 229
Query: 326 LINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHN 385
L++L+ L + + + + +L L +NL+HN L+ L HL + L HN
Sbjct: 230 LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 53/280 (18%), Positives = 100/280 (35%), Gaps = 63/280 (22%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKL 145
N ++L+ + SF HL L L N + I + L+ L L+ N+L
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124
Query: 146 SGHIPSEI-SLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNF 204
+ IP+ L+ L L + N + SIP + +
Sbjct: 125 T-TIPNGAFVYLSKLKELWLRNNPIE-SIP-----------------------SYAFNRI 159
Query: 205 TNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWG---RCPQLSLLD 261
+L L L +L+ I G L L+
Sbjct: 160 PSLRRLDLGEL-----------------------KRLS-----YISEGAFEGLSNLRYLN 191
Query: 262 VSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPG 321
+++ N+ IP + +L LDLS N++ P +++L ++ + +++
Sbjct: 192 LAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERN 249
Query: 322 ELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHN 361
+L +L ++L+ N+L+ + L L ++L HN
Sbjct: 250 AFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 52/194 (26%), Positives = 75/194 (38%), Gaps = 10/194 (5%)
Query: 253 RC-PQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLS 311
C Q S + N+ +P I S + L+L N I ++ +L + LS
Sbjct: 40 SCSNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLS 96
Query: 312 GNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIEL 371
N + G L NL L+L N L+ + L KL L L +N + IP
Sbjct: 97 RNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYA 155
Query: 372 -DNLIHLSELDLSHNFLGEKISSRI-CRMESLEKLNLSYNNLSGLIPRCFEELHGLLHID 429
+ + L LDL IS + +L LNL+ NL IP L L +D
Sbjct: 156 FNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPN-LTPLIKLDELD 213
Query: 430 ISYNKLEGHIPNST 443
+S N L I +
Sbjct: 214 LSGNHLS-AIRPGS 226
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 35/131 (26%), Positives = 56/131 (42%), Gaps = 14/131 (10%)
Query: 90 NLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHI 149
L+ IS +F +L YL+L L +I P ++ L KL+ LD N LS I
Sbjct: 172 RLSYISEG------AFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLS-AI 222
Query: 150 PSEI-SLLTHLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIPRS-LSNFTN 206
L HL L + ++Q+ I L L + L N L +P + +
Sbjct: 223 RPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHH 280
Query: 207 LVFLYLYNNSF 217
L ++L++N +
Sbjct: 281 LERIHLHHNPW 291
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 66/280 (23%), Positives = 94/280 (33%), Gaps = 55/280 (19%)
Query: 108 FPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTILHISR 166
+ YL+L N + I +L LE L N + I + L L L +
Sbjct: 74 PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFD 132
Query: 167 NQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIG 226
N L IP + + L L+L NN SIP
Sbjct: 133 NWLT-VIP-----------------------SGAFEYLSKLRELWLRNNPIE-SIPSYA- 166
Query: 227 NLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGES-PQLQYLD 285
+ R P L LD+ I E L+YL+
Sbjct: 167 ------------------------FNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLN 202
Query: 286 LSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLE 345
L I ++P L ++ L + +SGN PG L +L+ L + + +S
Sbjct: 203 LGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERN 260
Query: 346 SLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHN 385
+ L L LNL+HN LS L +L EL L HN
Sbjct: 261 AFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 5e-21
Identities = 55/280 (19%), Positives = 96/280 (34%), Gaps = 63/280 (22%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKL 145
N ++L + +F HL L L N + I + L+ L L+ N L
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135
Query: 146 SGHIPSEI-SLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNF 204
+ IPS L+ L L + N + SIP + +
Sbjct: 136 T-VIPSGAFEYLSKLRELWLRNNPIE-SIP-----------------------SYAFNRV 170
Query: 205 TNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWG---RCPQLSLLD 261
+L+ L L +L I G L L+
Sbjct: 171 PSLMRLDLGEL-----------------------KKLE-----YISEGAFEGLFNLKYLN 202
Query: 262 VSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPG 321
+ + NI ++P + L+ L++S N+ P + L ++ + +++S
Sbjct: 203 LGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERN 260
Query: 322 ELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHN 361
L +L L+L+ N+LS+ + L L L+L HN
Sbjct: 261 AFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 6e-20
Identities = 47/194 (24%), Positives = 76/194 (39%), Gaps = 10/194 (5%)
Query: 253 RC-PQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLS 311
C Q S + + ++ +P I +YL+L N I ++ +L + L
Sbjct: 51 SCSNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLG 107
Query: 312 GNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIE- 370
N + G L +L L+L N L+ + L KL L L +N + IP
Sbjct: 108 RNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYA 166
Query: 371 LDNLIHLSELDLSHNFLGEKISSRI-CRMESLEKLNLSYNNLSGLIPRCFEELHGLLHID 429
+ + L LDL E IS + +L+ LNL N+ +P L GL ++
Sbjct: 167 FNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPN-LTPLVGLEELE 224
Query: 430 ISYNKLEGHIPNST 443
+S N I +
Sbjct: 225 MSGNHFP-EIRPGS 237
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 21/86 (24%), Positives = 37/86 (43%), Gaps = 6/86 (6%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKL 145
L + ++G + SF L L + N+++ I L+ L L+ N L
Sbjct: 219 GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL 278
Query: 146 SGHIPSEI-SLLTHLTILHISRNQLN 170
S +P ++ + L +L LH+ N N
Sbjct: 279 S-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 55/256 (21%), Positives = 99/256 (38%), Gaps = 40/256 (15%)
Query: 509 IGKGGHGSVYIARVPSGEIFAVKKFHSPLPDN-----FCS---------HPR-------- 546
IG G G+VY + G++ AVK + P F + H
Sbjct: 32 IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 547 ---QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHW 603
Q IV ++ E SL L+ S + + +++ + A + YLH I+H
Sbjct: 90 TAPQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAK---SIIHR 144
Query: 604 DISSKNVLLDLGYEAHVSDFRIAKFLNL--DSSNWSKLAGTHGNVAPEL---AYTMKVTE 658
D+ S N+ L + DF +A + S + +L+G+ +APE+ + +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 659 KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQV 718
+ DVY+FG++ E++ G+ P + + L L + + +M
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMA- 263
Query: 719 AFSCLDQNPVSRPTMK 734
CL + RP+
Sbjct: 264 --ECLKKKRDERPSFP 277
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 69/385 (17%), Positives = 133/385 (34%), Gaps = 39/385 (10%)
Query: 90 NLTSISLNG-TLLEFSFSSFPHLAYLDLYNNELFDI-IPPQISNLSKLEYLDFLTNKL-S 146
+L + ++ L S L +LDL N+ + + + NL+KL +L K
Sbjct: 101 DLEYLDVSHNRLQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ 160
Query: 147 GHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNF-LNHLILDSNFLGGSIPR-SLSNF 204
+ L +L + + G + N + HL+ N L S++
Sbjct: 161 LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNAL 220
Query: 205 TNLVF--LYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIP-----LSIDWGRCPQ- 256
+L + L + + + + + + + + W R +
Sbjct: 221 GHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEY 280
Query: 257 LSLLDVSINNITGNIPFEIGES--PQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNK 314
L++ +++I F E+ L + + + +N LS +
Sbjct: 281 LNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD 340
Query: 315 LSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQ--QIPIELD 372
S + +L+ + N ++ V + +L +L L L N L ++ +
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTK 400
Query: 373 NLIHLSELDLSHNFLGEKISSRICR-MESLEKLNLSYNNLSGL----------------- 414
N+ L LD+S N L R C ES+ LNLS N L+G
Sbjct: 401 NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNN 460
Query: 415 ----IPRCFEELHGLLHIDISYNKL 435
IP+ L L ++++ N+L
Sbjct: 461 RIMSIPKDVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 76/368 (20%), Positives = 131/368 (35%), Gaps = 26/368 (7%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKL 145
L + L+ +L F L YLD+ +N L +I ++ L +LD N
Sbjct: 77 ELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNI---SCCPMASLRHLDLSFNDF 133
Query: 146 -SGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILD--SNFLGGSIPRSLS 202
+ E LT LT L +S + + L+ ++LD S + G SL
Sbjct: 134 DVLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQ 192
Query: 203 --NFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLL 260
N T L ++ N+ FS + + L L + +N N ++ +LL
Sbjct: 193 IPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLL 252
Query: 261 DVSINNITGNIP-----FEIGESPQLQYLDLSSNYIVGEIPTQLGNII-----YLNRISL 310
+V++ +I F+ ++YL++ + I I + L +
Sbjct: 253 NVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHV 312
Query: 311 SGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIE 370
+ LS + + S +LN + N + +
Sbjct: 313 KNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQG 372
Query: 371 LDNLIHLSELDLSHNFLG--EKISSRICRMESLEKLNLSYNNL-SGLIPRCFEELHGLLH 427
L L L L N L K++ M SLE L++S N+L S R +L
Sbjct: 373 CSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432
Query: 428 IDISYNKL 435
+++S N L
Sbjct: 433 LNLSSNML 440
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-23
Identities = 54/340 (15%), Positives = 103/340 (30%), Gaps = 21/340 (6%)
Query: 113 YLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTILHISRNQLNG 171
L L N + ++ P IS LS+L L N++ + + L L +S N+L
Sbjct: 56 ALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL-Q 113
Query: 172 SIPHEVGQLNFLNHLILDSNFLGGSIPRS--LSNFTNLVFLYLYNNSFSGSIPQQIGNLK 229
+I + L HL L N +P N T L FL L F + +L
Sbjct: 114 NIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLH 170
Query: 230 -SLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNIT--GNIPFEIGESPQLQYLDL 286
S + L + G S+ L L+ + + N+ QL + L
Sbjct: 171 LSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKL 230
Query: 287 SSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLES 346
+ + ++++ + + + ++ N +
Sbjct: 231 NDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITE 290
Query: 347 LG----------SLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRIC 396
+L L ++ + ++ LS +
Sbjct: 291 RIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPP 350
Query: 397 RMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLE 436
S LN + N + + + L L + + N L+
Sbjct: 351 SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 3e-20
Identities = 58/365 (15%), Positives = 119/365 (32%), Gaps = 47/365 (12%)
Query: 90 NLTSISLNGT-LLEFSFSSFPHL----AYLDLYNNELFDIIPPQISNL-SKLEYLDFLTN 143
LT + L+ + HL LDL + + + + + +L F N
Sbjct: 147 KLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPN 206
Query: 144 KLSGHI------PSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSI 197
L L+++ + + +L + LN +
Sbjct: 207 SLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCS 266
Query: 198 PRSLSNF--TNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWG--- 252
+ F + +L +YN + + I ++ L I + + L
Sbjct: 267 VKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYS 326
Query: 253 RCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSG 312
++++ +SI++ +L+ + N + + L + L
Sbjct: 327 VFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQR 386
Query: 313 NKLS-----GRIPGELGSL----------------------INLEYLDLSANHLSNFVLE 345
N L + + SL ++ L+LS+N L+ V
Sbjct: 387 NGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR 446
Query: 346 SLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLN 405
L K+ L+L +N++ IP ++ +L L EL+++ N L R+ SL+ +
Sbjct: 447 CLPP--KVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIW 503
Query: 406 LSYNN 410
L N
Sbjct: 504 LHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 3e-18
Identities = 67/368 (18%), Positives = 121/368 (32%), Gaps = 25/368 (6%)
Query: 6 LKNNRVIISLVFPLILFLVLDFSLAVSSNSTEEAHALVKWKASLEVHSRSLLHSWSLS-- 63
L + L + L L L + + + + H SL
Sbjct: 153 LSAAK-FRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSV 211
Query: 64 --FVNATKISLCTWSGIHCNHAG-RVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNE 120
++ + S I N + L+ ++ TLL + +++
Sbjct: 212 QVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQ------HIETTWKC 265
Query: 121 LFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-----SLLTHLTILHISRNQLNGSIPH 175
+ Q +EYL+ ++ I E + L L I H+ S
Sbjct: 266 SVKLF--QFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEA 323
Query: 176 EVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMK 235
+N +L + + ++ FL N F+ S+ Q LK L +
Sbjct: 324 LYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLI 383
Query: 236 LCINQLNGAIPLSIDW-GRCPQLSLLDVSINNIT-GNIPFEIGESPQLQYLDLSSNYIVG 293
L N L L LDVS+N++ + + L+LSSN + G
Sbjct: 384 LQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTG 442
Query: 294 EIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKL 353
+ L + + L N++ IP ++ L L+ L++++N L + L L
Sbjct: 443 SVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSL 499
Query: 354 YYLNLSHN 361
Y+ L N
Sbjct: 500 QYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 36/111 (32%), Positives = 53/111 (47%), Gaps = 8/111 (7%)
Query: 328 NLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNF 386
+ L LS N +S + + L +L L LSHN++ + + + L LD+SHN
Sbjct: 53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNR 111
Query: 387 LGEKISSRICRMESLEKLNLSYNNLSGLIPRC--FEELHGLLHIDISYNKL 435
L + IS M SL L+LS+N+ L P C F L L + +S K
Sbjct: 112 L-QNISCC--PMASLRHLDLSFNDFDVL-PVCKEFGNLTKLTFLGLSAAKF 158
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 27/136 (19%), Positives = 55/136 (40%), Gaps = 12/136 (8%)
Query: 90 NLTSISLNG---TLLEFSFSSFPHLAYLDLYNNEL----FDIIPPQISNLSKLEYLDFLT 142
L ++ L +++ L+ + L + + L+ +
Sbjct: 378 RLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSS 437
Query: 143 NKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPR-SL 201
N L+G + L + +L + N++ SIP +V L L L + SN L S+P
Sbjct: 438 NMLTGSVFR--CLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVF 493
Query: 202 SNFTNLVFLYLYNNSF 217
T+L +++L++N +
Sbjct: 494 DRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 7e-09
Identities = 39/195 (20%), Positives = 70/195 (35%), Gaps = 10/195 (5%)
Query: 253 RCPQLSLLDVSINNITGNIPFEIGES-PQLQYLDLSSNYIVGEIPTQ-LGNIIYLNRISL 310
+L +L +S N I ++ F + L+YLD+S N + I + ++ +L+ L
Sbjct: 74 FLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISCCPMASLRHLD---L 128
Query: 311 SGNKL-SGRIPGELGSLINLEYLDLSANHLSNFVLESLGSL-VKLYYLNLSHNKLSQQIP 368
S N + E G+L L +L LSA L + L + L+L +
Sbjct: 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGET 188
Query: 369 IELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHI 428
L + + L L + + +L L LS L+ + L
Sbjct: 189 ESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTR 247
Query: 429 DISYNKLEGHIPNST 443
+ + +T
Sbjct: 248 GPTLLNVTLQHIETT 262
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 51/298 (17%), Positives = 99/298 (33%), Gaps = 41/298 (13%)
Query: 149 IPSEISLLTHLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207
IPS ++ + L +S N++ I + + L L+L SN + S S+ +L
Sbjct: 46 IPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102
Query: 208 VFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267
L L N S ++ S F L+ L++ N
Sbjct: 103 EHLDLSYNYLS-NLSS------SWFK-------------------PLSSLTFLNLLGNPY 136
Query: 268 TGNIPFEI-GESPQLQYLDLSSNYIVGEIPTQ-LGNIIYLNRISLSGNKLSGRIPGELGS 325
+ +LQ L + + +I + + +L + + + L P L S
Sbjct: 137 KTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKS 196
Query: 326 LINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLS----QQIPI----ELDNLIHL 377
+ N+ +L L + + + L L L ++ L
Sbjct: 197 IQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTF 256
Query: 378 SELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKL 435
+ ++ L + + + ++ L +L S N L + F+ L L I + N
Sbjct: 257 RNVKITDESLFQ-VMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 46/291 (15%), Positives = 89/291 (30%), Gaps = 47/291 (16%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKL 145
+ S+ L+ + +L L L +N + I S+L LE+LD N L
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112
Query: 146 SGHIPSEI-SLLTHLTILHISRNQLNGSIPHEV--GQLNFLNHLILDSNFLGGSIP-RSL 201
S ++ S L+ LT L++ N ++ L L L + + I +
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 202 SNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLD 261
+ T L L + + S + +S L
Sbjct: 171 AGLTFLEELEIDASDLQ-SYEPKS-------------------------LKSIQNVSHLI 204
Query: 262 VSINNITGNIPFEIGES-PQLQYLDLSSNYIVGEIPTQLGNI--------IYLNRISLSG 312
+ + + + ++ L+L + ++L + ++
Sbjct: 205 LHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD 263
Query: 313 NKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKL 363
L ++ L + L L+ S N L + L L + L N
Sbjct: 264 ESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-22
Identities = 50/263 (19%), Positives = 103/263 (39%), Gaps = 26/263 (9%)
Query: 196 SIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWG--- 252
SIP L + L L NN + + +L + L N +N +I+
Sbjct: 45 SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-----TIEEDSFS 97
Query: 253 RCPQLSLLDVSINNITGNIPFEIGES-PQLQYLDLSSNYIVGEIPTQ--LGNIIYLNRIS 309
L LD+S N ++ N+ + L +L+L N + ++ L +
Sbjct: 98 SLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILR 155
Query: 310 LSGNKLSGRIP-GELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIP 368
+ +I + L LE L++ A+ L ++ +SL S+ + +L L + +
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLE 215
Query: 369 IELDNLIHLSELDLSHNFLGEKISSRIC--------RMESLEKLNLSYNNLSGLIPRCFE 420
I +D + L+L L S + + + + ++ +L + +
Sbjct: 216 IFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLN 274
Query: 421 ELHGLLHIDISYNKLEGHIPNST 443
++ GLL ++ S N+L+ +P+
Sbjct: 275 QISGLLELEFSRNQLKS-VPDGI 296
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 46/197 (23%), Positives = 73/197 (37%), Gaps = 11/197 (5%)
Query: 244 AIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQ-LGNI 302
A+P+ I + + N I+ L L L SN + I +
Sbjct: 25 AVPVGIP----AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGL 79
Query: 303 IYLNRISLSGNKLSGRIP-GELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHN 361
L ++ LS N + L L L L L L L YL L N
Sbjct: 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDN 139
Query: 362 KLSQQIPIE-LDNLIHLSELDLSHNFLGEKISSRI-CRMESLEKLNLSYNNLSGLIPRCF 419
L Q +P + +L +L+ L L N + + R + SL++L L N ++ + P F
Sbjct: 140 AL-QALPDDTFRDLGNLTHLFLHGNRI-SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197
Query: 420 EELHGLLHIDISYNKLE 436
+L L+ + + N L
Sbjct: 198 RDLGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 49/242 (20%), Positives = 83/242 (34%), Gaps = 35/242 (14%)
Query: 196 SIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCP 255
++P + ++L+ N S +P + ++
Sbjct: 25 AVPVGI--PAASQRIFLHGNRIS-HVPA--ASFRAC-----------------------R 56
Query: 256 QLSLLDVSINNITGNIPFEIGES-PQLQYLDLSSNYIVGEIPTQ-LGNIIYLNRISLSGN 313
L++L + N + I L+ LDLS N + + + L+ + L
Sbjct: 57 NLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRC 115
Query: 314 KLSGRIP-GELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELD 372
L + G L L+YL L N L ++ L L +L L N++S
Sbjct: 116 GLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFR 174
Query: 373 NLIHLSELDLSHNFLGEKISSRICR-MESLEKLNLSYNNLSGLIPRCFEELHGLLHIDIS 431
L L L L N + + R + L L L NNLS L L L ++ ++
Sbjct: 175 GLHSLDRLLLHQNRV-AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLN 233
Query: 432 YN 433
N
Sbjct: 234 DN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 48/241 (19%), Positives = 81/241 (33%), Gaps = 33/241 (13%)
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207
+P I + + N+++ L L L SN L + + L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 208 VFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267
L L +N+ S+ + +L L + +
Sbjct: 83 EQLDLSDNAQLRSVDPAT-------------------------FHGLGRLHTLHLDRCGL 117
Query: 268 TGNIPFEI-GESPQLQYLDLSSNYIVGEIPTQ-LGNIIYLNRISLSGNKLSGRIPGELGS 325
+ + LQYL L N + +P ++ L + L GN++S
Sbjct: 118 Q-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG 175
Query: 326 LINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIE-LDNLIHLSELDLSH 384
L +L+ L L N +++ + L +L L L N LS +P E L L L L L+
Sbjct: 176 LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLND 234
Query: 385 N 385
N
Sbjct: 235 N 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 15/209 (7%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKL 145
I L+G + SF + +L L L++N L I + L+ LE LD N
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 146 SGHIPSEI-SLLTHLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIP-RSLS 202
+ L L LH+ R L + + L L +L L N L ++P +
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL-QALPDDTFR 150
Query: 203 NFTNLVFLYLYNNSFSGSIPQQI-GNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLD 261
+ NL L+L+ N S S+P++ L SL + L N++ + +L L
Sbjct: 151 DLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRD-LGRLMTLY 207
Query: 262 VSINNITGNIPFEIGES-PQLQYLDLSSN 289
+ NN++ +P E LQYL L+ N
Sbjct: 208 LFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 52/257 (20%), Positives = 80/257 (31%), Gaps = 55/257 (21%)
Query: 108 FPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTILHISR 166
+ L+ N + + L L +N L+ I + + L L L +S
Sbjct: 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSD 89
Query: 167 NQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIP-RSLSNFTNLVFLYLYNNSFSGSIPQQ 224
N S+ L L+ L LD L + L +LYL +N+ ++P
Sbjct: 90 NAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNALQ-ALPDD 147
Query: 225 IGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYL 284
+ L L +L
Sbjct: 148 T--FRDL-----------------------------------------------GNLTHL 158
Query: 285 DLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVL 344
L N I + L+R+ L N+++ P L L L L AN+LS
Sbjct: 159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPT 218
Query: 345 ESLGSLVKLYYLNLSHN 361
E+L L L YL L+ N
Sbjct: 219 EALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 37/141 (26%), Positives = 65/141 (46%), Gaps = 6/141 (4%)
Query: 105 FSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTILH 163
F L L L L ++ P L+ L+YL N L +P + L +LT L
Sbjct: 101 FHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLF 159
Query: 164 ISRNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIP 222
+ N+++ S+P L+ L+ L+L N + P + + L+ LYL+ N+ S ++P
Sbjct: 160 LHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALP 217
Query: 223 QQI-GNLKSLFDMKLCINQLN 242
+ L++L ++L N
Sbjct: 218 TEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 24/86 (27%), Positives = 39/86 (45%), Gaps = 6/86 (6%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKL 145
NLT + L+G ++ E +F L L L+ N + + P +L +L L N L
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
Query: 146 SGHIPSEI-SLLTHLTILHISRNQLN 170
S +P+E + L L L ++ N
Sbjct: 214 S-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 51/235 (21%), Positives = 94/235 (40%), Gaps = 18/235 (7%)
Query: 201 LSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLL 260
F + L S + ++ Q L S+ + + + + P ++ L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ----YLPNVTKL 73
Query: 261 DVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIP 320
++ N +T +I + L +L L N + ++ + L ++ L +SL N +S I
Sbjct: 74 FLNGNKLT-DI-KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DIN 128
Query: 321 GELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSEL 380
G L L LE L L N +++ + L L KL L+L N++S +P L L L L
Sbjct: 129 G-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL 183
Query: 381 DLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKL 435
LS N + + + + +++L+ L L L + + L
Sbjct: 184 YLSKNHI-SDLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 66/310 (21%), Positives = 114/310 (36%), Gaps = 68/310 (21%)
Query: 103 FSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTIL 162
FS +F +L + D + + L+ ++ + + + + I L ++T L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 73
Query: 163 HISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIP 222
++ N+L I L+N NL +L+L N
Sbjct: 74 FLNGNKLT-------------------------DIK-PLANLKNLGWLFLDEN------- 100
Query: 223 QQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQ 282
++ +L SL D +L L + N I+ +I + PQL+
Sbjct: 101 -KVKDLSSLKD--------------------LKKLKSLSLEHNGIS-DING-LVHLPQLE 137
Query: 283 YLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNF 342
L L +N I T L + L+ +SL N++S I L L L+ L LS NH+S+
Sbjct: 138 SLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISD- 192
Query: 343 VLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLE 402
L +L L L L L + + NL+ + + + L I E
Sbjct: 193 -LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI--ISDDGDYE 249
Query: 403 KLNLSYNNLS 412
K N+ ++
Sbjct: 250 KPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 45/184 (24%), Positives = 85/184 (46%), Gaps = 14/184 (7%)
Query: 253 RCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSG 312
+ ++ ++T + E + + +++ I + + + + ++ L+G
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNG 77
Query: 313 NKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELD 372
NKL+ I L +L NL +L L N + + L SL L KL L+L HN +S L
Sbjct: 78 NKLT-DIKP-LANLKNLGWLFLDENKVKD--LSSLKDLKKLKSLSLEHNGISDING--LV 131
Query: 373 NLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISY 432
+L L L L +N + I+ + R+ L+ L+L N +S ++P L L ++ +S
Sbjct: 132 HLPQLESLYLGNNKI-TDITV-LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 433 NKLE 436
N +
Sbjct: 188 NHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 45/228 (19%), Positives = 89/228 (39%), Gaps = 18/228 (7%)
Query: 90 NLTSISLNGTLLE--FSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSG 147
+L + + + + + N+++ + I L + L NKL+
Sbjct: 25 ETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT- 81
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207
I ++ L +L L + N++ + + L L L L+ N + S L + L
Sbjct: 82 DI-KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGI--SDINGLVHLPQL 136
Query: 208 VFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267
LYL NN + + L L + L NQ++ +PL+ +L L +S N+I
Sbjct: 137 ESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVPLA----GLTKLQNLYLSKNHI 190
Query: 268 TGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKL 315
+ ++ + L L+L S + + N++ N + + L
Sbjct: 191 S-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-22
Identities = 31/184 (16%), Positives = 71/184 (38%), Gaps = 13/184 (7%)
Query: 255 PQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIY---LNRISLS 311
+ + + L Y+ L++ + T L I Y + ++++
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINV-----TDLTGIEYAHNIKDLTIN 74
Query: 312 GNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIEL 371
+ P + L NLE L + +++ + +L L L L++SH+ I ++
Sbjct: 75 NIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 372 DNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDIS 431
+ L ++ +DLS+N I + + L+ LN+ ++ + E+ L +
Sbjct: 133 NTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAF 189
Query: 432 YNKL 435
+
Sbjct: 190 SQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-22
Identities = 30/160 (18%), Positives = 67/160 (41%), Gaps = 7/160 (4%)
Query: 255 PQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNK 314
L+ + ++ N+T ++ I + ++ L +++ + P + + L R+ + G
Sbjct: 44 NSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKD 99
Query: 315 LSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNL 374
++ L L +L LD+S + + +L + +L K+ ++LS+N I L L
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTL 158
Query: 375 IHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGL 414
L L++ + + I L +L + G
Sbjct: 159 PELKSLNIQFDGV-HDYRG-IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 29/165 (17%), Positives = 61/165 (36%), Gaps = 9/165 (5%)
Query: 200 SLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSL 259
+ + +L ++ L N + + I ++ D+ + P+S L
Sbjct: 39 TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNPIS----GLSNLER 92
Query: 260 LDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRI 319
L + ++T + + L LD+S + I T++ + +N I LS N I
Sbjct: 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152
Query: 320 PGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLS 364
L +L L+ L++ + + + + KL L +
Sbjct: 153 MP-LKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIG 194
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 28/166 (16%), Positives = 56/166 (33%), Gaps = 9/166 (5%)
Query: 104 SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILH 163
+ + L Y+ L N + D+ I ++ L + + IS L++L L
Sbjct: 39 TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATN--YNPISGLSNLERLR 94
Query: 164 ISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQ 223
I + + L L L + + SI ++ + + L N I
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-M 153
Query: 224 QIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITG 269
+ L L + + + ++ + P+L+ L I G
Sbjct: 154 PLKTLPELKSLNIQFDGVHDYRGIE----DFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 25/132 (18%), Positives = 51/132 (38%), Gaps = 5/132 (3%)
Query: 90 NLTSISLNGTLLE--FSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSG 147
N+ +++N S +L L + ++ P +S L+ L LD +
Sbjct: 67 NIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207
I ++I+ L + + +S N I + L L L + + + + +F L
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKL 183
Query: 208 VFLYLYNNSFSG 219
LY ++ + G
Sbjct: 184 NQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 15/91 (16%), Positives = 40/91 (43%), Gaps = 4/91 (4%)
Query: 346 SLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLN 405
+ + L Y+ L++ ++ IE ++ +L +++ + I + +LE+L
Sbjct: 39 TEAQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINNIHA-TNYNP-ISGLSNLERLR 94
Query: 406 LSYNNLSGLIPRCFEELHGLLHIDISYNKLE 436
+ +++ L L +DIS++ +
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHD 125
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 5e-22
Identities = 61/363 (16%), Positives = 106/363 (29%), Gaps = 70/363 (19%)
Query: 79 HCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYL 138
CN + + L +E L + E I L+ L
Sbjct: 14 SCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRL 73
Query: 139 DFLTNKLSGHIPSEISLL---THLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGG 195
++ I + + L L + ++ G+ P + + +
Sbjct: 74 TVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPD----------- 122
Query: 196 SIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCP 255
L L L N S++ + L+ P
Sbjct: 123 -----------LNILNLRNVSWAT-RDAWLAELQQWLK---------------------P 149
Query: 256 QLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKL 315
L +L ++ + ++ P L LDLS N +GE +
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG-----------------LI 192
Query: 316 SGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIP-IELDNL 374
S P + +L L + S + V+L L+LSHN L D
Sbjct: 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP 252
Query: 375 IHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNK 434
L+ L+LS L +++ L L+LSYN L +EL + ++ + N
Sbjct: 253 SQLNSLNLSFTGL-KQVPK--GLPAKLSVLDLSYNRLDRNPS--PDELPQVGNLSLKGNP 307
Query: 435 LEG 437
Sbjct: 308 FLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 42/215 (19%), Positives = 79/215 (36%), Gaps = 17/215 (7%)
Query: 256 QLSLLDVSINNITGNIPF-EIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRI---SLS 311
L L ++ F +I +S L+ L + + I I ++ ++ + +L
Sbjct: 44 SLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLE 103
Query: 312 GNKLSGRIPGELGSLI--NLEYLDLSANHLSNFV--LESLGSLVK--LYYLNLSHNKLSQ 365
+++G P L +L L+L + L L +K L L+++
Sbjct: 104 NLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLN 163
Query: 366 QIPIELDNLIHLSELDLSHNFL--GEKISSRIC--RMESLEKLNLSYNN---LSGLIPRC 418
++ LS LDLS N + S +C + +L+ L L SG+
Sbjct: 164 FSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL 223
Query: 419 FEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEAL 453
L +D+S+N L + + L +L
Sbjct: 224 AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSL 258
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 21/156 (13%), Positives = 52/156 (33%), Gaps = 9/156 (5%)
Query: 308 ISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLES---LGSLVKLYYLNLSHNKLS 364
+ + ++ ++L+ L + A + + +L + + L L L + +++
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 365 QQIPIELDNLIH--LSELDLSHNFLGEKISS----RICRMESLEKLNLSYNNLSGLIPRC 418
P L L+ L+L + + + + L+ L+++ +
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 419 FEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEALQ 454
L +D+S N G + LQ
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 31/162 (19%), Positives = 45/162 (27%), Gaps = 31/162 (19%)
Query: 90 NLTSISLNGTLLEF----SFSSFPHLAYLDLYNNELFD-------IIPPQISNLSKLEYL 138
L +S+ FP L+ LDL +N + P + L L
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALR 209
Query: 139 DFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQ-LNFLNHLILDSNFLG--- 194
+ SG + + L L +S N L + + LN L L L
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVP 269
Query: 195 GSIPRSL----------------SNFTNLVFLYLYNNSFSGS 220
+P L + L L N F S
Sbjct: 270 KGLPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLDS 311
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-21
Identities = 55/269 (20%), Positives = 96/269 (35%), Gaps = 50/269 (18%)
Query: 502 DFDAKHCIGKGGHGSVYIARVPSGEIFAVK---KFHSPLPDN-----------------F 541
F K +G G G++ + AVK D F
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYF 84
Query: 542 CSHPRQSF--IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 599
C+ + F I E + + + D + L + + +++ L +LH+
Sbjct: 85 CTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGL---EPITLLQQTTSGLAHLHSLN--- 138
Query: 600 IVHWDISSKNVLL-----DLGYEAHVSDFRIAKFLNLDSSNWSKL---AGTHGNVAPEL- 650
IVH D+ N+L+ +A +SDF + K L + ++S+ GT G +APE+
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 651 --AYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLD 707
T D++S G + VI +G HP + NI + L +
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-----QANILLGACSLDCLHPE 253
Query: 708 VQNKFMSIMQVAF--SCLDQNPVSRPTMK 734
K ++ + +P RP+ K
Sbjct: 254 ---KHEDVIARELIEKMIAMDPQKRPSAK 279
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 48/260 (18%), Positives = 81/260 (31%), Gaps = 51/260 (19%)
Query: 508 CIGKGGHGSVYIAR-VPSGEIFAVK-------------------------------KFHS 535
IG+G +VY + A +F+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 536 PLPDNFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNN 595
+ E + SG+L L K + + + + L +LH
Sbjct: 93 SWESTVKGKKCIVLVT-ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT- 147
Query: 596 CFPPIVHWDISSKNVLLDLGY-EAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTM 654
PPI+H D+ N+ + + D +A + + GT +APE+ Y
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMAPEM-YEE 204
Query: 655 KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714
K E DVY+FG+ LE+ ++P + + S + S D K
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----YRRVTSGVKPASFD---KVAI 256
Query: 715 IMQVAF--SCLDQNPVSRPT 732
C+ QN R +
Sbjct: 257 PEVKEIIEGCIRQNKDERYS 276
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 47/287 (16%), Positives = 100/287 (34%), Gaps = 63/287 (21%)
Query: 498 RATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKK------------------FHSPL- 537
R DF+ C+G+GG G V+ A+ +A+K+ + L
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 538 -------------PDNFCSHPRQS-----FIVYEYLESGSLDKILNNDASAKELGWTQRL 579
+ S +I + +L +N + +E + L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 580 NVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS------ 633
++ +A+A+ +LH+ ++H D+ N+ + V DF + ++ D
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 634 ------SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS 687
+ + GT ++PE + + K D++S G++ E++ +P F
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP----FSTQM 231
Query: 688 SSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
++ + + P ++Q L +P+ RP
Sbjct: 232 ERVRTLTDVRNLKFPPLFTQKYPCEYVMVQ---DMLSPSPMERPEAI 275
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 47/274 (17%), Positives = 100/274 (36%), Gaps = 55/274 (20%)
Query: 498 RATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKK------------------------ 532
R DF IG GG G V+ A+ G+ + +K+
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIV 67
Query: 533 ------------FHSPLPDNFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLN 580
+ ++ S + FI E+ + G+L++ + ++L L
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLALE 126
Query: 581 VIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLA 640
+ + + + Y+H+ +++ D+ N+ L + + DF + L D ++
Sbjct: 127 LFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-TRSK 182
Query: 641 GTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR 700
GT ++PE + ++ D+Y+ G++ E++ FE S +++ I+
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT---AFETSKFFTDLRDGIISDI 239
Query: 701 LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
K +++Q L + P RP
Sbjct: 240 FD-------KKEKTLLQ---KLLSKKPEDRPNTS 263
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-20
Identities = 65/374 (17%), Positives = 126/374 (33%), Gaps = 72/374 (19%)
Query: 111 LAYLDLYNNELFDI-IPPQISNLSKLEYLDFLTNKLS----GHIPSEISLLTHLTILHIS 165
+ LD+ EL D + L + + + L+ I S + + L L++
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 166 RNQLNGS----IPHEVGQLNF-LNHLILDSNFLG----GSIPRSLSNFTNLVFLYLYNNS 216
N+L + + + + L L + L G + +L L L+L +N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 217 FSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNIT----GNIP 272
+ L+ L + L +L L + +++ +
Sbjct: 125 LGDA------GLQLLCEGLLDPQ---------------CRLEKLQLEYCSLSAASCEPLA 163
Query: 273 FEIGESPQLQYLDLSSNYI----VGEIPTQLG-NIIYLNRISLSGNKLSGRIPGELGSLI 327
+ P + L +S+N I V + L + L + L ++ +L ++
Sbjct: 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV 223
Query: 328 ----NLEYLDLSANHLSNFVLESLGSLVK-----LYYLNLSHNKLS----QQIPIELDNL 374
+L L L +N L + + L + L L + ++ + L
Sbjct: 224 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAK 283
Query: 375 IHLSELDLSHNFLGEKISSRICRM-----ESLEKLNLSYNNLSGLIPRCFEEL------- 422
L EL L+ N LG++ + +C LE L + + + C
Sbjct: 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT---AACCSHFSSVLAQN 340
Query: 423 HGLLHIDISYNKLE 436
LL + IS N+LE
Sbjct: 341 RFLLELQISNNRLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-19
Identities = 70/384 (18%), Positives = 124/384 (32%), Gaps = 76/384 (19%)
Query: 105 FSSFPHLAYLDLYNNELFD-----IIPPQISNLSKLEYLDFLTNKLS----GHIPSEISL 155
P LA L+L +NEL D ++ + K++ L L+ G + S +
Sbjct: 52 LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRT 111
Query: 156 LTHLTILHISRNQLNGS----IPHEVGQLNF-LNHLILDSNFLG----GSIPRSLSNFTN 206
L L LH+S N L + + + L L L+ L + L +
Sbjct: 112 LPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPD 171
Query: 207 LVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINN 266
L + NN + + ++ L L + L L +
Sbjct: 172 FKELTVSNNDINEA------GVRVLCQG-LKDSPCQ--------------LEALKLESCG 210
Query: 267 IT----GNIPFEIGESPQLQYLDLSSNYIVGE-----IPTQLGNIIYLNRISLSGNKLSG 317
+T ++ + L+ L L SN + P L L + + ++
Sbjct: 211 VTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITA 270
Query: 318 R----IPGELGSLINLEYLDLSANHLSNFVLESLGSLVK-----LYYLNLSHNKLS---- 364
+ + L + +L+ L L+ N L + L + L L + +
Sbjct: 271 KGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACC 330
Query: 365 QQIPIELDNLIHLSELDLSHNFLGEKISSRICRM-----ESLEKLNLSYNNLSGLIPRCF 419
L L EL +S+N L + +C+ L L L+ ++S
Sbjct: 331 SHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS---DSSC 387
Query: 420 EEL-------HGLLHIDISYNKLE 436
L H L +D+S N L
Sbjct: 388 SSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-16
Identities = 67/355 (18%), Positives = 117/355 (32%), Gaps = 70/355 (19%)
Query: 105 FSSFPHLAYLDLYNNELFD-----IIPPQISNLSKLEYLDFLTNKLS----GHIPSEISL 155
+ P L L L +N L D + + +LE L LS + S +
Sbjct: 109 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRA 168
Query: 156 LTHLTILHISRNQLNGSIPHEVGQL-----NFLNHLILDSNFLG----GSIPRSLSNFTN 206
L +S N +N + + Q L L L+S + + +++ +
Sbjct: 169 KPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKAS 228
Query: 207 LVFLYLYNNSFSGSIPQQIGN--LKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSI 264
L L L +N ++G+ + L L + +L L +
Sbjct: 229 LRELALGSN--------KLGDVGMAELCPGLLHPS---------------SRLRTLWIWE 265
Query: 265 NNIT----GNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIY-----LNRISLSGNKL 315
IT G++ + L+ L L+ N + E L + L + +
Sbjct: 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 325
Query: 316 SGRIPGELGSLI----NLEYLDLSANHLSNFVLESLGSLVK-----LYYLNLSHNKLS-- 364
+ S++ L L +S N L + + L + L L L+ +S
Sbjct: 326 TAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 385
Query: 365 --QQIPIELDNLIHLSELDLSHNFLGEKISSRICRM-----ESLEKLNLSYNNLS 412
+ L L ELDLS+N LG+ ++ LE+L L S
Sbjct: 386 SCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 38/181 (20%), Positives = 65/181 (35%), Gaps = 23/181 (12%)
Query: 278 SPQLQYLDLSSNYIVGEIPTQLGNII-YLNRISLSGNKLSGR----IPGELGSLINLEYL 332
S +Q LD+ + +L ++ + L L+ I L L L
Sbjct: 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 333 DLSANHLSNFVLESLGSLVK-----LYYLNLSHNKLS----QQIPIELDNLIHLSELDLS 383
+L +N L + + + ++ + L+L + L+ + L L L EL LS
Sbjct: 62 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121
Query: 384 HNFLGEKISSRICRME-----SLEKLNLSYNNLS----GLIPRCFEELHGLLHIDISYNK 434
N LG+ +C LEKL L Y +LS + + +S N
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181
Query: 435 L 435
+
Sbjct: 182 I 182
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 47/291 (16%), Positives = 90/291 (30%), Gaps = 39/291 (13%)
Query: 101 LEFSFSSFPHLAYLDLYNNELFD-----IIPPQISNLSKLEYLDFLTNKLS----GHIPS 151
L + P L + NN++ + + + +LE L + ++ +
Sbjct: 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG 221
Query: 152 EISLLTHLTILHISRNQLNGS-----IPHEVGQLNFLNHLILDSNFLG----GSIPRSLS 202
++ L L + N+L P + + L L + + G + R L
Sbjct: 222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLR 281
Query: 203 NFTNLVFLYLYNNSFSGSIPQQIGNL-----KSLFDMKLCINQL--NGAIPLSIDWGRCP 255
+L L L N + + L + + S +
Sbjct: 282 AKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNR 341
Query: 256 QLSLLDVSINNITGNIPFEIGES-----PQLQYLDLSSNYIVGEIPTQLGNIIYLNR--- 307
L L +S N + E+ + L+ L L+ + + L + N
Sbjct: 342 FLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 401
Query: 308 -ISLSGNKLSGRIPGELGSLI-----NLEYLDLSANHLSNFVLESLGSLVK 352
+ LS N L +L + LE L L + S + + L +L K
Sbjct: 402 ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 452
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 9e-20
Identities = 62/263 (23%), Positives = 93/263 (35%), Gaps = 46/263 (17%)
Query: 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF---------CSHPR--- 546
+ + +G+G G V+ + +G AVKK L S PR
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV--RLEVFRVEELVACAGLSSPRIVP 114
Query: 547 ---------QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCF 597
I E LE GSL +++ E + L + + L YLH
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTRR- 170
Query: 598 PPIVHWDISSKNVLLDL-GYEAHVSDFRIAKFLNLDSSNWSKLAGT--HGNV---APELA 651
I+H D+ + NVLL G A + DF A L D S L G G APE+
Sbjct: 171 --ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 652 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711
K D++S + L ++ G HP F + I + P P ++
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---LKI----ASEPPPIREIPPS 281
Query: 712 FMSIMQVAF--SCLDQNPVSRPT 732
+ + L + PV R +
Sbjct: 282 C-APLTAQAIQEGLRKEPVHRAS 303
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 2e-19
Identities = 39/167 (23%), Positives = 66/167 (39%), Gaps = 10/167 (5%)
Query: 271 IPFEIGESPQLQYLDLSSNYIVGEIPTQ--LGNIIYLNRISLSGNKLSGRIPGELGSLIN 328
+P + LDLS N + + + + L+ + LS N L+ + N
Sbjct: 33 VPQSL--PSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPN 89
Query: 329 LEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIE-LDNLIHLSELDLSHN-- 385
L YLDLS+NHL L L L L +N + + +++ L +L LS N
Sbjct: 90 LRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQNQI 148
Query: 386 -FLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDIS 431
++ ++ L L+LS N L L ++L + +
Sbjct: 149 SRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 45/174 (25%), Positives = 75/174 (43%), Gaps = 14/174 (8%)
Query: 244 AIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGES--PQLQYLDLSSNYIVGEIPTQ-LG 300
+P S+ +LLD+S NN++ + E + L L LS N++ I ++
Sbjct: 32 NVPQSLP----SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFV 85
Query: 301 NIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSH 360
+ L + LS N L L LE L L NH+ + + +L L LS
Sbjct: 86 PVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQ 145
Query: 361 NKLSQQIPIE----LDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNN 410
N++ + P+E + L L LDLS N L + + + ++ + K L +N
Sbjct: 146 NQI-SRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 31/157 (19%), Positives = 58/157 (36%), Gaps = 16/157 (10%)
Query: 90 NLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQI-SNLSKLEYLDFLTNKLSGH 148
NL+ + E++ + +L L L +N L + I + + L YLD +N L
Sbjct: 50 NLSRLRA-----EWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNHLH-T 102
Query: 149 IPSEI-SLLTHLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIP----RSLS 202
+ + S L L +L + N + + + L L L N + P + +
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQI-SRFPVELIKDGN 160
Query: 203 NFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCIN 239
L+ L L +N + L + L ++
Sbjct: 161 KLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 9e-14
Identities = 38/130 (29%), Positives = 57/130 (43%), Gaps = 6/130 (4%)
Query: 328 NLEYLDLSANHLSNFVLE-SLGSLVKLYYLNLSHNKLSQQIPIE-LDNLIHLSELDLSHN 385
LDLS N+LS E + L L+ L LSHN L I E + +L LDLS N
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSN 98
Query: 386 FLGEKISSRICR-MESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTT 444
L + + +++LE L L N++ + FE++ L + +S N++ P
Sbjct: 99 HL-HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELI 156
Query: 445 FRDAPLEALQ 454
L L
Sbjct: 157 KDGNKLPKLM 166
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 40/140 (28%), Positives = 60/140 (42%), Gaps = 15/140 (10%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLYNNELFDIIPPQI-SNLSKLEYLDFLTNK 144
NL S+ L+ + +F P+L YLDL +N L + + S+L LE L N
Sbjct: 65 NLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNH 123
Query: 145 LSGHIPSEI-SLLTHLTILHISRNQLNGSIPHEV----GQLNFLNHLILDSNFLGGSIPR 199
+ + + L L++S+NQ++ P E+ +L L L L SN L
Sbjct: 124 IV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLT 181
Query: 200 SLSNFTNLV--FLYLYNNSF 217
L V LYL+NN
Sbjct: 182 DLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 39/171 (22%), Positives = 66/171 (38%), Gaps = 17/171 (9%)
Query: 108 FPHLAYLDLYNNELFDIIPPQI-SNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTILHIS 165
+ A LDL +N L + + L+ L L N L+ I SE + +L L +S
Sbjct: 38 PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS 96
Query: 166 RNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIPR-SLSNFTNLVFLYLYNNSFSGSIPQ 223
N L+ ++ + L L L+L +N + + R + + L LYL N S P
Sbjct: 97 SNHLH-TLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQNQIS-RFPV 153
Query: 224 QI----GNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGN 270
++ L L + L N+L + +L + + N
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLK-----KLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 30/101 (29%), Positives = 51/101 (50%), Gaps = 10/101 (9%)
Query: 356 LNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRI--CRMESLEKLNLSYNNLSG 413
L+ S +L +P L + + + LDLSHN L + + R+ +L L LS+N+L+
Sbjct: 23 LSCSKQQLPN-VPQSLPS--YTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLNF 78
Query: 414 LIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEALQ 454
+ F + L ++D+S N L + F D L+AL+
Sbjct: 79 ISSEAFVPVPNLRYLDLSSNHLH-TLDEF-LFSD--LQALE 115
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 91.7 bits (227), Expect = 2e-19
Identities = 60/343 (17%), Positives = 103/343 (30%), Gaps = 18/343 (5%)
Query: 53 SRSLLHSWSLSFVNATKISLCTWSGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLA 112
S H W L + C F LT S GTLL + +
Sbjct: 227 SAWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVE 286
Query: 113 YLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGS 172
+ + L ++L H I + +
Sbjct: 287 WRTPDGRNRPSHVWLCDLPA------ASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPEC 340
Query: 173 IPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLF 232
+ L L + L + L L N +I + L L
Sbjct: 341 WCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLL 399
Query: 233 DMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIV 292
K + + + + LD + E ++ L L+ +
Sbjct: 400 YEKETLQYFSTLKAVDPMR-----AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT 454
Query: 293 GEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVK 352
+ L ++ + + LS N+L +P L +L LE L S N L N ++ + +L +
Sbjct: 455 -VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN--VDGVANLPR 509
Query: 353 LYYLNLSHNKLSQ-QIPIELDNLIHLSELDLSHNFLGEKISSR 394
L L L +N+L Q L + L L+L N L ++ +
Sbjct: 510 LQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 88.3 bits (218), Expect = 3e-18
Identities = 46/257 (17%), Positives = 82/257 (31%), Gaps = 13/257 (5%)
Query: 157 THLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNS 216
L ++ + + +L R + L L
Sbjct: 302 CDLPAASLNDQLPQHTFRVIWTGSDSQKECVL-LKDRPECWCRDSATDEQLFRCELSVEK 360
Query: 217 FSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIG 276
S + ++ + K L +++ L L L + +
Sbjct: 361 -STVLQSELESCKELQELEPENK-----WCLLTIILLMRALDPLLYEKETLQYFSTLKAV 414
Query: 277 ESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSA 336
+ + YLD + + E + + L+ L+ + L L+ + +LDLS
Sbjct: 415 DPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSH 472
Query: 337 NHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGE-KISSRI 395
N L + +L +L L L S N L + + NL L EL L +N L + +
Sbjct: 473 NRLRA-LPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPL 529
Query: 396 CRMESLEKLNLSYNNLS 412
L LNL N+L
Sbjct: 530 VSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 84.8 bits (209), Expect = 3e-17
Identities = 55/341 (16%), Positives = 104/341 (30%), Gaps = 31/341 (9%)
Query: 117 YNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHE 176
F P ++ S Y +L + H ++ ++
Sbjct: 214 LVQNAFFTDP---NDQSAWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSR 270
Query: 177 VGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKL 236
+G L + S R+ + L L + + K
Sbjct: 271 MGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKE 330
Query: 237 CINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIP 296
C+ + D QL ++S+ T + E+ +LQ L+ + + + I
Sbjct: 331 CVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTII 389
Query: 297 TQLGNIIYLNRISLSGNKLSG---------------------RIPGELGSLINLEYLDLS 335
+ + L + S ++ L L+
Sbjct: 390 LLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLA 449
Query: 336 ANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRI 395
L+ L L L+ + +L+LSHN+L +P L L L L S N L E + +
Sbjct: 450 HKDLTV--LCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNAL-ENVDG-V 504
Query: 396 CRMESLEKLNLSYNNLSGL-IPRCFEELHGLLHIDISYNKL 435
+ L++L L N L + L+ +++ N L
Sbjct: 505 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.2 bits (158), Expect = 4e-11
Identities = 49/334 (14%), Positives = 101/334 (30%), Gaps = 14/334 (4%)
Query: 105 FSSFPHLAYLDLYNNELFDIIPPQISNLSKLEY-LDFLTNKLSGHIPSEISLLTHLTILH 163
+SS+ + + L + D P + L L+ + N P++ S + L
Sbjct: 178 YSSWHYRSCLLPQLHPQPDSGPQGRLPENVLLKELELVQNAFF-TDPNDQSAWFYHRWLL 236
Query: 164 ISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTN-LVFLYLYNNSFSGSIP 222
+ V + + GS +L + + + P
Sbjct: 237 GRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRP 296
Query: 223 QQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQ 282
+ + + + LL + + QL
Sbjct: 297 SHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLL----KDRPECWCRDSATDEQLF 352
Query: 283 YLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNF 342
+LS + ++L + L + I + +L L Y + + S
Sbjct: 353 RCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFST- 410
Query: 343 VLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLE 402
L+++ + Y +L L + + + L L+H L + + ++ +
Sbjct: 411 -LKAVDPMRAAYLDDLRSKFL-LENSVLKMEYADVRVLHLAHKDL-TVLCH-LEQLLLVT 466
Query: 403 KLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLE 436
L+LS+N L +P L L + S N LE
Sbjct: 467 HLDLSHNRLRA-LPPALAALRCLEVLQASDNALE 499
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 52/263 (19%), Positives = 95/263 (36%), Gaps = 37/263 (14%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKK--FHSPLPDNF-------------CSH 544
+F + IG+G VY A + G A+KK + +H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 545 P-----RQSF-------IVYEYLESGSLDKILNNDASAKE-LGWTQRLNVIKGVADALFY 591
P SF IV E ++G L +++ + K + + AL +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 592 LHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELA 651
+H+ ++H DI NV + + D + +F + ++ L GT ++PE
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208
Query: 652 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711
+ K D++S G L E+ + P F + + S P PS +
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 266
Query: 712 FMSIMQVAFSCLDQNPVSRPTMK 734
++ C++ +P RP +
Sbjct: 267 LRQLVN---MCINPDPEKRPDVT 286
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 4e-19
Identities = 61/279 (21%), Positives = 97/279 (34%), Gaps = 44/279 (15%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF-------------CSHPR 546
+DF+ +G G G V+ PSG + A K H + C+ P
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 547 -----QSF-------IVYEYLESGSLDKILNNDASAKE--LGWTQRLNVIKGVADALFYL 592
+F I E+++ GSLD++L E LG V V L YL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 147
Query: 593 HNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAY 652
I+H D+ N+L++ E + DF ++ L S + GT ++PE
Sbjct: 148 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQ 203
Query: 653 TMKVTEKCDVYSFGVLALEVIKGKHP-------RDFLFEMSSSSSNMNIEILDSRLPYPS 705
+ + D++S G+ +E+ G++P L + R P
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263
Query: 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744
L+ F LD P V S +F
Sbjct: 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 302
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 55/253 (21%), Positives = 91/253 (35%), Gaps = 54/253 (21%)
Query: 196 SIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKS-LFDMKLCINQLNGAIPLSIDWGRC 254
IP +L + L L N + +L S F
Sbjct: 21 KIPDNL--PFSTKNLDLSFN--------PLRHLGSYSFF-------------------SF 51
Query: 255 PQLSLLDVSINNITGNIP---FEIGESPQLQYLDLSSN---YIVGEIPTQLGNIIYLNRI 308
P+L +LD+S I I ++ L L L+ N + + L + L ++
Sbjct: 52 PELQVLDLSRCEIQ-TIEDGAYQ--SLSHLSTLILTGNPIQSLALGAFSGLSS---LQKL 105
Query: 309 SLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLG---SLVKLYYLNLSHNKLSQ 365
L+ +G L L+ L+++ N + + + +L L +L+LS NK+ Q
Sbjct: 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQS--FKLPEYFSNLTNLEHLDLSSNKI-Q 162
Query: 366 QIPIE-LDNLIHL----SELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFE 420
I L L + LDLS N + I + L++L L N L + F+
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQLKSVPDGIFD 221
Query: 421 ELHGLLHIDISYN 433
L L I + N
Sbjct: 222 RLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 20/189 (10%)
Query: 260 LDVSINNITGNIPFEIGES-PQLQYLDLSSNYIVGEIP----TQLGNIIYLNRISLSGNK 314
LD+S N + ++ S P+LQ LDLS I I L + L+ + L+GN
Sbjct: 33 LDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSH---LSTLILTGNP 87
Query: 315 LSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIE--LD 372
+ G L +L+ L +L++ +G L L LN++HN + Q +
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI-QSFKLPEYFS 146
Query: 373 NLIHLSELDLSHNFLGEKISSRI-CRMESLE----KLNLSYNNLSGLIPRCFEELHGLLH 427
NL +L LDLS N + + I + + L+LS N ++ + P F+E+ L
Sbjct: 147 NLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LKE 204
Query: 428 IDISYNKLE 436
+ + N+L+
Sbjct: 205 LALDTNQLK 213
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 50/255 (19%), Positives = 80/255 (31%), Gaps = 58/255 (22%)
Query: 113 YLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTILHISRNQLNG 171
LDL N L + + +L+ LD ++ I L+HL+ L ++ N +
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ- 89
Query: 172 SIPHEV-GQLNFLNHLILDSNFLGGSIP-RSLSNFTNLVFLYLYNNSFSGSIPQQIGNLK 229
S+ L+ L L+ L S+ + + L L + +N I + K
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNL-ASLENFPIGHLKTLKELNVAHN--------LIQSFK 140
Query: 230 S--LFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGES-PQLQYLDL 286
F L LD+S N I +I Q+ L+L
Sbjct: 141 LPEYFS-------------------NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNL 180
Query: 287 SSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLES 346
+ LS N ++ I I L+ L L N L +
Sbjct: 181 --------------------SLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGI 219
Query: 347 LGSLVKLYYLNLSHN 361
L L + L N
Sbjct: 220 FDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 34/132 (25%), Positives = 57/132 (43%), Gaps = 5/132 (3%)
Query: 307 RISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQ 366
+ LS N L S L+ LDLS + + SL L L L+ N + Q
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI-QS 90
Query: 367 IPIEL-DNLIHLSELDLSHNFLGEKISSRI-CRMESLEKLNLSYNNLSGLI-PRCFEELH 423
+ + L L +L L + + +++L++LN+++N + P F L
Sbjct: 91 LALGAFSGLSSLQKLVAVETNL-ASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 424 GLLHIDISYNKL 435
L H+D+S NK+
Sbjct: 150 NLEHLDLSSNKI 161
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 46/211 (21%), Positives = 77/211 (36%), Gaps = 40/211 (18%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLYNNELFDIIPPQI-SNLSKLEYLDFLTNK 144
L + L+ T+ + ++ S HL+ L L N + + S LS L+ L +
Sbjct: 53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI-QSLALGAFSGLSSLQKLVAVETN 111
Query: 145 LSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNF 204
L+ I L L L+++ N + S +P SN
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQ-SFK----------------------LPEYFSNL 148
Query: 205 TNLVFLYLYNNSFSGSIPQQI----GNLKSL-FDMKLCINQLNGAIPLSIDWGRCPQLSL 259
TNL L L +N SI + L + L +N +N I + +L
Sbjct: 149 TNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF--KEIRLKE 204
Query: 260 LDVSINNITGNIPFEIGES-PQLQYLDLSSN 289
L + N + ++P I + LQ + L +N
Sbjct: 205 LALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 34/129 (26%), Positives = 59/129 (45%), Gaps = 7/129 (5%)
Query: 328 NLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNF 386
+ + LDLS N L + S S +L L+LS ++ Q I +L HLS L L+ N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNP 87
Query: 387 LGEKISSRI-CRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTF 445
+ + ++ + SL+KL NL+ L L L +++++N ++ F
Sbjct: 88 I-QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYF 145
Query: 446 RDAPLEALQ 454
+ L L+
Sbjct: 146 SN--LTNLE 152
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 6e-19
Identities = 60/340 (17%), Positives = 104/340 (30%), Gaps = 93/340 (27%)
Query: 90 NLTSISLNGTLLEF----SFSSFPHLAYLDLYNNELFDIIPPQI-SNLSKLEYLDFL-TN 143
N + T L +FS F L +++ N++ ++I + SNL KL + N
Sbjct: 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 144 KLSGHIPSEI-SLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLS 202
L +I E L +L L IS + +P
Sbjct: 91 NLL-YINPEAFQNLPNLQYLLISNTGIK-HLP-----------------------DVHKI 125
Query: 203 NFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDV 262
+ V L + +N +I ++ F G + +L +
Sbjct: 126 HSLQKVLLDIQDNINIHTIE------RNSFV------------------GLSFESVILWL 161
Query: 263 SINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRI-SLSGNKLSGRIPG 321
+ N I I QL L+LS N N + L + G
Sbjct: 162 NKNGIQ-EIHNSAFNGTQLDELNLSDN----------------NNLEELPNDVFHG---- 200
Query: 322 ELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELD 381
LD+S + + L +L KL + + K ++P L+ L+ L E
Sbjct: 201 ----ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT-LEKLVALMEAS 252
Query: 382 LSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEE 421
L++ S C + + + + E
Sbjct: 253 LTYP-------SHCCAFANWRRQISELHPICNKSILRQEV 285
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 39/185 (21%), Positives = 70/185 (37%), Gaps = 6/185 (3%)
Query: 257 LSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQ-LGNIIYLNRISLS-GNK 314
L + + L+ +++S N ++ I N+ L+ I + N
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 315 LSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIE-LDN 373
L P +L NL+YL +S + + ++ L++ N I
Sbjct: 92 LLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151
Query: 374 L-IHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNN-LSGLIPRCFEELHGLLHIDIS 431
L L L+ N + ++I + L++LNLS NN L L F G + +DIS
Sbjct: 152 LSFESVILWLNKNGI-QEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDIS 210
Query: 432 YNKLE 436
++
Sbjct: 211 RTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 7e-13
Identities = 43/247 (17%), Positives = 77/247 (31%), Gaps = 40/247 (16%)
Query: 196 SIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCP 255
IP L N + L I + G
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLR-VIQK--GAFSGF-----------------------G 54
Query: 256 QLSLLDVSINNITGNIPFEI-GESPQLQYLDLS-SNYIVGEIPTQLGNIIYLNRISLSGN 313
L +++S N++ I ++ P+L + + +N ++ P N+ L + +S
Sbjct: 55 DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT 114
Query: 314 KLSGRIP-GELGSLINLEYLDLSAN----HLSNFVLESLGSLVKLYYLNLSHNKLSQQIP 368
+ +P + LD+ N + L L L+ N + Q+I
Sbjct: 115 GIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFE--SVILWLNKNGI-QEIH 170
Query: 369 IELDNLIHLSELDLSHNFLGEKISSRICR-MESLEKLNLSYNNLSGLIPRCFEELHGLLH 427
N L EL+LS N E++ + + L++S + L E L L
Sbjct: 171 NSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA 230
Query: 428 IDISYNK 434
K
Sbjct: 231 RSTYNLK 237
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 57/266 (21%), Positives = 97/266 (36%), Gaps = 44/266 (16%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFH-SPLPDNF-------------CSHP 545
D++ + IG G +G R G+I K+ + + HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 546 -----RQSF---------IVYEYLESGSLDKILNNDASAKE-LGWTQRLNVIKGVADALF 590
IV EY E G L ++ ++ L L V+ + AL
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 591 YLH--NNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAP 648
H ++ ++H D+ NV LD + DF +A+ LN D+S GT ++P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 649 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708
E M EK D++S G L E+ P F + S + +I + + + +
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPP----FT-AFSQKELAGKIREGK--FRRI-- 236
Query: 709 QNKFMS--IMQVAFSCLDQNPVSRPT 732
S + ++ L+ RP+
Sbjct: 237 -PYRYSDELNEIITRMLNLKDYHRPS 261
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 62/263 (23%), Positives = 101/263 (38%), Gaps = 54/263 (20%)
Query: 503 FDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF------------CSHP---- 545
D+ IG+G G V +AR SG AVK H
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 546 -RQSF-------IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCF 597
+S+ ++ E+L+ G+L I++ L Q V + V AL YLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQ-- 160
Query: 598 PPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVT 657
++H DI S ++LL L +SDF ++ D L GT +APE+
Sbjct: 161 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYA 219
Query: 658 EKCDVYSFGVLALEVIKGK------HPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711
+ D++S G++ +E++ G+ P + + S P P L +K
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-------------PPPKLKNSHK 266
Query: 712 FMSIMQVAF--SCLDQNPVSRPT 732
+++ F L ++P R T
Sbjct: 267 VSPVLR-DFLERMLVRDPQERAT 288
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 60/266 (22%), Positives = 108/266 (40%), Gaps = 54/266 (20%)
Query: 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF------------CSHP- 545
+ IG+G G+VY A V +G+ A+++ + +P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 546 ----RQSF-------IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN 594
S+ +V EYL GSL ++ + Q V + AL +LH+
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS 134
Query: 595 NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTM 654
N ++H DI S N+LL + ++DF + + S S + GT +APE+
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 655 KVTEKCDVYSFGVLALEVIKGK------HPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708
K D++S G++A+E+I+G+ +P L+ ++++ P L
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-------------GTPELQN 238
Query: 709 QNKFMSIMQVAF--SCLDQNPVSRPT 732
K +I + F CL+ + R +
Sbjct: 239 PEKLSAIFR-DFLNRCLEMDVEKRGS 263
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 61/261 (23%), Positives = 100/261 (38%), Gaps = 43/261 (16%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFH-SPLPDNF-------------CSHP 545
+ IG+G G + + G + +K+ + S + HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 546 -----RQSF-------IVYEYLESGSLDKILNNDASA--KELGWTQRLNVIKGVADALFY 591
R+SF IV +Y E G L K +N +E Q L+ + AL +
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE---DQILDWFVQICLALKH 140
Query: 592 LHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELA 651
+H+ I+H DI S+N+ L + DF IA+ LN GT ++PE+
Sbjct: 141 VHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC 197
Query: 652 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711
K D+++ G + E+ KH FE S + + +I+ P SL
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHA----FEAGSMKNLVL-KIISGSFPPVSLHYSYD 252
Query: 712 FMSIMQVAFSCLDQNPVSRPT 732
S++ +NP RP+
Sbjct: 253 LRSLVS---QLFKRNPRDRPS 270
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 44/235 (18%), Positives = 82/235 (34%), Gaps = 41/235 (17%)
Query: 201 LSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLL 260
N V L S + + + K L +
Sbjct: 15 DPGLANAVKQNLGKQSVT-----DLVSQKEL-----------------------SGVQNF 46
Query: 261 DVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIP 320
+ +NI ++ + L+ L LS N I ++ + L ++ L +S++ N+L +
Sbjct: 47 NGDNSNIQ-SLA-GMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NLN 101
Query: 321 GELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSEL 380
G L L L N L + +SL L L L++ +NKL + L L L L
Sbjct: 102 G--IPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVL 155
Query: 381 DLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKL 435
DL N + + R++ + ++L+ + EL+ + +
Sbjct: 156 DLHGNEI-TNTGG-LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 42/197 (21%), Positives = 77/197 (39%), Gaps = 19/197 (9%)
Query: 239 NQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQ 298
+N P ++ ++T + + E +Q + ++ I +
Sbjct: 7 TPINQVFPDP----GLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNI--QSLAG 58
Query: 299 LGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNL 358
+ L + LS N++S + L L LE L ++ N L N L + S L L L
Sbjct: 59 MQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKN--LNGIPSA-CLSRLFL 113
Query: 359 SHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRC 418
+N+L L +L +L L + +N L + I + + LE L+L N ++
Sbjct: 114 DNNELRDTDS--LIHLKNLEILSIRNNKL-KSIVM-LGFLSKLEVLDLHGNEITNTGG-- 167
Query: 419 FEELHGLLHIDISYNKL 435
L + ID++ K
Sbjct: 168 LTRLKKVNWIDLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 33/158 (20%), Positives = 64/158 (40%), Gaps = 13/158 (8%)
Query: 279 PQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANH 338
+L + + + + + + + + G + NL+ L LS N
Sbjct: 19 ANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQ 74
Query: 339 LSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRM 398
+S+ L L L KL L+++ N+L + LS L L +N L S + +
Sbjct: 75 ISD--LSPLKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNEL-RDTDS-LIHL 127
Query: 399 ESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLE 436
++LE L++ N L ++ L L +D+ N++
Sbjct: 128 KNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 51/265 (19%), Positives = 90/265 (33%), Gaps = 45/265 (16%)
Query: 151 SEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFL 210
L + ++ + + + +L+ + + D++ + + FTNL L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKEL 68
Query: 211 YLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGN 270
+L +N QI +L L +L L V+ N +
Sbjct: 69 HLSHN--------QISDLSPL--------------------KDLTKLEELSVNRNRLKN- 99
Query: 271 IPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLE 330
S L L L +N + L ++ L +S+ NKL I LG L LE
Sbjct: 100 --LNGIPSACLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLE 153
Query: 331 YLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEK 390
LDL N ++N L L K+ +++L+ K + L + + + G
Sbjct: 154 VLDLHGNEITN--TGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTV---KDPDGRW 208
Query: 391 IS-SRICRMESLEKLNLSYNNLSGL 414
IS I S + +
Sbjct: 209 ISPYYISNGGSYVDGCVLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 8e-16
Identities = 46/289 (15%), Positives = 91/289 (31%), Gaps = 69/289 (23%)
Query: 103 FSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTIL 162
F + +L + D++ LS ++ + + + + + + T+L L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKEL 68
Query: 163 HISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIP 222
H+S NQ++ + L + T L L + N
Sbjct: 69 HLSHNQIS-DLS-------------------------PLKDLTKLEELSVNRN------- 95
Query: 223 QQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQ 282
++ NL + LS L + N + L+
Sbjct: 96 -RLKNLNGI---------------------PSACLSRLFLDNNELRDTDSLI--HLKNLE 131
Query: 283 YLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNF 342
L + +N + I LG + L + L GN+++ G L L + ++DL+ N
Sbjct: 132 ILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNWIDLTGQKCVN- 186
Query: 343 VLESLGSLVKLYYLNLSHNKLSQQI-PIELDNLIHLSELDLSHNFLGEK 390
E + +LY N + + I P + N + +
Sbjct: 187 --EPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 44/244 (18%), Positives = 84/244 (34%), Gaps = 64/244 (26%)
Query: 90 NLTSISLNGTLLE--FSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSG 147
+ + + + + ++ F +L L L +N++ D+ P + +L+KLE L N+L
Sbjct: 42 GVQNFNGDNSNIQSLAGMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRL-- 97
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207
++ + L+ L LD+N L SL + NL
Sbjct: 98 ---KNLNGIPSAC----------------------LSRLFLDNNEL--RDTDSLIHLKNL 130
Query: 208 VFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267
L + NN ++ ++ L G +L +LD+ N I
Sbjct: 131 EILSIRNN--------KLKSIVML--------------------GFLSKLEVLDLHGNEI 162
Query: 268 TGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRIS-LSGNKLSGRIPGELGSL 326
T ++ ++DL+ V E + N + G +S GS
Sbjct: 163 TNTGGLT--RLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSY 220
Query: 327 INLE 330
++
Sbjct: 221 VDGC 224
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 32/184 (17%), Positives = 56/184 (30%), Gaps = 15/184 (8%)
Query: 89 INLTSISLNGTLLE--FSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLS 146
NL + L+ + L L + N L ++ I + L L N+L
Sbjct: 63 TNLKELHLSHNQISDLSPLKDLTKLEELSVNRNRLKNLNG--IPSA-CLSRLFLDNNELR 119
Query: 147 GHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTN 206
+ L +L IL I N+L SI +G L+ L L L N + + L+
Sbjct: 120 D--TDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEI--TNTGGLTRLKK 173
Query: 207 LVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINN 266
+ ++ L + + L+ + +G V
Sbjct: 174 VNWIDLTGQKCV---NEPVKYQPELYITNT-VKDPDGRWISPYYISNGGSYVDGCVLWEL 229
Query: 267 ITGN 270
Sbjct: 230 PVYT 233
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 64/263 (24%), Positives = 108/263 (41%), Gaps = 54/263 (20%)
Query: 503 FDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF------------CSHP---- 545
FD +G+G +GSVY A +G+I A+K+ P+ + C P
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVK 88
Query: 546 -RQSF-------IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCF 597
S+ IV EY +GS+ I+ K L + +++ L YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHFM-- 144
Query: 598 PPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVT 657
+H DI + N+LL+ A ++DF +A L + + + GT +APE+ +
Sbjct: 145 -RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 203
Query: 658 EKCDVYSFGVLALEVIKGK------HPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711
D++S G+ A+E+ +GK HP +F + ++ P P+
Sbjct: 204 CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-------------PPPTFRKPEL 250
Query: 712 FMSIMQ--VAFSCLDQNPVSRPT 732
+ V CL ++P R T
Sbjct: 251 WSDNFTDFVK-QCLVKSPEQRAT 272
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 9e-18
Identities = 56/277 (20%), Positives = 94/277 (33%), Gaps = 60/277 (21%)
Query: 495 EIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIF-AVKKFH----SPLPDNF-------- 541
+ D IG+G G V+ R+ + AVK L F
Sbjct: 110 VLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILK 167
Query: 542 -------------CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADA 588
C+ + +IV E ++ G L + L L ++ A
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAG 225
Query: 589 LFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-- 646
+ YL + C +H D++++N L+ +SDF +++ +G V
Sbjct: 226 MEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVY---AASGGLRQVPV 279
Query: 647 ---APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS--- 699
APE + + + DV+SFG+L E G P +S N + +
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYP---NLS------NQQTREFVEK 330
Query: 700 --RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
RLP P + +M+ C P RP+
Sbjct: 331 GGRLPCPE-LCPDAVFRLME---QCWAYEPGQRPSFS 363
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 58/275 (21%), Positives = 115/275 (41%), Gaps = 48/275 (17%)
Query: 493 YEEIIRATN---DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF------- 541
YE + R + ++ +G G G VY A+ +G + A K + +
Sbjct: 8 YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEI 67
Query: 542 -----CSHP-----RQSF-------IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKG 584
C HP ++ I+ E+ G++D I+ + L Q V +
Sbjct: 68 EILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQ 125
Query: 585 VADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHG 644
+ +AL +LH+ I+H D+ + NVL+ L + ++DF ++ GT
Sbjct: 126 MLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY 182
Query: 645 NVAPELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS 699
+APE+ + + K D++S G+ +E+ + + P E++ M + + +
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP---HHELNP----MRVLLKIA 235
Query: 700 RLPYPSLDVQNKFMSIMQ--VAFSCLDQNPVSRPT 732
+ P+L +K+ + + LD+NP +RP+
Sbjct: 236 KSDPPTLLTPSKWSVEFRDFLK-IALDKNPETRPS 269
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 42/276 (15%), Positives = 92/276 (33%), Gaps = 55/276 (19%)
Query: 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKK---------------------FHSP--- 536
+ +G+GG V + + G +A+K+ F+ P
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 537 -LPDNFCSHPRQS---FIVYEYLESGSLDKILNNDASAKELGWTQR--LNVIKGVADALF 590
L +++ + + G+L + T+ L ++ G+ L
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGICRGLE 148
Query: 591 YLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---- 646
+H H D+ N+LL + + D + +
Sbjct: 149 AIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 647 -----APEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEIL 697
APEL ++ + + E+ DV+S G + ++ G+ P ++M + +
Sbjct: 206 TISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGP----YDMVFQKGDSVALAV 260
Query: 698 DSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTM 733
++L P + ++ Q+ S + +P RP +
Sbjct: 261 QNQLSIPQSPRHSS--ALWQLLNSMMTVDPHQRPHI 294
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 39/160 (24%), Positives = 63/160 (39%), Gaps = 10/160 (6%)
Query: 278 SPQLQYLDLSSNYIVGEIPTQLGNI-IYLNRISLSGNKLSGRIPGELGSLINLEYLDLSA 336
++ + +P ++ + LS N L L L L+L
Sbjct: 9 VASHLEVNCDKRNL-TALPP---DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 337 NHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRI- 395
L+ L+ G+L L L+LSHN+L Q +P+ L L+ LD+S N L +
Sbjct: 65 AELTK--LQVDGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRL-TSLPLGAL 120
Query: 396 CRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKL 435
+ L++L L N L L P L + ++ N L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 49/206 (23%), Positives = 73/206 (35%), Gaps = 38/206 (18%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKL 145
+ T + L+ T + + L L+L EL + L L LD N+L
Sbjct: 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL--QVDGTLPVLGTLDLSHNQL 89
Query: 146 SGHIPSEISLLTHLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIP-RSLSN 203
+P L LT+L +S N+L S+P L L L L N L ++P L+
Sbjct: 90 Q-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNEL-KTLPPGLLTP 146
Query: 204 FTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVS 263
L L L NN+ + +P L + L L L +
Sbjct: 147 TPKLEKLSLANNNLT-ELP------AGLLN-GL------------------ENLDTLLLQ 180
Query: 264 INNITGNIPFEIGESPQLQYLDLSSN 289
N++ IP S L + L N
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 47/176 (26%), Positives = 81/176 (46%), Gaps = 8/176 (4%)
Query: 260 LDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRI 319
L +S N + + +L L+L + ++ G + L + LS N+L +
Sbjct: 36 LHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQV-DGTLPVLGTLDLSHNQLQ-SL 92
Query: 320 PGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLS 378
P +L L LD+S N L++ L +L L +L L L N+L + +P L L
Sbjct: 93 PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL-KTLPPGLLTPTPKLE 151
Query: 379 ELDLSHNFLGEKISSRIC-RMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYN 433
+L L++N L ++ + + +E+L+ L L N+L IP+ F H L + N
Sbjct: 152 KLSLANNNL-TELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 44/158 (27%), Positives = 69/158 (43%), Gaps = 7/158 (4%)
Query: 281 LQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLS 340
L LS N + L L +++L +L+ ++ G+L L LDLS N L
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ 90
Query: 341 NFVLESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFLGEKISSRIC-RM 398
+ + +L L L++S N+L +P+ L L EL L N L + + +
Sbjct: 91 S-LPLLGQTLPALTVLDVSFNRL-TSLPLGALRGLGELQELYLKGNEL-KTLPPGLLTPT 147
Query: 399 ESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLE 436
LEKL+L+ NNL+ L L L + + N L
Sbjct: 148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 58/260 (22%), Positives = 85/260 (32%), Gaps = 65/260 (25%)
Query: 130 SNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILD 189
S ++ ++ L+ +P ++ TILH+S N L +
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLL-YTFS--------------- 47
Query: 190 SNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSI 249
+L +T L L L ++ L +
Sbjct: 48 --------LATLMPYTRLTQLNLDRA--------ELTKL-QVDG---------------- 74
Query: 250 DWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIP----TQLGNIIYL 305
P L LD+S N + ++P P L LD+S N + +P LG L
Sbjct: 75 ---TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGE---L 126
Query: 306 NRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQ 365
+ L GN+L PG L LE L L+ N+L+ L L L L L N L
Sbjct: 127 QELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL-Y 185
Query: 366 QIPIELDNLIHLSELDLSHN 385
IP L L N
Sbjct: 186 TIPKGFFGSHLLPFAFLHGN 205
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 64/265 (24%), Positives = 102/265 (38%), Gaps = 57/265 (21%)
Query: 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFH-SPLPDNF------------CSHP-- 545
F IGKG G V+ + ++ A+K D C P
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 546 ---RQSF-------IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNN 595
S+ I+ EYL GS +L L TQ +++ + L YLH+
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE 138
Query: 596 CFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMK 655
+H DI + NVLL E ++DF +A L + GT +APE+
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 195
Query: 656 VTEKCDVYSFGVLALEVIKGK------HPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709
K D++S G+ A+E+ +G+ HP LF + + P+L +
Sbjct: 196 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-------------NPPTL--E 240
Query: 710 NKFMSIMQ--VAFSCLDQNPVSRPT 732
+ ++ V +CL++ P RPT
Sbjct: 241 GNYSKPLKEFVE-ACLNKEPSFRPT 264
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 4e-17
Identities = 42/205 (20%), Positives = 70/205 (34%), Gaps = 46/205 (22%)
Query: 508 CIGKGGHGSVYIAR--VPSGEIFAVKKFHSPLPDNFC-------------SHP------- 545
CI GG G +Y+A +G +K HP
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 546 ----------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNN 595
+IV EY+ SL + ++L + + + + AL YLH+
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLHSI 201
Query: 596 CFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMK 655
+V+ D+ +N++L + + D +N L GT G APE+ T
Sbjct: 202 ---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY----LYGTPGFQAPEIVRT-G 252
Query: 656 VTEKCDVYSFGVLALEVIKGKHPRD 680
T D+Y+ G + R+
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPTRN 277
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 48/225 (21%)
Query: 486 PLLGKIV---YEEIIRATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN- 540
++GKI+ Y+ I+ +G GG +VY+A A+K P +
Sbjct: 3 HMIGKIINERYK-IVDK---------LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKE 52
Query: 541 -FC-------------SHP------------RQSFIVYEYLESGSLDKILNNDASAKELG 574
SH ++V EY+E +L + + + L
Sbjct: 53 ETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LS 109
Query: 575 WTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS- 633
+N + D + + H+ IVH DI +N+L+D + DF IAK L+ S
Sbjct: 110 VDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166
Query: 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 678
+ + + GT +PE A E D+YS G++ E++ G+ P
Sbjct: 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 1e-16
Identities = 50/295 (16%), Positives = 97/295 (32%), Gaps = 57/295 (19%)
Query: 500 TNDFDAKHCIGKGGH--GSVYIAR-VPSGEIFAVKKF------HSPLPD--------NFC 542
++ IGKG +V +AR P+GE V++ + +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 543 SHP-----RQSF-------IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALF 590
+HP R +F +V ++ GS ++ + +++GV AL
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT-HFMDGMNELAIAYILQGVLKALD 142
Query: 591 YLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---- 646
Y+H+ VH + + ++L+ + + ++S R + +
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 647 ---APELAYTMKV--TEKCDVYSFGVLALEVIKGK------HPRDFLFEMSSS------S 689
+PE+ K D+YS G+ A E+ G L E +
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259
Query: 690 SNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744
++ + P S+ S+ + + S P + F S FH
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTF---SPHFH 311
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 58/290 (20%), Positives = 102/290 (35%), Gaps = 66/290 (22%)
Query: 498 RATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKK------------------------ 532
R +DF+ +G+G G V AR +A+KK
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQ 62
Query: 533 --------FHSPLPDNFCSHPRQS----FIVYEYLESGSL-DKILNNDASAKELGWTQRL 579
+ + FI EY E+G+L D I + + + + +
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR---DEYW 119
Query: 580 NVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKL 639
+ + + +AL Y+H+ I+H D+ N+ +D + DF +AK ++
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 640 A--------------GTHGNVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFE 684
+ GT VA E L T EK D+YS G++ E+I F
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-------FS 229
Query: 685 MSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
N+ ++ + +P NK ++ +D +P RP +
Sbjct: 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGAR 279
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 61/284 (21%), Positives = 104/284 (36%), Gaps = 58/284 (20%)
Query: 506 KHCIGKGGHGSVYIA--RVPSGEIF-AVKKFHSPL----PDNFCS---------HPR--- 546
+G G GSV R+ +I A+K + +P
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 547 --------QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 598
+V E G L K L +E+ + ++ V+ + YL F
Sbjct: 75 LIGVCQAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKNF- 131
Query: 599 PIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYT 653
VH D++++NVLL + A +SDF ++K L D S ++ A + G APE
Sbjct: 132 --VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT--ARSAGKWPLKWYAPECINF 187
Query: 654 MKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLD 707
K + + DV+S+GV E + G+ P +M E++ R+ P +
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPYK---KMK------GPEVMAFIEQGKRMECPP-E 237
Query: 708 VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPDHNV 751
+ ++M C RP E + + +Y+ V
Sbjct: 238 CPPELYALMS---DCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 57/261 (21%), Positives = 90/261 (34%), Gaps = 53/261 (20%)
Query: 508 CIGKGGHGSVYIAR-VPSGEIFAVK---------------------KFHSPLPDN----- 540
+GKG +G VY R + + A+K N
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHK---NIVQYL 85
Query: 541 -FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 599
S I E + GSL +L + + K + + L YLH+N
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142
Query: 600 IVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNWSKLAGTHGNVAPE--LAYTMK 655
IVH DI NVL++ Y + SDF +K L + GT +APE
Sbjct: 143 IVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 656 VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM-NIEILDSRLPYP---SLDVQNK 711
+ D++S G +E+ GK P +E+ + M + + P S + +
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPP---FYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA- 257
Query: 712 FMSIMQVAFSCLDQNPVSRPT 732
F+ C + +P R
Sbjct: 258 FIL------KCFEPDPDKRAC 272
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 62/274 (22%), Positives = 107/274 (39%), Gaps = 53/274 (19%)
Query: 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKF---HSPLPD---------NFCSHP- 545
F+ +G G +G VY R V +G++ A+K + + H
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 546 -----------------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADA 588
Q ++V E+ +GS+ ++ N L + + +
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRG 141
Query: 589 LFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAP 648
L +LH + ++H DI +NVLL E + DF ++ L+ + GT +AP
Sbjct: 142 LSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
Query: 649 ELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPY 703
E+ + + K D++S G+ A+E+ +G P L +M M L R P
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP---LCDMHP----MRALFLIPRNPA 251
Query: 704 PSLDVQN---KFMSIMQVAFSCLDQNPVSRPTMK 734
P L + KF S ++ CL +N RP +
Sbjct: 252 PRLKSKKWSKKFQSFIES---CLVKNHSQRPATE 282
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 32/210 (15%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+V E E G L+K L + + + + ++ V+ + YL + F VH D++++
Sbjct: 93 MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESNF---VHRDLAAR 146
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTMKVTEKCDVY 663
NVLL + A +SDF ++K L D + + A THG APE K + K DV+
Sbjct: 147 NVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPECINYYKFSSKSDVW 204
Query: 664 SFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQNKFMSIMQ 717
SFGVL E G+ P M E+ R+ P+ + +M
Sbjct: 205 SFGVLMWEAFSYGQKPYR---GMK------GSEVTAMLEKGERMGCPA-GCPREMYDLMN 254
Query: 718 VAFSCLDQNPVSRPTMKRFEVQSKQFHYNP 747
C + +RP E++ + ++Y+
Sbjct: 255 ---LCWTYDVENRPGFAAVELRLRNYYYDV 281
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 64/282 (22%), Positives = 111/282 (39%), Gaps = 65/282 (23%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVK-----KFHSPLPD--------NFCSHP- 545
+D++ + IG G V A P E A+K K + + + + C HP
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 546 ----RQSF-------IVYEYLESGSLDKILNNDASAKELGWTQRLN------VIKGVADA 588
SF +V + L GS+ I+ + AK + L+ +++ V +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKH-IVAKGEHKSGVLDESTIATILREVLEG 133
Query: 589 LFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN--LDSSNWSK---LAGTH 643
L YLH N +H D+ + N+LL ++DF ++ FL D + GT
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 644 GNVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGK------HPRDFLFEMSSSSSNM 692
+APE+ Y K D++SFG+ A+E+ G P L +
Sbjct: 191 CWMAPEVMEQVRGYD----FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246
Query: 693 NIEILDSRLPYPSLDVQNKFMSIMQ--VAFSCLDQNPVSRPT 732
L++ ++ K+ + ++ CL ++P RPT
Sbjct: 247 ----LET--GVQDKEMLKKYGKSFRKMIS-LCLQKDPEKRPT 281
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 40/201 (19%), Positives = 68/201 (33%), Gaps = 39/201 (19%)
Query: 509 IGKGGHGSVYIARVPS-GEIFAVKKFHSPLPDN------F---------CSHP------- 545
+G+GG G VY A I A+K L + P
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101
Query: 546 -----RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 600
Q ++ + L +L L + + +++ + AL H
Sbjct: 102 FGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA---GA 155
Query: 601 VHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APELAYTMKVT 657
H D+ +N+L+ A++ DF IA ++L T G + APE T
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHAT 213
Query: 658 EKCDVYSFGVLALEVIKGKHP 678
+ D+Y+ + E + G P
Sbjct: 214 YRADIYALTCVLYECLTGSPP 234
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 8e-16
Identities = 60/273 (21%), Positives = 100/273 (36%), Gaps = 72/273 (26%)
Query: 503 FDAKHCIGKGGHGSVYIAR-VPSGEIFAVKK---FHSPLPDNF------------CSHP- 545
F IG G G+VY AR V + E+ A+KK + + HP
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 546 ----RQSF-------IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN 594
R + +V EY + D + + +E + V G L YLH+
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE---VEIAAVTHGALQGLAYLHS 172
Query: 595 NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTM 654
+ ++H D+ + N+LL + DF A + +S GT +APE+ M
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVILAM 225
Query: 655 KVTE---KCDVYSFGVLALEVIKGK------HPRDFLFEMSSSSSNMNIEILDSRLPYPS 705
+ K DV+S G+ +E+ + K + L+ ++ + P+
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-------------ESPA 272
Query: 706 LDVQN------KFMSIMQVAFSCLDQNPVSRPT 732
L + F+ CL + P RPT
Sbjct: 273 LQSGHWSEYFRNFVDS------CLQKIPQDRPT 299
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 50/282 (17%), Positives = 88/282 (31%), Gaps = 63/282 (22%)
Query: 498 RATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD----------------- 539
R T +F IG G GSV+ G I+A+K+ S P
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR--SKKPLAGSVDEQNALREVYAHA 65
Query: 540 NFCSHP-----RQSF-------IVYEYLESGSL-DKILNNDASAKELGWTQRLNVIKGVA 586
H ++ I EY GSL D I N + +++ V
Sbjct: 66 VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 587 DALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLA------ 640
L Y+H+ +VH DI N+ + + + + + K+
Sbjct: 126 RGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 641 -GTHGNV--------APE-LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS 690
+ V A E L K D+++ + + + +
Sbjct: 183 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL--------PRNG 234
Query: 691 NMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT 732
+ EI RLP + +F +++ + +P RP+
Sbjct: 235 DQWHEIRQGRLPRIPQVLSQEFTELLK---VMIHPDPERRPS 273
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 58/270 (21%), Positives = 95/270 (35%), Gaps = 55/270 (20%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFH-SPLPDNF-------------CSHP 545
ND + +G G G V+ R +G + AVK+ S + P
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 546 R-----QSF-------IVYEYLESGSLDKILNNDASAKE--LGWTQRLNVIKGVADALFY 591
+F I E + + + E LG + + AL+Y
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYY 139
Query: 592 LHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELA 651
L ++H D+ N+LLD + + DF I+ L +D + AG +APE
Sbjct: 140 LKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSAGCAAYMAPERI 196
Query: 652 YTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD--SRLPYP 704
T+ + DV+S G+ +E+ G+ P + + E+L + P
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFPY--------KNCKTDFEVLTKVLQEEPP 248
Query: 705 SLDVQNKFMSIMQ--VAFSCLDQNPVSRPT 732
L F Q V CL ++ RP
Sbjct: 249 LLPGHMGFSGDFQSFVK-DCLTKDHRKRPK 277
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 12/180 (6%)
Query: 260 LDVSINNITGNIPFEIGES-PQLQYLDLSSNYI----VGEIPTQLGNIIYLNRISLSGNK 314
LD+ N ++ ++P + +L+ L L+ N + G I +L N L + ++ NK
Sbjct: 42 LDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAG-IFKELKN---LETLWVTDNK 96
Query: 315 LSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIEL-DN 373
L G L+NL L L N L + SL KL YL+L +N+L Q +P + D
Sbjct: 97 LQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNEL-QSLPKGVFDK 155
Query: 374 LIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYN 433
L L EL L +N L ++ L+ L L N L + F+ L L + + N
Sbjct: 156 LTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 55/182 (30%), Positives = 87/182 (47%), Gaps = 12/182 (6%)
Query: 113 YLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTILHISRNQLNG 171
LDL +N+L + L+KL L NKL +P+ I L +L L ++ N+L
Sbjct: 41 KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ- 98
Query: 172 SIPHEV-GQLNFLNHLILDSNFLGGSIPRSL-SNFTNLVFLYLYNNSFSGSIPQQI-GNL 228
++P V QL L L LD N L S+P + + T L +L L N S+P+ + L
Sbjct: 99 ALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKL 156
Query: 229 KSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGES-PQLQYLDLS 287
SL +++L NQL +P + + +L L + N + +P +S +L+ L L
Sbjct: 157 TSLKELRLYNNQLK-RVPEGA-FDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQ 213
Query: 288 SN 289
N
Sbjct: 214 EN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 47/168 (27%), Positives = 75/168 (44%), Gaps = 10/168 (5%)
Query: 270 NIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINL 329
NIP + LDL SN + + L + L+ NKL G L NL
Sbjct: 34 NIP------ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNL 87
Query: 330 EYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFLG 388
E L ++ N L + LV L L L N+L + +P + D+L L+ L L +N L
Sbjct: 88 ETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNEL- 145
Query: 389 EKISSRIC-RMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKL 435
+ + + ++ SL++L L N L + F++L L + + N+L
Sbjct: 146 QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQL 193
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 7e-13
Identities = 48/195 (24%), Positives = 76/195 (38%), Gaps = 14/195 (7%)
Query: 196 SIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCP 255
+IP ++ + L L +N S + L L + L N+L +P I +
Sbjct: 30 AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGI-FKELK 85
Query: 256 QLSLLDVSINNITGNIPFEIGESP-QLQYLDLSSNYIVGEIP----TQLGNIIYLNRISL 310
L L V+ N + +P + + L L L N + +P L + YL+ L
Sbjct: 86 NLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLS---L 140
Query: 311 SGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIE 370
N+L G L +L+ L L N L + L +L L L +N+L +
Sbjct: 141 GYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGA 200
Query: 371 LDNLIHLSELDLSHN 385
D+L L L L N
Sbjct: 201 FDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 51/157 (32%), Positives = 70/157 (44%), Gaps = 16/157 (10%)
Query: 90 NLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQI-SNLSKLEYLDFLTNKLSGH 148
L+S+ +F L L L +N+L +P I L LE L NKL
Sbjct: 48 KLSSLPSK------AFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQ-A 99
Query: 149 IPSEI-SLLTHLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIPRSL-SNFT 205
+P + L +L L + RNQL S+P V L L +L L N L S+P+ + T
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL-QSLPKGVFDKLT 157
Query: 206 NLVFLYLYNNSFSGSIPQQI-GNLKSLFDMKLCINQL 241
+L L LYNN +P+ L L +KL NQL
Sbjct: 158 SLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQL 193
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 57/243 (23%), Positives = 84/243 (34%), Gaps = 64/243 (26%)
Query: 125 IPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEV-GQLNFL 183
IP I + + LD +NKLS LT L +L+++ N+L ++P + +L L
Sbjct: 31 IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNL 87
Query: 184 NHLILDSNFLGGSIPRSL-SNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLN 242
L + N L ++P + NL L L N S+P +FD L
Sbjct: 88 ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLP------PRVFD-SL------ 132
Query: 243 GAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIP----TQ 298
+L YL L N + +P +
Sbjct: 133 ------------------------------------TKLTYLSLGYNELQ-SLPKGVFDK 155
Query: 299 LGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNL 358
L + L + L N+L G L L+ L L N L + SL KL L L
Sbjct: 156 LTS---LKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
Query: 359 SHN 361
N
Sbjct: 213 QEN 215
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 49/205 (23%), Positives = 83/205 (40%), Gaps = 41/205 (20%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN--FC-------------SHP------- 545
+G GG V++AR + AVK + L + F +HP
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 546 ---------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNC 596
+IV EY++ +L I++ + + + + VI AL + H N
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQN- 135
Query: 597 FPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APELAYT 653
I+H D+ N+++ V DF IA+ + ++ ++ A G +PE A
Sbjct: 136 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 654 MKVTEKCDVYSFGVLALEVIKGKHP 678
V + DVYS G + EV+ G+ P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 48/215 (22%), Positives = 82/215 (38%), Gaps = 38/215 (17%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
++ + + G L + +G LN +A + YL + VH D++++
Sbjct: 92 QLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRRL---VHRDLAAR 146
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTMKVTEKCDVY 663
NVL+ ++DF +AK L + + G V A E T + DV+
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEK---EYHAEGGKVPIKWMALESILHRIYTHQSDVW 203
Query: 664 SFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYP---SLDVQNKFMS 714
S+GV E++ G P D + EI RLP P ++DV
Sbjct: 204 SYGVTVWELMTFGSKPYD---GIP------ASEISSILEKGERLPQPPICTIDVYM---- 250
Query: 715 IMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPDH 749
IM+ C + SRP + ++ + +P
Sbjct: 251 IMR---KCWMIDADSRPKFRELIIEFSKMARDPQR 282
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 2e-15
Identities = 58/279 (20%), Positives = 103/279 (36%), Gaps = 54/279 (19%)
Query: 509 IGKGGHGSVYIA--RVPSGEIF-AVKKFHS----PLPDNFCS---------HP------- 545
+G G GSV R+ +I A+K + +P
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 546 ----RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIV 601
+V E G L K L +E+ + ++ V+ + YL F V
Sbjct: 404 VCQAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKNF---V 458
Query: 602 HWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APELAYTMKVTE 658
H +++++NVLL + A +SDF ++K L D S ++ + + APE K +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 659 KCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQNKF 712
+ DV+S+GV E + G+ P +M E++ R+ P + +
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYK---KMK------GPEVMAFIEQGKRMECPP-ECPPEL 568
Query: 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPDHNV 751
++M C RP E + + +Y+ V
Sbjct: 569 YALMS---DCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 45/302 (14%), Positives = 84/302 (27%), Gaps = 63/302 (20%)
Query: 494 EEIIRATNDFDAKHCIGKGGHGSVYIAR------VPSGEIFAVKKFHSPLPDNF------ 541
E + H +G+G VY A + + F +K P F
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 542 ------CSHP------------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRL--NV 581
S +V E G+L +N + E Q L +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 582 IKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAH-----------VSDFRIAKFLN 630
+ + +H+ I+H DI N +L G+ + D + +
Sbjct: 178 AMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 631 LDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS 688
L ++ T G E+ + D + ++ G + ++ +
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM-----KVKNE 289
Query: 689 SSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPD 748
E L R P LD+ N+F +M L+ ++
Sbjct: 290 GGECKPEGLFRR--LPHLDMWNEFFHVM------LNIPDCHHLPSLDL--LRQKLKKVFQ 339
Query: 749 HN 750
+
Sbjct: 340 QH 341
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 51/267 (19%), Positives = 82/267 (30%), Gaps = 54/267 (20%)
Query: 498 RATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------NF 541
F +G G +G V+ R G ++AVK+ SP
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 542 CSHP-----RQSF-------IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADAL 589
HP Q++ + E AS E Q ++ AL
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPE---AQVWGYLRDTLLAL 170
Query: 590 FYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPE 649
+LH+ +VH D+ N+ L + DF + L + G +APE
Sbjct: 171 AHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQEGDPRYMAPE 226
Query: 650 L---AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYP-S 705
L +Y DV+S G+ LEV + L S
Sbjct: 227 LLQGSYG----TAADVFSLGLTILEVACNMEL----PHGGEGWQQLRQGYLPPEFTAGLS 278
Query: 706 LDVQNKFMSIMQVAFSCLDQNPVSRPT 732
++++ + L+ +P R T
Sbjct: 279 SELRS-VLV------MMLEPDPKLRAT 298
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 3e-15
Identities = 59/273 (21%), Positives = 108/273 (39%), Gaps = 54/273 (19%)
Query: 495 EIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIF-AVK--KFHSPLPDNF---------- 541
E+ R D KH +G G +G VY + AVK K + + F
Sbjct: 216 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 273
Query: 542 -----------CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALF 590
C+ +I+ E++ G+L L + +E+ L + ++ A+
Sbjct: 274 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAME 332
Query: 591 YLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---A 647
YL F +H +++++N L+ + V+DF +++ + D+ ++ AG + A
Sbjct: 333 YLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTA 387
Query: 648 PELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RL 701
PE K + K DV++FGVL E+ G P + ++ + R+
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP---GID------LSQVYELLEKDYRM 438
Query: 702 PYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
P K +M+ +C NP RP+
Sbjct: 439 ERPE-GCPEKVYELMR---ACWQWNPSDRPSFA 467
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 4e-15
Identities = 66/273 (24%), Positives = 106/273 (38%), Gaps = 56/273 (20%)
Query: 495 EIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVK--KFHSPLPDNFCS--------- 543
EI R + +G+G G V++ A+K K + P+ F
Sbjct: 263 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 320
Query: 544 HPR-----------QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYL 592
H + +IV EY+ GSL L + + K L Q +++ +A + Y+
Sbjct: 321 HEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV 379
Query: 593 HNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----A 647
+ VH D+ + N+L+ V+DF +A+ + + A A
Sbjct: 380 ERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT----ARQGAKFPIKWTA 432
Query: 648 PELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RL 701
PE A + T K DV+SFG+L E+ KG+ P M N E+LD R+
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP---GMV------NREVLDQVERGYRM 483
Query: 702 PYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
P P + +M C + P RPT +
Sbjct: 484 PCPP-ECPESLHDLMC---QCWRKEPEERPTFE 512
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 4e-15
Identities = 66/273 (24%), Positives = 106/273 (38%), Gaps = 56/273 (20%)
Query: 495 EIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVK--KFHSPLPDNFCS--------- 543
EI R + +G+G G V++ A+K K + P+ F
Sbjct: 180 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 237
Query: 544 HPR-----------QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYL 592
H + +IV EY+ GSL L + + K L Q +++ +A + Y+
Sbjct: 238 HEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV 296
Query: 593 HNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----A 647
+ VH D+ + N+L+ V+DF +A+ + + A A
Sbjct: 297 ERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTA 349
Query: 648 PELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RL 701
PE A + T K DV+SFG+L E+ KG+ P M N E+LD R+
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP---GMV------NREVLDQVERGYRM 400
Query: 702 PYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
P P + +M C + P RPT +
Sbjct: 401 PCPP-ECPESLHDLMC---QCWRKEPEERPTFE 429
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 54/274 (19%), Positives = 95/274 (34%), Gaps = 62/274 (22%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD-------------NFCSHP--------- 545
+ +GG VY A+ V SG +A+K+ S + HP
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 546 ----------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNN 595
+ F++ L G L + L S L L + A+ ++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR- 154
Query: 596 CFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGN---------- 645
PPI+H D+ +N+LL + DF A ++
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 646 --VAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR 700
PE+ + EK D+++ G + + +HP FE + + I++ +
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAK-----LRIVNGK 265
Query: 701 LPYPSLDVQ-NKFMSIMQVAFSCLDQNPVSRPTM 733
P D Q F S+++ + L NP R ++
Sbjct: 266 YSIPPHDTQYTVFHSLIR---AMLQVNPEERLSI 296
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 48/211 (22%), Positives = 82/211 (38%), Gaps = 15/211 (7%)
Query: 90 NLTSISLNGTLL----EFSFSSFPHLAYLDLYNNELFDIIPPQI-SNLSKLEYLDFLTNK 144
+ ++ L T L +FS+ P+++ + + + + NLSK+ +++ +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 145 LSGHIPSEI-SLLTHLTILHISRNQLNGSIPHE--VGQLNFLNHLILDSNFLGGSIP-RS 200
+I + L L L I L P V + L + N SIP +
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 201 LSNFTN-LVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSL 259
N + L LYNN F+ S+ N L + L N+ I G SL
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSL 209
Query: 260 LDVSINNITGNIPFEIGESPQLQYLDLSSNY 290
LDVS ++T +P + E L+ L + +
Sbjct: 210 LDVSQTSVT-ALPSKGLEH--LKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 37/214 (17%), Positives = 68/214 (31%), Gaps = 10/214 (4%)
Query: 154 SLLTHLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIPR-SLSNFTNLVFLY 211
SL L + L +IP L ++ + + + + S N + + +
Sbjct: 28 SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIE 86
Query: 212 LYNNSFSGSIPQQI-GNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGN 270
+ N I L L + + L P +L+++ N +
Sbjct: 87 IRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTS 145
Query: 271 IPFEI--GESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGEL--GSL 326
IP G + L L +N + N L+ + L+ NK I + G
Sbjct: 146 IPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY 204
Query: 327 INLEYLDLSANHLSNFVLESLGSLVKLYYLNLSH 360
LD+S ++ + L L +L N
Sbjct: 205 SGPSLLDVSQTSVTALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 7e-13
Identities = 28/182 (15%), Positives = 62/182 (34%), Gaps = 14/182 (7%)
Query: 255 PQLSLLDVSINNITGNIPFEIGES-PQLQYLDLSSNYIVGEIPTQ-LGNIIYLNRISLSG 312
P +S + VSI+ + + ++ ++++ + + I L + L + +
Sbjct: 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFN 114
Query: 313 NKLSGRIPGE--LGSLINLEYLDLSAN----HLSNFVLESLGSLVKLYYLNLSHNKLSQQ 366
L P + S L+++ N + + L + L L +N
Sbjct: 115 TGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE--TLTLKLYNNGF-TS 170
Query: 367 IPIELDNLIHLSELDLSHNFLGEKISSRICR--MESLEKLNLSYNNLSGLIPRCFEELHG 424
+ N L + L+ N I L++S +++ L + E L
Sbjct: 171 VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKE 230
Query: 425 LL 426
L+
Sbjct: 231 LI 232
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 18/119 (15%), Positives = 41/119 (34%), Gaps = 3/119 (2%)
Query: 328 NLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNF 386
+ + L L HL + +L + + +S + QQ+ NL ++ +++ +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 387 LGEKISSRICR-MESLEKLNLSYNNLSGLIPRCF-EELHGLLHIDISYNKLEGHIPNST 443
I + + L+ L + L ++I+ N IP +
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 7e-15
Identities = 59/269 (21%), Positives = 108/269 (40%), Gaps = 52/269 (19%)
Query: 495 EIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVK--KFHSPLPDNFCS--------- 543
EI R + +G G G V++A AVK K S + F +
Sbjct: 184 EIPR--ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ 241
Query: 544 HPR-----------QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYL 592
H + +I+ E++ GSL L +D + + ++ +A+ + ++
Sbjct: 242 HDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFI 300
Query: 593 HNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APE 649
+ +H D+ + N+L+ ++DF +A+ + + ++ G + APE
Sbjct: 301 EQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPE 355
Query: 650 LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPY 703
T K DV+SFG+L +E++ G+ P MS N E++ + R+P
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYP---GMS------NPEVIRALERGYRMPR 406
Query: 704 PSLDVQNKFMSIMQVAFSCLDQNPVSRPT 732
P + + +IM C P RPT
Sbjct: 407 PE-NCPEELYNIMM---RCWKNRPEERPT 431
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 7e-15
Identities = 62/273 (22%), Positives = 99/273 (36%), Gaps = 60/273 (21%)
Query: 495 EIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVK--KFHSPLPDNF----------- 541
I ++ IG G G V++ + + A+K + + ++F
Sbjct: 4 VIDP--SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS 61
Query: 542 ----------CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFY 591
C +V E++E G L L L + V + + Y
Sbjct: 62 HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAY 119
Query: 592 LHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD---SSNWSKLAGTHGNV-- 646
L C +H D++++N L+ VSDF + +F+ D SS +K V
Sbjct: 120 LEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP-----VKW 171
Query: 647 -APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS----- 699
+PE+ + + K DV+SFGVL EV +GK P S N E+++
Sbjct: 172 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP---YENRS------NSEVVEDISTGF 222
Query: 700 RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT 732
RL P IM C + P RP
Sbjct: 223 RLYKPR-LASTHVYQIMN---HCWRERPEDRPA 251
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 59/273 (21%), Positives = 104/273 (38%), Gaps = 58/273 (21%)
Query: 495 EIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIF-AVK--KFHSPLPDNF---------- 541
E+ R D KH +G G +G VY + AVK K + + F
Sbjct: 9 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 66
Query: 542 -----------CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALF 590
C+ +I+ E++ G+L L + +E+ L + ++ A+
Sbjct: 67 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAME 125
Query: 591 YLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---- 646
YL F +H D++++N L+ + V+DF +++ + D+ A
Sbjct: 126 YLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT----AHAGAKFPIKW 178
Query: 647 -APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS----- 699
APE K + K DV++FGVL E+ G P + ++ +
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP---YPGID------LSQVYELLEKDY 229
Query: 700 RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT 732
R+ P K +M+ +C NP RP+
Sbjct: 230 RMERPE-GCPEKVYELMR---ACWQWNPSDRPS 258
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 27/216 (12%)
Query: 542 CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIV 601
+ R + IV EY+E+GSLD L + Q + +++GV + YL + + V
Sbjct: 119 VTRGRLAMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLGY---V 173
Query: 602 HWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APELAYTMKVTE 658
H D++++NVL+D VSDF +++ L D G + APE +
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSS 233
Query: 659 KCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQNKF 712
DV+SFGV+ EV+ G+ P M+ N +++ S RLP P +
Sbjct: 234 ASDVWSFGVVMWEVLAYGERPYW---NMT------NRDVISSVEEGYRLPAPM-GCPHAL 283
Query: 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPD 748
+M C ++ RP + +P+
Sbjct: 284 HQLML---DCWHKDRAQRPRFSQIVSVLDALIRSPE 316
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 542 CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIV 601
S + I+ EY+E+G+LDK L E Q + +++G+A + YL N + V
Sbjct: 115 ISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMNY---V 169
Query: 602 HWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APELAYTMKVTE 658
H D++++N+L++ VSDF +++ L D +G + APE K T
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS 229
Query: 659 KCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQNKF 712
DV+SFG++ EV+ G+ P E+S N E++ + RLP P D +
Sbjct: 230 ASDVWSFGIVMWEVMTYGERPYW---ELS------NHEVMKAINDGFRLPTPM-DCPSAI 279
Query: 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPD 748
+M C Q RP + PD
Sbjct: 280 YQLMM---QCWQQERARRPKFADIVSILDKLIRAPD 312
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 69/273 (25%), Positives = 108/273 (39%), Gaps = 60/273 (21%)
Query: 495 EIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVK--KFHSPLPDNF----------- 541
E+ R + +G G G V + + AVK K S D F
Sbjct: 4 ELKR--EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS 61
Query: 542 ----------CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFY 591
CS +IV EY+ +G L L + K L +Q L + V + + +
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAF 119
Query: 592 LHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAG------THGN 645
L ++ F +H D++++N L+D VSDF + +++ LD S + +
Sbjct: 120 LESHQF---IHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWS--- 172
Query: 646 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS----- 699
APE+ + K + K DV++FG+L EV GK P + N E++
Sbjct: 173 -APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP---YDLYT------NSEVVLKVSQGH 222
Query: 700 RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT 732
RL P + IM SC + P RPT
Sbjct: 223 RLYRPH-LASDTIYQIMY---SCWHELPEKRPT 251
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 53/276 (19%), Positives = 98/276 (35%), Gaps = 57/276 (20%)
Query: 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVK-----KFHSPLPDNFC---------SHPR 546
+ IG GG V+ +I+A+K + + D++
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 547 QS--------------FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYL 592
++V E + L+ L S +R + K + +A+ +
Sbjct: 88 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTI 143
Query: 593 HNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK--LAGTHGNVAPEL 650
H + IVH D+ N L+ G + DF IA + D+++ K GT + PE
Sbjct: 144 HQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 651 -----------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS 699
K++ K DV+S G + + GK P F+ + + I+D
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLHAIIDP 255
Query: 700 RLPYPSLDVQNK-FMSIMQVAFSCLDQNPVSRPTMK 734
D+ K +++ CL ++P R ++
Sbjct: 256 NHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIP 288
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 27/216 (12%)
Query: 542 CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIV 601
+ + IV EY+E+GSLD L + Q + +++G+A + YL + + V
Sbjct: 115 VTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMGY---V 169
Query: 602 HWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---APELAYTMKVTE 658
H D++++N+L++ VSDF + + L D G + +PE K T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229
Query: 659 KCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQNKF 712
DV+S+G++ EV+ G+ P +EMS N +++ + RLP P D
Sbjct: 230 ASDVWSYGIVLWEVMSYGERP---YWEMS------NQDVIKAVDEGYRLPPPM-DCPAAL 279
Query: 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPD 748
+M C ++ +RP ++ + NP
Sbjct: 280 YQLML---DCWQKDRNNRPKFEQIVSILDKLIRNPG 312
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 63/277 (22%), Positives = 104/277 (37%), Gaps = 68/277 (24%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF--------------CSHP 545
+D + +G+G +G V R VPSG+I AVK+ + + P
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 546 R-----QSF-------IVYEYLESGSLDKILNNDASAKELGWTQRLN------VIKGVAD 587
+ I E ++ SLDK + + Q + + +
Sbjct: 67 FTVTFYGALFREGDVWICMELMD-TSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120
Query: 588 ALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVA 647
AL +LH+ ++H D+ NVL++ + + DF I+ +L D AG +A
Sbjct: 121 ALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDAGCKPYMA 177
Query: 648 PE--------LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS 699
PE Y++ K D++S G+ +E+ + P D S + L
Sbjct: 178 PERINPELNQKGYSV----KSDIWSLGITMIELAILRFPYD--------SWGTPFQQLKQ 225
Query: 700 --RLPYPSLDVQNKFMSIMQVAF--SCLDQNPVSRPT 732
P P L +KF + F CL +N RPT
Sbjct: 226 VVEEPSPQLP-ADKFSAEFV-DFTSQCLKKNSKERPT 260
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 63/271 (23%), Positives = 94/271 (34%), Gaps = 52/271 (19%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF--------------CSHP 545
D IG+G +GSV PSG+I AVK+ S + + P
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 546 R-----QSF-------IVYEYLESGSLDKILNNDASAKELGWTQRL--NVIKGVADALFY 591
+ I E + S DK S + + + + AL +
Sbjct: 82 YIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 592 LHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPE-- 649
L N I+H DI N+LLD + DF I+ L DS ++ AG +APE
Sbjct: 141 LKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERI 197
Query: 650 --LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD--SRLPYPS 705
A + DV+S G+ E+ G+ P N + L + P
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGRFPY--------PKWNSVFDQLTQVVKGDPPQ 249
Query: 706 L--DVQNKFMSIMQ--VAFSCLDQNPVSRPT 732
L + +F V CL ++ RP
Sbjct: 250 LSNSEEREFSPSFINFVN-LCLTKDESKRPK 279
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 34/216 (15%), Positives = 78/216 (36%), Gaps = 25/216 (11%)
Query: 531 KKFHSPLPDNFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALF 590
++ S +I + +L +N S ++ L++ +A+A+
Sbjct: 119 STKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVE 178
Query: 591 YLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLA---------- 640
+LH+ ++H D+ N+ + V DF + ++ D + L
Sbjct: 179 FLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235
Query: 641 --GTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD 698
GT ++PE + + K D++S G++ E++ + F + ++ +
Sbjct: 236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YS----FSTQMERVRIITDVRN 288
Query: 699 SRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+ P + ++Q L +P RP
Sbjct: 289 LKFPLLFTQKYPQEHMMVQ---DMLSPSPTERPEAT 321
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 31/287 (10%), Positives = 65/287 (22%), Gaps = 73/287 (25%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVK------------------------------------ 531
+ G V++ R V E FA+K
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 532 KFHSPLPDNFCSHPRQS-----------------FIVYEYLES--GSLDKILNNDASAKE 572
+ LP + + Q ++ L L+ +
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 573 -LGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631
G + + L + +VH + N+ + + D +
Sbjct: 190 DEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG- 245
Query: 632 DSSNWSKLAGTHGNVAPEL--AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS 689
+ + E A T T + + G+ V P F + +
Sbjct: 246 --TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP----FGLVTPG 299
Query: 690 SNMNIEILDSRLPYPSLDVQNKFMSIMQVAFS----CLDQNPVSRPT 732
+ + R+P + + L+ + R
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL 346
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-14
Identities = 30/127 (23%), Positives = 55/127 (43%), Gaps = 6/127 (4%)
Query: 284 LDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFV 343
+ L++ I E Q N + + L G K+ I +L + +D S N +
Sbjct: 2 VKLTAELI--EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-- 56
Query: 344 LESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGE-KISSRICRMESLE 402
L+ L +L L +++N++ + L L+EL L++N L E + ++SL
Sbjct: 57 LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116
Query: 403 KLNLSYN 409
L + N
Sbjct: 117 YLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-10
Identities = 19/105 (18%), Positives = 39/105 (37%), Gaps = 5/105 (4%)
Query: 332 LDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKI 391
+ L+A + + V+ L+L K+ I L +D S N + K+
Sbjct: 2 VKLTAELIEQ--AAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI-RKL 57
Query: 392 SSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLE 436
+ L+ L ++ N + + + L L + ++ N L
Sbjct: 58 DG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-09
Identities = 20/95 (21%), Positives = 43/95 (45%), Gaps = 7/95 (7%)
Query: 322 ELGSLINLEYLDLSANHLSNFVLESLGS-LVKLYYLNLSHNKLSQQIPIE-LDNLIHLSE 379
+ + + LDL + V+E+LG+ L + ++ S N++ + ++ L L
Sbjct: 14 QYTNAVRDRELDLRGYKIP--VIENLGATLDQFDAIDFSDNEIRK---LDGFPLLRRLKT 68
Query: 380 LDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGL 414
L +++N + + L +L L+ N+L L
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVEL 103
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 6e-06
Identities = 22/130 (16%), Positives = 45/130 (34%), Gaps = 28/130 (21%)
Query: 89 INLTSISLNG---TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKL 145
+ + L G ++E ++ +D +NE+ + L +L+ L N++
Sbjct: 19 VRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRI 76
Query: 146 SGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFT 205
L LT L ++ N L +L L+ L++
Sbjct: 77 CRIGEGLDQALPDLTELILTNNSLV--------ELGDLDP---------------LASLK 113
Query: 206 NLVFLYLYNN 215
+L +L + N
Sbjct: 114 SLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 23/116 (19%), Positives = 40/116 (34%), Gaps = 8/116 (6%)
Query: 200 SLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSL 259
+N L L I NL + D I+ + I + +L
Sbjct: 14 QYTNAVRDRELDLRGYKIP-----VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKT 68
Query: 260 LDVSINNITGNIPFEIGESPQLQYLDLSSNYI--VGEIPTQLGNIIYLNRISLSGN 313
L V+ N I P L L L++N + +G++ L ++ L + + N
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 54/280 (19%), Positives = 98/280 (35%), Gaps = 65/280 (23%)
Query: 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVK-----KFHSPLPDNFC---------SHPR 546
+ IG GG V+ +I+A+K + + D++
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 547 QSFIV--YEYLES------------GSLDKILNNDASAKELGWTQRLNVIKGVADALFYL 592
I+ Y+Y + L+ L S +R + K + +A+ +
Sbjct: 69 DK-IIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTI 124
Query: 593 HNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK--LAGTHGNVAPEL 650
H + IVH D+ N L+ G + DF IA + D+++ K GT + PE
Sbjct: 125 HQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 651 -----------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS 699
K++ K DV+S G + + GK P F+ + + I+D
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLHAIIDP 236
Query: 700 RLPYP-----SLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
D+Q+ + CL ++P R ++
Sbjct: 237 NHEIEFPDIPEKDLQD-VLK------CCLKRDPKQRISIP 269
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 45/195 (23%), Positives = 71/195 (36%), Gaps = 32/195 (16%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
++ + + G L + +G LN +A + YL + VH D++++
Sbjct: 92 QLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRRL---VHRDLAAR 146
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTMKVTEKCDVY 663
NVL+ ++DF +AK L + + G V A E T + DV+
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEK---EYHAEGGKVPIKWMALESILHRIYTHQSDVW 203
Query: 664 SFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQNKFMSIMQ 717
S+GV E++ G P D + EI RLP P IM
Sbjct: 204 SYGVTVWELMTFGSKPYD---GIP------ASEISSILEKGERLPQPP-ICTIDVYMIMV 253
Query: 718 VAFSCLDQNPVSRPT 732
C + SRP
Sbjct: 254 ---KCWMIDADSRPK 265
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 70/273 (25%), Positives = 103/273 (37%), Gaps = 60/273 (21%)
Query: 495 EIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVK--KFHSPLPDNF----------- 541
EI D +G G G V + A+K K S D F
Sbjct: 20 EIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS 77
Query: 542 ----------CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFY 591
C+ R FI+ EY+ +G L L Q L + K V +A+ Y
Sbjct: 78 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEY 135
Query: 592 LHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD---SSNWSKLAGTHGNV-- 646
L + F +H D++++N L++ VSDF +++++ D SS SK V
Sbjct: 136 LESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-----VRW 187
Query: 647 -APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS----- 699
PE+ K + K D+++FGVL E+ GK P + N E +
Sbjct: 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP---YERFT------NSETAEHIAQGL 238
Query: 700 RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT 732
RL P K +IM SC + RPT
Sbjct: 239 RLYRPH-LASEKVYTIMY---SCWHEKADERPT 267
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 61/272 (22%), Positives = 110/272 (40%), Gaps = 58/272 (21%)
Query: 495 EIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVK--KFHSPLPDNFCS--------- 543
E+ R +G G G V++ AVK K S PD F +
Sbjct: 9 EVPR--ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ 66
Query: 544 HPR---------QS--FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYL 592
H R Q +I+ EY+E+GSL L + +L + L++ +A+ + ++
Sbjct: 67 HQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI 125
Query: 593 HNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD---SSNWSKLAGTHGNV--- 646
+ +H D+ + N+L+ ++DF +A+ + + + +K +
Sbjct: 126 EERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-----IKWT 177
Query: 647 APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----R 700
APE T K DV+SFG+L E++ G+ P M+ N E++ + R
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP---GMT------NPEVIQNLERGYR 228
Query: 701 LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT 732
+ P + + +M+ C + P RPT
Sbjct: 229 MVRPD-NCPEELYQLMR---LCWKERPEDRPT 256
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 45/196 (22%), Positives = 70/196 (35%), Gaps = 32/196 (16%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+V E GSL L VA+ + YL + F +H D++++
Sbjct: 96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKRF---IHRDLAAR 150
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTMKVTEKCDVY 663
N+LL + DF + + L + ++ H V APE T + D +
Sbjct: 151 NLLLATRDLVKIGDFGLMRALPQNDDHYV--MQEHRKVPFAWCAPESLKTRTFSHASDTW 208
Query: 664 SFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS------RLPYPSLDVQNKFMSIM 716
FGV E+ G+ P ++ +IL RLP P D ++M
Sbjct: 209 MFGVTLWEMFTYGQEPWI---GLN------GSQILHKIDKEGERLPRPE-DCPQDIYNVM 258
Query: 717 QVAFSCLDQNPVSRPT 732
C P RPT
Sbjct: 259 V---QCWAHKPEDRPT 271
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 9e-14
Identities = 59/297 (19%), Positives = 110/297 (37%), Gaps = 69/297 (23%)
Query: 493 YEEIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPDNF----------C 542
+E+ ++ N ++ +G G G+V G AVK+ D
Sbjct: 9 FEQSLK--NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD 66
Query: 543 SHP------------RQSFIVYEYLESGSL-DKILNNDASAKELGWTQRL---NVIKGVA 586
HP R +I E +L D + + + S + L + ++++ +A
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 587 DALFYLHNNCFPPIVHWDISSKNVLLDLGYEAH-------------VSDFRIAKFLNLDS 633
+ +LH+ I+H D+ +N+L+ +SDF + K L+
Sbjct: 126 SGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 634 SNWSK----LAGTHGNVAPEL-------AYTMKVTEKCDVYSFGVLALEVI-KGKHPRDF 681
S++ +GT G APEL ++T D++S G + ++ KGKHP F
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP--F 240
Query: 682 LFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVA----FSCLDQNPVSRPTMK 734
+ I+ + + S++ A +D +P+ RPT
Sbjct: 241 -----GDKYSRESNIIRGIFSLDEMKCLH-DRSLIAEATDLISQMIDHDPLKRPTAM 291
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 9e-14
Identities = 52/280 (18%), Positives = 96/280 (34%), Gaps = 65/280 (23%)
Query: 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVK-----KFHSPLPDNFC---------SHPR 546
+ IG GG V+ +I+A+K + + D++
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 547 QS--------------FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYL 592
++V E + L+ L S +R + K + +A+ +
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTI 171
Query: 593 HNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK--LAGTHGNVAPEL 650
H + IVH D+ N L+ G + DF IA + D+++ K G + PE
Sbjct: 172 HQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 651 -----------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS 699
K++ K DV+S G + + GK P F+ + + I+D
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLHAIIDP 283
Query: 700 RLPYP-----SLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
D+Q+ + CL ++P R ++
Sbjct: 284 NHEIEFPDIPEKDLQD-VLK------CCLKRDPKQRISIP 316
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 48/195 (24%), Positives = 75/195 (38%), Gaps = 32/195 (16%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+V +YL GSL + LG LN +A ++YL + VH +++++
Sbjct: 90 QLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHGM---VHRNLAAR 144
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTMKVTEKCDVY 663
NVLL + V+DF +A L D +L + A E + K T + DV+
Sbjct: 145 NVLLKSPSQVQVADFGVADLLPPDDK---QLLYSEAKTPIKWMALESIHFGKYTHQSDVW 201
Query: 664 SFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQNKFMSIMQ 717
S+GV E++ G P + E+ D RL P +M
Sbjct: 202 SYGVTVWELMTFGAEPYA---GLR------LAEVPDLLEKGERLAQPQ-ICTIDVYMVMV 251
Query: 718 VAFSCLDQNPVSRPT 732
C + RPT
Sbjct: 252 ---KCWMIDENIRPT 263
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-13
Identities = 31/144 (21%), Positives = 61/144 (42%), Gaps = 11/144 (7%)
Query: 307 RISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQ 366
+ + ++ L +L ++L LS N++ + SL + L L+L N + +
Sbjct: 29 ELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEK--ISSLSGMENLRILSLGRNLIKK- 84
Query: 367 IPIE-LDNLI-HLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIP-RCFEELH 423
IE LD + L EL +S+N + +S I ++ +L L +S N ++ L
Sbjct: 85 --IENLDAVADTLEELWISYNQI-ASLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALD 140
Query: 424 GLLHIDISYNKLEGHIPNSTTFRD 447
L + ++ N L + +
Sbjct: 141 KLEDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-13
Identities = 35/127 (27%), Positives = 58/127 (45%), Gaps = 7/127 (5%)
Query: 260 LDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRI 319
L I I + + ++L LS+N I +I + L + L +SL N + +I
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KI 85
Query: 320 PGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIE-LDNLIHLS 378
LE L +S N +++ L + LV L L +S+NK++ I+ L L L
Sbjct: 86 ENLDAVADTLEELWISYNQIAS--LSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143
Query: 379 ELDLSHN 385
+L L+ N
Sbjct: 144 DLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 6e-08
Identities = 39/196 (19%), Positives = 63/196 (32%), Gaps = 66/196 (33%)
Query: 197 IPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQ 256
+ +LS L L N+ +I +L +
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-----KISSLSGM-----------------------EN 71
Query: 257 LSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLS 316
L +L + N I I + L+ L +S N I LS
Sbjct: 72 LRILSLGRNLIK-KIENLDAVADTLEELWISYNQI---------------------ASLS 109
Query: 317 GRIPGELGSLINLEYLDLSANHLSNF-VLESLGSLVKLYYLNLSHNKLSQQIPIE----- 370
G + L+NL L +S N ++N+ ++ L +L KL L L+ N L
Sbjct: 110 G-----IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164
Query: 371 -----LDNLIHLSELD 381
+ L +L +LD
Sbjct: 165 YRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 30/133 (22%), Positives = 52/133 (39%), Gaps = 13/133 (9%)
Query: 90 NLTSISLNG-----TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNK 144
+ L+G ++ + S+ +L L N + I +S + L L N
Sbjct: 24 EAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISS--LSGMENLRILSLGRNL 81
Query: 145 LSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLG--GSIPRSLS 202
+ I + ++ L L IS NQ+ S+ + +L L L + +N + G I L+
Sbjct: 82 IK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEI-DKLA 137
Query: 203 NFTNLVFLYLYNN 215
L L L N
Sbjct: 138 ALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 36/187 (19%), Positives = 66/187 (35%), Gaps = 41/187 (21%)
Query: 110 HLAYLDLYNN-ELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQ 168
++L+ + + +S L ++L TN + I S +S + +L IL + RN
Sbjct: 24 EAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNL 81
Query: 169 LNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNL 228
+ I + + L L + N + + + NL LY+ NN +I N
Sbjct: 82 IK-KIENLDAVADTLEELWISYNQI--ASLSGIEKLVNLRVLYMSNN--------KITNW 130
Query: 229 KSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGES---------- 278
I++L +L L ++ N + + S
Sbjct: 131 GE-------IDKL----------AALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRL 173
Query: 279 PQLQYLD 285
P L+ LD
Sbjct: 174 PNLKKLD 180
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 65/276 (23%), Positives = 108/276 (39%), Gaps = 73/276 (26%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVK--------------------KFHSPLPD 539
DF+ +GKG G+VY+AR S I A+K + S L
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-- 66
Query: 540 NFCSHP------------RQSFIVYEYLESGSL-DKI-----LNNDASAKELGWTQRLNV 581
HP + +++ EY G++ ++ + +A
Sbjct: 67 ---RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT---------Y 114
Query: 582 IKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAG 641
I +A+AL Y H+ ++H DI +N+LL E ++DF + SS + L G
Sbjct: 115 ITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTDLCG 169
Query: 642 THGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRL 701
T + PE+ EK D++S GVL E + GK P FE +++ I
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FE-ANTYQETYKRISRVEF 224
Query: 702 PYP---SLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+P + ++ +S + L NP RP ++
Sbjct: 225 TFPDFVTEGARD-LISRL------LKHNPSQRPMLR 253
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 44/211 (20%), Positives = 80/211 (37%), Gaps = 49/211 (23%)
Query: 542 CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIV 601
C ++ +V E+++ GSLD L + + + +L V K +A A+ +L N +
Sbjct: 81 CVCGDENILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEENTL---I 135
Query: 602 HWDISSKNVLLDLGYEAH--------VSDFRIAKFLNLDSS-----NWSKLAGTHGNVAP 648
H ++ +KN+LL + +SD I+ + W V P
Sbjct: 136 HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPW---------VPP 186
Query: 649 E-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RL 701
E + + D +SFG E+ G P L + + L +L
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICSGGDKP---LSALD------SQRKLQFYEDRHQL 237
Query: 702 PYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT 732
P P + +++ +C+D P RP+
Sbjct: 238 PAPKAA---ELANLIN---NCMDYEPDHRPS 262
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 51/214 (23%), Positives = 84/214 (39%), Gaps = 35/214 (16%)
Query: 542 CSHPRQS--FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 599
P + +V EYL SG L L + L ++ L + + YL +
Sbjct: 93 SYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRRC-- 148
Query: 600 IVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTM 654
VH D++++N+L++ ++DF +AK L LD + G APE
Sbjct: 149 -VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV--VREPGQSPIFWYAPESLSDN 205
Query: 655 KVTEKCDVYSFGVLALEVI-KGKHP----RDFLFEMSSSSSNMN----IEILDS--RLPY 703
+ + DV+SFGV+ E+ +FL M +E+L+ RLP
Sbjct: 206 IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPA 265
Query: 704 P---SLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
P +V +M+ C +P RP+
Sbjct: 266 PPACPAEVHE----LMK---LCWAPSPQDRPSFS 292
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 50/296 (16%), Positives = 106/296 (35%), Gaps = 64/296 (21%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFH-SPLPDNF------------CSHP- 545
+ + +G+G +V+ R +G++FA+K F+ +H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 546 -------------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYL 592
R ++ E+ GSL +L ++A L ++ L V++ V + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 593 HNNCFPPIVHWDISSKNVLLDLGYEAH----VSDFRIAKFLNLDSSNWSKLAGTHGNVAP 648
N IVH +I N++ +G + ++DF A+ L D + L GT + P
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLYGTEEYLHP 184
Query: 649 EL--------AYTMKVTEKCDVYSFGVLALEVIKGKHP----------RDFLFEMSSSSS 690
++ + K D++S GV G P ++ ++++ +
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 691 NMNIEIL----------DSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRF 736
+ I + +P + + + V + L+ + +F
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 33/290 (11%), Positives = 71/290 (24%), Gaps = 82/290 (28%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKFHSPL-------------------------PDNFC 542
+G+ + A +GE F V +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 543 SHPR------------------------QSFIVYEYL----ESGSL----DKILNNDASA 570
H R +++ + +L + +L++ ++
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 571 KELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630
K L RL + V L LH+ +VH + +++LD ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 631 LDSSNWSKLA-GTHGNVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFE 684
+ + A + +T D ++ G+ + P
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP----NT 318
Query: 685 MSSSSSNMN-IEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTM 733
++ I +P P + + L R
Sbjct: 319 DDAALGGSEWIFRSCKNIPQPVRAL------LEG----FLRYPKEDRLLP 358
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 72.4 bits (177), Expect = 3e-13
Identities = 56/216 (25%), Positives = 82/216 (37%), Gaps = 39/216 (18%)
Query: 498 RATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN-------------FCS 543
+ ++ K +G GG G V +GE A+K+ L +
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 544 HP------------------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGV 585
HP + EY E G L K LN + L ++ +
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 586 ADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAH---VSDFRIAKFLNLDSSNWSKLAGT 642
+ AL YLH N I+H D+ +N++L G + + D AK L+ ++ GT
Sbjct: 131 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVGT 186
Query: 643 HGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 678
+APEL K T D +SFG LA E I G P
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 33/141 (23%), Positives = 55/141 (39%), Gaps = 5/141 (3%)
Query: 271 IPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLE 330
IP + + + L N I P L RI LS N++S P L +L
Sbjct: 26 IPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLN 83
Query: 331 YLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFLGE 389
L L N ++ L L L L+ NK+ + ++ +L +L+ L L N L
Sbjct: 84 SLVLYGNKITELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQT 142
Query: 390 KISSRICRMESLEKLNLSYNN 410
+ +++ ++L N
Sbjct: 143 IAKGTFSPLRAIQTMHL-AQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 31/117 (26%), Positives = 53/117 (45%), Gaps = 6/117 (5%)
Query: 104 SFSSFPHLAYLDLYNNELFDIIPPQI-SNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTI 161
+FS + L +DL NN++ + P L L L NK++ +P + L L +
Sbjct: 51 AFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQL 108
Query: 162 LHISRNQLNGSIPHEVGQ-LNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSF 217
L ++ N++N + + Q L+ LN L L N L + S + ++L N F
Sbjct: 109 LLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 32/129 (24%), Positives = 52/129 (40%), Gaps = 4/129 (3%)
Query: 307 RISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQ 366
I L N + PG L +DLS N +S ++ L L L L NK+ +
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI-TE 94
Query: 367 IPIEL-DNLIHLSELDLSHNFLGEKISSRI-CRMESLEKLNLSYNNLSGLIPRCFEELHG 424
+P L + L L L L+ N + + + +L L+L N L + F L
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153
Query: 425 LLHIDISYN 433
+ + ++ N
Sbjct: 154 IQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 27/129 (20%), Positives = 57/129 (44%), Gaps = 5/129 (3%)
Query: 328 NLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNF 386
+ + L N + + KL ++LS+N++ ++ + L L+ L L N
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNK 91
Query: 387 LGEKISSRI-CRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTF 445
+ ++ + + SL+ L L+ N ++ L F++LH L + + NKL+ I T
Sbjct: 92 I-TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFS 149
Query: 446 RDAPLEALQ 454
++ +
Sbjct: 150 PLRAIQTMH 158
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 31/133 (23%), Positives = 56/133 (42%), Gaps = 8/133 (6%)
Query: 114 LDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTILHISRNQLNGS 172
+ L N + I P S KL +D N++S + + L L L + N++
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-E 94
Query: 173 IPHEV-GQLNFLNHLILDSNFLGGSIPR-SLSNFTNLVFLYLYNNSFSGSIPQQI-GNLK 229
+P + L L L+L++N + + + + NL L LY+N +I + L+
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLR 152
Query: 230 SLFDMKLCINQLN 242
++ M L N
Sbjct: 153 AIQTMHLAQNPFI 165
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 50/214 (23%), Positives = 83/214 (38%), Gaps = 37/214 (17%)
Query: 542 CSHPRQS--FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 599
C + +V EY+ GSL L +G Q L + + + + YLH +
Sbjct: 102 CEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQHY-- 155
Query: 600 IVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTM 654
+H D++++NVLLD + DF +AK + + G+ APE
Sbjct: 156 -IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR--VREDGDSPVFWYAPECLKEY 212
Query: 655 KVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSS----SNMN----IEILDS--RLPY 703
K DV+SFGV E++ + + M E+L+ RLP
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPR 272
Query: 704 P---SLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
P +V + +M+ +C + RPT +
Sbjct: 273 PDKCPAEVYH----LMK---NCWETEASFRPTFE 299
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 44/212 (20%), Positives = 83/212 (39%), Gaps = 35/212 (16%)
Query: 542 CSHPRQS--FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 599
C+ + ++ E+L SGSL + L + ++ Q+L + + YL + +
Sbjct: 92 CTEDGGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQY-- 147
Query: 600 IVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTM 654
VH D++++NVL++ ++ + DF + K + D ++ + APE
Sbjct: 148 -VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT--VKDDRDSPVFWYAPECLMQS 204
Query: 655 KVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSS----NMN----IEILDS--RLPY 703
K DV+SFGV E++ + M + L RLP
Sbjct: 205 KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPC 264
Query: 704 P---SLDVQNKFMSIMQVAFSCLDQNPVSRPT 732
P +V +M+ C + P +R +
Sbjct: 265 PPNCPDEVYQ----LMR---KCWEFQPSNRTS 289
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 51/299 (17%), Positives = 107/299 (35%), Gaps = 70/299 (23%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFH-SPLPDNF------------CSHP- 545
+ + +G+G +V+ R +G++FA+K F+ +H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 546 -------------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYL 592
R ++ E+ GSL +L ++A L ++ L V++ V + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 593 HNNCFPPIVHWDISSKNVLLDLGYEAH----VSDFRIAKFLNLDSSNWSKLAGTHGNVAP 648
N IVH +I N++ +G + ++DF A+ L D + L GT + P
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLYGTEEYLHP 184
Query: 649 EL--------AYTMKVTEKCDVYSFGVLALEVIKGKHP----------RDFLFEMSSSSS 690
++ + K D++S GV G P ++ ++++ +
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 691 NMNIEIL----------DSRLPYP---SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRF 736
+ I + +P S +Q ++ + L+ + +F
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA---NILEADQEKCWGFDQF 300
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 59/290 (20%), Positives = 101/290 (34%), Gaps = 65/290 (22%)
Query: 509 IGKGGHGSVYIARVP-----SGEIFAVKKFHSPLPDNF---------------------- 541
+GKG GSV + R +GE+ AVKK ++
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 542 --CSHPRQS--FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCF 597
C + ++ EYL GSL L + + + L + + YL +
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 598 PPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAY 652
+H D++++N+L++ + DF + K L D + G APE
Sbjct: 136 ---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK--VKEPGESPIFWYAPESLT 190
Query: 653 TMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNM------NIEILDS-----R 700
K + DV+SFGV+ E+ + + E N +++ R
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250
Query: 701 LPYP---SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNP 747
LP P ++ IM C + N RP+ + ++ Q N
Sbjct: 251 LPRPDGCPDEIYM----IMT---ECWNNNVNQRPSFRDLALRVDQIRDNM 293
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 48/347 (13%), Positives = 95/347 (27%), Gaps = 81/347 (23%)
Query: 111 LAYLDLYNNELFD----IIPPQISNLSKLEYLDFLTNKLSG----HIPSEISLLTHLTIL 162
+ L + + + + ++ + N + + I+ L I
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 163 HISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIP 222
S + I ++ + ++L L + L +N
Sbjct: 66 EFSDIFTGR-----------VKDEIPEA---LRLLLQALLKCPKLHTVRLSDN------- 104
Query: 223 QQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNIT-------------G 269
G PL + L L + N +
Sbjct: 105 -AFGP--------------TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 149
Query: 270 NIPFEIGESPQLQYLDLSSNYI----VGEIPTQLGNIIYLNRISLSGNKLSGR-IPGELG 324
+ + +P L+ + N + + E + L+ + + N + I L
Sbjct: 150 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL 209
Query: 325 SLI----NLEYLDLSANHLSNFVLESLGSLVK----LYYLNLSHNKLS----QQIPIELD 372
+ L+ LDL N ++ +L +K L L L+ LS +
Sbjct: 210 EGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFS 269
Query: 373 NLIH--LSELDLSHNFLGEKISSRICR-----MESLEKLNLSYNNLS 412
L + L L L +N + + M L L L+ N S
Sbjct: 270 KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 48/310 (15%), Positives = 104/310 (33%), Gaps = 57/310 (18%)
Query: 183 LNHLILDSNFLGG----SIPRSLSNFTNLVFLYLYNNSFSGSIPQQIG-------NLKSL 231
+ L + + S+ L ++ + L N+ + + +L+
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 232 FDMKLCINQLNGAIPLSIDW-----GRCPQLSLLDVSINNITGNIPFEIGE----SPQLQ 282
+ ++ IP ++ +CP+L + +S N + + L+
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 283 YLDLSSNYI-------------VGEIPTQLGNIIYLNRISLSGNKLSGR----IPGELGS 325
+L L +N + + + N L I N+L S
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185
Query: 326 LINLEYLDLSANHL-----SNFVLESLGSLVKLYYLNLSHNKLS----QQIPIELDNLIH 376
L + + N + + +LE L +L L+L N + + I L + +
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 245
Query: 377 LSELDLSHNFLGEKISSRICRM------ESLEKLNLSYNNLSG----LIPRCFEE-LHGL 425
L EL L+ L + ++ + L+ L L YN + + +E + L
Sbjct: 246 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 305
Query: 426 LHIDISYNKL 435
L ++++ N+
Sbjct: 306 LFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 26/167 (15%), Positives = 48/167 (28%), Gaps = 35/167 (20%)
Query: 305 LNRISLSGNKLSGR----IPGELGSLINLEYLDLSANHLSNFVLESLGSLVK----LYYL 356
+ SL + ++ + L +++ + LS N + L + L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 357 NLSHNKLSQQIPIELDNLIHLSE----------LDLSHNFLGEK----ISSRICRMESLE 402
S + + L L + + LS N G + + + LE
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 403 KLNLSYNNLS-------------GLIPRCFEELHGLLHIDISYNKLE 436
L L N L + + + L I N+LE
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 172
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 53/290 (18%), Positives = 98/290 (33%), Gaps = 55/290 (18%)
Query: 106 SSFPHLAYLDLYNNELFD----IIPPQISNLSKLEYLDF---LTNKLSGHIPSEISLL-- 156
+ + L N + + I++ LE +F T ++ IP + LL
Sbjct: 29 LEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQ 88
Query: 157 -----THLTILHISRNQLNGSIPHEVGQL----NFLNHLILDSNFLG------------- 194
L + +S N + + L HL L +N LG
Sbjct: 89 ALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQE 148
Query: 195 GSIPRSLSNFTNLVFLYLYNNSFSG----SIPQQIGNLKSLFDMKLCINQLN--GAIP-L 247
++ + N L + N + + + L +K+ N + G L
Sbjct: 149 LAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLL 208
Query: 248 SIDWGRCPQLSLLDVSINNITGNIPFEIGES----PQLQYLDLSSNYI-------VGEIP 296
C +L +LD+ N T + + P L+ L L+ + V +
Sbjct: 209 LEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAF 268
Query: 297 TQLGNIIYLNRISLSGNKLSGRIPGELGSLI-----NLEYLDLSANHLSN 341
++L NI L + L N++ L ++I +L +L+L+ N S
Sbjct: 269 SKLENI-GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 8e-13
Identities = 50/198 (25%), Positives = 79/198 (39%), Gaps = 38/198 (19%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+IV EY+ GSL L + LG L V +A+ YL N F VH D++++
Sbjct: 263 YIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNF---VHRDLAAR 318
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSN------WSKLAGTHGNVAPELAYTMKVTEKCDV 662
NVL+ A VSDF + K + W+ APE K + K DV
Sbjct: 319 NVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEALREKKFSTKSDV 369
Query: 663 YSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQNKFMSIM 716
+SFG+L E+ G+ P + +++ ++ P +M
Sbjct: 370 WSFGILLWEIYSFGRVPYP---RIP------LKDVVPRVEKGYKMDAPD-GCPPAVYDVM 419
Query: 717 QVAFSCLDQNPVSRPTMK 734
+ +C + +RPT
Sbjct: 420 K---NCWHLDAATRPTFL 434
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 25/131 (19%), Positives = 50/131 (38%), Gaps = 11/131 (8%)
Query: 90 NLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHI 149
T + G F P L ++ NN++ DI S + + +N+L +
Sbjct: 43 EFTVLEATGI-----FKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN-V 96
Query: 150 PSEI-SLLTHLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIPR-SLSNFTN 206
++ L L L + N++ + ++ L+ + L L N + ++ + +
Sbjct: 97 QHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI-TTVAPGAFDTLHS 154
Query: 207 LVFLYLYNNSF 217
L L L N F
Sbjct: 155 LSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 31/143 (21%), Positives = 51/143 (35%), Gaps = 10/143 (6%)
Query: 270 NIPFEIGESPQLQYLDLSSNYIVGEIPT-QLGNIIYLNRISLSGNKLSGRIPGELGSLIN 328
+IP L L++N T + L +I+ S NK++ G
Sbjct: 29 HIP------QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 329 LEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFL 387
+ + L++N L N + L L L L N++ + + L + L L N +
Sbjct: 83 VNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQI 141
Query: 388 GEKISSRICRMESLEKLNLSYNN 410
+ SL LNL N
Sbjct: 142 TTVAPGAFDTLHSLSTLNL-LAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 9e-11
Identities = 32/134 (23%), Positives = 59/134 (44%), Gaps = 9/134 (6%)
Query: 114 LDLYNNELFDIIPPQI-SNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTILHISRNQLNG 171
L L NNE + I L +L ++F NK++ I + + + ++ N+L
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE- 94
Query: 172 SIPHEV-GQLNFLNHLILDSNFLGGSIPR-SLSNFTNLVFLYLYNNSFSGSIPQQI-GNL 228
++ H++ L L L+L SN + + S +++ L LY+N + ++ L
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTL 152
Query: 229 KSLFDMKLCINQLN 242
SL + L N N
Sbjct: 153 HSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 31/132 (23%), Positives = 58/132 (43%), Gaps = 13/132 (9%)
Query: 328 NLEYLDLSANHLSNFVLESLG---SLVKLYYLNLSHNKLSQQIPIE-LDNLIHLSELDLS 383
L L+ N + VLE+ G L +L +N S+NK+ I + ++E+ L+
Sbjct: 33 YTAELRLNNNEFT--VLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLT 89
Query: 384 HNFLGEKISSRIC-RMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNS 442
N L E + ++ +ESL+ L L N ++ + F L + + + N++ +
Sbjct: 90 SNRL-ENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPG 147
Query: 443 TTFRDAPLEALQ 454
F L +L
Sbjct: 148 -AF--DTLHSLS 156
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 49/196 (25%), Positives = 78/196 (39%), Gaps = 38/196 (19%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+IV EY+ GSL L + LG L V +A+ YL N F VH D++++
Sbjct: 91 YIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNF---VHRDLAAR 146
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSN------WSKLAGTHGNVAPELAYTMKVTEKCDV 662
NVL+ A VSDF + K + W+ APE K + K DV
Sbjct: 147 NVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEALREKKFSTKSDV 197
Query: 663 YSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQNKFMSIM 716
+SFG+L E+ G+ P + +++ ++ P +M
Sbjct: 198 WSFGILLWEIYSFGRVPYP---RIP------LKDVVPRVEKGYKMDAPD-GCPPAVYEVM 247
Query: 717 QVAFSCLDQNPVSRPT 732
+ +C + RP+
Sbjct: 248 K---NCWHLDAAMRPS 260
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 40/195 (20%), Positives = 72/195 (36%), Gaps = 33/195 (16%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+I+ E G L L + L + + A+ YL + VH DI+ +
Sbjct: 88 WIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESINC---VHRDIAVR 142
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTMKVTEKCDVY 663
N+L+ + DF +++++ + + + +PE + T DV+
Sbjct: 143 NILVASPECVKLGDFGLSRYIEDEDYY----KASVTRLPIKWMSPESINFRRFTTASDVW 198
Query: 664 SFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQNKFMSIMQ 717
F V E++ GK P F + N +++ RLP P ++M
Sbjct: 199 MFAVCMWEILSFGKQP---FFWLE------NKDVIGVLEKGDRLPKPD-LCPPVLYTLMT 248
Query: 718 VAFSCLDQNPVSRPT 732
C D +P RP
Sbjct: 249 ---RCWDYDPSDRPR 260
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 36/296 (12%), Positives = 74/296 (25%), Gaps = 89/296 (30%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVK------------------------------------ 531
+G+ + A +GE F V
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 532 -KFHSPLPDNFCSHPRQSFIV----------------YEYLESGSL----DKILNNDASA 570
P + P++ ++ +L + +L++ ++
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 571 KELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630
K L RL + V L LH+ +VH + +++LD ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 631 LDSSNWSKLAGTHGNVAPEL-----------AYTMKVTEKCDVYSFGVLALEVIKGKHPR 679
+ + G PEL +T D ++ G++ + P
Sbjct: 258 ARVV----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP- 312
Query: 680 DFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKR 735
++ I S P + + L R +
Sbjct: 313 ---ITKDAALGGSE-WIFRSCKNIPQ--------PVRALLEGFLRYPKEDRLLPLQ 356
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 42/217 (19%), Positives = 72/217 (33%), Gaps = 44/217 (20%)
Query: 542 CSHPRQS--FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP 599
C + ++ EYL GSL L + + + L + + YL +
Sbjct: 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKRY-- 166
Query: 600 IVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTM 654
+H D++++N+L++ + DF + K L D + G APE
Sbjct: 167 -IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYK--VKEPGESPIFWYAPESLTES 223
Query: 655 KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM- 713
K + DV+SFGV+ E+ F + S S + + V +
Sbjct: 224 KFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275
Query: 714 ------------------SIMQVAFSCLDQNPVSRPT 732
IM C + N RP+
Sbjct: 276 LKNNGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPS 309
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 44/195 (22%), Positives = 74/195 (37%), Gaps = 33/195 (16%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+I+ E G L L L + ++ AL YL + F VH DI+++
Sbjct: 91 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKRF---VHRDIAAR 145
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTMKVTEKCDVY 663
NVL+ + DF +++++ + + G + APE + T DV+
Sbjct: 146 NVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKLPIKWMAPESINFRRFTSASDVW 201
Query: 664 SFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQNKFMSIMQ 717
FGV E++ G P + N +++ RLP P + S+M
Sbjct: 202 MFGVCMWEILMHGVKP---FQGVK------NNDVIGRIENGERLPMPP-NCPPTLYSLMT 251
Query: 718 VAFSCLDQNPVSRPT 732
C +P RP
Sbjct: 252 ---KCWAYDPSRRPR 263
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 68.3 bits (166), Expect = 6e-12
Identities = 80/491 (16%), Positives = 149/491 (30%), Gaps = 145/491 (29%)
Query: 37 EEAHALVKWKASLEVHSRSLLH-------SWSLSFVNATKISLCTWSGIHCNHAGRVFGI 89
+ L + L L+ +W ++ + +C + C ++F +
Sbjct: 135 QPYLKLRQALLELRPAKNVLIDGVLGSGKTW-VA------LDVCLSYKVQCKMDFKIFWL 187
Query: 90 NL-----------------TSISLNGTLLEFSFSSFPH-----------LAYLDLYNNEL 121
NL I N T S+ L Y N L
Sbjct: 188 NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247
Query: 122 FDIIPPQISNLSKLEYLDF------------LTNKLSGHIPSEISL------LTHLTILH 163
++ + N + +T+ LS + ISL LT +
Sbjct: 248 --LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKS 305
Query: 164 ISRNQLN---GSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLV--FLYLYNNSFS 218
+ L+ +P EV N + I S+ + + ++ + +
Sbjct: 306 LLLKYLDCRPQDLPREVLTTNPR--RL-------SIIAESIRDGLATWDNWKHVNCDKLT 356
Query: 219 GSIPQQIGNL-----KSLFDMKLCINQLNGAIP---LSIDWG------------RCPQLS 258
I + L + +FD L + + IP LS+ W + + S
Sbjct: 357 TIIESSLNVLEPAEYRKMFDR-LSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS 415
Query: 259 LLD-------VSINNITGNIPFEIGESPQL------QYLDLSSNYIVGEIPTQLGNIIYL 305
L++ +SI +I + ++ L Y + IP L Y
Sbjct: 416 LVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFY- 474
Query: 306 NRISLSGNKLSGRIPGELGSLINLEYLDL-----------SANHLSNFVLESLGSLVKLY 354
+ I G+ L E +L + +LD +A + S +L +L L K Y
Sbjct: 475 SHI---GHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQL-KFY 530
Query: 355 --YLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLS 412
Y+ + K + + + ++ FL KI + + + L ++
Sbjct: 531 KPYICDNDPKYERLV----NAILD---------FL-PKIEENLICSKYTDLLRIALMAED 576
Query: 413 GLIPRCFEELH 423
I FEE H
Sbjct: 577 EAI---FEEAH 584
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 2e-11
Identities = 98/669 (14%), Positives = 187/669 (27%), Gaps = 230/669 (34%)
Query: 121 LFDIIPPQ--------ISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISR----NQ 168
LF + + + + ++ Y FL + + + S++T + I R NQ
Sbjct: 67 LFWTLLSKQEEMVQKFVEEVLRINY-KFLMSPIKTE-QRQPSMMTRMYIEQRDRLYNDNQ 124
Query: 169 L----NGSIPHEVGQL-NFLNHLILDSNFL----GGS--------IPRS---LSNFTNLV 208
+ N S +L L L N L GS + S +
Sbjct: 125 VFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKI 184
Query: 209 F-LYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGA-IPLSIDWGRCPQL--------- 257
F L L N + ++ + + L D + + I L I + +L
Sbjct: 185 FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ-AELRRLLKSKPY 243
Query: 258 --SLL---DVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSG 312
LL +V +LS ++ T+ +
Sbjct: 244 ENCLLVLLNVQNAKA-------------WNAFNLSCKILL---TTRFKQVT--------- 278
Query: 313 NKLSGRIPGELGSLINLEYLDLSANHLSNFVL-ESLGSLVKLYYLNLSHNKLSQQIPIEL 371
+ LS I+L+ +H E L+K YL+ L +++
Sbjct: 279 DFLSAATTTH----ISLD------HHSMTLTPDEVKSLLLK--YLDCRPQDLPREV---- 322
Query: 372 DNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDIS 431
+ + + E I + ++ + +N + L+ +I L + +
Sbjct: 323 -LTTNP----RRLSIIAESIRDGLATWDNWKHVN--CDKLTTIIESSLNVLEPAEYRKM- 374
Query: 432 YNKL----EG-HIPNSTTFRDAPLEALQGNKGLCGDIRGFLSCMSYRKASRKIWIVIVFP 486
+++L HIP L + W
Sbjct: 375 FDRLSVFPPSAHIPTIL------LSLI--------------------------W------ 396
Query: 487 LLGKIVYEEIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPDNFCSHPR 546
++ +++ N + K S +PS + + L + + H
Sbjct: 397 --FDVIKSDVMVVVNKLHKYSLVEKQPKESTI--SIPSIYL----ELKVKLENEYALHRS 448
Query: 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVH---- 602
IV Y + D ++D L D FY H I H
Sbjct: 449 ---IVDHYNIPKTFD---SDDLIPPYL-------------DQYFYSH------IGHHLKN 483
Query: 603 ------WDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELA----Y 652
+ V LD F K + DS+ W G++ L Y
Sbjct: 484 IEHPERMTLFRM-VFLDF-------RFLEQK-IRHDSTAW----NASGSILNTLQQLKFY 530
Query: 653 TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712
+ + Y V A+ DFL ++ + + +K+
Sbjct: 531 KPYICDNDPKYERLVNAIL--------DFLPKIEENL------------------ICSKY 564
Query: 713 MSIMQVAFS 721
++++A
Sbjct: 565 TDLLRIALM 573
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 50/281 (17%), Positives = 92/281 (32%), Gaps = 83/281 (29%)
Query: 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVK--------------------KFHSPLPDN 540
+ +GKGG + + E+FA K H L
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL--- 98
Query: 541 FCSHP------------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADA 588
+H F+V E SL ++ + E R ++ +
Sbjct: 99 --AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE--PEAR-YYLRQIVLG 153
Query: 589 LFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAP 648
YLH N ++H D+ N+ L+ E + DF +A + D L GT +AP
Sbjct: 154 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 210
Query: 649 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708
E+ + + DV+S G + ++ + L + P+ + +
Sbjct: 211 EVLSKKGHSFEVDVWSIGCI-------------MYTL-----------LVGKPPFETSCL 246
Query: 709 QNKFMSIMQVAFSC---------------LDQNPVSRPTMK 734
+ ++ I + +S L +P +RPT+
Sbjct: 247 KETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTIN 287
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 9e-12
Identities = 25/107 (23%), Positives = 53/107 (49%), Gaps = 4/107 (3%)
Query: 305 LNRISLSGNKLS-GRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKL 363
+ + L ++ + G++ G LE+L L++ + +L L KL L LS N++
Sbjct: 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS--IANLPKLNKLKKLELSDNRV 76
Query: 364 SQQIPIELDNLIHLSELDLSHNFLGE-KISSRICRMESLEKLNLSYN 409
S + + + +L+ L+LS N + + + ++E+L+ L+L
Sbjct: 77 SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-09
Identities = 26/107 (24%), Positives = 47/107 (43%), Gaps = 5/107 (4%)
Query: 256 QLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKL 315
+L L + N + E +L++L + + I L + L ++ LS N++
Sbjct: 21 ELVLDNSRSNEGK--LEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRV 76
Query: 316 SGRIPGELGSLINLEYLDLSANHLSNF-VLESLGSLVKLYYLNLSHN 361
SG + NL +L+LS N + + +E L L L L+L +
Sbjct: 77 SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 23/86 (26%), Positives = 42/86 (48%), Gaps = 3/86 (3%)
Query: 351 VKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNN 410
VK L+ S + + + D L L + L I++ + ++ L+KL LS N
Sbjct: 19 VKELVLDNSRSNEGKLEGL-TDEFEELEFLSTINVGL-TSIAN-LPKLNKLKKLELSDNR 75
Query: 411 LSGLIPRCFEELHGLLHIDISYNKLE 436
+SG + E+ L H+++S NK++
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 29/127 (22%), Positives = 47/127 (37%), Gaps = 25/127 (19%)
Query: 89 INLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGH 148
+ L + N LE F L +L N L I + L+KL+ L+ N++SG
Sbjct: 22 LVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGG 79
Query: 149 IPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLV 208
+ +LT L++S N++ L+ + L NL
Sbjct: 80 LEVLAEKCPNLTHLNLSGNKIK--------DLSTIEP---------------LKKLENLK 116
Query: 209 FLYLYNN 215
L L+N
Sbjct: 117 SLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 39/178 (21%), Positives = 58/178 (32%), Gaps = 58/178 (32%)
Query: 183 LNHLILDSNFLG-GSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQL 241
+ L+LD++ G + F L FL N + I NL L
Sbjct: 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKL---------- 63
Query: 242 NGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGN 301
+L L++S N ++G + + P L +L+LS N I L
Sbjct: 64 -------------NKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI-----KDLST 105
Query: 302 IIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSN------FVLESLGSLVKL 353
I L L NL+ LDL ++N V + L L L
Sbjct: 106 IEP------------------LKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYL 145
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 53/275 (19%), Positives = 90/275 (32%), Gaps = 71/275 (25%)
Query: 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVK--------------------KFHSPLPDN 540
+ +GKGG + + E+FA K H L
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL--- 72
Query: 541 FCSHP------------RQSFIVYEYLESGSL-DKI-----LNNDASAKELGWTQRLNVI 582
+H F+V E SL + L + +
Sbjct: 73 --AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY---------YL 121
Query: 583 KGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGT 642
+ + YLH N ++H D+ N+ L+ E + DF +A + D L GT
Sbjct: 122 RQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 178
Query: 643 HGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLP 702
+APE+ + + DV+S G + ++ GK P FE +S + I +
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP----FE-TSCLKETYLRIKKNEYS 233
Query: 703 YP---SLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
P + + + L +P +RPT+
Sbjct: 234 IPKHINPVAASLIQKM-------LQTDPTARPTIN 261
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-11
Identities = 30/107 (28%), Positives = 53/107 (49%), Gaps = 4/107 (3%)
Query: 305 LNRISLSGNKLS-GRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKL 363
+ + L K + G+I G +NLE+L L L + + +L L KL L LS N++
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS--VSNLPKLPKLKKLELSENRI 83
Query: 364 SQQIPIELDNLIHLSELDLSHNFLGE-KISSRICRMESLEKLNLSYN 409
+ + + L +L+ L+LS N L + + ++E L+ L+L
Sbjct: 84 FGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 22/86 (25%), Positives = 43/86 (50%), Gaps = 3/86 (3%)
Query: 351 VKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNN 410
V+ L+ + + + ++L L L + L +S+ + ++ L+KL LS N
Sbjct: 26 VRELVLDNCKSNDGKIEGL-TAEFVNLEFLSLINVGL-ISVSN-LPKLPKLKKLELSENR 82
Query: 411 LSGLIPRCFEELHGLLHIDISYNKLE 436
+ G + E+L L H+++S NKL+
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 28/127 (22%), Positives = 48/127 (37%), Gaps = 25/127 (19%)
Query: 89 INLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGH 148
+ L + N +E + F +L +L L N L + + L KL+ L+ N++ G
Sbjct: 29 LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGG 86
Query: 149 IPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLV 208
+ L +LT L++S N+L ++ L L L
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLKD-----------ISTL------------EPLKKLECLK 123
Query: 209 FLYLYNN 215
L L+N
Sbjct: 124 SLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 39/178 (21%), Positives = 58/178 (32%), Gaps = 58/178 (32%)
Query: 183 LNHLILDSNFLG-GSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQL 241
+ L+LD+ G I + F NL FL L N + NL L
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLPKL---------- 70
Query: 242 NGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGN 301
P+L L++S N I G + + P L +L+LS N + +
Sbjct: 71 -------------PKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL-----KDIST 112
Query: 302 IIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSN------FVLESLGSLVKL 353
+ L L L+ LDL ++N V + L L L
Sbjct: 113 LEP------------------LKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 54/283 (19%), Positives = 95/283 (33%), Gaps = 84/283 (29%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVK--------------------KFHSPLPD 539
DF + +GKG VY A + +G A+K K H L
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-- 68
Query: 540 NFCSHP------------RQSFIVYEYLESGSL-DKILNNDASAKELGWTQRLNVIKGVA 586
HP ++V E +G + + N E R + + +
Sbjct: 69 ---KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSE--NEAR-HFMHQII 122
Query: 587 DALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV 646
+ YLH++ I+H D++ N+LL ++DF +A L + L GT +
Sbjct: 123 TGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYI 179
Query: 647 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706
+PE+A + DV+S G + + + L R P+ +
Sbjct: 180 SPEIATRSAHGLESDVWSLGCM-------------FYTL-----------LIGRPPFDTD 215
Query: 707 DVQNKFMSIMQVAFSC---------------LDQNPVSRPTMK 734
V+N ++ + L +NP R ++
Sbjct: 216 TVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLS 258
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 65.0 bits (157), Expect = 3e-11
Identities = 39/226 (17%), Positives = 83/226 (36%), Gaps = 34/226 (15%)
Query: 189 DSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQI--GNLKSLFD--MKLCINQLNGA 244
D + + I + F + L+ + F I +L + D L ++ G
Sbjct: 123 DCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT 182
Query: 245 IPLSIDWGRCPQLSLLDVSINNITGNIPFEIGES--PQLQYLDL---SSNYIVGEIPTQL 299
LSI P L L++ + ++ +I S P L+ L L +Y
Sbjct: 183 NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF 242
Query: 300 GNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGS---LVKLYYL 356
+ S ++ NL++L + N V+E L +L +
Sbjct: 243 RPL-------FSKDRFP-----------NLKWLGIVDAEEQNVVVEMFLESDILPQLETM 284
Query: 357 NLSHNKLS----QQIPIELDNLIHLSELDLSHNFLGEKISSRICRM 398
++S L+ + + +D + HL +++ +N+L +++ + +
Sbjct: 285 DISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS 330
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 59.2 bits (142), Expect = 2e-09
Identities = 31/182 (17%), Positives = 58/182 (31%), Gaps = 41/182 (22%)
Query: 247 LSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLN 306
LS P L+ L + N N+ P L+ L++ S + + +
Sbjct: 164 LSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILG----- 215
Query: 307 RISLSGNKLSGRIPGELGSLINLEYLDL---SANHLSNFVLESL------GSLVKLYYLN 357
L NLE L L ++ + + L +L
Sbjct: 216 -----------------SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLG 258
Query: 358 LSHNKLSQQIPIEL---DNLIHLSELDLSHNFLG----EKISSRICRMESLEKLNLSYNN 410
+ + + D L L +D+S L + + +++ L+ +N+ YN
Sbjct: 259 IVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNY 318
Query: 411 LS 412
LS
Sbjct: 319 LS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.1 bits (108), Expect = 3e-05
Identities = 16/74 (21%), Positives = 32/74 (43%), Gaps = 7/74 (9%)
Query: 103 FSFSSFPHLAYLDLYNNELFDIIPPQISN---LSKLEYLDFLTNKLSG----HIPSEISL 155
FS FP+L +L + + E +++ L +LE +D L+ + +
Sbjct: 246 FSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDK 305
Query: 156 LTHLTILHISRNQL 169
+ HL +++ N L
Sbjct: 306 IKHLKFINMKYNYL 319
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 66/275 (24%), Positives = 108/275 (39%), Gaps = 72/275 (26%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAV---KKFHSPLPDNF------------CSH 544
+ F+ IGKG G V I + + +++A+ K + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 545 P-----RQSF-------IVYEYLESGSL------DKILNNDAS---AKELGWTQRLNVIK 583
P SF +V + L G L + + EL
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICEL---------- 124
Query: 584 GVADALFYLHNNCFPPIVHWDISSKNVLLDL-GYEAHVSDFRIAKFLNLDSSNWSKLAGT 642
AL YL N I+H D+ N+LLD G+ H++DF IA L ++ + +AGT
Sbjct: 125 --VMALDYLQNQ---RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITT-MAGT 177
Query: 643 HGNVAPEL-------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE 695
+APE+ Y+ V D +S GV A E+++G+ P + S+SS +
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP--YHIRSSTSSKEIVHT 231
Query: 696 ILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSR 730
+ + YPS + +S+++ L+ NP R
Sbjct: 232 FETTVVTYPS-AWSQEMVSLLK---KLLEPNPDQR 262
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 25/260 (9%), Positives = 56/260 (21%), Gaps = 81/260 (31%)
Query: 508 CIGKGGHGSVYIAR-------VPSGEIFAVKKFHSPL--PDNFC-------------SHP 545
G + A V A+ PD+ P
Sbjct: 38 FHGGVPPLQFWQALDTALDRQV------ALTFVDPQGVLPDDVLQETLSRTLRLSRIDKP 91
Query: 546 R------------QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLH 593
+V E++ GSL ++ + ++ +A A H
Sbjct: 92 GVARVLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH 146
Query: 594 NNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYT 653
+ V + + + ++
Sbjct: 147 RA---GVALSIDHPSRVRVSIDGDVVLAYPATM--------------------PD----- 178
Query: 654 MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI--EILDSRLPYPSLDVQNK 711
+ D+ G ++ + P + S + + P+ ++
Sbjct: 179 --ANPQDDIRGIGASLYALLVNRWP----LPEAGVRSGLAPAERDTAGQPIEPADIDRDI 232
Query: 712 FMSIMQVAFSCLDQNPVSRP 731
I VA + + R
Sbjct: 233 PFQISAVAARSVQGDGGIRS 252
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 58/263 (22%), Positives = 94/263 (35%), Gaps = 61/263 (23%)
Query: 509 IGKGGHGSVY--IARVPSGEIF--AVKKFH----SPLPDNFCS---------HPR----- 546
IG+G G V+ I P A+K + + F HP
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 547 ------QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 600
+I+ E G L L L + ++ AL YL + F
Sbjct: 458 GVITENPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKRF--- 512
Query: 601 VHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTMK 655
VH DI+++NVL+ + DF +++++ + S + K + G + APE +
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYK--ASKGKLPIKWMAPESINFRR 568
Query: 656 VTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQ 709
T DV+ FGV E++ G P + N +++ RLP P +
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQ---GVK------NNDVIGRIENGERLPMPP-NCP 618
Query: 710 NKFMSIMQVAFSCLDQNPVSRPT 732
S+M C +P RP
Sbjct: 619 PTLYSLMT---KCWAYDPSRRPR 638
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 46/195 (23%), Positives = 76/195 (38%), Gaps = 30/195 (15%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+V Y++ G L + N + VA + +L + F VH D++++
Sbjct: 167 LVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKKF---VHRDLAAR 221
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTMKVTEKCDVY 663
N +LD + V+DF +A+ + D S T + A E T K T K DV+
Sbjct: 222 NCMLDEKFTVKVADFGLARDM-YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 280
Query: 664 SFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQNKFMSIMQ 717
SFGVL E++ +G P +++ +I RL P + +M
Sbjct: 281 SFGVLLWELMTRGAPP---YPDVN------TFDITVYLLQGRRLLQPE-YCPDPLYEVML 330
Query: 718 VAFSCLDQNPVSRPT 732
C RP+
Sbjct: 331 ---KCWHPKAEMRPS 342
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 49/297 (16%), Positives = 90/297 (30%), Gaps = 72/297 (24%)
Query: 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVK--------KFHSPLPDNF----------- 541
ND+ + +G + + + +A+K K N
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 542 ----------CSHP------------RQSFIVYEYLESGSL-DKILNNDASAKELGWTQR 578
+ + +I+YEY+E+ S+ K
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 579 LNV----IKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634
+ V IK V ++ Y+HN I H D+ N+L+D +SDF +++ +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEY--MVDK 205
Query: 635 NWSKLAGTHGNVAPELAYTMKVT--EKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM 692
GT+ + PE K D++S G+ + P F + S +
Sbjct: 206 KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLVEL 261
Query: 693 NIEILDSRLPYPSLDVQNKFMSIMQVAFSC---------------LDQNPVSRPTMK 734
I + YP + + + L +NP R T +
Sbjct: 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 28/104 (26%), Positives = 46/104 (44%), Gaps = 5/104 (4%)
Query: 114 LDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSI 173
L L N+ ++P ++SN L +D N++S S +T L L +S N+L I
Sbjct: 36 LYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93
Query: 174 PHEV-GQLNFLNHLILDSNFLGGSIPR-SLSNFTNLVFLYLYNN 215
P L L L L N + +P + ++ + L L + N
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 9e-09
Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 99 TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-SLLT 157
TL+ S++ HL +DL NN + + SN+++L L N+L IP L
Sbjct: 44 TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC-IPPRTFDGLK 102
Query: 158 HLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSN 191
L +L + N ++ +P L+ L+HL + +N
Sbjct: 103 SLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 29/105 (27%), Positives = 43/105 (40%), Gaps = 3/105 (2%)
Query: 282 QYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSN 341
L L N +P +L N +L I LS N++S ++ L L LS N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC 92
Query: 342 FVLESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHN 385
+ L L L+L N + +P ++L LS L + N
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 34/121 (28%), Positives = 60/121 (49%), Gaps = 13/121 (10%)
Query: 125 IPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEV-GQLNFL 183
IP ++ L YLD N+ + +P E+S HLT++ +S N+++ ++ ++ + L
Sbjct: 29 IPRDVTEL----YLDG--NQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80
Query: 184 NHLILDSNFLGGSIP-RSLSNFTNLVFLYLYNNSFSGSIPQQI-GNLKSLFDMKLCINQL 241
LIL N L IP R+ +L L L+ N S +P+ +L +L + + N L
Sbjct: 81 LTLILSYNRL-RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPL 138
Query: 242 N 242
Sbjct: 139 Y 139
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 3/81 (3%)
Query: 356 LNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRIC-RMESLEKLNLSYNNLSGL 414
L L N+ +P EL N HL+ +DLS+N + +S++ M L L LSYN L +
Sbjct: 36 LYLDGNQF-TLVPKELSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRLRCI 93
Query: 415 IPRCFEELHGLLHIDISYNKL 435
PR F+ L L + + N +
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDI 114
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 41/134 (30%), Positives = 53/134 (39%), Gaps = 12/134 (8%)
Query: 282 QYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSN 341
Q L L N I P ++I L + L N+L G SL L LDL N
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ--- 99
Query: 342 FVLESL-----GSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRIC 396
L L LV L L + NKL ++P ++ L HL+ L L N L
Sbjct: 100 --LTVLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFD 156
Query: 397 RMESLEKLNLSYNN 410
R+ SL L + N
Sbjct: 157 RLSSLTHAYL-FGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 40/120 (33%), Positives = 59/120 (49%), Gaps = 19/120 (15%)
Query: 105 FSSFPHLAYLDLYNNEL-------FDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-SLL 156
F S +L L L +N+L FD +L++L LD TN+L+ +PS + L
Sbjct: 60 FDSLINLKELYLGSNQLGALPVGVFD-------SLTQLTVLDLGTNQLTV-LPSAVFDRL 111
Query: 157 THLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPR-SLSNFTNLVFLYLYNN 215
HL L + N+L +P + +L L HL LD N L SIP + ++L YL+ N
Sbjct: 112 VHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL-KSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 40/131 (30%), Positives = 59/131 (45%), Gaps = 7/131 (5%)
Query: 113 YLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTILHISRNQLNG 171
L L++N++ + P +L L+ L +N+L +P + LT LT+L + NQL
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 172 SIPHEV-GQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQI-GNLK 229
+P V +L L L + N L +PR + T+L L L N SIP L
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLS 159
Query: 230 SLFDMKLCINQ 240
SL L N
Sbjct: 160 SLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 41/128 (32%), Positives = 61/128 (47%), Gaps = 3/128 (2%)
Query: 307 RISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQ 366
+ L N+++ PG SLINL+ L L +N L + SL +L L+L N+L
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQL-TV 102
Query: 367 IPIEL-DNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGL 425
+P + D L+HL EL + N L ++ I R+ L L L N L + F+ L L
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSL 161
Query: 426 LHIDISYN 433
H + N
Sbjct: 162 THAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 30/118 (25%), Positives = 49/118 (41%), Gaps = 5/118 (4%)
Query: 125 IPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEV-GQLNFL 183
+P I + + L N+++ P L +L L++ NQL ++P V L L
Sbjct: 34 VPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90
Query: 184 NHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQL 241
L L +N L +L L++ N + +P+ I L L + L NQL
Sbjct: 91 TVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 33/108 (30%), Positives = 54/108 (50%), Gaps = 5/108 (4%)
Query: 330 EYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFLG 388
+ L L N ++ SL+ L L L N+L +P+ + D+L L+ LDL N L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQL- 100
Query: 389 EKISSRIC-RMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKL 435
+ S + R+ L++L + N L+ +PR E L L H+ + N+L
Sbjct: 101 TVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQL 147
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 65/285 (22%), Positives = 108/285 (37%), Gaps = 91/285 (31%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVK--------------------KFHSPLPD 539
+DFD +GKG G+VY+AR + I A+K + S L
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-- 71
Query: 540 NFCSHP------------RQSFIVYEYLESGSL-DKI-----LNNDASAKELGWTQRLNV 581
HP ++ +++ E+ G L ++ + SA
Sbjct: 72 ---RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSAT---------F 119
Query: 582 IKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLA- 640
++ +ADAL Y H ++H DI +N+L+ E ++DF WS A
Sbjct: 120 MEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADF-----------GWSVHAP 165
Query: 641 --------GTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM 692
GT + PE+ EK D++ GVL E + G P F+ S S +
Sbjct: 166 SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP----FD-SPSHTET 220
Query: 693 NIEILDSRLPYP---SLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+ I++ L +P S ++ +S + L +P R +K
Sbjct: 221 HRRIVNVDLKFPPFLSDGSKD-LISKL------LRYHPPQRLPLK 258
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 51/339 (15%), Positives = 100/339 (29%), Gaps = 62/339 (18%)
Query: 109 PHLAYLDLYNNELFDIIPPQI-----SNLSKLEYLDFLTNKLSGHIPSEISLL-----TH 158
+ LDL N L+ I ++ + + + L+ N L E+ + +
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81
Query: 159 LTILHISRNQLNGSIPHEVGQL-----NFLNHLILDSNFLGGSIPRSL-----SNFTNLV 208
+T L++S N L+ E+ + + L L N + ++
Sbjct: 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141
Query: 209 FLYLYNNS--------FSGSIPQQIGNLKSLFDMKLCINQL--NGAIPL-SIDWGRCPQL 257
L L N + N+ SL L N L L +
Sbjct: 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLN---LRGNNLASKNCAELAKFLASIPASV 198
Query: 258 SLLDVSINNITGNIPFEIGE-----SPQLQYLDLSSNYIVGEIPTQLGNIIYLNR----I 308
+ LD+S N + E+ + L+L N + G L + + +
Sbjct: 199 TSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTV 258
Query: 309 SLSGNKLSGRIPGE--------LGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSH 360
L + + + E ++ + +D + + + +L++
Sbjct: 259 YLDYDIV-KNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADV 317
Query: 361 NKLSQQIPIE----------LDNLIHLSELDLSHNFLGE 389
L Q I L+ L E + L E
Sbjct: 318 PSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPLLE 356
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 43/188 (22%), Positives = 74/188 (39%), Gaps = 30/188 (15%)
Query: 278 SPQLQYLDLSSNYIVGEIPTQLGNII-----YLNRISLSGNKLSGRIPGELGSLI----- 327
+ LDLS N + +L + ++LSGN L + EL ++
Sbjct: 21 PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80
Query: 328 NLEYLDLSANHLSNFVLESLGSLVK-----LYYLNLSHNKLSQQIPIELDNLI-----HL 377
N+ L+LS N LS + L + + L+L N S + E +
Sbjct: 81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASI 140
Query: 378 SELDLSHNFLGEKISSRICRM-----ESLEKLNLSYNNLS----GLIPRCFEELH-GLLH 427
+ L+L N LG K S + ++ ++ LNL NNL+ + + + +
Sbjct: 141 TSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTS 200
Query: 428 IDISYNKL 435
+D+S N L
Sbjct: 201 LDLSANLL 208
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 55/336 (16%), Positives = 103/336 (30%), Gaps = 54/336 (16%)
Query: 157 THLTILHISRNQLNGSIPHEVGQL-----NFLNHLILDSNFLGGSIPRSL-----SNFTN 206
+T L +S N L E+ Q + L L N LG L + N
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81
Query: 207 LVFLYLYNNSFSGSIPQQIGNL-----KSLFDMKLCINQL--NGAIPLSIDWGRCPQ-LS 258
+ L L N S ++ ++ + L N + + P ++
Sbjct: 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141
Query: 259 LLDVSINNITGNIPFEIGES-----PQLQYLDLSSNYI----VGEIPTQLGNI-IYLNRI 308
L++ N++ E+ + + L+L N + E+ L +I + +
Sbjct: 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSL 201
Query: 309 SLSGNKLSGRIPGELGSLI-----NLEYLDLSANHLSNFVLESLGSLVK----LYYLNLS 359
LS N L + EL + ++ L+L N L LE+L L L + L
Sbjct: 202 DLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLD 261
Query: 360 HNKLSQQIPIE-------LDNLIHLSELDLSHNFLGEKISSRICRM-----ESLEKLNLS 407
++ + + N+ + +D + + S I + + +L
Sbjct: 262 YDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLL 321
Query: 408 YNNLS-----GLIPRCFEELHGLLHIDISYNKLEGH 438
L L + L H
Sbjct: 322 NQCLIFAQKHQTNIEDLNIPDELRESIQTCKPLLEH 357
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 25/106 (23%), Positives = 44/106 (41%), Gaps = 15/106 (14%)
Query: 345 ESLGSLVKLYYLNLSHNKLSQQIPIEL-----DNLIHLSELDLSHNFLGEKISSRICRM- 398
E + L+LS N L +EL + ++ L+LS N LG K S + ++
Sbjct: 16 EFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQIL 75
Query: 399 ----ESLEKLNLSYNNLSG----LIPRCFEELH-GLLHIDISYNKL 435
++ LNLS N LS + + + + +D+ +N
Sbjct: 76 AAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDF 121
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 56/341 (16%), Positives = 112/341 (32%), Gaps = 51/341 (14%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLY------NNELFDIIPPQISNLSKLEYLD 139
NL S+ LN L P L L +++ + +S +L L
Sbjct: 212 NLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLS 271
Query: 140 FLTNKLSGHIPSEISLLTHLTILHISRNQLNG-SIPHEVGQLNFLNHLILDSNFLGGSIP 198
+ + ++P+ S+ + LT L++S + + + Q L L + +
Sbjct: 272 GFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLE 331
Query: 199 RSLSNFTNLVFLYLYN-NSFSGSIPQQIGN--LKSLFDMKLCINQLNGAIPLSIDWGRCP 255
S +L L ++ F + L S+ CP
Sbjct: 332 VLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSM-------------------GCP 372
Query: 256 QLSLLDVSINNITGNIPFEIGES-PQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNK 314
+L + +T I + P + L I L+
Sbjct: 373 KLESVLYFCRQMTNAALITIARNRPNMTRFRLC-------------IIEPKAPDYLTLEP 419
Query: 315 LSGRIPGELGSLINLEYLDLSANHLSNFVLESLGS-LVKLYYLNLSHNKLSQQ-IPIELD 372
L + +L L LS L++ V E +G+ K+ L+++ S + L
Sbjct: 420 LDIGFGAIVEHCKDLRRLSLS-GLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLS 478
Query: 373 NLIHLSELDLSH-NFLGEKISSRICRMESLEKLNLSYNNLS 412
L +L++ F + + + ++E++ L +S ++S
Sbjct: 479 GCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 49/386 (12%), Positives = 113/386 (29%), Gaps = 63/386 (16%)
Query: 90 NLTSISLNG------TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSK----LEYLD 139
N + L+ L ++ +L LDL +++ D+ +S+ L L+
Sbjct: 131 NFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLN 190
Query: 140 FLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPR 199
+S S ++ + + N L L L+ +
Sbjct: 191 -----ISCL----ASEVSFSALERLVTRCPN------------LKSLKLNRAVPLEKLAT 229
Query: 200 SLSNFTNLVFLYLY------NNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGR 253
L L L + + K L + + + +P
Sbjct: 230 LLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYS--V 287
Query: 254 CPQLSLLDVSINNITGNIPFEIGES-PQLQYLDLS---SNYIVGEIPTQLGNIIYLNRIS 309
C +L+ L++S + ++ P+LQ L + + + + + ++ L
Sbjct: 288 CSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFP 347
Query: 310 LSGNKLSGRIP-GELG------SLINLEYLDLSANHLSNFVLESLG-SLVKLYYLNLSHN 361
+ + E G LE + ++N L ++ + + L
Sbjct: 348 SEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCII 407
Query: 362 KLSQQIPIE-----------LDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNN 410
+ + +++ L L LS + + +E L++++
Sbjct: 408 EPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAG 467
Query: 411 LSGL-IPRCFEELHGLLHIDISYNKL 435
S L + L ++I
Sbjct: 468 DSDLGMHHVLSGCDSLRKLEIRDCPF 493
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 48/202 (23%), Positives = 71/202 (35%), Gaps = 46/202 (22%)
Query: 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF---------CSHP---- 545
T+ ++ K IG G + + FAVK D HP
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 546 --------RQSFIVYEYLESGSL-DKILN------NDASAKELGWTQRLNVIKGVADALF 590
+ ++V E ++ G L DKIL +ASA V+ + +
Sbjct: 81 LKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA----------VLFTITKTVE 130
Query: 591 YLHNNCFPPIVHWDISSKNVLLDLGYEAH----VSDFRIAKFLNLDSSNWSKLAGTHGNV 646
YLH +VH D+ N+L + DF AK L ++ T V
Sbjct: 131 YLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFV 187
Query: 647 APELAYTMKVTEKCDVYSFGVL 668
APE+ CD++S GVL
Sbjct: 188 APEVLERQGYDAACDIWSLGVL 209
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 42/153 (27%), Positives = 66/153 (43%), Gaps = 2/153 (1%)
Query: 282 QYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSN 341
+ LDL S + + L ++L N+L G L L L L+ N L++
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 342 FVLESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFLGEKISSRICRMES 400
L L +L L L N+L + +P + D L L EL L+ N L + ++ +
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN 156
Query: 401 LEKLNLSYNNLSGLIPRCFEELHGLLHIDISYN 433
L+ L+LS N L + F+ L L I + N
Sbjct: 157 LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 44/143 (30%), Positives = 65/143 (45%), Gaps = 10/143 (6%)
Query: 105 FSSFPHLAYLDLYNNELFDIIPPQI-SNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTIL 162
F L +L+L N+L + + +L++L L N+L+ +P + LT L L
Sbjct: 55 FRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKL 112
Query: 163 HISRNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIPRSL-SNFTNLVFLYLYNNSFSGS 220
++ NQL S+P V +L L L L++N L SIP TNL L L N S
Sbjct: 113 YLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKLTNLQTLSLSTNQLQ-S 169
Query: 221 IPQQI-GNLKSLFDMKLCINQLN 242
+P L L + L NQ +
Sbjct: 170 VPHGAFDRLGKLQTITLFGNQFD 192
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 42/132 (31%), Positives = 59/132 (44%), Gaps = 8/132 (6%)
Query: 114 LDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTILHISRNQLNGS 172
LDL + L + L+KL +L+ N+L + + + LT L L ++ NQL S
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA-S 97
Query: 173 IPHEV-GQLNFLNHLILDSNFLGGSIPRSL-SNFTNLVFLYLYNNSFSGSIPQQI-GNLK 229
+P V L L+ L L N L S+P + T L L L N SIP L
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLT 155
Query: 230 SLFDMKLCINQL 241
+L + L NQL
Sbjct: 156 NLQTLSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 35/131 (26%), Positives = 62/131 (47%), Gaps = 4/131 (3%)
Query: 307 RISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQ 366
++ L L+ L L +L+L N L L +L L L++N+L
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQL-AS 97
Query: 367 IPIEL-DNLIHLSELDLSHNFLGEKISSRIC-RMESLEKLNLSYNNLSGLIPRCFEELHG 424
+P+ + D+L L +L L N L + + S + R+ L++L L+ N L + F++L
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN 156
Query: 425 LLHIDISYNKL 435
L + +S N+L
Sbjct: 157 LQTLSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 48/162 (29%), Positives = 71/162 (43%), Gaps = 18/162 (11%)
Query: 136 EYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSNFLG 194
E LD + L+ + LT LT L++ NQL ++ V L L L L +N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQL- 95
Query: 195 GSIPRSL-SNFTNLVFLYLYNNSFSGSIPQ----QIGNLKSLFDMKLCINQLNGAIPLSI 249
S+P + + T L LYL N S+P ++ LK L L NQL +IP
Sbjct: 96 ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELR---LNTNQLQ-SIPAGA 150
Query: 250 -DWGRCPQLSLLDVSINNITGNIPFEIGES-PQLQYLDLSSN 289
D + L L +S N + ++P + +LQ + L N
Sbjct: 151 FD--KLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 33/108 (30%), Positives = 53/108 (49%), Gaps = 4/108 (3%)
Query: 330 EYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFLG 388
E LDL + L+ + L KL +LNL +N+L Q + + D+L L L L++N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQL- 95
Query: 389 EKISSRI-CRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKL 435
+ + + L+KL L N L L F+ L L + ++ N+L
Sbjct: 96 ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL 143
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 9e-06
Identities = 39/158 (24%), Positives = 63/158 (39%), Gaps = 14/158 (8%)
Query: 210 LYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITG 269
L L + + L L + L NQL + + + +L L ++ N +
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGV-FDDLTELGTLGLANNQLA- 96
Query: 270 NIPFEIGESP-QLQYLDLSSNYIVGEIP----TQLGNIIYLNRISLSGNKLSGRIP-GEL 323
++P + + QL L L N + +P +L L + L+ N+L IP G
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTK---LKELRLNTNQLQ-SIPAGAF 151
Query: 324 GSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHN 361
L NL+ L LS N L + + L KL + L N
Sbjct: 152 DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 32/132 (24%), Positives = 46/132 (34%), Gaps = 32/132 (24%)
Query: 90 NLTSISLNG----TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKL 145
L ++ L +L F L L L N+L +P + D LT
Sbjct: 84 ELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQL-KSLPSGV--------FDRLTK-- 132
Query: 146 SGHIPSEISLLTHLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIPR-SLSN 203
L L ++ NQL SIP +L L L L +N L S+P +
Sbjct: 133 -------------LKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQL-QSVPHGAFDR 177
Query: 204 FTNLVFLYLYNN 215
L + L+ N
Sbjct: 178 LGKLQTITLFGN 189
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 60/454 (13%), Positives = 133/454 (29%), Gaps = 60/454 (13%)
Query: 17 FPLILFLVLDFSLAVSSNSTEEAHALVKWKASLEVHSRSL--LHSWSLSFVNATKISLCT 74
FP + L L + + + + S +L L S + + + L
Sbjct: 72 FPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDR 131
Query: 75 WSGIHCNHAGRVFGINLTSISLNG------TLLEFSFSSFPHLAYLDLYNNELFDIIPPQ 128
+ + +L ++ L+ L + + L + + +
Sbjct: 132 LAKARAD--------DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKW 183
Query: 129 ISNLSK----LEYLDFLTNKLSG----HIPSEISLLTHLTILHISRNQL--NGSIPHEVG 178
+ L++ LE L+F + + + + L + + ++
Sbjct: 184 LHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAA 243
Query: 179 QLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSG--SIPQQIGNLKSLFDMKL 236
L L+ + +L L L L + + ++ L D+
Sbjct: 244 NLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKL-DLLY 302
Query: 237 CINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGES-PQLQYLDLSSNYIVGEI 295
+ + L +CP L +L+ N I + + QL+ L +
Sbjct: 303 ALLETEDHCTLI---QKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERG------ 352
Query: 296 PTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGS----LV 351
+ G +S G + LEY+ + + ++N LES+G+ L
Sbjct: 353 ADEQGMEDEEGLVSQRGLIALAQ------GCQELEYMAVYVSDITNESLESIGTYLKNLC 406
Query: 352 KLYYLNLSHNKLSQQIPIE------LDNLIHLSELDLSHN--FLGEKISSRICRM-ESLE 402
+ L + +P++ L L L + S I + ++
Sbjct: 407 DFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVR 466
Query: 403 KLNLSYNNLSGL-IPRCFEELHGLLHIDISYNKL 435
+ L Y S + L +++
Sbjct: 467 WMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCF 500
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 47/195 (24%), Positives = 77/195 (39%), Gaps = 30/195 (15%)
Query: 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608
+V Y++ G L + N + VA + YL + F VH D++++
Sbjct: 103 LVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKKF---VHRDLAAR 157
Query: 609 NVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTMKVTEKCDVY 663
N +LD + V+DF +A+ + D +S T + A E T K T K DV+
Sbjct: 158 NCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 216
Query: 664 SFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQNKFMSIMQ 717
SFGVL E++ +G P +++ +I RL P + +M
Sbjct: 217 SFGVLLWELMTRGAPP---YPDVN------TFDITVYLLQGRRLLQPE-YCPDPLYEVML 266
Query: 718 VAFSCLDQNPVSRPT 732
C RP+
Sbjct: 267 ---KCWHPKAEMRPS 278
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 47/194 (24%), Positives = 77/194 (39%), Gaps = 50/194 (25%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVK---KFHSPLPDNF---------CSHP---------- 545
+G G V++ + +G++FA+K K + + H
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 546 --RQSFIVYEYLESGSL-DKILN------NDASAKELGWTQRLNVIKGVADALFYLHNNC 596
++V + + G L D+IL DAS VI+ V A+ YLH N
Sbjct: 77 STTHYYLVMQLVSGGELFDRILERGVYTEKDAS----------LVIQQVLSAVKYLHENG 126
Query: 597 FPPIVHWDISSKNVLL-DLGYEAHV--SDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYT 653
IVH D+ +N+L + + +DF ++K + S GT G VAPE+
Sbjct: 127 ---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTACGTPGYVAPEVLAQ 181
Query: 654 MKVTEKCDVYSFGV 667
++ D +S GV
Sbjct: 182 KPYSKAVDCWSIGV 195
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 58/279 (20%), Positives = 96/279 (34%), Gaps = 60/279 (21%)
Query: 495 EIIRATNDFDAKHCIGKGGHGSVY--IARVPSGEIFAV-----KKFHSPL-PDNFCS--- 543
I + IGKG G VY + + + F
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74
Query: 544 ------HPR-------------QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKG 584
HP ++ Y+ G L + + + + ++
Sbjct: 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQ 132
Query: 585 VADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHG 644
VA + YL F VH D++++N +LD + V+DF +A+ + D +S H
Sbjct: 133 VARGMEYLAEQKF---VHRDLAARNCMLDESFTVKVADFGLARDIL-DREYYSVQQHRHA 188
Query: 645 NV-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILD 698
+ A E T + T K DV+SFGVL E++ +G P + ++
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP---YRHID------PFDLTH 239
Query: 699 S-----RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT 732
RLP P + +MQ C + +P RPT
Sbjct: 240 FLAQGRRLPQPE-YCPDSLYQVMQ---QCWEADPAVRPT 274
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 50/243 (20%), Positives = 86/243 (35%), Gaps = 61/243 (25%)
Query: 471 SYRKASRKIWIVIVFPLLGKIVYEEIIRATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFA 529
+ + K+++ + + VY + +R +++ +G G G V +A + + A
Sbjct: 107 ALSLSRNKVFVFFDLTVDDQSVYPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVA 164
Query: 530 VKKFH-SPLPDNF-------------------CSHP-----------RQSFIVYEYLESG 558
++ +HP +IV E +E G
Sbjct: 165 IRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGG 224
Query: 559 SL-DKILNN------DASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVL 611
L DK++ N + A+ YLH N I+H D+ +NVL
Sbjct: 225 ELFDKVVGNKRLKEATCK----------LYFYQMLLAVQYLHENG---IIHRDLKPENVL 271
Query: 612 LDLGYEAH---VSDFRIAKFLNLDSSNWSKLAGTHGNVAPE-LAYTMKV--TEKCDVYSF 665
L E ++DF +K L ++S L GT +APE L D +S
Sbjct: 272 LSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330
Query: 666 GVL 668
GV+
Sbjct: 331 GVI 333
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 52/226 (23%), Positives = 80/226 (35%), Gaps = 39/226 (17%)
Query: 542 CSHPRQSFIVYEYLESGSLDKIL----NNDASAKELGWTQRLNVIKGVADALFYLHNNCF 597
FI+ E + G L L + L L+V + +A YL N F
Sbjct: 102 SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF 161
Query: 598 PPIVHWDISSKNVLLDLGYEAHV---SDFRIAKFLNLDSSNWSKLAGTHGNV-----APE 649
+H DI+++N LL V DF +A+ ++ +++ + G + PE
Sbjct: 162 ---IHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYR-KGGCAMLPVKWMPPE 215
Query: 650 -LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLP 702
T K D +SFGVL E+ G P S N E+L+ R+
Sbjct: 216 AFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP---YPSKS------NQEVLEFVTSGGRMD 265
Query: 703 YPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPD 748
P + IM C P RP + + +PD
Sbjct: 266 PPK-NCPGPVYRIMT---QCWQHQPEDRPNFAIILERIEYCTQDPD 307
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 39/196 (19%), Positives = 74/196 (37%), Gaps = 50/196 (25%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVK---KFHSPLPDN-----------FCSHP-------- 545
+GKG V V +G+ +A D+ HP
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 546 ----RQSFIVYEYLESGSL-DKILN------NDASAKELGWTQRLNVIKGVADALFYLHN 594
+++++ + G L + I+ DAS + I+ + +A+ + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS----------HCIQQILEAVLHCHQ 128
Query: 595 NCFPPIVHWDISSKNVLL-DLGYEAHV--SDFRIAKFLNLDSSNWSKLAGTHGNVAPELA 651
+VH ++ +N+LL A V +DF +A + + W AGT G ++PE+
Sbjct: 129 MG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185
Query: 652 YTMKVTEKCDVYSFGV 667
+ D+++ GV
Sbjct: 186 RKDPYGKPVDLWACGV 201
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 51/216 (23%), Positives = 83/216 (38%), Gaps = 52/216 (24%)
Query: 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVK---KFHSPLPDNFC-----------SH 544
+ + +G G +G V + R + A+K K N H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 545 P------------RQSFIVYEYLESGSL-DKILN------NDASAKELGWTQRLNVIKGV 585
P R ++V E + G L D+I++ DA+ +IK V
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA----------VIIKQV 145
Query: 586 ADALFYLHNNCFPPIVHWDISSKNVLL---DLGYEAHVSDFRIAKFLNLDSSNWSKLAGT 642
+ YLH + IVH D+ +N+LL + + DF ++ + + GT
Sbjct: 146 LSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKERLGT 201
Query: 643 HGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 678
+APE+ K EKCDV+S GV+ ++ G P
Sbjct: 202 AYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 44/217 (20%)
Query: 542 CSHPRQSFIVYEYLESGSLDKIL------------NNDASAKELGWTQRLNVIKGVADAL 589
C+ R +V+EY+ G L++ L D + LG Q L V VA +
Sbjct: 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGM 171
Query: 590 FYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV--- 646
YL F VH D++++N L+ G + DF +++ ++ S+++ + G +
Sbjct: 172 VYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYR-VGGRTMLPIR 225
Query: 647 --APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS--- 699
PE + Y K T + DV+SFGV+ E+ GK P +++S N E +D
Sbjct: 226 WMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQP---WYQLS------NTEAIDCITQ 275
Query: 700 --RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
L P + +IM+ C + P R ++K
Sbjct: 276 GRELERPR-ACPPEVYAIMR---GCWQREPQQRHSIK 308
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 39/121 (32%), Positives = 60/121 (49%), Gaps = 8/121 (6%)
Query: 99 TLLEFSFSSFPHLAYLDLYNNELFDIIPPQISN-LSKLEYLDFLTNKLSGHIPSEI-SLL 156
+L F L L L N+L +P + N L+ L YL+ TN+L +P+ + L
Sbjct: 42 SLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQLQS-LPNGVFDKL 99
Query: 157 THLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIPR-SLSNFTNLVFLYLYN 214
T L L ++ NQL S+P V +L L L L N L S+P T+L +++L++
Sbjct: 100 TQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL-KSVPDGVFDRLTSLQYIWLHD 157
Query: 215 N 215
N
Sbjct: 158 N 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 40/130 (30%), Positives = 59/130 (45%), Gaps = 3/130 (2%)
Query: 282 QYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSN 341
YLDL +N + + L ++ L GNKL G L +L YL+LS N L +
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 342 FVLESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFLGEKISSRICRMES 400
L +L L L+ N+L Q +P + D L L +L L N L R+ S
Sbjct: 91 LPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTS 149
Query: 401 LEKLNLSYNN 410
L+ + L ++N
Sbjct: 150 LQYIWL-HDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 46/132 (34%), Positives = 64/132 (48%), Gaps = 8/132 (6%)
Query: 113 YLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTILHISRNQLNG 171
YLDL N L + L+ L L NKL +P+ + + LT LT L++S NQL
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 172 SIPHEV-GQLNFLNHLILDSNFLGGSIPRSL-SNFTNLVFLYLYNNSFSGSIPQQI-GNL 228
S+P+ V +L L L L++N L S+P + T L L LY N S+P + L
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRL 147
Query: 229 KSLFDMKLCINQ 240
SL + L N
Sbjct: 148 TSLQYIWLHDNP 159
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 9e-07
Identities = 33/108 (30%), Positives = 53/108 (49%), Gaps = 4/108 (3%)
Query: 330 EYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFLG 388
YLDL N L + L L L L NKL Q +P + + L L+ L+LS N L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQL- 88
Query: 389 EKISSRIC-RMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKL 435
+ + + + ++ L++L L+ N L L F++L L + + N+L
Sbjct: 89 QSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 38/119 (31%), Positives = 53/119 (44%), Gaps = 6/119 (5%)
Query: 125 IPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEV-GQLNFL 183
+P I ++ YLD TN L LT LT L++ N+L S+P+ V +L L
Sbjct: 22 VPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78
Query: 184 NHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQI-GNLKSLFDMKLCINQL 241
+L L +N L T L L L N S+P + L L D++L NQL
Sbjct: 79 TYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 55/273 (20%), Positives = 99/273 (36%), Gaps = 58/273 (21%)
Query: 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVK---KFHSPLPDNF------------CS 543
++ + + +GKG G V + + +G+ AVK K +
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 544 HP------------RQSFIVYEYLESGSL-DKILN------NDASAKELGWTQRLNVIKG 584
HP ++V E G L D+I++ DA+ +I+
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA----------RIIRQ 134
Query: 585 VADALFYLHNNCFPPIVHWDISSKNVLL---DLGYEAHVSDFRIAKFLNLDSSNWSKLAG 641
V + Y+H N IVH D+ +N+LL + DF ++ S G
Sbjct: 135 VLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKMKDKIG 190
Query: 642 THGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRL 701
T +APE+ EKCDV+S GV+ ++ G P F ++ ++ ++ +
Sbjct: 191 TAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPP--F---NGANEYDILKKVEKGKY 244
Query: 702 PYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+ + S + L P R + +
Sbjct: 245 TFELPQWKKVSESAKDLIRKMLTYVPSMRISAR 277
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 49/204 (24%), Positives = 71/204 (34%), Gaps = 59/204 (28%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVK-----KFHSPLPDNF---------------CSHP-- 545
+G G G V +A + + A+K KF +HP
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 546 ---------RQSFIVYEYLESGSL-DKILNN------DASAKELGWTQRLNVIKGVADAL 589
+IV E +E G L DK++ N + A+
Sbjct: 78 IKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK----------LYFYQMLLAV 127
Query: 590 FYLHNNCFPPIVHWDISSKNVLLDLGYEAH---VSDFRIAKFLNLDSSNWSKLAGTHGNV 646
YLH N I+H D+ +NVLL E ++DF +K L ++S L GT +
Sbjct: 128 QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYL 183
Query: 647 APE-LAYTMKV--TEKCDVYSFGV 667
APE L D +S GV
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGV 207
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 28/109 (25%), Positives = 47/109 (43%), Gaps = 7/109 (6%)
Query: 113 YLDLYNNELFDIIPPQI-SNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTILHISRNQLN 170
L L +NEL I + L L L+ N+L+G I +H+ L + N++
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKIK 91
Query: 171 GSIPHEV-GQLNFLNHLILDSNFLGGSIPR-SLSNFTNLVFLYLYNNSF 217
I +++ L+ L L L N + + S + +L L L +N F
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 31/103 (30%), Positives = 45/103 (43%), Gaps = 9/103 (8%)
Query: 91 LTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIP 150
L IS +G F PHL L+L N+L I P S ++ L NK+ I
Sbjct: 41 LGRISSDGL-----FGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EIS 94
Query: 151 SEI-SLLTHLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSN 191
+++ L L L++ NQ++ + LN L L L SN
Sbjct: 95 NKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 25/106 (23%), Positives = 47/106 (44%), Gaps = 3/106 (2%)
Query: 282 QYLDLSSNYIVGEIPTQL-GNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLS 340
L L+ N + L G + +L ++ L N+L+G P +++ L L N +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 341 NFVLESLGSLVKLYYLNLSHNKLSQQIPIE-LDNLIHLSELDLSHN 385
+ L +L LNL N++ + ++L L+ L+L+ N
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 33/109 (30%), Positives = 52/109 (47%), Gaps = 9/109 (8%)
Query: 330 EYLDLSANHLSNFVLESLG---SLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHN 385
L L+ N L + S G L L L L N+L I + H+ EL L N
Sbjct: 32 TELLLNDNELGR--ISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGEN 88
Query: 386 FLGEKISSRIC-RMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYN 433
+ E IS+++ + L+ LNL N +S ++P FE L+ L ++++ N
Sbjct: 89 KIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 21/83 (25%), Positives = 37/83 (44%), Gaps = 3/83 (3%)
Query: 355 YLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFLGEKISSRIC-RMESLEKLNLSYNNLS 412
L L+ N+L + L L HL +L+L N L I +++L L N +
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKIK 91
Query: 413 GLIPRCFEELHGLLHIDISYNKL 435
+ + F LH L +++ N++
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQI 114
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 50/212 (23%), Positives = 74/212 (34%), Gaps = 39/212 (18%)
Query: 542 CSHPRQSFIVYEYLESGSLDKIL----NNDASAKELGWTQRLNVIKGVADALFYLHNNCF 597
FI+ E + G L L + L L+V + +A YL N F
Sbjct: 143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF 202
Query: 598 PPIVHWDISSKNVLLDLGYEAHV---SDFRIAKFLNLDSSNWSKLAGTHGNV-----APE 649
+H DI+++N LL V DF +A+ ++ + + + G + PE
Sbjct: 203 ---IHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYR-KGGCAMLPVKWMPPE 256
Query: 650 -LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLP 702
T K D +SFGVL E+ G P S N E+L+ R+
Sbjct: 257 AFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP---YPSKS------NQEVLEFVTSGGRMD 306
Query: 703 YPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
P + IM C P RP
Sbjct: 307 PPK-NCPGPVYRIMT---QCWQHQPEDRPNFA 334
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 41/193 (21%), Positives = 68/193 (35%), Gaps = 46/193 (23%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKFH-SPLPD---------NFCSHP------------ 545
+G+G S + FAVK + HP
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78
Query: 546 RQSFIVYEYLESGSL-DKILN------NDASAKELGWTQRLNVIKGVADALFYLHNNCFP 598
+F+V E L G L ++I +AS +++ + A+ ++H+
Sbjct: 79 LHTFLVMELLNGGELFERIKKKKHFSETEAS----------YIMRKLVSAVSHMHDVG-- 126
Query: 599 PIVHWDISSKNVLL-DLGYEAHV--SDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMK 655
+VH D+ +N+L D + DF A+ D+ T APEL
Sbjct: 127 -VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG 185
Query: 656 VTEKCDVYSFGVL 668
E CD++S GV+
Sbjct: 186 YDESCDLWSLGVI 198
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 4e-09
Identities = 47/199 (23%), Positives = 74/199 (37%), Gaps = 58/199 (29%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVK-----KFHSPLPDNF---------CSHP-------- 545
+GKG G V + + + +AVK + HP
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 546 ----RQSFIVYEYLESGSL-DKILNN------DASAKELGWTQRLNVIKGVADALFYLHN 594
+IV E G L D+I+ DA+ +IK V + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIKQVFSGITYMHK 139
Query: 595 NCFPPIVHWDISSKNVLL---DLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPEL- 650
+ IVH D+ +N+LL + + + DF ++ ++ GT +APE+
Sbjct: 140 HN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYIAPEVL 195
Query: 651 --AYTMKVTEKCDVYSFGV 667
Y EKCDV+S GV
Sbjct: 196 RGTYD----EKCDVWSAGV 210
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 56/256 (21%), Positives = 86/256 (33%), Gaps = 80/256 (31%)
Query: 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPL------------------PDNF 541
NDF IG+GG G VY R +G+++A+K +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 542 CSHPRQSFIVY---------------EYLESGSLDKILNNDASAKELGWTQRLNVIKGVA 586
P FIV + + G L L+ E A
Sbjct: 249 GDCP---FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-------------A 292
Query: 587 DALFY----------LHNNCFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSS 634
D FY +HN +V+ D+ N+LLD HV SD +A +
Sbjct: 293 DMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLD--EHGHVRISDLGLACDFSKKKP 347
Query: 635 NWSKLAGTHGNVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS 689
+ GTHG +APE+ AY D +S G + ++++G P F +
Sbjct: 348 H--ASVGTHGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP--FRQHKTKDK 399
Query: 690 SNMNIEILDSRLPYPS 705
++ L + P
Sbjct: 400 HEIDRMTLTMAVELPD 415
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 51/189 (26%), Positives = 83/189 (43%), Gaps = 17/189 (8%)
Query: 253 RCP-QLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLS 311
+ ++ ++T + S + S V I L N+ YL L
Sbjct: 16 DAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQY-LPNVRYLA---LG 71
Query: 312 GNKLSGRIPGELG---SLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIP 368
GNKL ++ L NL YL L+ N L + L L L L N+L Q +P
Sbjct: 72 GNKLH-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL-QSLP 125
Query: 369 IEL-DNLIHLSELDLSHNFLGEKISSRIC-RMESLEKLNLSYNNLSGLIPRCFEELHGLL 426
+ D L +L+ L+L+HN L + + + ++ +L +L+LSYN L L F++L L
Sbjct: 126 DGVFDKLTNLTYLNLAHNQL-QSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLK 184
Query: 427 HIDISYNKL 435
+ + N+L
Sbjct: 185 DLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 20/138 (14%)
Query: 90 NLTSISLNGTLLEFSFSSFPH--------LAYLDLYNNELFDIIPPQISN-LSKLEYLDF 140
NLT + L G S P+ L L L N+L +P + + L+ L YL+
Sbjct: 86 NLTYLILTGN----QLQSLPNGVFDKLTNLKELVLVENQL-QSLPDGVFDKLTNLTYLNL 140
Query: 141 LTNKLSGHIPSEI-SLLTHLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIP 198
N+L +P + LT+LT L +S NQL S+P V +L L L L N L S+P
Sbjct: 141 AHNQLQS-LPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL-KSVP 197
Query: 199 R-SLSNFTNLVFLYLYNN 215
T+L +++L++N
Sbjct: 198 DGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 27/154 (17%)
Query: 104 SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISL-----LTH 158
+ + + + N+++ + I L + YL NKL + LT+
Sbjct: 36 TQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLH-------DISALKELTN 86
Query: 159 LTILHISRNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIPRSLSN-FTNLVFLYLYNNS 216
LT L ++ NQL S+P+ V +L L L+L N L S+P + + TNL +L L +N
Sbjct: 87 LTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQL-QSLPDGVFDKLTNLTYLNLAHNQ 144
Query: 217 FSGSIPQQI----GNLKSLFDMKLCINQLNGAIP 246
S+P+ + NL L L NQL ++P
Sbjct: 145 LQ-SLPKGVFDKLTNLTELD---LSYNQLQ-SLP 173
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 19/109 (17%), Positives = 42/109 (38%), Gaps = 10/109 (9%)
Query: 330 EYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGE 389
+L +++ + L + + +++ + I L ++ L L N
Sbjct: 22 IKANLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQGI--QYLPNVRYLALGGN---- 73
Query: 390 KISSRIC--RMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLE 436
K+ + +L L L+ N L L F++L L + + N+L+
Sbjct: 74 KLHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ 122
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-09
Identities = 33/106 (31%), Positives = 55/106 (51%), Gaps = 6/106 (5%)
Query: 113 YLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTILHISRNQLNG 171
L+L +N+L + L++L L N++ +P + LT LTIL++ N+L
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHENKLQ- 89
Query: 172 SIPHEV-GQLNFLNHLILDSNFLGGSIPR-SLSNFTNLVFLYLYNN 215
S+P+ V +L L L LD+N L S+P T+L ++L+ N
Sbjct: 90 SLPNGVFDKLTQLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 36/105 (34%), Positives = 45/105 (42%), Gaps = 3/105 (2%)
Query: 307 RISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQ 366
R+ L NKL G L L L LS N + + L KL L L NKL Q
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKL-QS 90
Query: 367 IPIEL-DNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNN 410
+P + D L L EL L N L R+ SL+K+ L + N
Sbjct: 91 LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWL-HTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 28/96 (29%), Positives = 40/96 (41%), Gaps = 18/96 (18%)
Query: 105 FSSFPHLAYLDLYNNEL-------FDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-SLL 156
F L L L N++ FD L+KL L NKL +P+ + L
Sbjct: 48 FDKLTQLTKLSLSQNQIQSLPDGVFD-------KLTKLTILYLHENKLQS-LPNGVFDKL 99
Query: 157 THLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSN 191
T L L + NQL S+P + +L L + L +N
Sbjct: 100 TQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 28/105 (26%), Positives = 42/105 (40%), Gaps = 2/105 (1%)
Query: 282 QYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSN 341
L+L SN + + L ++SLS N++ G L L L L N L +
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQS 90
Query: 342 FVLESLGSLVKLYYLNLSHNKLSQQIPIE-LDNLIHLSELDLSHN 385
L +L L L N+L + +P D L L ++ L N
Sbjct: 91 LPNGVFDKLTQLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 29/106 (27%), Positives = 50/106 (47%), Gaps = 4/106 (3%)
Query: 330 EYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIEL-DNLIHLSELDLSHNFLG 388
L+L +N L + L +L L+LS N++ Q +P + D L L+ L L N L
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENKL- 88
Query: 389 EKISSRIC-RMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYN 433
+ + + + ++ L++L L N L + F+ L L I + N
Sbjct: 89 QSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.1 bits (137), Expect = 8e-09
Identities = 22/95 (23%), Positives = 34/95 (35%), Gaps = 2/95 (2%)
Query: 294 EIPTQLGNIIYLNRISLSGNKLSGRIP-GELGSLINLEYLDLSANHLSNFVLESLGSLVK 352
+ L L + + + + +L L L L + + L ++ +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 353 LYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFL 387
L LNLS N L + L L EL LS N L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.1 bits (137), Expect = 8e-09
Identities = 28/101 (27%), Positives = 42/101 (41%), Gaps = 4/101 (3%)
Query: 313 NKLSGRIPGELGSLINLEYLDLSAN-HLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIE- 370
+ L NL L + HL + L L L +L L + + L + +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75
Query: 371 LDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNL 411
LS L+LS N L E +S + + SL++L LS N L
Sbjct: 76 FHFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 21/104 (20%), Positives = 40/104 (38%), Gaps = 5/104 (4%)
Query: 360 HNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSR-ICRMESLEKLNLSYNNLSGLIPRC 418
+ L +L+EL + + + + R + + L L + + L + P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 419 FEELHGLLHIDISYNKLEGHIPNSTTFRDAPLE--ALQGNKGLC 460
F L +++S+N LE + T + L+ L GN C
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWK-TVQGLSLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 23/147 (15%), Positives = 46/147 (31%), Gaps = 9/147 (6%)
Query: 253 RCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQ-LGNIIYLNRISLS 311
S L + + + + + L L + + + + + L + L +++
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 312 GNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIEL 371
+ L P L L+LS N L + +++ L L L LS N P+
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGN------PLHC 117
Query: 372 DNLIHLSELDLSHNFLGEKISSRICRM 398
+ + G C
Sbjct: 118 SCALRWLQRWEEEGLGGVPEQKLQCHG 144
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 8e-06
Identities = 21/102 (20%), Positives = 36/102 (35%), Gaps = 2/102 (1%)
Query: 142 TNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEV-GQLNFLNHLILDSNFLGGSIPRS 200
T + + +LT L+I Q + L L +L + + L P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 201 LSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLN 242
L L L N+ S+ + SL ++ L N L+
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 21/111 (18%), Positives = 35/111 (31%), Gaps = 14/111 (12%)
Query: 73 CTW-SGIHCNHAGRVFGI-------NLTSISLNG-----TLLEFSFSSFPHLAYLDLYNN 119
SG+ C G + + NLT + + L L L + +
Sbjct: 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 120 ELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLN 170
L + P +L L+ N L + + L L +S N L+
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 2e-05
Identities = 21/98 (21%), Positives = 39/98 (39%), Gaps = 10/98 (10%)
Query: 196 SIPRSLSNFTNLVFLYLYNNSFSGSIP-QQIGNLKSLFDMKLCINQLNGAIPLSIDWG-- 252
L NL LY+ N + + + L L ++ + + L +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-----FVAPDAF 76
Query: 253 -RCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSN 289
P+LS L++S N + ++ ++ + LQ L LS N
Sbjct: 77 HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-09
Identities = 43/211 (20%), Positives = 84/211 (39%), Gaps = 37/211 (17%)
Query: 542 CSHPRQSFIVYEYLESGSLDKIL-------NNDASAKELGWTQRLNVIKGVADALFYLHN 594
S + + ++ E + G L L N+ ++ + + +AD + YL+
Sbjct: 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA 156
Query: 595 NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APE 649
N F VH D++++N ++ + + DF + + + ++ + K G G + +PE
Sbjct: 157 NKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY-ETDYYRK--GGKGLLPVRWMSPE 210
Query: 650 LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPY 703
T DV+SFGV+ E+ + P +S N ++L L
Sbjct: 211 SLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGLS------NEQVLRFVMEGGLLDK 261
Query: 704 PSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
P + + +M+ C NP RP+
Sbjct: 262 PD-NCPDMLFELMR---MCWQYNPKMRPSFL 288
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 8e-09
Identities = 47/190 (24%), Positives = 75/190 (39%), Gaps = 37/190 (19%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVK-----KFHSPLPD--------NFCSHP--------- 545
+G G G V++ SG +K + P+ HP
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 546 ---RQSFIVYEYLESGSL-DKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIV 601
+IV E E G L ++I++ A K L ++K + +AL Y H+ +V
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVV 146
Query: 602 HWDISSKNVLLDLGYEAH---VSDFRIAKFLNLDSSNWSKLAGTHGNVAPE-LAYTMKVT 657
H D+ +N+L + DF +A+ + + AGT +APE VT
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHSTNAAGTALYMAPEVFKR--DVT 203
Query: 658 EKCDVYSFGV 667
KCD++S GV
Sbjct: 204 FKCDIWSAGV 213
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 42/194 (21%), Positives = 70/194 (36%), Gaps = 37/194 (19%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVK-----KFHSPLPDNF------------CSHP----- 545
IGKG V +G+ FAVK KF S + HP
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 546 -------RQSFIVYEYLESGSL-DKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCF 597
++V+E+++ L +I+ + + ++ + +AL Y H+N
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN- 150
Query: 598 PPIVHWDISSKNVLLDLGYEAH---VSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTM 654
I+H D+ VLL + + F +A L GT +APE+
Sbjct: 151 --IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE 208
Query: 655 KVTEKCDVYSFGVL 668
+ DV+ GV+
Sbjct: 209 PYGKPVDVWGCGVI 222
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 47/198 (23%), Positives = 81/198 (40%), Gaps = 33/198 (16%)
Query: 549 FIVYEYLESGSLDKIL---NNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDI 605
++ +++ G L L + K + L + +A + YL N F +H D+
Sbjct: 117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNF---LHRDL 173
Query: 606 SSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTMKVTEKC 660
+++N +L V+DF ++K + S ++ + G + A E T K
Sbjct: 174 AARNCMLRDDMTVCVADFGLSK--KIYSGDYYR-QGRIAKMPVKWIAIESLADRVYTSKS 230
Query: 661 DVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQNKFMS 714
DV++FGV E+ +G P + N E+ D RL P D ++
Sbjct: 231 DVWAFGVTMWEIATRGMTP---YPGVQ------NHEMYDYLLHGHRLKQPE-DCLDELYE 280
Query: 715 IMQVAFSCLDQNPVSRPT 732
IM SC +P+ RPT
Sbjct: 281 IMY---SCWRTDPLDRPT 295
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 56/274 (20%), Positives = 100/274 (36%), Gaps = 68/274 (24%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVK-----KFHSPLPDNFC-------------------- 542
+G G +G V + + A+K +F +
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 543 SHP------------RQSFIVYEYLESGSL-DKILN------NDASAKELGWTQRLNVIK 583
HP + ++V E+ E G L ++I+N DA+ N++K
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA----------NIMK 153
Query: 584 GVADALFYLHNNCFPPIVHWDISSKNVLL---DLGYEAHVSDFRIAKFLNLDSSNWSKLA 640
+ + YLH + IVH DI +N+LL + + DF ++ F +
Sbjct: 154 QILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS-KDYKLRDRL 209
Query: 641 GTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR 700
GT +APE K EKCDV+S GV+ ++ G P F + ++ ++ +
Sbjct: 210 GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP--F---GGQNDQDIIKKVEKGK 263
Query: 701 LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+ D +N ++ L + R T +
Sbjct: 264 YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAE 297
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 39/199 (19%), Positives = 70/199 (35%), Gaps = 41/199 (20%)
Query: 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD------------NFCSHPR-- 546
+G G G V+ +G A K + N H
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 547 ----------QSFIVYEYLESGSL-DKILNNDASAKELGWTQR--LNVIKGVADALFYLH 593
+V EY++ G L D+I+ + T+ + +K + + + ++H
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRII-----DESYNLTELDTILFMKQICEGIRHMH 204
Query: 594 NNCFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNWSKLAGTHGNVAPE-L 650
I+H D+ +N+L + DF +A+ GT +APE +
Sbjct: 205 QM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKLKVNFGTPEFLAPEVV 260
Query: 651 AYTMKVTEKCDVYSFGVLA 669
Y V+ D++S GV+A
Sbjct: 261 NYD-FVSFPTDMWSVGVIA 278
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 42/192 (21%), Positives = 76/192 (39%), Gaps = 47/192 (24%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKFH-SPLPDNF---------CSHP------------ 545
+G+G VY + + + +A+K + SHP
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETP 120
Query: 546 RQSFIVYEYLESGSL-DKILN------NDASAKELGWTQRLNVIKGVADALFYLHNNCFP 598
+ +V E + G L D+I+ DA+ + +K + +A+ YLH N
Sbjct: 121 TEISLVLELVTGGELFDRIVEKGYYSERDAA----------DAVKQILEAVAYLHENG-- 168
Query: 599 PIVHWDISSKNVLL-DLGYEAHV--SDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMK 655
IVH D+ +N+L +A + +DF ++K + + GT G APE+
Sbjct: 169 -IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKTVCGTPGYCAPEILRGCA 226
Query: 656 VTEKCDVYSFGV 667
+ D++S G+
Sbjct: 227 YGPEVDMWSVGI 238
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 39/198 (19%), Positives = 78/198 (39%), Gaps = 33/198 (16%)
Query: 549 FIVYEYLESGSLDKIL---NNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDI 605
++ +++ G L L + L + + +A + YL + F +H D+
Sbjct: 107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNF---IHRDL 163
Query: 606 SSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-----APELAYTMKVTEKC 660
+++N +L V+DF +++ + S ++ + G + A E T
Sbjct: 164 AARNCMLAEDMTVCVADFGLSR--KIYSGDYYR-QGCASKLPVKWLALESLADNLYTVHS 220
Query: 661 DVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-----RLPYPSLDVQNKFMS 714
DV++FGV E++ +G+ P + N EI + RL P + +
Sbjct: 221 DVWAFGVTMWEIMTRGQTP---YAGIE------NAEIYNYLIGGNRLKQPP-ECMEEVYD 270
Query: 715 IMQVAFSCLDQNPVSRPT 732
+M C +P RP+
Sbjct: 271 LMY---QCWSADPKQRPS 285
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 43/200 (21%), Positives = 75/200 (37%), Gaps = 52/200 (26%)
Query: 506 KHCIGKGGHGSVYIAR-VPSGEIFAVKKFH-SPLP-----------------------DN 540
K +G G +G V +G+ A+K + SP +N
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYEN 93
Query: 541 FCSHPRQSFIVYEYLESGSL-DKILN--------NDASAKELGWTQRLNVIKGVADALFY 591
R I+ E +E G L +I +A+ +++ + A+ +
Sbjct: 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA----------EIMRDIGTAIQF 143
Query: 592 LHNNCFPPIVHWDISSKNVLL-DLGYEAHV--SDFRIAKFLNLDSSNWSKLAGTHGNVAP 648
LH++ I H D+ +N+L +A + +DF AK + T VAP
Sbjct: 144 LHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPCYTPYYVAP 198
Query: 649 ELAYTMKVTEKCDVYSFGVL 668
E+ K + CD++S GV+
Sbjct: 199 EVLGPEKYDKSCDMWSLGVI 218
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 43/201 (21%), Positives = 77/201 (38%), Gaps = 41/201 (20%)
Query: 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFH-SPLPD-----------NFCSHPR 546
+ +D +G G G V+ +G +F K + D N HP+
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 547 ------------QSFIVYEYLESGSL-DKILNNDASAKELGWTQR--LNVIKGVADALFY 591
+ ++ E+L G L D+I A++ ++ +N ++ + L +
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIA-----AEDYKMSEAEVINYMRQACEGLKH 164
Query: 592 LHNNCFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNWSKLAGTHGNVAPE 649
+H + IVH DI +N++ + + V DF +A LN T APE
Sbjct: 165 MHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPE 220
Query: 650 -LAYTMKVTEKCDVYSFGVLA 669
+ V D+++ GVL
Sbjct: 221 IVDREP-VGFYTDMWAIGVLG 240
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 65/295 (22%), Positives = 111/295 (37%), Gaps = 79/295 (26%)
Query: 492 VYEEIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIF---AVK--KFHSPLPD------- 539
+Y + ND + IG+G G V AR+ + A+K K ++ D
Sbjct: 18 IYPVLDW--NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGE 75
Query: 540 -----NFCSHP------------RQSFIVYEYLESGSLDKIL-------------NNDAS 569
HP ++ EY G+L L +++
Sbjct: 76 LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 135
Query: 570 AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629
A L Q L+ VA + YL F +H D++++N+L+ Y A ++DF +++
Sbjct: 136 ASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR-- 190
Query: 630 NLDSSNWSKLAGTHGNV-----APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFL 682
+ K T G + A E L Y+ T DV+S+GVL E++ G P
Sbjct: 191 --GQEVYVK--KTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTP---Y 242
Query: 683 FEMSSSSSNMNIEILDS-----RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT 732
M+ E+ + RL P + ++ +M+ C + P RP+
Sbjct: 243 CGMT------CAELYEKLPQGYRLEKPL-NCDDEVYDLMR---QCWREKPYERPS 287
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 42/198 (21%), Positives = 75/198 (37%), Gaps = 35/198 (17%)
Query: 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD------------NFCSHPR 546
+ +D +G G G V+ +G FA K +P + HP
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 547 -----QSF-------IVYEYLESGSL-DKILNNDASAKELGWTQRLNVIKGVADALFYLH 593
+F ++YE++ G L +K+ + E + + ++ V L ++H
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED---EAVEYMRQVCKGLCHMH 272
Query: 594 NNCFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNWSKLAGTHGNVAPELA 651
N VH D+ +N++ + DF + L+ + GT APE+A
Sbjct: 273 EN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSVKVTTGTAEFAAPEVA 328
Query: 652 YTMKVTEKCDVYSFGVLA 669
V D++S GVL+
Sbjct: 329 EGKPVGYYTDMWSVGVLS 346
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 49/215 (22%), Positives = 84/215 (39%), Gaps = 55/215 (25%)
Query: 494 EEIIRATNDFDAK----HCIGKGGHGSVYIAR-VPSGEIFAVK-----KFHSPLPDNF-- 541
E ++ A+ F +GKG V +G FA K K +
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 542 -------CSHP------------RQSFIVYEYLESGSL-DKILN------NDASAKELGW 575
HP ++V++ + G L + I+ DAS
Sbjct: 78 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS------ 131
Query: 576 TQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL-DLGYEAHV--SDFRIAKFLNLD 632
+ I+ + +++ Y H+N IVH ++ +N+LL A V +DF +A +N D
Sbjct: 132 ----HCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-D 183
Query: 633 SSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGV 667
S W AGT G ++PE+ ++ D+++ GV
Sbjct: 184 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 4e-08
Identities = 48/205 (23%), Positives = 84/205 (40%), Gaps = 51/205 (24%)
Query: 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVK-----KFHSPLPDNF---------CSH 544
++++D K +GKG V +G FA K K + H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 545 P------------RQSFIVYEYLESGSL-DKILNN------DASAKELGWTQRLNVIKGV 585
P ++V++ + G L + I+ DAS + I+ +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS----------HCIQQI 114
Query: 586 ADALFYLHNNCFPPIVHWDISSKNVLL-DLGYEAHV--SDFRIAKFLNLDSSNWSKLAGT 642
+++ Y H+N IVH ++ +N+LL A V +DF +A +N DS W AGT
Sbjct: 115 LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGT 170
Query: 643 HGNVAPELAYTMKVTEKCDVYSFGV 667
G ++PE+ ++ D+++ GV
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGV 195
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 46/196 (23%), Positives = 73/196 (37%), Gaps = 52/196 (26%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVK-----KFHSPLPDNF---------CSHP-------- 545
+GKG G V + + + +AVK + HP
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 546 ----RQSFIVYEYLESGSL-DKILN------NDASAKELGWTQRLNVIKGVADALFYLHN 594
+IV E G L D+I+ +DA+ +IK V + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIKQVFSGITYMHK 139
Query: 595 NCFPPIVHWDISSKNVLL-DLGYEAH--VSDFRIAKFLNLDSSNWSKLAGTHGNVAPELA 651
+ IVH D+ +N+LL + + DF ++ ++ GT +APE+
Sbjct: 140 HN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYIAPEV- 194
Query: 652 YTMKVTEKCDVYSFGV 667
EKCDV+S GV
Sbjct: 195 LRGTYDEKCDVWSAGV 210
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 4e-08
Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 45/218 (20%)
Query: 542 CSHPRQSFIVYEYLESGSLDKIL-------------NNDASAKELGWTQRLNVIKGVADA 588
C +V+EY++ G L+K L + ELG +Q L++ +A
Sbjct: 86 CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASG 145
Query: 589 LFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-- 646
+ YL + F VH D++++N L+ + DF +++ ++ S+++ + G H +
Sbjct: 146 MVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYR-VGGHTMLPI 199
Query: 647 ---APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-- 699
PE + Y K T + DV+SFGV+ E+ GK P F++S N E+++
Sbjct: 200 RWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQP---WFQLS------NTEVIECIT 249
Query: 700 ---RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
L P + +M C + P R +K
Sbjct: 250 QGRVLERPR-VCPKEVYDVML---GCWQREPQQRLNIK 283
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 53/364 (14%), Positives = 100/364 (27%), Gaps = 59/364 (16%)
Query: 118 NNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEV 177
N + + I NL LE + KL + L L N EV
Sbjct: 11 NRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEFQNQRFSAEV 70
Query: 178 GQLNFLNHLILDSNFLGGSIPRSL-----SNFTNLVFLYLYNNSFSG----SIPQQIGNL 228
L+ L L L + + S L + L + ++
Sbjct: 71 --LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRA 128
Query: 229 KSLFDMKLCINQL--NGAIPLS-IDWGRCPQLSLLDVSINNITGN----IPFEIGESPQL 281
+ L L +N L L + Q++ L +S N +T + + + +
Sbjct: 129 RKLG---LQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSV 185
Query: 282 QYLDLSSNYI----VGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLI----NLEYLD 333
+L L + + + QL L ++++ N L +LE L
Sbjct: 186 THLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLH 245
Query: 334 LSANHLSNF-------VLESLGSLVKLYYLNLSHNKLSQQ---------------IPIEL 371
L N LS+ + + ++ +S+ +
Sbjct: 246 LYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARV 305
Query: 372 DNLIHLSELDLSHNFLG----EKISSRICRMESLEKLNLSYNNLSG----LIPRCFEELH 423
+ L DL + + + + + L + FE+
Sbjct: 306 QRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSGSPSGSWSHPQFEKGA 365
Query: 424 GLLH 427
G H
Sbjct: 366 GHHH 369
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 6e-08
Identities = 40/197 (20%), Positives = 66/197 (33%), Gaps = 56/197 (28%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF------------CSHP---------- 545
IG+G G V IA + A KK ++ HP
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 546 --RQSFIVYEYLESGSL-DKILN------NDASAKELGWTQRLNVIKGVADALFYLHNNC 596
++V E G L +++++ +DA+ ++K V A+ Y H
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDAA----------RIMKDVLSAVAYCHKL- 125
Query: 597 FPPIVHWDISSKNVLL---DLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPEL--- 650
+ H D+ +N L + DF +A GT V+P++
Sbjct: 126 --NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTKVGTPYYVSPQVLEG 182
Query: 651 AYTMKVTEKCDVYSFGV 667
Y +CD +S GV
Sbjct: 183 LYG----PECDEWSAGV 195
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 7e-08
Identities = 50/245 (20%), Positives = 74/245 (30%), Gaps = 78/245 (31%)
Query: 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVK-----KFHSPLPDNF------------ 541
+ K IG+G +G V +A + I A+K K P +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 542 CSHPRQS------------FIVYEYLESGSL-DKILNNDASAKELGWTQRL--------- 579
HP + +V E G L DK+ + +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 580 ---------------------------NVIKGVADALFYLHNNCFPPIVHWDISSKNVLL 612
N+++ + AL YLHN I H DI +N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLF 201
Query: 613 DLGYEAHV--SDFRIAKFLNL----DSSNWSKLAGTHGNVAPEL--AYTMKVTEKCDVYS 664
+ DF ++K + + AGT VAPE+ KCD +S
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 665 FGVLA 669
GVL
Sbjct: 262 AGVLL 266
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 50/265 (18%), Positives = 84/265 (31%), Gaps = 84/265 (31%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVK---KFHSPLPDN------------FCSH 544
+DF+ IG+G V + + +G+++A+K K+
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 545 PRQSFIV------------Y---EYLESGSL-------DKILNNDAS---AKELGWTQRL 579
+I Y EY G L + + + + E+
Sbjct: 121 R---WITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEI------ 171
Query: 580 NVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNWS 637
A+ +H VH DI N+LLD H+ +DF L D + S
Sbjct: 172 ------VMAIDSVHRLG---YVHRDIKPDNILLD--RCGHIRLADFGSCLKLRADGTVRS 220
Query: 638 KLA-GTHGNVAPELAYTMKVTEK-------CDVYSFGVLALEVIKGKHP-----RDFLFE 684
+A GT ++PE+ + CD ++ GV A E+ G+ P +
Sbjct: 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG 280
Query: 685 MSSSSSNMNIEILDSRLPYPSLDVQ 709
I L P +D
Sbjct: 281 --------KIVHYKEHLSLPLVDEG 297
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 53/256 (20%), Positives = 87/256 (33%), Gaps = 76/256 (29%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVK---KFHSPLPDN------------FCSH 544
DF+ IG+G G V + + + ++FA+K K+
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 545 PRQSFIV------------Y---EYLESGSL--------DKILNNDAS--AKELGWTQRL 579
+I Y +Y G L D++ A E+
Sbjct: 134 K---WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM------ 184
Query: 580 NVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNWS 637
A+ +H VH DI N+L+D H+ +DF L D + S
Sbjct: 185 ------VIAIDSVHQLH---YVHRDIKPDNILMD--MNGHIRLADFGSCLKLMEDGTVQS 233
Query: 638 KLA-GTHGNVAPELAYTMKVTEK-----CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN 691
+A GT ++PE+ M+ + CD +S GV E++ G+ P F + S
Sbjct: 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP----FY-AESLVE 288
Query: 692 M--NIEILDSRLPYPS 705
I R +P+
Sbjct: 289 TYGKIMNHKERFQFPT 304
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 52/257 (20%), Positives = 90/257 (35%), Gaps = 85/257 (33%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVK---KFH--------------SPLPDNFC 542
DF +G+G +V +AR + + +A+K K H + +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM--SRL 87
Query: 543 SHPRQSFIV------------Y---EYLESGSL------DKILNNDAS---AKELGWTQR 578
HP F V Y Y ++G L + + E
Sbjct: 88 DHP---FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE------ 138
Query: 579 LNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSN- 635
+ AL YLH I+H D+ +N+LL+ + H+ +DF AK L+ +S
Sbjct: 139 ------IVSALEYLHGK---GIIHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQA 187
Query: 636 --WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEMSSS 688
S GT V+PEL + D+++ G + +++ G P +F+
Sbjct: 188 RANS-FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK--- 243
Query: 689 SSNMNIEILDSRLPYPS 705
I+ +P
Sbjct: 244 -------IIKLEYDFPE 253
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 39/198 (19%), Positives = 78/198 (39%), Gaps = 48/198 (24%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKF------------------------HSP----LPD 539
+G+G V +G+ +A K P L +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 540 NFCSHPRQSFIVYEYLESGSL-DKILNNDASAKELGW-TQR--LNVIKGVADALFYLHNN 595
+ + + ++ EY G + L + ++ + +IK + + ++YLH N
Sbjct: 97 VY-ENTSEIILILEYAAGGEIFSLCL-----PELAEMVSENDVIRLIKQILEGVYYLHQN 150
Query: 596 CFPPIVHWDISSKNVLLDLGYEAH---VSDFRIAKFLNLDSSNWSKLAGTHGNVAPE-LA 651
IVH D+ +N+LL Y + DF +++ + + ++ GT +APE L
Sbjct: 151 N---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIMGTPEYLAPEILN 206
Query: 652 YTMKVTEKCDVYSFGVLA 669
Y +T D+++ G++A
Sbjct: 207 YD-PITTATDMWNIGIIA 223
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 4e-07
Identities = 41/217 (18%), Positives = 85/217 (39%), Gaps = 43/217 (19%)
Query: 542 CSHPRQSFIVYEYLESGSLDKIL-------------NNDASAKELGWTQRLNVIKGVADA 588
+ + +++ Y G L + L ++ L ++++ +A
Sbjct: 81 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAG 140
Query: 589 LFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-- 646
+ YL ++ VH D++++NVL+ +SD + + + ++++ K + +
Sbjct: 141 MEYLSSHHV---VHKDLATRNVLVYDKLNVKISDLGLFR--EVYAADYYK-LLGNSLLPI 194
Query: 647 ---APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS--- 699
APE K + D++S+GV+ EV G P S N ++++
Sbjct: 195 RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP---YCGYS------NQDVVEMIRN 245
Query: 700 --RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
LP P D ++M C ++ P RP K
Sbjct: 246 RQVLPCPD-DCPAWVYALMI---ECWNEFPSRRPRFK 278
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 44/198 (22%), Positives = 76/198 (38%), Gaps = 53/198 (26%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVK-------------------------KFHSPLPDNFC 542
+G G +G V + E FA+K + + +N
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD-VYENLY 128
Query: 543 SHPRQSFIVYEYLESGSL-DKILN--------NDASAKELGWTQRLNVIKGVADALFYLH 593
+ + IV E L+ G L +I + +AS ++K + +A+ YLH
Sbjct: 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS----------EIMKSIGEAIQYLH 178
Query: 594 NNCFPPIVHWDISSKNVLL-DLGYEAHV--SDFRIAKFLNLDSSNWSKLAGTHGNVAPEL 650
+ I H D+ +N+L A + +DF AK ++ + T VAPE+
Sbjct: 179 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPCYTPYYVAPEV 234
Query: 651 AYTMKVTEKCDVYSFGVL 668
K + CD++S GV+
Sbjct: 235 LGPEKYDKSCDMWSLGVI 252
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 37/174 (21%), Positives = 61/174 (35%), Gaps = 59/174 (33%)
Query: 585 VADALFYL-HNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTH 643
VA + +L C +H D++++N+LL + DF +A+ + D +
Sbjct: 202 VAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---VRKGD 254
Query: 644 GNV-----APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD 698
+ APE + T + DV+SFGVL L+E+ S ++
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVL-------------LWEIFSLGAS------- 294
Query: 699 SRLPYPSLDVQNKFM--------------------SIMQVAFSCLDQNPVSRPT 732
PYP + + +F M C P RPT
Sbjct: 295 ---PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML---DCWHGEPSQRPT 342
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 46/224 (20%), Positives = 78/224 (34%), Gaps = 66/224 (29%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSP--LPDN-------------FCSH 544
D++ IG+G G V + R + +++A+K + + F +
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 545 PRQSFIV------------Y---EYLESGSL------DKILNNDAS--AKELGWTQRLNV 581
P ++V Y EY+ G L + A E
Sbjct: 129 P---WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAE--------- 176
Query: 582 IKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNWSKL 639
V AL +H+ +H D+ N+LLD H+ +DF +N +
Sbjct: 177 ---VVLALDAIHSMG---FIHRDVKPDNMLLD--KSGHLKLADFGTCMKMNKEGMVRCDT 228
Query: 640 A-GTHGNVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 678
A GT ++PE+ +CD +S GV E++ G P
Sbjct: 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 35/133 (26%), Positives = 53/133 (39%), Gaps = 34/133 (25%)
Query: 588 ALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNWSKLAGTHGN 645
L +LH I++ D+ +NVLLD + +V SD +A L + AGT G
Sbjct: 301 GLEHLHQRN---IIYRDLKPENVLLD--DDGNVRISDLGLAVELKAGQTKTKGYAGTPGF 355
Query: 646 VAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP---------RDFLFEMSSSSSNM 692
+APEL Y V D ++ GV E+I + P L +
Sbjct: 356 MAPELLLGEEYDFSV----DYFALGVTLYEMIAARGPFRARGEKVENKELKQR------- 404
Query: 693 NIEILDSRLPYPS 705
+L+ + YP
Sbjct: 405 ---VLEQAVTYPD 414
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 51/227 (22%), Positives = 84/227 (37%), Gaps = 68/227 (29%)
Query: 542 CSHPRQSFIVYEYLESGSL-----------DKILNNDASAKELGWTQRLNVIKGVADALF 590
C+H ++ EY G L + + L+ VA +
Sbjct: 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMA 178
Query: 591 YLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---- 646
+L + +H D++++NVLL G+ A + DF +A+ + DS+ + + +
Sbjct: 179 FLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY---IVKGNARLPVKW 232
Query: 647 -APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPS 705
APE + T + DV+S+G+L L+E+ S N PYP
Sbjct: 233 MAPESIFDCVYTVQSDVWSYGIL-------------LWEIFSLGLN----------PYPG 269
Query: 706 LDVQNKFM--------------------SIMQVAFSCLDQNPVSRPT 732
+ V +KF SIMQ +C P RPT
Sbjct: 270 ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQ---ACWALEPTHRPT 313
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 40/204 (19%), Positives = 69/204 (33%), Gaps = 58/204 (28%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVK---------KFHSPLPDNF---------CSHPR--- 546
+G G V R +G +A K + HP
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 547 ---------QSFIVYEYLESGSL-DKILN------NDASAKELGWTQRLNVIKGVADALF 590
++ E + G L D + +A+ + IK + D +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT----------SFIKQILDGVN 129
Query: 591 YLHNNCFPPIVHWDISSKNVLLDLGYEAH----VSDFRIAKFLNLDSSNWSKLAGTHGNV 646
YLH I H+D+ +N++L + DF +A + D + + GT V
Sbjct: 130 YLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTPEFV 185
Query: 647 APE-LAYTMKVTEKCDVYSFGVLA 669
APE + Y + + D++S GV+
Sbjct: 186 APEIVNYE-PLGLEADMWSIGVIT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 40/213 (18%), Positives = 71/213 (33%), Gaps = 58/213 (27%)
Query: 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVK-------KFHSPLPD-----------N 540
+ +D +G G V R +G +A K +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 541 FCSHPR------------QSFIVYEYLESGSL-DKILN------NDASAKELGWTQRLNV 581
H ++ E + G L D + +A+ +
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT----------SF 120
Query: 582 IKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAH----VSDFRIAKFLNLDSSNWS 637
IK + D + YLH I H+D+ +N++L + DF +A + D +
Sbjct: 121 IKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFK 176
Query: 638 KLAGTHGNVAPE-LAYTMKVTEKCDVYSFGVLA 669
+ GT VAPE + Y + + D++S GV+
Sbjct: 177 NIFGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 208
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 44/266 (16%), Positives = 88/266 (33%), Gaps = 37/266 (13%)
Query: 129 ISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLIL 188
S+ S + LD L + + + R+ ++ + + +
Sbjct: 43 ASDESLWQTLDLTGKNLHPDVTGRLLSQGVI-AFRCPRSFMDQPLAEHFSPFRVQHMDLS 101
Query: 189 DSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLS 248
+S ++ LS + L L L S I + +L +
Sbjct: 102 NSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNL---------------VR 146
Query: 249 IDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNII----- 303
++ C S + ++ + + +L L+LS + E + +
Sbjct: 147 LNLSGCSGFS--EFALQTLLSSCS-------RLDELNLSWCFDFTE--KHVQVAVAHVSE 195
Query: 304 YLNRISLSG--NKLSGRIPGELG-SLINLEYLDLS-ANHLSNFVLESLGSLVKLYYLNLS 359
+ +++LSG L L NL +LDLS + L N + L L +L+LS
Sbjct: 196 TITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLS 255
Query: 360 H-NKLSQQIPIELDNLIHLSELDLSH 384
+ + +EL + L L +
Sbjct: 256 RCYDIIPETLLELGEIPTLKTLQVFG 281
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 43/256 (16%), Positives = 81/256 (31%), Gaps = 40/256 (15%)
Query: 48 SLEVHSRSLLHSWSLSFVNATKISL-CTWSGIHCNHAGRVFGINLTSISLNGTL-----L 101
+L++ ++L + ++ I+ C S + A + + L+ ++ L
Sbjct: 51 TLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 110
Query: 102 EFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDF-----LTNKLSGHIPSEISLL 156
S L L L L D I ++ S L L+ + + S S L
Sbjct: 111 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 170
Query: 157 THLTI---LHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLY 213
L + + + ++ H + LN N + + NLV L L
Sbjct: 171 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS 230
Query: 214 NNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVS-INNITGNIP 272
++ + N C + + L L +S +I
Sbjct: 231 DSV-------MLKN--------DCFQEF----------FQLNYLQHLSLSRCYDIIPETL 265
Query: 273 FEIGESPQLQYLDLSS 288
E+GE P L+ L +
Sbjct: 266 LELGEIPTLKTLQVFG 281
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 9e-04
Identities = 36/143 (25%), Positives = 60/143 (41%), Gaps = 21/143 (14%)
Query: 305 LNRISLSGNKLS-GRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSH-NK 362
+ + LS + + + G L L+ L L LS+ ++ +L L LNLS +
Sbjct: 95 VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSG 154
Query: 363 LSQQIPIEL-DNLIHLSELDLSHNFL-----GEKISSRICRMESLEKLNLSYNN------ 410
S+ L + L EL+LS F + + + ++ +LNLS
Sbjct: 155 FSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSE--TITQLNLSGYRKNLQKS 212
Query: 411 -LSGLIPRCFEELHGLLHIDISY 432
LS L+ RC L+H+D+S
Sbjct: 213 DLSTLVRRC----PNLVHLDLSD 231
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 38/204 (18%), Positives = 73/204 (35%), Gaps = 58/204 (28%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVK---------KFHSPLPDNF---------CSHPR--- 546
+G G V R +G +A K ++ HP
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 547 ---------QSFIVYEYLESGSL-DKILNN------DASAKELGWTQRLNVIKGVADALF 590
++ E + G L D + +A+ +K + + ++
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT----------EFLKQILNGVY 128
Query: 591 YLHNNCFPPIVHWDISSKNVLL-DLGYEAH---VSDFRIAKFLNLDSSNWSKLAGTHGNV 646
YLH+ I H+D+ +N++L D + DF +A ++ + + + GT V
Sbjct: 129 YLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFKNIFGTPEFV 184
Query: 647 APE-LAYTMKVTEKCDVYSFGVLA 669
APE + Y + + D++S GV+
Sbjct: 185 APEIVNYE-PLGLEADMWSIGVIT 207
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 29/97 (29%), Positives = 43/97 (44%), Gaps = 16/97 (16%)
Query: 588 ALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNWSKLAGTHGN 645
L LH IV+ D+ +N+LLD H+ SD +A + + GT G
Sbjct: 298 GLEDLHRER---IVYRDLKPENILLD--DHGHIRISDLGLAVHVPEGQTIKG-RVGTVGY 351
Query: 646 VAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 678
+APE+ YT D ++ G L E+I G+ P
Sbjct: 352 MAPEVVKNERYTFSP----DWWALGCLLYEMIAGQSP 384
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 5e-06
Identities = 44/215 (20%), Positives = 76/215 (35%), Gaps = 69/215 (32%)
Query: 506 KHCIGKGGHGSVYIAR-VPSGEIFAVK---KFHSPLPD------------NFCSHP---- 545
+ +G+G H V + + + +AVK K P H
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 546 --------RQSFIVYEYLESGSL-DKILNN------DASAKELGWTQRLNVIKGVADALF 590
+ ++V+E + GS+ I +AS V++ VA AL
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS----------VVVQDVASALD 125
Query: 591 YLHNNCFPPIVHWDISSKNVLLDLGYEAHVS-----DFRIAKFLNLDSS-------NWSK 638
+LHN I H D+ +N+L + + VS DF + + L+
Sbjct: 126 FLHNKG---IAHRDLKPENILCE--HPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 639 LAGTHGNVAPE-----LAYTMKVTEKCDVYSFGVL 668
G+ +APE ++CD++S GV+
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 46/217 (21%), Positives = 86/217 (39%), Gaps = 43/217 (19%)
Query: 542 CSHPRQSFIVYEYLESGSLDKIL-------------NNDASAKELGWTQRLNVIKGVADA 588
C+ +++ EY G+L + L N +++ + ++ +A
Sbjct: 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 169
Query: 589 LFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-- 646
+ YL + +H D++++NVL+ ++DF +A+ +N T+G +
Sbjct: 170 MEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---KKTTNGRLPV 223
Query: 647 ---APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS--- 699
APE + T + DV+SFGVL E+ G P + E+
Sbjct: 224 KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP---YPGIP------VEELFKLLKE 274
Query: 700 --RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
R+ P+ + N+ +M+ C P RPT K
Sbjct: 275 GHRMDKPA-NCTNELYMMMR---DCWHAVPSQRPTFK 307
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 8e-06
Identities = 30/93 (32%), Positives = 44/93 (47%), Gaps = 6/93 (6%)
Query: 125 IPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEV-GQLNFL 183
+P I + + L N+++ P LT LT L + NQL +P V +L L
Sbjct: 24 VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQL 80
Query: 184 NHLILDSNFLGGSIPR-SLSNFTNLVFLYLYNN 215
L L+ N L SIPR + N +L ++L NN
Sbjct: 81 TQLSLNDNQL-KSIPRGAFDNLKSLTHIWLLNN 112
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 62/282 (21%), Positives = 108/282 (38%), Gaps = 90/282 (31%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAV---KK------------------------ 532
N+F+ +GKG G V + + +G +A+ KK
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 533 -FHSPLPDNFCSHPRQSFIVYEYLESGSL------DKILNNDAS---AKELGWTQRLNVI 582
F + L +F +H R F V EY G L +++ + D + E
Sbjct: 208 PFLTALKYSFQTHDRLCF-VMEYANGGELFFHLSRERVFSEDRARFYGAE---------- 256
Query: 583 KGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNWSKLA 640
+ AL YLH+ +V+ D+ +N++LD + H+ +DF + K D +
Sbjct: 257 --IVSALDYLHSEK--NVVYRDLKLENLMLD--KDGHIKITDFGLCKEGIKDGATMKTFC 310
Query: 641 GTHGNVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEMSSSSSN 691
GT +APE+ Y V D + GV+ E++ G+ P + LFE+
Sbjct: 311 GTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLPFYNQDHEKLFEL------ 360
Query: 692 MNIEILDSRLPYP---SLDVQNKFMSIMQVAFSCLDQNPVSR 730
IL + +P + + S++ L ++P R
Sbjct: 361 ----ILMEEIRFPRTLGPEAK----SLLS---GLLKKDPKQR 391
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 6/93 (6%)
Query: 125 IPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEV-GQLNFL 183
+P I + + L N+++ P L +L L+ + N+L +IP V +L L
Sbjct: 27 VPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQL 83
Query: 184 NHLILDSNFLGGSIPR-SLSNFTNLVFLYLYNN 215
L L+ N L SIPR + N +L +YLYNN
Sbjct: 84 TQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 8e-05
Identities = 29/81 (35%), Positives = 42/81 (51%), Gaps = 4/81 (4%)
Query: 113 YLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEI-SLLTHLTILHISRNQLNG 171
L L NN++ + P +L L+ L F +NKL+ IP+ + LT LT L ++ N L
Sbjct: 37 RLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLNDNHLK- 94
Query: 172 SIPHEV-GQLNFLNHLILDSN 191
SIP L L H+ L +N
Sbjct: 95 SIPRGAFDNLKSLTHIYLYNN 115
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 43/216 (19%), Positives = 74/216 (34%), Gaps = 43/216 (19%)
Query: 542 CSHPRQS-FIVYEYLESGSL-------------DKILNNDASAKELGWTQRLNVIKGVAD 587
C+ P ++ E+ + G+L K+ D L + VA
Sbjct: 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAK 159
Query: 588 ALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV- 646
+ +L + +H D++++N+LL + DF +A+ + D + +
Sbjct: 160 GMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---VRKGDARLP 213
Query: 647 ----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS-- 699
APE + T + DV+SFGVL E+ G P + + E
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP---YPGVKI-----DEEFCRRLK 265
Query: 700 ---RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT 732
R+ P + M C P RPT
Sbjct: 266 EGTRMRAPD-YTTPEMYQTML---DCWHGEPSQRPT 297
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 57/280 (20%), Positives = 88/280 (31%), Gaps = 93/280 (33%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVK-------------KFHSPLP---------DNFCSHP 545
+GKGG G+V+ + A+K P HP
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 546 ------------RQSFIVYEYLESGS--LDKILNNDASAKELGWTQRL------NVIKGV 585
+V E D I L V
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK----------GPLGEGPSRCFFGQV 148
Query: 586 ADALFYLHNNCFPPIVHWDISSKNVLLDLGY-EAHVSDFRIAKFLNLDSSNWSKLAGTHG 644
A+ + H+ +VH DI +N+L+DL A + DF L+ ++ GT
Sbjct: 149 VAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDFDGTRV 203
Query: 645 NVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR 700
PE Y V+S G+L +++ G P FE EIL++
Sbjct: 204 YSPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIP----FERDQ-------EILEAE 249
Query: 701 LPYPSLDVQNKFMS------IMQVAFSCLDQNPVSRPTMK 734
L +P+ +S I + CL P SRP+++
Sbjct: 250 LHFPA------HVSPDCCALIRR----CLAPKPSSRPSLE 279
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 46/217 (21%), Positives = 86/217 (39%), Gaps = 43/217 (19%)
Query: 542 CSHPRQSFIVYEYLESGSLDKIL-------------NNDASAKELGWTQRLNVIKGVADA 588
C+ +++ EY G+L + L N +++ + ++ +A
Sbjct: 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 215
Query: 589 LFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-- 646
+ YL + +H D++++NVL+ ++DF +A+ +N T+G +
Sbjct: 216 MEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---KKTTNGRLPV 269
Query: 647 ---APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS--- 699
APE + T + DV+SFGVL E+ G P + E+
Sbjct: 270 KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP---YPGIP------VEELFKLLKE 320
Query: 700 --RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
R+ P+ + N+ +M+ C P RPT K
Sbjct: 321 GHRMDKPA-NCTNELYMMMR---DCWHAVPSQRPTFK 353
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 45/215 (20%), Positives = 82/215 (38%), Gaps = 43/215 (20%)
Query: 542 CSHPRQSFIVYEYLESGSL-------------DKILNNDASAKELGWTQRLNVIKGVADA 588
C+ +++ EY G+L + ++L ++ VA
Sbjct: 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARG 203
Query: 589 LFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV-- 646
+ YL + +H D++++NVL+ ++DF +A+ ++ T+G +
Sbjct: 204 MEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY---KKTTNGRLPV 257
Query: 647 ---APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDS--- 699
APE + T + DV+SFGVL E+ G P + E+
Sbjct: 258 KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP---YPGVP------VEELFKLLKE 308
Query: 700 --RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPT 732
R+ PS + N+ +M+ C P RPT
Sbjct: 309 GHRMDKPS-NCTNELYMMMR---DCWHAVPSQRPT 339
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 55/274 (20%), Positives = 97/274 (35%), Gaps = 84/274 (30%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVK-----KFHSPLPDN---------FCSHP-------- 545
IGKG V +AR + +G A+K + + +HP
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 546 ----RQSFIVYEYLESGSL-DKILNNDASAKELGWTQRLN----------VIKGVADALF 590
+ +++ EY G + D ++ + R+ ++ V
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAH----------GRMKEKEARSKFRQIVSAVQ---- 128
Query: 591 YLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGN---VA 647
Y H IVH D+ ++N+LLD ++DF + + KL G A
Sbjct: 129 YCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG----GKLDAFCGAPPYAA 181
Query: 648 PEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPY 703
PEL Y + DV+S GV+ ++ G P F+ + + +L +
Sbjct: 182 PELFQGKKYDGP---EVDVWSLGVILYTLVSGSLP----FD-GQNLKELRERVLRGKYRI 233
Query: 704 P---SLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
P S D +N + + NP+ R T++
Sbjct: 234 PFYMSTDCENLLKRFLVL-------NPIKRGTLE 260
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 6e-05
Identities = 62/278 (22%), Positives = 104/278 (37%), Gaps = 83/278 (29%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAV---KKFHSPLPD------------NFCSH 544
NDFD +GKG G V + R +G +A+ +K D H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 545 P-----RQSF-------IVYEYLESGSL------DKILNNDAS---AKELGWTQRLNVIK 583
P + +F V EY G L +++ + + E
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE----------- 113
Query: 584 GVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNWSKLAG 641
+ AL YLH+ +V+ DI +N++LD + H+ +DF + K D + G
Sbjct: 114 -IVSALEYLHSR---DVVYRDIKLENLMLD--KDGHIKITDFGLCKEGISDGATMKTFCG 167
Query: 642 THGNVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEMSSSSSNM 692
T +APE+ Y V D + GV+ E++ G+ P + LFE+
Sbjct: 168 TPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLPFYNQDHERLFEL------- 216
Query: 693 NIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSR 730
IL + +P + + S++ L ++P R
Sbjct: 217 ---ILMEEIRFPR-TLSPEAKSLLA---GLLKKDPKQR 247
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 7e-05
Identities = 48/233 (20%), Positives = 85/233 (36%), Gaps = 72/233 (30%)
Query: 542 CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKG---------------VA 586
C+ + ++ EY G L L + T + VA
Sbjct: 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVA 155
Query: 587 DALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV 646
+ +L + +H D++++N+LL G + DF +A+ + DS+ + + +
Sbjct: 156 KGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKNDSNY---VVKGNARL 209
Query: 647 -----APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRL 701
APE + T + DV+S+G+ L+E+ S S+
Sbjct: 210 PVKWMAPESIFNCVYTFESDVWSYGIF-------------LWELFSLGSS---------- 246
Query: 702 PYPSLDVQNKFM--------------------SIMQVAFSCLDQNPVSRPTMK 734
PYP + V +KF IM+ +C D +P+ RPT K
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFK 296
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 44/226 (19%), Positives = 94/226 (41%), Gaps = 53/226 (23%)
Query: 542 CSHPRQSFIVYEYLESGSLDKIL---------------------NNDASAKELGWTQRLN 580
C+ + +++EY+ G L++ L + L ++L
Sbjct: 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC 178
Query: 581 VIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLA 640
+ + VA + YL F VH D++++N L+ ++DF +++ N+ S+++ K A
Sbjct: 179 IARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSR--NIYSADYYK-A 232
Query: 641 GTHGNV-----APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMN 693
+ + PE + Y + T + DV+++GV+ E+ G P + M+ +
Sbjct: 233 DGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP---YYGMA------H 282
Query: 694 IEILDS-----RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
E++ L P + + ++M+ C + P RP+
Sbjct: 283 EEVIYYVRDGNILACPE-NCPLELYNLMR---LCWSKLPADRPSFC 324
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 59/255 (23%), Positives = 92/255 (36%), Gaps = 82/255 (32%)
Query: 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVK--KFHSPLPDN--------------FCS 543
DF+ +GKG G V ++ + E++AVK K + D+
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 544 HP-----RQSF-------IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFY 591
P F V EY+ G L + Q++ K A+FY
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDL------------MYHIQQVGRFK-EPHAVFY 447
Query: 592 ----------LHNNCFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNWSKL 639
L + I++ D+ NV+LD E H+ +DF + K D
Sbjct: 448 AAEIAIGLFFLQSK---GIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTF 502
Query: 640 AGTHGNVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEMSSSSS 690
GT +APE+ Y V D ++FGVL E++ G+ P D LF+
Sbjct: 503 CGTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAPFEGEDEDELFQS----- 553
Query: 691 NMNIEILDSRLPYPS 705
I++ + YP
Sbjct: 554 -----IMEHNVAYPK 563
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 51/255 (20%), Positives = 91/255 (35%), Gaps = 86/255 (33%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVK---KFH--------------SPLPDNFC 542
+ FD +G G G V + + SG +A+K K L
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA--V 98
Query: 543 SHPRQSFIVY---------------EYLESGSL------DKILNNDAS---AKELGWTQR 578
+ P F+V EY+ G + + + A +
Sbjct: 99 NFP---FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ------ 149
Query: 579 LNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNW 636
+ YLH+ +++ D+ +N+L+D + ++ +DF AK + W
Sbjct: 150 ------IVLTFEYLHSLD---LIYRDLKPENLLID--QQGYIQVTDFGFAK--RVKGRTW 196
Query: 637 SKLAGTHGNVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNM 692
+ L GT +APE+ Y V D ++ GVL E+ G P F + +
Sbjct: 197 T-LCGTPEALAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP----FF---ADQPI 244
Query: 693 NI--EILDSRLPYPS 705
I +I+ ++ +PS
Sbjct: 245 QIYEKIVSGKVRFPS 259
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 50/236 (21%), Positives = 81/236 (34%), Gaps = 77/236 (32%)
Query: 542 CSHPRQSFIVYEYLESGSL--------------------DKILNNDASAKELGWTQRLNV 581
C+ ++++EY G L K L + L + L
Sbjct: 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCF 177
Query: 582 IKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAG 641
VA + +L VH D++++NVL+ G + DF +A+ + DS+ +
Sbjct: 178 AYQVAKGMEFLEFKSC---VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY---VVR 231
Query: 642 THGNV-----APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEI 696
+ + APE + T K DV+S+G+L L+E+ S N
Sbjct: 232 GNARLPVKWMAPESLFEGIYTIKSDVWSYGIL-------------LWEIFSLGVN----- 273
Query: 697 LDSRLPYPSLDVQNKFM--------------------SIMQVAFSCLDQNPVSRPT 732
PYP + V F IMQ SC + RP+
Sbjct: 274 -----PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQ---SCWAFDSRKRPS 321
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 32/111 (28%), Positives = 44/111 (39%), Gaps = 11/111 (9%)
Query: 279 PQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANH 338
Q LDL + LNR S L I E + L L+LS N
Sbjct: 127 GSQQALDLKGLRSD-PDLVAQNIDVVLNRRSCMAATLR--IIEEN--IPELLSLNLSNNR 181
Query: 339 LSNFVLESLGSLVK----LYYLNLSHNKLSQQIPIELDNLIHLSELDLSHN 385
L L+ + S+V+ L LNLS N+L + ++ + L EL L N
Sbjct: 182 LYR--LDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGN 230
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 5e-04
Identities = 30/178 (16%), Positives = 56/178 (31%), Gaps = 21/178 (11%)
Query: 531 KKFHSPLPDNFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALF 590
K + PD F Q FIV E+ G + + K +++ + +L
Sbjct: 122 KGSANDRPDFFKDD--QLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASLA 175
Query: 591 YLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPEL 650
+ H D+ NVLL + K + + G +
Sbjct: 176 VAEASL--RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTI---------PSCGLQVSII 224
Query: 651 AYTMKVTEK--CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706
YT+ E+ V+ + ++ G D+ F++ N PY ++
Sbjct: 225 DYTLSRLERDGIVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNV 280
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 7e-04
Identities = 59/256 (23%), Positives = 95/256 (37%), Gaps = 88/256 (34%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVK--KFHSPLPDN-------------FCSH 544
DF +G G G V++ R +G +A+K K + +H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 545 PRQSFIV------------Y---EYLESGSL------DKILNNDAS---AKELGWTQRLN 580
P FI+ + +Y+E G L + N + A E
Sbjct: 66 P---FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE-------- 114
Query: 581 VIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNWSK 638
V AL YLH+ I++ D+ +N+LLD H+ +DF AK + ++
Sbjct: 115 ----VCLALEYLHSK---DIIYRDLKPENILLD--KNGHIKITDFGFAK--YVPDVTYT- 162
Query: 639 LAGTHGNVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEMSSSS 689
L GT +APE+ Y + D +SFG+L E++ G P +E
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTPFYDSNTMKTYEK---- 214
Query: 690 SNMNIEILDSRLPYPS 705
IL++ L +P
Sbjct: 215 ------ILNAELRFPP 224
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 7e-04
Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 24/126 (19%)
Query: 588 ALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNWSK-LAGTHG 644
AL +LH+ I++ D+ +N+LLD E H+ +DF ++K ++D + GT
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILLD--EEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVE 191
Query: 645 NVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-----RDFLFEMSSSSSNMNIEILDS 699
+APE+ T+ D +SFGVL E++ G P R M IL +
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM----------ILKA 241
Query: 700 RLPYPS 705
+L P
Sbjct: 242 KLGMPQ 247
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 8e-04
Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 29/156 (18%)
Query: 588 ALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNWSKLAGTHGN 645
AL YLH I++ D+ NVLLD E H+ +D+ + K S GT
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNY 176
Query: 646 VAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE------ 695
+APE+ Y V D ++ GVL E++ G+ P F SS + + N E
Sbjct: 177 IAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP--FDIVGSSDNPDQNTEDYLFQV 230
Query: 696 ILDSRLPYP-SLDVQNKFMSIMQVAFSCLDQNPVSR 730
IL+ ++ P SL V+ S+++ S L+++P R
Sbjct: 231 ILEKQIRIPRSLSVKAA--SVLK---SFLNKDPKER 261
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 752 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.98 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.98 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.98 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.97 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.92 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.92 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.92 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.92 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.92 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.92 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.91 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.91 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.91 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.91 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.9 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.9 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.89 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.89 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.88 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.87 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.85 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.85 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.84 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.84 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.83 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.83 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.82 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.82 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.82 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.82 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.81 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.8 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.8 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.79 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.77 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.77 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.76 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.76 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.74 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.72 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.72 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.71 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.69 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.68 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.66 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.59 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.59 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.59 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.58 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.56 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.53 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.51 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.49 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.49 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.42 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.39 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.39 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.39 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.36 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.25 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.19 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 99.02 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.96 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.96 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.92 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.75 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.59 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.54 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.52 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.48 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.37 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.97 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.74 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.73 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.63 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.54 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.46 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.44 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.3 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.26 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.22 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.19 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.96 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.91 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.83 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.78 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.76 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.67 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.48 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.26 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.13 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.95 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.92 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.18 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.29 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 91.9 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 88.01 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-58 Score=549.12 Aligned_cols=433 Identities=33% Similarity=0.487 Sum_probs=285.6
Q ss_pred hhcCCCCHHHHHHHHHHHHccccCCccccCCCCccccCCCCCCCCcccceeeCCCCCEEEEEcCCCCCccc---ccc---
Q 041438 29 LAVSSNSTEEAHALVKWKASLEVHSRSLLHSWSLSFVNATKISLCTWSGIHCNHAGRVFGINLTSISLNGT---LLE--- 102 (752)
Q Consensus 29 ~~~~~~~~~~~~aLl~fk~~~~~~~~~~l~sW~~~~~~~~~~~~c~w~gv~C~~~~~v~~l~l~~~~l~g~---l~~--- 102 (752)
++++++.++|++|||+||+++. ||. .+++|+ . +.+||.|.||+|+ .++|+.++|++.++.|. +++
T Consensus 4 ~~~~~~~~~~~~all~~k~~~~-~~~-~l~~W~----~--~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~ 74 (768)
T 3rgz_A 4 ASPSQSLYREIHQLISFKDVLP-DKN-LLPDWS----S--NKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLL 74 (768)
T ss_dssp ----CCHHHHHHHHHHHHTTCS-CTT-SSTTCC----T--TSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTT
T ss_pred CccccCCHHHHHHHHHHHhhCC-Ccc-cccCCC----C--CCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHh
Confidence 3444556889999999999997 666 899996 2 2489999999998 89999999999999887 432
Q ss_pred -------------------cccCCCCCCCEEECCCCcccccCCc--cCcCCCCCCeeecCCCcccccCCccc--------
Q 041438 103 -------------------FSFSSFPHLAYLDLYNNELFDIIPP--QISNLSKLEYLDFLTNKLSGHIPSEI-------- 153 (752)
Q Consensus 103 -------------------~~f~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~-------- 153 (752)
..|+.+++|++|||++|.+++.+|. .|+++++|++|+|++|.+++.+|..+
T Consensus 75 ~L~~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~ 154 (768)
T 3rgz_A 75 SLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLE 154 (768)
T ss_dssp TCTTCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCS
T ss_pred ccCcccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCC
Confidence 4677888888888888888877776 67777777766666666655444332
Q ss_pred ------------------------------------------ccccccceeeccCcccCCCCCcccCCCCCCcEEEccCC
Q 041438 154 ------------------------------------------SLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSN 191 (752)
Q Consensus 154 ------------------------------------------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 191 (752)
..+++|++|+|++|.+++.+|. ++++++|++|+|++|
T Consensus 155 ~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n 233 (768)
T 3rgz_A 155 VLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGN 233 (768)
T ss_dssp EEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSS
T ss_pred EEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCC
Confidence 1233333444444444443333 444455555555555
Q ss_pred CCCCcCC----------------------------------------------cCccCC-CcceEEeecccccccccccc
Q 041438 192 FLGGSIP----------------------------------------------RSLSNF-TNLVFLYLYNNSFSGSIPQQ 224 (752)
Q Consensus 192 ~l~~~~p----------------------------------------------~~~~~l-~~L~~L~L~~N~l~~~~p~~ 224 (752)
++++.+| ..+.++ ++|++|+|++|++++.+|..
T Consensus 234 ~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~ 313 (768)
T 3rgz_A 234 KLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPF 313 (768)
T ss_dssp CCCSCHHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGG
T ss_pred cCCCcccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchH
Confidence 4444333 333332 55666666666665555555
Q ss_pred ccCccccccccccccccCCCcC-------------------------CCC------------------------------
Q 041438 225 IGNLKSLFDMKLCINQLNGAIP-------------------------LSI------------------------------ 249 (752)
Q Consensus 225 ~~~l~~L~~l~l~~N~l~~~~~-------------------------~~~------------------------------ 249 (752)
|+++++|++|++++|++++.+| ..+
T Consensus 314 ~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~ 393 (768)
T 3rgz_A 314 FGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPK 393 (768)
T ss_dssp GGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTT
T ss_pred HhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhccc
Confidence 5555555555555444432222 100
Q ss_pred -------------------CCCCCCCCcEEEccccccCCCCCcccC------------------------CCCCCCEEec
Q 041438 250 -------------------DWGRCPQLSLLDVSINNITGNIPFEIG------------------------ESPQLQYLDL 286 (752)
Q Consensus 250 -------------------~~~~l~~L~~L~Ls~N~l~~~~p~~~~------------------------~l~~L~~L~L 286 (752)
.+..+++|++|++++|++++.+|..+. .+++|++|+|
T Consensus 394 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 473 (768)
T 3rgz_A 394 NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473 (768)
T ss_dssp CCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEEC
T ss_pred CCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEe
Confidence 012233444444444444444443333 3334444444
Q ss_pred CCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcc-----------------
Q 041438 287 SSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGS----------------- 349 (752)
Q Consensus 287 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~----------------- 349 (752)
++|++++.+|..+.++++|+.|+|++|++++.+|.+++.+++|++|+|++|++++.+|..++.
T Consensus 474 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ 553 (768)
T 3rgz_A 474 DFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGT 553 (768)
T ss_dssp CSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESB
T ss_pred cCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCc
Confidence 444444444444455555555555555555555555555555555555555554444433333
Q ss_pred -----------------------------------------------------------------------------ccc
Q 041438 350 -----------------------------------------------------------------------------LVK 352 (752)
Q Consensus 350 -----------------------------------------------------------------------------l~~ 352 (752)
+++
T Consensus 554 ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~ 633 (768)
T 3rgz_A 554 IPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGS 633 (768)
T ss_dssp CCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBC
T ss_pred CChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhcccc
Confidence 345
Q ss_pred ccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccC
Q 041438 353 LYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISY 432 (752)
Q Consensus 353 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~ 432 (752)
|++|||++|+++|.+|..++++++|+.|+|++|++++.+|..++.+++|+.|||++|+++|.+|..+..+++|++||+++
T Consensus 634 L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~ 713 (768)
T 3rgz_A 634 MMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN 713 (768)
T ss_dssp CCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCS
T ss_pred ccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcC
Confidence 66777777777788888899999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccCcCCCCcccCCCCcccccCCCCCCCCccccccccccc
Q 041438 433 NKLEGHIPNSTTFRDAPLEALQGNKGLCGDIRGFLSCMSYR 473 (752)
Q Consensus 433 N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~~c~~~~ 473 (752)
|+++|.+|....|..++...+.||+++||.+ +..|....
T Consensus 714 N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~--l~~C~~~~ 752 (768)
T 3rgz_A 714 NNLSGPIPEMGQFETFPPAKFLNNPGLCGYP--LPRCDPSN 752 (768)
T ss_dssp SEEEEECCSSSSGGGSCGGGGCSCTEEESTT--SCCCCSCC
T ss_pred CcccccCCCchhhccCCHHHhcCCchhcCCC--CcCCCCCc
Confidence 9999999999999999999999999999964 33786544
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-53 Score=490.79 Aligned_cols=409 Identities=20% Similarity=0.279 Sum_probs=293.9
Q ss_pred CHHHHHHHHHHHHccccCCcc-------ccCCCCccccCCCCCCCCcc---cceeeCCCCCEEEEEcCCCCCcccccccc
Q 041438 35 STEEAHALVKWKASLEVHSRS-------LLHSWSLSFVNATKISLCTW---SGIHCNHAGRVFGINLTSISLNGTLLEFS 104 (752)
Q Consensus 35 ~~~~~~aLl~fk~~~~~~~~~-------~l~sW~~~~~~~~~~~~c~w---~gv~C~~~~~v~~l~l~~~~l~g~l~~~~ 104 (752)
...|+.||.+||+++..+++. ...+|+ .+.+||.| .||+|+..|+|++++|+++++.|+++ .+
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~------~~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp-~~ 100 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWN------FNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVP-DA 100 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCC------CSSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEEC-GG
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCC------CCCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCC-hH
Confidence 456999999999998755433 233676 23589999 99999888999999999999999987 48
Q ss_pred cCCCCCCCEEECCCC-----------------------------------------------------------------
Q 041438 105 FSSFPHLAYLDLYNN----------------------------------------------------------------- 119 (752)
Q Consensus 105 f~~l~~L~~L~L~~n----------------------------------------------------------------- 119 (752)
|+.|++|++|+|++|
T Consensus 101 l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~ 180 (636)
T 4eco_A 101 IGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180 (636)
T ss_dssp GGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCC
T ss_pred HhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccc
Confidence 999999999999998
Q ss_pred -------------cccccCCccCcCCCCCCeeecCCCccccc-----------------CCcccc--cccccceeeccCc
Q 041438 120 -------------ELFDIIPPQISNLSKLEYLDFLTNKLSGH-----------------IPSEIS--LLTHLTILHISRN 167 (752)
Q Consensus 120 -------------~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L~Ls~N 167 (752)
++++ +|..|+++++|++|+|++|+|++. +|..++ ++++|++|+|++|
T Consensus 181 ~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n 259 (636)
T 4eco_A 181 ITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNC 259 (636)
T ss_dssp CCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECC
T ss_pred cchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCC
Confidence 4446 788999999999999999999996 899999 9999999999999
Q ss_pred ccCCCCCcccCCCCCCcEEEccCCC-CCC-cCCcCccCC------CcceEEeeccccccccccc--cccCcccccccccc
Q 041438 168 QLNGSIPHEVGQLNFLNHLILDSNF-LGG-SIPRSLSNF------TNLVFLYLYNNSFSGSIPQ--QIGNLKSLFDMKLC 237 (752)
Q Consensus 168 ~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l------~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~l~l~ 237 (752)
++.+.+|..|+++++|++|+|++|+ ++| .+|..++++ ++|++|+|++|+++ .+|. .|+++++|+.|+++
T Consensus 260 ~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~ 338 (636)
T 4eco_A 260 PNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECL 338 (636)
T ss_dssp TTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECC
T ss_pred cCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCc
Confidence 9999999999999999999999998 998 788877776 88888888888888 6777 78888888888888
Q ss_pred ccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCC-CCEEecCCCcCcCCCCccccCCc--ccCEEEccCCc
Q 041438 238 INQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQ-LQYLDLSSNYIVGEIPTQLGNII--YLNRISLSGNK 314 (752)
Q Consensus 238 ~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~ 314 (752)
+|+++|.+| .++.+++|++|++++|+++ .+|..+..+++ |++|++++|.++ .+|..+..+. +|+.|++++|+
T Consensus 339 ~N~l~g~ip---~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~ 413 (636)
T 4eco_A 339 YNQLEGKLP---AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNE 413 (636)
T ss_dssp SCCCEEECC---CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSC
T ss_pred CCcCccchh---hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCc
Confidence 888887777 3455566666666666665 45555666665 666666666665 4555554433 55555555555
Q ss_pred CcccCCcccC-------CCcccceeeccccccccccchhhcccc-------------------------------cccEE
Q 041438 315 LSGRIPGELG-------SLINLEYLDLSANHLSNFVLESLGSLV-------------------------------KLYYL 356 (752)
Q Consensus 315 l~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~~~~~~~l~-------------------------------~L~~L 356 (752)
+++.+|..+. .+++|++|+|++|.++.+++..+..++ +|++|
T Consensus 414 l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L 493 (636)
T 4eco_A 414 IGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSI 493 (636)
T ss_dssp TTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEE
T ss_pred CCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEE
Confidence 5555555554 444555555555555544433333344 55555
Q ss_pred EcCCCcCccccchhcc--ccccCCeeecCCccCCCCCCcccccccccceEEc------cCCcCCcCCchhhhccCCCcEE
Q 041438 357 NLSHNKLSQQIPIELD--NLIHLSELDLSHNFLGEKISSRICRMESLEKLNL------SYNNLSGLIPRCFEELHGLLHI 428 (752)
Q Consensus 357 ~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L------~~N~l~~~~p~~~~~l~~L~~L 428 (752)
+|++|+++ .+|..+. .+++|++|+|++|++++ +|..+..+++|+.|+| ++|++.+.+|..+..+++|++|
T Consensus 494 ~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L 571 (636)
T 4eco_A 494 DLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQL 571 (636)
T ss_dssp ECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEE
T ss_pred ECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEE
Confidence 55555555 3444444 66666666666666665 5556666666666666 3455666666666666666666
Q ss_pred EccCCcccCcCCCCcccCCCCcccccCCCCCCC
Q 041438 429 DISYNKLEGHIPNSTTFRDAPLEALQGNKGLCG 461 (752)
Q Consensus 429 ~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~ 461 (752)
+|++|++ +.+|.... ..+....+.+|+..|-
T Consensus 572 ~Ls~N~l-~~ip~~~~-~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 572 QIGSNDI-RKVNEKIT-PNISVLDIKDNPNISI 602 (636)
T ss_dssp ECCSSCC-CBCCSCCC-TTCCEEECCSCTTCEE
T ss_pred ECCCCcC-CccCHhHh-CcCCEEECcCCCCccc
Confidence 6666666 55554422 4444555666666654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=485.98 Aligned_cols=383 Identities=20% Similarity=0.269 Sum_probs=287.6
Q ss_pred CCCHHHHHHHHHHHHccccCCccccCCCCccccCCCCCCC--Ccc------------cceeeCCCCCEEEEEcCCCCCcc
Q 041438 33 SNSTEEAHALVKWKASLEVHSRSLLHSWSLSFVNATKISL--CTW------------SGIHCNHAGRVFGINLTSISLNG 98 (752)
Q Consensus 33 ~~~~~~~~aLl~fk~~~~~~~~~~l~sW~~~~~~~~~~~~--c~w------------~gv~C~~~~~v~~l~l~~~~l~g 98 (752)
++..+|++||++||+++. +| +|+.+... ...+| |.| .||+|+..++|+.++|+++++.|
T Consensus 265 ~~~~~d~~ALl~~k~~l~-~~-----~W~~~~~~-~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G 337 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALD-GK-----NWRYYSGT-INNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKG 337 (876)
T ss_dssp CHHHHHHHHHHHHHHHTT-GG-----GCCCCCSS-CSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEE
T ss_pred ccchHHHHHHHHHHHHcC-CC-----CCCcCCCc-ccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCC
Confidence 345679999999999985 33 89733200 01244 999 99999988999999999999999
Q ss_pred cccccccCCCCCCCEEEC-CCCccccc-----------------------------------------------------
Q 041438 99 TLLEFSFSSFPHLAYLDL-YNNELFDI----------------------------------------------------- 124 (752)
Q Consensus 99 ~l~~~~f~~l~~L~~L~L-~~n~l~~~----------------------------------------------------- 124 (752)
.++ .+|+.|++|++|+| ++|.++|.
T Consensus 338 ~ip-~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~ 416 (876)
T 4ecn_A 338 RVP-DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP 416 (876)
T ss_dssp EEC-GGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCC
T ss_pred cCc-hHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccc
Confidence 987 48999999999999 77765544
Q ss_pred -----------------------CCccCcCCCCCCeeecCCCcccc-----------------cCCcccc--ccccccee
Q 041438 125 -----------------------IPPQISNLSKLEYLDFLTNKLSG-----------------HIPSEIS--LLTHLTIL 162 (752)
Q Consensus 125 -----------------------~p~~~~~l~~L~~L~L~~N~l~~-----------------~~p~~~~--~l~~L~~L 162 (752)
+|..|+++++|++|+|++|+|++ .+|..++ ++++|++|
T Consensus 417 i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L 496 (876)
T 4ecn_A 417 IKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDV 496 (876)
T ss_dssp CCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEE
T ss_pred cccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEE
Confidence 78889999999999999999998 3888887 99999999
Q ss_pred eccCcccCCCCCcccCCCCCCcEEEccCCC-CCC-cCCcCccCCC-------cceEEeeccccccccccc--cccCcccc
Q 041438 163 HISRNQLNGSIPHEVGQLNFLNHLILDSNF-LGG-SIPRSLSNFT-------NLVFLYLYNNSFSGSIPQ--QIGNLKSL 231 (752)
Q Consensus 163 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l~-------~L~~L~L~~N~l~~~~p~--~~~~l~~L 231 (752)
+|++|.+.+.+|..|+++++|++|+|++|+ ++| .+|..+++++ +|++|+|++|+|+ .+|. .|+++++|
T Consensus 497 ~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L 575 (876)
T 4ecn_A 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKL 575 (876)
T ss_dssp EEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTC
T ss_pred ECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCC
Confidence 999999999999999999999999999998 998 8888776665 9999999999999 7888 89999999
Q ss_pred ccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCC-CCEEecCCCcCcCCCCccccCCcc--cCEE
Q 041438 232 FDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQ-LQYLDLSSNYIVGEIPTQLGNIIY--LNRI 308 (752)
Q Consensus 232 ~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L 308 (752)
+.|++++|+++ .+| .|+.+++|+.|+|++|+++ .+|..+..+++ |++|+|++|.|+ .+|..+..+.. |+.|
T Consensus 576 ~~L~Ls~N~l~-~lp---~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L 649 (876)
T 4ecn_A 576 GLLDCVHNKVR-HLE---AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSV 649 (876)
T ss_dssp CEEECTTSCCC-BCC---CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEE
T ss_pred CEEECCCCCcc-cch---hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEE
Confidence 99999999999 666 5788999999999999999 78888999998 999999999998 67877776654 8888
Q ss_pred EccCCcCcccCCccc---C--CCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhcc-------cccc
Q 041438 309 SLSGNKLSGRIPGEL---G--SLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELD-------NLIH 376 (752)
Q Consensus 309 ~Ls~N~l~~~~p~~~---~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-------~l~~ 376 (752)
+|++|++++.+|... . .+++|+.|+|++|.++.++...+..+++|+.|+|++|+|+...+..+. ++++
T Consensus 650 ~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~ 729 (876)
T 4ecn_A 650 DFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYL 729 (876)
T ss_dssp ECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGG
T ss_pred ECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCC
Confidence 888888877655322 1 223566666666666654444444555555555555555422222221 1124
Q ss_pred CCeeecCCccCCCCCCcccc--cccccceEEccCCcCCcCCchhhhccCCCcEEEccC
Q 041438 377 LSELDLSHNFLGEKISSRIC--RMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISY 432 (752)
Q Consensus 377 L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~ 432 (752)
|++|+|++|+|+ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++
T Consensus 730 L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~ 785 (876)
T 4ecn_A 730 LTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRH 785 (876)
T ss_dssp CCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCC
T ss_pred ccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCC
Confidence 555555555554 3333333 44555555555555544 344444455555554433
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=411.06 Aligned_cols=226 Identities=27% Similarity=0.340 Sum_probs=189.7
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEec
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~~ 555 (752)
..|++.++||+|+||.||+|+. .+|+.||||+++..... +++.+.+..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 5699999999999999999995 57999999998543221 4456778899999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 635 (752)
++|+|.+++.+. .+++.+++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+......
T Consensus 154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 999999999753 389999999999999999999999 9999999999999999999999999999988765555
Q ss_pred cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHH
Q 041438 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSI 715 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 715 (752)
....+||+.|||||++.+..|+.++||||+||++|||++|++||.. ....+....+.....+. .......++++
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-----~~~~~~~~~i~~~~~~~-~~~~~~~s~~~ 300 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-----EPPLKAMKMIRDNLPPR-LKNLHKVSPSL 300 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-----SCHHHHHHHHHHSSCCC-CSCGGGSCHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-----cCHHHHHHHHHcCCCCC-CCccccCCHHH
Confidence 6667999999999999999999999999999999999999999952 12222233333332221 11234567789
Q ss_pred HHHHHhccCcCCCCCCCHHHHHHH
Q 041438 716 MQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 716 ~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.++|.+||++||++|||++|+++|
T Consensus 301 ~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 301 KGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcC
Confidence 999999999999999999999986
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=414.81 Aligned_cols=228 Identities=22% Similarity=0.328 Sum_probs=184.7
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~ 552 (752)
.++|++.+.||+|+||+||+|+. .+|+.||||+++..... +++.+++..|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 36899999999999999999994 67999999998654322 4556778899999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
|||+||+|.+++..... ..+++.+++.|+.||+.||+|||++ |||||||||+|||+++++.+||+|||+|+.....
T Consensus 103 Ey~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 99999999999975432 3478899999999999999999999 9999999999999999999999999999876533
Q ss_pred CCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHH
Q 041438 633 SSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (752)
.......+||+.|||||++.+..|+.++||||+||++|||+||+.||.. ....+....+.....+... ...+
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~-----~~~~~~~~~i~~~~~~~~~---~~~s 250 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-----GSMKNLVLKIISGSFPPVS---LHYS 250 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-----SSHHHHHHHHHHTCCCCCC---TTSC
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-----cCHHHHHHHHHcCCCCCCC---ccCC
Confidence 2233456899999999999999999999999999999999999999962 2233344455555543221 3456
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+++.++|.+||++||++|||++|+++|
T Consensus 251 ~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 251 YDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 788999999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=406.12 Aligned_cols=233 Identities=23% Similarity=0.261 Sum_probs=189.4
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------CccccCCceEEEEEeccCC
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------NFCSHPRQSFIVYEYLESG 558 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------~~~~~~~~~~lV~E~~~~g 558 (752)
..+.|++.++||+|+||.||+|+. .+|+.||||+++..... +++.+.+..|+|||||+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 356789999999999999999995 57999999998654322 4556778899999999999
Q ss_pred ChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC-ceEEeecccceeccCCCCC--
Q 041438 559 SLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY-EAHVSDFRIAKFLNLDSSN-- 635 (752)
Q Consensus 559 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~-~~kl~DfG~a~~~~~~~~~-- 635 (752)
+|.++++..+ .+++.+++.|+.||+.||+|||++ +||||||||+|||++.++ ++||+|||+|+........
T Consensus 136 ~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 136 SLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp BHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 9999997643 489999999999999999999999 999999999999999887 6999999999987543221
Q ss_pred ---cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHH
Q 041438 636 ---WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712 (752)
Q Consensus 636 ---~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (752)
....+||+.|||||++.+..|+.++||||+||++|||+||++||.. .........+.....+... .....+
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~-----~~~~~~~~~i~~~~~~~~~-~~~~~s 283 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ-----YFRGPLCLKIASEPPPIRE-IPPSCA 283 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTT-----TCCSCCHHHHHHSCCGGGG-SCTTSC
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCC-----CCHHHHHHHHHcCCCCchh-cCccCC
Confidence 1235799999999999999999999999999999999999999962 2223334444443332211 123456
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
+++.++|.+||++||++|||++|+++++.+.
T Consensus 284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 7899999999999999999999999998765
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=404.51 Aligned_cols=224 Identities=21% Similarity=0.334 Sum_probs=190.2
Q ss_pred hcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCC----C-----------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLP----D-----------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~----~-----------------------~~~~~~~~~~lV 551 (752)
.++|++.+.||+|+||+||+|+ ..+|+.||||++.+... . +++.+++..|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4689999999999999999999 46799999998854210 0 445677889999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
||||+||+|.+++.+.+ .+++.+++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 111 mEy~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999997643 489999999999999999999999 999999999999999999999999999998754
Q ss_pred CC--CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 632 DS--SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 632 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
.. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||. .....+....+....+.+|.
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~-----~~~~~~~~~~i~~~~~~~p~---- 255 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEGLIFAKIIKLEYDFPE---- 255 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSC-----CSSHHHHHHHHHHTCCCCCT----
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC-----CCCHHHHHHHHHcCCCCCCc----
Confidence 32 23445689999999999999999999999999999999999999995 22334455566666666653
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTMKRFEV 738 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~~evl~ 738 (752)
..++++.++|.+||++||++|||++|++.
T Consensus 256 ~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 256 KFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred ccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 35667899999999999999999998753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=412.00 Aligned_cols=226 Identities=27% Similarity=0.339 Sum_probs=189.1
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEec
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~~ 555 (752)
+.|++.++||+|+||.||+|+. .+|+.||||++...... +++.+.+..|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 5699999999999999999995 57999999998643322 4456678899999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 635 (752)
+||+|.+++... .+++.+++.|+.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.+......
T Consensus 231 ~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 231 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred CCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 999999999754 389999999999999999999999 9999999999999999999999999999988765555
Q ss_pred cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHH
Q 041438 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSI 715 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 715 (752)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||.. .........+.....+.. ......++++
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-----~~~~~~~~~i~~~~~~~~-~~~~~~s~~~ 377 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-----EPPLKAMKMIRDNLPPRL-KNLHKVSPSL 377 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-----SCHHHHHHHHHHSCCCCC-SCTTSSCHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-----cCHHHHHHHHHcCCCCCC-cccccCCHHH
Confidence 6667999999999999999999999999999999999999999852 112222333333222111 1224456789
Q ss_pred HHHHHhccCcCCCCCCCHHHHHHH
Q 041438 716 MQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 716 ~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.++|.+||+.||++|||++|+++|
T Consensus 378 ~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 378 KGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcC
Confidence 999999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=391.81 Aligned_cols=223 Identities=19% Similarity=0.282 Sum_probs=173.6
Q ss_pred hcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC---------------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV 551 (752)
.++|++.+.||+|+||+||+|+ ..+|+.||||++++.... +++.+++..|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4789999999999999999999 467999999998654321 445677889999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||| +|+|.+++.+.+ .+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 92 mEy~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred EeCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 9999 579999987654 489999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCCcccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
. ......+||+.|||||++.+..+ ++++||||+||++|||+||+.||.. .........+.......|. .
T Consensus 165 ~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~-----~~~~~~~~~i~~~~~~~p~----~ 234 (275)
T 3hyh_A 165 G-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD-----ESIPVLFKNISNGVYTLPK----F 234 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHHTCCCCCT----T
T ss_pred C-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC-----CCHHHHHHHHHcCCCCCCC----C
Confidence 3 23345689999999999998876 6899999999999999999999962 2233344555555555553 3
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.++++.+++.+||++||++|||++|+++|
T Consensus 235 ~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 235 LSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 45678999999999999999999999986
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=394.67 Aligned_cols=234 Identities=22% Similarity=0.333 Sum_probs=181.7
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E 553 (752)
.+++++.++||+|+||+||+|++. ..||||+++..... +++. .+..|+|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEE
Confidence 467888999999999999999864 36999998654322 3343 456899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
||++|+|.+++.... ..+++.++..|+.|||+||+|||++ +||||||||+|||+++++.+||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 999999999997543 3589999999999999999999999 99999999999999999999999999998764322
Q ss_pred --CCcccccCCCCccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCC--Ch
Q 041438 634 --SNWSKLAGTHGNVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYP--SL 706 (752)
Q Consensus 634 --~~~~~~~gt~~y~aPE~~~~---~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 706 (752)
......+||+.|||||++.+ .+|+.++|||||||++|||+||+.||... ................| ..
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~-----~~~~~~~~~~~~~~~~p~~~~ 261 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI-----NNRDQIIFMVGRGYASPDLSK 261 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC-----CCHHHHHHHHHTTCCCCCSTT
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC-----ChHHHHHHHHhcCCCCCCccc
Confidence 22344689999999999864 35899999999999999999999998521 11112222222222111 11
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
....+++++.+++.+||+.||++|||++||+++|+.+..+
T Consensus 262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 2245667899999999999999999999999999988644
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=401.66 Aligned_cols=237 Identities=25% Similarity=0.402 Sum_probs=187.0
Q ss_pred cccccceeeccCCceEEEEEEeC------CCcEEEEEccCCCCCC------------------------CccccCCceEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVP------SGEIFAVKKFHSPLPD------------------------NFCSHPRQSFI 550 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~------------------------~~~~~~~~~~l 550 (752)
++|.+.++||+|+||.||+|++. +++.||||+++..... +++.+.+..|+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 57888999999999999999853 5789999998753221 56777888999
Q ss_pred EEEeccCCChHHHhccCcc------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCce
Q 041438 551 VYEYLESGSLDKILNNDAS------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEA 618 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~ 618 (752)
|||||++|+|.++++.... ..+++|.++..|+.||++||+|||+. +||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 9999999999999976432 23589999999999999999999999 99999999999999999999
Q ss_pred EEeecccceeccCCCC--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHh
Q 041438 619 HVSDFRIAKFLNLDSS--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIE 695 (752)
Q Consensus 619 kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~ 695 (752)
||+|||+|+....... .....+||+.|||||++.+..++.++|||||||++|||+| |+.||... ...+....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~-----~~~~~~~~ 272 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL-----SNTEAIDC 272 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS-----CHHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Confidence 9999999987643322 2234579999999999999999999999999999999999 89998521 12222333
Q ss_pred hhcc-CCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCCCC
Q 041438 696 ILDS-RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPDH 749 (752)
Q Consensus 696 ~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 749 (752)
+... +.+.| ..+++++.+++.+||+.||++|||++||+++|+.+...|..
T Consensus 273 i~~g~~~~~p----~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp~ 323 (329)
T 4aoj_A 273 ITQGRELERP----RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 323 (329)
T ss_dssp HHHTCCCCCC----TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC-
T ss_pred HHcCCCCCCc----ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCcc
Confidence 3333 23333 34567899999999999999999999999999999876653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=399.48 Aligned_cols=224 Identities=21% Similarity=0.301 Sum_probs=186.2
Q ss_pred cccccceeeccCCceEEEEEEe----CCCcEEEEEccCCCCCC--------------------------CccccCCceEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV----PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFI 550 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~l 550 (752)
++|++.+.||+|+||+||+|+. .+++.||||++++.... +++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 6799999999999999999984 25789999988643211 34566788999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
|||||+||+|.+++.+.+ .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999997643 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
.........+||+.|||||++.+..|+.++||||+||++|||+||+.||.. ....+....+.......|. .
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~-----~~~~~~~~~i~~~~~~~p~----~ 248 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG-----KDRKETMTMILKAKLGMPQ----F 248 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHHCCCCCCT----T
T ss_pred CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC-----cCHHHHHHHHHcCCCCCCC----c
Confidence 555555567999999999999999999999999999999999999999962 2333445556666666553 3
Q ss_pred HHHHHHHHHHhccCcCCCCCCCH-----HHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTM-----KRFEVQ 739 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~-----~evl~~ 739 (752)
.++++.++|.+||++||++|||+ +|+++|
T Consensus 249 ~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 249 LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 56678999999999999999985 566654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=397.93 Aligned_cols=231 Identities=19% Similarity=0.312 Sum_probs=188.2
Q ss_pred cccccceeeccCCceEEEEEEe------CCCcEEEEEccCCCCCC-------------------------CccccCCceE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV------PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSF 549 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~ 549 (752)
.++++.++||+|+||+||+|++ .+++.||||+++..... +++.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 4677889999999999999985 35789999998754322 5667778899
Q ss_pred EEEEeccCCChHHHhccCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC
Q 041438 550 IVYEYLESGSLDKILNNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY 616 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~ 616 (752)
+|||||++|+|.+++..... ...+++.++..|+.|||+||+|||++ +||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 99999999999999965321 23589999999999999999999999 999999999999999999
Q ss_pred ceEEeecccceeccCCC--CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccch
Q 041438 617 EAHVSDFRIAKFLNLDS--SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMN 693 (752)
Q Consensus 617 ~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~ 693 (752)
.+||+|||+|+...... ......+||+.|||||++.+..|+.++|||||||++|||+| |+.||... ...+..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~-----~~~~~~ 257 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY-----SNQDVV 257 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC-----CHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC-----CHHHHH
Confidence 99999999998764332 22334589999999999999999999999999999999998 89998521 122233
Q ss_pred HhhhccC-CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 694 IEILDSR-LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 694 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
..+.... .+.| ..+++++.+++.+||+.||++|||++||+++|+.+
T Consensus 258 ~~i~~~~~~~~p----~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 258 EMIRNRQVLPCP----DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHcCCCCCCc----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 3333332 2233 34567899999999999999999999999999875
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=399.03 Aligned_cols=233 Identities=23% Similarity=0.389 Sum_probs=189.6
Q ss_pred cccccceeeccCCceEEEEEEeC------CCcEEEEEccCCCCCC------------------------CccccCCceEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVP------SGEIFAVKKFHSPLPD------------------------NFCSHPRQSFI 550 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~------------------------~~~~~~~~~~l 550 (752)
++|.+.++||+|+||+||+|++. +++.||||+++..... +++.+++..|+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57889999999999999999853 4789999998653211 56677888999
Q ss_pred EEEeccCCChHHHhccCc----------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEE
Q 041438 551 VYEYLESGSLDKILNNDA----------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV 620 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl 620 (752)
|||||++|+|.++++..+ ....++|.++..|+.||++||+|||++ +||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999997643 234689999999999999999999999 9999999999999999999999
Q ss_pred eecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhh
Q 041438 621 SDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEIL 697 (752)
Q Consensus 621 ~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 697 (752)
+|||+|+........ .....||+.|||||++.+..|+.++|||||||++|||+| |+.||... ...+....+.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~-----~~~~~~~~i~ 244 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-----SNNEVIECIT 244 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-----CHHHHHHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHH
Confidence 999999876433221 123468999999999999999999999999999999999 89998521 2223333444
Q ss_pred ccC-CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 698 DSR-LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 698 ~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
... .+.| ..+++++.+++.+||+.||++|||++|+.+.|+++..
T Consensus 245 ~~~~~~~p----~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 245 QGRVLQRP----RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCC----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 433 2333 3456789999999999999999999999999998753
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=422.46 Aligned_cols=376 Identities=25% Similarity=0.254 Sum_probs=313.3
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceee
Q 041438 84 GRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILH 163 (752)
Q Consensus 84 ~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 163 (752)
..++.++|+++.+.+. ++..|.++++|++|+|++|+|+++.|.+|+++++|++|+|++|++++..|..|+++++|++|+
T Consensus 32 ~~l~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKIL-KSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp TTCCEEECTTSCCCEE-CTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCcCEEECCCCCcCEe-ChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence 4678899999998764 455799999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcccCCCCCcccCCCCCCcEEEccCCCCCC-cCCcCccCCCcceEEeeccccccccccccccCccccc----cccccc
Q 041438 164 ISRNQLNGSIPHEVGQLNFLNHLILDSNFLGG-SIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLF----DMKLCI 238 (752)
Q Consensus 164 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~l~l~~ 238 (752)
|++|.+++..+..|+++++|++|+|++|++++ .+|..|+++++|++|+|++|++++..|..|+.+++|+ .+++++
T Consensus 111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~ 190 (606)
T 3vq2_A 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190 (606)
T ss_dssp CTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTT
T ss_pred ccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccC
Confidence 99999998888899999999999999999986 5699999999999999999999988777666555433 233333
Q ss_pred cccCCCcCC-----------------------------------------------------------------------
Q 041438 239 NQLNGAIPL----------------------------------------------------------------------- 247 (752)
Q Consensus 239 N~l~~~~~~----------------------------------------------------------------------- 247 (752)
|++++..+.
T Consensus 191 n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 270 (606)
T 3vq2_A 191 NPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270 (606)
T ss_dssp CCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECC
T ss_pred CCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccc
Confidence 333211110
Q ss_pred ------------------------------------------------------------------------CCCCCCCC
Q 041438 248 ------------------------------------------------------------------------SIDWGRCP 255 (752)
Q Consensus 248 ------------------------------------------------------------------------~~~~~~l~ 255 (752)
...+..++
T Consensus 271 ~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~ 350 (606)
T 3vq2_A 271 TNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALP 350 (606)
T ss_dssp CTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCCCT
T ss_pred cccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhccCC
Confidence 01223455
Q ss_pred CCcEEEccccccCCC--CCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCC-cccCCCccccee
Q 041438 256 QLSLLDVSINNITGN--IPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIP-GELGSLINLEYL 332 (752)
Q Consensus 256 ~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L 332 (752)
+|++|++++|++++. .|..+..+++|++|++++|.+++ +|..+..+++|+.|++++|++.+..| ..+..+++|++|
T Consensus 351 ~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 429 (606)
T 3vq2_A 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYL 429 (606)
T ss_dssp TCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEE
T ss_pred CCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEE
Confidence 666666666666654 35666777777777777777764 55778888999999999999988877 688999999999
Q ss_pred eccccccccccchhhcccccccEEEcCCCcCcc-ccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcC
Q 041438 333 DLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQ-QIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNL 411 (752)
Q Consensus 333 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 411 (752)
++++|.+++..|..|..+++|++|++++|++++ .+|..|..+++|++|+|++|++++..|..+..+++|++|+|++|++
T Consensus 430 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 509 (606)
T 3vq2_A 430 DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509 (606)
T ss_dssp ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred ECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcC
Confidence 999999999999999999999999999999987 4788999999999999999999999999999999999999999999
Q ss_pred CcCCchhhhccCCCcEEEccCCcccCcCCCC-cccC-CCCcccccCCCCCCCC
Q 041438 412 SGLIPRCFEELHGLLHIDISYNKLEGHIPNS-TTFR-DAPLEALQGNKGLCGD 462 (752)
Q Consensus 412 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~-~~~~~~~~~n~~~c~~ 462 (752)
++.+|..|..+++|+.||+++|+++. +|.. ..+. .+....+.+|++.|..
T Consensus 510 ~~~~~~~~~~l~~L~~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~~N~~~c~c 561 (606)
T 3vq2_A 510 LFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVACIC 561 (606)
T ss_dssp SCEEGGGTTTCTTCCEEECTTSCCCC-EESCGGGSCTTCCEEECCSCCCCCSS
T ss_pred CCcCHHHccCCCcCCEEECCCCcCcc-cCHhHhhhcccCcEEEccCCCcccCC
Confidence 99999999999999999999999985 4443 2332 3556688999999863
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=405.97 Aligned_cols=371 Identities=23% Similarity=0.238 Sum_probs=313.6
Q ss_pred CCCcccc--eeeCCC---------CCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccc-cCCccCcCCCCCCee
Q 041438 71 SLCTWSG--IHCNHA---------GRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFD-IIPPQISNLSKLEYL 138 (752)
Q Consensus 71 ~~c~w~g--v~C~~~---------~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L 138 (752)
+.|.|.+ |.|+.. .++..++|+++.+.+. .+..|..+++|++|+|++|.+.+ +.+..|.++++|++|
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~-~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L 84 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAEL-NETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIIL 84 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEE-CTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcC-ChhHhccCccccEEECcCCcccceECcccccccccCCEE
Confidence 4577766 888642 3577888888888754 45578889999999999998874 446778999999999
Q ss_pred ecCCCcccccCCcccccccccceeeccCcccCCCCCcc--cCCCCCCcEEEccCCCCCCcCCcC-ccCCCcceEEeeccc
Q 041438 139 DFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHE--VGQLNFLNHLILDSNFLGGSIPRS-LSNFTNLVFLYLYNN 215 (752)
Q Consensus 139 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N 215 (752)
+|++|++++..|..|+++++|++|+|++|++++.+|.. |..+++|++|+|++|++++..|.. |.++++|++|+|++|
T Consensus 85 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n 164 (455)
T 3v47_A 85 KLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN 164 (455)
T ss_dssp ECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTC
T ss_pred eCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCC
Confidence 99999998888888999999999999999998755544 888999999999999998887776 788999999999999
Q ss_pred cccccccccccCc--cccccccccccccCCCcCCCCC------CCCCCCCcEEEccccccCCCCCcccCCC---CCCCEE
Q 041438 216 SFSGSIPQQIGNL--KSLFDMKLCINQLNGAIPLSID------WGRCPQLSLLDVSINNITGNIPFEIGES---PQLQYL 284 (752)
Q Consensus 216 ~l~~~~p~~~~~l--~~L~~l~l~~N~l~~~~~~~~~------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L 284 (752)
++++..|..+.++ .+|+.+++++|.+.+..+..+. +..+++|++|++++|++++..|..+... ++|+.|
T Consensus 165 ~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L 244 (455)
T 3v47_A 165 KVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSL 244 (455)
T ss_dssp CBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEE
T ss_pred cccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeE
Confidence 9988888888877 6788899999988876554332 2356789999999999988887766543 788999
Q ss_pred ecCCCcCcCC----------CCccccC--CcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhccccc
Q 041438 285 DLSSNYIVGE----------IPTQLGN--IIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVK 352 (752)
Q Consensus 285 ~Ls~N~l~~~----------~p~~~~~--l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 352 (752)
++++|.+.+. .+..+.. .++|+.|++++|++++.+|..|+.+++|++|+|++|++++..+..|..+++
T Consensus 245 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 324 (455)
T 3v47_A 245 ILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH 324 (455)
T ss_dssp ECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred eeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCccc
Confidence 9998866542 1222332 268999999999999999999999999999999999999999999999999
Q ss_pred ccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccC
Q 041438 353 LYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISY 432 (752)
Q Consensus 353 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~ 432 (752)
|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|+|++|++++.++..|..+++|++|++++
T Consensus 325 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 404 (455)
T 3v47_A 325 LLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 404 (455)
T ss_dssp CCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccC
Confidence 99999999999998899999999999999999999999999999999999999999999999888899999999999999
Q ss_pred CcccCcCCCC
Q 041438 433 NKLEGHIPNS 442 (752)
Q Consensus 433 N~l~~~~p~~ 442 (752)
|++++.+|..
T Consensus 405 N~l~~~~~~~ 414 (455)
T 3v47_A 405 NPWDCSCPRI 414 (455)
T ss_dssp SCBCCCTTTT
T ss_pred CCcccCCCcc
Confidence 9999998854
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=383.31 Aligned_cols=222 Identities=19% Similarity=0.253 Sum_probs=174.9
Q ss_pred cccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Cccc----cCCceEEE
Q 041438 503 FDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCS----HPRQSFIV 551 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~----~~~~~~lV 551 (752)
|++.++||+|+||.||+|+. .+++.||||++...... +++. .....|+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 36778899999999999994 57899999988644322 1221 23457999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCEEeC-CCCceEEeeccccee
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP--IVHWDISSKNVLLD-LGYEAHVSDFRIAKF 628 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~--ivH~DlKp~NIll~-~~~~~kl~DfG~a~~ 628 (752)
||||++|+|.+++.+.. .+++..++.|+.||+.||+|||++ + ||||||||+|||++ .++.+||+|||+|+.
T Consensus 108 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 99999999999997643 488999999999999999999998 7 99999999999998 478999999999986
Q ss_pred ccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhh
Q 041438 629 LNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708 (752)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (752)
.. .......+||+.|||||++.+ +|++++|||||||++|||+||+.||... .........+..... +....
T Consensus 182 ~~--~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~----~~~~~~~~~i~~~~~--~~~~~ 252 (290)
T 3fpq_A 182 KR--ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC----QNAAQIYRRVTSGVK--PASFD 252 (290)
T ss_dssp CC--TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC----SSHHHHHHHHTTTCC--CGGGG
T ss_pred CC--CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC----CcHHHHHHHHHcCCC--CCCCC
Confidence 43 233455689999999998865 6999999999999999999999998521 111122222322222 11122
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...++++.++|.+||++||++|||++|+++|
T Consensus 253 ~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 3345678999999999999999999999875
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=438.72 Aligned_cols=350 Identities=34% Similarity=0.494 Sum_probs=282.3
Q ss_pred EEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCC-CCCeeecCCCcccccCCccccc--cccccee
Q 041438 86 VFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLS-KLEYLDFLTNKLSGHIPSEISL--LTHLTIL 162 (752)
Q Consensus 86 v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~--l~~L~~L 162 (752)
+..+++.++.+.|.++...|..+++|++|+|++|++++.+|..+.+++ +|++|+|++|++++.+|..+.. +++|++|
T Consensus 320 L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L 399 (768)
T 3rgz_A 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQEL 399 (768)
T ss_dssp CCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEE
T ss_pred ccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEE
Confidence 334444445554444444455566666666666666555555555555 5666666666666555555554 6667777
Q ss_pred eccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccC
Q 041438 163 HISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLN 242 (752)
Q Consensus 163 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 242 (752)
+|++|++++.+|..|.++++|++|+|++|++++.+|..|.++++|++|+|++|++++.+|..+..+++|+.|++++|+++
T Consensus 400 ~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 479 (768)
T 3rgz_A 400 YLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLT 479 (768)
T ss_dssp ECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCC
T ss_pred ECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCccc
Confidence 77777777778888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred CCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcc
Q 041438 243 GAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGE 322 (752)
Q Consensus 243 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 322 (752)
+.+|.. ++.+++|++|++++|++++.+|..++.+++|++|+|++|++++.+|..++++++|+.|++++|+++|.+|..
T Consensus 480 ~~~p~~--l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~ 557 (768)
T 3rgz_A 480 GEIPSG--LSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557 (768)
T ss_dssp SCCCGG--GGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGG
T ss_pred CcCCHH--HhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChH
Confidence 887765 468899999999999999999999999999999999999999999999999999999999999988777654
Q ss_pred ----------------------------------------------------------------------cCCCccccee
Q 041438 323 ----------------------------------------------------------------------LGSLINLEYL 332 (752)
Q Consensus 323 ----------------------------------------------------------------------~~~l~~L~~L 332 (752)
++.+++|++|
T Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~L 637 (768)
T 3rgz_A 558 MFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL 637 (768)
T ss_dssp GGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEE
T ss_pred HhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEE
Confidence 3346789999
Q ss_pred eccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCC
Q 041438 333 DLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLS 412 (752)
Q Consensus 333 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 412 (752)
||++|++++.+|..|+++++|+.|+|++|+++|.+|..++++++|+.|||++|+++|.+|..+..+++|++|+|++|+++
T Consensus 638 dLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~ 717 (768)
T 3rgz_A 638 DMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717 (768)
T ss_dssp ECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEE
T ss_pred ECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCcEEEccCCc-ccCc
Q 041438 413 GLIPRCFEELHGLLHIDISYNK-LEGH 438 (752)
Q Consensus 413 ~~~p~~~~~l~~L~~L~ls~N~-l~~~ 438 (752)
|.+|.. ..+..+....+.+|+ +.|.
T Consensus 718 g~iP~~-~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 718 GPIPEM-GQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp EECCSS-SSGGGSCGGGGCSCTEEEST
T ss_pred ccCCCc-hhhccCCHHHhcCCchhcCC
Confidence 999964 223334444566675 5553
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=387.55 Aligned_cols=243 Identities=23% Similarity=0.285 Sum_probs=183.1
Q ss_pred cccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccC----CceEEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHP----RQSFIVYE 553 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~----~~~~lV~E 553 (752)
.+|.+.++||+|+||+||+|++ +|+.||||+++..... +++.++ ...|+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 4688899999999999999987 6899999988643211 223222 25799999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNC-----FPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-----~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
||++|+|.++++.. .++++.+.+++.|+++||+|||+++ .++||||||||+|||++.++++||+|||+|+.
T Consensus 82 y~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 99999999999754 3899999999999999999999762 45899999999999999999999999999988
Q ss_pred ccCCCCC----cccccCCCCccCccccccC------CCCCccchhhHHHHHHHHHhCCCCcchhhcccc----------c
Q 041438 629 LNLDSSN----WSKLAGTHGNVAPELAYTM------KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------S 688 (752)
Q Consensus 629 ~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~----------~ 688 (752)
....... ....+||+.|||||++.+. .++.|+|||||||++|||+||.+||........ .
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 7543322 2235799999999998764 367899999999999999999888642211110 0
Q ss_pred cccchHhhhccCC--CCCCh-hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCCC
Q 041438 689 SSNMNIEILDSRL--PYPSL-DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPD 748 (752)
Q Consensus 689 ~~~~~~~~~~~~~--~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 748 (752)
.......+..... ..|.. ...+.++.+.+++.+||+.||++||||+||++.|+++....+
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence 0111222222222 22221 123456788999999999999999999999999999876543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=394.53 Aligned_cols=238 Identities=20% Similarity=0.296 Sum_probs=189.8
Q ss_pred HHHhhcccccceeeccCCceEEEEEEeC------CCcEEEEEccCCCCCC--------------------------Cccc
Q 041438 496 IIRATNDFDAKHCIGKGGHGSVYIARVP------SGEIFAVKKFHSPLPD--------------------------NFCS 543 (752)
Q Consensus 496 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--------------------------~~~~ 543 (752)
+....++|++.+.||+|+||.||+|+.. .++.||||+++..... ++|.
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 3344578999999999999999999843 2468999988653221 3343
Q ss_pred c-CCceEEEEEeccCCChHHHhccCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCC
Q 041438 544 H-PRQSFIVYEYLESGSLDKILNNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKN 609 (752)
Q Consensus 544 ~-~~~~~lV~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~N 609 (752)
+ ....|+|||||++|+|.++++.... ...+++.++..|+.|||+||+|||++ +||||||||+|
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~N 215 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 215 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccc
Confidence 3 4568999999999999999975432 23489999999999999999999999 99999999999
Q ss_pred EEeCCCCceEEeecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccc
Q 041438 610 VLLDLGYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMS 686 (752)
Q Consensus 610 Ill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~ 686 (752)
||+++++.+||+|||+|+........ ....+||+.|||||++.+..|+.++|||||||++|||+| |+.||...
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~---- 291 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV---- 291 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC----
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC----
Confidence 99999999999999999976544322 234579999999999999999999999999999999998 99998521
Q ss_pred cccccchHhhhcc-CCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 687 SSSSNMNIEILDS-RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 687 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
.........+... +.+.| ..+++++.+++.+||+.||++|||++|++++|+++.
T Consensus 292 ~~~~~~~~~i~~g~~~~~p----~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 292 KIDEEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp CCSHHHHHHHHHTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCCCCC----ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1112222222222 23333 335667899999999999999999999999998874
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=381.38 Aligned_cols=227 Identities=21% Similarity=0.382 Sum_probs=170.4
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------Ccccc---------
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSH--------- 544 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~--------- 544 (752)
.++|++.+.||+|+||+||+|+. .+|+.||||+++..... +++.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 46799999999999999999994 57999999988643221 11111
Q ss_pred ---CCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEe
Q 041438 545 ---PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVS 621 (752)
Q Consensus 545 ---~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~ 621 (752)
....|+|||||++|+|.+++.........++..++.|+.||++||+|||++ +|+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 124689999999999999998766555567778899999999999999999 99999999999999999999999
Q ss_pred ecccceeccCCCCC------------cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccccc
Q 041438 622 DFRIAKFLNLDSSN------------WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS 689 (752)
Q Consensus 622 DfG~a~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~ 689 (752)
|||+|+........ .+..+||+.|||||++.+..|+.++||||+||++|||++ ||....+ .
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~----~ 233 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME----R 233 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH----H
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH----H
Confidence 99999876543211 223579999999999999999999999999999999996 7642110 0
Q ss_pred ccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 690 SNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
......+.. ...|. .....++.+.++|.+||++||++|||+.|+++|
T Consensus 234 ~~~~~~~~~--~~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 234 VRTLTDVRN--LKFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHHHT--TCCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhc--CCCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111222222 22332 234556677899999999999999999999975
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=379.56 Aligned_cols=292 Identities=28% Similarity=0.486 Sum_probs=220.7
Q ss_pred CCCHHHHHHHHHHHHccccCCccccCCCCccccCCCCCCCCc--ccceeeCCC---CCEEEEEcCCCCCcc--ccccccc
Q 041438 33 SNSTEEAHALVKWKASLEVHSRSLLHSWSLSFVNATKISLCT--WSGIHCNHA---GRVFGINLTSISLNG--TLLEFSF 105 (752)
Q Consensus 33 ~~~~~~~~aLl~fk~~~~~~~~~~l~sW~~~~~~~~~~~~c~--w~gv~C~~~---~~v~~l~l~~~~l~g--~l~~~~f 105 (752)
.|.++|++||++||+++. +|. .+++|.. +.+||. |.||+|+.. ++|+.++|+++.+.| .++ ..|
T Consensus 2 ~c~~~~~~aL~~~k~~~~-~~~-~l~~W~~------~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~-~~l 72 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLG-NPT-TLSSWLP------TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIP-SSL 72 (313)
T ss_dssp CSCHHHHHHHHHHHHHTT-CCG-GGTTCCT------TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECC-GGG
T ss_pred CCCHHHHHHHHHHHHhcC-Ccc-cccCCCC------CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccC-hhH
Confidence 578999999999999995 454 7899962 247898 999999854 789999999999888 554 478
Q ss_pred CCCCCCCEEECCC-CcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCc
Q 041438 106 SSFPHLAYLDLYN-NELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLN 184 (752)
Q Consensus 106 ~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 184 (752)
..+++|++|+|++ |++.+.+|..|+++++|++|+|++|++++.+|..|.++++|++|+|++|.|++.+|..|..+++|+
T Consensus 73 ~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 152 (313)
T 1ogq_A 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152 (313)
T ss_dssp GGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCC
T ss_pred hCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCC
Confidence 8899999999994 888888898999999999999999999888888899999999999999999988888899999999
Q ss_pred EEEccCCCCCCcCCcCccCCC-cceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEcc
Q 041438 185 HLILDSNFLGGSIPRSLSNFT-NLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVS 263 (752)
Q Consensus 185 ~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls 263 (752)
+|+|++|++++.+|..+.+++ +|++|+|++|++++.+|..|..++ |+ .|+++
T Consensus 153 ~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~--------------------------~L~Ls 205 (313)
T 1ogq_A 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LA--------------------------FVDLS 205 (313)
T ss_dssp EEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CS--------------------------EEECC
T ss_pred eEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-cc--------------------------EEECc
Confidence 999999999888888888887 889999999999888888777654 55 55555
Q ss_pred ccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeecccccccccc
Q 041438 264 INNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFV 343 (752)
Q Consensus 264 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 343 (752)
+|++++..|..+..+++|++|+|++|.+++.+|. +..+++|++|+|++|++++.+|..+..+++|++|+|++|++++.+
T Consensus 206 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~i 284 (313)
T 1ogq_A 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284 (313)
T ss_dssp SSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEEC
T ss_pred CCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccC
Confidence 5555555555555555555555555555544443 455555555555555555555555555555566666666555555
Q ss_pred chhhcccccccEEEcCCCc
Q 041438 344 LESLGSLVKLYYLNLSHNK 362 (752)
Q Consensus 344 ~~~~~~l~~L~~L~Ls~N~ 362 (752)
|.. ..+++|+.|++++|+
T Consensus 285 p~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 285 PQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp CCS-TTGGGSCGGGTCSSS
T ss_pred CCC-ccccccChHHhcCCC
Confidence 543 555556666666665
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=423.26 Aligned_cols=383 Identities=22% Similarity=0.220 Sum_probs=241.5
Q ss_pred CcccceeeCCCCCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCccc-ccCCccCcCCCCCCeeecCCCcccccCCc
Q 041438 73 CTWSGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELF-DIIPPQISNLSKLEYLDFLTNKLSGHIPS 151 (752)
Q Consensus 73 c~w~gv~C~~~~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 151 (752)
|.|..|-+ ....+..++|+.+.+.+. .+.+|..+++|++|+|++|.+. .+.|.+|+++++|++|+|++|+|++..|.
T Consensus 14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i-~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ-VLNTTERLLLSFNYIRTV-TASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS-SCTTCCEEEEESCCCCEE-CSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC-CCCCcCEEECCCCcCCcc-ChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 56777776 557788889988887653 4457888888888888888554 34477888888888888888888888888
Q ss_pred ccccccccceeeccCcccCCCCCcc--cCCCCCCcEEEccCCCCCCcCC-cCccCCCcceEEeeccccccccccccccCc
Q 041438 152 EISLLTHLTILHISRNQLNGSIPHE--VGQLNFLNHLILDSNFLGGSIP-RSLSNFTNLVFLYLYNNSFSGSIPQQIGNL 228 (752)
Q Consensus 152 ~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 228 (752)
.|.++++|++|+|++|.+++.+|.. |+++++|++|+|++|++++..+ ..|+++++|++|+|++|.+++..|..+..+
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l 171 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence 8888888888888888888766655 8888888888888888887655 568888888888888888887777766655
Q ss_pred --cccccccccccccCCCcCCC------------------------------CC--------------------------
Q 041438 229 --KSLFDMKLCINQLNGAIPLS------------------------------ID-------------------------- 250 (752)
Q Consensus 229 --~~L~~l~l~~N~l~~~~~~~------------------------------~~-------------------------- 250 (752)
++|+.|+++.|.+.+..|.. +.
T Consensus 172 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~ 251 (844)
T 3j0a_A 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251 (844)
T ss_dssp HHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSS
T ss_pred cCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccc
Confidence 44444444444443322211 00
Q ss_pred --------CCC--CCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCC
Q 041438 251 --------WGR--CPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIP 320 (752)
Q Consensus 251 --------~~~--l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 320 (752)
|.. .++|+.|++++|.+++..|..|..+++|+.|+|++|.+++..|..|.++++|+.|+|++|++++..|
T Consensus 252 l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 331 (844)
T 3j0a_A 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYS 331 (844)
T ss_dssp STTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCS
T ss_pred cCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCH
Confidence 000 1345555555555555555555555555555555555555555555555555555555555555555
Q ss_pred cccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCcc-----------------------------------
Q 041438 321 GELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQ----------------------------------- 365 (752)
Q Consensus 321 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~----------------------------------- 365 (752)
..|.++++|++|+|++|.++++.+..|..+++|++|+|++|.+++
T Consensus 332 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N 411 (844)
T 3j0a_A 332 SNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSEN 411 (844)
T ss_dssp CSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSC
T ss_pred HHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccC
Confidence 555555555555555555555444444444444444444444332
Q ss_pred -----------------------------cc------------------------------chhccccccCCeeecCCcc
Q 041438 366 -----------------------------QI------------------------------PIELDNLIHLSELDLSHNF 386 (752)
Q Consensus 366 -----------------------------~~------------------------------p~~~~~l~~L~~L~Ls~N~ 386 (752)
.. +..|.++++|++|+|++|.
T Consensus 412 ~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~ 491 (844)
T 3j0a_A 412 RLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNY 491 (844)
T ss_dssp CCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHH
T ss_pred ccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCc
Confidence 11 1223444555555555555
Q ss_pred CCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCCcccCcCCCCcccCCCCcccccCCCCCCC
Q 041438 387 LGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEALQGNKGLCG 461 (752)
Q Consensus 387 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~ 461 (752)
+++.+|..|..+++|+.|+|++|+|++++|..+. ++|+.|||++|++++.+|.. +..+....+.+||+.|.
T Consensus 492 l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~ 562 (844)
T 3j0a_A 492 LNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICE 562 (844)
T ss_dssp HTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCS
T ss_pred ccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccc
Confidence 5555555555555666666666666555554444 55666666666666655543 44566677889999985
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=403.98 Aligned_cols=356 Identities=21% Similarity=0.187 Sum_probs=255.1
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceee
Q 041438 84 GRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILH 163 (752)
Q Consensus 84 ~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 163 (752)
..++.++|+++.+.+. .+.+|..+++|++|+|++|+++++.|.+|+++++|++|+|++|++++..|..|+++++|++|+
T Consensus 33 ~~l~~L~Ls~n~i~~~-~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 111 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTI-QNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLF 111 (606)
T ss_dssp TTCCEEECTTCCCSEE-CTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEE
T ss_pred CcCcEEEccCCccCcC-ChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEee
Confidence 3678899999999854 466899999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccc--ccccccccc
Q 041438 164 ISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLF--DMKLCINQL 241 (752)
Q Consensus 164 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~--~l~l~~N~l 241 (752)
|++|+|++..|..|+++++|++|+|++|++++..+..+.++++|++|+|++|++++..|..|+++++|+ .|++++|++
T Consensus 112 L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l 191 (606)
T 3t6q_A 112 FIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191 (606)
T ss_dssp CTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCC
T ss_pred ccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCcc
Confidence 999999988888999999999999999999986655666699999999999999998899999999998 789999998
Q ss_pred CCCcCCCCCCC-----------------------------------------------CC--CCCcEEEccccccCCCCC
Q 041438 242 NGAIPLSIDWG-----------------------------------------------RC--PQLSLLDVSINNITGNIP 272 (752)
Q Consensus 242 ~~~~~~~~~~~-----------------------------------------------~l--~~L~~L~Ls~N~l~~~~p 272 (752)
++..|..+... .+ .+|+.|++++|.+++..+
T Consensus 192 ~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~ 271 (606)
T 3t6q_A 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS 271 (606)
T ss_dssp CEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCT
T ss_pred CccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCH
Confidence 87666443110 00 045555666666665555
Q ss_pred cccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeecccccccccc-chhhcccc
Q 041438 273 FEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFV-LESLGSLV 351 (752)
Q Consensus 273 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~ 351 (752)
..|..+++|++|++++|.++ .+|..+.++++|++|++++|++++..|..+..+++|++|++++|.+.+.. +..+..++
T Consensus 272 ~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~ 350 (606)
T 3t6q_A 272 NTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE 350 (606)
T ss_dssp TTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCT
T ss_pred HHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccC
Confidence 55666666666666666665 45555566666666666666666555555555566666666666555322 33355555
Q ss_pred cccEEEcCCCcCcccc--chhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCch-hhhccCCCcEE
Q 041438 352 KLYYLNLSHNKLSQQI--PIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPR-CFEELHGLLHI 428 (752)
Q Consensus 352 ~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L 428 (752)
+|++|++++|++++.. +..+..+++|++|++++|.+.+..|..|..+++|++|++++|++++..|. .+..+++|+.|
T Consensus 351 ~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 430 (606)
T 3t6q_A 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430 (606)
T ss_dssp TCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEE
T ss_pred cCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEE
Confidence 5566666655555444 44555555555555555555555555555555555555555555554433 25555555555
Q ss_pred EccCCcccCcCCC
Q 041438 429 DISYNKLEGHIPN 441 (752)
Q Consensus 429 ~ls~N~l~~~~p~ 441 (752)
++++|.+++..|.
T Consensus 431 ~l~~n~l~~~~~~ 443 (606)
T 3t6q_A 431 NLSHSLLDISSEQ 443 (606)
T ss_dssp ECTTCCCBTTCTT
T ss_pred ECCCCccCCcCHH
Confidence 5555555554443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=401.68 Aligned_cols=294 Identities=20% Similarity=0.188 Sum_probs=236.0
Q ss_pred cCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCC
Q 041438 165 SRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGA 244 (752)
Q Consensus 165 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 244 (752)
++|.+++..+..|+.+++|++|+|++|+++ .+|..+.++++|++|+|++|++++..|..+.++++|+.|++++|.+.+.
T Consensus 262 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~ 340 (606)
T 3t6q_A 262 QKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLE 340 (606)
T ss_dssp TTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCB
T ss_pred ecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccc
Confidence 333333333444566667777777777776 4566677777777777777777776677777777777777777777765
Q ss_pred cCCCCCCCCCCCCcEEEccccccCCCC--CcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCc-
Q 041438 245 IPLSIDWGRCPQLSLLDVSINNITGNI--PFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPG- 321 (752)
Q Consensus 245 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~- 321 (752)
+|.. .+..+++|++|++++|.+++.. +..+..+++|++|++++|.+.+..|..|.++++|+.|++++|++++..|.
T Consensus 341 ~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 419 (606)
T 3t6q_A 341 LGTG-CLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQS 419 (606)
T ss_dssp CCSS-TTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCC
T ss_pred cchh-hhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccch
Confidence 5543 2567888999999999888766 77888889999999999999888888899999999999999999877654
Q ss_pred ccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccc---cchhccccccCCeeecCCccCCCCCCcccccc
Q 041438 322 ELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQ---IPIELDNLIHLSELDLSHNFLGEKISSRICRM 398 (752)
Q Consensus 322 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 398 (752)
.+..+++|++|++++|.+++..+..|..+++|++|++++|++++. .+..+..+++|++|+|++|++++..|..|..+
T Consensus 420 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 499 (606)
T 3t6q_A 420 PFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSL 499 (606)
T ss_dssp TTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred hhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccc
Confidence 488899999999999999988888899999999999999999763 33668889999999999999999889999999
Q ss_pred cccceEEccCCcCCcCCchhhhccCCCcEEEccCCcccCcCCCC-cccCCCCcccccCCCCCCC
Q 041438 399 ESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNS-TTFRDAPLEALQGNKGLCG 461 (752)
Q Consensus 399 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~ 461 (752)
++|+.|+|++|++++.+|..|..++.| +|++++|++++.+|.. ..+..+....+.+|++.|.
T Consensus 500 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 562 (606)
T 3t6q_A 500 KMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562 (606)
T ss_dssp TTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECS
T ss_pred cCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcccc
Confidence 999999999999999999999999999 9999999999877753 3345566678899999885
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=402.92 Aligned_cols=143 Identities=28% Similarity=0.307 Sum_probs=98.7
Q ss_pred CcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccc--------hhccccccCCeeecCCccCCCCC
Q 041438 320 PGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIP--------IELDNLIHLSELDLSHNFLGEKI 391 (752)
Q Consensus 320 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~ 391 (752)
|..|..+++|++|+|++|+++++++..|.++++|++|+|++|++++..+ ..|.++++|++|+|++|+++...
T Consensus 473 p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~ 552 (680)
T 1ziw_A 473 PSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIP 552 (680)
T ss_dssp SCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCC
T ss_pred CcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCC
Confidence 3445555566666666666666666666666666666666666654321 22566677777777777777665
Q ss_pred CcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCCcccCcCCCCc--ccCCCCcccccCCCCCCCC
Q 041438 392 SSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNST--TFRDAPLEALQGNKGLCGD 462 (752)
Q Consensus 392 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~~~~~~~~~~n~~~c~~ 462 (752)
+..|.++++|+.|+|++|+++++++..|..+++|+.|++++|++++..|... .+..+....+.+||+.|..
T Consensus 553 ~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c 625 (680)
T 1ziw_A 553 VEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTC 625 (680)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCC
T ss_pred HHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCC
Confidence 6667778888888888888887777777788888888888888877665432 3556667788999999863
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=396.89 Aligned_cols=382 Identities=19% Similarity=0.165 Sum_probs=269.9
Q ss_pred CCcccceeeCCC------------CCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeee
Q 041438 72 LCTWSGIHCNHA------------GRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLD 139 (752)
Q Consensus 72 ~c~w~gv~C~~~------------~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 139 (752)
.|.|.|+ |+.. ..++.++|+++.+.+.. +..|..+++|++|+|++|+|+++.|.+|+++++|++|+
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 80 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIG-HGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLD 80 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEEC-SSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccC-hhhhhcCCcccEEECCCCCcCccChhhccccccCCEEE
Confidence 4899998 8522 26788999999887643 45799999999999999999999999999999999999
Q ss_pred cCCCcccccCCcccccccccceeeccCcccCCC-CCcccCCCCCCcEEEccCCCC-CCcCCcCccCCCcceEEeeccccc
Q 041438 140 FLTNKLSGHIPSEISLLTHLTILHISRNQLNGS-IPHEVGQLNFLNHLILDSNFL-GGSIPRSLSNFTNLVFLYLYNNSF 217 (752)
Q Consensus 140 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l-~~~~p~~~~~l~~L~~L~L~~N~l 217 (752)
|++|++++..|..|+++++|++|+|++|.+++. .|..|+++++|++|+|++|++ +...+..|.++++|++|+|++|++
T Consensus 81 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l 160 (549)
T 2z81_A 81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160 (549)
T ss_dssp CTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence 999999998888899999999999999999973 678899999999999999984 544457899999999999999999
Q ss_pred cccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCC--------------------------
Q 041438 218 SGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNI-------------------------- 271 (752)
Q Consensus 218 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-------------------------- 271 (752)
++..|..++++++|+.|+++.|.+... |.. .++.+++|++|++++|++++..
T Consensus 161 ~~~~~~~l~~l~~L~~L~l~~n~~~~~-~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 238 (549)
T 2z81_A 161 RNYQSQSLKSIRDIHHLTLHLSESAFL-LEI-FADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238 (549)
T ss_dssp CEECTTTTTTCSEEEEEEEECSBSTTH-HHH-HHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHH
T ss_pred cccChhhhhccccCceEecccCccccc-chh-hHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchh
Confidence 998888887766555555554443221 100 0112333444444444333310
Q ss_pred -Cc-------------------------------------c--------------------------cCCCCCCCEEecC
Q 041438 272 -PF-------------------------------------E--------------------------IGESPQLQYLDLS 287 (752)
Q Consensus 272 -p~-------------------------------------~--------------------------~~~l~~L~~L~Ls 287 (752)
+. . +...++|+.|+++
T Consensus 239 ~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~ 318 (549)
T 2z81_A 239 SFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVE 318 (549)
T ss_dssp HHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEE
T ss_pred HHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEec
Confidence 00 0 0011345555555
Q ss_pred CCcCcCCCCccc-cCCcccCEEEccCCcCcccCC---cccCCCcccceeeccccccccccc--hhhcccccccEEEcCCC
Q 041438 288 SNYIVGEIPTQL-GNIIYLNRISLSGNKLSGRIP---GELGSLINLEYLDLSANHLSNFVL--ESLGSLVKLYYLNLSHN 361 (752)
Q Consensus 288 ~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~Ls~N 361 (752)
+|.+. .+|..+ .++++|+.|++++|++++.+| ..++.+++|++|+|++|++++..+ ..+..+++|++|+|++|
T Consensus 319 ~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N 397 (549)
T 2z81_A 319 NSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRN 397 (549)
T ss_dssp SSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTC
T ss_pred cCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCC
Confidence 55554 344333 456777777777777776543 336667777777777777776543 45677777777777777
Q ss_pred cCccccchhccccccCCeeecCCccCCCCCCc-----------------ccccccccceEEccCCcCCcCCchhhhccCC
Q 041438 362 KLSQQIPIELDNLIHLSELDLSHNFLGEKISS-----------------RICRMESLEKLNLSYNNLSGLIPRCFEELHG 424 (752)
Q Consensus 362 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-----------------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 424 (752)
+++ .+|..+..+++|++|+|++|.+++.... .+..+++|++|+|++|+|+.+ |. ...+++
T Consensus 398 ~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~~i-p~-~~~l~~ 474 (549)
T 2z81_A 398 TFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKTL-PD-ASLFPV 474 (549)
T ss_dssp CCC-CCCSCCCCCTTCCEEECTTSCCSCCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCSSC-CC-GGGCTT
T ss_pred CCc-cCChhhcccccccEEECCCCCcccccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccCcC-CC-cccCcc
Confidence 776 4566666666666666666666543221 113577888888888888854 44 456888
Q ss_pred CcEEEccCCcccCcCCC-CcccCCCCcccccCCCCCCC
Q 041438 425 LLHIDISYNKLEGHIPN-STTFRDAPLEALQGNKGLCG 461 (752)
Q Consensus 425 L~~L~ls~N~l~~~~p~-~~~~~~~~~~~~~~n~~~c~ 461 (752)
|+.||+++|++++.+|. ...+..+....+.+|++.|.
T Consensus 475 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 512 (549)
T 2z81_A 475 LLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512 (549)
T ss_dssp CCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred CCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence 88888888888887775 34455666677888888875
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=401.59 Aligned_cols=344 Identities=20% Similarity=0.252 Sum_probs=308.0
Q ss_pred CCEEEEEcCCCCCccc-----------------ccccccC--CCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCc
Q 041438 84 GRVFGINLTSISLNGT-----------------LLEFSFS--SFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNK 144 (752)
Q Consensus 84 ~~v~~l~l~~~~l~g~-----------------l~~~~f~--~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 144 (752)
.....++|+++.+.|. ++ ..++ .+++|++|+|++|++.+.+|..|+++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip-~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT-EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTT-SCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCc-hhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 4677899999999995 43 4666 99999999999999999999999999999999999998
Q ss_pred -ccc-cCCcccccc------cccceeeccCcccCCCCCc--ccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeecc
Q 041438 145 -LSG-HIPSEISLL------THLTILHISRNQLNGSIPH--EVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYN 214 (752)
Q Consensus 145 -l~~-~~p~~~~~l------~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 214 (752)
++| .+|..++.+ ++|++|+|++|+++ .+|. .|+++++|++|+|++|+++|.+| .|.++++|++|+|++
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~ 362 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAY 362 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCS
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCC
Confidence 999 899999887 99999999999999 8898 99999999999999999999999 999999999999999
Q ss_pred ccccccccccccCccc-cccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccC-------CCCCCCEEec
Q 041438 215 NSFSGSIPQQIGNLKS-LFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIG-------ESPQLQYLDL 286 (752)
Q Consensus 215 N~l~~~~p~~~~~l~~-L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-------~l~~L~~L~L 286 (752)
|+++ .+|..+.++++ |+.|++++|+++ .+|..+....+++|+.|++++|++++.+|..+. .+++|++|+|
T Consensus 363 N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~L 440 (636)
T 4eco_A 363 NQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINL 440 (636)
T ss_dssp SEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEEC
T ss_pred Cccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEEC
Confidence 9999 88889999999 999999999999 677655444456999999999999999999888 8889999999
Q ss_pred CCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCC-------cccceeeccccccccccchhhc--ccccccEEE
Q 041438 287 SSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSL-------INLEYLDLSANHLSNFVLESLG--SLVKLYYLN 357 (752)
Q Consensus 287 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-------~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~ 357 (752)
++|.+++..+..+..+++|+.|+|++|+++...+..+... ++|++|+|++|+++. +|..+. .+++|+.|+
T Consensus 441 s~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~~~l~~L~~L~ 519 (636)
T 4eco_A 441 SNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGID 519 (636)
T ss_dssp CSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCCB-CCGGGSTTTCTTCCEEE
T ss_pred cCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCCc-cChhhhhccCCCcCEEE
Confidence 9999996555566779999999999999995444444433 399999999999996 455665 999999999
Q ss_pred cCCCcCccccchhccccccCCeeec------CCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEcc
Q 041438 358 LSHNKLSQQIPIELDNLIHLSELDL------SHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDIS 431 (752)
Q Consensus 358 Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls 431 (752)
|++|++++ +|..+..+++|++|+| ++|++.+.+|..+..+++|+.|+|++|++ +.+|..+. ++|+.||++
T Consensus 520 Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls 595 (636)
T 4eco_A 520 LSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIK 595 (636)
T ss_dssp CCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECC
T ss_pred CCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECc
Confidence 99999998 8999999999999999 56889999999999999999999999999 55677665 799999999
Q ss_pred CCcccC
Q 041438 432 YNKLEG 437 (752)
Q Consensus 432 ~N~l~~ 437 (752)
+|++..
T Consensus 596 ~N~l~~ 601 (636)
T 4eco_A 596 DNPNIS 601 (636)
T ss_dssp SCTTCE
T ss_pred CCCCcc
Confidence 998874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=380.22 Aligned_cols=233 Identities=19% Similarity=0.261 Sum_probs=177.3
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Cc------cccCC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NF------CSHPR 546 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~------~~~~~ 546 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||+++..... ++ +.+.+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36799999999999999999994 67999999998654322 11 22346
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
..|+|||||+ |+|.+++...+ .+++.+++.|++||+.||+|||++ |||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 58999997643 489999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCC----CCCcccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCcchhhcccc----------cc--
Q 041438 627 KFLNLD----SSNWSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------SS-- 689 (752)
Q Consensus 627 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~~pf~~~~~~~~----------~~-- 689 (752)
+.+... .......+||+.|||||++.+.. ++.++||||+||++|||++|++||........ ..
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 876432 22334569999999999988754 69999999999999999999999953211000 00
Q ss_pred ------ccchHhhhccCCCCCChhh----HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 690 ------SNMNIEILDSRLPYPSLDV----QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 690 ------~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
................... ...++++.+||.+||+.||++|||++|+++|
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000111111111111111 1235678999999999999999999999976
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=385.54 Aligned_cols=354 Identities=21% Similarity=0.246 Sum_probs=314.0
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccC-CcccccccccceeeccCcccCCCCCcccCCCCCCcEEE
Q 041438 109 PHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHI-PSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLI 187 (752)
Q Consensus 109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 187 (752)
++|++|+|++|+|+++.|..|+++++|++|+|++|.+.+.+ +..|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 78999999999999999999999999999999999998544 67899999999999999999999999999999999999
Q ss_pred ccCCCCCCcCCcC--ccCCCcceEEeecccccccccccc-ccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccc
Q 041438 188 LDSNFLGGSIPRS--LSNFTNLVFLYLYNNSFSGSIPQQ-IGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSI 264 (752)
Q Consensus 188 L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~ 264 (752)
|++|++++..|.. |.++++|++|+|++|++++..|.. +.++++|++|++++|++++..+..+.--..++|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 9999999855554 999999999999999999988876 8999999999999999999887665333347899999999
Q ss_pred cccCCCCCccc--------CCCCCCCEEecCCCcCcCCCCccccCC---cccCEEEccCCcCcccC----------Cccc
Q 041438 265 NNITGNIPFEI--------GESPQLQYLDLSSNYIVGEIPTQLGNI---IYLNRISLSGNKLSGRI----------PGEL 323 (752)
Q Consensus 265 N~l~~~~p~~~--------~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~----------p~~~ 323 (752)
|.+++..+..+ ..+++|++|++++|.+++..|..+... .+|+.|++++|.+.+.. +..+
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~ 269 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTT
T ss_pred CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCccccc
Confidence 99998766543 367899999999999999888877655 89999999999765432 2223
Q ss_pred CC--CcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCccccccccc
Q 041438 324 GS--LINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESL 401 (752)
Q Consensus 324 ~~--l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 401 (752)
.. .++|++|++++|.+++..+..|+.+++|++|+|++|++++..|..|.++++|++|+|++|.+++..+..|..+++|
T Consensus 270 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 349 (455)
T 3v47_A 270 KGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKL 349 (455)
T ss_dssp GGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTC
T ss_pred ccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccC
Confidence 22 2689999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceEEccCCcCCcCCchhhhccCCCcEEEccCCcccCcCCCC-cccCCCCcccccCCCCCCCC
Q 041438 402 EKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNS-TTFRDAPLEALQGNKGLCGD 462 (752)
Q Consensus 402 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~ 462 (752)
++|+|++|++++..|..|..+++|++|++++|++++..+.. ..+..+....+.+|+..|..
T Consensus 350 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 411 (455)
T 3v47_A 350 EVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 411 (455)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCC
Confidence 99999999999999999999999999999999999866643 34566777789999998863
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=395.30 Aligned_cols=376 Identities=23% Similarity=0.238 Sum_probs=309.2
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceee
Q 041438 84 GRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILH 163 (752)
Q Consensus 84 ~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 163 (752)
..+..++++++.+.+. .+.+|..+++|++|+|++|+++++.|.+|+++++|++|+|++|++++..|..|.++++|++|+
T Consensus 28 ~~l~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHL-GSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (570)
T ss_dssp SSCCEEECCSCCCCEE-CTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred ccccEEEccCCccCcc-ChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence 3577889998888753 455789999999999999999998889999999999999999999988889999999999999
Q ss_pred ccCcccCCCCCcccCCCCCCcEEEccCCCCCC-cCCcCccCCCcceEEeeccccccccccccccCcccc----ccccccc
Q 041438 164 ISRNQLNGSIPHEVGQLNFLNHLILDSNFLGG-SIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSL----FDMKLCI 238 (752)
Q Consensus 164 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L----~~l~l~~ 238 (752)
|++|++++..+..|+++++|++|+|++|++++ .+|..|+++++|++|++++|++++..|..++.+++| ..+++++
T Consensus 107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~ 186 (570)
T 2z63_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (570)
T ss_dssp CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence 99999997777789999999999999999987 468899999999999999999988877777777777 6667776
Q ss_pred cccCCCcCCCC---------------------------------------------------------------------
Q 041438 239 NQLNGAIPLSI--------------------------------------------------------------------- 249 (752)
Q Consensus 239 N~l~~~~~~~~--------------------------------------------------------------------- 249 (752)
|.+++..|..+
T Consensus 187 n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 266 (570)
T 2z63_A 187 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266 (570)
T ss_dssp CCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEE
T ss_pred CCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhc
Confidence 66554333211
Q ss_pred ----------CCCCCCCCcEEEccccccCCCCCccc------------------------------------------CC
Q 041438 250 ----------DWGRCPQLSLLDVSINNITGNIPFEI------------------------------------------GE 277 (752)
Q Consensus 250 ----------~~~~l~~L~~L~Ls~N~l~~~~p~~~------------------------------------------~~ 277 (752)
.+..+++|+.|++++|.+++ +|..+ ..
T Consensus 267 ~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~-l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~ 345 (570)
T 2z63_A 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD 345 (570)
T ss_dssp TTEEESCSTTTTGGGTTCSEEEEESCEECS-CCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCB
T ss_pred chhhhhhchhhhcCcCcccEEEecCccchh-hhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCcccccccccc
Confidence 12223455555555555442 22111 45
Q ss_pred CCCCCEEecCCCcCcCCC--CccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccc-hhhccccccc
Q 041438 278 SPQLQYLDLSSNYIVGEI--PTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVL-ESLGSLVKLY 354 (752)
Q Consensus 278 l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~ 354 (752)
+++|++|++++|.+++.. |..+.++++|+.|++++|.+.+..+. +..+++|++|++++|.+.+..+ ..|..+++|+
T Consensus 346 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 424 (570)
T 2z63_A 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424 (570)
T ss_dssp CTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCC
T ss_pred CCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCC
Confidence 788999999999998654 67788999999999999999876655 8899999999999999988765 5788999999
Q ss_pred EEEcCCCcCccccchhccccccCCeeecCCccCC-CCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCC
Q 041438 355 YLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLG-EKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYN 433 (752)
Q Consensus 355 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 433 (752)
+|++++|++++..|..|.++++|++|+|++|.++ +.+|..+..+++|++|+|++|++++..|..|..+++|++|++++|
T Consensus 425 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 504 (570)
T 2z63_A 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504 (570)
T ss_dssp EEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCC
Confidence 9999999999889999999999999999999997 578888999999999999999999998999999999999999999
Q ss_pred cccCcCCCC-cccCCCCcccccCCCCCCCC
Q 041438 434 KLEGHIPNS-TTFRDAPLEALQGNKGLCGD 462 (752)
Q Consensus 434 ~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~ 462 (752)
++++..|.. ..+..+....+.+|+..|..
T Consensus 505 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 534 (570)
T 2z63_A 505 QLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 534 (570)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred cCCCCCHHHhhcccCCcEEEecCCcccCCC
Confidence 999877753 34556666788899988863
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=376.53 Aligned_cols=178 Identities=28% Similarity=0.338 Sum_probs=148.4
Q ss_pred HHHHHhhcccccceeeccCCceEEEEEEe----CCCcEEEEEccCCCCCC-----------------------CccccCC
Q 041438 494 EEIIRATNDFDAKHCIGKGGHGSVYIARV----PSGEIFAVKKFHSPLPD-----------------------NFCSHPR 546 (752)
Q Consensus 494 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-----------------------~~~~~~~ 546 (752)
+.+-+..++|++.++||+|+||+||+|+. .+++.||||++...... +++.+.+
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 33344568899999999999999999984 35789999987543221 3455678
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC-CceEEeeccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG-YEAHVSDFRI 625 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~-~~~kl~DfG~ 625 (752)
..|+|||||++|+|.+++. .+++.+++.+++||+.||+|||++ ||+||||||+|||++.+ +.+||+|||+
T Consensus 94 ~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 8999999999999999984 288899999999999999999999 99999999999999876 7999999999
Q ss_pred ceeccCCCC----------------------------CcccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCC
Q 041438 626 AKFLNLDSS----------------------------NWSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGK 676 (752)
Q Consensus 626 a~~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~ 676 (752)
|+....... .....+||+.|+|||++.+.. |+.++||||+||++|||+||+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 986543211 122347999999999988764 899999999999999999999
Q ss_pred CCcc
Q 041438 677 HPRD 680 (752)
Q Consensus 677 ~pf~ 680 (752)
.||.
T Consensus 245 ~Pf~ 248 (361)
T 4f9c_A 245 YPFY 248 (361)
T ss_dssp SSSS
T ss_pred CCCC
Confidence 9984
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=398.26 Aligned_cols=352 Identities=26% Similarity=0.303 Sum_probs=237.7
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceee
Q 041438 84 GRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILH 163 (752)
Q Consensus 84 ~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 163 (752)
.+++.++|+++.+.+ +++..|..+++|++|+|++|+++++.|.+|+++++|++|+|++|+++++.+..|+++++|++|+
T Consensus 25 ~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 25 TNITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103 (680)
T ss_dssp TTCSEEECCSSCCCC-CCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCcEEECCCCCCCC-cCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence 467889999888876 4455789999999999999999999999999999999999999999977777899999999999
Q ss_pred ccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeecccccccccccccc--Ccccccccccccccc
Q 041438 164 ISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIG--NLKSLFDMKLCINQL 241 (752)
Q Consensus 164 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~l~l~~N~l 241 (752)
|++|++++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|++++..+..+. .+++|+.|++++|++
T Consensus 104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l 183 (680)
T 1ziw_A 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183 (680)
T ss_dssp CCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCC
T ss_pred CCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcc
Confidence 999999988888899999999999999999988888899999999999999998887777654 447788888888887
Q ss_pred CCCcCCCC-------------------------------------------------CCCCC--CCCcEEEccccccCCC
Q 041438 242 NGAIPLSI-------------------------------------------------DWGRC--PQLSLLDVSINNITGN 270 (752)
Q Consensus 242 ~~~~~~~~-------------------------------------------------~~~~l--~~L~~L~Ls~N~l~~~ 270 (752)
++..|..+ .|..+ ++|+.|++++|++++.
T Consensus 184 ~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~ 263 (680)
T 1ziw_A 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263 (680)
T ss_dssp CCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEE
T ss_pred cccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCcc
Confidence 76655321 11122 2366777777777666
Q ss_pred CCcccCCCCCCCEEecCCCcCcCCCCccccCCc---------------------------------ccCEEEccCCcCcc
Q 041438 271 IPFEIGESPQLQYLDLSSNYIVGEIPTQLGNII---------------------------------YLNRISLSGNKLSG 317 (752)
Q Consensus 271 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~---------------------------------~L~~L~Ls~N~l~~ 317 (752)
.|..|..+++|++|+|++|.+++..|..|.+++ +|+.|++++|++++
T Consensus 264 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~ 343 (680)
T 1ziw_A 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343 (680)
T ss_dssp CTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCC
T ss_pred CcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCC
Confidence 666666777777777777766665554444433 34444444444444
Q ss_pred cCCcccCCCcccceeeccccccc--cccchhhccc--ccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCC-
Q 041438 318 RIPGELGSLINLEYLDLSANHLS--NFVLESLGSL--VKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKIS- 392 (752)
Q Consensus 318 ~~p~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~- 392 (752)
..+..|.++++|++|++++|.++ .+....|..+ ++|+.|++++|++++..|..|..+++|++|+|++|.+++.+|
T Consensus 344 ~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 423 (680)
T 1ziw_A 344 IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423 (680)
T ss_dssp CCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCS
T ss_pred CChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCc
Confidence 44444444444444444333211 1111111111 133334444445555556666666666666666666655443
Q ss_pred cccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCCccc
Q 041438 393 SRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLE 436 (752)
Q Consensus 393 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 436 (752)
..|..+++|++|++++|++++..+..|..+++|+.|++++|.++
T Consensus 424 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~ 467 (680)
T 1ziw_A 424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK 467 (680)
T ss_dssp GGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCB
T ss_pred ccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccccc
Confidence 45666666666666666665555555555555555555555544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=397.63 Aligned_cols=226 Identities=20% Similarity=0.288 Sum_probs=186.3
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC---------------------------C---CccccCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP---------------------------D---NFCSHPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------------------------~---~~~~~~~~~ 548 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||++++... . ..+.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 57899999999999999999994 5799999998753210 0 345667889
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
|+|||||+||+|.+++.+.+ .+++..++.|+.||+.||+|||++ |||||||||+|||++.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999997643 489999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChh
Q 041438 629 LNLDSSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLD 707 (752)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (752)
.... .....+||+.|||||++.+ ..|+.++||||+||++|||++|++||..... .........+.......|
T Consensus 342 ~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~--~~~~~i~~~i~~~~~~~p--- 414 (689)
T 3v5w_A 342 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT--KDKHEIDRMTLTMAVELP--- 414 (689)
T ss_dssp CSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC--CCHHHHHHHHHHCCCCCC---
T ss_pred cCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhhcCCCCCCC---
Confidence 7543 2345699999999999864 5799999999999999999999999963211 111223344555555555
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRPT-----MKRFEVQ 739 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 739 (752)
...++++.++|.+||++||++|++ ++|+.+|
T Consensus 415 -~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 415 -DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp -TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred -ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 245677899999999999999998 6787765
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=393.65 Aligned_cols=355 Identities=22% Similarity=0.206 Sum_probs=299.1
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceee
Q 041438 84 GRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILH 163 (752)
Q Consensus 84 ~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 163 (752)
..+..++++++.+.+ +.+.+|..+++|++|+|++|+|+++.|.+|+++++|++|+|++|++++..+..|+++++|++|+
T Consensus 56 ~~L~~L~Ls~n~l~~-i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 134 (606)
T 3vq2_A 56 SELQWLDLSRCEIET-IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLN 134 (606)
T ss_dssp TTCCEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEE
T ss_pred ccCcEEeCCCCcccc-cCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEe
Confidence 467788999888875 3455789999999999999999998899999999999999999999988888899999999999
Q ss_pred ccCcccCC-CCCcccCCCCCCcEEEccCCCCCCcCCcCccCCC---------------------------cceEEeeccc
Q 041438 164 ISRNQLNG-SIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFT---------------------------NLVFLYLYNN 215 (752)
Q Consensus 164 Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~---------------------------~L~~L~L~~N 215 (752)
|++|.+++ .+|..|+++++|++|+|++|++++..|..|..++ +|+.|+|++|
T Consensus 135 L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n 214 (606)
T 3vq2_A 135 VAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGN 214 (606)
T ss_dssp CCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred CCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCC
Confidence 99999986 5688999999999999999998887766554433 2333333333
Q ss_pred ccc-----------------------------------------------------------------------------
Q 041438 216 SFS----------------------------------------------------------------------------- 218 (752)
Q Consensus 216 ~l~----------------------------------------------------------------------------- 218 (752)
.++
T Consensus 215 ~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~ 294 (606)
T 3vq2_A 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAG 294 (606)
T ss_dssp CSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEES
T ss_pred ccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecC
Confidence 321
Q ss_pred -------------------------cccc--------------------ccccCccccccccccccccCCCcCCCCCCCC
Q 041438 219 -------------------------GSIP--------------------QQIGNLKSLFDMKLCINQLNGAIPLSIDWGR 253 (752)
Q Consensus 219 -------------------------~~~p--------------------~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~ 253 (752)
+.+| ..+..+++|++|++++|++++..+....+..
T Consensus 295 ~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~ 374 (606)
T 3vq2_A 295 VSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLG 374 (606)
T ss_dssp CCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHHC
T ss_pred ccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhcc
Confidence 1111 1223445566666666666655322334568
Q ss_pred CCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCC-ccccCCcccCEEEccCCcCcccCCcccCCCccccee
Q 041438 254 CPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIP-TQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYL 332 (752)
Q Consensus 254 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 332 (752)
+++|++|++++|.+++ +|..+..+++|++|++++|.+.+..| ..+.++++|+.|++++|.+++..|..+.++++|++|
T Consensus 375 ~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 453 (606)
T 3vq2_A 375 TNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTL 453 (606)
T ss_dssp CSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred CCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEE
Confidence 8999999999999986 56889999999999999999999888 789999999999999999999999999999999999
Q ss_pred ecccccccc-ccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcC
Q 041438 333 DLSANHLSN-FVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNL 411 (752)
Q Consensus 333 ~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 411 (752)
++++|.+++ ..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++.+|..+..+++|+.|+|++|++
T Consensus 454 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l 533 (606)
T 3vq2_A 454 KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533 (606)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCC
T ss_pred ECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcC
Confidence 999999998 5788999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCchhhhccC-CCcEEEccCCcccCcCCC
Q 041438 412 SGLIPRCFEELH-GLLHIDISYNKLEGHIPN 441 (752)
Q Consensus 412 ~~~~p~~~~~l~-~L~~L~ls~N~l~~~~p~ 441 (752)
+.+ |..+..++ +|+.|++++|++.+..+.
T Consensus 534 ~~~-p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 534 ETS-KGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp CCE-ESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred ccc-CHhHhhhcccCcEEEccCCCcccCCcc
Confidence 955 66688887 699999999999986664
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=389.85 Aligned_cols=404 Identities=24% Similarity=0.250 Sum_probs=312.8
Q ss_pred cccCCCCccccCCCCCCCCccc----ceeeCCC----------CCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCc
Q 041438 55 SLLHSWSLSFVNATKISLCTWS----GIHCNHA----------GRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNE 120 (752)
Q Consensus 55 ~~l~sW~~~~~~~~~~~~c~w~----gv~C~~~----------~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~ 120 (752)
..+++|..+... ..++|.+. .|.|... ..++.+||+++.+.+ +++.+|.++++|++|||++|+
T Consensus 11 ~~~~~~~~~~p~--~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~-l~~~~f~~l~~L~~L~Ls~N~ 87 (635)
T 4g8a_A 11 DKLAAANSSIPE--SWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCE 87 (635)
T ss_dssp ----------------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCC
T ss_pred chhhcccCCCCC--CCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCC-CCHHHHhCCCCCCEEECCCCc
Confidence 445666532211 12456553 4678632 257889999999874 566789999999999999999
Q ss_pred ccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCc-CCc
Q 041438 121 LFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGS-IPR 199 (752)
Q Consensus 121 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~ 199 (752)
|+++.|.+|++|++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|+++++|++|+|++|++++. .|.
T Consensus 88 i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~ 167 (635)
T 4g8a_A 88 IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 167 (635)
T ss_dssp CCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCG
T ss_pred CCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCch
Confidence 9999999999999999999999999998889999999999999999999988888999999999999999999864 688
Q ss_pred CccCCCcceEEeeccccccccccccccCccccc----cccccccccCCCcCCC---------------------------
Q 041438 200 SLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLF----DMKLCINQLNGAIPLS--------------------------- 248 (752)
Q Consensus 200 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~l~l~~N~l~~~~~~~--------------------------- 248 (752)
.+.++++|++|+|++|+|++..|..|..+.++. .++++.|.++...+..
T Consensus 168 ~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~ 247 (635)
T 4g8a_A 168 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQG 247 (635)
T ss_dssp GGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHT
T ss_pred hhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcC
Confidence 899999999999999999988888776655443 2333333332111000
Q ss_pred --------------------------------------------------------------------------CCCCCC
Q 041438 249 --------------------------------------------------------------------------IDWGRC 254 (752)
Q Consensus 249 --------------------------------------------------------------------------~~~~~l 254 (752)
..+...
T Consensus 248 l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~ 327 (635)
T 4g8a_A 248 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYN 327 (635)
T ss_dssp TTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSC
T ss_pred Ccccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccc
Confidence 011223
Q ss_pred CCCcEEEccccccCCCCCc-------------------ccCCCCCCCEEecCCCcCcCC---------------------
Q 041438 255 PQLSLLDVSINNITGNIPF-------------------EIGESPQLQYLDLSSNYIVGE--------------------- 294 (752)
Q Consensus 255 ~~L~~L~Ls~N~l~~~~p~-------------------~~~~l~~L~~L~Ls~N~l~~~--------------------- 294 (752)
..|+.|++++|.+.+..+. ....+++|+.|++++|.+...
T Consensus 328 ~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~ 407 (635)
T 4g8a_A 328 FGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFN 407 (635)
T ss_dssp CCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSC
T ss_pred hhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhcccc
Confidence 4556666666665443222 223466788888888876421
Q ss_pred ----CCccccCCcccCEEEccCCcCcccCC-cccCCCcccceeeccccccccccchhhcccccccEEEcCCCcC-ccccc
Q 041438 295 ----IPTQLGNIIYLNRISLSGNKLSGRIP-GELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKL-SQQIP 368 (752)
Q Consensus 295 ----~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l-~~~~p 368 (752)
.+..+..+++|+.++++.|+.....+ ..|..+++++.++++.|.+.+..+..+..++.|+.|+|++|++ .+..|
T Consensus 408 ~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~ 487 (635)
T 4g8a_A 408 GVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 487 (635)
T ss_dssp SEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEEC
T ss_pred ccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCc
Confidence 23345566777777777776654433 5678899999999999999999999999999999999999985 45678
Q ss_pred hhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCCcccCcCCCCcc-c-C
Q 041438 369 IELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTT-F-R 446 (752)
Q Consensus 369 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~-~-~ 446 (752)
..|..+++|++|+|++|+|++.+|..|.++++|++|+|++|+|++++|..|..+++|+.|||++|++++..|.... + .
T Consensus 488 ~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~ 567 (635)
T 4g8a_A 488 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPS 567 (635)
T ss_dssp SCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCT
T ss_pred hhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhC
Confidence 8999999999999999999999999999999999999999999999999999999999999999999999887532 2 3
Q ss_pred CCCcccccCCCCCCC
Q 041438 447 DAPLEALQGNKGLCG 461 (752)
Q Consensus 447 ~~~~~~~~~n~~~c~ 461 (752)
.+....+.+||+.|.
T Consensus 568 ~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 568 SLAFLNLTQNDFACT 582 (635)
T ss_dssp TCCEEECTTCCBCCS
T ss_pred cCCEEEeeCCCCccc
Confidence 456678899999996
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=380.90 Aligned_cols=362 Identities=20% Similarity=0.223 Sum_probs=272.2
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceee
Q 041438 84 GRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILH 163 (752)
Q Consensus 84 ~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 163 (752)
..++.++++++.+.+. ++..|..+++|++|+|++|+|+++.|..|+++++|++|+|++|+|+. +|.. .+++|++|+
T Consensus 21 ~~L~~L~Ls~n~i~~~-~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L~ 96 (520)
T 2z7x_B 21 QKTTILNISQNYISEL-WTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLKHLD 96 (520)
T ss_dssp TTCSEEECCSSCCCCC-CHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EECC--CCCCCSEEE
T ss_pred ccccEEECCCCccccc-ChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cCcc--ccCCccEEe
Confidence 4677788887777653 33467888888888888888888778888888888888888888874 4444 788888888
Q ss_pred ccCcccCC-CCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcc--eEEeeccccc--cccccccccC-----------
Q 041438 164 ISRNQLNG-SIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL--VFLYLYNNSF--SGSIPQQIGN----------- 227 (752)
Q Consensus 164 Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--~~~~p~~~~~----------- 227 (752)
|++|+|++ .+|..|+++++|++|+|++|++++ ..|.++++| ++|+|++|++ .+..|..+.+
T Consensus 97 L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~ 173 (520)
T 2z7x_B 97 LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173 (520)
T ss_dssp CCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECC
T ss_pred ccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEec
Confidence 88888876 467788888888888888888875 356667777 8888888888 6666666555
Q ss_pred ---------------ccccccccccccc-------cCCCcCCCCCCCC---------------------------CCCCc
Q 041438 228 ---------------LKSLFDMKLCINQ-------LNGAIPLSIDWGR---------------------------CPQLS 258 (752)
Q Consensus 228 ---------------l~~L~~l~l~~N~-------l~~~~~~~~~~~~---------------------------l~~L~ 258 (752)
+++|+.+++++|. +.+.+|. ++. +++|+
T Consensus 174 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~---l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~ 250 (520)
T 2z7x_B 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAK---LQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVW 250 (520)
T ss_dssp SSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHG---GGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCS
T ss_pred cCcchhhhhhhhhhcccceeeccccccccccccceeecchhh---hccccchhhccccccccCHHHHHHHHHHhhhCccc
Confidence 3344444444443 1111110 011 23567
Q ss_pred EEEccccccCCCCCccc-----CCCCCCCEEecCCCcC--------------------------cCCCCccccCCcccCE
Q 041438 259 LLDVSINNITGNIPFEI-----GESPQLQYLDLSSNYI--------------------------VGEIPTQLGNIIYLNR 307 (752)
Q Consensus 259 ~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l--------------------------~~~~p~~~~~l~~L~~ 307 (752)
+|++++|+++|.+|..+ ..+++|+.+++++|.+ .+.. .+..+++|++
T Consensus 251 ~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~ 328 (520)
T 2z7x_B 251 YFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLH 328 (520)
T ss_dssp EEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCE
T ss_pred EEEeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccE
Confidence 77777777777777666 5555555555555554 2211 1267889999
Q ss_pred EEccCCcCcccCCcccCCCcccceeecccccccc--ccchhhcccccccEEEcCCCcCccccch-hccccccCCeeecCC
Q 041438 308 ISLSGNKLSGRIPGELGSLINLEYLDLSANHLSN--FVLESLGSLVKLYYLNLSHNKLSQQIPI-ELDNLIHLSELDLSH 384 (752)
Q Consensus 308 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~ 384 (752)
|++++|++++..|..++.+++|++|+|++|++++ ..|..+..+++|++|+|++|++++.+|. .+..+++|++|+|++
T Consensus 329 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~ 408 (520)
T 2z7x_B 329 LDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSS 408 (520)
T ss_dssp EECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCS
T ss_pred EEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcC
Confidence 9999999999899999999999999999999998 4567899999999999999999985554 588999999999999
Q ss_pred ccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCCcccCcCCC--CcccCCCCcccccCCCCCCC
Q 041438 385 NFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPN--STTFRDAPLEALQGNKGLCG 461 (752)
Q Consensus 385 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~--~~~~~~~~~~~~~~n~~~c~ 461 (752)
|++++..|..+. ++|+.|+|++|+++ .+|..+..+++|++|++++|++++ +|. ...+..+....+.+|+..|.
T Consensus 409 N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 409 NILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp SCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCccc
Confidence 999988777664 79999999999999 557777799999999999999995 554 33455566678899999885
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=376.75 Aligned_cols=305 Identities=21% Similarity=0.165 Sum_probs=224.2
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEc
Q 041438 109 PHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLIL 188 (752)
Q Consensus 109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 188 (752)
+++++|+|++|+|+++.|..|.++++|++|+|++|.|+++.|..|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 111 (477)
T 2id5_A 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDI 111 (477)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEEC
T ss_pred CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEEC
Confidence 58999999999999999999999999999999999999999999999999999999999999877778999999999999
Q ss_pred cCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccC
Q 041438 189 DSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNIT 268 (752)
Q Consensus 189 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 268 (752)
++|++++..|..|.++++|++|+|++|++++..+..|.++++|+ .|++++|+++
T Consensus 112 s~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~--------------------------~L~l~~n~l~ 165 (477)
T 2id5_A 112 SENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLE--------------------------QLTLEKCNLT 165 (477)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCC--------------------------EEEEESCCCS
T ss_pred CCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCC--------------------------EEECCCCcCc
Confidence 99999999999999999999999999999887777776665555 5555555555
Q ss_pred CCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhc
Q 041438 269 GNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLG 348 (752)
Q Consensus 269 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 348 (752)
+..+..+..+++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.+|.......+|++|+|++|+++++++..|.
T Consensus 166 ~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~ 245 (477)
T 2id5_A 166 SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVR 245 (477)
T ss_dssp SCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHT
T ss_pred ccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhc
Confidence 44444555555566666666665555555555666666666666555555554444445666666666666665555666
Q ss_pred ccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEE
Q 041438 349 SLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHI 428 (752)
Q Consensus 349 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 428 (752)
.+++|+.|+|++|++++..+..|.++++|++|+|++|++++..|..|..+++|+.|+|++|+++++.+..|..+++|+.|
T Consensus 246 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 325 (477)
T 2id5_A 246 HLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETL 325 (477)
T ss_dssp TCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEE
T ss_pred CccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEE
Confidence 66666666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred EccCCcccCcC
Q 041438 429 DISYNKLEGHI 439 (752)
Q Consensus 429 ~ls~N~l~~~~ 439 (752)
++++|++.+..
T Consensus 326 ~l~~N~l~c~c 336 (477)
T 2id5_A 326 ILDSNPLACDC 336 (477)
T ss_dssp ECCSSCEECSG
T ss_pred EccCCCccCcc
Confidence 66666666543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=383.88 Aligned_cols=342 Identities=21% Similarity=0.207 Sum_probs=227.8
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEc
Q 041438 109 PHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLIL 188 (752)
Q Consensus 109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 188 (752)
++|++|+|++|+|+++.|..|+++++|++|+|++|+|+++.|+.|.++++|++|+|++|+|+ .+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 45555555555555555555555555555555555555555555555555555555555555 33333 4555555555
Q ss_pred cCCCCCCc-CCcCccCCCcceEEeeccccccccccccccCcccc--cccccccccc--CCCcCCCCCC------------
Q 041438 189 DSNFLGGS-IPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSL--FDMKLCINQL--NGAIPLSIDW------------ 251 (752)
Q Consensus 189 ~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~l~l~~N~l--~~~~~~~~~~------------ 251 (752)
++|++++. +|..|+++++|++|+|++|++++. .+..+++| +.|++++|++ ++..|..+.-
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~ 205 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHP 205 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECS
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecC
Confidence 55555542 234555555555555555555432 22333333 5555555554 3333222100
Q ss_pred ------------C-------------------------------------------------------CCCCCcEEEccc
Q 041438 252 ------------G-------------------------------------------------------RCPQLSLLDVSI 264 (752)
Q Consensus 252 ------------~-------------------------------------------------------~l~~L~~L~Ls~ 264 (752)
. ..++|++|++++
T Consensus 206 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~ 285 (562)
T 3a79_B 206 NSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYN 285 (562)
T ss_dssp SSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEE
T ss_pred ccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEec
Confidence 0 112677777777
Q ss_pred cccCCCCCccc-----CCC--------------------------CCCCEEecCCCcCcCCCCccccCCcccCEEEccCC
Q 041438 265 NNITGNIPFEI-----GES--------------------------PQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGN 313 (752)
Q Consensus 265 N~l~~~~p~~~-----~~l--------------------------~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 313 (752)
|.++|.+|..+ ..+ .+|++|++++|.+.... ....+++|+.|++++|
T Consensus 286 n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n 363 (562)
T 3a79_B 286 LTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQN 363 (562)
T ss_dssp EEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSS
T ss_pred cEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCC
Confidence 77777777655 222 34666666666664221 1267889999999999
Q ss_pred cCcccCCcccCCCcccceeecccccccccc--chhhcccccccEEEcCCCcCccccc-hhccccccCCeeecCCccCCCC
Q 041438 314 KLSGRIPGELGSLINLEYLDLSANHLSNFV--LESLGSLVKLYYLNLSHNKLSQQIP-IELDNLIHLSELDLSHNFLGEK 390 (752)
Q Consensus 314 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~ 390 (752)
++++.+|..++++++|++|+|++|+++++. |..|..+++|++|+|++|++++.+| ..+..+++|++|+|++|++++.
T Consensus 364 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 443 (562)
T 3a79_B 364 VFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS 443 (562)
T ss_dssp CCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGG
T ss_pred ccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcc
Confidence 999989999999999999999999999854 5678999999999999999998444 5688999999999999999887
Q ss_pred CCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCCcccCcCCC-CcccCCCCcccccCCCCCCC
Q 041438 391 ISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPN-STTFRDAPLEALQGNKGLCG 461 (752)
Q Consensus 391 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~~~~~~~~~~~n~~~c~ 461 (752)
.|..+. ++|++|+|++|+++.+ |..+..+++|++|++++|++++..+. ...+..+....+.+|++.|.
T Consensus 444 ~~~~l~--~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~ 512 (562)
T 3a79_B 444 VFRCLP--PKVKVLDLHNNRIMSI-PKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 512 (562)
T ss_dssp GGSSCC--TTCSEEECCSSCCCCC-CTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCC
T ss_pred hhhhhc--CcCCEEECCCCcCccc-ChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCC
Confidence 776554 7899999999999965 55555999999999999999954333 34455566678899999986
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=389.16 Aligned_cols=229 Identities=19% Similarity=0.281 Sum_probs=193.1
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEe
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~ 554 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||++...... +++.+....|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 46899999999999999999994 67999999988653211 445677899999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC--CceEEeecccceeccCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG--YEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~--~~~kl~DfG~a~~~~~~ 632 (752)
|+||+|.+++.... ..+++.+++.+++||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 99999999986533 3489999999999999999999999 99999999999999854 89999999999987633
Q ss_pred CCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHH
Q 041438 633 SSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (752)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||.. ....+....+.......+.......+
T Consensus 311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~-----~~~~~~~~~i~~~~~~~~~~~~~~~s 384 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-----ENDDETLRNVKSCDWNMDDSAFSGIS 384 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-----SSHHHHHHHHHTTCCCCCSGGGTTSC
T ss_pred -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-----cCHHHHHHHHHhCCCCCCcccccCCC
Confidence 334456899999999999999999999999999999999999999952 22333445555555555555556677
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+++.++|.+||+.||++|||++|+++|
T Consensus 385 ~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 385 EDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 889999999999999999999999986
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=393.15 Aligned_cols=346 Identities=20% Similarity=0.210 Sum_probs=297.6
Q ss_pred CCEEEEEcCCCCCcc-----------------cccccccC--CCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCc
Q 041438 84 GRVFGINLTSISLNG-----------------TLLEFSFS--SFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNK 144 (752)
Q Consensus 84 ~~v~~l~l~~~~l~g-----------------~l~~~~f~--~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 144 (752)
..+..++|+++.+.| .+++ .++ .+++|++|+|++|++.+.+|..|+++++|++|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~-~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE-ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCCh-hhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 467889999999998 2443 444 99999999999999999999999999999999999998
Q ss_pred -ccc-cCCccccccc-------ccceeeccCcccCCCCCc--ccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeec
Q 041438 145 -LSG-HIPSEISLLT-------HLTILHISRNQLNGSIPH--EVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLY 213 (752)
Q Consensus 145 -l~~-~~p~~~~~l~-------~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 213 (752)
++| .+|..|+.++ +|++|+|++|+|+ .+|. .|+++++|++|+|++|+++ .+| .|.++++|+.|+|+
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls 603 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLD 603 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECC
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECc
Confidence 998 8898888777 9999999999999 8888 9999999999999999999 778 89999999999999
Q ss_pred cccccccccccccCccc-cccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcc---cC--CCCCCCEEecC
Q 041438 214 NNSFSGSIPQQIGNLKS-LFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFE---IG--ESPQLQYLDLS 287 (752)
Q Consensus 214 ~N~l~~~~p~~~~~l~~-L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~---~~--~l~~L~~L~Ls 287 (752)
+|+++ .+|..+.++++ |+.|++++|+++ .+|..+.....++|+.|+|++|++++.+|.. +. .+++|+.|+|+
T Consensus 604 ~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls 681 (876)
T 4ecn_A 604 YNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLS 681 (876)
T ss_dssp SSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECC
T ss_pred CCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEcc
Confidence 99999 88989999999 999999999999 6675543333456999999999999877632 22 34589999999
Q ss_pred CCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCC-------Ccccceeeccccccccccchhhc--ccccccEEEc
Q 041438 288 SNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGS-------LINLEYLDLSANHLSNFVLESLG--SLVKLYYLNL 358 (752)
Q Consensus 288 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-------l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~L 358 (752)
+|.++...+..+..+++|+.|+|++|+|+...+..+.. +++|++|+|++|+|+. +|..+. .+++|+.|+|
T Consensus 682 ~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~~-lp~~l~~~~l~~L~~L~L 760 (876)
T 4ecn_A 682 YNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDV 760 (876)
T ss_dssp SSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCCC-CCGGGSTTTCTTCCEEEC
T ss_pred CCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCcc-chHHhhhccCCCcCEEEe
Confidence 99999544445568999999999999999544444433 3499999999999995 456665 8999999999
Q ss_pred CCCcCccccchhccccccCCeeecCC------ccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccC
Q 041438 359 SHNKLSQQIPIELDNLIHLSELDLSH------NFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISY 432 (752)
Q Consensus 359 s~N~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~ 432 (752)
++|+|++ +|..+..+++|+.|+|++ |++.+.+|..+..+++|+.|+|++|++ +.+|..+. ++|+.|||++
T Consensus 761 s~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~ 836 (876)
T 4ecn_A 761 SYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIAD 836 (876)
T ss_dssp CSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCS
T ss_pred CCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCC
Confidence 9999997 788899999999999976 888999999999999999999999999 66677665 6999999999
Q ss_pred CcccCcCC
Q 041438 433 NKLEGHIP 440 (752)
Q Consensus 433 N~l~~~~p 440 (752)
|++...-+
T Consensus 837 N~l~~i~~ 844 (876)
T 4ecn_A 837 NPNISIDV 844 (876)
T ss_dssp CTTCEEEC
T ss_pred CCCCccCh
Confidence 99875443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=375.99 Aligned_cols=356 Identities=21% Similarity=0.219 Sum_probs=281.9
Q ss_pred CCcccceee---CCCCCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccc-
Q 041438 72 LCTWSGIHC---NHAGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSG- 147 (752)
Q Consensus 72 ~c~w~gv~C---~~~~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~- 147 (752)
.|...++.. ..-..+..++|+++.+.+.. +..|..+++|++|+|++|+|+++ |.. .+++|++|+|++|++++
T Consensus 30 ~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~l-p~~--~l~~L~~L~L~~N~l~~~ 105 (520)
T 2z7x_B 30 QNYISELWTSDILSLSKLRILIISHNRIQYLD-ISVFKFNQELEYLDLSHNKLVKI-SCH--PTVNLKHLDLSFNAFDAL 105 (520)
T ss_dssp SSCCCCCCHHHHTTCTTCCEEECCSSCCCEEE-GGGGTTCTTCCEEECCSSCCCEE-ECC--CCCCCSEEECCSSCCSSC
T ss_pred CCcccccChhhccccccccEEecCCCccCCcC-hHHhhcccCCCEEecCCCceeec-Ccc--ccCCccEEeccCCccccc
Confidence 355555543 23356888999999988643 45899999999999999999974 544 89999999999999998
Q ss_pred cCCcccccccccceeeccCcccCCCCCcccCCCCCC--cEEEccCCCC--CCcCCcCccC--------------------
Q 041438 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFL--NHLILDSNFL--GGSIPRSLSN-------------------- 203 (752)
Q Consensus 148 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--~~~~p~~~~~-------------------- 203 (752)
.+|..|+++++|++|+|++|.|++ ..|..+++| ++|+|++|++ .+..|..|..
T Consensus 106 ~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~ 182 (520)
T 2z7x_B 106 PICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFIL 182 (520)
T ss_dssp CCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCC
T ss_pred cchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhh
Confidence 478999999999999999999986 467888888 9999999999 7777776665
Q ss_pred ------CCcceEEeecccc-------ccccccccccCc---------------------------cccccccccccccCC
Q 041438 204 ------FTNLVFLYLYNNS-------FSGSIPQQIGNL---------------------------KSLFDMKLCINQLNG 243 (752)
Q Consensus 204 ------l~~L~~L~L~~N~-------l~~~~p~~~~~l---------------------------~~L~~l~l~~N~l~~ 243 (752)
+++|+.|++++|. +.+.+| .++.+ ++|++|++++|+++|
T Consensus 183 ~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 261 (520)
T 2z7x_B 183 DVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQG 261 (520)
T ss_dssp CCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEES
T ss_pred hhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccC
Confidence 4455555555554 333332 22222 245555555566655
Q ss_pred CcCCCCC---CCCCCC--------------------------CcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCC
Q 041438 244 AIPLSID---WGRCPQ--------------------------LSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGE 294 (752)
Q Consensus 244 ~~~~~~~---~~~l~~--------------------------L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 294 (752)
.+|..+. .+.+++ |+.|++++|.+.+.. .+..+++|++|++++|++++.
T Consensus 262 ~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~ 339 (520)
T 2z7x_B 262 QLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDT 339 (520)
T ss_dssp CCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTT
T ss_pred ccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChh
Confidence 5554320 033444 555555555554321 126889999999999999999
Q ss_pred CCccccCCcccCEEEccCCcCcc--cCCcccCCCcccceeecccccccc-ccchhhcccccccEEEcCCCcCccccchhc
Q 041438 295 IPTQLGNIIYLNRISLSGNKLSG--RIPGELGSLINLEYLDLSANHLSN-FVLESLGSLVKLYYLNLSHNKLSQQIPIEL 371 (752)
Q Consensus 295 ~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 371 (752)
+|..++++++|+.|++++|++++ .+|..++.+++|++|+|++|.+++ ++...+..+++|++|++++|++++..|..+
T Consensus 340 ~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l 419 (520)
T 2z7x_B 340 VFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419 (520)
T ss_dssp TTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSC
T ss_pred hhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhh
Confidence 99999999999999999999997 566789999999999999999999 655668999999999999999998888776
Q ss_pred cccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCCcccCcCC
Q 041438 372 DNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIP 440 (752)
Q Consensus 372 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 440 (752)
. ++|+.|+|++|+++ .+|..+..+++|++|+|++|+++++++..|..+++|++|++++|++++..+
T Consensus 420 ~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 420 P--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp C--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred c--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence 5 79999999999998 567777799999999999999997766569999999999999999998654
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=381.98 Aligned_cols=346 Identities=22% Similarity=0.208 Sum_probs=299.2
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEc
Q 041438 109 PHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLIL 188 (752)
Q Consensus 109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 188 (752)
+++++|+|++|+|+++.+.+|.++++|++|+|++|+++++.|..|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 57999999999999999999999999999999999999999999999999999999999999988899999999999999
Q ss_pred cCCCCCCcCCcCccCCCcceEEeeccccccc-cccccccCccccccccccccccCCCcCCCCCCCCCCCC----cEEEcc
Q 041438 189 DSNFLGGSIPRSLSNFTNLVFLYLYNNSFSG-SIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQL----SLLDVS 263 (752)
Q Consensus 189 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L----~~L~Ls 263 (752)
++|++++..+..|+++++|++|+|++|.+++ .+|..|+++++|+.|++++|++++..+.. ++.+++| ..|+++
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~--~~~l~~L~~~~~~L~l~ 185 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD--LRVLHQMPLLNLSLDLS 185 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGG--GHHHHTCTTCCCEEECT
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHH--ccchhccchhhhhcccC
Confidence 9999998877789999999999999999997 46999999999999999999998766543 3344455 566776
Q ss_pred ccccCCCC------------------------------------------------------------------------
Q 041438 264 INNITGNI------------------------------------------------------------------------ 271 (752)
Q Consensus 264 ~N~l~~~~------------------------------------------------------------------------ 271 (752)
+|.+++..
T Consensus 186 ~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~ 265 (570)
T 2z63_A 186 LNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265 (570)
T ss_dssp TCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEE
T ss_pred CCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhh
Confidence 66655433
Q ss_pred ---------CcccCCCCCCCEEecCCCcCcCCCCccc------------------------------------------c
Q 041438 272 ---------PFEIGESPQLQYLDLSSNYIVGEIPTQL------------------------------------------G 300 (752)
Q Consensus 272 ---------p~~~~~l~~L~~L~Ls~N~l~~~~p~~~------------------------------------------~ 300 (752)
|..+..+++|++|++++|.+++ +|..+ .
T Consensus 266 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~-l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~ 344 (570)
T 2z63_A 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV 344 (570)
T ss_dssp ETTEEESCSTTTTGGGTTCSEEEEESCEECS-CCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCC
T ss_pred cchhhhhhchhhhcCcCcccEEEecCccchh-hhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccc
Confidence 3344556778888888887763 34322 4
Q ss_pred CCcccCEEEccCCcCcccC--CcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccc-hhccccccC
Q 041438 301 NIIYLNRISLSGNKLSGRI--PGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIP-IELDNLIHL 377 (752)
Q Consensus 301 ~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L 377 (752)
.+++|+.|++++|++++.. |..+.++++|++|++++|.+++.++. +..+++|+.|++++|++++..| ..+..+++|
T Consensus 345 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L 423 (570)
T 2z63_A 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423 (570)
T ss_dssp BCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTC
T ss_pred cCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCC
Confidence 5678999999999998664 67888999999999999999998776 9999999999999999988766 578999999
Q ss_pred CeeecCCccCCCCCCcccccccccceEEccCCcCC-cCCchhhhccCCCcEEEccCCcccCcCCCC-cccCCCCcccccC
Q 041438 378 SELDLSHNFLGEKISSRICRMESLEKLNLSYNNLS-GLIPRCFEELHGLLHIDISYNKLEGHIPNS-TTFRDAPLEALQG 455 (752)
Q Consensus 378 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~ 455 (752)
++|++++|.+.+..|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|++++|++++..|.. .....+....+.+
T Consensus 424 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 503 (570)
T 2z63_A 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMAS 503 (570)
T ss_dssp CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCC
Confidence 99999999999999999999999999999999998 678999999999999999999999987754 3445556667777
Q ss_pred CCC
Q 041438 456 NKG 458 (752)
Q Consensus 456 n~~ 458 (752)
|.-
T Consensus 504 n~l 506 (570)
T 2z63_A 504 NQL 506 (570)
T ss_dssp SCC
T ss_pred CcC
Confidence 753
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=378.36 Aligned_cols=335 Identities=21% Similarity=0.222 Sum_probs=297.4
Q ss_pred CCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEE
Q 041438 107 SFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHL 186 (752)
Q Consensus 107 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 186 (752)
.+++++.|++++|.+..+.+..|.++++|++|+|++|.|+++.|..|+.+++|++|+|++|.|++..|..|+++++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 46789999999999999888889999999999999999999999999999999999999999999999999999999999
Q ss_pred EccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccc
Q 041438 187 ILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINN 266 (752)
Q Consensus 187 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~ 266 (752)
+|++|.|++.++..|.++++|++|+|++|.|++..|..|+++++|+.|++++|.+++.. ++.+++|+.|++++|.
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-----~~~l~~L~~L~l~~n~ 203 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD-----LSLIPSLFHANVSYNL 203 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC-----GGGCTTCSEEECCSSC
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC-----hhhhhhhhhhhcccCc
Confidence 99999999888888899999999999999999999999999999999999999998752 4567999999999999
Q ss_pred cCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchh
Q 041438 267 ITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLES 346 (752)
Q Consensus 267 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 346 (752)
+++. ...++|+.|++++|.+....+.. .++|+.|+|++|.+++ +..+..+++|++|+|++|.+++.+|..
T Consensus 204 l~~l-----~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~ 273 (597)
T 3oja_B 204 LSTL-----AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHP 273 (597)
T ss_dssp CSEE-----ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGG
T ss_pred cccc-----cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHH
Confidence 9853 34568999999999998554433 2689999999999987 477999999999999999999999999
Q ss_pred hcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCc
Q 041438 347 LGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLL 426 (752)
Q Consensus 347 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 426 (752)
|+.+++|+.|+|++|++++ +|..+..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|++++.. +..+++|+
T Consensus 274 ~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~ 348 (597)
T 3oja_B 274 FVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLK 348 (597)
T ss_dssp GTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCS
T ss_pred hcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCCc-cCcccccCCCCCEEECCCCCCCCcC---hhhcCCCC
Confidence 9999999999999999986 57778889999999999999985 6677889999999999999999874 66778999
Q ss_pred EEEccCCcccCcCCCCcccCCCCcccccCCCCCCCC
Q 041438 427 HIDISYNKLEGHIPNSTTFRDAPLEALQGNKGLCGD 462 (752)
Q Consensus 427 ~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~ 462 (752)
.|++++|++++..+. .-+.......+.+++..|+.
T Consensus 349 ~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~ 383 (597)
T 3oja_B 349 NLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKI 383 (597)
T ss_dssp EEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCT
T ss_pred EEEeeCCCCCChhHH-HHHHHHhhhccccccccCCc
Confidence 999999999875432 12334444567788888874
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=372.60 Aligned_cols=334 Identities=22% Similarity=0.250 Sum_probs=274.3
Q ss_pred CCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccC
Q 041438 111 LAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDS 190 (752)
Q Consensus 111 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 190 (752)
.+++|+++|++++ +|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 33 ~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 33 ESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence 3679999999998 565554 8999999999999999889999999999999999999999999999999999999999
Q ss_pred CCCCCcCCcCccCCCcceEEeecccccccc-ccccccCccccccccccccccCCCcCCCCCCCCCCCC--cEEEcccccc
Q 041438 191 NFLGGSIPRSLSNFTNLVFLYLYNNSFSGS-IPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQL--SLLDVSINNI 267 (752)
Q Consensus 191 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L--~~L~Ls~N~l 267 (752)
|+|+. +|.. .+++|++|+|++|++++. +|..|+++++|++|++++|++++. .+..+++| +.|++++|.+
T Consensus 110 N~l~~-lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~-----~~~~l~~L~L~~L~L~~n~l 181 (562)
T 3a79_B 110 NRLQN-ISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL-----DLLPVAHLHLSCILLDLVSY 181 (562)
T ss_dssp SCCCE-ECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT-----TTGGGTTSCEEEEEEEESSC
T ss_pred CcCCc-cCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC-----chhhhhhceeeEEEeecccc
Confidence 99994 5655 899999999999999974 578999999999999999999863 34455666 9999999999
Q ss_pred --CCCCCcccCCCC------------------------------------------------------------------
Q 041438 268 --TGNIPFEIGESP------------------------------------------------------------------ 279 (752)
Q Consensus 268 --~~~~p~~~~~l~------------------------------------------------------------------ 279 (752)
++..|..+..+.
T Consensus 182 ~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l 261 (562)
T 3a79_B 182 HIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIET 261 (562)
T ss_dssp CCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEE
T ss_pred cccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcC
Confidence 777777665543
Q ss_pred ---------------CCCEEecCCCcCcCCCCccc-----cCCc--------------------------ccCEEEccCC
Q 041438 280 ---------------QLQYLDLSSNYIVGEIPTQL-----GNII--------------------------YLNRISLSGN 313 (752)
Q Consensus 280 ---------------~L~~L~Ls~N~l~~~~p~~~-----~~l~--------------------------~L~~L~Ls~N 313 (752)
+|++|++++|.++|.+|..+ .+++ +|+.|++++|
T Consensus 262 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n 341 (562)
T 3a79_B 262 TWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341 (562)
T ss_dssp CHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESS
T ss_pred cHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCC
Confidence 56667777777776666655 3332 2555555555
Q ss_pred cCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccc--cchhccccccCCeeecCCccCCC-C
Q 041438 314 KLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQ--IPIELDNLIHLSELDLSHNFLGE-K 390 (752)
Q Consensus 314 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~-~ 390 (752)
.+.... ....+++|++|+|++|++++..|..+..+++|++|+|++|++++. .|..|.++++|++|+|++|++++ .
T Consensus 342 ~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 419 (562)
T 3a79_B 342 PFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHA 419 (562)
T ss_dssp CCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCC
T ss_pred Cccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCcc
Confidence 553211 126889999999999999999999999999999999999999874 45779999999999999999998 4
Q ss_pred CCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCCcccCcCCCCcccCCCCcccccCCCCC
Q 041438 391 ISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEALQGNKGL 459 (752)
Q Consensus 391 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~ 459 (752)
.+..+..+++|++|+|++|++++.+|..+. ++|+.|++++|+++...+.......+....+.+|.-.
T Consensus 420 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~ 486 (562)
T 3a79_B 420 YDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLK 486 (562)
T ss_dssp SSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCC
T ss_pred ChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCC
Confidence 555688999999999999999988776654 7899999999999843333445555666677777643
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=356.76 Aligned_cols=335 Identities=21% Similarity=0.231 Sum_probs=293.6
Q ss_pred CCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEE
Q 041438 107 SFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHL 186 (752)
Q Consensus 107 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 186 (752)
.++++++|++++|.++.+.+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|+++++|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 46899999999999999888889999999999999999999988999999999999999999999999999999999999
Q ss_pred EccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccc
Q 041438 187 ILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINN 266 (752)
Q Consensus 187 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~ 266 (752)
+|++|+++...+..|.++++|++|+|++|++++..|..|.++++|++|++++|++++. .++.+++|+.|++++|.
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-----~~~~l~~L~~L~l~~n~ 197 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-----DLSLIPSLFHANVSYNL 197 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC-----CGGGCTTCSEEECCSSC
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc-----ccccccccceeeccccc
Confidence 9999999977777789999999999999999999899999999999999999999865 24577999999999999
Q ss_pred cCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchh
Q 041438 267 ITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLES 346 (752)
Q Consensus 267 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 346 (752)
+++. ...++|++|++++|.+... |.. ..++|+.|++++|++++. ..+..+++|++|+|++|.+++..+..
T Consensus 198 l~~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~ 267 (390)
T 3o6n_A 198 LSTL-----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHP 267 (390)
T ss_dssp CSEE-----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGG
T ss_pred cccc-----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhH
Confidence 8753 3456899999999999865 332 247899999999999864 57899999999999999999999999
Q ss_pred hcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCc
Q 041438 347 LGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLL 426 (752)
Q Consensus 347 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 426 (752)
|..+++|++|+|++|++++ +|..+..+++|++|+|++|++++ +|..+..+++|+.|+|++|++++.. +..+++|+
T Consensus 268 ~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~ 342 (390)
T 3o6n_A 268 FVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLK 342 (390)
T ss_dssp GTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCS
T ss_pred ccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCccee-cCccccccCcCCEEECCCCccceeC---chhhccCC
Confidence 9999999999999999985 56677889999999999999985 5666888999999999999999873 67788999
Q ss_pred EEEccCCcccCcCCCCcccCCCCcccccCCCCCCCC
Q 041438 427 HIDISYNKLEGHIPNSTTFRDAPLEALQGNKGLCGD 462 (752)
Q Consensus 427 ~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~ 462 (752)
.|++++|++++.... ..+.......+.+++..|..
T Consensus 343 ~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~ 377 (390)
T 3o6n_A 343 NLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKI 377 (390)
T ss_dssp EEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCT
T ss_pred EEEcCCCCccchhHH-HHHHHHHhhcccccCceecc
Confidence 999999999874321 12333344456677777763
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=386.44 Aligned_cols=305 Identities=21% Similarity=0.221 Sum_probs=240.7
Q ss_pred CCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccC-CcccccccccceeeccCcccCCCCCcccCCCCCCcE
Q 041438 107 SFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHI-PSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNH 185 (752)
Q Consensus 107 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 185 (752)
-.++|++|||++|+|+++.|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+|++|.|++..|..|+++++|++
T Consensus 22 lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 101 (844)
T 3j0a_A 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFE 101 (844)
T ss_dssp SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCC
T ss_pred CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCE
Confidence 4578999999999999999999999999999999999665555 889999999999999999999999999999999999
Q ss_pred EEccCCCCCCcCCcC--ccCCCcceEEeecccccccccc-ccccCccccccccccccccCCCcCCCCCCCCC--CCCcEE
Q 041438 186 LILDSNFLGGSIPRS--LSNFTNLVFLYLYNNSFSGSIP-QQIGNLKSLFDMKLCINQLNGAIPLSIDWGRC--PQLSLL 260 (752)
Q Consensus 186 L~L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l--~~L~~L 260 (752)
|+|++|++++.+|.. |.++++|++|+|++|.+++..+ ..|+++++|++|++++|++++..+..+ ..+ ++|+.|
T Consensus 102 L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l--~~l~~~~L~~L 179 (844)
T 3j0a_A 102 LRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHEL--EPLQGKTLSFF 179 (844)
T ss_dssp EECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGG--HHHHHCSSCCC
T ss_pred eeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHc--ccccCCccceE
Confidence 999999999876665 9999999999999999998765 579999999999999999998776543 333 677777
Q ss_pred EccccccCCCCCcccCCCCC------CCEEecCCCcCcCCCCccccC---------------------------------
Q 041438 261 DVSINNITGNIPFEIGESPQ------LQYLDLSSNYIVGEIPTQLGN--------------------------------- 301 (752)
Q Consensus 261 ~Ls~N~l~~~~p~~~~~l~~------L~~L~Ls~N~l~~~~p~~~~~--------------------------------- 301 (752)
+++.|.+++..|..+..+++ |++|++++|.+++..|..+..
T Consensus 180 ~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~ 259 (844)
T 3j0a_A 180 SLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNT 259 (844)
T ss_dssp EECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTT
T ss_pred ECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhh
Confidence 77777777776666655554 777777777666554443321
Q ss_pred -----CcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhcccccc
Q 041438 302 -----IIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIH 376 (752)
Q Consensus 302 -----l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 376 (752)
.++|+.|++++|.+.+..|..|..+++|+.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++
T Consensus 260 f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 339 (844)
T 3j0a_A 260 FAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPK 339 (844)
T ss_dssp TTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTT
T ss_pred hhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCC
Confidence 145677777777777666677777777777777777777766667777777777777777776666667777777
Q ss_pred CCeeecCCccCCCCCCcccccccccceEEccCCcCCc
Q 041438 377 LSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSG 413 (752)
Q Consensus 377 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 413 (752)
|+.|+|++|.+.+..+..|..+++|+.|+|++|.+++
T Consensus 340 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~ 376 (844)
T 3j0a_A 340 VAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT 376 (844)
T ss_dssp CCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC
T ss_pred CCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc
Confidence 7777777777766666666667777777777766654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=346.73 Aligned_cols=258 Identities=31% Similarity=0.561 Sum_probs=206.0
Q ss_pred cccchHHHHHHhhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-------------------------Ccc
Q 041438 488 LGKIVYEEIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-------------------------NFC 542 (752)
Q Consensus 488 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------~~~ 542 (752)
..+++++++....++|++.+.||+|+||.||+|+..+++.||||++...... +++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 3457889999999999999999999999999999888999999998654321 445
Q ss_pred ccCCceEEEEEeccCCChHHHhccCcc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEe
Q 041438 543 SHPRQSFIVYEYLESGSLDKILNNDAS-AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVS 621 (752)
Q Consensus 543 ~~~~~~~lV~E~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~ 621 (752)
......++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.+.++|+||||||+||+++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 567788999999999999999987543 3458999999999999999999999877799999999999999999999999
Q ss_pred ecccceeccCCCCC-cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccccc-----------
Q 041438 622 DFRIAKFLNLDSSN-WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS----------- 689 (752)
Q Consensus 622 DfG~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~----------- 689 (752)
|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||+.........
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 99999876543322 233469999999999988889999999999999999999999996322111111
Q ss_pred -ccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCC
Q 041438 690 -SNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNP 747 (752)
Q Consensus 690 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 747 (752)
........+..... ......+..+.+++.+||+.||++|||++|++++|+......
T Consensus 257 ~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~ 313 (326)
T 3uim_A 257 KEKKLEALVDVDLQG--NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313 (326)
T ss_dssp SSCCSTTSSCTTCTT--SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred hchhhhhhcChhhcc--ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence 00111111111111 123566788999999999999999999999999998765443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=370.29 Aligned_cols=347 Identities=24% Similarity=0.216 Sum_probs=267.0
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCccccc-CCccccccccccee
Q 041438 84 GRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGH-IPSEISLLTHLTIL 162 (752)
Q Consensus 84 ~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L 162 (752)
..+..++++++.+.+. ++.+|..+++|++|+|++|++++..|..|+++++|++|+|++|++++. .|..|+++++|++|
T Consensus 50 ~~L~~L~Ls~n~i~~~-~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L 128 (549)
T 2z81_A 50 ANLQVLILKSSRINTI-EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128 (549)
T ss_dssp TTCCEEECTTSCCCEE-CTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CcccEEECCCCCcCcc-ChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence 4688899999988864 456799999999999999999999888899999999999999999974 57789999999999
Q ss_pred eccCcccCCCCC-cccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCcccccccccccccc
Q 041438 163 HISRNQLNGSIP-HEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQL 241 (752)
Q Consensus 163 ~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l 241 (752)
+|++|.+.+.+| ..|.++++|++|+|++|++++..|..+.++++|++|++++|.+....+..++.+++|++|++++|++
T Consensus 129 ~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l 208 (549)
T 2z81_A 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208 (549)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBC
T ss_pred ECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCcc
Confidence 999999544554 6899999999999999999999999998888777777777776533333334566666666666666
Q ss_pred CCCc--CCC-----------------------------------------------------------------------
Q 041438 242 NGAI--PLS----------------------------------------------------------------------- 248 (752)
Q Consensus 242 ~~~~--~~~----------------------------------------------------------------------- 248 (752)
++.. |..
T Consensus 209 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l 288 (549)
T 2z81_A 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTI 288 (549)
T ss_dssp TTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEE
T ss_pred ccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccc
Confidence 5521 000
Q ss_pred ------------------------------------C--C-CCCCCCCcEEEccccccCCCCC---cccCCCCCCCEEec
Q 041438 249 ------------------------------------I--D-WGRCPQLSLLDVSINNITGNIP---FEIGESPQLQYLDL 286 (752)
Q Consensus 249 ------------------------------------~--~-~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L 286 (752)
+ . +..+++|++|++++|++++.+| ..++.+++|++|+|
T Consensus 289 ~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~L 368 (549)
T 2z81_A 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368 (549)
T ss_dssp ESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEEC
T ss_pred cccccchhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEc
Confidence 0 0 0235667777777777766553 23566677777777
Q ss_pred CCCcCcCCCC--ccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCc
Q 041438 287 SSNYIVGEIP--TQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLS 364 (752)
Q Consensus 287 s~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 364 (752)
++|++++..+ ..+..+++|+.|++++|+++ .+|..+..+++|++|+|++|++++++... .++|++|+|++|+++
T Consensus 369 s~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~---~~~L~~L~Ls~N~l~ 444 (549)
T 2z81_A 369 SQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCI---PQTLEVLDVSNNNLD 444 (549)
T ss_dssp TTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCCCTTS---CTTCSEEECCSSCCS
T ss_pred cCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccccchh---cCCceEEECCCCChh
Confidence 7777765432 44667777777777777777 45666777777777777777776543322 256777788888777
Q ss_pred cccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCCcccCcCCC
Q 041438 365 QQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPN 441 (752)
Q Consensus 365 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 441 (752)
+.+ ..+++|++|+|++|+|+. +|. ...+++|+.|+|++|++++.+|..|..+++|+.|++++|++.+.+|.
T Consensus 445 ~~~----~~l~~L~~L~Ls~N~l~~-ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 445 SFS----LFLPRLQELYISRNKLKT-LPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp CCC----CCCTTCCEEECCSSCCSS-CCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred hhc----ccCChhcEEECCCCccCc-CCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence 643 578999999999999985 454 46789999999999999999999999999999999999999988773
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=342.46 Aligned_cols=227 Identities=24% Similarity=0.361 Sum_probs=186.3
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC------------------------CccccCCceEEEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E 553 (752)
..++|++.+.||+|+||.||+|+ ..+++.||||++...... +++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 35689999999999999999999 467999999987543221 34556778999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++|+|.+++.... +++.++..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999997643 88899999999999999999999 99999999999999999999999999998876555
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc-cCCCCCChhhHHHH
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD-SRLPYPSLDVQNKF 712 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 712 (752)
.......||+.|+|||++.+..+++++||||+||++|||++|+.||... ........+.. ...... .....+
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~~~~~~~~~~~--~~~~~~ 243 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE-----NPLRALYLIATNGTPELQ--NPEKLS 243 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHHHHCSCCCS--CGGGSC
T ss_pred cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCCCCC--CccccC
Confidence 5555668999999999999999999999999999999999999998521 11111111111 111111 124456
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..+.+++.+||+.||++|||++|+++|
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 244 AIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 678999999999999999999999875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.32 Aligned_cols=239 Identities=28% Similarity=0.387 Sum_probs=184.0
Q ss_pred HHHHhhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC--------------------------CccccCCce
Q 041438 495 EIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQS 548 (752)
Q Consensus 495 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~ 548 (752)
++....++|++.+.||+|+||.||+|+. +|+.||||++...... +++......
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3334567899999999999999999987 6889999998654322 445667788
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCEEeCCCCceEEeecccc
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP--IVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~--ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
++||||+++|+|.+++........+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 99999999999999998765445589999999999999999999999 8 999999999999999999999999999
Q ss_pred eeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhh--hccCCCCC
Q 041438 627 KFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEI--LDSRLPYP 704 (752)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~ 704 (752)
+.............||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+ .......+
T Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~-----~~~~~~~~~~~~~~~~~~~ 261 (309)
T 3p86_A 187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL-----NPAQVVAAVGFKCKRLEIP 261 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS-----CHHHHHHHHHHSCCCCCCC
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcCCCCCCC
Confidence 86554433344568999999999999999999999999999999999999998521 111111222 12222222
Q ss_pred ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 705 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
...++++.+++.+||+.||++|||++|+++.|+.+...
T Consensus 262 ----~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 262 ----RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 34556789999999999999999999999999988643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=347.00 Aligned_cols=225 Identities=23% Similarity=0.297 Sum_probs=187.7
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC----C-----------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP----D-----------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~-----------------------~~~~~~~~~~lV 551 (752)
.++|++.+.||+|+||.||+|+. .+|+.||+|++++... . +++...+..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 47899999999999999999995 5799999998854210 0 345567889999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999987543 488899999999999999999999 999999999999999999999999999987544
Q ss_pred CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||.. .........+.......+. ..
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-----~~~~~~~~~i~~~~~~~p~----~~ 228 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-----QDHERLFELILMEEIRFPR----TL 228 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHHCCCCCCT----TS
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC-----CCHHHHHHHHHcCCCCCCC----CC
Confidence 44445566899999999999999999999999999999999999999852 2222334444445555542 34
Q ss_pred HHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 041438 712 FMSIMQVAFSCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 739 (752)
++++.++|.+||+.||++|| +++|+++|
T Consensus 229 s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 56789999999999999999 89999876
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=353.53 Aligned_cols=226 Identities=24% Similarity=0.378 Sum_probs=182.7
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC----------------------C------CccccCCceE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP----------------------D------NFCSHPRQSF 549 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------------------~------~~~~~~~~~~ 549 (752)
..++|++.+.||+|+||.||+|+. .+++.||||++++... . +++.+.+..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 357899999999999999999995 5689999998754210 0 3455678899
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 101 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999997643 488999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 630 NLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
..........+||+.|+|||++.+..++.++||||+||++|||++|+.||.. ....+....+.......+.
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-----~~~~~~~~~i~~~~~~~p~---- 245 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA-----ENEDDLFEAILNDEVVYPT---- 245 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHHCCCCCCT----
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC-----CCHHHHHHHHHcCCCCCCC----
Confidence 4444445556899999999999988899999999999999999999999852 2233445556666665553
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCH------HHHHHH
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTM------KRFEVQ 739 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~------~evl~~ 739 (752)
..+.++.+++.+||++||++||++ +|+++|
T Consensus 246 ~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 246 WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 245578899999999999999998 677654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=340.20 Aligned_cols=239 Identities=26% Similarity=0.332 Sum_probs=192.5
Q ss_pred ccchHHHHHHhhcc----------cccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC------------------
Q 041438 489 GKIVYEEIIRATND----------FDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD------------------ 539 (752)
Q Consensus 489 ~~~~~~~~~~~~~~----------y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------------ 539 (752)
+.++++++..+++. |+..+.||+|+||.||+|+.. +|+.||||++......
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45678888877754 788899999999999999964 7999999988643322
Q ss_pred ------CccccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC
Q 041438 540 ------NFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD 613 (752)
Q Consensus 540 ------~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~ 613 (752)
+++...+..++||||+++++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEC
Confidence 3445667899999999999999998753 389999999999999999999999 999999999999999
Q ss_pred CCCceEEeecccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccch
Q 041438 614 LGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN 693 (752)
Q Consensus 614 ~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~ 693 (752)
.++.+||+|||++..............||+.|+|||++.+..++.++|||||||++|||++|+.||... ......
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~-----~~~~~~ 250 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD-----SPVQAM 250 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHH
T ss_pred CCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHH
Confidence 999999999999988765444445568999999999999999999999999999999999999998521 111122
Q ss_pred HhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 694 IEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
..+.....+.. ......++.+.+++.+||+.||++|||++|+++|-
T Consensus 251 ~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 251 KRLRDSPPPKL-KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp HHHHHSSCCCC-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred HHHhcCCCCCc-CccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 22222222211 11234566789999999999999999999999863
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=345.51 Aligned_cols=225 Identities=21% Similarity=0.347 Sum_probs=188.2
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV 551 (752)
..++|++.+.||+|+||.||+|+. .+|+.||||++...... +++...+..|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 467899999999999999999995 68999999988654321 445667889999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+++|+|.+++...+ .+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999997543 388899999999999999999999 999999999999999999999999999987653
Q ss_pred CCCCcccccCCCCccCccccccCCCC-CccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVT-EKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
. ......+||+.|+|||++.+..+. +++||||+||++|||++|+.||+. .........+.......|. .
T Consensus 167 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-----~~~~~~~~~i~~~~~~~p~----~ 236 (328)
T 3fe3_A 167 G-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-----QNLKELRERVLRGKYRIPF----Y 236 (328)
T ss_dssp S-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHHCCCCCCT----T
T ss_pred C-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-----CCHHHHHHHHHhCCCCCCC----C
Confidence 3 334556899999999999888764 799999999999999999999862 2223344455555555543 2
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.++++.+++.+||+.||++|||++|+++|
T Consensus 237 ~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 237 MSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp SCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 45678899999999999999999999976
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=351.01 Aligned_cols=225 Identities=24% Similarity=0.341 Sum_probs=184.3
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------CccccCCceE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSF 549 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~ 549 (752)
..++|++.+.||+|+||.||+|+. .+++.||+|++++.... +++...+..|
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 357899999999999999999995 56889999998653211 3345677899
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+||||+++|+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 130 lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999997543 488999999999999999999999 9999999999999999999999999999875
Q ss_pred cCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccc----ccccchHhhhccCCCCCC
Q 041438 630 NLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----SSSNMNIEILDSRLPYPS 705 (752)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~ 705 (752)
..........+||+.|+|||++.+..++.++||||+||++|||++|+.||+....... ........+.......|.
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 283 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 283 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence 4444455567899999999999999999999999999999999999999953211111 111233445555555553
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCCCH
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTM 733 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rps~ 733 (752)
..+.++.++|.+||+.||++||++
T Consensus 284 ----~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 284 ----SLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----TSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ----cCCHHHHHHHHHHhcCCHhHcCCC
Confidence 345678899999999999999996
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=345.45 Aligned_cols=229 Identities=19% Similarity=0.248 Sum_probs=190.6
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------------CccccCCc
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------------NFCSHPRQ 547 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------------~~~~~~~~ 547 (752)
..++|++.+.||+|+||.||+|+. .+|+.||+|+++..... +++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 357899999999999999999995 57999999988653221 34556678
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC----ceEEeec
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY----EAHVSDF 623 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~----~~kl~Df 623 (752)
.|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+. ||+||||||+||+++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999997543 488999999999999999999999 999999999999998776 7999999
Q ss_pred ccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCC
Q 041438 624 RIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPY 703 (752)
Q Consensus 624 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 703 (752)
|+++..... ......+||+.|+|||++.+..++.++||||+||++|+|++|..||.. ....+....+......+
T Consensus 164 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~-----~~~~~~~~~i~~~~~~~ 237 (361)
T 2yab_A 164 GLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-----DTKQETLANITAVSYDF 237 (361)
T ss_dssp SSCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-----SSHHHHHHHHHTTCCCC
T ss_pred CCceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC-----CCHHHHHHHHHhcCCCC
Confidence 999887543 233456899999999999998999999999999999999999999852 22233444555555555
Q ss_pred CChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 704 PSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 704 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+.......+..+.++|.+||..||++|||++|+++|
T Consensus 238 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 238 DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 544445566789999999999999999999999865
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=352.73 Aligned_cols=315 Identities=19% Similarity=0.168 Sum_probs=279.6
Q ss_pred CCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcC
Q 041438 118 NNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSI 197 (752)
Q Consensus 118 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 197 (752)
+++++. +|..+. ++|++|+|++|+|+++.|..|.++++|++|+|++|.|++..|..|.++++|++|+|++|++++..
T Consensus 20 ~~~l~~-ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 96 (477)
T 2id5_A 20 RKRFVA-VPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIP 96 (477)
T ss_dssp SCCCSS-CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCC
T ss_pred CCCcCc-CCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccC
Confidence 334443 344443 58999999999999999999999999999999999999988999999999999999999999888
Q ss_pred CcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCC
Q 041438 198 PRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGE 277 (752)
Q Consensus 198 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 277 (752)
+..|.++++|++|+|++|++++..|..|.+ +++|+.|++++|.+++..+..|..
T Consensus 97 ~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~--------------------------l~~L~~L~l~~n~l~~~~~~~~~~ 150 (477)
T 2id5_A 97 LGVFTGLSNLTKLDISENKIVILLDYMFQD--------------------------LYNLKSLEVGDNDLVYISHRAFSG 150 (477)
T ss_dssp TTSSTTCTTCCEEECTTSCCCEECTTTTTT--------------------------CTTCCEEEECCTTCCEECTTSSTT
T ss_pred cccccCCCCCCEEECCCCccccCChhHccc--------------------------cccCCEEECCCCccceeChhhccC
Confidence 888999999999999999998776665544 456668888888888888889999
Q ss_pred CCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEE
Q 041438 278 SPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLN 357 (752)
Q Consensus 278 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 357 (752)
+++|++|+|++|.+++..+..|.++++|+.|+|++|.+.+..+..|..+++|++|++++|.+.+..+.......+|+.|+
T Consensus 151 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~ 230 (477)
T 2id5_A 151 LNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLS 230 (477)
T ss_dssp CTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEE
T ss_pred CCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEE
Confidence 99999999999999988888899999999999999999999999999999999999999998877777666777999999
Q ss_pred cCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCCcccC
Q 041438 358 LSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEG 437 (752)
Q Consensus 358 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 437 (752)
|++|++++..+..|..+++|+.|+|++|.+++..+..|..+++|+.|+|++|++++..|..|..+++|+.|++++|++++
T Consensus 231 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 310 (477)
T 2id5_A 231 ITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTT 310 (477)
T ss_dssp EESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSC
T ss_pred CcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCce
Confidence 99999998777889999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred cCCCC-cccCCCCcccccCCCCCCC
Q 041438 438 HIPNS-TTFRDAPLEALQGNKGLCG 461 (752)
Q Consensus 438 ~~p~~-~~~~~~~~~~~~~n~~~c~ 461 (752)
..+.. ..+..+....+.+|++.|.
T Consensus 311 ~~~~~~~~l~~L~~L~l~~N~l~c~ 335 (477)
T 2id5_A 311 LEESVFHSVGNLETLILDSNPLACD 335 (477)
T ss_dssp CCGGGBSCGGGCCEEECCSSCEECS
T ss_pred eCHhHcCCCcccCEEEccCCCccCc
Confidence 66543 2344566678899999886
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=354.15 Aligned_cols=231 Identities=19% Similarity=0.276 Sum_probs=192.5
Q ss_pred HhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEE
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFI 550 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~l 550 (752)
+..++|++.+.||+|+||.||+|+. .+|+.||+|++...... +++.+.+..|+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3467899999999999999999984 67999999988654321 45567788999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC---CCCceEEeecccce
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD---LGYEAHVSDFRIAK 627 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~---~~~~~kl~DfG~a~ 627 (752)
||||+++|+|.+.+.... .+++..+..++.||+.||+|||+. ||+||||||+||+++ +++.+||+|||+++
T Consensus 88 v~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999987653 488999999999999999999999 999999999999998 46789999999998
Q ss_pred eccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChh
Q 041438 628 FLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLD 707 (752)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (752)
.............||+.|+|||++.+..++.++||||+||++|+|++|..||. ..........+.......+...
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~-----~~~~~~~~~~i~~~~~~~~~~~ 236 (444)
T 3soa_A 162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW-----DEDQHRLYQQIKAGAYDFPSPE 236 (444)
T ss_dssp CCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCC-----CSSHHHHHHHHHHTCCCCCTTT
T ss_pred EecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCC-----CccHHHHHHHHHhCCCCCCccc
Confidence 87655544456789999999999999999999999999999999999999985 2223334455555555555444
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
....++++.+++.+||+.||++|||++|+++|
T Consensus 237 ~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 237 WDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 45667789999999999999999999999976
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=348.35 Aligned_cols=321 Identities=25% Similarity=0.371 Sum_probs=191.1
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeec
Q 041438 85 RVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHI 164 (752)
Q Consensus 85 ~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 164 (752)
.+..++++++.+.+..+ |..+++|++|+|++|+++++.+ |+++++|++|+|++|++++..+ +..+++|++|+|
T Consensus 69 ~L~~L~Ls~n~l~~~~~---~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l 141 (466)
T 1o6v_A 69 NLTQINFSNNQLTDITP---LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLEL 141 (466)
T ss_dssp TCCEEECCSSCCCCCGG---GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEE
T ss_pred CCCEEECCCCccCCchh---hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEEC
Confidence 34455555555544321 5555555555555555555433 5555555555555555554422 555555555555
Q ss_pred cCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCC
Q 041438 165 SRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGA 244 (752)
Q Consensus 165 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 244 (752)
++|.+++. + .+..+++|++|+++ |.+.+..+ +.++++|++|++++|.+++. ..+.++++|+.|++++|++++.
T Consensus 142 ~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~ 214 (466)
T 1o6v_A 142 SSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDI 214 (466)
T ss_dssp EEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC
T ss_pred CCCccCCC-h-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccc
Confidence 55555532 2 35555555555554 33433322 56666666666666666543 2356666666666666666655
Q ss_pred cCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccC
Q 041438 245 IPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELG 324 (752)
Q Consensus 245 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 324 (752)
.| ++.+++|+.|++++|++++. ..+..+++|++|++++|.+++..| +..+++|+.|++++|++++..+ +.
T Consensus 215 ~~----~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~ 284 (466)
T 1o6v_A 215 TP----LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LA 284 (466)
T ss_dssp GG----GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GT
T ss_pred cc----ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--cc
Confidence 44 34556666666666666643 245566666666666666665544 6666666666666666665443 66
Q ss_pred CCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceE
Q 041438 325 SLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKL 404 (752)
Q Consensus 325 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 404 (752)
.+++|++|+|++|++++..+ +..+++|+.|+|++|++++..| +..+++|++|++++|.+++. ..+..+++|+.|
T Consensus 285 ~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 358 (466)
T 1o6v_A 285 GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWL 358 (466)
T ss_dssp TCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEE
T ss_pred CCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEE
Confidence 66666666666666666544 5666666666666666665544 56666666666666666654 345666666666
Q ss_pred EccCCcCCcCCchhhhccCCCcEEEccCCcccC
Q 041438 405 NLSYNNLSGLIPRCFEELHGLLHIDISYNKLEG 437 (752)
Q Consensus 405 ~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 437 (752)
++++|++++.+| +..+++|+.|++++|++++
T Consensus 359 ~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 359 SAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp ECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred eCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 666666666655 6666666666666666665
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.54 Aligned_cols=251 Identities=28% Similarity=0.433 Sum_probs=197.8
Q ss_pred chHHHHHHhhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC------------------------CccccCC
Q 041438 491 IVYEEIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD------------------------NFCSHPR 546 (752)
Q Consensus 491 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~ 546 (752)
+++.++...+++|++.+.||+|+||.||+|+..+++.||||++...... +++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 4455666788999999999999999999999888999999987654322 4456678
Q ss_pred ceEEEEEeccCCChHHHhccCcc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDAS-AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRI 625 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~ 625 (752)
..++||||+++|+|.+++..... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 89999999999999999976432 23589999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCC--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccccccc----------ch
Q 041438 626 AKFLNLDSS--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN----------MN 693 (752)
Q Consensus 626 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~----------~~ 693 (752)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............ ..
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 987543221 123346899999999999899999999999999999999999998532111100000 00
Q ss_pred HhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 694 IEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
....+.... .......+..+.+++.+||+.||++|||++|++++|+.+...
T Consensus 266 ~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 266 EQIVDPNLA--DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CSSSSSSCT--TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhcChhhc--cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 011111111 112356778899999999999999999999999999987543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=341.64 Aligned_cols=230 Identities=19% Similarity=0.256 Sum_probs=192.2
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEec
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~ 555 (752)
.++|++.+.||+|+||.||+|+. .+++.||+|.+...... +++.+.+..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 57899999999999999999995 56899999987643211 4456678899999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC--CCceEEeecccceeccCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL--GYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~--~~~~kl~DfG~a~~~~~~~ 633 (752)
++|+|.+++.... ..+++.+++.++.||+.||+|||+. ||+||||||+||+++. ++.+||+|||+++.....
T Consensus 84 ~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 84 SGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 9999999997543 3488999999999999999999999 9999999999999987 789999999999887533
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHH
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
.......||+.|+|||++.+..+++++||||+||++|+|++|+.||.. .........+.......+.......+.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-----~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T 1tki_A 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-----ETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-----SSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC-----CCHHHHHHHHHcCCCCCChhhhccCCH
Confidence 233446899999999999988899999999999999999999999852 222334455555666555444456677
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
++.+++.+||+.||++|||++|+++|-
T Consensus 233 ~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 233 EAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 899999999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=347.67 Aligned_cols=227 Identities=23% Similarity=0.337 Sum_probs=186.4
Q ss_pred HhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC----C------------------------CccccCCce
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP----D------------------------NFCSHPRQS 548 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~------------------------~~~~~~~~~ 548 (752)
...++|++.+.||+|+||.||+|+. .+|+.||||++++... . +++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 4578999999999999999999995 5789999998864210 0 345567889
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999997543 488999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhh
Q 041438 629 LNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708 (752)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (752)
...........+||+.|+|||++.+..++.++||||+||++|||++|+.||.. .........+.......+.
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-----~~~~~~~~~i~~~~~~~p~--- 239 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-----QDEEELFHSIRMDNPFYPR--- 239 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHHCCCCCCT---
T ss_pred cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC-----CCHHHHHHHHHhCCCCCCc---
Confidence 54444444566899999999999999999999999999999999999999852 2222333444444444442
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHH-HHHHH
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPTMK-RFEVQ 739 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~ 739 (752)
..++++.++|.+||+.||++||++. |+++|
T Consensus 240 -~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 240 -WLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp -TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred -ccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 3456788999999999999999998 66543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=346.94 Aligned_cols=226 Identities=22% Similarity=0.357 Sum_probs=186.8
Q ss_pred hhcccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCC----C------------------------CccccCCceE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLP----D------------------------NFCSHPRQSF 549 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~------------------------~~~~~~~~~~ 549 (752)
..++|++.+.||+|+||.||+|+.. +++.||||++++... . .++...+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4678999999999999999999964 588999998754210 0 3345667899
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+||||+++|+|.+++...+ .+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999997543 488999999999999999999999 9999999999999999999999999999875
Q ss_pred cCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 630 NLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||.. ....+....+.......+.
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-----~~~~~~~~~i~~~~~~~p~---- 242 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-----EDEDELFQSIMEHNVAYPK---- 242 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHHCCCCCCT----
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC-----CCHHHHHHHHHhCCCCCCC----
Confidence 4444444556899999999999999999999999999999999999999852 2233344555555555552
Q ss_pred HHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPT-----MKRFEVQ 739 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 739 (752)
..+.++.++|.+||+.||++||+ ++|+++|
T Consensus 243 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 243 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 35567899999999999999995 5677655
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=336.74 Aligned_cols=236 Identities=25% Similarity=0.333 Sum_probs=182.2
Q ss_pred hhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------Cc----cccCCceEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NF----CSHPRQSFIV 551 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~----~~~~~~~~lV 551 (752)
..++|++.+.||+|+||.||+|+. +++.||||++...... ++ .......++|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv 84 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI 84 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence 357899999999999999999987 7899999987643211 11 1123457899
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeecCCCCCCEEeCCCCceEEeec
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLH--------NNCFPPIVHWDISSKNVLLDLGYEAHVSDF 623 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH--------~~~~~~ivH~DlKp~NIll~~~~~~kl~Df 623 (752)
|||+++|+|.++++.. .+++..+..++.|++.||+||| +. +|+||||||+||+++.++.+||+||
T Consensus 85 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 85 THYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp ECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCC
T ss_pred hhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeC
Confidence 9999999999999643 3899999999999999999999 87 9999999999999999999999999
Q ss_pred ccceeccCCCCC----cccccCCCCccCccccccC------CCCCccchhhHHHHHHHHHhC----------CCCcchhh
Q 041438 624 RIAKFLNLDSSN----WSKLAGTHGNVAPELAYTM------KVTEKCDVYSFGVLALEVIKG----------KHPRDFLF 683 (752)
Q Consensus 624 G~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~ksDIwSlGvil~elltg----------~~pf~~~~ 683 (752)
|+|+........ .....||+.|+|||++.+. .+++++|||||||++|||+|| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 999876543322 1234799999999998876 455799999999999999999 77774222
Q ss_pred ccccccccchHhhhcc---CCCCCCh-hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 684 EMSSSSSNMNIEILDS---RLPYPSL-DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 684 ~~~~~~~~~~~~~~~~---~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
...... ......... ....+.. .....++++.+++.+||+.||++|||++|+++.|+++
T Consensus 238 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDPSF-EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSCCH-HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcch-hhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 111111 111111111 1112211 1244677899999999999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=345.90 Aligned_cols=227 Identities=25% Similarity=0.267 Sum_probs=186.2
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------CccccCCceEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFI 550 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~l 550 (752)
.++|++.+.||+|+||.||+|+. .+++.||||++++.... +++...+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 57899999999999999999995 46889999987543210 23455678899
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999997543 478899999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.. ....+....+.......+. .
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-----~~~~~~~~~i~~~~~~~~~----~ 261 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-----RNTAEMYDNILNKPLQLKP----N 261 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-----SBHHHHHHHHHHSCCCCCS----S
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC-----CCHHHHHHHHHhcccCCCC----C
Confidence 444445567899999999999999999999999999999999999999852 2223344455555554442 3
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHHHh
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 741 (752)
.+.++.++|.+||+.||++||++.+.++.++
T Consensus 262 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~ 292 (373)
T 2r5t_A 262 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 292 (373)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTTTTTHHHHH
T ss_pred CCHHHHHHHHHHcccCHHhCCCCCCCHHHHh
Confidence 4567889999999999999999865444443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=335.88 Aligned_cols=234 Identities=24% Similarity=0.375 Sum_probs=186.0
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEe
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~ 554 (752)
.++|++.+.||+|+||.||+|+. .+++.||+|++...... +++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 57899999999999999999995 57999999987542211 445667889999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++|+|.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999998643 3488999999999999999999999 999999999999999999999999999987643322
Q ss_pred Cc--------------ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccC
Q 041438 635 NW--------------SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR 700 (752)
Q Consensus 635 ~~--------------~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 700 (752)
.. ....||+.|+|||++.+..++.++|||||||++|||++|..||.....................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY 243 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc
Confidence 11 1357999999999999999999999999999999999999998532221111111222222222
Q ss_pred CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 701 LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 701 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
.+ ..+++.+.+++.+||+.||++|||++|+++.|+++.
T Consensus 244 ~~------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 244 CP------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp CC------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11 123346889999999999999999999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=342.57 Aligned_cols=233 Identities=21% Similarity=0.340 Sum_probs=187.4
Q ss_pred hcccccceeeccCCceEEEEEEe--------CCCcEEEEEccCCCCCC--------------------------CccccC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV--------PSGEIFAVKKFHSPLPD--------------------------NFCSHP 545 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~--------------------------~~~~~~ 545 (752)
.++|++.+.||+|+||.||+|+. .++..||||+++..... +++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 47899999999999999999984 24567999998654221 345567
Q ss_pred CceEEEEEeccCCChHHHhccCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe
Q 041438 546 RQSFIVYEYLESGSLDKILNNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL 612 (752)
Q Consensus 546 ~~~~lV~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll 612 (752)
+..|+||||+++|+|.+++..... ...+++.+++.++.||+.||+|||++ +|+||||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 789999999999999999986432 13478999999999999999999999 99999999999999
Q ss_pred CCCCceEEeecccceeccCCCC--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhcccccc
Q 041438 613 DLGYEAHVSDFRIAKFLNLDSS--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSS 689 (752)
Q Consensus 613 ~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~ 689 (752)
+.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||... ..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~-----~~ 311 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-----PV 311 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CG
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC-----CH
Confidence 9999999999999987654322 1233467889999999999999999999999999999999 99998521 11
Q ss_pred ccchHhhhccC-CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 690 SNMNIEILDSR-LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 690 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
.+....+.... ...+ ..++.++.+++.+||+.||++||+++|++++|+++.
T Consensus 312 ~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 312 EELFKLLKEGHRMDKP----ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp GGHHHHHHTTCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 22222222222 1222 345567899999999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=328.14 Aligned_cols=237 Identities=24% Similarity=0.374 Sum_probs=189.4
Q ss_pred hhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEec
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~ 555 (752)
..++|++.+.||+|+||.||+|+..++..||+|+++..... +++.+....++||||+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 35789999999999999999999888889999998754322 4456677889999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 635 (752)
++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+.........
T Consensus 86 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 9999999997643 3488999999999999999999999 9999999999999999999999999999876543211
Q ss_pred -cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHH
Q 041438 636 -WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 636 -~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
.....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||+.. ........+......... ...++
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~---~~~~~ 232 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY-----TNSEVVLKVSQGHRLYRP---HLASD 232 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS-----CHHHHHHHHHTTCCCCCC---TTSCH
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc-----ChHHHHHHHHcCCCCCCC---CcChH
Confidence 122356778999999998889999999999999999999 99998521 111222222222221111 22345
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCCC
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPD 748 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 748 (752)
.+.+++.+||+.||++|||++|++++|+++....+
T Consensus 233 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~k 267 (268)
T 3sxs_A 233 TIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267 (268)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC---
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhccC
Confidence 78899999999999999999999999999865443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=343.62 Aligned_cols=234 Identities=20% Similarity=0.224 Sum_probs=191.0
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------CccccCCceEEEEEecc
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------~~~~~~~~~~lV~E~~~ 556 (752)
..++|++.+.||+|+||.||+|+. .+++.||||++++.... +++.+.+..|+||||++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 99 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK 99 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence 467899999999999999999995 57899999998654322 44566788999999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC----CceEEeecccceeccCC
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG----YEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~----~~~kl~DfG~a~~~~~~ 632 (752)
+|+|.+++.... .+++..+..++.||+.||+|||+. ||+||||||+||++.++ +.+||+|||+++.....
T Consensus 100 gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 100 GGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp SCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 999999987543 488999999999999999999999 99999999999998533 35999999999987655
Q ss_pred CCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHH
Q 041438 633 SSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (752)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .....+....+.......+...+...+
T Consensus 174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~~~~i~~~~~~~~~~~~~~~s 251 (342)
T 2qr7_A 174 NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP--DDTPEEILARIGSGKFSLSGGYWNSVS 251 (342)
T ss_dssp TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST--TSCHHHHHHHHHHCCCCCCSTTTTTSC
T ss_pred CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC--cCCHHHHHHHHccCCcccCccccccCC
Confidence 444555689999999999988889999999999999999999999985211 112223344455555554433334566
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
+++.+++.+||+.||++|||++|+++|-
T Consensus 252 ~~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 252 DTAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 7899999999999999999999999763
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=341.40 Aligned_cols=230 Identities=24% Similarity=0.333 Sum_probs=185.7
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------CccccCCceEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFI 550 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~l 550 (752)
.++|++.+.||+|+||.||+|+. .+++.||+|++++.... +++......|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 46899999999999999999995 56899999998654211 34456678999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++++||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999997543 488999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccc----cccccchHhhhccCCCCCCh
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS----SSSSNMNIEILDSRLPYPSL 706 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 706 (752)
.........+||+.|+|||++.+..++.++||||+||++|||++|+.||....... .........+.......+.
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~- 240 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR- 240 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT-
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC-
Confidence 44444555689999999999999999999999999999999999999996321111 1111223344444555442
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCH------HHHHHH
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTM------KRFEVQ 739 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~ 739 (752)
..+.++.+++.+||+.||++||++ +|+++|
T Consensus 241 ---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 241 ---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ---TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ---CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 345678899999999999999996 566544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=333.52 Aligned_cols=240 Identities=20% Similarity=0.280 Sum_probs=188.2
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------Ccccc--CCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSH--PRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~--~~~~~lV 551 (752)
.++|++.+.||+|+||.||+|+. .+++.||||+++..... +++.. ....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 46799999999999999999995 46999999998643211 22222 3377999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe----CCCCceEEeecccce
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL----DLGYEAHVSDFRIAK 627 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll----~~~~~~kl~DfG~a~ 627 (752)
|||+++++|.+++........+++.+++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999998765444589999999999999999999999 99999999999999 778889999999998
Q ss_pred eccCCCCCcccccCCCCccCccccc--------cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhcc
Q 041438 628 FLNLDSSNWSKLAGTHGNVAPELAY--------TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS 699 (752)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 699 (752)
...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||....... ........+...
T Consensus 165 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~ 242 (319)
T 4euu_A 165 ELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR-RNKEVMYKIITG 242 (319)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG-GCHHHHHHHHHH
T ss_pred ecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc-hhHHHHHHHhcC
Confidence 875433 334457999999999876 5678999999999999999999999995321111 111112222211
Q ss_pred ---------------------CCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 700 ---------------------RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 700 ---------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
..+............+.+++.+||+.||++|||++|+++|..+..
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 112112223567778999999999999999999999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=336.23 Aligned_cols=228 Identities=18% Similarity=0.291 Sum_probs=187.0
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------------CccccCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------------NFCSHPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------------~~~~~~~~~ 548 (752)
.++|++.+.||+|+||.||+|+. .+|+.||+|+++..... +++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 46799999999999999999995 47999999988643211 345567789
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC----ceEEeecc
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY----EAHVSDFR 624 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~----~~kl~DfG 624 (752)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999997543 488999999999999999999999 999999999999999877 79999999
Q ss_pred cceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCC
Q 041438 625 IAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYP 704 (752)
Q Consensus 625 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (752)
+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.. .........+.......+
T Consensus 164 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-----~~~~~~~~~~~~~~~~~~ 237 (326)
T 2y0a_A 164 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-----DTKQETLANVSAVNYEFE 237 (326)
T ss_dssp TCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-----SSHHHHHHHHHHTCCCCC
T ss_pred CCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC-----CCHHHHHHHHHhcCCCcC
Confidence 998875332 33445899999999999989999999999999999999999999852 122223333334444444
Q ss_pred ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 705 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.......+..+.+++.+||+.||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 33334556778999999999999999999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=342.52 Aligned_cols=229 Identities=21% Similarity=0.300 Sum_probs=190.6
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV 551 (752)
..++|++.+.||+|+||.||+|+. .+|+.||+|++...... +++.+.+..|+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 357899999999999999999985 57899999998654321 345667889999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC---CceEEeeccccee
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG---YEAHVSDFRIAKF 628 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~---~~~kl~DfG~a~~ 628 (752)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.+ +.+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999987543 488999999999999999999999 99999999999999865 4599999999987
Q ss_pred ccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhh
Q 041438 629 LNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708 (752)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (752)
.... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.. .........+.......+...+
T Consensus 181 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~-----~~~~~~~~~i~~~~~~~~~~~~ 254 (362)
T 2bdw_A 181 VNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-----EDQHRLYAQIKAGAYDYPSPEW 254 (362)
T ss_dssp CTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHHTCCCCCTTGG
T ss_pred ecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC-----CCHHHHHHHHHhCCCCCCcccc
Confidence 6533 233456899999999999998999999999999999999999999852 2223344445555555555455
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...++++.++|.+||+.||++|||++|+++|
T Consensus 255 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 255 DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 6677889999999999999999999999876
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=326.90 Aligned_cols=249 Identities=30% Similarity=0.460 Sum_probs=197.8
Q ss_pred ccchHHHHHHhhcccccc------eeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------
Q 041438 489 GKIVYEEIIRATNDFDAK------HCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD----------------------- 539 (752)
Q Consensus 489 ~~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------- 539 (752)
..++++++..++++|... +.||+|+||.||+|+. +++.||||++......
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 357899999999999877 8999999999999986 6889999988643210
Q ss_pred -----CccccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC
Q 041438 540 -----NFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL 614 (752)
Q Consensus 540 -----~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~ 614 (752)
+++.+.+..++||||+++++|.+++........+++..+..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 34556678899999999999999997654445689999999999999999999999 9999999999999999
Q ss_pred CCceEEeecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccccc---
Q 041438 615 GYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS--- 689 (752)
Q Consensus 615 ~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~--- 689 (752)
++.+||+|||+++........ .....||+.|+|||.+.+ .++.++|||||||++|+|++|+.||..........
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 999999999999876543222 223478999999998765 58899999999999999999999986322111000
Q ss_pred ------ccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 690 ------SNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 690 ------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
........+..... .....+..+.+++.+||+.||++|||++|++++|+++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKKMND---ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHTTSCCHHHHSCSSCSC---CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHhhhhhhhhhhhccccccc---cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 00111222222221 124567789999999999999999999999999999754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=333.27 Aligned_cols=233 Identities=19% Similarity=0.262 Sum_probs=179.0
Q ss_pred hhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC--------------------------CccccCCceEEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~ 552 (752)
..++|++.+.||+|+||.||+|+..+|+.||+|++...... +++...+..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 35789999999999999999999888999999988643221 3455677899999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++ ++.+++.... ..+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++.....
T Consensus 99 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99986 8888886543 3488999999999999999999999 9999999999999999999999999999987655
Q ss_pred CCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhcc------------
Q 041438 633 SSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS------------ 699 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~------------ 699 (752)
........||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ..........
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--LPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--HHHHHHHHCCCCTTTSGGGTTS
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHHCCCChHHhhhhhcc
Confidence 444555689999999999876 5689999999999999999999999853211000 0000000000
Q ss_pred ------CCCC-CC----hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 700 ------RLPY-PS----LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 700 ------~~~~-~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.... .. ......++++.+++.+||+.||++|||++|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000 00 0012234578899999999999999999999975
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=343.37 Aligned_cols=344 Identities=25% Similarity=0.349 Sum_probs=299.3
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceee
Q 041438 84 GRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILH 163 (752)
Q Consensus 84 ~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 163 (752)
.++..+++.++++.. ++ .+..+++|++|+|++|+++++.| |.++++|++|+|++|++++..+ +.++++|++|+
T Consensus 46 ~~l~~L~l~~~~i~~-l~--~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 46 DQVTTLQADRLGIKS-ID--GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HTCCEEECCSSCCCC-CT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred ccccEEecCCCCCcc-Cc--chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 356777887777654 22 47889999999999999998755 9999999999999999997765 99999999999
Q ss_pred ccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCC
Q 041438 164 ISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNG 243 (752)
Q Consensus 164 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 243 (752)
|++|.+++..+ +.++++|++|+|++|++++. + .+.++++|++|+++ |.+.+..+ +.++++|+.|++++|++++
T Consensus 119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~~ 191 (466)
T 1o6v_A 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD 191 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCCC
Confidence 99999997644 99999999999999999974 3 48999999999997 56665443 8999999999999999987
Q ss_pred CcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCccc
Q 041438 244 AIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGEL 323 (752)
Q Consensus 244 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 323 (752)
.. .+..+++|++|++++|.+++..| ++.+++|++|++++|.+++. ..+..+++|+.|++++|.+++..+ +
T Consensus 192 ~~----~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~ 261 (466)
T 1o6v_A 192 IS----VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--L 261 (466)
T ss_dssp CG----GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--G
T ss_pred Ch----hhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--h
Confidence 53 25788999999999999998776 77899999999999999864 468899999999999999997765 8
Q ss_pred CCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccce
Q 041438 324 GSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEK 403 (752)
Q Consensus 324 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 403 (752)
..+++|++|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|+.|+|++|++++..| +..+++|+.
T Consensus 262 ~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~ 335 (466)
T 1o6v_A 262 SGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQR 335 (466)
T ss_dssp TTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCE
T ss_pred hcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCE
Confidence 999999999999999999766 8899999999999999987655 8899999999999999998876 789999999
Q ss_pred EEccCCcCCcCCchhhhccCCCcEEEccCCcccCcCCCCcccCCCCcccccCCCCCC
Q 041438 404 LNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEALQGNKGLC 460 (752)
Q Consensus 404 L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c 460 (752)
|++++|++++. ..+..+++|+.|++++|++++..| ...+..+....+.+|++..
T Consensus 336 L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 336 LFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp EECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG-GTTCTTCCEEECCCEEEEC
T ss_pred eECCCCccCCc--hhhccCCCCCEEeCCCCccCccch-hhcCCCCCEEeccCCcccC
Confidence 99999999987 478999999999999999999887 4455555566677776544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.62 Aligned_cols=231 Identities=20% Similarity=0.211 Sum_probs=188.2
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCC------CC-----------------------CccccCCceE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPL------PD-----------------------NFCSHPRQSF 549 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~-----------------------~~~~~~~~~~ 549 (752)
.++|++.+.||+|+||.||+|+. .+++.||||+++... .. +++...+..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46799999999999999999985 579999999874211 00 3455678899
Q ss_pred EEEEeccCCChHHHhccCc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCc---eEEeeccc
Q 041438 550 IVYEYLESGSLDKILNNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE---AHVSDFRI 625 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~---~kl~DfG~ 625 (752)
+|||||++|+|.+.+.... ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988876532 223488999999999999999999999 9999999999999986554 99999999
Q ss_pred ceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCC
Q 041438 626 AKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPS 705 (752)
Q Consensus 626 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (752)
++............+||+.|+|||++.+..++.++||||+||++|||++|+.||... .......+.......+.
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~i~~~~~~~~~ 253 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT------KERLFEGIIKGKYKMNP 253 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS------HHHHHHHHHHTCCCCCH
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc------HHHHHHHHHcCCCCCCc
Confidence 998765444445568999999999999999999999999999999999999998521 22334444455554443
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
......+.++.++|.+||+.||++|||+.|+++|
T Consensus 254 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 254 RQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 3334566789999999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=335.63 Aligned_cols=222 Identities=24% Similarity=0.365 Sum_probs=185.6
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC----C-----------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP----D-----------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~-----------------------~~~~~~~~~~lV 551 (752)
.++|++.+.||+|+||.||+|+. .+|+.||+|++++... . +++.+....|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 47899999999999999999995 5799999998754210 0 345567889999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999997643 488899999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||.. .........+.......+. ..
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-----~~~~~~~~~i~~~~~~~p~----~~ 226 (318)
T 1fot_A 159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-----SNTMKTYEKILNAELRFPP----FF 226 (318)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-----SSHHHHHHHHHHCCCCCCT----TS
T ss_pred ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-----CCHHHHHHHHHhCCCCCCC----CC
Confidence 22345899999999999999999999999999999999999999852 2223344455555555542 34
Q ss_pred HHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 041438 712 FMSIMQVAFSCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 739 (752)
+.++.+++.+||+.||++|| +++|+++|
T Consensus 227 ~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 227 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 56788999999999999999 88888865
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=331.28 Aligned_cols=237 Identities=15% Similarity=0.155 Sum_probs=187.0
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEec
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~ 555 (752)
.++|++.+.||+|+||.||+|+. .+++.||||++...... +++......++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 46799999999999999999994 68999999987543221 3445567889999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCc-----eEEeecccceecc
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE-----AHVSDFRIAKFLN 630 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~-----~kl~DfG~a~~~~ 630 (752)
+++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++. +||+|||+++...
T Consensus 89 -~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 89 -GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp -CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred -CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 889999997643 3488999999999999999999999 9999999999999987776 9999999999876
Q ss_pred CCCCC-------cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCC
Q 041438 631 LDSSN-------WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPY 703 (752)
Q Consensus 631 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 703 (752)
..... .....||+.|+|||++.+..+++++|||||||++|||++|+.||..... .........+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA--ATNKQKYERIGEKKQST 240 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS--CCHHHHHHHHHHHHHHS
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc--cccHHHHHHHHhhccCc
Confidence 43321 2345799999999999999999999999999999999999999863211 01111111221111111
Q ss_pred CC-hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 704 PS-LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 704 ~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
+. ......++++.+++.+||+.||++||+++++++.|+++.
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 11 011234568999999999999999999999999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=327.50 Aligned_cols=233 Identities=23% Similarity=0.338 Sum_probs=188.4
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEecc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~~ 556 (752)
.++|++.+.||+|+||.||+|+..+++.||+|++...... +++.+....++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 4689999999999999999999888999999998764322 44556778999999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC-CC
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS-SN 635 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 635 (752)
+++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 89 ~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 89 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 999999997543 3488999999999999999999999 99999999999999999999999999998654321 11
Q ss_pred cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
.....+|+.|+|||++.+..+++++||||+||++|||++ |+.||... ........+......... ...++.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~---~~~~~~ 235 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSEVVEDISTGFRLYKP---RLASTH 235 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHTTCCCCCC---TTSCHH
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHhcCccCCCC---CcCCHH
Confidence 223456788999999998999999999999999999999 99998521 112222222222111111 234567
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
+.+++.+||+.||++|||++|++++|+++..
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 236 VYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 8899999999999999999999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=334.96 Aligned_cols=235 Identities=25% Similarity=0.411 Sum_probs=185.9
Q ss_pred hcccccceeeccCCceEEEEEEeC----CCcEEEEEccCCCCCC-------------------------CccccCCceEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP----SGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFI 550 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~l 550 (752)
.++|++.+.||+|+||.||+|+.. .+..||||+++..... +++.+.+..|+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 468999999999999999999963 3456999998754221 34556678899
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+++|+|.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999996543 3488999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCCc---ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc-CCCCCC
Q 041438 631 LDSSNW---SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RLPYPS 705 (752)
Q Consensus 631 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~ 705 (752)
...... ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||... ........+... ..+.+
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~- 276 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM-----TNRDVISSVEEGYRLPAP- 276 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS-----CHHHHHHHHHTTCCCCCC-
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC-----CHHHHHHHHHcCCCCCCC-
Confidence 433221 22356778999999998899999999999999999999 99998521 111222222222 22222
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCCC
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPD 748 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 748 (752)
..++..+.+++.+||+.||++|||++|+++.|+++...+.
T Consensus 277 ---~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 277 ---MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred ---CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 3455678999999999999999999999999999876553
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=329.89 Aligned_cols=239 Identities=18% Similarity=0.225 Sum_probs=183.9
Q ss_pred HhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEE
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E 553 (752)
...++|++.+.||+|+||.||+|+. .+++.||||++...... .+.......++|||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 3467899999999999999999994 68999999975433221 22345677899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe---CCCCceEEeecccceecc
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL---DLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll---~~~~~~kl~DfG~a~~~~ 630 (752)
|+ +++|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||++ ++++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred cc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 99 889999997533 3489999999999999999999999 99999999999999 788999999999998875
Q ss_pred CCCC-------CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCC
Q 041438 631 LDSS-------NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPY 703 (752)
Q Consensus 631 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 703 (752)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA--TKRQKYERISEKKMST 237 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS--SSSSHHHHHHHHHHHS
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh--hhhhhhhhhhcccccc
Confidence 4332 123457999999999999999999999999999999999999999632211 1111222222222222
Q ss_pred CCh-hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 704 PSL-DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 704 ~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
+.. .....++++.+++.+||+.||++|||++|+++.|+++.
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 211 11233567999999999999999999999999998875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=352.20 Aligned_cols=234 Identities=21% Similarity=0.325 Sum_probs=187.7
Q ss_pred HHHHHHhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCC------CC---------------------Ccccc
Q 041438 493 YEEIIRATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPL------PD---------------------NFCSH 544 (752)
Q Consensus 493 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~---------------------~~~~~ 544 (752)
++++....++|++.+.||+|+||.||+|+. .+++.||+|++++.. .. +++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 345556788999999999999999999995 468999999875311 00 44567
Q ss_pred CCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecc
Q 041438 545 PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFR 624 (752)
Q Consensus 545 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG 624 (752)
.+..|+||||+++|+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence 78899999999999999999754 388899999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCC-CcccccCCCCccCccccccCC----CCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhcc
Q 041438 625 IAKFLNLDSS-NWSKLAGTHGNVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS 699 (752)
Q Consensus 625 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 699 (752)
+|+....... .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.. .........+...
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-----~~~~~~~~~i~~~ 288 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-----DSLVGTYSKIMNH 288 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC-----SSHHHHHHHHHTH
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC-----CChhhHHHHHHhc
Confidence 9987654322 223468999999999988665 78999999999999999999999852 2222233333332
Q ss_pred C--CCCCChhhHHHHHHHHHHHHhccCcCCCC--CCCHHHHHHHH
Q 041438 700 R--LPYPSLDVQNKFMSIMQVAFSCLDQNPVS--RPTMKRFEVQS 740 (752)
Q Consensus 700 ~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~L 740 (752)
. ...+. ....++++.++|.+||..+|++ ||+++|+++|-
T Consensus 289 ~~~~~~p~--~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 289 KNSLTFPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp HHHCCCCT--TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred cccccCCC--cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 1 22331 1235567899999999999988 99999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=331.30 Aligned_cols=236 Identities=22% Similarity=0.324 Sum_probs=183.4
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV 551 (752)
.++|++.+.||+|+||.||+|+. .+++.||+|++...... +++...+..|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46899999999999999999994 57899999987543221 345567789999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+++++|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999997543 488999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC-CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCC-ChhhH
Q 041438 632 DSS-NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYP-SLDVQ 709 (752)
Q Consensus 632 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 709 (752)
... ......||+.|+|||++.+..++.++||||+||++|||+||+.||... ..............+.. .....
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE-----TAVSIAIKHIQDSVPNVTTDVRK 238 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS-----CHHHHHHHHHSSCCCCHHHHSCT
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHhhccCCCcchhccc
Confidence 322 223357999999999999999999999999999999999999998521 11111122222222111 11113
Q ss_pred HHHHHHHHHHHhccCcCCCCCC-CHHHHHHHHhhhhcC
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRP-TMKRFEVQSKQFHYN 746 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~~~~~ 746 (752)
..++.+.+++.+||+.||++|| +++++.+.|+++...
T Consensus 239 ~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 239 DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 3556789999999999999998 999999999987544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=336.92 Aligned_cols=237 Identities=16% Similarity=0.199 Sum_probs=186.0
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEec
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~ 555 (752)
.++|++.+.||+|+||.||+|+. .+++.||||++...... +++...+..++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 46899999999999999999994 68999999987543221 3345567789999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCc-----eEEeecccceecc
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE-----AHVSDFRIAKFLN 630 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~-----~kl~DfG~a~~~~ 630 (752)
+++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++...
T Consensus 88 -~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 88 -GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp -CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred -CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 889999998642 3589999999999999999999999 9999999999999998887 9999999999765
Q ss_pred CCCCC-------cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCC
Q 041438 631 LDSSN-------WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPY 703 (752)
Q Consensus 631 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 703 (752)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....+....+.....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~--~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK--ADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC--CSSHHHHHHHHHHHHHHS
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc--cccHHHHHHHHHhhhccC
Confidence 43321 234589999999999999999999999999999999999999996321 011111222222222222
Q ss_pred CChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 704 PSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 704 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
+........+++.+++.+||+.||++||+++++.+.|+++.
T Consensus 240 ~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 240 PIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp CHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 21111111228999999999999999999999999998764
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=329.59 Aligned_cols=307 Identities=25% Similarity=0.382 Sum_probs=260.0
Q ss_pred cCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCc
Q 041438 105 FSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLN 184 (752)
Q Consensus 105 f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 184 (752)
+..+++|++|++++|.+..+ | .|..+++|++|+|++|++++..+ |..+++|++|+|++|.++.. +.|.++++|+
T Consensus 40 ~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~ 113 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLR 113 (347)
T ss_dssp HHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCS
T ss_pred chhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCC
Confidence 45677888999999988774 3 48888999999999998886544 88899999999999988853 3688899999
Q ss_pred EEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccc
Q 041438 185 HLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSI 264 (752)
Q Consensus 185 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~ 264 (752)
+|+|++|++++..+ +.++++|++|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|+.|++++
T Consensus 114 ~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~----~~~l~~L~~L~l~~ 186 (347)
T 4fmz_A 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP----IANLTDLYSLSLNY 186 (347)
T ss_dssp EEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG----GGGCTTCSEEECTT
T ss_pred EEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh----hccCCCCCEEEccC
Confidence 99999999886544 8888999999999986654444 48888899999999998887654 56788999999999
Q ss_pred cccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccc
Q 041438 265 NNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVL 344 (752)
Q Consensus 265 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 344 (752)
|.+++..+ +..+++|++|++++|.+.+..+ +..+++|+.|++++|++++..+ +..+++|++|++++|.+++.
T Consensus 187 n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-- 258 (347)
T 4fmz_A 187 NQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI-- 258 (347)
T ss_dssp SCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--
T ss_pred Cccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--
Confidence 99987554 7889999999999999987655 8889999999999999987655 88999999999999999885
Q ss_pred hhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCC
Q 041438 345 ESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHG 424 (752)
Q Consensus 345 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 424 (752)
..+..+++|++|++++|++++. ..+..+++|++|++++|.+++..+..+..+++|++|+|++|++++..| +..+++
T Consensus 259 ~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~ 334 (347)
T 4fmz_A 259 NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSK 334 (347)
T ss_dssp GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTT
T ss_pred hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhc
Confidence 4688999999999999999865 468899999999999999999999999999999999999999999877 888999
Q ss_pred CcEEEccCCccc
Q 041438 425 LLHIDISYNKLE 436 (752)
Q Consensus 425 L~~L~ls~N~l~ 436 (752)
|++|++++|+++
T Consensus 335 L~~L~l~~N~i~ 346 (347)
T 4fmz_A 335 MDSADFANQVIK 346 (347)
T ss_dssp CSEESSSCC---
T ss_pred cceeehhhhccc
Confidence 999999999985
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=344.93 Aligned_cols=235 Identities=22% Similarity=0.300 Sum_probs=179.5
Q ss_pred hcccccc-eeeccCCceEEEEEEe-CCCcEEEEEccCCCCC-----------------C---Cccc----cCCceEEEEE
Q 041438 500 TNDFDAK-HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP-----------------D---NFCS----HPRQSFIVYE 553 (752)
Q Consensus 500 ~~~y~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----------------~---~~~~----~~~~~~lV~E 553 (752)
.++|.+. +.||+|+||.||+|+. .+++.||||+++.... . +++. .....|+|||
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E 139 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEE
Confidence 4677776 7899999999999995 5789999998753210 0 1122 2456899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC---CCceEEeecccceecc
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL---GYEAHVSDFRIAKFLN 630 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~---~~~~kl~DfG~a~~~~ 630 (752)
||++|+|.+++.... ...+++..++.|+.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 140 ~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 140 CLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp CCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred eCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 999999999997643 23589999999999999999999999 9999999999999997 7889999999998765
Q ss_pred CCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........+.......+......
T Consensus 216 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~ 293 (400)
T 1nxk_A 216 SH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGMKTRIRMGQYEFPNPEWSE 293 (400)
T ss_dssp ------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCS-SCCSHHHHHHHTCCCCCTTTTTT
T ss_pred CC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccc-ccHHHHHHHHcCcccCCCccccc
Confidence 32 22345689999999999999999999999999999999999999986322111 11123334444444444333445
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
.+.++.++|.+||+.||++|||++|+++|-
T Consensus 294 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 294 VSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 677899999999999999999999999874
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=334.66 Aligned_cols=225 Identities=22% Similarity=0.305 Sum_probs=180.3
Q ss_pred hcccccceeeccCCceEEEEEEe----CCCcEEEEEccCCCCCC----------------------------CccccCCc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV----PSGEIFAVKKFHSPLPD----------------------------NFCSHPRQ 547 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~----------------------------~~~~~~~~ 547 (752)
.++|++.+.||+|+||.||+|+. .+++.||+|++++.... +++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 57899999999999999999986 57899999998754210 34456678
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
.|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999997543 378899999999999999999999 99999999999999999999999999998
Q ss_pred eccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChh
Q 041438 628 FLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLD 707 (752)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (752)
............+||+.|+|||++.+..++.++|||||||++|||++|+.||.. .........+.......+.
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-----~~~~~~~~~i~~~~~~~p~-- 242 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-----ENRKKTIDKILKCKLNLPP-- 242 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC-----SSHHHHHHHHHHTCCCCCT--
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC-----CCHHHHHHHHHhCCCCCCC--
Confidence 654444344456899999999999998999999999999999999999999852 1222333444444444442
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 739 (752)
..+.++.+++.+||+.||++|| +++|+++|
T Consensus 243 --~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 243 --YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp --TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred --CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 3456788999999999999999 77788765
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=338.51 Aligned_cols=233 Identities=20% Similarity=0.286 Sum_probs=169.7
Q ss_pred cccccc---eeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------CccccCCceEEEEEe
Q 041438 501 NDFDAK---HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 501 ~~y~~~---~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------~~~~~~~~~~lV~E~ 554 (752)
++|++. +.||+|+||.||+|+. .+++.||||++...... +++.+....|+||||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~ 87 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMEL 87 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEc
Confidence 345554 7899999999999995 57899999988643211 455677889999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC---ceEEeecccceeccC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY---EAHVSDFRIAKFLNL 631 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~---~~kl~DfG~a~~~~~ 631 (752)
+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 88 LNGGELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp CCSCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 99999999997643 488999999999999999999999 999999999999997665 799999999987665
Q ss_pred CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccc--cccccchHhhhccCCCCCChhhH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS--SSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....+....+.......+.....
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (325)
T 3kn6_A 162 DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK 241 (325)
T ss_dssp ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHH
T ss_pred CCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccccc
Confidence 5444555688999999999999999999999999999999999999996322111 11122344455555555555555
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..++++.+++.+||+.||++|||++|+++|
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 677889999999999999999999999865
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=338.79 Aligned_cols=222 Identities=20% Similarity=0.287 Sum_probs=185.7
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC----C-----------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP----D-----------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~-----------------------~~~~~~~~~~lV 551 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||++++... . +++.+....|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 57899999999999999999995 5799999998753210 0 344567789999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+++|+|.+++...+ .+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999997643 488999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.. .........+.......+. ..
T Consensus 194 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-----~~~~~~~~~i~~~~~~~p~----~~ 261 (350)
T 1rdq_E 194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-----DQPIQIYEKIVSGKVRFPS----HF 261 (350)
T ss_dssp C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHHCCCCCCT----TC
T ss_pred C---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC-----CCHHHHHHHHHcCCCCCCC----CC
Confidence 2 2345899999999999999999999999999999999999999852 2223344455555555542 34
Q ss_pred HHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 041438 712 FMSIMQVAFSCLDQNPVSRPT-----MKRFEVQ 739 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 739 (752)
+.++.++|.+||+.||++||+ ++|+++|
T Consensus 262 ~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 567899999999999999998 8888765
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=331.43 Aligned_cols=222 Identities=21% Similarity=0.220 Sum_probs=176.2
Q ss_pred hcccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC---------------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV 551 (752)
.++|++.++||+|+||.||+|+.. +|+.||||++...... +++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 368999999999999999999964 7999999987654322 445667889999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+ +++|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 569998887643 3589999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... ....+.... .+.......
T Consensus 210 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--------~~~~~~~~~--~~~~~~~~~ 277 (311)
T 3p1a_A 210 AG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--------GWQQLRQGY--LPPEFTAGL 277 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH--------HHHHHTTTC--CCHHHHTTS
T ss_pred CC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHhccC--CCcccccCC
Confidence 32 2334579999999998876 78999999999999999999976653111 111121111 111122345
Q ss_pred HHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 712 FMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
++++.+++.+||+.||++|||++|+++|
T Consensus 278 ~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 278 SSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 5679999999999999999999999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=352.19 Aligned_cols=237 Identities=20% Similarity=0.292 Sum_probs=188.3
Q ss_pred hHHHHHHhhcccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCC------CC---------------------Cccc
Q 041438 492 VYEEIIRATNDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPL------PD---------------------NFCS 543 (752)
Q Consensus 492 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~---------------------~~~~ 543 (752)
.+.++....++|++.++||+|+||.||+|+.. +++.||+|++++.. .. +++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34566667899999999999999999999954 58899999875311 00 3456
Q ss_pred cCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeec
Q 041438 544 HPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDF 623 (752)
Q Consensus 544 ~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~Df 623 (752)
+.+..|+|||||++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence 7788999999999999999997632 3489999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCCC-cccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhh
Q 041438 624 RIAKFLNLDSSN-WSKLAGTHGNVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEIL 697 (752)
Q Consensus 624 G~a~~~~~~~~~-~~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 697 (752)
|+|+........ ....+||+.|+|||++. ...++.++|||||||++|||++|+.||.. ....+....+.
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~-----~~~~~~~~~i~ 294 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-----ESLVETYGKIM 294 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC-----SSHHHHHHHHH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC-----CChhHHHHhhh
Confidence 999876543332 23358999999999987 45689999999999999999999999852 12222223332
Q ss_pred cc--CCCCCChhhHHHHHHHHHHHHhccCcCCCC--CCCHHHHHHH
Q 041438 698 DS--RLPYPSLDVQNKFMSIMQVAFSCLDQNPVS--RPTMKRFEVQ 739 (752)
Q Consensus 698 ~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 739 (752)
.. ....|.. ....++++.++|.+||..+|++ ||+++|+++|
T Consensus 295 ~~~~~~~~p~~-~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 295 NHKERFQFPTQ-VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp THHHHCCCCSS-CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hccccccCCcc-cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 21 2233321 1234567899999999988888 9999999876
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=336.63 Aligned_cols=230 Identities=20% Similarity=0.281 Sum_probs=176.9
Q ss_pred hhcccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC----------------------CccccCCceEEEEEec
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD----------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----------------------~~~~~~~~~~lV~E~~ 555 (752)
..++|++.+.||+|+||.||+|+.. +++.||||+++..... +++......++||||+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 4578999999999999999999964 6889999998654211 4456678899999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC---CCceEEeecccceeccCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL---GYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~---~~~~kl~DfG~a~~~~~~ 632 (752)
++|+|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+++.....
T Consensus 131 ~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 131 TGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999999997543 488999999999999999999999 9999999999999975 889999999999876432
Q ss_pred CCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHH
Q 041438 633 SSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (752)
.......||+.|+|||++.+..+++++|||||||++|||++|+.||... .........+.......+.......+
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~~i~~~~~~~~~~~~~~~~ 279 (349)
T 2w4o_A 205 -VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE----RGDQFMFRRILNCEYYFISPWWDEVS 279 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT----TCHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred -cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC----cccHHHHHHHHhCCCccCCchhhhCC
Confidence 2233457999999999999999999999999999999999999998521 11112333444444433332334566
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.++.+++.+||+.||++|||++|+++|
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 280 LNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 789999999999999999999999975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.17 Aligned_cols=225 Identities=19% Similarity=0.283 Sum_probs=181.2
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC-----C----------------------CccccCCceEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP-----D----------------------NFCSHPRQSFI 550 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~----------------------~~~~~~~~~~l 550 (752)
..++|++.+.||+|+||.||+|+. .+++.||||++..... . +++......++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 357899999999999999999995 6899999998753210 0 44566788999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+ +|+|.+++.... .+++.+++.++.||+.||+|||+. ||+||||||+||++++++.+||+|||++....
T Consensus 87 v~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EEECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 99999 679988886543 488999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
.. ......+||+.|+|||++.+..+ ++++||||+||++|+|++|+.||+.. ........+.......+ .
T Consensus 160 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~-----~~~~~~~~i~~~~~~~p----~ 229 (336)
T 3h4j_B 160 DG-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE-----FIPNLFKKVNSCVYVMP----D 229 (336)
T ss_dssp TS-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS-----SSTTCBCCCCSSCCCCC----T
T ss_pred CC-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHHcCCCCCc----c
Confidence 33 23344589999999999988776 78999999999999999999999622 11112222222222333 2
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
..++++.+++.+||+.||++|||++|+++|-
T Consensus 230 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 230 FLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 3456788999999999999999999998764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=351.53 Aligned_cols=225 Identities=21% Similarity=0.282 Sum_probs=184.3
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC------C---------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP------D---------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~---------------------~~~~~~~~~~lV 551 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||+++.... . +++...+..|+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 57899999999999999999994 5799999998753210 0 345566788999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ . ||+||||||+|||++.++.+||+|||+|+...
T Consensus 227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999987543 48899999999999999999998 8 99999999999999999999999999998654
Q ss_pred CCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.. .........+.......+. .
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-----~~~~~~~~~i~~~~~~~p~----~ 371 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-----QDHEKLFELILMEEIRFPR----T 371 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHHCCCCCCT----T
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC-----CCHHHHHHHHHhCCCCCCc----c
Confidence 444445557899999999999999999999999999999999999999852 2223333444444554442 3
Q ss_pred HHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 739 (752)
.++++.++|.+||+.||++|| +++|+++|
T Consensus 372 ~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 372 LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 456788999999999999999 99999865
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=365.20 Aligned_cols=226 Identities=22% Similarity=0.358 Sum_probs=189.8
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC----C------------------------CccccCCceE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP----D------------------------NFCSHPRQSF 549 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~------------------------~~~~~~~~~~ 549 (752)
..++|++.+.||+|+||.||+|+. .+++.||||++++... . .++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 467899999999999999999994 5788999998764210 0 2345667899
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+||||+++|+|.+++...+ .+++..++.|+.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+..
T Consensus 419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999997643 488999999999999999999999 9999999999999999999999999999875
Q ss_pred cCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 630 NLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||.. ....+....+......+|.
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~-----~~~~~~~~~i~~~~~~~p~---- 563 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-----EDEDELFQSIMEHNVAYPK---- 563 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHSSCCCCCT----
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC-----CCHHHHHHHHHhCCCCCCc----
Confidence 5444455567899999999999999999999999999999999999999962 2334455666666666653
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCH-----HHHHHH
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTM-----KRFEVQ 739 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~ 739 (752)
..++++.++|.+||++||++||++ +|+++|
T Consensus 564 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 564 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 356678999999999999999997 666644
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=336.34 Aligned_cols=324 Identities=21% Similarity=0.209 Sum_probs=258.7
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceee
Q 041438 84 GRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILH 163 (752)
Q Consensus 84 ~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 163 (752)
.++..++++++.+.+. + .|..+++|++|+|++|+|+++ | |+++++|++|+|++|+|++. | |+++++|++|+
T Consensus 42 ~~L~~L~Ls~n~l~~~-~--~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~ 112 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T--GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLN 112 (457)
T ss_dssp TTCCEEECCSSCCCCC-T--TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEE
T ss_pred CCCCEEEccCCCcccC-h--hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEE
Confidence 4577888888888874 2 688899999999999999885 3 88999999999999999875 3 88899999999
Q ss_pred ccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCC
Q 041438 164 ISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNG 243 (752)
Q Consensus 164 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 243 (752)
|++|++++. | ++.+++|++|+|++|++++. + ++++++|++|++++|+..+.+ .++.+++|+.|++++|++++
T Consensus 113 L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~ 184 (457)
T 3bz5_A 113 CDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE 184 (457)
T ss_dssp CCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC
T ss_pred CCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce
Confidence 999999874 4 88899999999999999975 3 788899999999999665555 47888999999999999987
Q ss_pred CcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCccc
Q 041438 244 AIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGEL 323 (752)
Q Consensus 244 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 323 (752)
. | ++.+++|+.|++++|++++. .+..+++|++|++++|++++ +| ++.+++|+.|++++|++++..+..+
T Consensus 185 l-~----l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l 253 (457)
T 3bz5_A 185 L-D----VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTL 253 (457)
T ss_dssp C-C----CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTC
T ss_pred e-c----cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHC
Confidence 3 2 57888999999999999875 47888999999999999987 45 7888999999999999998776666
Q ss_pred CCCc-------ccceeeccccccccccchhhcccccccEEEcCCCcCccccch--------hccccccCCeeecCCccCC
Q 041438 324 GSLI-------NLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPI--------ELDNLIHLSELDLSHNFLG 388 (752)
Q Consensus 324 ~~l~-------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~--------~~~~l~~L~~L~Ls~N~l~ 388 (752)
.++. +|+.|++++|.+.+..| ++.+++|+.|++++|.+.+.+|. .+.++++|++|+|++|+++
T Consensus 254 ~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~ 331 (457)
T 3bz5_A 254 SKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELT 331 (457)
T ss_dssp TTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCS
T ss_pred CCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccc
Confidence 6655 56777777777666555 46788899999999987666654 2556678888888888888
Q ss_pred CCCCcccccccccceEEccCCcCCcCCchhhh-------------ccCCCcEEEccCCcccCcCCCC
Q 041438 389 EKISSRICRMESLEKLNLSYNNLSGLIPRCFE-------------ELHGLLHIDISYNKLEGHIPNS 442 (752)
Q Consensus 389 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-------------~l~~L~~L~ls~N~l~~~~p~~ 442 (752)
+. + ++.+++|+.|++++|++++. + .+. .+..|..+++++|+++|.+|..
T Consensus 332 ~l-~--l~~l~~L~~L~l~~N~l~~l-~-~L~~L~l~~n~l~g~~~~~~l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 332 EL-D--VSHNTKLKSLSCVNAHIQDF-S-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp CC-C--CTTCTTCSEEECCSSCCCBC-T-TGGGSSGGGTSEEEEEEEEECCCBCCBTTBEEEECCTT
T ss_pred cc-c--cccCCcCcEEECCCCCCCCc-c-ccccccccCCcEEecceeeecCccccccCcEEEEcChh
Confidence 85 2 77888888888888888874 2 111 1234667788888888877753
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.82 Aligned_cols=239 Identities=17% Similarity=0.218 Sum_probs=188.2
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEe
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~ 554 (752)
..++|++.+.||+|+||.||+|+. .+++.||||++...... .+.......++||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 467899999999999999999994 68999999987543322 122455678999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe---CCCCceEEeecccceeccC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL---DLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll---~~~~~~kl~DfG~a~~~~~ 631 (752)
+ +++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||++ ++++.+||+|||.++....
T Consensus 87 ~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 87 L-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp C-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred c-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 9 889999997433 3489999999999999999999999 99999999999999 4788999999999988764
Q ss_pred CCCC-------cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCC
Q 041438 632 DSSN-------WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYP 704 (752)
Q Consensus 632 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (752)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .........+.......+
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA--ATKRQKYERISEKKMSTP 238 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC--SSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc--hhhhhhhhhhcccccCCc
Confidence 4321 2345799999999999999999999999999999999999999863211 111122222222222222
Q ss_pred Ch-hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 705 SL-DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 705 ~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
.. .....++++.+++.+||+.||++|||++|+++.|+++..
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 10 112345678999999999999999999999999998753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=329.17 Aligned_cols=226 Identities=22% Similarity=0.306 Sum_probs=177.8
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC-----------------------------C----------
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP-----------------------------D---------- 539 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----------------------------~---------- 539 (752)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 47899999999999999999984 5789999998854320 0
Q ss_pred -----------Ccccc--CCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 041438 540 -----------NFCSH--PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDIS 606 (752)
Q Consensus 540 -----------~~~~~--~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlK 606 (752)
+++.+ ....|+||||+++++|.++... ..+++.+++.++.||+.||+|||+. +|+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 22222 4678999999999999886543 3489999999999999999999999 99999999
Q ss_pred CCCEEeCCCCceEEeecccceeccCCCCCcccccCCCCccCccccccCC---CCCccchhhHHHHHHHHHhCCCCcchhh
Q 041438 607 SKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFLF 683 (752)
Q Consensus 607 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDIwSlGvil~elltg~~pf~~~~ 683 (752)
|+||+++.++.+||+|||+++.............||+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~- 243 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE- 243 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS-
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc-
Confidence 9999999999999999999988765444444568999999999988665 378899999999999999999998521
Q ss_pred ccccccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 684 EMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
........+.......+. ....++++.+++.+||+.||++|||++|+++|
T Consensus 244 ----~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 244 ----RIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp ----SHHHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ----cHHHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 111222233333333332 12345678999999999999999999999865
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=331.84 Aligned_cols=247 Identities=24% Similarity=0.330 Sum_probs=185.7
Q ss_pred hhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccC----CceEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHP----RQSFIV 551 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~----~~~~lV 551 (752)
..++|++.+.||+|+||.||+|+.. ++.||||++...... +++... ...++|
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 113 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI 113 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence 4578999999999999999999874 899999987432111 122222 678999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNC-----FPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-----~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
|||+++|+|.++++.. .+++..++.++.|++.||+|||+.+ .++|+||||||+||+++.++.+||+|||++
T Consensus 114 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 189 (337)
T 3mdy_A 114 TDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189 (337)
T ss_dssp ECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence 9999999999999654 3889999999999999999999762 238999999999999999999999999999
Q ss_pred eeccCCCCC----cccccCCCCccCccccccCCCCCc------cchhhHHHHHHHHHhC----------CCCcchhhccc
Q 041438 627 KFLNLDSSN----WSKLAGTHGNVAPELAYTMKVTEK------CDVYSFGVLALEVIKG----------KHPRDFLFEMS 686 (752)
Q Consensus 627 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~k------sDIwSlGvil~elltg----------~~pf~~~~~~~ 686 (752)
+........ .....||+.|+|||++.+...+.+ +|||||||++|||+|| +.||.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 269 (337)
T 3mdy_A 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269 (337)
T ss_dssp EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence 876543322 124579999999999987776665 9999999999999999 55553211111
Q ss_pred cccccchHhhhccC--CCCCC-hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCCCCC
Q 041438 687 SSSSNMNIEILDSR--LPYPS-LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPDHN 750 (752)
Q Consensus 687 ~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~ 750 (752)
.........+.... ...+. .....+++++.+++.+||+.||++|||++|++++|+++..+.+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 336 (337)
T 3mdy_A 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDIK 336 (337)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTCC
T ss_pred CchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcccC
Confidence 11111111111111 11221 112367788999999999999999999999999999998776543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=333.98 Aligned_cols=242 Identities=22% Similarity=0.296 Sum_probs=183.4
Q ss_pred hhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------Ccccc----CCceEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSH----PRQSFIV 551 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~----~~~~~lV 551 (752)
..++|++.+.||+|+||.||+|+.. ++.||||++...... +++.. ....++|
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 4578999999999999999999874 899999988543211 22222 2346999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCC-------CCCeeecCCCCCCEEeCCCCceEEeecc
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNC-------FPPIVHWDISSKNVLLDLGYEAHVSDFR 624 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-------~~~ivH~DlKp~NIll~~~~~~kl~DfG 624 (752)
|||+++|+|.+++.... +++..++.++.|++.||+|||+.+ .++|+||||||+||+++.++.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 99999999999997543 899999999999999999999862 2389999999999999999999999999
Q ss_pred cceeccCCCCC--cccccCCCCccCccccccC-----CCCCccchhhHHHHHHHHHhCCCCcchhhccccc---------
Q 041438 625 IAKFLNLDSSN--WSKLAGTHGNVAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS--------- 688 (752)
Q Consensus 625 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-----~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~--------- 688 (752)
+++........ .....||+.|+|||++.+. .++.++|||||||++|||+||+.||.........
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 99876543322 2335799999999998863 4567899999999999999999998632211000
Q ss_pred -ccc-chHhhhccCC-CCCCh--hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 689 -SSN-MNIEILDSRL-PYPSL--DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 689 -~~~-~~~~~~~~~~-~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
... ....+..... +.... .....++++.+++.+||+.||++|||++|+++.|+++..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 001 1111111111 11111 123456679999999999999999999999999998863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=331.10 Aligned_cols=228 Identities=20% Similarity=0.351 Sum_probs=180.3
Q ss_pred hhcccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC-------------------------Cccc---------
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD-------------------------NFCS--------- 543 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------------------------~~~~--------- 543 (752)
..++|++.+.||+|+||.||+|+.. +|+.||||+++..... +++.
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 4678999999999999999999964 8999999998643221 1111
Q ss_pred ------------------------------------------------cCCceEEEEEeccCCChHHHhccCccccccCH
Q 041438 544 ------------------------------------------------HPRQSFIVYEYLESGSLDKILNNDASAKELGW 575 (752)
Q Consensus 544 ------------------------------------------------~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~ 575 (752)
.....++|||||++|+|.+++.........++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 11237999999999999999988766566777
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC------------CcccccCCC
Q 041438 576 TQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS------------NWSKLAGTH 643 (752)
Q Consensus 576 ~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~------------~~~~~~gt~ 643 (752)
..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....... ......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 88999999999999999999 999999999999999999999999999998764421 123347999
Q ss_pred CccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHHHhcc
Q 041438 644 GNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCL 723 (752)
Q Consensus 644 ~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 723 (752)
.|+|||++.+..++.++||||+||++|||++|..|+.... ......... ..+ ......++++.+++.+||
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-------~~~~~~~~~--~~~-~~~~~~~~~~~~li~~~l 310 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-------RIITDVRNL--KFP-LLFTQKYPQEHMMVQDML 310 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-------HHHHHHHTT--CCC-HHHHHHCHHHHHHHHHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-------HHHHHhhcc--CCC-cccccCChhHHHHHHHHc
Confidence 9999999999999999999999999999999988863211 111122222 222 233556677899999999
Q ss_pred CcCCCCCCCHHHHHHH
Q 041438 724 DQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 724 ~~dP~~Rps~~evl~~ 739 (752)
+.||++|||++|+++|
T Consensus 311 ~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 311 SPSPTERPEATDIIEN 326 (332)
T ss_dssp CSSGGGSCCHHHHHHS
T ss_pred cCCCCcCCCHHHHhhc
Confidence 9999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=327.85 Aligned_cols=233 Identities=22% Similarity=0.297 Sum_probs=175.0
Q ss_pred cccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEe
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~ 554 (752)
++|++.+.||+|+||.||+|+..+|+.||+|+++..... +++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 579999999999999999999888999999988643211 345566789999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++ +|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 986 9999887543 3488899999999999999999999 999999999999999999999999999987654433
Q ss_pred CcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccccc----------ccc---chHh--hhc
Q 041438 635 NWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------SSN---MNIE--ILD 698 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~----------~~~---~~~~--~~~ 698 (752)
......||+.|+|||++.+. .++.++||||+||++|||++|+.||......... ... .... ..+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 44455789999999998764 5899999999999999999999998532110000 000 0000 000
Q ss_pred cCCC----CC-ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 699 SRLP----YP-SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 699 ~~~~----~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.... .+ .......++++.+++.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 00 00012345678899999999999999999999875
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=355.04 Aligned_cols=355 Identities=21% Similarity=0.229 Sum_probs=291.8
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceee
Q 041438 84 GRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILH 163 (752)
Q Consensus 84 ~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 163 (752)
.....++|+++.+.+ +++.+|.++++|++|+|++|+|+++.+.+|.++++|++|+|++|+|+++.+..|+++++|++|+
T Consensus 76 ~~L~~L~Ls~N~i~~-i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~ 154 (635)
T 4g8a_A 76 PELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 154 (635)
T ss_dssp TTCCEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCC-cChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeec
Confidence 467789999988875 5567899999999999999999999999999999999999999999998888999999999999
Q ss_pred ccCcccCCC-CCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcce----EEeecccccccccccc--------------
Q 041438 164 ISRNQLNGS-IPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLV----FLYLYNNSFSGSIPQQ-------------- 224 (752)
Q Consensus 164 Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~L~~N~l~~~~p~~-------------- 224 (752)
|++|.|++. +|..++.+++|++|+|++|+|++..|..|..+.+++ .++++.|.++...+..
T Consensus 155 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n 234 (635)
T 4g8a_A 155 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 234 (635)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred cccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcc
Confidence 999999864 678899999999999999999988887776544332 3444444433221111
Q ss_pred --------------------------------------------------------------------------------
Q 041438 225 -------------------------------------------------------------------------------- 224 (752)
Q Consensus 225 -------------------------------------------------------------------------------- 224 (752)
T Consensus 235 ~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 314 (635)
T 4g8a_A 235 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLV 314 (635)
T ss_dssp CSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEE
T ss_pred cccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccc
Confidence
Q ss_pred ---------ccCccccccccccccccCCCcCCC-----------------CCCCCCCCCcEEEccccccCCC--------
Q 041438 225 ---------IGNLKSLFDMKLCINQLNGAIPLS-----------------IDWGRCPQLSLLDVSINNITGN-------- 270 (752)
Q Consensus 225 ---------~~~l~~L~~l~l~~N~l~~~~~~~-----------------~~~~~l~~L~~L~Ls~N~l~~~-------- 270 (752)
+....+|+.|++.+|.+.+..+.. ..+..+++|+.|+++.|.+...
T Consensus 315 ~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~ 394 (635)
T 4g8a_A 315 SVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 394 (635)
T ss_dssp SCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHH
T ss_pred ccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchh
Confidence 111223444555555554332211 1233567888888888877431
Q ss_pred -----------------CCcccCCCCCCCEEecCCCcCcCCCC-ccccCCcccCEEEccCCcCcccCCcccCCCccccee
Q 041438 271 -----------------IPFEIGESPQLQYLDLSSNYIVGEIP-TQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYL 332 (752)
Q Consensus 271 -----------------~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 332 (752)
.+..+..+++|+.++++.|.+....+ ..|..+.+++.++++.|.+.+..+..+..+++|+.|
T Consensus 395 ~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L 474 (635)
T 4g8a_A 395 GTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 474 (635)
T ss_dssp SCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred hhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhh
Confidence 23345677888888888888766554 568899999999999999999999999999999999
Q ss_pred ecccccc-ccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcC
Q 041438 333 DLSANHL-SNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNL 411 (752)
Q Consensus 333 ~Ls~N~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 411 (752)
+|++|.+ .+..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++.++..|..+++|+.|+|++|+|
T Consensus 475 ~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l 554 (635)
T 4g8a_A 475 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 554 (635)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCC
T ss_pred hhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcC
Confidence 9999985 556788999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCchhhhcc-CCCcEEEccCCcccCcC
Q 041438 412 SGLIPRCFEEL-HGLLHIDISYNKLEGHI 439 (752)
Q Consensus 412 ~~~~p~~~~~l-~~L~~L~ls~N~l~~~~ 439 (752)
++.+|..|..+ ++|+.|+|++|++....
T Consensus 555 ~~~~~~~l~~l~~~L~~L~L~~Np~~C~C 583 (635)
T 4g8a_A 555 MTSKKQELQHFPSSLAFLNLTQNDFACTC 583 (635)
T ss_dssp CBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred CCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence 99999999998 68999999999998754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=340.05 Aligned_cols=229 Identities=19% Similarity=0.267 Sum_probs=186.7
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEe
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~ 554 (752)
.++|++.+.||+|+||.||+|+. .+|+.||+|++...... +++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 56899999999999999999995 57899999988653211 445667889999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC--CCceEEeecccceeccCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL--GYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~--~~~~kl~DfG~a~~~~~~ 632 (752)
+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 99999999987543 3488999999999999999999999 9999999999999974 577999999999987543
Q ss_pred CCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHH
Q 041438 633 SSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (752)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+.......+
T Consensus 205 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~s 278 (387)
T 1kob_A 205 E-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-----DDLETLQNVKRCDWEFDEDAFSSVS 278 (387)
T ss_dssp S-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-----SHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred c-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCCCCccccccCC
Confidence 2 234458999999999999999999999999999999999999998521 1122233333333333333334566
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+++.++|.+||+.||++|||++|+++|
T Consensus 279 ~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 279 PEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 789999999999999999999999976
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=326.34 Aligned_cols=233 Identities=23% Similarity=0.341 Sum_probs=185.1
Q ss_pred hhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEec
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~ 555 (752)
..++|++.+.||+|+||.||+|+..++..||||+++..... +++.+.+..++||||+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 45789999999999999999999888889999998764322 3456677889999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC-C
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS-S 634 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~-~ 634 (752)
++++|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.++...... .
T Consensus 102 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 102 ANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp TTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 9999999997633 3488999999999999999999999 99999999999999999999999999998654321 1
Q ss_pred CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHH
Q 041438 635 NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
......+|+.|+|||++.+..++.++||||+||++|||+| |+.||... ........+......... ...++
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~-----~~~~~~~~~~~~~~~~~~---~~~~~ 248 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-----TNSETAEHIAQGLRLYRP---HLASE 248 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS-----CHHHHHHHHHTTCCCCCC---TTCCH
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-----ChhHHHHHHhcccCCCCC---CcCCH
Confidence 1122356788999999998899999999999999999998 99998521 111222222222211111 22345
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
.+.+++.+||+.||++|||++|++++|+++.
T Consensus 249 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 249 KVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 7889999999999999999999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=346.34 Aligned_cols=236 Identities=22% Similarity=0.272 Sum_probs=186.5
Q ss_pred hHHHHHHhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCC------CC---------------------Cccc
Q 041438 492 VYEEIIRATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPL------PD---------------------NFCS 543 (752)
Q Consensus 492 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~---------------------~~~~ 543 (752)
.++++....++|++.+.||+|+||.||+|+. .+|+.||||++++.. .. .++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 4556666789999999999999999999995 579999999885321 00 3456
Q ss_pred cCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeec
Q 041438 544 HPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDF 623 (752)
Q Consensus 544 ~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~Df 623 (752)
+.+..|+||||+++|+|.+++.+.+ ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++++||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence 6788999999999999999997543 2488999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCCC-cccccCCCCccCccccc-------cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHh
Q 041438 624 RIAKFLNLDSSN-WSKLAGTHGNVAPELAY-------TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE 695 (752)
Q Consensus 624 G~a~~~~~~~~~-~~~~~gt~~y~aPE~~~-------~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~ 695 (752)
|+++........ ....+||+.|+|||++. +..++.++|||||||++|||++|+.||.. ....+....
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-----~~~~~~~~~ 281 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA-----DSTAETYGK 281 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC-----SSHHHHHHH
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC-----CCHHHHHHH
Confidence 999887543322 23358999999999987 35689999999999999999999999852 122222233
Q ss_pred hhcc--CCCCCChhhHHHHHHHHHHHHhccCcCCCCC---CCHHHHHHH
Q 041438 696 ILDS--RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSR---PTMKRFEVQ 739 (752)
Q Consensus 696 ~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---ps~~evl~~ 739 (752)
+... ....+. .....++++.++|.+||. +|++| |+++|+++|
T Consensus 282 i~~~~~~~~~p~-~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 282 IVHYKEHLSLPL-VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHTHHHHCCCC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHhcccCcCCCc-cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 3321 122221 113456688999999999 99998 589998876
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=333.21 Aligned_cols=230 Identities=23% Similarity=0.301 Sum_probs=183.2
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~ 552 (752)
..++|++.+.||+|+||.||+|+. .+++.||||++...... +++.+.+..|+||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 357899999999999999999995 47999999987543211 4456678889999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++|+|.+++.... .+++.+++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++.....
T Consensus 85 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 85 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999999987543 488999999999999999999999 9999999999999999999999999999876432
Q ss_pred C--CCcccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 633 S--SNWSKLAGTHGNVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 633 ~--~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
. .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... ................+ ...
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~~~~~~~~~~~--~~~ 232 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS----DSCQEYSDWKEKKTYLN--PWK 232 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC----TTSHHHHHHHTTCTTST--TGG
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc----hHHHHHHHHhcccccCC--ccc
Confidence 2 22334589999999999987775 789999999999999999999985211 11111222222222222 224
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
..+..+.+++.+||+.||++|||++|++++-
T Consensus 233 ~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 233 KIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 5567788999999999999999999998763
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=339.32 Aligned_cols=226 Identities=26% Similarity=0.370 Sum_probs=181.8
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC---------------------------CCccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP---------------------------DNFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------------------------~~~~~~~~~~~lV 551 (752)
.++|++.+.||+|+||.||+|+. .+++.||+|++.+... .+++...+..|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 47899999999999999999994 5689999998753210 0345667889999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+.+|+|.+++.... .+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+|+....
T Consensus 94 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999997643 488999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCCcccccCCCCccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhh
Q 041438 632 DSSNWSKLAGTHGNVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (752)
. ......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ..........+.......+
T Consensus 168 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~p---- 240 (384)
T 4fr4_A 168 E-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS--STSSKEIVHTFETTVVTYP---- 240 (384)
T ss_dssp T-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT--TSCHHHHHHHHHHCCCCCC----
T ss_pred C-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC--CccHHHHHHHHhhcccCCC----
Confidence 3 33455689999999999874 458999999999999999999999985211 1111222233333344444
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCC-HHHHHH
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPT-MKRFEV 738 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps-~~evl~ 738 (752)
...+.++.++|.+||+.||++||+ ++++.+
T Consensus 241 ~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 241 SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 234567899999999999999998 677664
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.71 Aligned_cols=227 Identities=24% Similarity=0.362 Sum_probs=172.4
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC----------------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~lV 551 (752)
.++|++.+.||+|+||.||+|+. .++.||||+++..... +++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46899999999999999999987 4899999998643211 345567788999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCC---eeecCCCCCCEEeCC--------CCceEE
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP---IVHWDISSKNVLLDL--------GYEAHV 620 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~---ivH~DlKp~NIll~~--------~~~~kl 620 (752)
|||+++++|.+++... .+++..++.++.|++.||+|||+. + |+||||||+||+++. ++.+||
T Consensus 85 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp EECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred EEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceEE
Confidence 9999999999998643 488999999999999999999999 7 999999999999986 678999
Q ss_pred eecccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccC
Q 041438 621 SDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR 700 (752)
Q Consensus 621 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 700 (752)
+|||.++...... .....||+.|+|||++.+..+++++||||+|+++|+|++|+.||.... .......+....
T Consensus 158 ~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~ 230 (271)
T 3dtc_A 158 TDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID-----GLAVAYGVAMNK 230 (271)
T ss_dssp CCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC-----HHHHHHHHHTSC
T ss_pred ccCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHhhhcCC
Confidence 9999998764332 234579999999999999999999999999999999999999985211 111122222222
Q ss_pred CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 701 LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 701 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
...+. ....++.+.+++.+||+.||++|||++|++++|+++
T Consensus 231 ~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 231 LALPI--PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCC--CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 22111 133456789999999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=328.44 Aligned_cols=228 Identities=19% Similarity=0.250 Sum_probs=186.6
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------------CccccCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------------NFCSHPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------------~~~~~~~~~ 548 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||+++..... +++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 56799999999999999999995 47899999988643211 345566789
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC----ceEEeecc
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY----EAHVSDFR 624 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~----~~kl~DfG 624 (752)
++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999997543 488899999999999999999999 999999999999999887 79999999
Q ss_pred cceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCC
Q 041438 625 IAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYP 704 (752)
Q Consensus 625 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (752)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.. .........+.......+
T Consensus 165 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-----~~~~~~~~~i~~~~~~~~ 238 (321)
T 2a2a_A 165 LAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-----DTKQETLANITSVSYDFD 238 (321)
T ss_dssp TCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-----SSHHHHHHHHHTTCCCCC
T ss_pred cceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC-----CCHHHHHHHHHhcccccC
Confidence 998775432 23445799999999999999999999999999999999999999852 122223333444444443
Q ss_pred ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 705 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.......+..+.+++.+||+.||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 239 EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 32234456678999999999999999999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=339.84 Aligned_cols=240 Identities=20% Similarity=0.299 Sum_probs=187.5
Q ss_pred HHHHHhhcccccceeeccCCceEEEEEEe------CCCcEEEEEccCCCCCC--------------------------Cc
Q 041438 494 EEIIRATNDFDAKHCIGKGGHGSVYIARV------PSGEIFAVKKFHSPLPD--------------------------NF 541 (752)
Q Consensus 494 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--------------------------~~ 541 (752)
.++....++|++.+.||+|+||.||+|+. .+++.||||+++..... ++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 94 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 94 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence 34445678999999999999999999973 35689999998654221 22
Q ss_pred ccc-CCceEEEEEeccCCChHHHhccCcc---------------------------------------------------
Q 041438 542 CSH-PRQSFIVYEYLESGSLDKILNNDAS--------------------------------------------------- 569 (752)
Q Consensus 542 ~~~-~~~~~lV~E~~~~g~L~~~l~~~~~--------------------------------------------------- 569 (752)
+.. ....++||||+++|+|.+++.....
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 333 3458999999999999999976532
Q ss_pred ------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC--C
Q 041438 570 ------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS--N 635 (752)
Q Consensus 570 ------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~ 635 (752)
...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchh
Confidence 11288999999999999999999999 999999999999999999999999999987643322 1
Q ss_pred cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc-CCCCCChhhHHHHH
Q 041438 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RLPYPSLDVQNKFM 713 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 713 (752)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||.... ........+... ....+ ...++
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----~~~~~~~~~~~~~~~~~~----~~~~~ 323 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK----IDEEFCRRLKEGTRMRAP----DYTTP 323 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC----CSHHHHHHHHHTCCCCCC----TTCCH
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc----hhHHHHHHHHcCCCCCCC----CCCCH
Confidence 233578899999999999999999999999999999998 999985211 111111222221 12222 23456
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
++.+++.+||+.||++|||++|++++|+++.
T Consensus 324 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 324 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 7899999999999999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=338.11 Aligned_cols=235 Identities=20% Similarity=0.221 Sum_probs=180.7
Q ss_pred hHHHHHHhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------Ccc
Q 041438 492 VYEEIIRATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------NFC 542 (752)
Q Consensus 492 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------~~~ 542 (752)
++++.....++|++.++||+|+||.||+|+. .+++.||||+++..... +++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence 3344444578999999999999999999995 57899999988642110 334
Q ss_pred ccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC--------
Q 041438 543 SHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL-------- 614 (752)
Q Consensus 543 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~-------- 614 (752)
...+..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.
T Consensus 106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 106 MYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEE
T ss_pred eECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccccccc
Confidence 4567889999999 8899999986542 3488999999999999999999999 9999999999999975
Q ss_pred -----------------CCceEEeecccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCC
Q 041438 615 -----------------GYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 677 (752)
Q Consensus 615 -----------------~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~ 677 (752)
++.+||+|||+|+..... .....||+.|+|||++.+..++.++||||+||++|||++|+.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence 788999999999875432 234579999999999999999999999999999999999999
Q ss_pred CcchhhccccccccchHhhhccCCC--------------------------CCCh----------------hhHHHHHHH
Q 041438 678 PRDFLFEMSSSSSNMNIEILDSRLP--------------------------YPSL----------------DVQNKFMSI 715 (752)
Q Consensus 678 pf~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~----------------~~~~~~~~l 715 (752)
||...... .....+.....+ ++.. ......+.+
T Consensus 258 pf~~~~~~-----~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 258 LFRTHEHM-----EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp SCCCSSHH-----HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred CCCCCcHH-----HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence 98521110 000000000000 0000 000112567
Q ss_pred HHHHHhccCcCCCCCCCHHHHHHH
Q 041438 716 MQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 716 ~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+++.+||+.||++|||++|+++|
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHhcCChhhCCCHHHHhcC
Confidence 899999999999999999999865
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.82 Aligned_cols=229 Identities=19% Similarity=0.259 Sum_probs=177.4
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E 553 (752)
++|++.+.||+|+||.||+|+. .+++.||||+++..... +++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5899999999999999999995 57899999998644321 34556788999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++ ++.+.+.... ..+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||.++......
T Consensus 82 ~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9987 6666655432 3488999999999999999999999 99999999999999999999999999999876555
Q ss_pred CCcccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhcc-------------
Q 041438 634 SNWSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS------------- 699 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~------------- 699 (752)
.......||+.|+|||++.+.. ++.++||||+||++|||++|..||.... ........+...
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~----~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN----DVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS----SHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC----CHHHHHHHHHHHhCCCChhhhhhhc
Confidence 5555568999999999988766 7999999999999999999988852111 000000000000
Q ss_pred ----CCCCC--------ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 700 ----RLPYP--------SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 700 ----~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..+.+ .......+.++.+++.+||+.||++|||++|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000 00112345678899999999999999999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=322.99 Aligned_cols=229 Identities=21% Similarity=0.302 Sum_probs=187.4
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV 551 (752)
..++|++.+.||+|+||.||+|+. .+++.||+|++...... +++......++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 467899999999999999999985 56899999988654321 445667788999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCc---eEEeeccccee
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE---AHVSDFRIAKF 628 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~---~kl~DfG~a~~ 628 (752)
|||+++++|.+.+.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||.+..
T Consensus 84 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999988886543 488899999999999999999999 9999999999999986655 99999999987
Q ss_pred ccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhh
Q 041438 629 LNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708 (752)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (752)
.... .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.. .........+.......+....
T Consensus 158 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-----~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T 3kk8_A 158 VNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-----EDQHRLYAQIKAGAYDYPSPEW 231 (284)
T ss_dssp CCSS-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHHTCCCCCTTTT
T ss_pred cccC-ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC-----CchhHHHHHHHhccccCCchhh
Confidence 6533 233446799999999999999999999999999999999999999852 2222333344444444443333
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...++++.+++.+||+.||++|||++|+++|
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 232 DTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 4566789999999999999999999999975
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.07 Aligned_cols=231 Identities=23% Similarity=0.365 Sum_probs=185.3
Q ss_pred hhcccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC-------------------------CccccCCceEEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~ 552 (752)
..++|++.+.||+|+||.||+|+.. +++.||||+++..... +++...+..|+||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 4568999999999999999999964 7899999988654211 4455667889999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++|+|.+++...+ ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 192 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999999997543 3488999999999999999999999 9999999999999999999999999999865422
Q ss_pred CCCc--ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc--CCCCCChh
Q 041438 633 SSNW--SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS--RLPYPSLD 707 (752)
Q Consensus 633 ~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 707 (752)
.... ....+++.|+|||++.+..++.++|||||||++|||+| |+.||.... .......... +.+.+
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~------~~~~~~~~~~~~~~~~~--- 337 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS------NQQTREFVEKGGRLPCP--- 337 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC------HHHHHHHHHTTCCCCCC---
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCCCCCCC---
Confidence 1111 11235678999999998889999999999999999998 999985211 1111222222 22222
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
..+++++.+++.+||+.||++|||++++++.|+++.
T Consensus 338 -~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 338 -ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 234567889999999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=329.32 Aligned_cols=232 Identities=19% Similarity=0.270 Sum_probs=166.1
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~ 552 (752)
..++|++.+.||+|+||.||+|+. .+|+.||||+++..... +++...+..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 467899999999999999999984 57899999988643221 3455677899999
Q ss_pred EeccCCChHHHhccCc---cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 553 EYLESGSLDKILNNDA---SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
||+++ +|.+++.... ....+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++..
T Consensus 83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 99985 9999886532 123488999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc----------
Q 041438 630 NLDSSNWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD---------- 698 (752)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~---------- 698 (752)
...........||+.|+|||++.+. .++.++||||+||++|||++|+.||..... .+....+.+
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-----EEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCTTTC
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCChhHh
Confidence 6544444556899999999998764 589999999999999999999999853211 000000000
Q ss_pred ----------cCCC-CCCh---------hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 699 ----------SRLP-YPSL---------DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 699 ----------~~~~-~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.... .+.. .....+.++.+++.+||+.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000 0000 001234578999999999999999999999976
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=336.72 Aligned_cols=234 Identities=21% Similarity=0.326 Sum_probs=187.7
Q ss_pred hhcccccceeeccCCceEEEEEEe--------CCCcEEEEEccCCCCCC--------------------------Ccccc
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV--------PSGEIFAVKKFHSPLPD--------------------------NFCSH 544 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~--------------------------~~~~~ 544 (752)
..++|++.+.||+|+||.||+|+. ..++.||||+++..... +++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 357899999999999999999984 23467999998654221 44566
Q ss_pred CCceEEEEEeccCCChHHHhccCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEE
Q 041438 545 PRQSFIVYEYLESGSLDKILNNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVL 611 (752)
Q Consensus 545 ~~~~~lV~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIl 611 (752)
.+..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+. +|+||||||+||+
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence 7789999999999999999986532 23589999999999999999999999 9999999999999
Q ss_pred eCCCCceEEeecccceeccCCCC--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccc
Q 041438 612 LDLGYEAHVSDFRIAKFLNLDSS--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSS 688 (752)
Q Consensus 612 l~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~ 688 (752)
+++++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||... .
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~-----~ 298 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-----P 298 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----C
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----C
Confidence 99999999999999987654322 2233467889999999999999999999999999999999 99998521 1
Q ss_pred cccchHhhhccC-CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 689 SSNMNIEILDSR-LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 689 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
..+....+.... ...+ ...++++.+++.+||+.||++|||++|++++|+++.
T Consensus 299 ~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 299 VEELFKLLKEGHRMDKP----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp HHHHHHHHHTTCCCCCC----SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCC----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 112222222221 1222 234567899999999999999999999999999886
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=338.34 Aligned_cols=234 Identities=24% Similarity=0.411 Sum_probs=175.6
Q ss_pred hcccccceeeccCCceEEEEEEeC----CCcEEEEEccCCCCCC-------------------------CccccCCceEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP----SGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFI 550 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~l 550 (752)
.++|++.+.||+|+||.||+|+.. ++..||||+++..... +++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 468999999999999999999853 5778999998754221 44556778899
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+++|+|.+++.... ..+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999997643 3488999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCc---ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc-CCCCCC
Q 041438 631 LDSSNW---SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RLPYPS 705 (752)
Q Consensus 631 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~ 705 (752)
...... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||... ........+... ..+.+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~-----~~~~~~~~i~~~~~~~~~- 272 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM-----SNQDVIKAVDEGYRLPPP- 272 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC-----CHHHHHHHHHTTEECCCC-
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHcCCCCCCC-
Confidence 432211 12245778999999999999999999999999999998 99998521 111112222111 11222
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCC
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNP 747 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 747 (752)
..++..+.+++.+||+.||++||+++|+++.|+++...+
T Consensus 273 ---~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 273 ---MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp ---TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ---ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 234567899999999999999999999999999886543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.45 Aligned_cols=243 Identities=22% Similarity=0.274 Sum_probs=181.5
Q ss_pred hhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC--------------------C--------ccccCCceEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD--------------------N--------FCSHPRQSFI 550 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------~--------~~~~~~~~~l 550 (752)
..++|++.+.||+|+||.||+|+. +++.||||++...... . ........++
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 357899999999999999999976 7899999987532111 1 1122345689
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCC------CCCeeecCCCCCCEEeCCCCceEEeecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNC------FPPIVHWDISSKNVLLDLGYEAHVSDFR 624 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~------~~~ivH~DlKp~NIll~~~~~~kl~DfG 624 (752)
||||+++|+|.+++.... .++..+..++.||++||+|||+.+ .++|+||||||+||+++.++.+||+|||
T Consensus 90 v~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 999999999999997544 578899999999999999999873 2389999999999999999999999999
Q ss_pred cceeccCCCC--------CcccccCCCCccCcccccc-------CCCCCccchhhHHHHHHHHHhCCCCcchhhcccccc
Q 041438 625 IAKFLNLDSS--------NWSKLAGTHGNVAPELAYT-------MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS 689 (752)
Q Consensus 625 ~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-------~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~ 689 (752)
+++....... ......||+.|+|||++.+ ..+++++|||||||++|||++|..||..........
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 9987653221 1223479999999999876 356789999999999999999988763211111100
Q ss_pred cc------------chHhhhcc---CCCCC--ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 690 SN------------MNIEILDS---RLPYP--SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 690 ~~------------~~~~~~~~---~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
.. ........ +...+ .......++++.++|.+||+.||++|||++|+++.|+++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 00 00001111 11111 111234667899999999999999999999999999998633
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=333.71 Aligned_cols=238 Identities=20% Similarity=0.353 Sum_probs=189.6
Q ss_pred HhhcccccceeeccCCceEEEEEEeC------CCcEEEEEccCCCCCC-------------------------CccccCC
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARVP------SGEIFAVKKFHSPLPD-------------------------NFCSHPR 546 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-------------------------~~~~~~~ 546 (752)
...++|++.+.||+|+||.||+|+.. +++.||||+++..... +++...+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 35688999999999999999999953 4589999998754321 4455678
Q ss_pred ceEEEEEeccCCChHHHhccCcc---------------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC
Q 041438 547 QSFIVYEYLESGSLDKILNNDAS---------------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDI 605 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~Dl 605 (752)
..++||||+++|+|.+++..... ...+++.+++.++.||++||+|||++ +|+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 89999999999999999976421 14589999999999999999999999 9999999
Q ss_pred CCCCEEeCCCCceEEeecccceeccCCC--CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchh
Q 041438 606 SSKNVLLDLGYEAHVSDFRIAKFLNLDS--SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFL 682 (752)
Q Consensus 606 Kp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~ 682 (752)
||+||+++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 9999999999999999999998654322 11233468899999999998899999999999999999999 99998521
Q ss_pred hccccccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 683 FEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
...+....+.+....... ...+.++.+++.+||+.||++|||++|++++|+++...
T Consensus 281 -----~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 281 -----AHEEVIYYVRDGNILACP---ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp -----CHHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred -----ChHHHHHHHhCCCcCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 122222333333322111 23456789999999999999999999999999998644
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=338.52 Aligned_cols=236 Identities=23% Similarity=0.303 Sum_probs=185.4
Q ss_pred hcccccceeeccCCceEEEEEEe------CCCcEEEEEccCCCCCC-------------------------CccccCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV------PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~ 548 (752)
.++|++.+.||+|+||.||+|+. .+++.||||+++..... +++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 46899999999999999999984 25678999998643221 345566788
Q ss_pred EEEEEeccCCChHHHhccCcc----ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC---ceEEe
Q 041438 549 FIVYEYLESGSLDKILNNDAS----AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY---EAHVS 621 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~---~~kl~ 621 (752)
++||||+++|+|.+++..... ...+++.+++.++.||++||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999976431 23588999999999999999999999 999999999999999554 59999
Q ss_pred ecccceeccCCC--CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhc
Q 041438 622 DFRIAKFLNLDS--SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILD 698 (752)
Q Consensus 622 DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 698 (752)
|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++ |..||... ........+..
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~-----~~~~~~~~i~~ 301 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-----SNQEVLEFVTS 301 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHHHHHHHHHT
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHc
Confidence 999998653221 22233578999999999999999999999999999999998 99998521 11222222222
Q ss_pred cCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 699 SRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 699 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
.....+. ...+..+.+++.+||+.||++|||++|++++|+.+...
T Consensus 302 ~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 302 GGRMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp TCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCC---ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 2211111 23456788999999999999999999999999887643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=332.09 Aligned_cols=236 Identities=22% Similarity=0.346 Sum_probs=190.9
Q ss_pred hHHHHHHhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------------
Q 041438 492 VYEEIIRATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------------- 539 (752)
Q Consensus 492 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------------- 539 (752)
.++......++|++.+.||+|+||.||+|+. .+|+.||||+++.....
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4455566678899999999999999999996 47999999987543210
Q ss_pred --CccccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCc
Q 041438 540 --NFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE 617 (752)
Q Consensus 540 --~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~ 617 (752)
+++......|+||||+++++|.+++... ..+++..+..++.||+.||.|||+. ||+||||||+||+++.++.
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 3445667889999999999999999753 3488999999999999999999999 9999999999999999999
Q ss_pred eEEeecccceeccCCCCCcccccCCCCccCcccccc------CCCCCccchhhHHHHHHHHHhCCCCcchhhcccccccc
Q 041438 618 AHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYT------MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN 691 (752)
Q Consensus 618 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~ 691 (752)
+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. .....
T Consensus 239 ikl~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-----~~~~~ 312 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-----RRQIL 312 (365)
T ss_dssp EEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC-----SSHHH
T ss_pred EEEEecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC-----CCHHH
Confidence 999999999877543 23345689999999998763 3588999999999999999999999852 11222
Q ss_pred chHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 692 MNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
....+.......+.......+..+.+++.+||+.||++|||++|+++|
T Consensus 313 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 313 MLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 333344444444433334456679999999999999999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.76 Aligned_cols=235 Identities=19% Similarity=0.300 Sum_probs=185.0
Q ss_pred HHHHhhcccccc-eeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccC
Q 041438 495 EIIRATNDFDAK-HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHP 545 (752)
Q Consensus 495 ~~~~~~~~y~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~ 545 (752)
......++|.+. +.||+|+||.||+|+. .+++.||||+++..... +++...
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 344556778887 8999999999999995 47999999988653221 345567
Q ss_pred CceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC---CCceEEee
Q 041438 546 RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL---GYEAHVSD 622 (752)
Q Consensus 546 ~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~---~~~~kl~D 622 (752)
+..++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+. ||+||||||+||+++. ++.+||+|
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred CeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEee
Confidence 88999999999999999986542 24589999999999999999999999 9999999999999987 78999999
Q ss_pred cccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCC
Q 041438 623 FRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLP 702 (752)
Q Consensus 623 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 702 (752)
||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.. .........+......
T Consensus 178 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-----~~~~~~~~~i~~~~~~ 251 (327)
T 3lm5_A 178 FGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG-----EDNQETYLNISQVNVD 251 (327)
T ss_dssp GGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHHTCCC
T ss_pred CccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC-----CCchHHHHHHHhcccc
Confidence 99998765332 23345799999999999999999999999999999999999999852 1122222333333333
Q ss_pred CCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 703 YPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 703 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+.......++.+.+++.+||+.||++|||++|+++|
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 252 YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 3333334566778999999999999999999999876
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=334.53 Aligned_cols=302 Identities=25% Similarity=0.283 Sum_probs=266.8
Q ss_pred ccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCC
Q 041438 104 SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFL 183 (752)
Q Consensus 104 ~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 183 (752)
+++.+++|++|+|++|+|+++ | .|+.+++|++|+|++|+|+++ | ++.+++|++|+|++|+|++. | ++++++|
T Consensus 37 ~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L 108 (457)
T 3bz5_A 37 SEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKL 108 (457)
T ss_dssp EHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTC
T ss_pred ChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcC
Confidence 577889999999999999986 4 799999999999999999985 4 89999999999999999975 3 9999999
Q ss_pred cEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEcc
Q 041438 184 NHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVS 263 (752)
Q Consensus 184 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls 263 (752)
++|+|++|++++. | ++++++|++|++++|++++. .++++++|++|++++|+..+.+ .++.+++|+.|+++
T Consensus 109 ~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~----~~~~l~~L~~L~ls 178 (457)
T 3bz5_A 109 TYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL----DVTPQTQLTTLDCS 178 (457)
T ss_dssp CEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC----CCTTCTTCCEEECC
T ss_pred CEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc----ccccCCcCCEEECC
Confidence 9999999999984 4 89999999999999999985 3889999999999999766655 36789999999999
Q ss_pred ccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeecccccccccc
Q 041438 264 INNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFV 343 (752)
Q Consensus 264 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 343 (752)
+|++++. | +..+++|+.|++++|.+++. .++.+++|+.|++++|++++ +| ++.+++|++|++++|++++.+
T Consensus 179 ~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~ 249 (457)
T 3bz5_A 179 FNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD 249 (457)
T ss_dssp SSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC
T ss_pred CCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC
Confidence 9999984 4 88999999999999999976 48899999999999999998 45 889999999999999999988
Q ss_pred chhhcccc-------cccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCc--------ccccccccceEEccC
Q 041438 344 LESLGSLV-------KLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISS--------RICRMESLEKLNLSY 408 (752)
Q Consensus 344 ~~~~~~l~-------~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~--------~~~~l~~L~~L~L~~ 408 (752)
+..+.++. +|+.|++++|++.+.+| +..+++|+.|+|++|.+.+.+|. .+..+++|++|++++
T Consensus 250 ~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~ 327 (457)
T 3bz5_A 250 VSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNN 327 (457)
T ss_dssp CTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTT
T ss_pred HHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCC
Confidence 76666655 56777788887777666 57889999999999987766554 255668999999999
Q ss_pred CcCCcCCchhhhccCCCcEEEccCCcccC
Q 041438 409 NNLSGLIPRCFEELHGLLHIDISYNKLEG 437 (752)
Q Consensus 409 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 437 (752)
|+++++ + +..+++|+.||+++|++++
T Consensus 328 N~l~~l-~--l~~l~~L~~L~l~~N~l~~ 353 (457)
T 3bz5_A 328 TELTEL-D--VSHNTKLKSLSCVNAHIQD 353 (457)
T ss_dssp CCCSCC-C--CTTCTTCSEEECCSSCCCB
T ss_pred Cccccc-c--cccCCcCcEEECCCCCCCC
Confidence 999996 3 8999999999999999998
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=320.41 Aligned_cols=228 Identities=20% Similarity=0.257 Sum_probs=187.4
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E 553 (752)
..++|++.+.||+|+||.||+|+. .+++.||+|++...... +++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 356899999999999999999995 46789999987653221 44566788999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe---CCCCceEEeecccceecc
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL---DLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll---~~~~~~kl~DfG~a~~~~ 630 (752)
|+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||.+....
T Consensus 87 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999887543 488999999999999999999999 99999999999999 788899999999998765
Q ss_pred CCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
... ......||+.|+|||++.+. +++++||||+||++|||++|+.||.. .........+.......+......
T Consensus 161 ~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 233 (277)
T 3f3z_A 161 PGK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSA-----PTDSEVMLKIREGTFTFPEKDWLN 233 (277)
T ss_dssp TTS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHHCCCCCCHHHHTT
T ss_pred Ccc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCC-----CCHHHHHHHHHhCCCCCCchhhhc
Confidence 332 33445799999999987654 89999999999999999999999852 222334444555555555443445
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.++.+.+++.+||+.||++|||+.|+++|
T Consensus 234 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 234 VSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 67789999999999999999999999964
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=326.38 Aligned_cols=235 Identities=21% Similarity=0.333 Sum_probs=188.2
Q ss_pred hhcccccceeeccCCceEEEEEEe------CCCcEEEEEccCCCCCC-------------------------CccccCCc
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV------PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQ 547 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-------------------------~~~~~~~~ 547 (752)
..++|++.+.||+|+||.||+|+. .+++.||||+++..... +++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 357899999999999999999984 34589999998754321 34556778
Q ss_pred eEEEEEeccCCChHHHhccCcc---------------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 041438 548 SFIVYEYLESGSLDKILNNDAS---------------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDIS 606 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlK 606 (752)
.++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||++ +|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence 9999999999999999986432 13488999999999999999999999 99999999
Q ss_pred CCCEEeCCCCceEEeecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhh
Q 041438 607 SKNVLLDLGYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLF 683 (752)
Q Consensus 607 p~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~ 683 (752)
|+||+++.++.+||+|||+++........ .....+|+.|+|||++.+..++.++||||+||++|||++ |+.||...
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~- 256 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI- 256 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC-
Confidence 99999999999999999999876543321 223467788999999999889999999999999999999 99998521
Q ss_pred ccccccccchHhhhccC-CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 684 EMSSSSSNMNIEILDSR-LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 684 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
........+.... ...+ ...++++.+++.+||+.||++|||++|++++|+++..
T Consensus 257 ----~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 257 ----PPERLFNLLKTGHRMERP----DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp ----CGGGHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CHHHHHHHhhcCCcCCCC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1122222222221 1122 3455678999999999999999999999999998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=338.32 Aligned_cols=235 Identities=19% Similarity=0.203 Sum_probs=179.9
Q ss_pred hhcccccceeeccCCceEEEEEEeCC------CcEEEEEccCCCCCC---------------------------------
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPS------GEIFAVKKFHSPLPD--------------------------------- 539 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~--------------------------------- 539 (752)
..++|++.+.||+|+||.||+|+... ++.||||++......
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998644 478999987543210
Q ss_pred --Ccccc----CCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC
Q 041438 540 --NFCSH----PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD 613 (752)
Q Consensus 540 --~~~~~----~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~ 613 (752)
+++.+ ....|+||||+ +++|.+++.... ..+++.+++.++.||+.||+|||+. +|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 11111 14479999999 889999997643 3589999999999999999999999 999999999999998
Q ss_pred --CCCceEEeecccceeccCCCCC-------cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhc
Q 041438 614 --LGYEAHVSDFRIAKFLNLDSSN-------WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFE 684 (752)
Q Consensus 614 --~~~~~kl~DfG~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~ 684 (752)
.++.+||+|||+++.+...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999876533211 1234599999999999999999999999999999999999999963211
Q ss_pred cccccc-------cchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 685 MSSSSS-------NMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 685 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
...... .......+...+. ...+.++.+++..||+.||++||+++++++.|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKCFPA-----ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHHSCT-----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhhhhHHHHHHHhccc-----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 000000 0001111111100 123567899999999999999999999999998775
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=323.02 Aligned_cols=227 Identities=22% Similarity=0.370 Sum_probs=161.7
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC------C---------------------CccccCCceEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP------D---------------------NFCSHPRQSFI 550 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~---------------------~~~~~~~~~~l 550 (752)
..++|++.+.||+|+||.||+|+. .+|+.||||++..... . +++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 457899999999999999999995 6799999998753210 0 34556788899
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+++++|.+++.... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 89 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999997643 3588999999999999999999999 99999999999999999999999999998875
Q ss_pred CCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
..........||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+.......+ ..
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~----~~ 234 (278)
T 3cok_A 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT-----VKNTLNKVVLADYEMP----SF 234 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCS-----CC-----CCSSCCCCC----TT
T ss_pred CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh-----HHHHHHHHhhcccCCc----cc
Confidence 44433444679999999999998889999999999999999999999985211 1111122222222222 22
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+.++.+++.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 235 LSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 45578899999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=328.43 Aligned_cols=232 Identities=25% Similarity=0.342 Sum_probs=180.8
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcE----EEEEccCCCCCC-------------------------CccccCCceE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEI----FAVKKFHSPLPD-------------------------NFCSHPRQSF 549 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~~~-------------------------~~~~~~~~~~ 549 (752)
.++|++.+.||+|+||.||+|+. .+++. ||+|.+...... +++ .....+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC-PGSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEE-CBSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-cCCccE
Confidence 46899999999999999999984 45554 788876433211 222 246688
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+||||+.+|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 91 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 9999999999999997643 3588899999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCC--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc-CCCCCC
Q 041438 630 NLDSS--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RLPYPS 705 (752)
Q Consensus 630 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~ 705 (752)
..... ......||..|+|||++.+..++.++|||||||++|||+| |+.||... ........+... ....+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~- 239 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL-----RLAEVPDLLEKGERLAQP- 239 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-----CTTHHHHHHHTTCBCCCC-
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc-----CHHHHHHHHHcCCCCCCC-
Confidence 54332 2234568889999999999999999999999999999999 99998521 111222222222 12222
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
...+.++.+++.+||+.||++|||++|++++|+++...
T Consensus 240 ---~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 240 ---QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp ---TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred ---CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 22344678899999999999999999999999987643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=326.50 Aligned_cols=230 Identities=26% Similarity=0.323 Sum_probs=176.7
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------------CccccC
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------------NFCSHP 545 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------------~~~~~~ 545 (752)
..++|++.+.||+|+||.||+|+. .+++.||||+++..... +++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467999999999999999999994 67999999988632210 122222
Q ss_pred C-----ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEE
Q 041438 546 R-----QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV 620 (752)
Q Consensus 546 ~-----~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl 620 (752)
. ..++||||+.+ +|.+++..... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCCC-BHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhhc-CHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 2 47999999985 99999976543 3489999999999999999999999 9999999999999999999999
Q ss_pred eecccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc--
Q 041438 621 SDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD-- 698 (752)
Q Consensus 621 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~-- 698 (752)
+|||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+..
T Consensus 162 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~ 235 (308)
T 3g33_A 162 ADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-----ADQLGKIFDLI 235 (308)
T ss_dssp CSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH-----HHHHHHHHHHH
T ss_pred eeCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHh
Confidence 999999876533 333456899999999999999999999999999999999999999852211 011111100
Q ss_pred --------------------cCCCCC-ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 699 --------------------SRLPYP-SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 699 --------------------~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...+.+ .......++++.+++.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000000 00112345678899999999999999999999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=335.47 Aligned_cols=224 Identities=19% Similarity=0.205 Sum_probs=178.9
Q ss_pred cceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEeccCCC
Q 041438 505 AKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEYLESGS 559 (752)
Q Consensus 505 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~~~~g~ 559 (752)
..+.||+|+||.||+|+. .+|+.||+|+++..... +++...+..++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 367899999999999985 57999999988653211 45566788999999999999
Q ss_pred hHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe--CCCCceEEeecccceeccCCCCCcc
Q 041438 560 LDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL--DLGYEAHVSDFRIAKFLNLDSSNWS 637 (752)
Q Consensus 560 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll--~~~~~~kl~DfG~a~~~~~~~~~~~ 637 (752)
|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++...... ...
T Consensus 173 L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~~ 246 (373)
T 2x4f_A 173 LFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLK 246 (373)
T ss_dssp EHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BCC
T ss_pred HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-ccc
Confidence 999886543 3488999999999999999999999 99999999999999 567889999999999875332 333
Q ss_pred cccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHH
Q 041438 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717 (752)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 717 (752)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.. .........+.......+.......++++.+
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 321 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG-----DNDAETLNNILACRWDLEDEEFQDISEEAKE 321 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCC-----SSHHHHHHHHHHTCCCSCSGGGTTSCHHHHH
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-----CCHHHHHHHHHhccCCCChhhhccCCHHHHH
Confidence 45799999999999988899999999999999999999999852 1222334445555554444444556778999
Q ss_pred HHHhccCcCCCCCCCHHHHHHH
Q 041438 718 VAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 718 li~~cl~~dP~~Rps~~evl~~ 739 (752)
+|.+||+.||++|||++|+++|
T Consensus 322 li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 322 FISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHcCCChhhCCCHHHHhcC
Confidence 9999999999999999999975
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=330.03 Aligned_cols=307 Identities=22% Similarity=0.180 Sum_probs=270.3
Q ss_pred EEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCc
Q 041438 88 GINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRN 167 (752)
Q Consensus 88 ~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 167 (752)
.+++.++.+. .+++..|..+++|++|+|++|+++++.+..|+++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 49 ~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 127 (390)
T 3o6n_A 49 IVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 127 (390)
T ss_dssp EEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCC
Confidence 3444444433 355556889999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCC
Q 041438 168 QLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPL 247 (752)
Q Consensus 168 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~ 247 (752)
+|+...+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++. .++.+++|+.+++++|.+++.
T Consensus 128 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~--- 201 (390)
T 3o6n_A 128 DLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL--- 201 (390)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE---
T ss_pred ccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc---
Confidence 99976666789999999999999999999999999999999999999999875 356778899999999998853
Q ss_pred CCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCc
Q 041438 248 SIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLI 327 (752)
Q Consensus 248 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 327 (752)
...++|+.|++++|.++.. |.. ..++|++|++++|.+++. ..+..+++|+.|++++|.+++..|..|..++
T Consensus 202 ----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 272 (390)
T 3o6n_A 202 ----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ 272 (390)
T ss_dssp ----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCS
T ss_pred ----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccc
Confidence 2346899999999999865 332 357999999999999864 5789999999999999999999999999999
Q ss_pred ccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEcc
Q 041438 328 NLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLS 407 (752)
Q Consensus 328 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 407 (752)
+|++|+|++|+++++ +..+..+++|++|+|++|+++ .+|..+..+++|++|+|++|.++... +..+++|+.|+++
T Consensus 273 ~L~~L~L~~n~l~~~-~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~~L~l~ 347 (390)
T 3o6n_A 273 RLERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLS 347 (390)
T ss_dssp SCCEEECCSSCCCEE-ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECC
T ss_pred cCCEEECCCCcCccc-CcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC---chhhccCCEEEcC
Confidence 999999999999986 455678999999999999998 56777899999999999999998763 6778999999999
Q ss_pred CCcCCcCC
Q 041438 408 YNNLSGLI 415 (752)
Q Consensus 408 ~N~l~~~~ 415 (752)
+|++++..
T Consensus 348 ~N~~~~~~ 355 (390)
T 3o6n_A 348 HNDWDCNS 355 (390)
T ss_dssp SSCEEHHH
T ss_pred CCCccchh
Confidence 99998753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=330.65 Aligned_cols=239 Identities=21% Similarity=0.280 Sum_probs=186.4
Q ss_pred hhcccccceeeccCCceEEEEEEe------CCCcEEEEEccCCCCCC--------------------------CccccCC
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV------PSGEIFAVKKFHSPLPD--------------------------NFCSHPR 546 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--------------------------~~~~~~~ 546 (752)
..++|++.+.||+|+||.||+|+. .+++.||||+++..... +++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 457899999999999999999985 24668999998643211 3455667
Q ss_pred ceEEEEEeccCCChHHHhccCccc--------------------cccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 041438 547 QSFIVYEYLESGSLDKILNNDASA--------------------KELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDIS 606 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~--------------------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlK 606 (752)
..++||||+++|+|.+++...... ..+++..++.++.||+.||+|||+. ||+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 899999999999999999765321 2378999999999999999999999 99999999
Q ss_pred CCCEEeCCCCceEEeecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhh
Q 041438 607 SKNVLLDLGYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLF 683 (752)
Q Consensus 607 p~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~ 683 (752)
|+||+++.++.+||+|||++......... .....||+.|+|||++.+..+++++|||||||++|||+| |..||...
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~- 278 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI- 278 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC-
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC-
Confidence 99999999999999999999876543322 223467889999999999999999999999999999998 99998522
Q ss_pred ccccccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCC
Q 041438 684 EMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNP 747 (752)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 747 (752)
................+. ....++++.+++.+||+.||++|||++|++++|+.+....
T Consensus 279 ----~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 279 ----PVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp ----CCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred ----CcHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 111122222222222111 1234567899999999999999999999999999986554
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=330.51 Aligned_cols=234 Identities=24% Similarity=0.335 Sum_probs=174.3
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCC----c
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPR----Q 547 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~----~ 547 (752)
.++|++.+.||+|+||.||+|+. .+++.||||+++..... +++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 57899999999999999999994 68999999998754321 1111111 2
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
.|+||||+++++|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 499999999999999997543 488999999999999999999999 99999999999999999999999999998
Q ss_pred eccCCCC---CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCC
Q 041438 628 FLNLDSS---NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYP 704 (752)
Q Consensus 628 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (752)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ................+
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~-----~~~~~~~~~~~~~~~~~ 239 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-----SPVSVAYQHVREDPIPP 239 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHCCCCCH
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHhcCCCCCc
Confidence 7653322 122347899999999999999999999999999999999999998521 11222222333222222
Q ss_pred ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHH-HHHhhhh
Q 041438 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFE-VQSKQFH 744 (752)
Q Consensus 705 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl-~~L~~~~ 744 (752)
.......+.++.+++.+||+.||++||++.+++ ..+.+..
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 212234566799999999999999999666655 4555443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=344.39 Aligned_cols=224 Identities=23% Similarity=0.350 Sum_probs=185.7
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC---C------------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP---D------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~------------------------~~~~~~~~~~lV 551 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||++..... . +++......|+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 47899999999999999999995 4799999998753210 0 445667889999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+++|+|.+++...+ .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 95 ~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999997543 488999999999999999999999 999999999999999999999999999988653
Q ss_pred CCCCcccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
. ......+||+.|+|||++.+..+ ++++||||+||++|||++|+.||+. .........+.+.....+. .
T Consensus 169 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~-----~~~~~~~~~i~~~~~~~p~----~ 238 (476)
T 2y94_A 169 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-----DHVPTLFKKICDGIFYTPQ----Y 238 (476)
T ss_dssp T-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC-----SSSHHHHHHHHTTCCCCCT----T
T ss_pred c-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC-----CCHHHHHHHHhcCCcCCCc----c
Confidence 3 33345689999999999988775 7899999999999999999999862 2223334445554444442 2
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.++++.+++.+||+.||++|||++|+++|
T Consensus 239 ~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 239 LNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 44578899999999999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=331.47 Aligned_cols=236 Identities=24% Similarity=0.250 Sum_probs=186.0
Q ss_pred HHHhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC-----C------------------------CccccC
Q 041438 496 IIRATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP-----D------------------------NFCSHP 545 (752)
Q Consensus 496 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~------------------------~~~~~~ 545 (752)
+....++|++.+.||+|+||.||+|+. .+++.||+|++..... . +++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345678899999999999999999995 5788999998753210 0 455677
Q ss_pred CceEEEEEeccCCChHHHhccCc-------------------------------------cccccCHHHHHHHHHHHHHH
Q 041438 546 RQSFIVYEYLESGSLDKILNNDA-------------------------------------SAKELGWTQRLNVIKGVADA 588 (752)
Q Consensus 546 ~~~~lV~E~~~~g~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qi~~a 588 (752)
+..++||||+++|+|.+++.... ....+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 88999999999999999985211 01224677889999999999
Q ss_pred HHHHHhCCCCCeeecCCCCCCEEeCCCC--ceEEeecccceeccCCCC----CcccccCCCCccCcccccc--CCCCCcc
Q 041438 589 LFYLHNNCFPPIVHWDISSKNVLLDLGY--EAHVSDFRIAKFLNLDSS----NWSKLAGTHGNVAPELAYT--MKVTEKC 660 (752)
Q Consensus 589 L~~lH~~~~~~ivH~DlKp~NIll~~~~--~~kl~DfG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~ks 660 (752)
|+|||+. +|+||||||+||+++.++ .+||+|||+++....... ......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998766 899999999987643221 1234579999999999875 6789999
Q ss_pred chhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 661 DVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 661 DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
|||||||++|||++|+.||.. .........+.......+.......++++.+++.+||+.||++||++.|+++|
T Consensus 258 DiwslG~il~el~~g~~pf~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPG-----VNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHHHHHCCCCCCC-----CChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 999999999999999999852 12223344555555555444445567789999999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=333.74 Aligned_cols=232 Identities=22% Similarity=0.261 Sum_probs=175.1
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEe
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~ 554 (752)
..++|++.+.||+|+||.||+|+. .+++.||||++...... +++......++||||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 457899999999999999999995 47999999998654321 445567889999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCc--eEEeecccceeccCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE--AHVSDFRIAKFLNLD 632 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~--~kl~DfG~a~~~~~~ 632 (752)
+++|+|.+++...+ .+++..++.++.|++.||+|||++ ||+||||||+||+++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999999986543 488999999999999999999999 9999999999999987765 999999999854322
Q ss_pred CCCcccccCCCCccCccccccCCCCCc-cchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 633 SSNWSKLAGTHGNVAPELAYTMKVTEK-CDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
.......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||...... .........+.......+. ....
T Consensus 172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~--~~~~ 247 (361)
T 3uc3_A 172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-RDYRKTIQRILSVKYSIPD--DIRI 247 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C-CCHHHHHHHHHTTCCCCCT--TSCC
T ss_pred -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH-HHHHHHHHHHhcCCCCCCC--cCCC
Confidence 22334579999999999988877655 89999999999999999999632211 1111222333333333332 1234
Q ss_pred HHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 712 FMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
++++.++|.+||+.||++|||++|+++|-
T Consensus 248 s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 248 SPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 56788999999999999999999999873
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=348.00 Aligned_cols=233 Identities=21% Similarity=0.302 Sum_probs=188.2
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFI 550 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~l 550 (752)
..++|++.+.||+|+||.||+|+. .+|+.||||++.+.... .++......|+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 357899999999999999999996 57999999988532100 34456788999
Q ss_pred EEEeccCCChHHHhccCcc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 551 VYEYLESGSLDKILNNDAS-AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
||||+++|+|.+++..... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999999999876432 34589999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 630 NLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
..........+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..........+.......+ .
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~-~~~~~~~~~~i~~~~~~~p----~ 414 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE-KVENKELKQRVLEQAVTYP----D 414 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC-CCCHHHHHHHHHHCCCCCC----T
T ss_pred cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc-chhHHHHHHHHhhcccCCC----c
Confidence 6544444456899999999999999999999999999999999999999963211 0111223344445444444 2
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCH-----HHHHHH
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTM-----KRFEVQ 739 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~ 739 (752)
..+.++.++|.+||+.||++||++ +|+++|
T Consensus 415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 345678899999999999999975 566643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=328.67 Aligned_cols=228 Identities=14% Similarity=0.196 Sum_probs=171.4
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEEe
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E~ 554 (752)
++|++.+.||+|+||.||+|+. .+++.||||++...... +++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 5799999999999999999995 47899999988643211 345567788999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++ +|.+++.... ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LDK-DLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred ccc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 985 9999887654 3488899999999999999999999 999999999999999999999999999987654444
Q ss_pred CcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc---------------
Q 041438 635 NWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD--------------- 698 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~--------------- 698 (752)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... .+....+..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV-----EEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCChHhchhhhc
Confidence 4455688999999999876 5689999999999999999999999853211 000000000
Q ss_pred ------cCCC---CC--ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 699 ------SRLP---YP--SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 699 ------~~~~---~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...+ .. .......++++.+++.+||+.||++|||++|+++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 00 00112234678899999999999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=327.30 Aligned_cols=238 Identities=18% Similarity=0.297 Sum_probs=172.0
Q ss_pred HhhcccccceeeccCCceEEEEEEeCC-Cc---EEEEEccCCCCCC--------------------------CccccCCc
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARVPS-GE---IFAVKKFHSPLPD--------------------------NFCSHPRQ 547 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~---~vavK~~~~~~~~--------------------------~~~~~~~~ 547 (752)
...++|++.+.||+|+||.||+|+... ++ .||||+++..... +++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 356789999999999999999998543 32 7999998654211 22222222
Q ss_pred ------eEEEEEeccCCChHHHhccCcc---ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCce
Q 041438 548 ------SFIVYEYLESGSLDKILNNDAS---AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEA 618 (752)
Q Consensus 548 ------~~lV~E~~~~g~L~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~ 618 (752)
.++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 3899999999999999865321 12588999999999999999999999 99999999999999999999
Q ss_pred EEeecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHh
Q 041438 619 HVSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIE 695 (752)
Q Consensus 619 kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~ 695 (752)
||+|||+++........ .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||... ........
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-----~~~~~~~~ 251 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI-----ENAEIYNY 251 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CGGGHHHH
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc-----ChHHHHHH
Confidence 99999999876433221 123356788999999999999999999999999999999 99998521 12222222
Q ss_pred hhccC-CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCC
Q 041438 696 ILDSR-LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNP 747 (752)
Q Consensus 696 ~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 747 (752)
+.... ...+ ...++++.+++.+||+.||++|||+.|+++.|+++...|
T Consensus 252 ~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 252 LIGGNRLKQP----PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HHTTCCCCCC----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HhcCCCCCCC----CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 33222 2222 334567899999999999999999999999999986554
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=319.19 Aligned_cols=230 Identities=25% Similarity=0.348 Sum_probs=179.2
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------------CccccCC
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------------NFCSHPR 546 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------------~~~~~~~ 546 (752)
..++|++.+.||+|+||.||+|+. .+++.||||++...... +++ ..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~ 94 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM--HN 94 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE--TT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee--cC
Confidence 357899999999999999999995 57999999988543221 111 23
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCEEeCCCCc-----eE
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP--IVHWDISSKNVLLDLGYE-----AH 619 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~--ivH~DlKp~NIll~~~~~-----~k 619 (752)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. + |+||||||+||+++.++. +|
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 95 PPRMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp TTEEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred CCeEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 3479999999999998886543 3588999999999999999999999 8 999999999999987776 99
Q ss_pred EeecccceeccCCCCCcccccCCCCccCccccc--cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhh
Q 041438 620 VSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAY--TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEIL 697 (752)
Q Consensus 620 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 697 (752)
|+|||+++.... ......||+.|+|||++. ...+++++||||+||++|||++|+.||.... .........+.
T Consensus 170 l~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~ 243 (287)
T 4f0f_A 170 VADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS---YGKIKFINMIR 243 (287)
T ss_dssp ECCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC---CCHHHHHHHHH
T ss_pred eCCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc---ccHHHHHHHHh
Confidence 999999985432 234468999999999984 4557899999999999999999999985211 11111112222
Q ss_pred ccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 698 DSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 698 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
....... .....++++.+++.+||+.||++|||++|+++.|+++
T Consensus 244 ~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EEGLRPT--IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HSCCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccCCCCC--CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 2222111 1134566789999999999999999999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=337.80 Aligned_cols=228 Identities=21% Similarity=0.305 Sum_probs=166.4
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------Cccc--cCCce
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCS--HPRQS 548 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~--~~~~~ 548 (752)
..++|++.+.||+|+||.||+|+. .+|+.||||++...... +++. .....
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 467899999999999999999984 67999999988543221 2222 23468
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
|+|||||++ +|.+++... .+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+|+.
T Consensus 87 ~lv~e~~~~-~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYMET-DLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCSE-EHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccCc-CHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 999999985 999998753 388899999999999999999999 999999999999999999999999999987
Q ss_pred ccCC---------------------CCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccc
Q 041438 629 LNLD---------------------SSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS 686 (752)
Q Consensus 629 ~~~~---------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~ 686 (752)
.... .......+||+.|+|||++.+ ..++.++||||+||++|||++|++||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~- 237 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM- 237 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 5321 111234589999999999886 56899999999999999999999999532110
Q ss_pred cccccchHhhhcc-------------------------------CCCCCC--hh----------hHHHHHHHHHHHHhcc
Q 041438 687 SSSSNMNIEILDS-------------------------------RLPYPS--LD----------VQNKFMSIMQVAFSCL 723 (752)
Q Consensus 687 ~~~~~~~~~~~~~-------------------------------~~~~~~--~~----------~~~~~~~l~~li~~cl 723 (752)
.....+... ...... .. ....++++.+++.+||
T Consensus 238 ----~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 238 ----NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp ----HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred ----HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 000011000 000000 00 0023457899999999
Q ss_pred CcCCCCCCCHHHHHHH
Q 041438 724 DQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 724 ~~dP~~Rps~~evl~~ 739 (752)
+.||++|||++|+++|
T Consensus 314 ~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 314 QFNPNKRISANDALKH 329 (388)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred ccCcccCCCHHHHhCC
Confidence 9999999999999988
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=342.26 Aligned_cols=237 Identities=17% Similarity=0.243 Sum_probs=186.4
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEec
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~ 555 (752)
.++|++.++||+|+||.||+|+. .+++.||||++...... .++...+..++||||+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 57899999999999999999994 67999999986543221 2344567789999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe---CCCCceEEeecccceeccCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL---DLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll---~~~~~~kl~DfG~a~~~~~~ 632 (752)
+++|.+++.... ..+++.+++.|+.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 86 -g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 86 -GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp -CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred -CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 889999997533 3489999999999999999999999 99999999999999 58889999999999987644
Q ss_pred CCC-------cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCC
Q 041438 633 SSN-------WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPS 705 (752)
Q Consensus 633 ~~~-------~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (752)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .........+.........
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA--GTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC--SSHHHHHHHHHHHHHHSCH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc--hhHHHHHHHHhhccccccH
Confidence 322 1245799999999999999999999999999999999999999963211 0111111122111111110
Q ss_pred -hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 706 -LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 706 -~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
.....++.++.+++.+||+.||++||+++++++.|+++.
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 011234567899999999999999999999999998874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=328.42 Aligned_cols=242 Identities=23% Similarity=0.296 Sum_probs=186.7
Q ss_pred hhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCC----ceEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPR----QSFIV 551 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~----~~~lV 551 (752)
..++|++.+.||+|+||.||+|+. +++.||||++...... +++.... ..++|
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv 118 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 118 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEE
T ss_pred ccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEE
Confidence 457899999999999999999987 5899999987543211 2222333 78999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeecCCCCCCEEeCCCCceEEeec
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLH--------NNCFPPIVHWDISSKNVLLDLGYEAHVSDF 623 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH--------~~~~~~ivH~DlKp~NIll~~~~~~kl~Df 623 (752)
|||+++|+|.+++... .+++.+++.++.|++.||+||| +. +|+||||||+||+++.++.+||+||
T Consensus 119 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp ECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCC
T ss_pred EeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEEC
Confidence 9999999999999754 3889999999999999999999 77 9999999999999999999999999
Q ss_pred ccceeccCCCCC----cccccCCCCccCccccccCC------CCCccchhhHHHHHHHHHhC----------CCCcchhh
Q 041438 624 RIAKFLNLDSSN----WSKLAGTHGNVAPELAYTMK------VTEKCDVYSFGVLALEVIKG----------KHPRDFLF 683 (752)
Q Consensus 624 G~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~------~~~ksDIwSlGvil~elltg----------~~pf~~~~ 683 (752)
|++......... .....||+.|+|||++.+.. ++.++|||||||++|||+|| +.||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 999877544321 23457999999999987652 34689999999999999999 67775322
Q ss_pred ccccccccchHhhhccCCC--CCCh-hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCCC
Q 041438 684 EMSSSSSNMNIEILDSRLP--YPSL-DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPD 748 (752)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 748 (752)
............+...... .+.. ........+.+++.+||+.||++|||++|++++|+++....+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 1111111222222222221 1211 123567789999999999999999999999999999876554
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.20 Aligned_cols=236 Identities=19% Similarity=0.187 Sum_probs=176.9
Q ss_pred hcccccceeeccCCceEEEEEEeC----CCcEEEEEccCCCCCC-----------------------------------C
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP----SGEIFAVKKFHSPLPD-----------------------------------N 540 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------------------------------~ 540 (752)
.++|++.+.||+|+||.||+|+.. +++.||||++...... +
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999964 6789999987653210 1
Q ss_pred cccc----CCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC
Q 041438 541 FCSH----PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY 616 (752)
Q Consensus 541 ~~~~----~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~ 616 (752)
++.. ....|+||||+ +++|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 2222 56789999999 889999997654 589999999999999999999999 999999999999998877
Q ss_pred --ceEEeecccceeccCCCC-------CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccc
Q 041438 617 --EAHVSDFRIAKFLNLDSS-------NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS 687 (752)
Q Consensus 617 --~~kl~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~ 687 (752)
.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 999999999987643221 11345799999999999999999999999999999999999999952111000
Q ss_pred ccccchHhhhccCCCCCChhh-----HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 688 SSSNMNIEILDSRLPYPSLDV-----QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
.. .......... .+.... ...+.++.+++.+||+.||++||+++++++.|+++..
T Consensus 269 ~~-~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 AV-QTAKTNLLDE--LPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HH-HHHHHHHHHT--TTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HH-HHHHHhhccc--ccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 00 0001111111 111000 1345579999999999999999999999999998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=318.38 Aligned_cols=233 Identities=23% Similarity=0.328 Sum_probs=187.7
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEecc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~~ 556 (752)
.++|++.+.||+|+||.||+|+..+++.||+|+++..... +++.+.+..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 4689999999999999999999888899999998765322 34556678999999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC-CC
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS-SN 635 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 635 (752)
+++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+....... ..
T Consensus 87 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 87 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp TCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 999999997643 3478899999999999999999999 99999999999999999999999999998654221 11
Q ss_pred cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHH
Q 041438 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (752)
.....++..|+|||++.+..++.++||||+|+++|||++ |+.||... ........+......... ...+..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~~~~~~i~~~~~~~~~---~~~~~~ 233 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSEVVEDISTGFRLYKP---RLASTH 233 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHTTCCCCCC---TTSCHH
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC-----CHHHHHHHHhcCCcCCCC---ccCcHH
Confidence 123467788999999998889999999999999999999 89998521 111222222222111111 234567
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
+.+++.+||+.||++|||++|++++|+++..
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 234 VYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999999998854
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=321.59 Aligned_cols=225 Identities=25% Similarity=0.392 Sum_probs=180.6
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC---------------------------CCccccCCceEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP---------------------------DNFCSHPRQSFI 550 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------------------------~~~~~~~~~~~l 550 (752)
+.++|++.+.||+|+||.||+|+. .+++.||||++..... .+++......++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 467899999999999999999984 5678999998743210 045566788999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999987543 488899999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
.. ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.. .........+.......+. .
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-----~~~~~~~~~~~~~~~~~~~----~ 229 (279)
T 3fdn_A 161 SS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-----NTYQETYKRISRVEFTFPD----F 229 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-----SSHHHHHHHHHHTCCCCCT----T
T ss_pred cc--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC-----CcHHHHHHHHHhCCCCCCC----c
Confidence 22 23345799999999999999999999999999999999999999852 1122223333333333332 2
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
.+..+.+++.+||+.||++|||++|+++|-
T Consensus 230 ~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 230 VTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred CCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 445688999999999999999999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=322.66 Aligned_cols=235 Identities=22% Similarity=0.340 Sum_probs=176.8
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC--------------------CccccCCceEEEEEeccCCC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD--------------------NFCSHPRQSFIVYEYLESGS 559 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------~~~~~~~~~~lV~E~~~~g~ 559 (752)
.++|++.+.||+|+||.||+|+. .++.||||++...... -+....+..++||||+++|+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~ 85 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGS 85 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTCB
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCCC
Confidence 46899999999999999999987 4789999998654211 01111245799999999999
Q ss_pred hHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCc-eEEeecccceeccCCCCCccc
Q 041438 560 LDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE-AHVSDFRIAKFLNLDSSNWSK 638 (752)
Q Consensus 560 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~-~kl~DfG~a~~~~~~~~~~~~ 638 (752)
|.+++........+++..+..++.|+++||+|||+....+|+||||||+||+++.++. +||+|||.+...... ...
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---~~~ 162 (307)
T 2eva_A 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTN 162 (307)
T ss_dssp HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---ccc
Confidence 9999987655455788999999999999999999921119999999999999988876 799999999865422 233
Q ss_pred ccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHH
Q 041438 639 LAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQV 718 (752)
Q Consensus 639 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 718 (752)
..||+.|+|||++.+..++.++|||||||++|||++|+.||+... ...............+.. ....+..+.++
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l 236 (307)
T 2eva_A 163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG---GPAFRIMWAVHNGTRPPL---IKNLPKPIESL 236 (307)
T ss_dssp --CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC---SSHHHHHHHHHTTCCCCC---BTTCCHHHHHH
T ss_pred CCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC---ccHHHHHHHHhcCCCCCc---ccccCHHHHHH
Confidence 479999999999999999999999999999999999999985211 111111111111111111 13345678899
Q ss_pred HHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 719 AFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 719 i~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
+.+||+.||++|||++|++++|+++.
T Consensus 237 i~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 237 MTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred HHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=324.69 Aligned_cols=239 Identities=23% Similarity=0.342 Sum_probs=181.3
Q ss_pred hcccccceeeccCCceEEEEEEe-----CCCcEEEEEccCCCCCC------------------------Ccc--ccCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-----PSGEIFAVKKFHSPLPD------------------------NFC--SHPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~------------------------~~~--~~~~~~ 548 (752)
.++|++.+.||+|+||.||+|+. .+++.||||+++..... +++ ......
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 47899999999999999999983 36899999998654211 122 123457
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 99999999999999997654 3488999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCC---cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcc-----ccccc-c----chHh
Q 041438 629 LNLDSSN---WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM-----SSSSS-N----MNIE 695 (752)
Q Consensus 629 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~-----~~~~~-~----~~~~ 695 (752)
....... .....++..|+|||++.+..+++++|||||||++|||+||..||...... ..... . ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6543221 12235777899999999999999999999999999999999997532210 00000 0 1111
Q ss_pred hhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 696 ILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
........+. ...+++++.+++.+||+.||++|||++|+++.|+++..
T Consensus 244 ~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 244 LLKNNGRLPR--PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHTTCCCCC--CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhccCcCCC--CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 1111111111 13456679999999999999999999999999998854
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=324.98 Aligned_cols=239 Identities=21% Similarity=0.316 Sum_probs=189.0
Q ss_pred hhcccccceeeccCCceEEEEEEe------CCCcEEEEEccCCCCCC--------------------------CccccCC
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV------PSGEIFAVKKFHSPLPD--------------------------NFCSHPR 546 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--------------------------~~~~~~~ 546 (752)
..++|++.+.||+|+||.||+|+. .+++.||||+++..... +++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 356899999999999999999984 35789999998754321 3455667
Q ss_pred ceEEEEEeccCCChHHHhccCcc---------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEE
Q 041438 547 QSFIVYEYLESGSLDKILNNDAS---------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVL 611 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIl 611 (752)
..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence 88999999999999999976532 12488999999999999999999999 9999999999999
Q ss_pred eCCCCceEEeecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccc
Q 041438 612 LDLGYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSS 688 (752)
Q Consensus 612 l~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~ 688 (752)
++.++.+||+|||.++........ .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||... .
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-----~ 252 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-----P 252 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-----C
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc-----c
Confidence 999999999999999876544322 123457789999999999999999999999999999999 99998521 1
Q ss_pred cccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCC
Q 041438 689 SSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNP 747 (752)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 747 (752)
................. ....+..+.+++.+||+.||++|||++|++++|+++..+.
T Consensus 253 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 253 VDSKFYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp SSHHHHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred chhHHHHHhccCCCCCC--cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 11112222222222111 1234567899999999999999999999999999876443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=319.45 Aligned_cols=231 Identities=23% Similarity=0.320 Sum_probs=174.2
Q ss_pred hhcccccceeeccCCceEEEEEEeC----CCcEEEEEccCCCCCC-------------------------CccccCCceE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP----SGEIFAVKKFHSPLPD-------------------------NFCSHPRQSF 549 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~ 549 (752)
..++|++.+.||+|+||.||+|+.. .+..||+|+++..... +++ ..+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence 4578999999999999999999853 3557999987653211 222 346789
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence 9999999999999997543 3488999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCC-cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccC-CCCCCh
Q 041438 630 NLDSSN-WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSR-LPYPSL 706 (752)
Q Consensus 630 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 706 (752)
...... .....+++.|+|||++.+..++.++|||||||++|||++ |..||... ........+.... .+.+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~-----~~~~~~~~i~~~~~~~~~-- 239 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-----KNNDVIGRIENGERLPMP-- 239 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC-----CGGGHHHHHHTTCCCCCC--
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC-----CHHHHHHHHHcCCCCCCC--
Confidence 533221 223356789999999998899999999999999999997 99998522 1122222232222 2222
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
...++.+.+++.+||+.||++|||++|++++|+++.
T Consensus 240 --~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 240 --PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 345567889999999999999999999999999875
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=345.76 Aligned_cols=306 Identities=22% Similarity=0.178 Sum_probs=272.0
Q ss_pred EEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcc
Q 041438 89 INLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQ 168 (752)
Q Consensus 89 l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 168 (752)
+++.++.+ +.+++..|..+++|++|+|++|.|+++.|..|+++++|++|+|++|.|++..|..|+++++|++|+|++|.
T Consensus 56 l~l~~~~l-~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 134 (597)
T 3oja_B 56 VTFKNSTM-RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 134 (597)
T ss_dssp EEESSCEE-SEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEeeCCCC-CCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCC
Confidence 44444443 34556668899999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCC
Q 041438 169 LNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLS 248 (752)
Q Consensus 169 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~ 248 (752)
|++..+..|+++++|++|+|++|.+++..|..|.++++|++|+|++|.+++.. ++.+++|+.|++++|.+++.
T Consensus 135 l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l---- 207 (597)
T 3oja_B 135 LSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTL---- 207 (597)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEE----
T ss_pred CCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccc----
Confidence 99877777899999999999999999999999999999999999999999763 56678899999999999863
Q ss_pred CCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcc
Q 041438 249 IDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLIN 328 (752)
Q Consensus 249 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 328 (752)
...++|+.|++++|.++...+.. .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++.+|..|+.+++
T Consensus 208 ---~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 279 (597)
T 3oja_B 208 ---AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQR 279 (597)
T ss_dssp ---ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSS
T ss_pred ---cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccC
Confidence 23468999999999998654432 3689999999999987 477999999999999999999999999999999
Q ss_pred cceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccC
Q 041438 329 LEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSY 408 (752)
Q Consensus 329 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 408 (752)
|++|+|++|.++++ |..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|.+++.. +..+++|+.|+|++
T Consensus 280 L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~ 354 (597)
T 3oja_B 280 LERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSH 354 (597)
T ss_dssp CCEEECTTSCCCEE-ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCS
T ss_pred CCEEECCCCCCCCC-CcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeC
Confidence 99999999999995 556688999999999999998 57788899999999999999998764 66788999999999
Q ss_pred CcCCcCC
Q 041438 409 NNLSGLI 415 (752)
Q Consensus 409 N~l~~~~ 415 (752)
|++++..
T Consensus 355 N~~~~~~ 361 (597)
T 3oja_B 355 NDWDCNS 361 (597)
T ss_dssp SCEEHHH
T ss_pred CCCCChh
Confidence 9998754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=336.33 Aligned_cols=240 Identities=20% Similarity=0.284 Sum_probs=187.0
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------Ccccc--CCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSH--PRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~--~~~~~lV 551 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||+++..... +++.. ....++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 46799999999999999999995 46999999998643211 22222 3367999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe----CCCCceEEeecccce
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL----DLGYEAHVSDFRIAK 627 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll----~~~~~~kl~DfG~a~ 627 (752)
|||+++|+|.+++........+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999998765444589999999999999999999999 99999999999999 777889999999998
Q ss_pred eccCCCCCcccccCCCCccCcccccc--------CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhcc
Q 041438 628 FLNLDSSNWSKLAGTHGNVAPELAYT--------MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS 699 (752)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 699 (752)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ....+....+...
T Consensus 165 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~-~~~~~~~~~~~~~ 242 (396)
T 4eut_A 165 ELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP-RRNKEVMYKIITG 242 (396)
T ss_dssp ECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT-TTCHHHHHHHHHS
T ss_pred EccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc-cchHHHHHHHhcC
Confidence 765332 2334579999999998765 45788999999999999999999999632111 1111122222221
Q ss_pred C---------------------CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 700 R---------------------LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 700 ~---------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
. .+............+.+++.+||+.||++||+++|++++++++.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 1 11111122567778999999999999999999999999998764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=338.13 Aligned_cols=230 Identities=19% Similarity=0.220 Sum_probs=171.1
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Ccc------ccCC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFC------SHPR 546 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~------~~~~ 546 (752)
.++|++.+.||+|+||.||+|+. .+++.||||++...... +++ ....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 57899999999999999999984 57899999998654221 122 2224
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
..|+||||+++ ++.+.+.. .+++..++.+++||+.||+|||+. ||+||||||+|||++.++.+||+|||+|
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 67999999987 57666642 278899999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccc-----------------cc
Q 041438 627 KFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS-----------------SS 689 (752)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~-----------------~~ 689 (752)
+..... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||........ ..
T Consensus 212 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 212 RTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp -----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred eecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 876532 234456899999999999999999999999999999999999999963211000 00
Q ss_pred ccchHhhhccCCCC----------------CChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 690 SNMNIEILDSRLPY----------------PSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 690 ~~~~~~~~~~~~~~----------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.............. .........+++.+++.+||+.||++|||++|+++|
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00011111111111 111112236679999999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=328.01 Aligned_cols=233 Identities=21% Similarity=0.366 Sum_probs=177.9
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcE----EEEEccCCCCCC-------------------------CccccCCceE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEI----FAVKKFHSPLPD-------------------------NFCSHPRQSF 549 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~~~-------------------------~~~~~~~~~~ 549 (752)
.++|++.+.||+|+||.||+|+. .+++. ||+|.++..... +++.. ...+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-SSEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeE
Confidence 56899999999999999999984 34443 688887543221 22333 4578
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 93 ~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 9999999999999997644 3488999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCc--ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCCh
Q 041438 630 NLDSSNW--SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706 (752)
Q Consensus 630 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (752)
....... ....+|+.|+|||++.+..++.++|||||||++|||+| |+.||+.. ...............+.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~------~~~~~~~~~~~~~~~~~- 240 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI------PASEISSILEKGERLPQ- 240 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CGGGHHHHHHTTCCCCC-
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC------CHHHHHHHHHcCCCCCC-
Confidence 5433222 23356889999999999999999999999999999999 99998521 11122222222221111
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
....+.++.+++.+||+.||++||+++|++++|+++...
T Consensus 241 -~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 241 -PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 123456788999999999999999999999999887543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=331.84 Aligned_cols=230 Identities=14% Similarity=0.109 Sum_probs=180.8
Q ss_pred hhcccccceeeccCCceEEEEEE------eCCCcEEEEEccCCCCCC------------------------CccccCCce
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR------VPSGEIFAVKKFHSPLPD------------------------NFCSHPRQS 548 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~------------------------~~~~~~~~~ 548 (752)
..++|++.+.||+|+||.||+|+ ..+++.||||+++..... +++...+..
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 46789999999999999999993 557899999998654321 334567788
Q ss_pred EEEEEeccCCChHHHhccCc--cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC-----------C
Q 041438 549 FIVYEYLESGSLDKILNNDA--SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL-----------G 615 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~-----------~ 615 (752)
|+||||+++|+|.+++.... ....+++..++.|+.||++||+|||+. +|+||||||+|||++. +
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------C
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccccc
Confidence 99999999999999997532 234589999999999999999999999 9999999999999998 8
Q ss_pred CceEEeecccceeccCC--CCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccch
Q 041438 616 YEAHVSDFRIAKFLNLD--SSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMN 693 (752)
Q Consensus 616 ~~~kl~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~ 693 (752)
+.+||+|||+|+..... .......+||+.|+|||++.+..++.++|||||||++|||+||+.||..... ....
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~ 294 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG-----GECK 294 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET-----TEEE
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC-----Ccee
Confidence 99999999999865422 2223445899999999999999999999999999999999999999852111 0000
Q ss_pred HhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCC-CCHHHHHHHHhhhh
Q 041438 694 IEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSR-PTMKRFEVQSKQFH 744 (752)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-ps~~evl~~L~~~~ 744 (752)
........ ...+.+.+++.+|++.+|.+| |+++++.+.|+++.
T Consensus 295 ---~~~~~~~~-----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 295 ---PEGLFRRL-----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp ---ECSCCTTC-----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred ---echhcccc-----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 11111111 113356678889999999999 68888888887764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=324.81 Aligned_cols=234 Identities=19% Similarity=0.314 Sum_probs=179.9
Q ss_pred hcccccc-eeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC-------------------------CccccCCceEEEE
Q 041438 500 TNDFDAK-HCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 500 ~~~y~~~-~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~ 552 (752)
.+.|++. +.||+|+||.||+|+ ..+++.||||+++..... +++.+.+..|+||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678885 789999999999999 457999999998654221 3445667899999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCc---eEEeecccceec
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE---AHVSDFRIAKFL 629 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~---~kl~DfG~a~~~ 629 (752)
||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++. +||+|||++...
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999997643 488899999999999999999999 9999999999999988766 999999999865
Q ss_pred cCCCC-------CcccccCCCCccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCcchhhccccc---------
Q 041438 630 NLDSS-------NWSKLAGTHGNVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS--------- 688 (752)
Q Consensus 630 ~~~~~-------~~~~~~gt~~y~aPE~~~~-----~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~--------- 688 (752)
..... .....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 1123469999999999875 45789999999999999999999998632211000
Q ss_pred -cccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 689 -SSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 689 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.......+.......+.......+.++.+++.+||+.||++|||++|+++|
T Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011233444455555543334556789999999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=323.48 Aligned_cols=239 Identities=20% Similarity=0.231 Sum_probs=176.8
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFI 550 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~l 550 (752)
..++|++.+.||+|+||.||+|+. .+|+.||||+++..... +++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 346899999999999999999994 67999999988653211 34456678899
Q ss_pred EEEeccCCChHHHhccCc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 551 VYEYLESGSLDKILNNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999987532 134588999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 630 NLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
...........|++.|+|||++.+..++.++|||||||++|||++|+.||.... .........+.....+.. ...
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~--~~~ 261 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIEQCDYPPL--PSD 261 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC------CCHHHHHHHHHTTCSCCC--CTT
T ss_pred cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc---hhHHHHHHHhhcccCCCC--ccc
Confidence 544433444578999999999999999999999999999999999999985211 011111222222222211 113
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
..+.++.+++.+||+.||++|||++|++++|++++.
T Consensus 262 ~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 262 HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 455678999999999999999999999999999873
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.68 Aligned_cols=233 Identities=21% Similarity=0.343 Sum_probs=184.8
Q ss_pred hcccccceeeccCCceEEEEEEe--------CCCcEEEEEccCCCCCC--------------------------CccccC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV--------PSGEIFAVKKFHSPLPD--------------------------NFCSHP 545 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~--------------------------~~~~~~ 545 (752)
.++|++.+.||+|+||.||+|+. .+++.||||+++..... +++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 57899999999999999999985 35778999998754321 345567
Q ss_pred CceEEEEEeccCCChHHHhccCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe
Q 041438 546 RQSFIVYEYLESGSLDKILNNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL 612 (752)
Q Consensus 546 ~~~~lV~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll 612 (752)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 788999999999999999986532 12488999999999999999999999 99999999999999
Q ss_pred CCCCceEEeecccceeccCCCC--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhcccccc
Q 041438 613 DLGYEAHVSDFRIAKFLNLDSS--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSS 689 (752)
Q Consensus 613 ~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~ 689 (752)
+.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||... ..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-----~~ 265 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-----PV 265 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-----CH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC-----CH
Confidence 9999999999999987654321 1223357788999999988889999999999999999999 99998521 11
Q ss_pred ccchHhhhccC-CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 690 SNMNIEILDSR-LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 690 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
.+....+.... ...+ ...+.++.+++.+||+.||++|||++|++++|+++.
T Consensus 266 ~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 266 EELFKLLKEGHRMDKP----ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HHHHHHHHHTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11222222221 1222 234567889999999999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=317.46 Aligned_cols=228 Identities=19% Similarity=0.280 Sum_probs=181.9
Q ss_pred hcccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC------------------------------CccccCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD------------------------------NFCSHPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------------------------~~~~~~~~~ 548 (752)
.++|++.+.||+|+||.||+|+.. +++.||+|.++..... +++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 367999999999999999999964 7999999987643211 345566788
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC----ceEEeecc
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY----EAHVSDFR 624 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~----~~kl~DfG 624 (752)
++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999999753 3488999999999999999999999 999999999999998877 79999999
Q ss_pred cceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCC
Q 041438 625 IAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYP 704 (752)
Q Consensus 625 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (752)
.+....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||... ........+.......+
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~ 231 (283)
T 3bhy_A 158 IAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE-----TKQETLTNISAVNYDFD 231 (283)
T ss_dssp TCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHTTCCCCC
T ss_pred cceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc-----chHHHHHHhHhcccCCc
Confidence 998765332 233457999999999999889999999999999999999999998521 12222233333333333
Q ss_pred ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 705 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.......+..+.+++.+||+.||++|||++|+++|
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 232 EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 32233456678999999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.72 Aligned_cols=219 Identities=19% Similarity=0.259 Sum_probs=181.0
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------------CccccC
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------------NFCSHP 545 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------------~~~~~~ 545 (752)
..++|++.+.||+|+||.||+|+ ..+++.||||+++..... +++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 46789999999999999999998 467899999988654210 345567
Q ss_pred CceEEEEEeccCC-ChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecc
Q 041438 546 RQSFIVYEYLESG-SLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFR 624 (752)
Q Consensus 546 ~~~~lV~E~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG 624 (752)
+..++||||+.+| +|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 8889999999777 9999997653 488999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCCCcccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCC
Q 041438 625 IAKFLNLDSSNWSKLAGTHGNVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPY 703 (752)
Q Consensus 625 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 703 (752)
+++...... ......||+.|+|||++.+..+ ++++|||||||++|||++|+.||..... ........
T Consensus 176 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------~~~~~~~~ 243 (335)
T 3dls_A 176 SAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----------TVEAAIHP 243 (335)
T ss_dssp TCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------GTTTCCCC
T ss_pred cceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------HHhhccCC
Confidence 998875433 3344679999999999988876 8899999999999999999999853211 11111122
Q ss_pred CChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 704 PSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 704 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+ ...++++.+++.+||++||++|||++|++++
T Consensus 244 ~----~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 244 P----YLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp S----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred C----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2 1234568899999999999999999999987
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=323.61 Aligned_cols=232 Identities=20% Similarity=0.304 Sum_probs=173.6
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~ 552 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||++...... +++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 36899999999999999999995 46999999987554322 3455677889999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++++|.+++.... .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||.+......
T Consensus 82 e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999998886543 388899999999999999999999 9999999999999999999999999999887654
Q ss_pred CCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhh---------------
Q 041438 633 SSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEI--------------- 696 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~--------------- 696 (752)
........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......... ......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL--YLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCSCCHHHHHHHHTC
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhcccccccccccccc
Confidence 444455689999999999876 56899999999999999999999998532110000 000000
Q ss_pred ---hccCCCCCC------hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 697 ---LDSRLPYPS------LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 697 ---~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.....+.+. ......+.++.+++.+||+.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000111110 0112345578899999999999999999999976
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=349.73 Aligned_cols=231 Identities=20% Similarity=0.262 Sum_probs=186.1
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC----C-----------------------CccccCCceEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP----D-----------------------NFCSHPRQSFI 550 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~-----------------------~~~~~~~~~~l 550 (752)
..++|++.+.||+|+||.||+|+. .+|+.||||++.+... . +++.+.+..|+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 467899999999999999999995 5799999998753210 0 34556788999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 262 VmEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 9999999999999976542 3489999999999999999999999 99999999999999999999999999998875
Q ss_pred CCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...... .........+......++ ..
T Consensus 338 ~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~-~~~~~i~~~i~~~~~~~p----~~ 411 (576)
T 2acx_A 338 EGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK-IKREEVERLVKEVPEEYS----ER 411 (576)
T ss_dssp TTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC-CCHHHHHHHHHHCCCCCC----TT
T ss_pred cCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc-hhHHHHHHHhhcccccCC----cc
Confidence 332 334458999999999999989999999999999999999999999632110 011122223333333333 33
Q ss_pred HHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 739 (752)
.++++.++|.+||+.||++|| +++|+++|
T Consensus 412 ~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 412 FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 556789999999999999999 78888865
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.50 Aligned_cols=272 Identities=31% Similarity=0.414 Sum_probs=215.6
Q ss_pred Cccc-ceeeCC--CCCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccc--cCCccCcCCCCCCeeecCC-Cccc
Q 041438 73 CTWS-GIHCNH--AGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFD--IIPPQISNLSKLEYLDFLT-NKLS 146 (752)
Q Consensus 73 c~w~-gv~C~~--~~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~L~~-N~l~ 146 (752)
-.|. +..|+. +..|++-.-+ ...+++.|+|++|++++ .+|..|+++++|++|+|++ |++.
T Consensus 25 ~~W~~~~~~C~~~w~gv~C~~~~--------------~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~ 90 (313)
T 1ogq_A 25 SSWLPTTDCCNRTWLGVLCDTDT--------------QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90 (313)
T ss_dssp TTCCTTSCTTTTCSTTEEECCSS--------------SCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEE
T ss_pred cCCCCCCCCCcCCCcceEeCCCC--------------CCceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCccc
Confidence 4685 445655 6667762110 12478899999999998 8899999999999999995 9999
Q ss_pred ccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeecccccccccccccc
Q 041438 147 GHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIG 226 (752)
Q Consensus 147 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 226 (752)
+.+|..|+++++|++|+|++|+|++.+|..|.++++|++|+|++|++++.+|..|.++++|++|+|++|++++.+|..++
T Consensus 91 ~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~ 170 (313)
T 1ogq_A 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170 (313)
T ss_dssp SCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGG
T ss_pred ccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHh
Confidence 89999999999999999999999988899999999999999999999988888899999999999999998888877765
Q ss_pred CccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccC
Q 041438 227 NLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLN 306 (752)
Q Consensus 227 ~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 306 (752)
+++ ++|+.|++++|++++.+|..+..++ |++|+|++|.+++..|..|..+++|+
T Consensus 171 ~l~-------------------------~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~ 224 (313)
T 1ogq_A 171 SFS-------------------------KLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQ 224 (313)
T ss_dssp CCC-------------------------TTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCS
T ss_pred hhh-------------------------hcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCC
Confidence 443 1566777777888777787777776 88888888888888888888888888
Q ss_pred EEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCcc
Q 041438 307 RISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNF 386 (752)
Q Consensus 307 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 386 (752)
.|+|++|++++.+|. +..+++|++|+|++|++++..|..|..+++|++|+|++|++++.+|.. ..+++|+.|++++|+
T Consensus 225 ~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 225 KIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp EEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred EEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 888888888766555 667777777777777777777777777777777777777777776665 667777777777776
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=320.23 Aligned_cols=227 Identities=22% Similarity=0.320 Sum_probs=186.4
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFI 550 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~l 550 (752)
..++|++.+.||+|+||.||+|+. .+++.||+|++...... +++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 356899999999999999999995 46889999987543211 44566788999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+++++|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 93 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999999886543 488999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
..........||+.|+|||++.+..++.++||||+|+++|+|++|+.||... ...+....+.......+. .
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~----~ 237 (294)
T 2rku_A 167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-----CLKETYLRIKKNEYSIPK----H 237 (294)
T ss_dssp STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHTTCCCCCT----T
T ss_pred cCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhhccCCCcc----c
Confidence 4444445568999999999999888999999999999999999999998521 112222333333333332 3
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
.+..+.+++.+||+.||++|||++|++++-
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 238 INPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred cCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 445788999999999999999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=334.58 Aligned_cols=229 Identities=21% Similarity=0.262 Sum_probs=176.2
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------------CccccC
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------------NFCSHP 545 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------------~~~~~~ 545 (752)
..++|++.+.||+|+||.||+|+. .+++.||||++...... +++ ..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DA 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE-ES
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE-ec
Confidence 467899999999999999999984 57899999987643110 222 34
Q ss_pred CceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC---CceEEee
Q 041438 546 RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG---YEAHVSD 622 (752)
Q Consensus 546 ~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~---~~~kl~D 622 (752)
+..|+||||+++|+|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.+ +.+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 56799999999999999887543 488999999999999999999999 99999999999999754 4599999
Q ss_pred cccceeccCCCCCcccccCCCCccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhcc
Q 041438 623 FRIAKFLNLDSSNWSKLAGTHGNVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS 699 (752)
Q Consensus 623 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 699 (752)
||+|+..... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||... .........+...
T Consensus 286 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~----~~~~~~~~~i~~~ 360 (419)
T 3i6u_A 286 FGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH----RTQVSLKDQITSG 360 (419)
T ss_dssp SSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC----SSSCCHHHHHHTT
T ss_pred cccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC----cchHHHHHHHhcC
Confidence 9999876532 23344689999999999863 56788999999999999999999998521 1122233344444
Q ss_pred CCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 700 RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 700 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
............++.+.+++.+||+.||++|||++|+++|
T Consensus 361 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 361 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 4444433334566789999999999999999999999976
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=332.37 Aligned_cols=232 Identities=20% Similarity=0.277 Sum_probs=179.7
Q ss_pred hhcccccceeeccC--CceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceE
Q 041438 499 ATNDFDAKHCIGKG--GHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSF 549 (752)
Q Consensus 499 ~~~~y~~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~ 549 (752)
..++|++.+.||+| +||.||+|+. .+|+.||||+++..... +++...+..|
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 46789999999999 9999999995 47999999998654321 4456678899
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+|||||++|+|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999976532 3488999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCC-------CCcccccCCCCccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccC
Q 041438 630 NLDS-------SNWSKLAGTHGNVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR 700 (752)
Q Consensus 630 ~~~~-------~~~~~~~gt~~y~aPE~~~~--~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 700 (752)
.... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ......+....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~ 253 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA-----TQMLLEKLNGT 253 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS-----TTHHHHC----
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcCC
Confidence 3221 11223478999999999987 5789999999999999999999999853211 01111110000
Q ss_pred CC-----------------------------------C-------CChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 041438 701 LP-----------------------------------Y-------PSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEV 738 (752)
Q Consensus 701 ~~-----------------------------------~-------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 738 (752)
.+ . ........++++.+++.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00 0 00011234567899999999999999999999997
Q ss_pred H
Q 041438 739 Q 739 (752)
Q Consensus 739 ~ 739 (752)
|
T Consensus 334 h 334 (389)
T 3gni_B 334 H 334 (389)
T ss_dssp S
T ss_pred C
Confidence 6
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.89 Aligned_cols=228 Identities=17% Similarity=0.241 Sum_probs=181.5
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC--------------------------CccccC--CceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD--------------------------NFCSHP--RQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~--~~~~lV 551 (752)
.++|++.+.||+|+||.||+|+. +++.||||+++..... +++... ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 46899999999999999999997 4889999998754321 233333 678999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP--IVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~--ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
|||+++|+|.+++..... ..+++..++.++.|++.||+|||+. + |+||||||+||+++.++.++|+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred ecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 999999999999986542 3589999999999999999999998 8 999999999999999999999999987653
Q ss_pred cCCCCCcccccCCCCccCccccccCCCCC---ccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCCh
Q 041438 630 NLDSSNWSKLAGTHGNVAPELAYTMKVTE---KCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706 (752)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (752)
.. ....||+.|+|||++.+..++. ++|||||||++|||++|+.||... ........+........
T Consensus 164 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-----~~~~~~~~~~~~~~~~~-- 231 (271)
T 3kmu_A 164 QS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL-----SNMEIGMKVALEGLRPT-- 231 (271)
T ss_dssp SC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS-----CHHHHHHHHHHSCCCCC--
T ss_pred cc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc-----ChHHHHHHHHhcCCCCC--
Confidence 32 2347899999999988766544 799999999999999999998521 11111222222221111
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
.....++++.+++.+||+.||++|||++|+++.|+++.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 232 IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11335567899999999999999999999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=329.04 Aligned_cols=227 Identities=21% Similarity=0.292 Sum_probs=173.4
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC----------------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~lV 551 (752)
.++|++.+.||+|+||.||+|...+++.||||++...... +++......|+|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4679999999999999999999888999999987643221 344566788999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|| +.+++|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++ ++.+||+|||+++....
T Consensus 88 ~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 55779999997643 488899999999999999999999 999999999999997 57899999999987654
Q ss_pred CCCC--cccccCCCCccCcccccc-----------CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc
Q 041438 632 DSSN--WSKLAGTHGNVAPELAYT-----------MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD 698 (752)
Q Consensus 632 ~~~~--~~~~~gt~~y~aPE~~~~-----------~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 698 (752)
.... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ........+.+
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~~~~~ 235 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII----NQISKLHAIID 235 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC----SHHHHHHHHHC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh----hHHHHHHHHhc
Confidence 3321 234579999999999865 668899999999999999999999985211 11112222332
Q ss_pred cCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 699 SRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 699 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
........ ...+.++.+++.+||+.||++|||++|+++|-
T Consensus 236 ~~~~~~~~--~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 236 PNHEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp TTSCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CCcccCCc--ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 22221110 12234688999999999999999999999874
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=327.60 Aligned_cols=282 Identities=21% Similarity=0.263 Sum_probs=190.5
Q ss_pred CCCHHHHHHHHHHHHccccCCccccCCCCccccCCCCCCCCcccceeeCCCCCEEEEEcCCCCCcccccccccCCCCCCC
Q 041438 33 SNSTEEAHALVKWKASLEVHSRSLLHSWSLSFVNATKISLCTWSGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLA 112 (752)
Q Consensus 33 ~~~~~~~~aLl~fk~~~~~~~~~~l~sW~~~~~~~~~~~~c~w~gv~C~~~~~v~~l~l~~~~l~g~l~~~~f~~l~~L~ 112 (752)
++..+|++||++||+++..|+.+.+.+|.... ....++|.|.|+.|+..... ......++++
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~--~~~~~~~~~~g~~~~~~~~~----------------l~~~~~~~l~ 84 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQAN--SNNPQIETRTGRALKATADL----------------LEDATQPGRV 84 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHT--TTCTTSCCSHHHHHHHHHHH----------------HHHHTSTTCC
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccc--cccccccccCCcchhhhHHH----------------Hhccccccee
Confidence 34567999999999999878877788895221 22458999999999631100 0112346788
Q ss_pred EEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCC
Q 041438 113 YLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNF 192 (752)
Q Consensus 113 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 192 (752)
+|+|++|+|+ .+|..+.++++|++|+|++|+|+ .+|..|+.+++|++|+|++|.|+ .+|..|+++++|++|+|++|+
T Consensus 85 ~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~ 161 (328)
T 4fcg_A 85 ALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACP 161 (328)
T ss_dssp EEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEET
T ss_pred EEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCC
Confidence 8888888887 46777888899999999999988 78888888999999999999988 778888888999999999988
Q ss_pred CCCcCCcCccC---------CCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEcc
Q 041438 193 LGGSIPRSLSN---------FTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVS 263 (752)
Q Consensus 193 l~~~~p~~~~~---------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls 263 (752)
+.+.+|..+.. +++|++|+|++|+|+ .+|..++++++|++|++++|++++
T Consensus 162 ~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-------------------- 220 (328)
T 4fcg_A 162 ELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-------------------- 220 (328)
T ss_dssp TCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC--------------------
T ss_pred CccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc--------------------
Confidence 88888877654 788888888888887 666666666555555555554443
Q ss_pred ccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeecccccccccc
Q 041438 264 INNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFV 343 (752)
Q Consensus 264 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 343 (752)
+|..+..+++|++|+|++|.+.+.+|..++++++|+.|+|++|++.+.+|..+..+++|++|+|++|++.+.+
T Consensus 221 -------l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~i 293 (328)
T 4fcg_A 221 -------LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRL 293 (328)
T ss_dssp -------CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCC
T ss_pred -------CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhc
Confidence 2333444555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred chhhcccccccEEEcCCCcC
Q 041438 344 LESLGSLVKLYYLNLSHNKL 363 (752)
Q Consensus 344 ~~~~~~l~~L~~L~Ls~N~l 363 (752)
|..++.+++|+.+++..|.+
T Consensus 294 P~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 294 PSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp CGGGGGSCTTCEEECCGGGS
T ss_pred cHHHhhccCceEEeCCHHHH
Confidence 55555555555555554444
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.02 Aligned_cols=238 Identities=20% Similarity=0.262 Sum_probs=178.3
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFI 550 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~l 550 (752)
..++|++.+.||+|+||.||+|+. .+++.||||++...... +++...+..|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 457899999999999999999995 47899999998643211 34556778899
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999997543 488999999999999999999999 99999999999999999999999999998765
Q ss_pred CCC-CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 631 LDS-SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 631 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
... .......|++.|+|||++.+..++.++||||||+++|||++|+.||.... ............+.+.....
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~ 259 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ------LSVMGAHINQAIPRPSTVRP 259 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH------HHHHHHHHHSCCCCGGGTST
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch------HHHHHHHhccCCCCccccCC
Confidence 332 12234578999999999999999999999999999999999999985221 11222222222222222223
Q ss_pred HHHHHHHHHHHhccCcCCCCCC-CHHHHHHHHhhhhcCCC
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRP-TMKRFEVQSKQFHYNPD 748 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~~~~~~~ 748 (752)
..+.++.+++.+||+.||++|| +++++++.|+++....+
T Consensus 260 ~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 260 GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 4556788999999999999999 99999999998765543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=321.84 Aligned_cols=238 Identities=21% Similarity=0.299 Sum_probs=182.6
Q ss_pred hcccccceeeccCCceEEEEEE-----eCCCcEEEEEccCCCCCC-------------------------CccccC--Cc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-----VPSGEIFAVKKFHSPLPD-------------------------NFCSHP--RQ 547 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~vavK~~~~~~~~-------------------------~~~~~~--~~ 547 (752)
.+.|++.+.||+|+||.||+|+ ..+++.||||+++..... +++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 3568899999999999999998 346899999998754321 223333 56
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
.++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 899999999999999996543 3488999999999999999999999 99999999999999999999999999998
Q ss_pred eccCCCC---CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcc-----ccc----cccchHh
Q 041438 628 FLNLDSS---NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM-----SSS----SSNMNIE 695 (752)
Q Consensus 628 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~-----~~~----~~~~~~~ 695 (752)
....... ......||..|+|||++.+..++.++||||+||++|||+||..|+...... ... .......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 8764432 123346888899999999999999999999999999999999997432110 000 0011111
Q ss_pred hhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 696 ILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
........+ .....++++.+++.+||+.||++|||++|+++.|+++.
T Consensus 255 ~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLKEGKRLP--CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHTTCCCC--CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccCCCC--CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111111111 11345567899999999999999999999999999863
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=328.21 Aligned_cols=237 Identities=19% Similarity=0.270 Sum_probs=187.6
Q ss_pred HHhhcccccceeeccCCceEEEEEEeC------CCcEEEEEccCCCCCC-------------------------CccccC
Q 041438 497 IRATNDFDAKHCIGKGGHGSVYIARVP------SGEIFAVKKFHSPLPD-------------------------NFCSHP 545 (752)
Q Consensus 497 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-------------------------~~~~~~ 545 (752)
....++|++.+.||+|+||.||+|+.. +++.||||++...... +++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 345678999999999999999999843 4788999998654221 345567
Q ss_pred CceEEEEEeccCCChHHHhccCcc-------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCce
Q 041438 546 RQSFIVYEYLESGSLDKILNNDAS-------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEA 618 (752)
Q Consensus 546 ~~~~lV~E~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~ 618 (752)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeE
Confidence 788999999999999999975321 13468899999999999999999999 99999999999999999999
Q ss_pred EEeecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHh
Q 041438 619 HVSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIE 695 (752)
Q Consensus 619 kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~ 695 (752)
||+|||+++........ .....+|+.|+|||++.+..++.++||||+||++|||++ |+.||... ........
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~~~~~~~ 252 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----SNEQVLRF 252 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----CHHHHHHH
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC-----CHHHHHHH
Confidence 99999999865433211 122356889999999999899999999999999999999 89998521 11222222
Q ss_pred hhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 696 ILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
+......... ...+..+.+++.+||+.||++|||++|++++|+++.
T Consensus 253 ~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 253 VMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 3332222111 234567889999999999999999999999998863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=335.81 Aligned_cols=231 Identities=26% Similarity=0.352 Sum_probs=185.0
Q ss_pred hhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC----------------------Ccccc-CCceEEEEEec
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD----------------------NFCSH-PRQSFIVYEYL 555 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~-~~~~~lV~E~~ 555 (752)
..++|++.+.||+|+||.||+|+. .++.||||+++..... +++.. ....|+||||+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 457899999999999999999987 4789999998764322 22333 34789999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 635 (752)
++|+|.+++...+. ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 270 ~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 270 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp TTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 99999999986432 3368899999999999999999999 9999999999999999999999999999865322
Q ss_pred cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc-CCCCCChhhHHHHH
Q 041438 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RLPYPSLDVQNKFM 713 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 713 (752)
.....++..|+|||++.+..++.++|||||||++|||+| |+.||... ...+....+... +.+.+ ..+++
T Consensus 343 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~-----~~~~~~~~i~~~~~~~~p----~~~~~ 413 (450)
T 1k9a_A 343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRVEKGYKMDAP----DGCPP 413 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS-----CTTTHHHHHHTTCCCCCC----TTCCH
T ss_pred ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHcCCCCCCC----CcCCH
Confidence 122367889999999999999999999999999999998 99998521 112222222222 22222 34567
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
++.++|.+||+.||++|||++|+++.|+++...
T Consensus 414 ~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 414 AVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 889999999999999999999999999987643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=320.00 Aligned_cols=235 Identities=23% Similarity=0.323 Sum_probs=173.0
Q ss_pred hhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E 553 (752)
..++|++.++||+|+||.||+|+.. ..||||+++..... ..+......++|||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e 99 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQ 99 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEE
Confidence 3568999999999999999999853 35999988654322 01234566899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccc
Confidence 999999999996543 4588999999999999999999999 99999999999999999999999999998654221
Q ss_pred --CCcccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCC-Chh
Q 041438 634 --SNWSKLAGTHGNVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYP-SLD 707 (752)
Q Consensus 634 --~~~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 707 (752)
.......||+.|+|||++. +..++.++|||||||++|||++|+.||.... ........+........ ...
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~ 250 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN----NRDQIIEMVGRGSLSPDLSKV 250 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC----CHHHHHHHHHHTSCCCCTTSS
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc----hHHHHHHHhcccccCcchhhc
Confidence 2223457999999999886 5668889999999999999999999985211 11111122222222111 111
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
...+++.+.+++.+||+.||++|||++|+++.|+++.
T Consensus 251 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 2345678999999999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.60 Aligned_cols=234 Identities=18% Similarity=0.320 Sum_probs=185.6
Q ss_pred hhcccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC--------------------Ccc---------------
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD--------------------NFC--------------- 542 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------------~~~--------------- 542 (752)
..++|++.+.||+|+||.||+|+.. +++.||+|+++..... +++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 88 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS 88 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence 4568999999999999999999964 7999999988654321 111
Q ss_pred -ccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEe
Q 041438 543 -SHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVS 621 (752)
Q Consensus 543 -~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~ 621 (752)
......++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+||++++++.+||+
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 89 RSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEEC
T ss_pred ccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEEC
Confidence 11345799999999999999997543 23588999999999999999999999 99999999999999999999999
Q ss_pred ecccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCC
Q 041438 622 DFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRL 701 (752)
Q Consensus 622 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 701 (752)
|||.+....... ......||+.|+|||++.+..++.++|||||||++|||++|..|+.... ...........
T Consensus 165 Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------~~~~~~~~~~~ 236 (284)
T 2a19_B 165 DFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------KFFTDLRDGII 236 (284)
T ss_dssp CCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------HHHHHHHTTCC
T ss_pred cchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-------HHHHHhhcccc
Confidence 999998875432 2334579999999999999899999999999999999999999974211 11112222221
Q ss_pred CCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCCCCC
Q 041438 702 PYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPDHN 750 (752)
Q Consensus 702 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~ 750 (752)
+ ...+..+.+++.+||+.||++|||++|++++++.+...+...
T Consensus 237 ~------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 237 S------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp C------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred c------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 1 123446789999999999999999999999999998776554
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=327.38 Aligned_cols=230 Identities=17% Similarity=0.253 Sum_probs=171.1
Q ss_pred HhhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------CccccCCceEE
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFI 550 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~l 550 (752)
...++|++.+.||+|+||.||+|+ ..+++.||||+++..... +++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 356789999999999999999998 457999999998643221 34556778999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe-----CCCCceEEeeccc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL-----DLGYEAHVSDFRI 625 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll-----~~~~~~kl~DfG~ 625 (752)
||||+++ +|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||++ ++.+.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999986 9999997654 388899999999999999999999 99999999999999 4555699999999
Q ss_pred ceeccCCCCCcccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc------
Q 041438 626 AKFLNLDSSNWSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD------ 698 (752)
Q Consensus 626 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~------ 698 (752)
++.............||+.|+|||++.+.. ++.++||||+||++|||++|+.||...... .....+..
T Consensus 184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 184 ARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-----DQLFKIFEVLGLPD 258 (329)
T ss_dssp HHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHHHCCCC
T ss_pred ccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-----HHHHHHHHHhCCCc
Confidence 987764444445568899999999988754 899999999999999999999998532110 00001000
Q ss_pred --------------cCCC-CCCh-----hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 699 --------------SRLP-YPSL-----DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 699 --------------~~~~-~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...+ .... .....++++.+++.+||+.||++|||++|+++|
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0000 0000 011134678899999999999999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=341.86 Aligned_cols=227 Identities=21% Similarity=0.309 Sum_probs=183.8
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~ 552 (752)
.++|++.+.||+|+||.||+|+. .+++.||||+++..... +++.+....|+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46799999999999999999995 47899999998653211 4556678899999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC---CCceEEeecccceec
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL---GYEAHVSDFRIAKFL 629 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~---~~~~kl~DfG~a~~~ 629 (752)
|||++|+|.+.+.... .+++..++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+++..
T Consensus 116 e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999998886543 488899999999999999999999 9999999999999975 455999999999887
Q ss_pred cCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 630 NLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
... ......+||+.|+|||++. ..++.++||||+||++|+|++|+.||.. ....+....+.......+...+.
T Consensus 190 ~~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~-----~~~~~~~~~i~~~~~~~~~~~~~ 262 (494)
T 3lij_A 190 ENQ-KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGG-----QTDQEILRKVEKGKYTFDSPEWK 262 (494)
T ss_dssp BTT-BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHHTCCCCCSGGGT
T ss_pred CCC-ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCC-----CCHHHHHHHHHhCCCCCCchhcc
Confidence 543 2334568999999999876 5699999999999999999999999852 22233445555555555554555
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..++.+.+++.+||+.||++|||++|+++|
T Consensus 263 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 263 NVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 677789999999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=329.84 Aligned_cols=230 Identities=23% Similarity=0.332 Sum_probs=181.1
Q ss_pred hcccccceeeccCCceEEEEEEe----CCCcEEEEEccCCCCC-------C----------------------CccccCC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV----PSGEIFAVKKFHSPLP-------D----------------------NFCSHPR 546 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-------~----------------------~~~~~~~ 546 (752)
.++|++.+.||+|+||.||+|+. .+++.||||+++.... . +++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 57899999999999999999986 4789999998864211 0 2344567
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
..++||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 8899999999999999997543 488899999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCC-CcccccCCCCccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCC
Q 041438 627 KFLNLDSS-NWSKLAGTHGNVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPY 703 (752)
Q Consensus 627 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 703 (752)
+....... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .........+.....+.
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 285 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-NSQAEISRRILKSEPPY 285 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-CCHHHHHHHHHHCCCCC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc-chHHHHHHHHhccCCCC
Confidence 87643222 2234579999999999885 34789999999999999999999998522111 11112223333333333
Q ss_pred CChhhHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHHH
Q 041438 704 PSLDVQNKFMSIMQVAFSCLDQNPVSRP-----TMKRFEVQS 740 (752)
Q Consensus 704 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~L 740 (752)
+ ...+..+.++|.+||+.||++|| +++|+++|.
T Consensus 286 ~----~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 286 P----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp C----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred C----cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 3 23456788999999999999999 999998875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=333.98 Aligned_cols=229 Identities=10% Similarity=0.003 Sum_probs=172.8
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------Ccc--ccC----------------
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------NFC--SHP---------------- 545 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------~~~--~~~---------------- 545 (752)
..+|++.+.||+|+||.||+|+. .+|+.||||+++..... ... .++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 45699999999999999999995 57999999998764321 000 011
Q ss_pred --------------------CceEEEEEeccCCChHHHhccCccccccCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 041438 546 --------------------RQSFIVYEYLESGSLDKILNNDASAKELGWTQR------LNVIKGVADALFYLHNNCFPP 599 (752)
Q Consensus 546 --------------------~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~qi~~aL~~lH~~~~~~ 599 (752)
...|+||||++ |+|.+++.... ..+++..+ ..++.||+.||+|||++ +
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 23799999999 79999998643 22445555 67889999999999999 9
Q ss_pred eeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcccccCCCCccCcccccc--CCCCCccchhhHHHHHHHHHhCCC
Q 041438 600 IVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKH 677 (752)
Q Consensus 600 ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDIwSlGvil~elltg~~ 677 (752)
|+||||||+|||++.++.+||+|||+|+.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999987642 2224567799999999987 679999999999999999999999
Q ss_pred Ccchhhcccccccc--chHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 678 PRDFLFEMSSSSSN--MNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 678 pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
||............ ............+ .....++.+.+++.+||+.||++|||++|+++|
T Consensus 292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFG--SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp STTBCCTTCTTCCCBCCTTSCCCCSCCCT--TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCcCcccccchhhhhhhhccccccchh--hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 99633211111000 0011111122222 113456688999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=326.44 Aligned_cols=226 Identities=22% Similarity=0.321 Sum_probs=186.2
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFI 550 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~l 550 (752)
..++|++.+.||+|+||.||+|+. .+++.||+|++...... +++.+.+..|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 457899999999999999999995 46889999987643211 44566788999
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+++++|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 119 v~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999999987543 488999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+....+.......+. .
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~~~~~~~~~~~~~~~----~ 263 (335)
T 2owb_A 193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-----CLKETYLRIKKNEYSIPK----H 263 (335)
T ss_dssp STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHHTCCCCCT----T
T ss_pred cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC-----CHHHHHHHHhcCCCCCCc----c
Confidence 4444445568999999999999988999999999999999999999998521 112222333333333332 3
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+..+.+++.+||+.||++|||++|++++
T Consensus 264 ~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 264 INPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 34568899999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=341.42 Aligned_cols=233 Identities=21% Similarity=0.362 Sum_probs=187.1
Q ss_pred hhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEec
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~ 555 (752)
..++|++.+.||+|+||.||+|+..+++.||||+++..... +++ ..+..++||||+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~-~~~~~~lv~e~~ 264 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFM 264 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEECCC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEE-eCCccEEEEeec
Confidence 46789999999999999999999888899999998754322 222 256789999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC-
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS- 634 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 634 (752)
++|+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 265 ~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 265 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp TTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 9999999997543 23478899999999999999999999 999999999999999999999999999987642211
Q ss_pred CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc-CCCCCChhhHHHH
Q 041438 635 NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RLPYPSLDVQNKF 712 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 712 (752)
......++..|+|||++.+..++.++|||||||++|||+| |+.||... ...+....+... +.+.+ ..++
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~-----~~~~~~~~i~~~~~~~~~----~~~~ 411 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-----SNPEVIRALERGYRMPRP----ENCP 411 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHHHHHHHHHHTCCCCCC----TTSC
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHcCCCCCCC----CCCC
Confidence 1122356788999999998899999999999999999999 99998521 111122222221 22222 3456
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
+++.++|.+||+.||++|||++++++.|+++..
T Consensus 412 ~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 412 EELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 678999999999999999999999999999853
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=331.76 Aligned_cols=227 Identities=21% Similarity=0.285 Sum_probs=174.4
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC----------------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~lV 551 (752)
..+|++.+.||+|+||.||+|+..+++.||||++...... +++...+..|+|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3569999999999999999999878999999988543221 234556778999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|| +.+++|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++....
T Consensus 135 ~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 56779999997654 478889999999999999999999 999999999999996 57999999999987653
Q ss_pred CCC--CcccccCCCCccCcccccc-----------CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc
Q 041438 632 DSS--NWSKLAGTHGNVAPELAYT-----------MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD 698 (752)
Q Consensus 632 ~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 698 (752)
... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ........+.+
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~----~~~~~~~~~~~ 282 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII----NQISKLHAIID 282 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC----CHHHHHHHHHC
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh----HHHHHHHHHhC
Confidence 322 1234579999999999865 368899999999999999999999985211 11122233333
Q ss_pred cCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 699 SRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 699 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
.....+.. ...+.++.+++.+||+.||++|||++|+++|-
T Consensus 283 ~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 283 PNHEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp TTSCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ccccCCCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 33222111 11245688999999999999999999999764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=342.80 Aligned_cols=227 Identities=20% Similarity=0.300 Sum_probs=186.2
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~ 552 (752)
.++|++.+.||+|+||.||+|+. .+++.||||++...... +++.+....|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 56899999999999999999995 47999999987432110 4556678899999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC---CCCceEEeecccceec
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD---LGYEAHVSDFRIAKFL 629 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~---~~~~~kl~DfG~a~~~ 629 (752)
|||.+|+|.+.+.... .+++..+..++.||+.||.|||+. +|+||||||+||+++ .++.+||+|||+++..
T Consensus 101 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999998886543 488999999999999999999999 999999999999995 4567999999999876
Q ss_pred cCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 630 NLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
... ......+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.. ....+....+.......+...+.
T Consensus 175 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~-----~~~~~~~~~i~~~~~~~~~~~~~ 247 (486)
T 3mwu_A 175 QQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG-----KNEYDILKRVETGKYAFDLPQWR 247 (486)
T ss_dssp CCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHHTCCCSCSGGGG
T ss_pred CCC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCC-----CCHHHHHHHHHhCCCCCCCcccC
Confidence 533 23344689999999999876 589999999999999999999999852 22233444555555555554556
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..++++.++|.+||+.||++|||+.|+++|
T Consensus 248 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 248 TISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 677889999999999999999999999987
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=321.76 Aligned_cols=235 Identities=22% Similarity=0.325 Sum_probs=188.7
Q ss_pred HhhcccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC-----------------------CccccCCceEEEEE
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E 553 (752)
...++|++.+.||+|+||.||+|+.. +++.||+|+++..... +++......++|||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 35678999999999999999999954 5889999998754321 44566788999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++++|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+.......
T Consensus 90 ~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 9999999999976432 4588999999999999999999999 99999999999999999999999999998765333
Q ss_pred CC-cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 634 SN-WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 634 ~~-~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
.. .....+|+.|+|||++.+..++.++||||+|+++|+|++ |..||... ... .............. ....
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~-----~~~-~~~~~~~~~~~~~~--~~~~ 237 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLS-QVYELLEKDYRMER--PEGC 237 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CGG-GHHHHHHTTCCCCC--CTTC
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----CHH-HHHHHHhccCCCCC--CCCC
Confidence 21 223457788999999998999999999999999999999 99998521 111 12222222211111 1344
Q ss_pred HHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 712 FMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
++.+.+++.+||+.||++|||++|+++.|+++.
T Consensus 238 ~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 238 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 567899999999999999999999999998764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.73 Aligned_cols=229 Identities=22% Similarity=0.293 Sum_probs=185.3
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E 553 (752)
..++|++.+.||+|+||.||+|+. .+|+.||+|+++..... +++......++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 356899999999999999999995 47999999998653211 34566788999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe---CCCCceEEeecccceecc
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL---DLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll---~~~~~~kl~DfG~a~~~~ 630 (752)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||.+....
T Consensus 87 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999986543 488899999999999999999999 99999999999999 778899999999997643
Q ss_pred CCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||... ........+.......+......
T Consensus 161 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~ 233 (304)
T 2jam_A 161 N--GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE-----TESKLFEKIKEGYYEFESPFWDD 233 (304)
T ss_dssp C--BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHHHCCCCCCTTTTTT
T ss_pred C--CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHcCCCCCCcccccc
Confidence 2 2233457999999999999999999999999999999999999998521 12222333444433333322345
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
.++++.+++.+||+.||++|||++|+++|-
T Consensus 234 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 234 ISESAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp SCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 567899999999999999999999999753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=319.12 Aligned_cols=227 Identities=26% Similarity=0.357 Sum_probs=184.0
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E 553 (752)
.+.|++.+.||+|+||.||+|+. .+++.||||++...... +++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 45699999999999999999984 57899999998654321 34455678899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++++|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.+.......
T Consensus 101 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 99999999999653 488999999999999999999999 99999999999999999999999999998876544
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHH
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.....+.. ....+.
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~---~~~~~~ 245 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH-----PMKVLFLIPKNNPPTL---EGNYSK 245 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSCCCCC---CSSCCH
T ss_pred cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC-----HHHHHHHhhcCCCCCC---ccccCH
Confidence 44445689999999999999999999999999999999999999985211 1111112222221111 123455
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHHHh
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~L~ 741 (752)
.+.+++.+||+.||++|||++|++++.-
T Consensus 246 ~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 246 PLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 7889999999999999999999998653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=343.69 Aligned_cols=228 Identities=21% Similarity=0.311 Sum_probs=189.2
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV 551 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||++...... +++......|+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 46899999999999999999995 48999999998543211 345567889999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe---CCCCceEEeeccccee
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL---DLGYEAHVSDFRIAKF 628 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll---~~~~~~kl~DfG~a~~ 628 (752)
|||+.+|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||++ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999887543 488999999999999999999999 99999999999999 5678999999999987
Q ss_pred ccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhh
Q 041438 629 LNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708 (752)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (752)
.... ......+||+.|+|||++.+ .++.++||||+||++|+|++|++||.. .........+.......+...+
T Consensus 179 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~-----~~~~~~~~~i~~~~~~~~~~~~ 251 (484)
T 3nyv_A 179 FEAS-KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG-----ANEYDILKKVEKGKYTFELPQW 251 (484)
T ss_dssp BCCC-CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHHCCCCCCSGGG
T ss_pred cccc-cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCC-----CCHHHHHHHHHcCCCCCCCccc
Confidence 6533 23345689999999998866 689999999999999999999999852 2223344555555555554455
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
...++++.++|.+||+.||++|||++|+++|-
T Consensus 252 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 252 KKVSESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 66778899999999999999999999999763
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.90 Aligned_cols=239 Identities=20% Similarity=0.291 Sum_probs=187.4
Q ss_pred HHHHhhcccccceeeccCCceEEEEEEe------CCCcEEEEEccCCCCCC--------------------------Ccc
Q 041438 495 EIIRATNDFDAKHCIGKGGHGSVYIARV------PSGEIFAVKKFHSPLPD--------------------------NFC 542 (752)
Q Consensus 495 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--------------------------~~~ 542 (752)
++.-..++|++.+.||+|+||.||+|+. .+++.||||+++..... +++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 3444568999999999999999999973 35789999998654321 222
Q ss_pred cc-CCceEEEEEeccCCChHHHhccCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 041438 543 SH-PRQSFIVYEYLESGSLDKILNNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSK 608 (752)
Q Consensus 543 ~~-~~~~~lV~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~ 608 (752)
.. ....++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~ 177 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR 177 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccc
Confidence 22 3458999999999999999986542 12278899999999999999999999 9999999999
Q ss_pred CEEeCCCCceEEeecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhcc
Q 041438 609 NVLLDLGYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEM 685 (752)
Q Consensus 609 NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~ 685 (752)
||+++.++.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-- 255 (316)
T 2xir_A 178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-- 255 (316)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--
T ss_pred eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc--
Confidence 999999999999999999876543322 223467889999999999999999999999999999998 999985211
Q ss_pred ccccccchHhhhccC-CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 686 SSSSSNMNIEILDSR-LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 686 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
........+.... ...+ ...++++.+++.+||+.||++|||++|++++|+++.
T Consensus 256 --~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 256 --IDEEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp --CSHHHHHHHHHTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --hhHHHHHHhccCccCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111122222221 2222 234567889999999999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.53 Aligned_cols=232 Identities=23% Similarity=0.298 Sum_probs=184.3
Q ss_pred hcccccce-eeccCCceEEEEEEe---CCCcEEEEEccCCCCCC-------------------------CccccCCceEE
Q 041438 500 TNDFDAKH-CIGKGGHGSVYIARV---PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFI 550 (752)
Q Consensus 500 ~~~y~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~l 550 (752)
.++|.+.+ .||+|+||.||+|+. .+++.||||+++..... +++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35676766 999999999999984 36788999998764321 223 3466899
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 999999999999997543 3488999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCC---cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccC-CCCCC
Q 041438 631 LDSSN---WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSR-LPYPS 705 (752)
Q Consensus 631 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~ 705 (752)
..... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||... ........+.... ...+
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-----~~~~~~~~i~~~~~~~~~- 235 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-----KGPEVMAFIEQGKRMECP- 235 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----CTHHHHHHHHTTCCCCCC-
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-----CHHHHHHHHhcCCcCCCC-
Confidence 43321 122356889999999988889999999999999999998 99998521 1122222222222 2222
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
...++++.+++.+||+.||++||+++|++++|+++.++
T Consensus 236 ---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 236 ---PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp ---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 34566789999999999999999999999999988643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=326.58 Aligned_cols=232 Identities=22% Similarity=0.318 Sum_probs=172.5
Q ss_pred cccccceeeccCCceEEEEEEeC--C--CcEEEEEccCCCCCC-------------------------Ccc-ccCCceEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVP--S--GEIFAVKKFHSPLPD-------------------------NFC-SHPRQSFI 550 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~-------------------------~~~-~~~~~~~l 550 (752)
..|++.+.||+|+||.||+|+.. + +..||||.++..... +++ ...+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 45778899999999999999843 2 246899988643221 222 33467899
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+++|+|.+++.... ..+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999997543 3478899999999999999999999 99999999999999999999999999998664
Q ss_pred CCCC----CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCC
Q 041438 631 LDSS----NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPS 705 (752)
Q Consensus 631 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (752)
.... ......+|+.|+|||++.+..++.++|||||||++|||+| |.+||... ...+....+.........
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~-----~~~~~~~~~~~~~~~~~p 318 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----NTFDITVYLLQGRRLLQP 318 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-----CSSCHHHHHHTTCCCCCC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC-----CHHHHHHHHHcCCCCCCC
Confidence 3221 1123467789999999999999999999999999999999 67777421 122222223332222111
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
..++..+.+++.+||+.||++|||++|++++|+++..
T Consensus 319 ---~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 319 ---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 2345678999999999999999999999999998863
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=326.76 Aligned_cols=232 Identities=20% Similarity=0.258 Sum_probs=175.7
Q ss_pred HhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------------CccccCCc
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------------NFCSHPRQ 547 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------------~~~~~~~~ 547 (752)
...++|++.+.||+|+||.||+|+. .+|+.||||+++..... +++.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 4567899999999999999999995 56999999998642110 34556678
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
.++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 8999999987 8988887543 3478899999999999999999999 99999999999999999999999999998
Q ss_pred eccCCCCCcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhcc-------
Q 041438 628 FLNLDSSNWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS------- 699 (752)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~------- 699 (752)
.............||+.|+|||++.+. .++.++|||||||++|||++|.+||..... ......+...
T Consensus 161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~-----~~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-----LDQLTRIFETLGTPTEE 235 (346)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCCCTT
T ss_pred eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHHcCCCChh
Confidence 776554445556899999999998764 489999999999999999999999853211 0111111100
Q ss_pred ---------------CCC-CCC-hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 700 ---------------RLP-YPS-LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 700 ---------------~~~-~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
..+ .+. ......+.++.++|.+||+.||++|||++|+++|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 000 000 00123346789999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=320.61 Aligned_cols=237 Identities=22% Similarity=0.299 Sum_probs=185.1
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Ccc--ccCCceE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFC--SHPRQSF 549 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~--~~~~~~~ 549 (752)
..++|++.+.||+|+||.||+|+. .+++.||+|++...... +++ ......+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 357899999999999999999995 47899999998654321 222 3456789
Q ss_pred EEEEeccCCChHHHhccCcc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCC-----eeecCCCCCCEEeCCCCceEEeec
Q 041438 550 IVYEYLESGSLDKILNNDAS-AKELGWTQRLNVIKGVADALFYLHNNCFPP-----IVHWDISSKNVLLDLGYEAHVSDF 623 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~-----ivH~DlKp~NIll~~~~~~kl~Df 623 (752)
+||||+++++|.+++..... ...+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 99999999999999975432 23489999999999999999999999 8 999999999999999999999999
Q ss_pred ccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCC
Q 041438 624 RIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPY 703 (752)
Q Consensus 624 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 703 (752)
|.++.............||+.|+|||++.+..++.++|||||||++|+|++|+.||... ........+.....+.
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~i~~~~~~~ 235 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-----SQKELAGKIREGKFRR 235 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHTCCCC
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc-----CHHHHHHHHhhccccc
Confidence 99987654332233457899999999999888999999999999999999999998522 1122222333333221
Q ss_pred CChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 704 PSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 704 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
.. ...+.++.+++.+||+.||++|||++|+++++......
T Consensus 236 ~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 236 IP---YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp CC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred CC---cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 11 23456788999999999999999999999987665433
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=314.60 Aligned_cols=233 Identities=21% Similarity=0.338 Sum_probs=186.3
Q ss_pred hhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEec
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~ 555 (752)
..++|++.+.||+|+||.||+|+..+++.||||+++..... +++ ..+..++||||+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 89 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYM 89 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSCEEEEECC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEE-cCCCcEEEEecC
Confidence 45789999999999999999999888889999998754322 222 345689999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 635 (752)
++++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||.+.........
T Consensus 90 ~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 9999999997532 22488999999999999999999999 9999999999999999999999999999876543211
Q ss_pred -cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccC-CCCCChhhHHHH
Q 041438 636 -WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSR-LPYPSLDVQNKF 712 (752)
Q Consensus 636 -~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 712 (752)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||... ...+....+.... ...+ ...+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~----~~~~ 236 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLERGYRMVRP----DNCP 236 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHHTTCCCCCC----TTCC
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc-----CHHHHHHHHhcccCCCCc----cccc
Confidence 123356789999999988889999999999999999999 99998521 1111222222221 1111 2345
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
.++.+++.+||+.||++|||++++++.|+++..
T Consensus 237 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 678999999999999999999999999998753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=317.97 Aligned_cols=229 Identities=23% Similarity=0.309 Sum_probs=174.6
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E 553 (752)
.++|++.+.||+|+||.||+|+. .+++.||+|++...... +++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 46899999999999999999995 57899999988654321 44566788899999
Q ss_pred eccCCChHHHhccCc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe---CCCCceEEeecccceec
Q 041438 554 YLESGSLDKILNNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL---DLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll---~~~~~~kl~DfG~a~~~ 629 (752)
|+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999886532 124588999999999999999999999 99999999999999 45678999999999876
Q ss_pred cCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 630 NLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
.... ......||+.|+|||++. ..++.++||||+||++|||++|+.||... .................. ...
T Consensus 178 ~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~-----~~~~~~~~~~~~~~~~~~-~~~ 249 (285)
T 3is5_A 178 KSDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT-----SLEEVQQKATYKEPNYAV-ECR 249 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCCCCCC---C
T ss_pred CCcc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC-----CHHHHHhhhccCCccccc-ccC
Confidence 5332 234457999999999875 56889999999999999999999998521 111111222212221111 112
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..++++.+++.+||+.||++|||++|+++|
T Consensus 250 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 250 PLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 245678899999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=340.58 Aligned_cols=235 Identities=22% Similarity=0.313 Sum_probs=188.7
Q ss_pred hhcccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEe
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~ 554 (752)
..++|++.+.||+|+||.||+|+.. +++.||||+++..... +++......|+||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3567999999999999999999965 4889999998754322 455667889999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+++|+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 999999999976432 4488999999999999999999999 999999999999999999999999999987643221
Q ss_pred -CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCChhhHHHH
Q 041438 635 -NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712 (752)
Q Consensus 635 -~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (752)
......++..|+|||++.+..++.++|||||||++|||+| |+.||.... .. .....+......+. ...++
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~-----~~-~~~~~~~~~~~~~~--~~~~~ 445 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LS-QVYELLEKDYRMER--PEGCP 445 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GG-GHHHHHHTTCCCCC--CTTCC
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC-----HH-HHHHHHHcCCCCCC--CCCCC
Confidence 1122356778999999998899999999999999999999 999985211 11 12222222222111 13456
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
+++.++|.+||+.||++|||++|+++.|+.+..
T Consensus 446 ~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 446 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 678999999999999999999999999998743
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=328.28 Aligned_cols=240 Identities=16% Similarity=0.170 Sum_probs=182.8
Q ss_pred hcccccceeeccCCceEEEEEEeC---------CCcEEEEEccCCCCCC-------------------------------
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP---------SGEIFAVKKFHSPLPD------------------------------- 539 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~vavK~~~~~~~~------------------------------- 539 (752)
.++|++.+.||+|+||.||+|+.. +++.||||++......
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 468999999999999999999965 3889999988654211
Q ss_pred ---Cccc-cCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC
Q 041438 540 ---NFCS-HPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG 615 (752)
Q Consensus 540 ---~~~~-~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~ 615 (752)
+++. .....|+||||+ +++|.+++.... ...+++.+++.++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPE 195 (352)
T ss_dssp CCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEETT
T ss_pred chhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcCC
Confidence 1122 257889999999 889999998652 24589999999999999999999999 99999999999999998
Q ss_pred C--ceEEeecccceeccCCCC-------CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccc
Q 041438 616 Y--EAHVSDFRIAKFLNLDSS-------NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS 686 (752)
Q Consensus 616 ~--~~kl~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~ 686 (752)
+ .+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 275 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT 275 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH
Confidence 8 899999999987653321 1133479999999999999999999999999999999999999986322100
Q ss_pred cccccchHhhhccCCCCC--ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 687 SSSSNMNIEILDSRLPYP--SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
.................. .......+.++.+++.+||+.||++|||++|+++.|+++.
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 276 EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp HHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 000011111111111111 0011233567899999999999999999999999999886
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=314.54 Aligned_cols=303 Identities=25% Similarity=0.381 Sum_probs=266.9
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceee
Q 041438 84 GRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILH 163 (752)
Q Consensus 84 ~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 163 (752)
..+..+++.++.+... ..|..+++|++|+|++|+++++.+ |.++++|++|+|++|+++.. +.|.++++|++|+
T Consensus 44 ~~L~~L~l~~~~i~~~---~~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~ 116 (347)
T 4fmz_A 44 ESITKLVVAGEKVASI---QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELY 116 (347)
T ss_dssp TTCSEEECCSSCCCCC---TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEE
T ss_pred ccccEEEEeCCccccc---hhhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEEE
Confidence 4567788887776542 247889999999999999998655 99999999999999999864 4699999999999
Q ss_pred ccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCC
Q 041438 164 ISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNG 243 (752)
Q Consensus 164 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 243 (752)
|++|.+++..+ +..+++|++|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|+.|++++|++++
T Consensus 117 l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~ 191 (347)
T 4fmz_A 117 LNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED 191 (347)
T ss_dssp CTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC
T ss_pred CcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc
Confidence 99999996544 9999999999999997665554 48999999999999999987655 8899999999999999987
Q ss_pred CcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCccc
Q 041438 244 AIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGEL 323 (752)
Q Consensus 244 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 323 (752)
..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|.+++..+ +..+++|+.|++++|.+++. ..+
T Consensus 192 ~~~----~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~ 261 (347)
T 4fmz_A 192 ISP----LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAV 261 (347)
T ss_dssp CGG----GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGG
T ss_pred ccc----ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhH
Confidence 654 5688999999999999997665 8899999999999999997655 89999999999999999864 568
Q ss_pred CCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccce
Q 041438 324 GSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEK 403 (752)
Q Consensus 324 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 403 (752)
..+++|++|++++|.+++. ..+..+++|+.|++++|++++..|..+..+++|++|+|++|++++..| +..+++|++
T Consensus 262 ~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~ 337 (347)
T 4fmz_A 262 KDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDS 337 (347)
T ss_dssp TTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSE
T ss_pred hcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccce
Confidence 9999999999999999986 468999999999999999999999999999999999999999998877 889999999
Q ss_pred EEccCCcCC
Q 041438 404 LNLSYNNLS 412 (752)
Q Consensus 404 L~L~~N~l~ 412 (752)
|++++|.|+
T Consensus 338 L~l~~N~i~ 346 (347)
T 4fmz_A 338 ADFANQVIK 346 (347)
T ss_dssp ESSSCC---
T ss_pred eehhhhccc
Confidence 999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=335.99 Aligned_cols=173 Identities=19% Similarity=0.239 Sum_probs=148.7
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------------CccccCCceE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------------NFCSHPRQSF 549 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------------~~~~~~~~~~ 549 (752)
..+|++.+.||+|+||.||+|+. .+++.||||+++..... +++......+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 46799999999999999999984 56899999998653210 2344567889
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCc--eEEeecccce
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE--AHVSDFRIAK 627 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~--~kl~DfG~a~ 627 (752)
+||||+. ++|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+|+
T Consensus 176 lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 9999997 599999876542 3489999999999999999999999 9999999999999999887 9999999998
Q ss_pred eccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcc
Q 041438 628 FLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD 680 (752)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~ 680 (752)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|++||.
T Consensus 251 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~ 300 (429)
T 3kvw_A 251 YEHQ---RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300 (429)
T ss_dssp ETTC---CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecCC---cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence 7542 2334589999999999999999999999999999999999999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=324.23 Aligned_cols=239 Identities=23% Similarity=0.315 Sum_probs=185.6
Q ss_pred hcccccceeeccCCceEEEEEEe-----CCCcEEEEEccCCCCCC------------------------Ccc--ccCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-----PSGEIFAVKKFHSPLPD------------------------NFC--SHPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~------------------------~~~--~~~~~~ 548 (752)
.++|++.+.||+|+||.||+|+. .+++.||||++...... +++ .+....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46899999999999999999983 46889999998654211 122 245668
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccccee
Confidence 99999999999999997643 3488999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCC---cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcc-----c--cc--cccchHhh
Q 041438 629 LNLDSSN---WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM-----S--SS--SSNMNIEI 696 (752)
Q Consensus 629 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~-----~--~~--~~~~~~~~ 696 (752)
....... .....||+.|+|||++.+..+++++|||||||++|+|++|+.||...... . .. ........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 7543321 22346888899999999988999999999999999999999998532210 0 00 00111111
Q ss_pred hccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 697 LDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
.......+. ....++.+.+++.+||+.||++|||++|++++|+.+..
T Consensus 257 ~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 257 LEEGQRLPA--PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred hhcccCCCC--CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 222211111 13456678999999999999999999999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=316.45 Aligned_cols=223 Identities=20% Similarity=0.264 Sum_probs=177.8
Q ss_pred hhcccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC---------------------------CccccCCceEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFI 550 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~l 550 (752)
..++|++.+.||+|+||.||+|+.. +++.||||+++..... +++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4678999999999999999999964 7999999988654221 34556788999
Q ss_pred EEEeccCCChHHHhccCcc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC--------------
Q 041438 551 VYEYLESGSLDKILNNDAS-AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG-------------- 615 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~-------------- 615 (752)
||||+++++|.+++..... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999976432 24488999999999999999999999 99999999999999844
Q ss_pred -----CceEEeecccceeccCCCCCcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhcccccc
Q 041438 616 -----YEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS 689 (752)
Q Consensus 616 -----~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~ 689 (752)
..+||+|||.+....... ...||+.|+|||++.+. .+++++|||||||++|||++|.+|+...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------- 234 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------- 234 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-------
T ss_pred ccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-------
Confidence 479999999998765332 24689999999998766 5678999999999999999999876311
Q ss_pred ccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 690 SNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.....+.....+... ...++++.+++.+||+.||++|||++|+++|
T Consensus 235 -~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 235 -DQWHEIRQGRLPRIP---QVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -HHHHHHHTTCCCCCS---SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -hHHHHHHcCCCCCCC---cccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 112222222222111 2345678899999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=322.58 Aligned_cols=234 Identities=22% Similarity=0.361 Sum_probs=176.3
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcE----EEEEccCCCCCC-------------------------CccccCCceE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEI----FAVKKFHSPLPD-------------------------NFCSHPRQSF 549 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~~~-------------------------~~~~~~~~~~ 549 (752)
.++|++.+.||+|+||.||+|+. .+++. ||+|.+...... +++. ....+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEE-SSSEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEe-cCCce
Confidence 57899999999999999999984 45554 577766433211 2222 34578
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 9999999999999997643 3488999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCCCh
Q 041438 630 NLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706 (752)
Q Consensus 630 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (752)
...... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||... ...............+.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~------~~~~~~~~~~~~~~~~~- 240 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI------PASEISSILEKGERLPQ- 240 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CGGGHHHHHHTTCCCCC-
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC------CHHHHHHHHHcCCCCCC-
Confidence 533222 223356788999999999999999999999999999999 99998521 11112222222221111
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCC
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNP 747 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 747 (752)
....+.++.+++.+||+.||++||+++|+++.|+++...|
T Consensus 241 -~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 241 -PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp -CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred -CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 1234567889999999999999999999999999886543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=324.99 Aligned_cols=232 Identities=19% Similarity=0.274 Sum_probs=173.6
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Ccccc--------
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSH-------- 544 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~-------- 544 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||++...... +++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 47899999999999999999995 67999999988544321 11111
Q ss_pred CCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecc
Q 041438 545 PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFR 624 (752)
Q Consensus 545 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG 624 (752)
.+..++||||+++ ++.+.+.... ..+++.+++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 4568999999986 7777776543 3488999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCC----CCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhcc
Q 041438 625 IAKFLNLDS----SNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS 699 (752)
Q Consensus 625 ~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 699 (752)
+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~ 247 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ--LALISQLCGS 247 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCC
Confidence 998765322 22234578999999998876 4579999999999999999999999853211000 0000000000
Q ss_pred ----------------CC-----CCCChh----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 700 ----------------RL-----PYPSLD----VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 700 ----------------~~-----~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.. ...... ....++.+.+++.+||+.||++|||++|+++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00 000000 00113568899999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=319.78 Aligned_cols=227 Identities=21% Similarity=0.321 Sum_probs=178.6
Q ss_pred hcccccceeeccCCceEEEEEEeC-CC-------cEEEEEccCCCCCC------------------------CccccCCc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP-SG-------EIFAVKKFHSPLPD------------------------NFCSHPRQ 547 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~------------------------~~~~~~~~ 547 (752)
.++|++.+.||+|+||.||+|+.. ++ ..||+|++...... +++...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 468999999999999999999843 33 47999988543221 44556778
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCc--------eE
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE--------AH 619 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~--------~k 619 (752)
.++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceee
Confidence 899999999999999997653 3488899999999999999999999 9999999999999998877 99
Q ss_pred EeecccceeccCCCCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCC-cchhhccccccccchHhhh
Q 041438 620 VSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHP-RDFLFEMSSSSSNMNIEIL 697 (752)
Q Consensus 620 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~p-f~~~~~~~~~~~~~~~~~~ 697 (752)
|+|||.+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..| |.. ..........
T Consensus 162 l~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~------~~~~~~~~~~ 231 (289)
T 4fvq_A 162 LSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA------LDSQRKLQFY 231 (289)
T ss_dssp ECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT------SCHHHHHHHH
T ss_pred eccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc------cchHHHHHHh
Confidence 999999875432 233468899999999887 6689999999999999999996554 421 1111122222
Q ss_pred ccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 698 DSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 698 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
......+. ..+.++.+++.+||+.||++|||++|++++|+++..
T Consensus 232 ~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 232 EDRHQLPA----PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HTTCCCCC----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hccCCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 22222221 123457899999999999999999999999999854
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=339.61 Aligned_cols=228 Identities=22% Similarity=0.303 Sum_probs=185.8
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------------------C
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------------------N 540 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------------------~ 540 (752)
..++|++.++||+|+||.||+|+. .+++.||||++...... +
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 357899999999999999999995 56899999998643210 3
Q ss_pred ccccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC---c
Q 041438 541 FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY---E 617 (752)
Q Consensus 541 ~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~---~ 617 (752)
++......|+|||||++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 4566788999999999999999886543 488999999999999999999999 999999999999998775 6
Q ss_pred eEEeecccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhh
Q 041438 618 AHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEIL 697 (752)
Q Consensus 618 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 697 (752)
+||+|||+++..... .......||+.|+|||++. ..++.++||||+||++|+|++|+.||.. .........+.
T Consensus 188 ~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~-----~~~~~~~~~i~ 260 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGG-----QNDQDIIKKVE 260 (504)
T ss_dssp EEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHH
T ss_pred EEEEECCCCEEcCCC-CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCC-----CCHHHHHHHHH
Confidence 999999999877543 2334568999999999876 4689999999999999999999999852 22333445555
Q ss_pred ccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 698 DSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 698 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
......+...+...++++.+++.+||++||++|||++|+++|
T Consensus 261 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 261 KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 555555544445667789999999999999999999999976
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=318.45 Aligned_cols=230 Identities=25% Similarity=0.308 Sum_probs=178.5
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------CccccCCceEEEEEec
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------~~~~~~~~~~lV~E~~ 555 (752)
..++|++.+.||+|+||.||+|+. .+|+.||||++...... +++...+..++||||+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 457899999999999999999995 46999999988654321 3445567889999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 635 (752)
++++|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.+.........
T Consensus 107 ~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (314)
T 3com_A 107 GAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK 181 (314)
T ss_dssp TTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC
T ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc
Confidence 9999999986432 3488999999999999999999999 9999999999999999999999999999877644444
Q ss_pred cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHH
Q 041438 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSI 715 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 715 (752)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+.....+.. ......+..+
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~-~~~~~~~~~l 255 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-----MRAIFMIPTNPPPTF-RKPELWSDNF 255 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSCCCCC-SSGGGSCHHH
T ss_pred cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHhcCCCccc-CCcccCCHHH
Confidence 4456899999999999998999999999999999999999999852111 111111111111111 1123345678
Q ss_pred HHHHHhccCcCCCCCCCHHHHHHH
Q 041438 716 MQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 716 ~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+++.+||+.||++|||++|+++|
T Consensus 256 ~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 256 TDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHccCChhhCcCHHHHHhC
Confidence 999999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=336.30 Aligned_cols=233 Identities=23% Similarity=0.358 Sum_probs=182.4
Q ss_pred hhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEec
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~ 555 (752)
..++|++.+.||+|+||.||+|+...+..||||+++..... +++. .+..++||||+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~iv~e~~ 260 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 260 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEc-CCceEEEehhh
Confidence 45689999999999999999999888888999998764322 2233 36789999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 635 (752)
++|+|.+++.... ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 261 ~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 261 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 9999999997532 23488999999999999999999999 9999999999999999999999999999876532211
Q ss_pred -cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc-CCCCCChhhHHHH
Q 041438 636 -WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RLPYPSLDVQNKF 712 (752)
Q Consensus 636 -~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 712 (752)
.....++..|+|||++.+..++.++|||||||++|||+| |+.||... ...+....+... +.+.+ ..++
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~-----~~~~~~~~i~~~~~~~~~----~~~~ 407 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-----VNREVLDQVERGYRMPCP----PECP 407 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHHTTCCCCCC----TTSC
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHcCCCCCCC----CCCC
Confidence 123356789999999998999999999999999999999 99998521 111222222222 22222 3456
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
+.+.++|.+||+.||++|||++++++.|+++..
T Consensus 408 ~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 408 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 678999999999999999999999999999854
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=324.56 Aligned_cols=229 Identities=19% Similarity=0.261 Sum_probs=169.9
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccC------C
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHP------R 546 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~------~ 546 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||++...... +++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 56899999999999999999995 67999999998654322 122222 3
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
..|+||||+ +++|.+++... .+++..+..++.||++||+|||+. ||+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 569999999 77999998753 388999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhcccc----------ccc-----
Q 041438 627 KFLNLDSSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------SSS----- 690 (752)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~----------~~~----- 690 (752)
+..... ....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ...
T Consensus 176 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 176 RQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp EECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 876432 344688999999999877 6789999999999999999999999863211000 000
Q ss_pred ---cchHhhhccCCCCCC----hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 691 ---NMNIEILDSRLPYPS----LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 691 ---~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.............+. ......++.+.+++.+||+.||++|||++|+++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000000000000 0112345678999999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=311.60 Aligned_cols=229 Identities=23% Similarity=0.303 Sum_probs=181.9
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~ 552 (752)
..++|++.+.||+|+||.||+|+. .+++.||||++...... +++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 457899999999999999999995 47899999987543211 3445667889999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 85 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999987543 488899999999999999999999 9999999999999999999999999999876432
Q ss_pred C--CCcccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 633 S--SNWSKLAGTHGNVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 633 ~--~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
. .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ................+ ...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~--~~~ 232 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS----DSCQEYSDWKEKKTYLN--PWK 232 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC----TTSHHHHHHHTTCTTST--TGG
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc----hHHHHHHHhhhcccccC--chh
Confidence 2 12234578999999999987765 789999999999999999999985211 11111222222222111 123
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..+..+.+++.+||+.||++|||++|+++|
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 233 KIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred hcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 456678899999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.75 Aligned_cols=223 Identities=25% Similarity=0.374 Sum_probs=183.1
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC---------------------------CCccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP---------------------------DNFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------------------------~~~~~~~~~~~lV 551 (752)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 57899999999999999999995 4688999998743210 0445567889999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+.....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999997543 488899999999999999999999 999999999999999999999999999976543
Q ss_pred CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||... ........+.......+ ...
T Consensus 167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~~~~~~~~~~~~~~----~~~ 235 (284)
T 2vgo_A 167 L--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP-----SHTETHRRIVNVDLKFP----PFL 235 (284)
T ss_dssp S--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHTTCCCCC----TTS
T ss_pred c--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC-----CHhHHHHHHhccccCCC----CcC
Confidence 2 223457999999999999999999999999999999999999998521 12222333444444443 234
Q ss_pred HHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 712 FMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+.++.+++.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 236 SDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred CHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 5578899999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.20 Aligned_cols=235 Identities=22% Similarity=0.327 Sum_probs=174.5
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV 551 (752)
..++|++.+.||+|+||.||+|+. .+|+.||||++...... +++...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 357899999999999999999995 46899999987543322 445667889999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||++++++.++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.++....
T Consensus 103 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999988888865433 388999999999999999999999 999999999999999999999999999987665
Q ss_pred CCCCcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccccccc---------cchHhh-----
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS---------NMNIEI----- 696 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~---------~~~~~~----- 696 (752)
.........||+.|+|||++.+. .++.++||||+||++|||++|+.||........... ......
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 44444556899999999998875 689999999999999999999999853211000000 000000
Q ss_pred --hccCCC---CCC---hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 697 --LDSRLP---YPS---LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 697 --~~~~~~---~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.....+ ... ......++.+.+++.+||+.||++|||++|+++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 000 0112345679999999999999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=314.71 Aligned_cols=229 Identities=20% Similarity=0.282 Sum_probs=186.5
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------------Cccc
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------------NFCS 543 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------------~~~~ 543 (752)
..++|++.+.||+|+||.||+|+. .+|+.||||+++..... +++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 467899999999999999999995 57899999988543210 3455
Q ss_pred cCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeec
Q 041438 544 HPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDF 623 (752)
Q Consensus 544 ~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~Df 623 (752)
.....++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 667889999999999999999754 3488899999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCCCcccccCCCCccCccccc------cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhh
Q 041438 624 RIAKFLNLDSSNWSKLAGTHGNVAPELAY------TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEIL 697 (752)
Q Consensus 624 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 697 (752)
|.+....... ......|++.|+|||++. ...++.++|||||||++|||++|+.||.. .........+.
T Consensus 169 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-----~~~~~~~~~~~ 242 (298)
T 1phk_A 169 GFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-----RKQMLMLRMIM 242 (298)
T ss_dssp TTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHH
T ss_pred cchhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC-----ccHHHHHHHHh
Confidence 9998765332 334457999999999875 45688999999999999999999999852 11222333344
Q ss_pred ccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 698 DSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 698 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
......+.......+..+.+++.+||+.||++|||++|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 243 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 444444433335567789999999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=321.17 Aligned_cols=233 Identities=28% Similarity=0.410 Sum_probs=179.1
Q ss_pred hcccccceeeccCCceEEEEEEeCC-----CcEEEEEccCCCCCC-------------------------CccccCCceE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPS-----GEIFAVKKFHSPLPD-------------------------NFCSHPRQSF 549 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-------------------------~~~~~~~~~~ 549 (752)
.++|++.+.||+|+||.||+|+... +..||||+++..... +++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4578889999999999999998532 346999998754221 3455677899
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+||||+++|+|.+++.... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999997543 3488999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCC---cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc-CCCCC
Q 041438 630 NLDSSN---WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RLPYP 704 (752)
Q Consensus 630 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~ 704 (752)
...... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||... ........+... ..+.+
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~-----~~~~~~~~~~~~~~~~~~ 272 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-----SNHEVMKAINDGFRLPTP 272 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHTTCCCCCC
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC-----CHHHHHHHHHCCCcCCCc
Confidence 543221 122356788999999998899999999999999999999 99998521 111222222222 22222
Q ss_pred ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 705 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
...+..+.+++.+||+.||++||+++|++++|+++...
T Consensus 273 ----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 273 ----MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ----TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 23456788999999999999999999999999987643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=320.39 Aligned_cols=233 Identities=23% Similarity=0.301 Sum_probs=181.6
Q ss_pred cccceeeccCCceEEEEEEe-----CCCcEEEEEccCCCCCC-------------------------Ccccc--CCceEE
Q 041438 503 FDAKHCIGKGGHGSVYIARV-----PSGEIFAVKKFHSPLPD-------------------------NFCSH--PRQSFI 550 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~-------------------------~~~~~--~~~~~l 550 (752)
|++.+.||+|+||.||++.+ .+++.||||+++..... +++.. ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48999999999999998863 36889999998764321 22322 467899
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+++|+|.+++.... +++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 113 v~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999997643 88999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCC---cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccc----cc-----cccchHhhhc
Q 041438 631 LDSSN---WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS----SS-----SSNMNIEILD 698 (752)
Q Consensus 631 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~----~~-----~~~~~~~~~~ 698 (752)
..... .....+|..|+|||++.+..++.++||||+||++|||+||+.||....... .. ..........
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 43321 223467888999999999899999999999999999999999986322100 00 0001112222
Q ss_pred cCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 699 SRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 699 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
.....+. ....+.++.+++.+||+.||++|||++|+++.|+++.
T Consensus 266 ~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 266 RGERLPR--PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp TTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCCCC--CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 2222111 1345567999999999999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=312.82 Aligned_cols=231 Identities=21% Similarity=0.285 Sum_probs=180.3
Q ss_pred hhcccccceeeccCCceEEEEEEeCC----CcEEEEEccCCCCCC-------------------------CccccCCceE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPS----GEIFAVKKFHSPLPD-------------------------NFCSHPRQSF 549 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-------------------------~~~~~~~~~~ 549 (752)
..++|++.+.||+|+||.||+|+... +..||+|.++..... +++ ..+..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII-EEEPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEE-CSSSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEE-cCCCCE
Confidence 45789999999999999999998432 346999998764221 222 245678
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+...
T Consensus 89 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 9999999999999997543 3488899999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCC-CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc-CCCCCCh
Q 041438 630 NLDSS-NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RLPYPSL 706 (752)
Q Consensus 630 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 706 (752)
..... ......+++.|+|||++.+..++.++|||||||++|||+| |+.||... ........+... ..+.+
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~-----~~~~~~~~~~~~~~~~~~-- 236 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL-----ENKDVIGVLEKGDRLPKP-- 236 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-----CGGGHHHHHHHTCCCCCC--
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC-----ChHHHHHHHhcCCCCCCC--
Confidence 53322 1223467889999999998899999999999999999998 99998521 111122222221 22222
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
...++.+.+++.+||+.||++|||++|++++|+++.
T Consensus 237 --~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 237 --DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 234567889999999999999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=314.03 Aligned_cols=234 Identities=22% Similarity=0.301 Sum_probs=180.8
Q ss_pred hhcccccceeeccCCceEEEEEEeCC----CcEEEEEccCCCCCC-------------------------Cc-cccCCce
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPS----GEIFAVKKFHSPLPD-------------------------NF-CSHPRQS 548 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-------------------------~~-~~~~~~~ 548 (752)
...+|++.+.||+|+||.||+|+..+ ...||+|.+...... ++ ....+..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 45678999999999999999998532 336899987653221 22 3345678
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||.++.
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence 99999999999999997543 3478899999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCC----CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCC
Q 041438 629 LNLDSS----NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPY 703 (752)
Q Consensus 629 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 703 (752)
...... ......+|+.|+|||.+.+..+++++||||+||++|||++ |.+||.. .........+.......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 252 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-----VNTFDITVYLLQGRRLL 252 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-----SCTTTHHHHHHTTCCCC
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc-----CCHHHHHHHHhcCCCCC
Confidence 643221 1223467889999999999999999999999999999999 5556531 11222222222222222
Q ss_pred CChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 704 PSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 704 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
.. ...+..+.+++.+||+.||++|||++|+++.|+++..
T Consensus 253 ~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 253 QP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 2345578899999999999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=328.99 Aligned_cols=176 Identities=20% Similarity=0.253 Sum_probs=148.0
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------------CccccCCce
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------------NFCSHPRQS 548 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------------~~~~~~~~~ 548 (752)
..++|++.+.||+|+||.||+|+. .+++.||||+++..... +++...+..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 467899999999999999999985 47889999998643210 233456788
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC--CCCceEEeecccc
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD--LGYEAHVSDFRIA 626 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~--~~~~~kl~DfG~a 626 (752)
++||||+.+ +|.+++..... ..+++..++.++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+|||+|
T Consensus 132 ~lv~e~~~~-~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 132 CLVFEMLSY-NLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEECCCC-BHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEecCCC-CHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999975 99999976532 3488999999999999999999942 11999999999999994 4778999999999
Q ss_pred eeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcc
Q 041438 627 KFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD 680 (752)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~ 680 (752)
+..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 209 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~ 259 (382)
T 2vx3_A 209 CQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS 259 (382)
T ss_dssp EETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 876432 334689999999999999999999999999999999999999996
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=317.23 Aligned_cols=236 Identities=20% Similarity=0.294 Sum_probs=175.4
Q ss_pred HhhcccccceeeccCCceEEEEEEeC----CCcEEEEEccCCCCCC--------------------------CccccCC-
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARVP----SGEIFAVKKFHSPLPD--------------------------NFCSHPR- 546 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--------------------------~~~~~~~- 546 (752)
...++|++.+.||+|+||.||+|+.. +++.||||+++..... +++....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 35678999999999999999999843 4558999998754321 1222222
Q ss_pred ----ceEEEEEeccCCChHHHhccC---ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceE
Q 041438 547 ----QSFIVYEYLESGSLDKILNND---ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAH 619 (752)
Q Consensus 547 ----~~~lV~E~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~k 619 (752)
..++||||+++|+|.+++... .....+++..++.++.||++||.|||+. +|+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence 459999999999999998532 1234589999999999999999999999 999999999999999999999
Q ss_pred EeecccceeccCCCC--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhh
Q 041438 620 VSDFRIAKFLNLDSS--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEI 696 (752)
Q Consensus 620 l~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~ 696 (752)
|+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||... ........+
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~~~~~~~~ 262 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV-----QNHEMYDYL 262 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CGGGHHHHH
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC-----CHHHHHHHH
Confidence 999999987643321 1223467889999999999999999999999999999999 88998521 122222223
Q ss_pred hccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 697 LDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
........ ....++++.+++.+||+.||++|||+++++++|+++.
T Consensus 263 ~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 263 LHGHRLKQ---PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp HTTCCCCC---BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCCCCCC---CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 22221111 1345567899999999999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=313.17 Aligned_cols=230 Identities=25% Similarity=0.343 Sum_probs=177.5
Q ss_pred hhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC----------------------Cc-cccCCceEEEEEec
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD----------------------NF-CSHPRQSFIVYEYL 555 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~-~~~~~~~~lV~E~~ 555 (752)
..++|++.+.||+|+||.||+|+. +|+.||||+++..... ++ ....+..++||||+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 357899999999999999999987 5889999998754321 22 23345789999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 635 (752)
++++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 98 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 9999999997543 23378899999999999999999999 9999999999999999999999999999865432
Q ss_pred cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccC-CCCCChhhHHHHH
Q 041438 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSR-LPYPSLDVQNKFM 713 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 713 (752)
.....+++.|+|||++.+..+++++||||||+++|||+| |+.||... ........+.... ...+ ...++
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-----~~~~~~~~~~~~~~~~~~----~~~~~ 241 (278)
T 1byg_A 171 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRVEKGYKMDAP----DGCPP 241 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-----CGGGHHHHHTTTCCCCCC----TTCCH
T ss_pred ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHhcCCCCCCc----ccCCH
Confidence 223467889999999998899999999999999999998 99998521 1112222222221 1111 34556
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
.+.+++.+||+.||++|||++|+++.|+++..
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 242 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 78999999999999999999999999998753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=329.83 Aligned_cols=220 Identities=17% Similarity=0.104 Sum_probs=169.8
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------------------C
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------------------N 540 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------------------~ 540 (752)
..++|++.+.||+|+||.||+|+. .+|+.||||++...... +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 357899999999999999999994 67999999998532110 0
Q ss_pred ccccCC-----------------ceEEEEEeccCCChHHHhccCcc----ccccCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 041438 541 FCSHPR-----------------QSFIVYEYLESGSLDKILNNDAS----AKELGWTQRLNVIKGVADALFYLHNNCFPP 599 (752)
Q Consensus 541 ~~~~~~-----------------~~~lV~E~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ 599 (752)
++..++ ..|+||||+ +|+|.+++..... ...+++..+..|+.||+.||+|||++ +
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 111111 378999999 5799999975421 12345688889999999999999999 9
Q ss_pred eeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcccccCCCCccCccccccC-----------CCCCccchhhHHHH
Q 041438 600 IVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTM-----------KVTEKCDVYSFGVL 668 (752)
Q Consensus 600 ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDIwSlGvi 668 (752)
|+||||||+|||++.++.+||+|||+|+... ......+| +.|+|||++.+. .++.++|||||||+
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~---~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETT---CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecC---CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999998643 23344577 999999999887 79999999999999
Q ss_pred HHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 669 ALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 669 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+|||++|+.||..... ......+.... ...++++.+++.+||+.||++|||+.|+++|
T Consensus 303 l~elltg~~Pf~~~~~-----~~~~~~~~~~~--------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 303 IYWIWCADLPITKDAA-----LGGSEWIFRSC--------KNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHSSCCC-----------CCSGGGGSSC--------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHCCCCCccccc-----ccchhhhhhhc--------cCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999999853211 11111221111 1234568899999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=319.31 Aligned_cols=230 Identities=21% Similarity=0.284 Sum_probs=178.0
Q ss_pred hcccccceeeccCCceEEEEEEe--CCCcEEEEEccCCCCCC-----------------------------CccccCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV--PSGEIFAVKKFHSPLPD-----------------------------NFCSHPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~-----------------------------~~~~~~~~~ 548 (752)
.++|++.+.||+|+||.||+|+. .+++.||||+++..... +++.+.+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 46899999999999999999985 46899999988642110 334566789
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC--------------
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL-------------- 614 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~-------------- 614 (752)
++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence 9999999 7799999976542 3488999999999999999999999 9999999999999987
Q ss_pred -----CCceEEeecccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccccc
Q 041438 615 -----GYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS 689 (752)
Q Consensus 615 -----~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~ 689 (752)
++.+||+|||.++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-- 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH-- 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH--
T ss_pred cccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH--
Confidence 668999999999875432 2345799999999999999999999999999999999999999852211000
Q ss_pred ccchHhhhcc------------------CCCCC-------------------ChhhHHHHHHHHHHHHhccCcCCCCCCC
Q 041438 690 SNMNIEILDS------------------RLPYP-------------------SLDVQNKFMSIMQVAFSCLDQNPVSRPT 732 (752)
Q Consensus 690 ~~~~~~~~~~------------------~~~~~-------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps 732 (752)
.......... ...+. .......++++.+++.+||+.||++|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 0000000000 00000 0011245678999999999999999999
Q ss_pred HHHHHHH
Q 041438 733 MKRFEVQ 739 (752)
Q Consensus 733 ~~evl~~ 739 (752)
++|+++|
T Consensus 323 ~~ell~h 329 (339)
T 1z57_A 323 LREALKH 329 (339)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999876
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.07 Aligned_cols=270 Identities=27% Similarity=0.315 Sum_probs=167.6
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEc
Q 041438 109 PHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLIL 188 (752)
Q Consensus 109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 188 (752)
++|++|+|++|+|+++.|..|+++++|++|+|++|++++..|..|.++++|++|+|++|+++ .+|..+. ++|++|+|
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l 130 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRI 130 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEEC
Confidence 56667777777776666666777777777777777776666666666677777777777666 3444333 56666666
Q ss_pred cCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccC
Q 041438 189 DSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNIT 268 (752)
Q Consensus 189 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 268 (752)
++|++++..+..|.++++|++|+|++|.++..
T Consensus 131 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~------------------------------------------------ 162 (332)
T 2ft3_A 131 HDNRIRKVPKGVFSGLRNMNCIEMGGNPLENS------------------------------------------------ 162 (332)
T ss_dssp CSSCCCCCCSGGGSSCSSCCEEECCSCCCBGG------------------------------------------------
T ss_pred CCCccCccCHhHhCCCccCCEEECCCCccccC------------------------------------------------
Confidence 66666655555566666666666666665420
Q ss_pred CCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhc
Q 041438 269 GNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLG 348 (752)
Q Consensus 269 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 348 (752)
+..|..+..+ +|++|++++|.+++ +|..+. ++|+.|++++|++++..+..|..+++|++|+|++|++++..+..|.
T Consensus 163 ~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 238 (332)
T 2ft3_A 163 GFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLS 238 (332)
T ss_dssp GSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGG
T ss_pred CCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhh
Confidence 1222222223 34444444444432 222222 3455555555555555555666666666666666666666666666
Q ss_pred ccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCccccc------ccccceEEccCCcCC--cCCchhhh
Q 041438 349 SLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICR------MESLEKLNLSYNNLS--GLIPRCFE 420 (752)
Q Consensus 349 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~------l~~L~~L~L~~N~l~--~~~p~~~~ 420 (752)
.+++|++|+|++|+++ .+|..+..+++|++|++++|++++..+..|+. ...|+.|++++|.+. +..|..|.
T Consensus 239 ~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~ 317 (332)
T 2ft3_A 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR 317 (332)
T ss_dssp GCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGT
T ss_pred CCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCccccc
Confidence 6677777777777765 55666677777777777777777666666554 356888888888887 67778888
Q ss_pred ccCCCcEEEccCCc
Q 041438 421 ELHGLLHIDISYNK 434 (752)
Q Consensus 421 ~l~~L~~L~ls~N~ 434 (752)
.+++|+.+++++|+
T Consensus 318 ~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 318 CVTDRLAIQFGNYK 331 (332)
T ss_dssp TBCCSTTEEC----
T ss_pred ccchhhhhhccccc
Confidence 88888888888875
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.64 Aligned_cols=280 Identities=22% Similarity=0.285 Sum_probs=216.3
Q ss_pred CCcccceeeCCC----------CCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecC
Q 041438 72 LCTWSGIHCNHA----------GRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFL 141 (752)
Q Consensus 72 ~c~w~gv~C~~~----------~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 141 (752)
.|.|..+.|... ..+..++++++.+.+ +.+..|..+++|++|+|++|+|+++.|..|+++++|++|+|+
T Consensus 32 ~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 32 HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISE-LRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCc-cCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 478999999632 257789999888874 445679999999999999999999999999999999999999
Q ss_pred CCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCC--CcCCcCccCCCcceEEeeccccccc
Q 041438 142 TNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLG--GSIPRSLSNFTNLVFLYLYNNSFSG 219 (752)
Q Consensus 142 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~ 219 (752)
+|+++. +|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|.++ +..|..|..+ +|++|++++|++++
T Consensus 111 ~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 111 KNHLVE-IPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp SSCCCS-CCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCcCCc-cCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 999994 555444 89999999999999887888999999999999999996 4788888888 89999999999885
Q ss_pred cccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccc
Q 041438 220 SIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQL 299 (752)
Q Consensus 220 ~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 299 (752)
+|..+. ++|++|++++|.+++..+..+..+++|++|+|++|.+++..+..+
T Consensus 187 -l~~~~~----------------------------~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~ 237 (332)
T 2ft3_A 187 -IPKDLP----------------------------ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSL 237 (332)
T ss_dssp -CCSSSC----------------------------SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGG
T ss_pred -cCcccc----------------------------CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHh
Confidence 333221 345566777777776666777777777777888777777777777
Q ss_pred cCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhccc------ccccEEEcCCCcCc--cccchhc
Q 041438 300 GNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSL------VKLYYLNLSHNKLS--QQIPIEL 371 (752)
Q Consensus 300 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l------~~L~~L~Ls~N~l~--~~~p~~~ 371 (752)
..+++|+.|++++|+++ .+|..+..+++|++|+|++|+|+++.+..|... ..|+.|++++|.+. +..|..|
T Consensus 238 ~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~ 316 (332)
T 2ft3_A 238 SFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATF 316 (332)
T ss_dssp GGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGG
T ss_pred hCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccc
Confidence 77777777777777777 566667777777777777777777766666543 45667777777665 4556666
Q ss_pred cccccCCeeecCCcc
Q 041438 372 DNLIHLSELDLSHNF 386 (752)
Q Consensus 372 ~~l~~L~~L~Ls~N~ 386 (752)
..+++|+.|++++|+
T Consensus 317 ~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 317 RCVTDRLAIQFGNYK 331 (332)
T ss_dssp TTBCCSTTEEC----
T ss_pred cccchhhhhhccccc
Confidence 666666666666653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.50 Aligned_cols=235 Identities=21% Similarity=0.292 Sum_probs=159.9
Q ss_pred hhcccccce-eeccCCceEEEEEEeC-CCcEEEEEccCCCCCC--------------------Ccccc----CCceEEEE
Q 041438 499 ATNDFDAKH-CIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD--------------------NFCSH----PRQSFIVY 552 (752)
Q Consensus 499 ~~~~y~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------------~~~~~----~~~~~lV~ 552 (752)
..++|++.+ .||+|+||.||+|+.. +++.||||++...... +++.. ....++||
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 367898855 6999999999999954 7999999988543111 12221 34579999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC---CCceEEeecccceec
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL---GYEAHVSDFRIAKFL 629 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~---~~~~kl~DfG~a~~~ 629 (752)
||+++|+|.+++..... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+++..
T Consensus 106 e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 106 ECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp ECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred eccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 99999999999986542 3589999999999999999999999 9999999999999976 455999999999876
Q ss_pred cCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 630 NLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ........+.......+.....
T Consensus 182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 258 (336)
T 3fhr_A 182 TQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA-ISPGMKRRIRLGQYGFPNPEWS 258 (336)
T ss_dssp ------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------CCCTTTST
T ss_pred ccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchh-hhhhHHHhhhccccccCchhhc
Confidence 432 2334578999999999988889999999999999999999999985322111 0111111222222223322234
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
..+.++.+++.+||+.||++|||++|+++|-
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 259 EVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 5567899999999999999999999999853
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.55 Aligned_cols=271 Identities=26% Similarity=0.318 Sum_probs=159.4
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEc
Q 041438 109 PHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLIL 188 (752)
Q Consensus 109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 188 (752)
++|++|+|++|+|+++.+..|+++++|++|+|++|++++..|..|.++++|++|+|++|+|+ .+|..+. ++|++|++
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l 128 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRV 128 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEEC
Confidence 45666666666666655555666666666666666666555555666666666666666655 3333332 45555555
Q ss_pred cCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccC
Q 041438 189 DSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNIT 268 (752)
Q Consensus 189 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 268 (752)
++|++++..+..|.++++|++|+|++|.++. .
T Consensus 129 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~------------------------------------------------~ 160 (330)
T 1xku_A 129 HENEITKVRKSVFNGLNQMIVVELGTNPLKS------------------------------------------------S 160 (330)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCG------------------------------------------------G
T ss_pred CCCcccccCHhHhcCCccccEEECCCCcCCc------------------------------------------------c
Confidence 5555555444445555555555555555432 0
Q ss_pred CCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhc
Q 041438 269 GNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLG 348 (752)
Q Consensus 269 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 348 (752)
+..+..+..+++|++|++++|.++. +|..+. ++|+.|++++|++++..|..|..+++|++|+|++|.+++..+..|.
T Consensus 161 ~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 237 (330)
T 1xku_A 161 GIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA 237 (330)
T ss_dssp GBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGG
T ss_pred CcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhcc
Confidence 1223333444444444444444442 222222 4556666666666655566666666666666666666666666666
Q ss_pred ccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccc------cccceEEccCCcCCc--CCchhhh
Q 041438 349 SLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRM------ESLEKLNLSYNNLSG--LIPRCFE 420 (752)
Q Consensus 349 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l------~~L~~L~L~~N~l~~--~~p~~~~ 420 (752)
.+++|++|+|++|+++ .+|..+..+++|++|+|++|++++..+..|+.. ..|+.|++++|.+.. +.|..|.
T Consensus 238 ~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~ 316 (330)
T 1xku_A 238 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316 (330)
T ss_dssp GSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGT
T ss_pred CCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccc
Confidence 6666777777777665 556666667777777777777766666666433 677888888888764 6677888
Q ss_pred ccCCCcEEEccCCc
Q 041438 421 ELHGLLHIDISYNK 434 (752)
Q Consensus 421 ~l~~L~~L~ls~N~ 434 (752)
.+.+++.++|++|+
T Consensus 317 ~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 317 CVYVRAAVQLGNYK 330 (330)
T ss_dssp TCCCGGGEEC----
T ss_pred cccceeEEEecccC
Confidence 88888888888875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=320.54 Aligned_cols=234 Identities=24% Similarity=0.362 Sum_probs=182.4
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEE--EEEccCCCCCC--------------------------CccccCCceEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIF--AVKKFHSPLPD--------------------------NFCSHPRQSFI 550 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~v--avK~~~~~~~~--------------------------~~~~~~~~~~l 550 (752)
.++|++.+.||+|+||.||+|+. .+++.+ |+|.++..... +++.+.+..|+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 47899999999999999999984 456654 99987542111 34456678899
Q ss_pred EEEeccCCChHHHhccCc-------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCc
Q 041438 551 VYEYLESGSLDKILNNDA-------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE 617 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~ 617 (752)
||||+++|+|.+++.... ....+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999997653 123589999999999999999999999 9999999999999999999
Q ss_pred eEEeecccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhh
Q 041438 618 AHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEI 696 (752)
Q Consensus 618 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~ 696 (752)
+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|||+| |+.||... ........+
T Consensus 181 ~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~-----~~~~~~~~~ 254 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-----TCAELYEKL 254 (327)
T ss_dssp EEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHG
T ss_pred EEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC-----cHHHHHHHh
Confidence 999999999754322 12223467889999999988889999999999999999998 99998521 111122222
Q ss_pred hcc-CCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 697 LDS-RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 697 ~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
... ....+ ...++++.+++.+||+.||++|||++|++++|+++...
T Consensus 255 ~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 255 PQGYRLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp GGTCCCCCC----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hcCCCCCCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 222 11122 23456789999999999999999999999999987643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=318.76 Aligned_cols=228 Identities=23% Similarity=0.269 Sum_probs=178.4
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------------CccccCC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------------NFCSHPR 546 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------------~~~~~~~ 546 (752)
.++|++.+.||+|+||.||+|+. .+++.||||++...... +++. .+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE-SS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc-CC
Confidence 46899999999999999999985 56899999988643210 2222 34
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCc---eEEeec
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE---AHVSDF 623 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~---~kl~Df 623 (752)
..|+||||+++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp SEEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred ceEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 5899999999999999987543 488899999999999999999999 9999999999999987654 999999
Q ss_pred ccceeccCCCCCcccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccC
Q 041438 624 RIAKFLNLDSSNWSKLAGTHGNVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR 700 (752)
Q Consensus 624 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 700 (752)
|+++..... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||.... ........+....
T Consensus 162 g~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~ 236 (322)
T 2ycf_A 162 GHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR----TQVSLKDQITSGK 236 (322)
T ss_dssp TTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT----CSSCHHHHHHHTC
T ss_pred ccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc----hHHHHHHHHHhCc
Confidence 999876432 1223457999999999864 5668999999999999999999999985211 1122233333344
Q ss_pred CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 701 LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 701 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...........+.++.+++.+||+.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 237 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 433322234456789999999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=323.53 Aligned_cols=236 Identities=22% Similarity=0.311 Sum_probs=185.1
Q ss_pred hhcccccceeeccCCceEEEEEEeC-CC-----cEEEEEccCCCCCC--------------------------CccccCC
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP-SG-----EIFAVKKFHSPLPD--------------------------NFCSHPR 546 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~~~--------------------------~~~~~~~ 546 (752)
..++|++.+.||+|+||.||+|+.. ++ ..||+|.++..... +++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 3578999999999999999999853 22 47999988654211 4455677
Q ss_pred ceEEEEEeccCCChHHHhccCcc-----------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC
Q 041438 547 QSFIVYEYLESGSLDKILNNDAS-----------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG 615 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~ 615 (752)
..++||||+++|+|.+++..... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC
Confidence 89999999999999999975421 23478899999999999999999999 99999999999999999
Q ss_pred CceEEeecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccc
Q 041438 616 YEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNM 692 (752)
Q Consensus 616 ~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~ 692 (752)
+.+||+|||+++........ .....+|+.|+|||++.+..++.++|||||||++|||+| |..||... .....
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-----~~~~~ 275 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI-----LVNSK 275 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC-----CSSHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc-----chhHH
Confidence 99999999999876543322 123457889999999999899999999999999999998 99998521 11112
Q ss_pred hHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 693 NIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
...........+. ....+..+.+++.+||+.||++|||++|++++|+++.
T Consensus 276 ~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 276 FYKLVKDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 2222222221111 1223567889999999999999999999999998864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.45 Aligned_cols=237 Identities=22% Similarity=0.305 Sum_probs=176.6
Q ss_pred hHHHHHHhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------Ccccc--
Q 041438 492 VYEEIIRATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSH-- 544 (752)
Q Consensus 492 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~-- 544 (752)
.++++....++|++.+.||+|+||.||+|+. .+++.||||++...... +++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3344455788999999999999999999995 57999999987543221 12222
Q ss_pred ----CCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEE
Q 041438 545 ----PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV 620 (752)
Q Consensus 545 ----~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl 620 (752)
....++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEE
Confidence 467899999999999999997643 24588999999999999999999999 9999999999999999999999
Q ss_pred eecccceeccCCCCCcccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHh
Q 041438 621 SDFRIAKFLNLDSSNWSKLAGTHGNVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE 695 (752)
Q Consensus 621 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~ 695 (752)
+|||++..............||+.|+|||++. +..++.++|||||||++|+|++|+.||.... .......
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~ 245 (326)
T 2x7f_A 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-----PMRALFL 245 (326)
T ss_dssp CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHH
T ss_pred eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc-----HHHHHHH
Confidence 99999987654333334457999999999987 5668999999999999999999999985211 1111112
Q ss_pred hhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 696 ILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+.....+.. .....+..+.+++.+||+.||++||+++|+++|
T Consensus 246 ~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 246 IPRNPAPRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHSCCCCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhcCccccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 222111111 112345678899999999999999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=322.74 Aligned_cols=226 Identities=25% Similarity=0.322 Sum_probs=178.9
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV 551 (752)
.+.|++.+.||+|+||.||+|+. .+++.||||++...... +++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45699999999999999999994 68999999988643221 345567889999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+.+ ++.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 133 ~e~~~g-~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCLG-SASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCSE-EHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 999984 8888875432 3488999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCCcccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhh
Q 041438 632 DSSNWSKLAGTHGNVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (752)
. ....||+.|+|||++. +..++.++|||||||++|||++|+.||.... .......+.....+.. ..
T Consensus 207 ~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~-----~~~~~~~~~~~~~~~~--~~ 275 (348)
T 1u5q_A 207 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQNESPAL--QS 275 (348)
T ss_dssp B----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSCCCCC--CC
T ss_pred C----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhcCCCCC--CC
Confidence 2 3357999999999874 5678999999999999999999999985211 1111222222222211 11
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhh
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQ 742 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 742 (752)
...+..+.+++.+||+.||++|||++|+++|.--
T Consensus 276 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 276 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 2345678899999999999999999999987543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=315.95 Aligned_cols=231 Identities=23% Similarity=0.339 Sum_probs=181.8
Q ss_pred Hhhcccccce-eeccCCceEEEEEEe---CCCcEEEEEccCCCCCC--------------------------CccccCCc
Q 041438 498 RATNDFDAKH-CIGKGGHGSVYIARV---PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQ 547 (752)
Q Consensus 498 ~~~~~y~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~--------------------------~~~~~~~~ 547 (752)
...++|++.+ .||+|+||.||+|.. .+++.||||+++..... +++ ..+.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 3457888888 999999999999963 45789999998754321 223 4567
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred cEEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 899999999999999997643 488899999999999999999999 99999999999999999999999999998
Q ss_pred eccCCCCCc---ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccC-CC
Q 041438 628 FLNLDSSNW---SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSR-LP 702 (752)
Q Consensus 628 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~ 702 (752)
......... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||... ........+.... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~~~~~~~~~~~~~~ 240 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-----KGSEVTAMLEKGERMG 240 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHHTTCCCC
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHHHcCCCCC
Confidence 765433211 22356788999999988889999999999999999999 99998521 1111222222221 12
Q ss_pred CCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 703 YPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 703 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
.+ ...++.+.+++.+||+.||++||+++|+++.|+++.
T Consensus 241 ~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 241 CP----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp CC----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 22 345567899999999999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=318.99 Aligned_cols=240 Identities=19% Similarity=0.311 Sum_probs=182.4
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------Cccc----cCCceE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCS----HPRQSF 549 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~----~~~~~~ 549 (752)
..++|++.+.||+|+||.||+|+. .+++.||||++...... +++. .....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 357899999999999999999995 68999999987432111 2222 234778
Q ss_pred EEEEeccCCChHHHhccCc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 550 IVYEYLESGSLDKILNNDA-SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
+||||+++|+|.+++.... ....+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999987532 124589999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCC---------cccccCCCCccCccccccCC---CCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhh
Q 041438 629 LNLDSSN---------WSKLAGTHGNVAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEI 696 (752)
Q Consensus 629 ~~~~~~~---------~~~~~gt~~y~aPE~~~~~~---~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 696 (752)
....... .....||+.|+|||++.+.. +++++|||||||++|||++|+.||........ . ....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~-~~~~ 259 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---S-VALA 259 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS---C-HHHH
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc---h-hhHH
Confidence 5321111 11235799999999987654 68999999999999999999999864322111 1 1111
Q ss_pred hccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCC
Q 041438 697 LDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNP 747 (752)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 747 (752)
.......+. ....+.++.+++.+||+.||++|||++|++++|+++...+
T Consensus 260 ~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 260 VQNQLSIPQ--SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp HHCC--CCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred hhccCCCCc--cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 112222221 1334567899999999999999999999999999986544
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=312.81 Aligned_cols=224 Identities=23% Similarity=0.348 Sum_probs=173.7
Q ss_pred hcccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCC---C------------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLP---D------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~------------------------~~~~~~~~~~lV 551 (752)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... . +++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 478999999999999999999964 799999998743210 0 445567889999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+++++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+.....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999997543 478899999999999999999999 999999999999999999999999999987653
Q ss_pred CCCCcccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
.. ......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.. .........+.......+ ..
T Consensus 164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-----~~~~~~~~~~~~~~~~~~----~~ 233 (276)
T 2h6d_A 164 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-----EHVPTLFKKIRGGVFYIP----EY 233 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHHCCCCCC----TT
T ss_pred Cc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC-----CcHHHHHHHhhcCcccCc----hh
Confidence 22 2334578999999999887765 6899999999999999999999852 111222233333333333 22
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.+..+.+++.+||+.||++|||++|+++|
T Consensus 234 ~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 234 LNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 34568899999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=320.53 Aligned_cols=236 Identities=24% Similarity=0.317 Sum_probs=181.5
Q ss_pred hcccccceeeccCCceEEEEEEe------CCCcEEEEEccCCCCCC-------------------------CccccCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV------PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~ 548 (752)
.++|++.+.||+|+||.||+|+. .+++.||||++...... +++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 57899999999999999999983 35789999998643221 345566788
Q ss_pred EEEEEeccCCChHHHhccCcc----ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC---CCceEEe
Q 041438 549 FIVYEYLESGSLDKILNNDAS----AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL---GYEAHVS 621 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~---~~~~kl~ 621 (752)
|+||||+++++|.+++..... ...+++..++.++.|++.||.|||+. +|+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999986532 13488999999999999999999999 9999999999999984 4469999
Q ss_pred ecccceeccCCCC--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhc
Q 041438 622 DFRIAKFLNLDSS--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILD 698 (752)
Q Consensus 622 DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 698 (752)
|||++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||... ........+..
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-----~~~~~~~~~~~ 260 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-----SNQEVLEFVTS 260 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHHHHHHHHHT
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc-----CHHHHHHHHhc
Confidence 9999986543221 1223467899999999998899999999999999999998 99998521 11122222222
Q ss_pred cCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 699 SRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 699 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
....... ...+..+.+++.+||+.||++||+++|++++++.+...
T Consensus 261 ~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 261 GGRMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp TCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCC---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 2211111 23456788999999999999999999999999987543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=328.36 Aligned_cols=236 Identities=19% Similarity=0.190 Sum_probs=171.8
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC--------------------Ccc------ccCCceEEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD--------------------NFC------SHPRQSFIVYE 553 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------~~~------~~~~~~~lV~E 553 (752)
..+|++.+.||+|+||.||+|+...+..||+|++...... +++ ......++|||
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 4579999999999999999999877777999987543221 122 12223789999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC-CCCceEEeecccceeccCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD-LGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~-~~~~~kl~DfG~a~~~~~~ 632 (752)
|++++.+............+++..++.++.||++||+|||+. ||+||||||+||+++ .++.+||+|||+|+.....
T Consensus 119 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 119 YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp CCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 998844333332222234588999999999999999999999 999999999999999 7899999999999876533
Q ss_pred CCCcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccccc----------cccchH----hhh
Q 041438 633 SSNWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------SSNMNI----EIL 697 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~----------~~~~~~----~~~ 697 (752)
. ......||+.|+|||++.+. .++.++||||+||++|||++|+.||......... ..+... ...
T Consensus 196 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 274 (394)
T 4e7w_A 196 E-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM 274 (394)
T ss_dssp C-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred C-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 3 23445789999999998765 4899999999999999999999999632110000 000000 000
Q ss_pred ccCCCC-CChh-----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 698 DSRLPY-PSLD-----VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 698 ~~~~~~-~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
....+. .... ....++++.+++.+||+.||++|||+.|+++|
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 011110 0000 01245679999999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=321.41 Aligned_cols=231 Identities=19% Similarity=0.216 Sum_probs=167.6
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Ccccc------CC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSH------PR 546 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~------~~ 546 (752)
.++|++.+.||+|+||.||+|+. .+++.||||++...... +++.. ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 47899999999999999999984 57899999998653221 12222 23
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
..|+||||+++ +|.+.+.. .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 68999999986 78888752 378899999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccc----------c-------
Q 041438 627 KFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------S------- 689 (752)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~----------~------- 689 (752)
+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......... .
T Consensus 175 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 175 RTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred cccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 876432 2233458999999999999999999999999999999999999999532110000 0
Q ss_pred ccchHhhhccCC----------------CCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 690 SNMNIEILDSRL----------------PYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 690 ~~~~~~~~~~~~----------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
............ +.........+.++.+++.+||+.||++|||++|+++|-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 000000000111 111111223467899999999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=334.30 Aligned_cols=233 Identities=19% Similarity=0.230 Sum_probs=161.0
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Ccc-----ccCCc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFC-----SHPRQ 547 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~-----~~~~~ 547 (752)
.++|++.+.||+|+||.||+|+. .+++.||||++...... +++ .....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 47899999999999999999984 57999999988654322 122 23356
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
.|+||||+. ++|.+++.... .+++..++.+++||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 899999986 59999987543 488999999999999999999999 99999999999999999999999999998
Q ss_pred eccCCCC---------------------------CcccccCCCCccCcccc-ccCCCCCccchhhHHHHHHHHHh-----
Q 041438 628 FLNLDSS---------------------------NWSKLAGTHGNVAPELA-YTMKVTEKCDVYSFGVLALEVIK----- 674 (752)
Q Consensus 628 ~~~~~~~---------------------------~~~~~~gt~~y~aPE~~-~~~~~~~ksDIwSlGvil~ellt----- 674 (752)
....... .....+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 7643211 12345789999999976 46679999999999999999999
Q ss_pred ------CCCCcchhhcccccc---------------ccch-----------------------Hhhhcc---CCCCC-Ch
Q 041438 675 ------GKHPRDFLFEMSSSS---------------SNMN-----------------------IEILDS---RLPYP-SL 706 (752)
Q Consensus 675 ------g~~pf~~~~~~~~~~---------------~~~~-----------------------~~~~~~---~~~~~-~~ 706 (752)
|+++|.......... .... ...... ..... ..
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 555553211000000 0000 000000 00000 00
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.....++++.+|+.+||..||++|||++|+++|
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 112335678999999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=327.92 Aligned_cols=173 Identities=24% Similarity=0.361 Sum_probs=141.9
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccC-----Cc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHP-----RQ 547 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~-----~~ 547 (752)
.++|++.+.||+|+||.||+|+. .+++.||||+++..... +++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 57899999999999999999994 57899999998754322 122222 56
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
.|+||||+.+ +|.+++.... .+++..++.+++||++||+|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 105 ~~lv~e~~~~-~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIADS-DLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCSE-EHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCCc-CHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 8999999975 9999997543 488999999999999999999999 99999999999999999999999999999
Q ss_pred eccCCCC----------------------CcccccCCCCccCcccc-ccCCCCCccchhhHHHHHHHHHhCCCCc
Q 041438 628 FLNLDSS----------------------NWSKLAGTHGNVAPELA-YTMKVTEKCDVYSFGVLALEVIKGKHPR 679 (752)
Q Consensus 628 ~~~~~~~----------------------~~~~~~gt~~y~aPE~~-~~~~~~~ksDIwSlGvil~elltg~~pf 679 (752)
....... .....+||+.|+|||++ .+..++.++||||+||++|||++|..||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 7654321 12456899999999986 4566999999999999999999876665
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=317.27 Aligned_cols=231 Identities=23% Similarity=0.328 Sum_probs=169.6
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV 551 (752)
..++|++.+.||+|+||.||+|+. .+|+.||||+++..... +++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 357899999999999999999995 68999999988654221 345567889999
Q ss_pred EEeccCCChHHHhccC-ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 552 YEYLESGSLDKILNND-ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
|||+++ +|.+++... .....+++..++.++.|++.||+|||+++ ||+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999985 888877642 12345899999999999999999999853 89999999999999999999999999998765
Q ss_pred CCCCCcccccCCCCccCcccc----ccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCCh
Q 041438 631 LDSSNWSKLAGTHGNVAPELA----YTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (752)
... ......||+.|+|||++ .+..++.++||||+||++|||++|+.||+.. ...............+..
T Consensus 162 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~~~-- 234 (290)
T 3fme_A 162 DDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW----GTPFQQLKQVVEEPSPQL-- 234 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC----SCHHHHHHHHHHSCCCCC--
T ss_pred ccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc----CchHHHHHHHhccCCCCc--
Confidence 332 22334799999999996 4567899999999999999999999998521 111112222222222211
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.....++++.+++.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 113455678999999999999999999999974
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=326.57 Aligned_cols=232 Identities=21% Similarity=0.235 Sum_probs=173.3
Q ss_pred HhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------Ccc--------------
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------NFC-------------- 542 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------~~~-------------- 542 (752)
...++|++.+.||+|+||.||+|+. .+|+.||||++...... +++
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 4578899999999999999999984 68999999987543221 111
Q ss_pred ------------------------ccCCceEEEEEeccCCChHHHhccC-ccccccCHHHHHHHHHHHHHHHHHHHhCCC
Q 041438 543 ------------------------SHPRQSFIVYEYLESGSLDKILNND-ASAKELGWTQRLNVIKGVADALFYLHNNCF 597 (752)
Q Consensus 543 ------------------------~~~~~~~lV~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~ 597 (752)
......++||||+++ +|.+.+... .....+++..++.++.||++||+|||+.
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 160 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-- 160 (383)
T ss_dssp --------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 223347899999985 888777642 1224588999999999999999999999
Q ss_pred CCeeecCCCCCCEEeC-CCCceEEeecccceeccCCCCCcccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhC
Q 041438 598 PPIVHWDISSKNVLLD-LGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKG 675 (752)
Q Consensus 598 ~~ivH~DlKp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg 675 (752)
||+||||||+||+++ .++.+||+|||+|+...... ......||+.|+|||++.+.. ++.++||||+||++|||++|
T Consensus 161 -gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 238 (383)
T 3eb0_A 161 -GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238 (383)
T ss_dssp -TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred -cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhC
Confidence 999999999999997 68899999999999765333 334457899999999887754 89999999999999999999
Q ss_pred CCCcchhhccccccccchHhhhc--------------cC---CCCCC---hh-----hHHHHHHHHHHHHhccCcCCCCC
Q 041438 676 KHPRDFLFEMSSSSSNMNIEILD--------------SR---LPYPS---LD-----VQNKFMSIMQVAFSCLDQNPVSR 730 (752)
Q Consensus 676 ~~pf~~~~~~~~~~~~~~~~~~~--------------~~---~~~~~---~~-----~~~~~~~l~~li~~cl~~dP~~R 730 (752)
+.||...... +....+.. .. ..++. .. ....+.++.+++.+||+.||++|
T Consensus 239 ~~pf~~~~~~-----~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 239 KPLFSGETSI-----DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp SCSSCCSSHH-----HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred CCCCCCCChH-----HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 9999632110 11111100 00 00000 00 11245568999999999999999
Q ss_pred CCHHHHHHH
Q 041438 731 PTMKRFEVQ 739 (752)
Q Consensus 731 ps~~evl~~ 739 (752)
||+.|+++|
T Consensus 314 ~t~~e~l~h 322 (383)
T 3eb0_A 314 INPYEAMAH 322 (383)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHhcC
Confidence 999999865
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=313.09 Aligned_cols=229 Identities=24% Similarity=0.283 Sum_probs=176.9
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEec
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~~ 555 (752)
++|.....||+|+||.||+|+. .+++.||||.+...... +++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455566999999999999994 57889999987654321 3455667889999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC-CCceEEeecccceeccCCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL-GYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~-~~~~kl~DfG~a~~~~~~~~ 634 (752)
++++|.+++........+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||.+........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999998654444567889999999999999999999 9999999999999987 89999999999987654333
Q ss_pred CcccccCCCCccCccccccCC--CCCccchhhHHHHHHHHHhCCCCcchhhccccccccchH-hhhccCCCCCChhhHHH
Q 041438 635 NWSKLAGTHGNVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI-EILDSRLPYPSLDVQNK 711 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~--~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 711 (752)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ....... .........+ ...
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~----~~~ 251 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE---PQAAMFKVGMFKVHPEIP----ESM 251 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS---HHHHHHHHHHHCCCCCCC----TTS
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc---hhHHHHhhcccccccccc----ccC
Confidence 334557999999999987653 78999999999999999999999852111 0111111 1111112222 234
Q ss_pred HHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 712 FMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+.++.+++.+||+.||++||+++|+++|
T Consensus 252 ~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 252 SAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 5678899999999999999999999865
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.26 Aligned_cols=231 Identities=23% Similarity=0.307 Sum_probs=177.5
Q ss_pred cccccceeeccCCceEEEEEEeC-CC---cEEEEEccCCCCCC-------------------------CccccCC-ceEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVP-SG---EIFAVKKFHSPLPD-------------------------NFCSHPR-QSFI 550 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~-------------------------~~~~~~~-~~~l 550 (752)
-.|++.+.||+|+||.||+|+.. ++ ..||+|++...... +++...+ ..++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 35667799999999999999842 33 37999988653221 2333333 3489
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+.+|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 101 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999997643 3478899999999999999999999 99999999999999999999999999998654
Q ss_pred CCC----CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccC-CCCCC
Q 041438 631 LDS----SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR-LPYPS 705 (752)
Q Consensus 631 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~ 705 (752)
... .......+++.|+|||.+.+..+++++|||||||++|+|++|..|+.. ..........+.... .+.+
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~----~~~~~~~~~~~~~~~~~~~~- 250 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR----HIDPFDLTHFLAQGRRLPQP- 250 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTT----TSCGGGHHHHHHTTCCCCCC-
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCc----cCCHHHHHHHhhcCCCCCCC-
Confidence 321 122334678899999999999999999999999999999996655421 111112222222222 1222
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
...++.+.+++.+||+.||++|||++|+++.|+++.
T Consensus 251 ---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 251 ---EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 234567889999999999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=321.55 Aligned_cols=232 Identities=19% Similarity=0.267 Sum_probs=165.4
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------Ccc--------cc
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFC--------SH 544 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~--------~~ 544 (752)
...+|++.+.||+|+||.||+|+. .+++.||||++...... +++ ..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 346899999999999999999995 57899999987432111 111 33
Q ss_pred CCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCEEeCCCCceEEee
Q 041438 545 PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP--IVHWDISSKNVLLDLGYEAHVSD 622 (752)
Q Consensus 545 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~--ivH~DlKp~NIll~~~~~~kl~D 622 (752)
....++||||+. |+|.+++........+++.+++.++.||+.||+|||+. + |+||||||+||+++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence 445799999997 59999887643344589999999999999999999999 8 99999999999999999999999
Q ss_pred cccceeccCCCCC------------cccccCCCCccCcccc---ccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccc
Q 041438 623 FRIAKFLNLDSSN------------WSKLAGTHGNVAPELA---YTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS 687 (752)
Q Consensus 623 fG~a~~~~~~~~~------------~~~~~gt~~y~aPE~~---~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~ 687 (752)
||+++........ .....||+.|+|||++ .+..+++++|||||||++|||++|+.||.....
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--- 258 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK--- 258 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH---
Confidence 9999876533211 1134689999999988 566789999999999999999999999852211
Q ss_pred ccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 688 SSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
..+.......+. ....+..+.+++.+||+.||++|||++|++++|+++..
T Consensus 259 ------~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 259 ------LRIVNGKYSIPP--HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -------------CCCCT--TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHhhcCcccCCc--ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111111222111 12223457789999999999999999999999998864
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=306.80 Aligned_cols=281 Identities=21% Similarity=0.268 Sum_probs=224.6
Q ss_pred CCCcccceeeCCC----------CCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeec
Q 041438 71 SLCTWSGIHCNHA----------GRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDF 140 (752)
Q Consensus 71 ~~c~w~gv~C~~~----------~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 140 (752)
..|.|..+.|... ..+..++++++.+.+ +++..|..+++|++|+|++|+++++.|..|+++++|++|+|
T Consensus 29 c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 29 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCE-eChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 4589999999632 256678999988876 44557999999999999999999999999999999999999
Q ss_pred CCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCC--cCCcCccCCCcceEEeecccccc
Q 041438 141 LTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGG--SIPRSLSNFTNLVFLYLYNNSFS 218 (752)
Q Consensus 141 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~ 218 (752)
++|+++. +|..+. ++|++|++++|.+++..+..|.++++|++|+|++|+++. ..+..|.++++|++|++++|+++
T Consensus 108 s~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 108 SKNQLKE-LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184 (330)
T ss_dssp CSSCCSB-CCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CCCcCCc-cChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence 9999994 555544 799999999999998888889999999999999999964 77889999999999999999987
Q ss_pred ccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCcc
Q 041438 219 GSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQ 298 (752)
Q Consensus 219 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 298 (752)
. +|..+ .++|++|++++|++++..|..+..+++|++|+|++|.+++..+..
T Consensus 185 ~-l~~~~----------------------------~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 235 (330)
T 1xku_A 185 T-IPQGL----------------------------PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGS 235 (330)
T ss_dssp S-CCSSC----------------------------CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTT
T ss_pred c-CCccc----------------------------cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhh
Confidence 4 33221 146778888888888887888888888888888888888877778
Q ss_pred ccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhccc------ccccEEEcCCCcCcc--ccchh
Q 041438 299 LGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSL------VKLYYLNLSHNKLSQ--QIPIE 370 (752)
Q Consensus 299 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l------~~L~~L~Ls~N~l~~--~~p~~ 370 (752)
+..+++|+.|+|++|+++ .+|..+..+++|++|+|++|+|+++.+..|... ..|+.|++++|.+.. ..|..
T Consensus 236 ~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~ 314 (330)
T 1xku_A 236 LANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST 314 (330)
T ss_dssp GGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGG
T ss_pred ccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccc
Confidence 888888888888888888 567778888888888888888888777766543 556666666666642 44455
Q ss_pred ccccccCCeeecCCc
Q 041438 371 LDNLIHLSELDLSHN 385 (752)
Q Consensus 371 ~~~l~~L~~L~Ls~N 385 (752)
|..+.+++.++|++|
T Consensus 315 f~~~~~l~~l~L~~N 329 (330)
T 1xku_A 315 FRCVYVRAAVQLGNY 329 (330)
T ss_dssp GTTCCCGGGEEC---
T ss_pred cccccceeEEEeccc
Confidence 555555555555555
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=308.92 Aligned_cols=224 Identities=19% Similarity=0.238 Sum_probs=174.1
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Ccc----ccCCceE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFC----SHPRQSF 549 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~----~~~~~~~ 549 (752)
..|++.+.||+|+||.||+|+. .++..||+|++...... +++ ......+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 4578889999999999999985 57889999987543221 111 1245689
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCEEeC-CCCceEEeecccc
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP--IVHWDISSKNVLLD-LGYEAHVSDFRIA 626 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~--ivH~DlKp~NIll~-~~~~~kl~DfG~a 626 (752)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||+. + |+||||||+||+++ +++.+||+|||++
T Consensus 106 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 9999999999999997543 478899999999999999999999 8 99999999999997 7889999999999
Q ss_pred eeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCCh
Q 041438 627 KFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706 (752)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (752)
..... .......||+.|+|||++. ..++.++||||+||++|+|++|+.||... .........+..... +..
T Consensus 180 ~~~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~----~~~~~~~~~~~~~~~--~~~ 250 (290)
T 1t4h_A 180 TLKRA--SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC----QNAAQIYRRVTSGVK--PAS 250 (290)
T ss_dssp GGCCT--TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC----SSHHHHHHHHTTTCC--CGG
T ss_pred ccccc--cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc----CcHHHHHHHHhccCC--ccc
Confidence 75432 2334457999999999876 45899999999999999999999998521 111111222222111 111
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.....++++.+++.+||+.||++|||++|+++|
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 123344678999999999999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=322.34 Aligned_cols=236 Identities=18% Similarity=0.156 Sum_probs=165.7
Q ss_pred HHHHHhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------Ccccc-----
Q 041438 494 EEIIRATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------NFCSH----- 544 (752)
Q Consensus 494 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------~~~~~----- 544 (752)
++.....++|++.+.||+|+||.||+|+. .+|+.||||++...... +++..
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 45567789999999999999999999995 57899999987543221 11211
Q ss_pred --CCceEEEEEeccCCChHHHhcc-CccccccCHHHHHHHHHHHHHHHHHHH--hCCCCCeeecCCCCCCEEeCC-CCce
Q 041438 545 --PRQSFIVYEYLESGSLDKILNN-DASAKELGWTQRLNVIKGVADALFYLH--NNCFPPIVHWDISSKNVLLDL-GYEA 618 (752)
Q Consensus 545 --~~~~~lV~E~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~~~~ivH~DlKp~NIll~~-~~~~ 618 (752)
....++||||+++ ++.+.+.. ......+++..+..++.|++.||.||| +. +|+||||||+||+++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence 1237899999987 55544432 122345788999999999999999999 88 9999999999999996 8999
Q ss_pred EEeecccceeccCCCCCcccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhh
Q 041438 619 HVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEIL 697 (752)
Q Consensus 619 kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 697 (752)
||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ......+.
T Consensus 172 kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-----~~~~~~~~ 245 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-----AGQLHEIV 245 (360)
T ss_dssp EECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHH
T ss_pred EEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-----HHHHHHHH
Confidence 999999998765433 233457899999999987654 89999999999999999999999853211 11111110
Q ss_pred c--------------cCCC------CCChh--------hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 698 D--------------SRLP------YPSLD--------VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 698 ~--------------~~~~------~~~~~--------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
. .... ..... ....++++.+++.+||+.||++|||++|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 0000 00000 01145679999999999999999999999976
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=314.14 Aligned_cols=230 Identities=17% Similarity=0.194 Sum_probs=175.6
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------Ccccc--CCceEEEEEe
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------NFCSH--PRQSFIVYEY 554 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------~~~~~--~~~~~lV~E~ 554 (752)
.++|++.+.||+|+||.||+|+. .+++.||||+++..... +++.. ....++||||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 57899999999999999999984 67999999998643211 22333 5668999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC-ceEEeecccceeccCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY-EAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~-~~kl~DfG~a~~~~~~~ 633 (752)
+.+++|.+++. .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||+++......
T Consensus 115 ~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 115 VNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp CCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred cCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999884 277899999999999999999999 999999999999999776 89999999998765433
Q ss_pred CCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhcccc---------ccccchHhhhccCCCC
Q 041438 634 SNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS---------SSSNMNIEILDSRLPY 703 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~---------~~~~~~~~~~~~~~~~ 703 (752)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ........+.......
T Consensus 186 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 186 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 3344589999999999877 6689999999999999999999999831110000 0000000000000000
Q ss_pred --------------------CChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 704 --------------------PSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 704 --------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
........++++.+++.+||+.||++|||++|+++|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000112246789999999999999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=316.31 Aligned_cols=230 Identities=23% Similarity=0.325 Sum_probs=176.5
Q ss_pred hhcccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC------------------------CccccCCceEEEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E 553 (752)
..++|++.+.||+|+||.||+|+.. +++.||+|++...... +++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4678999999999999999999964 6899999988654321 34556778999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++++|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999999886532 3488999999999999999999999 99999999999999999999999999976432221
Q ss_pred CCcccccCCCCccCcccc-----ccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhh
Q 041438 634 SNWSKLAGTHGNVAPELA-----YTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~-----~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (752)
.......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.... .......+.....+.. ...
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~-~~~ 245 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-----PMRVLLKIAKSDPPTL-LTP 245 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSCCCCC-SSG
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC-----HHHHHHHHhccCCccc-CCc
Confidence 222335789999999987 36678999999999999999999999985221 1111222222222211 112
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...+..+.+++.+||+.||++|||++|+++|
T Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 246 SKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred cccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 3456678999999999999999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=326.07 Aligned_cols=229 Identities=18% Similarity=0.224 Sum_probs=174.6
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------------Cccc----
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------------NFCS---- 543 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------------~~~~---- 543 (752)
.++|++.++||+|+||.||+|+. .+++.||||+++..... +++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 47899999999999999999984 57899999998643110 1111
Q ss_pred cCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC-------
Q 041438 544 HPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY------- 616 (752)
Q Consensus 544 ~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~------- 616 (752)
.....++||||+. +++.+.+.... ...+++..++.++.||+.||+|||+++ ||+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 116 NGTHICMVFEVLG-HHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TEEEEEEEECCCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCceEEEEEeccC-ccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhh
Confidence 3457899999995 56666665432 234889999999999999999999964 899999999999998775
Q ss_pred ------------------------------------------ceEEeecccceeccCCCCCcccccCCCCccCccccccC
Q 041438 617 ------------------------------------------EAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTM 654 (752)
Q Consensus 617 ------------------------------------------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 654 (752)
.+||+|||.++..... .....||+.|+|||++.+.
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHTS
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcCC
Confidence 7999999999876532 3345799999999999999
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCcchhhccccccc-cchHhh-------------------------------------
Q 041438 655 KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS-NMNIEI------------------------------------- 696 (752)
Q Consensus 655 ~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~-~~~~~~------------------------------------- 696 (752)
.++.++|||||||++|||+||+.||........... .....+
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 999999999999999999999999953211000000 000000
Q ss_pred -----hccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 697 -----LDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 697 -----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
....... ....+..+.+++.+||+.||++|||++|+++|
T Consensus 349 ~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 349 GLFEVLVEKYEW----SQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CHHHHHHHTSCC----CHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred chhHhhhhhccc----chhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0000011 24566789999999999999999999999875
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=315.45 Aligned_cols=307 Identities=28% Similarity=0.345 Sum_probs=149.5
Q ss_pred EEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeecc
Q 041438 86 VFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHIS 165 (752)
Q Consensus 86 v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 165 (752)
+..++++++++.+- +. -.++|++|++++|++++ +|.. +++|++|+|++|++++. |.. .++|++|+|+
T Consensus 73 l~~L~l~~~~l~~l-p~----~~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~ 139 (454)
T 1jl5_A 73 AHELELNNLGLSSL-PE----LPPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVS 139 (454)
T ss_dssp CSEEECTTSCCSCC-CS----CCTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC-CSC---CTTCCEEECC
T ss_pred CCEEEecCCccccC-CC----CcCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcc-cCC---CCCCCEEECc
Confidence 45566666655541 11 12566666666666665 3432 25566666666666542 211 1456666666
Q ss_pred CcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCc
Q 041438 166 RNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAI 245 (752)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~ 245 (752)
+|++++ +| .|+++++|++|++++|++++ +|..+ .+|++|+|++|++++ +| .++++++|+.|++++|++++.
T Consensus 140 ~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l- 210 (454)
T 1jl5_A 140 NNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKL- 210 (454)
T ss_dssp SSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSC-
T ss_pred CCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcC-
Confidence 666664 44 46666666666666666664 33332 356666666666664 33 456666666666666666542
Q ss_pred CCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCC
Q 041438 246 PLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGS 325 (752)
Q Consensus 246 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 325 (752)
|. ..++|++|++++|+++ .+| .+..+++|++|++++|++++ +|.. +++|+.|++++|++++ +|..
T Consensus 211 ~~-----~~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~--- 275 (454)
T 1jl5_A 211 PD-----LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL--- 275 (454)
T ss_dssp CC-----CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---
T ss_pred CC-----CcCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---
Confidence 21 1135666666666665 344 35556666666666666654 2322 2455555666665554 2322
Q ss_pred Ccccceeeccccccccccchh---------------hccc-ccccEEEcCCCcCccccchhccccccCCeeecCCccCCC
Q 041438 326 LINLEYLDLSANHLSNFVLES---------------LGSL-VKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGE 389 (752)
Q Consensus 326 l~~L~~L~Ls~N~l~~~~~~~---------------~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 389 (752)
.++|++|++++|+++++.... +..+ ++|++|++++|++++ +|.. +++|++|++++|++++
T Consensus 276 ~~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~ 351 (454)
T 1jl5_A 276 PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE 351 (454)
T ss_dssp CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC
T ss_pred cCcCCEEECcCCccCcccCcCCcCCEEECcCCcCCcccCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc
Confidence 245555555555555422100 0111 345555555555543 2322 3455555555555543
Q ss_pred CCCcccccccccceEEccCCcCCc--CCchhhhcc-------------CCCcEEEccCCcccC
Q 041438 390 KISSRICRMESLEKLNLSYNNLSG--LIPRCFEEL-------------HGLLHIDISYNKLEG 437 (752)
Q Consensus 390 ~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l-------------~~L~~L~ls~N~l~~ 437 (752)
+|. .+++|++|++++|++++ .+|..+..+ ++|+.||+++|++++
T Consensus 352 -lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~ 410 (454)
T 1jl5_A 352 -VPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLRE 410 (454)
T ss_dssp -CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC------------------------
T ss_pred -ccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCc
Confidence 222 24555555555555555 445555444 455555555555554
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.32 Aligned_cols=234 Identities=21% Similarity=0.245 Sum_probs=174.0
Q ss_pred hcccccceeeccCCceEEEEEEeC--CCc--EEEEEccCCCCCC---------------------------CccccCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP--SGE--IFAVKKFHSPLPD---------------------------NFCSHPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~---------------------------~~~~~~~~~ 548 (752)
.++|++.+.||+|+||.||+|+.. +++ .||||+++..... +++. ....
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPM 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc-cCCc
Confidence 468999999999999999999842 333 6999998754211 2222 2448
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 89999999999999997643 3488999999999999999999999 999999999999999999999999999988
Q ss_pred ccCCCCC---cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCC
Q 041438 629 LNLDSSN---WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYP 704 (752)
Q Consensus 629 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (752)
....... .....+|..|+|||++.+..++.++||||||+++|||++ |+.||... ........+.......+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~~~~~~~~~~~~~~~ 245 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-----NGSQILHKIDKEGERLP 245 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHTSCCCCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC-----CHHHHHHHHHccCCCCC
Confidence 7543321 123467888999999998889999999999999999999 99998521 11222223322222222
Q ss_pred ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 705 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
. ....+.++.+++.+||+.||++|||+++++++|+++...
T Consensus 246 ~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 246 R--PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp C--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred C--CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 1 134566789999999999999999999999999987543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=318.20 Aligned_cols=230 Identities=19% Similarity=0.264 Sum_probs=174.2
Q ss_pred hcccccceeeccCCceEEEEEEeC-CC-cEEEEEccCCCCCC-----------------------------CccccCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP-SG-EIFAVKKFHSPLPD-----------------------------NFCSHPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~-----------------------------~~~~~~~~~ 548 (752)
.++|++.+.||+|+||.||+|+.. ++ +.||+|+++..... +++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 468999999999999999999853 44 78999998642110 234456788
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe----------------
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL---------------- 612 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll---------------- 612 (752)
++||||+ ++++.+++.... ...+++.+++.++.||+.||+|||+. +|+||||||+||++
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccc
Confidence 9999999 557777776543 23488999999999999999999999 99999999999999
Q ss_pred ---CCCCceEEeecccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccccc
Q 041438 613 ---DLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSS 689 (752)
Q Consensus 613 ---~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~ 689 (752)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-- 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH-- 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--
T ss_pred ccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 56789999999999875432 2345899999999999999999999999999999999999999853211000
Q ss_pred ccchHhhhcc------------------CCCCC-------------------ChhhHHHHHHHHHHHHhccCcCCCCCCC
Q 041438 690 SNMNIEILDS------------------RLPYP-------------------SLDVQNKFMSIMQVAFSCLDQNPVSRPT 732 (752)
Q Consensus 690 ~~~~~~~~~~------------------~~~~~-------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps 732 (752)
.......... ...++ .......+.++.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 0000000000 00000 0011234567899999999999999999
Q ss_pred HHHHHHH
Q 041438 733 MKRFEVQ 739 (752)
Q Consensus 733 ~~evl~~ 739 (752)
++|+++|
T Consensus 328 ~~e~l~h 334 (355)
T 2eu9_A 328 LAEALLH 334 (355)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999865
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=326.64 Aligned_cols=234 Identities=21% Similarity=0.236 Sum_probs=172.0
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------Cccc------cCCceEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------NFCS------HPRQSFIVY 552 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------~~~~------~~~~~~lV~ 552 (752)
..+|++.+.||+|+||.||+|+. .+|+.||||++...... +++. +....++||
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 45799999999999999999996 46999999988543221 1111 112367899
Q ss_pred EeccCCChHHHhccC-ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC-CceEEeecccceecc
Q 041438 553 EYLESGSLDKILNND-ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG-YEAHVSDFRIAKFLN 630 (752)
Q Consensus 553 E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~-~~~kl~DfG~a~~~~ 630 (752)
||+++ ++.+.+... .....+++..++.++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||+++...
T Consensus 133 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp ECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred hcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99987 676666432 1234589999999999999999999999 99999999999999955 568999999999765
Q ss_pred CCCCCcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccccc----------cccchHhhhcc
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------SSNMNIEILDS 699 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~----------~~~~~~~~~~~ 699 (752)
... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ..+.... ...
T Consensus 209 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~-~~~ 286 (420)
T 1j1b_A 209 RGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE-MNP 286 (420)
T ss_dssp TTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH-HCS
T ss_pred cCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh-hCh
Confidence 332 23345889999999998765 6899999999999999999999999632110000 0000000 010
Q ss_pred C---CCCCC---hhh-----HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 700 R---LPYPS---LDV-----QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 700 ~---~~~~~---~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
. ..++. ..+ ...++++.+++.+||+.||++|||+.|+++|
T Consensus 287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 11110 001 1235678999999999999999999999976
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.90 Aligned_cols=233 Identities=23% Similarity=0.342 Sum_probs=169.5
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC-------------------------CccccCCceEEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~ 552 (752)
..++|++.+.||+|+||.||+|+ ..+++.||||++...... +++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 46789999999999999999998 457899999988643211 3345567889999
Q ss_pred EeccCCChHHHhccC-----ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 553 EYLESGSLDKILNND-----ASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 553 E~~~~g~L~~~l~~~-----~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
||+++++|.+++... .....+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998741 1123488999999999999999999999 99999999999999999999999999997
Q ss_pred eccCCCC-----CcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCC
Q 041438 628 FLNLDSS-----NWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRL 701 (752)
Q Consensus 628 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 701 (752)
....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ............
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~ 244 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP-----MKVLMLTLQNDP 244 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG-----GGHHHHHHTSSC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch-----hhHHHHHhccCC
Confidence 6543221 1223479999999998875 5689999999999999999999999863211 111111111111
Q ss_pred CC-CC-----hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 702 PY-PS-----LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 702 ~~-~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+. .. ......+.++.+++.+||+.||++|||++|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 10 00 0012334578899999999999999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=319.70 Aligned_cols=242 Identities=19% Similarity=0.215 Sum_probs=175.5
Q ss_pred chHHHHHHhhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-------------------------------
Q 041438 491 IVYEEIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD------------------------------- 539 (752)
Q Consensus 491 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------------------- 539 (752)
..++++....++|++.+.||+|+||.||+|+..+|+.||||++......
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 4567888899999999999999999999999888999999987542110
Q ss_pred ----Ccc-----ccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCE
Q 041438 540 ----NFC-----SHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNV 610 (752)
Q Consensus 540 ----~~~-----~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NI 610 (752)
+++ ......|+||||+.+ +|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred cceeeeEEeccCCCcceEEEEEccCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 122 223467999999985 8888887543 3588999999999999999999999 999999999999
Q ss_pred EeCCCCceEEeecccceeccCCCCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccc-
Q 041438 611 LLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS- 688 (752)
Q Consensus 611 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~- 688 (752)
+++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.........
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp EECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EEcCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999999865432 22344578999999998877 66899999999999999999999998632110000
Q ss_pred -----------------cccchHhhhccC-CCCCCh----hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 689 -----------------SSNMNIEILDSR-LPYPSL----DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 689 -----------------~~~~~~~~~~~~-~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
............ ...+.. .....++.+.+++.+||+.||++|||++|+++|
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 000000000010 011110 112234578999999999999999999999976
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=339.09 Aligned_cols=229 Identities=22% Similarity=0.293 Sum_probs=177.6
Q ss_pred cccccce-eeccCCceEEEEEEeC---CCcEEEEEccCCCCCC-------------------------CccccCCceEEE
Q 041438 501 NDFDAKH-CIGKGGHGSVYIARVP---SGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 501 ~~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV 551 (752)
+++.+.+ .||+|+||.||+|... ++..||||+++..... +++. .+..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~-~~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-SSSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEec-cCCeEEE
Confidence 3444444 8999999999999853 5678999999764321 2333 3568999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 414 ~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 99999999999997543 4589999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCc---ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccC-CCCCCh
Q 041438 632 DSSNW---SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSR-LPYPSL 706 (752)
Q Consensus 632 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 706 (752)
..... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||... ...+....+.... ...+
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~-----~~~~~~~~i~~~~~~~~p-- 561 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-----KGPEVMAFIEQGKRMECP-- 561 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CSHHHHHHHHTTCCCCCC--
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHcCCCCCCC--
Confidence 32211 12245689999999999999999999999999999998 99998521 1122222222222 2222
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
..+++++.++|.+||+.||++||+++++++.|+.+.
T Consensus 562 --~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 562 --PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp --TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 345678999999999999999999999999999875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=318.61 Aligned_cols=228 Identities=20% Similarity=0.246 Sum_probs=174.9
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------Cccc-----cCCc
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCS-----HPRQ 547 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~-----~~~~ 547 (752)
..++|++.+.||+|+||.||+|+. .+++.||||++...... +++. ....
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 457899999999999999999984 57889999998643211 1121 2246
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
.|+||||+.+ +|.+++... .+++.++..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||.++
T Consensus 105 ~~iv~e~~~~-~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCSE-EHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccCc-CHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 8999999985 999998653 388999999999999999999999 99999999999999999999999999998
Q ss_pred eccCCCCC---cccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc-----
Q 041438 628 FLNLDSSN---WSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD----- 698 (752)
Q Consensus 628 ~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~----- 698 (752)
........ .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ......+..
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~~~ 251 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-----LDQLNHILGILGSP 251 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG-----GGHHHHHHHHHCSC
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh-----HHHHHHHHHHhCCC
Confidence 76533221 234589999999998654 4589999999999999999999999853211 111111100
Q ss_pred ------------------cCC---CCCC-hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 699 ------------------SRL---PYPS-LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 699 ------------------~~~---~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
... ..+. ......+.++.+++.+||+.||++|||++|+++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0000 0012235678999999999999999999999976
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=322.47 Aligned_cols=232 Identities=22% Similarity=0.301 Sum_probs=178.8
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E 553 (752)
.++|++.+.||+|+||.||+|+. .+++.||+|+++..... +++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 56899999999999999999995 47899999988654211 34556778999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+++++|.+++.... .+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 999999999997643 4888999999999999999999832 8999999999999999999999999999765322
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccc--------------------------
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS-------------------------- 687 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~-------------------------- 687 (752)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 22345799999999999999999999999999999999999999852111000
Q ss_pred -------cc----ccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 688 -------SS----SNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 688 -------~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
.. ......+.....+.. .....+.++.+++.+||+.||++|||++|+++|-
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCC--CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred cccccCCCCcccchhhhhHHhccCCCCC--CcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 00 000011111111110 1122455789999999999999999999999763
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=318.53 Aligned_cols=229 Identities=20% Similarity=0.268 Sum_probs=158.5
Q ss_pred hcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------Ccc------ccCC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------NFC------SHPR 546 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------~~~------~~~~ 546 (752)
.++|++.+.||+|+||.||+|+ ..+|+.||||++...... +++ ....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 5789999999999999999998 467999999998654321 112 1235
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
..|+||||+ +++|.+++... .+++..+..++.||++||+|||+. ||+||||||+||+++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 56999988652 489999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhcccc------------------
Q 041438 627 KFLNLDSSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS------------------ 687 (752)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~------------------ 687 (752)
+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||........
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 180 RHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred cccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 875422 344589999999999877 6789999999999999999999999853211000
Q ss_pred ccccchHhhhccCCCCCChhh----HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 688 SSSNMNIEILDSRLPYPSLDV----QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
................+.... ...++.+.+++.+||+.||++|||++|+++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000111111111111111 1234678999999999999999999999976
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=309.37 Aligned_cols=228 Identities=20% Similarity=0.290 Sum_probs=182.9
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV 551 (752)
..++|++.+.||+|+||.||+|+. .+++.||||++...... +++......++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 457899999999999999999995 47899999997543211 345567788999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC---CceEEeeccccee
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG---YEAHVSDFRIAKF 628 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~---~~~kl~DfG~a~~ 628 (752)
|||+++++|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.+ +.+||+|||.+..
T Consensus 100 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 99999999998886543 488999999999999999999999 99999999999999754 4699999999987
Q ss_pred ccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhh
Q 041438 629 LNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708 (752)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (752)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||... ........+.......+....
T Consensus 174 ~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~ 246 (287)
T 2wei_A 174 FQQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK-----NEYDILKRVETGKYAFDLPQW 246 (287)
T ss_dssp BCCCS-SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCCCCCSGGG
T ss_pred ecCCC-ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCCCCCCchhh
Confidence 65332 2334468999999998765 4899999999999999999999998521 122233334444444433333
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...+.++.+++.+||+.||++|||++|++++
T Consensus 247 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 247 RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 4566789999999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=338.21 Aligned_cols=233 Identities=23% Similarity=0.362 Sum_probs=186.0
Q ss_pred hhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEec
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~ 555 (752)
..++|++.++||+|+||.||+|+...++.||||+++..... +++. .+..|+||||+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~lv~e~~ 343 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 343 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEe-eccceEeeehh
Confidence 45679999999999999999999888889999998764322 2233 36789999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC-C
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS-S 634 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~-~ 634 (752)
++|+|.+++.... ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 344 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 344 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp TTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred cCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 9999999997532 23488999999999999999999999 99999999999999999999999999998654211 0
Q ss_pred CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc-CCCCCChhhHHHH
Q 041438 635 NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RLPYPSLDVQNKF 712 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 712 (752)
......++..|+|||++.+..++.++|||||||++|||++ |+.||... ...+....+... +.+.+ ..++
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~-----~~~~~~~~i~~~~~~~~~----~~~~ 490 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-----VNREVLDQVERGYRMPCP----PECP 490 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC-----CHHHHHHHHHTTCCCCCC----TTCC
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHcCCCCCCC----CCCC
Confidence 1122356788999999998899999999999999999999 99998521 111222222222 12222 3455
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
..+.++|.+||+.||++|||++++++.|+++..
T Consensus 491 ~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 491 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 678999999999999999999999999999853
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=314.74 Aligned_cols=231 Identities=20% Similarity=0.294 Sum_probs=178.8
Q ss_pred HhhcccccceeeccCCceEEEEEEe--CCCcEEEEEccCCCCCC-----------------------------Cccc---
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARV--PSGEIFAVKKFHSPLPD-----------------------------NFCS--- 543 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~-----------------------------~~~~--- 543 (752)
++.++|++.+.||+|+||.||+|+. .+|+.||+|+++..... +++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4678999999999999999999996 46889999987532110 1222
Q ss_pred --cCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEe
Q 041438 544 --HPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVS 621 (752)
Q Consensus 544 --~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~ 621 (752)
.....++||||+. |+|.+++..... ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 3456799999998 599999976542 3488999999999999999999999 99999999999999999999999
Q ss_pred ecccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhh----
Q 041438 622 DFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEIL---- 697 (752)
Q Consensus 622 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~---- 697 (752)
|||.++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.
T Consensus 163 Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~ 236 (326)
T 1blx_A 163 DFGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKILDVIG 236 (326)
T ss_dssp SCCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHC
T ss_pred cCcccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHHHcC
Confidence 999998754322 233457899999999999999999999999999999999999998632110 0000000
Q ss_pred ------------------ccCCCCC-ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 698 ------------------DSRLPYP-SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 698 ------------------~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
......+ .......+..+.+++.+||+.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000 00112345678899999999999999999999965
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=312.14 Aligned_cols=233 Identities=18% Similarity=0.272 Sum_probs=176.2
Q ss_pred hhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC--------------------------CccccCCceEEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~ 552 (752)
..++|++.+.||+|+||.||+|+... .||+|+++..... +++.+....++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 46789999999999999999998743 5999988643211 3445567789999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
||+++++|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++ ++.+||+|||+++.....
T Consensus 109 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp BCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred ecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 9999999999997643 3588899999999999999999999 999999999999998 679999999998765321
Q ss_pred -----CCCcccccCCCCccCcccccc---------CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc
Q 041438 633 -----SSNWSKLAGTHGNVAPELAYT---------MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD 698 (752)
Q Consensus 633 -----~~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 698 (752)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ........+..
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-----~~~~~~~~~~~ 257 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ-----PAEAIIWQMGT 257 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC-----CHHHHHHHHHT
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHhcc
Confidence 112233468999999998874 34788999999999999999999998521 11112222222
Q ss_pred cCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 699 SRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 699 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
...+.. .....+.++.+++.+||+.||++|||++|+++.|+++...
T Consensus 258 ~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 258 GMKPNL--SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp TCCCCC--CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred CCCCCC--CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 221111 1122345688999999999999999999999999988643
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=314.77 Aligned_cols=238 Identities=23% Similarity=0.353 Sum_probs=183.5
Q ss_pred hcccccceeeccCCceEEEEEEe-----CCCcEEEEEccCCCCCC------------------------Ccccc--CCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-----PSGEIFAVKKFHSPLPD------------------------NFCSH--PRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~------------------------~~~~~--~~~~ 548 (752)
.++|++.+.||+|+||.||+|+. .+++.||||++...... +++.. ....
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46799999999999999999983 46899999998654321 12222 2468
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 99999999999999997653 3488999999999999999999999 999999999999999999999999999988
Q ss_pred ccCCCCC---cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhc-----cccccc-c----chHh
Q 041438 629 LNLDSSN---WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFE-----MSSSSS-N----MNIE 695 (752)
Q Consensus 629 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~-----~~~~~~-~----~~~~ 695 (752)
....... .....++..|+|||++.+..++.++|||||||++|||+||..||..... ...... . ....
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 7543321 1223577789999999988899999999999999999999999753210 000000 0 1111
Q ss_pred hhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 696 ILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
.+......+. ....+.++.+++.+||+.||++|||++|+++.|+++.
T Consensus 275 ~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 275 LLKNNGRLPR--PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHTTCCCCC--CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhcCCCCCC--CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2222111111 1345567899999999999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.34 Aligned_cols=220 Identities=22% Similarity=0.315 Sum_probs=178.5
Q ss_pred HHhhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCC--------------------------------Cccc
Q 041438 497 IRATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------------------NFCS 543 (752)
Q Consensus 497 ~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------------------------~~~~ 543 (752)
....++|++.+.||+|+||.||+|+ ..+++.||||+++..... +++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 3456789999999999999999998 467899999988543211 3345
Q ss_pred cCCceEEEEEeccC-CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC-CCCceEEe
Q 041438 544 HPRQSFIVYEYLES-GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD-LGYEAHVS 621 (752)
Q Consensus 544 ~~~~~~lV~E~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~-~~~~~kl~ 621 (752)
..+..++||||+.+ ++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEe
Confidence 56788999999986 89999987543 488899999999999999999999 999999999999999 78899999
Q ss_pred ecccceeccCCCCCcccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccC
Q 041438 622 DFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR 700 (752)
Q Consensus 622 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 700 (752)
|||+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .+....
T Consensus 193 Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----------~~~~~~ 259 (320)
T 3a99_A 193 DFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------EIIRGQ 259 (320)
T ss_dssp CCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------HHHHCC
T ss_pred eCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----------hhhccc
Confidence 99999876532 2334579999999999887765 688999999999999999999985321 111222
Q ss_pred CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 701 LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 701 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...+ ...++++.+++.+||+.||++|||++|++++
T Consensus 260 ~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 260 VFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2222 2234578899999999999999999999875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=309.87 Aligned_cols=228 Identities=21% Similarity=0.258 Sum_probs=177.1
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC----C------------------------Ccc--ccCCc
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP----D------------------------NFC--SHPRQ 547 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~------------------------~~~--~~~~~ 547 (752)
..++|++.+.||+|+||.||+|+. .+++.||+|+++.... . +++ .+...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 357899999999999999999995 5789999998854210 0 222 34567
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
.++||||++++ +.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999986 777776543 24588999999999999999999999 99999999999999999999999999998
Q ss_pred eccCCC--CCcccccCCCCccCccccccCC--CCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCC
Q 041438 628 FLNLDS--SNWSKLAGTHGNVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPY 703 (752)
Q Consensus 628 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~--~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 703 (752)
...... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.. .........+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-----~~~~~~~~~i~~~~~~~ 232 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-----DNIYKLFENIGKGSYAI 232 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC-----SSHHHHHHHHHHCCCCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC-----chHHHHHHHHhcCCCCC
Confidence 765322 1223457899999999987654 37899999999999999999999852 11222233333444443
Q ss_pred CChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 704 PSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 704 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
+. ..++.+.+++.+||+.||++|||++|+++|-
T Consensus 233 ~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 233 PG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp CS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred CC----ccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 32 3456788999999999999999999999763
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=325.42 Aligned_cols=238 Identities=18% Similarity=0.249 Sum_probs=161.5
Q ss_pred hhccccc-ceeeccCCceEEEEEEeC---CCcEEEEEccCCCCCC----------------------Ccc--ccCCceEE
Q 041438 499 ATNDFDA-KHCIGKGGHGSVYIARVP---SGEIFAVKKFHSPLPD----------------------NFC--SHPRQSFI 550 (752)
Q Consensus 499 ~~~~y~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~----------------------~~~--~~~~~~~l 550 (752)
..+.|++ .++||+|+||.||+|+.. +++.||||++...... +++ ......|+
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 3456776 558999999999999954 5889999998754322 223 34678899
Q ss_pred EEEeccCCChHHHhccCc------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe----CCCCceEE
Q 041438 551 VYEYLESGSLDKILNNDA------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL----DLGYEAHV 620 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll----~~~~~~kl 620 (752)
||||+.+ +|.+++.... ....+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999976 8888776322 122488999999999999999999999 99999999999999 67789999
Q ss_pred eecccceeccCCC---CCcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccccc----cccc
Q 041438 621 SDFRIAKFLNLDS---SNWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----SSNM 692 (752)
Q Consensus 621 ~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~----~~~~ 692 (752)
+|||+|+...... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||......... ....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 9999998765332 122345899999999998874 4899999999999999999999999532110000 0000
Q ss_pred hHhhhcc----------------------------CCCCCChh------hHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 041438 693 NIEILDS----------------------------RLPYPSLD------VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEV 738 (752)
Q Consensus 693 ~~~~~~~----------------------------~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 738 (752)
...+... ........ .......+.++|.+||+.||++|||++|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 00000000 0001346889999999999999999999998
Q ss_pred HH
Q 041438 739 QS 740 (752)
Q Consensus 739 ~L 740 (752)
|-
T Consensus 334 hp 335 (405)
T 3rgf_A 334 DP 335 (405)
T ss_dssp SG
T ss_pred Ch
Confidence 63
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.36 Aligned_cols=229 Identities=21% Similarity=0.318 Sum_probs=181.6
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCC--------------------C--------------------
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLP--------------------D-------------------- 539 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------------~-------------------- 539 (752)
.++|++.+.||+|+||.||+|+. +++.||||++..... .
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 57899999999999999999999 999999998753210 0
Q ss_pred -CccccCCceEEEEEeccCCChHHH------hccCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCEE
Q 041438 540 -NFCSHPRQSFIVYEYLESGSLDKI------LNNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHWDISSKNVL 611 (752)
Q Consensus 540 -~~~~~~~~~~lV~E~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~ivH~DlKp~NIl 611 (752)
+++.+.+..++||||+++|+|.++ +.... ...+++..++.++.|++.||+|||+ . ||+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 345567889999999999999998 54321 3458999999999999999999999 8 9999999999999
Q ss_pred eCCCCceEEeecccceeccCCCCCcccccCCCCccCccccccC-CCCC-ccchhhHHHHHHHHHhCCCCcchhhcccccc
Q 041438 612 LDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTM-KVTE-KCDVYSFGVLALEVIKGKHPRDFLFEMSSSS 689 (752)
Q Consensus 612 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDIwSlGvil~elltg~~pf~~~~~~~~~~ 689 (752)
++.++.+||+|||.+...... ......||+.|+|||++.+. .++. ++|||||||++|||++|+.||.... ..
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~ 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI----SL 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS----CS
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC----cH
Confidence 999999999999999876433 33445799999999999877 5665 9999999999999999999985211 11
Q ss_pred ccchHhhhccCCCCCCh---------------hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 690 SNMNIEILDSRLPYPSL---------------DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 690 ~~~~~~~~~~~~~~~~~---------------~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
......+.......+.. .....+.++.+++.+||+.||++|||++|+++|
T Consensus 259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 22223333333322210 013355678999999999999999999999875
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=315.96 Aligned_cols=330 Identities=24% Similarity=0.244 Sum_probs=181.4
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCC-------------CeeecCCCcccccCC
Q 041438 84 GRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKL-------------EYLDFLTNKLSGHIP 150 (752)
Q Consensus 84 ~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-------------~~L~L~~N~l~~~~p 150 (752)
.++..++++++.+ |++++ +|+.+++|++|++++|++++.+|..++++++| ++|++++|++++. |
T Consensus 11 ~~L~~L~l~~n~l-~~iP~-~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~l-p 87 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPV-EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSL-P 87 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCC-C
T ss_pred ccchhhhcccCch-hhCCh-hHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccC-C
Confidence 3456677777777 66654 57888888888888888888888888887764 7888888887753 3
Q ss_pred cccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccc
Q 041438 151 SEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKS 230 (752)
Q Consensus 151 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 230 (752)
.. .++|++|+|++|.+++ +|.. +++|++|++++|++++. |.. .++|++|+|++|++++ +| .|+++++
T Consensus 88 ~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~ 154 (454)
T 1jl5_A 88 EL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK-LP-ELQNSSF 154 (454)
T ss_dssp SC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS-CC-CCTTCTT
T ss_pred CC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC-Cc-ccCCCCC
Confidence 31 3677777888777776 5543 25677777777777652 221 1567777777777765 45 4677777
Q ss_pred cccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEc
Q 041438 231 LFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISL 310 (752)
Q Consensus 231 L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 310 (752)
|++|++++|++++ +|.. .++|++|++++|++++ +| .+..+++|++|++++|++++ +|... .+|+.|++
T Consensus 155 L~~L~l~~N~l~~-lp~~-----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l 222 (454)
T 1jl5_A 155 LKIIDVDNNSLKK-LPDL-----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVA 222 (454)
T ss_dssp CCEEECCSSCCSC-CCCC-----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEEC
T ss_pred CCEEECCCCcCcc-cCCC-----cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEEC
Confidence 7777777777765 3321 2466777777777665 34 46666777777777776664 33322 35666666
Q ss_pred cCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCC
Q 041438 311 SGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEK 390 (752)
Q Consensus 311 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 390 (752)
++|+++ .+| .++.+++|++|++++|++++++. .+++|+.|++++|++++ +|.. .++|++|++++|++++.
T Consensus 223 ~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l~~----~~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l 292 (454)
T 1jl5_A 223 GNNILE-ELP-ELQNLPFLTTIYADNNLLKTLPD----LPPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL 292 (454)
T ss_dssp CSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCCS----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE
T ss_pred cCCcCC-ccc-ccCCCCCCCEEECCCCcCCcccc----cccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc
Confidence 666666 344 36666666666666666665332 12556666666666554 2222 24555555555555441
Q ss_pred --CCcc-------------cccc-cccceEEccCCcCCcCCchhhhccCCCcEEEccCCcccCcCCCCcccCCCCccccc
Q 041438 391 --ISSR-------------ICRM-ESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPLEALQ 454 (752)
Q Consensus 391 --~~~~-------------~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~ 454 (752)
.|.. +..+ ++|++|++++|+++++ |.. +++|+.|++++|++++ +|. ....+....+.
T Consensus 293 ~~~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~l-p~~---~~~L~~L~L~~N~l~~-lp~--~l~~L~~L~L~ 365 (454)
T 1jl5_A 293 SELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIEL-PAL---PPRLERLIASFNHLAE-VPE--LPQNLKQLHVE 365 (454)
T ss_dssp SCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSC-CCC--CCTTCCEEECC
T ss_pred cCcCCcCCEEECcCCcCCcccCCcCcCCEEECCCCccccc-ccc---CCcCCEEECCCCcccc-ccc--hhhhccEEECC
Confidence 1110 1112 3556666666666553 322 3556666666666653 343 23334444445
Q ss_pred CCCC
Q 041438 455 GNKG 458 (752)
Q Consensus 455 ~n~~ 458 (752)
+|+.
T Consensus 366 ~N~l 369 (454)
T 1jl5_A 366 YNPL 369 (454)
T ss_dssp SSCC
T ss_pred CCCC
Confidence 5543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=316.18 Aligned_cols=228 Identities=20% Similarity=0.285 Sum_probs=169.8
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCc-----
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQ----- 547 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~----- 547 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||++...... +++.....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 57899999999999999999984 57999999998754322 22222332
Q ss_pred -eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 548 -SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 548 -~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
.++||||+.+ +|.+++.. .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 121 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQT-DLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCCE-EHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEccccc-cHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 3999999985 88888742 388999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccc-----------------
Q 041438 627 KFLNLDSSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------------- 688 (752)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~----------------- 688 (752)
+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.........
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 192 RHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 865432 334578999999999887 67899999999999999999999999632110000
Q ss_pred -cccchHhhhccCCCCCChh----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 689 -SSNMNIEILDSRLPYPSLD----VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 689 -~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...............+... ....++++.+++.+||+.||++|||++|+++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000001111111111 12235678999999999999999999999976
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=309.13 Aligned_cols=229 Identities=24% Similarity=0.371 Sum_probs=171.1
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------Ccc------------
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------NFC------------ 542 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------~~~------------ 542 (752)
..++|++.+.||+|+||.||+|+. .+++.||||++...... +++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467899999999999999999995 57999999987532110 111
Q ss_pred -ccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEe
Q 041438 543 -SHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVS 621 (752)
Q Consensus 543 -~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~ 621 (752)
......|+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence 12456899999999999999997543 3477899999999999999999999 99999999999999999999999
Q ss_pred ecccceeccCCC--------------CCcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccc
Q 041438 622 DFRIAKFLNLDS--------------SNWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS 686 (752)
Q Consensus 622 DfG~a~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~ 686 (752)
|||.+....... .......||+.|+|||++.+. .++.++||||+||++|||++ ||....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--- 232 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--- 232 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH---
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch---
Confidence 999998754221 112335789999999998765 68999999999999999998 442111
Q ss_pred cccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 687 SSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
........+.......+.......+..+.+++.+||+.||++|||++|+++|
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 233 -ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 0111222222223333322223455678899999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=309.50 Aligned_cols=228 Identities=21% Similarity=0.285 Sum_probs=172.8
Q ss_pred hhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC----------------------------CccccCCceEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD----------------------------NFCSHPRQSFI 550 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~l 550 (752)
..++|++.+.||+|+||.||+|+..+++.||||++...... +++......++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 46789999999999999999999888999999988543221 33455678899
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||| +.+++|.+++.... .+++..++.++.|+++||+|||+. +|+||||||+||++++ +.+||+|||+++...
T Consensus 106 v~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999 55779999997643 478899999999999999999999 9999999999999974 899999999998765
Q ss_pred CCCCC--cccccCCCCccCcccccc-----------CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhh
Q 041438 631 LDSSN--WSKLAGTHGNVAPELAYT-----------MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEIL 697 (752)
Q Consensus 631 ~~~~~--~~~~~gt~~y~aPE~~~~-----------~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 697 (752)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ........+.
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----~~~~~~~~~~ 253 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII----NQISKLHAII 253 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC----SHHHHHHHHH
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH----HHHHHHHHHH
Confidence 33221 233478999999999875 467889999999999999999999985211 1111222233
Q ss_pred ccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 041438 698 DSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQS 740 (752)
Q Consensus 698 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 740 (752)
+........ ...+.++.+++.+||+.||++||+++|++++-
T Consensus 254 ~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 254 DPNHEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp CTTSCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred hcccccCCc--ccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 322221110 12245688999999999999999999999764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=316.32 Aligned_cols=229 Identities=17% Similarity=0.236 Sum_probs=174.5
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------------Ccccc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------------NFCSH 544 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------------~~~~~ 544 (752)
.++|++.+.||+|+||.||+|+. .+++.||||+++..... +++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 46899999999999999999994 67999999988643110 11111
Q ss_pred ----CCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC------C
Q 041438 545 ----PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD------L 614 (752)
Q Consensus 545 ----~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~------~ 614 (752)
....++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+++ ||+||||||+||+++ .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence 12689999999 7899999976432 34889999999999999999999953 899999999999994 4
Q ss_pred CCceEEeecccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccc-cccch
Q 041438 615 GYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS-SSNMN 693 (752)
Q Consensus 615 ~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~-~~~~~ 693 (752)
.+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||......... .....
T Consensus 174 ~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred cceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 457999999999876532 23457999999999999999999999999999999999999999632210000 00000
Q ss_pred H------------------------------------------hhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCC
Q 041438 694 I------------------------------------------EILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRP 731 (752)
Q Consensus 694 ~------------------------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 731 (752)
. .+.......+ ...+.++.++|.+||+.||++||
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS----KDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCC----HHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCC----cchHHHHHHHHHHHhccCccccC
Confidence 0 0111111111 45677899999999999999999
Q ss_pred CHHHHHHH
Q 041438 732 TMKRFEVQ 739 (752)
Q Consensus 732 s~~evl~~ 739 (752)
|++|+++|
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=337.85 Aligned_cols=223 Identities=25% Similarity=0.359 Sum_probs=174.9
Q ss_pred eeeccCCceEEEEEEe---CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEeccC
Q 041438 507 HCIGKGGHGSVYIARV---PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
+.||+|+||.||+|.+ ..++.||||+++..... +++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 5799999999999964 35688999998753221 2333 4568899999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC--
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN-- 635 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-- 635 (752)
|+|.+++.... .+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+........
T Consensus 454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999997543 488999999999999999999999 9999999999999999999999999999876543221
Q ss_pred -cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccC-CCCCChhhHHHH
Q 041438 636 -WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSR-LPYPSLDVQNKF 712 (752)
Q Consensus 636 -~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 712 (752)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||... ...+....+.... ...+ ..++
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~-----~~~~~~~~i~~~~~~~~p----~~~~ 598 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-----KGSEVTAMLEKGERMGCP----AGCP 598 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHHTTCCCCCC----TTCC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHcCCCCCCC----CCCC
Confidence 122356788999999999999999999999999999998 99998521 1112222222222 2222 3456
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
+++.++|.+||+.||++||+++++++.|+++.+
T Consensus 599 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 599 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 788999999999999999999999999998754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=319.02 Aligned_cols=229 Identities=21% Similarity=0.258 Sum_probs=167.4
Q ss_pred hhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC----------------------CccccCCceEEEEEecc
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD----------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~~~~lV~E~~~ 556 (752)
...+|++.+.||+|+||+||.....+++.||||++...... +++.+....|+|||||.
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 34578899999999999976655678999999988654221 33455677899999997
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC-----CCceEEeecccceeccC
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL-----GYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~-----~~~~kl~DfG~a~~~~~ 631 (752)
+ +|.+++..... ...+..+..++.||++||+|||+. +|+||||||+||+++. ...+||+|||+|+....
T Consensus 102 g-~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 102 A-TLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp E-EHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred C-CHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 5 99999976542 244556789999999999999999 9999999999999953 33588999999987653
Q ss_pred CC---CCcccccCCCCccCccccc---cCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCC
Q 041438 632 DS---SNWSKLAGTHGNVAPELAY---TMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYP 704 (752)
Q Consensus 632 ~~---~~~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (752)
.. .......||+.|+|||++. ...++.++||||+||++|||++ |..||... ................
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~------~~~~~~~~~~~~~~~~ 249 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS------LQRQANILLGACSLDC 249 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST------TTHHHHHHTTCCCCTT
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh------hHHHHHHHhccCCccc
Confidence 32 1223457999999999987 4567889999999999999999 99998521 1111111111111111
Q ss_pred ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 705 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..........+.++|.+||+.||++|||++|+++|
T Consensus 250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 11123445668899999999999999999999964
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.31 Aligned_cols=219 Identities=22% Similarity=0.334 Sum_probs=172.8
Q ss_pred HhhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------------Ccc
Q 041438 498 RATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------------NFC 542 (752)
Q Consensus 498 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------------~~~ 542 (752)
...++|++.+.||+|+||.||+|+. .+++.||||+++..... +++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3467899999999999999999984 57899999998643210 233
Q ss_pred ccCCceEEEEEe-ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC-CCCceEE
Q 041438 543 SHPRQSFIVYEY-LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD-LGYEAHV 620 (752)
Q Consensus 543 ~~~~~~~lV~E~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~-~~~~~kl 620 (752)
...+..++|||| +.+++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++ +++.+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEE
Confidence 445678999999 78899999997643 488999999999999999999999 999999999999999 8899999
Q ss_pred eecccceeccCCCCCcccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhcc
Q 041438 621 SDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS 699 (752)
Q Consensus 621 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 699 (752)
+|||++...... ......||..|+|||++.+..+ +.++||||+||++|||++|+.||.... .+...
T Consensus 182 ~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----------~~~~~ 248 (312)
T 2iwi_A 182 IDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----------EILEA 248 (312)
T ss_dssp CCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------HHHHT
T ss_pred EEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----------HHhhh
Confidence 999999876533 2344579999999999887666 458999999999999999999985321 12222
Q ss_pred CCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 700 RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 700 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
....+ ...+.++.+++.+||+.||++|||++|+++|
T Consensus 249 ~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 249 ELHFP----AHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp CCCCC----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ccCCc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 33332 2345578899999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=308.96 Aligned_cols=227 Identities=20% Similarity=0.260 Sum_probs=166.9
Q ss_pred hcccccceeeccCCceEEEEEEeC-CCcEEEEEccCCCCCC------------------------Cc-------------
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP-SGEIFAVKKFHSPLPD------------------------NF------------- 541 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------------------~~------------- 541 (752)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999964 5899999987533211 11
Q ss_pred -cccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC-CCCceE
Q 041438 542 -CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD-LGYEAH 619 (752)
Q Consensus 542 -~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~-~~~~~k 619 (752)
+.+....++||||++ |+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+||+++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEE
Confidence 134467899999998 5999998643 388899999999999999999999 999999999999997 567999
Q ss_pred EeecccceeccCCC---CCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHh
Q 041438 620 VSDFRIAKFLNLDS---SNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIE 695 (752)
Q Consensus 620 l~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~ 695 (752)
|+|||.++...... .......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~ 236 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL-----EQMQL 236 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-----HHHHH
Confidence 99999998764321 12233467999999998765 67899999999999999999999998632110 11111
Q ss_pred hhccC----------------------CCCCC----hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 696 ILDSR----------------------LPYPS----LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 696 ~~~~~----------------------~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+.... ...+. ......+.++.+++.+||+.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 11000 00000 0012345678999999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.98 Aligned_cols=233 Identities=23% Similarity=0.281 Sum_probs=174.4
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------Ccc-----ccCCc
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFC-----SHPRQ 547 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~-----~~~~~ 547 (752)
..++|++.+.||+|+||.||+|+. .+|+.||||++...... +++ .....
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 357899999999999999999995 47999999998643211 111 12367
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
.++||||+.+ +|.+++... .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~~-~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQT-DLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCSE-EHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccCc-cHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 8999999985 999998753 388999999999999999999999 99999999999999999999999999998
Q ss_pred eccCCCCC----------cccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhcccc---------
Q 041438 628 FLNLDSSN----------WSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS--------- 687 (752)
Q Consensus 628 ~~~~~~~~----------~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~--------- 687 (752)
........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 76532211 123478999999998764 6789999999999999999999999853211000
Q ss_pred ----------ccccchHhhhccCCCCCCh----hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 688 ----------SSSNMNIEILDSRLPYPSL----DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 688 ----------~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
................+.. .....++++.+++.+||+.||++|||++|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000001111111111100 112345678999999999999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=312.71 Aligned_cols=232 Identities=23% Similarity=0.288 Sum_probs=159.1
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~ 552 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||+++..... +++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 47899999999999999999995 57999999988654221 3455677889999
Q ss_pred EeccCCChHHHhccCc--cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 553 EYLESGSLDKILNNDA--SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||+++ +|.+++.... ....+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99986 8888776311 1245889999999999999999999953 89999999999999999999999999998765
Q ss_pred CCCCCcccccCCCCccCcccc----ccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCC-CCCC
Q 041438 631 LDSSNWSKLAGTHGNVAPELA----YTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRL-PYPS 705 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~ 705 (752)
... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||...... ......+..... ..+.
T Consensus 178 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~ 252 (327)
T 3aln_A 178 DSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV----FDQLTQVVKGDPPQLSN 252 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCCCSCCCCCCC
T ss_pred ccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH----HHHHHHHhcCCCCCCCC
Confidence 332 22334799999999998 4566899999999999999999999998632110 111111111111 1111
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
......++.+.+++.+||+.||++|||++|++++
T Consensus 253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 1112345678999999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=309.13 Aligned_cols=229 Identities=21% Similarity=0.309 Sum_probs=162.4
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV 551 (752)
..++|++.+.||+|+||.||+|+. .+|+.||||++...... +++...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 357899999999999999999996 47999999988654221 345567889999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
|||+ ++.+..+..... ..+++..++.++.|++.||+|||+ . ||+||||||+||+++.++.+||+|||++....
T Consensus 103 ~e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 446665554322 348899999999999999999998 6 89999999999999999999999999998764
Q ss_pred CCCCCcccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCC
Q 041438 631 LDSSNWSKLAGTHGNVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPS 705 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (752)
... ......||+.|+|||++. +..++.++|||||||++|||++|+.||... .........+.....+...
T Consensus 177 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~~~~~~~~~~~~~~~~ 251 (318)
T 2dyl_A 177 DDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC----KTDFEVLTKVLQEEPPLLP 251 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC----CSHHHHHHHHHHSCCCCCC
T ss_pred CCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC----CccHHHHHHHhccCCCCCC
Confidence 332 233457999999999984 456889999999999999999999998521 1111222233332222111
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.....+.++.+++.+||+.||++||+++|+++|
T Consensus 252 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 252 -GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp -SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 112345678899999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=321.25 Aligned_cols=228 Identities=22% Similarity=0.341 Sum_probs=166.1
Q ss_pred cccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC----------------------CccccCCceEEEEEeccCC
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD----------------------NFCSHPRQSFIVYEYLESG 558 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~~~~lV~E~~~~g 558 (752)
+.|.+.+.||+|+||+||.+...+|+.||||++...... +++.+.+..|+|||||. |
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 345567889999999998777778999999987543211 33455678899999996 5
Q ss_pred ChHHHhccCccccc----cCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC-------------CceEEe
Q 041438 559 SLDKILNNDASAKE----LGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG-------------YEAHVS 621 (752)
Q Consensus 559 ~L~~~l~~~~~~~~----l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~-------------~~~kl~ 621 (752)
+|.+++........ .++..++.++.||+.||+|||+. +|+||||||+||+++.+ +.+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 99999986542111 13345678999999999999999 99999999999999654 489999
Q ss_pred ecccceeccCCCCC----cccccCCCCccCcccccc-------CCCCCccchhhHHHHHHHHHh-CCCCcchhhcccccc
Q 041438 622 DFRIAKFLNLDSSN----WSKLAGTHGNVAPELAYT-------MKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSS 689 (752)
Q Consensus 622 DfG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~-------~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~ 689 (752)
|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.....
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~----- 245 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS----- 245 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT-----
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh-----
Confidence 99999987543321 223579999999999875 568999999999999999999 9999852111
Q ss_pred ccchHhhhccCCCCC---ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 690 SNMNIEILDSRLPYP---SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 690 ~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
....+.......+ .......+.++.+++.+||+.||++|||+.|+++|
T Consensus 246 --~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 246 --RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp --HHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --hHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 1112222222211 11224567789999999999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=333.58 Aligned_cols=231 Identities=23% Similarity=0.320 Sum_probs=181.3
Q ss_pred hhcccccceeeccCCceEEEEEEeC----CCcEEEEEccCCCCCC-------------------------CccccCCceE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP----SGEIFAVKKFHSPLPD-------------------------NFCSHPRQSF 549 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~ 549 (752)
..++|++.+.||+|+||.||+|+.. .+..||||+++..... +++ ..+..|
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-ecCceE
Confidence 4578999999999999999999853 3567999987653221 223 345689
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 9999999999999997543 3488999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCC-cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccC-CCCCCh
Q 041438 630 NLDSSN-WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSR-LPYPSL 706 (752)
Q Consensus 630 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 706 (752)
...... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||... ........+.... .+.+
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~-----~~~~~~~~i~~~~~~~~~-- 614 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-----KNNDVIGRIENGERLPMP-- 614 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHHTCCCCCC--
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHcCCCCCCC--
Confidence 433221 223457789999999998899999999999999999997 99998521 1112222222222 2222
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
..+++.+.+++.+||+.||++|||++|+++.|+++.
T Consensus 615 --~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 615 --PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 244567899999999999999999999999999874
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=316.18 Aligned_cols=220 Identities=16% Similarity=0.073 Sum_probs=167.4
Q ss_pred hhcccccceeeccCCceEEEEEE-eCCCcEEEEEccCCCCCCC---------------cc--------------------
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN---------------FC-------------------- 542 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---------------~~-------------------- 542 (752)
....|...+.||+|+||.||+|+ ..+|+.||||+++...... ..
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34568888999999999999999 5679999999887321110 00
Q ss_pred --------------cc-----CCceEEEEEeccCCChHHHhccC----ccccccCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 041438 543 --------------SH-----PRQSFIVYEYLESGSLDKILNND----ASAKELGWTQRLNVIKGVADALFYLHNNCFPP 599 (752)
Q Consensus 543 --------------~~-----~~~~~lV~E~~~~g~L~~~l~~~----~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ 599 (752)
.. ....+++|+++ +++|.+++... .....+++..+..++.||++||+|||++ +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 00 12356777766 46999988521 1234588899999999999999999999 9
Q ss_pred eeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcccccCCCCccCcccc----------ccCCCCCccchhhHHHHH
Q 041438 600 IVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELA----------YTMKVTEKCDVYSFGVLA 669 (752)
Q Consensus 600 ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ksDIwSlGvil 669 (752)
|+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 999999999999999999999999999875433 334577 999999998 555688999999999999
Q ss_pred HHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 670 LEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 670 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
|||+||+.||.... .......+..... ..++++.+++.+||+.||++||++.|++++
T Consensus 308 ~elltg~~Pf~~~~-----~~~~~~~~~~~~~--------~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 308 YWIWCADLPNTDDA-----ALGGSEWIFRSCK--------NIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHSSCCCCTTG-----GGSCSGGGGSSCC--------CCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHCCCCCCCcc-----hhhhHHHHHhhcc--------cCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99999999986322 1111222222111 223568899999999999999998887654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=308.09 Aligned_cols=227 Identities=19% Similarity=0.270 Sum_probs=169.7
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCC------
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPR------ 546 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~------ 546 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||++...... +++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46899999999999999999995 57999999998654322 1222222
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
..|+||||+.+ +|.+++.. .+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQT-DLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCSE-EGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEeccccC-CHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 35999999985 88887742 388899999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccc-----------------
Q 041438 627 KFLNLDSSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS----------------- 688 (752)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~----------------- 688 (752)
+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.........
T Consensus 174 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 174 RHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp TC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred cCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 865422 234578999999998877 67899999999999999999999998632110000
Q ss_pred -cccchHhhhccC-----CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 689 -SSNMNIEILDSR-----LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 689 -~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
............ .... ......++++.+++.+||+.||++|||++|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000000000 0000 0112346678999999999999999999999976
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=328.09 Aligned_cols=233 Identities=27% Similarity=0.302 Sum_probs=175.0
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------Ccc------ccCCc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFC------SHPRQ 547 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~------~~~~~ 547 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||+++..... +++ ...+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999999985 57999999998654211 111 22667
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCc---eEEeecc
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE---AHVSDFR 624 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~---~kl~DfG 624 (752)
.++||||+++|+|.+++........+++..++.++.|++.||+|||+. ||+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999998765445688999999999999999999999 9999999999999987665 9999999
Q ss_pred cceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcc----ccc-----cccchHh
Q 041438 625 IAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM----SSS-----SSNMNIE 695 (752)
Q Consensus 625 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~----~~~-----~~~~~~~ 695 (752)
.+....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ... .......
T Consensus 170 ~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 170 YAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred ccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 998765432 334468999999999999999999999999999999999999998521100 000 0000000
Q ss_pred hh------ccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHH
Q 041438 696 IL------DSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRF 736 (752)
Q Consensus 696 ~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 736 (752)
.. ....+.+.......++.+.+++.+||+.||++|||++|+
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 01 111122222234567889999999999999999999884
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=337.40 Aligned_cols=354 Identities=19% Similarity=0.150 Sum_probs=288.3
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccc----cCCccCcCCCCCCeeecCCCcccccCCcccc-ccc--
Q 041438 85 RVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFD----IIPPQISNLSKLEYLDFLTNKLSGHIPSEIS-LLT-- 157 (752)
Q Consensus 85 ~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~-- 157 (752)
+++.++|+++.+........|..+++|++|+|++|++++ .++..+..+++|++|+|++|.++...+..+. .++
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~ 83 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence 467888888887755444447889999999999999985 3567788999999999999999875554443 455
Q ss_pred --ccceeeccCcccCC----CCCcccCCCCCCcEEEccCCCCCCcCCcCcc-----CCCcceEEeeccccccccc----c
Q 041438 158 --HLTILHISRNQLNG----SIPHEVGQLNFLNHLILDSNFLGGSIPRSLS-----NFTNLVFLYLYNNSFSGSI----P 222 (752)
Q Consensus 158 --~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~~----p 222 (752)
+|++|+|++|+|+. .++..+..+++|++|+|++|++++..+..+. ..++|++|+|++|++++.. +
T Consensus 84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 163 (461)
T 1z7x_W 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 163 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHH
Confidence 79999999999984 5688899999999999999999865554433 3568999999999998744 6
Q ss_pred ccccCccccccccccccccCCCcCCCCC---CCCCCCCcEEEccccccCCC----CCcccCCCCCCCEEecCCCcCcCCC
Q 041438 223 QQIGNLKSLFDMKLCINQLNGAIPLSID---WGRCPQLSLLDVSINNITGN----IPFEIGESPQLQYLDLSSNYIVGEI 295 (752)
Q Consensus 223 ~~~~~l~~L~~l~l~~N~l~~~~~~~~~---~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~ 295 (752)
..+..+++|++|++++|.+++..+..+. ....++|++|++++|.+++. ++..+..+++|++|+|++|.+++..
T Consensus 164 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~ 243 (461)
T 1z7x_W 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 243 (461)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred HHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHH
Confidence 6677789999999999998754332211 01256899999999999874 5777788999999999999987643
Q ss_pred -----CccccCCcccCEEEccCCcCccc----CCcccCCCcccceeeccccccccccchhhccc-----ccccEEEcCCC
Q 041438 296 -----PTQLGNIIYLNRISLSGNKLSGR----IPGELGSLINLEYLDLSANHLSNFVLESLGSL-----VKLYYLNLSHN 361 (752)
Q Consensus 296 -----p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-----~~L~~L~Ls~N 361 (752)
+..+..+++|+.|++++|.++.. ++..+..+++|++|+|++|.+++..+..+... ++|++|+|++|
T Consensus 244 ~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n 323 (461)
T 1z7x_W 244 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 323 (461)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred HHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCC
Confidence 33344688999999999999864 56777889999999999999988766666543 79999999999
Q ss_pred cCccc----cchhccccccCCeeecCCccCCCCCCccccc-----ccccceEEccCCcCCc----CCchhhhccCCCcEE
Q 041438 362 KLSQQ----IPIELDNLIHLSELDLSHNFLGEKISSRICR-----MESLEKLNLSYNNLSG----LIPRCFEELHGLLHI 428 (752)
Q Consensus 362 ~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L 428 (752)
.+++. ++..+..+++|++|+|++|.+++..+..++. .++|++|+|++|++++ .+|..+..+++|++|
T Consensus 324 ~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L 403 (461)
T 1z7x_W 324 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 403 (461)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred CCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEE
Confidence 99876 5677788899999999999998776665554 6799999999999996 778889999999999
Q ss_pred EccCCcccCc
Q 041438 429 DISYNKLEGH 438 (752)
Q Consensus 429 ~ls~N~l~~~ 438 (752)
++++|++++.
T Consensus 404 ~l~~N~i~~~ 413 (461)
T 1z7x_W 404 DLSNNCLGDA 413 (461)
T ss_dssp ECCSSSCCHH
T ss_pred ECCCCCCCHH
Confidence 9999998753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=295.34 Aligned_cols=213 Identities=22% Similarity=0.330 Sum_probs=163.4
Q ss_pred hcccccc-eeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------Ccccc----CCceEEEEE
Q 041438 500 TNDFDAK-HCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------NFCSH----PRQSFIVYE 553 (752)
Q Consensus 500 ~~~y~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------~~~~~----~~~~~lV~E 553 (752)
.++|.+. +.||+|+||.||+|+. .+++.||||+++..... +++.. ....++|||
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 95 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 95 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEe
Confidence 4677777 7899999999999995 67899999988542110 22222 567899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC---CCceEEeecccceecc
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL---GYEAHVSDFRIAKFLN 630 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~---~~~~kl~DfG~a~~~~ 630 (752)
|+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++....
T Consensus 96 ~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 96 CLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp CCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred ecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 9999999999986542 3589999999999999999999999 9999999999999997 7889999999987542
Q ss_pred CCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
+..++.++||||+||++|||++|+.||........ .......+.......+......
T Consensus 172 ----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 228 (299)
T 3m2w_A 172 ----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGMKTRIRMGQYEFPNPEWSE 228 (299)
T ss_dssp ----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSCTTCCSSCHHHHTT
T ss_pred ----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-hHHHHHHHhhccccCCchhccc
Confidence 13467899999999999999999999853221110 0111112222223333323345
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.++++.+++.+||+.||++|||++|+++|
T Consensus 229 ~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 229 VSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 56789999999999999999999999986
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=289.64 Aligned_cols=252 Identities=23% Similarity=0.265 Sum_probs=154.3
Q ss_pred CCCcccceeeCCCCCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCccccc--
Q 041438 71 SLCTWSGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGH-- 148 (752)
Q Consensus 71 ~~c~w~gv~C~~~~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-- 148 (752)
..|.|.++.|...+ + + .++. .-.++|++|+|++|+++++.+..|+++++|++|+|++|+++..
T Consensus 5 C~C~~~~l~c~~~~-l-----~------~ip~---~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~ 69 (306)
T 2z66_A 5 CSCSGTEIRCNSKG-L-----T------SVPT---GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGC 69 (306)
T ss_dssp CEEETTEEECCSSC-C-----S------SCCS---CCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEE
T ss_pred CeeCCCEEEcCCCC-c-----c------cCCC---CCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccC
Confidence 34899999997533 1 1 1111 1236788999999999887777788899999999999988743
Q ss_pred CCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCC-cCccCCCcceEEeeccccccccccccccC
Q 041438 149 IPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIP-RSLSNFTNLVFLYLYNNSFSGSIPQQIGN 227 (752)
Q Consensus 149 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 227 (752)
.|..+..+++|++|+|++|.++ .+|..+..+++|++|+|++|++++..+ ..|.++++|++|+|++|.+++..+..|.+
T Consensus 70 ~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 148 (306)
T 2z66_A 70 CSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 148 (306)
T ss_dssp EEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTT
T ss_pred cccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhccc
Confidence 3566777888888888888887 456667778888888888888776554 56777777777777777777665555544
Q ss_pred ccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCC-CCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccC
Q 041438 228 LKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITG-NIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLN 306 (752)
Q Consensus 228 l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 306 (752)
+++| ++|++++|.+++ ..|..+..+++|++|+|++|.+++..|..|..+++|+
T Consensus 149 l~~L--------------------------~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 202 (306)
T 2z66_A 149 LSSL--------------------------EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 202 (306)
T ss_dssp CTTC--------------------------CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred CcCC--------------------------CEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCC
Confidence 4433 344444444443 3344444455555555555555444444444444444
Q ss_pred EEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccc-cccEEEcCCCcCc
Q 041438 307 RISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLV-KLYYLNLSHNKLS 364 (752)
Q Consensus 307 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~ 364 (752)
.|+|++|++++..+..+..+++|++|+|++|++++..+..+..++ +|++|+|++|.++
T Consensus 203 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~ 261 (306)
T 2z66_A 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261 (306)
T ss_dssp EEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEE
T ss_pred EEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCee
Confidence 444444444444444444444444444444444444444444442 4444444444443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.98 E-value=8.8e-33 Score=288.63 Aligned_cols=209 Identities=11% Similarity=-0.002 Sum_probs=160.9
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV 551 (752)
.++|++.+.||+|+||.||+|+. .+++.||||+++..... +++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 46799999999999999999996 45899999999765332 344566789999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+++++|.+++... ....++..++.|++.||+|||++ ||+||||||+||+++.++.+||+++
T Consensus 110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~-------- 173 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP-------- 173 (286)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSC--------
T ss_pred EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEec--------
Confidence 9999999999999542 24457889999999999999999 9999999999999999999998843
Q ss_pred CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
.|++| ++.++|||||||++|||+||+.||......... .............+.......
T Consensus 174 ------------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T 3uqc_A 174 ------------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL--APAERDTAGQPIEPADIDRDI 232 (286)
T ss_dssp ------------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS--EECCBCTTSCBCCHHHHCTTS
T ss_pred ------------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh--HHHHHHhccCCCChhhcccCC
Confidence 34443 688999999999999999999998632211000 001111111111111112345
Q ss_pred HHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 712 FMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
++++.+++.+||+.||++| |++|+++.|+++...
T Consensus 233 ~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 233 PFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 6678999999999999999 999999999987644
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=294.93 Aligned_cols=286 Identities=21% Similarity=0.187 Sum_probs=192.5
Q ss_pred CCCcccceeeCCCCCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCC
Q 041438 71 SLCTWSGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIP 150 (752)
Q Consensus 71 ~~c~w~gv~C~~~~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 150 (752)
.+|.|.|+ |+. +++++. .++. . -.++|++|+|++|+|+++.+..|.++++|++|+|++|++++..|
T Consensus 28 ~~C~~~~~-c~~---------~~~~l~-~iP~-~--~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 93 (353)
T 2z80_A 28 LSCDRNGI-CKG---------SSGSLN-SIPS-G--LTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE 93 (353)
T ss_dssp CEECTTSE-EEC---------CSTTCS-SCCT-T--CCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECT
T ss_pred CCCCCCeE-eeC---------CCCCcc-cccc-c--ccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCH
Confidence 67999988 752 222222 1222 1 22589999999999998888889999999999999999998888
Q ss_pred cccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCC-cCccCCCcceEEeeccc-cccccccccccCc
Q 041438 151 SEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIP-RSLSNFTNLVFLYLYNN-SFSGSIPQQIGNL 228 (752)
Q Consensus 151 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l 228 (752)
..|.++++|++|+|++|+|++..+..|+++++|++|+|++|++++..+ ..|.++++|++|++++| .+.+..+..|+++
T Consensus 94 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l 173 (353)
T 2z80_A 94 DSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL 173 (353)
T ss_dssp TTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred hhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCC
Confidence 889999999999999999997666668899999999999999986555 57888999999999988 4665555555555
Q ss_pred cccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEE
Q 041438 229 KSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRI 308 (752)
Q Consensus 229 ~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 308 (752)
++ |++|++++|++++..|..+..+++|++|++++|.++...+..+..+++|+.|
T Consensus 174 ~~--------------------------L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L 227 (353)
T 2z80_A 174 TF--------------------------LEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECL 227 (353)
T ss_dssp CE--------------------------EEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEE
T ss_pred CC--------------------------CCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEE
Confidence 44 4466666666666666666667777777777777654333344456667777
Q ss_pred EccCCcCcccCCcccC---CCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCc
Q 041438 309 SLSGNKLSGRIPGELG---SLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHN 385 (752)
Q Consensus 309 ~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 385 (752)
++++|++++..+..+. ....++.++|++|.+++. .+. .+|..+..+++|++|+|++|
T Consensus 228 ~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~-------------------~l~-~l~~~l~~l~~L~~L~Ls~N 287 (353)
T 2z80_A 228 ELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE-------------------SLF-QVMKLLNQISGLLELEFSRN 287 (353)
T ss_dssp EEESCBCTTCCCC------CCCCCCEEEEESCBCCHH-------------------HHH-HHHHHHHTCTTCCEEECCSS
T ss_pred ECCCCccccccccccccccccchhhccccccccccCc-------------------chh-hhHHHHhcccCCCEEECCCC
Confidence 7777766654443322 223344444444444331 110 24455566666666666666
Q ss_pred cCCCCCCcccccccccceEEccCCcCCcCCc
Q 041438 386 FLGEKISSRICRMESLEKLNLSYNNLSGLIP 416 (752)
Q Consensus 386 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 416 (752)
+++...+..|..+++|++|+|++|++++..|
T Consensus 288 ~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 288 QLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 6664444445666677777777777766544
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-32 Score=292.55 Aligned_cols=280 Identities=18% Similarity=0.214 Sum_probs=180.3
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEc
Q 041438 109 PHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLIL 188 (752)
Q Consensus 109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 188 (752)
+.....++++|+++.+ |..+. ++|++|+|++|+++++.+..|.++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 31 ~~~~~c~~~~~~l~~i-P~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (353)
T 2z80_A 31 DRNGICKGSSGSLNSI-PSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107 (353)
T ss_dssp CTTSEEECCSTTCSSC-CTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCeEeeCCCCCcccc-ccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence 3344456666666553 33332 25555555555555554445555555555555555555544555555555555555
Q ss_pred cCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccC
Q 041438 189 DSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNIT 268 (752)
Q Consensus 189 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 268 (752)
++|++++..+..|.++++|++|+|++|+++
T Consensus 108 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-------------------------------------------------- 137 (353)
T 2z80_A 108 SYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-------------------------------------------------- 137 (353)
T ss_dssp CSSCCSSCCHHHHTTCTTCSEEECTTCCCS--------------------------------------------------
T ss_pred CCCcCCcCCHhHhCCCccCCEEECCCCCCc--------------------------------------------------
Confidence 555555443333444455555555444444
Q ss_pred CCCC-cccCCCCCCCEEecCCC-cCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchh
Q 041438 269 GNIP-FEIGESPQLQYLDLSSN-YIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLES 346 (752)
Q Consensus 269 ~~~p-~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 346 (752)
+..+ ..+..+++|++|++++| .+.+..+..|.++++|+.|++++|++++..|..+..+++|++|++++|.++..+...
T Consensus 138 ~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~ 217 (353)
T 2z80_A 138 TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIF 217 (353)
T ss_dssp SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHH
T ss_pred ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhh
Confidence 2222 23444555555555555 344444556666777777777777777777777777778888888888877766666
Q ss_pred hcccccccEEEcCCCcCccccchhcc---ccccCCeeecCCccCCC----CCCcccccccccceEEccCCcCCcCCchhh
Q 041438 347 LGSLVKLYYLNLSHNKLSQQIPIELD---NLIHLSELDLSHNFLGE----KISSRICRMESLEKLNLSYNNLSGLIPRCF 419 (752)
Q Consensus 347 ~~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 419 (752)
+..+++|+.|++++|++++..+..+. ....++.++|++|.+++ .+|..+..+++|+.|+|++|+++.+++..|
T Consensus 218 ~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~ 297 (353)
T 2z80_A 218 VDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIF 297 (353)
T ss_dssp HHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTT
T ss_pred hhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHH
Confidence 66778888888888888766554433 35667788888888766 367778899999999999999997766667
Q ss_pred hccCCCcEEEccCCcccCcCCC
Q 041438 420 EELHGLLHIDISYNKLEGHIPN 441 (752)
Q Consensus 420 ~~l~~L~~L~ls~N~l~~~~p~ 441 (752)
..+++|++|++++|++.+..|.
T Consensus 298 ~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 298 DRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp TTCTTCCEEECCSSCBCCCHHH
T ss_pred hcCCCCCEEEeeCCCccCcCCC
Confidence 9999999999999999987763
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=293.39 Aligned_cols=217 Identities=15% Similarity=0.139 Sum_probs=168.7
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC---------------------Cc-----------------
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD---------------------NF----------------- 541 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~----------------- 541 (752)
.++|++.+.||+|+||.||+|+. +|+.||||+++..... ..
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46899999999999999999988 7899999998754210 00
Q ss_pred --------------------c-------------ccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHH
Q 041438 542 --------------------C-------------SHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADA 588 (752)
Q Consensus 542 --------------------~-------------~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~a 588 (752)
+ ......|+|||||++|++.+.+.+ ..+++..++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 0 026789999999999976666643 237899999999999999
Q ss_pred HHHHH-hCCCCCeeecCCCCCCEEeCCCC--------------------ceEEeecccceeccCCCCCcccccCCCCccC
Q 041438 589 LFYLH-NNCFPPIVHWDISSKNVLLDLGY--------------------EAHVSDFRIAKFLNLDSSNWSKLAGTHGNVA 647 (752)
Q Consensus 589 L~~lH-~~~~~~ivH~DlKp~NIll~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~a 647 (752)
|+||| +. +|+||||||+|||++.++ .+||+|||+|+..... ..+||+.|+|
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~a 245 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTC
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccC
Confidence 99999 89 999999999999999887 8999999999876532 3489999999
Q ss_pred ccccccCCCCCccchhhHHHH-HHHHHhCCCCcchhhccccccccchHhhh---ccCCCCCChhhHHHHHHHHHHHHhcc
Q 041438 648 PELAYTMKVTEKCDVYSFGVL-ALEVIKGKHPRDFLFEMSSSSSNMNIEIL---DSRLPYPSLDVQNKFMSIMQVAFSCL 723 (752)
Q Consensus 648 PE~~~~~~~~~ksDIwSlGvi-l~elltg~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl 723 (752)
||++.+.. +.++||||+|++ .+++++|..||....+... ....+. ......+.......++++.++|.+||
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L 320 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY----LTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTML 320 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH----HHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGG
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhH----HHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHh
Confidence 99998776 889999998777 7788899999853211100 111111 11112223334678889999999999
Q ss_pred CcCCCCCCCHHHHH-HH
Q 041438 724 DQNPVSRPTMKRFE-VQ 739 (752)
Q Consensus 724 ~~dP~~Rps~~evl-~~ 739 (752)
++| |++|++ +|
T Consensus 321 ~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 321 NFS-----SATDLLCQH 332 (336)
T ss_dssp GSS-----SHHHHHHHC
T ss_pred ccC-----CHHHHHhcC
Confidence 976 999988 54
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-32 Score=317.45 Aligned_cols=215 Identities=25% Similarity=0.342 Sum_probs=167.6
Q ss_pred hcccccceeeccCCceEEEEEEeC--CCcEEEEEccCCCCCC-------------------------CccccCCc-----
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP--SGEIFAVKKFHSPLPD-------------------------NFCSHPRQ----- 547 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~-------------------------~~~~~~~~----- 547 (752)
.++|++.+.||+|+||.||+|+.. +|+.||||++...... +++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999964 6899999988643211 22333333
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
.|+||||+++++|.+++.. .+++.+++.|+.||+.||.|||++ ||+||||||+||+++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999987753 488999999999999999999999 99999999999999975 89999999998
Q ss_pred eccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChh
Q 041438 628 FLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLD 707 (752)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (752)
..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||..... . ..+. ...
T Consensus 230 ~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~-----~---------~~~~-~~~ 289 (681)
T 2pzi_A 230 RINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV-----D---------GLPE-DDP 289 (681)
T ss_dssp ETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC-----S---------SCCT-TCH
T ss_pred hcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc-----c---------cccc-ccc
Confidence 76533 3457999999999887654 8899999999999999999998752110 0 0111 112
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCC-HHHHHHHHhhh
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRPT-MKRFEVQSKQF 743 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~L~~~ 743 (752)
....++.+.++|.+||++||++||+ ++++...+..+
T Consensus 290 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 290 VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 2344567899999999999999995 55566655543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=283.12 Aligned_cols=248 Identities=21% Similarity=0.172 Sum_probs=145.0
Q ss_pred EEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCC--CCcccCCCCCCcEEEccC
Q 041438 113 YLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGS--IPHEVGQLNFLNHLILDS 190 (752)
Q Consensus 113 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~ 190 (752)
.++.++++++.+ |..+. ++|++|+|++|+++.+.+..|.++++|++|+|++|.++.. .|..+..+++|++|+|++
T Consensus 11 ~l~c~~~~l~~i-p~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~ 87 (306)
T 2z66_A 11 EIRCNSKGLTSV-PTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87 (306)
T ss_dssp EEECCSSCCSSC-CSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred EEEcCCCCcccC-CCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence 456666666653 33332 4666667777666655445566666666666666666522 244445555666666666
Q ss_pred CCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCC
Q 041438 191 NFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGN 270 (752)
Q Consensus 191 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 270 (752)
|.++. +|..+.++++|++|+|++|++++..+. ..+..+++|++|++++|.+++.
T Consensus 88 n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~-------------------------~~~~~l~~L~~L~l~~n~l~~~ 141 (306)
T 2z66_A 88 NGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEF-------------------------SVFLSLRNLIYLDISHTHTRVA 141 (306)
T ss_dssp CSEEE-EEEEEETCTTCCEEECTTSEEESSTTT-------------------------TTTTTCTTCCEEECTTSCCEEC
T ss_pred Ccccc-ChhhcCCCCCCCEEECCCCcccccccc-------------------------hhhhhccCCCEEECCCCcCCcc
Confidence 65553 344455555555555555555432220 0133455666666666666666
Q ss_pred CCcccCCCCCCCEEecCCCcCcC-CCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcc
Q 041438 271 IPFEIGESPQLQYLDLSSNYIVG-EIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGS 349 (752)
Q Consensus 271 ~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 349 (752)
.+..+..+++|++|+|++|.+++ ..|..+..+++|+.|++++|++++..|..|..+++|++|+|++|.+++..+..|..
T Consensus 142 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 221 (306)
T 2z66_A 142 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 221 (306)
T ss_dssp STTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTT
T ss_pred chhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccC
Confidence 66666666777777777776665 45666666666666666666666655666666666666666666666655555555
Q ss_pred cccccEEEcCCCcCccccchhccccc-cCCeeecCCccCCC
Q 041438 350 LVKLYYLNLSHNKLSQQIPIELDNLI-HLSELDLSHNFLGE 389 (752)
Q Consensus 350 l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~ 389 (752)
+++|++|+|++|++++..|..+..++ +|++|+|++|.+++
T Consensus 222 l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~ 262 (306)
T 2z66_A 222 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 262 (306)
T ss_dssp CTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred cccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence 66666666666666555555555552 55555555555543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=290.65 Aligned_cols=250 Identities=22% Similarity=0.166 Sum_probs=155.2
Q ss_pred cCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcc-cccCCcccc-------cccccceeeccCcccCCCCCcc
Q 041438 105 FSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKL-SGHIPSEIS-------LLTHLTILHISRNQLNGSIPHE 176 (752)
Q Consensus 105 f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l-~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~~ 176 (752)
++..++|++|++++|++ .+|..+... |++|+|++|++ .+.+|..+. ++++|++|+|++|+|++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 45566788888888888 566665544 88888888888 445666555 6888888888888888888887
Q ss_pred c--CCCCCCcEEEccCCCCCCcCCcCccCC-----CcceEEeeccccccccccccccCccccccccccccccCCCc--CC
Q 041438 177 V--GQLNFLNHLILDSNFLGGSIPRSLSNF-----TNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAI--PL 247 (752)
Q Consensus 177 ~--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~--~~ 247 (752)
+ ..+++|++|+|++|++++. |..+.++ ++|++|+|++|++++..|..|+++++|++|++++|++.+.+ +.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 6 7888888888888888877 7777777 88888888888888777777777777776666666655432 22
Q ss_pred CCCCCCCCCCcEEEccccccCCC--CC-cccCCCCCCCEEecCCCcCcCCCC-ccccCCcccCEEEccCCcCcccCCccc
Q 041438 248 SIDWGRCPQLSLLDVSINNITGN--IP-FEIGESPQLQYLDLSSNYIVGEIP-TQLGNIIYLNRISLSGNKLSGRIPGEL 323 (752)
Q Consensus 248 ~~~~~~l~~L~~L~Ls~N~l~~~--~p-~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 323 (752)
.+.++.+++|++|++++|+|++. ++ ..+..+++|++|+|++|++++..| ..+..+++|+.|+|++|+|+ .+|..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 22334555555555555555521 11 222344555555555555554443 23334445555555555554 333333
Q ss_pred CCCcccceeeccccccccccchhhcccccccEEEcCCCcCc
Q 041438 324 GSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLS 364 (752)
Q Consensus 324 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 364 (752)
. ++|++|+|++|+|++. |. +..+++|++|+|++|+++
T Consensus 273 ~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 273 P--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp C--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred c--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 3 4444444444444443 22 444444444444444443
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-34 Score=321.97 Aligned_cols=351 Identities=20% Similarity=0.130 Sum_probs=278.6
Q ss_pred CCCCCEEECCCCcccccCCcc-CcCCCCCCeeecCCCcccc----cCCcccccccccceeeccCcccCCCCCccc-CCCC
Q 041438 108 FPHLAYLDLYNNELFDIIPPQ-ISNLSKLEYLDFLTNKLSG----HIPSEISLLTHLTILHISRNQLNGSIPHEV-GQLN 181 (752)
Q Consensus 108 l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~ 181 (752)
.++|++|||++|+++...... |..+++|++|+|++|+++. .++..+..+++|++|+|++|.++...+..+ ..++
T Consensus 2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~ 81 (461)
T 1z7x_W 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ 81 (461)
T ss_dssp CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence 357899999999998765444 8899999999999999985 346678888999999999999986544333 3344
Q ss_pred ----CCcEEEccCCCCCC----cCCcCccCCCcceEEeecccccccccccccc-----CccccccccccccccCCCcCCC
Q 041438 182 ----FLNHLILDSNFLGG----SIPRSLSNFTNLVFLYLYNNSFSGSIPQQIG-----NLKSLFDMKLCINQLNGAIPLS 248 (752)
Q Consensus 182 ----~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~l~l~~N~l~~~~~~~ 248 (752)
+|++|+|++|+++. .+|..|..+++|++|+|++|.+++..+..+. ..++|++|++++|++++.....
T Consensus 82 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~ 161 (461)
T 1z7x_W 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP 161 (461)
T ss_dssp STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred hCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHH
Confidence 79999999999994 5688999999999999999999876555443 3567999999999998643211
Q ss_pred C--CCCCCCCCcEEEccccccCCCCCcccC-----CCCCCCEEecCCCcCcCC----CCccccCCcccCEEEccCCcCcc
Q 041438 249 I--DWGRCPQLSLLDVSINNITGNIPFEIG-----ESPQLQYLDLSSNYIVGE----IPTQLGNIIYLNRISLSGNKLSG 317 (752)
Q Consensus 249 ~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~ 317 (752)
+ .+..+++|++|++++|.++...+..+. ..++|++|+|++|.+++. ++..+..+++|++|++++|.+++
T Consensus 162 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~ 241 (461)
T 1z7x_W 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241 (461)
T ss_dssp HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred HHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCCh
Confidence 1 234578999999999999865554443 367999999999999874 57778889999999999999975
Q ss_pred cC-----CcccCCCcccceeeccccccccc----cchhhcccccccEEEcCCCcCccccchhcccc-----ccCCeeecC
Q 041438 318 RI-----PGELGSLINLEYLDLSANHLSNF----VLESLGSLVKLYYLNLSHNKLSQQIPIELDNL-----IHLSELDLS 383 (752)
Q Consensus 318 ~~-----p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls 383 (752)
.. +..+..+++|++|+|++|.+++. .+..+..+++|++|+|++|.+++..+..+... ++|++|+|+
T Consensus 242 ~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~ 321 (461)
T 1z7x_W 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321 (461)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred HHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcC
Confidence 42 33345689999999999999986 46677889999999999999987666555543 799999999
Q ss_pred CccCCCC----CCcccccccccceEEccCCcCCcCCchhhhc-----cCCCcEEEccCCcccC----cCCCC-cccCCCC
Q 041438 384 HNFLGEK----ISSRICRMESLEKLNLSYNNLSGLIPRCFEE-----LHGLLHIDISYNKLEG----HIPNS-TTFRDAP 449 (752)
Q Consensus 384 ~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~ls~N~l~~----~~p~~-~~~~~~~ 449 (752)
+|.+++. ++..+..+++|++|+|++|++++..+..+.. .++|++|++++|++++ .+|.. .....+.
T Consensus 322 ~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~ 401 (461)
T 1z7x_W 322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 401 (461)
T ss_dssp TSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCC
T ss_pred CCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCcc
Confidence 9999876 4566777899999999999999876666653 6799999999999985 44432 1234445
Q ss_pred cccccCCCC
Q 041438 450 LEALQGNKG 458 (752)
Q Consensus 450 ~~~~~~n~~ 458 (752)
...+.+|+-
T Consensus 402 ~L~l~~N~i 410 (461)
T 1z7x_W 402 ELDLSNNCL 410 (461)
T ss_dssp EEECCSSSC
T ss_pred EEECCCCCC
Confidence 566677753
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-30 Score=286.78 Aligned_cols=228 Identities=21% Similarity=0.213 Sum_probs=175.4
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEc
Q 041438 109 PHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLIL 188 (752)
Q Consensus 109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 188 (752)
++|++|+|++|+|+++.|..|.++++|++|+|++|+|+++.|..|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 68999999999999999999999999999999999999999899999999999999999999888888999999999999
Q ss_pred cCCCCCCcCCcCccCCCcceEEeeccc-cccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEcccccc
Q 041438 189 DSNFLGGSIPRSLSNFTNLVFLYLYNN-SFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267 (752)
Q Consensus 189 ~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l 267 (752)
++|+|+...+..|.++++|++|+|++| .+....+..|.++++ |+.|+|++|++
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~--------------------------L~~L~L~~n~l 208 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFN--------------------------LKYLNLGMCNI 208 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTT--------------------------CCEEECTTSCC
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCC--------------------------CCEEECCCCcc
Confidence 999999888888999999999999984 444443344555554 45555555555
Q ss_pred CCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhh
Q 041438 268 TGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESL 347 (752)
Q Consensus 268 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 347 (752)
++. | .+..+++|++|+|++|.|++..|..|.++++|+.|+|++|++++..+..|.++++|++|+|++|+|+++++..|
T Consensus 209 ~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 286 (452)
T 3zyi_A 209 KDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLF 286 (452)
T ss_dssp SSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSS
T ss_pred ccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHh
Confidence 543 2 35556666666666666666666666666666666666666666666666667777777777777776666666
Q ss_pred cccccccEEEcCCCcCc
Q 041438 348 GSLVKLYYLNLSHNKLS 364 (752)
Q Consensus 348 ~~l~~L~~L~Ls~N~l~ 364 (752)
..+++|+.|+|++|.+.
T Consensus 287 ~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 287 TPLRYLVELHLHHNPWN 303 (452)
T ss_dssp TTCTTCCEEECCSSCEE
T ss_pred ccccCCCEEEccCCCcC
Confidence 66777777777777664
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=271.02 Aligned_cols=206 Identities=25% Similarity=0.228 Sum_probs=104.2
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcc-cCCCCCcccCCCCCCcEEE
Q 041438 109 PHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQ-LNGSIPHEVGQLNFLNHLI 187 (752)
Q Consensus 109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~ 187 (752)
++|++|+|++|+|+++.+..|.++++|++|+|++|+++++.|..|.++++|++|+|++|. ++...|..|..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 455555555555555555555555555555555555555555555555555555555554 4444455555555555555
Q ss_pred ccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEcccccc
Q 041438 188 LDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267 (752)
Q Consensus 188 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l 267 (752)
|++|++++..|..|.++++|++|+|++|++++.
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~----------------------------------------------- 144 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQAL----------------------------------------------- 144 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCC-----------------------------------------------
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCccccc-----------------------------------------------
Confidence 555555544444455555555555555444432
Q ss_pred CCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhh
Q 041438 268 TGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESL 347 (752)
Q Consensus 268 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 347 (752)
.+..+..+++|++|+|++|.+++..+..|.++++|+.|++++|++++..|..|..+++|++|+|++|.++++++..|
T Consensus 145 ---~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 221 (285)
T 1ozn_A 145 ---PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEAL 221 (285)
T ss_dssp ---CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHH
T ss_pred ---CHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHc
Confidence 22333334444444444444443333334444444444444444444444444455555555555555555444445
Q ss_pred cccccccEEEcCCCcCc
Q 041438 348 GSLVKLYYLNLSHNKLS 364 (752)
Q Consensus 348 ~~l~~L~~L~Ls~N~l~ 364 (752)
..+++|++|+|++|.+.
T Consensus 222 ~~l~~L~~L~l~~N~~~ 238 (285)
T 1ozn_A 222 APLRALQYLRLNDNPWV 238 (285)
T ss_dssp TTCTTCCEEECCSSCEE
T ss_pred ccCcccCEEeccCCCcc
Confidence 55555555555555554
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-30 Score=286.27 Aligned_cols=235 Identities=26% Similarity=0.306 Sum_probs=209.0
Q ss_pred CCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCC
Q 041438 125 IPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNF 204 (752)
Q Consensus 125 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 204 (752)
+|..+. ++|++|+|++|+|+++.|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++
T Consensus 69 iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 146 (452)
T 3zyi_A 69 VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYL 146 (452)
T ss_dssp CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSC
T ss_pred cCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhccc
Confidence 344443 689999999999999999999999999999999999999989999999999999999999998888889999
Q ss_pred CcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccc-cccCCCCCcccCCCCCCCE
Q 041438 205 TNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSI-NNITGNIPFEIGESPQLQY 283 (752)
Q Consensus 205 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~ 283 (752)
++|++|+|++|+|++..+..|.++ ++|+.|++++ |.+....+..|..+++|++
T Consensus 147 ~~L~~L~L~~N~l~~~~~~~~~~l--------------------------~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~ 200 (452)
T 3zyi_A 147 SKLRELWLRNNPIESIPSYAFNRV--------------------------PSLMRLDLGELKKLEYISEGAFEGLFNLKY 200 (452)
T ss_dssp TTCCEEECCSCCCCEECTTTTTTC--------------------------TTCCEEECCCCTTCCEECTTTTTTCTTCCE
T ss_pred CCCCEEECCCCCcceeCHhHHhcC--------------------------CcccEEeCCCCCCccccChhhccCCCCCCE
Confidence 999999999999986665555544 4556777776 3444444557889999999
Q ss_pred EecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcC
Q 041438 284 LDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKL 363 (752)
Q Consensus 284 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 363 (752)
|+|++|.+++. | .+..+++|+.|+|++|++++..|..|.++++|++|+|++|+++++.+..|.++++|+.|+|++|+|
T Consensus 201 L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 278 (452)
T 3zyi_A 201 LNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL 278 (452)
T ss_dssp EECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcC
Confidence 99999999865 4 588999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchhccccccCCeeecCCccCCC
Q 041438 364 SQQIPIELDNLIHLSELDLSHNFLGE 389 (752)
Q Consensus 364 ~~~~p~~~~~l~~L~~L~Ls~N~l~~ 389 (752)
++..+..|..+++|+.|+|++|.+..
T Consensus 279 ~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 279 SSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp SCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred CccChHHhccccCCCEEEccCCCcCC
Confidence 98888899999999999999999864
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-30 Score=275.45 Aligned_cols=236 Identities=18% Similarity=0.213 Sum_probs=183.9
Q ss_pred CCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEE
Q 041438 131 NLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFL 210 (752)
Q Consensus 131 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 210 (752)
..++++.|+|++|+++ .+|..+..+++|++|+|++|.|+ .+|..|+++++|++|+|++|+++ .+|..|.++++|++|
T Consensus 79 ~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L 155 (328)
T 4fcg_A 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155 (328)
T ss_dssp TSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEE
T ss_pred cccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEE
Confidence 3578999999999998 67888889999999999999999 88999999999999999999999 778899999999999
Q ss_pred eeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCc
Q 041438 211 YLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNY 290 (752)
Q Consensus 211 ~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 290 (752)
+|++|++.+.+|..++... +.+ .+..+++|++|++++|+++ .+|..+..+++|++|+|++|.
T Consensus 156 ~L~~n~~~~~~p~~~~~~~-----------~~~------~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~ 217 (328)
T 4fcg_A 156 SIRACPELTELPEPLASTD-----------ASG------EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSP 217 (328)
T ss_dssp EEEEETTCCCCCSCSEEEC------------CC------CEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSC
T ss_pred ECCCCCCccccChhHhhcc-----------chh------hhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCC
Confidence 9999998888887765421 111 1345677778888888877 667777778888888888888
Q ss_pred CcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchh
Q 041438 291 IVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIE 370 (752)
Q Consensus 291 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 370 (752)
+++ +|..+..+++|+.|+|++|++.+.+|..++++++|++|+|++|++.+..|..+..+++|++|+|++|++.+.+|..
T Consensus 218 l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~ 296 (328)
T 4fcg_A 218 LSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSL 296 (328)
T ss_dssp CCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGG
T ss_pred CCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHH
Confidence 774 4556777777777777777777777777777777777777777777777767777777777777777777777777
Q ss_pred ccccccCCeeecCCccCC
Q 041438 371 LDNLIHLSELDLSHNFLG 388 (752)
Q Consensus 371 ~~~l~~L~~L~Ls~N~l~ 388 (752)
+.++++|+.+++..|.+.
T Consensus 297 l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 297 IAQLPANCIILVPPHLQA 314 (328)
T ss_dssp GGGSCTTCEEECCGGGSC
T ss_pred HhhccCceEEeCCHHHHH
Confidence 777777766666665553
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=297.34 Aligned_cols=267 Identities=26% Similarity=0.303 Sum_probs=174.0
Q ss_pred CCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccC
Q 041438 111 LAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDS 190 (752)
Q Consensus 111 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 190 (752)
+++|++++|+|+. +|..+. ++|++|+|++|+|+. +|. .+++|++|+|++|+|++ +|. .+++|++|+|++
T Consensus 42 l~~L~ls~n~L~~-lp~~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~ 110 (622)
T 3g06_A 42 NAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFS 110 (622)
T ss_dssp CCEEECCSSCCSC-CCSCCC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECS
T ss_pred CcEEEecCCCcCc-cChhhC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcC
Confidence 5566666666663 344443 566666666666663 333 45666666666666663 343 456666666666
Q ss_pred CCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCC
Q 041438 191 NFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGN 270 (752)
Q Consensus 191 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 270 (752)
|+|++. |. .+++|+.|+|++|+|++ +|.. +++|++|++++|++++. |. .+++|+.|++++|.|++
T Consensus 111 N~l~~l-~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l-~~-----~~~~L~~L~L~~N~l~~- 175 (622)
T 3g06_A 111 NPLTHL-PA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL-PA-----LPSELCKLWAYNNQLTS- 175 (622)
T ss_dssp CCCCCC-CC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC-CC-----CCTTCCEEECCSSCCSC-
T ss_pred CcCCCC-CC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCc-CC-----ccCCCCEEECCCCCCCC-
Confidence 666653 22 44666666666666664 3332 25566666666666542 21 23567777777777775
Q ss_pred CCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhccc
Q 041438 271 IPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSL 350 (752)
Q Consensus 271 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 350 (752)
+| ..+++|+.|+|++|.|++ +|.. +++|+.|++++|.++. +|. .+++|++|+|++|+|++++ ..+
T Consensus 176 l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~---~~~~L~~L~Ls~N~L~~lp----~~l 240 (622)
T 3g06_A 176 LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPA---LPSGLKELIVSGNRLTSLP----VLP 240 (622)
T ss_dssp CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCC---CCTTCCEEECCSSCCSCCC----CCC
T ss_pred Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCC---CCCCCCEEEccCCccCcCC----CCC
Confidence 34 345778888888888775 3332 3677788888888774 333 2367888888888887744 455
Q ss_pred ccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccC
Q 041438 351 VKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELH 423 (752)
Q Consensus 351 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 423 (752)
++|+.|+|++|+|+. +|. .+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|..+..++
T Consensus 241 ~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 241 SELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 778888888888874 443 5677888888888887 4567788888888888888888888777776654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=270.59 Aligned_cols=165 Identities=22% Similarity=0.181 Sum_probs=120.4
Q ss_pred CCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeec
Q 041438 255 PQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDL 334 (752)
Q Consensus 255 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 334 (752)
++|++|++++|.+++..|..+..+++|++|++++|.+++..+..|.++++|+.|+|++|++++..+..|..+++|++|+|
T Consensus 105 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 184 (285)
T 1ozn_A 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184 (285)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEEC
Confidence 34445555555555555666777788888888888888777777888888888888888888777777888888888888
Q ss_pred cccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcC
Q 041438 335 SANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGL 414 (752)
Q Consensus 335 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 414 (752)
++|.+++..+..|..+++|+.|++++|++++..+..+..+++|++|+|++|.+....+.. .-...++.+..+.|.+...
T Consensus 185 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~ 263 (285)
T 1ozn_A 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCS 263 (285)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEE
T ss_pred CCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccC
Confidence 888888888888888888888888888888777777888888888888888776543221 1123344455566666666
Q ss_pred Cchhhh
Q 041438 415 IPRCFE 420 (752)
Q Consensus 415 ~p~~~~ 420 (752)
.|..+.
T Consensus 264 ~p~~l~ 269 (285)
T 1ozn_A 264 LPQRLA 269 (285)
T ss_dssp ESGGGT
T ss_pred CchHhC
Confidence 665543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-30 Score=283.25 Aligned_cols=227 Identities=20% Similarity=0.214 Sum_probs=155.1
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEc
Q 041438 109 PHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLIL 188 (752)
Q Consensus 109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 188 (752)
+++++|+|++|+|+++.+..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (440)
T 3zyj_A 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL 143 (440)
T ss_dssp TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence 67888999999988888888888888999999988888888888888888888888888888777778888888888888
Q ss_pred cCCCCCCcCCcCccCCCcceEEeecccc-ccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEcccccc
Q 041438 189 DSNFLGGSIPRSLSNFTNLVFLYLYNNS-FSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267 (752)
Q Consensus 189 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l 267 (752)
++|+|+...+..|.++++|++|+|++|+ +....+..|.+++ +|++|++++|++
T Consensus 144 ~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~--------------------------~L~~L~L~~n~l 197 (440)
T 3zyj_A 144 RNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLS--------------------------NLRYLNLAMCNL 197 (440)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCS--------------------------SCCEEECTTSCC
T ss_pred CCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhccc--------------------------ccCeecCCCCcC
Confidence 8888887777788888888888888743 4433333444444 444555555555
Q ss_pred CCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhh
Q 041438 268 TGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESL 347 (752)
Q Consensus 268 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 347 (752)
+.. | .+..+++|++|+|++|.|++..|..|.++++|+.|+|++|++++..+..|.++++|++|+|++|+|+++++..|
T Consensus 198 ~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 275 (440)
T 3zyj_A 198 REI-P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLF 275 (440)
T ss_dssp SSC-C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTT
T ss_pred ccc-c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHh
Confidence 422 2 24455555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred cccccccEEEcCCCcC
Q 041438 348 GSLVKLYYLNLSHNKL 363 (752)
Q Consensus 348 ~~l~~L~~L~Ls~N~l 363 (752)
..+++|+.|+|++|.+
T Consensus 276 ~~l~~L~~L~L~~Np~ 291 (440)
T 3zyj_A 276 TPLHHLERIHLHHNPW 291 (440)
T ss_dssp SSCTTCCEEECCSSCE
T ss_pred ccccCCCEEEcCCCCc
Confidence 5555555555555554
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-29 Score=281.77 Aligned_cols=247 Identities=24% Similarity=0.273 Sum_probs=176.8
Q ss_pred CCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeecc
Q 041438 135 LEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYN 214 (752)
Q Consensus 135 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 214 (752)
.+.++.+++.++ .+|..+. ++++.|+|++|+|++..+..|.++++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 457888888887 4565553 6788888888888877778888888888888888888877777888888888888888
Q ss_pred ccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCC-cCcC
Q 041438 215 NSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSN-YIVG 293 (752)
Q Consensus 215 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~ 293 (752)
|+|++..+..|. .+++|++|+|++|+|++..+..|..+++|++|+|++| .+..
T Consensus 122 n~l~~~~~~~~~--------------------------~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~ 175 (440)
T 3zyj_A 122 NRLTTIPNGAFV--------------------------YLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSY 175 (440)
T ss_dssp SCCSSCCTTTSC--------------------------SCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCE
T ss_pred CcCCeeCHhHhh--------------------------ccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcce
Confidence 887755544443 3455667777777777777777888888888888884 4444
Q ss_pred CCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccc
Q 041438 294 EIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDN 373 (752)
Q Consensus 294 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 373 (752)
..+..|.++++|+.|+|++|+++.. | .+..+++|++|+|++|+|+++.+..|.++++|+.|+|++|++++..+..|.+
T Consensus 176 i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 253 (440)
T 3zyj_A 176 ISEGAFEGLSNLRYLNLAMCNLREI-P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDN 253 (440)
T ss_dssp ECTTTTTTCSSCCEEECTTSCCSSC-C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTT
T ss_pred eCcchhhcccccCeecCCCCcCccc-c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcC
Confidence 4445677777777777777777743 3 3666777777777777777766677777777777777777776666666666
Q ss_pred cccCCeeecCCccCCCCCCcccccccccceEEccCCcCC
Q 041438 374 LIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLS 412 (752)
Q Consensus 374 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 412 (752)
+++|++|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 254 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 254 LQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred CCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 666666666666666666666666666666666666654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=281.46 Aligned_cols=253 Identities=21% Similarity=0.204 Sum_probs=197.8
Q ss_pred cccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCC-CCcCCcCcc-------CCCcceEEeecccccccccc
Q 041438 151 SEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFL-GGSIPRSLS-------NFTNLVFLYLYNNSFSGSIP 222 (752)
Q Consensus 151 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l-~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p 222 (752)
+.++..++|+.|++++|.+ .+|..+... |+.|+|++|++ .+.+|..+. ++++|++|+|++|++++.+|
T Consensus 37 ~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 112 (312)
T 1wwl_A 37 ELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAP 112 (312)
T ss_dssp EEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCC
T ss_pred EEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhH
Confidence 3467788899999999998 667666544 88888888888 345555554 67778888888888777666
Q ss_pred ccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCC-----CCCCEEecCCCcCcCCCCc
Q 041438 223 QQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGES-----PQLQYLDLSSNYIVGEIPT 297 (752)
Q Consensus 223 ~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~ 297 (752)
..+ .++.+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|.
T Consensus 113 ~~~------------------------~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~ 167 (312)
T 1wwl_A 113 PPL------------------------LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCE 167 (312)
T ss_dssp CCS------------------------SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTT
T ss_pred HHH------------------------HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHH
Confidence 554 123455666777777777766 6666655 7888888888888888778
Q ss_pred cccCCcccCEEEccCCcCccc--CCccc--CCCcccceeecccccccc---ccchhhcccccccEEEcCCCcCccccc-h
Q 041438 298 QLGNIIYLNRISLSGNKLSGR--IPGEL--GSLINLEYLDLSANHLSN---FVLESLGSLVKLYYLNLSHNKLSQQIP-I 369 (752)
Q Consensus 298 ~~~~l~~L~~L~Ls~N~l~~~--~p~~~--~~l~~L~~L~Ls~N~l~~---~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~ 369 (752)
.|+++++|+.|+|++|++.+. .|..+ ..+++|++|+|++|+|++ .....+..+++|++|+|++|++++.+| .
T Consensus 168 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 247 (312)
T 1wwl_A 168 QVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAP 247 (312)
T ss_dssp TCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCS
T ss_pred HhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchh
Confidence 888888888888888887664 23333 788999999999999984 334556788999999999999998775 5
Q ss_pred hccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCCcccC
Q 041438 370 ELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEG 437 (752)
Q Consensus 370 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 437 (752)
.+..+++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++. |. +..+++|++|++++|++++
T Consensus 248 ~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 248 SCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred hhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 6777899999999999998 5566555 8999999999999988 65 8999999999999999976
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-31 Score=283.47 Aligned_cols=264 Identities=23% Similarity=0.191 Sum_probs=136.5
Q ss_pred eecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccc
Q 041438 138 LDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSF 217 (752)
Q Consensus 138 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 217 (752)
++++.+.+....+..+..+++|++|+|++|+|++..|..|.++++|++|+|++|++++..| |..+++|++|+|++|+|
T Consensus 15 ~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l 92 (317)
T 3o53_A 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV 92 (317)
T ss_dssp ESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEE
T ss_pred eeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcc
Confidence 3444444443333334444445555555555554444445555555555555555544333 45555555555555555
Q ss_pred cccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCc
Q 041438 218 SGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPT 297 (752)
Q Consensus 218 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 297 (752)
++..+ . ++|++|++++|++++..+.. +++|++|++++|.+++..+.
T Consensus 93 ~~l~~-----~--------------------------~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~ 138 (317)
T 3o53_A 93 QELLV-----G--------------------------PSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDL 138 (317)
T ss_dssp EEEEE-----C--------------------------TTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGB
T ss_pred ccccC-----C--------------------------CCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccch
Confidence 43211 1 23334444444443332221 23444555555555444444
Q ss_pred cccCCcccCEEEccCCcCcccCCccc-CCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhcccccc
Q 041438 298 QLGNIIYLNRISLSGNKLSGRIPGEL-GSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIH 376 (752)
Q Consensus 298 ~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 376 (752)
.+..+++|+.|++++|++++..+..+ ..+++|++|+|++|.+++... ...+++|++|+|++|++++..+ .+..+++
T Consensus 139 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~~ 215 (317)
T 3o53_A 139 DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAG 215 (317)
T ss_dssp CTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTT
T ss_pred hhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccccc--ccccccCCEEECCCCcCCcchh-hhcccCc
Confidence 45555555555555555554444443 245555555555555555422 2235566666666666654333 3666666
Q ss_pred CCeeecCCccCCCCCCcccccccccceEEccCCcCC-cCCchhhhccCCCcEEEcc-CCcccCcCCC
Q 041438 377 LSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLS-GLIPRCFEELHGLLHIDIS-YNKLEGHIPN 441 (752)
Q Consensus 377 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~ls-~N~l~~~~p~ 441 (752)
|++|+|++|++++ +|..+..+++|+.|+|++|+++ +.+|..+..++.|+.++++ .+.++|..|.
T Consensus 216 L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 216 VTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp CSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred ccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 6666666666653 3445666677777777777776 5566677777777777776 4456665554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-31 Score=282.02 Aligned_cols=243 Identities=22% Similarity=0.212 Sum_probs=204.2
Q ss_pred ccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCcccccccccc
Q 041438 158 HLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLC 237 (752)
Q Consensus 158 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~ 237 (752)
+++.++++.+.+...++..+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+ +.
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~----------- 77 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LE----------- 77 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ET-----------
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hh-----------
Confidence 45667788888876666667778889999999999988888888888899999999988876543 33
Q ss_pred ccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcc
Q 041438 238 INQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSG 317 (752)
Q Consensus 238 ~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 317 (752)
.+++|++|++++|++++.. ..++|++|++++|.+++..+.. +++|+.|++++|++++
T Consensus 78 ---------------~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~ 134 (317)
T 3o53_A 78 ---------------SLSTLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITM 134 (317)
T ss_dssp ---------------TCTTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCS
T ss_pred ---------------hcCCCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCC
Confidence 4456778888888887543 3389999999999999876654 5789999999999999
Q ss_pred cCCcccCCCcccceeeccccccccccchhhc-ccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccc
Q 041438 318 RIPGELGSLINLEYLDLSANHLSNFVLESLG-SLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRIC 396 (752)
Q Consensus 318 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 396 (752)
..+..++.+++|++|+|++|.+++..+..+. .+++|++|+|++|++++. + ....+++|++|+|++|++++..+. +.
T Consensus 135 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~~~-~~ 211 (317)
T 3o53_A 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGPE-FQ 211 (317)
T ss_dssp GGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECGG-GG
T ss_pred ccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcchhh-hc
Confidence 8898999999999999999999998888774 789999999999999866 3 234589999999999999876555 89
Q ss_pred cccccceEEccCCcCCcCCchhhhccCCCcEEEccCCccc-CcCC
Q 041438 397 RMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLE-GHIP 440 (752)
Q Consensus 397 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p 440 (752)
.+++|+.|+|++|+++++ |..+..+++|+.|++++|+++ +.+|
T Consensus 212 ~l~~L~~L~L~~N~l~~l-~~~~~~l~~L~~L~l~~N~~~~~~~~ 255 (317)
T 3o53_A 212 SAAGVTWISLRNNKLVLI-EKALRFSQNLEHFDLRGNGFHCGTLR 255 (317)
T ss_dssp GGTTCSEEECTTSCCCEE-CTTCCCCTTCCEEECTTCCCBHHHHH
T ss_pred ccCcccEEECcCCcccch-hhHhhcCCCCCEEEccCCCccCcCHH
Confidence 999999999999999965 778999999999999999998 4443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-28 Score=276.74 Aligned_cols=263 Identities=25% Similarity=0.243 Sum_probs=222.1
Q ss_pred CCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEee
Q 041438 133 SKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYL 212 (752)
Q Consensus 133 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 212 (752)
.+++.|++++|.|+ .+|..+. ++|++|+|++|.|+. +|. .+++|++|+|++|+|++ +|. .+++|++|+|
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEEC
Confidence 35899999999999 6677665 899999999999994 555 57899999999999995 554 6799999999
Q ss_pred ccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCc
Q 041438 213 YNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIV 292 (752)
Q Consensus 213 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 292 (752)
++|+|++. |. .+++|+.|++++|++++. |. .+++|++|++++|++++. |. .+++|+.|++++|.|+
T Consensus 109 s~N~l~~l-~~---~l~~L~~L~L~~N~l~~l-p~-----~l~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~ 174 (622)
T 3g06_A 109 FSNPLTHL-PA---LPSGLCKLWIFGNQLTSL-PV-----LPPGLQELSVSDNQLASL-PA---LPSELCKLWAYNNQLT 174 (622)
T ss_dssp CSCCCCCC-CC---CCTTCCEEECCSSCCSCC-CC-----CCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCS
T ss_pred cCCcCCCC-CC---CCCCcCEEECCCCCCCcC-CC-----CCCCCCEEECcCCcCCCc-CC---ccCCCCEEECCCCCCC
Confidence 99999964 44 568899999999999874 32 348999999999999864 43 3578999999999999
Q ss_pred CCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhcc
Q 041438 293 GEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELD 372 (752)
Q Consensus 293 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 372 (752)
+ +| ..+++|+.|++++|++++ +|.. +++|+.|++++|.++.++. .+++|+.|+|++|+|++ +| .
T Consensus 175 ~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~l~~----~~~~L~~L~Ls~N~L~~-lp---~ 238 (622)
T 3g06_A 175 S-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLPA----LPSGLKELIVSGNRLTS-LP---V 238 (622)
T ss_dssp C-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSCCC----CCTTCCEEECCSSCCSC-CC---C
T ss_pred C-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccccCC----CCCCCCEEEccCCccCc-CC---C
Confidence 6 55 456899999999999996 4433 4789999999999997653 35889999999999986 45 5
Q ss_pred ccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCCcccCcCCC
Q 041438 373 NLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPN 441 (752)
Q Consensus 373 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 441 (752)
.+++|+.|+|++|.|+...+ .+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|.
T Consensus 239 ~l~~L~~L~Ls~N~L~~lp~----~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 239 LPSELKELMVSGNRLTSLPM----LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred CCCcCcEEECCCCCCCcCCc----ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence 66899999999999986444 5789999999999999 5588899999999999999999987764
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=283.68 Aligned_cols=234 Identities=23% Similarity=0.200 Sum_probs=116.4
Q ss_pred ccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCcccccccccc
Q 041438 158 HLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLC 237 (752)
Q Consensus 158 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~ 237 (752)
+|++|+|++|.|++..|..|+.+++|++|+|++|.+++.+| |.++++|++|+|++|.|++..+. +
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~-----~-------- 99 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG-----P-------- 99 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC-----T--------
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC-----C--------
Confidence 55555555555555445555555555555555555554443 55555555555555555532211 2
Q ss_pred ccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcc
Q 041438 238 INQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSG 317 (752)
Q Consensus 238 ~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 317 (752)
+|++|++++|.|++..+. .+++|++|+|++|.+++..|..++++++|+.|+|++|.+++
T Consensus 100 ------------------~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 158 (487)
T 3oja_A 100 ------------------SIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT 158 (487)
T ss_dssp ------------------TCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCE
T ss_pred ------------------CcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCC
Confidence 233334444443333222 12344444444444444444444444444444444444444
Q ss_pred cCCcccC-CCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccc
Q 041438 318 RIPGELG-SLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRIC 396 (752)
Q Consensus 318 ~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 396 (752)
.+|..+. .+++|++|+|++|.|++.++ +..+++|+.|+|++|+|++.+| .+..+++|+.|+|++|.|++ +|..+.
T Consensus 159 ~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~ 234 (487)
T 3oja_A 159 VNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALR 234 (487)
T ss_dssp EEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCC
T ss_pred cChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhc
Confidence 4444443 44455555555555544422 2235555555555555554333 25555555555555555554 344455
Q ss_pred cccccceEEccCCcCC-cCCchhhhccCCCcEEEcc
Q 041438 397 RMESLEKLNLSYNNLS-GLIPRCFEELHGLLHIDIS 431 (752)
Q Consensus 397 ~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~ls 431 (752)
.+++|+.|++++|.++ +.+|..+..++.|+.++++
T Consensus 235 ~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 235 FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred cCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 5566666666666665 4455556666666666554
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=8e-28 Score=249.00 Aligned_cols=216 Identities=23% Similarity=0.281 Sum_probs=110.0
Q ss_pred CCCcccceeeCCCCCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCC
Q 041438 71 SLCTWSGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIP 150 (752)
Q Consensus 71 ~~c~w~gv~C~~~~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 150 (752)
++|.|.|+.|.-.+.+..++++ +++++. +|..+. ++|++|+|++|+|+++.+
T Consensus 3 ~~C~~~~~~C~c~~~~~~l~~~-------------------------~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~ 54 (270)
T 2o6q_A 3 ALCKKDGGVCSCNNNKNSVDCS-------------------------SKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPS 54 (270)
T ss_dssp CCBGGGTCSBEEETTTTEEECT-------------------------TSCCSS-CCSCCC--TTCSEEECCSSCCSCCCT
T ss_pred ccCCCCCCCCEeCCCCCEEEcc-------------------------CCCCCc-cCCCCC--CCCCEEECcCCCCCeeCH
Confidence 7899999999643333344444 444443 232222 345555555555554444
Q ss_pred cccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccc
Q 041438 151 SEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKS 230 (752)
Q Consensus 151 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 230 (752)
..|.++++|++|+|++|+|+...+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.+++
T Consensus 55 ~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~- 133 (270)
T 2o6q_A 55 KAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLT- 133 (270)
T ss_dssp TSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCT-
T ss_pred HHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCc-
Confidence 4555555555555555555544444445555555555555555554444555555555555555555544433333322
Q ss_pred cccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEc
Q 041438 231 LFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISL 310 (752)
Q Consensus 231 L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 310 (752)
+|++|++++|+|++..+..|..+++|++|+|++|.+++..+..|.++++|+.|+|
T Consensus 134 -------------------------~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 188 (270)
T 2o6q_A 134 -------------------------KLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKL 188 (270)
T ss_dssp -------------------------TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred -------------------------CCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEEC
Confidence 2333444444444333333444455555555555555444444555555555555
Q ss_pred cCCcCcccCCcccCCCcccceeeccccccc
Q 041438 311 SGNKLSGRIPGELGSLINLEYLDLSANHLS 340 (752)
Q Consensus 311 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 340 (752)
++|++++..+..|..+++|+.|+|++|.+.
T Consensus 189 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 189 DNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 555555444445555555555666655554
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-29 Score=283.38 Aligned_cols=223 Identities=23% Similarity=0.211 Sum_probs=191.2
Q ss_pred CCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCC
Q 041438 178 GQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQL 257 (752)
Q Consensus 178 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L 257 (752)
...++|++|+|++|.+++..|..|.++++|++|+|++|.+++..| |+ .+++|
T Consensus 31 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~--------------------------~l~~L 82 (487)
T 3oja_A 31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LE--------------------------SLSTL 82 (487)
T ss_dssp TTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CT--------------------------TCTTC
T ss_pred ccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cc--------------------------cCCCC
Confidence 345578999999999988888888888999999999988886554 33 44567
Q ss_pred cEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeecccc
Q 041438 258 SLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSAN 337 (752)
Q Consensus 258 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 337 (752)
++|+|++|.|++..+ .++|++|++++|.|++..+.. +++|+.|+|++|.+++..|..++.+++|++|+|++|
T Consensus 83 ~~L~Ls~N~l~~l~~-----~~~L~~L~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 154 (487)
T 3oja_A 83 RTLDLNNNYVQELLV-----GPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN 154 (487)
T ss_dssp CEEECCSSEEEEEEE-----CTTCCEEECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTS
T ss_pred CEEEecCCcCCCCCC-----CCCcCEEECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCC
Confidence 788888888876543 389999999999999877654 578999999999999999999999999999999999
Q ss_pred ccccccchhhc-ccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCc
Q 041438 338 HLSNFVLESLG-SLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIP 416 (752)
Q Consensus 338 ~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 416 (752)
.+++.+|..+. .+++|+.|+|++|.|++..+ +..+++|+.|+|++|.|++.+|. +..+++|+.|+|++|+|+++ |
T Consensus 155 ~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~l-p 230 (487)
T 3oja_A 155 EIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVLI-E 230 (487)
T ss_dssp CCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCEE-C
T ss_pred CCCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCccc-c
Confidence 99999888886 79999999999999987633 44699999999999999986665 88999999999999999984 7
Q ss_pred hhhhccCCCcEEEccCCccc-CcCC
Q 041438 417 RCFEELHGLLHIDISYNKLE-GHIP 440 (752)
Q Consensus 417 ~~~~~l~~L~~L~ls~N~l~-~~~p 440 (752)
..+..+++|+.|++++|++. +.+|
T Consensus 231 ~~l~~l~~L~~L~l~~N~l~c~~~~ 255 (487)
T 3oja_A 231 KALRFSQNLEHFDLRGNGFHCGTLR 255 (487)
T ss_dssp TTCCCCTTCCEEECTTCCBCHHHHH
T ss_pred hhhccCCCCCEEEcCCCCCcCcchH
Confidence 77999999999999999998 4443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=241.09 Aligned_cols=109 Identities=18% Similarity=0.161 Sum_probs=55.7
Q ss_pred CCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEcc
Q 041438 110 HLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILD 189 (752)
Q Consensus 110 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 189 (752)
+|++|+|++|+|+++.+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.|++..+..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 45555555555555555555555555555555555555544455555555555555555554444444555555555555
Q ss_pred CCCCCCcCCcCccCCCcceEEeecccccc
Q 041438 190 SNFLGGSIPRSLSNFTNLVFLYLYNNSFS 218 (752)
Q Consensus 190 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 218 (752)
+|++++..+..+.++++|++|+|++|+++
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 137 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQ 137 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccc
Confidence 55444444434444444444444444443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=238.39 Aligned_cols=227 Identities=21% Similarity=0.160 Sum_probs=132.3
Q ss_pred eeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCcccccccccccccc
Q 041438 162 LHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQL 241 (752)
Q Consensus 162 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l 241 (752)
.+.++..++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--------------- 73 (276)
T 2z62_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ--------------- 73 (276)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTT---------------
T ss_pred EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHcc---------------
Confidence 444555555 3444443 3566666666666666555666666666666666666544433332
Q ss_pred CCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCc
Q 041438 242 NGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPG 321 (752)
Q Consensus 242 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 321 (752)
.+++|++|++++|.+++..+..|..+++|++|++++|.+++..+..+.++++|++|++++|++++..
T Consensus 74 -----------~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-- 140 (276)
T 2z62_A 74 -----------SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK-- 140 (276)
T ss_dssp -----------TCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCC--
T ss_pred -----------CCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceec--
Confidence 2334445555556555555555566666666666666665544444555555555555555554321
Q ss_pred ccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCC----eeecCCccCCCCCCccccc
Q 041438 322 ELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLS----ELDLSHNFLGEKISSRICR 397 (752)
Q Consensus 322 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~~~~~~~ 397 (752)
.|..|..+++|++|+|++|++++..+..+..+++|+ .|++++|.+++..+..+..
T Consensus 141 ---------------------l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~ 199 (276)
T 2z62_A 141 ---------------------LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199 (276)
T ss_dssp ---------------------CCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS
T ss_pred ---------------------CchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCC
Confidence 244444555555555555555544444444444444 5666666665555544443
Q ss_pred ccccceEEccCCcCCcCCchhhhccCCCcEEEccCCcccCcCCC
Q 041438 398 MESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPN 441 (752)
Q Consensus 398 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 441 (752)
.+|+.|+|++|++++.++..|..+++|+.|++++|++++..|.
T Consensus 200 -~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 200 -IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp -CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTT
T ss_pred -CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCc
Confidence 3677788888888777777777788888888888888776654
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-25 Score=230.86 Aligned_cols=181 Identities=23% Similarity=0.217 Sum_probs=84.7
Q ss_pred CCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEcc
Q 041438 110 HLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILD 189 (752)
Q Consensus 110 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 189 (752)
+|++|+|++|+|+++.+..|.++++|++|+|++|+|+.+.+..|.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 44455555555544444445555555555555555544444444445555555555555544444444444555555555
Q ss_pred CCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCC
Q 041438 190 SNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITG 269 (752)
Q Consensus 190 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 269 (752)
+|++++..+..|.++++|++|+|++|+|++..+..|. .+++|+.|++++|++++
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~--------------------------~l~~L~~L~L~~n~l~~ 171 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFD--------------------------KLTSLKELRLYNNQLKR 171 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT--------------------------TCTTCCEEECCSSCCSC
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHcc--------------------------CCcccceeEecCCcCcE
Confidence 5555444444444455555555555544433222222 22233344444444444
Q ss_pred CCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCc
Q 041438 270 NIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLS 316 (752)
Q Consensus 270 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 316 (752)
..+..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|.+.
T Consensus 172 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 172 VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred eChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 44444444445555555555554444444444445555555555443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=237.42 Aligned_cols=163 Identities=22% Similarity=0.181 Sum_probs=98.6
Q ss_pred CCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeec
Q 041438 255 PQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDL 334 (752)
Q Consensus 255 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 334 (752)
++|++|++++|.+++..+..+..+++|++|+|++|++++..+..|.++++|+.|++++|++++..+..|+.+++|++|+|
T Consensus 85 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 164 (272)
T 3rfs_A 85 TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL 164 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEEC
Confidence 34444444444444444444555555555555555555555555555555566666666555555555566666666666
Q ss_pred cccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcC
Q 041438 335 SANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGL 414 (752)
Q Consensus 335 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 414 (752)
++|++++.++..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|.+.+ .+++|+.|+++.|.++|.
T Consensus 165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~ 237 (272)
T 3rfs_A 165 SYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGV 237 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGG
T ss_pred CCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCCc
Confidence 6666666655556666666666666666666666666666666777777666643 344677777777777777
Q ss_pred CchhhhccCC
Q 041438 415 IPRCFEELHG 424 (752)
Q Consensus 415 ~p~~~~~l~~ 424 (752)
+|..++.+..
T Consensus 238 ip~~~~~~~~ 247 (272)
T 3rfs_A 238 VRNSAGSVAP 247 (272)
T ss_dssp BBCTTSCBCG
T ss_pred ccCcccccCC
Confidence 7777665543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=231.51 Aligned_cols=208 Identities=25% Similarity=0.246 Sum_probs=113.8
Q ss_pred CCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcE
Q 041438 106 SSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNH 185 (752)
Q Consensus 106 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 185 (752)
..+++|+.|++++|.++.+ +.++.+++|++|+|++|++++. ..+..+++|++|+|++|.|++..+..|.++++|++
T Consensus 38 ~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 113 (272)
T 3rfs_A 38 NELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKE 113 (272)
T ss_dssp HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred ccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCE
Confidence 3445556666666655542 2355555566666666655542 24555555555555555555555555555555555
Q ss_pred EEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEcccc
Q 041438 186 LILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSIN 265 (752)
Q Consensus 186 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N 265 (752)
|+|++|++++..+..|.++++|++|+|++|++++..+..|+ .+++|+.|++++|
T Consensus 114 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--------------------------~l~~L~~L~l~~n 167 (272)
T 3rfs_A 114 LVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFD--------------------------KLTNLTELDLSYN 167 (272)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT--------------------------TCTTCCEEECCSS
T ss_pred EECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhc--------------------------cCccCCEEECCCC
Confidence 55555555555555555555555555555555544333332 3344555555555
Q ss_pred ccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccch
Q 041438 266 NITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLE 345 (752)
Q Consensus 266 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 345 (752)
++++..+..+..+++|++|+|++|.+++..|..+..+++|+.|++++|.+.+. +++|+.|+++.|.++|.+|.
T Consensus 168 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~ 240 (272)
T 3rfs_A 168 QLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRN 240 (272)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBC
T ss_pred CcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccC
Confidence 55555555555566666666666666655555555666666666666655432 23455555555555555555
Q ss_pred hhccc
Q 041438 346 SLGSL 350 (752)
Q Consensus 346 ~~~~l 350 (752)
.++.+
T Consensus 241 ~~~~~ 245 (272)
T 3rfs_A 241 SAGSV 245 (272)
T ss_dssp TTSCB
T ss_pred ccccc
Confidence 54443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-28 Score=282.60 Aligned_cols=349 Identities=12% Similarity=0.062 Sum_probs=169.1
Q ss_pred CEEEEEcCCCCCcccccccccCC-CCC-CCEEECCCCc-ccc-cCCccCcCCCCCCeeecCCCccccc----CCcccccc
Q 041438 85 RVFGINLTSISLNGTLLEFSFSS-FPH-LAYLDLYNNE-LFD-IIPPQISNLSKLEYLDFLTNKLSGH----IPSEISLL 156 (752)
Q Consensus 85 ~v~~l~l~~~~l~g~l~~~~f~~-l~~-L~~L~L~~n~-l~~-~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l 156 (752)
.+..++|+++.+.+..... +.. +++ |++|+|++|. ++. .++..+.++++|++|+|++|.+++. ++..+..+
T Consensus 113 ~L~~L~L~~~~i~~~~~~~-l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~ 191 (592)
T 3ogk_B 113 QLKSVHFRRMIVSDLDLDR-LAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHN 191 (592)
T ss_dssp TCCEEEEESCBCCHHHHHH-HHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHC
T ss_pred CCCeEEeeccEecHHHHHH-HHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcC
Confidence 4566676666554332111 111 222 5555555544 111 0111123445555555555554433 12223344
Q ss_pred cccceeeccCcccCC----CCCcccCCCCCCcEEEccCCCCCCcCCcCccC---------------------------CC
Q 041438 157 THLTILHISRNQLNG----SIPHEVGQLNFLNHLILDSNFLGGSIPRSLSN---------------------------FT 205 (752)
Q Consensus 157 ~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~---------------------------l~ 205 (752)
++|++|+|++|.+++ .++..+.++++|++|+|++|.+.+ +|..+.+ ++
T Consensus 192 ~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~ 270 (592)
T 3ogk_B 192 TSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPR 270 (592)
T ss_dssp CCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCT
T ss_pred CCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccc
Confidence 555555555555542 122223344555555555555443 3344444 44
Q ss_pred cceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEe
Q 041438 206 NLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLD 285 (752)
Q Consensus 206 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 285 (752)
+|+.|+++++. .+.+|..+..+++|++|++++|.+++..... .+..+++|+.|+++++...+.++..+..+++|++|+
T Consensus 271 ~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~-~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~ 348 (592)
T 3ogk_B 271 KLCRLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETEDHCT-LIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLR 348 (592)
T ss_dssp TCCEEEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHHHHHH-HHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEE
T ss_pred cccccCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHHHHHH-HHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEE
Confidence 55555554432 2244555555666666666666544322211 124556666666662222222232334455666666
Q ss_pred cC-----------CCcCcCC-CCccccCCcccCEEEccCCcCcccCCcccCC-Ccccceeecc----ccccccc-----c
Q 041438 286 LS-----------SNYIVGE-IPTQLGNIIYLNRISLSGNKLSGRIPGELGS-LINLEYLDLS----ANHLSNF-----V 343 (752)
Q Consensus 286 Ls-----------~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~~~-----~ 343 (752)
++ .|.+++. ++..+..+++|+.|+++.|++++..+..+.. +++|+.|+|+ .|.+++. .
T Consensus 349 L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~ 428 (592)
T 3ogk_B 349 IERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGV 428 (592)
T ss_dssp EECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHH
T ss_pred eecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHH
Confidence 66 2444432 1122334566666666666665544444443 5566666664 4555543 2
Q ss_pred chhhcccccccEEEcCCC--cCccccchhccc-cccCCeeecCCccCCCC-CCcccccccccceEEccCCcCCcC-Cchh
Q 041438 344 LESLGSLVKLYYLNLSHN--KLSQQIPIELDN-LIHLSELDLSHNFLGEK-ISSRICRMESLEKLNLSYNNLSGL-IPRC 418 (752)
Q Consensus 344 ~~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~-~p~~ 418 (752)
+..+.++++|+.|+|++| .+++..+..+.. +++|++|+|++|.+++. ++..+..+++|++|+|++|.+++. ++..
T Consensus 429 ~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~ 508 (592)
T 3ogk_B 429 RSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAA 508 (592)
T ss_dssp HHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHH
T ss_pred HHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHH
Confidence 233455666666666532 244444444433 56666666666666542 233345556666666666666543 2333
Q ss_pred hhccCCCcEEEccCCcccC
Q 041438 419 FEELHGLLHIDISYNKLEG 437 (752)
Q Consensus 419 ~~~l~~L~~L~ls~N~l~~ 437 (752)
+..+++|++|++++|++++
T Consensus 509 ~~~l~~L~~L~ls~n~it~ 527 (592)
T 3ogk_B 509 VTKLPSLRYLWVQGYRASM 527 (592)
T ss_dssp HHHCSSCCEEEEESCBCCT
T ss_pred HHhcCccCeeECcCCcCCH
Confidence 4456666666666666553
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=7.7e-25 Score=228.75 Aligned_cols=181 Identities=22% Similarity=0.229 Sum_probs=99.5
Q ss_pred ccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCC
Q 041438 104 SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFL 183 (752)
Q Consensus 104 ~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 183 (752)
.+..+++++++++++|+++.+ |..+. ++|++|+|++|+|++..+..|.++++|++|+|++|.|++..+. +.+++|
T Consensus 5 ~~~~l~~l~~l~~~~~~l~~i-p~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L 79 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL 79 (290)
T ss_dssp EEECSTTCCEEECTTSCCSSC-CSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred cccccCCccEEECCCCCCCcC-CCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence 345667777777777777654 33332 5677777777777766666777777777777777777644332 556666
Q ss_pred cEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEcc
Q 041438 184 NHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVS 263 (752)
Q Consensus 184 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls 263 (752)
++|+|++|+|+ .+|..+.++++|++|+|++|+|++..|..|.++ ++|++|+|+
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l--------------------------~~L~~L~L~ 132 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL--------------------------GELQELYLK 132 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTC--------------------------TTCCEEECT
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCC--------------------------CCCCEEECC
Confidence 66666666666 345555556666666666665554443333332 233344444
Q ss_pred ccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCc
Q 041438 264 INNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLS 316 (752)
Q Consensus 264 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 316 (752)
+|+|++..+..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|+|+
T Consensus 133 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~ 185 (290)
T 1p9a_G 133 GNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185 (290)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC
Confidence 44444433334444444444444444444333333444444444444444444
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.92 E-value=8.7e-25 Score=223.56 Aligned_cols=190 Identities=25% Similarity=0.248 Sum_probs=101.7
Q ss_pred CCCcccceeeCCCCCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCC
Q 041438 71 SLCTWSGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIP 150 (752)
Q Consensus 71 ~~c~w~gv~C~~~~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 150 (752)
+||.|.|.+|... .++++++++.++. +|..+. ++|++|+|++|++++..+
T Consensus 3 ~Cp~~~gC~C~~~---------------------------~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~ 52 (251)
T 3m19_A 3 TCETVTGCTCNEG---------------------------KKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSD 52 (251)
T ss_dssp -CHHHHSSEEEGG---------------------------GTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCT
T ss_pred cCCCCCceEcCCC---------------------------CeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCH
Confidence 6889999999521 2335555555554 233333 356666666666666666
Q ss_pred cccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccc
Q 041438 151 SEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKS 230 (752)
Q Consensus 151 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 230 (752)
..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++
T Consensus 53 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-- 130 (251)
T 3m19_A 53 ATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRL-- 130 (251)
T ss_dssp TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC--
T ss_pred hHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccC--
Confidence 566666666666666666666555556666666666666666665555556666666666666666554333333222
Q ss_pred cccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEc
Q 041438 231 LFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISL 310 (752)
Q Consensus 231 L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 310 (752)
++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 131 ------------------------~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 186 (251)
T 3m19_A 131 ------------------------TKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITL 186 (251)
T ss_dssp ------------------------TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred ------------------------CcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEe
Confidence 23334444444444333334444444444444444444444444444444444444
Q ss_pred cCCcCc
Q 041438 311 SGNKLS 316 (752)
Q Consensus 311 s~N~l~ 316 (752)
++|.+.
T Consensus 187 ~~N~~~ 192 (251)
T 3m19_A 187 FGNQFD 192 (251)
T ss_dssp CSCCBC
T ss_pred eCCcee
Confidence 444443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=227.68 Aligned_cols=203 Identities=26% Similarity=0.247 Sum_probs=117.8
Q ss_pred cccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccc
Q 041438 153 ISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLF 232 (752)
Q Consensus 153 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 232 (752)
+.++++|+++++++|.++ .+|..+. ++++.|+|++|+|++..|..|.++++|++|+|++|+|++..+.
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--------- 73 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--------- 73 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC---------
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC---------
Confidence 344455555555555555 2333332 3455555555555555555555556666666666555532211
Q ss_pred cccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccC
Q 041438 233 DMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSG 312 (752)
Q Consensus 233 ~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 312 (752)
+.+++|++|++++|+|+ .+|..+..+++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus 74 -------------------~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~ 133 (290)
T 1p9a_G 74 -------------------GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133 (290)
T ss_dssp -------------------SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTT
T ss_pred -------------------CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCC
Confidence 12344555555555555 3445555666666666666666665556666666666666666
Q ss_pred CcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCC
Q 041438 313 NKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLG 388 (752)
Q Consensus 313 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 388 (752)
|++++..+..|..+++|+.|+|++|+|+++++..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|.+.
T Consensus 134 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 6666666666666666666666666666666666666666666666666665 44555555556666666666553
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=235.00 Aligned_cols=160 Identities=17% Similarity=0.093 Sum_probs=67.6
Q ss_pred cccceeeccCcccCCCCCccc--CCCCCCcEEEccCCCCCCcCC----cCccCCCcceEEeeccccccccccccccCccc
Q 041438 157 THLTILHISRNQLNGSIPHEV--GQLNFLNHLILDSNFLGGSIP----RSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKS 230 (752)
Q Consensus 157 ~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 230 (752)
++|++|+|++|.+++..|..+ ..+++|++|+|++|++++..+ ..+..+++|++|+|++|++++..|..|+++++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 345555555555555555444 445555555555555544333 22234455555555555554444444444433
Q ss_pred cccccccccccCCC--cCCCCCCCCCCCCcEEEccccccCCCCC--c-ccCCCCCCCEEecCCCcCcCCCCccccCC---
Q 041438 231 LFDMKLCINQLNGA--IPLSIDWGRCPQLSLLDVSINNITGNIP--F-EIGESPQLQYLDLSSNYIVGEIPTQLGNI--- 302 (752)
Q Consensus 231 L~~l~l~~N~l~~~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~p--~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--- 302 (752)
|++|++++|++.+. ++....++.+++|++|+|++|+++...+ . .+..+++|++|+|++|+|++..|..+..+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 250 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS 250 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence 33333333332221 1111112233444444444444432111 1 12344445555555555544444444333
Q ss_pred cccCEEEccCCcCc
Q 041438 303 IYLNRISLSGNKLS 316 (752)
Q Consensus 303 ~~L~~L~Ls~N~l~ 316 (752)
++|++|+|++|+|+
T Consensus 251 ~~L~~L~Ls~N~l~ 264 (310)
T 4glp_A 251 SALNSLNLSFAGLE 264 (310)
T ss_dssp TTCCCEECCSSCCC
T ss_pred CcCCEEECCCCCCC
Confidence 24444444444444
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.4e-27 Score=254.26 Aligned_cols=258 Identities=19% Similarity=0.149 Sum_probs=129.4
Q ss_pred EECCCCcccccCCccCcCCCCCCeeecCCCcccccCC----ccccccc-ccceeeccCcccCCCCCcccCCC-----CCC
Q 041438 114 LDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIP----SEISLLT-HLTILHISRNQLNGSIPHEVGQL-----NFL 183 (752)
Q Consensus 114 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~L 183 (752)
++|++|++++.+|..+...++|++|+|++|+|++..+ ..|..++ +|++|+|++|.|++..+..|..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4566666666666555555556666666666665554 5555565 66666666666665555555554 666
Q ss_pred cEEEccCCCCCCcCCcCccC----C-CcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCC-CCCC
Q 041438 184 NHLILDSNFLGGSIPRSLSN----F-TNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGR-CPQL 257 (752)
Q Consensus 184 ~~L~L~~N~l~~~~p~~~~~----l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-l~~L 257 (752)
++|+|++|++++..+..+.. + ++|++|+|++|+|++..+..+... +.. .++|
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~----------------------l~~~~~~L 140 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQA----------------------FSNLPASI 140 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHH----------------------HTTSCTTC
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHH----------------------HHhCCCce
Confidence 66666666666555543333 2 566666666666665544433221 001 1234
Q ss_pred cEEEccccccCCCCC----cccCCCC-CCCEEecCCCcCcCCCCcccc----CC-cccCEEEccCCcCccc----CCccc
Q 041438 258 SLLDVSINNITGNIP----FEIGESP-QLQYLDLSSNYIVGEIPTQLG----NI-IYLNRISLSGNKLSGR----IPGEL 323 (752)
Q Consensus 258 ~~L~Ls~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~----~p~~~ 323 (752)
++|+|++|++++..+ ..+...+ +|++|+|++|.|++..+..+. .. ++|+.|+|++|.+++. ++..+
T Consensus 141 ~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l 220 (362)
T 3goz_A 141 TSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIF 220 (362)
T ss_dssp CEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred eEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHH
Confidence 444444444442211 1222222 444455555544443333222 22 3455555555554431 22222
Q ss_pred CC-Ccccceeeccccccccccc----hhhcccccccEEEcCCCcCcccc-------chhccccccCCeeecCCccCCCCC
Q 041438 324 GS-LINLEYLDLSANHLSNFVL----ESLGSLVKLYYLNLSHNKLSQQI-------PIELDNLIHLSELDLSHNFLGEKI 391 (752)
Q Consensus 324 ~~-l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~-------p~~~~~l~~L~~L~Ls~N~l~~~~ 391 (752)
.. .++|++|+|++|.+++..+ ..+..+++|+.|+|++|.+.+.. +..+..+++|++||+++|.+....
T Consensus 221 ~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~ 300 (362)
T 3goz_A 221 SSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSH 300 (362)
T ss_dssp HHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGG
T ss_pred hcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcc
Confidence 22 2355555555555554433 22334455555555555533222 234555666666666666665543
Q ss_pred Cc
Q 041438 392 SS 393 (752)
Q Consensus 392 ~~ 393 (752)
+.
T Consensus 301 ~~ 302 (362)
T 3goz_A 301 SI 302 (362)
T ss_dssp CH
T ss_pred hH
Confidence 33
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-26 Score=250.95 Aligned_cols=230 Identities=23% Similarity=0.208 Sum_probs=142.9
Q ss_pred eeecCCCcccccCCcccccccccceeeccCcccCCCCC----cccCCCC-CCcEEEccCCCCCCcCCcCccCC-----Cc
Q 041438 137 YLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIP----HEVGQLN-FLNHLILDSNFLGGSIPRSLSNF-----TN 206 (752)
Q Consensus 137 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~ 206 (752)
+++|++|++++.+|..+...++|++|+|++|.|++..+ ..|..++ +|++|+|++|++++..+..|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46788888888888777777778888888888887666 6677777 78888888888887777767665 77
Q ss_pred ceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCC-CCCcEEEccccccCCCCCccc----CC-CCC
Q 041438 207 LVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRC-PQLSLLDVSINNITGNIPFEI----GE-SPQ 280 (752)
Q Consensus 207 L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~----~~-l~~ 280 (752)
|++|+|++|++++..+..+... +..+ ++|++|+|++|+|++..+..+ .. .++
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~----------------------l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 139 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKT----------------------LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHH----------------------HHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTT
T ss_pred ccEEECcCCcCChHHHHHHHHH----------------------HHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCc
Confidence 8888888888876665544331 1122 466777777777776555443 33 257
Q ss_pred CCEEecCCCcCcCCCCc----cccCCc-ccCEEEccCCcCcccCCcccC----CC-cccceeeccccccccc----cchh
Q 041438 281 LQYLDLSSNYIVGEIPT----QLGNII-YLNRISLSGNKLSGRIPGELG----SL-INLEYLDLSANHLSNF----VLES 346 (752)
Q Consensus 281 L~~L~Ls~N~l~~~~p~----~~~~l~-~L~~L~Ls~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~----~~~~ 346 (752)
|++|+|++|.+++..+. .+..++ +|++|+|++|++++..+..+. .+ ++|++|||++|.|++. .+..
T Consensus 140 L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~ 219 (362)
T 3goz_A 140 ITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYI 219 (362)
T ss_dssp CCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred eeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHH
Confidence 78888888877753332 233333 666666666666655443332 22 3666666666666552 2223
Q ss_pred hcc-cccccEEEcCCCcCccccch----hccccccCCeeecCCccCC
Q 041438 347 LGS-LVKLYYLNLSHNKLSQQIPI----ELDNLIHLSELDLSHNFLG 388 (752)
Q Consensus 347 ~~~-l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~ 388 (752)
+.. .++|++|+|++|++++..+. .+..+++|+.|+|++|.+.
T Consensus 220 l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~ 266 (362)
T 3goz_A 220 FSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVK 266 (362)
T ss_dssp HHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHT
T ss_pred HhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCcc
Confidence 333 23566666666666544332 2334455555555555533
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=235.35 Aligned_cols=228 Identities=17% Similarity=0.133 Sum_probs=181.9
Q ss_pred CCCCEEECCCCcccccCCc---cCcCCCCCCeeecCCCcccccCCccc--ccccccceeeccCcccCCCCC----cccCC
Q 041438 109 PHLAYLDLYNNELFDIIPP---QISNLSKLEYLDFLTNKLSGHIPSEI--SLLTHLTILHISRNQLNGSIP----HEVGQ 179 (752)
Q Consensus 109 ~~L~~L~L~~n~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~~ 179 (752)
..++.|.++++.++...-. .+..+++|++|+|++|++++..|..+ ..+++|++|+|++|.+++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 4578888888887542111 12345779999999999999999988 899999999999999998665 44568
Q ss_pred CCCCcEEEccCCCCCCcCCcCccCCCcceEEeecccccccc--c--cccccCccccccccccccccCCCcCCCC-CCCCC
Q 041438 180 LNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGS--I--PQQIGNLKSLFDMKLCINQLNGAIPLSI-DWGRC 254 (752)
Q Consensus 180 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~l~l~~N~l~~~~~~~~-~~~~l 254 (752)
+++|++|+|++|++++..|..|.++++|++|+|++|++.+. + +..++++++|++|++++|+++...+... .++.+
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l 223 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAG 223 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHT
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcC
Confidence 99999999999999999999999999999999999998753 2 2335789999999999999974322111 13567
Q ss_pred CCCcEEEccccccCCCCCcccCCC---CCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccce
Q 041438 255 PQLSLLDVSINNITGNIPFEIGES---PQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEY 331 (752)
Q Consensus 255 ~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 331 (752)
++|++|+|++|+|++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|+.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~ 298 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDN 298 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence 899999999999999888877776 69999999999999 5676664 6888888888888864 32 566777777
Q ss_pred eecccccccc
Q 041438 332 LDLSANHLSN 341 (752)
Q Consensus 332 L~Ls~N~l~~ 341 (752)
|+|++|+|+.
T Consensus 299 L~L~~N~l~~ 308 (310)
T 4glp_A 299 LTLDGNPFLV 308 (310)
T ss_dssp EECSSTTTSC
T ss_pred EECcCCCCCC
Confidence 7777777764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-26 Score=261.99 Aligned_cols=162 Identities=19% Similarity=0.102 Sum_probs=110.8
Q ss_pred eeccCCceEEEEEE-eCCCcEEEEEccCCCCCC-----------------------------------CccccCCceEEE
Q 041438 508 CIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD-----------------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 508 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-----------------------------------~~~~~~~~~~lV 551 (752)
..+.|+.|.+..++ .-.|+.||||.+.+.... .++++.+..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45677777777766 457999999998654211 456778899999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||++|++|.+++...+ +++.. +|+.||+.||+|+|++ |||||||||+|||+++++.+||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999998654 34443 5899999999999999 999999999999999999999999999998766
Q ss_pred CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCc
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPR 679 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf 679 (752)
........+||+.|||||++.+. +..++|+||+|++.+++.++..++
T Consensus 392 ~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 55556667999999999998764 667899999999988876665553
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=221.01 Aligned_cols=183 Identities=18% Similarity=0.185 Sum_probs=110.2
Q ss_pred CCCeeecCCCcccccCCcccccccccceeeccCcc-cCCCCCcccCCCCCCcEEEccC-CCCCCcCCcCccCCCcceEEe
Q 041438 134 KLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQ-LNGSIPHEVGQLNFLNHLILDS-NFLGGSIPRSLSNFTNLVFLY 211 (752)
Q Consensus 134 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ 211 (752)
+|++|+|++|+|+++.+..|.++++|++|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 67777777777777766677777777777777775 7666666777777777777776 777766666777777777777
Q ss_pred eccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEcccc-ccCCCCCcccCCCCCCC-EEecCCC
Q 041438 212 LYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSIN-NITGNIPFEIGESPQLQ-YLDLSSN 289 (752)
Q Consensus 212 L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~Ls~N 289 (752)
|++|++++ +|. |.++++|+ .|++|++++| ++++..+..|..+++|+ +|++++|
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~-----------------------~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n 166 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTD-----------------------IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNN 166 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCC-----------------------SEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSC
T ss_pred CCCCCCcc-ccc-cccccccc-----------------------cccEEECCCCcchhhcCcccccchhcceeEEEcCCC
Confidence 77777764 333 33333222 1226666666 66655555566666666 6666666
Q ss_pred cCcCCCCccccCCcccCEEEccCCc-CcccCCcccCCC-cccceeeccccccccc
Q 041438 290 YIVGEIPTQLGNIIYLNRISLSGNK-LSGRIPGELGSL-INLEYLDLSANHLSNF 342 (752)
Q Consensus 290 ~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~ 342 (752)
.++...+..|.. ++|+.|++++|+ +++..+..|.++ ++|++|+|++|+++++
T Consensus 167 ~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l 220 (239)
T 2xwt_C 167 GFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL 220 (239)
T ss_dssp CCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCC
T ss_pred CCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccC
Confidence 665322223332 455555555552 544444444444 4444444444444443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-26 Score=245.97 Aligned_cols=103 Identities=21% Similarity=0.201 Sum_probs=55.0
Q ss_pred CEEECCCCcccccCCccCcCC--CCCCeeecCCCcccccCCcccccccccceeeccCcccCCC-CCcccCCCCCCcEEEc
Q 041438 112 AYLDLYNNELFDIIPPQISNL--SKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGS-IPHEVGQLNFLNHLIL 188 (752)
Q Consensus 112 ~~L~L~~n~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L 188 (752)
+.+++++|.+. +..+..+ ++++.|++++|.+++..+. +..+++|++|+|++|.+++. +|..+..+++|++|+|
T Consensus 50 ~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L 125 (336)
T 2ast_B 50 QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 125 (336)
T ss_dssp SEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEEC
T ss_pred eeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeC
Confidence 44555555543 3344444 5555555555555554443 33455555555555555543 4445555555555555
Q ss_pred cCCCCCCcCCcCccCCCcceEEeeccc-ccc
Q 041438 189 DSNFLGGSIPRSLSNFTNLVFLYLYNN-SFS 218 (752)
Q Consensus 189 ~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~ 218 (752)
++|++++..|..++.+++|++|+|++| .++
T Consensus 126 ~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~ 156 (336)
T 2ast_B 126 EGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS 156 (336)
T ss_dssp TTCBCCHHHHHHHTTCTTCSEEECTTCBSCC
T ss_pred cCcccCHHHHHHHhcCCCCCEEECCCCCCCC
Confidence 555555555555555555555555555 344
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-27 Score=274.02 Aligned_cols=203 Identities=12% Similarity=0.059 Sum_probs=132.2
Q ss_pred CCCCCCEEECCCCcccccCCccCcCC--CCCCeeecCCCc-ccc-cCCcccccccccceeeccCcccCCC----CCcccC
Q 041438 107 SFPHLAYLDLYNNELFDIIPPQISNL--SKLEYLDFLTNK-LSG-HIPSEISLLTHLTILHISRNQLNGS----IPHEVG 178 (752)
Q Consensus 107 ~l~~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~L~~N~-l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~ 178 (752)
.+++|++|+|++|.+++..+..+..+ ++|++|+|++|. ++. .++....++++|++|+|++|.+++. ++..+.
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~ 189 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ 189 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence 67888899998888877666666653 448899988876 221 1222334778999999999988765 333456
Q ss_pred CCCCCcEEEccCCCCCC----cCCcCccCCCcceEEeeccccccccccccccCccccccccccccccC-CCcCCCCCCCC
Q 041438 179 QLNFLNHLILDSNFLGG----SIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLN-GAIPLSIDWGR 253 (752)
Q Consensus 179 ~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~-~~~~~~~~~~~ 253 (752)
.+++|++|+|++|.+++ .++..+.++++|++|+|++|.+.+ +|..+.++++|++|+++..... ...+....+..
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~ 268 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVF 268 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCC
T ss_pred cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhc
Confidence 77889999999999873 344456678899999999998886 5677888888888888753222 11111223445
Q ss_pred CCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCC-ccccCCcccCEEEcc
Q 041438 254 CPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIP-TQLGNIIYLNRISLS 311 (752)
Q Consensus 254 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls 311 (752)
+++|+.|+++++. .+.+|..+..+++|++|+|++|.+++... ..+..+++|+.|+++
T Consensus 269 ~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~ 326 (592)
T 3ogk_B 269 PRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR 326 (592)
T ss_dssp CTTCCEEEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE
T ss_pred cccccccCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc
Confidence 5666666666542 23445555566666666666666543322 223455555555555
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-24 Score=218.87 Aligned_cols=68 Identities=13% Similarity=0.211 Sum_probs=38.8
Q ss_pred ccceeeccCcccCCCCCcccCCCCCCcEEEccCCC-CCCcCCcCccCCCcceEEeecc-ccccccccccc
Q 041438 158 HLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNF-LGGSIPRSLSNFTNLVFLYLYN-NSFSGSIPQQI 225 (752)
Q Consensus 158 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~ 225 (752)
+|++|+|++|+|++..+..|.++++|++|+|++|+ ++.+.+..|.++++|++|+|++ |++++..+..|
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f 101 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL 101 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence 56666666666665555556666666666666664 5555555555566666666655 55554433333
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-26 Score=253.48 Aligned_cols=186 Identities=22% Similarity=0.317 Sum_probs=106.5
Q ss_pred CCCCcEEEccccccCC----CCCcccCCCCCCCEEecCCCcCcCCCCcccc----CC---------cccCEEEccCCcCc
Q 041438 254 CPQLSLLDVSINNITG----NIPFEIGESPQLQYLDLSSNYIVGEIPTQLG----NI---------IYLNRISLSGNKLS 316 (752)
Q Consensus 254 l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l---------~~L~~L~Ls~N~l~ 316 (752)
+++|++|+|++|.+++ .+|..+..+++|++|+|++|.+++..+..+. .+ ++|++|+|++|+++
T Consensus 93 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~ 172 (386)
T 2ca6_A 93 CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 172 (386)
T ss_dssp CTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCT
T ss_pred CCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCC
Confidence 3444455555555444 2344444555555555555555433222222 22 55666666666654
Q ss_pred -ccCC---cccCCCcccceeecccccccc-----ccchhhcccccccEEEcCCCcCc----cccchhccccccCCeeecC
Q 041438 317 -GRIP---GELGSLINLEYLDLSANHLSN-----FVLESLGSLVKLYYLNLSHNKLS----QQIPIELDNLIHLSELDLS 383 (752)
Q Consensus 317 -~~~p---~~~~~l~~L~~L~Ls~N~l~~-----~~~~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls 383 (752)
+.++ ..+..+++|++|+|++|.++. ..+..+..+++|+.|+|++|.++ +.+|..+..+++|++|+|+
T Consensus 173 ~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~ 252 (386)
T 2ca6_A 173 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 252 (386)
T ss_dssp GGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECT
T ss_pred cHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECC
Confidence 2222 244455666666666666652 23335666666777777777664 4556666666777777777
Q ss_pred CccCCCC----CCcccc--cccccceEEccCCcCCc----CCchhh-hccCCCcEEEccCCcccCcC
Q 041438 384 HNFLGEK----ISSRIC--RMESLEKLNLSYNNLSG----LIPRCF-EELHGLLHIDISYNKLEGHI 439 (752)
Q Consensus 384 ~N~l~~~----~~~~~~--~l~~L~~L~L~~N~l~~----~~p~~~-~~l~~L~~L~ls~N~l~~~~ 439 (752)
+|.+++. ++..+. .+++|+.|+|++|.+++ .+|..+ .++++|++|++++|++++..
T Consensus 253 ~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 253 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp TCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred CCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 7776654 344442 26777777777777776 356555 55677777777777776543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=214.28 Aligned_cols=186 Identities=26% Similarity=0.292 Sum_probs=153.3
Q ss_pred CCCcccceeeCCCCCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCC
Q 041438 71 SLCTWSGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIP 150 (752)
Q Consensus 71 ~~c~w~gv~C~~~~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 150 (752)
..|.|.+|.|...+. + +....-.++|++|+|++|+|+++.+..|+++++|++|+|++|+++++.+
T Consensus 5 C~C~~~~v~c~~~~l-~--------------~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 69 (208)
T 2o6s_A 5 CSCSGTTVECYSQGR-T--------------SVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPN 69 (208)
T ss_dssp CEEETTEEECCSSCC-S--------------SCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred CEECCCEEEecCCCc-c--------------CCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccCh
Confidence 458999999975431 1 1112234689999999999999888889999999999999999998888
Q ss_pred cccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccc
Q 041438 151 SEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKS 230 (752)
Q Consensus 151 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 230 (752)
..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++
T Consensus 70 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 149 (208)
T 2o6s_A 70 GVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTS 149 (208)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred hhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCC
Confidence 88999999999999999999888888999999999999999999888888999999999999999999877777888888
Q ss_pred cccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCC
Q 041438 231 LFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQ 280 (752)
Q Consensus 231 L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 280 (752)
|+.|++++|.+.+ .+++|+.|+++.|+++|.+|..++.++.
T Consensus 150 L~~L~l~~N~~~~---------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 150 LQYIWLHDNPWDC---------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp CCEEECCSCCBCC---------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ccEEEecCCCeec---------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 8877777776653 3456677777777777777766665543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-26 Score=253.44 Aligned_cols=257 Identities=22% Similarity=0.219 Sum_probs=142.2
Q ss_pred CCccCcCCCCCCeeecCCCcccccCC----cccccccccceeeccCc---ccCCCCCccc-------CCCCCCcEEEccC
Q 041438 125 IPPQISNLSKLEYLDFLTNKLSGHIP----SEISLLTHLTILHISRN---QLNGSIPHEV-------GQLNFLNHLILDS 190 (752)
Q Consensus 125 ~p~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~Ls~N---~l~~~~p~~~-------~~l~~L~~L~L~~ 190 (752)
++..+..+++|++|+|++|+|++..+ ..|..+++|++|+|++| ++++.+|..+ ..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 45556666777777777777765533 33556777777777774 3444455444 6778888888888
Q ss_pred CCCCC----cCCcCccCCCcceEEeeccccccccccccccC-ccccccccccccccCCCcCCCCCCCCCCCCcEEEcccc
Q 041438 191 NFLGG----SIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGN-LKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSIN 265 (752)
Q Consensus 191 N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N 265 (752)
|++++ .+|..+.++++|++|+|++|.|+...+..+.. +..+ ..|++.+ ..++|++|++++|
T Consensus 104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l-----~~~~~~~---------~~~~L~~L~L~~n 169 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL-----AVNKKAK---------NAPPLRSIICGRN 169 (386)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHH-----HHHHHHH---------TCCCCCEEECCSS
T ss_pred CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHH-----hhhhhcc---------cCCCCcEEECCCC
Confidence 88887 46777888889999999999887555544433 1111 1122211 1145666666666
Q ss_pred ccC-CCCC---cccCCCCCCCEEecCCCcCc--C---CCCccccCCcccCEEEccCCcCc----ccCCcccCCCccccee
Q 041438 266 NIT-GNIP---FEIGESPQLQYLDLSSNYIV--G---EIPTQLGNIIYLNRISLSGNKLS----GRIPGELGSLINLEYL 332 (752)
Q Consensus 266 ~l~-~~~p---~~~~~l~~L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L 332 (752)
+++ +.+| ..+..+++|++|+|++|.|+ | ..|..+..+++|+.|+|++|.++ +.+|..+..+++|++|
T Consensus 170 ~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L 249 (386)
T 2ca6_A 170 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 249 (386)
T ss_dssp CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEE
T ss_pred CCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEE
Confidence 665 2333 24445556666666666654 1 22334445555555555555553 3334444444444444
Q ss_pred eccccccccccchhhcccccccEEEcCCCcCccccchhcc--ccccCCeeecCCccCCC----CCCccc-ccccccceEE
Q 041438 333 DLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELD--NLIHLSELDLSHNFLGE----KISSRI-CRMESLEKLN 405 (752)
Q Consensus 333 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~----~~~~~~-~~l~~L~~L~ 405 (752)
+|++|.+++..... ++..+. .+++|+.|+|++|.+++ .+|..+ .++++|++|+
T Consensus 250 ~L~~n~i~~~~~~~--------------------l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~ 309 (386)
T 2ca6_A 250 GLNDCLLSARGAAA--------------------VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 309 (386)
T ss_dssp ECTTCCCCHHHHHH--------------------HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEE
T ss_pred ECCCCCCchhhHHH--------------------HHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEE
Confidence 44444444431110 233332 24555555555555544 233333 3355566666
Q ss_pred ccCCcCCcCC
Q 041438 406 LSYNNLSGLI 415 (752)
Q Consensus 406 L~~N~l~~~~ 415 (752)
|++|++++..
T Consensus 310 l~~N~l~~~~ 319 (386)
T 2ca6_A 310 LNGNRFSEED 319 (386)
T ss_dssp CTTSBSCTTS
T ss_pred ccCCcCCcch
Confidence 6666665554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-25 Score=239.63 Aligned_cols=251 Identities=18% Similarity=0.174 Sum_probs=141.6
Q ss_pred CCCeeecCCCcccccCCcccccc--cccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCc-CCcCccCCCcceEE
Q 041438 134 KLEYLDFLTNKLSGHIPSEISLL--THLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGS-IPRSLSNFTNLVFL 210 (752)
Q Consensus 134 ~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L 210 (752)
.++.|++++|.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 3678899888876 4566666 7888888888888866554 44577777777777777654 56666667777777
Q ss_pred eeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEcccc-ccCCC-CCcccCCCCCCCEEecCC
Q 041438 211 YLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSIN-NITGN-IPFEIGESPQLQYLDLSS 288 (752)
Q Consensus 211 ~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~Ls~ 288 (752)
+|++|++++..+..++.+ ++|++|++++| .+++. ++..+..+++|++|++++
T Consensus 124 ~L~~~~l~~~~~~~l~~~--------------------------~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~ 177 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKN--------------------------SNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSW 177 (336)
T ss_dssp ECTTCBCCHHHHHHHTTC--------------------------TTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCC
T ss_pred eCcCcccCHHHHHHHhcC--------------------------CCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCC
Confidence 777776665555444333 33445555554 34331 333344455555555555
Q ss_pred C-cCcCC-CCccccCCcccCEEEccCCcCcccCCcccCCCcccceeecccc--ccc-cccchhhcccccccEEEcCCCc-
Q 041438 289 N-YIVGE-IPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSAN--HLS-NFVLESLGSLVKLYYLNLSHNK- 362 (752)
Q Consensus 289 N-~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N--~l~-~~~~~~~~~l~~L~~L~Ls~N~- 362 (752)
| .+++. ++..+..++ .+|++|+|++| .++ +..+..+..+++|+.|++++|.
T Consensus 178 ~~~l~~~~~~~~~~~l~-----------------------~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~ 234 (336)
T 2ast_B 178 CFDFTEKHVQVAVAHVS-----------------------ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM 234 (336)
T ss_dssp CTTCCHHHHHHHHHHSC-----------------------TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTT
T ss_pred CCCcChHHHHHHHHhcc-----------------------cCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCc
Confidence 5 44432 233344444 04444444444 232 2234445555566666666665
Q ss_pred CccccchhccccccCCeeecCCcc-CCCCCCcccccccccceEEccCCcCCcCCchhhhccC-CCcEEEccCCcccCcCC
Q 041438 363 LSQQIPIELDNLIHLSELDLSHNF-LGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELH-GLLHIDISYNKLEGHIP 440 (752)
Q Consensus 363 l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~~~~p 440 (752)
+++..+..+..+++|++|+|++|. +.......+..+++|+.|++++| ++. ..+..+. .+..|++++|++++..|
T Consensus 235 l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~ 310 (336)
T 2ast_B 235 LKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIAR 310 (336)
T ss_dssp CCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTC
T ss_pred CCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccC
Confidence 454555555566666666666663 22111124555666666766666 322 2233332 25555567777777666
Q ss_pred C
Q 041438 441 N 441 (752)
Q Consensus 441 ~ 441 (752)
.
T Consensus 311 ~ 311 (336)
T 2ast_B 311 P 311 (336)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-23 Score=213.28 Aligned_cols=180 Identities=24% Similarity=0.284 Sum_probs=128.2
Q ss_pred CcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccc
Q 041438 257 LSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSA 336 (752)
Q Consensus 257 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 336 (752)
.++++++++.++. +|..+. ++++.|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++
T Consensus 16 ~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 4466666666663 343333 4677777777777766666677777777777777777776666677777777777777
Q ss_pred cccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCc
Q 041438 337 NHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIP 416 (752)
Q Consensus 337 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 416 (752)
|+++++++..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++.++
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 172 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH 172 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence 77777777777777777777777777776666667777777777777777777666677777777777777777777777
Q ss_pred hhhhccCCCcEEEccCCcccCcC
Q 041438 417 RCFEELHGLLHIDISYNKLEGHI 439 (752)
Q Consensus 417 ~~~~~l~~L~~L~ls~N~l~~~~ 439 (752)
..|..+++|+.|++++|++++..
T Consensus 173 ~~~~~l~~L~~L~l~~N~~~c~~ 195 (251)
T 3m19_A 173 GAFDRLGKLQTITLFGNQFDCSR 195 (251)
T ss_dssp TTTTTCTTCCEEECCSCCBCTTS
T ss_pred HHHhCCCCCCEEEeeCCceeCCc
Confidence 77777777777777777776653
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-23 Score=224.87 Aligned_cols=223 Identities=17% Similarity=0.071 Sum_probs=127.4
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCC-cccccccccce-eeccCcccCCCCCcccCCCCCCcEE
Q 041438 109 PHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIP-SEISLLTHLTI-LHISRNQLNGSIPHEVGQLNFLNHL 186 (752)
Q Consensus 109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L 186 (752)
+++++|+|++|+|+.+.+.+|+++++|++|+|++|++.+.+| .+|.++++|++ +.++.|+|+++.|..|.++++|++|
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L 109 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 109 (350)
T ss_dssp TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence 467777777777777666777777777777777777655443 45677776654 5556677776667777777777777
Q ss_pred EccCCCCCCcCCcCccCCCcceEEeecc-ccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEcccc
Q 041438 187 ILDSNFLGGSIPRSLSNFTNLVFLYLYN-NSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSIN 265 (752)
Q Consensus 187 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N 265 (752)
++++|+|++..+..+....++..|++.+ |++....+..|..+. ..++.|+|++|
T Consensus 110 ~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~-------------------------~~l~~L~L~~N 164 (350)
T 4ay9_X 110 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS-------------------------FESVILWLNKN 164 (350)
T ss_dssp EEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSB-------------------------SSCEEEECCSS
T ss_pred cccccccccCCchhhcccchhhhhhhccccccccccccchhhcc-------------------------hhhhhhccccc
Confidence 7777777766666666666666776654 445544333433322 23445555555
Q ss_pred ccCCCCCcccCCCCCCCEEecCC-CcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccc
Q 041438 266 NITGNIPFEIGESPQLQYLDLSS-NYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVL 344 (752)
Q Consensus 266 ~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 344 (752)
+|+.+.+..| ..++|+.|++++ |.++...++.|.++++|+.|+|++|+|+..++..|.++++|+.+++ +.++..+
T Consensus 165 ~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~~lP- 240 (350)
T 4ay9_X 165 GIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLP- 240 (350)
T ss_dssp CCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCCCCC-
T ss_pred cccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcCcCC-
Confidence 5554333322 334555555543 4444333345555555555555555555444444444444443333 2233322
Q ss_pred hhhcccccccEEEcCCC
Q 041438 345 ESLGSLVKLYYLNLSHN 361 (752)
Q Consensus 345 ~~~~~l~~L~~L~Ls~N 361 (752)
.+..+++|+.++++++
T Consensus 241 -~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 241 -TLEKLVALMEASLTYP 256 (350)
T ss_dssp -CTTTCCSCCEEECSCH
T ss_pred -CchhCcChhhCcCCCC
Confidence 2445555555555443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-23 Score=224.03 Aligned_cols=241 Identities=20% Similarity=0.148 Sum_probs=110.8
Q ss_pred eeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCC-cCccCCCcceE-Eeecc
Q 041438 137 YLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIP-RSLSNFTNLVF-LYLYN 214 (752)
Q Consensus 137 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L~~ 214 (752)
+++.++|+++ .+|..+ .++|++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+| .+|.++++|++ +.+++
T Consensus 13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 4555555555 334333 2345555555555554433445555555555555555433222 34444444432 33334
Q ss_pred ccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCC
Q 041438 215 NSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGE 294 (752)
Q Consensus 215 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 294 (752)
|+|++..|+.|.+ +++|++|++++|+|++..+..+....++..|++.+
T Consensus 90 N~l~~l~~~~f~~--------------------------l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~------ 137 (350)
T 4ay9_X 90 NNLLYINPEAFQN--------------------------LPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQD------ 137 (350)
T ss_dssp TTCCEECTTSBCC--------------------------CTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEES------
T ss_pred CcccccCchhhhh--------------------------ccccccccccccccccCCchhhcccchhhhhhhcc------
Confidence 4444333333322 23333444444444444444444444444444432
Q ss_pred CCccccCCcccCEEEccCCcCcccCCcccCCCc-ccceeeccccccccccchhhcccccccEEEcCC-CcCccccchhcc
Q 041438 295 IPTQLGNIIYLNRISLSGNKLSGRIPGELGSLI-NLEYLDLSANHLSNFVLESLGSLVKLYYLNLSH-NKLSQQIPIELD 372 (752)
Q Consensus 295 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~ 372 (752)
.|++....+..|..+. .++.|+|++|+|+.+.+..|. ..+|+.|++++ |.++.+.+..|.
T Consensus 138 -----------------~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~-~~~L~~l~l~~~n~l~~i~~~~f~ 199 (350)
T 4ay9_X 138 -----------------NINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFN-GTQLDELNLSDNNNLEELPNDVFH 199 (350)
T ss_dssp -----------------CTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSST-TEEEEEEECTTCTTCCCCCTTTTT
T ss_pred -----------------ccccccccccchhhcchhhhhhccccccccCCChhhcc-ccchhHHhhccCCcccCCCHHHhc
Confidence 1334434444444443 355555555555554444332 23455555543 444444344555
Q ss_pred ccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCCc
Q 041438 373 NLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNK 434 (752)
Q Consensus 373 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 434 (752)
++++|++|||++|+|+...+..|.++++|+.+++ ++++.+ | .+..+++|+.++++++.
T Consensus 200 ~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~~l-P-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 200 GASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKL-P-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp TEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCCCC-C-CTTTCCSCCEEECSCHH
T ss_pred cCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcCcC-C-CchhCcChhhCcCCCCc
Confidence 5556666666666555554444433333332222 223332 3 25666666666665543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=220.46 Aligned_cols=207 Identities=26% Similarity=0.299 Sum_probs=105.1
Q ss_pred eeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeecccc
Q 041438 137 YLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNS 216 (752)
Q Consensus 137 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 216 (752)
.+.+..+.++..++ +..+++|++|++++|.++. +| .+..+++|++|+|++|++++..+ +.++++|++|+|++|+
T Consensus 23 ~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~ 96 (308)
T 1h6u_A 23 KIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP 96 (308)
T ss_dssp HHHTTCSSTTSEEC--HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred HHHhCCCCcCceec--HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCc
Confidence 33444444443322 3455566666666666553 23 45555666666666666654433 5556666666666665
Q ss_pred ccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCC
Q 041438 217 FSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIP 296 (752)
Q Consensus 217 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 296 (752)
+++. + .+ ..+++|++|++++|++++.. .+..+++|++|++++|.+++..+
T Consensus 97 l~~~-~-~~--------------------------~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~ 146 (308)
T 1h6u_A 97 LKNV-S-AI--------------------------AGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP 146 (308)
T ss_dssp CSCC-G-GG--------------------------TTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG
T ss_pred CCCc-h-hh--------------------------cCCCCCCEEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc
Confidence 5432 1 12 23344555555555555432 15555566666666666554332
Q ss_pred ccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhcccccc
Q 041438 297 TQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIH 376 (752)
Q Consensus 297 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 376 (752)
+..+++|+.|++++|++++..+ +..+++|++|+|++|.+++..+ +..+++|++|+|++|++++..+ +..+++
T Consensus 147 --l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~ 218 (308)
T 1h6u_A 147 --LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSN 218 (308)
T ss_dssp --GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTT
T ss_pred --ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCC
Confidence 5555555555555555554322 5555555555555555555433 4455555555555555543332 444444
Q ss_pred CCeeecCCccC
Q 041438 377 LSELDLSHNFL 387 (752)
Q Consensus 377 L~~L~Ls~N~l 387 (752)
|+.|+|++|++
T Consensus 219 L~~L~l~~N~i 229 (308)
T 1h6u_A 219 LFIVTLTNQTI 229 (308)
T ss_dssp CCEEEEEEEEE
T ss_pred CCEEEccCCee
Confidence 44444444444
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=221.96 Aligned_cols=198 Identities=23% Similarity=0.331 Sum_probs=146.7
Q ss_pred cCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCc
Q 041438 105 FSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLN 184 (752)
Q Consensus 105 f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 184 (752)
+..+++|++|++++|+++.+ | .+..+++|++|+|++|++++..+ +..+++|++|+|++|++++. ..+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCC
Confidence 34567788888888888764 3 57778888888888888876544 77788888888888887753 3577777888
Q ss_pred EEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccc
Q 041438 185 HLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSI 264 (752)
Q Consensus 185 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~ 264 (752)
+|+|++|++++.. .+.++++|++|+|++|++++..+ ++ .+++|+.|++++
T Consensus 111 ~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~--------------------------~l~~L~~L~l~~ 160 (308)
T 1h6u_A 111 TLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LA--------------------------GLTNLQYLSIGN 160 (308)
T ss_dssp EEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GG--------------------------GCTTCCEEECCS
T ss_pred EEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--cc--------------------------CCCCccEEEccC
Confidence 8888888877643 27777777777777777765432 33 445666777777
Q ss_pred cccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccc
Q 041438 265 NNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVL 344 (752)
Q Consensus 265 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 344 (752)
|++++..+ +..+++|+.|++++|.+++..+ +..+++|+.|+|++|++++..+ +..+++|++|+|++|.+++.+.
T Consensus 161 n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~~~ 234 (308)
T 1h6u_A 161 AQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPV 234 (308)
T ss_dssp SCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECCCE
T ss_pred CcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecCCe
Confidence 77776444 7778888888888888876544 7788888888888888886653 7888899999999999877543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.6e-26 Score=261.29 Aligned_cols=349 Identities=15% Similarity=0.137 Sum_probs=198.2
Q ss_pred CCCCCCEEECCCCcccccCCccCc-CCCCCCeeecCCC-ccccc-CCcccccccccceeeccCcccCCCCCcccC----C
Q 041438 107 SFPHLAYLDLYNNELFDIIPPQIS-NLSKLEYLDFLTN-KLSGH-IPSEISLLTHLTILHISRNQLNGSIPHEVG----Q 179 (752)
Q Consensus 107 ~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~ 179 (752)
.+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .
T Consensus 103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~ 182 (594)
T 2p1m_B 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT 182 (594)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence 445555555555555544444443 4555555555555 33321 222233555555555555555543332222 3
Q ss_pred CCCCcEEEccCCC--CCCc-CCcCccCCCcceEEeeccc-cccccccccccCccccccccccccc---------------
Q 041438 180 LNFLNHLILDSNF--LGGS-IPRSLSNFTNLVFLYLYNN-SFSGSIPQQIGNLKSLFDMKLCINQ--------------- 240 (752)
Q Consensus 180 l~~L~~L~L~~N~--l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~l~l~~N~--------------- 240 (752)
+++|++|+|++|. ++.. ++..+.++++|++|+|++| .+.+ +|..+.++++|++|+++.+.
T Consensus 183 ~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l 261 (594)
T 2p1m_B 183 YTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVAL 261 (594)
T ss_dssp CCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHH
T ss_pred CCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHH
Confidence 4455555555554 1100 1111123455555555555 2222 44444444445444432221
Q ss_pred -----------cCCCcCCCC--CCCCCCCCcEEEccccccCCCCCc-ccCCCCCCCEEecCCCcCcCC-CCccccCCccc
Q 041438 241 -----------LNGAIPLSI--DWGRCPQLSLLDVSINNITGNIPF-EIGESPQLQYLDLSSNYIVGE-IPTQLGNIIYL 305 (752)
Q Consensus 241 -----------l~~~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L 305 (752)
+.......+ .+..+++|+.|++++|.+++.... .+..+++|++|++++| +... ++.....+++|
T Consensus 262 ~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L 340 (594)
T 2p1m_B 262 SGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDL 340 (594)
T ss_dssp HTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTC
T ss_pred hcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCC
Confidence 111000000 012467899999999987654332 3567889999999988 4322 22333457888
Q ss_pred CEEEcc---------CCcCcccCCcccC-CCcccceeeccccccccccchhhc-ccccccEEEcC--C----CcCccc--
Q 041438 306 NRISLS---------GNKLSGRIPGELG-SLINLEYLDLSANHLSNFVLESLG-SLVKLYYLNLS--H----NKLSQQ-- 366 (752)
Q Consensus 306 ~~L~Ls---------~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls--~----N~l~~~-- 366 (752)
++|+++ .|.+++.....+. ++++|++|+++.|.+++.....+. .+++|+.|+|+ + |.++..
T Consensus 341 ~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~ 420 (594)
T 2p1m_B 341 RELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPL 420 (594)
T ss_dssp CEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCT
T ss_pred CEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCch
Confidence 999884 3455433222232 477888888888888877666665 58889999988 4 566532
Q ss_pred ---cchhccccccCCeeecCCccCCCCCCccccc-ccccceEEccCCcCCcCCchhh-hccCCCcEEEccCCcccCcCCC
Q 041438 367 ---IPIELDNLIHLSELDLSHNFLGEKISSRICR-MESLEKLNLSYNNLSGLIPRCF-EELHGLLHIDISYNKLEGHIPN 441 (752)
Q Consensus 367 ---~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~ls~N~l~~~~p~ 441 (752)
++..+..+++|+.|+|++ .+++.....++. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|++++..+.
T Consensus 421 ~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~ 499 (594)
T 2p1m_B 421 DIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALL 499 (594)
T ss_dssp HHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHH
T ss_pred hhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHH
Confidence 223367788899999977 666655555555 7889999999998877655555 6688899999999888543221
Q ss_pred --CcccCCCCcccccCCCC
Q 041438 442 --STTFRDAPLEALQGNKG 458 (752)
Q Consensus 442 --~~~~~~~~~~~~~~n~~ 458 (752)
...+..+....+.+|+.
T Consensus 500 ~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 500 ANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HTGGGGGGSSEEEEESSCC
T ss_pred HHHHhCCCCCEEeeeCCCC
Confidence 11233444455555543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.89 E-value=4e-23 Score=233.87 Aligned_cols=188 Identities=26% Similarity=0.342 Sum_probs=117.2
Q ss_pred CCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEcc
Q 041438 110 HLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILD 189 (752)
Q Consensus 110 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 189 (752)
+|++|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. |.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 46677777887777 455442 67888888888887 455 346778888888888876 555 554 77888888
Q ss_pred CCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCC
Q 041438 190 SNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITG 269 (752)
Q Consensus 190 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 269 (752)
+|+|++ +|. .+++|+.|+|++|+|++ +|. .+ ++|+.|+|++|+|++
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l--------------------------~~L~~L~Ls~N~L~~ 174 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LP--------------------------TSLEVLSVRNNQLTF 174 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CC--------------------------TTCCEEECCSSCCSC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cC--------------------------CCcCEEECCCCCCCC
Confidence 888776 444 56777777777777764 332 12 345566666666665
Q ss_pred CCCcccCCCCCCCEEecCCCcCcCCCCccccCCccc-------CEEEccCCcCcccCCcccCCCcccceeeccccccccc
Q 041438 270 NIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYL-------NRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNF 342 (752)
Q Consensus 270 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 342 (752)
+|. |. ++|++|+|++|.|+ .+|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|.|++.
T Consensus 175 -lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~ 245 (571)
T 3cvr_A 175 -LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSR 245 (571)
T ss_dssp -CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHH
T ss_pred -cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCc
Confidence 343 43 66666666666666 3444 433 44 66666666665 3444455566666666666666665
Q ss_pred cchhhcccc
Q 041438 343 VLESLGSLV 351 (752)
Q Consensus 343 ~~~~~~~l~ 351 (752)
.|..+..+.
T Consensus 246 ~p~~l~~l~ 254 (571)
T 3cvr_A 246 IRESLSQQT 254 (571)
T ss_dssp HHHHHHHHH
T ss_pred CHHHHHHhh
Confidence 555555443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.2e-25 Score=256.13 Aligned_cols=349 Identities=15% Similarity=0.084 Sum_probs=217.2
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCCEEECCCC-ccccc-CCccCcCCCCCCeeecCCCcccccCCcccc----ccc
Q 041438 84 GRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNN-ELFDI-IPPQISNLSKLEYLDFLTNKLSGHIPSEIS----LLT 157 (752)
Q Consensus 84 ~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~l~ 157 (752)
..+..++|+++.+.+.....-...+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 356677777776665443322225778888888887 55442 334445778888888888887765544443 556
Q ss_pred ccceeeccCcc--cCCC-CCcccCCCCCCcEEEccCC-CCCCcCCcCccCCCcceEEeecccc-----------------
Q 041438 158 HLTILHISRNQ--LNGS-IPHEVGQLNFLNHLILDSN-FLGGSIPRSLSNFTNLVFLYLYNNS----------------- 216 (752)
Q Consensus 158 ~L~~L~Ls~N~--l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~----------------- 216 (752)
+|++|+|++|. ++.. ++..+..+++|++|+|++| .+++ +|..+..+++|+.|+++.+.
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~ 263 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSG 263 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHT
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhc
Confidence 88888888876 2110 1111234578888888887 4443 66667777778877754441
Q ss_pred ---------cc----ccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCC-CCcccCCCCCCC
Q 041438 217 ---------FS----GSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGN-IPFEIGESPQLQ 282 (752)
Q Consensus 217 ---------l~----~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~ 282 (752)
+. +.++..+..+++|++|++++|.+++..... ....+++|+.|++++| ++.. ++.....+++|+
T Consensus 264 ~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~-~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~ 341 (594)
T 2p1m_B 264 CKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVK-LLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLR 341 (594)
T ss_dssp CTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHH-HHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCC
T ss_pred CCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHH-HHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCC
Confidence 11 112233335677788888888765432211 1346778888888877 4322 222223467888
Q ss_pred EEec---------CCCcCcCCCCcccc-CCcccCEEEccCCcCcccCCcccC-CCcccceeecc--c----ccccccc--
Q 041438 283 YLDL---------SSNYIVGEIPTQLG-NIIYLNRISLSGNKLSGRIPGELG-SLINLEYLDLS--A----NHLSNFV-- 343 (752)
Q Consensus 283 ~L~L---------s~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~~~-- 343 (752)
+|++ +.|.+++.....+. ++++|+.|.++.|.+++..+..+. .+++|+.|+|+ + |.+++.+
T Consensus 342 ~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~ 421 (594)
T 2p1m_B 342 ELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLD 421 (594)
T ss_dssp EEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTH
T ss_pred EEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchh
Confidence 8877 33445433222232 367788888888887765554444 46788888888 4 5565322
Q ss_pred ---chhhcccccccEEEcCCCcCccccchhccc-cccCCeeecCCccCCCCCCccc-ccccccceEEccCCcCCcCCch-
Q 041438 344 ---LESLGSLVKLYYLNLSHNKLSQQIPIELDN-LIHLSELDLSHNFLGEKISSRI-CRMESLEKLNLSYNNLSGLIPR- 417 (752)
Q Consensus 344 ---~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~- 417 (752)
+..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++.....+ ..+++|++|+|++|.+++..+.
T Consensus 422 ~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~ 500 (594)
T 2p1m_B 422 IGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLA 500 (594)
T ss_dssp HHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHH
T ss_pred hHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHH
Confidence 22356677888888876 666555555555 7788888888888766544444 5578888888888888654443
Q ss_pred hhhccCCCcEEEccCCccc
Q 041438 418 CFEELHGLLHIDISYNKLE 436 (752)
Q Consensus 418 ~~~~l~~L~~L~ls~N~l~ 436 (752)
....+++|+.|++++|+++
T Consensus 501 ~~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 501 NASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp TGGGGGGSSEEEEESSCCB
T ss_pred HHHhCCCCCEEeeeCCCCC
Confidence 3445778888888888763
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.87 E-value=5.1e-22 Score=224.83 Aligned_cols=189 Identities=24% Similarity=0.316 Sum_probs=123.0
Q ss_pred CCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeec
Q 041438 134 KLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLY 213 (752)
Q Consensus 134 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 213 (752)
+|+.|+|++|+|++ +|..+ +++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. |.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 66666666666665 44433 255666666666666 344 334556666666666665 444 443 56666666
Q ss_pred cccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcC
Q 041438 214 NNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVG 293 (752)
Q Consensus 214 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 293 (752)
+|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|++|.|++
T Consensus 129 ~N~l~~-lp~-----------------------------~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~ 174 (571)
T 3cvr_A 129 NNQLTM-LPE-----------------------------LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF 174 (571)
T ss_dssp SSCCSC-CCC-----------------------------CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC
T ss_pred CCcCCC-CCC-----------------------------cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC
Confidence 665554 222 23567788888888886 444 56788888999888886
Q ss_pred CCCccccCCcccCEEEccCCcCcccCCcccCCCccc-------ceeeccccccccccchhhcccccccEEEcCCCcCccc
Q 041438 294 EIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINL-------EYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQ 366 (752)
Q Consensus 294 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 366 (752)
+|. |. ++|+.|+|++|+|+ .+|. |.. +| +.|+|++|+|+.+ |..+..+++|+.|+|++|+|++.
T Consensus 175 -lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~l-p~~l~~l~~L~~L~L~~N~l~~~ 245 (571)
T 3cvr_A 175 -LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRITHI-PENILSLDPTCTIILEDNPLSSR 245 (571)
T ss_dssp -CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCCCC-CGGGGGSCTTEEEECCSSSCCHH
T ss_pred -cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcceec-CHHHhcCCCCCEEEeeCCcCCCc
Confidence 555 55 78888888888888 4555 554 66 8888888888764 44555578888888888888777
Q ss_pred cchhcccccc
Q 041438 367 IPIELDNLIH 376 (752)
Q Consensus 367 ~p~~~~~l~~ 376 (752)
+|..+..++.
T Consensus 246 ~p~~l~~l~~ 255 (571)
T 3cvr_A 246 IRESLSQQTA 255 (571)
T ss_dssp HHHHHHHHHH
T ss_pred CHHHHHHhhc
Confidence 7777766554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-21 Score=194.66 Aligned_cols=178 Identities=25% Similarity=0.191 Sum_probs=108.4
Q ss_pred CEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCC
Q 041438 112 AYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSN 191 (752)
Q Consensus 112 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 191 (752)
+.++.+++.++.+ |..+ .++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRTSV-PTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCSSC-CSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCccCC-CCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 3466777777664 3333 357788888888888777777777888888888888887666666777777777777777
Q ss_pred CCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCC
Q 041438 192 FLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNI 271 (752)
Q Consensus 192 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 271 (752)
++++..+..|.++++|++|+|++|+|++..+..|.+++ +|+.|++++|++++..
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--------------------------~L~~L~l~~N~l~~~~ 140 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLT--------------------------QLKDLRLYQNQLKSVP 140 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT--------------------------TCCEEECCSSCCSCCC
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCC--------------------------cCCEEECCCCccceeC
Confidence 77766666677777777777777777655444444333 3444555555544444
Q ss_pred CcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCC
Q 041438 272 PFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGS 325 (752)
Q Consensus 272 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 325 (752)
+..+..+++|++|++++|.+.+ .+++|+.|+++.|+++|.+|..++.
T Consensus 141 ~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~ 187 (208)
T 2o6s_A 141 DGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGS 187 (208)
T ss_dssp TTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSS
T ss_pred HHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCcc
Confidence 4444445555555555554432 1223444444444444444444433
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.85 E-value=5.1e-21 Score=192.53 Aligned_cols=158 Identities=23% Similarity=0.254 Sum_probs=130.0
Q ss_pred CCCCcccceeeCCCCCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccC
Q 041438 70 ISLCTWSGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHI 149 (752)
Q Consensus 70 ~~~c~w~gv~C~~~~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 149 (752)
.+.|+|.+|.|...+ ++ .++. .-.++|++|+|++|+|+++.|..|.++++|++|+|++|+|+.+.
T Consensus 16 ~~~Cs~~~v~c~~~~-l~-----------~ip~---~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~ 80 (229)
T 3e6j_A 16 QCSCSGTTVDCRSKR-HA-----------SVPA---GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALP 80 (229)
T ss_dssp TCEEETTEEECTTSC-CS-----------SCCS---CCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCEEeCCEeEccCCC-cC-----------ccCC---CCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcC
Confidence 478999999997432 11 1221 12378999999999999999999999999999999999998887
Q ss_pred CcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCcc
Q 041438 150 PSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLK 229 (752)
Q Consensus 150 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 229 (752)
+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+.++++|++|+|++|+|++..+..|..++
T Consensus 81 ~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 159 (229)
T 3e6j_A 81 VGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159 (229)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCT
T ss_pred hhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCC
Confidence 788899999999999999999888888999999999999999999 6788889999999999999999977666676666
Q ss_pred ccccccccccccCC
Q 041438 230 SLFDMKLCINQLNG 243 (752)
Q Consensus 230 ~L~~l~l~~N~l~~ 243 (752)
+|+.|++++|.+.+
T Consensus 160 ~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 160 SLTHAYLFGNPWDC 173 (229)
T ss_dssp TCCEEECTTSCBCT
T ss_pred CCCEEEeeCCCccC
Confidence 66655555555543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2e-22 Score=228.23 Aligned_cols=159 Identities=17% Similarity=0.219 Sum_probs=122.1
Q ss_pred ccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC--------------------------------CccccCCceEEE
Q 041438 504 DAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD--------------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 504 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------------~~~~~~~~~~lV 551 (752)
...+.||+|+||.||+|+. .++.+|+|+....... .++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 6788899875332110 223345677999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||+++ .+||+|||+|+....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999864 458999999999999999 9999999999999998 999999999998754
Q ss_pred CCCC-------cccccCCCCccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCc
Q 041438 632 DSSN-------WSKLAGTHGNVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPR 679 (752)
Q Consensus 632 ~~~~-------~~~~~gt~~y~aPE~~~~--~~~~~ksDIwSlGvil~elltg~~pf 679 (752)
.... .....||+.|||||++.. ..|+.++|+|+..+-..+-+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 3211 124589999999999886 56788899999999888888877775
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.7e-22 Score=236.99 Aligned_cols=221 Identities=18% Similarity=0.149 Sum_probs=107.4
Q ss_pred CCHHHHHHHHHHHHccccCCccccCCCCccccCCCCCCCCcccceeeCCCCCEEEEEcCCCCCcccccccccCCCCCCCE
Q 041438 34 NSTEEAHALVKWKASLEVHSRSLLHSWSLSFVNATKISLCTWSGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLAY 113 (752)
Q Consensus 34 ~~~~~~~aLl~fk~~~~~~~~~~l~sW~~~~~~~~~~~~c~w~gv~C~~~~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~ 113 (752)
....++++|+++..+........-..|. .+....+.|.++.+.. .+++.++|..+++... ....|+.
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~~-------~~~~l~~ 195 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPT-----GDSTPSGTATNSAVST-PLTPKIELFANGKDEA-------NQALLQH 195 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCc-----CCCCccccCCCceecC-CccceEEeeCCCCCcc-------hhhHhhc
Confidence 3456899999998876544333344553 2223567899998874 6788888876666542 1123444
Q ss_pred EECCCCcccc---------cCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCc
Q 041438 114 LDLYNNELFD---------IIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLN 184 (752)
Q Consensus 114 L~L~~n~l~~---------~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 184 (752)
++|+.|.|.+ +.|..|..+++|+.|+|++|+|. .+|..+..+++|++|+|++|.|+ .+|..|+++++|+
T Consensus 196 l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~ 273 (727)
T 4b8c_D 196 KKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLR 273 (727)
T ss_dssp --------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCC
T ss_pred CccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCC
Confidence 5555555443 34667778888888888888877 55666667888888888888887 6777778888888
Q ss_pred EEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccc
Q 041438 185 HLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSI 264 (752)
Q Consensus 185 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~ 264 (752)
+|+|++|+|+ .+|..|++|++|++|+|++|.|+ .+|..|+++++|+.|+|++|.|++.+|..+.... ..+..|+|++
T Consensus 274 ~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~-~~~~~l~l~~ 350 (727)
T 4b8c_D 274 VLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKS-VTGLIFYLRD 350 (727)
T ss_dssp EEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHH-HHHHHHHHHH
T ss_pred EEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcc-hhhhHHhhcc
Confidence 8888888887 56777888888888888888776 5566677777666666666666655543321000 0111245555
Q ss_pred cccCCCCC
Q 041438 265 NNITGNIP 272 (752)
Q Consensus 265 N~l~~~~p 272 (752)
|.+++.+|
T Consensus 351 N~l~~~~p 358 (727)
T 4b8c_D 351 NRPEIPLP 358 (727)
T ss_dssp CCCCCCCC
T ss_pred CcccCcCc
Confidence 66555555
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.5e-20 Score=187.89 Aligned_cols=134 Identities=22% Similarity=0.266 Sum_probs=118.2
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEc
Q 041438 109 PHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLIL 188 (752)
Q Consensus 109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 188 (752)
++|++|+|++|+|+++.+..|.++++|++|+|++|+|+++.|..|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 68999999999999988889999999999999999999999999999999999999999999777777899999999999
Q ss_pred cCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccC
Q 041438 189 DSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLN 242 (752)
Q Consensus 189 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 242 (752)
++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|++++|.+.
T Consensus 112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 999999999999999999999999999999877777776666665555555544
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.84 E-value=1e-20 Score=204.06 Aligned_cols=177 Identities=25% Similarity=0.248 Sum_probs=133.5
Q ss_pred cEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCcccc-CCcccCEEEccCCcCcccCCcccCCCcccceeeccc
Q 041438 258 SLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLG-NIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSA 336 (752)
Q Consensus 258 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 336 (752)
+.+++++|+|+. +|..+. +.++.|+|++|+|++..+..|. ++++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 467777777764 454432 3577788888888777777776 778888888888888877777788888888888888
Q ss_pred cccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCccc---ccccccceEEccCCcCCc
Q 041438 337 NHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRI---CRMESLEKLNLSYNNLSG 413 (752)
Q Consensus 337 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~ 413 (752)
|+|+++.+..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 88887777778888888888888888877777788888888888888888877666655 557888888888888887
Q ss_pred CCchhhhccCC--CcEEEccCCcccC
Q 041438 414 LIPRCFEELHG--LLHIDISYNKLEG 437 (752)
Q Consensus 414 ~~p~~~~~l~~--L~~L~ls~N~l~~ 437 (752)
+.+..|..++. ++.|+|++|++..
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred cCHHHhhhccHhhcceEEecCCCccC
Confidence 77777777776 3677777777764
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.83 E-value=4.4e-21 Score=200.39 Aligned_cols=78 Identities=18% Similarity=0.264 Sum_probs=39.4
Q ss_pred CCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeecc
Q 041438 135 LEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYN 214 (752)
Q Consensus 135 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 214 (752)
+..+.+..+.+++..+ +..+++|+.|++++|.++.. + .+..+++|++|+|++|++++..+ +.++++|++|+|++
T Consensus 26 ~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~ 99 (291)
T 1h6t_A 26 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDE 99 (291)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred HHHHHhcCCCcccccc--hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCC
Confidence 3344444444443322 34455555555555555533 2 25555555555555555554333 55555555555555
Q ss_pred cccc
Q 041438 215 NSFS 218 (752)
Q Consensus 215 N~l~ 218 (752)
|+++
T Consensus 100 n~l~ 103 (291)
T 1h6t_A 100 NKVK 103 (291)
T ss_dssp SCCC
T ss_pred CcCC
Confidence 5554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.83 E-value=5.4e-21 Score=218.80 Aligned_cols=171 Identities=24% Similarity=0.287 Sum_probs=72.7
Q ss_pred cCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceE
Q 041438 130 SNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVF 209 (752)
Q Consensus 130 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 209 (752)
..|++|+.|+|++|.|+.. | .|..+++|+.|+|++|+|++..| +..+++|+.|+|++|+|++. | .+..+++|+.
T Consensus 40 ~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l-~-~l~~l~~L~~ 113 (605)
T 1m9s_A 40 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL-S-SLKDLKKLKS 113 (605)
T ss_dssp HHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC-T-TSTTCTTCCE
T ss_pred hcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC-h-hhccCCCCCE
Confidence 3444455555555554432 2 24445555555555555544333 44555555555555555432 1 3445555555
Q ss_pred EeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCC
Q 041438 210 LYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSN 289 (752)
Q Consensus 210 L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 289 (752)
|+|++|+|++. ..+.++++|+.|+|++|++++. + .+..+++|+.|+|++|+|++..| +..+++|+.|+|++|
T Consensus 114 L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l-~---~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N 185 (605)
T 1m9s_A 114 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI-T---VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKN 185 (605)
T ss_dssp EECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC-G---GGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred EEecCCCCCCC--ccccCCCccCEEECCCCccCCc-h---hhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCC
Confidence 55555554432 1233333333333333322221 0 12233344444444444443333 444444444444444
Q ss_pred cCcCCCCccccCCcccCEEEccCCcCc
Q 041438 290 YIVGEIPTQLGNIIYLNRISLSGNKLS 316 (752)
Q Consensus 290 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 316 (752)
.|++. ..+..+++|+.|+|++|.+.
T Consensus 186 ~i~~l--~~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 186 HISDL--RALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp CCCBC--GGGTTCTTCSEEECCSEEEE
T ss_pred CCCCC--hHHccCCCCCEEEccCCcCc
Confidence 44432 12344444444444444443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.83 E-value=9.6e-21 Score=216.75 Aligned_cols=194 Identities=25% Similarity=0.346 Sum_probs=121.6
Q ss_pred CCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEE
Q 041438 131 NLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFL 210 (752)
Q Consensus 131 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 210 (752)
.+.++..+.|+.+.+....+ +..|++|+.|+|++|.|... | .|..+++|+.|+|++|+|++..| +..+++|+.|
T Consensus 19 ~l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L 92 (605)
T 1m9s_A 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWL 92 (605)
T ss_dssp HHHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEE
T ss_pred HHHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEE
Confidence 34456777788888876554 56788888888888888753 3 57888888888888888887655 7888888888
Q ss_pred eeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCc
Q 041438 211 YLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNY 290 (752)
Q Consensus 211 ~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 290 (752)
+|++|+|++. | .+..+ ++|+.|+|++|+|++. ..+..+++|+.|+|++|.
T Consensus 93 ~Ls~N~l~~l-~-~l~~l--------------------------~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~ 142 (605)
T 1m9s_A 93 FLDENKIKDL-S-SLKDL--------------------------KKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNK 142 (605)
T ss_dssp ECCSSCCCCC-T-TSTTC--------------------------TTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSC
T ss_pred ECcCCCCCCC-h-hhccC--------------------------CCCCEEEecCCCCCCC--ccccCCCccCEEECCCCc
Confidence 8888888742 2 34444 4455555555555442 234555555555555555
Q ss_pred CcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccc
Q 041438 291 IVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQ 366 (752)
Q Consensus 291 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 366 (752)
|++. ..+..+++|+.|+|++|+|++..| +..+++|+.|+|++|+|+++ ..+..+++|+.|+|++|++++.
T Consensus 143 l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 143 ITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred cCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 5543 345555555555555555554444 55555555555555555553 2355555555555555555543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.1e-20 Score=185.53 Aligned_cols=154 Identities=21% Similarity=0.251 Sum_probs=79.1
Q ss_pred cEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCC-ccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccc
Q 041438 258 SLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIP-TQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSA 336 (752)
Q Consensus 258 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 336 (752)
+.+++++|.++. +|..+. +.+++|+|++|.|++..| ..|.++++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 356666666653 333332 234555555555554433 2344555555555555555544444444444455554444
Q ss_pred cccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCc
Q 041438 337 NHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIP 416 (752)
Q Consensus 337 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 416 (752)
|+|++++ +..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|
T Consensus 91 N~l~~~~------------------------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 146 (220)
T 2v70_A 91 NRLENVQ------------------------HKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAP 146 (220)
T ss_dssp SCCCCCC------------------------GGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCT
T ss_pred CccCccC------------------------HhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECH
Confidence 4444444 4445555555555555555555555555555555555555555555555
Q ss_pred hhhhccCCCcEEEccCCcccCc
Q 041438 417 RCFEELHGLLHIDISYNKLEGH 438 (752)
Q Consensus 417 ~~~~~l~~L~~L~ls~N~l~~~ 438 (752)
..|..+++|+.|++++|++++.
T Consensus 147 ~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 147 GAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp TTTTTCTTCCEEECCSCCEECS
T ss_pred HHhcCCCCCCEEEecCcCCcCC
Confidence 5555555555555555555543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.3e-20 Score=196.77 Aligned_cols=171 Identities=25% Similarity=0.311 Sum_probs=120.3
Q ss_pred CCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCccccee
Q 041438 253 RCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYL 332 (752)
Q Consensus 253 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 332 (752)
.+++|+.|++++|.++.. + .+..+++|++|+|++|++++..+ +.++++|+.|++++|++++. ..+..+++|++|
T Consensus 44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 117 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSL 117 (291)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTCCEE
T ss_pred hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCCCEE
Confidence 345666677777766644 2 35666777777777777765544 67777777777777777652 237777777777
Q ss_pred eccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCC
Q 041438 333 DLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLS 412 (752)
Q Consensus 333 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 412 (752)
+|++|+++++ ..+..+++|+.|++++|++++. ..+..+++|++|+|++|++++..+ +..+++|+.|+|++|+++
T Consensus 118 ~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~ 191 (291)
T 1h6t_A 118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 191 (291)
T ss_dssp ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence 7777777764 3567777777777777777654 467777777778888777776655 777778888888888877
Q ss_pred cCCchhhhccCCCcEEEccCCcccC
Q 041438 413 GLIPRCFEELHGLLHIDISYNKLEG 437 (752)
Q Consensus 413 ~~~p~~~~~l~~L~~L~ls~N~l~~ 437 (752)
+. | .+..+++|+.|++++|+++.
T Consensus 192 ~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 192 DL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp BC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred CC-h-hhccCCCCCEEECcCCcccC
Confidence 65 3 37777888888888887765
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.83 E-value=4.5e-20 Score=184.35 Aligned_cols=151 Identities=23% Similarity=0.288 Sum_probs=75.8
Q ss_pred cEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeecccc
Q 041438 258 SLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSAN 337 (752)
Q Consensus 258 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 337 (752)
+.+++++|.++. +|..+. ++|+.|+|++|.|++..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 356666666653 333322 45555555555555544445555555555555555555555555555555555555555
Q ss_pred ccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcC
Q 041438 338 HLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNL 411 (752)
Q Consensus 338 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 411 (752)
+|+.+++..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 164 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCc
Confidence 55554444445555555555555555444444444444444444444444444444444444444444444444
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.7e-20 Score=185.98 Aligned_cols=135 Identities=23% Similarity=0.268 Sum_probs=110.3
Q ss_pred CCCCEEECCCCcccccCC-ccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEE
Q 041438 109 PHLAYLDLYNNELFDIIP-PQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLI 187 (752)
Q Consensus 109 ~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 187 (752)
+.+++|+|++|+|+++.| ..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..+..|.++++|++|+
T Consensus 32 ~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 111 (220)
T 2v70_A 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLM 111 (220)
T ss_dssp TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEE
T ss_pred CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEE
Confidence 456888899998888755 4578888888888888888888888888888888888888888888888888888888888
Q ss_pred ccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCC
Q 041438 188 LDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNG 243 (752)
Q Consensus 188 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 243 (752)
|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|++++|.+++
T Consensus 112 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 112 LRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp CTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred CCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 88888888888888888888888888888888778777776666655555555543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=9.9e-23 Score=231.84 Aligned_cols=217 Identities=20% Similarity=0.136 Sum_probs=109.1
Q ss_pred cCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceE
Q 041438 130 SNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVF 209 (752)
Q Consensus 130 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 209 (752)
..+++|+.|+|++|+|+ .+|..++++++|+.|++++|......|. .+..+.+.+.+|..++++++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~-----------ll~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL-----------LMRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHH-----------HHHHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHH-----------HHHhcccccCCHHHHHHHHhccc
Confidence 55667777777777776 5577777777777777765542111110 01112233455556666666666
Q ss_pred Ee-eccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCC
Q 041438 210 LY-LYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSS 288 (752)
Q Consensus 210 L~-L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 288 (752)
|+ ++.|.+. .|..+.+++|.++...+ ..|+.|+|++|+|++ +|. +..+++|+.|+|++
T Consensus 414 L~~l~~n~~~-----------~L~~l~l~~n~i~~l~~--------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~ 472 (567)
T 1dce_A 414 VDPMRAAYLD-----------DLRSKFLLENSVLKMEY--------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSH 472 (567)
T ss_dssp HCGGGHHHHH-----------HHHHHHHHHHHHHHHHH--------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCS
T ss_pred Ccchhhcccc-----------hhhhhhhhcccccccCc--------cCceEEEecCCCCCC-CcC-ccccccCcEeecCc
Confidence 65 5555432 33344444444443211 124445555555543 232 44444444444444
Q ss_pred CcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCcccc-
Q 041438 289 NYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQI- 367 (752)
Q Consensus 289 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~- 367 (752)
|.| + .+|..|+.+++|++|+|++|+|+++ | .|+.+++|+.|+|++|+|++..
T Consensus 473 N~l------------------------~-~lp~~~~~l~~L~~L~Ls~N~l~~l-p-~l~~l~~L~~L~Ls~N~l~~~~~ 525 (567)
T 1dce_A 473 NRL------------------------R-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNRLQQSAA 525 (567)
T ss_dssp SCC------------------------C-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSCCCSSST
T ss_pred ccc------------------------c-ccchhhhcCCCCCEEECCCCCCCCC-c-ccCCCCCCcEEECCCCCCCCCCC
Confidence 444 4 3444444555555555555555542 2 4555555555555555555444
Q ss_pred chhccccccCCeeecCCccCCCCCCcc---cccccccceEEc
Q 041438 368 PIELDNLIHLSELDLSHNFLGEKISSR---ICRMESLEKLNL 406 (752)
Q Consensus 368 p~~~~~l~~L~~L~Ls~N~l~~~~~~~---~~~l~~L~~L~L 406 (752)
|..+..+++|+.|+|++|++++.+|.. +..+++|+.|++
T Consensus 526 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 526 IQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp TGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred cHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 555555555555555555555443321 233566666653
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.82 E-value=3.8e-20 Score=199.64 Aligned_cols=81 Identities=22% Similarity=0.303 Sum_probs=40.7
Q ss_pred CeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccC-CCCCCcEEEccCCCCCCcCCcCccCCCcceEEeecc
Q 041438 136 EYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVG-QLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYN 214 (752)
Q Consensus 136 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 214 (752)
+.+++++|+|+. +|..+. ..++.|+|++|+|++..+..|. ++++|++|+|++|+|+++.|..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 355566665553 333332 2355555555555554444444 555555555555555544444555555555555555
Q ss_pred ccccc
Q 041438 215 NSFSG 219 (752)
Q Consensus 215 N~l~~ 219 (752)
|+|++
T Consensus 98 N~l~~ 102 (361)
T 2xot_A 98 NHLHT 102 (361)
T ss_dssp SCCCE
T ss_pred CcCCc
Confidence 55443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.5e-22 Score=230.39 Aligned_cols=166 Identities=23% Similarity=0.145 Sum_probs=130.3
Q ss_pred ccccccccccCcccccccc-ccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCC
Q 041438 217 FSGSIPQQIGNLKSLFDMK-LCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEI 295 (752)
Q Consensus 217 l~~~~p~~~~~l~~L~~l~-l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 295 (752)
+.+.+|..++++++|+.|+ ++.|.+. +|..+.+++|.++...+
T Consensus 397 ~~~~~~~~l~~l~~L~~L~~l~~n~~~-------------~L~~l~l~~n~i~~l~~----------------------- 440 (567)
T 1dce_A 397 PLLYEKETLQYFSTLKAVDPMRAAYLD-------------DLRSKFLLENSVLKMEY----------------------- 440 (567)
T ss_dssp TGGGHHHHHHHHHHHHHHCGGGHHHHH-------------HHHHHHHHHHHHHHHHH-----------------------
T ss_pred cccCCHHHHHHHHhcccCcchhhcccc-------------hhhhhhhhcccccccCc-----------------------
Confidence 5566777777777777776 5555442 23344444454442211
Q ss_pred CccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccc
Q 041438 296 PTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLI 375 (752)
Q Consensus 296 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 375 (752)
..|+.|+|++|+|++ +|. |+.+++|+.|+|++|.|+. +|..|+.+++|+.|+|++|+|++ +| .++.++
T Consensus 441 -------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~-lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~ 508 (567)
T 1dce_A 441 -------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN-VD-GVANLP 508 (567)
T ss_dssp -------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCS
T ss_pred -------cCceEEEecCCCCCC-CcC-ccccccCcEeecCcccccc-cchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCC
Confidence 136667777777775 455 8889999999999999995 57799999999999999999997 56 899999
Q ss_pred cCCeeecCCccCCCCC-CcccccccccceEEccCCcCCcCCch---hhhccCCCcEEEc
Q 041438 376 HLSELDLSHNFLGEKI-SSRICRMESLEKLNLSYNNLSGLIPR---CFEELHGLLHIDI 430 (752)
Q Consensus 376 ~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~L~l 430 (752)
+|+.|+|++|+|++.+ |..+..+++|+.|+|++|++++.+|. .+..+++|+.||+
T Consensus 509 ~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 509 RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 9999999999999987 99999999999999999999998764 3456899999975
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.5e-20 Score=195.04 Aligned_cols=145 Identities=15% Similarity=0.122 Sum_probs=113.9
Q ss_pred hHHHHHHhhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCC---------------------------------
Q 041438 492 VYEEIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLP--------------------------------- 538 (752)
Q Consensus 492 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------------------------- 538 (752)
....+......|++.+.||+|+||.||+|+..+|+.||||.++....
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 44556667777888999999999999999997899999999863211
Q ss_pred ------CCccccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe
Q 041438 539 ------DNFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL 612 (752)
Q Consensus 539 ------~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll 612 (752)
..++ ..+..|+||||+++|+|.+ +.. .....++.|++.||+|||+. ||+||||||+|||+
T Consensus 161 l~~~~v~~~~-~~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl 226 (282)
T 1zar_A 161 LQGLAVPKVY-AWEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV 226 (282)
T ss_dssp TTTSSSCCEE-EEETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred ccCCCcCeEE-eccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEE
Confidence 0111 2345699999999999988 421 23457999999999999999 99999999999999
Q ss_pred CCCCceEEeecccceeccCCCCCcccccCCCCccCcccccc----------CCCCCccchhh
Q 041438 613 DLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYT----------MKVTEKCDVYS 664 (752)
Q Consensus 613 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~ksDIwS 664 (752)
+ ++.+||+|||+|+.. ..|+|||++.+ .+++.++|+|.
T Consensus 227 ~-~~~vkl~DFG~a~~~-------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVEV-------------GEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp E-TTEEEECCCTTCEET-------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred E-CCcEEEEECCCCeEC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 9 999999999999743 35788998753 34556667765
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.2e-19 Score=180.53 Aligned_cols=154 Identities=28% Similarity=0.320 Sum_probs=98.2
Q ss_pred CcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccc
Q 041438 257 LSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSA 336 (752)
Q Consensus 257 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 336 (752)
.+.++.+++.++. +|..+. ++|++|+|++|.|++..|..|.++++|+.|+|++|+|+...+..|..+++|++|+|++
T Consensus 21 ~~~v~c~~~~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHAS-VPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcCc-cCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 4567777777763 343332 6677777777777766666677777777777777777665556666666666666666
Q ss_pred cccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcC
Q 041438 337 NHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGL 414 (752)
Q Consensus 337 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 414 (752)
|+|+++++..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+++.
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 6666666666666666666666666665 4555556666666666666666555555555555666666666655544
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.80 E-value=1e-20 Score=201.36 Aligned_cols=289 Identities=13% Similarity=0.050 Sum_probs=142.5
Q ss_pred CCCCCEEECCCCcccccCCccCcC-CCCCCeeecCCCccc--ccCCcccccccccceeeccCcccCCCCCcccCC-----
Q 041438 108 FPHLAYLDLYNNELFDIIPPQISN-LSKLEYLDFLTNKLS--GHIPSEISLLTHLTILHISRNQLNGSIPHEVGQ----- 179 (752)
Q Consensus 108 l~~L~~L~L~~n~l~~~~p~~~~~-l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~----- 179 (752)
+++++.|.++++ +....-..+.. +++|++|||++|+|. ...+..+. .++.+.+..|.| .+.+|.+
T Consensus 24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~---~~~~~~~~~~~I---~~~aF~~~~~~~ 96 (329)
T 3sb4_A 24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYP---NGKFYIYMANFV---PAYAFSNVVNGV 96 (329)
T ss_dssp HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSG---GGCCEEECTTEE---CTTTTEEEETTE
T ss_pred hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcccccc---cccccccccccc---CHHHhccccccc
Confidence 445666666543 21111112222 566777777777766 33222222 244455555532 2345555
Q ss_pred ---CCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCcccccccccccccc--CCCcCCCCCCCCC
Q 041438 180 ---LNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQL--NGAIPLSIDWGRC 254 (752)
Q Consensus 180 ---l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l--~~~~~~~~~~~~l 254 (752)
+++|+.|+|.+ .++.+.+.+|.++++|+.|+|++|.+..+.+.+|.++.++..+.+..+.. ....-....|..+
T Consensus 97 ~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~ 175 (329)
T 3sb4_A 97 TKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEG 175 (329)
T ss_dssp EEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEES
T ss_pred ccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccc
Confidence 67777777766 66666666677777777777777766656666666555554443333211 0000001112223
Q ss_pred CCCc-EEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceee
Q 041438 255 PQLS-LLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLD 333 (752)
Q Consensus 255 ~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 333 (752)
..|+ .+++.... .++..+ ...-....+++.+.+.++-...........+++|+.|+
T Consensus 176 ~~L~~~i~~~~~~---~l~~~~--------------------~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~ 232 (329)
T 3sb4_A 176 EPLETTIQVGAMG---KLEDEI--------------------MKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLD 232 (329)
T ss_dssp CCCEEEEEECTTC---CHHHHH--------------------HHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEE
T ss_pred cccceeEEecCCC---cHHHHH--------------------hhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEE
Confidence 3333 22222110 011000 00001122333343333211100000001245566666
Q ss_pred ccccccccccchhhcccccccEEEcCCCcCccccchhccccccCC-eeecCCccCCCCCCcccccccccceEEccCCcCC
Q 041438 334 LSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLS-ELDLSHNFLGEKISSRICRMESLEKLNLSYNNLS 412 (752)
Q Consensus 334 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 412 (752)
|++|+++.+...+|.++++|+.|+|++| ++.+.+..|.++++|+ .+++.+ .++.+.+..|.++++|+.+++++|+++
T Consensus 233 L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~ 310 (329)
T 3sb4_A 233 ISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKIT 310 (329)
T ss_dssp CTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCC
T ss_pred CCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccC
Confidence 6666666655556666666666666655 5555555666666666 666665 555555666666666666666666666
Q ss_pred cCCchhhhccCCCcEEE
Q 041438 413 GLIPRCFEELHGLLHID 429 (752)
Q Consensus 413 ~~~p~~~~~l~~L~~L~ 429 (752)
.+.+.+|.++++|+.++
T Consensus 311 ~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 311 TLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EECTTTTCTTCCCCEEE
T ss_pred ccchhhhcCCcchhhhc
Confidence 66666666666666665
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.80 E-value=4.7e-20 Score=189.51 Aligned_cols=172 Identities=18% Similarity=0.218 Sum_probs=110.9
Q ss_pred CCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEE
Q 041438 131 NLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFL 210 (752)
Q Consensus 131 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 210 (752)
++.+++.++|++|.+++.. .+..+++|++|++++|.|+. +| .+..+++|++|+|++|+|++..| +.++++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 4555666666666666443 45666666677776666663 33 56666666666666666665444 6666666666
Q ss_pred eeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCc
Q 041438 211 YLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNY 290 (752)
Q Consensus 211 ~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 290 (752)
+|++|++++. |. +.. ++|+.|++++|++++. ..+..+++|++|+|++|+
T Consensus 91 ~L~~N~l~~l-~~---------------------------~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~ 139 (263)
T 1xeu_A 91 SVNRNRLKNL-NG---------------------------IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNK 139 (263)
T ss_dssp ECCSSCCSCC-TT---------------------------CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSC
T ss_pred ECCCCccCCc-Cc---------------------------ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCc
Confidence 6666666532 11 011 5667777777777753 246777777777777777
Q ss_pred CcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeecccccccccc
Q 041438 291 IVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFV 343 (752)
Q Consensus 291 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 343 (752)
|++. + .+..+++|+.|++++|++++. ..+..+++|+.|++++|.++..+
T Consensus 140 i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 140 LKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp CCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred CCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCCc
Confidence 7754 2 567777777777777777765 55677777777777777776654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.8e-20 Score=190.19 Aligned_cols=168 Identities=22% Similarity=0.302 Sum_probs=98.5
Q ss_pred CCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEE
Q 041438 108 FPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLI 187 (752)
Q Consensus 108 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 187 (752)
+.++..+++++|.++++. .+..+++|++|+|++|+|+.. | .+..+++|++|+|++|+|++..+ +.++++|++|+
T Consensus 18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 445666777777777643 567777888888888877743 3 57777888888888888876544 77788888888
Q ss_pred ccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEcccccc
Q 041438 188 LDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267 (752)
Q Consensus 188 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l 267 (752)
|++|++++..+ +.. ++|++|+|++|++++. + .+.++++|+.|++++|++++.. .+..+++|+.|++++|++
T Consensus 92 L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~~----~l~~l~~L~~L~L~~N~i 162 (263)
T 1xeu_A 92 VNRNRLKNLNG--IPS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSIV----MLGFLSKLEVLDLHGNEI 162 (263)
T ss_dssp CCSSCCSCCTT--CCC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBCG----GGGGCTTCCEEECTTSCC
T ss_pred CCCCccCCcCc--ccc-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCCh----HHccCCCCCEEECCCCcC
Confidence 88888876432 222 7788888888877753 2 3444444444444333333321 122333444444444444
Q ss_pred CCCCCcccCCCCCCCEEecCCCcCc
Q 041438 268 TGNIPFEIGESPQLQYLDLSSNYIV 292 (752)
Q Consensus 268 ~~~~p~~~~~l~~L~~L~Ls~N~l~ 292 (752)
++. ..+..+++|++|++++|.++
T Consensus 163 ~~~--~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 163 TNT--GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp CBC--TTSTTCCCCCEEEEEEEEEE
T ss_pred cch--HHhccCCCCCEEeCCCCccc
Confidence 433 23334444444444444443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.77 E-value=6e-20 Score=215.40 Aligned_cols=177 Identities=22% Similarity=0.266 Sum_probs=78.5
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccc---------cCCcccccccccceeeccCcccCCCCCcccCC
Q 041438 109 PHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSG---------HIPSEISLLTHLTILHISRNQLNGSIPHEVGQ 179 (752)
Q Consensus 109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~---------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 179 (752)
+.++.|+|.+|.+... +.. .|+.++|++|.|.+ ..|..|..+++|+.|+|++|.|. .+|..+.+
T Consensus 173 ~~~~~l~L~~n~~~~~-~~~-----~l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~ 245 (727)
T 4b8c_D 173 PLTPKIELFANGKDEA-NQA-----LLQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFK 245 (727)
T ss_dssp -------------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGG
T ss_pred CccceEEeeCCCCCcc-hhh-----HhhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcC
Confidence 5688899999988774 332 24444555554443 33555556666666666666665 44544555
Q ss_pred CCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcE
Q 041438 180 LNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSL 259 (752)
Q Consensus 180 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~ 259 (752)
+++|++|+|++|+|+ .+|..|.++++|++|+|++|+|+ .+|..|++| ++|++
T Consensus 246 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l--------------------------~~L~~ 297 (727)
T 4b8c_D 246 YDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSC--------------------------FQLKY 297 (727)
T ss_dssp CCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGG--------------------------TTCSE
T ss_pred CCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCC--------------------------CCCCE
Confidence 666666666666665 45555566666666666666655 445444443 34445
Q ss_pred EEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcc-cCEEEccCCcCcccCCc
Q 041438 260 LDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIY-LNRISLSGNKLSGRIPG 321 (752)
Q Consensus 260 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~ 321 (752)
|+|++|.|+ .+|..|+.+++|++|+|++|.|++.+|..+..+.. +..++|++|.+++.+|.
T Consensus 298 L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 298 FYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp EECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred EECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 666666554 44555666666666666666666666665544321 12355666666665554
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.77 E-value=8.6e-19 Score=186.49 Aligned_cols=261 Identities=15% Similarity=0.075 Sum_probs=162.1
Q ss_pred CCCCCEEECCCCccc--ccCCccCcCCCCCCeeecCCCcccccCCccccc--------ccccceeeccCcccCCCCCccc
Q 041438 108 FPHLAYLDLYNNELF--DIIPPQISNLSKLEYLDFLTNKLSGHIPSEISL--------LTHLTILHISRNQLNGSIPHEV 177 (752)
Q Consensus 108 l~~L~~L~L~~n~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~--------l~~L~~L~Ls~N~l~~~~p~~~ 177 (752)
+++|++|||++|+|. ...+..+. .++.+.+..|.| .+.+|.+ +++|+.|+|.+ .++.+.+.+|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~---~~~~~~~~~~~I---~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF 120 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYP---NGKFYIYMANFV---PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF 120 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSG---GGCCEEECTTEE---CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred hccCeEEecCcceeEEecCcccccc---cccccccccccc---CHHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence 788999999999998 44443343 356666666643 4567777 99999999999 8887888899
Q ss_pred CCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccc----cccccccccCccccc-cccccccccCCCcCCCCC--
Q 041438 178 GQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSF----SGSIPQQIGNLKSLF-DMKLCINQLNGAIPLSID-- 250 (752)
Q Consensus 178 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l----~~~~p~~~~~l~~L~-~l~l~~N~l~~~~~~~~~-- 250 (752)
.++++|+.|+|++|.+..+.+.+|.++.++..+.+..+.. .......|.++..|+ .+.+.... .++....
T Consensus 121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~~~ 197 (329)
T 3sb4_A 121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG---KLEDEIMKA 197 (329)
T ss_dssp TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTC---CHHHHHHHT
T ss_pred hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCC---cHHHHHhhc
Confidence 9999999999999999988899999988888887766432 223334455555554 22221110 0000000
Q ss_pred CCCCCCCcEEEccccccCCCCCccc-CCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCccc
Q 041438 251 WGRCPQLSLLDVSINNITGNIPFEI-GESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINL 329 (752)
Q Consensus 251 ~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 329 (752)
.-...++..+.+.++-.. .....+ ..+++|+.|+|++|.++...+..|.++.+|+.++|.+| ++.+.+.+|.++++|
T Consensus 198 ~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L 275 (329)
T 3sb4_A 198 GLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRL 275 (329)
T ss_dssp TCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred ccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhc
Confidence 001234455555443211 111111 12566666666666666555566666666666666665 555556666666666
Q ss_pred c-eeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeee
Q 041438 330 E-YLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELD 381 (752)
Q Consensus 330 ~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 381 (752)
+ .+++.+ .++.+.+.+|.++++|+.|++++|+++.+.+..|.++++|+.|+
T Consensus 276 ~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 276 AGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp CEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred cEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 6 666665 56666666666666666666666666655555666666655554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.4e-18 Score=168.75 Aligned_cols=151 Identities=19% Similarity=0.281 Sum_probs=75.5
Q ss_pred CCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCccccee
Q 041438 253 RCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYL 332 (752)
Q Consensus 253 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 332 (752)
.+++|+.|++++|.++ .+| .+..+++|++|++++|.++. +..+..+++|++|++++|++++..+..++.+++|++|
T Consensus 42 ~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L 117 (197)
T 4ezg_A 42 QMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117 (197)
T ss_dssp HHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred hcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE
Confidence 3445556666666665 233 45555666666666664432 2345555555555555555555455555555555555
Q ss_pred eccccccccccchhhcccccccEEEcCCCc-CccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcC
Q 041438 333 DLSANHLSNFVLESLGSLVKLYYLNLSHNK-LSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNL 411 (752)
Q Consensus 333 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 411 (752)
+|++|.+++..+..+..+++|++|++++|+ ++ .+| .+..+++|++|++++|.+++.. .+..+++|+.|++++|++
T Consensus 118 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp ECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC--
T ss_pred EecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCccc
Confidence 555555555445555555555555555554 32 222 3444444444444444443321 333344444444444443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.3e-18 Score=168.81 Aligned_cols=154 Identities=18% Similarity=0.315 Sum_probs=136.5
Q ss_pred CCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccE
Q 041438 276 GESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYY 355 (752)
Q Consensus 276 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 355 (752)
..+++|++|++++|.++ .+| .+..+++|++|++++|.++. +..+..+++|++|++++|.+++..+..|+.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 56789999999999998 555 68999999999999998763 457999999999999999999988899999999999
Q ss_pred EEcCCCcCccccchhccccccCCeeecCCcc-CCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCCc
Q 041438 356 LNLSHNKLSQQIPIELDNLIHLSELDLSHNF-LGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNK 434 (752)
Q Consensus 356 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 434 (752)
|+|++|++++..|..+..+++|++|+|++|. ++. ++ .+..+++|+.|++++|++++.. .+..+++|++|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IM-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CG-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCccc-cH-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCcc
Confidence 9999999998889999999999999999998 655 44 6899999999999999999864 78999999999999999
Q ss_pred ccC
Q 041438 435 LEG 437 (752)
Q Consensus 435 l~~ 437 (752)
+.+
T Consensus 193 i~~ 195 (197)
T 4ezg_A 193 IGG 195 (197)
T ss_dssp ---
T ss_pred cCC
Confidence 864
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=7.8e-18 Score=164.27 Aligned_cols=112 Identities=26% Similarity=0.307 Sum_probs=85.2
Q ss_pred CCCEEECCCCcccccCCc-cCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEc
Q 041438 110 HLAYLDLYNNELFDIIPP-QISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLIL 188 (752)
Q Consensus 110 ~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 188 (752)
+|++|+|++|+|+++.+. .|+++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 677788888877776664 4777777777777777777777777777777777777777777777777777777777777
Q ss_pred cCCCCCCcCCcCccCCCcceEEeeccccccccc
Q 041438 189 DSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSI 221 (752)
Q Consensus 189 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 221 (752)
++|+|++..|..|..+++|++|+|++|.+++..
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 777777777777777777777777777776543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.4e-17 Score=160.20 Aligned_cols=137 Identities=25% Similarity=0.320 Sum_probs=117.8
Q ss_pred CCCcccceeeCCCCCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCC
Q 041438 71 SLCTWSGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIP 150 (752)
Q Consensus 71 ~~c~w~gv~C~~~~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 150 (752)
..|.|.++.|...+ + . .++ ..-.++|++|+|++|+++++.+..|+++++|++|+|++|+|++..+
T Consensus 5 C~C~~~~l~~~~~~-l----------~-~~p---~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 69 (177)
T 2o6r_A 5 CSCSGTEIRCNSKG-L----------T-SVP---TGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPD 69 (177)
T ss_dssp CEEETTEEECCSSC-C----------S-SCC---TTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred CEeCCCEEEecCCC-C----------c-cCC---CCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeCh
Confidence 34889999997432 1 1 111 2234789999999999999888889999999999999999998888
Q ss_pred cccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeecccccccccc
Q 041438 151 SEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIP 222 (752)
Q Consensus 151 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 222 (752)
..|.++++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|.+.+..|
T Consensus 70 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 70 GVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 889999999999999999998888889999999999999999998888788999999999999999987554
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=3.1e-18 Score=167.08 Aligned_cols=132 Identities=22% Similarity=0.250 Sum_probs=100.0
Q ss_pred CEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCc-ccCCCcccceeeccccccccccchhhcccccccEEEcCC
Q 041438 282 QYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPG-ELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSH 360 (752)
Q Consensus 282 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 360 (752)
+++++++|.++ .+|..+.. +|+.|++++|++++..+. .|+.+++|++|+|++|+|+++.|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 67888888885 45555443 778888888888776664 477788888888888888887777777888888888888
Q ss_pred CcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCc
Q 041438 361 NKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIP 416 (752)
Q Consensus 361 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 416 (752)
|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 88877777777777777777777777777777777777777777777777776544
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.72 E-value=8.6e-17 Score=175.00 Aligned_cols=270 Identities=10% Similarity=0.029 Sum_probs=132.1
Q ss_pred CCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEE
Q 041438 108 FPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLI 187 (752)
Q Consensus 108 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 187 (752)
...++.+.+.+ .++.+.+.+|.+. +|+.+.|..| ++.+...+|.+ .+|+.+.|.. .++.+.+.+|.++++|+.++
T Consensus 112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 35556666543 3555566666663 5666666555 55555566665 3566666654 45545555566666666666
Q ss_pred ccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEcccccc
Q 041438 188 LDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267 (752)
Q Consensus 188 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l 267 (752)
|++|+++.+...+|. .++|+.+.|.+| ++.+...+|.++. +|+.+++..| +
T Consensus 187 l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~--------------------------~L~~l~l~~~-l 237 (401)
T 4fdw_A 187 LSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTS--------------------------QLKTIEIPEN-V 237 (401)
T ss_dssp CTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCT--------------------------TCCCEECCTT-C
T ss_pred cCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCC--------------------------CCCEEecCCC-c
Confidence 666666655445554 355655555432 4433333333333 3333333322 2
Q ss_pred CCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhh
Q 041438 268 TGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESL 347 (752)
Q Consensus 268 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 347 (752)
+.+...+|.+ .+|+.+.+. |.++...+.+|.++++|+.+++.+|.+.. +.+..+...+|
T Consensus 238 ~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~-------------------~~~~~I~~~aF 296 (401)
T 4fdw_A 238 STIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFND-------------------DPEAMIHPYCL 296 (401)
T ss_dssp CEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCC-------------------CTTCEECTTTT
T ss_pred cCcccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccC-------------------CcccEECHHHh
Confidence 2223333333 344444442 22333333444444444444444443320 00013334444
Q ss_pred cccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccC-CCc
Q 041438 348 GSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELH-GLL 426 (752)
Q Consensus 348 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~ 426 (752)
.++++|+.++|. |.++.+....|.++++|+.++|..| ++.+...+|.++ +|+.+++++|.+..+.+..|.+++ .++
T Consensus 297 ~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~ 373 (401)
T 4fdw_A 297 EGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDIT 373 (401)
T ss_dssp TTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCC
T ss_pred hCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCcc
Confidence 445555555554 2344444445555555555555333 444444555555 555555555555555555555553 455
Q ss_pred EEEccCCcc
Q 041438 427 HIDISYNKL 435 (752)
Q Consensus 427 ~L~ls~N~l 435 (752)
.|++..|.+
T Consensus 374 ~l~vp~~~~ 382 (401)
T 4fdw_A 374 VIRVPAESV 382 (401)
T ss_dssp EEEECGGGH
T ss_pred EEEeCHHHH
Confidence 666655543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.3e-16 Score=173.58 Aligned_cols=242 Identities=10% Similarity=0.069 Sum_probs=151.8
Q ss_pred cccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccc
Q 041438 157 THLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKL 236 (752)
Q Consensus 157 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l 236 (752)
..++.+.+.+ .++.+...+|.+. +|+.+.|.+| ++.+...+|.+. +|+.+.|.+ .++.+.+.+|.+
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~--------- 178 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYY--------- 178 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTT---------
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhC---------
Confidence 4445555432 3443444555553 4666665554 554555555553 466665543 333333333333
Q ss_pred cccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCc
Q 041438 237 CINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLS 316 (752)
Q Consensus 237 ~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 316 (752)
|++|+.++++.|+++.....+|. ..+|+.+.|..+ ++.....+|.++.+|+.+++.+| ++
T Consensus 179 -----------------c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~ 238 (401)
T 4fdw_A 179 -----------------CYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VS 238 (401)
T ss_dssp -----------------CTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CC
T ss_pred -----------------cccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-cc
Confidence 33333444444444433333333 345555555432 44344455555555555555543 44
Q ss_pred ccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCc-----cccchhccccccCCeeecCCccCCCCC
Q 041438 317 GRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLS-----QQIPIELDNLIHLSELDLSHNFLGEKI 391 (752)
Q Consensus 317 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 391 (752)
.+...+|.+ .+|+.++| .|.++.+...+|.++++|+.+++.+|.+. .+.+..|.++++|+.++|. |.++.+.
T Consensus 239 ~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~ 315 (401)
T 4fdw_A 239 TIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILG 315 (401)
T ss_dssp EECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEEC
T ss_pred Ccccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEh
Confidence 455555666 56777777 45566666777777777777777776664 5677899999999999999 5588888
Q ss_pred CcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCCcccC
Q 041438 392 SSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEG 437 (752)
Q Consensus 392 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 437 (752)
...|.++.+|+.+.|..| ++.+.+.+|.++ +|+.+++++|.+..
T Consensus 316 ~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~ 359 (401)
T 4fdw_A 316 QGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQ 359 (401)
T ss_dssp TTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCB
T ss_pred hhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcc
Confidence 899999999999999655 888888999999 99999999998754
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.6e-17 Score=158.37 Aligned_cols=133 Identities=22% Similarity=0.172 Sum_probs=99.3
Q ss_pred CCCCCCEEECCCCccc-ccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcE
Q 041438 107 SFPHLAYLDLYNNELF-DIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNH 185 (752)
Q Consensus 107 ~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 185 (752)
..++|++|+|++|+++ +.+|..|..+++|++|+|++|.|++. ..|..+++|++|+|++|++++.+|..+..+++|++
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 3467888888888887 56777788888888888888888866 66788888888888888888777777777888888
Q ss_pred EEccCCCCCCcC-CcCccCCCcceEEeecccccccccc---ccccCcccccccccccccc
Q 041438 186 LILDSNFLGGSI-PRSLSNFTNLVFLYLYNNSFSGSIP---QQIGNLKSLFDMKLCINQL 241 (752)
Q Consensus 186 L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~l~l~~N~l 241 (752)
|+|++|++++.. +..+..+++|++|+|++|.+++..+ ..+..+++|+.|+++.|.+
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~ 159 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRED 159 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCCh
Confidence 888888888643 2677888888888888888876544 3555555555544444444
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-17 Score=155.71 Aligned_cols=130 Identities=20% Similarity=0.199 Sum_probs=110.1
Q ss_pred CCCCCCCEEECCCCccc-ccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCc
Q 041438 106 SSFPHLAYLDLYNNELF-DIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLN 184 (752)
Q Consensus 106 ~~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 184 (752)
...++|++|++++|+++ +.+|..+..+++|++|+|++|++++. ..|..+++|++|+|++|.|++.+|..+..+++|+
T Consensus 14 ~~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~ 91 (149)
T 2je0_A 14 RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLT 91 (149)
T ss_dssp CCGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCC
T ss_pred CCCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCC
Confidence 34578999999999998 67888899999999999999999876 7789999999999999999987888888899999
Q ss_pred EEEccCCCCCCc-CCcCccCCCcceEEeecccccccccc---ccccCcccccccccc
Q 041438 185 HLILDSNFLGGS-IPRSLSNFTNLVFLYLYNNSFSGSIP---QQIGNLKSLFDMKLC 237 (752)
Q Consensus 185 ~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~l~l~ 237 (752)
+|+|++|++++. .+..+.++++|++|++++|.+++..+ ..+..+++|+.|+++
T Consensus 92 ~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 92 HLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp EEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred EEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 999999999874 34788999999999999999987665 467767666666554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.69 E-value=7.1e-17 Score=153.76 Aligned_cols=131 Identities=25% Similarity=0.151 Sum_probs=68.3
Q ss_pred CCCCEEecCCCcCc-CCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEE
Q 041438 279 PQLQYLDLSSNYIV-GEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLN 357 (752)
Q Consensus 279 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 357 (752)
++|++|++++|.++ +.+|..+..+++|+.|++++|.+++. ..+..+++|++|+|++|.+++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 45566666666655 45555555566666666666666544 4555556666666666666555555555555555555
Q ss_pred cCCCcCccccc-hhccccccCCeeecCCccCCCCCC---cccccccccceEEccCCcC
Q 041438 358 LSHNKLSQQIP-IELDNLIHLSELDLSHNFLGEKIS---SRICRMESLEKLNLSYNNL 411 (752)
Q Consensus 358 Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L~~N~l 411 (752)
|++|++++... ..+..+++|+.|++++|.+++..+ ..+..+++|++|++++|.+
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~ 159 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRED 159 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCCh
Confidence 55555554321 344444444444444444443333 2334444444444444443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.1e-16 Score=156.14 Aligned_cols=109 Identities=24% Similarity=0.275 Sum_probs=78.4
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEc
Q 041438 109 PHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLIL 188 (752)
Q Consensus 109 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 188 (752)
++|++|+|++|+|+. +|..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 31 ~~l~~L~L~~n~i~~-ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 109 (193)
T 2wfh_A 31 RDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL 109 (193)
T ss_dssp TTCCEEECCSSCCCS-CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCch-hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence 467777777777764 4567777777777777777777776677777777777777777777766667777777777777
Q ss_pred cCCCCCCcCCcCccCCCcceEEeecccccc
Q 041438 189 DSNFLGGSIPRSLSNFTNLVFLYLYNNSFS 218 (752)
Q Consensus 189 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 218 (752)
++|+|+...+..|.++++|+.|+|++|.+.
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 110 HGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 777777666666777777777777777665
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.6e-16 Score=152.75 Aligned_cols=130 Identities=25% Similarity=0.195 Sum_probs=105.8
Q ss_pred CCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccC
Q 041438 111 LAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDS 190 (752)
Q Consensus 111 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 190 (752)
.+.+++++|+++.+ |..+ .++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 9 ~~~l~~~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTSV-PTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSSC-CTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCccC-CCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 35688899998875 4333 36899999999999988888889999999999999999987777889999999999999
Q ss_pred CCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCC
Q 041438 191 NFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNG 243 (752)
Q Consensus 191 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 243 (752)
|+|++..+..|.++++|++|+|++|+|++..+..|.++++|+.|++++|.+.+
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 99998888888999999999999999987666666666666655555555544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=9.5e-17 Score=149.58 Aligned_cols=127 Identities=23% Similarity=0.240 Sum_probs=68.1
Q ss_pred CCCCEEecCCCcCc-CCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEE
Q 041438 279 PQLQYLDLSSNYIV-GEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLN 357 (752)
Q Consensus 279 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 357 (752)
++|+.|++++|.++ +.+|..+..+++|+.|++++|.+++. ..++.++ +|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~------------------------~L~~L~ 70 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLN------------------------KLKKLE 70 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCT------------------------TCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCC------------------------CCCEEE
Confidence 45555555555555 44555555555555555555555443 3444444 445555
Q ss_pred cCCCcCccccchhccccccCCeeecCCccCCCC-CCcccccccccceEEccCCcCCcCCc---hhhhccCCCcEEEcc
Q 041438 358 LSHNKLSQQIPIELDNLIHLSELDLSHNFLGEK-ISSRICRMESLEKLNLSYNNLSGLIP---RCFEELHGLLHIDIS 431 (752)
Q Consensus 358 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~ls 431 (752)
|++|++++.+|..+..+++|++|++++|.+++. .+..+..+++|++|++++|++++..+ ..+..+++|+.||++
T Consensus 71 Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 555555444444444455555555555555442 22445556666666666666666554 456666666666664
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=2.5e-16 Score=161.16 Aligned_cols=126 Identities=17% Similarity=0.152 Sum_probs=95.0
Q ss_pred HHHHHhhcccccceeeccCCceEEEEEEe-CCCcE--EEEEccCCCCCC-------------------------------
Q 041438 494 EEIIRATNDFDAKHCIGKGGHGSVYIARV-PSGEI--FAVKKFHSPLPD------------------------------- 539 (752)
Q Consensus 494 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------------- 539 (752)
..+.....-|++.+.||+|+||.||+|+. .+|+. ||||+++.....
T Consensus 40 ~~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (258)
T 1zth_A 40 YKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK 119 (258)
T ss_dssp HHHHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred HHHHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence 44444444578899999999999999996 78999 999986432100
Q ss_pred -----------Cc----cccCCceEEEEEeccC-C----ChHHHhccCccccccCHHHHHHHHHHHHHHHHHHH-hCCCC
Q 041438 540 -----------NF----CSHPRQSFIVYEYLES-G----SLDKILNNDASAKELGWTQRLNVIKGVADALFYLH-NNCFP 598 (752)
Q Consensus 540 -----------~~----~~~~~~~~lV~E~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~~~ 598 (752)
+. .......++||||+.+ | +|.++... .++..+..++.|++.||.||| +.
T Consensus 120 E~~~l~~l~~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~--- 190 (258)
T 1zth_A 120 EFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA--- 190 (258)
T ss_dssp HHHHHHHHHHTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---
T ss_pred HHHHHHHHHhCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---
Confidence 00 0001345799999953 3 66665432 234567899999999999999 88
Q ss_pred CeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 599 PIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 599 ~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||+||||||+|||+++ .++|+|||+|....
T Consensus 191 givHrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 191 ELVHADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp CEECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred CEEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 9999999999999998 99999999998653
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.66 E-value=3.5e-15 Score=162.73 Aligned_cols=315 Identities=13% Similarity=0.043 Sum_probs=229.9
Q ss_pred ccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCC
Q 041438 100 LLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQ 179 (752)
Q Consensus 100 l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 179 (752)
+.+.+|.++.+|+.+.|.. .++.+...+|.++++|+.++|..| ++.+...+|.++++|+.+.+..+ +......+|.+
T Consensus 62 Ig~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~ 138 (394)
T 4fs7_A 62 IGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKG 138 (394)
T ss_dssp ECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTT
T ss_pred hHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeec
Confidence 4466899999999999974 488888999999999999999765 77777889999999999888755 45456667777
Q ss_pred CCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcE
Q 041438 180 LNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSL 259 (752)
Q Consensus 180 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~ 259 (752)
...++....... ..+...+|.++++|+.+.+.++. ..+....|.++.+|+.+.+..| ++.. + ...|..+..|+.
T Consensus 139 ~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I-~-~~~F~~~~~L~~ 212 (394)
T 4fs7_A 139 CDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKII-R-DYCFAECILLEN 212 (394)
T ss_dssp CCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEE-C-TTTTTTCTTCCB
T ss_pred ccccccccCccc--cccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEe-C-chhhccccccce
Confidence 765444443333 33445678888889988887654 4466677888888888888765 3221 1 224677888888
Q ss_pred EEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeecccccc
Q 041438 260 LDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHL 339 (752)
Q Consensus 260 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 339 (752)
+.+..+... +........+|+.+.+..+ ++......|.++..|+.+.+..+... +....|..+..++.+....+.+
T Consensus 213 i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i 288 (394)
T 4fs7_A 213 MEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV 288 (394)
T ss_dssp CCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE
T ss_pred eecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceee
Confidence 877765432 2333445567888877654 33345567778888888888777554 5667788888888887776653
Q ss_pred ccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhh
Q 041438 340 SNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCF 419 (752)
Q Consensus 340 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 419 (752)
....|..+.+|+.+.+..+ ++.+...+|.++++|+.++|.++ ++.+...+|.++.+|+.+++..| ++.+...+|
T Consensus 289 ---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF 362 (394)
T 4fs7_A 289 ---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAF 362 (394)
T ss_dssp ---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTB
T ss_pred ---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHh
Confidence 3456778888888888755 66666778888888888888654 66667778888888888888776 777777788
Q ss_pred hccCCCcEEEccCC
Q 041438 420 EELHGLLHIDISYN 433 (752)
Q Consensus 420 ~~l~~L~~L~ls~N 433 (752)
.++.+|+.+++..+
T Consensus 363 ~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 363 QGCINLKKVELPKR 376 (394)
T ss_dssp TTCTTCCEEEEEGG
T ss_pred hCCCCCCEEEECCC
Confidence 88888888888654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=4.5e-16 Score=151.76 Aligned_cols=109 Identities=27% Similarity=0.288 Sum_probs=59.8
Q ss_pred ccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEcc
Q 041438 328 NLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLS 407 (752)
Q Consensus 328 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 407 (752)
+|++|+|++|+|+.+ |..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus 32 ~l~~L~L~~n~i~~i-p~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~ 110 (193)
T 2wfh_A 32 DVTELYLDGNQFTLV-PKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH 110 (193)
T ss_dssp TCCEEECCSSCCCSC-CGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCchh-HHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence 444444555544432 2445555555555555555555545555555555555555555555555555555566666666
Q ss_pred CCcCCcCCchhhhccCCCcEEEccCCcccC
Q 041438 408 YNNLSGLIPRCFEELHGLLHIDISYNKLEG 437 (752)
Q Consensus 408 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 437 (752)
+|+|+++.+..|..+++|+.|++++|++.+
T Consensus 111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 111 GNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 666665555556666666666666666543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.61 E-value=4.6e-16 Score=149.35 Aligned_cols=131 Identities=18% Similarity=0.208 Sum_probs=94.7
Q ss_pred ccCCCCCCCEEECCCCcccccCCccCcCCC-CCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCC
Q 041438 104 SFSSFPHLAYLDLYNNELFDIIPPQISNLS-KLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNF 182 (752)
Q Consensus 104 ~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 182 (752)
.|...++|++|+|++|+|+.+ |. +..+. +|++|+|++|+|++. ..|..+++|++|+|++|+|++..+..|..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 466778888888888888865 43 44444 888888888888876 56888888888888888888665555688888
Q ss_pred CcEEEccCCCCCCcCCc--CccCCCcceEEeecccccccccccc----ccCccccccccccccc
Q 041438 183 LNHLILDSNFLGGSIPR--SLSNFTNLVFLYLYNNSFSGSIPQQ----IGNLKSLFDMKLCINQ 240 (752)
Q Consensus 183 L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~l~l~~N~ 240 (752)
|++|+|++|+|+. +|. .+.++++|++|+|++|.++. +|.. +..+++|+.|+++.|.
T Consensus 90 L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~ 151 (176)
T 1a9n_A 90 LTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVK 151 (176)
T ss_dssp CCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECC
T ss_pred CCEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCC
Confidence 8888888888864 444 77888888888888888874 3432 5555544444444443
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.6e-15 Score=161.31 Aligned_cols=125 Identities=13% Similarity=0.164 Sum_probs=94.9
Q ss_pred HHHHHhhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC------------C---------------------
Q 041438 494 EEIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD------------N--------------------- 540 (752)
Q Consensus 494 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------~--------------------- 540 (752)
..+.+...=|++...||+|++|.||+|+..+|+.||||+++..... .
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 3444444459999999999999999999889999999987542110 0
Q ss_pred -----c-cccC-----CceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCC
Q 041438 541 -----F-CSHP-----RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKN 609 (752)
Q Consensus 541 -----~-~~~~-----~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~N 609 (752)
. ...+ ...++||||++|+++.++... +....++.|++.+|.|||+. |||||||||.|
T Consensus 168 ~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~N 235 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEFN 235 (397)
T ss_dssp HHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred HHHHhcCCCCCeeeeccCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHH
Confidence 0 0001 123699999999887654321 23456889999999999999 99999999999
Q ss_pred EEeCCCC----------ceEEeecccceecc
Q 041438 610 VLLDLGY----------EAHVSDFRIAKFLN 630 (752)
Q Consensus 610 Ill~~~~----------~~kl~DfG~a~~~~ 630 (752)
||+++++ .+.|+||+-+....
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred EEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 9998776 38999999887643
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.8e-17 Score=162.62 Aligned_cols=149 Identities=23% Similarity=0.250 Sum_probs=74.7
Q ss_pred CcEEEccccccCCCCCc------ccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccc
Q 041438 257 LSLLDVSINNITGNIPF------EIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLE 330 (752)
Q Consensus 257 L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 330 (752)
++.++++.|.++|..|. .+..+++|++|+|++|.+++ +| .+.++++|+.|++++|+++ .+|..+..+++|+
T Consensus 20 l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~ 96 (198)
T 1ds9_A 20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96 (198)
T ss_dssp CCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCS
T ss_pred ccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCC
Confidence 33444444444444433 45555555555555555554 33 4555555555555555554 2333444444455
Q ss_pred eeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCC-cccccccccceEEccCC
Q 041438 331 YLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKIS-SRICRMESLEKLNLSYN 409 (752)
Q Consensus 331 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N 409 (752)
+|+|++|++++++ .+..+++|++|+++ +|++++..+ ..+..+++|++|++++|
T Consensus 97 ~L~L~~N~l~~l~--~~~~l~~L~~L~l~------------------------~N~i~~~~~~~~l~~l~~L~~L~l~~N 150 (198)
T 1ds9_A 97 ELWISYNQIASLS--GIEKLVNLRVLYMS------------------------NNKITNWGEIDKLAALDKLEDLLLAGN 150 (198)
T ss_dssp EEEEEEEECCCHH--HHHHHHHSSEEEES------------------------EEECCCHHHHHHHTTTTTCSEEEECSC
T ss_pred EEECcCCcCCcCC--ccccCCCCCEEECC------------------------CCcCCchhHHHHHhcCCCCCEEEecCC
Confidence 5555555444422 34444444444444 444443222 33455555566666666
Q ss_pred cCCcCCch----------hhhccCCCcEEEccCCccc
Q 041438 410 NLSGLIPR----------CFEELHGLLHIDISYNKLE 436 (752)
Q Consensus 410 ~l~~~~p~----------~~~~l~~L~~L~ls~N~l~ 436 (752)
++++.+|. .+..+++|+.|| +|.++
T Consensus 151 ~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 151 PLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred ccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 65555443 366777777776 55554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.59 E-value=2.5e-15 Score=144.24 Aligned_cols=108 Identities=23% Similarity=0.198 Sum_probs=54.7
Q ss_pred CCCCCCCEEecCCCcCcCCCCccccCCc-ccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhccccccc
Q 041438 276 GESPQLQYLDLSSNYIVGEIPTQLGNII-YLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLY 354 (752)
Q Consensus 276 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 354 (752)
..+++|+.|++++|.++. +|. +..+. +|+.|++++|.+++. ..|..+++|++|+|++|.|+++++..|..+++|+
T Consensus 16 ~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 16 TNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91 (176)
T ss_dssp ECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred CCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence 344555555555555553 232 22222 555555555555543 3455555566666666665555444455555555
Q ss_pred EEEcCCCcCccccch--hccccccCCeeecCCccCC
Q 041438 355 YLNLSHNKLSQQIPI--ELDNLIHLSELDLSHNFLG 388 (752)
Q Consensus 355 ~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~ 388 (752)
+|+|++|+|+. +|. .+..+++|+.|++++|.++
T Consensus 92 ~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 92 ELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp EEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG
T ss_pred EEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCC
Confidence 55555555532 232 4444444444444444443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.59 E-value=2.6e-17 Score=161.36 Aligned_cols=115 Identities=24% Similarity=0.216 Sum_probs=92.2
Q ss_pred ccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCccccccccc
Q 041438 322 ELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESL 401 (752)
Q Consensus 322 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 401 (752)
.+..+++|++|+|++|.++++ | .+..+++|++|++++|+++ .+|..+..+++|++|+|++|++++. | .+..+++|
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~l-~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~l-~-~~~~l~~L 117 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-S-GIEKLVNL 117 (198)
T ss_dssp HHHHTTTCSEEECSEEEESCC-C-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCCH-H-HHHHHHHS
T ss_pred HHhcCCCCCEEECCCCCCccc-c-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCcC-C-ccccCCCC
Confidence 566677777777777777774 3 6777778888888888876 4566777778888888888888774 3 57889999
Q ss_pred ceEEccCCcCCcCCc-hhhhccCCCcEEEccCCcccCcCCC
Q 041438 402 EKLNLSYNNLSGLIP-RCFEELHGLLHIDISYNKLEGHIPN 441 (752)
Q Consensus 402 ~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~ 441 (752)
+.|+|++|++++..+ ..+..+++|++|++++|++++.+|.
T Consensus 118 ~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 999999999998654 5789999999999999999888765
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.58 E-value=3.5e-14 Score=154.81 Aligned_cols=296 Identities=11% Similarity=0.030 Sum_probs=235.9
Q ss_pred cccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCc
Q 041438 120 ELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPR 199 (752)
Q Consensus 120 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 199 (752)
.++.+...+|.++++|+.+.|.. .++.+...+|.++++|+.++|..| ++.+-..+|.++.+|+.+.+..+ +..+...
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~ 134 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE 134 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred eEeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence 46778889999999999999975 488788899999999999999865 66666788999999999888765 5557778
Q ss_pred CccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCC
Q 041438 200 SLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESP 279 (752)
Q Consensus 200 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 279 (752)
+|.++..++....... ......+|.++++|+.+.+..+..+ ++ ...|..+++|+.+++..| ++.+...+|.++.
T Consensus 135 aF~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~~~--I~-~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~ 208 (394)
T 4fs7_A 135 AFKGCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSMET--LH-NGLFSGCGKLKSIKLPRN-LKIIRDYCFAECI 208 (394)
T ss_dssp TTTTCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTCCE--EC-TTTTTTCTTCCBCCCCTT-CCEECTTTTTTCT
T ss_pred eeecccccccccCccc--cccchhhhcccCCCcEEecCCccce--ec-cccccCCCCceEEEcCCC-ceEeCchhhcccc
Confidence 8888876665544433 3345678999999999998765321 22 224788999999999876 6666778899999
Q ss_pred CCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcC
Q 041438 280 QLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLS 359 (752)
Q Consensus 280 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 359 (752)
.|+.+.+..+... +...+....+|+.+.+..+ ++.+....|.++.+|+.+.+..+. ..+....|.....++.+...
T Consensus 209 ~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~-~~i~~~~F~~~~~l~~~~~~ 284 (394)
T 4fs7_A 209 LLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNK-LRIGGSLFYNCSGLKKVIYG 284 (394)
T ss_dssp TCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTT-CEECSCTTTTCTTCCEEEEC
T ss_pred ccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCc-ceeeccccccccccceeccC
Confidence 9999999887653 3344555678999988654 444666789999999999998774 45667789999999999988
Q ss_pred CCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCC
Q 041438 360 HNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYN 433 (752)
Q Consensus 360 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 433 (752)
.+.+ ....|..+.+|+.+.+.++ ++.+...+|.++.+|+.++|.++ ++.+...+|.++.+|+.+++..|
T Consensus 285 ~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 285 SVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp SSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred ceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 7654 4567899999999999765 77777888999999999999754 88787889999999999999766
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.56 E-value=1.1e-14 Score=138.81 Aligned_cols=105 Identities=25% Similarity=0.335 Sum_probs=72.5
Q ss_pred EEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCC
Q 041438 113 YLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNF 192 (752)
Q Consensus 113 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 192 (752)
++++++|+|+. +|..+. ++|++|+|++|+|+++.|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 13 ~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 45555666655 343332 667777777777777767777777777777777777776666667777777777777777
Q ss_pred CCCcCCcCccCCCcceEEeecccccccc
Q 041438 193 LGGSIPRSLSNFTNLVFLYLYNNSFSGS 220 (752)
Q Consensus 193 l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 220 (752)
|++..+..|.++++|++|+|++|.++..
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 7776666677777777777777777643
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.6e-14 Score=136.67 Aligned_cols=104 Identities=24% Similarity=0.334 Sum_probs=77.2
Q ss_pred EEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCC
Q 041438 113 YLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNF 192 (752)
Q Consensus 113 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 192 (752)
.+++++|+++. +|..+. ++|++|+|++|+|+++.|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 16 ~l~~~~n~l~~-iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 16 LVNCQNIRLAS-VPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCCCc-cCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 46667777754 344443 677778888888877777777778888888888888877666667778888888888888
Q ss_pred CCCcCCcCccCCCcceEEeeccccccc
Q 041438 193 LGGSIPRSLSNFTNLVFLYLYNNSFSG 219 (752)
Q Consensus 193 l~~~~p~~~~~l~~L~~L~L~~N~l~~ 219 (752)
|++..+..|.++++|++|+|++|.+..
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred cceeCHHHhccccCCCEEEeCCCCccc
Confidence 887666667788888888888887763
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.51 E-value=3.1e-14 Score=135.66 Aligned_cols=106 Identities=26% Similarity=0.248 Sum_probs=88.4
Q ss_pred CCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeecc
Q 041438 135 LEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYN 214 (752)
Q Consensus 135 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 214 (752)
.+.|++++|+|+. +|..+ .++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus 11 ~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 5789999999985 56555 38899999999999988899999999999999999999988888889999999999999
Q ss_pred ccccccccccccCccccccccccccccCC
Q 041438 215 NSFSGSIPQQIGNLKSLFDMKLCINQLNG 243 (752)
Q Consensus 215 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 243 (752)
|+|++..+..|.++++|+.|++++|.++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 99998777777777766666666665553
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.1e-12 Score=142.72 Aligned_cols=319 Identities=10% Similarity=0.114 Sum_probs=190.7
Q ss_pred ccccccCCCC-CCCEEECCCCcccccCCccCcCCCCCCeeecCCCc---ccccCCcccccccccceeeccCcccCCCCCc
Q 041438 100 LLEFSFSSFP-HLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNK---LSGHIPSEISLLTHLTILHISRNQLNGSIPH 175 (752)
Q Consensus 100 l~~~~f~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 175 (752)
+.+.+|.+.. .|+.+.+..+ ++.+...+|.++++|+.+.+..|. ++.+...+|.+..+|+.+.+..+ ++.+...
T Consensus 54 Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~ 131 (394)
T 4gt6_A 54 IGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSE 131 (394)
T ss_dssp ECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTT
T ss_pred cCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhh
Confidence 3456788874 5999999754 888889999999999999998774 77777888999999999888755 5556677
Q ss_pred ccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCC
Q 041438 176 EVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCP 255 (752)
Q Consensus 176 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~ 255 (752)
+|.+..+|+.+.+..+ +..+....|.++.+|+.+.+.++ ++.+...+|.+ ..|+.+.+..+-.. . ....|..+.
T Consensus 132 aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i--~~~af~~c~ 205 (394)
T 4gt6_A 132 AFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-I--GTNAFSECF 205 (394)
T ss_dssp TTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-E--CTTTTTTCT
T ss_pred hhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-c--ccchhhhcc
Confidence 8899999999999754 45467778899999999988765 44455556654 45666655433211 0 112355666
Q ss_pred CCcEEEccccccCCCCCcc-------------cCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcc
Q 041438 256 QLSLLDVSINNITGNIPFE-------------IGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGE 322 (752)
Q Consensus 256 ~L~~L~Ls~N~l~~~~p~~-------------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 322 (752)
.++......+......-.. +.....+..+.+.. .++.....+|.++.+|+.+.+.++..+ +...+
T Consensus 206 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~a 283 (394)
T 4gt6_A 206 ALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSVVS-IGTGA 283 (394)
T ss_dssp TCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTCCE-ECTTT
T ss_pred ccceecccccccccccceeecccccccccccccccccccceEEcCC-cceEcccceeeecccccEEecccccce-ecCcc
Confidence 6766665544432111100 11122233333322 222233445666666666666544332 44555
Q ss_pred cCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccc
Q 041438 323 LGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLE 402 (752)
Q Consensus 323 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 402 (752)
|.++++|+.+.+. +.++.+...+|.++.+|+.++|..+ ++.+...+|.++++|+.+.|..+ ++.+...+|.++.+|+
T Consensus 284 F~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~ 360 (394)
T 4gt6_A 284 FMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALN 360 (394)
T ss_dssp TTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCC
T ss_pred cccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCC
Confidence 6666666666664 4455555566666666666666543 44455556666666666666433 5555555666666666
Q ss_pred eEEccCCcCCcCCchhhhccCCCcEEEccCCc
Q 041438 403 KLNLSYNNLSGLIPRCFEELHGLLHIDISYNK 434 (752)
Q Consensus 403 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 434 (752)
.+++.+|.... ..+....+|+.+.+..|.
T Consensus 361 ~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~ 389 (394)
T 4gt6_A 361 NIEYSGSRSQW---NAISTDSGLQNLPVAPGS 389 (394)
T ss_dssp EEEESSCHHHH---HTCBCCCCC---------
T ss_pred EEEECCceeeh---hhhhccCCCCEEEeCCCC
Confidence 66666554321 234445555555554443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.49 E-value=7.3e-14 Score=133.55 Aligned_cols=104 Identities=25% Similarity=0.282 Sum_probs=85.7
Q ss_pred CeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccc
Q 041438 136 EYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNN 215 (752)
Q Consensus 136 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 215 (752)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 68999999997 5566554 88999999999999888999999999999999999999887778899999999999999
Q ss_pred cccccccccccCccccccccccccccC
Q 041438 216 SFSGSIPQQIGNLKSLFDMKLCINQLN 242 (752)
Q Consensus 216 ~l~~~~p~~~~~l~~L~~l~l~~N~l~ 242 (752)
+|++..+..|.++++|+.|++++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 998766666776666665555555554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.42 E-value=6e-12 Score=137.04 Aligned_cols=299 Identities=11% Similarity=0.099 Sum_probs=218.2
Q ss_pred ccccccCCCCCCCEEECCCCc---ccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcc
Q 041438 100 LLEFSFSSFPHLAYLDLYNNE---LFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHE 176 (752)
Q Consensus 100 l~~~~f~~l~~L~~L~L~~n~---l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 176 (752)
+.+.+|.++++|+.+.+..|. ++.+...+|.++.+|+.+.+..+ ++.+...+|.+..+|+.+.+..+ +..+...+
T Consensus 78 Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~ 155 (394)
T 4gt6_A 78 IGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEG-VTSVADGM 155 (394)
T ss_dssp ECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTT-CCEECTTT
T ss_pred EhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhcccccccccce-eeeecccc
Confidence 456789999999999998764 77888899999999999988765 66677889999999999999754 45466788
Q ss_pred cCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCC---------
Q 041438 177 VGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPL--------- 247 (752)
Q Consensus 177 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~--------- 247 (752)
|....+|+.+.+..+ ++.+...+|.+ .+|+.+.+..+-. .....+|.+..++.......+........
T Consensus 156 F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~-~i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (394)
T 4gt6_A 156 FSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVT-RIGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGD 232 (394)
T ss_dssp TTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCC-EECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSC
T ss_pred eecccccccccccce-eeEeccccccc-cceeEEEECCccc-ccccchhhhccccceecccccccccccceeeccccccc
Confidence 999999999999876 55566667765 6799999876543 35566777777776665544332211000
Q ss_pred --CCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCC
Q 041438 248 --SIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGS 325 (752)
Q Consensus 248 --~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 325 (752)
...+.....+..+.+. +.++..-..+|..+..|+.+.+..+..+ .....|.++.+|+.+.+. +.++.+...+|.+
T Consensus 233 ~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~ 309 (394)
T 4gt6_A 233 YALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAG 309 (394)
T ss_dssp EEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTT
T ss_pred ccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecC
Confidence 0011122344455543 3344455678889999999999876553 566788999999999996 5677677889999
Q ss_pred CcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEE
Q 041438 326 LINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLN 405 (752)
Q Consensus 326 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 405 (752)
+.+|+.++|..+ ++.+...+|.++.+|+.+.+..+ ++.+...+|.++++|+.+++.+|.... ..+....+|+.+.
T Consensus 310 c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~ 384 (394)
T 4gt6_A 310 CISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLP 384 (394)
T ss_dssp CTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----
T ss_pred CCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEE
Confidence 999999999864 88888889999999999999755 777778899999999999999886532 4566677888888
Q ss_pred ccCCcC
Q 041438 406 LSYNNL 411 (752)
Q Consensus 406 L~~N~l 411 (752)
+..|.+
T Consensus 385 i~~~~~ 390 (394)
T 4gt6_A 385 VAPGSI 390 (394)
T ss_dssp ------
T ss_pred eCCCCE
Confidence 776654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.39 E-value=6.6e-13 Score=141.98 Aligned_cols=89 Identities=20% Similarity=0.139 Sum_probs=43.0
Q ss_pred CcCCCCCCeeecCC-CcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcc
Q 041438 129 ISNLSKLEYLDFLT-NKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207 (752)
Q Consensus 129 ~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 207 (752)
|..+++|++|+|++ |+|+++.+..|.+|++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|..++ |
T Consensus 27 l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L 105 (347)
T 2ifg_A 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-L 105 (347)
T ss_dssp SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-C
T ss_pred CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-c
Confidence 44444444444443 444444444444444444444444444444444444445555555555555444444444443 5
Q ss_pred eEEeecccccc
Q 041438 208 VFLYLYNNSFS 218 (752)
Q Consensus 208 ~~L~L~~N~l~ 218 (752)
+.|+|++|.|.
T Consensus 106 ~~l~l~~N~~~ 116 (347)
T 2ifg_A 106 QELVLSGNPLH 116 (347)
T ss_dssp CEEECCSSCCC
T ss_pred eEEEeeCCCcc
Confidence 55555555554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.39 E-value=5e-13 Score=142.92 Aligned_cols=109 Identities=25% Similarity=0.318 Sum_probs=96.1
Q ss_pred CcccceeeCCCCCEEEEEcCCCCCcccccccccCCCCCCCEEECCC-CcccccCCccCcCCCCCCeeecCCCcccccCCc
Q 041438 73 CTWSGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYN-NELFDIIPPQISNLSKLEYLDFLTNKLSGHIPS 151 (752)
Q Consensus 73 c~w~gv~C~~~~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 151 (752)
|.|.+|.|...+ +|.+ +++ +..+++|++|+|++ |+|+++.+..|++|++|++|+|++|+|+++.|.
T Consensus 8 C~~~~v~~~~~n----------~l~~-ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 8 HGSSGLRCTRDG----------ALDS-LHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp SSSSCEECCSSC----------CCTT-TTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred ccCCEEEcCCCC----------CCCc-cCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 899999886431 2332 444 88999999999996 999999999999999999999999999999999
Q ss_pred ccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCC
Q 041438 152 EISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGG 195 (752)
Q Consensus 152 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 195 (752)
.|.+|++|++|+|++|+|++..+..|..++ |+.|+|++|.+..
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred HhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 999999999999999999987777787777 9999999999985
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.6e-14 Score=155.49 Aligned_cols=167 Identities=23% Similarity=0.212 Sum_probs=102.0
Q ss_pred CCCcEEEccccccCCCCCccc----C-CCCCCCEEecCCCcCcCCCCccc-cCCcccCEEEccCCcCcccCCccc-----
Q 041438 255 PQLSLLDVSINNITGNIPFEI----G-ESPQLQYLDLSSNYIVGEIPTQL-GNIIYLNRISLSGNKLSGRIPGEL----- 323 (752)
Q Consensus 255 ~~L~~L~Ls~N~l~~~~p~~~----~-~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~----- 323 (752)
+.|+.|+|++|.|+......+ . ..++|++|+|++|.|+......+ ..+.+|+.|+|++|.|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 456677777777765433222 2 22578888888887764333222 234567777777777764433333
Q ss_pred CCCcccceeecccccccccc----chhhcccccccEEEcCCCcCcccc----chhccccccCCeeecCCccCCCCC----
Q 041438 324 GSLINLEYLDLSANHLSNFV----LESLGSLVKLYYLNLSHNKLSQQI----PIELDNLIHLSELDLSHNFLGEKI---- 391 (752)
Q Consensus 324 ~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~---- 391 (752)
...++|++|+|++|.|+... +..+...++|++|+|++|+|+... +..+...++|++|+|++|.|+...
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 23567777778777776533 233456677777777777776432 445566667777777777776532
Q ss_pred CcccccccccceEEccCCcCCcCCchhhhc
Q 041438 392 SSRICRMESLEKLNLSYNNLSGLIPRCFEE 421 (752)
Q Consensus 392 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 421 (752)
+..+...++|++|+|++|.|+......+..
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~ 261 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSSEGRQVLRD 261 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred HHHHHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence 223334567777777777776654444443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=5.8e-14 Score=151.15 Aligned_cols=160 Identities=22% Similarity=0.273 Sum_probs=125.9
Q ss_pred CCCCCEEecCCCcCcCCCCccccCC-----cccCEEEccCCcCcccCCccc-CCCcccceeeccccccccccchhhc---
Q 041438 278 SPQLQYLDLSSNYIVGEIPTQLGNI-----IYLNRISLSGNKLSGRIPGEL-GSLINLEYLDLSANHLSNFVLESLG--- 348 (752)
Q Consensus 278 l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~--- 348 (752)
++.|+.|+|++|.|+......+... .+|+.|+|++|.++......+ ..+++|++|+|++|.|+......+.
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 4679999999999986544444333 799999999999975433333 3567899999999999887666653
Q ss_pred --ccccccEEEcCCCcCccc----cchhccccccCCeeecCCccCCCCC----CcccccccccceEEccCCcCCcC----
Q 041438 349 --SLVKLYYLNLSHNKLSQQ----IPIELDNLIHLSELDLSHNFLGEKI----SSRICRMESLEKLNLSYNNLSGL---- 414 (752)
Q Consensus 349 --~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~---- 414 (752)
..++|+.|+|++|.|+.. ++..+..+++|++|+|++|.|++.. +..+...++|+.|+|++|.|+..
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence 457899999999999753 3445577899999999999997643 45566778999999999999864
Q ss_pred CchhhhccCCCcEEEccCCcccC
Q 041438 415 IPRCFEELHGLLHIDISYNKLEG 437 (752)
Q Consensus 415 ~p~~~~~l~~L~~L~ls~N~l~~ 437 (752)
++..+...++|++|||++|.+++
T Consensus 231 l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 231 LARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHHHHHHCSSCCEEECTTSSCCH
T ss_pred HHHHHHhCCCCCEEeccCCCCCH
Confidence 34455667999999999999874
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.25 E-value=3e-10 Score=122.83 Aligned_cols=131 Identities=12% Similarity=0.119 Sum_probs=61.9
Q ss_pred cccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhccccc
Q 041438 273 FEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVK 352 (752)
Q Consensus 273 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 352 (752)
..+....+|+.+.+..+ +.......|.++..|+.+.+..+ ++.+...+|.++.+|+.+.+.. .+..+...+|.++.+
T Consensus 211 ~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~-~i~~i~~~aF~~c~~ 287 (379)
T 4h09_A 211 YGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYA-KVKTVPYLLCSGCSN 287 (379)
T ss_dssp TTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECC-CCSEECTTTTTTCTT
T ss_pred cccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccccccc-cceeccccccccccc
Confidence 34444455555555433 22233344455555555555443 3334444455555555555533 244444445555555
Q ss_pred ccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEcc
Q 041438 353 LYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLS 407 (752)
Q Consensus 353 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 407 (752)
|+.+.+.++.++.+....|.++.+|+.++|..+ ++.+...+|.++.+|+.+.+.
T Consensus 288 L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 288 LTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp CCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred cccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence 555555555554444445555555555555432 333334444444555544443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.19 E-value=1.2e-09 Score=117.98 Aligned_cols=284 Identities=11% Similarity=-0.006 Sum_probs=199.4
Q ss_pred ccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCC
Q 041438 100 LLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQ 179 (752)
Q Consensus 100 l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 179 (752)
+.+.+|.++.+|+.++|..+ ++.+...+|.++ +|+.+.+..+ ++.+...+|.+ .+|+.+.+..+ ++..-..+|.+
T Consensus 60 Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~lp~~-~~~i~~~~F~~ 134 (379)
T 4h09_A 60 IGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEFPGA-TTEIGNYIFYN 134 (379)
T ss_dssp ECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEECCTT-CCEECTTTTTT
T ss_pred hHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccCCCc-ccccccccccc
Confidence 44667888888888888644 777778888887 6777777644 55566667765 47888888765 33244455555
Q ss_pred CCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccc------------cccccCccccccccccccccCCCcCC
Q 041438 180 LNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSI------------PQQIGNLKSLFDMKLCINQLNGAIPL 247 (752)
Q Consensus 180 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~------------p~~~~~l~~L~~l~l~~N~l~~~~~~ 247 (752)
. +|+.+.+..+ ++.+....|.++.+++.+.+..+...... ...+.....+..+.+..+. . ...
T Consensus 135 ~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~i~ 209 (379)
T 4h09_A 135 S-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTV-K--TVT 209 (379)
T ss_dssp C-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTC-C--EEC
T ss_pred c-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccce-e--EEe
Confidence 4 5666665543 45466677888888888877665432111 1112222222222221111 0 001
Q ss_pred CCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCc
Q 041438 248 SIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLI 327 (752)
Q Consensus 248 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 327 (752)
...+..+.+|+.+.+..+ ++.....+|..+..|+.+.+..+ ++......|.++.+|+.+.+..+ +..+....|.+++
T Consensus 210 ~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~ 286 (379)
T 4h09_A 210 AYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCS 286 (379)
T ss_dssp TTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCT
T ss_pred ecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccc
Confidence 123566788888888654 55566778889999999999877 66566788999999999999754 6667778899999
Q ss_pred ccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccc
Q 041438 328 NLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRM 398 (752)
Q Consensus 328 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 398 (752)
+|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+...+|.++++|+.+.+..+ ++.+-..+|.+.
T Consensus 287 ~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 287 NLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp TCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred ccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 9999999999999999999999999999999765 77777889999999999999765 555555566554
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=99.02 E-value=1.5e-12 Score=131.99 Aligned_cols=140 Identities=21% Similarity=0.175 Sum_probs=81.3
Q ss_pred CCCcccceeeCCCC-CEEEEEcCC---CCCcccccccccCCCC---------CCCEEECCCCcccccCCccCcCCCCCCe
Q 041438 71 SLCTWSGIHCNHAG-RVFGINLTS---ISLNGTLLEFSFSSFP---------HLAYLDLYNNELFDIIPPQISNLSKLEY 137 (752)
Q Consensus 71 ~~c~w~gv~C~~~~-~v~~l~l~~---~~l~g~l~~~~f~~l~---------~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 137 (752)
..|.|.|+.|+..+ +|+.+...+ ..+.|.+.+..+..+. .-+.|||+. |...+.|+.
T Consensus 76 ~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~----------l~~dp~L~~ 145 (267)
T 3rw6_A 76 ALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKG----------LRSDPDLVA 145 (267)
T ss_dssp HHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTT----------GGGCHHHHH
T ss_pred HHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHHHHHhccchhccccCHHH----------cCCCcchhh
Confidence 46899999998543 554443333 2333444332221111 223344332 344444554
Q ss_pred --eecCCCccc---ccCCcccccccccceeeccCcccCC--CCCcccCCCCCCcEEEccCCCCCCcCCcCccCCC--cce
Q 041438 138 --LDFLTNKLS---GHIPSEISLLTHLTILHISRNQLNG--SIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFT--NLV 208 (752)
Q Consensus 138 --L~L~~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~ 208 (752)
++++.|+.. +..+....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+
T Consensus 146 ~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~ 223 (267)
T 3rw6_A 146 QNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLE 223 (267)
T ss_dssp TTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCS
T ss_pred cCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcc
Confidence 666677432 2222223467778888888888876 3456666777888888888888765 2344444 788
Q ss_pred EEeecccccccccc
Q 041438 209 FLYLYNNSFSGSIP 222 (752)
Q Consensus 209 ~L~L~~N~l~~~~p 222 (752)
+|+|++|.+.+..|
T Consensus 224 ~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 224 ELWLDGNSLCDTFR 237 (267)
T ss_dssp EEECTTSTTGGGCS
T ss_pred eEEccCCcCccccC
Confidence 88888888776554
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.96 E-value=1e-10 Score=124.72 Aligned_cols=83 Identities=16% Similarity=0.286 Sum_probs=48.4
Q ss_pred CCCCCEEecCCCcCcCCCCccc---cCCcccCEEEccCCcCccc----CCcccCCCcccceeeccccccccccchhhcc-
Q 041438 278 SPQLQYLDLSSNYIVGEIPTQL---GNIIYLNRISLSGNKLSGR----IPGELGSLINLEYLDLSANHLSNFVLESLGS- 349 (752)
Q Consensus 278 l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~- 349 (752)
+++|++|+|++|.+....+..+ ..+++|++|+|+.|.+.+. ++..+..+++|+.|+|++|.|+......+..
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a 330 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS 330 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence 4455555555555543222112 1355677777777766542 2333345678888888888887665555544
Q ss_pred cccccEEEcCCCc
Q 041438 350 LVKLYYLNLSHNK 362 (752)
Q Consensus 350 l~~L~~L~Ls~N~ 362 (752)
+ ...++++.|+
T Consensus 331 l--g~~~~~~~~~ 341 (362)
T 2ra8_A 331 L--PMKIDVSDSQ 341 (362)
T ss_dssp C--CSEEECCSBC
T ss_pred c--CCEEEecCCc
Confidence 2 4568888887
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.96 E-value=1.3e-10 Score=123.88 Aligned_cols=85 Identities=20% Similarity=0.276 Sum_probs=63.2
Q ss_pred CCcccCEEEccCCcCcccCCccc---CCCcccceeeccccccccccc----hhhcccccccEEEcCCCcCccccchhccc
Q 041438 301 NIIYLNRISLSGNKLSGRIPGEL---GSLINLEYLDLSANHLSNFVL----ESLGSLVKLYYLNLSHNKLSQQIPIELDN 373 (752)
Q Consensus 301 ~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 373 (752)
.+++|+.|+|++|.+....+..+ ..+++|++|+|+.|.|++... ..+..+++|+.|+|++|.|+...-..+..
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~ 329 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHH
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHH
Confidence 47899999999999875333222 357899999999999987543 34456899999999999987554444443
Q ss_pred cccCCeeecCCcc
Q 041438 374 LIHLSELDLSHNF 386 (752)
Q Consensus 374 l~~L~~L~Ls~N~ 386 (752)
.- ...+++++|+
T Consensus 330 al-g~~~~~~~~~ 341 (362)
T 2ra8_A 330 SL-PMKIDVSDSQ 341 (362)
T ss_dssp HC-CSEEECCSBC
T ss_pred Hc-CCEEEecCCc
Confidence 11 4678999987
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.92 E-value=2.4e-09 Score=109.24 Aligned_cols=124 Identities=13% Similarity=0.052 Sum_probs=93.3
Q ss_pred HHHhhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCC---CC----------------------CccccCCceEE
Q 041438 496 IIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPL---PD----------------------NFCSHPRQSFI 550 (752)
Q Consensus 496 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~----------------------~~~~~~~~~~l 550 (752)
+....++|++...++.|+.+.||++... ++.+++|+..... .. .++.+.+..|+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3455678999999999999999999754 6899999876421 11 22344567899
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNC---------------------------------- 596 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---------------------------------- 596 (752)
||||++|.++.+... +......++.++++++..||+..
T Consensus 88 v~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 999999999887632 11233578899999999999810
Q ss_pred ----------------------CCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 597 ----------------------FPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 597 ----------------------~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
.+.++|+|++|.||+++++..+.|+||+.+..
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 03589999999999998765567999988754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.75 E-value=1.2e-08 Score=103.72 Aligned_cols=119 Identities=14% Similarity=0.087 Sum_probs=83.2
Q ss_pred hhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEec
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~ 555 (752)
...+|.+....+.|..+.||++...+|+.+++|........ .+....+..++||||+
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34556654444566679999998777888999987653211 1223345679999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNC--------------------------------------- 596 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--------------------------------------- 596 (752)
+|.++. ... . ....++.++++.+..+|+..
T Consensus 98 ~G~~l~--~~~------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 98 PGQDLL--SSH------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp SSEETT--TSC------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred CCcccC--cCc------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 998874 211 1 12356778888888888741
Q ss_pred ----------------CCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 597 ----------------FPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 597 ----------------~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
.+.++|+|++|.||+++++..+.|+|||.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 01399999999999998776667999998864
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.59 E-value=2.5e-08 Score=100.87 Aligned_cols=104 Identities=27% Similarity=0.263 Sum_probs=68.2
Q ss_pred CCCcccce--eecccccccc---ccchhhcccccccEEEcCCCcCcc--ccchhccccccCCeeecCCccCCCCCCcccc
Q 041438 324 GSLINLEY--LDLSANHLSN---FVLESLGSLVKLYYLNLSHNKLSQ--QIPIELDNLIHLSELDLSHNFLGEKISSRIC 396 (752)
Q Consensus 324 ~~l~~L~~--L~Ls~N~l~~---~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 396 (752)
...+.|.. ++++.|+... .......++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+.
T Consensus 138 ~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~ 215 (267)
T 3rw6_A 138 RSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELD 215 (267)
T ss_dssp GGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGG
T ss_pred CCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhh
Confidence 33444554 5666664332 222233567788888888888876 3456677788888888888888765 2334
Q ss_pred ccc--ccceEEccCCcCCcCCc-------hhhhccCCCcEEE
Q 041438 397 RME--SLEKLNLSYNNLSGLIP-------RCFEELHGLLHID 429 (752)
Q Consensus 397 ~l~--~L~~L~L~~N~l~~~~p-------~~~~~l~~L~~L~ 429 (752)
.+. +|++|+|++|.+++.+| ..+..+++|+.||
T Consensus 216 ~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 216 KIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 444 78888888888887555 2466778888775
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.54 E-value=2.8e-08 Score=95.47 Aligned_cols=63 Identities=19% Similarity=0.267 Sum_probs=34.1
Q ss_pred cccCCeeecCCccCCCC----CCcccccccccceEEc--cCCcCCcC----CchhhhccCCCcEEEccCCccc
Q 041438 374 LIHLSELDLSHNFLGEK----ISSRICRMESLEKLNL--SYNNLSGL----IPRCFEELHGLLHIDISYNKLE 436 (752)
Q Consensus 374 l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L--~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~ 436 (752)
.++|++|+|++|.|+.. +...+...++|++|+| ++|.|+.. +...+...+.|++|+|++|.+.
T Consensus 92 n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 92 NNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp CSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred CCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 34444555555544432 2233444456666666 56666543 2334455567777777777764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.52 E-value=2.4e-07 Score=99.05 Aligned_cols=119 Identities=13% Similarity=0.211 Sum_probs=86.9
Q ss_pred cceeeccCCceEEEEEEeCCCcEEEEEccC--CCCC-----C----------------------CccccC---CceEEEE
Q 041438 505 AKHCIGKGGHGSVYIARVPSGEIFAVKKFH--SPLP-----D----------------------NFCSHP---RQSFIVY 552 (752)
Q Consensus 505 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~-----~----------------------~~~~~~---~~~~lV~ 552 (752)
..+.++.|.++.||++...+ ..+++|+.. .... . .++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 46789999999999998754 678889876 2210 0 122222 3478999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNC------------------------------------ 596 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~------------------------------------ 596 (752)
||++|..+.+.. ...++..+...++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999997774321 123677888999999999999999831
Q ss_pred -------------------CCCeeecCCCCCCEEeCCCCc--eEEeecccceec
Q 041438 597 -------------------FPPIVHWDISSKNVLLDLGYE--AHVSDFRIAKFL 629 (752)
Q Consensus 597 -------------------~~~ivH~DlKp~NIll~~~~~--~kl~DfG~a~~~ 629 (752)
.+.++|+|++|.||+++.++. +.|+||+.+...
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 247999999999999997653 689999998753
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.48 E-value=3.3e-08 Score=94.99 Aligned_cols=87 Identities=18% Similarity=0.205 Sum_probs=44.9
Q ss_pred Ccccceeecccccccccc----chhhcccccccEEEcCCCcCccc----cchhccccccCCeeec--CCccCCCCC----
Q 041438 326 LINLEYLDLSANHLSNFV----LESLGSLVKLYYLNLSHNKLSQQ----IPIELDNLIHLSELDL--SHNFLGEKI---- 391 (752)
Q Consensus 326 l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~~~~---- 391 (752)
.++|++|+|++|.|.... ...+...+.|++|+|++|.|+.. +...+...++|++|+| ++|.|+...
T Consensus 64 ~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l 143 (185)
T 1io0_A 64 NTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEI 143 (185)
T ss_dssp CCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHH
T ss_pred CCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHH
Confidence 344555555555544322 22333345566666666665432 2334445556666666 556665432
Q ss_pred CcccccccccceEEccCCcCC
Q 041438 392 SSRICRMESLEKLNLSYNNLS 412 (752)
Q Consensus 392 ~~~~~~l~~L~~L~L~~N~l~ 412 (752)
...+...++|++|+|++|.+.
T Consensus 144 ~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 144 ANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCcCEEeccCCCCC
Confidence 223334466777777777664
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.37 E-value=1.4e-07 Score=98.31 Aligned_cols=161 Identities=19% Similarity=0.170 Sum_probs=104.7
Q ss_pred ceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-------------------------CccccC---CceEEEEEeccC
Q 041438 506 KHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-------------------------NFCSHP---RQSFIVYEYLES 557 (752)
Q Consensus 506 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~---~~~~lV~E~~~~ 557 (752)
.+.++.|....||++. +.+++|+....... ...... ...|+|||+++|
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 4568999999999863 56888875432000 111111 235899999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNC----------------------------------------- 596 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~----------------------------------------- 596 (752)
.++.+... ..++.+++..++.|+++.+..||+..
T Consensus 101 ~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 101 VPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp EECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred eECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 88765332 23666788888999999999998610
Q ss_pred --------------CCCeeecCCCCCCEEeCC--CCceEEeecccceeccCCCCCcccccCCCCc---cCcccccc----
Q 041438 597 --------------FPPIVHWDISSKNVLLDL--GYEAHVSDFRIAKFLNLDSSNWSKLAGTHGN---VAPELAYT---- 653 (752)
Q Consensus 597 --------------~~~ivH~DlKp~NIll~~--~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y---~aPE~~~~---- 653 (752)
.+.++|+|++|.||++++ ...+.|+||+.+....... .......+ ..|+....
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~----Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN----DFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH----HHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH----HHHHHHhhccccCHHHHHHHHHH
Confidence 135899999999999997 4567899999987643210 01111111 22221110
Q ss_pred C-C---------CCCccchhhHHHHHHHHHhCCCCc
Q 041438 654 M-K---------VTEKCDVYSFGVLALEVIKGKHPR 679 (752)
Q Consensus 654 ~-~---------~~~ksDIwSlGvil~elltg~~pf 679 (752)
. . .....+.|++|.++|.+.+|..+|
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 0 012258999999999999999886
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.74 E-value=1.9e-05 Score=74.00 Aligned_cols=80 Identities=19% Similarity=0.197 Sum_probs=32.1
Q ss_pred cCEEEccCCcCcccCCcccCCCcccceeeccccc-cccccchhhccc----ccccEEEcCCCc-CccccchhccccccCC
Q 041438 305 LNRISLSGNKLSGRIPGELGSLINLEYLDLSANH-LSNFVLESLGSL----VKLYYLNLSHNK-LSQQIPIELDNLIHLS 378 (752)
Q Consensus 305 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~ 378 (752)
|+.||++++.++..--..+.++++|++|+|+++. |++.....+..+ ++|++|+|++|. ++...-..+..+++|+
T Consensus 63 L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~ 142 (176)
T 3e4g_A 63 IQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLK 142 (176)
T ss_dssp EEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCC
T ss_pred EeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCC
Confidence 4444444444333222233444445555555442 444333333332 245555555442 4332222333333333
Q ss_pred eeecCC
Q 041438 379 ELDLSH 384 (752)
Q Consensus 379 ~L~Ls~ 384 (752)
.|+|++
T Consensus 143 ~L~L~~ 148 (176)
T 3e4g_A 143 YLFLSD 148 (176)
T ss_dssp EEEEES
T ss_pred EEECCC
Confidence 333333
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.73 E-value=1.4e-05 Score=74.96 Aligned_cols=84 Identities=13% Similarity=0.139 Sum_probs=58.1
Q ss_pred cccceeeccccccccccchhhcccccccEEEcCCCc-Cccccchhcccc----ccCCeeecCCcc-CCCCCCcccccccc
Q 041438 327 INLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNK-LSQQIPIELDNL----IHLSELDLSHNF-LGEKISSRICRMES 400 (752)
Q Consensus 327 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~~~~~~~l~~ 400 (752)
.+|+.|||+++.|+......+.++++|+.|+|+++. ++...-..+..+ ++|++|+|+++. ++..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 478999999999888777778888888999988885 665444445543 357777777763 55544444555666
Q ss_pred cceEEccCCc
Q 041438 401 LEKLNLSYNN 410 (752)
Q Consensus 401 L~~L~L~~N~ 410 (752)
|++|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 6666666653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00012 Score=74.54 Aligned_cols=114 Identities=18% Similarity=0.185 Sum_probs=78.4
Q ss_pred eeccCCce-EEEEEEe-CCCcEEEEEccCCCC----------------------CCCccccCCceEEEEEeccCCChHHH
Q 041438 508 CIGKGGHG-SVYIARV-PSGEIFAVKKFHSPL----------------------PDNFCSHPRQSFIVYEYLESGSLDKI 563 (752)
Q Consensus 508 ~lg~G~~g-~Vy~~~~-~~~~~vavK~~~~~~----------------------~~~~~~~~~~~~lV~E~~~~g~L~~~ 563 (752)
.+..|..| .||+... .++..+++|+-.... .-.++.+.+..|+|||+++|.++.+.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~ 110 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV 110 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence 45556555 6998874 356788999653211 01345567788999999999888776
Q ss_pred hccCccccccCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------------
Q 041438 564 LNNDASAKELGWTQRLNVIKGVADALFYLHNNC----------------------------------------------- 596 (752)
Q Consensus 564 l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~----------------------------------------------- 596 (752)
.... ......+..+++..|..||+..
T Consensus 111 ~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 111 LEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp HHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred ccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 5321 1233456667777777777531
Q ss_pred --------CCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 597 --------FPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 597 --------~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
.+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11379999999999999877677999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00016 Score=75.04 Aligned_cols=114 Identities=16% Similarity=0.135 Sum_probs=75.2
Q ss_pred ceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-------------------------Ccc-ccCCceEEEEEeccCCC
Q 041438 506 KHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-------------------------NFC-SHPRQSFIVYEYLESGS 559 (752)
Q Consensus 506 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------~~~-~~~~~~~lV~E~~~~g~ 559 (752)
.+.++.|....||+. |+.+++|+-...... .++ ...+..++||||++|..
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 466888988899988 567888875321100 112 13345789999999988
Q ss_pred hHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 041438 560 LDKILNNDASAKELGWTQRLNVIKGVADALFYLHNN-------------------------------------------- 595 (752)
Q Consensus 560 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-------------------------------------------- 595 (752)
+.+..-. .++..+...++.++++.|..||+.
T Consensus 100 l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 100 LGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp CHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred Cchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 7653211 133445555555555555555542
Q ss_pred -------------CCCCeeecCCCCCCEEeCC---CCc-eEEeeccccee
Q 041438 596 -------------CFPPIVHWDISSKNVLLDL---GYE-AHVSDFRIAKF 628 (752)
Q Consensus 596 -------------~~~~ivH~DlKp~NIll~~---~~~-~kl~DfG~a~~ 628 (752)
..+.++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 455 48999998865
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.44 E-value=9.1e-05 Score=70.72 Aligned_cols=61 Identities=21% Similarity=0.295 Sum_probs=31.3
Q ss_pred ccCCeeecCCccCCCCC----CcccccccccceEEccCC---cCCc----CCchhhhccCCCcEEEccCCcc
Q 041438 375 IHLSELDLSHNFLGEKI----SSRICRMESLEKLNLSYN---NLSG----LIPRCFEELHGLLHIDISYNKL 435 (752)
Q Consensus 375 ~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N---~l~~----~~p~~~~~l~~L~~L~ls~N~l 435 (752)
+.|+.|+|++|.|+..- ...+..-+.|++|+|++| .+.. .+...+..-+.|+.|+++.|..
T Consensus 98 ~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 98 PSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp SSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred CccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 44444444444443221 122333455677777654 3332 1334556667788888876654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00053 Score=72.72 Aligned_cols=31 Identities=23% Similarity=0.219 Sum_probs=26.4
Q ss_pred CCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 598 PPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 598 ~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
+.++|+|+.|.||+++++..+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 4799999999999999644578999998865
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00045 Score=72.68 Aligned_cols=31 Identities=29% Similarity=0.422 Sum_probs=27.7
Q ss_pred CCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 598 PPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 598 ~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
+.++|+|+++.||+++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 4899999999999998778899999998754
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00011 Score=70.08 Aligned_cols=87 Identities=20% Similarity=0.244 Sum_probs=40.9
Q ss_pred CCcccceeeccccccccccc----hhhcccccccEEEcCCCcCcccc----chhccccccCCeeecCCc---cCCCC---
Q 041438 325 SLINLEYLDLSANHLSNFVL----ESLGSLVKLYYLNLSHNKLSQQI----PIELDNLIHLSELDLSHN---FLGEK--- 390 (752)
Q Consensus 325 ~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N---~l~~~--- 390 (752)
.-+.|+.|+|++|+|..... +.+..-+.|+.|+|++|+|+... -..+..-+.|++|+|++| .+...
T Consensus 68 ~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~ 147 (197)
T 1pgv_A 68 NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEM 147 (197)
T ss_dssp TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHH
T ss_pred hCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHH
Confidence 33445555555555543322 22334455555555555554321 222333345666666543 22221
Q ss_pred -CCcccccccccceEEccCCcC
Q 041438 391 -ISSRICRMESLEKLNLSYNNL 411 (752)
Q Consensus 391 -~~~~~~~l~~L~~L~L~~N~l 411 (752)
+...+..-+.|+.|+++.|.+
T Consensus 148 ~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 148 DMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHhCCCcCeEeccCCCc
Confidence 223344456677777766654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0027 Score=60.82 Aligned_cols=102 Identities=18% Similarity=0.109 Sum_probs=66.3
Q ss_pred ChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCccc
Q 041438 559 SLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK 638 (752)
Q Consensus 559 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 638 (752)
+|.+++...+ .+++++++|.++.|.+.+|.-+-.+. .-..+=+.|..|++..+|.+...+ +.+.
T Consensus 34 SL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 7899998665 56999999999999999987763211 111233456899999999888664 1111
Q ss_pred ccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCC
Q 041438 639 LAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 678 (752)
Q Consensus 639 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~p 678 (752)
.....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123566888653 3456788899999999999864444
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0022 Score=69.02 Aligned_cols=31 Identities=19% Similarity=0.268 Sum_probs=26.4
Q ss_pred CCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 598 PPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 598 ~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+.++|+|+.|.||+++.+ .++++||..+...
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~G 257 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFYG 257 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCEEE
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCcccccC
Confidence 379999999999999865 5899999887753
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0015 Score=58.04 Aligned_cols=35 Identities=23% Similarity=0.257 Sum_probs=15.8
Q ss_pred CCeeecCCCcccccCCcccccccccceeeccCccc
Q 041438 135 LEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQL 169 (752)
Q Consensus 135 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 169 (752)
|++|+|++|+|+.+.+..|..+++|+.|+|++|.+
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 44444444444444444444444444444444433
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0041 Score=67.48 Aligned_cols=77 Identities=12% Similarity=0.062 Sum_probs=46.8
Q ss_pred CCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCcccccC--CCCccCccccccCC---CCCccchhhHHHHHHHH
Q 041438 598 PPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAG--THGNVAPELAYTMK---VTEKCDVYSFGVLALEV 672 (752)
Q Consensus 598 ~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~ksDIwSlGvil~el 672 (752)
+.++|+|++|.||+++.++ ++++||+.+........ ...... ...|.+|+...... .....++.+....+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 3899999999999998776 99999999876431110 000010 13456666543111 11234455777777777
Q ss_pred HhCC
Q 041438 673 IKGK 676 (752)
Q Consensus 673 ltg~ 676 (752)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6653
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0019 Score=57.41 Aligned_cols=55 Identities=24% Similarity=0.258 Sum_probs=30.2
Q ss_pred eeeccCcccC-CCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccc
Q 041438 161 ILHISRNQLN-GSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSF 217 (752)
Q Consensus 161 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 217 (752)
.++.+++.++ ..+|..+. .+|++|+|++|+|+.+.+..|..+++|+.|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 4455555554 23333221 2456666666666655556666666666666666655
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0067 Score=62.46 Aligned_cols=30 Identities=23% Similarity=0.319 Sum_probs=25.5
Q ss_pred CeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 599 PIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 599 ~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
.++|+|+.|.||+ ..++.+.++||..+...
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 5899999999999 55667899999988753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0089 Score=62.06 Aligned_cols=138 Identities=15% Similarity=0.166 Sum_probs=76.9
Q ss_pred cchHHHHHHhhccccc-----ceeeccCCceEEEEEEeCCCcEEEEEccCCC-CCC--------------------Ccc-
Q 041438 490 KIVYEEIIRATNDFDA-----KHCIGKGGHGSVYIARVPSGEIFAVKKFHSP-LPD--------------------NFC- 542 (752)
Q Consensus 490 ~~~~~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~--------------------~~~- 542 (752)
.++-+++......|.+ .+.|+.|....+|++...+| .+++|..... ... ...
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 3555666666666654 34567788899999987655 6889987652 111 011
Q ss_pred --------ccCCceEEEEEeccCCChHH----H----------hccC----ccc-----cccCHHHHHH-----------
Q 041438 543 --------SHPRQSFIVYEYLESGSLDK----I----------LNND----ASA-----KELGWTQRLN----------- 580 (752)
Q Consensus 543 --------~~~~~~~lV~E~~~~g~L~~----~----------l~~~----~~~-----~~l~~~~~~~----------- 580 (752)
...+..+++|||++|..+.. . ++.. ... ....|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 11245689999999865321 0 1110 000 0011211100
Q ss_pred -HHHHHHHHHHHHHhC----CCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 581 -VIKGVADALFYLHNN----CFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 581 -i~~qi~~aL~~lH~~----~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
+...+...++++++. ..++++|+|+++.||+++++..+.|+||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244455666532 123799999999999998775568999988764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.26 E-value=0.0082 Score=61.35 Aligned_cols=34 Identities=18% Similarity=0.209 Sum_probs=28.9
Q ss_pred ccccceeeccCCceEEEEEEeCCCcEEEEEccCC
Q 041438 502 DFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHS 535 (752)
Q Consensus 502 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~ 535 (752)
...-.+.+|.|..+.||+.+..+|+.|++|+...
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~ 49 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPD 49 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCT
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCC
Confidence 3455688999999999999999999999998653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.13 E-value=0.0086 Score=61.90 Aligned_cols=55 Identities=15% Similarity=0.158 Sum_probs=39.2
Q ss_pred cceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEeccCCCh
Q 041438 505 AKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEYLESGSL 560 (752)
Q Consensus 505 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~~~~g~L 560 (752)
..+.|+.|....+|+... ++..+++|+....... .++...+..++||||+++..+
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 356789999999999986 4678889975432110 223344678999999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.95 E-value=0.021 Score=59.51 Aligned_cols=32 Identities=31% Similarity=0.268 Sum_probs=27.8
Q ss_pred CCeeecCCCCCCEEeCCC----CceEEeecccceec
Q 041438 598 PPIVHWDISSKNVLLDLG----YEAHVSDFRIAKFL 629 (752)
Q Consensus 598 ~~ivH~DlKp~NIll~~~----~~~kl~DfG~a~~~ 629 (752)
+.++|||+.+.||+++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 379999999999999874 67899999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.92 E-value=0.037 Score=57.50 Aligned_cols=28 Identities=21% Similarity=0.173 Sum_probs=25.0
Q ss_pred CeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 599 PIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 599 ~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
.++|+|+++.||+++ + .+.|+||+.+..
T Consensus 196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 196 LRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp EECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 689999999999999 4 899999988765
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.18 E-value=0.055 Score=56.61 Aligned_cols=32 Identities=22% Similarity=0.202 Sum_probs=28.1
Q ss_pred CCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 598 PPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 598 ~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+.++|+|+.+.||++++++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 37999999999999998788999999887653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.29 E-value=0.13 Score=55.24 Aligned_cols=29 Identities=24% Similarity=0.375 Sum_probs=24.9
Q ss_pred eeecCCCCCCEEe------CCCCceEEeeccccee
Q 041438 600 IVHWDISSKNVLL------DLGYEAHVSDFRIAKF 628 (752)
Q Consensus 600 ivH~DlKp~NIll------~~~~~~kl~DfG~a~~ 628 (752)
++|+|+.+.||++ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4566799999998865
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=91.90 E-value=0.27 Score=52.00 Aligned_cols=30 Identities=27% Similarity=0.346 Sum_probs=26.7
Q ss_pred CeeecCCCCCCEEeCCC----CceEEeeccccee
Q 041438 599 PIVHWDISSKNVLLDLG----YEAHVSDFRIAKF 628 (752)
Q Consensus 599 ~ivH~DlKp~NIll~~~----~~~kl~DfG~a~~ 628 (752)
.++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 68999999999999876 6899999998864
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=88.01 E-value=1.2 Score=47.81 Aligned_cols=29 Identities=17% Similarity=0.334 Sum_probs=26.1
Q ss_pred CeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 599 PIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 599 ~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
.++|+|+.+.||+ +.++.+.++||..|..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 6899999999999 7788899999998875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 752 | ||||
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-38 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-38 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-37 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-35 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-34 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-34 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-34 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-34 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-34 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-34 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-33 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-33 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-33 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-33 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-32 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-32 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-32 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-31 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-31 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-31 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-30 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-30 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-30 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-29 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-29 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-29 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-29 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-29 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-28 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-28 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-28 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-28 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-28 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-28 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-26 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-26 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-26 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-26 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-08 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-25 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-24 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-24 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-24 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-07 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-23 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-16 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-22 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-21 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-21 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-20 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-20 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-19 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-19 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-19 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-11 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-17 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-16 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-16 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-16 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-08 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-08 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 8e-08 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 9e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-06 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.003 |
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 1e-38
Identities = 56/265 (21%), Positives = 95/265 (35%), Gaps = 40/265 (15%)
Query: 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF--------------CSHP- 545
D++ + IG G +G R G+I K+ HP
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 546 -------------RQSFIVYEYLESGSLDKILNNDASAKE-LGWTQRLNVIKGVADALFY 591
+IV EY E G L ++ ++ L L V+ + AL
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 592 LH--NNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPE 649
H ++ ++H D+ NV LD + DF +A+ LN D+S GT ++PE
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE 184
Query: 650 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709
M EK D++S G L E+ P + S + +I + +
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFT-----AFSQKELAGKIREGKFRRIPYRYS 239
Query: 710 NKFMSIMQVAFSCLDQNPVSRPTMK 734
++ I+ L+ RP+++
Sbjct: 240 DELNEIIT---RMLNLKDYHRPSVE 261
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-38
Identities = 54/270 (20%), Positives = 93/270 (34%), Gaps = 42/270 (15%)
Query: 495 EIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPDN-------------- 540
EI IG G G+VY + AVK + P
Sbjct: 4 EIPD--GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 541 FCSHP-----------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADAL 589
H Q IV ++ E SL L+ + + +++ + A +
Sbjct: 60 KTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGM 117
Query: 590 FYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNVA 647
YLH I+H D+ S N+ L + DF +A + S + + +L+G+ +A
Sbjct: 118 DYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 648 PELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYP 704
PE+ + + DVY+FG++ E++ G+ P + + L L
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234
Query: 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+ +M CL + RP
Sbjct: 235 RSNCPKAMKRLMA---ECLKKKRDERPLFP 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-37
Identities = 51/257 (19%), Positives = 93/257 (36%), Gaps = 34/257 (13%)
Query: 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFH--SPLPDNF---------CSHP---- 545
+G G G V++ AVK S PD F H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 546 -------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 598
+I+ EY+E+GSL L S +L + L++ +A+ + ++
Sbjct: 73 LYAVVTQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN-- 129
Query: 599 PIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK-LAGTHGNVAPELAYTMKVT 657
+H D+ + N+L+ ++DF +A+ + + + APE T
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 658 EKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717
K DV+SFG+L E++ + ++ + R+ P + + +M+
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLERGYRMVRPD-NCPEELYQLMR 244
Query: 718 VAFSCLDQNPVSRPTMK 734
C + P RPT
Sbjct: 245 ---LCWKERPEDRPTFD 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 9e-35
Identities = 61/297 (20%), Positives = 103/297 (34%), Gaps = 68/297 (22%)
Query: 499 ATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF-------------CSH 544
+DF+ +G G G V+ PSG + A K H + C+
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 545 P------------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYL 592
P + I E+++ GSLD++L A + V V L YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYL 120
Query: 593 HNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAY 652
I+H D+ N+L++ E + DF ++ L S + GT ++PE
Sbjct: 121 REKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQ 176
Query: 653 TMKVTEKCDVYSFGVLALEVIKGKHP---------------------------------R 679
+ + D++S G+ +E+ G++P
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 680 DFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAF--SCLDQNPVSRPTMK 734
+ M S E+LD + P + + S+ F CL +NP R +K
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-34
Identities = 54/258 (20%), Positives = 89/258 (34%), Gaps = 36/258 (13%)
Query: 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPDN-------------------- 540
++ IG G G V++ + + A+K
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 541 ---FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCF 597
C +V+E++E G L L L + V + + YL C
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYLEEAC- 121
Query: 598 PPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK-LAGTHGNVAPELAYTMKV 656
++H D++++N L+ VSDF + +F+ D S +PE+ +
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 657 TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIM 716
+ K DV+SFGVL EV +E S+S + RL P L +
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDISTGFRLYKPRLAST----HVY 232
Query: 717 QVAFSCLDQNPVSRPTMK 734
Q+ C + P RP
Sbjct: 233 QIMNHCWKERPEDRPAFS 250
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (329), Expect = 2e-34
Identities = 61/286 (21%), Positives = 110/286 (38%), Gaps = 57/286 (19%)
Query: 493 YEEIIRATNDFDAK---------HCIGKGGHGSVYIARVPS----GEIFAVKKFHSPLPD 539
+E+ A +F + IG G G V + A+K S +
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 540 N-------------------------FCSHPRQSFIVYEYLESGSLDKILNNDASAKELG 574
+ I+ E++E+GSLD L + +
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN--DGQFT 126
Query: 575 WTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634
Q + +++G+A + YL + VH D++++N+L++ VSDF +++FL D+S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 635 NWS-----KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSS 688
+ + APE K T DV+S+G++ EV+ G+ P + ++
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP----YWDMTN 239
Query: 689 SSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+N D RLP P +D + +M C ++ RP
Sbjct: 240 QDVINAIEQDYRLPPP-MDCPSALHQLML---DCWQKDRNHRPKFG 281
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-34
Identities = 61/262 (23%), Positives = 100/262 (38%), Gaps = 45/262 (17%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN------------------- 540
DF+ +GKG G+VY+AR S I A+K +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 541 --------FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYL 592
+ + +++ EY G++ + L + + I +A+AL Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYC 122
Query: 593 HNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAY 652
H+ ++H DI +N+LL E ++DF + SS + L GT + PE+
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTTLCGTLDYLPPEMIE 177
Query: 653 TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712
EK D++S GVL E + GK P FE ++ I +P V
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYK-RISRVEFTFPD-FVTEGA 231
Query: 713 MSIMQVAFSCLDQNPVSRPTMK 734
++ L NP RP ++
Sbjct: 232 RDLIS---RLLKHNPSQRPMLR 250
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-34
Identities = 56/263 (21%), Positives = 96/263 (36%), Gaps = 36/263 (13%)
Query: 495 EIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPL--PDNF---------CS 543
EI R + +G+G G V++ A+K P+ F
Sbjct: 13 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 70
Query: 544 HP-----------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYL 592
H +IV EY+ GSL L + + K L Q +++ +A + Y+
Sbjct: 71 HEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV 129
Query: 593 HNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK-LAGTHGNVAPELA 651
VH D+ + N+L+ V+DF +A+ + + + APE A
Sbjct: 130 ERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 652 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711
+ T K DV+SFG+L E+ + + ++ R+P P +
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVLDQVERGYRMPCPP-ECPES 242
Query: 712 FMSIMQVAFSCLDQNPVSRPTMK 734
+M C + P RPT +
Sbjct: 243 LHDLMC---QCWRKEPEERPTFE 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 5e-34
Identities = 56/259 (21%), Positives = 97/259 (37%), Gaps = 38/259 (14%)
Query: 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPDN-------------------- 540
D +G G G V + A+K
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 541 ---FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCF 597
C+ R FI+ EY+ +G L L Q L + K V +A+ YL +
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ- 120
Query: 598 PPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL-NLDSSNWSKLAGTHGNVAPELAYTMKV 656
+H D++++N L++ VSDF +++++ + + ++ PE+ K
Sbjct: 121 --FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 657 TEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSI 715
+ K D+++FGVL E+ GK P +E ++S RL P L + +
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMP----YERFTNSETAEHIAQGLRLYRPHLASE----KV 230
Query: 716 MQVAFSCLDQNPVSRPTMK 734
+ +SC + RPT K
Sbjct: 231 YTIMYSCWHEKADERPTFK 249
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 7e-34
Identities = 58/257 (22%), Positives = 85/257 (33%), Gaps = 38/257 (14%)
Query: 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSP-----------------------L 537
+ IGKG G V + G AVK + L
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 538 PDNFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCF 597
+IV EY+ GSL L + LG L V +A+ YL N
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN-- 122
Query: 598 PPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVT 657
VH D++++NVL+ A VSDF + K SS APE K +
Sbjct: 123 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFS 178
Query: 658 EKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717
K DV+SFG+L E+ + + ++ P +M+
Sbjct: 179 TKSDVWSFGILLWEIYSFGRV---PYPRIPLKDVVPRVEKGYKMDAPD-GCPPAVYEVMK 234
Query: 718 VAFSCLDQNPVSRPTMK 734
+C + RP+
Sbjct: 235 ---NCWHLDAAMRPSFL 248
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 3e-33
Identities = 62/275 (22%), Positives = 104/275 (37%), Gaps = 44/275 (16%)
Query: 493 YEEIIRATN---DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF------- 541
YE + R N ++ +G G G VY A+ + + A K + +
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 542 -----CSHP------------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKG 584
C HP +I+ E+ G++D ++ + L +Q V K
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQ 118
Query: 585 VADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHG 644
DAL YLH+N I+H D+ + N+L L + ++DF ++ GT
Sbjct: 119 TLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPY 175
Query: 645 NVAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS 699
+APE+ K DV+S G+ +E+ + + P L M E
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP-- 233
Query: 700 RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
L PS + F ++ CL++N +R T
Sbjct: 234 TLAQPS-RWSSNFKDFLK---KCLEKNVDARWTTS 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 4e-33
Identities = 59/251 (23%), Positives = 102/251 (40%), Gaps = 38/251 (15%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN------------------------FCS 543
IG+G G+VY A V +G+ A+++ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 544 HPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHW 603
+ ++V EYL GSL ++ + Q V + AL +LH+N ++H
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHR 140
Query: 604 DISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVY 663
DI S N+LL + ++DF + + S S + GT +APE+ K D++
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 664 SFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCL 723
S G++A+E+I+G+ P +L E + + L P + F + CL
Sbjct: 201 SLGIMAIEMIEGEPP--YLNENPLRALYLIATNGTPELQNPE-KLSAIFRDFLN---RCL 254
Query: 724 DQNPVSRPTMK 734
D + R + K
Sbjct: 255 DMDVEKRGSAK 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (318), Expect = 5e-33
Identities = 53/259 (20%), Positives = 95/259 (36%), Gaps = 36/259 (13%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD-------------------- 539
D KH +G G +G VY AVK +
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 540 ---NFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNC 596
C+ +I+ E++ G+L L + + +E+ L + ++ A+ YL
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLEKK- 134
Query: 597 FPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN-WSKLAGTHGNVAPELAYTMK 655
+H D++++N L+ + V+DF +++ + D+ + APE K
Sbjct: 135 --NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 656 VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSI 715
+ K DV++FGVL E+ + S + D R+ P K +
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMS---PYPGIDLSQVYELLEKDYRMERPE-GCPEKVYEL 248
Query: 716 MQVAFSCLDQNPVSRPTMK 734
M+ +C NP RP+
Sbjct: 249 MR---ACWQWNPSDRPSFA 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (318), Expect = 9e-33
Identities = 64/280 (22%), Positives = 109/280 (38%), Gaps = 50/280 (17%)
Query: 486 PLLGKIVYEEIIRATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN---- 540
P + ++ +++ F IG G G+VY AR V + E+ A+KK +
Sbjct: 2 PDVAELFFKDDPE--KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 541 -----------------------FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQ 577
+++V EY + D + + K L +
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVE 116
Query: 578 RLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS 637
V G L YLH++ ++H D+ + N+LL + DF A + +S
Sbjct: 117 IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS--- 170
Query: 638 KLAGTHGNVAPELAYTM---KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI 694
GT +APE+ M + K DV+S G+ +E+ + K P LF M++ S+ +I
Sbjct: 171 -FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHI 226
Query: 695 EILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+ S F + + SCL + P RPT +
Sbjct: 227 -AQNESPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSE 262
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (313), Expect = 3e-32
Identities = 46/288 (15%), Positives = 97/288 (33%), Gaps = 64/288 (22%)
Query: 501 NDFDAKHCIGKGGHGSVYIARVP------SGEIFAVKKFHSPLPDNF------------- 541
N+ + IG+G G V+ AR P + AVK +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 542 CSHPR------------QSFIVYEYLESGSLDKILNN---------------------DA 568
+P +++EY+ G L++ L +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 569 SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628
L ++L + + VA + YL VH D++++N L+ ++DF +++
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 629 LNLDSSNWS--KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS 686
+ + A + PE + + T + DV+++GV+ E+
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ----PYYG 245
Query: 687 SSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+ + + D + + + ++M+ C + P RP+
Sbjct: 246 MAHEEVIYYVRDGNILACPENCPLELYNLMR---LCWSKLPADRPSFC 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 4e-32
Identities = 55/287 (19%), Positives = 95/287 (33%), Gaps = 66/287 (22%)
Query: 506 KHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPDNF-----------CSHP--------- 545
+ IGKG G V+ + GE AVK F S ++ H
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 546 -------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCF- 597
Q ++V +Y E GSL LN + + + A L +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 598 ----PPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS----KLAGTHGNVAPE 649
P I H D+ SKN+L+ ++D +A + + GT +APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 650 LAYTM------KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI--------- 694
+ + ++ D+Y+ G++ E+ + + ++
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 695 -----EILDSRLP--YPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+ L +P + S + IM+ C N +R T
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTAL 286
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 8e-32
Identities = 47/258 (18%), Positives = 87/258 (33%), Gaps = 45/258 (17%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------NFCSHP-------- 545
IG+G +VY + A + HP
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 546 --------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCF 597
+ +V E + SG+L L K + + + + L +LH
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT- 132
Query: 598 PPIVHWDISSKNVLL-DLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKV 656
PPI+H D+ N+ + + D +A + + GT +APE+ Y K
Sbjct: 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPEM-YEEKY 189
Query: 657 TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIM 716
E DVY+FG+ LE+ ++P + + + + ++ +
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP------EVK 243
Query: 717 QVAFSCLDQNPVSRPTMK 734
++ C+ QN R ++K
Sbjct: 244 EIIEGCIRQNKDERYSIK 261
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 5e-31
Identities = 59/277 (21%), Positives = 102/277 (36%), Gaps = 49/277 (17%)
Query: 509 IGKGGHGSVYIARVP---SGEIFAVKKFHSPLPDNF--------------CSHP------ 545
+G G G+V + AVK + D +P
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 546 -----RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 600
+V E E G L+K L + + + + ++ V+ + YL +
Sbjct: 75 GICEAESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---F 128
Query: 601 VHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK---LAGTHGNVAPELAYTMKVT 657
VH D++++NVLL + A +SDF ++K L D + + APE K +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 658 EKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIM 716
K DV+SFGVL E G+ P + S + R+ P+ + +M
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKP----YRGMKGSEVTAMLEKGERMGCPA-GCPREMYDLM 243
Query: 717 QVAFSCLDQNPVSRPTMKRFEVQSKQFHY---NPDHN 750
C + +RP E++ + ++Y N H+
Sbjct: 244 N---LCWTYDVENRPGFAAVELRLRNYYYDVVNEGHH 277
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 5e-31
Identities = 52/257 (20%), Positives = 86/257 (33%), Gaps = 44/257 (17%)
Query: 509 IGKGGHGSVYIARV---PSGEIFAVKKFHSPLPDNF-------------CSHP------- 545
+G G GSV A+K +P
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 546 ----RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIV 601
+V E G L K L +E+ + ++ V+ + YL V
Sbjct: 77 VCQAEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFV 131
Query: 602 HWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK---LAGTHGNVAPELAYTMKVTE 658
H D++++NVLL + A +SDF ++K L D S ++ APE K +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 659 KCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717
+ DV+S+GV E + G+ P ++ M R+ P + + ++M
Sbjct: 192 RSDVWSYGVTMWEALSYGQKP----YKKMKGPEVMAFIEQGKRMECPP-ECPPELYALMS 246
Query: 718 VAFSCLDQNPVSRPTMK 734
C RP
Sbjct: 247 ---DCWIYKWEDRPDFL 260
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 7e-31
Identities = 55/263 (20%), Positives = 94/263 (35%), Gaps = 41/263 (15%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN------------------- 540
D+D +G+G +G V +A + E AVK +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 541 ------FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN 594
++ EY G L + D + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 595 NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAY 652
I H DI +N+LLD +SDF +A ++ +K+ GT VAPEL
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 653 TMKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711
+ E DV+S G++ ++ G+ P D + S S + P + +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEKKTYLNPWKKIDSA 235
Query: 712 FMSIMQVAFSCLDQNPVSRPTMK 734
++++ L +NP +R T+
Sbjct: 236 PLALLH---KILVENPSARITIP 255
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 121 bits (304), Expect = 1e-30
Identities = 48/278 (17%), Positives = 102/278 (36%), Gaps = 43/278 (15%)
Query: 485 FPLLGKIVYEEIIRATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN--- 540
+P +I ++ ++ + +D +G G G V+ +G FA K +P +
Sbjct: 13 YPQPVEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET 69
Query: 541 ---------------------FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRL 579
+ ++YE++ G L + + + ++ + +
Sbjct: 70 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAV 127
Query: 580 NVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNWS 637
++ V L ++H N VH D+ +N++ + DF + L+ S
Sbjct: 128 EYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 184
Query: 638 KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEIL 697
GT APE+A V D++S GVL+ ++ G P + + N++
Sbjct: 185 T-TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP---FGGENDDETLRNVKSC 240
Query: 698 DSRLPYPSL-DVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
D + + + ++ L +P +R T+
Sbjct: 241 DWNMDDSAFSGISEDGKDFIR---KLLLADPNTRMTIH 275
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 3e-30
Identities = 46/267 (17%), Positives = 91/267 (34%), Gaps = 45/267 (16%)
Query: 498 RATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN---------------- 540
+ DF +G+G +V +AR + + +A+K
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 541 -----------FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADAL 589
+ + Y ++G L K + T + AL
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSAL 121
Query: 590 FYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW--SKLAGTHGNVA 647
YLH I+H D+ +N+LL+ ++DF AK L+ +S + GT V+
Sbjct: 122 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 648 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLD 707
PEL + D+++ G + +++ G P + + + +I+ +P
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKIIKLEYDFPE-K 232
Query: 708 VQNKFMSIMQVAFSCLDQNPVSRPTMK 734
K +++ L + R +
Sbjct: 233 FFPKARDLVE---KLLVLDATKRLGCE 256
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 7e-30
Identities = 52/289 (17%), Positives = 93/289 (32%), Gaps = 65/289 (22%)
Query: 501 NDFDAKHCIGKGGHGSVYIA------RVPSGEIFAVKKFHSPLPDN-------------- 540
+ + +G G G V A + AVK +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 541 ------------FCSHPRQSFIVYEYLESGSLDKILNN--------------------DA 568
C+ ++++EY G L L + +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 569 SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628
L + L VA + +L VH D++++NVL+ G + DF +A+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 629 LNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEM 685
+ DS+ +APE + T K DV+S+G+L E+ G +P +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP---GI 270
Query: 686 SSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
++ + ++ P + IMQ SC + RP+
Sbjct: 271 PVDANFYKLIQNGFKMDQPF-YATEEIYIIMQ---SCWAFDSRKRPSFP 315
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 8e-30
Identities = 52/263 (19%), Positives = 90/263 (34%), Gaps = 44/263 (16%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN------------------- 540
DF +GKG G V++A + + FA+K +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 541 ---------FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFY 591
F V EYL G L + + + ++ + L +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQF 118
Query: 592 LHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELA 651
LH+ IV+ D+ N+LLD ++DF + K L + + GT +APE+
Sbjct: 119 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175
Query: 652 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711
K D +SFGVL E++ G+ P + I YP ++ +
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFH-----GQDEEELFHSIRMDNPFYPR-WLEKE 229
Query: 712 FMSIMQVAFSCLDQNPVSRPTMK 734
++ + P R ++
Sbjct: 230 AKDLLV---KLFVREPEKRLGVR 249
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 1e-29
Identities = 50/276 (18%), Positives = 94/276 (34%), Gaps = 53/276 (19%)
Query: 501 NDFDAKHCIGKGGHGSVYIARVPSG---EIFAVKKFHSPLPDN----------------- 540
ND + IG+G G V AR+ A+K+ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 541 ---------FCSHPRQSFIVYEYLESGSLDKILNN-------------DASAKELGWTQR 578
C H ++ EY G+L L +++A L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 579 LNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK 638
L+ VA + YL +H D++++N+L+ Y A ++DF +++ +
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM- 185
Query: 639 LAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD 698
+A E T DV+S+GVL E++ + + + ++
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----PYCGMTCAELYEKLPQ 241
Query: 699 SRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
L+ ++ +M+ C + P RP+
Sbjct: 242 GYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFA 274
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 116 bits (291), Expect = 2e-29
Identities = 46/274 (16%), Positives = 93/274 (33%), Gaps = 53/274 (19%)
Query: 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF------------------- 541
+++ K +G+G V P+ + +AVK +F
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 542 ---------------CSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVA 586
F+V++ ++ G L L L + +++ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALL 120
Query: 587 DALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV 646
+ + LH IVH D+ +N+LLD ++DF + L+ ++ GT +
Sbjct: 121 EVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREVCGTPSYL 176
Query: 647 APELAYTM------KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR 700
APE+ ++ D++S GV+ ++ G P M I+
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-----HRKQMLMLRMIMSGN 231
Query: 701 LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+ S + + ++ + L P R T +
Sbjct: 232 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 117 bits (293), Expect = 5e-29
Identities = 45/261 (17%), Positives = 87/261 (33%), Gaps = 38/261 (14%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN------------------- 540
+ +D +G G G V+ +G +F K ++P P +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 541 -----FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNN 595
+ ++ E+L G L + ++ + +N ++ + L ++H +
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 596 CFPPIVHWDISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYT 653
IVH DI +N++ + + V DF +A LN D T APE+
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-TATAEFAAPEIVDR 202
Query: 654 MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713
V D+++ GVL ++ G P + + +
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSPFA-----GEDDLETLQNVKRCDWEFDEDAFSSVSP 257
Query: 714 SIMQVAFSCLDQNPVSRPTMK 734
+ L + P R T+
Sbjct: 258 EAKDFIKNLLQKEPRKRLTVH 278
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 8e-29
Identities = 49/260 (18%), Positives = 84/260 (32%), Gaps = 46/260 (17%)
Query: 509 IGKGGHGSVYIARVP----SGEIFAVKKFHSPLPDNF-------------CSHP------ 545
IG+G G VY + AVK + SHP
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 546 -------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 598
+V Y++ G L + N+ + + +
Sbjct: 95 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLASK 149
Query: 599 PIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS----SNWSKLAGTHGNVAPELAYTM 654
VH D++++N +LD + V+DF +A+ + N + +A E T
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209
Query: 655 KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMS 714
K T K DV+SFGVL E++ P ++ ++ + +L R +
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 265
Query: 715 IMQVAFSCLDQNPVSRPTMK 734
+M C RP+
Sbjct: 266 VML---KCWHPKAEMRPSFS 282
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 9e-29
Identities = 44/252 (17%), Positives = 92/252 (36%), Gaps = 37/252 (14%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN-----------------------FCSH 544
+G+G G V+ S + + K D
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 545 PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWD 604
+ +++E++ + + +N SA EL + ++ + V +AL +LH++ I H+D
Sbjct: 73 MEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFD 127
Query: 605 ISSKNVLLDLGYEAHV--SDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDV 662
I +N++ + + +F A+ L + L APE+ V+ D+
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYAPEVHQHDVVSTATDM 186
Query: 663 YSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSC 722
+S G L ++ G +P F ++ + I+++ + + + M
Sbjct: 187 WSLGTLVYVLLSGINP----FLAETNQQIIE-NIMNAEYTFDEEAFKEISIEAMDFVDRL 241
Query: 723 LDQNPVSRPTMK 734
L + SR T
Sbjct: 242 LVKERKSRMTAS 253
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-28
Identities = 60/270 (22%), Positives = 92/270 (34%), Gaps = 45/270 (16%)
Query: 495 EIIRATNDFDAKHCIGKGGHGSVYIARVPS----GEIFAVKKFHSPLPDNF--------- 541
EI R + CIG+G G V+ S A+K + D+
Sbjct: 3 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 542 ----CSHP-----------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVA 586
HP +I+ E G L L L + ++
Sbjct: 61 TMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLS 118
Query: 587 DALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS-NWSKLAGTHGN 645
AL YL + VH DI+++NVL+ + DF +++++ + SK
Sbjct: 119 TALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 175
Query: 646 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDSRLPYP 704
+APE + T DV+ FGV E++ G P + N E RLP P
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----RLPMP 231
Query: 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+ S+M C +P RP
Sbjct: 232 P-NCPPTLYSLMT---KCWAYDPSRRPRFT 257
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 1e-28
Identities = 61/267 (22%), Positives = 100/267 (37%), Gaps = 45/267 (16%)
Query: 501 NDFDAKHCIGKGGHGSVYIARVPSGE-----IFAVKKFHSPLPDN--------------- 540
+ + IG G G VY + + A+K + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 541 ----------FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALF 590
S + I+ EY+E+G+LDK L E Q + +++G+A +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMK 124
Query: 591 YLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV---A 647
YL N VH D++++N+L++ VSDF +++ L D +G + A
Sbjct: 125 YLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 648 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLD 707
PE K T DV+SFG++ EV+ + S+ M RLP P
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERP---YWELSNHEVMKAINDGFRLPTPM-- 236
Query: 708 VQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+ +I Q+ C Q RP
Sbjct: 237 --DCPSAIYQLMMQCWQQERARRPKFA 261
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 3e-28
Identities = 54/271 (19%), Positives = 94/271 (34%), Gaps = 44/271 (16%)
Query: 495 EIIRATNDFDAKHCIGKGGHGSVYIAR-VPSGE----IFAVKKFHSPLPDNF-------- 541
I++ T +F +G G G+VY +P GE A+K+
Sbjct: 4 RILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 542 -----CSHP-----------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGV 585
+P ++ + + G L +G LN +
Sbjct: 63 YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQI 120
Query: 586 ADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW--SKLAGTH 643
A + YL + +VH D++++NVL+ ++DF +AK L + +
Sbjct: 121 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 644 GNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPY 703
+A E T + DV+S+GV E++ ++ +S +I RLP
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---PYDGIPASEISSILEKGERLPQ 234
Query: 704 PSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
P IM C + SRP +
Sbjct: 235 PP-ICTIDVYMIMV---KCWMIDADSRPKFR 261
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 4e-28
Identities = 51/283 (18%), Positives = 93/283 (32%), Gaps = 59/283 (20%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR--------VPSGEIFAVKKFHSPLPDN------------ 540
+ +G+G G V +A AVK S +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 541 --------------FCSHPRQSFIVYEYLESGSLDKIL-------------NNDASAKEL 573
C+ +++ EY G+L + L + ++L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 574 GWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633
++ VA + YL + +H D++++NVL+ ++DF +A+ ++
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 634 SNWS--KLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN 691
+APE + T + DV+SFGVL E+ +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---PYPGVPVEEL 246
Query: 692 MNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+ R+ PS + N+ +M+ C P RPT K
Sbjct: 247 FKLLKEGHRMDKPS-NCTNELYMMMR---DCWHAVPSQRPTFK 285
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 112 bits (282), Expect = 5e-28
Identities = 47/261 (18%), Positives = 91/261 (34%), Gaps = 35/261 (13%)
Query: 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF-------------CSHP 545
+ +D + +G G V +A + ++ A+K + HP
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 546 ------------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLH 593
+++ + + G L + +I V DA+ YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLH 124
Query: 594 NNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYT 653
+ + LD + +SDF ++K + S S GT G VAPE+
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED-PGSVLSTACGTPGYVAPEVLAQ 183
Query: 654 MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713
++ D +S GV+A ++ G P + + + +IL + + S +
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFY-----DENDAKLFEQILKAEYEFDSPYWDDISD 238
Query: 714 SIMQVAFSCLDQNPVSRPTMK 734
S ++++P R T +
Sbjct: 239 SAKDFIRHLMEKDPEKRFTCE 259
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 111 bits (279), Expect = 6e-28
Identities = 58/268 (21%), Positives = 104/268 (38%), Gaps = 46/268 (17%)
Query: 500 TNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF---------------CS 543
++ ++ +G GG V++AR + AVK + L + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 544 HP----------------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVAD 587
HP +IV EY++ +L I++ + + + + VI
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQ 122
Query: 588 ALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK---LAGTHG 644
AL + H N I+H D+ N+++ V DF IA+ + ++ ++ + GT
Sbjct: 123 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 645 NVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYP 704
++PE A V + DVYS G + EV+ G+ P F S S + + P
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAY-QHVREDPIPP 234
Query: 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPT 732
S + + V L +NP +R
Sbjct: 235 SARHEGLSADLDAVVLKALAKNPENRYQ 262
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 6e-28
Identities = 54/283 (19%), Positives = 90/283 (31%), Gaps = 58/283 (20%)
Query: 501 NDFDAKHCIGKGGHGSVYIARV------PSGEIFAVKKFHSPLPDN-------------- 540
N +G G G V A + AVK
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 541 ------------FCSHPRQSFIVYEYLESGSLDKILNN---------------DASAKEL 573
C+ + ++ EY G L L + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 574 GWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633
L+ VA + +L + +H D++++N+LL G + DF +A+ + DS
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 634 SNWSK--LAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSN 691
+ K +APE + T + DV+S+G+ E+ M S
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--PGMPVDSKF 257
Query: 692 MNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+ R+ P + IM+ +C D +P+ RPT K
Sbjct: 258 YKMIKEGFRMLSPE-HAPAEMYDIMK---TCWDADPLKRPTFK 296
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 7e-28
Identities = 51/268 (19%), Positives = 79/268 (29%), Gaps = 46/268 (17%)
Query: 501 NDFDAKHCIGKGGHGSVYIARVPS----GEIFAVKKFHSPLPDN---------------F 541
D +G G G V + AVK +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 542 CSHP-----------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALF 590
H +V E GSL L VA+ +
Sbjct: 68 LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMG 125
Query: 591 YLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW---SKLAGTHGNVA 647
YL + +H D++++N+LL + DF + + L + ++ A
Sbjct: 126 YLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 648 PELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL 706
PE T + D + FGV E+ G+ P ++ S I+ RLP P
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKEGERLPRPE- 238
Query: 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
D ++M C P RPT
Sbjct: 239 DCPQDIYNVMV---QCWAHKPEDRPTFV 263
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (272), Expect = 7e-27
Identities = 43/274 (15%), Positives = 81/274 (29%), Gaps = 45/274 (16%)
Query: 497 IRATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHS-------------------- 535
+R N + IG G G +Y+ + +GE A+K
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGG 62
Query: 536 ---PLPDNFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYL 592
P + + +V E L D ++ L + + + Y+
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYI 119
Query: 593 HNNCFPPIVHWDISSKNVL---LDLGYEAHVSDFRIAKFLNLDSSN-------WSKLAGT 642
H+ +H D+ N L G ++ DF +AK ++ L GT
Sbjct: 120 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 643 HGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLP 702
+ ++ + + D+ S G + + G P L + I P
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 703 YPSL--DVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
L ++F + + C +P
Sbjct: 237 IEVLCKGYPSEFATYLN---FCRSLRFDDKPDYS 267
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 1e-26
Identities = 53/257 (20%), Positives = 95/257 (36%), Gaps = 34/257 (13%)
Query: 506 KHCIGKGGHGSVYIAR-VPSGEIFAVKKF-----------------HSP-------LPDN 540
+G G +G V + E FA+K P + +N
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYEN 76
Query: 541 FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 600
+ + IV E L+ G L + D + + ++K + +A+ YLH+ I
Sbjct: 77 LYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSIN---I 132
Query: 601 VHWDISSKNVLLDLGYE---AHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVT 657
H D+ +N+L ++DF AK +S + T VAPE+ K
Sbjct: 133 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAPEVLGPEKYD 191
Query: 658 EKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQ 717
+ CD++S GV+ ++ G P + + S M I + +P+ + +
Sbjct: 192 KSCDMWSLGVIMYILLCGYPPFYSNHGL-AISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 250
Query: 718 VAFSCLDQNPVSRPTMK 734
+ + L P R T+
Sbjct: 251 LIRNLLKTEPTQRMTIT 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 109 bits (274), Expect = 1e-26
Identities = 51/265 (19%), Positives = 91/265 (34%), Gaps = 46/265 (17%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN------------------- 540
NDF IG+GG G VY R +G+++A+K
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 541 -----------FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADAL 589
P + + + + G L L+ E + L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE---ADMRFYAAEIILGL 120
Query: 590 FYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPE 649
++HN +V+ D+ N+LLD +SD +A + + S GTHG +APE
Sbjct: 121 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPE 175
Query: 650 -LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708
L + D +S G + ++++G P F + ++ L + P
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEIDRMTLTMAVELPD-SF 232
Query: 709 QNKFMSIMQVAFSCLDQNPVSRPTM 733
+ S+++ L ++ R
Sbjct: 233 SPELRSLLE---GLLQRDVNRRLGC 254
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 2e-26
Identities = 45/280 (16%), Positives = 90/280 (32%), Gaps = 52/280 (18%)
Query: 495 EIIRATNDFDAKHCIGKGGHGSVYIA------RVPSGEIFAVKKFHSPLPDN-------- 540
E+ R +G+G G VY + A+K +
Sbjct: 16 EVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 541 -----------------FCSHPRQSFIVYEYLESGSLDKILN-------NDASAKELGWT 576
S + + ++ E + G L L N+ +
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 577 QRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS-- 634
+ + + +AD + YL+ N VH D++++N ++ + + DF + + +
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 635 NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI 694
K ++PE T DV+SFGV+ E+ S+ +
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ----PYQGLSNEQVLR 246
Query: 695 EILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+++ L + + +M+ C NP RP+
Sbjct: 247 FVMEGGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFL 283
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 107 bits (268), Expect = 3e-26
Identities = 67/318 (21%), Positives = 110/318 (34%), Gaps = 30/318 (9%)
Query: 73 CTWSGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNL 132
C + C+ G L + + P A LDL NN++ +I NL
Sbjct: 10 CHLRVVQCSDLG------LEKVPKD---------LPPDTALLDLQNNKITEIKDGDFKNL 54
Query: 133 SKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNF 192
L L + NK+S P + L L L++S+NQL L L +
Sbjct: 55 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITK 114
Query: 193 LGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWG 252
+ S+ L+ + L SG +K L +++ + +I G
Sbjct: 115 VRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-----TIPQG 168
Query: 253 RCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSG 312
P L+ L + N IT + L L LS N I L N +L + L+
Sbjct: 169 LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN 228
Query: 313 NKLSGRIPGELGSLINLEYLDLSANHLSNF------VLESLGSLVKLYYLNLSHNKLSQQ 366
NKL ++PG L ++ + L N++S ++L N +
Sbjct: 229 NKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287
Query: 367 --IPIELDNLIHLSELDL 382
P + + + L
Sbjct: 288 EIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.5 bits (223), Expect = 2e-20
Identities = 54/305 (17%), Positives = 106/305 (34%), Gaps = 39/305 (12%)
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207
+P ++ +L + N++ + L L+ LIL +N + P + + L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 208 VFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNI 267
LYL N + L+ L + I ++ ++ + + L +
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV---FNGLNQMIVVELGTNPLKS 138
Query: 268 TGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLI 327
+G +L Y+ ++ I ++ L+ L GNK++ L L
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELH---LDGNKITKVDAASLKGLN 195
Query: 328 NLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFL 387
NL L LS N +S SL + L L+L++NKL +
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPG------------------- 236
Query: 388 GEKISSRICRMESLEKLNLSYNNLSGLIPRCF------EELHGLLHIDISYNKLEGHIPN 441
+ + ++ + L NN+S + F + + + N ++
Sbjct: 237 ------GLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 290
Query: 442 STTFR 446
+TFR
Sbjct: 291 PSTFR 295
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 75.5 bits (184), Expect = 2e-15
Identities = 43/219 (19%), Positives = 76/219 (34%), Gaps = 4/219 (1%)
Query: 255 PQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNK 314
P +LLD+ N IT + L L L +N I P ++ L R+ LS N+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 315 LSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNL 374
L +L L + + V L ++ + L + K S +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGM 149
Query: 375 IHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNK 434
LS + ++ + I + SL +L+L N ++ + + L+ L + +S+N
Sbjct: 150 KKLSYIRIADTNI-TTIPQGLPP--SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 435 LEGHIPNSTTFRDAPLEALQGNKGLCGDIRGFLSCMSYR 473
+ S E N L G +
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQ 245
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 70.5 bits (171), Expect = 9e-14
Identities = 38/202 (18%), Positives = 72/202 (35%), Gaps = 6/202 (2%)
Query: 271 IPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLE 330
+P ++ P LDL +N I N+ L+ + L NK+S PG L+ LE
Sbjct: 25 VPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 331 YLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEK 390
L LS N L + +L +L K+ + + L+ +I + G
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG-I 141
Query: 391 ISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPNSTTFRDAPL 450
+ M+ L + ++ N++ + L + + NK+ S +
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT---ELHLDGNKITKVDAASLKGLNNLA 198
Query: 451 EALQGNKGLCGDIRGFLSCMSY 472
+ + G L+ +
Sbjct: 199 KLGLSFNSISAVDNGSLANTPH 220
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 28/139 (20%), Positives = 51/139 (36%), Gaps = 4/139 (2%)
Query: 304 YLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKL 363
+L + S L ++P +L + LDL N ++ +L L+ L L +NK+
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 364 SQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELH 423
S+ P L+ L L LS N L E ++ L + +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL-NQM 126
Query: 424 GLLHIDISYNKLEGHIPNS 442
++ + + K G +
Sbjct: 127 IVVELGTNPLKSSGIENGA 145
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 103 bits (258), Expect = 5e-25
Identities = 39/283 (13%), Positives = 81/283 (28%), Gaps = 51/283 (18%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKF-----------------------HSPLPDNFCSH 544
IG+G G ++ + + + A+K P F
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 72
Query: 545 PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWD 604
+ +V + L D + ++ K + + +H +V+ D
Sbjct: 73 GLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRD 126
Query: 605 ISSKNVLLDLGYEAH-----VSDFRIAKFLNLDSSN-------WSKLAGTHGNVAPELAY 652
I N L+ + V DF + KF + L+GT ++
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 653 TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSL--DVQN 710
+ + + D+ + G + + ++G P L ++ I P L
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPE 246
Query: 711 KFMSIMQVAFSCLDQNPVSRPTM----KRFEVQSKQFHYNPDH 749
+F M + + P F ++ + D
Sbjct: 247 EFYKYMH---YARNLAFDATPDYDYLQGLFSKVLERLNTTEDE 286
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 2e-24
Identities = 51/288 (17%), Positives = 84/288 (29%), Gaps = 59/288 (20%)
Query: 495 EIIRATNDFDAKHCIGKGGHGSVYIAR------VPSGEIFAVKKF--------------- 533
E R + +G+G G V A + AVK
Sbjct: 9 EFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 66
Query: 534 --------HSP----LPDNFCSHPRQSFIVYEYLESGSLDKILNN-------------DA 568
H L ++ E+ + G+L L + D
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 569 SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628
L + VA + +L + +H D++++N+LL + DF +A+
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD 183
Query: 629 LNLDSSNWSK--LAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS 686
+ D K +APE + T + DV+SFGVL E+ +
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS--PYPGVK 241
Query: 687 SSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
+R+ P + Q C P RPT
Sbjct: 242 IDEEFCRRLKEGTRMRAPDYTTP----EMYQTMLDCWHGEPSQRPTFS 285
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (254), Expect = 3e-24
Identities = 54/263 (20%), Positives = 96/263 (36%), Gaps = 46/263 (17%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN------------------- 540
DF +G G G V++ R +G +A+K +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 541 --------FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYL 592
+Q F++ +Y+E G L +L V AL YL
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN---PVAKFYAAEVCLALEYL 120
Query: 593 HNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAY 652
H+ I++ D+ +N+LLD ++DF AK++ L GT +APE+
Sbjct: 121 HS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAPEVVS 174
Query: 653 TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712
T + D +SFG+L E++ G P S++ +IL++ L +P
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFY-----DSNTMKTYEKILNAELRFPP-FFNEDV 228
Query: 713 MSIMQVAFSCLDQNPVSRPTMKR 735
++ + ++ R +
Sbjct: 229 KDLLS---RLITRDLSQRLGNLQ 248
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 8e-24
Identities = 52/281 (18%), Positives = 86/281 (30%), Gaps = 51/281 (18%)
Query: 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHS---------------------PLPD 539
+ IG G G VY A+ SGE+ A+KK L
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 540 NFCSHPRQS-----FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN 594
F S + +V +Y+ + + + L + + +L Y+H+
Sbjct: 81 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 595 NCFPPIVHWDISSKNVLLDL-GYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYT 653
I H DI +N+LLD + DF AK L N S + + +
Sbjct: 141 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 654 MKVTEKCDVYSFGVLALEVIKGKHP------------------RDFLFEMSSSSSNMNIE 695
T DV+S G + E++ G+ ++ + N
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 257
Query: 696 ILDSRLPYPSLDVQNKFMSIMQVAF--SCLDQNPVSRPTMK 734
+P V +A L+ P +R T
Sbjct: 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.4 bits (247), Expect = 9e-24
Identities = 51/269 (18%), Positives = 89/269 (33%), Gaps = 57/269 (21%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN------------------- 540
+ + +G GG GSVY V A+K +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 541 -------------FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVAD 587
+ P ++ E E + L + V +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLE 121
Query: 588 ALFYLHNNCFPPIVHWDISSKNVLLDL-GYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNV 646
A+ + HN ++H DI +N+L+DL E + DF L + ++ GT
Sbjct: 122 AVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYS 176
Query: 647 APE-LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPS 705
PE + Y V+S G+L +++ G P FE EI+ ++ +
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDE-------EIIRGQVFFRQ 225
Query: 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
V ++ +++ CL P RPT +
Sbjct: 226 -RVSSECQHLIR---WCLALRPSDRPTFE 250
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 98.3 bits (243), Expect = 5e-23
Identities = 80/335 (23%), Positives = 135/335 (40%), Gaps = 33/335 (9%)
Query: 37 EEAHALVKWKASLEVHSRSLLHSWSLSFVNATKISLCTWSGIHCNHAGRVFGINLTSISL 96
++ AL++ K L + + L SW T TW G+ C+ + + ++ L
Sbjct: 6 QDKQALLQIKKDL--GNPTTLSSWL----PTTDCCNRTWLGVLCDTDTQT--YRVNNLDL 57
Query: 97 NGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTN-KLSGHIPSEISL 155
+G L + IP ++NL L +L L G IP I+
Sbjct: 58 SGLNLPKPYP------------------IPSSLANLPYLNFLYIGGINNLVGPIPPAIAK 99
Query: 156 LTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNN 215
LT L L+I+ ++G+IP + Q+ L L N L G++P S+S+ NLV + N
Sbjct: 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159
Query: 216 SFSGSIPQQIGNLKSLFDMKLCI-NQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFE 274
SG+IP G+ LF N+L G IP + + N+
Sbjct: 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVD----LSRNMLEGDASV 215
Query: 275 IGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDL 334
+ S + + + ++G LN + L N++ G +P L L L L++
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275
Query: 335 SANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPI 369
S N+L + G+L + ++NK P+
Sbjct: 276 SFNNLCG-EIPQGGNLQRFDVSAYANNKCLCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 84.0 bits (206), Expect = 3e-18
Identities = 59/262 (22%), Positives = 107/262 (40%), Gaps = 4/262 (1%)
Query: 202 SNFTNLVFLYLYNNSFSG--SIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSL 259
+ + L L + IP + NL L + + N P+ + QL
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGIN-NLVGPIPPAIAKLTQLHY 105
Query: 260 LDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRI 319
L ++ N++G IP + + L LD S N + G +P + ++ L I+ GN++SG I
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 320 PGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSE 379
P GS L + + + + + L +++LS N + L ++
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM-LEGDASVLFGSDKNTQ 224
Query: 380 LDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHI 439
++ ++L L+L N + G +P+ +L L +++S+N L G I
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 440 PNSTTFRDAPLEALQGNKGLCG 461
P + + A NK LCG
Sbjct: 285 PQGGNLQRFDVSAYANNKCLCG 306
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 50.9 bits (120), Expect = 2e-07
Identities = 20/65 (30%), Positives = 30/65 (46%), Gaps = 1/65 (1%)
Query: 184 NHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNG 243
N L L +N + G++P+ L+ L L + N+ G IP Q GNL+ N+
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLC 305
Query: 244 AIPLS 248
PL
Sbjct: 306 GSPLP 310
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 7e-23
Identities = 49/271 (18%), Positives = 96/271 (35%), Gaps = 51/271 (18%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN------------------- 540
+ +D +G G V R +G +A K +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 541 -----------FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADAL 589
+ ++ E + G L L + L + +K + + +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGV 126
Query: 590 FYLHNNCFPPIVHWDISSKNVLLD----LGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGN 645
+YLH+ I H+D+ +N++L + DF +A ++ + + GT
Sbjct: 127 YYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK-NIFGTPEF 182
Query: 646 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP--RDFLFEMSSSSSNMNIEILDSRLPY 703
VAPE+ + + D++S GV+ ++ G P D E ++ S +N E D
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 704 PSLDVQNKFMSIMQVAFSCLDQNPVSRPTMK 734
S ++ F+ L ++P R T++
Sbjct: 243 TSALAKD-FIR------RLLVKDPKKRMTIQ 266
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 96.1 bits (238), Expect = 2e-22
Identities = 48/281 (17%), Positives = 97/281 (34%), Gaps = 53/281 (18%)
Query: 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD--------------------- 539
+ IG+G +G VY A+ GE FA+KK D
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 540 -----NFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN 594
+ ++ +V+E+L+ + + L + + + + + Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD 118
Query: 595 NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPE-LAYT 653
++H D+ +N+L++ E ++DF +A+ + ++ T AP+ L +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 654 MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713
K + D++S G + E++ G + E I + +P++ K+
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 714 SIMQVAF--------------------SCLDQNPVSRPTMK 734
V L +P R T K
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 97.0 bits (240), Expect = 4e-22
Identities = 67/362 (18%), Positives = 125/362 (34%), Gaps = 49/362 (13%)
Query: 104 SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILH 163
S + + L + I + L+ L ++F N+L+ P + LT L +
Sbjct: 39 SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 94
Query: 164 ISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPR------------SLSNFTNLVFLY 211
++ NQ+ P L + + ++S+ + L L
Sbjct: 95 MNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLT 154
Query: 212 LYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNI 271
G+ + L +L ++ N + L L + N I+
Sbjct: 155 SLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD-ISVLAKLTNLESLIATNNQISDIT 213
Query: 272 PFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEY 331
P I L L L+ N + L ++ L + L+ N++S P L L L
Sbjct: 214 PLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTE 267
Query: 332 LDLSANHLSNF--------------------VLESLGSLVKLYYLNLSHNKLSQQIPIEL 371
L L AN +SN + + +L L YL L N +S P+
Sbjct: 268 LKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVS- 326
Query: 372 DNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDIS 431
+L L L ++N + + S + + ++ L+ +N +S L P L + + ++
Sbjct: 327 -SLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLN 381
Query: 432 YN 433
Sbjct: 382 DQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 86.2 bits (212), Expect = 1e-18
Identities = 56/286 (19%), Positives = 98/286 (34%), Gaps = 42/286 (14%)
Query: 52 HSRSLLHSWSLSFVNATKISLCTWSGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHL 111
S ++ +LS + + + + + IS N + +L
Sbjct: 140 SSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNL 199
Query: 112 AYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNG 171
L NN++ DI P I + L+ L N+L ++ LT+LT L ++ NQ++
Sbjct: 200 ESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 255
Query: 172 SIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSL 231
P LS T L L L N S P +
Sbjct: 256 LAP--------------------------LSGLTKLTELKLGANQISNISPLAGLTALTN 289
Query: 232 FDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYI 291
++ + L+ L + NNI+ P +LQ L ++N +
Sbjct: 290 LELNENQLEDI------SPISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKV 341
Query: 292 VGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSAN 337
+ L N+ +N +S N++S P L +L + L L+
Sbjct: 342 SD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 78.1 bits (191), Expect = 6e-16
Identities = 77/346 (22%), Positives = 137/346 (39%), Gaps = 29/346 (8%)
Query: 103 FSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTIL 162
F+ ++ L + D + ++L ++ L + + L +LT +
Sbjct: 16 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQI 71
Query: 163 HISRNQLNGSIPHEVGQLNFLNHLILDSNFLGG--------SIPRSLSNFTNLVFLYLYN 214
+ S NQL P + L L +++++N + ++ + +
Sbjct: 72 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 129
Query: 215 NSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFE 274
N + + + N S + L + P +L + +I+ N +
Sbjct: 130 NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD 189
Query: 275 IGESPQLQ---YLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEY 331
I +L L ++N I P + L+ +SL+GN+L G L SL NL
Sbjct: 190 ISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTD 245
Query: 332 LDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKI 391
LDL+ N +SN L L L KL L L N++S P L L L+ L+L+ N +
Sbjct: 246 LDLANNQISN--LAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ--LED 299
Query: 392 SSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEG 437
S I +++L L L +NN+S + P L L + + NK+
Sbjct: 300 ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.2 bits (233), Expect = 9e-22
Identities = 46/276 (16%), Positives = 85/276 (30%), Gaps = 56/276 (20%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN--------------------------- 540
+G+G +VY AR + +I A+KK
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 541 --FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 598
H +V++++E+ I +N L + + L YLH +
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 599 PIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKV-T 657
I+H D+ N+LLD ++DF +AK + ++ T APEL + ++
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 658 EKCDVYSFGVLALEVIKGKHP-----------------RDFLFEMSSSSSNMNIEILDSR 700
D+++ G + E++ E ++ +
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 701 LPYPSLDVQNKFMSIMQVAF--SCLDQNPVSRPTMK 734
P L + NP +R T
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT 275
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.1 bits (233), Expect = 2e-21
Identities = 50/263 (19%), Positives = 86/263 (32%), Gaps = 43/263 (16%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN------------------- 540
NDFD +GKG G V + R +G +A+K +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 541 --------FCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYL 592
+ V EY G L L+ + + + A L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---FTEERARFYGAEIVSA---L 118
Query: 593 HNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAY 652
+V+ DI +N++LD ++DF + K D + GT +APE+
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 653 TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712
D + GV+ E++ G+ P F + IL + +P + +
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP----FYNQDHERLFEL-ILMEEIRFPR-TLSPEA 232
Query: 713 MSIMQVAFSCLDQNPVSRPTMKR 735
S++ L ++P R
Sbjct: 233 KSLLA---GLLKKDPKQRLGGGP 252
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.6 bits (229), Expect = 4e-21
Identities = 46/291 (15%), Positives = 96/291 (32%), Gaps = 60/291 (20%)
Query: 498 RATNDFDAKHCIGKGGHGSVYIAR--VPSGEIFAVKKFHSPLPD---------------- 539
RA ++ IG+G +G V+ AR G A+K+ +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 540 -NFCSHP-----------------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNV 581
HP + +V+E+++ + + ++
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDM 121
Query: 582 IKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAG 641
+ + L +LH++ +VH D+ +N+L+ + ++DF +A+ + + +
Sbjct: 122 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS-FQMALTSVVV 177
Query: 642 THGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP------RDFLFEMSSSSSNMNIE 695
T APE+ D++S G + E+ + K D L ++ E
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 696 ILDSRLPYPSLDVQNKFMSIMQVAFS------------CLDQNPVSRPTMK 734
+ P +K ++ + CL NP R +
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 1e-20
Identities = 45/281 (16%), Positives = 95/281 (33%), Gaps = 53/281 (18%)
Query: 502 DFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------------- 539
+F IG+G +G VY AR +GE+ A+KK
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 540 -----NFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN 594
+ + ++V+E+L + + + + + + L + H+
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 595 NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPE-LAYT 653
+ ++H D+ +N+L++ ++DF +A+ + ++ T APE L
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 654 MKVTEKCDVYSFGVLALEVIKGKHP------RDFLFEMSSSSSNMNIEILDSRLPYPSL- 706
+ D++S G + E++ + D LF + + + + P
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 707 ---------DVQNKFMSIMQVAFS----CLDQNPVSRPTMK 734
D + + S L +P R + K
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 89.1 bits (220), Expect = 9e-20
Identities = 43/260 (16%), Positives = 90/260 (34%), Gaps = 40/260 (15%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKF------------------------HS 535
+ FD +G G G V + + SG +A+K +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 536 PLPDNFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNN 595
P + + +Y +E + ++ ++ + YLH+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 596 CFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMK 655
+++ D+ +N+L+D V+DF AK L GT +APE+ +
Sbjct: 161 D---LIYRDLKPENLLIDQQGYIQVTDFGFAKR---VKGRTWTLCGTPEALAPEIILSKG 214
Query: 656 VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSI 715
+ D ++ GVL E+ G P + + +I+ ++ +PS + +
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFF-----ADQPIQIYEKIVSGKVRFPS-HFSSDLKDL 268
Query: 716 MQVAFSCLDQNPVSRPTMKR 735
++ + L + R +
Sbjct: 269 LR---NLLQVDLTKRFGNLK 285
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.4 bits (213), Expect = 5e-19
Identities = 55/271 (20%), Positives = 100/271 (36%), Gaps = 47/271 (17%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR----VPSGEIFAVKKF----------------------- 533
+F+ +G G +G V++ R +G+++A+K
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 534 ---HSP---LPDNFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVAD 587
SP + ++ +Y+ G L L+ E + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY---VGEIVL 140
Query: 588 ALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWS-KLAGTHGNV 646
AL +LH I++ DI +N+LLD ++DF ++K D + + GT +
Sbjct: 141 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 647 APELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYP 704
AP++ + D +S GVL E++ G P E +S + IL S PYP
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR-RILKSEPPYP 256
Query: 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKR 735
++ ++Q L ++P R
Sbjct: 257 Q-EMSALAKDLIQ---RLLMKDPKKRLGCGP 283
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.0 bits (212), Expect = 9e-19
Identities = 45/282 (15%), Positives = 85/282 (30%), Gaps = 63/282 (22%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF-------------CSHP--------- 545
IG+G +G V A + A+KK + H
Sbjct: 16 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 75
Query: 546 -------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFP 598
+ + +L L K+L + L + + L Y+H+
Sbjct: 76 RAPTIEQMKDVYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA--- 128
Query: 599 PIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSK---LAGTHGNVAPELAYT-M 654
++H D+ N+LL+ + + DF +A+ + D + T APE+
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 655 KVTEKCDVYSFGVLALEVIKGKHP-----------------RDFLFEMSSSSSNMNIEIL 697
T+ D++S G + E++ + E + N+
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 248
Query: 698 DSRLPYPSLDVQNKFMSIMQVAF-----SCLDQNPVSRPTMK 734
LP+ + N+ L NP R ++
Sbjct: 249 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 290
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.7 bits (211), Expect = 9e-19
Identities = 41/301 (13%), Positives = 92/301 (30%), Gaps = 69/301 (22%)
Query: 497 IRATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDN--------------F 541
+ ++ IG+G G V+ AR +G+ A+KK
Sbjct: 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL 65
Query: 542 CSHP--------------------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNV 581
H ++V+++ E + N + ++ V
Sbjct: 66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRV 122
Query: 582 IKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS----NWS 637
++ + + L+Y+H N I+H D+ + NVL+ ++DF +A+ +L + ++
Sbjct: 123 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 179
Query: 638 KLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHP------------------ 678
T PEL + D++ G + E+
Sbjct: 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239
Query: 679 ---RDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAF--SCLDQNPVSRPTM 733
+ + + +E++ + ++ + L +P R
Sbjct: 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299
Query: 734 K 734
Sbjct: 300 D 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 85.7 bits (211), Expect = 1e-18
Identities = 34/204 (16%), Positives = 70/204 (34%), Gaps = 35/204 (17%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF----------CSHP---- 545
+D+ +G+G + V+ A + + E VK P
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 94
Query: 546 ----------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNN 595
R +V+E++ + ++ + L + + AL Y H+
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM 148
Query: 596 CFPPIVHWDISSKNVLLDL-GYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTM 654
I+H D+ NV++D + + D+ +A+F + ++A + L
Sbjct: 149 G---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 655 KVTEKCDVYSFGVLALEVIKGKHP 678
D++S G + +I K P
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (206), Expect = 2e-18
Identities = 47/263 (17%), Positives = 82/263 (31%), Gaps = 7/263 (2%)
Query: 196 SIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCP 255
++P + ++L+ N S ++L + L N L +
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 256 QLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKL 315
+ + P +L L L + P + L + L N L
Sbjct: 83 EQLD-LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL 141
Query: 316 SGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLI 375
L NL +L L N +S+ + L L L L N+++ P +L
Sbjct: 142 QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 376 HLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKL 435
L L L N L + + + +L+ L L+ N R L S +++
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGSSSEV 260
Query: 436 EGHIPNS---TTFRDAPLEALQG 455
+P + LQG
Sbjct: 261 PCSLPQRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.6 bits (202), Expect = 6e-18
Identities = 49/259 (18%), Positives = 81/259 (31%), Gaps = 31/259 (11%)
Query: 108 FPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHI------------------ 149
+ L+ N + + L L +N L+
Sbjct: 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 150 -------PSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLS 202
P+ L L LH+ R L P L L +L L N L +
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150
Query: 203 NFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDV 262
+ NL L+L+ N S + L SL + L N++ P + +
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL--YL 208
Query: 263 SINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGE 322
NN++ + LQYL L+ N V + +L + S +++ +P
Sbjct: 209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQR 267
Query: 323 LGSLINLEYLDLSANHLSN 341
L + L+AN L
Sbjct: 268 LA---GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.5 bits (150), Expect = 3e-11
Identities = 44/240 (18%), Positives = 87/240 (36%), Gaps = 6/240 (2%)
Query: 50 EVHSRSLLHSWSLSFVNATKISLCTWSGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFP 109
V + S +L+ + L + ++L+ + ++ +F
Sbjct: 46 HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLG 105
Query: 110 HLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQL 169
L L L L ++ P L+ L+YL N L L +LT L + N++
Sbjct: 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI 165
Query: 170 NGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLK 229
+ L+ L+ L+L N + P + + L+ LYL+ N+ S + + L+
Sbjct: 166 SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225
Query: 230 SLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSN 289
+L ++L N W L S + + ++P + L++N
Sbjct: 226 ALQYLRLNDNPWVCDCRARPLW---AWLQKFRGSSSEVPCSLPQRLA---GRDLKRLAAN 279
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.9 bits (201), Expect = 1e-17
Identities = 45/277 (16%), Positives = 91/277 (32%), Gaps = 43/277 (15%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD-----------NFCSHPRQS 548
++ IG+G +G+V+ A+ + EI A+K+ D +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 549 FIV--YEYLESGSLDKILNNDASAKEL-------GWTQRLNVIKGVADALFYLHNNCFPP 599
IV ++ L S ++ G V + L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 600 IVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKV-TE 658
++H D+ +N+L++ E +++F +A+ + +S T P++ + K+ +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 659 KCDVYSFGVLALEVIKGKHP-------RDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711
D++S G + E+ P D L + E S P
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 712 FMSIMQVAF--------------SCLDQNPVSRPTMK 734
+ + + + L NPV R + +
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.5 bits (195), Expect = 2e-16
Identities = 43/301 (14%), Positives = 89/301 (29%), Gaps = 69/301 (22%)
Query: 493 YEEIIRATNDFDAK----HCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPDNF------ 541
+E+ + + A +G G +G+V A +G A+KK + P
Sbjct: 6 RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY 65
Query: 542 --------CSHP------------------RQSFIVYEYLESGSLDKILNNDASAKELGW 575
H ++V ++ + + + ++LG
Sbjct: 66 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGE 120
Query: 576 TQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635
+ ++ + L Y+H H D+ N+ ++ E + DF +A+ DS
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA--DSEM 175
Query: 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEM---------- 685
+ + M+ T+ D++S G + E+I GK +
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235
Query: 686 --------SSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAF----SCLDQNPVSRPTM 733
S+ + D + + +A L + R T
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295
Query: 734 K 734
Sbjct: 296 G 296
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.4 bits (192), Expect = 4e-16
Identities = 49/301 (16%), Positives = 88/301 (29%), Gaps = 67/301 (22%)
Query: 488 LGKIVYEEIIRATNDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD------- 539
L K ++E + +G G +GSV A +G AVKK P
Sbjct: 9 LNKTIWE----VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT 64
Query: 540 -------NFCSHP-----------------RQSFIVYEYLESGSLDKILNNDASAKELGW 575
H + +L L+ I+ ++L
Sbjct: 65 YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QKLTD 120
Query: 576 TQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635
+I + L Y+H+ H D+ N+ ++ E + DF +A+ D
Sbjct: 121 DHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARH--TDDEM 175
Query: 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP----------------- 678
+A + M + D++S G + E++ G+
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235
Query: 679 -RDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAF----SCLDQNPVSRPTM 733
+ SS + S P ++ N F+ +A L + R T
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
Query: 734 K 734
Sbjct: 296 A 296
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.7 bits (190), Expect = 7e-16
Identities = 46/300 (15%), Positives = 86/300 (28%), Gaps = 76/300 (25%)
Query: 501 NDFDAKHCIGKGGHGSVYIAR-VPSGEIFAVKKFHSPLPD--------------NFCSHP 545
+ IG G G V A A+KK P + +H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 546 ------------------RQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVAD 587
+ ++V E +++ I EL + ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLC 130
Query: 588 ALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNWSKLAGTHGNVA 647
+ +LH+ +H D+ N+++ + DF +A+ S + T A
Sbjct: 131 GIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRA 186
Query: 648 PELAYTMKVTEKCDVYSFGVLALEVIKGKHP-----------------RDFLFEMSSSSS 690
PE+ M E D++S G + E+++ K E
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 691 NMNIEILDSRLPYPSLDVQNKFMSIMQVAFS----------------CLDQNPVSRPTMK 734
+++R Y L F + A S L +P R ++
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 63.9 bits (154), Expect = 2e-11
Identities = 45/281 (16%), Positives = 94/281 (33%), Gaps = 43/281 (15%)
Query: 509 IGKGGHGSVYIAR-VPSGEIFAVKKFHS-------------------------------- 535
+G G +V++A+ + + A+K
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80
Query: 536 ----PLPDNFCSHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFY 591
L P +V + G L + + + K + L Y
Sbjct: 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDY 140
Query: 592 LHNNCFPPIVHWDISSKNVLLDL-GYEAHVSDFRIAKFLNLDSS--NWSKLAGTHGNVAP 648
+H C I+H DI +NVL+++ ++ +IA N +++ T +P
Sbjct: 141 MHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSP 198
Query: 649 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNI-EILDSRLPYPSLD 707
E+ D++S L E+I G + S + + +I +I++ PS
Sbjct: 199 EVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYL 258
Query: 708 VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPD 748
++N + L +N +V ++++ ++ D
Sbjct: 259 LRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 299
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.7 bits (135), Expect = 3e-09
Identities = 40/269 (14%), Positives = 89/269 (33%), Gaps = 15/269 (5%)
Query: 74 TWSGIHCNHAGRVFGINLTSISLNGTLLE---FSFSSFPHLAYLDLYNNELFDIIPPQI- 129
T +H + GR+ + + + ++ S + ++DL N+ + I
Sbjct: 8 TGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGIL 67
Query: 130 SNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILD 189
S SKL+ L +LS I + ++ ++L L++S + + L+
Sbjct: 68 SQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELN 127
Query: 190 SNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQL-------N 242
++ + + V + + SG + S +
Sbjct: 128 LSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM 187
Query: 243 GAIPLSIDWGRCPQLSLLDVS-INNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGN 301
++ + L L +S +I E+GE P L+ L + G +
Sbjct: 188 LKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEA 247
Query: 302 IIYLNRISLSGNKLSGRIPGELGSLINLE 330
L + ++ + + +G+ N E
Sbjct: 248 ---LPHLQINCSHFTTIARPTIGNKKNQE 273
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (126), Expect = 4e-08
Identities = 45/269 (16%), Positives = 101/269 (37%), Gaps = 14/269 (5%)
Query: 114 LDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNG-S 172
LDL L + ++ + + + + + S + + +S + + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVST 62
Query: 173 IPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYN--NSFSGSIPQQIGNLKS 230
+ + Q + L +L L+ L I +L+ +NLV L L ++ + +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 231 LFDMKLCINQLNG----AIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDL 286
L ++ L + ++ QL+L N ++ + P L +LDL
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 287 SSNYIV-GEIPTQLGNIIYLNRISLSG-NKLSGRIPGELGSLINLEYLDLSANHLSNFVL 344
S + ++ + + + YL +SLS + ELG + L+ L + + + L
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF-GIVPDGTL 241
Query: 345 ESLGSLVKLYYLNLSHNKLSQQIPIELDN 373
+ L L +L ++ + + + N
Sbjct: 242 QLLKE--ALPHLQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 5e-07
Identities = 35/266 (13%), Positives = 78/266 (29%), Gaps = 17/266 (6%)
Query: 191 NFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSID 250
N R LS ++ + + + + + M L + + + I
Sbjct: 11 NLHPDVTGRLLSQ--GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGI- 66
Query: 251 WGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISL 310
+C +L L + ++ I + ++ L L+LS E Q L
Sbjct: 67 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 126
Query: 311 SGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHN--------- 361
+ + + + ++ +LS + S + +
Sbjct: 127 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV 186
Query: 362 KLSQQIPIELDNLIHLSELDLSH-NFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFE 420
L E L +L L LS + + + + +L+ L + G + E
Sbjct: 187 MLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKE 246
Query: 421 ELHGLLHIDISYNKLEGHIPNSTTFR 446
L H+ I+ + + +
Sbjct: 247 ---ALPHLQINCSHFTTIARPTIGNK 269
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.5 bits (134), Expect = 6e-09
Identities = 19/98 (19%), Positives = 36/98 (36%), Gaps = 5/98 (5%)
Query: 327 INLEYLDLSANHLSNF-VLESLGSLVKLYYLNLSHNKLS----QQIPIELDNLIHLSELD 381
++++ LD+ LS+ E L L + + L L+ + I L L+EL+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 382 LSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCF 419
L N LG+ + + + +L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 99
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 6e-07
Identities = 14/94 (14%), Positives = 32/94 (34%), Gaps = 5/94 (5%)
Query: 278 SPQLQYLDLSSNYIVGEIPTQL-GNIIYLNRISLSGNKLSGRIPGELGSLI----NLEYL 332
S +Q LD+ + +L + + L L+ ++ S + L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 333 DLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQ 366
+L +N L + + + ++ + L
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 4e-06
Identities = 20/94 (21%), Positives = 36/94 (38%), Gaps = 15/94 (15%)
Query: 328 NLEYLDLSANHLSNFVLESLGSLVK----LYYLNLSHNKLSQQIPIEL-----DNLIHLS 378
L L L+ +S+ SL + + L L+LS+N L ++L L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 379 ELDLSHNFLGEKISSRICRMESLEKLNLSYNNLS 412
+L L + E++ + L+ L +L
Sbjct: 430 QLVLYDIYWSEEM------EDRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 6e-06
Identities = 20/80 (25%), Positives = 30/80 (37%), Gaps = 9/80 (11%)
Query: 352 KLYYLNLSHNKLS----QQIPIELDNLIHLSELDLSHNFLGEKISSRICR-----MESLE 402
L L L+ +S + L L ELDLS+N LG+ ++ LE
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 403 KLNLSYNNLSGLIPRCFEEL 422
+L L S + + L
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 3e-05
Identities = 19/83 (22%), Positives = 31/83 (37%), Gaps = 9/83 (10%)
Query: 301 NIIYLNRISLSGNKLSGRIPGELGSLI----NLEYLDLSANHLSNFVLESLGSLVK---- 352
L + L+ +S L + + +L LDLS N L + + L V+
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 353 -LYYLNLSHNKLSQQIPIELDNL 374
L L L S+++ L L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 2e-04
Identities = 15/82 (18%), Positives = 32/82 (39%), Gaps = 9/82 (10%)
Query: 254 CPQLSLLDVSINNITGNIPFEIGES----PQLQYLDLSSNYIVGEIPTQLGNII-----Y 304
L +L ++ +++ + + + L+ LDLS+N + QL +
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 305 LNRISLSGNKLSGRIPGELGSL 326
L ++ L S + L +L
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 4e-04
Identities = 18/85 (21%), Positives = 29/85 (34%), Gaps = 9/85 (10%)
Query: 279 PQLQYLDLSSNYIVGE----IPTQLGNIIYLNRISLSGNKLSGRIPGELGSLI-----NL 329
L+ L L+ + + L L + LS N L +L + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 330 EYLDLSANHLSNFVLESLGSLVKLY 354
E L L + S + + L +L K
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 6e-04
Identities = 17/90 (18%), Positives = 31/90 (34%), Gaps = 5/90 (5%)
Query: 111 LAYLDLYNNELFDIIPPQI-SNLSKLEYLDFLTNKLSG----HIPSEISLLTHLTILHIS 165
+ LD+ EL D ++ L + + + L+ I S + + L L++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 166 RNQLNGSIPHEVGQLNFLNHLILDSNFLGG 195
N+L H V Q + L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 8e-04
Identities = 16/87 (18%), Positives = 29/87 (33%), Gaps = 7/87 (8%)
Query: 227 NLKSLFDMKLCINQLN--GAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQ---- 280
L + L ++ L+ L LD+S N + ++ ES +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 281 -LQYLDLSSNYIVGEIPTQLGNIIYLN 306
L+ L L Y E+ +L +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 8e-04
Identities = 16/103 (15%), Positives = 26/103 (25%), Gaps = 5/103 (4%)
Query: 159 LTILHISRNQLNGS-IPHEVGQLNFLNHLILDSNFLGG----SIPRSLSNFTNLVFLYLY 213
+ L I +L+ + + L + LD L I +L L L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 214 NNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQ 256
+N + K+ L G
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 106
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (131), Expect = 7e-09
Identities = 35/184 (19%), Positives = 54/184 (29%), Gaps = 10/184 (5%)
Query: 108 FPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRN 167
L L N L+ + ++L L+ L +++ + L +L
Sbjct: 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLN-----LDRAELTKLQVDGTLPVLGTLDL 84
Query: 168 QLNGSIPH--EVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQI 225
N L L L + N L +L L LYL N P +
Sbjct: 85 SHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLL 144
Query: 226 GNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLD 285
L + L N L + L L + N++ IP S L +
Sbjct: 145 TPTPKLEKLSLANNNLTELPAGLL--NGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF 201
Query: 286 LSSN 289
L N
Sbjct: 202 LHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (103), Expect = 3e-05
Identities = 47/212 (22%), Positives = 85/212 (40%), Gaps = 9/212 (4%)
Query: 224 QIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQY 283
++ + S ++ L A+P + ++L +S N + + +L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP----KDTTILHLSENLLYTFSLATLMPYTRLTQ 59
Query: 284 LDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFV 343
L+L + ++ +S + +P +L L LD+S N L++
Sbjct: 60 LNLDRAELTKLQVDGTLPVLGTLDLS---HNQLQSLPLLGQTLPALTVLDVSFNRLTSLP 116
Query: 344 LESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEK 403
L +L L +L L L N+L P L L +L L++N L E + + +E+L+
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176
Query: 404 LNLSYNNLSGLIPRCFEELHGLLHIDISYNKL 435
L L N+L IP+ F H L + N
Sbjct: 177 LLLQENSLYT-IPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 8e-05
Identities = 46/209 (22%), Positives = 75/209 (35%), Gaps = 6/209 (2%)
Query: 252 GRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLS 311
+ ++ N+T +P ++ L LS N + L L +++L
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 312 GNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIEL 371
+L+ +L L +++ + +L L L++S N+L+ L
Sbjct: 64 RAELTKLQVDG--TLPVL-GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 372 DNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDIS 431
L L EL L N L + LEKL+L+ NNL+ L L L + +
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 432 YNKLEGHIPNSTTFRDAPLEALQGNKGLC 460
N L P L GN LC
Sbjct: 181 ENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 4e-04
Identities = 23/101 (22%), Positives = 40/101 (39%), Gaps = 1/101 (0%)
Query: 117 YNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHE 176
N L + + L +L+ L N+L P ++ L L ++ N L
Sbjct: 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGL 167
Query: 177 VGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSF 217
+ L L+ L+L N +IP+ L F +L+ N +
Sbjct: 168 LNGLENLDTLLLQEN-SLYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.4 bits (125), Expect = 8e-09
Identities = 27/108 (25%), Positives = 41/108 (37%), Gaps = 6/108 (5%)
Query: 331 YLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEK 390
L L+ L+ L L L+ + +L+LSHN+L P L L L L S N L
Sbjct: 2 VLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 391 ISSRICRMESLEKLNLSYNNLSGL-IPRCFEELHGLLHIDISYNKLEG 437
++L L N L + L+ +++ N L
Sbjct: 59 DGVANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.7 bits (118), Expect = 6e-08
Identities = 30/108 (27%), Positives = 45/108 (41%), Gaps = 6/108 (5%)
Query: 308 ISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQI 367
+ L+ L+ + L L+ + +LDLS N L +L +L L L S N +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALP-PALAALRCLEVLQASDNA--LEN 57
Query: 368 PIELDNLIHLSELDLSHNFLGE-KISSRICRMESLEKLNLSYNNLSGL 414
+ NL L EL L +N L + + L LNL N+L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.4 bits (112), Expect = 4e-07
Identities = 29/121 (23%), Positives = 46/121 (38%), Gaps = 7/121 (5%)
Query: 113 YLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGS 172
L L + +L + + L + +LD N+L P+ ++ L L +L S N L
Sbjct: 2 VLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58
Query: 173 IPHEVGQLNFLNHLILDSNFL-GGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSL 231
L L L+L +N L + + L + LV L L NS L +
Sbjct: 59 DGVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
Query: 232 F 232
Sbjct: 116 L 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.5 bits (107), Expect = 2e-06
Identities = 29/122 (23%), Positives = 50/122 (40%), Gaps = 6/122 (4%)
Query: 260 LDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRI 319
L ++ ++T + + + + +LDLS N + P L + L + S N
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA--LEN 57
Query: 320 PGELGSLINLEYLDLSANHLSNF-VLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLS 378
+ +L L+ L L N L ++ L S +L LNL N L Q+ I+ L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 379 EL 380
+
Sbjct: 118 SV 119
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 1e-05
Identities = 22/110 (20%), Positives = 39/110 (35%), Gaps = 8/110 (7%)
Query: 186 LILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAI 245
L L L ++ L + L L +N P + L+ L ++ N L
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59
Query: 246 PLSIDWGRCPQLSLLDVSINNITGNIPFE-IGESPQLQYLDLSSNYIVGE 294
P+L L + N + + + + P+L L+L N + E
Sbjct: 60 G----VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.5 bits (125), Expect = 1e-08
Identities = 29/146 (19%), Positives = 57/146 (39%), Gaps = 6/146 (4%)
Query: 310 LSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPI 369
L ++ ++ + + L L + L + LN + ++ + I
Sbjct: 4 LKPEQVE-QLKLIMSKRYDGSQQALDLKGLRS--DPDLVAQNIDVVLNRRSS-MAATLRI 59
Query: 370 ELDNLIHLSELDLSHNFL--GEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLH 427
+N+ L L+LS+N L + +SS + + +L+ LNLS N L + L
Sbjct: 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119
Query: 428 IDISYNKLEGHIPNSTTFRDAPLEAL 453
+ + N L + +T+ A E
Sbjct: 120 LWLDGNSLSDTFRDQSTYISAIRERF 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (100), Expect = 3e-05
Identities = 23/134 (17%), Positives = 47/134 (35%), Gaps = 3/134 (2%)
Query: 172 SIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSL 231
+ + + + LD L L V L ++ + ++ N+ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67
Query: 232 FDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYI 291
+ L N+L +S + P L +L++S N + + + +L+ L L N +
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 292 VGEIPTQLGNIIYL 305
Q I +
Sbjct: 128 SDTFRDQSTYISAI 141
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (85), Expect = 0.003
Identities = 18/97 (18%), Positives = 36/97 (37%), Gaps = 2/97 (2%)
Query: 89 INLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDI--IPPQISNLSKLEYLDFLTNKLS 146
+ L S L + P L L+L NN L+ + + + L+ L+ N+L
Sbjct: 45 VVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 104
Query: 147 GHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFL 183
+ L L + N L+ + + ++ +
Sbjct: 105 SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.0 bits (125), Expect = 3e-08
Identities = 30/217 (13%), Positives = 56/217 (25%), Gaps = 4/217 (1%)
Query: 148 HIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNL 207
IPS++ + L +L L + + N + I + +
Sbjct: 22 EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 208 VFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQ--LNGAIPLSIDWGRCPQLSLLDVSIN 265
+ + + L I+ + + L + +IN
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 266 NITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGS 325
T +G S + L L+ N I N L
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 326 LINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNK 362
LD+S + + L +L KL + + K
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.1 bits (115), Expect = 7e-07
Identities = 36/244 (14%), Positives = 67/244 (27%), Gaps = 17/244 (6%)
Query: 73 CTWSGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNL 132
C+ C + +T I + + L +L I S
Sbjct: 8 CSNRVFLCQES------KVTEIPSD---------LPRNAIELRFVLTKLRVIQKGAFSGF 52
Query: 133 SKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSI--PHEVGQLNFLNHLILDS 190
LE ++ N + I +++ N P L L +L++ +
Sbjct: 53 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 112
Query: 191 NFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSID 250
+ + V L + +N +I + S + L +N+ +
Sbjct: 113 TGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA 172
Query: 251 WGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISL 310
+ L NN+ + LD+S I L N+ L S
Sbjct: 173 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
Query: 311 SGNK 314
K
Sbjct: 233 YNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.4 bits (108), Expect = 5e-06
Identities = 35/221 (15%), Positives = 59/221 (26%), Gaps = 6/221 (2%)
Query: 196 SIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCP 255
IP L N + L L +++ N + I +
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 256 QLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPT--QLGNIIYLNRISLSGN 313
+ NN+ P P LQYL +S+ I L I + N
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 314 KLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDN 373
+ +G L L+ N + + +N L +
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 374 LIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGL 414
LD+S + S + ++ L + NL L
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKL 238
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 8e-06
Identities = 33/230 (14%), Positives = 61/230 (26%), Gaps = 5/230 (2%)
Query: 158 HLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSF 217
+ +++ IP ++ L L + S F +L + + N
Sbjct: 9 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 218 SGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGE 277
I + + N + P L L +S I
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 278 SPQLQYLDLSS--NYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLS 335
S Q LD+ N E + +G + L+ N + E
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 336 ANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHN 385
N+L + L++S ++ L+NL L +
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 51.2 bits (121), Expect = 8e-08
Identities = 29/204 (14%), Positives = 64/204 (31%), Gaps = 18/204 (8%)
Query: 156 LTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNN 215
++ + + ++ +LN ++ +I +++ + + N+ L+L N
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 216 SFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEI 275
+ P + + ++ IN + E
Sbjct: 79 KLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLES 138
Query: 276 GESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLS 335
+ D++ + ++ T ++ I L L L+ L LS
Sbjct: 139 LYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV------------PLAGLTKLQNLYLS 186
Query: 336 ANHLSNFVLESLGSLVKLYYLNLS 359
NH+S+ L +L L L L L
Sbjct: 187 KNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 9e-05
Identities = 30/208 (14%), Positives = 61/208 (29%), Gaps = 18/208 (8%)
Query: 200 SLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSL 259
S F + L S + ++ Q L S+ + + + + P ++
Sbjct: 19 SDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ----YLPNVTK 72
Query: 260 LDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRI 319
L ++ N +T P L+ L + + + I
Sbjct: 73 LFLNGNKLTDIKPLA-----NLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDI 127
Query: 320 PGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSE 379
G + S +N + + LS + L L L
Sbjct: 128 NG-----LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQN 182
Query: 380 LDLSHNFLGEKISSRICRMESLEKLNLS 407
L LS N + + + + +++L+ L L
Sbjct: 183 LYLSKNHI-SDLRA-LAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 3e-04
Identities = 26/185 (14%), Positives = 57/185 (30%), Gaps = 16/185 (8%)
Query: 104 SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILH 163
+ + + + N+++ + I L + L NKL+ P L +L L
Sbjct: 41 TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP-----LANLKNLG 93
Query: 164 ISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQ 223
N + + + I + N ++
Sbjct: 94 WLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLS 153
Query: 224 QIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQY 283
++ L +L I+ + + +L L +S N+I+ ++ + L
Sbjct: 154 RLTKLDTLSLEDNQISDI-------VPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDV 204
Query: 284 LDLSS 288
L+L S
Sbjct: 205 LELFS 209
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.5 bits (124), Expect = 9e-08
Identities = 58/325 (17%), Positives = 95/325 (29%), Gaps = 24/325 (7%)
Query: 110 HLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQL 169
L+L N L + P +L E L N L+ +P L L + + + L
Sbjct: 39 QAHELELNNLGLSSL-PELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93
Query: 170 NGSIPH-EVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNL 228
+ P E ++ L + + +L L S
Sbjct: 94 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153
Query: 229 KSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSS 288
+ L A S+ LSL + N E+ P L + +
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213
Query: 289 NYIVGEIPTQLGNIIYLNRISLSGNKLSG--------RIPGELGSLINLEYLDLSANHLS 340
N + R + + L L N S
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273
Query: 341 NFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMES 400
N + L LN+S+NKL + +P L L S N ++ ++
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRL---ERLIASFN----HLAEVPELPQN 325
Query: 401 LEKLNLSYNNLSGL--IPRCFEELH 423
L++L++ YN L IP E+L
Sbjct: 326 LKQLHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 1e-07
Identities = 52/328 (15%), Positives = 95/328 (28%), Gaps = 24/328 (7%)
Query: 90 NLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHI 149
+ LN L PHL L N L + +P +L K +D K +
Sbjct: 39 QAHELELNNLGLSSLPELPPHLESLVASCNSLTE-LPELPQSL-KSLLVDNNNLKALSDL 96
Query: 150 PSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVF 209
P + L +L S ++ ++ + L + +N +
Sbjct: 97 PPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELP 156
Query: 210 LYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITG 269
+ K + + G L L + +N
Sbjct: 157 ELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLL 216
Query: 270 NIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLN----------RISLSGNKLSGRI 319
++ S + + + + E+P L + N S I
Sbjct: 217 KTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEI 276
Query: 320 PGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSE 379
+LE L++S N L +L L S N L+ ++P N L +
Sbjct: 277 RSLCDLPPSLEELNVSNNKLIEL----PALPPRLERLIASFNHLA-EVPELPQN---LKQ 328
Query: 380 LDLSHNFLGEKISSRICRMESLEKLNLS 407
L + +N + ES+E L ++
Sbjct: 329 LHVEYN----PLREFPDIPESVEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 4e-06
Identities = 51/319 (15%), Positives = 87/319 (27%), Gaps = 23/319 (7%)
Query: 133 SKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQL-------NFLNH 185
+ L+ LS +P L HL L S N L +P L N L
Sbjct: 38 RQAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 186 LILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAI 245
L L + + L L I N +
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 246 PLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQL--GNII 303
+ P L+ + N++ + + ++ + L
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 304 YLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKL 363
+L S + + + + L +L N
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 364 SQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELH 423
S +I D L EL++S+N K+ LE+L S+N+L+ + E
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNN----KLIELPALPPRLERLIASFNHLAEVP----ELPQ 324
Query: 424 GLLHIDISYNKLEGHIPNS 442
L + + YN L P+
Sbjct: 325 NLKQLHVEYNPLRE-FPDI 342
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 50.2 bits (119), Expect = 1e-07
Identities = 20/150 (13%), Positives = 40/150 (26%), Gaps = 32/150 (21%)
Query: 509 IGKGGHGSVYIARVPSGEIFAVKKFHSPLPDN-------FCSHPRQS------------- 548
+G+G +V+ VK S
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 549 -------FIVYEY-LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPI 600
+ Y E ++ L + + V+ + + + ++ I
Sbjct: 68 LQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---I 124
Query: 601 VHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630
VH D+S NVL+ + DF + +
Sbjct: 125 VHGDLSQYNVLVS-EEGIWIIDFPQSVEVG 153
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.0 bits (118), Expect = 3e-07
Identities = 40/229 (17%), Positives = 75/229 (32%), Gaps = 20/229 (8%)
Query: 156 LTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNN 215
L + + ++ + ++ L+ + L + +I + NL+ L L +N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDN 73
Query: 216 SFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEI 275
+ LK+L + N +S G +L S +
Sbjct: 74 QI-----TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128
Query: 276 GESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLS 335
L + +I N LS L +L L L
Sbjct: 129 SNLQVL-------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKAD 181
Query: 336 ANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSH 384
N +S+ + L SL L ++L +N++S P L N +L + L++
Sbjct: 182 DNKISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 2e-05
Identities = 29/198 (14%), Positives = 60/198 (30%), Gaps = 22/198 (11%)
Query: 104 SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSE---ISLLTHLT 160
+ + + L + + I + L+ L L+ N+++ P + L+
Sbjct: 36 TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELS 93
Query: 161 ILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFL---------- 210
+ + + + G S + L N +
Sbjct: 94 GNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNL 153
Query: 211 -YLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITG 269
YL + S + NL L +K N+++ PL P L + + N I+
Sbjct: 154 QYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPL----ASLPNLIEVHLKNNQISD 209
Query: 270 NIPFEIGESPQLQYLDLS 287
P + L + L+
Sbjct: 210 VSPL--ANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 5e-05
Identities = 30/230 (13%), Positives = 65/230 (28%), Gaps = 22/230 (9%)
Query: 203 NFTNLVFLYLYNNSFSGSIPQ-QIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLD 261
N + + ++ + ++ Q + + +L + + G L L+
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-------VQYLNNLIGLE 69
Query: 262 VSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPG 321
+ N IT P + L + V I + +
Sbjct: 70 LKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129
Query: 322 ELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELD 381
L L + + L+ LS L NL L+ L
Sbjct: 130 NLQVLYLDLNQITNISPLAGLT----------NLQYLSIGNAQVSDLTPLANLSKLTTLK 179
Query: 382 LSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDIS 431
N + + + + +L +++L N +S + P L + ++
Sbjct: 180 ADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (102), Expect = 1e-05
Identities = 30/148 (20%), Positives = 57/148 (38%), Gaps = 9/148 (6%)
Query: 286 LSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLE 345
L++ I E Q N + + L G K+ I +L + +D S N + L+
Sbjct: 3 LTAELI--EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLD 57
Query: 346 SLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGE----KISSRICRMESL 401
L +L L +++N++ + L L+EL L++N L E + + + L
Sbjct: 58 GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL 117
Query: 402 EKLNLSYNNLSGLIPRCFEELHGLLHID 429
L N ++ + +D
Sbjct: 118 CILRNPVTNKKHYRLYVIYKVPQVRVLD 145
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (100), Expect = 2e-05
Identities = 27/163 (16%), Positives = 44/163 (26%), Gaps = 29/163 (17%)
Query: 127 PQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHL 186
Q +N + LD K+ I + + L + S N++
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF----------- 59
Query: 187 ILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIP 246
L L + NN L L ++ L N L
Sbjct: 60 ---------------PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGD 104
Query: 247 LSIDWG--RCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLS 287
L L +L + N + I + PQ++ LD
Sbjct: 105 LDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 38/328 (11%), Positives = 71/328 (21%), Gaps = 26/328 (7%)
Query: 114 LDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSG----HIPSEISLLTHLTILHISRNQL 169
LD E + + ++ + N + + I+ L I S
Sbjct: 12 LDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71
Query: 170 NGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLK 229
L L +L L + + S + +
Sbjct: 72 GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN 131
Query: 230 SLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSN 289
L + + N N + + L +
Sbjct: 132 GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 191
Query: 290 YIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGS 349
+V G L +L + A +
Sbjct: 192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL------ 245
Query: 350 LVKLYYLNLSHNKLSQQIPIEL------DNLIHLSELDLSHNFLGEKISSRIC-----RM 398
L L+ LS + + I L L L +N + + +M
Sbjct: 246 ----RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301
Query: 399 ESLEKLNLSYNNLSGLIPRCFEELHGLL 426
L L L+ N S +E+ +
Sbjct: 302 PDLLFLELNGNRFSEE-DDVVDEIREVF 328
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 3e-04
Identities = 41/332 (12%), Positives = 90/332 (27%), Gaps = 38/332 (11%)
Query: 88 GINLTSISLNG-TLLEFSFSSFPHLAYLDLYNNELFD----IIPPQISNLSKLEYLDFLT 142
+ L +I+ + + + L N + + I++ LE +F
Sbjct: 9 SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 143 N---KLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPR 199
++ IP + LL + + + S L + +
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128
Query: 200 SLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSL 259
+ + ++ ++ N L + N+L L
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188
Query: 260 LDVSINNITGNIPFEIGESPQL-----------QYLDLSSNYIVGEIPTQLGNIIYLNRI 308
V + + + ++ + L + L +
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248
Query: 309 SLSGNKLSGRIPGELG------SLINLEYLDLSANHLSNFVLESLGS-----LVKLYYLN 357
L+ LS R + I L+ L L N + + +L + + L +L
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308
Query: 358 LSHNKLSQQIPI--------ELDNLIHLSELD 381
L+ N+ S++ + L ELD
Sbjct: 309 LNGNRFSEEDDVVDEIREVFSTRGRGELDELD 340
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 45/328 (13%), Positives = 101/328 (30%), Gaps = 30/328 (9%)
Query: 158 HLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGG----SIPRSLSNFTNLVFLYLY 213
L + I+ S+ + + + + ++L N +G + ++++ +L
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 214 NNS---FSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGN 270
+ IP+ + L ++ + + + P + L
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 271 IPFE-----IGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGS 325
+ G +L+ N P I NR+ K +
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 326 L--INLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDN----LIHLSE 379
L + + + + + +LE L +L L+L N + L +L E
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247
Query: 380 LDLSHNFLGEKISSRICRM------ESLEKLNLSYNNLSGLIPRCFEE-----LHGLLHI 428
L L+ L + ++ + L+ L L YN + R + + LL +
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 429 DISYNKLEGHIPNSTTFRDAPLEALQGN 456
+++ N+ R+ +G
Sbjct: 308 ELNGNRFSEEDDVVDEIREVFSTRGRGE 335
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 39/201 (19%), Positives = 75/201 (37%), Gaps = 18/201 (8%)
Query: 156 LTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNN 215
L + + + ++ L+ + L D + SI + NL + NN
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNN 72
Query: 216 SFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEI 275
+ P L ++ ++ L ++ +L +++ N +
Sbjct: 73 QLTDITP--------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 124
Query: 276 GESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLS 335
L L+LSSN I + L +++ S N+++ P L +L LE LD+S
Sbjct: 125 KNLTNLNRLELSSNTISDISALS--GLTSLQQLNFSSNQVTDLKP--LANLTTLERLDIS 180
Query: 336 ANHLSNFVLESLGSLVKLYYL 356
+N +S+ + L L L L
Sbjct: 181 SNKVSD--ISVLAKLTNLESL 199
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.6 bits (93), Expect = 2e-04
Identities = 39/196 (19%), Positives = 77/196 (39%), Gaps = 13/196 (6%)
Query: 254 CP-----QLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQL-GNIIYLNR 307
CP + + +D + + IP +I L L+ N + L G + +L +
Sbjct: 2 CPAMCHCEGTTVDCTGRGLK-EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVK 58
Query: 308 ISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQI 367
+ L N+L+G P +++ L L N + + L +L LNL N++S +
Sbjct: 59 LELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVM 118
Query: 368 PIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLH 427
P ++L L+ L+ + E L K +L+ P ++ +
Sbjct: 119 PGSFEHLNSLTSLN-LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP---SKVRDVQI 174
Query: 428 IDISYNKLEGHIPNST 443
D+ +++ + NS
Sbjct: 175 KDLPHSEFKCSSENSE 190
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 37.7 bits (86), Expect = 0.003
Identities = 24/160 (15%), Positives = 50/160 (31%), Gaps = 5/160 (3%)
Query: 301 NIIYLNRISLSGNKLS-GRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLS 359
++ L G ++ L +L ++L LS N++ + SL + L L+L
Sbjct: 21 VATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK--ISSLSGMENLRILSLG 78
Query: 360 HNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCF 419
N + LD + E +S + + +
Sbjct: 79 RNL--IKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWGEIDKL 136
Query: 420 EELHGLLHIDISYNKLEGHIPNSTTFRDAPLEALQGNKGL 459
L L + ++ N L + + +E ++ L
Sbjct: 137 AALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNL 176
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 752 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.96 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.83 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.82 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.82 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.81 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.81 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.8 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.79 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.78 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.77 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.75 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.58 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.57 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.56 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.56 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.55 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.54 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.54 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.5 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.39 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.37 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.36 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.35 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.57 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.55 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.98 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.83 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.65 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.32 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.13 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.01 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.58 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.15 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.07 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 90.53 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=389.59 Aligned_cols=225 Identities=24% Similarity=0.352 Sum_probs=187.3
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEec
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~~ 555 (752)
++|++.++||+|+||+||+|+. .+|+.||||+++..... +++...+..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999994 67999999988643322 4456678899999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 635 (752)
++|+|.+++.+. .+++.+++.++.||+.||+|||++ ||+||||||+|||++.++++||+|||+|+........
T Consensus 100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 999999988654 389999999999999999999999 9999999999999999999999999999987655555
Q ss_pred cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhcc-CCCCCChhhHHHHHH
Q 041438 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS-RLPYPSLDVQNKFMS 714 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 714 (752)
....+||+.|+|||++.+..+++++||||+||++|||+||+.||... ........+... ....+ .....+++
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-----~~~~~~~~~~~~~~~~~~--~~~~~s~~ 245 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE-----NPLRALYLIATNGTPELQ--NPEKLSAI 245 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHHHHCSCCCS--SGGGSCHH
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC-----CHHHHHHHHHhCCCCCCC--CcccCCHH
Confidence 56678999999999999999999999999999999999999998521 111222222222 22222 12456678
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+.++|.+||++||++|||++|+++|
T Consensus 246 ~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 246 FRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=387.61 Aligned_cols=223 Identities=25% Similarity=0.399 Sum_probs=188.1
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV 551 (752)
.++|++.+.||+|+||.||+|+. .+++.||||++.+.... +++.+++..|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 46899999999999999999995 57899999987532100 456677889999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
||||++|+|.+++.... .+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 85 mEy~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EeecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999997543 488999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
. ......||+.|+|||++.+..+++++||||+||++|||++|+.||.. ....+....+.......|. ..
T Consensus 159 ~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-----~~~~~~~~~i~~~~~~~p~----~~ 227 (263)
T d2j4za1 159 S--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-----NTYQETYKRISRVEFTFPD----FV 227 (263)
T ss_dssp C--CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-----SSHHHHHHHHHTTCCCCCT----TS
T ss_pred C--cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC-----CCHHHHHHHHHcCCCCCCc----cC
Confidence 2 33456899999999999999999999999999999999999999852 2223344455555555542 34
Q ss_pred HHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 712 FMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
++++.+++.+||++||++|||++|+++|
T Consensus 228 s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 228 TEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 5678899999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=384.85 Aligned_cols=228 Identities=23% Similarity=0.307 Sum_probs=183.8
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E 553 (752)
.++|++.+.||+|+||+||+|+. .+|+.||||+++..... +++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 57899999999999999999995 57999999998643221 44566788999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
||++|+|.+++.... .+++.+++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999997543 489999999999999999999999 99999999999999999999999999999765332
Q ss_pred --CCcccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 634 --SNWSKLAGTHGNVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 634 --~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
......+||+.|||||++.+..+ +.++||||+||++|||+||++||.... ................+ ....
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~----~~~~~~~~~~~~~~~~~--~~~~ 231 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS----DSCQEYSDWKEKKTYLN--PWKK 231 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS----TTSHHHHHHHTTCTTST--TGGG
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCCCCC--cccc
Confidence 22345689999999999988776 678999999999999999999985211 11112222222222211 2245
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.++++.+++.+||+.||++|||++|+++|
T Consensus 232 ~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 232 IDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 56788899999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-47 Score=388.00 Aligned_cols=232 Identities=23% Similarity=0.290 Sum_probs=174.5
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Cccc--cCCceEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCS--HPRQSFI 550 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~--~~~~~~l 550 (752)
.++|++.+.||+|+||+||+|+. .+|+.||||+++..... +++. .....|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 36899999999999999999985 57999999998654332 2222 2456899
Q ss_pred EEEeccCCChHHHhccCc-cccccCHHHHHHHHHHHHHHHHHHHhCC--CCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 551 VYEYLESGSLDKILNNDA-SAKELGWTQRLNVIKGVADALFYLHNNC--FPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~--~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
|||||++|+|.+++.+.. ....+++..++.++.||+.||+|||++. ..+|+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999987532 2345899999999999999999999971 0139999999999999999999999999999
Q ss_pred eccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChh
Q 041438 628 FLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLD 707 (752)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (752)
............+||+.|+|||++.+..+++++|||||||++|||+||+.||.. ....+....+.....+...
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~-----~~~~~~~~~i~~~~~~~~~-- 235 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-----FSQKELAGKIREGKFRRIP-- 235 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-----SSHHHHHHHHHHTCCCCCC--
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC-----CCHHHHHHHHHcCCCCCCC--
Confidence 876554445567899999999999999999999999999999999999999852 1222333444444433221
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...++++.+++.+||+.||++|||++|+++|
T Consensus 236 -~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 236 -YRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -cccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 2456678999999999999999999999865
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-46 Score=379.00 Aligned_cols=231 Identities=23% Similarity=0.334 Sum_probs=179.8
Q ss_pred cccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEeccC
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~~~ 557 (752)
++|++.+.||+|+||.||+|++.+++.||||+++..... +++..++..++|||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 579999999999999999999988999999998764432 556677889999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC-c
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN-W 636 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~ 636 (752)
|+|.+++.... ..+++..+..++.||++||+|+|++ +|+||||||+||++++++.+||+|||+|+........ .
T Consensus 85 g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 85 GCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp CBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 99999987543 4488999999999999999999999 9999999999999999999999999999876543322 2
Q ss_pred ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhC-CCCcchhhccccccccchHhhhccC-CCCCChhhHHHHHH
Q 041438 637 SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKG-KHPRDFLFEMSSSSSNMNIEILDSR-LPYPSLDVQNKFMS 714 (752)
Q Consensus 637 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 714 (752)
....||+.|+|||++.+..++.++|||||||++|||+|+ ++||.. ....+....+.... ...| ..++++
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~-----~~~~~~~~~i~~~~~~~~p----~~~~~~ 230 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-----RSNSEVVEDISTGFRLYKP----RLASTH 230 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-----CCHHHHHHHHHHTCCCCCC----TTSCHH
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC-----CCHHHHHHHHHhcCCCCCc----cccCHH
Confidence 335789999999999999999999999999999999995 555431 11122223333322 2222 234567
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
+.+++.+||+.||++|||++|++++|+++..
T Consensus 231 l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 231 VYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 8999999999999999999999999998753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-46 Score=384.78 Aligned_cols=229 Identities=22% Similarity=0.298 Sum_probs=186.5
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEe
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~ 554 (752)
.+.|++.+.||+|+||.||+|+. .+++.||||+++..... +++.+++..|+||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 35799999999999999999995 57999999998654322 455667889999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
|++|+|.+++.+.. ..+++.+++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 91 ~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 91 CAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp CTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred CCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence 99999999976533 3489999999999999999999999 999999999999999999999999999987643322
Q ss_pred CcccccCCCCccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 635 NWSKLAGTHGNVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
.....+||+.|+|||++. +..|+.++||||+||++|||+||+.||.. ....+....+.....+... ...
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~-----~~~~~~~~~i~~~~~~~~~-~~~ 239 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE-----LNPMRVLLKIAKSEPPTLA-QPS 239 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTT-----SCGGGHHHHHHHSCCCCCS-SGG
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCC-----CCHHHHHHHHHcCCCCCCC-ccc
Confidence 334468999999999874 45589999999999999999999999852 2223334444444433221 124
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..++++.++|.+||++||++|||++|+++|
T Consensus 240 ~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 566789999999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-45 Score=386.24 Aligned_cols=228 Identities=21% Similarity=0.280 Sum_probs=177.6
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~E 553 (752)
.+.|++.+.||+|+||+||+|+. .+|+.||||++...... +++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46699999999999999999995 57999999998643221 44567788999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC---CCCceEEeecccceecc
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD---LGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~---~~~~~kl~DfG~a~~~~ 630 (752)
||++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||++. +++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999997543 489999999999999999999999 999999999999994 57899999999998765
Q ss_pred CCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
.. ......+||+.|+|||++.+..+++++||||+||++|||++|+.||.. .........+.......+......
T Consensus 162 ~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-----~~~~~~~~~i~~~~~~~~~~~~~~ 235 (307)
T d1a06a_ 162 PG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-----ENDAKLFEQILKAEYEFDSPYWDD 235 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-----SSHHHHHHHHHTTCCCCCTTTTTT
T ss_pred CC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC-----CCHHHHHHHHhccCCCCCCccccC
Confidence 33 233456899999999999999999999999999999999999999852 222334445555555544434456
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.++++.+++.+||++||++|||++|+++|
T Consensus 236 ~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 67789999999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=378.52 Aligned_cols=234 Identities=22% Similarity=0.343 Sum_probs=181.4
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E 553 (752)
.++|++.+.||+|+||.||+|+.. ..||||+++..... +++ ..+..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~-~~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEE-eccEEEEEEe
Confidence 468999999999999999999864 36999998654322 233 3456899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
||++|+|.+++.... ..+++.++..++.||++||+|||++ +||||||||+|||++.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 999999999997543 3489999999999999999999999 99999999999999999999999999998765322
Q ss_pred --CCcccccCCCCccCccccccC---CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCC--Ch
Q 041438 634 --SNWSKLAGTHGNVAPELAYTM---KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYP--SL 706 (752)
Q Consensus 634 --~~~~~~~gt~~y~aPE~~~~~---~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 706 (752)
.......||+.|||||++.+. .++.++|||||||++|||+||+.||... ................+ ..
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~-----~~~~~~~~~~~~~~~~p~~~~ 233 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI-----NNRDQIIFMVGRGYLSPDLSK 233 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC-----CCHHHHHHHHHHTSCCCCGGG
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC-----ChHHHHHHHHhcCCCCCcchh
Confidence 223445899999999998643 4789999999999999999999998521 11112222222222111 11
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
....+++++.+++.+||+.||++|||++|++++|+.+..+
T Consensus 234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 1234567899999999999999999999999999998754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-45 Score=382.32 Aligned_cols=234 Identities=25% Similarity=0.421 Sum_probs=178.3
Q ss_pred cccccceeeccCCceEEEEEEeC-CC---cEEEEEccCCCCCC-------------------------CccccCCceEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVP-SG---EIFAVKKFHSPLPD-------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV 551 (752)
++|++.+.||+|+||+||+|+.. ++ ..||||++...... +++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45777899999999999999853 33 36899987654321 556677889999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
||||++|+|.+++.... ..+++.++..++.||++||+|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 106 ~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999887643 3489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCc-----ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc-CCCCC
Q 041438 632 DSSNW-----SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RLPYP 704 (752)
Q Consensus 632 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~ 704 (752)
..... ....||+.|+|||++.+..++.++|||||||++|||+| |+.||... ...+....+... +.+.+
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~-----~~~~~~~~i~~~~~~~~~ 255 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-----TNQDVINAIEQDYRLPPP 255 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHTTCCCCCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC-----CHHHHHHHHHcCCCCCCC
Confidence 32221 12357899999999999999999999999999999998 89998521 112222223222 22222
Q ss_pred ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCCC
Q 041438 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPD 748 (752)
Q Consensus 705 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 748 (752)
..+++++.+++.+||+.||++|||++|+++.|+++..+|+
T Consensus 256 ----~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~ 295 (299)
T d1jpaa_ 256 ----MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295 (299)
T ss_dssp ----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChh
Confidence 3456678999999999999999999999999999887764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-46 Score=384.65 Aligned_cols=224 Identities=21% Similarity=0.315 Sum_probs=184.8
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC----C-----------------------CccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP----D-----------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~-----------------------~~~~~~~~~~lV~ 552 (752)
++|++.+.||+|+||+||+|+. .+|+.||||++++... . +++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 6899999999999999999995 5799999998753210 0 4456778899999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
|||++|+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999987543 488999999999999999999999 9999999999999999999999999999987533
Q ss_pred CC--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 633 SS--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 633 ~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
.. .....+||+.|+|||++.+..++.++||||+||++|||+||+.||.. .........+.......|. .
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-----~~~~~~~~~i~~~~~~~p~----~ 232 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-----GNEYLIFQKIIKLEYDFPE----K 232 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHTTCCCCCT----T
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC-----cCHHHHHHHHHcCCCCCCc----c
Confidence 22 23345899999999999999999999999999999999999999962 2223344555555555552 3
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.++++.++|.+||+.||++|||++|++++
T Consensus 233 ~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 233 FFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 45678999999999999999999997543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-45 Score=369.52 Aligned_cols=229 Identities=24% Similarity=0.350 Sum_probs=190.4
Q ss_pred cccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEeccC
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~~~ 557 (752)
++|++.++||+|+||.||+|+.++++.||||+++..... +++.+++..++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 689999999999999999999988999999998764432 556777899999999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC-Cc
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS-NW 636 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~ 636 (752)
|++.+++.... ..+++..+.+++.||++||+|||+. ||+||||||+||++++++.+||+|||+|+....... ..
T Consensus 84 g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 84 GCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp EEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 99999976543 3578899999999999999999999 999999999999999999999999999987654332 22
Q ss_pred ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccC-CCCCChhhHHHHHH
Q 041438 637 SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSR-LPYPSLDVQNKFMS 714 (752)
Q Consensus 637 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 714 (752)
....||+.|+|||.+.+..++.|+|||||||++|||+| |+.||+.. ...+....+.... .+.| ...+++
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~-----~~~~~~~~i~~~~~~~~p----~~~~~~ 229 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-----TNSETAEHIAQGLRLYRP----HLASEK 229 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-----CHHHHHHHHHTTCCCCCC----TTCCHH
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC-----CHHHHHHHHHhCCCCCCc----ccccHH
Confidence 34578999999999999999999999999999999998 89998521 1222333333332 2222 344567
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
+.++|.+||+.||++|||++|++++|.++
T Consensus 230 l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 230 VYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 89999999999999999999999999764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-45 Score=384.62 Aligned_cols=225 Identities=23% Similarity=0.296 Sum_probs=191.2
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC----C-----------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP----D-----------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~-----------------------~~~~~~~~~~lV 551 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||++++... . +++.+.+..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 46899999999999999999994 6899999998864211 0 445677889999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
||||++|+|.+++...+ .+++..++.++.||+.||+|||++ ||+||||||+|||++++|.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999987654 488899999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
........+||+.|+|||++.+..|++++||||+||++|||++|++||.. ....+....+.......|. ..
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~-----~~~~~~~~~i~~~~~~~p~----~~ 228 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-----QDHERLFELILMEEIRFPR----TL 228 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHHCCCCCCT----TS
T ss_pred CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC-----cCHHHHHHHHhcCCCCCCc----cC
Confidence 55555667999999999999999999999999999999999999999852 2233344555555666553 35
Q ss_pred HHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 041438 712 FMSIMQVAFSCLDQNPVSRPT-----MKRFEVQ 739 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 739 (752)
++++.++|.+||++||++||+ ++|+++|
T Consensus 229 s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 667899999999999999995 8888875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.1e-45 Score=386.66 Aligned_cols=229 Identities=19% Similarity=0.282 Sum_probs=192.6
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEe
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~ 554 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||++...... +++.+.+..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46899999999999999999995 57999999998654321 456677899999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC--CCCceEEeecccceeccCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD--LGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~--~~~~~kl~DfG~a~~~~~~ 632 (752)
|++|+|.+++.... ..+++..++.|+.||+.||+|||++ |||||||||+|||++ .++.+||+|||+|+.....
T Consensus 105 ~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 99999999986443 3489999999999999999999999 999999999999996 4578999999999987543
Q ss_pred CCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHH
Q 041438 633 SSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (752)
.......||+.|||||++.+..++.++||||+||++|||+||+.||.. ....+....+.......+.......+
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-----~~~~~~~~~i~~~~~~~~~~~~~~~s 253 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-----ENDDETLRNVKSCDWNMDDSAFSGIS 253 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHHTCCCSCCGGGGGCC
T ss_pred -cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC-----CCHHHHHHHHHhCCCCCCcccccCCC
Confidence 334456899999999999999999999999999999999999999852 22334445555555555544445667
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+++.++|.+||+.||++|||++|+++|
T Consensus 254 ~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 254 EDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 789999999999999999999999987
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-45 Score=373.42 Aligned_cols=232 Identities=20% Similarity=0.308 Sum_probs=186.9
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEecc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~~ 556 (752)
.++|++.+.||+|+||.||+|+.++++.||||+++..... +++ ..+..++|||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~-~~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeee-ccCCeEEEEEeCC
Confidence 4689999999999999999999988899999998764332 333 3456799999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC-C
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS-N 635 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~ 635 (752)
+|+|.+++.... ...+++..+..|+.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+....... .
T Consensus 91 ~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 91 NGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999999886543 23589999999999999999999999 999999999999999999999999999998754332 2
Q ss_pred cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccC-CCCCChhhHHHHHH
Q 041438 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR-LPYPSLDVQNKFMS 714 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 714 (752)
.....||+.|+|||++.+..++.++|||||||++|||+||..|+.. .....+....+.... ...| ...+++
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~----~~~~~~~~~~i~~~~~~~~p----~~~~~~ 238 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP----GMTNPEVIQNLERGYRMVRP----DNCPEE 238 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST----TCCHHHHHHHHHTTCCCCCC----TTCCHH
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC----CCCHHHHHHHHHhcCCCCCc----ccChHH
Confidence 2345789999999999999999999999999999999996655421 111122223333222 2222 345567
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
+.+++.+||+.||++|||++||++.|+++.
T Consensus 239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 899999999999999999999999998864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-45 Score=379.54 Aligned_cols=236 Identities=21% Similarity=0.289 Sum_probs=190.5
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEe
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~ 554 (752)
..++|++.+.||+|+||+||+|+. .+++.||||+++..... +++.+.+..++||||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 456899999999999999999995 46899999998765433 456677889999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
|++|+|.+++.... ...+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 95 ~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999997643 24589999999999999999999999 999999999999999999999999999987654332
Q ss_pred C-cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHH
Q 041438 635 N-WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 635 ~-~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
. .....|++.|+|||++.+..++.|+|||||||++|||++|..||.. ..........+......+. ....++
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~-----~~~~~~~~~~i~~~~~~~~--~~~~~~ 243 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-----GIDLSQVYELLEKDYRMER--PEGCPE 243 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST-----TCCHHHHHHHHHTTCCCCC--CTTCCH
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-----cchHHHHHHHHhcCCCCCC--CccchH
Confidence 2 2234688999999999999999999999999999999997777531 1111222223332222111 134566
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
++.+++.+||+.||++|||++|+++.|+.+..
T Consensus 244 ~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 244 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 89999999999999999999999999988743
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=375.79 Aligned_cols=228 Identities=18% Similarity=0.291 Sum_probs=190.2
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------------CccccCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------------NFCSHPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------------~~~~~~~~~ 548 (752)
.++|++.+.||+|+||+||+|+. .+|+.||||++++.... +++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999995 67999999988543211 456677889
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC----ceEEeecc
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY----EAHVSDFR 624 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~----~~kl~DfG 624 (752)
|+|||||++|+|.+++...+ .+++..++.++.||+.||+|||+. +|+||||||+||+++.++ .+|++|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999997643 489999999999999999999999 999999999999998776 49999999
Q ss_pred cceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCC
Q 041438 625 IAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYP 704 (752)
Q Consensus 625 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (752)
+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.. ....+....+.......+
T Consensus 163 ~a~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-----~~~~~~~~~i~~~~~~~~ 236 (293)
T d1jksa_ 163 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-----DTKQETLANVSAVNYEFE 236 (293)
T ss_dssp TCEECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHTTCCCCC
T ss_pred hhhhcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC-----CCHHHHHHHHHhcCCCCC
Confidence 999875432 33456899999999999999999999999999999999999999852 222333444555555555
Q ss_pred ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 705 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.......++++.++|.+||+.||++|||++|+++|
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 237 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 44445567789999999999999999999999875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-44 Score=385.46 Aligned_cols=229 Identities=19% Similarity=0.270 Sum_probs=191.8
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC------------------------CccccCCceEEEEEe
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~lV~E~ 554 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||+++..... +++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 45799999999999999999995 67999999988654311 456677889999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC--CCCceEEeecccceeccCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD--LGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~--~~~~~kl~DfG~a~~~~~~ 632 (752)
|++|+|.+++.... ..+++.+++.|+.||+.||+|||++ ||+||||||+|||++ .++.+||+|||+|+.....
T Consensus 108 ~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999998876543 3489999999999999999999999 999999999999998 6789999999999987643
Q ss_pred CCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHH
Q 041438 633 SSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKF 712 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (752)
.......||+.|+|||++.+..++.++||||+||++|||+||+.||.. .........+.......+.......+
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-----~~~~~~~~~i~~~~~~~~~~~~~~~s 256 (352)
T d1koba_ 183 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-----EDDLETLQNVKRCDWEFDEDAFSSVS 256 (352)
T ss_dssp -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-----SSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred -CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC-----CCHHHHHHHHHhCCCCCCcccccCCC
Confidence 334456899999999999999999999999999999999999999852 22233344555555555544445667
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+++.++|.+||++||++|||++|+++|
T Consensus 257 ~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 257 PEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 789999999999999999999999886
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-45 Score=385.20 Aligned_cols=235 Identities=23% Similarity=0.317 Sum_probs=182.8
Q ss_pred hhcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccCCceEEEE
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~lV~ 552 (752)
..++|++.++||+|+||+||+|+. .+|+.||+|+++..... +++.++...|+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 467899999999999999999995 57999999998654322 4556778899999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||++|+|.+++.+.+ .+++..++.++.|++.||+|||+ . ||+||||||+|||+++++++||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999997643 48899999999999999999996 6 899999999999999999999999999987643
Q ss_pred CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccc----------ccc-----------
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------SSS----------- 690 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~----------~~~----------- 690 (752)
. .....+||+.|+|||++.+..|++++||||+||++|||++|+.||........ ...
T Consensus 158 ~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp H--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred C--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 2 23346899999999999999999999999999999999999999952110000 000
Q ss_pred ----------------cchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--Hhhh
Q 041438 691 ----------------NMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ--SKQF 743 (752)
Q Consensus 691 ----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~~ 743 (752)
+....+..... +.......+.++.+++.+||+.||++|||++|+++| +++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCC--CCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCC--ccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 00000000000 000111234678899999999999999999999986 4443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=379.23 Aligned_cols=232 Identities=21% Similarity=0.293 Sum_probs=184.3
Q ss_pred hcccccceeeccCCceEEEEEEeC-CC-----cEEEEEccCCCCCC--------------------------CccccCCc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP-SG-----EIFAVKKFHSPLPD--------------------------NFCSHPRQ 547 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~~~--------------------------~~~~~~~~ 547 (752)
.++|++.+.||+|+||+||+|+.. .+ ..||||++...... +++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 368999999999999999999853 22 36999987543221 45567788
Q ss_pred eEEEEEeccCCChHHHhccCcc--------------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCC
Q 041438 548 SFIVYEYLESGSLDKILNNDAS--------------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISS 607 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp 607 (752)
.|+|||||++|+|.+++..... ...+++..++.|+.||++||+|||++ +||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 9999999999999999976431 23488999999999999999999999 999999999
Q ss_pred CCEEeCCCCceEEeecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhc
Q 041438 608 KNVLLDLGYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFE 684 (752)
Q Consensus 608 ~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~ 684 (752)
+||+++.++.+||+|||+|+........ .....||+.|||||++.+..+++++|||||||++|||+| |+.||...
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~-- 270 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI-- 270 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC--
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC--
Confidence 9999999999999999999876544332 224568999999999999999999999999999999998 89998521
Q ss_pred cccccccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHh
Q 041438 685 MSSSSSNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSK 741 (752)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 741 (752)
........++......+. ....++++.++|.+||+.||++|||++||+++|.
T Consensus 271 ---~~~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 ---PVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp ---CCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---CHHHHHHHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 122223333333322221 1345667999999999999999999999999996
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4e-44 Score=368.71 Aligned_cols=228 Identities=20% Similarity=0.289 Sum_probs=191.1
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------------Ccccc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------------NFCSH 544 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------------~~~~~ 544 (752)
.++|++.+.||+|+||+||+|+. .+|+.||||++++.... +++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999995 67999999998643211 44567
Q ss_pred CCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecc
Q 041438 545 PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFR 624 (752)
Q Consensus 545 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG 624 (752)
++..|+|||||++|+|.+++...+ .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 788999999999999999997543 489999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCCCcccccCCCCccCcccccc------CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc
Q 041438 625 IAKFLNLDSSNWSKLAGTHGNVAPELAYT------MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD 698 (752)
Q Consensus 625 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 698 (752)
+|+...... ......||+.|+|||++.+ ..+++++||||+||++|||+||+.||.. .........+..
T Consensus 156 ~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-----~~~~~~~~~i~~ 229 (277)
T d1phka_ 156 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-----RKQMLMLRMIMS 229 (277)
T ss_dssp TCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHH
T ss_pred heeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC-----CCHHHHHHHHHh
Confidence 999876433 3445689999999998763 3478899999999999999999999962 223334445555
Q ss_pred cCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 699 SRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 699 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.....+.......++++.+++.+||++||++|||++|+++|
T Consensus 230 ~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 230 GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 55555544456778899999999999999999999999876
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=376.11 Aligned_cols=235 Identities=20% Similarity=0.276 Sum_probs=177.1
Q ss_pred hhcccccceeeccCCceEEEEEEeC------CCcEEEEEccCCCCCC--------------------------Cc-cccC
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARVP------SGEIFAVKKFHSPLPD--------------------------NF-CSHP 545 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--------------------------~~-~~~~ 545 (752)
..++|++.++||+|+||.||+|+.. +++.||||+++..... ++ ....
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 3478999999999999999999842 3578999998653321 12 2334
Q ss_pred CceEEEEEeccCCChHHHhccCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe
Q 041438 546 RQSFIVYEYLESGSLDKILNNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL 612 (752)
Q Consensus 546 ~~~~lV~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll 612 (752)
...++|||||++|+|.+++..... ...+++.++..++.||++||+|||++ +|+||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeE
Confidence 568999999999999999975431 23488999999999999999999999 99999999999999
Q ss_pred CCCCceEEeecccceeccCCCC--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCC-CCcchhhcccccc
Q 041438 613 DLGYEAHVSDFRIAKFLNLDSS--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGK-HPRDFLFEMSSSS 689 (752)
Q Consensus 613 ~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~-~pf~~~~~~~~~~ 689 (752)
++++.+||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||+||. +||... ...
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~----~~~ 243 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----KID 243 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----CCS
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC----CHH
Confidence 9999999999999987654332 233458999999999999999999999999999999999974 566421 111
Q ss_pred ccchHhhhcc-CCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 690 SNMNIEILDS-RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 690 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
......+... +.+.+ ...++++.+++.+||+.||++|||++|+++||+++.
T Consensus 244 ~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 244 EEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HHHHHHHHHTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCC----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1112222222 22222 335567899999999999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-44 Score=365.04 Aligned_cols=222 Identities=19% Similarity=0.250 Sum_probs=174.3
Q ss_pred cccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Cccc----cCCceEEE
Q 041438 503 FDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCS----HPRQSFIV 551 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~----~~~~~~lV 551 (752)
|++.++||+|+||+||+|+. .+++.||+|++...... +++. .....|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 36778899999999999995 57889999987654321 1221 23557999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCEEeC-CCCceEEeeccccee
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPP--IVHWDISSKNVLLD-LGYEAHVSDFRIAKF 628 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~--ivH~DlKp~NIll~-~~~~~kl~DfG~a~~ 628 (752)
||||++|+|.+++.+.. .+++..++.++.||++||+|||++ + |+||||||+|||++ +++.+||+|||+|+.
T Consensus 91 mE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 99999999999997543 488999999999999999999998 7 99999999999996 578999999999986
Q ss_pred ccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhh
Q 041438 629 LNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDV 708 (752)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (752)
... ......+||+.|+|||++.+ +++.++||||+||++|||++|+.||... .........+..... +....
T Consensus 165 ~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~----~~~~~~~~~i~~~~~--~~~~~ 235 (270)
T d1t4ha_ 165 KRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC----QNAAQIYRRVTSGVK--PASFD 235 (270)
T ss_dssp CCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC----SSHHHHHHHHTTTCC--CGGGG
T ss_pred ccC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc----ccHHHHHHHHHcCCC--CcccC
Confidence 432 33445689999999998865 5999999999999999999999998521 111222223322221 11122
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 709 QNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 709 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...++++.++|.+||++||++|||++|+++|
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 236 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 3345678999999999999999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-44 Score=375.85 Aligned_cols=222 Identities=25% Similarity=0.321 Sum_probs=180.8
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIVY 552 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV~ 552 (752)
..|+..+.||+|+||.||+|+. .+|+.||||+++..... +++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4599999999999999999994 67899999998654321 4456678899999
Q ss_pred EeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCC
Q 041438 553 EYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 553 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~ 632 (752)
|||.+|++..++... ..+++.+++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 999999998766543 3489999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCcccccCCCCccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhH
Q 041438 633 SSNWSKLAGTHGNVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQ 709 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (752)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.. .........+.....+... ..
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~-----~~~~~~~~~i~~~~~~~~~--~~ 237 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-----MNAMSALYHIAQNESPALQ--SG 237 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT-----SCHHHHHHHHHHSCCCCCS--CT
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC-----CCHHHHHHHHHhCCCCCCC--CC
Confidence 234589999999999864 4589999999999999999999999852 1122223333333333221 13
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 710 NKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 710 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
..++++.++|.+||+.||++|||++|+++|
T Consensus 238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 456689999999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=380.03 Aligned_cols=223 Identities=24% Similarity=0.346 Sum_probs=188.5
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC----C------------------------CccccCCceEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP----D------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~------------------------~~~~~~~~~~lV 551 (752)
++|++.+.||+|+||+||+|+. .+|+.||||++++... . +++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 6899999999999999999995 5799999999853210 0 445677889999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
||||++|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999997644 478899999999999999999999 999999999999999999999999999997765
Q ss_pred CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
.........||+.|+|||++.+..+++++||||+||++|||+||+.||.. .........+.......|. ..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~-----~~~~~~~~~i~~~~~~~p~----~~ 226 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-----QDEEELFHSIRMDNPFYPR----WL 226 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHHCCCCCCT----TS
T ss_pred ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC-----CCHHHHHHHHHcCCCCCCc----cC
Confidence 55555667899999999999999999999999999999999999999952 2233344445555555542 34
Q ss_pred HHHHHHHHHhccCcCCCCCCCHH-HHHH
Q 041438 712 FMSIMQVAFSCLDQNPVSRPTMK-RFEV 738 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rps~~-evl~ 738 (752)
++++.++|.+||++||++|||+. |+++
T Consensus 227 s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 227 EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 56789999999999999999996 6764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-44 Score=377.02 Aligned_cols=234 Identities=22% Similarity=0.304 Sum_probs=185.5
Q ss_pred hcccccce-eeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------Cccc----cCCceEEEEE
Q 041438 500 TNDFDAKH-CIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------NFCS----HPRQSFIVYE 553 (752)
Q Consensus 500 ~~~y~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------~~~~----~~~~~~lV~E 553 (752)
.++|++.. .||+|+||.||+|+. .+++.||||+++..... +++. .....|+|||
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE 89 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 89 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEE
Confidence 56898875 599999999999994 67999999987542111 1222 2456899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC---CCceEEeecccceecc
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL---GYEAHVSDFRIAKFLN 630 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~---~~~~kl~DfG~a~~~~ 630 (752)
||+||+|.+++...+. ..+++.+++.|+.||+.||+|||+. ||+||||||+|||++. .+.+||+|||+|+...
T Consensus 90 y~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 90 CLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp CCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred CCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeecc
Confidence 9999999999976432 4589999999999999999999999 9999999999999985 5679999999999876
Q ss_pred CCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHH
Q 041438 631 LDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQN 710 (752)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (752)
... .....+||+.|+|||++.+..|++++||||+||++|||+||+.||....... ........+.......+......
T Consensus 166 ~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~ 243 (335)
T d2ozaa1 166 SHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGMKTRIRMGQYEFPNPEWSE 243 (335)
T ss_dssp CCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------CCCSCSSSCCTTHHHH
T ss_pred CCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH-HHHHHHHHHhcCCCCCCCccccc
Confidence 433 3345689999999999999999999999999999999999999996321110 11112223334444455444556
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.++++.++|.+||+.||++|||++|+++|
T Consensus 244 ~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 244 VSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 77889999999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-44 Score=368.65 Aligned_cols=230 Identities=23% Similarity=0.287 Sum_probs=184.6
Q ss_pred hcccccce-eeccCCceEEEEEEeC---CCcEEEEEccCCCCCC-------------------------CccccCCceEE
Q 041438 500 TNDFDAKH-CIGKGGHGSVYIARVP---SGEIFAVKKFHSPLPD-------------------------NFCSHPRQSFI 550 (752)
Q Consensus 500 ~~~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~l 550 (752)
.++|.+.+ +||+|+||.||+|... ++..||||+++..... +++. .+..|+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec-cCeEEE
Confidence 35677777 4999999999999743 4568999998654322 3443 456899
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
|||||++|+|.+++.... ..+++.++..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 86 vmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999999986543 3589999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCC---cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccC-CCCCC
Q 041438 631 LDSSN---WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSR-LPYPS 705 (752)
Q Consensus 631 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~ 705 (752)
..... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||... ...+....+.... .+.|
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~-----~~~~~~~~i~~~~~~~~p- 234 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-----KGPEVMAFIEQGKRMECP- 234 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----CTHHHHHHHHTTCCCCCC-
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC-----CHHHHHHHHHcCCCCCCC-
Confidence 43321 223468999999999999999999999999999999998 99998521 1222233333332 2233
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
..+++++.++|.+||+.||++|||+.+|.+.|+.+.
T Consensus 235 ---~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 235 ---PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp ---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 345678899999999999999999999999998764
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=3.1e-43 Score=370.84 Aligned_cols=293 Identities=29% Similarity=0.473 Sum_probs=168.5
Q ss_pred CCCHHHHHHHHHHHHccccCCccccCCCCccccCCCCCCCC--cccceeeCCC---CCEEEEEcCCCCCcccc-cccccC
Q 041438 33 SNSTEEAHALVKWKASLEVHSRSLLHSWSLSFVNATKISLC--TWSGIHCNHA---GRVFGINLTSISLNGTL-LEFSFS 106 (752)
Q Consensus 33 ~~~~~~~~aLl~fk~~~~~~~~~~l~sW~~~~~~~~~~~~c--~w~gv~C~~~---~~v~~l~l~~~~l~g~l-~~~~f~ 106 (752)
.|.|+|++||++||+++.++ ..+++|. .+ .||| .|.||+|+.. +||+.++|.++++.|.. .+.+++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~--~~l~sW~----~~--~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~ 73 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNP--TTLSSWL----PT--TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCC--GGGTTCC----TT--SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGG
T ss_pred CCCHHHHHHHHHHHHHCCCC--CcCCCCC----CC--CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHh
Confidence 47899999999999999754 3689996 22 3899 5999999854 37888888877777643 233455
Q ss_pred CCCCCCEEECCC-CcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcE
Q 041438 107 SFPHLAYLDLYN-NELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNH 185 (752)
Q Consensus 107 ~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 185 (752)
.|++|++|+|++ |+++|.+|.+|++|++|++|+|++|++.+..+..+..+.+|+++++++|.+.+.+|..+++++.|+.
T Consensus 74 ~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~ 153 (313)
T d1ogqa_ 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153 (313)
T ss_dssp GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCE
T ss_pred cCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccce
Confidence 555555555554 4555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred EEccCCCCCCcCCcCccCCCcc-eEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccc
Q 041438 186 LILDSNFLGGSIPRSLSNFTNL-VFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSI 264 (752)
Q Consensus 186 L~L~~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~ 264 (752)
+++++|.+++.+|..+..+.++ +.+++++|++++..|..+.
T Consensus 154 l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~-------------------------------------- 195 (313)
T d1ogqa_ 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA-------------------------------------- 195 (313)
T ss_dssp EECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGG--------------------------------------
T ss_pred eecccccccccccccccccccccccccccccccccccccccc--------------------------------------
Confidence 5555555555555555544443 4455555555544444433
Q ss_pred cccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccc
Q 041438 265 NNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVL 344 (752)
Q Consensus 265 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 344 (752)
.+.. ..+++++|.+.+.+|..+..+++|+.+++++|.+.+.+| .++.+++|++|+|++|++++.+|
T Consensus 196 ------------~l~~-~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP 261 (313)
T d1ogqa_ 196 ------------NLNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLP 261 (313)
T ss_dssp ------------GCCC-SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCC
T ss_pred ------------cccc-ccccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCC
Confidence 3322 234444444444444444444444444444444444332 34444555555555555555555
Q ss_pred hhhcccccccEEEcCCCcCccccchhccccccCCeeecCCcc
Q 041438 345 ESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNF 386 (752)
Q Consensus 345 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 386 (752)
..|+++++|++|+|++|+|+|.+| .++++++|+.+++++|+
T Consensus 262 ~~l~~L~~L~~L~Ls~N~l~g~iP-~~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 262 QGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302 (313)
T ss_dssp GGGGGCTTCCEEECCSSEEEEECC-CSTTGGGSCGGGTCSSS
T ss_pred hHHhCCCCCCEEECcCCcccccCC-CcccCCCCCHHHhCCCc
Confidence 555555555555555555555555 24555666666666665
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8e-44 Score=373.63 Aligned_cols=222 Identities=24% Similarity=0.359 Sum_probs=187.0
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~lV 551 (752)
.++|++.+.||+|+||+||+|+. .+|+.||||++++.... +++.+++..|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 36899999999999999999995 67999999988532110 445677899999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
||||+||++..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 83 mE~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eeecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999999987654 367889999999999999999999 999999999999999999999999999998653
Q ss_pred CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
. ....+||+.|+|||++.+..+++++||||+||++|||+||+.||.. ....+....+.......+. ..
T Consensus 157 ~---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~-----~~~~~~~~~i~~~~~~~p~----~~ 224 (316)
T d1fota_ 157 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-----SNTMKTYEKILNAELRFPP----FF 224 (316)
T ss_dssp C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-----SSHHHHHHHHHHCCCCCCT----TS
T ss_pred c---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC-----cCHHHHHHHHHcCCCCCCC----CC
Confidence 2 3346899999999999999999999999999999999999999852 2233344555565555542 34
Q ss_pred HHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 041438 712 FMSIMQVAFSCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 739 (752)
++++.+++.+||++||++|| |++|+++|
T Consensus 225 s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 225 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 56788999999999999996 89999876
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.7e-44 Score=382.04 Aligned_cols=226 Identities=20% Similarity=0.288 Sum_probs=181.4
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC---------------------------C---CccccCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP---------------------------D---NFCSHPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------------------------~---~~~~~~~~~ 548 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||++.+... . +++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 47899999999999999999995 5799999998743210 0 345667889
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
|+|||||++|+|.+++.... .+++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999997643 478899999999999999999999 999999999999999999999999999997
Q ss_pred ccCCCCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChh
Q 041438 629 LNLDSSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLD 707 (752)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (752)
.... .....+||+.|+|||++.+ ..+++++||||+||++|||+||+.||..... .................+
T Consensus 157 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~--- 229 (364)
T d1omwa3 157 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT--KDKHEIDRMTLTMAVELP--- 229 (364)
T ss_dssp CSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS--SCHHHHHHHSSSCCCCCC---
T ss_pred cCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcccCCCCCC---
Confidence 7543 2344689999999999874 5689999999999999999999999852110 001111122222222232
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRPT-----MKRFEVQ 739 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 739 (752)
...++++.++|.+||++||++||| ++|+++|
T Consensus 230 -~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 230 -DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 345667899999999999999999 6888765
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=367.32 Aligned_cols=236 Identities=27% Similarity=0.389 Sum_probs=181.5
Q ss_pred hcccccceeeccCCceEEEEEEeCCC-----cEEEEEccCCCCCC-------------------------CccccCCceE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSG-----EIFAVKKFHSPLPD-------------------------NFCSHPRQSF 549 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~-------------------------~~~~~~~~~~ 549 (752)
.+.|++.+.||+|+||.||+|++... ..||||+++..... +++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688999999999999999985432 47999998654321 4566778899
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
+|||||.+|++.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 86 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999998886543 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCC---cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccC-CCCCC
Q 041438 630 NLDSSN---WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR-LPYPS 705 (752)
Q Consensus 630 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~ 705 (752)
...... .....||+.|+|||++.+..++.++|||||||++|||++|..|+.. .....+....+.+.. .+.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~----~~~~~~~~~~i~~~~~~~~~- 235 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW----ELSNHEVMKAINDGFRLPTP- 235 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT----TCCHHHHHHHHHTTCCCCCC-
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc----cCCHHHHHHHHhccCCCCCc-
Confidence 543222 2234689999999999999999999999999999999997666431 111122223333322 2222
Q ss_pred hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcCCC
Q 041438 706 LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYNPD 748 (752)
Q Consensus 706 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 748 (752)
...+.++.++|.+||+.||++|||++||++.|+++...|+
T Consensus 236 ---~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~ 275 (283)
T d1mqba_ 236 ---MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275 (283)
T ss_dssp ---TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ---hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence 3455678999999999999999999999999999877664
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-43 Score=367.16 Aligned_cols=234 Identities=24% Similarity=0.351 Sum_probs=182.0
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC---------------------------Ccccc----CCc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD---------------------------NFCSH----PRQ 547 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~----~~~ 547 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||++++.... +++.. ...
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999994 68999999998764332 11111 124
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
.|+|||||++|+|.+++...+ .+++.+++.++.||+.||+|||++ ||+||||||+||+++.++..+++|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 789999999999999887543 488999999999999999999999 99999999999999999999999999988
Q ss_pred eccCCCC---CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCC
Q 041438 628 FLNLDSS---NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYP 704 (752)
Q Consensus 628 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (752)
....... .....+||+.|+|||++.+..+++++||||+||++|||+||++||.. ....+....+.......+
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-----~~~~~~~~~~~~~~~~~~ 234 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-----DSPVSVAYQHVREDPIPP 234 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-----SSHHHHHHHHHHCCCCCG
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC-----cCHHHHHHHHHhcCCCCC
Confidence 6543322 23345899999999999999999999999999999999999999852 122223333333333333
Q ss_pred ChhhHHHHHHHHHHHHhccCcCCCCCC-CHHHHHHHHhhhh
Q 041438 705 SLDVQNKFMSIMQVAFSCLDQNPVSRP-TMKRFEVQSKQFH 744 (752)
Q Consensus 705 ~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~~~ 744 (752)
.......++++.++|.+||++||++|| |++++++.|.++.
T Consensus 235 ~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 235 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 223345667899999999999999999 8999999998864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=372.54 Aligned_cols=229 Identities=19% Similarity=0.259 Sum_probs=192.9
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEec
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~ 555 (752)
.++|++.+.||+|+||+||+|+. .+|+.||||+++..... +++.+.+..|+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 46899999999999999999995 57899999998754321 4556778999999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCC--CceEEeecccceeccCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLG--YEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~--~~~kl~DfG~a~~~~~~~ 633 (752)
++|+|.+++...+ ..+++.+++.|+.||+.||+|||+. ||+||||||+|||++.+ ..+||+|||+++.....
T Consensus 84 ~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 84 SGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 9999999997643 3489999999999999999999999 99999999999999844 57999999999876532
Q ss_pred CCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHHHH
Q 041438 634 SNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNKFM 713 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (752)
.......||+.|+|||...+..+++++||||+||++|+|++|+.||. ..........+.......+.......++
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~-----~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL-----AETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTC-----CSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCC-----CCCHHHHHHHHHhCCCCCChhhccCCCH
Confidence 23344689999999999999999999999999999999999999985 2223344555666666666544455677
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 714 SIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 714 ~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
++.+++.+||++||++|||++|+++|
T Consensus 233 ~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 233 EAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 89999999999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=364.03 Aligned_cols=234 Identities=21% Similarity=0.322 Sum_probs=182.9
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEecc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYLE 556 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~~ 556 (752)
.++|++.+.||+|+||.||+|+..+++.||||+++..... +++ ..+..++|||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~-~~~~~~lv~Ey~~ 94 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMS 94 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSCEEEECCCT
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEE-ecCCeEEEEEecC
Confidence 3689999999999999999999888889999998755432 334 3456899999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC-C
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS-N 635 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~ 635 (752)
+|++..++.... ...+++.++..|+.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+....... .
T Consensus 95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999998887543 23489999999999999999999999 999999999999999999999999999987643322 2
Q ss_pred cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhcc-CCCCCChhhHHHHHH
Q 041438 636 WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDS-RLPYPSLDVQNKFMS 714 (752)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 714 (752)
.....||+.|+|||++.+..++.++|||||||++|||+||..|+.. .....+....+... +.+.+ ..++++
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~----~~~~~~~~~~i~~~~~~~~~----~~~~~~ 242 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP----GMVNREVLDQVERGYRMPCP----PECPES 242 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST----TCCHHHHHHHHHTTCCCCCC----TTSCHH
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC----CCCHHHHHHHHHhcCCCCCC----cccCHH
Confidence 2345789999999999999999999999999999999997666531 11112222222222 22222 345667
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
+.++|.+||+.||++|||+++|++.|+.+..+
T Consensus 243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 99999999999999999999999999987643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=363.86 Aligned_cols=222 Identities=25% Similarity=0.366 Sum_probs=176.2
Q ss_pred eeeccCCceEEEEEEeC---CCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEeccC
Q 041438 507 HCIGKGGHGSVYIARVP---SGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEYLES 557 (752)
Q Consensus 507 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~~~~ 557 (752)
++||+|+||.||+|.+. +++.||||+++..... +++. .+..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCCEEEEEEcCCC
Confidence 57999999999999853 3578999998653321 3443 4567899999999
Q ss_pred CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc-
Q 041438 558 GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW- 636 (752)
Q Consensus 558 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~- 636 (752)
|+|.+++.... .+++.++..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.........
T Consensus 92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999997643 489999999999999999999999 99999999999999999999999999999765433221
Q ss_pred --ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc-CCCCCChhhHHHH
Q 041438 637 --SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RLPYPSLDVQNKF 712 (752)
Q Consensus 637 --~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 712 (752)
....||+.|+|||++.+..++.++|||||||++|||+| |+.||... ...+....+... +.+.| ..++
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~-----~~~~~~~~i~~~~~~~~p----~~~~ 236 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-----KGSEVTAMLEKGERMGCP----AGCP 236 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHHTTCCCCCC----TTCC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC-----CHHHHHHHHHcCCCCCCC----cccC
Confidence 23478999999999999999999999999999999998 89998521 112222233322 22333 3456
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 713 MSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 713 ~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
+++.+++.+||+.||++|||++||.+.|+.+.
T Consensus 237 ~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 237 REMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 78899999999999999999999999888753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-43 Score=374.82 Aligned_cols=222 Identities=20% Similarity=0.284 Sum_probs=186.2
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCC----C-----------------------CccccCCceEEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLP----D-----------------------NFCSHPRQSFIV 551 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~-----------------------~~~~~~~~~~lV 551 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||++++... . +++......++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 36899999999999999999995 5799999998753210 0 345667888999
Q ss_pred EEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccC
Q 041438 552 YEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNL 631 (752)
Q Consensus 552 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~ 631 (752)
|||+.+|+|.+++...+ .+++..++.++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 120 ~e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999987643 488999999999999999999999 999999999999999999999999999998753
Q ss_pred CCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCChhhHHH
Q 041438 632 DSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPSLDVQNK 711 (752)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (752)
. .....||+.|||||++.+..+++++||||+||++|||+||+.||.. .........+.......+ ...
T Consensus 194 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~-----~~~~~~~~~i~~~~~~~p----~~~ 261 (350)
T d1rdqe_ 194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-----DQPIQIYEKIVSGKVRFP----SHF 261 (350)
T ss_dssp C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHHHHHCCCCCC----TTC
T ss_pred c---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC-----cCHHHHHHHHhcCCCCCC----ccC
Confidence 2 3346899999999999999999999999999999999999999852 222334445555555544 245
Q ss_pred HHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 041438 712 FMSIMQVAFSCLDQNPVSRP-----TMKRFEVQ 739 (752)
Q Consensus 712 ~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 739 (752)
++++.++|.+||++||++|+ |++|+++|
T Consensus 262 s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 66789999999999999994 89999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-43 Score=366.55 Aligned_cols=238 Identities=20% Similarity=0.352 Sum_probs=189.7
Q ss_pred HHHHhhcccccceeeccCCceEEEEEEeC------CCcEEEEEccCCCCCC-------------------------Cccc
Q 041438 495 EIIRATNDFDAKHCIGKGGHGSVYIARVP------SGEIFAVKKFHSPLPD-------------------------NFCS 543 (752)
Q Consensus 495 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-------------------------~~~~ 543 (752)
+++-..++|++.+.||+|+||.||+|+.. +++.||||+++..... +++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 33345678999999999999999999853 4678999998754322 4456
Q ss_pred cCCceEEEEEeccCCChHHHhccCcc---------------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 041438 544 HPRQSFIVYEYLESGSLDKILNNDAS---------------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVH 602 (752)
Q Consensus 544 ~~~~~~lV~E~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH 602 (752)
..+..++||||+++|+|.+++..... ...+++.++..|+.|++.||+|||+. +|||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEe
Confidence 67889999999999999999864321 23478899999999999999999999 9999
Q ss_pred cCCCCCCEEeCCCCceEEeecccceeccCCCC--CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCC-CCc
Q 041438 603 WDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS--NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGK-HPR 679 (752)
Q Consensus 603 ~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~-~pf 679 (752)
|||||+|||++.++.+||+|||+|+....... ......||+.|+|||++.+..+++++|||||||++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 99999999999999999999999986643322 223457899999999999999999999999999999999986 566
Q ss_pred chhhccccccccchHhhhccCCC-CCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 680 DFLFEMSSSSSNMNIEILDSRLP-YPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
.. ....+....+.+...+ .+ ..+++++.+++.+||+.||++||||.||++.|+++.
T Consensus 244 ~~-----~~~~e~~~~v~~~~~~~~p----~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YG-----MAHEEVIYYVRDGNILACP----ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TT-----SCHHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CC-----CCHHHHHHHHHcCCCCCCC----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 42 1222333444444332 22 345667899999999999999999999999999873
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-43 Score=356.52 Aligned_cols=229 Identities=25% Similarity=0.344 Sum_probs=179.1
Q ss_pred hcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC----------------------Ccc-ccCCceEEEEEecc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD----------------------NFC-SHPRQSFIVYEYLE 556 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~-~~~~~~~lV~E~~~ 556 (752)
.++|++.+.||+|+||.||+|+. .|+.||||+++..... +++ +..+..|+||||++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 46789999999999999999998 5789999999764322 333 33466899999999
Q ss_pred CCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCCc
Q 041438 557 SGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSNW 636 (752)
Q Consensus 557 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 636 (752)
+|+|.+++.... ...+++..++.|+.||+.||+|||+. +|+||||||+||+++.++.+|++|||+++..... .
T Consensus 85 ~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---~ 157 (262)
T d1byga_ 85 KGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---Q 157 (262)
T ss_dssp TEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC---C
Confidence 999999997543 23589999999999999999999999 9999999999999999999999999999875432 2
Q ss_pred ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc-CCCCCChhhHHHHHH
Q 041438 637 SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RLPYPSLDVQNKFMS 714 (752)
Q Consensus 637 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 714 (752)
....+|..|+|||++.+..+++++|||||||++|||+| |++||.. ....+....+... +.+.+ ...+++
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-----~~~~~~~~~i~~~~~~~~~----~~~~~~ 228 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-----IPLKDVVPRVEKGYKMDAP----DGCPPA 228 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-----SCGGGHHHHHTTTCCCCCC----TTCCHH
T ss_pred ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC-----CCHHHHHHHHHcCCCCCCC----ccCCHH
Confidence 33478899999999999999999999999999999998 6888752 1222223333322 22333 334567
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 715 IMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 715 l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
+.+++.+||+.||++|||++|++++|+++..
T Consensus 229 ~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 229 VYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 8999999999999999999999999998853
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=357.36 Aligned_cols=230 Identities=23% Similarity=0.328 Sum_probs=175.2
Q ss_pred hcccccceeeccCCceEEEEEEeCC----CcEEEEEccCCCCCC-------------------------CccccCCceEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVPS----GEIFAVKKFHSPLPD-------------------------NFCSHPRQSFI 550 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-------------------------~~~~~~~~~~l 550 (752)
.++|++.+.||+|+||.||+|+... +..||||+++..... +++ ..+..|+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-ecCeEEE
Confidence 3689999999999999999998532 457899988643322 333 3467899
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
||||+++|++.+++.... ..+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 85 v~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheecc
Confidence 999999999999876543 3589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC-CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccC-CCCCChh
Q 041438 631 LDSS-NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSR-LPYPSLD 707 (752)
Q Consensus 631 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 707 (752)
.... ......||+.|+|||++.+..++.++|||||||++|||+| |.+||... ...+....+.... .+.+
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~-----~~~~~~~~i~~~~~~~~~--- 231 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-----KNNDVIGRIENGERLPMP--- 231 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC-----CGGGHHHHHHTTCCCCCC---
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC-----CHHHHHHHHHcCCCCCCC---
Confidence 4322 2234578999999999999999999999999999999998 89998522 2222333333332 2232
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 708 VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 708 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
...++++.++|.+||+.||++|||++||+++|+.+.
T Consensus 232 -~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 232 -PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 345678999999999999999999999999998874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=361.49 Aligned_cols=234 Identities=22% Similarity=0.323 Sum_probs=184.8
Q ss_pred hcccccceeeccCCceEEEEEEeC--------CCcEEEEEccCCCCCC--------------------------CccccC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP--------SGEIFAVKKFHSPLPD--------------------------NFCSHP 545 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--------------------------~~~~~~ 545 (752)
.++|++.+.||+|+||.||+|+.. ++..||||+++..... +++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 478999999999999999999842 2347999999765432 456677
Q ss_pred CceEEEEEeccCCChHHHhccCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe
Q 041438 546 RQSFIVYEYLESGSLDKILNNDAS-------------AKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL 612 (752)
Q Consensus 546 ~~~~lV~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll 612 (752)
+..++|||||++|+|.+++..... ...+++.+++.++.||+.||+|||+. +||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 889999999999999999975532 23589999999999999999999999 99999999999999
Q ss_pred CCCCceEEeecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhcccccc
Q 041438 613 DLGYEAHVSDFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSS 689 (752)
Q Consensus 613 ~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~ 689 (752)
+.++.+||+|||.++........ .....||+.|+|||.+.+..|++++|||||||++|||++ |.+||... ..
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~-----~~ 243 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-----PV 243 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC-----CH
Confidence 99999999999999977544322 233578999999999999999999999999999999998 68887521 11
Q ss_pred ccchHhhhcc-CCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 690 SNMNIEILDS-RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 690 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
......+... +.+.+ ...++++.++|.+||++||++||||+||++.|+++.+
T Consensus 244 ~~~~~~i~~~~~~~~p----~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 EELFKLLKEGHRMDKP----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHHHHTTCCCCCC----SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCC----ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 2222222222 22222 3355679999999999999999999999999998753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=357.77 Aligned_cols=217 Identities=22% Similarity=0.332 Sum_probs=177.0
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------------CccccCC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------------NFCSHPR 546 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------------~~~~~~~ 546 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||++++.... +++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 36899999999999999999995 67999999987542110 3445668
Q ss_pred ceEEEEEeccC-CChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC-CCceEEeecc
Q 041438 547 QSFIVYEYLES-GSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL-GYEAHVSDFR 624 (752)
Q Consensus 547 ~~~lV~E~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~-~~~~kl~DfG 624 (752)
..|+||||+.+ +++.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 88999999976 57888876543 488999999999999999999999 9999999999999985 4789999999
Q ss_pred cceeccCCCCCcccccCCCCccCccccccCCC-CCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCC
Q 041438 625 IAKFLNLDSSNWSKLAGTHGNVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPY 703 (752)
Q Consensus 625 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 703 (752)
+|+.... .......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... .+.......
T Consensus 157 ~a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----------~i~~~~~~~ 223 (273)
T d1xwsa_ 157 SGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------EIIRGQVFF 223 (273)
T ss_dssp TCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------HHHHCCCCC
T ss_pred cceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----------HHhhcccCC
Confidence 9987543 23345689999999999987765 678999999999999999999986321 222333333
Q ss_pred CChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 704 PSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 704 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
+ ...++++.++|.+||+.||++|||++|+++|
T Consensus 224 ~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 224 R----QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp S----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C----CCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 3 2345678999999999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=354.74 Aligned_cols=231 Identities=22% Similarity=0.246 Sum_probs=175.1
Q ss_pred hcccccceeeccCCceEEEEEEeC--CC--cEEEEEccCCCCCC---------------------------CccccCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP--SG--EIFAVKKFHSPLPD---------------------------NFCSHPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~---------------------------~~~~~~~~~ 548 (752)
.++|++.+.||+|+||.||+|+.. ++ ..||||++++.... +++. .+..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~-~~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-ecch
Confidence 367999999999999999999842 22 37899998754321 3333 3567
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
++|||||++|++.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 89999999999998887543 4589999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCC---cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhccCCCCC
Q 041438 629 LNLDSSN---WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDSRLPYP 704 (752)
Q Consensus 629 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (752)
....... .....|+..|+|||++.+..++.++|||||||++|||+| |+.||... ...+....+.......+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-----~~~~~~~~i~~~~~~~~ 235 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-----NGSQILHKIDKEGERLP 235 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHTSCCCCC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc-----CHHHHHHHHHhCCCCCC
Confidence 7544322 123467889999999999999999999999999999998 89998521 22222333333332222
Q ss_pred ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 705 SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 705 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
. ....++++.+++.+||+.||++|||++||.+.|++.
T Consensus 236 ~--~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 236 R--PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp C--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C--cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 134566799999999999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-42 Score=361.52 Aligned_cols=230 Identities=23% Similarity=0.384 Sum_probs=179.4
Q ss_pred cccccceeeccCCceEEEEEEe-CCCc----EEEEEccCCCCCC-------------------------CccccCCceEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGE----IFAVKKFHSPLPD-------------------------NFCSHPRQSFI 550 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~-------------------------~~~~~~~~~~l 550 (752)
.+|++.+.||+|+||+||+|+. .+|+ .||+|+++..... +++. .+..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-~~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCeeE
Confidence 5799999999999999999985 3444 5899987643221 3333 356788
Q ss_pred EEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceecc
Q 041438 551 VYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLN 630 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~ 630 (752)
+|||+.+|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 88 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 999999999998887643 4588999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhccccccccchHhhhcc-CCCCCCh
Q 041438 631 LDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSSSNMNIEILDS-RLPYPSL 706 (752)
Q Consensus 631 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 706 (752)
..... .....||+.|+|||++.+..++.++|||||||++|||+| |++||+.. ...+....+..+ +.+.|
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~-----~~~~~~~~i~~~~~~~~p-- 235 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-----PASEISSILEKGERLPQP-- 235 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-----CGGGHHHHHHHTCCCCCC--
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHcCCCCCCC--
Confidence 43332 223468999999999999999999999999999999998 78888521 122222223222 23333
Q ss_pred hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 707 DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 707 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
..+++++.+++.+||+.||++|||++|++++|+++..
T Consensus 236 --~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 236 --PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp --TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 3455678999999999999999999999999988753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-42 Score=360.17 Aligned_cols=224 Identities=20% Similarity=0.233 Sum_probs=172.9
Q ss_pred cceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------------CccccCCceEEEEEe
Q 041438 505 AKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 505 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------------~~~~~~~~~~lV~E~ 554 (752)
..++||+|+||+||+|+. .+|+.||||+++..... +++.+.+..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468899999999999994 57999999998643211 455667889999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+.++++..+.... ..+++..++.+++||+.||+|||++ +|+||||||+|||++.++.+||+|||.|+.......
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9998777666433 3488899999999999999999999 999999999999999999999999999988765555
Q ss_pred CcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhc---------------
Q 041438 635 NWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILD--------------- 698 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~--------------- 698 (752)
.....+||+.|+|||++.+. .++.++||||+||++|||+||++||......+ ....+..
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-----~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-----QLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHHHCCCCTTTSSSTTS
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-----HHHHHHHhcCCCChhhccchhc
Confidence 55556899999999988754 57999999999999999999999985321110 0000000
Q ss_pred -----cCCCCCChh----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 699 -----SRLPYPSLD----VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 699 -----~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.....+... ....++++.+++.+||+.||++|||++|+++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000001100 12335678999999999999999999999976
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-42 Score=357.86 Aligned_cols=246 Identities=20% Similarity=0.284 Sum_probs=182.9
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E 553 (752)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... +++.++...|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999995 67999999998654221 44566788999999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
|+.+ ++.+++.... ...+++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~~-~~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSE-EHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCC-chhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9987 4444443322 23489999999999999999999999 99999999999999999999999999998876555
Q ss_pred CCcccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCcchhhccc----------cccccch---Hhhhcc
Q 041438 634 SNWSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMS----------SSSSNMN---IEILDS 699 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~~pf~~~~~~~----------~~~~~~~---~~~~~~ 699 (752)
.......||+.|+|||.+.... ++.++||||+||++|+|++|+.||....... ...+... ....+.
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 5555668999999999877665 5889999999999999999999995321100 0000000 000000
Q ss_pred CCCCC---Ch----hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HhhhhcCCCCCCC
Q 041438 700 RLPYP---SL----DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ--SKQFHYNPDHNVR 752 (752)
Q Consensus 700 ~~~~~---~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~~~~~~~~~~r 752 (752)
....+ .. .....++++.+++.+||++||++|||++|+++| ++++ ..|-+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~-~~p~p~~~ 297 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV-TKPVPHLR 297 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC-CCCCCCCC
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC-CCCCCCCC
Confidence 00000 00 012234678999999999999999999999997 6554 44444443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=357.34 Aligned_cols=236 Identities=21% Similarity=0.313 Sum_probs=187.9
Q ss_pred hcccccceeeccCCceEEEEEEe------CCCcEEEEEccCCCCCC--------------------------CccccCCc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV------PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQ 547 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--------------------------~~~~~~~~ 547 (752)
.++|++.++||+|+||.||+|+. .+++.||||+++..... +++...+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 47899999999999999999984 35678999998754321 45666778
Q ss_pred eEEEEEeccCCChHHHhccCc---------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEe
Q 041438 548 SFIVYEYLESGSLDKILNNDA---------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLL 612 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll 612 (752)
.++|||||++|+|.+++.... ....+++..+..++.||++||+|||++ +||||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 999999999999999997543 123588999999999999999999999 99999999999999
Q ss_pred CCCCceEEeecccceeccCCCCCc--ccccCCCCccCccccccCCCCCccchhhHHHHHHHHHh-CCCCcchhhcccccc
Q 041438 613 DLGYEAHVSDFRIAKFLNLDSSNW--SKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFLFEMSSSS 689 (752)
Q Consensus 613 ~~~~~~kl~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~ellt-g~~pf~~~~~~~~~~ 689 (752)
+.++.+|++|||.++......... ....||+.|+|||++.+..++.++|||||||++|||+| |++||.. ...
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~-----~~~ 253 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG-----MPV 253 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-----CCS
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC-----CCH
Confidence 999999999999999875433222 33578999999999999999999999999999999999 5555531 112
Q ss_pred ccchHhhhccCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 690 SNMNIEILDSRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
......++........ ....+.++.++|.+||+.||++||||+|+++.|+++..
T Consensus 254 ~~~~~~~i~~~~~~~~--~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 254 DSKFYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp SHHHHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 2223333333322221 13345678999999999999999999999999987643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=354.22 Aligned_cols=240 Identities=23% Similarity=0.280 Sum_probs=181.1
Q ss_pred cccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-----------------------CccccC----CceEEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-----------------------NFCSHP----RQSFIVYE 553 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~----~~~~lV~E 553 (752)
.+|.+.+.||+|+||.||+|+. +|+.||||+++..... +++.+. ...|+|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 4688899999999999999986 6899999988543211 222221 25799999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNC-----FPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-----~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
||++|+|.+++++. .++|.++..++.|++.||+|+|+.. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 82 y~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 99999999999764 3899999999999999999999731 23999999999999999999999999999998
Q ss_pred ccCCCC----CcccccCCCCccCccccccCC------CCCccchhhHHHHHHHHHhCCCCcchhhccccc----------
Q 041438 629 LNLDSS----NWSKLAGTHGNVAPELAYTMK------VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS---------- 688 (752)
Q Consensus 629 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~---------- 688 (752)
...... ......||+.|+|||++.+.. ++.|+|||||||++|||+||..||.........
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 754332 223458999999999987643 577899999999999999999887422111100
Q ss_pred cccchHhhhccCC--CCCCh-hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhc
Q 041438 689 SSNMNIEILDSRL--PYPSL-DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHY 745 (752)
Q Consensus 689 ~~~~~~~~~~~~~--~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 745 (752)
............. ..+.. ........+.+++.+||+.||++|||+.||+++|+++..
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 0111112222222 11211 123455679999999999999999999999999998864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=356.58 Aligned_cols=234 Identities=24% Similarity=0.331 Sum_probs=183.5
Q ss_pred hcccccceeeccCCceEEEEEEeC-CCc--EEEEEccCCCCCC--------------------------CccccCCceEE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP-SGE--IFAVKKFHSPLPD--------------------------NFCSHPRQSFI 550 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~--------------------------~~~~~~~~~~l 550 (752)
.++|++.++||+|+||.||+|++. +|. .||||+++..... +++.+.+..++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 378999999999999999999853 454 4788876432111 44556788999
Q ss_pred EEEeccCCChHHHhccCc-------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCc
Q 041438 551 VYEYLESGSLDKILNNDA-------------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYE 617 (752)
Q Consensus 551 V~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~ 617 (752)
||||+++|+|.+++.... ....+++.++..++.||+.||.|+|+. +|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCc
Confidence 999999999999997542 234689999999999999999999999 9999999999999999999
Q ss_pred eEEeecccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCC-CcchhhccccccccchHhh
Q 041438 618 AHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH-PRDFLFEMSSSSSNMNIEI 696 (752)
Q Consensus 618 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~-pf~~~~~~~~~~~~~~~~~ 696 (752)
+||+|||+|+...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||.. ....+....+
T Consensus 166 ~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~-----~~~~~~~~~i 239 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-----MTCAELYEKL 239 (309)
T ss_dssp EEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-----CCHHHHHHHG
T ss_pred eEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC-----CCHHHHHHHH
Confidence 9999999998654332 2234578999999999999999999999999999999999764 5641 1122222333
Q ss_pred hcc-CCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhhcC
Q 041438 697 LDS-RLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFHYN 746 (752)
Q Consensus 697 ~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 746 (752)
... +.+.+ ...++++.++|.+||+.||++||||+||+++|+++...
T Consensus 240 ~~~~~~~~~----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 240 PQGYRLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp GGTCCCCCC----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HhcCCCCCC----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 332 22222 34566899999999999999999999999999988643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-41 Score=354.90 Aligned_cols=235 Identities=18% Similarity=0.256 Sum_probs=175.4
Q ss_pred hhcccccceeeccCCceEEEEEEe-CC-CcEEEEEccCCCCCC-----------------------------Ccc-----
Q 041438 499 ATNDFDAKHCIGKGGHGSVYIARV-PS-GEIFAVKKFHSPLPD-----------------------------NFC----- 542 (752)
Q Consensus 499 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~-----------------------------~~~----- 542 (752)
+.++|++.++||+|+||+||+|+. .+ ++.||||+++..... +++
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 467999999999999999999995 44 678999987543211 111
Q ss_pred ccCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEee
Q 041438 543 SHPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSD 622 (752)
Q Consensus 543 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~D 622 (752)
......+++|||+.++.+........ ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 12346789999999876655443322 4488999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhcccc----------c----
Q 041438 623 FRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------S---- 688 (752)
Q Consensus 623 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~----------~---- 688 (752)
||.++..... .......||+.|+|||++.+..++.++||||+||++|||+||++||........ .
T Consensus 160 fg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 160 FGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp CCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred hhhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence 9999865432 233456899999999999999999999999999999999999999952211000 0
Q ss_pred ---cccchHhhhccCCCCCC-hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 689 ---SSNMNIEILDSRLPYPS-LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 689 ---~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...............+. ......++.+.+++.+||++||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000001111110 0112345678899999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.3e-41 Score=351.39 Aligned_cols=233 Identities=21% Similarity=0.274 Sum_probs=175.6
Q ss_pred cccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEEe
Q 041438 501 NDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYEY 554 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E~ 554 (752)
++|++.++||+|+||+||+|+..+|+.||||+++..... +.+.+.+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 689999999999999999999989999999998654321 345667889999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSS 634 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 634 (752)
+.++.+..+.... ..+++..++.++.||+.||+|||+. +||||||||+|||++.++.+|++|||.|........
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9987777666543 3489999999999999999999999 999999999999999999999999999988765554
Q ss_pred CcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhcccc----------cccc---chHhh----
Q 041438 635 NWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------SSSN---MNIEI---- 696 (752)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~----------~~~~---~~~~~---- 696 (752)
......|++.|+|||.+.+. .++.++||||+||++|||++|+.||........ .... .....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 45556899999999998765 469999999999999999999999952211000 0000 00000
Q ss_pred --hccCCCCC-ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 697 --LDSRLPYP-SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 697 --~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
.....+.+ .......++++.+++.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 00112345678899999999999999999999865
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-41 Score=349.43 Aligned_cols=226 Identities=23% Similarity=0.333 Sum_probs=178.5
Q ss_pred ceeeccCCceEEEEEEeCC----CcEEEEEccCCCCCC-------------------------Cccc-cCCceEEEEEec
Q 041438 506 KHCIGKGGHGSVYIARVPS----GEIFAVKKFHSPLPD-------------------------NFCS-HPRQSFIVYEYL 555 (752)
Q Consensus 506 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-------------------------~~~~-~~~~~~lV~E~~ 555 (752)
.++||+|+||+||+|++.. ...||||+++..... +++. .+...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5789999999999998543 236899998643221 3333 356789999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCCCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDSSN 635 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 635 (752)
++|+|.+++.... ..+++..+..++.|++.||.|+|+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 9999999987654 3467888999999999999999999 9999999999999999999999999999876543222
Q ss_pred ----cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccC-CCCCChhhHH
Q 041438 636 ----WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSR-LPYPSLDVQN 710 (752)
Q Consensus 636 ----~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 710 (752)
.....||+.|+|||.+.+..++.++|||||||++|||+||..||.... ........+.... ...| ..
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~----~~~~~~~~i~~g~~~~~p----~~ 258 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVYLLQGRRLLQP----EY 258 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHHHTTCCCCCC----TT
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC----CHHHHHHHHHcCCCCCCc----cc
Confidence 223478999999999999999999999999999999999888864211 1222233333332 2222 23
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 711 KFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 711 ~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
+++++.++|.+||+.||++||+++||+++|+++.
T Consensus 259 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 4567899999999999999999999999999886
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-41 Score=351.86 Aligned_cols=234 Identities=19% Similarity=0.257 Sum_probs=187.5
Q ss_pred hcccccceeeccCCceEEEEEEeC------CCcEEEEEccCCCCCC-------------------------CccccCCce
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARVP------SGEIFAVKKFHSPLPD-------------------------NFCSHPRQS 548 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-------------------------~~~~~~~~~ 548 (752)
.++|++.+.||+|+||.||+|++. +++.||||+++..... +++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 478999999999999999999852 3678999998754321 455667889
Q ss_pred EEEEEeccCCChHHHhccCc-------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEe
Q 041438 549 FIVYEYLESGSLDKILNNDA-------SAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVS 621 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~ 621 (752)
++|||||++|+|.+++.... ....+++..+..++.|+++||.|||++ +|+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 99999999999999987432 123468899999999999999999999 99999999999999999999999
Q ss_pred ecccceeccCCCCC--cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCC-CCcchhhccccccccchHhhhc
Q 041438 622 DFRIAKFLNLDSSN--WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGK-HPRDFLFEMSSSSSNMNIEILD 698 (752)
Q Consensus 622 DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~-~pf~~~~~~~~~~~~~~~~~~~ 698 (752)
|||+|+........ .....||+.|+|||.+.+..++.++|||||||++|||+||. +||.. ....+....+.+
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-----~~~~~~~~~i~~ 250 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-----LSNEQVLRFVME 250 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-----SCHHHHHHHHHT
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-----CCHHHHHHHHHh
Confidence 99999876543322 22347899999999999999999999999999999999985 66641 122223333444
Q ss_pred cCCCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhhh
Q 041438 699 SRLPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQFH 744 (752)
Q Consensus 699 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 744 (752)
...+... ...++.+.++|.+||+.||++|||++||+++|++..
T Consensus 251 ~~~~~~p---~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 251 GGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp TCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred CCCCCCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 3322111 344567999999999999999999999999998763
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-40 Score=348.53 Aligned_cols=236 Identities=17% Similarity=0.222 Sum_probs=179.3
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEec
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~ 555 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||++...... .+..+.+..++||||+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 46799999999999999999995 67999999987543322 2334567789999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeC---CCCceEEeecccceeccCC
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLD---LGYEAHVSDFRIAKFLNLD 632 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~---~~~~~kl~DfG~a~~~~~~ 632 (752)
.+ ++.+.+.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++ .+..+|++|||+|+.....
T Consensus 86 ~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 86 GP-SLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CC-BHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred CC-chhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 55 7766665433 3589999999999999999999999 999999999999986 3457999999999987543
Q ss_pred CCC-------cccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCCCC
Q 041438 633 SSN-------WSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPYPS 705 (752)
Q Consensus 633 ~~~-------~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (752)
... .....||+.|+|||++.+..+++++|||||||++|||+||+.||......... .............+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~--~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--QKYERISEKKMSTPI 237 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---------HHHHHHHHHHSCH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH--HHHHHhhcccCCCCh
Confidence 321 23457999999999999999999999999999999999999998532211111 111111111111111
Q ss_pred h-hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 706 L-DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 706 ~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
. .....++++.+++.+||+.||++||+++++.+.|+++
T Consensus 238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1 1123556789999999999999999999998888765
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.1e-40 Score=342.48 Aligned_cols=236 Identities=15% Similarity=0.156 Sum_probs=182.4
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-----------------------CccccCCceEEEEEec
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-----------------------NFCSHPRQSFIVYEYL 555 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~lV~E~~ 555 (752)
.++|++.+.||+|+||.||+|+. .+|+.||||++...... .++......++||||+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 36899999999999999999994 57999999987543221 3445677889999999
Q ss_pred cCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCC-----CCceEEeecccceecc
Q 041438 556 ESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDL-----GYEAHVSDFRIAKFLN 630 (752)
Q Consensus 556 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~-----~~~~kl~DfG~a~~~~ 630 (752)
+++|.+++.... ..+++.++..++.|++.||+|||+. ||+||||||+||+++. ++.+||+|||+|+...
T Consensus 84 -~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 84 -GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp -CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred -CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 579999987544 3488999999999999999999999 9999999999999974 5689999999999865
Q ss_pred CCCC-------CcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCC
Q 041438 631 LDSS-------NWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPY 703 (752)
Q Consensus 631 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 703 (752)
.... .....+||+.|||||++.+..+++++|||||||++|||+||+.||...... ........+...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~--~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA--TNKQKYERIGEKKQST 235 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC--CHHHHHHHHHHHHHHS
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch--hHHHHHHHHHhccCCC
Confidence 4321 123457999999999999999999999999999999999999999522110 1111111121111111
Q ss_pred CCh-hhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHhhh
Q 041438 704 PSL-DVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQSKQF 743 (752)
Q Consensus 704 ~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 743 (752)
+.. .....++++.+++..|++.+|++||+++.+.+.++++
T Consensus 236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 111 1123456789999999999999999999988887765
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-40 Score=352.21 Aligned_cols=239 Identities=21% Similarity=0.225 Sum_probs=174.6
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------Ccc------ccCCceEEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------NFC------SHPRQSFIVYE 553 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------~~~------~~~~~~~lV~E 553 (752)
-+|+..++||+|+||+||+|+. .+|+.||||+++..... +++ ....+.|+|||
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 3688899999999999999995 57999999998654322 111 12345789999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC-ceEEeecccceeccCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY-EAHVSDFRIAKFLNLD 632 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~-~~kl~DfG~a~~~~~~ 632 (752)
||+++.+..+.........+++.+++.+++||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 998754444433222334589999999999999999999999 999999999999999775 8999999999887543
Q ss_pred CCCcccccCCCCccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCcchhhcccc----------ccccchHhh----h
Q 041438 633 SSNWSKLAGTHGNVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------SSSNMNIEI----L 697 (752)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~----------~~~~~~~~~----~ 697 (752)
. .....+||+.|+|||.+.+ ..++.++||||+||++|||++|++||........ ...+..... .
T Consensus 177 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 255 (350)
T d1q5ka_ 177 E-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255 (350)
T ss_dssp S-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---
T ss_pred c-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchh
Confidence 3 3344689999999998765 4689999999999999999999999952211000 000000000 0
Q ss_pred ccCCCC----C--ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--Hhhh
Q 041438 698 DSRLPY----P--SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ--SKQF 743 (752)
Q Consensus 698 ~~~~~~----~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~~ 743 (752)
....+. + .......++++.+++.+||+.||++|||++|+++| ++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 001000 0 00112345678999999999999999999999976 4444
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-40 Score=345.70 Aligned_cols=234 Identities=17% Similarity=0.209 Sum_probs=168.4
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------C--------cccc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------N--------FCSH 544 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~--------~~~~ 544 (752)
.++|++.++||+|+||+||+|+. .+|+.||||++...... + +...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 57899999999999999999995 68999999988543221 1 1122
Q ss_pred CCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecc
Q 041438 545 PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFR 624 (752)
Q Consensus 545 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG 624 (752)
....|+||||+.++.+....... ..+++..++.+++|++.||+|||+. ||+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhhcc---cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 45689999999987666554332 3478899999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCC----CcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhcccc----------c-
Q 041438 625 IAKFLNLDSS----NWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS----------S- 688 (752)
Q Consensus 625 ~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~----------~- 688 (752)
+++....... .....+||+.|+|||++.+. .+++++||||+||++|||++|+.||........ .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9987653221 12334799999999998765 589999999999999999999999852111000 0
Q ss_pred -------ccc-chHhhhccCCCCCChh----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 689 -------SSN-MNIEILDSRLPYPSLD----VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 689 -------~~~-~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
... ................ .....+++.+++.+||++||++|||++|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000 0000000000000000 01123467899999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-40 Score=346.36 Aligned_cols=229 Identities=23% Similarity=0.332 Sum_probs=180.3
Q ss_pred hcccccceeeccCCceEEEEEEe----CCCcEEEEEccCCCCC-------C----------------------CccccCC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV----PSGEIFAVKKFHSPLP-------D----------------------NFCSHPR 546 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-------~----------------------~~~~~~~ 546 (752)
.++|++.+.||+|+||+||+|+. .+|+.||||++++... . +++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 47899999999999999999984 2589999998864321 0 3445678
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
..++||||+.+|+|.+++.... .+++..++.++.||+.||+|+|+. +|+||||||+||+++.++.+||+|||+|
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred ceeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 8999999999999999997654 367789999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCC-CcccccCCCCccCccccccC--CCCCccchhhHHHHHHHHHhCCCCcchhhccccccccchHhhhccCCCC
Q 041438 627 KFLNLDSS-NWSKLAGTHGNVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSSNMNIEILDSRLPY 703 (752)
Q Consensus 627 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 703 (752)
+.+..... ......|++.|+|||.+.+. .++.++||||+||++|||+||+.||...... ...............+.
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~-~~~~~i~~~~~~~~~~~ 255 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-NSQAEISRRILKSEPPY 255 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-CCHHHHHHHHHHCCCCC
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcccCCCCC
Confidence 87643322 23445899999999998754 4688999999999999999999999632211 11111222233334444
Q ss_pred CChhhHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 041438 704 PSLDVQNKFMSIMQVAFSCLDQNPVSRPT-----MKRFEVQ 739 (752)
Q Consensus 704 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 739 (752)
+ ...++++.+++.+||++||++||| ++|+++|
T Consensus 256 ~----~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 256 P----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp C----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred c----ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 3 345678999999999999999994 7888864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-39 Score=343.53 Aligned_cols=234 Identities=19% Similarity=0.252 Sum_probs=171.4
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Cccc------cCC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCS------HPR 546 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~------~~~ 546 (752)
.++|++.++||+|+||+||+|+. .+|+.||||+++..... +++. ...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 57899999999999999999995 57999999998754322 1122 223
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
..|+||||+ +.++..+.+.. .+++..++.+++||+.||+|||++ ||+||||||+|||++.++.+|++|||.|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence 579999999 45888877543 389999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCCCcccccCCCCccCccccccC-CCCCccchhhHHHHHHHHHhCCCCcchhhcccc------------------
Q 041438 627 KFLNLDSSNWSKLAGTHGNVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS------------------ 687 (752)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~------------------ 687 (752)
+.... ..+...||+.|+|||++.+. .++.++||||+||++|||++|++||........
T Consensus 169 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 169 RQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp EECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred eccCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 87653 23456899999999988764 468999999999999999999999853211000
Q ss_pred ccccchHhhhccCCCCC----ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--Hhhhh
Q 041438 688 SSSNMNIEILDSRLPYP----SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ--SKQFH 744 (752)
Q Consensus 688 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~~~ 744 (752)
................. .......++++.++|.+||+.||++|||++|+++| ++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00000000000000000 00112345678899999999999999999999987 55543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-39 Score=342.65 Aligned_cols=233 Identities=19% Similarity=0.206 Sum_probs=169.9
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC-------------------------CccccC----CceE
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD-------------------------NFCSHP----RQSF 549 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~----~~~~ 549 (752)
.++|++.++||+|+||+||+|+. .+|+.||||++++.... +++... ...+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46799999999999999999984 68999999998653321 112111 1234
Q ss_pred EEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 550 IVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 550 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
++++|+.+|+|.+++... .+++..++.++.||+.||+|||++ |||||||||+|||++.++.+||+|||+|+..
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 556677789999999754 389999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCC---CcccccCCCCccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCcchhhccccc---------c-------
Q 041438 630 NLDSS---NWSKLAGTHGNVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSS---------S------- 689 (752)
Q Consensus 630 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~---------~------- 689 (752)
..... .....+||+.|+|||++. +..+++++||||+||++|||++|+.||......... .
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 44322 234457999999999875 455789999999999999999999998532110000 0
Q ss_pred --ccchHhhhccC---CCCCC-hhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 690 --SNMNIEILDSR---LPYPS-LDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 690 --~~~~~~~~~~~---~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
........... ...+. ......+.++.+++.+||+.||++|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000000 00110 0112234578899999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-39 Score=334.71 Aligned_cols=233 Identities=17% Similarity=0.209 Sum_probs=179.9
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------CccccCCceEEEEE
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCSHPRQSFIVYE 553 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~lV~E 553 (752)
++|++.++||+|+||+||+|+. .+++.||||+++..... +++.+....++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999994 68899999998644322 34566788899999
Q ss_pred eccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccceeccCCC
Q 041438 554 YLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 554 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~~~~~ 633 (752)
++.++++..++...+ .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999888876543 478899999999999999999999 99999999999999999999999999999876655
Q ss_pred CCcccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCcchhhcccc-----------cccc---chHhhhc
Q 041438 634 SNWSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS-----------SSSN---MNIEILD 698 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~~pf~~~~~~~~-----------~~~~---~~~~~~~ 698 (752)
.......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||........ .... ......+
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 5555567889999999887665 68999999999999999999999631110000 0000 0000000
Q ss_pred c-C------CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 699 S-R------LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 699 ~-~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
. . ...........++.+.+++.+||++||++||||+|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0 000001112345678899999999999999999999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.2e-39 Score=339.26 Aligned_cols=230 Identities=18% Similarity=0.193 Sum_probs=174.4
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------Cccc--cCCceEEEEEe
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------NFCS--HPRQSFIVYEY 554 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------~~~~--~~~~~~lV~E~ 554 (752)
.++|++.++||+|+||+||+|+. .+|+.||||+++..... +++. .....++||||
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 46899999999999999999995 67999999998654321 1222 34568999999
Q ss_pred ccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCC-ceEEeecccceeccCCC
Q 041438 555 LESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGY-EAHVSDFRIAKFLNLDS 633 (752)
Q Consensus 555 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~-~~kl~DfG~a~~~~~~~ 633 (752)
|.+++|..+. +.+++..++.+++||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 114 ~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~- 183 (328)
T d3bqca1 114 VNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG- 183 (328)
T ss_dssp CCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-
T ss_pred cCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC-
Confidence 9999987764 2388999999999999999999999 999999999999998655 5899999999887543
Q ss_pred CCcccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCcchhhcccc-----------------------cc
Q 041438 634 SNWSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS-----------------------SS 689 (752)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~~pf~~~~~~~~-----------------------~~ 689 (752)
......+||+.|+|||.+.+.. ++.++||||+||++|||++|+.||........ ..
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 2344568999999999987654 79999999999999999999999842110000 00
Q ss_pred ccchHhhhccCCC------CCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 690 SNMNIEILDSRLP------YPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 690 ~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
............. .+.......++++.++|.+||+.||++|||++|+++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000000 0111123345678999999999999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-38 Score=337.62 Aligned_cols=230 Identities=19% Similarity=0.224 Sum_probs=166.6
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Ccc------ccCC
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFC------SHPR 546 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~------~~~~ 546 (752)
.++|++.++||+|+||+||+|+. .+|+.||||++...... +++ +...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 36899999999999999999995 57999999998654322 111 2346
Q ss_pred ceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccc
Q 041438 547 QSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIA 626 (752)
Q Consensus 547 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a 626 (752)
..|+|||||.++ +.+.+. ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+|++|||.+
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchH-HHHhhh-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 789999999875 444443 2378899999999999999999999 9999999999999999999999999998
Q ss_pred eeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccc-----------------ccc
Q 041438 627 KFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMS-----------------SSS 689 (752)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~-----------------~~~ 689 (752)
+..... ......+||+.|+|||++.+..+++++||||+||++|||++|++||....... ...
T Consensus 167 ~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 167 RTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred hccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 876532 33445689999999999999999999999999999999999999984211000 000
Q ss_pred ccchHhhhccC----------------CCCCChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 690 SNMNIEILDSR----------------LPYPSLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 690 ~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
........... .+.........++++.+++.+||+.||++||||+|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00111111111 111122234467789999999999999999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-38 Score=337.60 Aligned_cols=230 Identities=19% Similarity=0.239 Sum_probs=171.0
Q ss_pred hcccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC--------------------------Cccc-----cCCc
Q 041438 500 TNDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD--------------------------NFCS-----HPRQ 547 (752)
Q Consensus 500 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~-----~~~~ 547 (752)
.++|++.++||+|+||+||+|+. .+|+.||||++++.... .++. +...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999994 67999999998765332 1111 2234
Q ss_pred eEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecccce
Q 041438 548 SFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFRIAK 627 (752)
Q Consensus 548 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~ 627 (752)
.+++|||+.+|+|.+++... .+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+|++|||.|.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhc
Confidence 46778888899999999653 389999999999999999999999 99999999999999999999999999997
Q ss_pred eccCCCCCcccccCCCCccCccccccCC-CCCccchhhHHHHHHHHHhCCCCcchhhcccc------------------c
Q 041438 628 FLNLDSSNWSKLAGTHGNVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFLFEMSS------------------S 688 (752)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~elltg~~pf~~~~~~~~------------------~ 688 (752)
.... ......||+.|+|||...+.. ++.++||||+||++|+|++|+.||........ .
T Consensus 170 ~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 170 HTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred ccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 6542 233457899999999877654 68999999999999999999999852111000 0
Q ss_pred cccchHhhhccCCCCCChh----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 041438 689 SSNMNIEILDSRLPYPSLD----VQNKFMSIMQVAFSCLDQNPVSRPTMKRFEVQ 739 (752)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 739 (752)
...............+... ....++++.++|.+||+.||++|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000011111111111111 12345678899999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-35 Score=316.07 Aligned_cols=233 Identities=17% Similarity=0.184 Sum_probs=169.1
Q ss_pred cccccceeeccCCceEEEEEEe-CCCcEEEEEccCCCCCC----------------------------------Cc--cc
Q 041438 501 NDFDAKHCIGKGGHGSVYIARV-PSGEIFAVKKFHSPLPD----------------------------------NF--CS 543 (752)
Q Consensus 501 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------------------------------~~--~~ 543 (752)
++|++.++||+|+||+||+|+. .+|+.||||++++.... .+ ..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4599999999999999999995 68999999998754210 01 11
Q ss_pred cCCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCEEeCCCC------
Q 041438 544 HPRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHN-NCFPPIVHWDISSKNVLLDLGY------ 616 (752)
Q Consensus 544 ~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~ivH~DlKp~NIll~~~~------ 616 (752)
.....+++|+++..+..............+++..++.++.||+.||+|||+ . ||+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccc
Confidence 234556778887665544333333334558889999999999999999998 6 999999999999997654
Q ss_pred ceEEeecccceeccCCCCCcccccCCCCccCccccccCCCCCccchhhHHHHHHHHHhCCCCcchhhccccccc------
Q 041438 617 EAHVSDFRIAKFLNLDSSNWSKLAGTHGNVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFLFEMSSSSS------ 690 (752)
Q Consensus 617 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~elltg~~pf~~~~~~~~~~~------ 690 (752)
.++++|||.|...... ....+||+.|+|||++.+..++.++||||+||+++||++|+.||...........
T Consensus 170 ~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 3999999999875432 2446899999999999999999999999999999999999999852211000000
Q ss_pred ----------cc------hHhhhcc-----CCC----CC--------ChhhHHHHHHHHHHHHhccCcCCCCCCCHHHHH
Q 041438 691 ----------NM------NIEILDS-----RLP----YP--------SLDVQNKFMSIMQVAFSCLDQNPVSRPTMKRFE 737 (752)
Q Consensus 691 ----------~~------~~~~~~~-----~~~----~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 737 (752)
.. .....+. ... .+ .......++++.+++.+||+.||++|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 00 0000000 000 00 001245677899999999999999999999999
Q ss_pred HH
Q 041438 738 VQ 739 (752)
Q Consensus 738 ~~ 739 (752)
+|
T Consensus 327 ~H 328 (362)
T d1q8ya_ 327 NH 328 (362)
T ss_dssp TC
T ss_pred cC
Confidence 86
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=5.7e-34 Score=299.50 Aligned_cols=276 Identities=29% Similarity=0.399 Sum_probs=209.4
Q ss_pred CCcc-cceeeCC--CCCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCccccc--CCccCcCCCCCCeeecCC-Ccc
Q 041438 72 LCTW-SGIHCNH--AGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDI--IPPQISNLSKLEYLDFLT-NKL 145 (752)
Q Consensus 72 ~c~w-~gv~C~~--~~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~--~p~~~~~l~~L~~L~L~~-N~l 145 (752)
.-+| .|..|+. +..|++-+- ..-.+++.|+|++|++++. +|+.|++|++|++|+|++ |++
T Consensus 24 l~sW~~~~d~C~~~w~gv~C~~~--------------~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l 89 (313)
T d1ogqa_ 24 LSSWLPTTDCCNRTWLGVLCDTD--------------TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNL 89 (313)
T ss_dssp GTTCCTTSCTTTTCSTTEEECCS--------------SSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTE
T ss_pred CCCCCCCCCCCCCcCCCeEEeCC--------------CCcEEEEEEECCCCCCCCCCCCChHHhcCcccccccccccccc
Confidence 3468 4778873 677887321 1123577788888877763 566777777777777765 667
Q ss_pred cccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccc
Q 041438 146 SGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQI 225 (752)
Q Consensus 146 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 225 (752)
+|.+|.+|++|++|++|+|++|+|.+..+..+..+..|+.+++++|++.+.+|.+|.++++|+.+++++|.+++.+|..+
T Consensus 90 ~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~ 169 (313)
T d1ogqa_ 90 VGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169 (313)
T ss_dssp ESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGG
T ss_pred ccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccccccccccccc
Confidence 66667667777777777777777666666666666666666666666666666666666666666666666655555444
Q ss_pred cCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCC-CEEecCCCcCcCCCCccccCCcc
Q 041438 226 GNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQL-QYLDLSSNYIVGEIPTQLGNIIY 304 (752)
Q Consensus 226 ~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~ 304 (752)
..+.++ +.+++++|++++..|..+.++..
T Consensus 170 --------------------------------------------------~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~ 199 (313)
T d1ogqa_ 170 --------------------------------------------------GSFSKLFTSMTISRNRLTGKIPPTFANLNL 199 (313)
T ss_dssp --------------------------------------------------GCCCTTCCEEECCSSEEEEECCGGGGGCCC
T ss_pred --------------------------------------------------cccccccccccccccccccccccccccccc
Confidence 333333 56777777777788888877755
Q ss_pred cCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCC
Q 041438 305 LNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSH 384 (752)
Q Consensus 305 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 384 (752)
+ .+++++|...+.+|..+..+++|+.+++++|.+.+.++ .++.+++|+.|+|++|+++|.+|..|+++++|++|+|++
T Consensus 200 ~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~ 277 (313)
T d1ogqa_ 200 A-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277 (313)
T ss_dssp S-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred c-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcC
Confidence 4 79999999999999999999999999999999998765 688899999999999999999999999999999999999
Q ss_pred ccCCCCCCcccccccccceEEccCCc-CCcC
Q 041438 385 NFLGEKISSRICRMESLEKLNLSYNN-LSGL 414 (752)
Q Consensus 385 N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~ 414 (752)
|+|+|.+|. ++.+++|+.+++++|+ +.|.
T Consensus 278 N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 278 NNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp SEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred CcccccCCC-cccCCCCCHHHhCCCccccCC
Confidence 999998885 6889999999999997 5665
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=3.5e-30 Score=278.05 Aligned_cols=320 Identities=26% Similarity=0.358 Sum_probs=186.9
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeec
Q 041438 85 RVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHI 164 (752)
Q Consensus 85 ~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 164 (752)
.++.+++.++++.. + ..+..+++|++|+|++|+|+++.| |+++++|++|+|++|+|++..| ++++++|+.|++
T Consensus 45 ~l~~L~l~~~~I~~-l--~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~ 117 (384)
T d2omza2 45 QVTTLQADRLGIKS-I--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 117 (384)
T ss_dssp TCCEEECCSSCCCC-C--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred CCCEEECCCCCCCC-c--cccccCCCCCEEeCcCCcCCCCcc--ccCCcccccccccccccccccc--cccccccccccc
Confidence 45555555554442 1 124455566666666666655432 5566666666666666654322 555666666666
Q ss_pred cCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCc-------------------cCCCcceEEeeccccccccccccc
Q 041438 165 SRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSL-------------------SNFTNLVFLYLYNNSFSGSIPQQI 225 (752)
Q Consensus 165 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-------------------~~l~~L~~L~L~~N~l~~~~p~~~ 225 (752)
++|.+++..+ ......+..+....|.+....+... ...+.........|... ....+
T Consensus 118 ~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 193 (384)
T d2omza2 118 FNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS--DISVL 193 (384)
T ss_dssp CSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCC--CCGGG
T ss_pred cccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccc--ccccc
Confidence 6665554322 2333445555555554433222111 11122222222222221 22344
Q ss_pred cCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCccc
Q 041438 226 GNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYL 305 (752)
Q Consensus 226 ~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 305 (752)
..++++..+++++|.+++..| +..+++|+.|++++|+++.. ..+..+++|+.|++++|.+++..+ +..+++|
T Consensus 194 ~~l~~~~~l~l~~n~i~~~~~----~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L 265 (384)
T d2omza2 194 AKLTNLESLIATNNQISDITP----LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKL 265 (384)
T ss_dssp GGCTTCSEEECCSSCCCCCGG----GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTC
T ss_pred ccccccceeeccCCccCCCCc----ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccC
Confidence 556666777777777766544 23456677777777777642 245666777777777777765433 5666777
Q ss_pred CEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCc
Q 041438 306 NRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHN 385 (752)
Q Consensus 306 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 385 (752)
+.|++++|++++.. .+..++.++.++++.|.+++. ..+..+++++.|++++|++++..+ +..+++|++|++++|
T Consensus 266 ~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n 339 (384)
T d2omza2 266 TELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANN 339 (384)
T ss_dssp SEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSS
T ss_pred CEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCC
Confidence 77777777776543 256667777777777777663 246667777777777777765432 667777777777777
Q ss_pred cCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCC
Q 041438 386 FLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYN 433 (752)
Q Consensus 386 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 433 (752)
+|++. + .+.++++|++|++++|++++++| +.++++|+.|+|++|
T Consensus 340 ~l~~l-~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 340 KVSDV-S-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CCCCC-G-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCC-h-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 77653 2 46677777777777777777654 667777777777776
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=2.3e-28 Score=263.65 Aligned_cols=306 Identities=27% Similarity=0.377 Sum_probs=246.1
Q ss_pred cceeeCCCCCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCccccc
Q 041438 76 SGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISL 155 (752)
Q Consensus 76 ~gv~C~~~~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 155 (752)
+|+.. -..+..++|+++.+.+- + .|+.+++|++|++++|+|.++.| ++++++|+.|++++|.+++..+ ...
T Consensus 60 ~gl~~--L~nL~~L~Ls~N~l~~l-~--~l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~~~~~~~~~~~--~~~ 130 (384)
T d2omza2 60 DGVEY--LNNLTQINFSNNQLTDI-T--PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKN 130 (384)
T ss_dssp TTGGG--CTTCCEEECCSSCCCCC-G--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTT
T ss_pred ccccc--CCCCCEEeCcCCcCCCC-c--cccCCcccccccccccccccccc--cccccccccccccccccccccc--ccc
Confidence 45533 23578899999988763 2 38999999999999999998643 8999999999999999987644 445
Q ss_pred ccccceeeccCcccCCCCC-------------------cccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeecccc
Q 041438 156 LTHLTILHISRNQLNGSIP-------------------HEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNS 216 (752)
Q Consensus 156 l~~L~~L~Ls~N~l~~~~p-------------------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 216 (752)
...+..+....|.+....+ ..+.............|... ....+..+++++.+++++|.
T Consensus 131 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~ 208 (384)
T d2omza2 131 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQ 208 (384)
T ss_dssp CTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSC
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccc--cccccccccccceeeccCCc
Confidence 6677788887777654322 22334444555555555544 34567888999999999999
Q ss_pred ccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCC
Q 041438 217 FSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIP 296 (752)
Q Consensus 217 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 296 (752)
+++..| +...++|+.+++++|+++... .+..+++|+.|++++|.+++..+ +..+++|++|++++|.+++..
T Consensus 209 i~~~~~--~~~~~~L~~L~l~~n~l~~~~----~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~- 279 (384)
T d2omza2 209 ISDITP--LGILTNLDELSLNGNQLKDIG----TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS- 279 (384)
T ss_dssp CCCCGG--GGGCTTCCEEECCSSCCCCCG----GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG-
T ss_pred cCCCCc--ccccCCCCEEECCCCCCCCcc----hhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC-
Confidence 987655 456788999999999988642 25678999999999999997654 778999999999999998654
Q ss_pred ccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhcccccc
Q 041438 297 TQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIH 376 (752)
Q Consensus 297 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 376 (752)
.+..+..++.+++++|.+++. ..+..+++++.|++++|+++++.+ +..+++|++|++++|+|++ ++ .+.++++
T Consensus 280 -~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~ 352 (384)
T d2omza2 280 -PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTN 352 (384)
T ss_dssp -GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTT
T ss_pred -ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hHcCCCC
Confidence 377889999999999999863 457888999999999999998753 8899999999999999985 33 6899999
Q ss_pred CCeeecCCccCCCCCCcccccccccceEEccCCc
Q 041438 377 LSELDLSHNFLGEKISSRICRMESLEKLNLSYNN 410 (752)
Q Consensus 377 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 410 (752)
|++|++++|++++.+| +.++++|+.|+|++|.
T Consensus 353 L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na 384 (384)
T d2omza2 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384 (384)
T ss_dssp CCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred CCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence 9999999999998765 8899999999999983
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=5.7e-28 Score=252.35 Aligned_cols=249 Identities=25% Similarity=0.336 Sum_probs=163.4
Q ss_pred CCCcccceeeCCCCCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCC
Q 041438 71 SLCTWSGIHCNHAGRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIP 150 (752)
Q Consensus 71 ~~c~w~gv~C~~~~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 150 (752)
.-|.|.+|.|+..+ +. ++|. .+ .+++++|+|++|+|+.+.+.+|.++++|++|++++|.++.+.|
T Consensus 8 c~c~~~~~~C~~~~-----------L~-~lP~-~l--~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~ 72 (305)
T d1xkua_ 8 CQCHLRVVQCSDLG-----------LE-KVPK-DL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP 72 (305)
T ss_dssp CEEETTEEECTTSC-----------CC-SCCC-SC--CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCT
T ss_pred CEecCCEEEecCCC-----------CC-ccCC-CC--CCCCCEEECcCCcCCCcChhHhhccccccccccccccccccch
Confidence 34789999997422 11 1222 22 2579999999999999888889999999999999999998888
Q ss_pred cccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeecccccc--ccccccccCc
Q 041438 151 SEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFS--GSIPQQIGNL 228 (752)
Q Consensus 151 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l 228 (752)
..|.++++|++|++++|+|+. +|..+ ...|+.|++++|.+.+..+..+.....+..++...|... ...+..+..+
T Consensus 73 ~~f~~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l 149 (305)
T d1xkua_ 73 GAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149 (305)
T ss_dssp TTTTTCTTCCEEECCSSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGC
T ss_pred hhhhCCCccCEecccCCccCc-Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccc
Confidence 899999999999999999984 45433 346888999999998877777888888888888887543 3334455566
Q ss_pred cccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEE
Q 041438 229 KSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRI 308 (752)
Q Consensus 229 ~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 308 (752)
++|+.+++++|.++.. |. ..+++|+.|++++|.+++..+..|..++.+++|++++|.+++..+..+.++++|++|
T Consensus 150 ~~L~~l~l~~n~l~~l-~~----~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L 224 (305)
T d1xkua_ 150 KKLSYIRIADTNITTI-PQ----GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL 224 (305)
T ss_dssp TTCCEEECCSSCCCSC-CS----SCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEE
T ss_pred cccCccccccCCcccc-Cc----ccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceee
Confidence 6666666666555432 11 123455555555555555555555555555555555555555545555555555555
Q ss_pred EccCCcCcccCCcccCCCcccceeecccccccccc
Q 041438 309 SLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFV 343 (752)
Q Consensus 309 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 343 (752)
+|++|+|+. +|.+|..+++|++|+|++|+|+.+.
T Consensus 225 ~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~~i~ 258 (305)
T d1xkua_ 225 HLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIG 258 (305)
T ss_dssp ECCSSCCSS-CCTTTTTCSSCCEEECCSSCCCCCC
T ss_pred ecccccccc-cccccccccCCCEEECCCCccCccC
Confidence 555555542 3444555555555555555555443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=1.1e-27 Score=250.19 Aligned_cols=285 Identities=23% Similarity=0.257 Sum_probs=208.6
Q ss_pred CCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccC
Q 041438 111 LAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDS 190 (752)
Q Consensus 111 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 190 (752)
.+.+|=++++++.+ |..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|.+....|..|.++++|++|++++
T Consensus 12 ~~~~~C~~~~L~~l-P~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 12 LRVVQCSDLGLEKV-PKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp TTEEECTTSCCCSC-CCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCCcc-CCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 45567778888764 55654 6899999999999987777899999999999999999988888999999999999999
Q ss_pred CCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCC
Q 041438 191 NFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGN 270 (752)
Q Consensus 191 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 270 (752)
|+|+.+ |..+ ...|+.|++++|.+.+..+..+.....+..++...|.... ...
T Consensus 89 n~l~~l-~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~------------------------~~~ 141 (305)
T d1xkua_ 89 NQLKEL-PEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS------------------------SGI 141 (305)
T ss_dssp SCCSBC-CSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG------------------------GGB
T ss_pred CccCcC-ccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccc------------------------cCC
Confidence 999954 4433 3578889999999887666555554444444444333221 223
Q ss_pred CCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhccc
Q 041438 271 IPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSL 350 (752)
Q Consensus 271 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 350 (752)
.+..+..+++|+++++++|.+.. +|..+ .++|+.|++++|.+++..+..|.+++.+++|++++|.++++.+..|.++
T Consensus 142 ~~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l 218 (305)
T d1xkua_ 142 ENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 218 (305)
T ss_dssp CTTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGS
T ss_pred CccccccccccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccccccccccccccccc
Confidence 34455666677777777777663 33332 4567777777777777777777777777888888888877777777778
Q ss_pred ccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCccc------ccccccceEEccCCcCC--cCCchhhhcc
Q 041438 351 VKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRI------CRMESLEKLNLSYNNLS--GLIPRCFEEL 422 (752)
Q Consensus 351 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~------~~l~~L~~L~L~~N~l~--~~~p~~~~~l 422 (752)
++|++|+|++|+|+ .+|..|..+++|++|+|++|+|+......| ..+.+|+.|+|++|.++ .+.|.+|..+
T Consensus 219 ~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~ 297 (305)
T d1xkua_ 219 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 297 (305)
T ss_dssp TTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTC
T ss_pred ccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhccc
Confidence 88888888888876 456677778888888888888876544443 35678999999999876 4677777776
Q ss_pred CCCcEEE
Q 041438 423 HGLLHID 429 (752)
Q Consensus 423 ~~L~~L~ 429 (752)
.....++
T Consensus 298 ~~~~~~~ 304 (305)
T d1xkua_ 298 YVRAAVQ 304 (305)
T ss_dssp CCGGGEE
T ss_pred ccCcccc
Confidence 6554443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.5e-27 Score=244.65 Aligned_cols=205 Identities=23% Similarity=0.187 Sum_probs=109.3
Q ss_pred CCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEcc-CCCCCCcCCcCccCCCcceEEeec
Q 041438 135 LEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILD-SNFLGGSIPRSLSNFTNLVFLYLY 213 (752)
Q Consensus 135 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~L~ 213 (752)
+++|+|++|+|+.+.+.+|.++++|++|++++|+|....+..+.++..++.++.. .|.++...|.+|.++++|++|+++
T Consensus 34 ~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~ 113 (284)
T d1ozna_ 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113 (284)
T ss_dssp CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECT
T ss_pred CCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecC
Confidence 4444455555444444445555555555555555554444444444555554432 344444445555555555555555
Q ss_pred cccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcC
Q 041438 214 NNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVG 293 (752)
Q Consensus 214 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 293 (752)
+|.+....+..+. ..++|+.+++++|+|++..+..|..+++|+.|++++|.+++
T Consensus 114 ~n~~~~~~~~~~~--------------------------~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~ 167 (284)
T d1ozna_ 114 RCGLQELGPGLFR--------------------------GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS 167 (284)
T ss_dssp TSCCCCCCTTTTT--------------------------TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE
T ss_pred Ccccccccccccc--------------------------hhcccchhhhccccccccChhHhccccchhhcccccCcccc
Confidence 5555433222222 22334445555555554444455555556666666666655
Q ss_pred CCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCcc
Q 041438 294 EIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQ 365 (752)
Q Consensus 294 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 365 (752)
..+..|.++++|+.+++++|++++..|..|.++++|++||+++|.+.+.++..|..+++|++|+|++|.+..
T Consensus 168 l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 168 VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred cchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence 555555666666666666666665556666666666666666666666666666666666666666666543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.3e-27 Score=243.79 Aligned_cols=267 Identities=20% Similarity=0.158 Sum_probs=188.5
Q ss_pred eecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeec-ccc
Q 041438 138 LDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLY-NNS 216 (752)
Q Consensus 138 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-~N~ 216 (752)
++.++++++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|++..+.+..+.+++.++.++.. .|.
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 344445555 3344332 456777777777776666667777777777777777777666666666666666543 344
Q ss_pred ccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCC
Q 041438 217 FSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIP 296 (752)
Q Consensus 217 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 296 (752)
++...+..| ..+++|++|++++|.+....+..+...++|+.+++++|.|++..+
T Consensus 93 ~~~l~~~~~--------------------------~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~ 146 (284)
T d1ozna_ 93 LRSVDPATF--------------------------HGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPD 146 (284)
T ss_dssp CCCCCTTTT--------------------------TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred cccccchhh--------------------------cccccCCEEecCCcccccccccccchhcccchhhhccccccccCh
Confidence 444333333 445566678888888777777778888888888999888887777
Q ss_pred ccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhcccccc
Q 041438 297 TQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIH 376 (752)
Q Consensus 297 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 376 (752)
..|..+++|+.|++++|++++..+..|.++++|+++++++|+++++.|..|..+++|++|++++|++++..+..|.++++
T Consensus 147 ~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~ 226 (284)
T d1ozna_ 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226 (284)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred hHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccc
Confidence 88888888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred CCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCchhhhccCCCcEEEccCCcccC
Q 041438 377 LSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHIDISYNKLEG 437 (752)
Q Consensus 377 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 437 (752)
|++|+|++|.+...-+. ..-...++.+....+++....|..+.+ ....+++.+.|+|
T Consensus 227 L~~L~l~~N~l~C~C~~-~~l~~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g 283 (284)
T d1ozna_ 227 LQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283 (284)
T ss_dssp CCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred cCEEEecCCCCCCCccc-hHHHHHHHhCcCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence 88888888888654221 111234556666667777666665543 3333455555544
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=7.8e-24 Score=215.91 Aligned_cols=199 Identities=26% Similarity=0.239 Sum_probs=108.6
Q ss_pred ccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCcccccccc
Q 041438 156 LTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMK 235 (752)
Q Consensus 156 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ 235 (752)
.+.+.+.+.+++.|+ .+|..+. ++|++|+|++|+|+++.+.+|.++++|++|+|++|+|+.. | .+
T Consensus 9 ~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~---------- 73 (266)
T d1p9ag_ 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VD---------- 73 (266)
T ss_dssp STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CC----------
T ss_pred cCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cc----------
Confidence 334444455555555 2343332 3455555555555555555555556666666666555422 1 11
Q ss_pred ccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcC
Q 041438 236 LCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKL 315 (752)
Q Consensus 236 l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 315 (752)
+.+++|++|+|++|++++. +..+..+++|++|++++|.+.+..+..+..+.+++.|++++|.+
T Consensus 74 ----------------~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l 136 (266)
T d1p9ag_ 74 ----------------GTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL 136 (266)
T ss_dssp ----------------SCCTTCCEEECCSSCCSSC-CCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCC
T ss_pred ----------------ccccccccccccccccccc-ccccccccccccccccccccceeecccccccccccccccccccc
Confidence 1234444555555555432 33455556666666666666555555555556666666666666
Q ss_pred cccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccC
Q 041438 316 SGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFL 387 (752)
Q Consensus 316 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 387 (752)
+...+..+..+++|+.|++++|+|+++++..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+
T Consensus 137 ~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred ceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence 6555555556666666666666666655555666666666666666665 4455555555555555555554
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.1e-23 Score=214.77 Aligned_cols=194 Identities=22% Similarity=0.210 Sum_probs=90.4
Q ss_pred CEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCC
Q 041438 112 AYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSN 191 (752)
Q Consensus 112 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 191 (752)
.+.|.++++|+. +|+.+. ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+.. | .++.+++|++|+|++|
T Consensus 13 ~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N 87 (266)
T d1p9ag_ 13 LEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHN 87 (266)
T ss_dssp CEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSS
T ss_pred eEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccccccccc
Confidence 334444555544 233332 3455555555555555555555555555555555555522 2 2344555555555555
Q ss_pred CCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCC
Q 041438 192 FLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNI 271 (752)
Q Consensus 192 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 271 (752)
++++ .+..+.++++|+.|++++|.+.+..+..+. .+.+++.|++++|.++...
T Consensus 88 ~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~--------------------------~l~~l~~L~l~~n~l~~l~ 140 (266)
T d1p9ag_ 88 QLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALR--------------------------GLGELQELYLKGNELKTLP 140 (266)
T ss_dssp CCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTT--------------------------TCTTCCEEECTTSCCCCCC
T ss_pred cccc-cccccccccccccccccccccceeeccccc--------------------------cccccccccccccccceec
Confidence 5553 234455555555555555555433322222 2223334444444444333
Q ss_pred CcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccc
Q 041438 272 PFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANH 338 (752)
Q Consensus 272 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 338 (752)
+..+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.
T Consensus 141 ~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np 206 (266)
T d1p9ag_ 141 PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP 206 (266)
T ss_dssp TTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCC
T ss_pred cccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCC
Confidence 444444444444444444444444444444444444444444444 333333344444444444443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.83 E-value=5.9e-19 Score=186.50 Aligned_cols=302 Identities=27% Similarity=0.316 Sum_probs=182.2
Q ss_pred EEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeecc
Q 041438 86 VFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHIS 165 (752)
Q Consensus 86 v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 165 (752)
+..+||+++++. ++++ ..++|++|+|++|+|+. +|..+ .+|+.|++++|+++.+ +.. .+.|++|+|+
T Consensus 40 l~~LdLs~~~L~-~lp~----~~~~L~~L~Ls~N~l~~-lp~~~---~~L~~L~l~~n~l~~l-~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 40 AHELELNNLGLS-SLPE----LPPHLESLVASCNSLTE-LPELP---QSLKSLLVDNNNLKAL-SDL---PPLLEYLGVS 106 (353)
T ss_dssp CSEEECTTSCCS-CCCS----CCTTCSEEECCSSCCSS-CCCCC---TTCCEEECCSSCCSCC-CSC---CTTCCEEECC
T ss_pred CCEEEeCCCCCC-CCCC----CCCCCCEEECCCCCCcc-cccch---hhhhhhhhhhcccchh-hhh---cccccccccc
Confidence 446677776665 3432 24677777777777764 35443 4667777777777632 221 1357777777
Q ss_pred CcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCc
Q 041438 166 RNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAI 245 (752)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~ 245 (752)
+|.|+. +|. ++.+++|++|++++|.+.... .. ...+..+.+.++... .+..+..++.++.+++..|.+....
T Consensus 107 ~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~~~-~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~~ 178 (353)
T d1jl5a_ 107 NNQLEK-LPE-LQNSSFLKIIDVDNNSLKKLP-DL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLP 178 (353)
T ss_dssp SSCCSS-CCC-CTTCTTCCEEECCSSCCSCCC-CC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSCC
T ss_pred cccccc-ccc-hhhhccceeeccccccccccc-cc---cccccchhhcccccc--ccccccccccceecccccccccccc
Confidence 777763 443 566777777777777776432 22 344555666555443 2345566666777777777665432
Q ss_pred CCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCC
Q 041438 246 PLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGS 325 (752)
Q Consensus 246 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 325 (752)
.. ....+.+..+.+.+. .++ .+..++.|+.+++++|.... .+. ...++..+.+.+|.+... +. .
T Consensus 179 ~~------~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~-~~---~ 242 (353)
T d1jl5a_ 179 DL------PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDL-PE---L 242 (353)
T ss_dssp CC------CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCC-CC---C
T ss_pred cc------ccccccccccccccc-ccc-cccccccccccccccccccc-ccc---cccccccccccccccccc-cc---c
Confidence 21 123445555555544 222 34567777888888777653 332 234566777777776532 22 2
Q ss_pred CcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEE
Q 041438 326 LINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLN 405 (752)
Q Consensus 326 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 405 (752)
..++...++..|.+.+... -.......++..|.+.+. ...+++|++|+|++|+|+.. |. .+++|+.|+
T Consensus 243 ~~~l~~~~~~~~~~~~l~~----l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~~l-p~---~~~~L~~L~ 310 (353)
T d1jl5a_ 243 PQSLTFLDVSENIFSGLSE----LPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLIEL-PA---LPPRLERLI 310 (353)
T ss_dssp CTTCCEEECCSSCCSEESC----CCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCSCC-CC---CCTTCCEEE
T ss_pred ccccccccccccccccccc----ccchhcccccccCccccc----cccCCCCCEEECCCCccCcc-cc---ccCCCCEEE
Confidence 3345556666655544221 113345667777776543 23357899999999998754 43 357889999
Q ss_pred ccCCcCCcCCchhhhccCCCcEEEccCCcccCcCCC
Q 041438 406 LSYNNLSGLIPRCFEELHGLLHIDISYNKLEGHIPN 441 (752)
Q Consensus 406 L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 441 (752)
|++|+|+.+ |.. +.+|++|++++|+++ .+|+
T Consensus 311 L~~N~L~~l-~~~---~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 311 ASFNHLAEV-PEL---PQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp CCSSCCSCC-CCC---CTTCCEEECCSSCCS-SCCC
T ss_pred CCCCcCCcc-ccc---cCCCCEEECcCCcCC-CCCc
Confidence 999999864 532 467899999999987 4554
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=1.6e-21 Score=188.01 Aligned_cols=143 Identities=14% Similarity=0.087 Sum_probs=102.2
Q ss_pred cccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC----------------------------------Ccc----cc
Q 041438 503 FDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD----------------------------------NFC----SH 544 (752)
Q Consensus 503 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------------------~~~----~~ 544 (752)
+.+.++||+|+||.||+|+..+|+.||||+++..... +.. ..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3468999999999999999889999999987532111 000 00
Q ss_pred CCceEEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCEEeCCCCceEEeecc
Q 041438 545 PRQSFIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNCFPPIVHWDISSKNVLLDLGYEAHVSDFR 624 (752)
Q Consensus 545 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ivH~DlKp~NIll~~~~~~kl~DfG 624 (752)
....+++|||++++.+.+ ++......++.|++.|++|||+. ||+||||||+|||++++ .++|+|||
T Consensus 82 ~~~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 82 WEGNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp EETTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCT
T ss_pred ecCCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECC
Confidence 122369999998754322 44566678999999999999999 99999999999999965 58999999
Q ss_pred cceeccCCCCCcccccCCCCccC------ccccccCCCCCccchhhHHHH
Q 041438 625 IAKFLNLDSSNWSKLAGTHGNVA------PELAYTMKVTEKCDVYSFGVL 668 (752)
Q Consensus 625 ~a~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~ksDIwSlGvi 668 (752)
.|.....+... .|.. .| +....|+.++|+||..--
T Consensus 148 ~a~~~~~~~~~--------~~l~rd~~~~~~-~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 148 QSVEVGEEGWR--------EILERDVRNIIT-YFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp TCEETTSTTHH--------HHHHHHHHHHHH-HHHHHHCCCCCHHHHHHH
T ss_pred CcccCCCCCcH--------HHHHHHHHHHHH-HHcCCCCCcccHHHHHHH
Confidence 99875422210 1111 11 113567889999997543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=2.4e-20 Score=186.94 Aligned_cols=85 Identities=20% Similarity=0.169 Sum_probs=46.4
Q ss_pred CCCEEECCCCcccccCCccCcCCCCCCeeecCCCccccc-CCcccccccccceeeccC-cccCCCCCcccCCCCCCcEEE
Q 041438 110 HLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGH-IPSEISLLTHLTILHISR-NQLNGSIPHEVGQLNFLNHLI 187 (752)
Q Consensus 110 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~ 187 (752)
++++|||++|+|+.+.+.+|.++++|++|+|++|.+... .+..|.+++++++|++.. |.+....+..|.++++|++|+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 556666666666655555566666666666666655432 233455555555555442 445444445555555555555
Q ss_pred ccCCCCC
Q 041438 188 LDSNFLG 194 (752)
Q Consensus 188 L~~N~l~ 194 (752)
+++|++.
T Consensus 110 l~~~~l~ 116 (242)
T d1xwdc1 110 ISNTGIK 116 (242)
T ss_dssp EESCCCC
T ss_pred cchhhhc
Confidence 5555554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.82 E-value=1.1e-20 Score=187.55 Aligned_cols=209 Identities=24% Similarity=0.269 Sum_probs=122.5
Q ss_pred CCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEe
Q 041438 132 LSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLY 211 (752)
Q Consensus 132 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 211 (752)
|.++..++++.+++++.. .+..+.+|+.|++++|.|+.. + .+..+++|++|+|++|++++..| +.++++|++|+
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~ 91 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc-h-hHhcCCCCcEeecCCceeecccc--ccccccccccc
Confidence 334444556666665543 345566666666666666633 2 36666666666666666665433 56666666666
Q ss_pred eccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcC
Q 041438 212 LYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYI 291 (752)
Q Consensus 212 L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 291 (752)
+++|.++.. + .+.+ +++|+.++++.+...+.. .+...+.++.+.++++.+
T Consensus 92 ~~~n~~~~i-~-~l~~--------------------------l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~ 141 (227)
T d1h6ua2 92 LSGNPLKNV-S-AIAG--------------------------LQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQI 141 (227)
T ss_dssp CCSCCCSCC-G-GGTT--------------------------CTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred ccccccccc-c-cccc--------------------------cccccccccccccccccc--hhccccchhhhhchhhhh
Confidence 666665421 1 2223 334445555555444322 234455566666666665
Q ss_pred cCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhc
Q 041438 292 VGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIEL 371 (752)
Q Consensus 292 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 371 (752)
.... .+.++++|+.|++++|.+.+.. .++++++|++|+|++|+++++. .+.++++|++|+|++|++++..| +
T Consensus 142 ~~~~--~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i~~--l 213 (227)
T d1h6ua2 142 TNIS--PLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVSP--L 213 (227)
T ss_dssp CCCG--GGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBCGG--G
T ss_pred chhh--hhccccccccccccccccccch--hhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCCCcc--c
Confidence 4322 2455566666666666665332 3666777777777777777643 26677777777777777775433 6
Q ss_pred cccccCCeeecCC
Q 041438 372 DNLIHLSELDLSH 384 (752)
Q Consensus 372 ~~l~~L~~L~Ls~ 384 (752)
+++++|++|++++
T Consensus 214 ~~l~~L~~L~lsn 226 (227)
T d1h6ua2 214 ANTSNLFIVTLTN 226 (227)
T ss_dssp TTCTTCCEEEEEE
T ss_pred ccCCCCCEEEeeC
Confidence 7777777777763
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.81 E-value=3.1e-20 Score=184.22 Aligned_cols=211 Identities=22% Similarity=0.292 Sum_probs=170.3
Q ss_pred ccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCcccccc
Q 041438 154 SLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFD 233 (752)
Q Consensus 154 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 233 (752)
..|.++..++++.+++++.+ .+..+.+|++|++++|.|+.. + .+..+++|++|+|++|++++..| +
T Consensus 16 ~~l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~ls~n~i~~~~~--l-------- 81 (227)
T d1h6ua2 16 PALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--L-------- 81 (227)
T ss_dssp HHHHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--G--------
T ss_pred HHHHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc-h-hHhcCCCCcEeecCCceeecccc--c--------
Confidence 45666677888888888654 556788899999999988854 3 48888899999998888875432 2
Q ss_pred ccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCC
Q 041438 234 MKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGN 313 (752)
Q Consensus 234 l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 313 (752)
..+++|+++++++|.++.. ..+..+++|+++++++|...+. ..+...+.+..+.++++
T Consensus 82 ------------------~~l~~l~~l~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~ 139 (227)
T d1h6ua2 82 ------------------KNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLN 139 (227)
T ss_dssp ------------------TTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSS
T ss_pred ------------------ccccccccccccccccccc--cccccccccccccccccccccc--chhccccchhhhhchhh
Confidence 3456777888888887743 3578899999999999998754 34677789999999999
Q ss_pred cCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCc
Q 041438 314 KLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISS 393 (752)
Q Consensus 314 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 393 (752)
.+.... .+...++|++|++++|.+++.. .+.++++|+.|+|++|++++. + .+.++++|++|+|++|++++..|
T Consensus 140 ~~~~~~--~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~- 212 (227)
T d1h6ua2 140 QITNIS--PLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP- 212 (227)
T ss_dssp CCCCCG--GGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG-
T ss_pred hhchhh--hhccccccccccccccccccch--hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc-
Confidence 987543 4778899999999999998754 488999999999999999864 3 38999999999999999987654
Q ss_pred ccccccccceEEccC
Q 041438 394 RICRMESLEKLNLSY 408 (752)
Q Consensus 394 ~~~~l~~L~~L~L~~ 408 (752)
+.++++|+.|++++
T Consensus 213 -l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 213 -LANTSNLFIVTLTN 226 (227)
T ss_dssp -GTTCTTCCEEEEEE
T ss_pred -cccCCCCCEEEeeC
Confidence 88999999999974
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=8.7e-20 Score=182.74 Aligned_cols=200 Identities=20% Similarity=0.095 Sum_probs=140.8
Q ss_pred CCCCeeecCCCcccccCCcccccccccceeeccCcccCCCC-CcccCCCCCCcEEEccC-CCCCCcCCcCccCCCcceEE
Q 041438 133 SKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSI-PHEVGQLNFLNHLILDS-NFLGGSIPRSLSNFTNLVFL 210 (752)
Q Consensus 133 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L 210 (752)
+++++|+|++|+|+.+.+..|.++++|++|+|++|.+...+ +..|.+++.+++|++.. |++....+..|.++++|++|
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 57899999999999888888999999999999999998654 55789999999999864 78988899999999999999
Q ss_pred eecccccccccccc-ccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCC-CCCEEecCC
Q 041438 211 YLYNNSFSGSIPQQ-IGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESP-QLQYLDLSS 288 (752)
Q Consensus 211 ~L~~N~l~~~~p~~-~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~ 288 (752)
++++|++....+.. +..+. .+..+..+++.+....+..|..++ .++.|++++
T Consensus 109 ~l~~~~l~~~~~~~~~~~l~--------------------------~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~ 162 (242)
T d1xwdc1 109 LISNTGIKHLPDVHKIHSLQ--------------------------KVLLDIQDNINIHTIERNSFVGLSFESVILWLNK 162 (242)
T ss_dssp EEESCCCCSCCCCTTTCBSS--------------------------CEEEEEESCTTCCEECTTSSTTSBSSCEEEECCS
T ss_pred ccchhhhccccccccccccc--------------------------ccccccccccccccccccccccccccceeeeccc
Confidence 99999987443221 22222 333444444455444444444443 566677777
Q ss_pred CcCcCCCCccccCCcccCE-EEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcC
Q 041438 289 NYIVGEIPTQLGNIIYLNR-ISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLS 359 (752)
Q Consensus 289 N~l~~~~p~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 359 (752)
|+++...+..+. ..++.. +++++|+++...+..|.++++|++|+|++|+|+.+++..|.++++|+.|++.
T Consensus 163 n~l~~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 163 NGIQEIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp SCCCEECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred cccccccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 777644444333 333333 3456666765555667777777777777777777666666666666665553
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.80 E-value=1e-17 Score=176.84 Aligned_cols=294 Identities=27% Similarity=0.313 Sum_probs=207.1
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceee
Q 041438 84 GRVFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILH 163 (752)
Q Consensus 84 ~~v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 163 (752)
..+..++|+++.+. ++++ .+.+|+.|++++|+++.+ +. + .+.|++|+|++|.++. +|. ++.+++|++|+
T Consensus 58 ~~L~~L~Ls~N~l~-~lp~----~~~~L~~L~l~~n~l~~l-~~-l--p~~L~~L~L~~n~l~~-lp~-~~~l~~L~~L~ 126 (353)
T d1jl5a_ 58 PHLESLVASCNSLT-ELPE----LPQSLKSLLVDNNNLKAL-SD-L--PPLLEYLGVSNNQLEK-LPE-LQNSSFLKIID 126 (353)
T ss_dssp TTCSEEECCSSCCS-SCCC----CCTTCCEEECCSSCCSCC-CS-C--CTTCCEEECCSSCCSS-CCC-CTTCTTCCEEE
T ss_pred CCCCEEECCCCCCc-cccc----chhhhhhhhhhhcccchh-hh-h--cccccccccccccccc-ccc-hhhhccceeec
Confidence 46778999988887 4432 357899999999999864 22 1 1469999999999985 454 68899999999
Q ss_pred ccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCC
Q 041438 164 ISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNG 243 (752)
Q Consensus 164 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 243 (752)
+++|.+... +.. ...+..+.+..+... .+..+..++.++.|++++|.+... +.... ....+....+.+..
T Consensus 127 l~~~~~~~~-~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~-~~~~~---~~~~l~~~~~~~~~ 196 (353)
T d1jl5a_ 127 VDNNSLKKL-PDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKL-PDLPL---SLESIVAGNNILEE 196 (353)
T ss_dssp CCSSCCSCC-CCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSC-CCCCT---TCCEEECCSSCCSS
T ss_pred ccccccccc-ccc---cccccchhhcccccc--ccccccccccceeccccccccccc-ccccc---cccccccccccccc
Confidence 999999843 333 456778888777665 345688899999999999998743 22222 22334444444432
Q ss_pred CcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCccc
Q 041438 244 AIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGEL 323 (752)
Q Consensus 244 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 323 (752)
++ .+..++.|+.+++++|.... .+ ....++..+.+.+|.+... +. ....+...++..|.+.+...
T Consensus 197 -~~---~~~~l~~L~~l~l~~n~~~~-~~---~~~~~l~~~~~~~~~~~~~-~~---~~~~l~~~~~~~~~~~~l~~--- 261 (353)
T d1jl5a_ 197 -LP---ELQNLPFLTTIYADNNLLKT-LP---DLPPSLEALNVRDNYLTDL-PE---LPQSLTFLDVSENIFSGLSE--- 261 (353)
T ss_dssp -CC---CCTTCTTCCEEECCSSCCSS-CC---SCCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSEESC---
T ss_pred -cc---cccccccccccccccccccc-cc---ccccccccccccccccccc-cc---cccccccccccccccccccc---
Confidence 22 24678899999999998764 33 2356788999999988743 22 23466777777777664321
Q ss_pred CCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccce
Q 041438 324 GSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEK 403 (752)
Q Consensus 324 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 403 (752)
-.......++..|.+.+.. ..+++|++|+|++|+|+ .+|. .+++|+.|+|++|+|+. +|. .+++|++
T Consensus 262 -l~~~~~~~~~~~~~~~~~~----~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~~-l~~---~~~~L~~ 328 (353)
T d1jl5a_ 262 -LPPNLYYLNASSNEIRSLC----DLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLAE-VPE---LPQNLKQ 328 (353)
T ss_dssp -CCTTCCEEECCSSCCSEEC----CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCE
T ss_pred -ccchhcccccccCcccccc----ccCCCCCEEECCCCccC-cccc---ccCCCCEEECCCCcCCc-ccc---ccCCCCE
Confidence 1134566777888877643 34678999999999998 4554 35789999999999975 443 2568999
Q ss_pred EEccCCcCCcCCchhhhccCCCcEEEc
Q 041438 404 LNLSYNNLSGLIPRCFEELHGLLHIDI 430 (752)
Q Consensus 404 L~L~~N~l~~~~p~~~~~l~~L~~L~l 430 (752)
|+|++|+|+.+ |.. ..+|+.|.+
T Consensus 329 L~L~~N~L~~l-p~~---~~~L~~L~~ 351 (353)
T d1jl5a_ 329 LHVEYNPLREF-PDI---PESVEDLRM 351 (353)
T ss_dssp EECCSSCCSSC-CCC---CTTCCEEEC
T ss_pred EECcCCcCCCC-Ccc---ccccCeeEC
Confidence 99999999864 543 235666655
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.79 E-value=7.9e-20 Score=176.10 Aligned_cols=135 Identities=22% Similarity=0.192 Sum_probs=108.8
Q ss_pred CCCCEEECCCCcccc-cCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEE
Q 041438 109 PHLAYLDLYNNELFD-IIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLI 187 (752)
Q Consensus 109 ~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 187 (752)
+++++|+|++|+|++ +.+..|+++++|++|+|++|++.+..+..|..+++|++|+|++|+|+++.|.+|.++++|++|+
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence 578999999999986 4566789999999999999999999999999999999999999999988888899999999999
Q ss_pred ccCCCCCCcCCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCC
Q 041438 188 LDSNFLGGSIPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGA 244 (752)
Q Consensus 188 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 244 (752)
|++|+|+++.|++|.++++|++|+|++|.+........ -...+..+.+..|.++..
T Consensus 109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~ 164 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCG 164 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBC
T ss_pred cCCccccccCHHHhcCCcccccccccccccccccchHH-HhhhhhhhcccCCCeEeC
Confidence 99999999889999999999999999998874432111 112244444444544433
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.78 E-value=2.4e-19 Score=172.61 Aligned_cols=175 Identities=21% Similarity=0.214 Sum_probs=123.9
Q ss_pred CcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCC-CCccccCCcccCEEEccCCcCcccCCcccCCCcccceeecc
Q 041438 257 LSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGE-IPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLS 335 (752)
Q Consensus 257 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 335 (752)
.++++.++|+++ .+|..+. +++++|+|++|+|++. .+..|.++++|+.|+|++|++...++..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 346777777777 3455442 5778888888888753 45667788888888888888888888888888888888888
Q ss_pred ccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCC
Q 041438 336 ANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLI 415 (752)
Q Consensus 336 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 415 (752)
+|+|+.+++.+|.++++|++|+|++|+|+++.+..|..+++|++|+|++|.+....... .-...++.+.+..|.++...
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeCC
Confidence 88888888888888888888888888888777778888888888888888776543221 11233555666667776665
Q ss_pred chhhhccCCCcEEEccCCcccCc
Q 041438 416 PRCFEELHGLLHIDISYNKLEGH 438 (752)
Q Consensus 416 p~~~~~l~~L~~L~ls~N~l~~~ 438 (752)
|..+ .+++.++|+.|.+...
T Consensus 166 p~~l---~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 166 PSKV---RDVQIKDLPHSEFKCS 185 (192)
T ss_dssp STTT---TTSBGGGSCTTTCCCC
T ss_pred Chhh---cCCEeeecCHhhCcCC
Confidence 6443 3445556666666543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1.8e-21 Score=213.74 Aligned_cols=110 Identities=16% Similarity=0.221 Sum_probs=76.5
Q ss_pred EEEEEcCCCCCcccccccccCCCCCCCEEECCCCcccc----cCCccCcCCCCCCeeecCCCccccc----CCcccc-cc
Q 041438 86 VFGINLTSISLNGTLLEFSFSSFPHLAYLDLYNNELFD----IIPPQISNLSKLEYLDFLTNKLSGH----IPSEIS-LL 156 (752)
Q Consensus 86 v~~l~l~~~~l~g~l~~~~f~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~-~l 156 (752)
+..+|++++.+++.-...-+..++++++|+|++|+|+. .++..+..+++|++|||++|+|+.. +...+. ..
T Consensus 4 l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~ 83 (460)
T d1z7xw1 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPS 83 (460)
T ss_dssp EEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTT
T ss_pred CCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCC
Confidence 56778877777764333345667888888888888873 3345677888888888888888632 112222 23
Q ss_pred cccceeeccCcccCCC----CCcccCCCCCCcEEEccCCCCCC
Q 041438 157 THLTILHISRNQLNGS----IPHEVGQLNFLNHLILDSNFLGG 195 (752)
Q Consensus 157 ~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~ 195 (752)
.+|++|+|++|+|+.. ++..+..+++|++|+|++|.++.
T Consensus 84 ~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 84 CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 4788888888888743 35567778888888888888764
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=1.8e-18 Score=167.40 Aligned_cols=79 Identities=23% Similarity=0.266 Sum_probs=40.9
Q ss_pred CCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeec
Q 041438 134 KLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLY 213 (752)
Q Consensus 134 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 213 (752)
++..+.++.+.+++.++ ...+.+|++|++++|.|+.. +.+..+++|++|+|++|++++..| +.++++|++|+++
T Consensus 19 ~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~ 92 (199)
T d2omxa2 19 EKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMN 92 (199)
T ss_dssp HHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred HHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccc
Confidence 33445555555554432 23455666666666665532 234555555555555555554332 5555555555555
Q ss_pred ccccc
Q 041438 214 NNSFS 218 (752)
Q Consensus 214 ~N~l~ 218 (752)
+|.+.
T Consensus 93 ~n~~~ 97 (199)
T d2omxa2 93 NNQIA 97 (199)
T ss_dssp SSCCC
T ss_pred ccccc
Confidence 55544
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=2.2e-18 Score=166.87 Aligned_cols=180 Identities=24% Similarity=0.325 Sum_probs=117.9
Q ss_pred cccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEc
Q 041438 231 LFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISL 310 (752)
Q Consensus 231 L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 310 (752)
.....++.+.+++.++. ..+++++.|++++|.++.. ..+..+++|++|++++|++++..| ++++++|+.|++
T Consensus 20 ~i~~~l~~~~~~~~~~~----~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l 91 (199)
T d2omxa2 20 KMKTVLGKTNVTDTVSQ----TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILM 91 (199)
T ss_dssp HHHHHTTCSSTTSEECH----HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred HHHHHhCCCCCCCccCH----HHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccc
Confidence 33344445554443221 2345666777777777643 235667777777777777775433 677777777777
Q ss_pred cCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCC
Q 041438 311 SGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEK 390 (752)
Q Consensus 311 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 390 (752)
++|.+.... .+.++++|+.|++++|.+.... .+..+++|+.|++++|++.. + ..+..+++|++|++++|++++.
T Consensus 92 ~~n~~~~~~--~l~~l~~L~~L~l~~~~~~~~~--~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l 165 (199)
T d2omxa2 92 NNNQIADIT--PLANLTNLTGLTLFNNQITDID--PLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL 165 (199)
T ss_dssp CSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC
T ss_pred ccccccccc--cccccccccccccccccccccc--ccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCC
Confidence 777776432 3677777777777777776643 36677777788887777753 2 2467777777788877777664
Q ss_pred CCcccccccccceEEccCCcCCcCCchhhhccCCCcEE
Q 041438 391 ISSRICRMESLEKLNLSYNNLSGLIPRCFEELHGLLHI 428 (752)
Q Consensus 391 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 428 (752)
. .+.++++|++|++++|+++++ + .+..+++|+.|
T Consensus 166 ~--~l~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~L 199 (199)
T d2omxa2 166 K--PLANLTTLERLDISSNKVSDI-S-VLAKLTNLESL 199 (199)
T ss_dssp G--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred c--cccCCCCCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence 3 367777888888888887764 2 46777777664
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=2.9e-18 Score=167.43 Aligned_cols=180 Identities=25% Similarity=0.331 Sum_probs=84.9
Q ss_pred eecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCCCCCCcCCcCccCCCcceEEeeccccc
Q 041438 138 LDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSNFLGGSIPRSLSNFTNLVFLYLYNNSF 217 (752)
Q Consensus 138 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 217 (752)
.++..+.+++.++. ..+.+|++|++++|.++... .+..+++|++|+|++|+|++.. .++++++|++|++++|+|
T Consensus 29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKV 102 (210)
T ss_dssp HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred HHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccc
Confidence 34444444433332 23445555555555554321 2444555555555555555432 234555555555555555
Q ss_pred cccccccccCccccccccccccccCCCcCCCCCCCCCCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCc
Q 041438 218 SGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPT 297 (752)
Q Consensus 218 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 297 (752)
++. | .+.+ +++|+.|++++|.+... ..+..+++++.+++++|.+++. .
T Consensus 103 ~~l-~-~l~~--------------------------l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~~--~ 150 (210)
T d1h6ta2 103 KDL-S-SLKD--------------------------LKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--T 150 (210)
T ss_dssp CCG-G-GGTT--------------------------CTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--G
T ss_pred ccc-c-cccc--------------------------ccccccccccccccccc--cccccccccccccccccccccc--c
Confidence 421 1 1222 23334444444443321 2244445555555555555421 2
Q ss_pred cccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcC
Q 041438 298 QLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLS 359 (752)
Q Consensus 298 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 359 (752)
.+..+++|+.+++++|++++.. .++++++|+.|+|++|+|+.+. .+.++++|++|+|+
T Consensus 151 ~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~l~--~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 151 VLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISDLR--ALAGLKNLDVLELF 208 (210)
T ss_dssp GGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCBCG--GGTTCTTCSEEEEE
T ss_pred cccccccccccccccccccccc--cccCCCCCCEEECCCCCCCCCh--hhcCCCCCCEEEcc
Confidence 3444555555555555555432 2555556666666666655432 35556666666654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=1.4e-20 Score=206.48 Aligned_cols=329 Identities=19% Similarity=0.148 Sum_probs=206.3
Q ss_pred CCCCEEECCCCcccccC-CccCcCCCCCCeeecCCCcccc----cCCcccccccccceeeccCcccCCC----CCcccC-
Q 041438 109 PHLAYLDLYNNELFDII-PPQISNLSKLEYLDFLTNKLSG----HIPSEISLLTHLTILHISRNQLNGS----IPHEVG- 178 (752)
Q Consensus 109 ~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~- 178 (752)
++|++||++.|+|++.. ...+..+++|++|+|++|+|+. .++..+...++|++|||++|.|+.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 36899999999998742 4456778999999999999873 3345677889999999999998631 223333
Q ss_pred CCCCCcEEEccCCCCCCc----CCcCccCCCcceEEeeccccccccccccccC---------------------------
Q 041438 179 QLNFLNHLILDSNFLGGS----IPRSLSNFTNLVFLYLYNNSFSGSIPQQIGN--------------------------- 227 (752)
Q Consensus 179 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~--------------------------- 227 (752)
...+|++|+|++|+++.. ++..+..+++|++|+|++|.++......+..
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 161 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence 235799999999999854 4566788999999999999987432222110
Q ss_pred ------ccccccccccccccCCCcCCCC--C-CCCCCCCcEEEccccccCCCC----CcccCCCCCCCEEecCCCcCcC-
Q 041438 228 ------LKSLFDMKLCINQLNGAIPLSI--D-WGRCPQLSLLDVSINNITGNI----PFEIGESPQLQYLDLSSNYIVG- 293 (752)
Q Consensus 228 ------l~~L~~l~l~~N~l~~~~~~~~--~-~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~- 293 (752)
...++.++++.+......-... . .........+++..+.+.... ...+...+.++.+++++|.+..
T Consensus 162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~ 241 (460)
T d1z7xw1 162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 241 (460)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccccc
Confidence 0111112222111110000000 0 001123344555555443211 1123345677788888887642
Q ss_pred ----CCCccccCCcccCEEEccCCcCcccC----CcccCCCcccceeeccccccccccchhh-----cccccccEEEcCC
Q 041438 294 ----EIPTQLGNIIYLNRISLSGNKLSGRI----PGELGSLINLEYLDLSANHLSNFVLESL-----GSLVKLYYLNLSH 360 (752)
Q Consensus 294 ----~~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~Ls~ 360 (752)
..+........++.+++++|.+.... ...+...+.++.+++++|.++......+ .....|+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~ 321 (460)
T d1z7xw1 242 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 321 (460)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred ccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccc
Confidence 12233445567888888888775332 2234456778888888888875443332 2345788888888
Q ss_pred CcCccccchh----ccccccCCeeecCCccCCCCC----Ccccc-cccccceEEccCCcCCcC----CchhhhccCCCcE
Q 041438 361 NKLSQQIPIE----LDNLIHLSELDLSHNFLGEKI----SSRIC-RMESLEKLNLSYNNLSGL----IPRCFEELHGLLH 427 (752)
Q Consensus 361 N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~~----~~~~~-~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~ 427 (752)
|.++...... +...++|++|+|++|++++.. +..+. ..+.|++|+|++|+|+.. ++..+..+++|++
T Consensus 322 ~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~ 401 (460)
T d1z7xw1 322 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE 401 (460)
T ss_dssp SCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCE
T ss_pred cchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCE
Confidence 8887554333 344567888888888886432 22222 345688888888888753 3455667788888
Q ss_pred EEccCCcccC
Q 041438 428 IDISYNKLEG 437 (752)
Q Consensus 428 L~ls~N~l~~ 437 (752)
|||++|+++.
T Consensus 402 L~Ls~N~i~~ 411 (460)
T d1z7xw1 402 LDLSNNCLGD 411 (460)
T ss_dssp EECCSSSCCH
T ss_pred EECCCCcCCH
Confidence 8888888864
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=3e-18 Score=167.33 Aligned_cols=165 Identities=25% Similarity=0.305 Sum_probs=120.2
Q ss_pred CCCCcEEEccccccCCCCCcccCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceee
Q 041438 254 CPQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLD 333 (752)
Q Consensus 254 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 333 (752)
+.+|+.|++++|.++... .+..+++|++|+|++|+|++.. .++++++|+.|++++|++++. | .+..+++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccccccc-c-cccccccccccc
Confidence 345667777777776433 2566777777777777777543 356777788888888877753 3 477778888888
Q ss_pred ccccccccccchhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCc
Q 041438 334 LSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSG 413 (752)
Q Consensus 334 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 413 (752)
+++|.+... ..+..++.|+.+++++|.+++ +..+..+++|+++++++|++++..+ +.++++|+.|+|++|+++.
T Consensus 119 l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~~ 192 (210)
T d1h6ta2 119 LEHNGISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 192 (210)
T ss_dssp CTTSCCCCC--GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred ccccccccc--ccccccccccccccccccccc--ccccccccccccccccccccccccc--ccCCCCCCEEECCCCCCCC
Confidence 888877653 357778888888888888864 3356778888888888888876433 7788888888888888876
Q ss_pred CCchhhhccCCCcEEEccC
Q 041438 414 LIPRCFEELHGLLHIDISY 432 (752)
Q Consensus 414 ~~p~~~~~l~~L~~L~ls~ 432 (752)
+ | .+..+++|++|+|++
T Consensus 193 l-~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 193 L-R-ALAGLKNLDVLELFS 209 (210)
T ss_dssp C-G-GGTTCTTCSEEEEEE
T ss_pred C-h-hhcCCCCCCEEEccC
Confidence 5 3 588888888888864
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=5e-16 Score=144.23 Aligned_cols=113 Identities=21% Similarity=0.229 Sum_probs=83.3
Q ss_pred ccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCC
Q 041438 104 SFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFL 183 (752)
Q Consensus 104 ~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 183 (752)
.|.+...+++|||++|+|+.+ +..+..+++|++|+|++|+|+.+ + .|..+++|++|+|++|+|+...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l-~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL-D-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE-C-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc-C-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 456667788888888888775 55667788888888888888754 2 47778888888888888876555556777888
Q ss_pred cEEEccCCCCCCcCC-cCccCCCcceEEeeccccccc
Q 041438 184 NHLILDSNFLGGSIP-RSLSNFTNLVFLYLYNNSFSG 219 (752)
Q Consensus 184 ~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~ 219 (752)
++|+|++|+|+.... ..+..+++|++|++++|.++.
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~ 126 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN 126 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred ccceeccccccccccccccccccccchhhcCCCcccc
Confidence 888888888775322 456777888888888887763
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=1.9e-15 Score=140.21 Aligned_cols=110 Identities=21% Similarity=0.115 Sum_probs=57.9
Q ss_pred cCCCCCCCEEecCCCcCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhccccccc
Q 041438 275 IGESPQLQYLDLSSNYIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLY 354 (752)
Q Consensus 275 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 354 (752)
+.+..++++|+|++|+|+. +|..+..+++|+.|+|++|+|+.. +.|..+++|++|++++|+++.+.+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 4455566666666666653 344455556666666666666533 2355555566666666665555554455555555
Q ss_pred EEEcCCCcCccccc-hhccccccCCeeecCCccC
Q 041438 355 YLNLSHNKLSQQIP-IELDNLIHLSELDLSHNFL 387 (752)
Q Consensus 355 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l 387 (752)
.|++++|+|+.... ..+..+++|++|++++|.+
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i 124 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 124 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGG
T ss_pred cceeccccccccccccccccccccchhhcCCCcc
Confidence 55555555543211 2333444444444444443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.56 E-value=3.4e-15 Score=131.71 Aligned_cols=103 Identities=29% Similarity=0.364 Sum_probs=87.8
Q ss_pred CEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCCCcEEEccCC
Q 041438 112 AYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNFLNHLILDSN 191 (752)
Q Consensus 112 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 191 (752)
|+|||++|+|+.+ + .+.++++|++|+|++|+|+ .+|..|+.+++|++|++++|+|++. | .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence 5799999999865 3 4899999999999999998 4577899999999999999999854 4 5899999999999999
Q ss_pred CCCCcC-CcCccCCCcceEEeeccccccc
Q 041438 192 FLGGSI-PRSLSNFTNLVFLYLYNNSFSG 219 (752)
Q Consensus 192 ~l~~~~-p~~~~~l~~L~~L~L~~N~l~~ 219 (752)
+|+... ...+..+++|++|++++|.++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 998654 3568889999999999999874
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.56 E-value=9.4e-17 Score=169.29 Aligned_cols=152 Identities=22% Similarity=0.209 Sum_probs=77.5
Q ss_pred cCCCCCCcEEEccCCCCCCc----CCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCC
Q 041438 177 VGQLNFLNHLILDSNFLGGS----IPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWG 252 (752)
Q Consensus 177 ~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~ 252 (752)
+...++|++|+|++|.++.. +...+...++|++|++++|.+.......++. .+..+..... ..
T Consensus 89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~--~l~~~~~~~~-----------~~ 155 (344)
T d2ca6a1 89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--ALQELAVNKK-----------AK 155 (344)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--HHHHHHHHHH-----------HH
T ss_pred HhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccc--cccccccccc-----------cc
Confidence 44556777777777777653 2233456678888888888775322222211 1111111110 01
Q ss_pred CCCCCcEEEccccccCCC----CCcccCCCCCCCEEecCCCcCcCC-----CCccccCCcccCEEEccCCcCccc----C
Q 041438 253 RCPQLSLLDVSINNITGN----IPFEIGESPQLQYLDLSSNYIVGE-----IPTQLGNIIYLNRISLSGNKLSGR----I 319 (752)
Q Consensus 253 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~ 319 (752)
..+.|+.+++++|.++.. +...+...+.|+.|+|++|.|... +...+...++|+.|+|++|.++.. +
T Consensus 156 ~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L 235 (344)
T d2ca6a1 156 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 235 (344)
T ss_dssp TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHH
T ss_pred cCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccc
Confidence 234666777777776532 122234456677777777766431 222344455555555555555321 1
Q ss_pred CcccCCCcccceeecccccccc
Q 041438 320 PGELGSLINLEYLDLSANHLSN 341 (752)
Q Consensus 320 p~~~~~l~~L~~L~Ls~N~l~~ 341 (752)
...+..+++|++|+|++|.|++
T Consensus 236 ~~~l~~~~~L~~L~Ls~n~i~~ 257 (344)
T d2ca6a1 236 AIALKSWPNLRELGLNDCLLSA 257 (344)
T ss_dssp HHHGGGCTTCCEEECTTCCCCH
T ss_pred cccccccccchhhhhhcCccCc
Confidence 2233444455555555555544
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=2e-16 Score=161.71 Aligned_cols=115 Identities=19% Similarity=0.172 Sum_probs=61.6
Q ss_pred CCCCEEecCCCc--CcCC-CCccccCCcccCEEEccCC-cCcccCCcccCCCcccceeeccc-cccccccchhhcccccc
Q 041438 279 PQLQYLDLSSNY--IVGE-IPTQLGNIIYLNRISLSGN-KLSGRIPGELGSLINLEYLDLSA-NHLSNFVLESLGSLVKL 353 (752)
Q Consensus 279 ~~L~~L~Ls~N~--l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L 353 (752)
++|+.|+++++. ++.. +...+.++++|++|++++| .+++.....+..+++|++|+|++ +.+++.....++++++|
T Consensus 148 ~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L 227 (284)
T d2astb2 148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL 227 (284)
T ss_dssp TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred cccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCC
Confidence 455555555432 2211 1222344556666666654 35555555566666777777776 35665555666777777
Q ss_pred cEEEcCCCcCcc-ccchhccccccCCeeecCCccCCCCCCccccc
Q 041438 354 YYLNLSHNKLSQ-QIPIELDNLIHLSELDLSHNFLGEKISSRICR 397 (752)
Q Consensus 354 ~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 397 (752)
+.|+++++ ++. ..+.....++ .|++..+.++...+..++.
T Consensus 228 ~~L~l~~~-~~d~~l~~l~~~lp---~L~i~~~~ls~~~~~~~~~ 268 (284)
T d2astb2 228 KTLQVFGI-VPDGTLQLLKEALP---HLQINCSHFTTIARPTIGN 268 (284)
T ss_dssp CEEECTTS-SCTTCHHHHHHHST---TSEESCCCSCCTTCSSCSS
T ss_pred CEEeeeCC-CCHHHHHHHHHhCc---cccccCccCCCCCCCccCc
Confidence 77777766 321 2222222333 3445666666665555443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=4.9e-16 Score=158.82 Aligned_cols=212 Identities=19% Similarity=0.200 Sum_probs=125.2
Q ss_pred CCCcEEEccCCCCCCc-CCcCccCCCcceEEeeccccccccccccccCccccccccccccccCCCcCCCCCCCCCCCCcE
Q 041438 181 NFLNHLILDSNFLGGS-IPRSLSNFTNLVFLYLYNNSFSGSIPQQIGNLKSLFDMKLCINQLNGAIPLSIDWGRCPQLSL 259 (752)
Q Consensus 181 ~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~L~~ 259 (752)
.+|++|||+++.++.. ++..+.++++|++|+|++|.+++..+..++.+ ++|+.
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~--------------------------~~L~~ 99 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKN--------------------------SNLVR 99 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTC--------------------------TTCSE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcC--------------------------CCCcC
Confidence 3555555555555432 22334555666666666665554444333333 33444
Q ss_pred EEcccc-ccCCC-CCcccCCCCCCCEEecCCC-cCcCC-CCccccC-CcccCEEEccCC--cCccc-CCcccCCCcccce
Q 041438 260 LDVSIN-NITGN-IPFEIGESPQLQYLDLSSN-YIVGE-IPTQLGN-IIYLNRISLSGN--KLSGR-IPGELGSLINLEY 331 (752)
Q Consensus 260 L~Ls~N-~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~-l~~L~~L~Ls~N--~l~~~-~p~~~~~l~~L~~ 331 (752)
|+++++ .++.. +..-...+++|++|+++++ .++.. +...+.. .++|+.|+++++ .++.. +...+.++++|++
T Consensus 100 L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~ 179 (284)
T d2astb2 100 LNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179 (284)
T ss_dssp EECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSE
T ss_pred ccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccc
Confidence 444442 23311 1111234567777777764 33321 1222322 468999999875 34322 2223456789999
Q ss_pred eecccc-ccccccchhhcccccccEEEcCC-CcCccccchhccccccCCeeecCCccCCCCCCcccccccccceEEccCC
Q 041438 332 LDLSAN-HLSNFVLESLGSLVKLYYLNLSH-NKLSQQIPIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYN 409 (752)
Q Consensus 332 L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 409 (752)
|++++| .+++.....+..+++|++|+|++ +.++......++++++|+.|+++++ ++...-..+. ..+..|.+..+
T Consensus 180 L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~--~~lp~L~i~~~ 256 (284)
T d2astb2 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLK--EALPHLQINCS 256 (284)
T ss_dssp EECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHH--HHSTTSEESCC
T ss_pred cccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHH--HhCccccccCc
Confidence 999986 57877778888999999999999 4687777778888999999999887 3322111111 23444556778
Q ss_pred cCCcCCchhhhc
Q 041438 410 NLSGLIPRCFEE 421 (752)
Q Consensus 410 ~l~~~~p~~~~~ 421 (752)
+++...+..++.
T Consensus 257 ~ls~~~~~~~~~ 268 (284)
T d2astb2 257 HFTTIARPTIGN 268 (284)
T ss_dssp CSCCTTCSSCSS
T ss_pred cCCCCCCCccCc
Confidence 888876666554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.54 E-value=2.2e-16 Score=166.48 Aligned_cols=135 Identities=21% Similarity=0.287 Sum_probs=81.4
Q ss_pred CcccCEEEccCCcCccc----CCcccCCCcccceeeccccccccc-----cchhhcccccccEEEcCCCcCccc----cc
Q 041438 302 IIYLNRISLSGNKLSGR----IPGELGSLINLEYLDLSANHLSNF-----VLESLGSLVKLYYLNLSHNKLSQQ----IP 368 (752)
Q Consensus 302 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~----~p 368 (752)
.+.|+.+++++|+++.. +...+...+.|++|+|++|+++.. ....+...++|+.|+|++|.++.. +.
T Consensus 157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~ 236 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236 (344)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccc
Confidence 34556666666655421 122233455667777777766542 233455667777777777776532 33
Q ss_pred hhccccccCCeeecCCccCCCCCCcccc------cccccceEEccCCcCCcCC----chhhh-ccCCCcEEEccCCccc
Q 041438 369 IELDNLIHLSELDLSHNFLGEKISSRIC------RMESLEKLNLSYNNLSGLI----PRCFE-ELHGLLHIDISYNKLE 436 (752)
Q Consensus 369 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~------~l~~L~~L~L~~N~l~~~~----p~~~~-~l~~L~~L~ls~N~l~ 436 (752)
..+..+++|++|+|++|.|++.....++ ....|++|++++|+|+..- ...+. +.++|++|++++|++.
T Consensus 237 ~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred ccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 4456677777777777777654322222 2356888888888876532 23332 5678888999888885
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.50 E-value=3.2e-14 Score=125.33 Aligned_cols=15 Identities=40% Similarity=0.332 Sum_probs=5.9
Q ss_pred cccccceEEccCCcC
Q 041438 397 RMESLEKLNLSYNNL 411 (752)
Q Consensus 397 ~l~~L~~L~L~~N~l 411 (752)
.+++|+.|++++|++
T Consensus 88 ~~~~L~~L~l~~N~i 102 (124)
T d1dcea3 88 SCPRLVLLNLQGNSL 102 (124)
T ss_dssp GCTTCCEEECTTSGG
T ss_pred CCCCCCEEECCCCcC
Confidence 333333444444433
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.39 E-value=1.9e-15 Score=145.34 Aligned_cols=115 Identities=22% Similarity=0.207 Sum_probs=87.0
Q ss_pred cccCCCCCCCEEECCCCcccccCCccCcCCCCCCeeecCCCcccccCCcccccccccceeeccCcccCCCCCcccCCCCC
Q 041438 103 FSFSSFPHLAYLDLYNNELFDIIPPQISNLSKLEYLDFLTNKLSGHIPSEISLLTHLTILHISRNQLNGSIPHEVGQLNF 182 (752)
Q Consensus 103 ~~f~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 182 (752)
.++..+++|++|+|++|+|+.+ + .|.++++|++|+|++|+|+. +|..+..+++|++|++++|+|+.. ..+..+++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~ 116 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASL--SGIEKLVN 116 (198)
T ss_dssp HHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCCH--HHHHHHHH
T ss_pred hHHhcccccceeECcccCCCCc-c-cccCCccccChhhccccccc-cccccccccccccccccccccccc--cccccccc
Confidence 4577788888888888888865 3 47888888888888888874 455566667888888888888753 34777888
Q ss_pred CcEEEccCCCCCCcCC-cCccCCCcceEEeecccccccccc
Q 041438 183 LNHLILDSNFLGGSIP-RSLSNFTNLVFLYLYNNSFSGSIP 222 (752)
Q Consensus 183 L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p 222 (752)
|++|+|++|+|+.... ..|..+++|++|+|++|.+....+
T Consensus 117 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred ccccccccchhccccccccccCCCccceeecCCCccccCcc
Confidence 8888888888875422 457788888888888888775444
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.37 E-value=1.4e-14 Score=139.18 Aligned_cols=127 Identities=22% Similarity=0.252 Sum_probs=60.4
Q ss_pred cccCCcccCEEEccCCcCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCccccchhccccccC
Q 041438 298 QLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHL 377 (752)
Q Consensus 298 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 377 (752)
.+..+++|++|+|++|+|+.. + .+.++++|++|+|++|.|+.+ +..+..+++|+.|++++|+++.. ..+..+++|
T Consensus 43 sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~i-~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L 117 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKKI-ENLDAVADTLEELWISYNQIASL--SGIEKLVNL 117 (198)
T ss_dssp HHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECSC-SSHHHHHHHCCEEECSEEECCCH--HHHHHHHHS
T ss_pred HHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccccc-ccccccccccccccccccccccc--ccccccccc
Confidence 344444444444444444422 1 244444455555555544432 22233334455555555555432 224445555
Q ss_pred CeeecCCccCCCCCC-cccccccccceEEccCCcCCcCCch----------hhhccCCCcEEE
Q 041438 378 SELDLSHNFLGEKIS-SRICRMESLEKLNLSYNNLSGLIPR----------CFEELHGLLHID 429 (752)
Q Consensus 378 ~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~----------~~~~l~~L~~L~ 429 (752)
+.|+|++|+++.... ..+..+++|+.|+|++|++....+. .+..+++|+.||
T Consensus 118 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 555555555544321 3345555566666666655443322 255677777776
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=9.1e-13 Score=120.97 Aligned_cols=66 Identities=23% Similarity=0.199 Sum_probs=27.8
Q ss_pred ccCCcccCEEEccCC-cCcccCCcccCCCcccceeeccccccccccchhhcccccccEEEcCCCcCc
Q 041438 299 LGNIIYLNRISLSGN-KLSGRIPGELGSLINLEYLDLSANHLSNFVLESLGSLVKLYYLNLSHNKLS 364 (752)
Q Consensus 299 ~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 364 (752)
+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|++|+|+
T Consensus 27 l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 93 (156)
T d2ifga3 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93 (156)
T ss_dssp SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred ccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc
Confidence 333344444444332 233333334444444444444444444444444444444444444444444
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=1.4e-12 Score=119.79 Aligned_cols=108 Identities=19% Similarity=0.134 Sum_probs=89.9
Q ss_pred CCCcEEEccccccCCCCCcccCCCCCCCEEecCCC-cCcCCCCccccCCcccCEEEccCCcCcccCCcccCCCcccceee
Q 041438 255 PQLSLLDVSINNITGNIPFEIGESPQLQYLDLSSN-YIVGEIPTQLGNIIYLNRISLSGNKLSGRIPGELGSLINLEYLD 333 (752)
Q Consensus 255 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 333 (752)
...+.++.+++.+. ..|..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|+.+.+.+|..+++|++|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34556888888776 35667888889999999766 48877778899999999999999999988889999999999999
Q ss_pred ccccccccccchhhcccccccEEEcCCCcCc
Q 041438 334 LSANHLSNFVLESLGSLVKLYYLNLSHNKLS 364 (752)
Q Consensus 334 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 364 (752)
|++|+|+.+++..|..+ +|+.|+|++|.+.
T Consensus 87 Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 87 LSFNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp CCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred ccCCCCcccChhhhccc-cccccccCCCccc
Confidence 99999998888777655 6889999999884
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.57 E-value=6.9e-09 Score=95.15 Aligned_cols=86 Identities=28% Similarity=0.202 Sum_probs=54.3
Q ss_pred chhhcccccccEEEcCCCcCcccc--chhccccccCCeeecCCccCCCCCCcccccccccceEEccCCcCCcCCch----
Q 041438 344 LESLGSLVKLYYLNLSHNKLSQQI--PIELDNLIHLSELDLSHNFLGEKISSRICRMESLEKLNLSYNNLSGLIPR---- 417 (752)
Q Consensus 344 ~~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~---- 417 (752)
...+..++.|++|+|++|+|+... +..+..+++|+.|+|++|.|+...+-.+.....|+.|++++|.++.....
T Consensus 58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y 137 (162)
T d1koha1 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137 (162)
T ss_dssp HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHH
T ss_pred HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhH
Confidence 344456667777777777776542 34466677777777777777665443444445677777777777665432
Q ss_pred ---hhhccCCCcEEE
Q 041438 418 ---CFEELHGLLHID 429 (752)
Q Consensus 418 ---~~~~l~~L~~L~ 429 (752)
.+..+++|+.||
T Consensus 138 ~~~i~~~~P~L~~LD 152 (162)
T d1koha1 138 ISAIRERFPKLLRLD 152 (162)
T ss_dssp HHHHHTTSTTCCEET
T ss_pred HHHHHHHCCCCCEEC
Confidence 255677787775
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.55 E-value=3.3e-09 Score=97.37 Aligned_cols=83 Identities=27% Similarity=0.240 Sum_probs=51.3
Q ss_pred cCCCcccceeecccccccccc--chhhcccccccEEEcCCCcCccccchhccccccCCeeecCCccCCCCCCc-------
Q 041438 323 LGSLINLEYLDLSANHLSNFV--LESLGSLVKLYYLNLSHNKLSQQIPIELDNLIHLSELDLSHNFLGEKISS------- 393 (752)
Q Consensus 323 ~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~------- 393 (752)
+..+++|++|+|++|+|+.+. +..+..+++|+.|+|++|+|+...+..+....+|++|++++|.+......
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~ 140 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA 140 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHH
T ss_pred HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHH
Confidence 344566666666666666543 34456667777777777777655444444455677777777777655432
Q ss_pred ccccccccceEE
Q 041438 394 RICRMESLEKLN 405 (752)
Q Consensus 394 ~~~~l~~L~~L~ 405 (752)
.+..+++|+.||
T Consensus 141 i~~~~P~L~~LD 152 (162)
T d1koha1 141 IRERFPKLLRLD 152 (162)
T ss_dssp HHTTSTTCCEET
T ss_pred HHHHCCCCCEEC
Confidence 244567777775
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.98 E-value=9.8e-06 Score=79.72 Aligned_cols=126 Identities=13% Similarity=0.091 Sum_probs=84.1
Q ss_pred HHHHHhhcccccceeeccCCceEEEEEEeCCCcEEEEEccCCCCCC-------------------------CccccCCce
Q 041438 494 EEIIRATNDFDAKHCIGKGGHGSVYIARVPSGEIFAVKKFHSPLPD-------------------------NFCSHPRQS 548 (752)
Q Consensus 494 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~ 548 (752)
+|+.+....|+..+..+-++.+.||+... +++.+++|+....... .+..+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 45666677888777655555678999865 5667788876543211 223456778
Q ss_pred EEEEEeccCCChHHHhccCccccccCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 041438 549 FIVYEYLESGSLDKILNNDASAKELGWTQRLNVIKGVADALFYLHNNC-------------------------------- 596 (752)
Q Consensus 549 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-------------------------------- 596 (752)
++|||+++|.++.+..... .....++.++++.+..||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 9999999998876544211 122334555666666666421
Q ss_pred ------------------------CCCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 597 ------------------------FPPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 597 ------------------------~~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
.+.++|+|+.|.||++++++..-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999776667999998864
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.83 E-value=8.1e-06 Score=74.42 Aligned_cols=86 Identities=19% Similarity=0.248 Sum_probs=42.2
Q ss_pred ccccccEEEcCCCcCccc----cchhccccccCCeeecCCccCCCCC----CcccccccccceEEccCCcCCcC------
Q 041438 349 SLVKLYYLNLSHNKLSQQ----IPIELDNLIHLSELDLSHNFLGEKI----SSRICRMESLEKLNLSYNNLSGL------ 414 (752)
Q Consensus 349 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~------ 414 (752)
..+.|+.|+|++|.+... +...+...+.|++|+|++|.++... ...+...++|++|+|++|.+...
T Consensus 42 ~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~ 121 (167)
T d1pgva_ 42 NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEM 121 (167)
T ss_dssp TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHH
T ss_pred hCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHH
Confidence 334444555554444321 1122333445555555555544321 12233445666777766654432
Q ss_pred -CchhhhccCCCcEEEccCCc
Q 041438 415 -IPRCFEELHGLLHIDISYNK 434 (752)
Q Consensus 415 -~p~~~~~l~~L~~L~ls~N~ 434 (752)
+...+...++|+.|+++.+.
T Consensus 122 ~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 122 DMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHhCCCccEeeCcCCC
Confidence 23445556777777776654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.65 E-value=1.4e-05 Score=72.70 Aligned_cols=62 Identities=18% Similarity=0.136 Sum_probs=30.7
Q ss_pred ccccccEEEcCCCcCcccc----chhccccccCCeeecCCccCCCC-------CCcccccccccceEEccCCc
Q 041438 349 SLVKLYYLNLSHNKLSQQI----PIELDNLIHLSELDLSHNFLGEK-------ISSRICRMESLEKLNLSYNN 410 (752)
Q Consensus 349 ~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~-------~~~~~~~l~~L~~L~L~~N~ 410 (752)
..+.|+.|+|++|.++... -..+...+.|++|+|++|.+... +...+...++|+.|+++.+.
T Consensus 70 ~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 70 TSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred hcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 3445555555555554321 12334445566666665544322 22333445667777776554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.32 E-value=0.00011 Score=71.48 Aligned_cols=30 Identities=17% Similarity=0.146 Sum_probs=25.8
Q ss_pred CeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 599 PIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 599 ~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
.++|+|+.|.||+++++..+-|+||+.+..
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 479999999999999876678999988754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.13 E-value=0.00012 Score=66.30 Aligned_cols=87 Identities=15% Similarity=0.201 Sum_probs=41.3
Q ss_pred ccccccEEEcCCCcCcccc----chhccccccCCeeecCCccCCCC----CCcccccccccceEEc--cCCcCCc----C
Q 041438 349 SLVKLYYLNLSHNKLSQQI----PIELDNLIHLSELDLSHNFLGEK----ISSRICRMESLEKLNL--SYNNLSG----L 414 (752)
Q Consensus 349 ~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L--~~N~l~~----~ 414 (752)
..+.|++|+|++|.++... -..+...++++.+++++|.++.. +...+...++|+.++| ++|.+.. .
T Consensus 44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~ 123 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME 123 (166)
T ss_dssp TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH
T ss_pred cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHH
Confidence 3444444444444443221 12233344555555555544322 1123344555655433 4455543 2
Q ss_pred CchhhhccCCCcEEEccCCcc
Q 041438 415 IPRCFEELHGLLHIDISYNKL 435 (752)
Q Consensus 415 ~p~~~~~l~~L~~L~ls~N~l 435 (752)
+...+...+.|+.|+++.+..
T Consensus 124 La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 124 IANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHhCCCcCEEeCcCCCC
Confidence 334455677777777766543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.01 E-value=0.00014 Score=65.74 Aligned_cols=88 Identities=20% Similarity=0.203 Sum_probs=44.1
Q ss_pred CCCcccceeecccccccccc----chhhcccccccEEEcCCCcCccc----cchhccccccCCee--ecCCccCCCC---
Q 041438 324 GSLINLEYLDLSANHLSNFV----LESLGSLVKLYYLNLSHNKLSQQ----IPIELDNLIHLSEL--DLSHNFLGEK--- 390 (752)
Q Consensus 324 ~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L--~Ls~N~l~~~--- 390 (752)
...++|++|+|++|.++... ...+...+.++.+++++|.++.. +...+...++|+.+ ++++|.+...
T Consensus 43 ~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~ 122 (166)
T d1io0a_ 43 KTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEM 122 (166)
T ss_dssp TTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH
T ss_pred hcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHH
Confidence 34444555555555554332 12334455666666666665432 12344455666653 3345555432
Q ss_pred -CCcccccccccceEEccCCcC
Q 041438 391 -ISSRICRMESLEKLNLSYNNL 411 (752)
Q Consensus 391 -~~~~~~~l~~L~~L~L~~N~l 411 (752)
+...+...+.|+.|+++.+..
T Consensus 123 ~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 123 EIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHhCCCcCEEeCcCCCC
Confidence 233344566777777766643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.58 E-value=0.002 Score=66.59 Aligned_cols=30 Identities=20% Similarity=0.283 Sum_probs=26.1
Q ss_pred CeeecCCCCCCEEeCCCCceEEeecccceec
Q 041438 599 PIVHWDISSKNVLLDLGYEAHVSDFRIAKFL 629 (752)
Q Consensus 599 ~ivH~DlKp~NIll~~~~~~kl~DfG~a~~~ 629 (752)
.++|+|+.|.|||++++ .++|+||..|...
T Consensus 224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~~G 253 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH-ETKVIDPEFAFYG 253 (392)
T ss_dssp EEECSCCCGGGEEECSS-CEEECCCTTCEEE
T ss_pred ceeccCCcCCceeEcCC-ceEEechhhcccC
Confidence 58999999999999876 5899999888753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.15 E-value=0.01 Score=58.91 Aligned_cols=30 Identities=23% Similarity=0.190 Sum_probs=27.0
Q ss_pred CeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 599 PIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 599 ~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
|+||+|+.++||+++.+...-|+||+.+..
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccCCcchhhhhcccccceeEeccccccc
Confidence 799999999999999887778999998864
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.07 E-value=0.0085 Score=59.94 Aligned_cols=29 Identities=24% Similarity=0.185 Sum_probs=24.2
Q ss_pred CCeeecCCCCCCEEeCCCCceEEeeccccee
Q 041438 598 PPIVHWDISSKNVLLDLGYEAHVSDFRIAKF 628 (752)
Q Consensus 598 ~~ivH~DlKp~NIll~~~~~~kl~DfG~a~~ 628 (752)
.++||+|+.|.|||++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 378999999999999743 46899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=90.53 E-value=0.27 Score=49.82 Aligned_cols=29 Identities=10% Similarity=0.236 Sum_probs=20.9
Q ss_pred ceeeccCCceEEEEEEeCC--------CcEEEEEccC
Q 041438 506 KHCIGKGGHGSVYIARVPS--------GEIFAVKKFH 534 (752)
Q Consensus 506 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~ 534 (752)
++.|+.|-.-.+|++..++ .+.|.+++.-
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g 83 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF 83 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC
Confidence 4678888888999998643 3457777654
|